ID	NAME	CLASS	GENES	DISEASES	DRUGS	DESCRIPTION
GO:0015056	F:corticotrophin-releasing factor receptor ac...; TAS:ProtInc		0:CRHR2|0:CRHR1			
GO:0043017	P:positive regulation of lymphotoxin A biosyn...; NAS:UniProtKB		0:CD86			
GO:0051712	P:positive regulation of killing of cells of ...; IMP:BHF-UCL		0:IFNG|0:FCER2|0:NOS2			
GO:0032513	P:negative regulation of protein phosphatase ...; IDA:BHF-UCL		0:FKBP1B|0:FKBP1A			
GO:0004114	F:3',5'-cyclic-nucleotide phosphodiesterase a...; NAS:UniProtKB		0:PDE6G|0:PDE6H|0:PDE6D|0:PDE8B			
GO:0045334	C:clathrin-coated endocytic vesicle; IDA:UniProtKB		0:CTLA4|0:RAB35			
GO:0000381	P:regulation of alternative nuclear mRNA spli...; IDA:UniProtKB		0:SRSF12|0:CELF4|0:CELF3|0:RBM15B|0:RBM25|0:CELF6|0:RBM5			
GO:0004771	F:sterol esterase activity; NAS:UniProtKB		0:LIPA|0:CEL			
GO:0051594	P:detection of glucose; IMP:UniProtKB		0:GCK			
GO:0005747	C:mitochondrial respiratory chain complex I; NAS:UniProtKB		0:NDUFS4|0:NDUFB3|0:NDUFA12|0:NDUFV3|0:MT-ND3|0:NDUFA3|0:NDUFA7|0:MT-ND4|0:NDUFB6|0:NDUFS6|0:NDUFA13|0:NDUFV2|0:NDUFB7|0:NDUFS3|0:NDUFB4|0:NDUFA2|0:MT-ND5|0:NDUFB11|0:NDUFA6|0:NDUFB8|0:NDUFA5|0:NDUFS2|0:NDUFB5|0:MT-ND1|0:NDUFA9|0:NDUFS1|0:MT-ND2|0:NDUFV1|0:NDUFA1|0:NDUFB1|0:NDUFS8|0:NDUFC2|0:NDUFS5|0:NDUFA10|0:NDUFB2|0:NDUFA4|0:NDUFB10|0:NDUFB9|0:NDUFAB1|0:NDUFA8|0:NDUFA11|0:NDUFS7|0:NDUFAF1|0:MT-ND4L|0:MT-ND6|0:NDUFC1			
GO:0032088	P:negative regulation of NF-kappaB transcript...; ISS:BHF-UCL		0:TLR9|0:NLRP3|0:PYDC1|0:SIVA1|0:NFKBIA|0:PSMD10|0:COMMD7|0:ARRB1|0:TRIM21|0:NLRC5|0:CYLD|0:DNAJA3|0:FOXP3|0:ARRB2|0:RBCK1|0:IRAK1|0:IRAK2|0:IRAK3|0:DAP|0:RPS3|0:FOXJ1			
GO:0008750	F:NAD(P)+ transhydrogenase (AB-specific) acti...; IEA:EC		0:NNT			
GO:0019430	P:removal of superoxide radicals; ISS:UniProtKB		0:APOA4|0:MT3|0:SOD2|0:SOD1|0:ATP7A			
GO:0007492	P:endoderm development; TAS:ProtInc		0:HOXC11|0:LAMC1			
GO:0032839	C:dendrite cytoplasm; ISS:UniProtKB		0:SOD1|0:UHMK1|0:GRIK3			
GO:0008092	F:cytoskeletal protein binding; TAS:ProtInc		0:ALDOC|0:ALDOB|0:DLG5|0:MYLIP|0:SDC2|0:FARP2|0:SDC3|0:EPB41L4A|0:FARP1|0:EPB41L4B|0:SDC1|0:EPB41L5|0:ANXA2P2|0:FRMD3|0:PTPN3|0:ANXA2|0:NF2|0:PTPN4|0:FRMD5|0:PKD2L1|0:CAPN10|0:PACSIN3|0:NCKIPSD|0:DLG1|0:ABI1|0:RPH3AL|0:PKD2			
GO:0007447	P:imaginal disc pattern formation; TAS:ProtInc		0:DVL2			
GO:0030346	F:protein phosphatase 2B binding; NAS:UniProtKB		0:SOD1|0:RCAN2|0:MYOZ2			
GO:0043190	C:ATP-binding cassette (ABC) transporter complex; TAS:ProtInc		0:ABCA2|0:ABCB6|0:ABCD4|0:ABCB8|0:ABCD2|0:ABCF2|0:ABCA7			
GO:0008094	F:DNA-dependent ATPase activity; TAS:ProtInc		0:CHD8|0:CDK7|0:TOP2A|0:ERCC6|0:RAD51L1|0:XRCC3|0:MYO18A|0:DMC1|0:XRCC2|0:RAD51L3|0:RAD51C|0:SMARCA4|0:SMARCAL1|0:SMARCA2|0:TTF2			
GO:0043033	C:isoamylase complex; TAS:ProtInc		0:AGL			
GO:0016598	P:protein arginylation; NAS:UniProtKB		0:ATE1			
GO:0050709	P:negative regulation of protein secretion; IDA:UniProtKB		0:DRD3|0:DRD4|0:INS|0:DRD2|0:SERGEF|0:DPH3			
GO:0006904	P:vesicle docking involved in exocytosis; TAS:ProtInc		0:RAB8A|0:YKT6|0:SYTL2|0:EXOC4|0:STXBP3|0:SCFD2|0:EXOC6|0:VPS33B|0:VPS33A|0:SCFD1|0:STXBP1|0:STXBP2|0:VPS45|0:EXOC6B|0:PLEK|0:VAMP3|0:VTI1B|0:CPLX2|0:RABEPK			
GO:0006537	P:glutamate biosynthetic process; IEA:InterPro		0:GLUD1|0:GLUD2|0:PRODH|0:PRODH2			
GO:0002084	P:protein depalmitoylation; IDA:UniProtKB		0:PPT1			
GO:0030168	P:platelet activation; TAS:UniProtKB		0:F2R|0:F2|0:PF4|0:VWF|0:CD40LG|0:FGA|0:FGB|0:FGG|0:TREML1|0:BLOC1S3|0:CD40|0:GP6|0:ADAMTS13|0:GP1BB|0:CD9|0:SAA1|0:COL3A1|0:PLSCR1|0:SAA2|0:IL11|0:IL6|0:GP1BA			
GO:0043508	P:negative regulation of JUN kinase activity; ISS:UniProtKB		0:PDCD4|0:HIPK3			
GO:0032287	P:myelin maintenance in the peripheral nervou...; ISS:UniProtKB		0:SOD1			
GO:0009052	P:pentose-phosphate shunt, non-oxidative branch; NAS:UniProtKB		0:RPIA			
GO:0070126	P:mitochondrial translational termination; IDA:UniProtKB		0:ICT1			
GO:0010642	P:negative regulation of platelet-derived gro...; IDA:UniProtKB		0:SNCA			
GO:0032863	P:activation of Rac GTPase activity; ISS:HGNC		0:DOCK7|0:SCRIB|0:RASGRF1			
GO:0046539	F:histamine N-methyltransferase activity; IEA:EC		0:HNMT			
GO:0006272	P:leading strand elongation; IDA:UniProtKB		0:POLA1			
GO:0031362	C:anchored to external side of plasma membrane; TAS:UniProtKB		0:GPIHBP1|0:CD59|0:PKHD1			
GO:0019439	P:aromatic compound catabolic process; IEA:UniProtKB-KW		0:PON3|0:PON1|0:PON2|0:EPHX2|0:EPHX1			
GO:0051092	P:positive regulation of NF-kappaB transcript...; TAS:UniProtKB		0:TNFRSF11A|0:TLR9|0:INS|0:TNFSF11|0:IL1B|0:IRAK1|0:EDA2R|0:PYCARD|0:EDA|0:IKBKB|0:TLR4|0:RELA|0:TLR2|0:TRAF6|0:NOD1|0:TNF|0:AGER|0:RHEBL1|0:IKBKG|0:BCL10|0:ARHGEF2|0:RNF31|0:NLRC3|0:PRDX3|0:RBCK1|0:TRAF1|0:MAP3K13|0:WNT5A|0:MTDH|0:NOD2|0:RNF25|0:RIPK1|0:TRAF5|0:IRAK2|0:TRAF2|0:IRAK3|0:UBE2V1|0:CARD11|0:SPHK1|0:CAMK2A|0:UBE2N|0:NPM1|0:PLA2G1B|0:TERF2IP|0:AGT|0:ERC1			
GO:0032713	P:negative regulation of interleukin-4 produc...; IDA:UniProtKB		0:FOXP3			
GO:0019185	C:snRNA-activating protein complex; IDA:UniProtKB		0:SNAPC4			
GO:0030104	P:water homeostasis; NAS:UniProtKB		0:NEDD4L|0:AQP9			
GO:0008627	P:induction of apoptosis by ionic changes; IDA:BHF-UCL		0:RYR2			
GO:0004558	F:alpha-glucosidase activity; NAS:UniProtKB		0:GAA|0:MGAM|0:GANC			
GO:0048203	P:vesicle targeting, trans-Golgi to endosome; IDA:UniProtKB		0:WIPI1			
GO:0045171	C:intercellular bridge; IDA:UniProtKB		0:RAB35			
GO:0048263	P:determination of dorsal identity; ISS:BHF-UCL		0:WNT8B			
GO:0050910	P:detection of mechanical stimulus involved i...; ISS:BHF-UCL		0:COL11A1|0:MKKS			
GO:0048844	P:artery morphogenesis; ISS:HGNC		0:SMAD7|0:ANGPTL3|0:ENG|0:TGFBR1|0:NF1			
GO:0031780	F:adrenocorticotropin hormone receptor binding; IPI:BHF-UCL		0:MRAP|0:MRAP2			
GO:0007143	P:female meiosis; ISS:UniProtKB		0:EREG			
GO:2000007	P:negative regulation of metanephric comma-sh...; IDA:UniProtKB		0:BMP4			
GO:0016810	F:hydrolase activity, acting on carbon-nitrog...; IEA:InterPro		0:DPYSL5|0:NADSYN1|0:DPYSL4			
GO:0002248	P:connective tissue replacement involved in i...; TAS:BHF-UCL		0:F2R|0:HIF1A|0:TGFB1			
GO:0005030	F:neurotrophin receptor activity; IEA:InterPro		0:NTRK2|0:NTRK1			
GO:0030316	P:osteoclast differentiation; NAS:UniProtKB		0:CSF1|0:TNFRSF11A|0:GAB2|0:TM7SF4|0:TNFSF11			
GO:0006111	P:regulation of gluconeogenesis; ISS:UniProtKB		0:ACN9			
GO:0004657	F:proline dehydrogenase activity; IEA:EC		0:PRODH|0:PRODH2			
GO:0010897	P:negative regulation of triglyceride catabol...; IDA:BHF-UCL		0:APOC3			
GO:0060242	P:contact inhibition; IDA:UniProtKB		0:YAP1			
GO:0022803	F:passive transmembrane transporter activity; EXP:Reactome		0:SLC5A8			
GO:0042289	F:MHC class II protein binding; NAS:UniProtKB		0:LAG3|0:CD4|0:CD74			
GO:0034191	F:apolipoprotein A-I receptor binding; IPI:BHF-UCL		0:APOA1			
GO:0004856	F:xylulokinase activity; TAS:ProtInc		0:XYLB			
GO:0008419	F:RNA lariat debranching enzyme activity; IMP:UniProtKB		0:DBR1			
GO:0008234	F:cysteine-type peptidase activity; NAS:UniProtKB		0:ATG4A|0:ATG4B|0:CTSL3|0:USP42|0:USP38|0:SENP5|0:USP31|0:USP19|0:SENP8|0:ATXN3L|0:UCHL3|0:USP17L3|0:USP34|0:USP41|0:USP30|0:SENP6|0:ATXN3|0:USP45|0:USP37|0:OTUD5|0:USP49|0:USP24|0:PGPEP1|0:OTUD7A|0:USP17L1P|0:USP17|0:USP17L5|0:USP40|0:USP36|0:USP27X|0:USP48|0:USP32|0:USP43|0:USP51|0:PGPEP1L|0:USP29|0:OTUD7B|0:USP47|0:USP35|0:ZRANB1|0:USP26|0:ESPL1|0:SENP7			
GO:0030091	P:protein repair; TAS:UniProtKB		0:MSRB3|0:MSRB2|0:SEPX1|0:PCMT1			
GO:0070286	P:axonemal dynein complex assembly; IMP:UniProtKB		0:C14orf104|0:LRRC50			
GO:0050840	F:extracellular matrix binding; NAS:UniProtKB		0:VEGFA|0:COL11A1			
GO:0010587	P:miRNA catabolic process; IMP:UniProtKB		0:LIN28B|0:ZCCHC11|0:LIN28A			
GO:0004931	F:extracellular ATP-gated cation channel acti...; TAS:ProtInc		0:P2RX7|0:P2RX4|0:P2RX2|0:P2RX6|0:P2RX3|0:P2RX5|0:P2RX1			
GO:0004988	F:mu-opioid receptor activity; TAS:ProtInc		0:OPRM1			
GO:0060017	P:parathyroid gland development; ISS:BHF-UCL		0:GCM2|0:TBX1|0:TGFBR1			
GO:0046483	P:heterocycle metabolic process; IDA:BHF-UCL		0:CYP2C19|0:CYP2E1|0:CYP3A4			
GO:0015183	F:L-aspartate transmembrane transporter activity; TAS:ProtInc		0:SLC25A12|0:SLC25A13|0:SLC1A6			
GO:0006139	P:nucleobase, nucleoside, nucleotide and nucl...; TAS:ProtInc		0:EXD2|0:EXD1|0:KIAA2022|0:SRBD1|0:METTL4|0:AKD1|0:NDUFA10|0:EXD3|0:SPEF2|0:SLC23A1|0:DPYSL2|0:OAS1|0:FPGS|0:DPYSL3|0:SLC29A1|0:OAS3|0:SLC29A2|0:BPNT1|0:CRMP1|0:SLC28A2|0:GDA|0:SLC28A1|0:NUDT2|0:SLC23A2			
GO:0050716	P:positive regulation of interleukin-1 secretion; NAS:UniProtKB		0:SAA1|0:SAA2			
GO:0004889	F:nicotinic acetylcholine-activated cation-se...; TAS:UniProtKB		0:CHRNA2|0:CHRNA3|0:CHRNB2|0:CHRNA7|0:CHRNA4|0:CHRNA1|0:CHRNA5|0:CHRNB3|0:CHRND|0:CHRNA6|0:CHRNE|0:CHRNB4			
GO:0030380	F:interleukin-17E receptor binding; TAS:UniProtKB		0:IL25			
GO:0061037	P:negative regulation of cartilage development; NAS:UniProtKB		0:WNT11			
GO:0060203	C:clathrin sculpted glutamate transport vesic...; EXP:Reactome		0:VAMP2			
GO:0016534	F:cyclin-dependent protein kinase 5 activator...; IEA:InterPro		0:CDK5R2			
GO:0030902	P:hindbrain development; ISS:UniProtKB		0:CEP290|0:SHH			
GO:0030369	F:ICAM-3 receptor activity; NAS:UniProtKB		0:CLEC4M			
GO:0060088	P:auditory receptor cell stereocilium organiz...; ISS:UniProtKB		0:SOD1			
GO:0042610	F:CD8 receptor binding; IPI:UniProtKB		0:LCK			
GO:0004320	F:oleoyl-[acyl-carrier-protein] hydrolase act...; IEA:EC		0:FASN|0:OLAH			
GO:0004305	F:ethanolamine kinase activity; IEA:EC		0:CHKB|0:CHKA|0:ETNK1|0:ETNK2			
GO:0004905	F:type I interferon receptor activity; TAS:ProtInc		0:IFNAR2|0:IFNAR1			
GO:0042310	P:vasoconstriction; TAS:HGNC		0:AVP|0:HTR2B|0:KEL			
GO:0010872	P:regulation of cholesterol esterification; ISS:BHF-UCL		0:ABCG1			
GO:0007076	P:mitotic chromosome condensation; NAS:UniProtKB		0:NUSAP1|0:NCAPG|0:NCAPD3|0:NCAPH|0:CHMP1A|0:SMC2|0:NCAPD2|0:SMC4|0:TTN|0:CDCA5|0:PAPD7			
GO:0008283	P:cell proliferation; TAS:UniProtKB		0:NRG1|0:ENPEP|0:CKLF|0:SCRIB|0:APPL1|0:CITED2|0:APPL2|0:RASGRP4|0:COL4A3|0:GLI2|0:POLA1|0:CD74|0:PROK2|0:PIM1|0:GLUL|0:DLX5|0:YAP1|0:MIF|0:PDXK|0:SRA1|0:UHRF2|0:MDM4|0:FURIN|0:TCF7L2|0:NANOG|0:PES1|0:UBE2L3|0:USP28|0:MAP3K11|0:HLCS|0:GOLPH3|0:DCTN2|0:WDR12|0:AMBN|0:AMELX|0:SRRT|0:LIG4|0:NASP|0:TMX1|0:PLCE1|0:IFI16|0:BHLHE41|0:SPHK2|0:RETNLB|0:CD5|0:CDV3|0:AR|0:BOP1|0:CSGALNACT1|0:C2orf29|0:RPS27|0:IGSF8|0:CD276|0:WT1AS|0:EDNRA|0:GFER|0:CSF1|0:FRAT2|0:RUNX3|0:ILK|0:CENPF|0:NOX5|0:DLGAP5|0:CUZD1|0:TXLNA|0:LAMA5|0:CITED1|0:TSPO|0:ZEB1|0:SERPINF1|0:CD160|0:TRAIP|0:MAS1|0:PRMT5|0:EGFR|0:TACSTD2|0:TAL1|0:RBBP7|0:IRF2|0:MTCP1|0:CHRM3|0:NDP|0:CYR61|0:ERBB4|0:PRL|0:TUSC2|0:CSE1L|0:ISG20|0:CXCL1|0:PEMT|0:KITLG|0:HDGF|0:TNFSF9|0:EMP2|0:IL1A|0:FSCN1|0:MAPRE2|0:E2F1|0:PRDM4|0:CKS1B|0:NR6A1|0:DAB2|0:TNFSF13B|0:BCAT1|0:CHRM4|0:PSPHL|0:OSM|0:TCF19|0:IL15RA|0:AREG|0:MYC|0:KRT16|0:MNAT1|0:DUSP22|0:LY86|0:PRDX1|0:REG1B|0:BCAR1|0:TRIM27|0:ZNF259|0:CLK1|0:CDK9|0:BST2|0:TFDP1|0:SYK|0:CDK5R1|0:KHDRBS1|0:MPL|0:CDC14A|0:C6orf108|0:SIPA1|0:FGF6|0:ADRA1D|0:CDC27|0:GPC4|0:CDK11B|0:REG3A|0:PIM2|0:INSIG1|0:GFI1B|0:EMP1|0:PDS5B|0:CREG1|0:TGFA|0:KIF15|0:CDK5|0:TXN|0:KLF10|0:GAB1|0:ERG|0:PYY|0:CHRM1|0:E4F1|0:PDAP1|0:CKS2|0:LRP1|0:ERBB2|0:NUDC|0:GRPR|0:CRIP1|0:BLZF1|0:CBFA2T3|0:UBR5|0:ELN|0:DKC1|0:IL9R|0:CDC16|0:SLC29A2|0:ELF5|0:SPOCK1|0:CHRM5|0:EPS8|0:MS4A2|0:MT3|0:IL5RA|0:EPS15|0:S100B|0:MIA|0:DTYMK|0:FGF5|0:CD70|0:GAS6|0:EVI5|0:CTF1|0:FES|0:CCKBR|0:IL2RA|0:PRG4|0:PRKD1|0:RAPGEF3|0:ARHGEF1|0:ZMYND11|0:IGFBP4|0:TGFBI|0:CD274|0:TSPY1|0:MET|0:NAB2|0:THPO|0:TNFRSF17|0:NPY|0:TNFSF8|0:CDK7|0:LMO1|0:USP8|0:OSMR|0:SKP2|0:AREGB|0:ZFP36L2|0:CUL5|0:STIL|0:LGI1|0:ERF|0:UBE2V2|0:VTI1B|0:UHRF1|0:CSF1R|0:TPX2|0:LAMP3|0:MAPRE1|0:FTH1|0:BIN1|0:MXD1|0:EPHB4|0:CDK3|0:MATK|0:PLK1|0:RAF1|0:ADRA1B|0:PCNA|0:KIF2C|0:INSL4|0:CD81|0:BUB1B|0:PA2G4|0:GCG|0:LRPAP1|0:ACHE|0:MKI67|0:CDC25C|0:PDZK1|0:NRD1|0:CDC25A|0:EHF|0:PTEN			
GO:0045650	P:negative regulation of macrophage different...; TAS:UniProtKB		0:C1QC|0:ADIPOQ|0:INHA|0:INHBA			
GO:0032632	P:interleukin-3 production; ISS:BHF-UCL		0:SLC11A1			
GO:0060665	P:regulation of branching involved in salivar...; IDA:MGI		0:HGF			
GO:0006562	P:proline catabolic process; TAS:ProtInc		0:PRODH|0:PRODH2|0:ALDH4A1			
GO:0048102	P:autophagic cell death; IMP:BHF-UCL		0:CDKN1B|0:CDKN2D			
GO:0007175	P:negative regulation of epidermal growth fac...; NAS:UniProtKB		0:CBLC|0:ZGPAT|0:ERRFI1|0:ZFYVE28|0:SNX6			
GO:0051492	P:regulation of stress fiber assembly; ISS:UniProtKB		0:TSC1|0:SYNPO			
GO:0060261	P:positive regulation of transcription initia...; ISS:BHF-UCL		0:SRF|0:TAF1|0:NKX2-5			
GO:0019217	P:regulation of fatty acid metabolic process; ISS:BHF-UCL		0:CAV1			
GO:0009143	P:nucleoside triphosphate catabolic process; ISS:UniProtKB		0:ENPP3|0:ENPP1|0:DCTPP1			
GO:0034499	P:late endosome to Golgi transport; IMP:UniProtKB		0:GCC2			
GO:0060586	P:multicellular organismal iron ion homeostasis; ISS:BHF-UCL		0:SLC11A2|0:SLC11A1			
GO:0051491	P:positive regulation of filopodium assembly; ISS:BHF-UCL		0:RHOQ|0:RALA|0:ARAP1|0:TGFB3			
GO:0043535	P:regulation of blood vessel endothelial cell...; ISS:UniProtKB		0:NF1|0:EPHA2			
GO:0010757	P:negative regulation of plasminogen activation; IMP:BHF-UCL		0:THBS1|0:SERPINE1|0:SERPINE2			
GO:0030336	P:negative regulation of cell migration; TAS:UniProtKB		0:CHRD|0:MIA3|0:GTPBP4|0:CLIC4|0:PODN|0:TBX5|0:DLC1|0:SFRP1|0:RNF20|0:NKX2-1|0:PTPRU|0:PTPRK|0:CITED2|0:NF1|0:DAG1|0:WNT11|0:SCAI|0:PTEN|0:DRD2|0:TPM1|0:SFRP2|0:THY1|0:ARAP3|0:SHH|0:SMAD7|0:NF2|0:VCL|0:ALOX15B			
GO:0045082	P:positive regulation of interleukin-10 biosy...; IDA:UniProtKB		0:IRF4			
GO:0034211	F:GTP-dependent protein kinase activity; IMP:UniProtKB		0:LRRK2			
GO:0001947	P:heart looping; ISS:UniProtKB		0:HAND1|0:GATA4|0:BBS7|0:BBS4|0:SOX17|0:HAND2|0:SRF|0:BBS5|0:ENG|0:MKKS|0:NKX2-5|0:SOX18|0:SETDB2|0:VANGL2			
GO:0070213	P:protein amino acid auto-ADP-ribosylation; IDA:BHF-UCL		0:TNKS			
GO:0008284	P:positive regulation of cell proliferation; TAS:UniProtKB		0:IGF2|0:HRAS|0:LIF|0:GHRHR|0:GHRH|0:OSM|0:INS|0:EDN2|0:FTMT|0:PDGFRB|0:EPO|0:C7orf68|0:INSR|0:LIFR|0:FGF5|0:POU3F2|0:CDCA7L|0:CXCR2|0:RPS15A|0:DERL2|0:CD47|0:IL31RA|0:GAB2|0:SFRP2|0:SPDYA|0:TBX3|0:UBE2A|0:IL34|0:RAB25|0:DPP4|0:SIRPG|0:PRDX3|0:WWTR1|0:PRAME|0:SFRP1|0:CCKBR|0:PDCD10|0:ACER2|0:TGFB2|0:IL11|0:BLOC1S2|0:FGF8|0:ROMO1|0:CLEC11A|0:TBX2|0:CD81|0:FGFR1OP|0:OSMR|0:CALR|0:FGF4|0:FGF19|0:FGFR2|0:FGF3|0:FGF6|0:FGFR3|0:FGFR4|0:FLT4|0:EIF5A|0:EIF5A2|0:HDAC1|0:HDAC2|0:SOX4|0:FXN|0:FOXM1|0:HDAC4|0:MLXIPL|0:ADAM17|0:ADAM10|0:CDC7|0:PDF|0:TIPIN|0:TGFBR1|0:ACER3|0:ALOX12|0:HTR4|0:NACC1|0:RARA|0:MVD|0:ASH2L|0:MLL2|0:CHRNA7|0:RPS9|0:RPS4X|0:NKX2-6|0:NKX2-5|0:IL3|0:PHIP|0:NACC2|0:POU3F3|0:LYN|0:HCLS1|0:KRT6A|0:SHC1|0:MDM2|0:CDC25B|0:CIAO1|0:CAPNS1|0:MST1R|0:SLAMF1|0:CD86|0:BNC1|0:TNFSF4|0:PRTN3|0:TCIRG1|0:TTK|0:CUL3|0:HOXC10|0:PTK2B|0:PTHLH|0:IL12RB2|0:TNFRSF11A|0:S1PR2|0:FIGF|0:TBC1D8|0:ADRA1D|0:TIMP1|0:NAP1L1|0:NOP2|0:FGF18|0:CXCL5|0:VIPR1|0:CAPN1|0:CHRM1|0:HTR1A|0:VIP|0:RHOG|0:STAMBP|0:IL9|0:GLP2R|0:IL12RB1|0:DNAJA2|0:CDC123|0:DDX11|0:CCL14|0:LRP5|0:TSPAN31|0:TNFSF13|0:SSR1|0:TSHR|0:S1PR3|0:NRP1|0:CTF1|0:CSF3|0:MCTS1|0:FLT3|0:EGR4|0:CDK13|0:CDK2|0:CXCL10|0:PTN|0:DHPS|0:IGF1R|0:FOSL1|0:ADRA2A|0:SERTAD1|0:NAMPT|0:REG1A|0:MATK|0:FLT3LG|0:TBRG4			
GO:0004331	F:fructose-2,6-bisphosphate 2-phosphatase act...; TAS:ProtInc		0:PFKFB1|0:PFKFB2|0:PFKFB4|0:C12orf5|0:PFKFB3|0:FBP2|0:FBP1			
GO:0045747	P:positive regulation of Notch signaling pathway; IDA:UniProtKB		0:WNT1|0:TP63			
GO:0034314	P:Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB		0:WASH3P|0:WASH4P|0:WASH2P|0:WASH1|0:JMY|0:WASH6P			
GO:0016560	P:protein import into peroxisome matrix, docking; IMP:UniProtKB		0:PEX13			
GO:0004844	F:uracil DNA N-glycosylase activity; TAS:ProtInc		0:CCNO|0:UNG|0:APEX1			
GO:0034038	F:deoxyhypusine synthase activity; EXP:Reactome		0:DHPS			
GO:0030301	P:cholesterol transport; NAS:UniProtKB		0:CD36|0:MSR1|0:OSBPL5			
GO:0090005	P:negative regulation of establishment of pro...; IMP:BHF-UCL		0:RHOQ			
GO:0045098	C:type III intermediate filament; IDA:UniProtKB		0:UPP2			
GO:0004818	F:glutamate-tRNA ligase activity; IEA:EC		0:EPRS|0:EARS2			
GO:0035325	F:Toll-like receptor binding; IPI:UniProtKB		0:TOLLIP			
GO:0006776	P:vitamin A metabolic process; TAS:ProtInc		0:RBP1|0:RLBP1|0:RBP2			
GO:0006265	P:DNA topological change; ISS:UniProtKB		0:TOP3B|0:TOP3A|0:TOP2B|0:TOP1MT|0:TOP2A|0:ERCC3|0:HMGB2|0:HMGB1			
GO:0034365	C:discoidal high-density lipoprotein particle; IDA:BHF-UCL		0:APOM			
GO:0006122	P:mitochondrial electron transport, ubiquinol...; NAS:UniProtKB		0:UQCR11|0:UQCRH|0:UQCRB|0:MT-CYB|0:UQCR10			
GO:0007260	P:tyrosine phosphorylation of STAT protein; TAS:ProtInc		0:F2R|0:STAT1|0:F2			
GO:0006612	P:protein targeting to membrane; TAS:ProtInc		0:RTP3|0:RTP4|0:NCF1|0:PARD3|0:ATG3|0:ATG4C|0:SDCBP|0:PRKCI|0:TAOK2|0:ICMT|0:SEC63			
GO:0000184	P:nuclear-transcribed mRNA catabolic process,...; TAS:UniProtKB		0:WIBG|0:NCBP2|0:UPF1|0:SMG1|0:NCBP1|0:PNRC2|0:DCPS|0:MAGOH|0:DCP1B|0:PARN|0:EIF4A3|0:EXOSC10|0:PAN2|0:DCP2|0:RBM8A|0:DCP1A|0:RNPS1|0:PAN3|0:CASC3|0:C19orf61|0:UPF2|0:C17orf71|0:UPF3B|0:EIF3E|0:KIAA0427|0:UPF3A|0:SMG7|0:SMG5|0:SMG6|0:GSPT1			
GO:0006569	P:tryptophan catabolic process; IEA:UniProtKB-KW		0:AFMID			
GO:0050897	F:cobalt ion binding; NAS:UniProtKB		0:PML|0:BIRC5			
GO:0050733	F:RS domain binding; NAS:UniProtKB		0:SRSF12|0:SRSF10			
GO:0045944	P:positive regulation of transcription from R...; TAS:UniProtKB		0:NEUROD1|0:MED21|0:IL17A|0:GSX1|0:MED14|0:OSM|0:MED13|0:MED6|0:EPC1|0:RORA|0:PLAGL1|0:MED17|0:MED12|0:PRPF6|0:THRAP3|0:IL6|0:IL11|0:SALL1|0:FOXO1|0:MAML3|0:NCOA3|0:GLI1|0:SOX2|0:RARA|0:SS18|0:CCNH|0:NCOA6|0:MKL2|0:HMGB1|0:MNAT1|0:MAML2|0:SUPT5H|0:RUNX1|0:TBL1X|0:JUN|0:UTF1|0:ZIC3|0:RBM14|0:GLI2|0:FOXD3|0:FSTL3|0:ASCL1|0:HOXA5|0:ELF1|0:TBL1XR1|0:ZMIZ2|0:ELK1|0:SIX1|0:SREBF1|0:PPARGC1B|0:ERCC3|0:INHBA|0:SOX8|0:SUPT4H1|0:ELF4|0:STRN3|0:CDK7|0:FOXH1|0:CRTC1|0:AATF|0:MED1|0:RELA|0:MLLT10|0:FOXO3|0:NR2C2|0:BMP6|0:GTF2H1|0:MAML1|0:TFAP4|0:TAF7|0:NRIP1|0:ERCC2|0:DCAF6|0:ARNTL|0:CLOCK|0:EPAS1|0:CAMTA2|0:HIF1A|0:NPAS2|0:CIITA|0:NUFIP1|0:CHD8|0:SKAP1|0:EP300|0:NR5A1|0:ATF4|0:MYO6|0:GATA4|0:HAND2|0:TGFB3|0:RARG|0:SLC11A1|0:ZBTB38|0:CSRNP3|0:GLIS1|0:TNFRSF1A|0:RNF10|0:SMAD2|0:GLIS3|0:GRIN1|0:CSRNP1|0:LPIN2|0:CSRNP2|0:IL4|0:SQSTM1			
GO:0007156	P:homophilic cell adhesion; TAS:ProtInc		0:CDH13|0:PVRL2|0:PTPRM|0:ROBO2|0:DSCAML1|0:ROBO1|0:PTPRT|0:FAT4|0:PCDHA13|0:CDH8|0:CELSR3|0:PCDH20|0:CDHR4|0:PCDHGB3|0:PCDHA9|0:DSC3|0:CDH22|0:PCDHB10|0:PCDHB16|0:PCDHGA6|0:PCDHB6|0:PCDHGB7|0:PCDHA6|0:PCDHGA9|0:PCDHGA2|0:CDH16|0:PCDH8|0:PCDH18|0:PCDHGA10|0:PCDHA12|0:PCDHB9|0:FAT1|0:PCDHGA7|0:PCDHB11|0:CDH18|0:PCDHGC4|0:PCDHAC2|0:PCDHGB2|0:PCDHA8|0:PCDH7|0:PCDHA5|0:CLSTN3|0:PCDH17|0:PCDHGB6|0:PCDHB5|0:DCHS2|0:CDH26|0:CDHR3|0:FREM2|0:DSG4|0:PCDH10|0:DSG3|0:DSC1|0:PCDHB14|0:PCDHGA11|0:PCDHGC3|0:DCHS1|0:PCDHGA3|0:PCDHB8|0:FAT2|0:PCDHA2|0:PCDHA11|0:CDH6|0:PCDH1|0:PCDH11Y|0:PCDH9|0:PCDHGB1|0:CLSTN2|0:PCDHGA8|0:PCDHB12|0:PCDHA4|0:DSG2|0:PCDHB2|0:PCDHB4|0:PCDHGB5|0:FAT3|0:CDH23|0:CDHR2|0:PCDHB15|0:CDHR5|0:PCDHGB4|0:PCDHGA5|0:PCDHGA4|0:DSC2|0:RET|0:PCDHGA12|0:PCDHA10|0:CLSTN1|0:PCDHB7|0:PCDHA1|0:PCDHAC1|0:CDH15|0:PCDHGA1|0:PCDHB18|0:CDH24|0:PCDHGC5|0:CDHR1|0:PCDH15|0:PCDH11X|0:PCDHB13|0:PCDHA7|0:CDH3|0:DSG1|0:PCDH19|0:CELSR1|0:PCDHA3|0:PCDHB3|0:PCDHB1|0:CELSR2|0:CADM3|0:NPTN|0:PVRL3|0:PVRL1|0:AMIGO2|0:AMIGO1|0:CADM1|0:CDH12|0:CEACAM1|0:CDH1|0:CDH20|0:CDH19|0:CDH10|0:CDH11|0:CDH7|0:CDH9|0:PKD1|0:CDH5|0:MPZL2|0:TRO			
GO:0001518	C:voltage-gated sodium channel complex; TAS:UniProtKB		0:SCN8A|0:SCN4B|0:SCN11A|0:SCN4A|0:SCN5A|0:SCN10A|0:SCN9A|0:SCN7A|0:SCN3A|0:SCN2B			
GO:0060401	P:cytosolic calcium ion transport; TAS:BHF-UCL		0:SLC8A1			
GO:0034186	F:apolipoprotein A-I binding; IPI:BHF-UCL		0:SCARB1|0:LCAT			
GO:0051402	P:neuron apoptosis; TAS:HGNC		0:NLRP1|0:GRIK2|0:ERBB3|0:APP|0:LIG4|0:BNIP3|0:BCL2|0:BID			
GO:0006970	P:response to osmotic stress; TAS:UniProtKB		0:KCNMA1|0:AQP9			
GO:0002904	P:positive regulation of B cell apoptosis; IDA:MGI		0:IL10			
GO:0009113	P:purine base biosynthetic process; TAS:ProtInc		0:SHMT1|0:GART|0:PPAT|0:PAICS|0:GMPS			
GO:0007597	P:blood coagulation, intrinsic pathway; IDA:BHF-UCL		0:F12|0:APOH			
GO:0060023	P:soft palate development; IMP:UniProtKB		0:FOXE1|0:TBX1|0:COL11A2			
GO:0070265	P:necrotic cell death; IMP:BHF-UCL		0:TNF|0:FASLG|0:FADD			
GO:0017065	F:single-strand selective uracil DNA N-glycos...; IDA:HGNC		0:SMUG1			
GO:0008061	F:chitin binding; TAS:UniProtKB		0:FIBCD1|0:CHIA|0:CHIT1			
GO:0031531	F:thyrotropin-releasing hormone receptor binding; IPI:UniProtKB		0:PSMC5			
GO:0071544	P:diphosphoinositol polyphosphate catabolic p...; IDA:UniProtKB		0:NUDT3			
GO:0040038	P:polar body extrusion after meiotic divisions; ISS:BHF-UCL		0:FMN2			
GO:0008568	F:microtubule-severing ATPase activity; IEA:EC		0:SPAST|0:KATNAL1|0:KATNAL2|0:KATNA1			
GO:0007229	P:integrin-mediated signaling pathway; TAS:UniProtKB		0:ADAM9|0:PLEK|0:LAT|0:BCAR1|0:ITGBL1|0:ITGAD|0:ITGB7|0:ITGAM|0:ITGB8|0:ITGA7|0:ITGB3|0:ITGA3|0:ITGAE|0:ITGA8|0:ITGB6|0:ITGA11|0:ITGA4|0:ITGA2|0:ITGA10|0:ITGAX|0:ITGB5|0:ITGA2B|0:ITGA9|0:ITGA5|0:ITGAL|0:ITGB4|0:ITGA1|0:ITGA6|0:COL3A1|0:LAMA5|0:ERBB2IP|0:ADAMTS13|0:CEACAM1|0:ADAMDEC1|0:DST|0:NEDD9|0:ITGB2|0:ANGPTL3|0:SYK|0:ILK|0:MYH9|0:ITGAV|0:ADAM10|0:CD47|0:ADAMTS1|0:ADAM11|0:PTK2|0:DOCK1|0:CCM2|0:COL16A1			
GO:0003712	F:transcription cofactor activity; TAS:ProtInc		0:NRG1|0:TFB2M|0:HES6|0:BTG1|0:PIR|0:CREB1|0:IRF3|0:TADA2A|0:ELK4|0:SLC26A3|0:TMF1|0:PSMC5|0:PHOX2B|0:TFDP2|0:SND1|0:LDB2|0:RFXANK|0:TRIP13|0:NFE2L1|0:NMI			
GO:0060054	P:positive regulation of epithelial cell prol...; NAS:UniProtKB		0:WNT7A|0:MMP12|0:FZD7|0:FGF10			
GO:0007623	P:circadian rhythm; TAS:ProtInc		0:ARNTL2|0:TIMELESS|0:EGR3|0:HEBP1|0:PER2|0:AANAT|0:HTR7|0:ARNTL|0:CLOCK|0:PER1|0:MTNR1A|0:CRY1			
GO:0001735	F:prenylcysteine oxidase activity; IDA:BHF-UCL		0:PCYOX1			
GO:0004317	F:3-hydroxypalmitoyl-[acyl-carrier-protein] d...; IEA:EC		0:FASN			
GO:0004081	F:bis(5'-nucleosyl)-tetraphosphatase (asymmet...; ISS:UniProtKB		0:NUDT2			
GO:0030593	P:neutrophil chemotaxis; TAS:UniProtKB		0:EDN3|0:EDN2|0:CXCR2|0:CKLF|0:ITGB2|0:SYK|0:IL8|0:PLA2G1B|0:CXCL3|0:SAA1|0:SAA2|0:TGFB2			
GO:0004616	F:phosphogluconate dehydrogenase (decarboxyla...; ISS:UniProtKB		0:HIBADH|0:GLYR1|0:PGD			
GO:0004534	F:5'-3' exoribonuclease activity; TAS:UniProtKB		0:XRN2			
GO:0006407	P:rRNA export from nucleus; IMP:UniProtKB		0:TSC1			
GO:0005882	C:intermediate filament; TAS:ProtInc		0:VIM|0:SYNM|0:KRT34|0:KRTAP19-8|0:KRTAP13-1|0:KRTAP17-1|0:KRTAP13-4|0:KRTAP19-1|0:KRT26|0:KRT37|0:IFFO1|0:KRTAP20-1|0:KRTAP19-5|0:KRTAP6-1|0:KRTAP19-3|0:KRTAP24-1|0:KRT222|0:KRTAP13-2|0:KRT33A|0:SYNC|0:KRTAP19-7|0:KRTAP20-4|0:KRTAP21-1|0:KRT40|0:KRT23|0:KRTAP27-1|0:KRT12|0:KRTAP19-4|0:KRT27|0:KRTAP22-2|0:KRT33B|0:KRT13|0:KRT24|0:KRT36|0:KRTAP21-2|0:KRTAP19-2|0:KRTAP15-1|0:KRT39|0:KRT28|0:KRTAP5-5|0:KRT32|0:KRT35|0:KRTAP22-1|0:KRTAP7-1|0:KRTAP20-2|0:IFLTD1|0:KRTAP6-3|0:KRTAP25-1|0:KRTAP20-3|0:KRTAP13-3|0:KRTAP19-6|0:KRTAP6-2|0:KRT38|0:KRT25|0:KRTAP21-3|0:KRTAP23-1|0:KRTAP8-1|0:SLC1A4|0:KRT16|0:KRT20|0:MICAL1|0:NES|0:NCKIPSD|0:FLG|0:KRT15|0:BFSP1|0:CLIP1|0:BFSP2|0:KRT19|0:PKP1|0:GFAP|0:PRPH|0:PNN|0:KRT17|0:KRT31			
GO:0008503	F:benzodiazepine receptor activity; TAS:ProtInc		0:GABRA2|0:GABRG2|0:GABRA4|0:GABRA6|0:GABRA3|0:TSPO			
GO:0004088	F:carbamoyl-phosphate synthase (glutamine-hyd...; ISS:BHF-UCL		0:CAD			
GO:0061072	P:iris morphogenesis; ISS:BHF-UCL		0:WNT2B|0:WNT9A|0:WNT2			
GO:0031702	F:type 1 angiotensin receptor binding; IPI:BHF-UCL		0:AGT|0:BDKRB2			
GO:0032367	P:intracellular cholesterol transport; IMP:UniProtKB		0:NPC2|0:ABCG1|0:ABCA1|0:VPS4B			
GO:0019388	P:galactose catabolic process; IDA:UniProtKB		0:GALE			
GO:0070509	P:calcium ion import; IMP:BHF-UCL		0:TRPC4|0:CBARA1|0:ATP2A1			
GO:0043966	P:histone H3 acetylation; IDA:UniProtKB		0:SAP130|0:ING4|0:PHF16|0:MYST3|0:TADA3|0:TADA2A|0:TAF6L|0:BRPF3|0:TAF9|0:SUPT3H|0:PHF17|0:MYST2|0:TAF12|0:TRIM16|0:BRPF1|0:TAF5L|0:ING5|0:BRD1|0:SUPT7L|0:TAF10|0:MYST4|0:PHF15|0:TADA1			
GO:0003835	F:beta-galactoside alpha-2,6-sialyltransferas...; IEA:EC		0:ST6GAL2|0:ST6GAL1			
GO:0000052	P:citrulline metabolic process; IDA:UniProtKB		0:DDAH1|0:DDAH2			
GO:0043181	P:vacuolar sequestering; IMP:BHF-UCL		0:GAA			
GO:0040019	P:positive regulation of embryonic development; ISS:UniProtKB		0:RBM19			
GO:0005960	C:glycine cleavage complex; TAS:ProtInc		0:C9orf6|0:GCSH			
GO:0006926	P:virus-infected cell apoptosis; IDA:HGNC		0:PMAIP1			
GO:0001517	F:N-acetylglucosamine 6-O-sulfotransferase ac...; IDA:UniProtKB		0:CHST6|0:CHST2|0:CHST7|0:CHST5|0:CHST4			
GO:0048738	P:cardiac muscle tissue development; ISS:BHF-UCL		0:TAZ|0:NDUFV2|0:RBP4			
GO:0032967	P:positive regulation of collagen biosyntheti...; ISS:BHF-UCL		0:HDAC2|0:F2R|0:BMP4|0:WNT4|0:F2|0:TGFB1|0:TGFB3|0:AMELX			
GO:0031982	C:vesicle; IDA:UniProtKB		0:CETP|0:NOD2|0:VAPA			
GO:0000009	F:alpha-1,6-mannosyltransferase activity; IC:UniProtKB		0:ALG12			
GO:0003697	F:single-stranded DNA binding; TAS:UniProtKB		0:HNRNPA1|0:ERCC5|0:TDP1|0:ERCC1|0:ERCC4|0:OBFC2B|0:RAD51|0:NEIL3|0:PCBP1|0:C10orf2|0:RAD51AP1|0:SUB1|0:SSBP3|0:SSBP4|0:SSBP1|0:HSPD1|0:HMGB2|0:OBFC2A|0:C17orf68|0:HMGB1|0:PURA|0:PURB|0:SSBP2|0:POLG2|0:RBMS1|0:FUBP1|0:RPA2|0:XPC|0:IGHMBP2|0:RAD23A|0:WBP11|0:RPA3|0:RPA4|0:HNRPDL|0:RAD23B|0:YBX1|0:RPA1|0:TREX1			
GO:0016558	P:protein import into peroxisome matrix; IMP:UniProtKB		0:PEX10|0:PEX16|0:PEX14|0:PEX7|0:PEX1|0:PEX12|0:PEX26			
GO:0004741	F:[pyruvate dehydrogenase (lipoamide)] phosph...; IEA:EC		0:PDP1|0:PDP2			
GO:0043117	P:positive regulation of vascular permeability; IDA:UniProtKB		0:FGFBP3|0:VEGFA			
GO:0071361	P:cellular response to ethanol; IDA:UniProtKB		0:ADCY7			
GO:0034116	P:positive regulation of heterotypic cell-cel...; NAS:BHF-UCL		0:TNF|0:IL1B			
GO:0005724	C:nuclear telomeric heterochromatin; NAS:UniProtKB		0:SIRT6|0:TNKS1BP1			
GO:0008339	F:MP kinase activity; IDA:UniProtKB		0:MAPK11|0:MAPK14|0:MAPK13			
GO:0033262	P:regulation of DNA replication involved in S...; TAS:HGNC		0:TIPIN			
GO:0043066	P:negative regulation of apoptosis; TAS:HGNC		0:DFFA|0:PF4|0:SORT1|0:CD44|0:SCG2|0:MAPK8|0:GSK3B|0:PSMD10|0:ALB|0:ANGPTL4|0:KRT18|0:DNAJA3|0:BMP4|0:AQP1|0:PRAME|0:NUP62|0:CD74|0:PIM1|0:PDCD10|0:BCL3|0:IL6|0:TDGF1|0:WNT5A|0:NUAK2|0:FAIM|0:TMBIM6|0:CASP3|0:WT1|0:WNT1|0:TAF9|0:SOX4|0:SMAD6|0:TAF9B|0:SERPINE1|0:CTNNB1|0:TMEM161A|0:ACVR1|0:NME2|0:ERCC5|0:ITCH|0:KLHL20|0:ASNS|0:PIM3|0:WNT11|0:CAT|0:RPS6KB1|0:FXN|0:PRDX5|0:ASCL1|0:DHRS2|0:SFRP1|0:HSPD1|0:PROC|0:BARD1|0:CIDEA|0:NKX2-6|0:NEUROD1|0:HTR2B|0:PHIP|0:POU3F3|0:IL4|0:OSR1|0:INS|0:CLCF1			
GO:0000236	P:mitotic prometaphase; IDA:BHF-UCL		0:CCNB1			
GO:0070679	F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL		0:ITPR3			
GO:0045090	P:retroviral genome replication; NAS:UniProtKB		0:SMARCB1|0:SUPT5H			
GO:0034405	P:response to fluid shear stress; IMP:BHF-UCL		0:P2RX4|0:NOS3|0:CITED2|0:AKT1			
GO:0005539	F:glycosaminoglycan binding; TAS:ProtInc		0:TGFBR2|0:ENG|0:LTBP4|0:PODXL2|0:HABP2|0:EPYC			
GO:0042824	C:MHC class I peptide loading complex; NAS:UniProtKB		0:CALR|0:TAPBP			
GO:0015227	F:acyl carnitine transporter activity; EXP:Reactome		0:SLC25A20			
GO:0051461	P:positive regulation of adrenocorticotropin ...; IDA:BHF-UCL		0:GHRL			
GO:0030514	P:negative regulation of BMP signaling pathway; TAS:UniProtKB		0:SMAD7|0:SMAD6|0:CAV1|0:SOST|0:SKI|0:LEMD3|0:SKOR1|0:TRIM33|0:FSTL3|0:CHRD|0:GREM1|0:HIPK2|0:VWC2|0:NOG|0:BMPER|0:NOTCH1|0:SMURF1			
GO:0031177	F:phosphopantetheine binding; IEA:InterPro		0:ALDH1L2|0:FASN|0:NDUFAB1			
GO:0030144	F:alpha-1,6-mannosyl-glycoprotein 6-beta-N-ac...; NAS:UniProtKB		0:MGAT5B|0:MGAT5			
GO:0008108	F:UDP-glucose:hexose-1-phosphate uridylyltran...; EXP:Reactome		0:GALT			
GO:0000215	F:tRNA 2'-phosphotransferase activity; IEA:EC		0:TRPT1			
GO:0051117	F:ATPase binding; ISS:UniProtKB		0:ALDOB|0:ATPIF1|0:WFS1|0:PTPN3|0:ATP6V1G3|0:LCK|0:UBXN1|0:S100A1|0:ATP6V1G1|0:ATP6V0A1|0:ATP6V0A4|0:GABARAPL2			
GO:0048495	F:Roundabout binding; IPI:UniProtKB		0:SLIT2|0:SLIT3|0:TGFB1I1|0:SLIT1			
GO:0043008	F:ATP-dependent protein binding; IDA:UniProtKB		0:BAT1|0:SAE1			
GO:0070820	C:tertiary granule; IDA:UniProtKB		0:STXBP3|0:STXBP2			
GO:0090279	P:regulation of calcium ion import; IDA:BHF-UCL		0:EGF|0:CTNNB1			
GO:0070006	F:metalloaminopeptidase activity; IDA:UniProtKB		0:XPNPEP1			
GO:0002474	P:antigen processing and presentation of pept...; IEA:UniProtKB-KW		0:B2M|0:HLA-C|0:MR1|0:HLA-F|0:HFE|0:HLA-G|0:HLA-H|0:HLA-A|0:HLA-B|0:HLA-E			
GO:0034450	F:ubiquitin-ubiquitin ligase activity; ISS:UniProtKB		0:PRPF19|0:SLC14A1|0:UBE2K|0:UBE4A|0:STUB1			
GO:0009296	P:flagellum assembly; ISS:BHF-UCL		0:BBS5|0:MKKS			
GO:0004051	F:arachidonate 5-lipoxygenase activity; TAS:ProtInc		0:ALOX5			
GO:0090047	P:positive regulation of transcription regula...; IDA:BHF-UCL		0:FZD2			
GO:0045907	P:positive regulation of vasoconstriction; ISS:BHF-UCL		0:ADRA1A|0:CAV1			
GO:0008486	F:diphosphoinositol-polyphosphate diphosphata...; ISS:UniProtKB		0:NUDT4|0:NUDT3|0:NUDT11|0:NUDT10			
GO:0034154	P:toll-like receptor 7 signaling pathway; IMP:UniProtKB		0:UNC93B1			
GO:0030225	P:macrophage differentiation; TAS:UniProtKB		0:IL31RA|0:MMP9|0:CSF1|0:CDC42			
GO:0070611	F:histone methyltransferase activity (H3-R2 s...; IDA:UniProtKB		0:PRMT6			
GO:0031999	P:negative regulation of fatty acid beta-oxid...; IMP:BHF-UCL		0:AKT1			
GO:0032423	P:regulation of mismatch repair; IMP:BHF-UCL		0:AXIN2			
GO:0001561	P:fatty acid alpha-oxidation; TAS:UniProtKB		0:HACL1|0:HAO1|0:PEX13|0:HAO2			
GO:0004808	F:tRNA (5-methylaminomethyl-2-thiouridylate)-...; NAS:UniProtKB		0:TRMU			
GO:0060169	P:negative regulation of adenosine receptor s...; IDA:UniProtKB		0:ADA			
GO:0046325	P:negative regulation of glucose import; ISS:BHF-UCL		0:ENPP1|0:PEA15|0:GSK3A|0:GRB10			
GO:0070736	F:protein-glycine ligase activity, initiating; ISS:UniProtKB		0:TTLL8|0:TTLL3			
GO:0031428	C:box C/D snoRNP complex; NAS:BHF-UCL		0:NOP58|0:FBL|0:NHP2L1|0:NOP56			
GO:0046755	P:non-lytic virus budding; ISS:UniProtKB		0:LRSAM1|0:TSG101			
GO:0019752	P:carboxylic acid metabolic process; IEA:InterPro		0:PDXDC2P|0:DDC|0:SGPL1|0:PDXDC1|0:GADL1|0:CSAD			
GO:0000228	C:nuclear chromosome; TAS:ProtInc		0:BIRC5|0:SMC2|0:SMARCB1|0:RAD21L1|0:RAD21|0:HOXD12|0:BARX1|0:PBRM1|0:PRRX2|0:GBX1|0:HDAC8|0:ZNF238|0:SMARCE1|0:ZBED1			
GO:0045578	P:negative regulation of B cell differentiation; TAS:UniProtKB		0:SFRP1|0:INHA|0:INHBA			
GO:0001817	P:regulation of cytokine production; IC:BHF-UCL		0:ACE2			
GO:0005899	C:insulin receptor complex; ISS:BHF-UCL		0:INSR|0:IRS1			
GO:0008635	P:activation of caspase activity by cytochrome c; TAS:UniProtKB		0:BAX|0:AIFM3|0:SIVA1|0:APAF1|0:TP53|0:CASP9|0:DIABLO|0:CYCS			
GO:0030305	F:heparanase activity; TAS:UniProtKB		0:HPSE2			
GO:0019899	F:enzyme binding; TAS:UniProtKB		0:UGT1A8|0:UGT1A4|0:UGT1A9|0:UGT1A6|0:UGT1A1|0:APOA5|0:UGT1A3|0:PARP4|0:PAWR|0:CYP2A6|0:CYP2C19|0:CYP2E1|0:PRKCA|0:CYB5A|0:CYP1A2|0:SORT1|0:NOXO1|0:APOB|0:APOA1|0:CYP3A4|0:YWHAH|0:MDM2|0:DFFB|0:CD40|0:PRKCE|0:DNMT3L|0:ZFHX3|0:HIST1H2AG|0:U2AF2|0:PIAS3|0:ADORA2A|0:MAPT|0:LONP2|0:RARA|0:HIST1H2AK|0:HDAC2|0:SNRPD3|0:HMGA1|0:A2M|0:ATG3|0:CTNNBL1|0:UBE2I|0:SUPT5H|0:PRKCD|0:CDC20|0:H2AFX|0:HIST1H2AI|0:CFTR|0:KIAA1967|0:NLRP1|0:DHCR24|0:CAD|0:PIAS1|0:HLCS|0:CBX4|0:NR5A1|0:POLB|0:FOXO4|0:CUTA|0:MDM4|0:CBX1|0:HIST1H2AM|0:PRKCH|0:HINFP|0:PLAUR|0:VAPB|0:CSF3|0:PLCB1|0:PCCA|0:LUC7L2|0:IL6R|0:CBX3|0:MSH3|0:NPC2|0:MLL5|0:PTEN|0:HIST1H2AL|0:COTL1|0:AKT1|0:HMOX1|0:CASP2|0:UBE4B|0:SERPINB12|0:BCHE|0:BIRC7|0:AKAP2|0:DNM2|0:ACIN1|0:TNKS1BP1|0:RFC5|0:ANK1|0:UBE2L3|0:PREX1			
GO:0008324	F:cation transmembrane transporter activity; IEA:InterPro		0:SFXN4|0:SFXN5|0:SLC41A3|0:SFXN1|0:SLC30A9|0:SFXN3|0:SLC41A2|0:SLC30A2|0:SLC41A1|0:SLC30A7|0:SFXN2|0:SLC30A10			
GO:0006836	P:neurotransmitter transport; IMP:UniProtKB		0:SV2B|0:CPLX4|0:SLC17A7|0:SLC17A8|0:SLC18A1|0:SLC32A1|0:SV2C|0:RIMS3|0:STX1B|0:RIMS4|0:CPLX1|0:STX3|0:SLC18A2|0:SV2A|0:CPLX2|0:ICA1|0:GABRA2			
GO:0014910	P:regulation of smooth muscle cell migration; ISS:BHF-UCL		0:PDGFA|0:PLAU|0:ACE			
GO:0003860	F:3-hydroxyisobutyryl-CoA hydrolase activity; EXP:Reactome		0:HIBCH			
GO:0042446	P:hormone biosynthetic process; ISS:UniProtKB		0:DUOX1|0:DIO1|0:TPO|0:DIO3|0:DIO2|0:DUOX2|0:TG|0:CHST8|0:CHST9			
GO:0005142	F:interleukin-11 receptor binding; NAS:UniProtKB		0:IL11			
GO:0001649	P:osteoblast differentiation; TAS:UniProtKB		0:BMP4|0:BMP2|0:GLI1|0:SOX2|0:GLI2|0:CYP24A1|0:AMELX|0:NF1|0:MSX2|0:DLX5|0:NOG|0:RUNX2			
GO:0070997	P:neuron death; ISS:BHF-UCL		0:LRRK2|0:BAG5			
GO:0019865	F:immunoglobulin binding; IDA:UniProtKB		0:VWF			
GO:0019240	P:citrulline biosynthetic process; NAS:BHF-UCL		0:CPS1			
GO:0046625	F:sphingolipid binding; IDA:UniProtKB		0:TRAF2			
GO:0009082	P:branched chain family amino acid biosynthet...; TAS:ProtInc		0:BCAT1			
GO:0014037	P:Schwann cell differentiation; ISS:BHF-UCL		0:ERBB3			
GO:0000026	F:alpha-1,2-mannosyltransferase activity; IMP:UniProtKB		0:PIGZ			
GO:0032754	P:positive regulation of interleukin-5 produc...; IDA:BHF-UCL		0:RARA			
GO:0001527	C:microfibril; NAS:UniProtKB		0:MFAP1|0:FBN1|0:MFAP5|0:MFAP2|0:MFAP4			
GO:0030041	P:actin filament polymerization; TAS:UniProtKB		0:GSN|0:ARPC4|0:ANG|0:ARHGAP6|0:WASF1|0:WASF3|0:RAC1|0:PREX1			
GO:0060118	P:vestibular receptor cell development; ISS:UniProtKB		0:GRXCR1			
GO:0007215	P:glutamate signaling pathway; TAS:ProtInc		0:GRIN2C|0:GRID2|0:GRIA4|0:GRIA3|0:GRIK2|0:GRIK4|0:GRIK1			
GO:0030884	F:exogenous lipid antigen binding; IDA:UniProtKB		0:CD1D			
GO:0004102	F:choline O-acetyltransferase activity; EXP:Reactome		0:CHAT			
GO:0000035	F:acyl binding; ISS:UniProtKB		0:GNAT1			
GO:0016208	F:AMP binding; IEA:InterPro		0:ACSS2|0:APRT|0:PYGL|0:ACSS1			
GO:0000395	P:nuclear mRNA 5'-splice site recognition; IDA:UniProtKB		0:SRSF12			
GO:0071569	P:protein ufmylation; IDA:UniProtKB		0:UFC1|0:UFM1|0:KIAA0776|0:UBA5			
GO:0061048	P:negative regulation of branching involved i...; IDA:UniProtKB		0:TNF			
GO:0044262	P:cellular carbohydrate metabolic process; IEA:InterPro		0:CS|0:ACLY			
GO:0043492	F:ATPase activity, coupled to movement of sub...; IDA:UniProtKB		0:RALBP1			
GO:0008422	F:beta-glucosidase activity; TAS:ProtInc		0:GBA2|0:GBA3|0:KL			
GO:0033365	P:protein localization in organelle; ISS:BHF-UCL		0:RAB3IP|0:COG3|0:BBS2			
GO:0032387	P:negative regulation of intracellular transport; IDA:HGNC		0:CRYAB|0:CRYAA			
GO:0043141	F:ATP-dependent 5'-3' DNA helicase activity; IDA:UniProtKB		0:PIF1|0:HELB|0:IGHMBP2			
GO:0002666	P:positive regulation of T cell tolerance ind...; ISS:BHF-UCL		0:TGFBR2			
GO:0008210	P:estrogen metabolic process; TAS:ProtInc		0:UGT2B11|0:UGT1A1			
GO:0000776	C:kinetochore; TAS:UniProtKB		0:DCTN1|0:XPO1|0:PSEN1|0:PAFAH1B1|0:DCTN2|0:PSEN2|0:APC|0:KIF22|0:SUMO3|0:SUGT1|0:CLIP1			
GO:0070531	C:BRCA1-A complex; IDA:UniProtKB		0:UIMC1|0:BRE|0:BRCC3|0:BRCA1|0:FAM175A|0:C19orf62|0:BARD1			
GO:0047026	F:3-alpha-hydroxysteroid dehydrogenase (A-spe...; IEA:EC		0:AKR1C3|0:AKR1C2			
GO:0006738	P:nicotinamide riboside catabolic process; IDA:UniProtKB		0:PNP			
GO:0030032	P:lamellipodium assembly; TAS:UniProtKB		0:CDH13|0:CCDC88A|0:RAC1|0:VCL|0:CYFIP1|0:ARFIP2			
GO:0010255	P:glucose mediated signaling pathway; ISS:BHF-UCL		0:MLXIPL			
GO:0014070	P:response to organic cyclic substance; IDA:UniProtKB		0:SFRP1			
GO:0000922	C:spindle pole; ISS:UniProtKB		0:CCNB1|0:DCTN1|0:KNTC1|0:CALM2|0:CETN1|0:SGOL1|0:DYNC1LI1|0:CCDC99|0:SMC3|0:SBDS|0:ZW10|0:CALM3|0:LATS1|0:NUMA1|0:LATS2|0:DYNC1I1|0:CENPF|0:CALM1|0:KATNA1|0:TUBGCP5|0:TUBGCP2|0:TUBGCP6|0:TUBGCP4|0:PLEKHG6|0:FAM82B|0:RASSF1|0:KATNB1|0:FAM110A|0:CKAP2|0:FAM110C|0:HAUS1|0:PRC1|0:PPP2CA|0:ALMS1|0:RANGAP1|0:KIF2A|0:HAUS8|0:FAM82A2|0:PSRC1|0:NUP62|0:TOPBP1|0:PPP2CB|0:SPAG5|0:FAM83D|0:TPX2|0:LRRC50|0:ODF2|0:FAM82A1|0:CEP63			
GO:0032027	F:myosin light chain binding; IDA:UniProtKB		0:CXCR4			
GO:0006269	P:DNA replication, synthesis of RNA primer; TAS:ProtInc		0:HELB|0:CCDC111|0:PRIM1|0:PRIM2			
GO:0007088	P:regulation of mitosis; TAS:ProtInc		0:RCC1|0:CAV2|0:C13orf34|0:L3MBTL1|0:KIF20B|0:PRMT5|0:PKMYT1|0:CDC25C|0:NEK2|0:CDC16|0:PIN1|0:CDK13			
GO:0070463	F:tubulin-dependent ATPase activity; IDA:UniProtKB		0:KIF18A			
GO:0060214	P:endocardium formation; ISS:BHF-UCL		0:SOX17|0:PROX1|0:SOX18			
GO:0046329	P:negative regulation of JNK cascade; TAS:UniProtKB		0:TAOK3|0:NCOR1|0:MEN1|0:DUSP3|0:ZNF675|0:GPS2|0:MECOM|0:HDAC3|0:AIDA|0:AMBP			
GO:0005171	F:hepatocyte growth factor receptor binding; IPI:UniProtKB		0:GLMN			
GO:0015355	F:secondary active monocarboxylate transmembr...; IEA:InterPro		0:SLC16A3|0:SLC16A8|0:SLC16A7|0:SLC16A1|0:SLC16A5			
GO:0019789	F:SUMO ligase activity; IDA:UniProtKB		0:PIAS2|0:PIAS1|0:PIAS4|0:TOPORS			
GO:0010460	P:positive regulation of heart rate; IDA:BHF-UCL		0:EDN3|0:EDN2|0:EDN1			
GO:0004769	F:steroid delta-isomerase activity; TAS:ProtInc		0:HSD3B2|0:HSD3B1|0:EBP			
GO:0046883	P:regulation of hormone secretion; ISS:UniProtKB		0:SCG5			
GO:0032777	C:Piccolo NuA4 histone acetyltransferase complex; IDA:UniProtKB		0:KAT5|0:EPC1|0:ING3			
GO:0046523	F:S-methyl-5-thioribose-1-phosphate isomerase...; IEA:EC		0:MRI1			
GO:0002504	P:antigen processing and presentation of pept...; IEA:UniProtKB-KW		0:HLA-DRB3|0:HLA-DRA|0:HLA-DRB4|0:HLA-DOB|0:HLA-DMA|0:HLA-DPB1|0:HLA-DMB|0:HLA-DRB1|0:HLA-DRB5|0:HLA-DQA2|0:HLA-DQA1|0:HLA-DPA1|0:HLA-DQB2			
GO:0043240	C:Fanconi anaemia nuclear complex; IDA:UniProtKB		0:C19orf40|0:APITD1|0:FANCM|0:STRA13			
GO:0035425	P:autocrine signaling; IDA:BHF-UCL		0:FZD1|0:C7orf68			
GO:0008599	F:protein phosphatase type 1 regulator activity; TAS:ProtInc		0:PPP1CA|0:PPP1R7			
GO:0061010	P:gall bladder development; IMP:BHF-UCL		0:NIPBL			
GO:0004718	F:Janus kinase activity; ISS:UniProtKB		0:JAK1|0:TYK2|0:JAK2			
GO:0031708	F:endothelin B receptor binding; IPI:BHF-UCL		0:EDN1|0:EDN3|0:EDN2			
GO:0009331	C:glycerol-3-phosphate dehydrogenase complex; IEA:InterPro		0:GPD1L|0:GPD2|0:GPD1			
GO:0051301	P:cell division; NAS:UniProtKB		0:CENPH|0:CENPO|0:CDC25B|0:CCNY|0:PMF1|0:CHFR|0:PARD6G|0:C12orf11|0:CEP63|0:TACC1|0:CCNB2|0:SEPT2|0:CCNE2|0:PPP1CB|0:CDCA2|0:ZNF830|0:NEK9|0:HAUS7|0:TERF1|0:HAUS3|0:PARD6B|0:SENP5|0:LZTS2|0:FZR1|0:STAG2|0:NEK4|0:PELO|0:SMC1A|0:MAPRE3|0:MAD1L1|0:FBXO5|0:CDC26|0:CINP|0:SKA3|0:PAPD5|0:UBE2S|0:ANAPC11|0:MAP9|0:CIT|0:CKAP5|0:DSN1|0:BIRC5|0:KATNB1|0:KNTC1|0:SAC3D1|0:SIRT2|0:NUF2|0:RCC1|0:PTTG1|0:C7orf11|0:WEE1|0:CCNT1|0:LIG1|0:MAPRE2|0:CDC25C|0:CKS1B|0:ANAPC7|0:CETN1|0:CDK6|0:SGOL1|0:CABLES2|0:CSNK1A1|0:CDCA3|0:SPC25|0:SSSCA1|0:CENPV|0:PDS5A|0:NEDD9|0:NCAPG|0:MAD2L2|0:ANAPC4|0:CDK20|0:HAUS4|0:CEP164|0:PARD6A|0:OIP5|0:FSD1|0:KIF23|0:HAUS1|0:DYNC1LI1|0:CDC23|0:MIS12|0:CCNF|0:CCNA1|0:SEPT10|0:UBE2I|0:KIF11|0:ANAPC13|0:CCDC99|0:USP16|0:RUVBL1|0:NEK1|0:CDC20|0:BUB1|0:CDC7|0:HELLS|0:SETDB2|0:SEPT1|0:ERCC6L|0:CDCA8|0:KIAA1009|0:CDC14A|0:SMC3|0:NUP37|0:KIF2A|0:NEK6|0:SETD8|0:NCAPD3|0:CCNK|0:PDCD6IP|0:TXNL4A|0:ZWINT|0:PPP1CA|0:CENPE|0:ZC3HC1|0:CEP55|0:TIMELESS|0:RNF8|0:C14orf106|0:SEPT14|0:ARHGEF2|0:CCNG2|0:SYCP1|0:ZW10|0:KIF20B|0:CD2AP|0:NSL1|0:PDS5B|0:LIG4|0:SYCE1|0:HAUS8|0:C21orf45|0:HMGA2|0:NCAPH|0:CASC5|0:ANAPC16|0:HAUS5|0:CDK5|0:CETN2|0:CABLES1|0:NUP43|0:HAUS2|0:CDK14|0:CETN3|0:CDK1|0:MAD2L1|0:E4F1|0:CCNA2|0:PSRC1|0:CKS2|0:NDE1|0:VPS4B|0:CLASP1|0:PAPD7|0:NUDC|0:CHMP1A|0:SEPT11|0:C13orf34|0:DYNLT3|0:NEK2|0:KIFC1|0:RCC2|0:SEPT9|0:SMC2|0:LATS1|0:TSG101|0:NCAPD2|0:ANAPC5|0:CDC16|0:CDC123|0:USP44|0:TIPIN|0:CDK4|0:ARL8A|0:CDCA5|0:BUB3|0:LMLN|0:HAUS6|0:EVI5|0:USP9X|0:KIF2B|0:CCNG1|0:SYCP2|0:CCND2|0:VPS24|0:RAD21|0:LIG3|0:CCNB1|0:CCNE1|0:CHMP1B|0:SEPT12|0:NDC80|0:SPAG5|0:STAG1|0:LRRCC1|0:CDK7|0:CDK2|0:SYCE2|0:MAEA|0:CDC25A|0:CCNB3|0:CCNT2|0:SEH1L|0:LATS2|0:ANAPC2|0:UBE2C|0:ARL3|0:FAM83D|0:NEK3|0:CENPF|0:TPX2|0:SYCP3|0:SPECC1L|0:LLGL2|0:MAPRE1|0:CDC6|0:AURKA|0:BOD1|0:CCND1|0:ANAPC1|0:ANAPC10|0:DCLRE1A|0:CEP110|0:CDK3|0:ARL8B|0:SPC24|0:DYNLT1|0:KATNA1|0:MAU2|0:ZWILCH|0:KIAA0174|0:SMC4|0:CUZD1|0:PPP1CC|0:NCAPG2|0:KIF2C|0:NEDD1|0:CCND3|0:CLASP2|0:BUB1B|0:SGOL2|0:PARD3B|0:SKA1|0:KLHL22|0:SKA2|0:CENPJ|0:BCAR1			
GO:0031145	P:anaphase-promoting complex-dependent protea...; IDA:UniProtKB		0:PSMB8|0:PSMD10|0:PSMC6|0:CDC26|0:ANAPC11|0:PSMD3|0:PSMB4|0:PSMA3|0:ANAPC7|0:PSMC1|0:PSMD13|0:PSMB10|0:ANAPC4|0:PSMF1|0:CDC23|0:PSMA6|0:PSME1|0:PSMA2|0:PSMB5|0:CDC27|0:PSMD4|0:PSMC5|0:PSMD7|0:PSMB1|0:CDK1|0:PSMD5|0:MAD2L1|0:PSMD12|0:PSMA5|0:PSMA1|0:PSMB6|0:ANAPC5|0:CDC16|0:PSMD1|0:PSMC4|0:PSMD8|0:BUB3|0:PSME2|0:PSMB2|0:CCNB1|0:PSMD11|0:PSMB7|0:PSMD6|0:ANAPC2|0:PSMA7|0:PSMD2|0:ANAPC1|0:ANAPC10|0:PSMD9|0:PSMB3|0:PSMC2|0:PSMD14|0:UBE2D1|0:PSMA4|0:UBE2E1|0:BUB1B|0:PSMC3|0:PSME3|0:PSMB9|0:FZR1|0:UBE2S|0:CDC20|0:UBE2C			
GO:0030529	C:ribonucleoprotein complex; TAS:UniProtKB		0:EEF2|0:XPO1|0:BRCA1|0:NUP62|0:CPSF6|0:JAKMIP1|0:NCL|0:ILF2|0:PABPN1|0:PABPC4|0:NCBP1|0:ERG|0:HSPA1A|0:HNRNPAB|0:ACTN4|0:HSPA8|0:HSPA1B|0:DHX9|0:ACTB|0:ILF3|0:TROVE2|0:LARP7|0:LARP6|0:NAA38|0:ZRSR1|0:CPSF3|0:LSM5|0:KRR1|0:LSM14B|0:PCBP2|0:LSM1|0:HEATR1|0:PUF60|0:PCBP3|0:FBLL1|0:HNRNPCL1|0:ZCCHC17|0:LSM7|0:NSA2|0:DCAF13|0:IMP4|0:PCBP4|0:RBMXL2|0:MVP|0:PCBP1|0:HNRPLL|0:IMP3|0:SRPRB|0:PA2G4|0:SRA1|0:IGHMBP2|0:PARP4|0:CELF1|0:MKRN3|0:SSB|0:RBM14			
GO:0050982	P:detection of mechanical stimulus; TAS:BHF-UCL		0:JUP|0:TCAP			
GO:0031727	F:CCR2 chemokine receptor binding; TAS:BHF-UCL		0:CCR2|0:CCL2			
GO:0015450	F:P-P-bond-hydrolysis-driven protein transmem...; IEA:InterPro		0:TOMM20|0:SEC61G|0:SEC61A2|0:TIMM23B|0:TIMM23|0:TIMM17B|0:SEC61A1|0:TOMM7|0:MRPL45|0:TIMM17A			
GO:0016514	C:SWI/SNF complex; TAS:BHF-UCL		0:ARID1A|0:SMARCC2|0:SMARCD1|0:SMARCB1|0:SMARCC1|0:SMARCE1|0:SMARCA2|0:ARID1B|0:SMARCA4|0:ACTL6A|0:SMARCD2|0:NCR1|0:ACTL6B|0:SMARCD3|0:RB1			
GO:0047316	F:glutamine-phenylpyruvate transaminase activity; IEA:EC		0:CCBL1			
GO:0035278	P:negative regulation of translation involved...; IDA:UniProtKB		0:EIF2C3|0:EIF2C2|0:EIF2C1|0:TNRC6A|0:EIF2C4			
GO:0033781	F:cholesterol 24-hydroxylase activity; IEA:EC		0:CYP46A1			
GO:0008375	F:acetylglucosaminyltransferase activity; TAS:ProtInc		0:A4GNT|0:GCNT6|0:XYLT1|0:XYLT2|0:GCNT7|0:LARGE			
GO:0046907	P:intracellular transport; TAS:UniProtKB		0:RGPD3|0:NUP50|0:RGPD6|0:RGPD2|0:RGPD5|0:RANBP1|0:ENAH|0:RGPD8|0:RGPD1|0:RGPD4|0:RANBP3L|0:RANBP3|0:BBS4|0:MKKS|0:SDCBP2|0:GNAS|0:NUDT4|0:APOE|0:CSPG5			
GO:0043274	F:phospholipase binding; ISS:BHF-UCL		0:SELE|0:ARHGAP6|0:APOC2|0:SNCA|0:DGKQ|0:PAFAH1B1			
GO:0006037	P:cell wall chitin metabolic process; TAS:UniProtKB		0:CHIA			
GO:0003690	F:double-stranded DNA binding; TAS:UniProtKB		0:TARDBP|0:ERCC5|0:TDP1|0:IFI16|0:PIN4|0:MEN1|0:NTHL1|0:RAD51|0:NKX2-8|0:APTX|0:RAD51AP1|0:HMGB2|0:HMGB1|0:SMAD2|0:KIN|0:HMGB3|0:NEIL3|0:EGFR|0:RBMS1|0:SAFB|0:MRE11A|0:XRCC6|0:CSDA|0:HLF|0:MTERF|0:ZNF638|0:XRCC5|0:HNRPDL|0:YBX1|0:CGGBP1|0:FEN1|0:SATB1|0:PNKP			
GO:0051790	P:short-chain fatty acid biosynthetic process; IDA:HGNC		0:OXSM			
GO:0016189	P:synaptic vesicle to endosome fusion; TAS:UniProtKB		0:EEA1			
GO:0046814	P:virion attachment, binding of host cell sur...; IDA:BHF-UCL		0:PVRL2			
GO:0030193	P:regulation of blood coagulation; IMP:BHF-UCL		0:F2RL1|0:FOXA2|0:CAV1			
GO:0050725	P:positive regulation of interleukin-1 beta b...; IDA:UniProtKB		0:AZU1			
GO:0045029	F:UDP-activated nucleotide receptor activity; NAS:UniProtKB		0:P2RY14			
GO:0070781	P:response to biotin; IDA:UniProtKB		0:HLCS			
GO:0019062	P:virion attachment to host cell surface rece...; TAS:UniProtKB		0:CLEC4M|0:CD209			
GO:0005861	C:troponin complex; NAS:UniProtKB		0:TNNT3|0:TNNI2|0:TNNI3|0:TNNC2|0:TNNT1|0:TNNT2|0:TNNC1|0:TNNI1			
GO:0043498	F:cell surface binding; ISS:BHF-UCL		0:PLG|0:NDP|0:ANGPTL3|0:F3|0:PDGFA|0:MIF|0:HSPD1|0:VEGFA|0:PDGFB|0:PLA2G1B|0:PDGFC|0:AIMP1|0:AMELX			
GO:0010370	C:perinucleolar chromocenter; IDA:BHF-UCL		0:TINF2			
GO:0070926	P:regulation of ATP:ADP antiporter activity; IMP:BHF-UCL		0:RIPK1			
GO:0006884	P:cell volume homeostasis; TAS:UniProtKB		0:AQP1|0:CLCN6|0:SLC12A4|0:TRPV4			
GO:0003906	F:DNA-(apurinic or apyrimidinic site) lyase a...; TAS:UniProtKB		0:APLF|0:RPS3|0:ALKBH1|0:NEIL3|0:NEIL2|0:NEIL1|0:APEX2|0:APEX1			
GO:0006467	P:protein thiol-disulfide exchange; TAS:UniProtKB		0:ERO1L|0:ERO1LB|0:QSOX1|0:PIGK|0:GLRX2			
GO:0000915	P:cytokinesis, actomyosin contractile ring as...; IMP:UniProtKB		0:RACGAP1			
GO:0061033	P:secretion by lung epithelial cell involved ...; IDA:UniProtKB		0:FGF10|0:FGF7			
GO:0008445	F:D-aspartate oxidase activity; TAS:UniProtKB		0:DDO			
GO:0046922	F:peptide-O-fucosyltransferase activity; TAS:UniProtKB		0:POFUT2|0:POFUT1			
GO:0000016	F:lactase activity; EXP:Reactome		0:LCT			
GO:0048471	C:perinuclear region of cytoplasm; TAS:BHF-UCL		0:TNKS2|0:CALCOCO2|0:CAV2|0:NEDD4|0:GALNT1|0:ENPP3|0:GALNT4|0:SORT1|0:ECE1|0:GALNT2|0:CDH1|0:GALNT6|0:SELE|0:BAG5|0:CSF1|0:SLC11A2|0:P2RX4|0:HDAC6|0:GALNT3|0:PCSK9|0:CTLA4|0:APLP1|0:CALR|0:TAF8|0:TPPP|0:ACHE|0:MAP1S|0:MYO16|0:LRPPRC|0:GTPBP4|0:NF2|0:CHODL|0:TAF10|0:SLC2A4|0:MYO9B|0:TF|0:PARK2|0:CLIC4|0:ABL1|0:STX6|0:GNB2|0:HMGB2|0:CDKN3|0:NPC1|0:TSC2|0:FAF1|0:S100A14|0:HSP90B1|0:HFE|0:VPS4A|0:SPINK5|0:FBXL5|0:TYR|0:WRNIP1|0:STMN2|0:NDFIP2|0:YWHAB|0:TLR4|0:ATXN2|0:TPD52L1|0:APEX1|0:PTPRM|0:INADL|0:BCL10|0:CYFIP2|0:PDE4A|0:INF2|0:S100A4|0:S100A13|0:ALG2|0:MTMR14|0:MAD2L1|0:DCUN1D3|0:SEPT9|0:VPS33B|0:HSPA1A|0:ITM2C|0:DNAJB6|0:SEC31A|0:LMNA|0:NDFIP1|0:ACTN4|0:VPS33A|0:CLN5|0:AGGF1|0:TNFSF12|0:CYB5R4|0:S100B|0:KIAA0427|0:HSPA1B|0:ZFYVE1|0:ATXN10|0:SEPT12|0:SET|0:ANP32A|0:TPD52L2|0:MYO6|0:WWC1|0:GSDMA|0:CTNNB1|0:MTDH|0:THBS3|0:ATP7A|0:DCTN3|0:S100A6|0:INHBB|0:TPD52|0:HSPA5|0:FGFR1OP|0:GDPD5|0:TRAIP|0:PKN3|0:ARF5|0:MOBP|0:KLHL20|0:UPF2|0:MAPK8IP1|0:MALT1|0:MRVI1|0:SCYL2|0:PAK2|0:PI4KB|0:MRAP|0:MMP23B|0:CMYA5|0:CYHR1|0:MRFAP1|0:MS4A3|0:DOK1|0:CALN1|0:KRT18|0:RHPN2|0:SEC24A|0:TRIM68|0:TWF2|0:STK33|0:CYLD|0:NANOS1|0:UNC45A|0:CCAR1|0:SORBS2|0:NDRG2|0:KAT5|0:ARHGAP10|0:TARBP2|0:SNCG|0:MAP3K4|0:HERC5|0:USP20|0:SYNC|0:RASEF|0:MOBKL3|0:TSNAX|0:TRIAP1|0:ADCY10|0:PTGDS|0:CDK5R1|0:SERBP1|0:PRKRA|0:SIPA1|0:SEC24B|0:PLCZ1|0:RC3H2|0:EIF4H|0:KPTN|0:GLB1|0:BNIP2|0:TRAPPC2L|0:KIF5A|0:PNPLA8|0:GRASP|0:EPN3|0:CABP2|0:SNAP47|0:CHERP|0:TSNAXIP1|0:MAL2|0:PTPRR|0:SLC2A10|0:TSTD1|0:CABP7|0:ERBB2|0:USP33|0:WDR44|0:PTGES2|0:HIP1R|0:NEURL|0:SH3RF1|0:RAP1GAP2|0:PDE9A|0:C14orf166|0:NCS1|0:LYN|0:SEC24C|0:TRAF4|0:RASD1|0:TRAPPC2P1|0:PSTPIP1|0:CABP1|0:TRAPPC2|0:SPAST|0:USP2|0:NDOR1|0:SERHL2|0:BCL3|0:RNF128|0:MMP23A|0:LDB3|0:RASIP1|0:TRIP10|0:RASA2|0:PLEKHG5|0:PLEKHF1|0:PLA2G16|0:GAK|0:SEC24D|0:TRIM37|0:SRFBP1|0:CENPF|0:CEP250|0:AATK|0:PLD1|0:MAP7|0:SPAG9|0:PLVAP|0:GAPDH|0:TP53BP2|0:PTOV1|0:CASC3|0:ARF1|0:NMRAL1|0:SLC2A12|0:CLINT1|0:SPIRE1|0:ARF3|0:NOS1|0:PAFAH1B1|0:CAV1|0:KIF5B|0:DYNC1I1|0:RAB14|0:PICK1|0:HECTD3|0:LRAT|0:LAMB1|0:MAGEE1|0:CYFIP1|0:ATP2A1|0:DNM3|0:UBQLN1|0:OBSL1			
GO:0031371	C:ubiquitin conjugating enzyme complex; TAS:HGNC		0:UBE2V1|0:STUB1			
GO:0004703	F:G-protein coupled receptor kinase activity; ISS:BHF-UCL		0:GRK7|0:GRK5|0:GRK6|0:GRK4|0:GRK1|0:ADRBK1			
GO:0004022	F:alcohol dehydrogenase (NAD) activity; NAS:UniProtKB		0:DHRS9|0:ADH1C|0:ADH6|0:ADH5|0:PTGR1			
GO:0006626	P:protein targeting to mitochondrion; TAS:UniProtKB		0:TOMM5|0:TOMM20|0:AIP|0:MFN2|0:MTX2|0:MTX3|0:MTX1|0:TOMM40|0:DNAJC19|0:TOMM70A|0:TOMM7|0:TOMM22|0:TOMM34|0:TIMM44|0:TSPO|0:TIMM23|0:TIMM17B|0:TIMM17A|0:TRNT1			
GO:0005932	C:microtubule basal body; TAS:BHF-UCL		0:BBS4|0:BBS2|0:RPGRIP1L|0:PKD2|0:OFD1|0:PKHD1|0:TTLL4|0:LCA5|0:TMEM67|0:TTLL11|0:B9D2|0:TTLL5|0:TTLL9|0:ALMS1|0:TTLL6|0:AHI1|0:CC2D2A|0:POC1A|0:IFT80|0:C19orf20|0:NPHP4|0:MKS1|0:TTLL7|0:IFT20|0:CEP250|0:GAS8|0:POC1B|0:BBS5|0:IFT88|0:IFT57|0:RAB3IP			
GO:0006857	P:oligopeptide transport; IEA:InterPro		0:SLC15A3|0:SLC15A5|0:SLC15A4			
GO:0003840	F:gamma-glutamyltransferase activity; NAS:UniProtKB		0:GGT5|0:GGT3P|0:GGT1|0:GGT7|0:GGT6|0:GGTLC3|0:GGTLC1|0:GGTLC2|0:GGT2			
GO:0003830	F:beta-1,4-mannosylglycoprotein 4-beta-N-acet...; IEA:EC		0:MGAT3			
GO:0090343	P:positive regulation of cell aging; IDA:UniProtKB		0:LMNA			
GO:0001591	F:dopamine receptor activity, coupled via Gi/Go; IDA:BHF-UCL		0:DRD2			
GO:0006433	P:prolyl-tRNA aminoacylation; IEA:InterPro		0:PARS2|0:EPRS			
GO:0055015	P:ventricular cardiac muscle cell development; ISS:BHF-UCL		0:NKX2-6|0:BMP10			
GO:0008203	P:cholesterol metabolic process; TAS:UniProtKB		0:APOA4|0:CETP|0:SOAT2|0:ANGPTL3|0:ABCG1|0:SOAT1|0:LCAT|0:ABCA1|0:SORL1|0:LDLR|0:CUBN|0:CYP7B1|0:SCAP|0:SREBF2|0:INSIG1|0:APOL1|0:SREBF1|0:FDXR|0:PCSK9|0:MBTPS1|0:LIPE|0:VLDLR|0:INSIG2|0:APOB|0:CYP11A1|0:CLN8|0:CLN6|0:IL4|0:OSBPL5|0:APOL2|0:LDLRAP1|0:OSBPL1A|0:RXRA|0:CELA3A|0:MBTPS2|0:APOF|0:CELA3B|0:NR0B2|0:STARD3|0:HDLBP|0:PPARD			
GO:0071173	P:spindle assembly checkpoint; IDA:UniProtKB		0:CASC5|0:BUB3			
GO:0019226	P:transmission of nerve impulse; NAS:UniProtKB		0:CNTNAP2			
GO:0015432	F:bile acid-exporting ATPase activity; TAS:ProtInc		0:ABCB11			
GO:0015207	F:adenine transmembrane transporter activity; TAS:ProtInc		0:SLC25A4|0:SLC25A5			
GO:0010933	P:positive regulation of macrophage tolerance...; ISS:BHF-UCL		0:IRAK3			
GO:0007283	P:spermatogenesis; TAS:UniProtKB		0:HILS1|0:ADCY10|0:SPATA19|0:SOHLH2|0:ZNF541|0:C10orf27|0:TSSK1B|0:HERC4|0:DAZ3|0:ACSBG2|0:SLC22A16|0:UTP14C|0:TXNDC3|0:AGFG1|0:CYLC2|0:WIPF3|0:SPATA6|0:PRM3|0:PSME4|0:TSSK4|0:TUBD1|0:NANOS3|0:CATSPER1|0:SPATA18|0:SOHLH1|0:ODF4|0:TSNAX|0:FOXA3|0:SPATA20|0:AZI1|0:SLC2A14|0:DAZ2|0:SLC26A8|0:ASF1B|0:CATSPER3|0:TSNAXIP1|0:ADCYAP1R1|0:TSPY2|0:DZIP1|0:PIWIL2|0:DAZ1|0:ZSCAN2|0:CATSPER2|0:C11orf20|0:CATSPER4|0:SPATA9|0:RNF151|0:RNF114|0:TSSK2|0:ODF3|0:TAF7L|0:SPEM1|0:PDILT|0:SIAH1|0:TCP11|0:MICALCL|0:GMCL1L|0:TXNRD3|0:KDM3A|0:SLC9A10|0:PIWIL3|0:GGN|0:SPATA16|0:TNP2|0:CATSPERB|0:PAX5|0:RNF17|0:GGNBP1|0:BOLL|0:DAZL|0:ZFP41|0:CREM|0:GMCL1|0:CATSPERG|0:NANOS2|0:ODF2|0:CADM1|0:SPATA5|0:GGNBP2|0:SLCO4C1|0:DAZ4|0:DNAJB13|0:RACGAP1|0:RPL10L|0:JAG2|0:MYCBPAP|0:MOV10L1|0:SPATA3|0:RPL39L|0:SPATA4|0:TCFL5|0:SUN5|0:XRN2|0:MYCBP|0:BPY2B|0:BPY2|0:BPY2C|0:NLRP14|0:PROK2|0:CYP26B1|0:TDRD9|0:TSSK3|0:PIWIL4|0:TDRD1|0:SERPINA5|0:TDRD6|0:MAEL|0:IFT81|0:ASZ1|0:ZNF296|0:ZNF35|0:SOD1|0:TESK2|0:ROPN1B|0:CCIN|0:DNMT3L|0:SPATA2|0:DEFB118|0:FAM50A|0:RBMY1J|0:WDR33|0:FOXJ1|0:ADC|0:ELL3|0:MTL5|0:C17orf75|0:CYLC1|0:CCNI|0:FSHB|0:ODF1|0:EIF5A2|0:GFER|0:PMCH|0:RBMY1H|0:C15orf2|0:RBMY1F|0:TXNDC2|0:MAK|0:KDM5D|0:NDRG3|0:PNMA1|0:USP9Y|0:THEG|0:RBMY1A1|0:ADAM29|0:SPANXA1|0:SPO11|0:CDY1B|0:OR7C1|0:VCX|0:DEDD|0:INSL3|0:PTTG1|0:WFDC2|0:DUSP13|0:NR6A1|0:PRKACG|0:CCT6B|0:MORC1|0:CCNA1|0:GPR64|0:RUVBL1|0:TRIM27|0:DNAH9|0:HIST1H1A|0:CDY1|0:FSHR|0:ADAM28|0:OAZ3|0:CDY2B|0:SYCP1|0:MEA1|0:PTCH2|0:SPAG11B|0:HSF2BP|0:SPAG4|0:RBMY1C|0:PRKAG1|0:ADAM18|0:BRD2|0:CDYL|0:HIST1H1T|0:LIG3|0:TSPY1|0:SPANXA2|0:CDY2A|0:TESK1|0:BCL2L2|0:HOXA10|0:DAZAP1|0:BCL2L10|0:SPAG9|0:SPA17|0:PRM2|0:KHDRBS3|0:SOX30|0:TSGA10|0:RBMY1B			
GO:0003730	F:mRNA 3'-UTR binding; TAS:ProtInc		0:TARDBP|0:SERBP1|0:AUH|0:SECISBP2|0:CIRBP|0:IGF2BP1|0:RBM38|0:IGF2BP2|0:CRYZ|0:CPSF1|0:IGF2BP3|0:ELAVL4|0:PARN|0:ELAVL2			
GO:0046293	P:formaldehyde biosynthetic process; IDA:UniProtKB		0:KDM3A			
GO:0020017	C:flagellar membrane; IEA:UniProtKB-SubCell		0:CATSPER1|0:CATSPER3|0:CATSPER2|0:CATSPER4|0:SLC9A10			
GO:0051787	F:misfolded protein binding; IPI:BHF-UCL		0:F12|0:STUB1|0:EDEM1|0:CLU			
GO:0051019	F:mitogen-activated protein kinase binding; ISS:UniProtKB		0:MICALCL			
GO:0032543	P:mitochondrial translation; IDA:UniProtKB		0:GFM2			
GO:0060160	P:negative regulation of dopamine receptor si...; ISS:BHF-UCL		0:DRD2			
GO:0045582	P:positive regulation of T cell differentiation; ISS:UniProtKB		0:IL7			
GO:0006984	P:ER-nucleus signaling pathway; TAS:HGNC		0:CRIPAK|0:PAK1			
GO:0050770	P:regulation of axonogenesis; IDA:UniProtKB		0:LRRC4C			
GO:0031668	P:cellular response to extracellular stimulus; IMP:BHF-UCL		0:NR4A2|0:CDKN1A			
GO:0050353	F:trimethyllysine dioxygenase activity; EXP:Reactome		0:TMLHE			
GO:0043022	F:ribosome binding; TAS:UniProtKB		0:WIBG|0:IGHMBP2|0:EIF3K|0:EIF5A|0:EIF6|0:EIF5A2|0:EIF5AL1|0:EIF2A|0:RPSA|0:SEC61A1|0:ERI1|0:ETF1			
GO:0007525	P:somatic muscle development; NAS:UniProtKB		0:NEB			
GO:0046782	P:regulation of viral transcription; IDA:UniProtKB		0:TARBP2			
GO:0018114	F:threonine racemase activity; ISS:UniProtKB		0:SRR			
GO:0060369	P:positive regulation of Fc receptor mediated...; IDA:BHF-UCL		0:CD226			
GO:0030891	C:VCB complex; TAS:UniProtKB		0:USP33			
GO:0030017	C:sarcomere; TAS:HGNC		0:MYLK2|0:SYNE1|0:MYPN|0:MYO18B|0:ABRA|0:MYH2|0:MYL1|0:MYH4|0:MYH7|0:MYL2|0:MYH6			
GO:0004090	F:carbonyl reductase (NADPH) activity; IEA:EC		0:CBR1|0:CBR3|0:DHRS2|0:DHRS4L2|0:DHRS4			
GO:0051792	P:medium-chain fatty acid biosynthetic process; IDA:HGNC		0:OXSM			
GO:0006700	P:C21-steroid hormone biosynthetic process; IDA:UniProtKB		0:CYP11A1			
GO:0004516	F:nicotinate phosphoribosyltransferase activity; IDA:UniProtKB		0:NAPRT1			
GO:0003289	P:atrial septum primum morphogenesis; ISS:BHF-UCL		0:GATA4			
GO:0034638	P:phosphatidylcholine catabolic process; TAS:BHF-UCL		0:LIPC			
GO:0032469	P:endoplasmic reticulum calcium ion homeostasis; IDA:BHF-UCL		0:WFS1			
GO:0015125	F:bile acid transmembrane transporter activity; TAS:ProtInc		0:SLCO1A2|0:SLCO1B3|0:AKR1C4			
GO:0007435	P:salivary gland morphogenesis; IEP:BHF-UCL		0:TGFB3|0:TGFB2|0:TGFB1			
GO:0004992	F:platelet activating factor receptor activity; TAS:ProtInc		0:PTAFR|0:PDGFRL|0:PDGFRB			
GO:0060503	P:bud dilation involved in lung branching; IDA:MGI		0:BMP4			
GO:0032403	F:protein complex binding; IPI:UniProtKB		0:ATM|0:LRP1|0:ERCC8|0:WRN|0:STRN4|0:CAV3|0:CIITA|0:PEX1|0:ING2|0:PEX26|0:STRN3|0:SKIL|0:ERCC6|0:PEX6|0:STRN|0:RPAIN|0:ULK1|0:RPTOR|0:C12orf44			
GO:0050863	P:regulation of T cell activation; IMP:HGNC		0:SIT1|0:LAT			
GO:0000132	P:establishment of mitotic spindle orientation; ISS:UniProtKB		0:CCDC99|0:ZW10|0:NDE1|0:PAFAH1B1|0:CENPA|0:NDC80|0:DYNLT1			
GO:0003828	F:alpha-N-acetylneuraminate alpha-2,8-sialylt...; IEA:EC		0:ST8SIA1			
GO:0050038	F:L-xylulose reductase (NADP+) activity; IEA:EC		0:DCXR			
GO:0032587	C:ruffle membrane; IEA:UniProtKB-SubCell		0:PLEK|0:TPM1|0:PLEKHA1|0:SNTG1|0:RPS3|0:ARHGEF2|0:WWC1|0:DIAPH1|0:THEM4|0:LCP1|0:AIF1|0:TLN1|0:EZR|0:FGD2|0:SPRY4|0:PDE4A|0:FERMT1|0:AIF1L|0:ARHGEF4|0:PDE9A|0:PDPN|0:NF2|0:RASGRP2|0:MYO6			
GO:0019370	P:leukotriene biosynthetic process; TAS:ProtInc		0:ALOX5AP|0:PRG3|0:MGST2|0:RNPEP|0:C9orf3|0:RNPEPL1|0:ALOX12|0:GGT5|0:ALOXE3|0:ALOX15B|0:ALOX12B|0:LTC4S|0:ALOX15|0:ALOX5|0:PLA2G1B|0:LTA4H			
GO:0019377	P:glycolipid catabolic process; IMP:UniProtKB		0:NAGA			
GO:0032092	P:positive regulation of protein binding; ISS:BHF-UCL		0:ADD2|0:WNT3A|0:VTN|0:ADD1|0:TCF7L2|0:EPB41|0:FKBP1A|0:AKTIP|0:TRIB3			
GO:0030215	F:semaphorin receptor binding; TAS:UniProtKB		0:PLXNB1			
GO:0008373	F:sialyltransferase activity; TAS:ProtInc		0:ST6GALNAC2|0:ST6GALNAC3|0:ST6GALNAC5|0:ST8SIA4|0:ST3GAL6|0:ST6GALNAC6			
GO:0006032	P:chitin catabolic process; IEA:InterPro		0:CHIA|0:CHIT1|0:CHID1|0:CHI3L1|0:OVGP1|0:CHI3L2			
GO:0001845	P:phagolysosome assembly; IMP:UniProtKB		0:CORO1A			
GO:0031507	P:heterochromatin formation; IMP:UniProtKB		0:BAHD1			
GO:0014003	P:oligodendrocyte development; IMP:UniProtKB		0:EIF2B3|0:EIF2B2|0:EIF2B5|0:EIF2B1|0:EIF2B4			
GO:0000012	P:single strand break repair; IMP:UniProtKB		0:TDP1|0:LIG4|0:APTX|0:TNP1|0:XRCC1|0:APLF			
GO:0046933	F:hydrogen ion transporting ATP synthase acti...; TAS:UniProtKB		0:ATP6V1B2|0:ATP6V1A|0:ATP5B|0:ATP5C1|0:ATP5E|0:ATP6V1B1|0:ATP5EP2|0:ATP5O|0:ATP6AP1L|0:ATP6V1F|0:ATP6AP1|0:ATP5D|0:ATP5A1|0:ATP6V0C			
GO:0016702	F:oxidoreductase activity, acting on single d...; IEA:UniProtKB-KW		0:BCO2|0:UTY|0:KDM2B|0:KDM4D|0:LEPRE1|0:ADI1|0:C17orf101|0:KDM5A|0:PTGS2|0:PLOD2|0:EGLN2|0:LEPREL1|0:ASPHD1|0:TET2|0:TMLHE|0:P4HTM|0:PLOD3|0:KDM4C|0:LEPREL2|0:P4HA3|0:KDM5B|0:PHF8|0:ASPHD2|0:ALKBH4|0:KDM3B|0:JMJD6|0:HIF1AN|0:PTGS1|0:BBOX1|0:OGFOD2|0:KDM6A|0:KDM4B|0:TET1|0:P4HA2|0:EGLN3|0:PHYHD1|0:ALKBH7|0:FTO|0:KDM5C|0:C14orf169|0:JHDM1D|0:ALKBH3|0:KDM3A|0:KDM2A|0:KDM6B|0:PHYH|0:KDM4A|0:OGFOD1|0:ALKBH5|0:ALKBH1|0:ASPH|0:EGLN1|0:KDM4DL|0:TET3|0:ALKBH2|0:P4HA1|0:ALKBH6|0:PLOD1|0:JMJD1C|0:KDM5D			
GO:0008395	F:steroid hydroxylase activity; TAS:ProtInc		0:CYP2C19|0:CYP2C9|0:CYP46A1			
GO:0007213	P:muscarinic acetylcholine receptor signaling...; TAS:UniProtKB		0:ADRBK1|0:CDK5R1|0:GNB1|0:AGRN			
GO:0031256	C:leading edge membrane; IDA:UniProtKB		0:PTPRK			
GO:0047017	F:prostaglandin-F synthase activity; IEA:EC		0:AKR1C3			
GO:0005502	F:11-cis retinal binding; IDA:UniProtKB		0:OPN4			
GO:0048147	P:negative regulation of fibroblast prolifera...; IMP:UniProtKB		0:SFRP1|0:MORC3|0:EMD|0:B4GALT7			
GO:0017159	F:pantetheine hydrolase activity; NAS:UniProtKB		0:VNN1|0:VNN2|0:VNN3			
GO:0070304	P:positive regulation of stress-activated pro...; IDA:UniProtKB		0:LYN			
GO:0060628	P:regulation of ER to Golgi vesicle-mediated ...; ISS:UniProtKB		0:SCFD1			
GO:0060558	P:regulation of calcidiol 1-monooxygenase act...; ISS:BHF-UCL		0:VDR			
GO:0071339	C:MLL1 complex; IDA:UniProtKB		0:CHD8|0:PHF20|0:RUVBL2|0:TEX10|0:TAF4|0:HCFC1|0:TAF9|0:MCRS1|0:RUVBL1|0:PRPF31|0:MLL|0:MAX|0:C17orf49|0:PELP1|0:RNF2|0:TAF1|0:WDR5|0:E2F6|0:INO80C|0:TAF6|0:MGA|0:RBBP5|0:SENP3|0:KIAA1267|0:TAF7|0:LAS1L			
GO:0007567	P:parturition; TAS:ProtInc		0:HPGD|0:PLA2G4B|0:PLA2G4C|0:CRHR1|0:MAFF|0:PTGFR|0:CRH			
GO:0046975	F:histone methyltransferase activity (H3-K36 ...; ISS:UniProtKB		0:NSD1			
GO:0034599	P:cellular response to oxidative stress; IMP:UniProtKB		0:TRAP1|0:STX3|0:TMEM161A|0:ETV5|0:DHRS2|0:LONP1|0:SLC11A2|0:G6PD|0:PYCR1			
GO:0030889	P:negative regulation of B cell proliferation; ISS:BHF-UCL		0:IL10|0:CDKN2A			
GO:0015939	P:pantothenate metabolic process; IDA:BHF-UCL		0:VNN1|0:VNN2			
GO:0050691	P:regulation of defense response to virus by ...; IDA:UniProtKB		0:IL28RA			
GO:0014842	P:regulation of satellite cell proliferation; IDA:UniProtKB		0:ANGPT1			
GO:0031226	C:intrinsic to plasma membrane; ISS:UniProtKB		0:RAB26			
GO:0003951	F:NAD+ kinase activity; IEA:InterPro		0:NADK|0:C5orf33			
GO:0002019	P:regulation of renal output by angiotensin; NAS:BHF-UCL		0:ACE|0:AGT			
GO:0051575	F:5'-deoxyribose-5-phosphate lyase activity; IMP:UniProtKB		0:XRCC6			
GO:0004370	F:glycerol kinase activity; NAS:UniProtKB		0:GK5|0:GK|0:GK3P|0:GK2			
GO:0043278	P:response to morphine; ISS:BHF-UCL		0:DRD3|0:DRD2			
GO:0033257	C:Bcl3/NF-kappaB2 complex; IDA:UniProtKB		0:BCL3|0:NFKB2			
GO:0045638	P:negative regulation of myeloid cell differe...; ISS:UniProtKB		0:ZBTB16			
GO:0015910	P:peroxisomal long-chain fatty acid import; TAS:ProtInc		0:ABCD3			
GO:0042246	P:tissue regeneration; NAS:UniProtKB		0:NINJ1|0:NINJ2|0:APOA5|0:KLK6			
GO:0008581	?:ubiquitin-specific protease 5 activity; IMP:UniProtKB		0:USP2|0:USP3			
GO:0006891	P:intra-Golgi vesicle-mediated transport; TAS:ProtInc		0:COPB2|0:COPG2|0:COG3|0:COPZ1|0:CUX1|0:COG2|0:GABARAPL2|0:COPB1|0:COPE|0:COG5|0:GOLGA3|0:COG1|0:NAPA|0:STX16|0:NAPG|0:GOSR1			
GO:0035252	F:UDP-xylosyltransferase activity; IDA:UniProtKB		0:GXYLT2|0:GXYLT1			
GO:0034363	C:intermediate-density lipoprotein particle; IDA:BHF-UCL		0:APOE|0:APOC3|0:APOB|0:APOC2			
GO:0051770	P:positive regulation of nitric-oxide synthas...; ISS:BHF-UCL		0:NAMPT|0:TLR4|0:TLR9|0:TLR2			
GO:0005868	C:cytoplasmic dynein complex; TAS:ProtInc		0:DYNC1LI1|0:DYNLT3|0:DYNLL1|0:DYNC1I1|0:DYNLT1|0:DYNLRB2|0:DYNLRB1|0:DYNC1H1|0:DYNC1LI2			
GO:0002003	P:angiotensin maturation; IDA:HGNC		0:ATP6AP2|0:REN			
GO:0005153	F:interleukin-8 receptor binding; TAS:ProtInc		0:IL8|0:YARS			
GO:0016197	P:endosome transport; TAS:UniProtKB		0:ABCA1|0:PICALM|0:RAB35|0:DPY30|0:VPS4A|0:ZFYVE16|0:KIAA1033|0:SNX17|0:ZFYVE20|0:HGS|0:RASSF9|0:DCLK1|0:TOM1|0:TINAGL1|0:SQSTM1			
GO:0004042	F:acetyl-CoA:L-glutamate N-acetyltransferase ...; IEA:EC		0:NAGS			
GO:0018346	P:protein amino acid prenylation; IEA:InterPro		0:PTAR1			
GO:0016608	F:growth hormone-releasing hormone activity; ISS:UniProtKB		0:GHRH|0:GHRL			
GO:0004525	F:ribonuclease III activity; IEA:InterPro		0:DICER1|0:RNASEN|0:MRPL44			
GO:0004435	F:phosphoinositide phospholipase C activity; TAS:ProtInc		0:HTR2B|0:PLCE1|0:PLCG1|0:HTR2C|0:PLCD3|0:PLCB3|0:PLCD4|0:PLCZ1|0:PLCH2|0:PLCG2|0:PLCH1|0:PLCB4|0:PLCL2|0:PLCL1|0:HTR2A|0:PLCB1|0:CASR|0:CHRM3|0:PLCB2|0:CHRM1|0:F2RL2|0:CHRM5|0:EDNRA|0:PLCD1|0:CCKBR|0:CCR5|0:C3AR1|0:BDKRB2			
GO:0033382	P:maintenance of granzyme B location in T cel...; ISS:UniProtKB		0:SRGN			
GO:0015670	P:carbon dioxide transport; IDA:UniProtKB		0:RHAG|0:AQP5			
GO:0060383	P:positive regulation of DNA strand elongation; IDA:BHF-UCL		0:POT1			
GO:0010887	P:negative regulation of cholesterol storage; TAS:BHF-UCL		0:PPARG|0:PPARA|0:NR1H3|0:NR1H2|0:ABCG1|0:ABCA1			
GO:0006222	P:UMP biosynthetic process; IEA:InterPro		0:UMPS|0:DPYD|0:DHODH			
GO:0006273	P:lagging strand elongation; IDA:UniProtKB		0:POLA1			
GO:0005080	F:protein kinase C binding; TAS:ProtInc		0:PLEK|0:UGT1A10|0:UGT1A7|0:HDAC7|0:YWHAG|0:PRKCSH|0:SQSTM1|0:HDAC5|0:TOP2B|0:PRKCB|0:TOP2A|0:PKN1|0:HDAC9|0:IRS1|0:ADAM9|0:PDLIM5|0:PICK1|0:HINT1|0:AVPR1A|0:GRK5|0:AVPR1B			
GO:0030109	F:HLA-B specific inhibitory MHC class I recep...; NAS:UniProtKB		0:KIR3DL1			
GO:0048184	F:follistatin binding; NAS:UniProtKB		0:INHBA|0:ACVR1			
GO:0006680	P:glucosylceramide catabolic process; IEA:InterPro		0:GBA2			
GO:0030913	P:paranodal junction assembly; ISS:UniProtKB		0:CD9			
GO:0006769	P:nicotinamide metabolic process; EXP:Reactome		0:NAPRT1|0:NAMPT			
GO:0008020	F:G-protein coupled photoreceptor activity; TAS:ProtInc		0:OPN4|0:OPN3|0:GNAT2|0:ELOVL4|0:CRY1			
GO:0006997	P:nucleus organization; TAS:ProtInc		0:ATXN7|0:NUMA1			
GO:0071222	P:cellular response to lipopolysaccharide; IMP:BHF-UCL		0:CD14|0:HMGB2|0:WNT5A|0:SERPINE1			
GO:0006526	P:arginine biosynthetic process; NAS:UniProtKB		0:NAGS|0:ASS1|0:OTC			
GO:0007500	P:mesodermal cell fate determination; TAS:ProtInc		0:TDGF3|0:KLF4|0:TRIM15			
GO:0006313	P:transposition, DNA-mediated; TAS:UniProtKB		0:C14orf115|0:SETMAR			
GO:0051480	P:cytosolic calcium ion homeostasis; ISS:UniProtKB		0:TRPC1|0:CAV1|0:F2|0:PDE6A|0:PDE6B|0:CLN3			
GO:0032958	P:inositol phosphate biosynthetic process; IDA:MGI		0:IP6K3			
GO:0050482	P:arachidonic acid secretion; TAS:BHF-UCL		0:DRD3|0:DRD4|0:ACE|0:BDKRB2|0:DRD2|0:NMUR2|0:PLA2G1B			
GO:0060396	P:growth hormone receptor signaling pathway; IMP:BHF-UCL		0:GH1|0:PIK3R1|0:SOCS2|0:GHR			
GO:0034359	C:mature chylomicron; IDA:BHF-UCL		0:APOB			
GO:0043295	F:glutathione binding; IDA:UniProtKB		0:LANCL1|0:GSS			
GO:0007341	P:penetration of zona pellucida; ISS:UniProtKB		0:SMCP			
GO:0005046	F:KDEL sequence binding; TAS:ProtInc		0:KDELR2|0:KDELR1			
GO:0005049	F:nuclear export signal receptor activity; TAS:ProtInc		0:XPO7|0:NUPL2			
GO:0016199	P:axon midline choice point recognition; ISS:UniProtKB		0:ROBO3|0:APP|0:ROBO2|0:ROBO1			
GO:0004823	F:leucine-tRNA ligase activity; EXP:Reactome		0:LARS|0:LARS2			
GO:0001702	P:gastrulation with mouth forming second; NAS:UniProtKB		0:NAT8|0:NAT8B			
GO:0050786	F:RAGE receptor binding; ISS:UniProtKB		0:S100A12|0:HMGB2|0:S100A7|0:S100A4|0:S100A13|0:S100B|0:HMGB1			
GO:0048311	P:mitochondrion distribution; IMP:UniProtKB		0:MSTO1			
GO:0018352	P:protein-pyridoxal-5-phosphate linkage; TAS:UniProtKB		0:GAD1			
GO:0015917	P:aminophospholipid transport; TAS:UniProtKB		0:ATP11B			
GO:0003218	P:cardiac left ventricle formation; ISS:BHF-UCL		0:HAND1|0:TBX5			
GO:0042277	F:peptide binding; ISS:UniProtKB		0:FURIN|0:ANG|0:PPIB|0:PPIA|0:PCSK5|0:TPP1			
GO:0015280	F:amiloride-sensitive sodium channel activity; TAS:ProtInc		0:ACCN3|0:ACCN2|0:SCNN1G|0:SCNN1D|0:SHROOM2|0:ACCN1|0:SCNN1B			
GO:0006812	P:cation transport; NAS:UniProtKB		0:PANX1|0:GRIN1|0:ATP13A2|0:ATP13A5|0:ATP13A4|0:ATP13A1|0:KIAA0195|0:ATP13A3|0:ATP10D			
GO:0043045	P:DNA methylation involved in embryo development; NAS:UniProtKB		0:ZFP57|0:PICK1			
GO:0055100	F:adiponectin binding; ISS:BHF-UCL		0:CDH13			
GO:0004310	F:farnesyl-diphosphate farnesyltransferase ac...; EXP:Reactome		0:FDFT1			
GO:0030141	C:stored secretory granule; TAS:BHF-UCL		0:TF|0:SCG3|0:APOA1|0:GHRHR|0:C7orf68|0:MPO|0:LTF|0:ELANE|0:CTSG|0:LACRT|0:BRCA2|0:SEMG2|0:SEMG1|0:PCSK5|0:HSPD1|0:SCG5|0:EXOC3L|0:PAM|0:CPA3|0:CYBA			
GO:0001880	P:Mullerian duct regression; NAS:UniProtKB		0:AMH|0:AMHR2			
GO:0017134	F:fibroblast growth factor binding; IPI:UniProtKB		0:FGFBP3|0:FGFR2|0:FGFR3|0:FIBP|0:KLB|0:API5|0:CEP57|0:KL|0:FGFR4			
GO:0006400	P:tRNA modification; TAS:ProtInc		0:WDR4|0:GTPBP3|0:CDK5RAP1|0:THG1L|0:SSB			
GO:0072166	P:posterior mesonephric tubule development; ISS:UniProtKB		0:OSR1			
GO:0003796	F:lysozyme activity; TAS:UniProtKB		0:SPACA3|0:LYZL6|0:LYZL2|0:SPACA5|0:SPACA5B|0:LYZL1|0:LYG1|0:LYZL4|0:LYG2|0:CHIA|0:LYZ			
GO:0046007	P:negative regulation of activated T cell pro...; NAS:UniProtKB		0:FOXP3			
GO:0016651	F:oxidoreductase activity, acting on NADH or ...; IDA:UniProtKB		0:ECSIT			
GO:0006475	P:internal protein amino acid acetylation; TAS:ProtInc		0:HAT1|0:NAA10			
GO:0015485	F:cholesterol binding; TAS:ProtInc		0:APOC3|0:ABCG1|0:ABCA1|0:CETP|0:SOAT2|0:APOA2|0:SOAT1|0:APOA1|0:NPC2|0:STARD3|0:SYP|0:TSPO2|0:IHH|0:TSPO|0:CAV1|0:APOF			
GO:0035307	P:positive regulation of protein amino acid d...; IDA:UniProtKB		0:TGFB1|0:PPP2R4|0:DLC1			
GO:0032508	P:DNA duplex unwinding; IMP:UniProtKB		0:POT1|0:RECQL4|0:RAD50|0:NBN|0:MRE11A|0:SUPV3L1			
GO:0032008	P:positive regulation of TOR signaling cascade; IMP:UniProtKB		0:RPTOR|0:RICTOR|0:GOLPH3|0:MLST8			
GO:0006944	P:cellular membrane fusion; TAS:ProtInc		0:VPS33B|0:NPLOC4|0:RIMS1|0:NAPA|0:OTOF|0:RABIF|0:VAMP3|0:NAPG|0:RABEP1|0:SNAP29|0:ATG7|0:GOSR2|0:STX11|0:SNAP23|0:GCA|0:VTI1B|0:VAPA|0:STAP1			
GO:0032119	P:sequestering of zinc ion; IDA:BHF-UCL		0:SLC30A8			
GO:0004911	F:interleukin-2 receptor activity; TAS:ProtInc		0:IL2RB|0:IL2RA			
GO:0047006	F:20-alpha-hydroxysteroid dehydrogenase activity; TAS:BHF-UCL		0:AKR1C1|0:HSD17B2			
GO:0033211	P:adiponectin-mediated signaling pathway; IDA:BHF-UCL		0:CSNK2B			
GO:0051437	P:positive regulation of ubiquitin-protein li...; EXP:Reactome		0:PSMB8|0:PSMD10|0:FZR1|0:SKP1|0:PSMC6|0:FBXO5|0:CDC26|0:ANAPC11|0:PSMD3|0:PSMB4|0:PSMA3|0:ANAPC7|0:PSMC1|0:PSMD13|0:PSMB10|0:ANAPC4|0:PSMF1|0:CDC23|0:PSMA6|0:CDC20|0:PSME1|0:PSMA2|0:PSMB5|0:CDC27|0:PSMD4|0:PSMC5|0:BTRC|0:PSMD7|0:PSMB1|0:CDK1|0:PSMD5|0:PSMD12|0:PSMA5|0:PSMA1|0:PSMB6|0:ANAPC5|0:CDC16|0:PSMD1|0:PSMC4|0:PSMD8|0:PSME2|0:PSMB2|0:CCNB1|0:PSMD11|0:PSMB7|0:PSMD6|0:CUL1|0:ANAPC2|0:UBE2C|0:PSMA7|0:PSMD2|0:ANAPC1|0:ANAPC10|0:PSMD9|0:PSMB3|0:PLK1|0:PSMC2|0:PSMD14|0:UBE2D1|0:PSMA4|0:UBE2E1|0:PSMC3|0:PSME3|0:PSMB9			
GO:0021889	P:olfactory bulb interneuron differentiation; ISS:UniProtKB		0:SALL1			
GO:0001727	F:lipid kinase activity; IDA:UniProtKB		0:DGKZ			
GO:0032808	P:lacrimal gland development; IMP:UniProtKB		0:FGF10			
GO:0051252	P:regulation of RNA metabolic process; NAS:UniProtKB		0:RASA1			
GO:0045453	P:bone resorption; TAS:UniProtKB		0:GPR55|0:TPP1|0:IL7|0:PTH|0:ZNF675			
GO:0030289	C:protein phosphatase 4 complex; ISS:UniProtKB		0:PPP4R1			
GO:0009411	P:response to UV; TAS:ProtInc		0:MAPK8|0:RPAIN|0:ERCC8|0:CIRBP|0:MEN1|0:DTL|0:UBE4B|0:REV1|0:ELANE|0:USP1|0:DDB2|0:BRSK1|0:UBE2A|0:UBE2B|0:CDKN2D|0:MSH6|0:USF1|0:GTF2H2|0:SERPINB13|0:POLD1			
GO:0042060	P:wound healing; TAS:UniProtKB		0:NRG1|0:INS|0:ERBB2|0:MIA3|0:DCBLD2|0:WNT5A|0:ENG|0:SLC11A1|0:TPM1|0:NF1|0:TGFB2|0:NOG|0:ERBB3|0:FUT10|0:SCARB1|0:PDGFA|0:EREG|0:SPRR3			
GO:0035108	P:limb morphogenesis; ISS:BHF-UCL		0:BMPR1B|0:PCSK5			
GO:0030501	P:positive regulation of bone mineralization; ISS:UniProtKB		0:BMP7|0:BMP2|0:WNT4|0:BMP6|0:BMP4|0:TFAP2A|0:TGFB3|0:TGFB1|0:BMPR1A|0:ACVR1|0:ACVR2B|0:ACVR2A|0:BMPR2|0:BMPR1B|0:KL|0:P2RX7|0:PKDCC			
GO:0007190	P:activation of adenylate cyclase activity; TAS:UniProtKB		0:NTRK2|0:NTRK1|0:ADCYAP1|0:ADCYAP1R1|0:ACR|0:CALCA|0:CRHR1|0:P2RY11|0:GLP1R|0:CAP2|0:CAP1|0:EDNRA|0:AVPR2|0:ADORA3|0:GNAS			
GO:0006446	P:regulation of translational initiation; TAS:ProtInc		0:NCBP2|0:NCBP1|0:KIAA0427|0:DDX1|0:HSPB1			
GO:0008306	P:associative learning; ISS:UniProtKB		0:CLN3			
GO:0043410	P:positive regulation of MAPKKK cascade; IMP:BHF-UCL		0:INS|0:F2R|0:IL6R|0:IL6|0:IGF2|0:ADRB3|0:ADRB2|0:LIF|0:TRAF7|0:OSM|0:IL11|0:SOX2|0:WWC1|0:GRM4|0:INSR			
GO:0007161	P:calcium-independent cell-matrix adhesion; TAS:ProtInc		0:PKD1			
GO:0035470	P:positive regulation of vascular wound healing; IDA:UniProtKB		0:VEGFB			
GO:0050658	P:RNA transport; NAS:UniProtKB		0:HNRNPA2B1|0:CKAP5|0:ATXN2			
GO:0010841	P:positive regulation of circadian sleep/wake...; NAS:BHF-UCL		0:CRH			
GO:0030119	C:AP-type membrane coat adaptor complex; TAS:ProtInc		0:AP3S1			
GO:0008478	F:pyridoxal kinase activity; IDA:UniProtKB		0:PDXK			
GO:0021766	P:hippocampus development; ISS:BHF-UCL		0:AXIN2|0:DVL2|0:ZEB2|0:GSK3B|0:BBS4|0:PAFAH1B1|0:MKKS|0:BBS2			
GO:0006426	P:glycyl-tRNA aminoacylation; IEA:InterPro		0:POLG2|0:GARS			
GO:0010837	P:regulation of keratinocyte proliferation; IMP:BHF-UCL		0:OVOL2			
GO:0030728	P:ovulation; ISS:UniProtKB		0:EREG			
GO:0030878	P:thyroid gland development; ISS:UniProtKB		0:NKX2-5|0:FOXE1|0:NKX2-1|0:HOXD3|0:SIX1			
GO:0046683	P:response to organophosphorus; IEP:UniProtKB		0:RFC3|0:TYMS|0:TRIM16|0:AKR1C1			
GO:0004157	F:dihydropyrimidinase activity; TAS:ProtInc		0:DPYS|0:DPYSL2|0:DPYSL3|0:CRMP1			
GO:0030372	F:high molecular weight B cell growth factor ...; NAS:UniProtKB		0:TXLNA			
GO:0004656	F:procollagen-proline 4-dioxygenase activity; TAS:ProtInc		0:P4HB|0:P4HA3|0:P4HA2|0:P4HA1			
GO:0001607	F:neuromedin U receptor activity; IDA:UniProtKB		0:NMUR2|0:NMUR1			
GO:0033861	P:negative regulation of NAD(P)H oxidase acti...; IDA:UniProtKB		0:INS|0:DRD5			
GO:0004573	F:mannosyl-oligosaccharide glucosidase activity; IEA:EC		0:MOGS			
GO:0031929	P:TOR signaling cascade; ISS:UniProtKB		0:RPS6KB1|0:RPS6|0:EIF4EBP1|0:RHEBL1|0:MTOR|0:CCDC88A			
GO:0045941	P:positive regulation of transcription; TAS:UniProtKB		0:NDP|0:PICALM|0:GDF6|0:GDF7|0:FZD4|0:FZD2|0:LRP5|0:FZD1|0:FZD7|0:TGFBR1|0:GDF2|0:BMP10|0:MSTN|0:ACVRL1|0:RHOG|0:ACVR1|0:TNNI2|0:RUNX1|0:IL29|0:NUP62|0:BLM|0:ETS1|0:ING5|0:CREB3L2|0:BLOC1S2|0:RNF111|0:LRP6|0:AXIN1|0:ZXDA|0:KDM3A|0:VHL|0:RGMB|0:IRF6|0:PHIP|0:SMARCAD1|0:NFKB1|0:CAMKK2			
GO:0008152	P:metabolic process; TAS:UniProtKB		0:PITPNM2|0:PRNP|0:FGF16|0:AQP9			
GO:0004832	F:valine-tRNA ligase activity; IEA:EC		0:VARS|0:VARS2			
GO:0031577	P:spindle checkpoint; IMP:UniProtKB		0:BIRC5			
GO:0019135	F:deoxyhypusine monooxygenase activity; IMP:UniProtKB		0:DOHH			
GO:0016607	C:nuclear speck; ISS:UniProtKB		0:EFTUD2|0:CDC5L|0:PRPF19|0:PPIH|0:MEF2C|0:SLU7|0:CXXC1|0:TFIP11|0:CCDC55|0:C1orf124|0:ATPAF2|0:PRPF31|0:TOPORS|0:SRSF2|0:FYTTD1|0:MECOM|0:THAP7|0:WBP4|0:TIMM50|0:PPP1R8|0:HSPA1A|0:RBM25|0:SRRM2|0:AFF2|0:HSPA1B|0:DGKQ|0:ZBTB16|0:POLDIP3|0:WT1|0:SUMO1|0:CRNKL1|0:PRPF3|0:PLRG1|0:CDK12|0:MAML3|0:AKAP17A|0:CCNL1|0:RREB1|0:WAC|0:FRG1|0:SMNDC1|0:PIAS3|0:PPIG|0:THOC1|0:PSME4|0:RBM27|0:SF3A3|0:PRPF8|0:MAGOH|0:POU4F2|0:RFWD2|0:MAML2|0:CCNL2|0:SF3B1|0:ZMIZ1|0:SRY|0:NOC3L|0:LUC7L3|0:RBM39|0:PRPF40B|0:TRIM22|0:TRIM69|0:NXF1|0:PIAS2|0:SRSF10|0:SRSF1|0:PRPF18|0:METTL3|0:EIF4A3|0:PIAS1|0:PSKH1|0:PRPF40A|0:SFRS18|0:RBM8A|0:TOE1|0:ZNF638|0:SON|0:EAF1|0:SRP54|0:SETD1B|0:RNPS1|0:DDX46|0:U2AF1L4|0:YLPM1|0:SART3|0:ELL|0:MBD1|0:RNF34|0:GATAD2A|0:SRSF4|0:PRPF4|0:CBY1|0:PNN|0:DDX3X|0:RING1|0:SRRM1|0:CTR9|0:BAT1|0:RCHY1|0:THOC4|0:MAML1|0:MLL5|0:SETD1A|0:CASC3|0:PPP1CC|0:DDX42|0:PYHIN1|0:CIR1|0:EAF2|0:GLIS2|0:BASP1|0:DYRK1A			
GO:0042054	F:histone methyltransferase activity; IMP:MGI		0:EED|0:SUZ12			
GO:0003924	F:GTPase activity; TAS:UniProtKB		0:GNA11|0:GNA13|0:GNAQ|0:GNA12|0:GNAL|0:GNA15|0:GNA14|0:RHOQ|0:GEM|0:GTPBP4|0:TRIM23|0:RHOG|0:GNB1|0:RAB5A|0:RAB14|0:TGM3|0:RAB11A|0:RAB2A|0:RAC3|0:RAP1B|0:RRAGC|0:RAB6A|0:RAB11B|0:ATL1|0:RERG|0:GFM2|0:RAB9A|0:RAB21|0:RALB|0:RAB4A|0:RRAS|0:GFM1|0:RAB6C|0:GTPBP1|0:GBP7|0:REM2|0:HRAS|0:TUFM|0:RAP2B|0:TUBA4A|0:EEF2|0:TUBB6|0:RIT1|0:RASL11A|0:TUBA1A|0:EEF1A2|0:RASL12|0:TUBB4Q|0:ERAS|0:HBS1L|0:TUBB1|0:TUBD1|0:MFN2|0:TUBA3E|0:GBP4|0:RHEBL1|0:GBP2|0:EHD3|0:TUBG1|0:EEF1A1P5|0:GBP1|0:EHD4|0:MTIF2|0:AGAP9|0:RNF112|0:TUBA3D|0:TUBB3|0:EEF1A1|0:DIRAS1|0:EHD2|0:RERGL|0:TUBB2B|0:TUBB4|0:GUF1|0:GBP5|0:GTPBP3|0:TUBE1|0:C8orf80|0:TUBG2|0:GBP3|0:TUBA1C|0:SRPR|0:AGAP3|0:RASL10B|0:TUBA3C|0:KRAS|0:TUBB2A|0:TUBB2C|0:TUBB|0:GTPBP2|0:SRL|0:EHD1|0:TUBAL3|0:TUBA8|0:EFTUD1|0:BMS1|0:EIF5B|0:RASL11B|0:MX1|0:RAP2C|0:NRAS|0:TUBA1B|0:DIRAS2|0:GSPT2|0:RALA|0:GBP6|0:REM1|0:RAB3A|0:RAB27B|0:DNM3|0:RAB27A|0:ATL3|0:GNGT2|0:RND1|0:GNL2|0:RAB18|0:GNG5|0:GNB5|0:ATL2|0:RASD2|0:SAR1A|0:DNM2|0:EEFSEC|0:RAB38|0:MFN1|0:RAB4B|0:ARL8A|0:NKIRAS2|0:RAB8B|0:RAB6B|0:RIT2|0:RHOJ|0:GNG8|0:RHOF|0:GNAT1|0:NKIRAS1|0:ARL8B|0:NUDT1|0:ARF5|0:RAB28|0:GNG10|0:EFTUD2|0:RRAS2|0:GNB2|0:DIRAS3|0:DNM1|0:RAB35|0:RHOD|0:GNAI2|0:RAB33A|0:RAB3B|0:RAB30|0:ARFRP1|0:ARHGAP5|0:GNG11|0:RND2|0:GNB3|0:GNAI3|0:EIF2S3|0:RAB3D|0:RABL2A|0:ARF6|0:RAB5B|0:ARL4D|0:ARL1|0:RAB31|0:NCF1|0:MRAS|0:RAP2A|0:RAB7L1|0:ARL4C|0:SEPT9|0:SEPT4|0:RASD1|0:RAB13|0:RAB7A|0:GNAO1|0:RRAD|0:GNG3|0:GNAZ|0:RAB1A|0:SEPT5|0:RND3|0:MX2|0:RAB5C|0:RASL10A|0:GNGT1|0:RAP1A|0:RAC2|0:ARF4|0:EIF5|0:RHOC|0:RHEB|0:RABL2B|0:DNM1L|0:ARF1|0:ARF3|0:OPA1|0:GSPT1|0:RAC1|0:RHOA|0:RAB22A|0:GNAS|0:RHOB|0:CDC42			
GO:0035014	F:phosphoinositide 3-kinase regulator activity; ISS:UniProtKB		0:PIK3R2|0:PIK3R3|0:PIK3R1			
GO:0030522	P:intracellular receptor mediated signaling p...; TAS:UniProtKB		0:DCBLD2|0:SLA2			
GO:0003285	P:septum secundum development; IMP:BHF-UCL		0:NKX2-5			
GO:0045323	C:interleukin-1 receptor complex; NAS:UniProtKB		0:IRAK1|0:TOLLIP			
GO:0002544	P:chronic inflammatory response; ISS:BHF-UCL		0:THBS1|0:VNN1			
GO:0031118	P:rRNA pseudouridine synthesis; ISS:UniProtKB		0:NHP2			
GO:0015295	F:solute:hydrogen symporter activity; IDA:UniProtKB		0:SLC11A2			
GO:0004723	F:calcium-dependent protein serine/threonine ...; NAS:UniProtKB		0:CAMK2G|0:PPP3R1			
GO:0048539	P:bone marrow development; ISS:UniProtKB		0:SBDS|0:LRRC17			
GO:0070765	C:gamma-secretase complex; IDA:UniProtKB		0:PSEN1			
GO:0045190	P:isotype switching; ISS:UniProtKB		0:MSH2|0:MSH6|0:LIG4|0:CD40LG			
GO:0033814	F:propanoyl-CoA C-acyltransferase activity; IEA:EC		0:SCP2			
GO:0003875	F:ADP-ribosylarginine hydrolase activity; IMP:UniProtKB		0:ADPRHL1|0:ADPRH			
GO:0000278	P:mitotic cell cycle; IMP:UniProtKB		0:CEP250|0:USP3|0:PRDM5			
GO:0031464	C:Cul4A-RING ubiquitin ligase complex; IDA:UniProtKB		0:DDB1|0:ERCC8|0:DTL|0:TRPC4AP|0:RBX1|0:CRBN|0:CUL4A			
GO:0019229	P:regulation of vasoconstriction; TAS:UniProtKB		0:ECE1|0:ACE2|0:BDKRB2|0:ACE|0:AGTR1|0:EDN3|0:EDN2|0:EDN1|0:AGT|0:NPPC|0:KCNMB4|0:KCNMB2			
GO:0004938	F:alpha2-adrenergic receptor activity; IDA:BHF-UCL		0:ADRA2B|0:ADRA2C|0:ADRA2A			
GO:0005673	C:transcription factor TFIIE complex; IEA:InterPro		0:GTF2E2			
GO:0015075	F:ion transmembrane transporter activity; TAS:ProtInc		0:SVOP|0:LASP1|0:PLP2|0:GJA1			
GO:0004883	F:glucocorticoid receptor activity; TAS:ProtInc		0:NR3C1			
GO:0002456	P:T cell mediated immunity; NAS:UniProtKB		0:GNL1			
GO:0044403	P:symbiosis, encompassing mutualism through p...; IDA:UniProtKB		0:SMC2			
GO:0008347	P:glial cell migration; IDA:UniProtKB		0:VCAN|0:TGFB2|0:AZU1			
GO:0070412	F:R-SMAD binding; IPI:BHF-UCL		0:FOS|0:MEN1|0:JUN|0:TRIM33|0:SMAD2|0:SMAD6|0:SMURF1|0:FOXH1|0:SMAD4|0:CTNNB1			
GO:0051549	P:positive regulation of keratinocyte migration; IMP:BHF-UCL		0:FGF10|0:FGF7|0:MMP9|0:ADAM9			
GO:0034776	P:response to histamine; IDA:BHF-UCL		0:DRD3|0:DRD4|0:DRD2			
GO:0015986	P:ATP synthesis coupled proton transport; TAS:ProtInc		0:ATP6V0B|0:ATP6V1B2|0:ATP6V1E2|0:ATP6V1A|0:ATP5L2|0:TCIRG1|0:ATP6V1C1|0:ATP6V0A2|0:ATP6V0C|0:ATP6V1H|0:ATP6V1B1|0:ATP6V1E1|0:ATP5EP2|0:ATP6V1D|0:ATP5G1|0:ATP5G2|0:ATP6AP1L|0:ATP6V0D2|0:ATP6V0E2|0:ATP6V0E1|0:ATP6V1F|0:ATP5G3|0:ATP6V0D1|0:ATP6AP1|0:ATP6V0A1|0:ATP6V0A4|0:ATP6V1C2|0:C16orf7			
GO:0051436	P:negative regulation of ubiquitin-protein li...; IDA:UniProtKB		0:PSMB8|0:PSMD10|0:FZR1|0:PSMC6|0:CDC26|0:ANAPC11|0:PSMD3|0:PSMB4|0:PSMA3|0:ANAPC7|0:PSMC1|0:PSMD13|0:PSMB10|0:ANAPC4|0:PSMF1|0:CDC23|0:PSMA6|0:CDC20|0:PSME1|0:PSMA2|0:PSMB5|0:CDC27|0:PSMD4|0:PSMC5|0:PSMD7|0:PSMB1|0:PSMD5|0:MAD2L1|0:PSMD12|0:PSMA5|0:PSMA1|0:PSMB6|0:ANAPC5|0:CDC16|0:PSMD1|0:PSMC4|0:PSMD8|0:BUB3|0:PSME2|0:PSMB2|0:PSMD11|0:PSMB7|0:PSMD6|0:ANAPC2|0:UBE2C|0:PSMA7|0:PSMD2|0:ANAPC1|0:ANAPC10|0:PSMD9|0:PSMB3|0:PSMC2|0:PSMD14|0:UBE2D1|0:PSMA4|0:UBE2E1|0:BUB1B|0:PSMC3|0:PSME3|0:PSMB9|0:FBXO5			
GO:0004578	F:chitobiosyldiphosphodolichol beta-mannosylt...; IEA:EC		0:ALG1			
GO:0033631	P:cell-cell adhesion mediated by integrin; IEP:BHF-UCL		0:ADAM9			
GO:0051383	P:kinetochore organization; TAS:UniProtKB		0:CENPH			
GO:0030347	F:syntaxin-2 binding; IPI:UniProtKB		0:STXBP3|0:STXBP1			
GO:0016071	P:mRNA metabolic process; NAS:UniProtKB		0:PABPC3|0:PCBP2|0:PCBP3|0:PCBP1			
GO:0006379	P:mRNA cleavage; TAS:ProtInc		0:CPSF1|0:NCBP1|0:POP4|0:RNASE4|0:PCF11|0:CPSF3|0:CSTF3|0:CSTF2|0:CSTF1			
GO:0060591	P:chondroblast differentiation; IDA:UniProtKB		0:FGF4|0:FGF2			
GO:0050665	P:hydrogen peroxide biosynthetic process; NAS:UniProtKB		0:SOD1|0:CYBA|0:DUOX1			
GO:0045199	P:maintenance of epithelial cell apical/basal...; TAS:UniProtKB		0:ANK1			
GO:0017096	F:acetylserotonin O-methyltransferase activity; NAS:UniProtKB		0:ASMT|0:ASMTL			
GO:0010975	P:regulation of neuron projection development; ISS:UniProtKB		0:FRMD7|0:CCDC88A|0:AKT1|0:NCS1|0:IL1RAPL1|0:PTEN			
GO:0004830	F:tryptophan-tRNA ligase activity; NAS:UniProtKB		0:WARS2|0:WARS			
GO:0060135	P:maternal process involved in female pregnancy; NAS:UniProtKB		0:APOL2			
GO:0050930	P:induction of positive chemotaxis; NAS:UniProtKB		0:SCG2|0:VEGFB|0:VEGFC|0:FIGF|0:VEGFA|0:IL8|0:CREB3|0:AZU1			
GO:0001829	P:trophectodermal cell differentiation; IEP:BHF-UCL		0:SRF|0:HOPX|0:HAND1			
GO:0042776	P:mitochondrial ATP synthesis coupled proton ...; NAS:UniProtKB		0:ATP5B|0:MT-ATP8|0:ATP5C1|0:ATP5A1|0:ATP5J2|0:ATP5E|0:ATP5J|0:MT-ATP6|0:ATP5I|0:ATP5F1|0:ATP5H|0:ATP5L|0:ATP5O|0:ATP5D			
GO:0008120	F:ceramide glucosyltransferase activity; TAS:ProtInc		0:UGCG			
GO:0002291	P:T cell activation via T cell receptor conta...; IMP:BHF-UCL		0:ICAM1|0:ITGAL			
GO:0030252	P:growth hormone secretion; TAS:UniProtKB		0:GHRH|0:GAL|0:GHRL|0:GHSR|0:LTBP4			
GO:0042520	P:positive regulation of tyrosine phosphoryla...; IDA:UniProtKB		0:IL12A			
GO:0009360	C:DNA polymerase III complex; IDA:UniProtKB		0:CRCP			
GO:0008510	F:sodium:bicarbonate symporter activity; TAS:ProtInc		0:SLC4A7|0:SLC4A5|0:SLC4A4			
GO:0051988	P:regulation of attachment of spindle microtu...; NAS:UniProtKB		0:APC			
GO:0030586	F:[methionine synthase] reductase activity; TAS:UniProtKB		0:MTRR			
GO:0030267	F:glyoxylate reductase (NADP) activity; IDA:UniProtKB		0:GRHPR			
GO:0001570	P:vasculogenesis; TAS:UniProtKB		0:CCM2|0:GLMN|0:TGFBR2|0:SOX17|0:CAV1|0:NKX2-5|0:SOX18|0:CUL7|0:TNNI3|0:RASA1|0:EGFL7|0:SHH|0:AGGF1|0:VEGFA			
GO:0051292	P:nuclear pore complex assembly; IMP:UniProtKB		0:TMEM48|0:AHCTF1			
GO:0042355	P:L-fucose catabolic process; NAS:UniProtKB		0:FUT4|0:FUT8|0:FUT1|0:FUT5|0:FUT2|0:FUT6|0:FUT9|0:FUT7|0:FUT10			
GO:0001783	P:B cell apoptosis; IDA:HGNC		0:BAX			
GO:0045806	P:negative regulation of endocytosis; ISS:UniProtKB		0:SCAMP5|0:LRSAM1|0:KIAA0226|0:PACSIN3			
GO:0015385	F:sodium:hydrogen antiporter activity; TAS:ProtInc		0:SLC9A9|0:SLC9A7|0:SLC9A4|0:SLC9A8|0:SLC9A3|0:SLC9A5|0:SLC9A2|0:SLC9A6			
GO:0030676	F:Rac guanyl-nucleotide exchange factor activity; IDA:UniProtKB		0:PREX2|0:DOCK2|0:ARHGEF2|0:ALS2			
GO:0009220	P:pyrimidine ribonucleotide biosynthetic process; TAS:ProtInc		0:CMPK1|0:AK5			
GO:0051345	P:positive regulation of hydrolase activity; IDA:UniProtKB		0:APOA1|0:WRN			
GO:0035261	P:external genitalia morphogenesis; IMP:BHF-UCL		0:NIPBL			
GO:0006696	P:ergosterol biosynthetic process; IEA:InterPro		0:SIGMAR1			
GO:0004781	F:sulfate adenylyltransferase (ATP) activity; ISS:UniProtKB		0:PAPSS1|0:PAPSS2			
GO:0004446	F:multiple inositol-polyphosphate phosphatase...; IEA:EC		0:MINPP1			
GO:0031214	P:biomineral tissue development; IEA:UniProtKB-KW		0:AMELY|0:TFIP11|0:FAM83H|0:SPP1|0:ECM1|0:SRGN|0:DSPP|0:HTN3|0:ODAM|0:IBSP|0:ENPP1|0:OTOP1|0:AMTN|0:PHEX|0:STATH|0:DMP1|0:HTN1|0:CNNM4			
GO:0034613	P:cellular protein localization; ISS:BHF-UCL		0:AXIN2|0:WNT5A|0:NIPBL|0:CNTNAP2			
GO:0015081	F:sodium ion transmembrane transporter activity; TAS:ProtInc		0:ACCN4|0:TRAPPC10|0:SLC8A1			
GO:0009446	P:putrescine biosynthetic process; IEA:UniProtKB-KW		0:AGMAT			
GO:0004950	F:chemokine receptor activity; TAS:ProtInc		0:DARC|0:XCR1|0:GPR17|0:CMKLR1|0:CX3CR1			
GO:0001991	P:regulation of systemic arterial blood press...; ISS:BHF-UCL		0:AGTR2			
GO:0005690	C:U4atac snRNP; TAS:BHF-UCL		0:PRPF31			
GO:0015319	F:sodium:inorganic phosphate symporter activity; IDA:MGI		0:SLC17A7			
GO:0009404	P:toxin metabolic process; ISS:UniProtKB		0:FMO2|0:FMO1|0:AS3MT			
GO:0006950	P:response to stress; TAS:UniProtKB		0:MAPK11|0:MAPK14|0:MAP4K4|0:MAPK13|0:AHR|0:PINK1|0:TAOK2|0:MKNK2|0:MKNK1|0:HSP90AA2|0:HSPB11|0:MAPKAP1|0:TRIB3|0:HSF2|0:HSP90B2P|0:HSP90AB4P|0:HSP90AA4P|0:TMEM204|0:HIGD1A|0:HSP90AB3P|0:SYVN1|0:MAFF|0:RTN3|0:GPR132|0:HSF4|0:AHSA2|0:HSP90AB2P|0:HSP90AA5P|0:HSPB9|0:CASC3|0:RPS6KA5|0:EIF2AK1|0:LUC7L3|0:NPM1|0:ADRA1A|0:PDIA5|0:AHSA1|0:EIF1|0:TMX1|0:PHF17|0:UCN2|0:STK39|0:C7orf68|0:NDRG4|0:TCAP|0:CYP11B1|0:SERP1|0:CGRRF1|0:MAPKAPK3|0:SGK3|0:ZNF443|0:SNN|0:GADD45B|0:SGK1|0:CGREF1|0:STIP1|0:TP53I11|0:ERRFI1|0:PRKRIR|0:HTRA2|0:AKR1B1			
GO:0004000	F:adenosine deaminase activity; TAS:ProtInc		0:ADA|0:CECR1|0:ADARB1|0:ADAD1|0:ADAD2|0:ADAL|0:ADARB2			
GO:0051270	P:regulation of cellular component movement; IMP:UniProtKB		0:ARAP1			
GO:0008119	F:thiopurine S-methyltransferase activity; TAS:ProtInc		0:TPMT			
GO:0015278	F:calcium-release channel activity; IDA:BHF-UCL		0:RASA3			
GO:0051612	P:negative regulation of serotonin uptake; IDA:UniProtKB		0:SNCA			
GO:0046715	F:boron transmembrane transporter activity; IDA:HGNC		0:SLC4A11			
GO:0034988	F:Fc-gamma receptor I complex binding; IDA:BHF-UCL		0:FLNA			
GO:0032743	P:positive regulation of interleukin-2 produc...; IMP:UniProtKB		0:TRAF6|0:MALT1|0:MAP3K7|0:TRAF2			
GO:0017174	F:glycine N-methyltransferase activity; IDA:UniProtKB		0:GNMT			
GO:0005667	C:transcription factor complex; TAS:UniProtKB		0:NKX2-5|0:LEF1|0:PARP1|0:SOX17|0:PRKDC|0:POU5F1|0:MEF2B|0:CTNNB1|0:HDAC9|0:USF1|0:ZFHX3|0:FOXE3|0:MED7|0:SNF8|0:GCM1|0:MED17|0:ASCC1|0:EPAS1|0:MED27|0:PITX2|0:MED23|0:XRCC6|0:FIGLA|0:NAA15|0:TCF3|0:FOXF2|0:RELA|0:SUB1|0:E2F4|0:E2F8|0:SMAD7|0:E2F7|0:TFDP1|0:E2F3|0:E2F2|0:SMAD6|0:TFDP2|0:E2F6|0:SMAD5|0:SMAD9|0:E2F5|0:TFDP3|0:ARNTL|0:CLOCK|0:HIF1A|0:NPAS2|0:RBM14|0:HAND2|0:RARG|0:NR6A1|0:NAA16|0:PTF1A|0:LMO4|0:HES6|0:MLXIPL|0:SOX2|0:PMF1|0:FOXF1|0:IVNS1ABP|0:HMGA1|0:NCOA6			
GO:0006144	P:purine base metabolic process; IEA:UniProtKB-KW		0:AMPD1|0:AMPD2|0:AMPD3|0:PRHOXNB			
GO:0055070	P:copper ion homeostasis; NAS:UniProtKB		0:CUTC			
GO:0016246	P:RNA interference; NAS:UniProtKB		0:SND1|0:CELF1			
GO:0030971	F:receptor tyrosine kinase binding; TAS:UniProtKB		0:ANGPT4|0:ANGPT1|0:ANGPT2|0:NRG1|0:NRG3|0:SQSTM1|0:PITPNM3			
GO:0002711	P:positive regulation of T cell mediated immu...; IC:BHF-UCL		0:IL1B			
GO:0051160	P:L-xylitol catabolic process; IDA:UniProtKB		0:SORD			
GO:0042542	P:response to hydrogen peroxide; ISS:UniProtKB		0:GLRX2|0:APTX|0:ADAM9|0:HMOX1|0:SOD1			
GO:0006996	P:organelle organization; TAS:ProtInc		0:KIF4A|0:KIF5C|0:KIF3A			
GO:0000775	C:chromosome, centromeric region; IEA:UniProtKB-SubCell		0:CENPB|0:PPP2R5C|0:DSCC1|0:BIRC5|0:PPP2R1A|0:CDCA8|0:CBX1|0:CTCF|0:ZNF330|0:TIGD4|0:JRKL|0:TIGD6|0:TIGD1|0:TIGD7|0:TIGD5|0:TIGD2|0:TIGD3|0:CENPBD1|0:CENPQ|0:CENPL|0:STAG2|0:TNKS|0:SUV39H2|0:APITD1|0:OIP5|0:DAXX|0:PPP2CA|0:CENPI|0:STAG3|0:ITGB3BP|0:SMC1B|0:SMC3|0:CENPP|0:C14orf106|0:C21orf45|0:SUV39H1|0:CENPW|0:STRA13|0:RCC2|0:PPP2R5A|0:PPP2CB|0:RAD21|0:STAG1			
GO:0001676	P:long-chain fatty acid metabolic process; IDA:HGNC		0:CYP4F2|0:CYP4A11|0:ACOT2|0:ACSBG1|0:ACOT4|0:ACOT1			
GO:0032206	P:positive regulation of telomere maintenance; IMP:BHF-UCL		0:TINF2			
GO:0032584	C:growth cone membrane; IEA:UniProtKB-SubCell		0:GAP43			
GO:0031253	C:cell projection membrane; IDA:UniProtKB		0:RAB35			
GO:0015038	F:glutathione disulfide oxidoreductase activity; TAS:UniProtKB		0:GLRX|0:GLRX2			
GO:0008340	P:determination of adult lifespan; ISS:BHF-UCL		0:LRRK2|0:MSH6			
GO:0030263	P:apoptotic chromosome condensation; IDA:UniProtKB		0:DFFB|0:ACIN1|0:TOP2A			
GO:0017022	F:myosin binding; TAS:UniProtKB		0:CALD1|0:ACTC1|0:RHOA|0:ARFGEF1|0:GIPC1|0:ACTA1			
GO:0040007	P:growth; NAS:UniProtKB		0:BMP3|0:GDF10|0:INHBE|0:BMP7|0:GDF5|0:GDF3|0:GDF11|0:NODAL|0:GDF6|0:GDF7|0:CNTF|0:BMP8A|0:BMP2|0:GDF1|0:BMP5|0:INHBA|0:INHBC|0:BMP6|0:GDF2|0:BMP8B|0:INHBB|0:ST6GAL2			
GO:0050821	P:protein stabilization; TAS:UniProtKB		0:WNT10B|0:DSC3|0:SMAD7|0:PPAP2B|0:CDKN2A|0:STX12|0:APOA1|0:PTEN|0:DSG1|0:GTPBP4|0:MORC3|0:RASSF1|0:PML|0:DNAJA3|0:A1CF|0:USP2|0:AHSP|0:MDM4|0:GNAQ|0:SOX4|0:SOX17|0:FLNA|0:TBRG1|0:COG7|0:UBE2B|0:COG3|0:HSPD1|0:PEX6|0:HPS4|0:GPIHBP1|0:CPN2|0:NAPG|0:PRKCD|0:VHL|0:CALR|0:PPARGC1A			
GO:0001578	P:microtubule bundle formation; ISS:BHF-UCL		0:TPPP|0:SPAST|0:TPPP3|0:MARK4|0:MAP1S|0:CLASP1|0:PSRC1			
GO:0032689	P:negative regulation of interferon-gamma pro...; ISS:BHF-UCL		0:RARA|0:FOXP3|0:TLR4			
GO:0021984	P:adenohypophysis development; ISS:BHF-UCL		0:GHRH|0:DRD2			
GO:0003707	F:steroid hormone receptor activity; TAS:ProtInc		0:ESRRB|0:ESRRA|0:HNF4G|0:NR2F1|0:PPARG|0:NR6A1|0:RARA|0:VDR|0:NR5A2|0:HNF4A|0:RARB|0:NR0B2|0:NR1H3|0:RORA|0:NR4A2|0:THRA|0:ESRRG|0:NR5A1|0:RARG|0:RXRB|0:NR0B1|0:RORB|0:RXRG|0:NR2E3|0:THRB|0:NR1D2|0:NR4A1|0:RXRA|0:NR1H2|0:NR1I2|0:NR2C2|0:NR2F2|0:RORC|0:PPARA|0:PGR|0:NR2C1|0:PGRMC2|0:NR2E1|0:NR4A3|0:NR2F6|0:NR1D1|0:PPARD|0:NR3C2			
GO:0000781	C:chromosome, telomeric region; IEA:UniProtKB-SubCell		0:PTGES3|0:TERF1|0:DCLRE1B|0:TEP1|0:TELO2|0:RIF1|0:SMG6			
GO:0043616	P:keratinocyte proliferation; ISS:UniProtKB		0:CDH13|0:EREG|0:FERMT1|0:KRT2|0:WNT16|0:SDR16C5|0:KLK8			
GO:0032444	C:activin responsive factor complex; IDA:BHF-UCL		0:SMAD2|0:FOXH1|0:SMAD4			
GO:0030297	F:transmembrane receptor protein tyrosine kin...; TAS:UniProtKB		0:NRG1|0:ANGPT4|0:NRG3|0:EGF			
GO:0000339	F:RNA cap binding; TAS:UniProtKB		0:EIF4E|0:SNUPN|0:EIF4G3|0:NCBP1|0:EIF4E2|0:EIF4A1			
GO:0008268	F:receptor signaling protein tyrosine kinase ...; TAS:UniProtKB		0:CSPG4			
GO:0045130	F:keratan sulfotransferase activity; IDA:UniProtKB		0:CHST1			
GO:0051925	P:regulation of calcium ion transport via vol...; IMP:UniProtKB		0:SESTD1			
GO:0048172	P:regulation of short-term neuronal synaptic ...; ISS:UniProtKB		0:GRIK2|0:SYNGR1|0:SHISA9|0:SYP			
GO:0045446	P:endothelial cell differentiation; TAS:UniProtKB		0:SCUBE1|0:JAG1|0:LAMA5|0:EDF1			
GO:0009156	P:ribonucleoside monophosphate biosynthetic p...; TAS:ProtInc		0:PRPS1|0:PRPS2|0:PRPS1L1|0:ADK			
GO:0047220	F:galactosylxylosylprotein 3-beta-galactosylt...; IEA:EC		0:B3GALT6			
GO:0060333	P:interferon-gamma-mediated signaling pathway; IC:BHF-UCL		0:SP100			
GO:0045218	P:zonula adherens maintenance; IMP:UniProtKB		0:KIAA1543|0:KIFC3|0:PLEKHA7			
GO:0008609	F:alkylglycerone-phosphate synthase activity; IDA:MGI		0:AGPS			
GO:0008356	P:asymmetric cell division; TAS:ProtInc		0:PARD3			
GO:0010739	P:positive regulation of protein kinase A sig...; ISS:BHF-UCL		0:MIF|0:ADIPOQ|0:AKAP12|0:AKAP5|0:MC1R			
GO:0048096	P:chromatin-mediated maintenance of transcrip...; TAS:UniProtKB		0:SMARCD1|0:BAZ1B|0:ARID1B|0:ARID1A			
GO:0009893	P:positive regulation of metabolic process; TAS:HGNC		0:PIGA			
GO:0045793	P:positive regulation of cell size; TAS:UniProtKB		0:EDN1|0:AMOT			
GO:0007005	P:mitochondrion organization; NAS:UniProtKB		0:PRDX3|0:FANCG|0:NOS3|0:CAV2|0:ATP7A|0:PPARGC1A			
GO:0042427	P:serotonin biosynthetic process; IEA:UniProtKB-KW		0:TPH2|0:TPH1			
GO:0034373	P:intermediate-density lipoprotein particle r...; TAS:BHF-UCL		0:LIPC			
GO:0033603	P:positive regulation of dopamine secretion; TAS:BHF-UCL		0:CHRNB2|0:GDNF			
GO:0002635	P:negative regulation of germinal center form...; ISS:BHF-UCL		0:FOXJ1			
GO:0006515	P:misfolded or incompletely synthesized prote...; IMP:BHF-UCL		0:STUB1|0:HDAC6			
GO:0006106	P:fumarate metabolic process; TAS:ProtInc		0:FH			
GO:0016236	P:macroautophagy; ISS:UniProtKB		0:NBR1|0:HDAC6|0:SQSTM1			
GO:0008329	F:pattern recognition receptor activity; TAS:UniProtKB		0:COLEC12|0:MARCO|0:DMBT1			
GO:0043200	P:response to amino acid stimulus; IDA:UniProtKB		0:MTOR			
GO:0008334	P:histone mRNA metabolic process; TAS:ProtInc		0:SSB			
GO:0014898	P:cardiac muscle hypertrophy in response to s...; TAS:BHF-UCL		0:CAMTA2|0:HDAC4			
GO:0031768	F:ghrelin receptor binding; ISS:UniProtKB		0:GHRL			
GO:0032093	F:SAM domain binding; IPI:UniProtKB		0:L3MBTL1			
GO:0060342	C:photoreceptor inner segment membrane; IDA:UniProtKB		0:RHO			
GO:0008456	F:alpha-N-acetylgalactosaminidase activity; IDA:UniProtKB		0:NAGA			
GO:0004138	F:deoxyguanosine kinase activity; TAS:ProtInc		0:DGUOK			
GO:0004103	F:choline kinase activity; NAS:UniProtKB		0:CHKB|0:CHKA|0:ETNK2			
GO:0008009	F:chemokine activity; TAS:UniProtKB		0:CKLF|0:CCL4L1|0:CCL4L2|0:PPBP|0:CCL14|0:PF4V1|0:CXCL3|0:CXCL16|0:CCL3L1|0:CCL3L3|0:CCL5|0:CXCL13|0:CCL19|0:CXCL1|0:CCL15|0:CCL26|0:CCL21|0:CXCL6|0:CCL3|0:IL8|0:CCL18|0:CXCL2|0:CXCL14|0:CXCL12|0:CXCL11|0:CCL20|0:CCL2|0:CXCL9|0:CXCL5|0:CCL25|0:C5|0:CCL23|0:CCL17|0:CCL8|0:XCL1|0:CCL24|0:CCL22|0:CCL11|0:CXCL10|0:CCL7|0:CCL16|0:CCL4|0:CCL1|0:CCL13|0:CCL27|0:XCL2|0:PF4|0:CCL28|0:CX3CL1			
GO:0045408	P:regulation of interleukin-6 biosynthetic pr...; IDA:UniProtKB		0:IL17F			
GO:0042476	P:odontogenesis; NAS:UniProtKB		0:LAMB1|0:AQP3|0:AQP6|0:AQP1|0:AQP5|0:FGF8|0:INHBA|0:AXIN2|0:WNT10A|0:OSR1|0:TGFB3|0:TGFB2|0:TUFT1|0:COL1A2|0:ZNF22|0:BGLAP|0:ENAM			
GO:0006044	P:N-acetylglucosamine metabolic process; TAS:ProtInc		0:CHST6|0:CHST2|0:CHST7|0:EXTL2|0:CHST5|0:CHST4|0:AMDHD2|0:GNPDA1|0:GNPDA2|0:LARGE|0:NAGK			
GO:0009597	P:detection of virus; NAS:UniProtKB		0:TLR3			
GO:0006513	P:protein monoubiquitination; IMP:UniProtKB		0:UBE2W|0:UBE2D3|0:TRIM21|0:DTL|0:UBE2R2|0:UBE2B|0:MGRN1			
GO:0008465	F:glycerate dehydrogenase activity; IDA:UniProtKB		0:GRHPR			
GO:0045639	P:positive regulation of myeloid cell differe...; IDA:UniProtKB		0:HOXA5			
GO:0034649	F:histone demethylase activity (H3-monomethyl...; ISS:UniProtKB		0:KDM1B			
GO:0006563	P:L-serine metabolic process; IEA:InterPro		0:SRR|0:SHMT2			
GO:0004730	F:pseudouridylate synthase activity; NAS:UniProtKB		0:PUS1			
GO:0003779	F:actin binding; TAS:UniProtKB		0:KCNMA1|0:ANLN|0:HPCA|0:CCDC88A|0:DAG1|0:SSH1|0:ACE|0:SSH2|0:TNNI3|0:NCALD|0:CXCR4|0:SYNE1|0:ANG|0:EMD|0:TPM2|0:CCR5|0:MEFV|0:TNNT2|0:FXYD5|0:MAEA|0:COTL1|0:FMNL1|0:GMFG|0:FMN2|0:DIAPH2|0:CAP2|0:TLN1|0:FMNL3|0:FHDC1|0:DAAM2|0:ABLIM2|0:DIAPH3|0:GRID2IP|0:LIMCH1|0:FMNL2|0:GMFB|0:C19orf46|0:C14orf49|0:ABLIM3|0:KLHL20|0:TMOD3|0:TMSL3|0:MYH3|0:CAPG|0:WASF4|0:CLMN|0:ACTN2|0:MYO15A|0:DIAPH1|0:SHROOM3|0:WASH4P|0:WASF1|0:KIAA1949|0:PALLD|0:NEBL|0:MTSS1L|0:EPB49|0:PHACTR2|0:ARPC4|0:VASP|0:LMOD2|0:WHAMM|0:SNTB1|0:EVL|0:MYBPC2|0:TMOD4|0:SYNPO2|0:WIPF3|0:EPB41L1|0:CORO1B|0:TNNI2|0:TMSB15A|0:TPM4|0:MYO1A|0:MYO19|0:DST|0:VCL|0:MYH8|0:TMSB4X|0:MYH7B|0:CORO2A|0:PARVB|0:WASH2P|0:TRIOBP|0:ACTR2|0:ACTN3|0:ADD3|0:WASH1|0:MYO1C|0:MYO10|0:MYBPC3|0:MYPN|0:GSN|0:MYH11|0:TNS1|0:WASF3|0:LASP1|0:NEB|0:TNS4|0:TMOD1|0:KLHL3|0:TMSB4XP1|0:DAAM1|0:MIB2|0:PFN4|0:FHOD3|0:MYLK|0:ARPC1B|0:MPRIP|0:MYO1B|0:WASL|0:PHACTR3|0:SNTG1|0:VILL|0:INF2|0:AVIL|0:SNTB2|0:MYH15|0:EPB41L2|0:MYH7|0:MYO1G|0:KLHL17|0:PXK|0:TMSB10|0:TPM3|0:RDX|0:SNTA1|0:EPB41L3|0:SYNPO2L|0:AFAP1|0:CFL2|0:ARPC5L|0:MYO1D|0:ACTR3|0:SYN1|0:ENAH|0:ARPC5|0:CAP1|0:KLHL4|0:TMSB4XP2|0:MYH14|0:MYO3A|0:PLEC|0:MYO7A|0:HIP1|0:MYO18B|0:SPIRE2|0:PPP1R9A|0:MYH1|0:SNTG2|0:DIXDC1|0:PLS3|0:FBXO25|0:MYO1E|0:INPPL1|0:FKBP15|0:PFN3|0:CAPZA2|0:XIRP1|0:MYO5B|0:FLNC|0:TMSL6|0:MYO1H|0:PHACTR4|0:ARPC2|0:JMY|0:MYRIP|0:HDAC6|0:DSTN|0:MYH6|0:MYBPC1|0:POF1B|0:TMOD2|0:MYO9A|0:KLHL5|0:MYH4|0:ACTN1|0:BAIAP2L1|0:DNASE1|0:MYO3B|0:PARVA|0:MYOT|0:MYO7B|0:FHOD1|0:ENC1|0:KLHL2|0:UTRN|0:CNN1|0:ARPC3|0:PHACTR1|0:FMN1|0:CORO1C|0:SSFA2|0:VIL1|0:ACTR3B|0:CFL1|0:PPP1R9B|0:CAPZA3|0:WASH6P|0:SYNE2|0:WDR1|0:TWF1|0:STK38L|0:TMSB4Y|0:TAGLN|0:EPB41|0:WIPF2|0:SPIRE1|0:MED28|0:WASH3P|0:XIRP2|0:PFN1|0:GC|0:KIF18A|0:GIPC1|0:ABRA|0:PDLIM5|0:DBNL|0:CGN|0:SYNPO|0:MYO1F|0:MYH13|0:DBN1|0:MYH2|0:CNN3|0:HIP1R|0:BCL7B|0:TLN2|0:KLHL1|0:TNNI1|0:PIP|0:NRAP|0:CORO2B|0:PFN2|0:FLNB|0:SPTBN5|0:ALDOA|0:TPM1|0:SPTBN2|0:CAPZA1|0:ARPC1A|0:SMTN|0:SPTAN1|0:TWF2|0:CALD1|0:ABLIM1|0:KPTN|0:CAPZB|0:IPP|0:FLII|0:WASF2|0:CNN2|0:WIPF1|0:IQGAP2|0:SPTBN1|0:LSP1|0:DMD|0:PARVG|0:SPTBN4			
GO:0060090	F:molecular adaptor activity; IPI:BHF-UCL		0:PDCD6|0:TRADD			
GO:0016757	F:transferase activity, transferring glycosyl...; IEA:UniProtKB-KW		0:C3orf39|0:C3orf21|0:C3orf64|0:ALG9|0:ALG1L|0:ALG11|0:B3GALTL|0:GYLTL1B|0:GLT8D1|0:B3GNTL1|0:DPAGT1|0:GALNTL5|0:GLT1D1|0:GLT8D2|0:GTDC1			
GO:0060338	P:regulation of type I interferon-mediated si...; IMP:MGI		0:CDC37|0:HSP90AB1			
GO:0045263	C:proton-transporting ATP synthase complex, c...; IEA:UniProtKB-KW		0:ATP6V0C|0:ATP5S|0:ATP5J2|0:ATP5G1|0:ATP5G2|0:ATP5G3			
GO:0006760	P:folic acid and derivative metabolic process; TAS:ProtInc		0:FTCD			
GO:0005584	C:collagen type I; IMP:UniProtKB		0:COL1A2|0:COL1A1			
GO:0004677	F:DNA-dependent protein kinase activity; TAS:UniProtKB		0:ATM|0:PRKDC|0:XRCC6BP1			
GO:0051041	P:positive regulation of calcium-independent ...; IDA:UniProtKB		0:CX3CL1			
GO:0009165	P:nucleotide biosynthetic process; NAS:UniProtKB		0:DHFRL1|0:PRPSAP2|0:PRPSAP1|0:DCTD|0:DHFRP1|0:DHFR			
GO:0043968	P:histone H2A acetylation; IDA:UniProtKB		0:RUVBL2|0:MEAF6|0:MORF4L1|0:RUVBL1|0:DMAP1|0:EPC1|0:TRRAP|0:ING3|0:YEATS4|0:EP400|0:BRD8|0:ACTL6A			
GO:0002162	F:dystroglycan binding; IPI:UniProtKB		0:DMD			
GO:0009253	P:peptidoglycan catabolic process; TAS:UniProtKB		0:PGLYRP4|0:PGLYRP2|0:LYG1|0:PGLYRP1|0:LYG2|0:PGLYRP3|0:SPACA3			
GO:0008670	F:2,4-dienoyl-CoA reductase (NADPH) activity; IEA:EC		0:DECR1|0:DECR2			
GO:0042577	F:lipid phosphatase activity; NAS:UniProtKB		0:INPP5K			
GO:0035039	P:male pronucleus assembly; ISS:HGNC		0:WBP2NL			
GO:0070195	C:growth hormone receptor complex; IDA:BHF-UCL		0:GHR			
GO:0005471	F:ATP:ADP antiporter activity; NAS:UniProtKB		0:SLC25A6			
GO:0042555	C:MCM complex; IMP:UniProtKB		0:MCM7			
GO:0070593	P:dendrite self-avoidance; ISS:UniProtKB		0:DSCAM			
GO:0043186	C:P granule; ISS:UniProtKB		0:PIWIL1			
GO:0005328	F:neurotransmitter:sodium symporter activity; IEA:InterPro		0:SLC6A17|0:SLC6A9|0:SLC6A11|0:SLC6A18|0:SLC6A5|0:SLC6A14|0:SLC6A12|0:SLC6A20|0:SLC6A19|0:SLC6A15|0:SLC6A7|0:SLC6A1|0:SLC6A16|0:SLC6A13			
GO:0004362	F:glutathione-disulfide reductase activity; EXP:Reactome		0:GSR			
GO:0042977	P:activation of JAK2 kinase activity; NAS:UniProtKB		0:GHR|0:JAK2|0:PRLR			
GO:0072175	P:epithelial tube formation; ISS:UniProtKB		0:PODXL			
GO:0006572	P:tyrosine catabolic process; TAS:ProtInc		0:TAT|0:GSTZ1|0:HPD|0:FAH|0:HGD			
GO:0050510	F:N-acetylgalactosaminyl-proteoglycan 3-beta-...; IEA:EC		0:CHPF|0:CHSY3|0:CHPF2|0:CHSY1			
GO:0009088	P:threonine biosynthetic process; IEA:InterPro		0:THNSL1			
GO:0008240	F:tripeptidyl-peptidase activity; TAS:ProtInc		0:TPP1|0:TPP2			
GO:0005912	C:adherens junction; TAS:BHF-UCL		0:RND1|0:SYNM|0:WTIP|0:MPP7|0:TNK2|0:CXADR|0:VEZT|0:PVRL4|0:TMEM204|0:TJP2|0:ADAM15|0:AHI1|0:ESAM|0:CTNNA1|0:MLLT4|0:AJAP1|0:FMN1|0:APC|0:CTNND2|0:NPHP1|0:PTPRK|0:SHROOM3|0:TRPV4|0:PPAP2B			
GO:0030033	P:microvillus assembly; NAS:UniProtKB		0:FXYD5			
GO:0019008	C:molybdopterin synthase complex; IPI:UniProtKB		0:MOCS1|0:MOCS2			
GO:0070296	P:sarcoplasmic reticulum calcium ion transport; TAS:BHF-UCL		0:ATP2A2			
GO:0006264	P:mitochondrial DNA replication; IMP:UniProtKB		0:DNA2|0:C10orf2			
GO:0010592	P:positive regulation of lamellipodium assembly; IMP:BHF-UCL		0:RAC1|0:WNT1			
GO:0031094	C:platelet dense tubular network; IDA:BHF-UCL		0:F2R			
GO:0035253	C:ciliary rootlet; ISS:UniProtKB		0:CROCC			
GO:0001554	P:luteolysis; IEP:UniProtKB		0:SLIT2|0:SLIT3|0:ROBO2			
GO:0008611	P:ether lipid biosynthetic process; IMP:UniProtKB		0:PEX7			
GO:0006355	P:regulation of transcription, DNA-dependent; TAS:UniProtKB		0:ZNF395|0:BRCA2|0:NANOG|0:POU5F1|0:NFATC1|0:GCM1|0:PITX2|0:ZNF350|0:CXXC1|0:ATF7|0:RPS6KA4|0:ING2|0:RPS6KA5|0:TCFL5|0:FOXO4|0:TRAPPC2P1|0:TRAPPC2|0:SP3|0:AIRE|0:NFKB2|0:CREM|0:CREB3L1|0:POU3F1|0:EMX2|0:REM2|0:IRX3|0:SEBOX|0:ZNF667|0:ARGFX|0:ZNF568|0:LIN28B|0:ZNF614|0:ESRRB|0:SSX10|0:HES2|0:TGIF2LY|0:BATF2|0:ZNF285|0:ZNF10|0:ZNF624|0:HOXC11|0:HOXA11|0:MKX|0:HSF5|0:ZSCAN20|0:ZNF57|0:ZNF17|0:RFX2|0:DMRT1|0:ZNF783|0:ZNF85|0:ZNF230|0:ZNF347|0:NFATC4|0:DBX2|0:ZNF311|0:LASS6|0:ZSCAN10|0:ZNF840|0:MYCL2|0:ZNF267|0:DMRTA2|0:ZNF461|0:ZNF642|0:ZNF766|0:ZNF226|0:ZNF34|0:NKX2-4|0:SSX4B|0:ZNF680|0:ZNF607|0:SETD7|0:HOXB2|0:ZNF133|0:HEYL|0:ZNF816|0:LEUTX|0:DUX4|0:ZNF25|0:SSX7|0:ZNF24|0:IRF3|0:ZNF549|0:NR1I3|0:ZNF417|0:MEIS1|0:KCNH4|0:ZNF439|0:ZNF733|0:ZNF561|0:ZNF565|0:ZNF790|0:DPRX|0:ARID2|0:STAT1|0:ZNF862|0:RERE|0:FOXD2|0:ZNF44|0:SIX6|0:ARX|0:IRX6|0:ZNF717|0:ATF2|0:VENTX|0:GTF2B|0:FOXB2|0:RFX6|0:HOXD3|0:ZSCAN23|0:ZNF746|0:ZNF620|0:SHOX2|0:RAB18|0:ZNF860|0:TBX6|0:ZKSCAN2|0:LASS2|0:ZFP92|0:E2F8|0:ZSCAN18|0:ZNF506|0:ZNF879|0:HIF3A|0:CSDE1|0:GCM2|0:IRF6|0:HOXA3|0:FOXJ2|0:ZNF343|0:NR3C1|0:HMX2|0:PDE8A|0:ZNF234|0:OTP|0:ZNF599|0:TBP|0:DRGX|0:ZNF829|0:ZNF813|0:BATF|0:FOXK1|0:EMX1|0:EBF4|0:MLLT1|0:GSX2|0:ZNF571|0:ZNF844|0:ZNF286A|0:DLX3|0:ZNF674|0:ZFP112|0:DMRTC2|0:ETV5|0:ZNF443|0:ZNF323|0:ZNF222|0:ZNF557|0:ZNF658|0:NPAS3|0:ZNF192|0:ZNF705F|0:PAX7|0:ATF6B|0:PBX4|0:ZNF510|0:ISL1|0:ZNF284|0:HSF2|0:NFIL3|0:ZNF709|0:FOXN2|0:ZNF713|0:ZNF18|0:SPIC|0:E2F7|0:ELK4|0:ZNF846|0:SSX3|0:KCNH3|0:LHX4|0:ZNF317|0:ZNF763|0:HOXC10|0:MEOX2|0:ZNF544|0:ZNF433|0:ZNF705G|0:PEG3|0:ZNF550|0:ZNF567|0:ZNF737|0:ZNF789|0:ZNF404|0:ZNF823|0:ZNF486|0:PASK|0:ZNF776|0:ZNF725|0:ZNF416|0:ZNF225|0:ZNF554|0:FOXQ1|0:ZSCAN5A|0:ZNF454|0:MEIS3P1|0:ZNF175|0:ZNF641|0:ISL2|0:TSHZ2|0:ZNF540|0:NR2E1|0:ZNF679|0:SIM1|0:ZFHX4|0:DBX1|0:EBF3|0:FOXD4L4|0:ZSCAN1|0:TPRX1|0:ZNF213|0:ZNF732|0:ZNF354B|0:HOXC9|0:ZNF777|0:IRX2|0:VSX1|0:NKX1-2|0:ZNF517|0:ZNF587|0:ZNF77|0:ZNF613|0:ZNF490|0:ZNF324B|0:RFX7|0:HSFX1|0:ZNF785|0:SCAND3|0:ZNF718|0:TSC22D1|0:SIX5|0:ZNF75A|0:ZNF334|0:FOXB1|0:POU6F1|0:ZNF320|0:HLF|0:ZNF275|0:MEIS3P2|0:MLL3|0:ZNF193|0:ZNF354C|0:SSX4|0:FOXD4L6|0:CREB3|0:ZNF627|0:ZNF468|0:ZNF514|0:ZNF780B|0:LASS3|0:LMX1A|0:POU2F2|0:ZIK1|0:ZNF548|0:NANOGP8|0:GATA3|0:ZNF806|0:PMS2L3|0:ZNF793|0:RAX2|0:LBX2|0:ZNF426|0:DMRT2|0:RAX|0:ZNF26|0:ZNF396|0:ZNF560|0:ZNF564|0:ZNF782|0:KCNH7|0:NFXL1|0:ZNF671|0:DUXA|0:CEBPE|0:ZNF440|0:ZFP28|0:POU3F4|0:ZNF397|0:GON4L|0:YEATS2|0:MEF2A|0:ZNF836|0:ZNF812|0:HOXB3|0:HOXB13|0:ZNF527|0:ZNF66P|0:PHOX2B|0:DLX6|0:GATAD1|0:ZNF221|0:ZFP30|0:ZNF167|0:ZNF444|0:ZNF558|0:DUX3|0:SSX8|0:TFB2M|0:ZNF229|0:TBPL1|0:NOTO|0:TSHZ3|0:ZNF449|0:IRF5|0:ZNF584|0:HOXA4|0:HOXA9|0:ZNF180|0:HMX3|0:FOXP1|0:ZNF736|0:PDE8B|0:ZNF791|0:ZNF487P|0:EVX2|0:ZNF799|0:ERG|0:NR4A2|0:FOXM1|0:ZNF534|0:DUX1|0:ZNF738|0:AHRR|0:ZNF324|0:ZNF586|0:ZNF726|0:HSFY2|0:TSHZ1|0:ZNF264|0:ZSCAN12|0:NFAT5|0:ZNF551|0:ZNF480|0:GBX2|0:ZNF287|0:ZNF676|0:CSDC2|0:UNCX|0:PAX6|0:ZSCAN5B|0:NFE2L3|0:BARHL1|0:ZNF585A|0:RUNX2|0:ZNF99|0:E2F2|0:ETV3L|0:SIM2|0:MAF|0:SHOX|0:ADNP|0:ZNF689|0:ZNF814|0:ZNF570|0:IRF9|0:ZNF682|0:MAFF|0:C5orf41|0:SMAD6|0:ZNF251|0:ZNF445|0:CBFA2T3|0:ZNF485|0:FOXD4L3|0:HOXC13|0:ZNF764|0:ZNF248|0:YBX2|0:CREB3L3|0:PRDM9|0:ZNF669|0:ZNF43|0:RHOXF2B|0:LHX5|0:ZNF543|0:ZNF566|0:ZNF778|0:ZNF20|0:NANOGP1|0:ZSCAN29|0:IRX1|0:CREBZF|0:RFX8|0:HSFX2|0:CREBL2|0:ZNF429|0:MIXL1|0:MTA3|0:ZSCAN2|0:ZNF773|0:ZNF300|0:ZNF460|0:ZNF626|0:ZNF700|0:ELF5|0:DMRTB1|0:PITX3|0:ZNF714|0:ZNF250|0:ZNF12|0:LHX2|0:ZFP57|0:ZNF420|0:SMAD5|0:HLX|0:RXRB|0:ZNF181|0:ZNF75CP|0:ZNF484|0:FOXI2|0:DMRT3|0:ZSCAN16|0:SMAD9|0:ZNF79|0:CBFA2T2|0:ZNF432|0:ZNF425|0:ZNF7|0:ZNF583|0:ZNF805|0:CEBPD|0:ZFP90|0:ZNF530|0:RBPJL|0:ZNF498|0:ZNF727|0:CARHSP1|0:ZNF577|0:ZNF563|0:ZNF528|0:ZNF555|0:SCAND2|0:ZNF132|0:ZNF786|0:TSC22D2|0:ZNF56|0:EBF2|0:ZNF573|0:ZNF616|0:ZNF735|0:ZNF729|0:ZNF606|0:ZNF772|0:NKX2-6|0:ADNP2|0:ZNF643|0:ETV1|0:ZNF235|0:ZNF780A|0:ZNF471|0:ZNF224|0:ZNF500|0:TLX2|0:KCNH2|0:ZNF547|0:ZNF321|0:SSX9|0:MSX2|0:DUX2|0:PHOX2A|0:ZNF792|0:ZNF124|0:DMRTA1|0:LHX8|0:ZNF101|0:FOXN4|0:ZKSCAN4|0:MEIS3|0:ZNF316|0:LHX1|0:RXRG|0:ZNF140|0:ZNF701|0:ZNF597|0:MGA|0:ZNF302|0:ZNF14|0:ZNF273|0:ZEB2|0:ZNF708|0:ZNF470|0:TGIF2LX|0:PAX3|0:LASS4|0:HOMEZ|0:ZNF446|0:FEV|0:ZNF232|0:FOXD4L1|0:ZSCAN4|0:THRB|0:ZSCAN5C|0:ZNF552|0:ZNF227|0:ETV2|0:ZNF419|0:NKX2-8|0:ZFHX2|0:ZNF677|0:MEF2B|0:ZFP1|0:ZNF611|0:KCNH1|0:ZNF695|0:ZNF114|0:IRX4|0:MYT1L|0:ZNF688|0:MTA1|0:ZNF720|0:ZNF730|0:ZNF559|0:MAFG|0:ZIM3|0:HOXA6|0:LIN28A|0:ZNF519|0:HOPX|0:ZNF304|0:ZNF473|0:FOXR2|0:ZSCAN30|0:STAT4|0:ZNF670|0:ZNF382|0:ALX3|0:ZNF765|0:POGK|0:LASS5|0:BATF3|0:ZNF595|0:PGBD1|0:ZNF724P|0:RFX1|0:HOXA10|0:NKX6-3|0:GTF2H4|0:KCNH6|0:ZNF630|0:E2F5|0:PER3|0:MLLT3|0:HOXD1|0:KRBA2|0:ZNF333|0:CREB3L2|0:ZNF155|0:ZNF542|0:KCNH8|0:FOXD4L2|0:HOXC12|0:LHX3|0:ZNF256|0:XBP1|0:HSFY1|0:ZNF98|0:ZNF431|0:ZNF28|0:ZNF662|0:NR1I2|0:ZNF266|0:NKX3-2|0:SSX5|0:ZNF684|0:ZNF492|0:ZNF182|0:ZNF673|0:IRX5|0:ZFP14|0:ZNF529|0:ZNF556|0:HESX1|0:ZNF605|0:ZNF747|0:NKX1-1|0:ZNF649|0:ETV7|0:ZNF442|0:FOXR1|0:ZNF479|0:ZNF705A|0:L3MBTL4|0:EOMES|0:ZNF223|0:NR3C2|0:FOXJ3|0:ZNF582|0:ZNF430|0:ZNF808|0:RHOXF2|0:ZNF880|0:ZNF589|0:NFE2L1|0:ZNF483|0:FOXI3|0:SSX6|0:ISX|0:RELB|0:ZNF615|0:RORC|0:FOXD4L5|0:ZKSCAN3|0:ZNF418|0:DUX5|0:ZNF233|0:ZNF734|0:L3MBTL1|0:TLX3|0:TFDP3|0:ESX1|0:ZNF197|0:ZNF141|0:ZNF596|0:ZNF716|0:ZNF707|0:FOXO6|0:SCAND1|0:BRF1|0:ZNF585B|0:POU5F2|0:ZNF546|0:ZNF621|0:ZFP82|0:TBX15|0:PBX3|0:ZNF761|0:ZNF610|0:ZNF394|0:HDX|0:ZNF283|0:ZNF699|0:NFIB|0:ZNF23|0:SPDEF|0:LHX6|0:SSX1|0:ZNF569|0:HSF1|0:KCNH5|0:ZNF100|0:ZNF337|0:BRF2|0:RFX4|0:ZNF436|0:HES4|0:GATAD2B|0:ZSCAN22|0:ZNF845|0:LHX9|0:ZNF562|0:ZNF383|0:THAP1|0:CARM1|0:RFX3|0:PTF1A|0:BAZ2B|0:BAZ1A|0:ZNF212|0:ZNF83|0:ZNF257|0:ZNF165|0:NAB1|0:TAF4B|0:SSX2|0:ZFP37|0:ZNF117|0:AKAP17A|0:ZNF71|0:CDC5L|0:CDK11A|0:ZNF331|0:IFI16|0:TGIF2|0:DMTF1|0:FOXE3|0:ZNF215|0:HNRNPD|0:HOXD12|0:REXO4|0:FOXS1|0:NKX6-2|0:HKR1|0:BHLHE41|0:ARID3A|0:HR|0:SALL2|0:TSC22D4|0:ZNF93|0:PRDM15|0:ZNF398|0:NFIA|0:ZNF187|0:BTF3P13|0:HOXB8|0:MYCL1|0:ZNF2|0:ZNF72|0:HIVEP2|0:SKOR1|0:FOXD4|0:HOXD11|0:ZNF41|0:ZKSCAN1|0:ZNF33B|0:ZNF268|0:CDK11B|0:ZNF91|0:RASSF7|0:HMG20B|0:ZNF92|0:ETV4|0:ZNF69|0:ZKSCAN5|0:ZNF205|0:ZNF253|0:TULP3|0:PRDM2|0:ZNF3|0:BTF3P12|0:NKX3-1|0:ZNF160|0:BARX1|0:SOX1|0:ASH2L|0:TCF20|0:ZNF135|0:SARNP|0:HOXB7|0:ZNF214|0:MYB|0:ZNF154|0:ZIM2|0:CHD6|0:ZNF81|0:DENND4A|0:ZNF184|0:TBX4|0:SSX2B|0:GTF2IRD1|0:ZNF19|0:GTF2H3|0:ZNF208|0:ESR1|0:ZNF90|0:HMGN2|0:HMG20A|0:TBX18|0:MED24|0:ANKRD30A|0:ERC1|0:ZNF73|0:RHOXF1|0:ZNF80|0:TULP4|0:HOXB6|0:ZNF33A|0:RUNX3|0:ZNF70|0:GCFC1|0:ZNF75D|0:PRRX2|0:YBX1|0:ZNF84|0:HOXC4|0:ZNF211|0:POLR2A|0:GBX1|0:VGLL1|0:LZTS1|0:ZNF134|0:ZNF195|0:OTX2|0:ZNF37A|0:POU5F1B|0:ZNF131|0:FOXL1|0:MYBL1|0:MYST4|0:ZNF169|0:CNOT8|0:NCOA2|0:C2orf3|0:ZNF207|0:ZNF277|0:HOXD4|0:ZNF138|0:DLX4|0:MYT1|0:ZNF236|0:ZNF146|0:EZH2|0:CNBP|0:MZF1|0:MLLT6|0:ZNF263|0:MYBBP1A|0:TMF1|0:CRABP2|0:TRIM22|0:ZNF274|0:PQBP1|0:HMGA2|0:MYST2|0:ATRX|0:RPL6|0:ZNF35|0:LIMD1|0:ELAVL2|0:PREB|0:ZNF74|0:TSC22D3|0:ZNF45|0:DDIT3|0:HCLS1|0:SLC2A4RG|0:RREB1|0:PATZ1|0:POU6F2|0:ZNHIT3|0:ZNF282|0:NOTCH2|0:HIC1|0:UBE2V1|0:SCRT1|0:NME2|0:RBAK|0:TBX21|0:NR1D2|0:MAGED1|0:EDF1|0:JMJD1C			
GO:0090197	P:positive regulation of chemokine secretion; IDA:UniProtKB		0:C5|0:CHIA			
GO:0004566	F:beta-glucuronidase activity; TAS:ProtInc		0:KL|0:GUSB|0:HPSE			
GO:0010956	P:negative regulation of calcidiol 1-monooxyg...; IDA:BHF-UCL		0:GFI1|0:CYP27B1|0:NFKB1			
GO:0000070	P:mitotic sister chromatid segregation; TAS:ProtInc		0:ZWINT|0:ESPL1|0:KIFC1|0:KIF25|0:DDX11|0:NDC80			
GO:0008405	F:arachidonic acid 11,12-epoxygenase activity; IDA:BHF-UCL		0:CYP2J2			
GO:0019900	F:kinase binding; NAS:UniProtKB		0:RB1|0:PIP5K1A|0:PARK2|0:PFKM|0:FAS|0:STUB1|0:SP100|0:PFKL|0:TRADD|0:CTNNB1|0:MOBKL1A|0:SIT1|0:CHIA|0:DGKQ|0:UBQLN1|0:TRIP6|0:TOLLIP|0:BTG1|0:ABI2|0:BARD1			
GO:0009755	P:hormone-mediated signaling pathway; TAS:HGNC		0:ADCY2|0:PRKAR2A|0:GNG10|0:GNB2|0:ADCY9|0:PRKACA|0:GNG5|0:PRKACG|0:ADCY6|0:GNG13|0:ADCY3|0:GNG11|0:GNB3|0:ADCY10|0:PRKAR2B|0:ADCY7|0:GNG2|0:PRKAR1A|0:GNG12|0:GNB4|0:GNG7|0:ADCY4|0:GNAS|0:GNG3|0:PRKAR1B|0:GCGR|0:ADCY1|0:GNB1|0:GNG8|0:ADCY8|0:PRKACB|0:ADCY5|0:GNG4|0:GCG|0:GHSR|0:ADIPOR1|0:KDM3A|0:LATS2|0:ASIP|0:TRH|0:AGRP|0:LATS1|0:ADIPOR2|0:NUP62|0:GHRL			
GO:0009401	P:phosphoenolpyruvate-dependent sugar phospho...; IEA:InterPro		0:SLC4A11			
GO:0030311	P:poly-N-acetyllactosamine biosynthetic process; IDA:UniProtKB		0:B3GNT8|0:B3GNT1			
GO:0001540	F:beta-amyloid binding; TAS:UniProtKB		0:APOA1|0:COL25A1|0:APOE|0:TGFB2|0:CST3|0:ITM2C|0:CD74|0:ITM2B|0:APBB1|0:CHRNA7|0:APBB2|0:BCHE|0:MAPK8IP2|0:ACHE			
GO:0008467	F:[heparan sulfate]-glucosamine 3-sulfotransf...; TAS:ProtInc		0:HS3ST5|0:HS3ST1|0:HS3ST6|0:HS3ST4|0:HS3ST3B1			
GO:0060259	P:regulation of feeding behavior; ISS:UniProtKB		0:AGRP|0:QRFP			
GO:0005813	C:centrosome; TAS:UniProtKB		0:RAB3IP|0:AXIN2|0:CKAP5|0:UXT|0:NIN|0:CDC45|0:SLC13A3|0:TOM1|0:PSMB4|0:IGBP1|0:MCM3|0:HIPK1|0:NAV1|0:TLN1|0:APEX1|0:RBM39|0:LITAF|0:DNAL4|0:G6PD|0:FLII|0:KEAP1|0:AKAP9|0:MED12|0:PLA2G6|0:ARHGAP1|0:MYOF|0:ZNF701|0:CEP97|0:TNFAIP3|0:CTAG2|0:NUDT21|0:PCGF5|0:ALMS1|0:CDC27|0:CDC16|0:ALS2|0:RPGRIP1L|0:CEP110|0:KIAA0368|0:CEP63|0:CLIC4|0:ESPL1|0:TMEM67|0:WRN|0:CALM2|0:SGOL1|0:DTL|0:PLK1S1|0:CEP290|0:TSGA14|0:DCAF12|0:DCLRE1B|0:MARK4|0:PSEN1|0:CEP57|0:MAP3K11|0:CDK5RAP2|0:KIF20B|0:KIFC3|0:CALM3|0:HAUS2|0:MZT1|0:DISC1|0:PLEKHA7|0:CCDC85B|0:CEP72|0:BRCA2|0:DHX9|0:DCTN2|0:BLOC1S2|0:CTNNB1|0:PSEN2|0:MZT2B|0:APC|0:CALM1|0:PLK1|0:RAB11FIP3|0:FGFR1OP|0:C16orf63|0:PAFAH1B1|0:CCDC64|0:MZT2A|0:MAD1L1|0:PPP4C|0:PPP4R2|0:AURKC|0:DCTN4|0:KIF15|0:NEK2|0:TUBGCP4|0:RABGAP1|0:RNF19A			
GO:0050528	F:acyloxyacyl hydrolase activity; IEA:EC		0:AOAH			
GO:0008294	F:calcium- and calmodulin-responsive adenylat...; TAS:ProtInc		0:ADCY1|0:ADCY8			
GO:0046638	P:positive regulation of alpha-beta T cell di...; IMP:UniProtKB		0:PNP|0:NKAP			
GO:0009060	P:aerobic respiration; TAS:UniProtKB		0:MT-CO1|0:OXA1L|0:UQCRC1|0:UQCRH|0:SURF1|0:SLC25A14|0:UQCRC2|0:UQCRB|0:ME3			
GO:0006706	P:steroid catabolic process; TAS:ProtInc		0:HSD17B14|0:CYP1A2|0:CYP3A4|0:STS			
GO:0006040	P:amino sugar metabolic process; TAS:ProtInc		0:ST3GAL2|0:ST3GAL6			
GO:0008523	F:sodium-dependent multivitamin transmembrane...; TAS:ProtInc		0:SLC23A2|0:SLC5A6			
GO:0008401	F:retinoic acid 4-hydroxylase activity; IDA:BHF-UCL		0:CYP2S1|0:CYP26C1|0:CYP26A1|0:CYP26B1			
GO:0071636	P:positive regulation of transforming growth ...; ISS:BHF-UCL		0:PTGS2			
GO:0047961	F:glycine N-acyltransferase activity; IEA:InterPro		0:GLYATL1|0:GLYATL2|0:GLYAT|0:GLYATL3			
GO:0007187	P:G-protein signaling, coupled to cyclic nucl...; TAS:ProtInc		0:XCR1|0:HTR4|0:LPAR3|0:SSTR3|0:PTGIR|0:HRH2|0:CNR1|0:HTR1D|0:MC1R|0:CCL2|0:MC5R|0:VIPR1|0:MC2R|0:CNR2|0:HRH3|0:CCR1|0:HTR6|0:PTH1R|0:HTR1E|0:TSHR|0:HTR1F|0:SSTR1|0:NPY|0:MTNR1A|0:SSTR4|0:MTNR1B|0:HTR1B			
GO:0006646	P:phosphatidylethanolamine biosynthetic process; IMP:UniProtKB		0:CHKB|0:CHKA|0:ETNK1|0:SLC27A1			
GO:0016557	P:peroxisome membrane biogenesis; IMP:UniProtKB		0:PEX19|0:PEX16			
GO:0010610	P:regulation of mRNA stability involved in re...; IMP:UniProtKB		0:IGF2BP1			
GO:0008200	F:ion channel inhibitor activity; TAS:UniProtKB		0:KCNMB2|0:KCNJ12|0:ENSA|0:KCNV1|0:RSC1A1|0:PDZD3			
GO:0031111	P:negative regulation of microtubule polymeri...; ISS:UniProtKB		0:FKBP4			
GO:0030513	P:positive regulation of BMP signaling pathway; ISS:UniProtKB		0:ENG|0:ACVRL1|0:BMPR2|0:FOXD1			
GO:0007601	P:visual perception; TAS:UniProtKB		0:RDH10|0:OPN3|0:OPN4|0:OPN5|0:RP9|0:PRPF3|0:PRCD|0:HMCN1|0:RD3|0:PPT1|0:TOPORS|0:CLDN19|0:C2orf71|0:VSX2|0:BBS7|0:GRM6|0:IMPDH1|0:SNRNP200|0:MT-CYB|0:PEX7|0:SPATA7|0:PROM1|0:ABCC6|0:KLHL7|0:HPS1|0:KCNV2|0:BBS9|0:PRPF8|0:ALMS1|0:CERKL|0:CACNA2D4|0:GUCA1B|0:BFSP2|0:PDCL|0:RAX2|0:SEMA4A|0:GRK7|0:LRAT|0:SLC24A2|0:RGS9|0:EYS|0:WDR36|0:PDC|0:DFNB31|0:KERA|0:MYO3A|0:IDH3B|0:BBS5|0:RPGRIP1|0:NYX|0:RORB|0:ELOVL4|0:PITPNM3|0:PHYH|0:CRB1|0:MYO3B|0:TIMP3|0:MERTK|0:MFRP|0:CYP4V2|0:ADAM9|0:SLC45A2|0:RP1L1|0:IRX5|0:PPEF2|0:MIP|0:RIMS1|0:CDH3|0:CA4|0:TTC8|0:CNNM4|0:WFS1|0:CRYGC|0:CRYGD|0:OPA1|0:TRPM1|0:COL2A1|0:DNAJC19|0:OPA3|0:CRYBA1|0:CRYAA|0:COL1A1|0:COL11A1|0:MYO7A|0:CABP4|0:RPGR|0:CRYBA4|0:TH|0:CHRNB2|0:SLC24A1|0:CRYGB|0:CRYGA|0:CNGA3|0:COL18A1|0:RABGGTB|0:TACSTD2|0:NDP|0:RGS16|0:PDE6D|0:GUCY2D|0:CHM|0:UNC119|0:RDH8|0:CRYBB3|0:RRH|0:EFEMP1|0:TULP2|0:LUM|0:SIX6|0:POU6F2|0:AOC2|0:OCLM|0:RP2|0:CRYZ|0:EYA4|0:GUCA1A|0:RABGGTA|0:TYR|0:ABLIM1|0:PRR4|0:EML2|0:OPN1LW|0:VSX1|0:ROM1|0:OPN1MW|0:RPE65|0:RS1|0:NRL|0:RAX|0:KRT12|0:PDE6A|0:GJA8|0:KIFC3|0:CRX|0:VAX2|0:AIPL1|0:PAX6|0:POU4F3|0:RLBP1|0:CNGA1|0:RDH5|0:RCVRN|0:GJA3|0:ARR3|0:ATXN7|0:PDE6B|0:GUCA1C|0:RBP3|0:OAT|0:GRM8|0:DHRS3|0:SFRP5|0:TGFBI|0:NR2E3|0:PDE6G|0:MYO9A|0:PRPH2|0:CHML|0:CNGB3|0:PITPNA|0:OPN1SW|0:CRYBB1|0:IMPG1|0:OPN1MW2|0:CRYBB2|0:GPR143|0:PDE6C|0:CDS1|0:PDE6H|0:PAX2|0:EYA3|0:GUCY2F|0:FSCN2|0:SIX3|0:RP1|0:BEST1|0:RGR|0:CYP1B1|0:IMPG2			
GO:0070402	F:NADPH binding; IDA:UniProtKB		0:DECR1|0:CBR3|0:CRYZ|0:CBR4|0:TP53I3			
GO:0004500	F:dopamine beta-monooxygenase activity; IEA:InterPro		0:DBH|0:MOXD2P|0:C9orf4|0:MOXD1|0:FRRS1			
GO:0044020	F:histone methyltransferase activity (H4-R3 s...; ISS:UniProtKB		0:PRMT6|0:PRMT7			
GO:0000185	P:activation of MAPKKK activity; TAS:ProtInc		0:MAP4K1|0:TRAF7|0:GADD45G|0:TAB1|0:GADD45B			
GO:0006354	P:RNA elongation; NAS:UniProtKB		0:TCEA3|0:TCEA1|0:TCEA2			
GO:0070091	P:glucagon secretion; ISS:BHF-UCL		0:IL6			
GO:0007224	P:smoothened signaling pathway; ISS:UniProtKB		0:PTCH1			
GO:0002115	P:store-operated calcium entry; IMP:UniProtKB		0:EFCAB4A|0:EFCAB4B			
GO:0042157	P:lipoprotein metabolic process; IMP:HGNC		0:APOA4|0:APOC1|0:APOL4|0:APOL5|0:APOC3|0:APOL1|0:APOL2|0:APOA5|0:APOLD1|0:APOL6|0:APOL3|0:NPC1L1			
GO:0007270	P:nerve-nerve synaptic transmission; NAS:UniProtKB		0:DRD2|0:KIF1B|0:DLGAP2			
GO:0006689	P:ganglioside catabolic process; TAS:ProtInc		0:NEU3			
GO:0051351	P:positive regulation of ligase activity; NAS:UniProtKB		0:XRCC4|0:NHEJ1			
GO:0034056	F:estrogen response element binding; IDA:UniProtKB		0:ESR1			
GO:0001682	P:tRNA 5'-leader removal; IEA:InterPro		0:POP1			
GO:0051606	P:detection of stimulus; IDA:UniProtKB		0:CADM1			
GO:0004473	F:malate dehydrogenase (oxaloacetate-decarbox...; IDA:UniProtKB		0:ME3|0:ME1			
GO:0005146	F:leukemia inhibitory factor receptor binding; TAS:ProtInc		0:LIF|0:CTF1			
GO:0050921	P:positive regulation of chemotaxis; IDA:BHF-UCL		0:PDGFB|0:TGFB1			
GO:0006436	P:tryptophanyl-tRNA aminoacylation; NAS:UniProtKB		0:WARS2|0:WARS			
GO:0004197	F:cysteine-type endopeptidase activity; TAS:UniProtKB		0:CASP3|0:CASP7|0:CASP6|0:CASP8|0:CTSB|0:CASP2|0:CTSH|0:UCHL1|0:CTSLL6|0:CASP4|0:LGMN|0:TINAGL1|0:PIGK|0:CARD16|0:PYCARD|0:CFLAR|0:CTSW|0:CARD18|0:CASP5|0:CTSZ|0:CASP12|0:PYDC1|0:CRADD|0:CARD17|0:CTSC|0:USP20|0:USP16|0:USP33|0:USP12|0:ATG4C|0:ATG4D|0:MALT1|0:USP15|0:CTSO|0:CTSL2|0:USP7|0:CTSK|0:CTSF|0:TINAG|0:USP11|0:CASP10|0:CTSL1|0:CASP1|0:PDIA3|0:CASP14|0:CASP9|0:USP9X|0:CTSS|0:USP2|0:USP14|0:BLMH|0:USP8|0:USP1|0:USP5|0:USP13|0:USP6			
GO:0060124	P:positive regulation of growth hormone secre...; NAS:BHF-UCL		0:GHRL|0:GHRH|0:DRD2|0:GHRHR			
GO:0048663	P:neuron fate commitment; NAS:UniProtKB		0:TGFBR1|0:PAX6			
GO:0008559	F:xenobiotic-transporting ATPase activity; TAS:ProtInc		0:ABCB1|0:ABCB4|0:ABCG2			
GO:0004396	F:hexokinase activity; TAS:ProtInc		0:HKDC1|0:HK3|0:HK1|0:HK2			
GO:0090324	P:negative regulation of oxidative phosphoryl...; IMP:BHF-UCL		0:MLXIPL			
GO:0042462	P:eye photoreceptor cell development; ISS:UniProtKB		0:MYO7A|0:TH|0:CEP290|0:RORB|0:TULP1			
GO:0031941	C:filamentous actin; ISS:UniProtKB		0:RAC3|0:MYO9B|0:CORO1A|0:MYO1A|0:MYO1C|0:CD2AP|0:MYO3A|0:MYO6|0:ESPN			
GO:0001300	P:chronological cell aging; IEP:BHF-UCL		0:ENG|0:SERPINE1			
GO:0042995	C:cell projection; IEA:UniProtKB-SubCell		0:SH3PXD2A|0:RHOU|0:FERMT3|0:ARPC4|0:SVIL|0:ACTR2|0:MRI1|0:ARHGAP24|0:ARPC5|0:ARPC2|0:CLSTN1|0:ACTR3B			
GO:0042322	P:negative regulation of circadian sleep/wake...; NAS:BHF-UCL		0:GHRL|0:CRH			
GO:0050294	F:steroid sulfotransferase activity; IDA:UniProtKB		0:SULT1E1|0:SULT2B1			
GO:0060068	P:vagina development; ISS:BHF-UCL		0:RBP4			
GO:0006895	P:Golgi to endosome transport; TAS:UniProtKB		0:SORT1|0:DOPEY2|0:MON2|0:VPS13A|0:AP2A1|0:RAB9B|0:RAB14			
GO:0051151	P:negative regulation of smooth muscle cell d...; IDA:UniProtKB		0:EREG|0:FOXO4			
GO:0060765	P:regulation of androgen receptor signaling p...; TAS:BHF-UCL		0:PARK7|0:TRIM68|0:RNF14|0:RNF6|0:HDAC6			
GO:0042292	F:URM1 activating enzyme activity; IDA:UniProtKB		0:MOCS3			
GO:0072125	P:negative regulation of glomerular mesangial...; IDA:UniProtKB		0:BMP7|0:BMP4			
GO:0048812	P:neuron projection morphogenesis; ISS:UniProtKB		0:MAP1S|0:DTNBP1|0:KLK8|0:ATP7A			
GO:0035082	P:axoneme assembly; ISS:UniProtKB		0:TTLL3			
GO:0007009	P:plasma membrane organization; TAS:ProtInc		0:A4GALT|0:SERP1			
GO:0008386	F:cholesterol monooxygenase (side-chain-cleav...; IDA:UniProtKB		0:CYP11A1			
GO:0003976	F:UDP-N-acetylglucosamine-lysosomal-enzyme N-...; IEA:EC		0:GNPTAB			
GO:0047749	F:cholestanetriol 26-monooxygenase activity; IEA:EC		0:CYP27A1|0:CYP2R1			
GO:0031014	F:troponin T binding; IPI:UniProtKB		0:TNNI2|0:TNNI3|0:TNNC1			
GO:0043548	F:phosphoinositide 3-kinase binding; IPI:UniProtKB		0:CORO1A|0:LCK|0:IRS1|0:IGF1R|0:INSR			
GO:0021549	P:cerebellum development; ISS:HGNC		0:SDF4|0:MYO16			
GO:0000902	P:cell morphogenesis; NAS:UniProtKB		0:STK4|0:LST1|0:WNT3|0:SSH1|0:ARHGEF2|0:SHROOM3|0:NOX4|0:SHROOM1|0:PDPN|0:VHL			
GO:0042801	F:polo kinase kinase activity; IEA:InterPro		0:PLK1|0:PLK5P|0:PLK2|0:PLK3			
GO:0035339	C:SPOTS complex; IDA:UniProtKB		0:SPTLC1|0:ORMDL3			
GO:0045646	P:regulation of erythrocyte differentiation; IMP:BHF-UCL		0:SPI1|0:CDK6			
GO:0031265	C:CD95 death-inducing signaling complex; NAS:UniProtKB		0:FAF1			
GO:0006651	P:diacylglycerol biosynthetic process; TAS:UniProtKB		0:ANG|0:PLCE1			
GO:0048499	P:synaptic vesicle membrane organization; NAS:UniProtKB		0:SYP			
GO:0017040	F:ceramidase activity; IEA:EC		0:ACER1|0:ACER2|0:ASAH2C|0:ASAH1|0:ASAH2			
GO:0005898	C:interleukin-13 receptor complex; TAS:ProtInc		0:IL13RA1			
GO:0007417	P:central nervous system development; TAS:UniProtKB		0:B3GNT5|0:NMUR2|0:DNER|0:CHD7|0:ALDH5A1|0:CYP26C1|0:ARNT2|0:LIG4|0:ZBTB16|0:PTEN|0:WWP1|0:RCAN2|0:KLK6|0:CHST8|0:ASCL2|0:NRCAM|0:NES|0:NHEJ1|0:PNMA1|0:ADAM23|0:GSTP1|0:PARK2|0:MBP|0:BTD|0:SH3GL2|0:UGT8|0:JRKL|0:POU6F2|0:C7orf16|0:NEUROG3|0:PTS|0:ALDH3A2|0:NHLH2|0:DRP2|0:PSPN|0:ACCN1|0:NPTX1|0:RCAN1|0:HPCAL4|0:PAX6|0:TAGLN3|0:RNF103|0:ATN1|0:IL1RAPL2|0:RPS6KA6|0:SNTG2|0:S100B|0:NHLH1|0:NPAS1|0:PCP4|0:SH3GL1|0:SERPINI1|0:PTPRZ1|0:SH3GL3|0:SHC3|0:NCKAP1|0:GRIK1|0:ADAM22|0:CNTN6|0:NPAS2|0:MOG|0:JARID2|0:RPS6KA3|0:MAL|0:CELSR1|0:PDGFC			
GO:0072240	P:metanephric DCT cell differentiation; ISS:UniProtKB		0:POU3F3			
GO:0009887	P:organ morphogenesis; TAS:UniProtKB		0:FOXL1|0:FHL1|0:BHLHE41|0:EVL|0:RFNG|0:LFNG|0:SEMA6A|0:COL18A1|0:HRAS|0:DGCR6|0:IL7|0:SIX6|0:TMEM176B|0:CDX2|0:TLE1|0:DGCR2|0:DCN|0:BRAF|0:ABLIM1|0:SYK|0:GNPAT|0:NKX6-1|0:PAX4|0:STX2|0:CRX|0:PAX6|0:HEY1|0:ITGAX|0:ELN|0:LY6H|0:FOXN1|0:PITX3|0:AES|0:LHX1|0:FABP1|0:FGD1|0:PAX3|0:FLI1|0:TLE3|0:PAX5|0:PITX2|0:HCCS|0:LHX3|0:SFTPB|0:TLE2|0:ETV7|0:FGF16|0:EPHB4|0:PKD2|0:APLP1|0:HEY2|0:ONECUT2|0:EREG			
GO:0032793	P:positive regulation of CREB transcription f...; IDA:UniProtKB		0:TSSK4			
GO:0006497	P:protein amino acid lipidation; ISS:UniProtKB		0:ATG7|0:ATG10			
GO:0043570	P:maintenance of DNA repeat elements; IMP:HGNC		0:AXIN2|0:TCF7L2|0:MSH2|0:MSH3			
GO:0043128	P:positive regulation of 1-phosphatidylinosit...; IDA:UniProtKB		0:CD81			
GO:0005221	F:intracellular cyclic nucleotide activated c...; TAS:ProtInc		0:KCNA10			
GO:0004660	F:protein farnesyltransferase activity; TAS:ProtInc		0:FNTB|0:FNTA			
GO:0042220	P:response to cocaine; ISS:UniProtKB		0:CHRNB2			
GO:0045356	P:positive regulation of interferon-alpha bio...; IDA:UniProtKB		0:TLR8|0:TLR3|0:TLR9|0:TLR7			
GO:0008601	F:protein phosphatase type 2A regulator activity; TAS:UniProtKB		0:PPP2R4|0:PPP2R5C|0:IGBP1|0:PPP2R2D|0:PPP2R2C|0:PPME1|0:EIF2AK2|0:PPP2R5D|0:PPP2R5E|0:PPP2R5A|0:PPP2R3A|0:PPP2R2B|0:PPP2R3B|0:PPP2R5B|0:PPP2R2A|0:PPP2R1A|0:SET			
GO:0004356	F:glutamate-ammonia ligase activity; IEA:InterPro		0:GLUL|0:LGSN			
GO:0016251	F:general RNA polymerase II transcription fac...; TAS:ProtInc		0:TBP|0:TAF11|0:TAF13|0:TAF10|0:GTF2A1|0:GTF2A2|0:TAF7|0:GTF2H3|0:TAF7L|0:TAF6|0:GTF2F2|0:GTF2F1|0:GTF2B|0:TAF4|0:TAF1A|0:TAF1C|0:ABT1|0:GTF2I|0:TAF12|0:TCEA1|0:GTF2H1			
GO:0043514	C:interleukin-12 complex; IDA:UniProtKB		0:IL12A|0:IL12B			
GO:0017004	P:cytochrome complex assembly; IDA:BHF-UCL		0:CYBA			
GO:0051260	P:protein homooligomerization; TAS:UniProtKB		0:BAX|0:MUC20|0:TERF1|0:PEX14|0:ATL3|0:DGKD|0:NACC1|0:ATL2|0:GCH1|0:CRYAB|0:HMOX1|0:VWF|0:CRYAA|0:LONP1|0:ATL1|0:STOM|0:SCUBE3|0:SPAST|0:AKR1C1|0:TAF10|0:C10orf2|0:PRND|0:PRNP|0:EIF2AK3|0:P2RX2|0:P2RX6|0:IGHMBP2|0:SCUBE1|0:GOPC|0:RAD51|0:ALAD|0:ITPR3|0:CAV1|0:TRIM72|0:CCDC88C|0:NACC2|0:COLEC12|0:SMARCAD1|0:ATG16L1|0:BCL10|0:SYT1			
GO:0021854	P:hypothalamus development; NAS:UniProtKB		0:NKX2-6|0:NR0B1			
GO:0004768	F:stearoyl-CoA 9-desaturase activity; TAS:ProtInc		0:SCD5|0:SCD			
GO:0045672	P:positive regulation of osteoclast different...; IDA:UniProtKB		0:TRAF6|0:TNFSF11			
GO:0006378	P:mRNA polyadenylation; TAS:UniProtKB		0:CPSF1|0:ZC3H3|0:APP|0:PAPOLA|0:CPSF3|0:CSTF3|0:GRSF1|0:CSTF2|0:CSTF1|0:PABPC1			
GO:0016973	P:poly(A)+ mRNA export from nucleus; IMP:UniProtKB		0:GLE1|0:HHEX|0:ZC3H3|0:PABPN1			
GO:0010703	P:negative regulation of histolysis; IC:BHF-UCL		0:CST3			
GO:0032075	P:positive regulation of nuclease activity; IDA:UniProtKB		0:HMGB2			
GO:0016936	F:galactoside binding; IEA:InterPro		0:LGALS1			
GO:0009229	P:thiamin diphosphate biosynthetic process; IEA:InterPro		0:TPK1			
GO:0050291	F:sphingosine N-acyltransferase activity; ISS:HGNC		0:LASS5|0:LASS1			
GO:0047237	F:glucuronylgalactosylproteoglycan 4-beta-N-a...; IEA:EC		0:CSGALNACT1|0:CSGALNACT2			
GO:0000214	C:tRNA-intron endonuclease complex; IEA:InterPro		0:CLP1|0:TSEN2|0:TSEN34			
GO:0004030	F:aldehyde dehydrogenase [NAD(P)+] activity; TAS:ProtInc		0:ALDH1A3|0:ALDH3B1|0:ALDH3A1|0:ALDH3B2|0:ALDH3A2|0:ALDH2			
GO:0004381	F:fucosylgalactoside 3-alpha-galactosyltransf...; NAS:UniProtKB		0:ABO			
GO:0035020	P:regulation of Rac protein signal transduction; ISS:HGNC		0:ARF6|0:RASGRF1			
GO:0042491	P:auditory receptor cell differentiation; ISS:UniProtKB		0:KCNMA1			
GO:0008489	F:UDP-galactose:glucosylceramide beta-1,4-gal...; TAS:ProtInc		0:UGT8			
GO:0035089	P:establishment of apical/basal cell polarity; ISS:BHF-UCL		0:SCRIB|0:FOXJ1			
GO:0017116	F:single-stranded DNA-dependent ATP-dependent...; IDA:UniProtKB		0:PIF1|0:HELB			
GO:0000815	C:ESCRT III complex; IDA:UniProtKB		0:CHMP7			
GO:0071456	P:cellular response to hypoxia; IEP:UniProtKB		0:VEGFA|0:AQP1|0:ANGPT4			
GO:0016578	P:histone deubiquitination; ISS:UniProtKB		0:ATXN7L3|0:KAT2A|0:ENY2|0:USP16|0:SUPT3H|0:USP3|0:ATXN7|0:TRRAP|0:MYSM1|0:USP22|0:TAF10|0:USP21			
GO:0032393	F:MHC class I receptor activity; TAS:UniProtKB		0:CD160|0:HLA-C|0:ULBP1|0:ULBP2|0:HLA-H|0:KIR3DS1|0:HLA-B|0:ULBP3|0:MR1|0:KLRF1|0:HLA-F|0:HLA-G|0:HLA-E			
GO:0042470	C:melanosome; ISS:UniProtKB		0:SILV|0:MLANA|0:GCHFR|0:TMEM33|0:HPS4|0:RAB27A|0:SERPINF1|0:RAB5A|0:SLC3A2|0:CAPG|0:ATP6V1B2|0:SDCBP|0:ATP1B3|0:RAB2A|0:DNAJC5|0:RAB35|0:CTSB|0:GNA13|0:SYPL1|0:RAC1|0:SLC1A4|0:HSP90B1|0:CCT4|0:RPN1|0:MMP14|0:PRDX1|0:TRPV2|0:MYH11|0:YWHAB|0:ERP29|0:FLOT1|0:PDIA4|0:RAB5B|0:ANXA2P2|0:PDCD6IP|0:SLC2A1|0:NAP1L1|0:TMED10|0:ATP6V1G2|0:SYNGR1|0:FASN|0:SLC1A5|0:SEC22B|0:CLTC|0:P4HB|0:ANXA11|0:RAB38|0:ANXA2|0:GPNMB|0:SND1|0:AHCY|0:ANXA6|0:STOM|0:PPIB|0:TPP1|0:CANX|0:RAB7A|0:PDIA3|0:HSPA8|0:ATP1A1|0:YWHAZ|0:GANAB|0:BSG|0:GGH|0:YWHAE|0:CTSD|0:TFRC|0:HSP90AA1|0:CALU|0:RAB5C|0:SLC24A5|0:NCSTN|0:PDIA6|0:HSP90AB1|0:ATP6V0A1|0:HSPA5|0:CNP|0:SYTL2|0:SYTL1			
GO:0001754	P:eye photoreceptor cell differentiation; ISS:UniProtKB		0:STAT3			
GO:0016868	F:intramolecular transferase activity, phosph...; IEA:InterPro		0:PGM5|0:PGM2L1			
GO:0006825	P:copper ion transport; TAS:UniProtKB		0:SCO1|0:SCO2|0:HEPHL1|0:CP|0:HEPH|0:CUTC|0:COX17|0:ATOX1			
GO:0004487	F:methylenetetrahydrofolate dehydrogenase (NA...; IEA:EC		0:MTHFD2|0:MTHFD2L			
GO:0002032	P:desensitization of G-protein coupled recept...; IMP:UniProtKB		0:ADRB2|0:ARRB2			
GO:0030948	P:negative regulation of vascular endothelial...; ISS:UniProtKB		0:HHEX|0:NEDD4			
GO:0045071	P:negative regulation of viral genome replica...; TAS:UniProtKB		0:TNF|0:PROX1|0:CCL5|0:TNIP1			
GO:0017145	P:stem cell division; IDA:UniProtKB		0:WWTR1			
GO:0004945	F:angiotensin type II receptor activity; TAS:ProtInc		0:AGTR1|0:RXFP4|0:AGTR2|0:MAS1			
GO:0033147	P:negative regulation of estrogen receptor si...; ISS:UniProtKB		0:STRN3			
GO:0003050	P:regulation of systemic arterial blood press...; ISS:UniProtKB		0:CORIN			
GO:0043984	P:histone H4-K16 acetylation; IMP:UniProtKB		0:MLL			
GO:0034063	P:stress granule assembly; ISS:UniProtKB		0:ATXN2|0:CIRBP			
GO:0051247	P:positive regulation of protein metabolic pr...; IDA:BHF-UCL		0:WFS1			
GO:0048678	P:response to axon injury; ISS:UniProtKB		0:SOD1			
GO:0006916	P:anti-apoptosis; TAS:UniProtKB		0:TRAF6|0:IKBKB|0:MYD88|0:PRKCI|0:RIPK2|0:NGF|0:SQSTM1|0:IRAK1|0:NGFR|0:NFKBIA|0:IGF1|0:TNF|0:NRG1|0:APOE|0:IL1B|0:TCF7L2|0:CRYAB|0:SH3GLB1|0:CRYAA|0:BCL2L10|0:BFAR|0:FOXO1|0:COMP|0:VEGFB|0:TMX1|0:BIRC5|0:HBXIP|0:ANGPT4|0:BCL2|0:TBX3|0:CERKL|0:PSEN1|0:TIAF1|0:PIM2|0:DHCR24|0:CCL2|0:CDK1|0:SON|0:AVEN|0:GLO1|0:PROK2|0:PEA15|0:GCLC|0:CD27|0:RELA|0:CD40LG|0:ANGPT1|0:CDKN2D|0:HMOX1|0:CFLAR|0:GPX1|0:TERT|0:TRIAP1|0:IFI6|0:SNCA|0:ALOX12|0:BIRC6|0:SERPINB9|0:HSP90B1|0:API5|0:HIPK3|0:XIAP|0:AATF|0:HSPA5|0:NOS3|0:CITED2|0:VNN1|0:NME5|0:CIAPIN1|0:MALT1|0:SPHK2|0:IL31RA|0:AZU1|0:BIRC7|0:BAG3|0:FAIM2|0:IL10|0:NME6|0:VHL|0:TNFAIP3|0:NPM1|0:PRLR|0:F7|0:THBS1|0:F3|0:SOCS3|0:HDAC1|0:SERPINB2|0:IL1A|0:TNFAIP8|0:PAX7|0:RNF7|0:BRAF|0:FAS|0:MPO|0:MYO18A|0:TNFRSF10D|0:IER3|0:PRKCZ|0:GDNF|0:TAX1BP1|0:SEMA4D|0:HDAC3|0:CBX4|0:TNFRSF18|0:TNFSF18|0:BIRC3|0:DAD1|0:FAIM3|0:YWHAZ|0:BAG4|0:BCL2L2|0:BAG1|0:NOL3|0:IGF1R|0:SOCS2|0:NAIP|0:BCL2A1|0:TNFRSF6B|0:BECN1|0:GSTP1|0:HSPA9|0:HSPB1|0:BNIP1|0:ANXA5|0:NOTCH2|0:SPHK1|0:DDAH2|0:MCL1|0:ANXA1|0:BNIP2|0:TXNDC5|0:IL2|0:ANXA4|0:HSPA1A|0:HTATIP2|0:PRDX2|0:TPT1|0:NFKB1|0:HSPA1B|0:CFL1|0:ARHGDIA			
GO:0005000	F:vasopressin receptor activity; TAS:UniProtKB		0:OXTR|0:NPSR1|0:AVPR1A|0:AVPR1B|0:AVPR2			
GO:0005247	F:voltage-gated chloride channel activity; TAS:ProtInc		0:CLIC4|0:CLCN7|0:CLIC3|0:CLIC6|0:CLIC2|0:CLIC5|0:CLIC1|0:CLCN6|0:CLCN4|0:CLCN3|0:CLCN1|0:CLCNKB|0:CLCN2|0:CLCNKA|0:PKD2			
GO:0006957	P:complement activation, alternative pathway; NAS:UniProtKB		0:C3|0:CFD|0:CFP|0:C4A|0:C2|0:C8G|0:C7|0:C9|0:C5|0:C8A|0:C8B|0:CFH|0:VSIG4|0:CFHR5|0:CFB			
GO:0031670	P:cellular response to nutrient; IMP:BHF-UCL		0:CDKN2B			
GO:0030029	P:actin filament-based process; IDA:BHF-UCL		0:SELE			
GO:0030127	C:COPII vesicle coat; NAS:UniProtKB		0:VMA21|0:SEC24B|0:SEC23B|0:SEC23A|0:SEC24A|0:SEC31A|0:SEC24C|0:SEC24D			
GO:0004067	F:asparaginase activity; IEA:EC		0:ASPG			
GO:0000173	P:inactivation of MAPK activity involved in o...; TAS:ProtInc		0:MBIP			
GO:0000153	C:cytoplasmic ubiquitin ligase complex; IPI:MGI		0:ATG3			
GO:0034231	P:islet amyloid polypeptide processing; ISS:BHF-UCL		0:PCSK2			
GO:0055012	P:ventricular cardiac muscle cell differentia...; IDA:BHF-UCL		0:NRG1			
GO:0019898	C:extrinsic to membrane; TAS:UniProtKB		0:WDFY3|0:MUC16|0:EZR|0:FARP2|0:EPB41L4A|0:MSN|0:EPB41L1|0:MYLIP|0:FARP1|0:EPB41L4B|0:EPB41L5|0:FRMD3|0:EPB41L2|0:PTPN3|0:RDX|0:EPB41L3|0:NF2|0:PTPN4|0:FRMD5|0:EPB41|0:SYTL4|0:DMBT1|0:GFRA1|0:GML|0:BST1|0:CNTFR|0:FOLR3|0:GFRA3|0:GFRA2|0:PLAUR|0:UMOD|0:PRNP			
GO:0043025	C:neuronal cell body; NAS:UniProtKB		0:RAC3|0:GRIN3A|0:SKOR1|0:ATXN10|0:SOD1|0:SRR|0:ITPR3|0:MAP1S|0:FRMD7|0:EFHC1|0:GNB2L1|0:CDK5R1|0:CHRNA3|0:CDK5|0:NCDN|0:ANG|0:STRN3|0:NRSN1|0:TGFB2|0:GRIN3B|0:ATP7A|0:CHRNA4|0:STRN|0:APOE|0:SNCAIP			
GO:0071438	C:invadopodium membrane; IDA:UniProtKB		0:DPP4			
GO:0035538	F:carbohydrate response element binding; TAS:BHF-UCL		0:MLXIPL			
GO:0021771	P:lateral geniculate nucleus development; ISS:UniProtKB		0:CHRNB2			
GO:0034227	P:tRNA thio-modification; NAS:UniProtKB		0:MOCS3|0:URM1|0:CTU2|0:CTU1			
GO:0005178	F:integrin binding; TAS:UniProtKB		0:ADAM9|0:VCAM1|0:COL4A3|0:THBS4|0:ACTN1|0:COL16A1|0:LAMA5|0:THBS1|0:COL3A1|0:ICAM3|0:VTN|0:KDR|0:CD226|0:ICAM1|0:ICAM2|0:ADAM17|0:CALR|0:ERBB2IP|0:DST|0:ANGPTL3|0:SYK|0:THY1|0:VWF|0:SFRP2|0:TNXB|0:FERMT3|0:LTBP4|0:ADAMDEC1|0:COL5A1|0:ADAM22|0:ADAM10|0:SRC|0:ADAM23|0:ADAM2|0:EDIL3|0:ADAMTS5|0:ICAM4|0:FBLN5|0:ADAM11|0:TGFBI|0:ADAMTS8|0:DMP1|0:ECM2|0:EGFL6|0:FCER2|0:ACTN2|0:ADAMTS13|0:ACTN3|0:ACTN4			
GO:0005623	C:cell; TAS:ProtInc		0:NPY			
GO:0033619	P:membrane protein proteolysis; IDA:UniProtKB		0:HM13			
GO:0001818	P:negative regulation of cytokine production; ISS:BHF-UCL		0:SLC11A1			
GO:0005463	F:UDP-N-acetylgalactosamine transmembrane tra...; NAS:UniProtKB		0:SLC35D1			
GO:0016784	F:3-mercaptopyruvate sulfurtransferase activity; IEA:EC		0:MPST			
GO:0050806	P:positive regulation of synaptic transmission; ISS:UniProtKB		0:GRIK2|0:LGI1			
GO:0007342	P:fusion of sperm to egg plasma membrane; TAS:ProtInc		0:IZUMO1|0:CD9|0:HYAL4|0:SPAM1|0:ROPN1B|0:SERPINA5|0:ADAM2|0:CRISP1			
GO:0060399	P:positive regulation of growth hormone recep...; IC:BHF-UCL		0:GHRL			
GO:0005764	C:lysosome; TAS:UniProtKB		0:LDLR|0:PCYOX1|0:PCSK9|0:NPC2|0:VMA21|0:ANKRD27|0:RAB7A|0:RAB9A|0:PPT1|0:AGA|0:TMEM97|0:BCL10|0:VPS4B|0:UVRAG|0:TPP1|0:UNC13D|0:ADA|0:SLC11A2|0:KCNE2|0:KCNE1|0:SPACA3|0:HPS4|0:ARSG|0:RAB27A|0:SFTPB|0:PSAPL1|0:CTSO|0:GALNS|0:DNASE2B|0:LGMN|0:CTSL2|0:CTSB|0:LRBA|0:DPP7|0:CTSK|0:GUSB|0:HYAL3|0:CHID1|0:IDUA|0:SGSH|0:RAB7B|0:DOC2A|0:WDR48|0:GLB1|0:MAN2B1|0:ASAH1|0:RNASE2|0:SMPD1|0:HEXB|0:CTSH|0:ZNRF1|0:PEBP4|0:GNS|0:IL4I1|0:CHIT1|0:GGH|0:CD74|0:FNBP1|0:PRCP|0:PRDX6|0:NAGA|0:CTBS|0:IDS|0:TRIP10|0:PLEKHF1|0:HEXA|0:HYAL1|0:CTSZ|0:NBR1|0:ACP5|0:NAAA|0:FUCA1|0:ARSD|0:KIAA0226|0:MANBA|0:SIAE|0:GLA|0:SLC11A1|0:RAB14|0:UNC93B1|0:TLR9|0:TLR7|0:PPT2|0:CTSA|0:CTSL1|0:PLA2G15|0:CTSS|0:CTSD|0:GM2A|0:ARSB|0:DNASE2|0:USP4|0:CTSF|0:TIAL1|0:HPS1|0:MPO|0:USP6|0:VAMP4|0:GALC|0:ARSA|0:AP3M1|0:RAMP3|0:ADRB2|0:IFI30|0:NAGLU|0:TOM1L1|0:HYAL2|0:LRP2|0:STS|0:USP5|0:TSPAN8|0:LIPA|0:RAMP2|0:SFTPD|0:TYR|0:CTSC			
GO:0016929	F:SUMO-specific protease activity; ISS:UniProtKB		0:SENP2|0:SENP1			
GO:0004609	F:phosphatidylserine decarboxylase activity; IEA:EC		0:PISD			
GO:0000790	C:nuclear chromatin; ISS:UniProtKB		0:TIMELESS|0:TIPIN|0:KLHDC3|0:RCC1|0:NPM2|0:USP3|0:CITED2|0:H1FNT			
GO:0008785	F:alkyl hydroperoxide reductase activity; NAS:UniProtKB		0:PRDX3			
GO:0022617	P:extracellular matrix disassembly; IMP:HGNC		0:PLG|0:ENG|0:LAMC1			
GO:0042738	P:exogenous drug catabolic process; IDA:UniProtKB		0:CYP2A6|0:CYP2C19|0:CYP1A2|0:CYP2C8|0:CYP2B6|0:CYP2C9|0:CYP3A4|0:NR1I2			
GO:0004809	F:tRNA (guanine-N2-)-methyltransferase activity; IEA:InterPro		0:TRMT1|0:C1orf25			
GO:0003887	F:DNA-directed DNA polymerase activity; TAS:ProtInc		0:POLG|0:POLA1|0:POLB|0:POLM|0:MYBBP1A|0:KIAA2022|0:DNTT|0:ESCO2|0:REV1|0:ESCO1|0:POLD2|0:PAPD5|0:POLK|0:ERVK2|0:PAPD7|0:POLN|0:POLD1|0:POLE|0:POLD3|0:POLG2|0:POLL|0:CHRAC1|0:POLE3|0:POLH|0:POLE4|0:POLI|0:POLQ|0:POLD4|0:REV3L|0:POLE2			
GO:0000797	C:condensin core heterodimer; NAS:UniProtKB		0:NCAPD2			
GO:0031430	C:M band; TAS:BHF-UCL		0:TTN|0:ANK2|0:ANK1|0:ENO1|0:SPTBN1|0:NBR1|0:OBSCN|0:OBSL1			
GO:0004978	F:adrenocorticotropin receptor activity; TAS:ProtInc		0:MC2R			
GO:0048845	P:venous blood vessel morphogenesis; ISS:UniProtKB		0:PROX1|0:ENG|0:CCBE1			
GO:0016034	F:maleylacetoacetate isomerase activity; EXP:Reactome		0:GSTZ1			
GO:0043089	P:positive regulation of Cdc42 GTPase activity; ISS:HGNC		0:ARAP1|0:RALBP1|0:SH3D20|0:ARHGAP27			
GO:0033625	P:positive regulation of integrin activation; TAS:BHF-UCL		0:PLEK|0:SRC			
GO:0055003	P:cardiac myofibril assembly; ISS:UniProtKB		0:OBSL1|0:TTN|0:MYL2|0:ACTC1			
GO:0032438	P:melanosome organization; NAS:UniProtKB		0:SILV|0:GPR143|0:SHROOM2|0:LYST|0:BLOC1S3|0:BLOC1S1|0:BLOC1S2			
GO:0010944	P:negative regulation of transcription by com...; TAS:BHF-UCL		0:OVOL2|0:SMAD7|0:HHEX			
GO:0010259	P:multicellular organismal aging; ISS:UniProtKB		0:WRN|0:CISD2			
GO:0017057	F:6-phosphogluconolactonase activity; IEA:EC		0:PGLS|0:H6PD			
GO:0047115	F:trans-1,2-dihydrobenzene-1,2-diol dehydroge...; IEA:EC		0:AKR1C1|0:AKR1C2|0:DHDH|0:AKR1C3			
GO:0018169	F:ribosomal S6-glutamic acid ligase activity; IDA:UniProtKB		0:UBE2M			
GO:0031260	C:pseudopodium membrane; IEA:UniProtKB-SubCell		0:RAB25			
GO:0043697	P:cell dedifferentiation; IMP:BHF-UCL		0:CDK6			
GO:0005164	F:tumor necrosis factor receptor binding; NAS:UniProtKB		0:TNF|0:BRE|0:TNFSF15|0:TNFSF9|0:TNFSF10|0:TNFSF13B|0:LTA|0:EDA|0:TNFSF18|0:TNFSF12|0:TNFSF13|0:CD70|0:TNFSF8|0:TNFSF14|0:CD40LG|0:LTB|0:TRAP1|0:TNFSF11			
GO:0008425	F:2-polyprenyl-6-methoxy-1,4-benzoquinone met...; IEA:InterPro		0:COQ3			
GO:0009651	P:response to salt stress; TAS:BHF-UCL		0:KMO|0:TNF			
GO:0002693	P:positive regulation of cellular extravasation; IMP:BHF-UCL		0:ICAM1			
GO:0018283	P:iron incorporation into metallo-sulfur cluster; IDA:HGNC		0:FXN|0:NFS1			
GO:0050689	P:negative regulation of defense response to ...; IDA:UniProtKB		0:TARBP2|0:MICB			
GO:0032319	P:regulation of Rho GTPase activity; ISS:BHF-UCL		0:PAFAH1B1			
GO:0004070	F:aspartate carbamoyltransferase activity; ISS:BHF-UCL		0:CAD			
GO:0070125	P:mitochondrial translational elongation; IDA:UniProtKB		0:GFM1			
GO:0001894	P:tissue homeostasis; TAS:UniProtKB		0:P2RX4|0:CUBN|0:BARD1			
GO:0000930	C:gamma-tubulin complex; TAS:UniProtKB		0:BLOC1S2|0:TUBG1			
GO:0004185	F:serine-type carboxypeptidase activity; TAS:ProtInc		0:CPVL|0:CTSA|0:SCPEP1|0:CPD|0:PRCP			
GO:0035497	F:cAMP response element binding; IMP:UniProtKB		0:CREB3L2			
GO:0010812	P:negative regulation of cell-substrate adhesion; IMP:BHF-UCL		0:PLG|0:WNT1|0:NOTCH1|0:FZD4|0:FZD7			
GO:0005344	F:oxygen transporter activity; TAS:UniProtKB		0:HBM|0:HBG1|0:HBQ1|0:HBA2|0:HBA1|0:HBG2|0:HBD|0:MB|0:HBB|0:CYGB|0:IPCEF1|0:HBZ|0:HBE1|0:NGB			
GO:0048260	P:positive regulation of receptor-mediated en...; TAS:HGNC		0:VTN|0:SERPINE1|0:PPT1|0:HIP1|0:LDLRAP1|0:APOA5|0:CBL			
GO:0008624	P:induction of apoptosis by extracellular sig...; TAS:ProtInc		0:ABR|0:ITSN1|0:TRAF6|0:ARHGAP4|0:ARHGEF18|0:ARHGEF6|0:VAV3|0:RASGRF1|0:SMPD2|0:NGEF|0:APH1B|0:FGD3|0:RAC1|0:BCL2L11|0:TIAM2|0:MCF2|0:FAS|0:SOS2|0:ITGB3BP|0:PSEN1|0:CASP2|0:TIAM1|0:ARHGEF16|0:NET1|0:FGD2|0:NGF|0:SQSTM1|0:CASP10|0:ARHGEF2|0:PSENEN|0:BAD|0:ARHGEF9|0:KALRN|0:MCF2L|0:ARHGEF4|0:PLEKHG2|0:ARHGEF11|0:APH1A|0:NGFR|0:YWHAE|0:VAV2|0:FGD1|0:NCSTN|0:PLEKHG5|0:PREX1|0:MAGED1|0:TRIO|0:ARHGEF12|0:FGD4|0:ARHGEF3|0:AATF|0:ARHGEF17|0:RASGRF2|0:PSEN2|0:ECT2|0:SOS1|0:ARHGEF7|0:OBSCN|0:AKAP13|0:VAV1|0:BAX|0:NDUFA13|0:IFI27|0:SORT1|0:CASP8|0:DAP|0:SENP1|0:DAPK1|0:CD38|0:BTK|0:RIPK3|0:FASTK|0:PRKCA|0:TNFRSF25|0:CFLAR|0:ADORA1|0:PDCD6|0:DPF2|0:DAP3|0:MAP3K5			
GO:0006303	P:double-strand break repair via nonhomologou...; TAS:UniProtKB		0:LIG4|0:XRCC4|0:PRKDC|0:XRCC6|0:POLA1|0:XRCC5|0:NHEJ1|0:MRE11A|0:XRCC6BP1			
GO:0032045	C:guanyl-nucleotide exchange factor complex; IDA:BHF-UCL		0:PDE3B			
GO:0045179	C:apical cortex; IDA:HGNC		0:TCHP			
GO:0030540	P:female genitalia development; IMP:UniProtKB		0:TBX3			
GO:0019371	P:cyclooxygenase pathway; IDA:BHF-UCL		0:PTGS2|0:PTGS1			
GO:0000300	C:peripheral to membrane of membrane fraction; IDA:MGI		0:JAKMIP1|0:RECK			
GO:0060695	P:negative regulation of cholesterol transpor...; IDA:BHF-UCL		0:APOA2			
GO:0003839	F:gamma-glutamylcyclotransferase activity; IDA:UniProtKB		0:A2LD1|0:GGCT			
GO:0050700	F:CARD domain binding; NAS:UniProtKB		0:NOD1|0:CARD11|0:RIPK2|0:CARD14|0:CARD9|0:NOD2|0:C9orf89			
GO:0070410	F:co-SMAD binding; ISS:BHF-UCL		0:CITED1|0:TRIM33|0:SMAD2|0:SMAD6|0:USP9X|0:SMAD1|0:USP9Y			
GO:0050896	P:response to stimulus; IEA:UniProtKB-KW		0:OR2K2|0:DTNBP1|0:OR2V2|0:OR7A17|0:OR10X1|0:OR10A2|0:OR8J3|0:OR6C1|0:OR9G1|0:CNGA3|0:OR4M2|0:OR4C13|0:OR4A4P|0:RP9|0:OR2T29|0:PRPF3|0:OR11L1|0:OR8K3|0:OR52A1|0:PRCD|0:OR1L3|0:OR1B1|0:OR5W2|0:OR13F1|0:OR8B4|0:TAS2R4|0:OR5K4|0:TAS2R9|0:OR2C1|0:OR5L2|0:OR4C3|0:OR52E1|0:TACSTD2|0:OR13A1|0:OR2A25|0:OR4D5|0:OR2M3|0:OR52E6|0:OR2T6|0:NDP|0:OR6C3|0:OR2T33|0:OR51V1|0:OR5AS1|0:OR10D3|0:OR4C46|0:OR51Q1|0:OR9G9|0:OR5AU1|0:PDE6D|0:HMCN1|0:OR2W3|0:RD3|0:OR1G1|0:OR2A5|0:OR2AK2|0:RSPO4|0:GUCY2D|0:TUB|0:OR7C1|0:PPT1|0:OR5M11|0:CLDN19|0:OR51L1|0:OR4A5|0:CHM|0:OR5M8|0:OR13C8|0:C2orf71|0:OR2A42|0:OR51E1|0:OR2G3|0:VSX2|0:OR1S1|0:OR51B5|0:OR10G2|0:TAS2R20|0:OR4F6|0:BBS7|0:OR6M1|0:OBP2A|0:OR52D1|0:RDH8|0:OPA1|0:LCN1|0:OR13H1|0:OR10A6|0:OR4D2|0:OR4F29|0:OR52E5|0:OR4A16|0:OR8G1|0:OR1D5|0:OR51B4|0:TAS2R42|0:OR52A5|0:OR6T1|0:OR51F2|0:OR1F2P|0:TAS2R8|0:OR2AP1|0:TAS2R13|0:OR5P2|0:OR51D1|0:OR2A14|0:IMPDH1|0:OR4Q3|0:SNRNP200|0:OR5H15|0:OR1S2|0:OR10J4|0:OR52H1|0:OR1L6|0:OR14A16|0:OR7C2|0:OR10G7|0:OR2AE1|0:OR13C4|0:BBS10|0:OR10H4|0:OR4N4|0:OR11H6|0:PEX7|0:OR1Q1|0:RP2|0:OR12D2|0:OR5B21|0:OR2D2|0:SPATA7|0:OR2T34|0:OR9K2|0:TAS1R1|0:PROM1|0:OR5K2|0:OR4C6|0:OR51A4|0:SCNN1A|0:OR7G3|0:OR6V1|0:GUCA1A|0:OR2L3|0:OR51G1|0:OR13C2|0:OR5L1|0:OR9I1|0:OR2J1|0:KLHL7|0:TAS2R3|0:OPA3|0:OR2B2|0:OR52K1|0:KCNV2|0:OR4F17|0:OR11H12|0:OR11H4|0:OR6C4|0:BBS9|0:OR8J2|0:OR2V1|0:OR6C2|0:PRPF8|0:OR4D6|0:OR4S2|0:OR5D18|0:OR8H2|0:ALMS1|0:OR10AD1|0:OR52P1P|0:OR2S2|0:OR5AK3P|0:OR6C70|0:OR7D4|0:OR2L5|0:OR2G2|0:SCNN1D|0:OR1J1|0:CERKL|0:OR4F5|0:OR10P1|0:OR2T2|0:OR4C45|0:OR2A12|0:OR10G3|0:OR10G8|0:OR11H1|0:CNGA4|0:OR4K17|0:USH1G|0:VSX1|0:OR5AR1|0:ROM1|0:OR52N2|0:OR11A1|0:CACNA2D4|0:TAS2R38|0:OR51I2|0:OR10A7|0:OR4D1|0:OR2B6|0:OR5AC1|0:OR1D4|0:OR14K1|0:OR2B8P|0:OR2C3|0:BBS1|0:OR1E2|0:OR10J3|0:OR52E2|0:OR5K1|0:BFSP2|0:OR1J2|0:OR8K1|0:OR52A4|0:TAS2R7|0:OR51S1|0:RS1|0:OR4K3|0:OR6Y1|0:OR3A1|0:OR1N2|0:OR5H14|0:OR13C5|0:OR5T2|0:OR6P1|0:OR52B2|0:OR4K14|0:PDCL|0:NRL|0:RAX2|0:OR14I1|0:OR2L2|0:OR8B8|0:OR52N5|0:OR56B1|0:OR5B17|0:GRM7|0:OR13J1|0:OR6C68|0:OR6N1|0:SEMA4A|0:HMCN2|0:GRK7|0:LRAT|0:OR2Z1|0:OR14J1|0:TAS2R50|0:PDE6A|0:TAS2R60|0:OR2T7|0:OR1E1|0:TAS2R10|0:OR5H1|0:OR5K3|0:OR56A4|0:OR5M9|0:RSPO1|0:OR2I1P|0:OR5H6|0:OR2M4|0:OR56B2P|0:OR9A2|0:OR2G6|0:OR2AT4|0:OR51A2|0:CRX|0:OR2A2|0:OR8H3|0:OR7G2|0:RDH12|0:OR1F1|0:EYS|0:OR10H3|0:OR5AK2|0:OR5V1|0:OR1A2|0:USH1C|0:OR5D13|0:OR7A10|0:OR2W1|0:OR4A15|0:OR8J1|0:OR4N5|0:OR10J6P|0:OR4D10|0:OR4S1|0:OR6A2|0:OR56B4|0:OR6S1|0:OR2L13|0:OR2A7|0:OR52Z1|0:OR52N1|0:OR6B2|0:OR8H1|0:OR10H5|0:OR6C65|0:OR10G4|0:OR4L1|0:OR4F16|0:OR2AJ1|0:OR6X1|0:OR4P4|0:RLBP1|0:OR10G9|0:OR10J5|0:OR56A1|0:OR51J1|0:OR13G1|0:OR4C16|0:OR52I1|0:OR2W6P|0:OR4E1|0:OR8A1|0:CNGA1|0:RDH5|0:OR5M1|0:OR14A2|0:OR9G4|0:WDR36|0:OR5AN1|0:OR10K2|0:OR5AC2|0:DFNB31|0:KERA|0:OR2T11|0:OR51M1|0:OR51I1|0:OR10S1|0:OR3A4|0:OR5A2|0:MYO3A|0:SLC24A6|0:OR52M1|0:TAS2R45|0:OR10W1|0:OR2B11|0:OR9Q1|0:OR2L8|0:MYO7A|0:OR4K5|0:OR2T3|0:OR5H2|0:OR52E8|0:OR2F2|0:OR14C36|0:IDH3B|0:OR11H2|0:OR52K2|0:OR5D14|0:OR10AG1|0:OR6B3|0:OR8D4|0:OR5AP2|0:TAS2R30|0:TAS2R39|0:OR4X1|0:OR1I1|0:OR8D1|0:OR13D1|0:RSPO2|0:OR2T12|0:OR6N2|0:OR10T2|0:OR5B2|0:ARR3|0:OR6C76|0:OR8U9|0:OR10H2|0:OR51B6|0:OR10A4|0:OR8B12|0:OR10Z1|0:OR1P1|0:OR1M1|0:OR4F4|0:OR1F12|0:OR1E3|0:OR10V1|0:OR1C1|0:OR2F1|0:BBS5|0:RSPO3|0:OR3A2|0:OR7G1|0:OR8B2|0:GRM8|0:RPGRIP1|0:NYX|0:OR2T27|0:OR6C74|0:OR6J1|0:OR4C12|0:OR5F1|0:OR9Q2|0:OR2M5|0:OR4K13|0:OR4F15|0:OR56A3|0:OR2J3|0:OR1A1|0:OR10A3|0:OR52B6|0:OR8K5|0:OR2B3|0:TAS2R40|0:OR5I1|0:OR2T8|0:OR7A2P|0:OR2AG2|0:OR1N1|0:CDH23|0:PITPNM3|0:OR5T3|0:OR4N2|0:OR6K6|0:OR8S1|0:TGFBI|0:OR4K2|0:OR2Y1|0:OR6B1|0:OR4A47|0:OR5R1|0:SLC24A5|0:OR10K1|0:OR2W5|0:OR2M2|0:USH2A|0:OR51G2|0:OR1L8|0:PHYH|0:PDE6G|0:OR2T5|0:OR2AG1|0:OR2T4|0:OR4K15|0:PRPH2|0:OR51B2|0:OR4D11|0:OR7E24|0:OR2A1|0:OMP|0:OR52N4|0:OR52L1|0:CRB1|0:OR2A4|0:OR12D3|0:CLRN1|0:MYO3B|0:CNGB3|0:OR4B1|0:MERTK|0:MFRP|0:CYP4V2|0:OR6C6|0:OR8I2|0:OR1L1|0:OR1K1|0:OR2M7|0:SLC45A2|0:OR51T1|0:OR6K3|0:OR8G5|0:OR5P3|0:OR6F1|0:OR9A4|0:OR3A3|0:OR6K2|0:OR5D16|0:OR4E2|0:OR6Q1|0:OR4C15|0:OR52I2|0:RPGR|0:RP1L1|0:OR1L4|0:OR10Q1|0:CRYBB2|0:OR51A7|0:OR4F3|0:IRX5|0:OR2T1|0:OR8G2|0:OR13C9|0:CDHR1|0:OR2H1|0:CNGA2|0:OR10AC1P|0:TAS2R12|0:PDE6H|0:MIP|0:OR5AL1|0:PCDH15|0:RIMS1|0:OR10H1|0:OR5M3|0:OR10C1|0:OR7D2|0:OR8U1|0:OR4X2|0:TAS2R31|0:OR52W1|0:TTC8|0:OR6C75|0:OR5M10|0:GUCY2F|0:OR51E2|0:OR51H1P|0:OR2T10|0:OR10A5|0:OR52J3|0:FSCN2|0:OR4D9|0:OR52E4|0:OR2J2|0:OR51F1|0:TAS2R41|0:OR52L2P|0:OR7A5|0:OR4C5|0:TAS2R46|0:TAS2R19|0:BEST1|0:OR10J1|0:OR14L1P|0:CNNM4|0:OR13C3|0:OR5C1|0:OR4Q2|0:OR10D4P|0:OR10R2|0:OR10G6|0:OR4K1|0:OR5B12|0:OR5J2|0:OR5A1|0:OR8D2|0:OR11G2|0:OR52B4|0:OR5B3|0:OR52R1|0:OR2D3|0:OR4F21|0:OR1J4|0:OR4C11|0:OR4M1|0:OR8U8|0:OR2T35|0:OR8B3|0:OR5T1			
GO:0019233	P:sensory perception of pain; TAS:UniProtKB		0:FAM134B|0:P2RX7|0:P2RX4|0:CHRNB2|0:CHRNA4|0:MRGPRX2|0:PROK2			
GO:0070483	P:detection of hypoxia; IDA:BHF-UCL		0:TGFB3|0:ENG			
GO:0051967	P:negative regulation of synaptic transmissio...; ISS:UniProtKB		0:DRD2|0:GRIK3			
GO:0000118	C:histone deacetylase complex; TAS:UniProtKB		0:HDAC4|0:PHF21A|0:HDAC11|0:HDAC10|0:ZNF217|0:HDAC6|0:SAP30|0:HDAC7|0:CBX5|0:TAF6L|0:SAP18|0:HDAC8|0:HDAC5|0:HDAC3|0:HDAC9			
GO:0003880	F:protein C-terminal carboxyl O-methyltransfe...; IDA:MGI		0:LCMT1			
GO:0035330	P:regulation of hippo signaling cascade; IMP:UniProtKB		0:NF2|0:WWC1			
GO:0043393	P:regulation of protein binding; TAS:HGNC		0:PRMT7|0:HDAC5|0:HDAC4|0:LDLRAP1|0:PRMT8			
GO:0006622	P:protein targeting to lysosome; TAS:ProtInc		0:NEDD4|0:GCC2|0:ZFYVE16|0:NAGPA|0:AP3M1			
GO:0004855	F:xanthine oxidase activity; IDA:UniProtKB		0:XDH			
GO:0042799	F:histone methyltransferase activity (H4-K20 ...; ISS:UniProtKB		0:NSD1			
GO:0030687	C:preribosome, large subunit precursor; IDA:UniProtKB		0:PES1|0:WDR12			
GO:0051648	P:vesicle localization; IMP:UniProtKB		0:MYO1A			
GO:0009266	P:response to temperature stimulus; TAS:ProtInc		0:GLRX2|0:ERO1L|0:FGF16			
GO:0000253	F:3-keto sterol reductase activity; EXP:Reactome		0:HSD17B7			
GO:0035058	P:sensory cilium assembly; ISS:UniProtKB		0:BBS10|0:BBS1|0:BBS4|0:VANGL2			
GO:0035198	F:miRNA binding; IDA:UniProtKB		0:SOX2|0:POU5F1			
GO:0032926	P:negative regulation of activin receptor sig...; IMP:HGNC		0:FST|0:SKI|0:LEMD3|0:FSTL3|0:ACVR1			
GO:0021522	P:spinal cord motor neuron differentiation; ISS:HGNC		0:MDGA2			
GO:0016482	P:cytoplasmic transport; ISS:UniProtKB		0:SRSF10|0:SRSF12			
GO:0010524	P:positive regulation of calcium ion transpor...; NAS:BHF-UCL		0:P2RX7|0:P2RX4|0:CAV1|0:PLA2G1B|0:P2RX2|0:P2RX3|0:P2RX5			
GO:0005525	F:GTP binding; TAS:UniProtKB		0:GNAT3|0:GNAI2|0:GNAI3|0:GNAI1|0:GNAO1|0:GNAZ|0:HRAS|0:GLUD1|0:PCK1|0:GEM|0:GLUD2|0:INSR|0:RRAGB|0:RRAGC|0:GTPBP4|0:TRIM23|0:RAC1|0:RAB5A|0:NMUR2|0:RAB28|0:RAB14|0:LSG1|0:TGM3|0:RAB2A|0:ARL4A|0:NME1|0:RAP1B|0:RHOH|0:GCH1|0:RAB6A|0:RHEBL1|0:RAB11B|0:EIF2B2|0:RRAGA|0:ARL8A|0:SRP54|0:RAB9A|0:RAB21|0:SEPT12|0:RALB|0:RAB4A|0:LRRK2|0:ARL8B|0:URGCP|0:DOCK8|0:DOCK3|0:DOCK2|0:NBR2|0:NCRNA00266|0:ARHGAP5|0:EHD3|0:DOCK5|0:EHD4|0:AGAP9|0:RNF112|0:DOCK9|0:DOCK10|0:DOCK11|0:EHD2|0:GIMAP1|0:DOCK4|0:SRL|0:EHD1|0:DOCK7|0:OLA1|0:BMS1|0:DOCK6|0:DOCK1|0:RAB33B|0:GBP7|0:FPGT|0:GPN2|0:NPR1|0:GNA11|0:REM2|0:TUFM|0:SEPT2|0:ARF5|0:RABL5|0:RHOBTB1|0:EFTUD2|0:RRAS2|0:RAB23|0:GUCY2D|0:ATL3|0:DIRAS3|0:TUBA4A|0:EEF2|0:GIMAP7|0:TUBB6|0:RAB11A|0:RASL11A|0:RND1|0:RAB43|0:ARL2|0:RHOT1|0:DNM1|0:RAB35|0:RHOBTB2|0:SEPT3|0:OPA1|0:TUBA1A|0:GTPBP5|0:RHOV|0:GNA13|0:EEF1A2|0:RAB24|0:RHOD|0:RASL12|0:GSPT1|0:C10orf129|0:RAC3|0:SPAG1|0:RAB18|0:GIMAP8|0:GUCY1B3|0:TUBB4Q|0:RAB33A|0:LRRK1|0:AK4|0:RAB3B|0:GNAQ|0:RAB1C|0:RAB30|0:ERAS|0:AGAP1|0:ARL17A|0:TUBB1|0:TUBD1|0:RAB1B|0:ATL2|0:ARL13B|0:MFN2|0:ARL16|0:TUBA3E|0:ARFRP1|0:MTG1|0:RAB20|0:GIMAP6|0:GBP4|0:RAB2B|0:RAB32|0:RHOQ|0:RND2|0:SUCLG2|0:RAB42|0:SEPT10|0:ARL5B|0:RASD2|0:RASEF|0:EIF2S3|0:RAB7B|0:DRG1|0:RAB17|0:GNL3L|0:GIMAP2|0:GMPPB|0:IRGM|0:RAB3D|0:ACSM1|0:TUBG1|0:RAB12|0:SEPT1|0:RABL2A|0:EEF1A1P5|0:RAB5B|0:RAB25|0:SAR1A|0:MOCS1|0:RHOU|0:ARL4D|0:RAB40AL|0:RHOT2|0:GVINP1|0:MTIF2|0:GNA12|0:SEPT14|0:ARL1|0:AK3|0:RAB3C|0:RAB41|0:EEFSEC|0:RHOA|0:TUBB3|0:RAB36|0:RAB31|0:AGAP2|0:C9orf86|0:DIRAS1|0:GMPPA|0:RERGL|0:MRAS|0:TUBB2B|0:ARL17B|0:TUBB4|0:GUCY1B2|0:MFN1|0:GUF1|0:SEPT7L|0:RAB22A|0:RHOG|0:IRGC|0:RAP2A|0:RAB40C|0:SEPT11|0:GBP5|0:ARL5A|0:ARL6|0:RAB7L1|0:ARL11|0:RERG|0:GTPBP3|0:ARL4C|0:SEPT9|0:SUCLG1|0:TUBE1|0:GFM2|0:SEPT4|0:C8orf80|0:RASD1|0:RAB13|0:TUBG2|0:GBP3|0:GIMAP5|0:RRAGD|0:RAB7A|0:GNAL|0:RAB40B|0:GNAS|0:PCK2|0:GUCY2C|0:RRAD|0:RAB4B|0:TUBA1C|0:DNAJC27|0:SRPR|0:AGAP3|0:RAB1A|0:TUBA4B|0:NKIRAS2|0:RAB8B|0:SEPT5|0:RASL10B|0:RAB37|0:KRAS|0:RAB6B|0:GPN3|0:HHAT|0:MX2|0:ACSM5|0:ARL9|0:TUBB2A|0:AK4P3|0:GUCY1A2|0:MMAA|0:GTPBP10|0:NPR2|0:RAB5C|0:RASL10A|0:ARL13A|0:TUBB2C|0:TUBB|0:RAB15|0:RAB44|0:GTPBP2|0:GIMAP4|0:ARL5C|0:RHOJ|0:RAB10|0:RAP1A|0:RHOF|0:TUBAL3|0:ARL14|0:RAC2|0:ARF4|0:CDC42|0:NUDT2|0:GTPBP8|0:EIF5|0:TUBA8|0:GPN1|0:EFTUD1|0:RABL3|0:C1orf89|0:SAR1B|0:RNGTT|0:RAB19|0:RHOC|0:RAB3A|0:NKIRAS1|0:RRAS|0:EIF5B|0:RASL11B|0:RAB34|0:GUCY2F|0:IFT27|0:RABL2B|0:RAP2C|0:DNM1L|0:GUCY1A3|0:ARF1|0:NRAS|0:TUBA1B|0:ARL10|0:GFM1|0:DIRAS2|0:RAB39B|0:DNM3|0:GSPT2|0:NIN|0:RAB40A|0:GBP6|0:SRPRB|0:RAB6C|0:SEPT8|0:GNA14|0:NOLC1|0:RTKN|0:ARL15|0:REM1|0:RAB8A|0:GNL3|0:ATL1|0:RAB27B|0:GNAT1|0:RAB27A|0:GNL2|0:RANBP17|0:RAB39|0:ERAL1|0:LANCL2|0:DNM2|0:TUBA3D|0:RAB38|0:GNAT2|0:TUBA3C|0:RAB26|0:GNA15|0:ADSSL1|0:ADSS|0:GNL1|0:RAB9B|0:GTPBP1|0:SEPHS1|0:SEPT7|0:DRG2|0:RAP2B|0:RIT1|0:HBS1L|0:GBP2|0:SCG5|0:ARHGEF5|0:GBP1|0:NCF1|0:ARFIP2|0:RND3|0:RIT2|0:ARL3|0:TPX2|0:RHEB|0:MX1|0:GTPBP6|0:RALA|0:ARF3|0:ARF6|0:SEPT6|0:EEF1A1|0:RHOB			
GO:0042113	P:B cell activation; NAS:UniProtKB		0:LAT2|0:LAX1|0:BANK1|0:IGBP1|0:CXCR5|0:BST2|0:GAPT|0:SKAP2|0:MS4A1|0:ICOSLG|0:PRKCB|0:CHRNB2|0:CHRNA4|0:AKAP17A			
GO:0009132	P:nucleoside diphosphate metabolic process; IEA:InterPro		0:NUDT7			
GO:0031394	P:positive regulation of prostaglandin biosyn...; NAS:BHF-UCL		0:PTGS2			
GO:0031267	F:small GTPase binding; ISS:UniProtKB		0:FGD1|0:ABCA1|0:FGD3|0:FGD6|0:FGD2|0:FGD5|0:FGD4			
GO:0030552	F:cAMP binding; ISS:UniProtKB		0:HCN4|0:PRKAR2A|0:CNGB1|0:PDE10A|0:HCN3|0:PRKAR2B|0:CNGA4|0:PRKAR1A|0:HCN2|0:RAPGEF3|0:PRKAR1B|0:HCN1|0:CNGA2|0:RAPGEF4			
GO:0019935	P:cyclic-nucleotide-mediated signaling; TAS:UniProtKB		0:NUDT4			
GO:0031493	F:nucleosomal histone binding; IDA:UniProtKB		0:L3MBTL1			
GO:0003706	F:ligand-regulated transcription factor activity; TAS:UniProtKB		0:RXRB|0:NR0B1|0:RXRA|0:NR2F2|0:NR2F1|0:ERF|0:NOTCH2			
GO:0006166	P:purine ribonucleoside salvage; IMP:UniProtKB		0:PRTFDC1|0:APRT|0:ADK|0:HPRT1			
GO:0003993	F:acid phosphatase activity; TAS:ProtInc		0:ACP5|0:ACPL2|0:ACPP|0:ACPT|0:MINPP1|0:PPIP5K2|0:PPIP5K1|0:ACP6|0:ACP2|0:ACP1			
GO:0022409	P:positive regulation of cell-cell adhesion; ISS:BHF-UCL		0:SMAD7|0:CD47|0:FSTL3|0:SIRPG|0:CITED2			
GO:0004794	F:L-threonine ammonia-lyase activity; IEA:EC		0:SDS|0:SDSL			
GO:0042417	P:dopamine metabolic process; ISS:UniProtKB		0:DRD3|0:DRD4|0:DRD1|0:DRD2|0:SNCAIP|0:ATP7A			
GO:0004594	F:pantothenate kinase activity; IEA:EC		0:PANK1|0:PANK2|0:PANK4|0:PANK3			
GO:0002897	P:positive regulation of central B cell toler...; ISS:BHF-UCL		0:FOXJ1			
GO:0030659	C:cytoplasmic vesicle membrane; ISS:UniProtKB		0:APPBP2|0:TMEM67|0:ECE2|0:CADPS2|0:CLIC4|0:PHLDA1|0:MARCH3|0:SYPL1|0:WHAMM|0:WLS|0:CADPS|0:NPC1L1|0:SLC18A1|0:AQP2|0:IL15RA|0:AQP6|0:MARCH11|0:SLC2A8|0:STXBP5|0:KIFC3|0:ENTPD7|0:CALY|0:RAB13|0:AP3S2|0:AGTRAP|0:CHMP4A|0:RAB21|0:MYOF|0:ZDHHC8|0:SLC18A2|0:TAOK2|0:RHBG|0:PLA2G4D|0:GPRC5A|0:YKT6|0:ARHGAP21|0:DYSF|0:GPRC5C|0:KCNQ1|0:ATP6V0A1|0:MARCH8|0:SMAGP|0:SH3KBP1|0:AP3S1|0:CAMKV|0:MARCH1|0:TRIM72|0:KIF1B			
GO:0032052	F:bile acid binding; ISS:BHF-UCL		0:PYGL|0:AKR1C1|0:AKR1C2|0:PLA2G1B			
GO:0060535	P:trachea cartilage morphogenesis; ISS:UniProtKB		0:WNT7B			
GO:0070513	F:death domain binding; IPI:UniProtKB		0:RIPK1|0:TRADD|0:CRADD|0:DAP			
GO:0045995	P:regulation of embryonic development; IMP:BHF-UCL		0:LAMA4|0:LAMA1|0:LAMA3|0:LAMA2|0:LAMA5|0:NIPBL|0:INSR			
GO:0005415	F:nucleoside:sodium symporter activity; IEA:InterPro		0:SLC28A1|0:SLC28A2			
GO:0000030	F:mannosyltransferase activity; IMP:UniProtKB		0:PIGV			
GO:0060414	P:aorta smooth muscle tissue morphogenesis; ISS:BHF-UCL		0:PROX1			
GO:0031589	P:cell-substrate adhesion; IMP:UniProtKB		0:VWF|0:CORO1A			
GO:0060452	P:positive regulation of cardiac muscle contr...; ISS:BHF-UCL		0:ADRA1A			
GO:0017070	F:U6 snRNA binding; NAS:UniProtKB		0:BAT1|0:EIF5A|0:NAA38|0:LSM7|0:LSM2			
GO:0005031	F:tumor necrosis factor receptor activity; TAS:UniProtKB		0:TNFRSF11A|0:EDA2R|0:TNFRSF19|0:TNFRSF1B|0:TNFRSF25|0:TNFRSF18|0:TNFRSF14|0:TNFRSF4|0:TNFRSF1A			
GO:0000346	C:transcription export complex; IDA:UniProtKB		0:THOC3|0:BAT1|0:THOC4			
GO:0035455	P:response to interferon-alpha; TAS:UniProtKB		0:KLHL20			
GO:0045542	P:positive regulation of cholesterol biosynth...; NAS:UniProtKB		0:ABCG1|0:PRKAA1			
GO:0009725	P:response to hormone stimulus; TAS:UniProtKB		0:SRF|0:STEAP2|0:RERG|0:ANG|0:GCLC|0:NKX2-1|0:FHL2|0:ADRA1A|0:LYN|0:ME1|0:HCLS1|0:SFRP4|0:MMS19|0:NCOA6|0:RBM14			
GO:0070774	F:phytoceramidase activity; IDA:UniProtKB		0:ACER3			
GO:0016018	F:cyclosporin A binding; TAS:UniProtKB		0:PPIC|0:PPIG|0:PPIE|0:PPIH|0:NKTR|0:PPID			
GO:0006601	P:creatine biosynthetic process; IDA:UniProtKB		0:GATM|0:GAMT			
GO:0030224	P:monocyte differentiation; IEP:UniProtKB		0:PPARG|0:IFI16|0:IL31RA|0:MYH9			
GO:0022027	P:interkinetic nuclear migration; ISS:BHF-UCL		0:HOOK3|0:PCM1			
GO:0008389	F:coumarin 7-hydroxylase activity; IDA:UniProtKB		0:CYP2A13|0:CYP2A6			
GO:0050672	P:negative regulation of lymphocyte prolifera...; IDA:UniProtKB		0:LST1			
GO:0035094	P:response to nicotine; IDA:UniProtKB		0:HMOX1|0:BCL2|0:CHRNA7			
GO:0004032	F:aldehyde reductase activity; TAS:ProtInc		0:AKR1B1|0:AKR7A2|0:AKR1A1			
GO:0045502	F:dynein binding; IPI:UniProtKB		0:SMC3|0:CENPF|0:LRRC50|0:SNCA			
GO:0035371	C:microtubule plus end; IDA:UniProtKB		0:DST			
GO:0006266	P:DNA ligation; TAS:ProtInc		0:TOP2A|0:XRCC6|0:MGMT			
GO:0046398	P:UDP-glucuronate metabolic process; IDA:UniProtKB		0:CSGALNACT1			
GO:0003065	P:positive regulation of heart rate by epinep...; ISS:BHF-UCL		0:TPM1			
GO:0042231	P:interleukin-13 biosynthetic process; TAS:UniProtKB		0:IL18			
GO:0006020	P:inositol metabolic process; ISS:UniProtKB		0:PPIP5K1|0:PPIP5K2			
GO:0006777	P:Mo-molybdopterin cofactor biosynthetic process; IMP:UniProtKB		0:MOCS3|0:MOCS1|0:MOCS2|0:FLAD1|0:GPHN|0:MOCOS|0:NFS1			
GO:0030641	P:regulation of cellular pH; IDA:UniProtKB		0:ATP1A4			
GO:0045163	P:clustering of voltage-gated potassium channels; ISS:BHF-UCL		0:KCNIP2|0:CNTN2|0:CNTNAP2			
GO:0031643	P:positive regulation of myelination; ISS:UniProtKB		0:RNF10|0:C11orf9			
GO:0009451	P:RNA modification; TAS:ProtInc		0:CDKAL1|0:PARN			
GO:0034205	P:beta-amyloid formation; IDA:BHF-UCL		0:FKBP1A			
GO:0030315	C:T-tubule; ISS:BHF-UCL		0:CACNA1S|0:CAV3|0:SLC30A1			
GO:0045556	P:positive regulation of TRAIL biosynthetic p...; IDA:UniProtKB		0:TNFRSF8			
GO:0042448	P:progesterone metabolic process; IDA:UniProtKB		0:DHRS9			
GO:0004080	F:biotin-[propionyl-CoA-carboxylase (ATP-hydr...; IDA:UniProtKB		0:HLCS			
GO:0008504	F:monoamine transmembrane transporter activity; TAS:UniProtKB		0:SLC18A2|0:SLC18A1			
GO:0003711	F:transcription elongation regulator activity; TAS:ProtInc		0:THOC1|0:ERCC6|0:TCEANC|0:TCEA3|0:SUPT6H|0:TCEA1|0:TCEA2|0:HTATSF1|0:TSFM|0:TCEB3B			
GO:0032946	P:positive regulation of mononuclear cell pro...; IDA:BHF-UCL		0:CSF1			
GO:0030509	P:BMP signaling pathway; TAS:BHF-UCL		0:SKI|0:UBE2D3|0:SMAD7|0:SMURF2|0:CER1|0:FSTL1|0:ZFYVE16|0:SMAD6|0:CHRDL1|0:GREM2|0:SMURF1|0:NOG|0:UBE2D1|0:BMPR1A|0:BMP7|0:ACVR1|0:ACVR2B|0:GDF6|0:GDF7|0:ACVR2A|0:TGFBR3|0:SMAD4|0:BMPR2|0:BMP6|0:GDF2|0:BMP10|0:USP9X|0:RGMB|0:USP9Y|0:SMAD5|0:SMAD1|0:BMPR1B|0:SMAD9|0:ENG			
GO:0005272	F:sodium channel activity; IEA:UniProtKB-KW		0:SLC4A11|0:HCN4|0:ACCN4|0:HCN3|0:HCN2|0:NALCN|0:HCN1|0:TRPM2			
GO:0007157	P:heterophilic cell-cell adhesion; TAS:UniProtKB		0:VCAM1|0:CD164|0:SELE|0:ITGAL|0:CADM3|0:PVRL1|0:AMIGO2|0:AMIGO3|0:AMIGO1|0:CADM1|0:ICAM1|0:REG3A|0:LGALS7B|0:LGALS7|0:CD209			
GO:0005093	F:Rab GDP-dissociation inhibitor activity; TAS:ProtInc		0:GDI2			
GO:0071549	P:cellular response to dexamethasone stimulus; IDA:UniProtKB		0:AQP1			
GO:0018395	P:peptidyl-lysine hydroxylation to 5-hydroxy-...; IDA:UniProtKB		0:JMJD6			
GO:0015288	F:porin activity; NAS:UniProtKB		0:TOMM40|0:TOMM40L|0:VDAC2|0:VDAC3|0:VDAC1|0:AQP9			
GO:0007140	P:male meiosis; TAS:ProtInc		0:TAF1L|0:CYP26B1|0:TDRD9|0:ASZ1|0:HSPA2|0:PIM2			
GO:0005518	F:collagen binding; TAS:UniProtKB		0:ACHE|0:USH2A|0:PDGFA|0:PDGFB|0:COMP|0:LUM|0:LACRT|0:PODN|0:VWF|0:ANTXR1|0:ADAM9|0:PAK1|0:COL5A3|0:SERPINH1|0:FN1|0:CD44|0:COL14A1|0:NID2|0:DSPP|0:ITGA11|0:ITGA2|0:ITGA10|0:SPARC|0:GP6|0:MMP9|0:ITGA1			
GO:0051493	P:regulation of cytoskeleton organization; NAS:UniProtKB		0:CRIPAK|0:NEXN|0:STMN3|0:CLIC4			
GO:0015111	F:iodide transmembrane transporter activity; TAS:ProtInc		0:SLC5A5|0:SLC26A4			
GO:0016308	F:1-phosphatidylinositol-4-phosphate 5-kinase...; TAS:HGNC		0:PIP4K2B|0:PIP5K1A|0:PIP5KL1|0:PIP5K1C|0:PIP5K1B|0:PIP4K2A|0:PIKFYVE			
GO:0004812	F:aminoacyl-tRNA ligase activity; IEA:InterPro		0:NCOA5			
GO:0001569	P:patterning of blood vessels; ISS:UniProtKB		0:CTNNB1|0:TGFBR2|0:SFRP2|0:ENG|0:SHH|0:NOTCH4			
GO:0046324	P:regulation of glucose import; TAS:BHF-UCL		0:APPL1|0:PRKAG2			
GO:0071001	C:U4/U6 snRNP; IDA:BHF-UCL		0:PPIH|0:PRPF6|0:PRPF4			
GO:0060731	P:positive regulation of intestinal epithelia...; IMP:BHF-UCL		0:SLC22A5			
GO:0016559	P:peroxisome fission; IEA:InterPro		0:FIS1|0:PEX11A|0:PEX11B			
GO:0042809	F:vitamin D receptor binding; NAS:UniProtKB		0:BAZ1B|0:RXRA|0:TAF11|0:MED1|0:TAF7|0:MED14|0:MED13|0:MED17|0:MED12|0:MED24|0:THRAP3|0:MED16|0:MED30|0:MED4			
GO:0090267	P:positive regulation of mitotic cell cycle s...; IMP:UniProtKB		0:DYNC1LI1			
GO:0003917	F:DNA topoisomerase type I activity; IMP:UniProtKB		0:TOP3B|0:TOP3A|0:TOP1MT|0:TOP1			
GO:0008565	F:protein transporter activity; TAS:ProtInc		0:IPO9|0:XPO6|0:COG3|0:AP2A2|0:XPO7|0:IPO8|0:KPNA5|0:KPNA7|0:KPNA2|0:SNUPN|0:RANBP17|0:TIMM22|0:TMCO6|0:AP1S3|0:AP1G1|0:AP2A1|0:SNX2|0:XPO1|0:IPO7|0:IPO4|0:SEC62|0:AP3B2|0:KPNA1|0:AP4S1|0:AP1S2|0:IPO13|0:TNPO2|0:AP1S1|0:AP1G2|0:AP3S2|0:AP2B1|0:RAMP3|0:XPOT|0:AP1B1|0:C3orf1|0:TNPO1|0:AP4B1|0:KPNA3|0:AP3B1|0:IPO5|0:NDUFA11|0:AP3D1|0:AP3S1|0:RAMP2|0:COX18|0:CHMP7|0:COG2|0:ZFYVE16|0:PGAP2|0:AP2S1|0:ARFGAP3|0:VTI1A|0:SNX15|0:VPS26A|0:RAMP1|0:CCT6B|0:EIF4ENIF1|0:TSNAX			
GO:0001573	P:ganglioside metabolic process; IMP:UniProtKB		0:CLN6			
GO:0004145	F:diamine N-acetyltransferase activity; TAS:ProtInc		0:SAT2|0:SAT1			
GO:0070669	P:response to interleukin-2; ISS:UniProtKB		0:CITED1			
GO:0048592	P:eye morphogenesis; IMP:UniProtKB		0:NIPBL|0:COL5A1|0:COL5A2			
GO:0002842	P:positive regulation of T cell mediated immu...; IDA:BHF-UCL		0:HSPD1			
GO:0090035	P:positive regulation of cellular chaperone-m...; IMP:BHF-UCL		0:STUB1|0:HDAC6			
GO:0021897	P:forebrain astrocyte development; ISS:HGNC		0:NF1			
GO:0017064	F:fatty acid amide hydrolase activity; IDA:UniProtKB		0:FAAH			
GO:0008508	F:bile acid:sodium symporter activity; TAS:ProtInc		0:SLC10A1|0:SLC10A6|0:SLC10A7|0:SLC10A4|0:SLC10A5|0:SLC10A3|0:SLC10A2			
GO:0000778	C:condensed nuclear chromosome kinetochore; IDA:BHF-UCL		0:CENPA			
GO:0010855	F:adenylate cyclase inhibitor activity; IDA:UniProtKB		0:GRM7			
GO:0007164	P:establishment of tissue polarity; TAS:ProtInc		0:FZD5|0:FZD2			
GO:0042256	P:mature ribosome assembly; IEA:InterPro		0:EIF6			
GO:0030507	F:spectrin binding; TAS:BHF-UCL		0:ADD2|0:ADD1|0:ANK1|0:EPB41			
GO:0016568	P:chromatin modification; NAS:UniProtKB		0:TAF5|0:L3MBTL1|0:SMARCAL1|0:UTY|0:CHD9|0:HDAC7|0:EPC2|0:RBBP7|0:NCOR1|0:BRE|0:ASF1A|0:KDM4D|0:RBL2|0:UTP3|0:KDM5A|0:PHF1|0:CBX6|0:ARID2|0:MSL3L2|0:VPS72|0:ASXL1|0:NR3C1|0:C11orf30|0:BANP|0:EYA4|0:SS18L1|0:MSL1|0:TLK1|0:CHD7|0:CABIN1|0:HIRA|0:AEBP2|0:TSPYL2|0:FOXA3|0:BCORL1|0:SUDS3|0:SMARCE1|0:H2AFY2|0:SRCAP|0:RCOR1|0:RCBTB1|0:HLTF|0:HMG20B|0:ASF1B|0:GFI1B|0:MORF4L2|0:KDM3B|0:ING2|0:HMGN5|0:RAG2|0:SMARCD3|0:KDM6A|0:KDM4B|0:FAM175A|0:UBN1|0:CBX4|0:PADI4|0:TBL1XR1|0:MBTD1|0:TLK2|0:CHD3|0:H2AFY|0:CECR2|0:DAPK3|0:HMG20A|0:KDM5C|0:C19orf62|0:ACTL6B|0:L3MBTL3|0:BMI1|0:MSL3|0:HMGN3|0:KDM4DL|0:CHD4|0:CHD5|0:RBL1|0:GSG2|0:FOXA2|0:L3MBTL4|0:CBX7|0:C20orf20|0:IKZF1|0:CTCF|0:DPF3|0:RRP8|0:DNMT1|0:SMARCD2|0:JARID2|0:JMJD1C|0:KDM5D|0:PHF21A|0:CBX2|0:L3MBTL2|0:SMARCAD1			
GO:0010463	P:mesenchymal cell proliferation; IDA:UniProtKB		0:FGF4|0:FGF7			
GO:0016814	F:hydrolase activity, acting on carbon-nitrog...; IEA:InterPro		0:APOBEC4|0:APOBEC3B|0:APOBEC3D|0:APOBEC3C|0:APOBEC3A|0:APOBEC3H			
GO:0019948	F:SUMO activating enzyme activity; IDA:UniProtKB		0:UBA2			
GO:0045931	P:positive regulation of mitotic cell cycle; ISS:UniProtKB		0:ASNS|0:SPHK1|0:CCNB1|0:EIF4E|0:MDM2|0:TERF1|0:BIRC5|0:FOXA1|0:RPS6KB1|0:DUSP3|0:USP2|0:USP22|0:EIF4EBP1|0:APP			
GO:0006029	P:proteoglycan metabolic process; TAS:ProtInc		0:IL17F|0:B4GALT7|0:SGSH|0:LECT1|0:HPSE			
GO:0004617	F:phosphoglycerate dehydrogenase activity; TAS:ProtInc		0:PHGDH			
GO:0071539	P:protein localization to centrosome; ISS:BHF-UCL		0:HOOK3|0:PCM1			
GO:0045239	C:tricarboxylic acid cycle enzyme complex; IEA:InterPro		0:FH			
GO:0048169	P:regulation of long-term neuronal synaptic p...; ISS:UniProtKB		0:DRD2|0:SYNGR1|0:NETO1|0:SYP			
GO:0033268	C:node of Ranvier; TAS:BHF-UCL		0:CNTN2|0:SCN2A|0:SCN8A|0:NFASC			
GO:0008537	C:proteasome activator complex; IEA:InterPro		0:PSME1|0:PSME2|0:PSME3			
GO:0004740	F:pyruvate dehydrogenase (acetyl-transferring...; TAS:ProtInc		0:PDK3|0:PDK4|0:PDK1|0:PDK2			
GO:0030388	P:fructose 1,6-bisphosphate metabolic process; IDA:UniProtKB		0:ALDOA|0:ALDOB|0:ALDOC			
GO:0002009	P:morphogenesis of an epithelium; IMP:BHF-UCL		0:VCL			
GO:0010804	P:negative regulation of tumor necrosis facto...; IDA:BHF-UCL		0:ADIPOQ			
GO:0008520	F:L-ascorbate:sodium symporter activity; IDA:UniProtKB		0:SLC23A1			
GO:0048739	P:cardiac muscle fiber development; ISS:BHF-UCL		0:TTN|0:TCAP|0:MYH11|0:MYH6			
GO:0000133	C:polarisome; TAS:UniProtKB		0:PRKCI			
GO:0046027	F:phospholipid:diacylglycerol acyltransferase...; EXP:Reactome		0:AGPAT3|0:AGPAT2|0:AGPAT5|0:AGPAT1|0:AGPAT4			
GO:0018149	P:peptide cross-linking; NAS:UniProtKB		0:THBS1|0:FN1|0:DSP|0:TGM3|0:CSTA|0:SPRR1B|0:EVPL|0:ANXA1|0:LOR|0:COL3A1|0:SPRR1A|0:TGM7|0:EPB42|0:TGM6|0:TGM1|0:TGM5|0:TGM4			
GO:0003863	F:3-methyl-2-oxobutanoate dehydrogenase (2-me...; TAS:ProtInc		0:BCKDHA|0:BCKDHB			
GO:0031937	P:positive regulation of chromatin silencing; IMP:BHF-UCL		0:SIRT1			
GO:0009648	P:photoperiodism; TAS:ProtInc		0:CLOCK			
GO:0016716	F:oxidoreductase activity, acting on paired d...; IEA:InterPro		0:TYRP1			
GO:0003963	F:RNA-3'-phosphate cyclase activity; TAS:ProtInc		0:RCL1|0:RTCD1			
GO:0048627	P:myoblast development; ISS:UniProtKB		0:SDC1			
GO:0009249	P:protein lipoylation; TAS:ProtInc		0:LIPT1|0:NNAT|0:ST3GAL6|0:NMT2|0:NMT1			
GO:0001516	P:prostaglandin biosynthetic process; ISS:UniProtKB		0:EDN2|0:EDN1|0:CD74|0:MIF|0:PTGES3|0:PTGIS|0:PTGES2|0:HPGDS|0:TBXAS1|0:PTGDS			
GO:0006688	P:glycosphingolipid biosynthetic process; TAS:UniProtKB		0:A4GALT|0:ST8SIA1|0:ST8SIA5|0:ST8SIA3|0:ST6GALNAC6|0:LARGE			
GO:0045066	P:regulatory T cell differentiation; IDA:BHF-UCL		0:CD28			
GO:0001560	P:regulation of cell growth by extracellular ...; TAS:UniProtKB		0:KIF26A|0:PPP1R9B			
GO:0019807	F:aspartoacylase activity; IEA:EC		0:ASPA			
GO:0008190	F:eukaryotic initiation factor 4E binding; TAS:UniProtKB		0:HHEX|0:EIF4EBP2|0:EIF4EBP3|0:OTX2			
GO:0090271	P:positive regulation of fibroblast growth fa...; ISS:BHF-UCL		0:PTGS2			
GO:0001760	F:aminocarboxymuconate-semialdehyde decarboxy...; IDA:UniProtKB		0:ACMSD			
GO:0045908	P:negative regulation of vasodilation; NAS:UniProtKB		0:INS			
GO:0007023	P:post-chaperonin tubulin folding pathway; TAS:ProtInc		0:TBCA|0:TBCC			
GO:0006545	P:glycine biosynthetic process; NAS:UniProtKB		0:DHFRL1|0:DHFRP1|0:DHFR			
GO:0031588	C:AMP-activated protein kinase complex; IDA:BHF-UCL		0:PRKAG2			
GO:0009416	P:response to light stimulus; TAS:ProtInc		0:FECH|0:COPS3			
GO:0032720	P:negative regulation of tumor necrosis facto...; ISS:BHF-UCL		0:RARA|0:LBP|0:ADIPOQ|0:POMC|0:BPI|0:MC1R|0:CIDEA|0:IRAK3|0:CHRNA7|0:TLR4			
GO:0046489	P:phosphoinositide biosynthetic process; IMP:UniProtKB		0:HTR2B|0:HTR2C|0:HTR2A			
GO:0008955	F:peptidoglycan glycosyltransferase activity; IDA:UniProtKB		0:CSGALNACT1			
GO:0016079	P:synaptic vesicle exocytosis; TAS:UniProtKB		0:PCLO|0:RIMS1			
GO:0000307	C:cyclin-dependent protein kinase holoenzyme ...; IDA:UniProtKB		0:CDK6|0:CDKN1A|0:CDK4|0:CCND2|0:CCND1|0:CCND3|0:CDK2			
GO:0070612	F:histone methyltransferase activity (H2A-R3 ...; IDA:UniProtKB		0:PRMT6			
GO:0030286	C:dynein complex; IEA:UniProtKB-KW		0:DNHD1|0:DCTN1|0:TCTE3|0:DNAH12|0:DYNLL2|0:DNAI1|0:DNAH6|0:DNAH14|0:DNAH10|0:DYNC2H1|0:DCTN2|0:DYNC2LI1			
GO:0006177	P:GMP biosynthetic process; IEA:UniProtKB-KW		0:IMPDH1|0:IMPDH2			
GO:0048839	P:inner ear development; ISS:UniProtKB		0:LHX3|0:MPV17			
GO:0005849	C:mRNA cleavage factor complex; NAS:UniProtKB		0:CPSF6|0:PCF11			
GO:0001507	P:acetylcholine catabolic process in synaptic...; TAS:ProtInc		0:ACHE|0:COLQ			
GO:0030510	P:regulation of BMP signaling pathway; TAS:BHF-UCL		0:PCSK6			
GO:0047184	F:1-acylglycerophosphocholine O-acyltransfera...; ISS:UniProtKB		0:TAZ|0:LPCAT3|0:LPCAT1|0:LPCAT2			
GO:0046986	P:negative regulation of hemoglobin biosynthe...; ISS:UniProtKB		0:EIF2AK1			
GO:0045055	P:regulated secretory pathway; NAS:UniProtKB		0:STEAP2|0:TMED10|0:RIMS1			
GO:0008476	F:protein-tyrosine sulfotransferase activity; TAS:ProtInc		0:TPST2|0:TPST1			
GO:0070733	F:protein adenylyltransferase activity; IDA:UniProtKB		0:FICD			
GO:0004980	F:melanocyte-stimulating hormone receptor act...; IPI:BHF-UCL		0:MC3R|0:MC4R|0:MC1R			
GO:0001816	P:cytokine production; IMP:BHF-UCL		0:G6PD			
GO:0005143	F:interleukin-12 receptor binding; TAS:UniProtKB		0:IL12A|0:IL12B			
GO:0030159	F:receptor signaling complex scaffold activity; NAS:UniProtKB		0:NUP62|0:LDLRAP1|0:ROPN1B|0:GRIP1|0:CARD10|0:NCK1|0:DLG5|0:CD3G|0:NCK2|0:MMS19|0:G3BP2|0:DEDD2|0:CD3E			
GO:0004397	F:histidine ammonia-lyase activity; EXP:Reactome		0:HAL			
GO:0030306	F:ADP-ribosylation factor binding; IPI:UniProtKB		0:GGA2|0:GGA3|0:RAB11FIP4|0:RAB11FIP3			
GO:0000235	C:astral microtubule; IDA:UniProtKB		0:PAFAH1B1			
GO:0019905	F:syntaxin binding; NAS:UniProtKB		0:CACNA1A|0:CPLX4|0:CPLX3|0:CPLX1|0:CPLX2|0:RAB11A			
GO:0006527	P:arginine catabolic process; TAS:ProtInc		0:NOS1|0:NOS3|0:NOS2|0:DDAH1|0:DDAH2|0:ASL|0:ARG1			
GO:0070779	P:D-aspartate import; IDA:UniProtKB		0:SLC1A1|0:SLC1A2|0:SLC1A3			
GO:0047341	F:fucose-1-phosphate guanylyltransferase acti...; IEA:EC		0:FPGT			
GO:0046470	P:phosphatidylcholine metabolic process; IEA:InterPro		0:APOA4|0:CETP|0:PON1|0:PLA2G1B|0:PNPLA6			
GO:0005260	F:channel-conductance-controlling ATPase acti...; NAS:UniProtKB		0:CFTR			
GO:0050677	P:positive regulation of urothelial cell prol...; IDA:UniProtKB		0:FGF10			
GO:0048103	P:somatic stem cell division; ISS:UniProtKB		0:CDKN2A|0:TGFB2			
GO:0047315	F:kynurenine-glyoxylate transaminase activity; ISS:UniProtKB		0:CCBL2			
GO:0016590	C:ACF complex; TAS:BHF-UCL		0:BAZ1A			
GO:0006024	P:glycosaminoglycan biosynthetic process; TAS:UniProtKB		0:EXT1|0:EXT2|0:B4GALT7|0:B3GALT6|0:XYLT2|0:B3GAT3|0:UGDH|0:GALNT5|0:XYLT1			
GO:0000701	F:purine-specific mismatch base pair DNA N-gl...; IDA:BHF-UCL		0:PCNA			
GO:0008026	F:ATP-dependent helicase activity; NAS:UniProtKB		0:SNRNP200|0:TDRD9|0:DDX50|0:SKIV2L2|0:GTF2F2|0:DHX57|0:DDX60L|0:DHX36|0:DHX16|0:C9orf102|0:ASCC3|0:CETN1|0:DDX60|0:DDX55|0:DDX41|0:DDX5|0:DDX19B|0:TDRD12|0:DDX51|0:DDX58|0:DHX35|0:DHX15|0:RECQL5|0:DDX10|0:DDX47|0:DHX30|0:DDX4|0:CETN2|0:YTHDC2|0:FANCM|0:DDX3Y|0:DHX38|0:DHX29|0:TTF2|0:DDX27|0:CHD6|0:DDX52|0:DDX19A|0:DDX6|0:HELQ|0:DDX53|0:DDX39|0:DDX59|0:DICER1|0:DHX40|0:DDX46|0:DDX49|0:HFM1|0:DDX17|0:DHX37|0:DHX34|0:DDX28|0:CHD5|0:EIF4A2|0:DDX31|0:C3orf26|0:DHX33|0:DDX42|0:EIF4A1|0:DDX1			
GO:0032862	P:activation of Rho GTPase activity; ISS:UniProtKB		0:GPR65|0:TSC1|0:FOXJ1|0:SYDE2|0:SYDE1			
GO:0070403	F:NAD binding; ISS:UniProtKB		0:GLUD1|0:SIRT2|0:HPGD|0:CRYL1|0:SIRT3|0:SIRT4|0:SIRT7|0:SIRT5|0:SIRT1|0:SIRT6			
GO:0045653	P:negative regulation of megakaryocyte differ...; IDA:UniProtKB		0:HIST1H4I|0:HIST1H4L|0:HIST1H4B|0:HIST1H4E|0:HIST2H4A|0:HIST1H4H|0:HIST1H4A|0:HIST4H4|0:PF4|0:HIST1H4D|0:HIST1H4K|0:HIST1H4J|0:HIST1H4C|0:HIST2H4B|0:HIST1H4F			
GO:0033858	F:N-acetylgalactosamine kinase activity; IEA:EC		0:GALK2			
GO:0060072	F:large conductance calcium-activated potassi...; IDA:UniProtKB		0:KCNMA1			
GO:0004906	F:interferon-gamma receptor activity; TAS:ProtInc		0:IFNGR2|0:IFNGR1			
GO:0004897	F:ciliary neurotrophic factor receptor activity; TAS:ProtInc		0:IL6ST|0:CNTFR			
GO:0032780	P:negative regulation of ATPase activity; ISS:UniProtKB		0:TNNI3|0:TNNT2|0:OXA1L|0:PXK			
GO:0005367	F:myo-inositol:sodium symporter activity; EXP:Reactome		0:SLC5A3			
GO:0004306	F:ethanolamine-phosphate cytidylyltransferase...; TAS:UniProtKB		0:PCYT2			
GO:0051225	P:spindle assembly; TAS:BHF-UCL		0:NCOR1|0:HAUS7|0:HAUS3|0:RCC1|0:HAUS4|0:HAUS1|0:CEP192|0:HAUS8|0:HAUS5|0:HAUS2|0:HDAC3|0:HAUS6|0:CEP63|0:TNKS			
GO:0043652	P:engulfment of apoptotic cell; IDA:BHF-UCL		0:THBS1			
GO:0032812	P:positive regulation of epinephrine secretion; IDA:HGNC		0:CARTPT			
GO:0003905	F:alkylbase DNA N-glycosylase activity; IEA:EC		0:MPG			
GO:0016403	F:dimethylargininase activity; IDA:UniProtKB		0:DDAH1|0:DDAH2			
GO:0006982	P:response to lipid hydroperoxide; TAS:UniProtKB		0:APOA4|0:GPX3			
GO:0001784	F:phosphotyrosine binding; IPI:BHF-UCL		0:CBLC|0:SAMSN1|0:PTPN5|0:LDLRAP1|0:PTPN3			
GO:0060644	P:mammary gland epithelial cell differentiation; ISS:UniProtKB		0:IRF6			
GO:0047391	F:alkylglycerophosphoethanolamine phosphodies...; IEA:EC		0:ENPP2			
GO:0007628	P:adult walking behavior; ISS:UniProtKB		0:DRD1|0:DRD2|0:KCNMA1			
GO:0031622	P:positive regulation of fever; ISS:BHF-UCL		0:TNF|0:PTGS2|0:PTGER3|0:TNFRSF11A|0:TNFSF11|0:IL1B			
GO:0006678	P:glucosylceramide metabolic process; IMP:UniProtKB		0:CLN3			
GO:0046500	P:S-adenosylmethionine metabolic process; IDA:UniProtKB		0:GNMT			
GO:0048550	P:negative regulation of pinocytosis; IMP:BHF-UCL		0:NR1H3|0:NR1H2			
GO:0047273	F:galactosylgalactosylglucosylceramide beta-D...; IEA:EC		0:B3GALNT1			
GO:0043235	C:receptor complex; TAS:UniProtKB		0:RIPK1|0:ERBB2|0:TRADD|0:ADRA2A|0:ADRB3|0:ADRB2|0:ERBB3|0:CSF1|0:CSF1R|0:BMPR1B			
GO:0004415	F:hyalurononglucosaminidase activity; TAS:ProtInc		0:HYAL3|0:SPAM1|0:MGEA5|0:HYAL4|0:HYAL1|0:HYAL2			
GO:0032364	P:oxygen homeostasis; NAS:UniProtKB		0:NARFL|0:EGLN1|0:HIF1A|0:SOD2|0:WNT7B|0:ALAS2			
GO:0018101	P:peptidyl-citrulline biosynthetic process fr...; IEA:InterPro		0:PADI1|0:PADI2|0:PADI4|0:PADI3|0:PADI6			
GO:0030539	P:male genitalia development; TAS:ProtInc		0:TBX3|0:LHCGR|0:HSD17B3			
GO:0001592	F:dopamine D3 receptor activity; IDA:BHF-UCL		0:DRD3			
GO:0090073	P:positive regulation of protein homodimeriza...; IDA:UniProtKB		0:TRAF4			
GO:0043512	C:inhibin A complex; IDA:HGNC		0:INHA|0:INHBA			
GO:0043304	P:regulation of mast cell degranulation; ISS:UniProtKB		0:UNC13D|0:STXBP2			
GO:0016881	F:acid-amino acid ligase activity; IEA:InterPro		0:SYVN1|0:HACE1|0:HERC4|0:HERC5|0:UBA3|0:HERC1|0:HERC6|0:HECW2|0:C12orf51|0:UBE3B|0:HERC3|0:HECW1|0:HECTD2|0:KIAA0317			
GO:0051387	P:negative regulation of nerve growth factor ...; IMP:BHF-UCL		0:AGT|0:AGTR2			
GO:0048291	P:isotype switching to IgG isotypes; IDA:BHF-UCL		0:HSPD1			
GO:0016627	F:oxidoreductase activity, acting on the CH-C...; IEA:InterPro		0:TECR|0:TECRL			
GO:0008095	F:inositol-1,4,5-trisphosphate receptor activity; TAS:ProtInc		0:CYTH3			
GO:0008282	C:ATP-sensitive potassium channel complex; ISS:BHF-UCL		0:KCNJ11|0:ABCC9			
GO:0009301	P:snRNA transcription; TAS:ProtInc		0:SNAPC2|0:SNAPC3			
GO:0003724	F:RNA helicase activity; TAS:ProtInc		0:DDX5|0:DHX16|0:DHX15|0:DDX10|0:DDX6|0:DDX1|0:DDX17|0:RAD54B			
GO:0051607	P:defense response to virus; TAS:BHF-UCL		0:IL6|0:RSAD2|0:BCL2|0:MICA|0:BST2|0:IL29|0:BNIP3L|0:BNIP3|0:ABCC9|0:SAMHD1|0:TLR8|0:TLR7|0:PTPRC|0:LYST|0:RELA|0:TLR3			
GO:0030118	C:clathrin coat; IEA:InterPro		0:PICALM|0:SNAP91			
GO:0006410	P:transcription, RNA-dependent; IDA:HGNC		0:APOBEC3F|0:APOBEC3G			
GO:0003676	F:nucleic acid binding; TAS:ProtInc		0:AEN|0:DUS3L|0:RP9|0:FAM90A9|0:ZCCHC12|0:GPATCH8|0:EDDM3B|0:C19orf22|0:TDRD9|0:ZBTB7C|0:SSX10|0:RBMXL1|0:SKIV2L2|0:GPATCH3|0:CCDC75|0:ZCCHC2|0:HELZ|0:ZBTB46|0:RNASE4|0:SSX2|0:ZC3H3|0:TIPARP|0:EXD2|0:MAMSTR|0:GPKOW|0:UNK|0:PHF19|0:RNASE9|0:FAM90A23|0:DHX57|0:C17orf42|0:REXO1L1|0:MKRN3|0:SSX4B|0:DHX36|0:FTSJ2|0:PRR3|0:TFIP11|0:ZCCHC16|0:TDRD5|0:SSX7|0:ZMAT5|0:ENDOG|0:DHX16|0:HNRNPUL2|0:REXO1|0:ZC3H12C|0:TRMT11|0:MYOCD|0:ZNF862|0:ZCCHC6|0:RNASE13|0:NUPL2|0:ENOX1|0:RNASE7|0:ZCCHC11|0:ZNF746|0:SNRNP200|0:ZC3H15|0:ZC3H12B|0:ENPP3|0:FAM90A17|0:SMNDC1|0:ZNF67P|0:ASCC3|0:ZC3H7A|0:PIAS3|0:ZCCHC24|0:CETN1|0:SF3A2|0:FAM90A20|0:C9orf23|0:ERI2|0:MKRN2|0:SREK1IP1|0:FTSJ1|0:BAT4|0:CLIP1|0:TDRD1|0:ZNF385B|0:CCAR1|0:SF3A3|0:SSX3|0:EXD1|0:MKL2|0:ZCCHC13|0:NARS|0:ZNF725|0:KIAA2022|0:DBF4|0:ARIH2|0:NPM2|0:KDM4C|0:TDRD12|0:ENDOD1|0:FAM90A22|0:METTL4|0:SREK1|0:DHX35|0:ENOX2|0:ZCCHC5|0:FAM90A16|0:PNLDC1|0:ZCCHC9|0:DHX15|0:SSX4|0:FTSJD1|0:FAM90A14|0:ZNF740|0:ENPP2|0:RECQL5|0:PMS2L3|0:DNAJC21|0:TDRD6|0:RNASE1|0:ZC3H4|0:ERI3|0:MKRN1|0:ZNF843|0:RNASE10|0:FAM90A7|0:ISG20L2|0:DDX4|0:ZC3H7B|0:SSX8|0:TSEN2|0:R3HCC1|0:ZC3H11A|0:CETN2|0:MKRN4P|0:SPAG7|0:REXO2|0:ERVK5|0:PRDM7|0:WBP4|0:KDM4B|0:R3HDM2|0:METTL5|0:YTHDC2|0:FAM90A19|0:ZNF480|0:UNKL|0:C4orf23|0:DPPA2|0:ZNF385C|0:DHX38|0:ZNF585A|0:MBNL3|0:NPM3|0:ZNF814|0:PNMA3|0:RBAK|0:PRDM9|0:ZCCHC4|0:DDX27|0:SND1|0:RNASE2|0:ZNF318|0:PAN2|0:C3orf33|0:RNF113A|0:N6AMT1|0:JAZF1|0:ZCCHC14|0:GPATCH1|0:AARSD1|0:FAM90A10|0:SSX2B|0:ZCCHC23|0:PHF20L1|0:TOE1|0:ZNF200|0:HELQ|0:ZNF833P|0:DARS|0:DDX39|0:AGGF1|0:ZC3H6|0:PRDM6|0:BCL11B|0:FIZ1|0:TDRD7|0:SF3B3|0:FAM90A13|0:ZNF321|0:DHX40|0:SSX9|0:GPATCH4|0:RBPMS2|0:ZC3H13|0:REXO1L2P|0:FAM90A15|0:EDDM3A|0:RNASE11|0:ZCCHC8|0:EXOG|0:DDX23|0:ENPP1|0:MKL1|0:ZXDB|0:ZNF622|0:XRN2|0:GPATCH2|0:RBBP6|0:ZNRD1|0:FAM90A24P|0:HFM1|0:KDM4A|0:ZNF695|0:TDRD3|0:STK31|0:FAM90A8|0:ZNF720|0:FTSJD2|0:NARS2|0:N6AMT2|0:DARS2|0:ZNF385D|0:RNF17|0:RNF113B|0:FAM90A18|0:ZCCHC3|0:DHX37|0:FTSJ3|0:ZC3H18|0:ZNF831|0:RNASE3|0:DBF4B|0:FAM90A1|0:EXD3|0:TSEN34|0:CIZ1|0:ZC3H10|0:SSX5|0:PINX1|0:ZNF852|0:ZNF673|0:ZNF747|0:LENG9|0:ZCCHC10|0:SF3B2|0:ZDBF2|0:ZFP62|0:PARP12|0:ZNF880|0:C3orf26|0:SSX6|0:RNASE12|0:R3HDM1|0:RNASE8|0:RNASE6|0:NCBP2L|0:DHX33|0:ZNF585B|0:ZCCHC7|0:DQX1|0:FAM90A12|0:ZFR2|0:TREX2|0:ZC3H12D|0:OSR1|0:SSX1|0:BCL11A|0:FAM90A5|0:ACIN1|0:SNRNP27|0:USP6|0:EHD3|0:EHD4|0:EHD2			
GO:0007501	P:mesodermal cell fate specification; TAS:ProtInc		0:EYA2			
GO:0000831	F:inositol hexakisphosphate 6-kinase activity; IDA:MGI		0:IP6K3			
GO:0015991	P:ATP hydrolysis coupled proton transport; TAS:UniProtKB		0:ATP4A|0:ATP6V0E2|0:ATP6V0E1|0:ATP6V1H|0:ATP1A4			
GO:0045751	P:negative regulation of Toll signaling pathway; IDA:HGNC		0:NLRP12			
GO:0032500	F:muramyl dipeptide binding; IDA:HGNC		0:NOD2			
GO:0008430	F:selenium binding; TAS:ProtInc		0:DIO2|0:GPX3|0:C17orf37|0:SEPW1|0:C11orf31|0:DIO1|0:SEPP1|0:SELENBP1			
GO:0004420	F:hydroxymethylglutaryl-CoA reductase (NADPH)...; IEA:EC		0:HMGCR			
GO:0070123	F:transforming growth factor beta receptor ac...; IDA:BHF-UCL		0:TGFBR3			
GO:0043526	P:neuroprotection; TAS:UniProtKB		0:AKT1S1|0:ATP7A|0:DHCR24|0:GRM4			
GO:0005615	C:extracellular space; TAS:UniProtKB		0:LIF|0:CNTF|0:MMP2|0:SERPINF1|0:LTBP4|0:COL18A1|0:COMP|0:ALB|0:NDP|0:LTBP2|0:SPON1|0:SERPINB1|0:HDGF|0:GHR|0:CST3|0:CLEC3B|0:TNF|0:SELP|0:EFEMP1|0:LUM|0:LIPG|0:IL1RN|0:TFPI|0:ADM|0:PLA2G2A|0:EDN3|0:BMPER|0:F12|0:NRG1|0:CPXM2|0:TNXB|0:PCSK6|0:MICA|0:AREG|0:WNT16|0:OGN|0:DCN|0:COL12A1|0:ANGPTL3|0:SOD3|0:MPO|0:ADAMTS4|0:ACE|0:FASLG|0:DPT|0:ERBB3|0:ULBP2|0:APCS|0:COL6A3|0:GH1|0:F3|0:PCSK1|0:KIT|0:ACE2|0:INS|0:PDGFA|0:CDH13|0:LGALS1|0:COL15A1|0:LBP|0:VTN|0:RBP4|0:TGFA|0:EDN2|0:CP|0:EDN1|0:COL1A1|0:KLKB1|0:SERPINA4|0:IL10|0:LMCD1|0:IGFBP7|0:SELE|0:COL6A2|0:ABI3BP|0:PECAM1|0:PSAP|0:AEBP1|0:FRZB|0:FBLN5|0:PCSK2|0:APOD|0:CILP|0:CSF1|0:F11|0:SFRP4|0:CTSD|0:ENG|0:ICAM1|0:SERPINE1|0:ENPP1|0:HSPG2|0:ADIPOQ|0:HSPD1|0:AGT|0:IL6R|0:C7orf68|0:VCAN|0:AREGB|0:ADAM9|0:IL6|0:CTSG|0:IL6ST|0:NOG|0:SERPINC1|0:CTSZ|0:PCOLCE|0:F2|0:FMOD|0:TGFB1|0:PLA2G1B|0:PLAU|0:FBLN1|0:CALR|0:TPSAB1|0:TNC|0:COL14A1|0:VCAM1|0:CNP|0:CXCL16|0:PDGFC|0:PLG|0:UTP11L|0:CARTPT|0:REN|0:SCG2|0:PCSK9|0:PCDH15|0:SCUBE1|0:ANGPTL4|0:MYOC|0:COPA|0:ANGPTL1|0:TPT1|0:GAS6|0:FGF9|0:GRP|0:PATE2|0:SPN|0:FGF10|0:SLIT2|0:VEGFB|0:EREG|0:HMGB2|0:GPX3|0:SERPINB9|0:FKRP|0:GHRL|0:VASH1|0:IL1A|0:DAG1|0:KLK14|0:AMY2A|0:COL25A1|0:PODN|0:ANGPT4|0:PXDN|0:SFRP2|0:LAMA1|0:GIF|0:COL1A2|0:HMGB1|0:IL26|0:SLIT3|0:IL34|0:SRGN|0:CPA1|0:ATRN|0:A2ML1|0:VGF|0:CALCA|0:LAMB1|0:CHIA|0:FSTL3|0:S100A13|0:MMP9|0:CXCL3|0:MMRN2|0:ANG|0:COL3A1|0:SFRP1|0:CHIT1|0:THBS4|0:PRSS3|0:FGF23|0:SHH|0:VEGFA|0:MMP8|0:SOD1|0:MASP1|0:LGI1|0:WNT4|0:FGF8|0:WNT5A|0:CECR1|0:ARSG|0:FBN1|0:LAMA5|0:ANGPT1|0:ANGPT2|0:AGRP|0:QSOX1|0:C20orf114|0:DEFA6|0:C3|0:DEFA3|0:SMPDL3B|0:A2M|0:DEFA5|0:CPAMD8|0:GC|0:SMPDL3A|0:FCN3|0:FIBCD1|0:DEFA1B|0:RNPEP|0:ANGPTL6|0:DEFA1|0:HGFAC|0:C4A|0:FCN2|0:ANGPTL5|0:FCN1|0:CD109|0:PZP|0:DEFA4|0:IGF2|0:TNN|0:CXCL13|0:BMP3|0:CCL19|0:GDF10|0:IFNE|0:CMTM1|0:TNFSF15|0:SCGB3A1|0:CKLF|0:IL33|0:TNFSF9|0:IL7|0:GDF15|0:CCL26|0:FAM3B|0:SPP1|0:BMP7|0:IL1F8|0:IFNA21|0:TNFSF10|0:GPI|0:IL22|0:CCL4L1|0:CMTM6|0:PPBPL2|0:TNFSF4|0:IL1F6|0:TNFSF13B|0:GRN|0:GDF5|0:CCL21|0:MSTN|0:CXCL6|0:LTA|0:CCL3|0:IFNA8|0:GDF3|0:CMTM3|0:IL18|0:CCL18|0:CCL3L1|0:IL25|0:GDF11|0:SLURP1|0:CXCL14|0:IL1F7|0:CMTM2|0:NODAL|0:CXCL12|0:CMTM7|0:PF4|0:IL1F5|0:IL29|0:CER1|0:IL19|0:IFNA7|0:TNFSF11|0:BMP1|0:CCL4L2|0:CCL3L3|0:GDF6|0:CXCL11|0:LEFTY2|0:CXCL5|0:CCL25|0:IFNA10|0:IL1F10|0:IL24|0:PPBP|0:IL17D|0:IL28B|0:IL23A|0:CCL23|0:CMTM4|0:TSLP|0:IFNA14|0:IL9|0:GDF7|0:CCL17|0:TNFSF18|0:IFNG|0:CCL8|0:CCL28|0:CLCF1|0:TNFSF12|0:BMP8A|0:BMP2|0:TNFSF13|0:XCL1|0:GREM2|0:IFNW1|0:CD70|0:CCL5|0:IFNA6|0:GDF1|0:BMP5|0:IFNA2|0:CTF1|0:LEFTY1|0:CCL24|0:MIF|0:IFNB1|0:THPO|0:IL1F9|0:CCL11|0:TNFSF8|0:IL28A|0:CXCL10|0:IL17B|0:IFNA5|0:IFNA16|0:CCL16|0:CX3CL1|0:IFNA13|0:IFNA4|0:IL11|0:TNFSF14|0:CD40LG|0:CMTM8|0:GDF9|0:BMP6|0:GDF2|0:IL31|0:BMP15|0:BMP10|0:IL20|0:IL17F|0:CMTM5|0:BMP8B|0:FLT3LG|0:CCL27|0:LTB|0:XCL2|0:IFNA17|0:IFNK|0:IFNA1|0:CSF2|0:NENF|0:SFTPC|0:BTD|0:SERPINB2|0:F8|0:FGFBP2|0:PON3|0:SFTPD|0:ENOX1|0:SSPO|0:IL15RA|0:DHH|0:GPC3|0:MUC16|0:LY86|0:LOXL3|0:SFTPA2|0:ENOX2|0:FGF6|0:GPC4|0:PLA2G7|0:OTOG|0:CTRB2|0:ABP1|0:CLCA1|0:SFTPA1|0:OLFM4|0:KNG1|0:EMR3|0:LY96|0:COL20A1|0:SERPINE2|0:LPO|0:GPC5|0:IHH|0:GGH|0:PLAT|0:LOX|0:CTRB1|0:CFI|0:OTOP1|0:CD97|0:SFTPB|0:GPC6|0:PRSS1|0:LOXL1|0:LOXL4|0:SERPINB5|0:BTC|0:GPC2|0:IL1B|0:PRSS2|0:SERPINA1|0:PCSK5|0:GHRH|0:LEP|0:VWC2|0:NPY|0:IL27|0:LRRC17|0:IL3|0:PXDNL|0:BMP4|0:KLK8|0:RELN|0:IL13|0:CHRD|0:WNT10B|0:EGFR|0:WNT2B|0:SULF2|0:WNT5B|0:IL22RA2|0:SULF1|0:ISG15|0:IL21|0:FGF22|0:SLIT1|0:GNL1|0:AHSG|0:WFDC1|0:NPPB|0:LAMC1|0:WNT3|0:HMOX1|0:TGFBR3|0:MMP7|0:TAC1|0:GNLY|0:COLQ|0:MMP13|0:CEACAM8|0:PRH1|0:IL17A|0:UTS2|0:IGFBP1|0:CXCL1|0:SDF2|0:ORM2|0:CCL15|0:DKK2|0:ASIP|0:MMP20|0:WFDC2|0:KDSR|0:SEMA3E|0:PLA2G3|0:AMH|0:AIMP1|0:LECT2|0:ANGPTL2|0:SMR3B|0:NUCB1|0:IL8|0:OSM|0:SCGB1D2|0:MMP3|0:CXCL2|0:SEMG2|0:CTRL|0:PTHLH|0:PRH2|0:GREM1|0:PRR4|0:CD5L|0:HPX|0:MSMB|0:FIGF|0:CHI3L1|0:CFHR1|0:RS1|0:IK|0:CLCA3P|0:FLT1|0:YARS|0:IDE|0:REG3A|0:MMP10|0:TCN2|0:SCRG1|0:IL13RA2|0:CCL20|0:IL15|0:CCL2|0:CXCL9|0:FGF18|0:FSTL1|0:LGALS7B|0:C5|0:SECTM1|0:FGF12|0:FKTN|0:HTRA1|0:EPO|0:SEMG1|0:C8A|0:MBL2|0:RTN3|0:CPN1|0:CRLF1|0:SFN|0:NUCB2|0:IL9R|0:FGF2|0:KLK5|0:TNFAIP2|0:CFP|0:MFNG|0:FJX1|0:FGF17|0:KL|0:PLA2R1|0:IL5RA|0:CCL14|0:MIA|0:HABP2|0:FGFBP1|0:EFNA5|0:LGALS7|0:CHI3L2|0:AKR1B1|0:KAL1|0:FGF5|0:IL32|0:DKKL1|0:MEP1B|0:IGFALS|0:CPB2|0:CSF3|0:SFRP5|0:SCGB1D1|0:LOXL2|0:SERPINA7|0:CYTL1|0:EDDM3A|0:IL16|0:CFHR3|0:TGFBI|0:CRISP1|0:CCL22|0:ORM1|0:IL17C|0:LALBA|0:SEMA3F|0:HYAL1|0:PTN|0:CCL7|0:LGALS3BP|0:PGC|0:PRSS8|0:GPC1|0:ENDOU|0:TAC3|0:CCL4|0:MEP1A|0:PCSK1N|0:EBI3|0:DKK3|0:C2|0:CCL1|0:FGF16|0:DLK1|0:PVR|0:CCL13|0:CFH|0:CRISP2|0:INSL4|0:EGFL6|0:LGALS8|0:HBEGF|0:SST|0:IL2|0:IL5|0:LYZ|0:SORD|0:IL4			
GO:0046949	P:fatty-acyl-CoA biosynthetic process; IEA:InterPro		0:DBT			
GO:0004582	F:dolichyl-phosphate beta-D-mannosyltransfera...; IDA:UniProtKB		0:DPM1			
GO:0043534	P:blood vessel endothelial cell migration; TAS:BHF-UCL		0:SOX18|0:MYH9|0:ID1			
GO:0048388	P:endosomal lumen acidification; TAS:UniProtKB		0:CLCN3			
GO:0008239	F:dipeptidyl-peptidase activity; TAS:ProtInc		0:DPP4|0:DPEP2|0:DPEP3|0:DPEP1|0:NAALAD2|0:FAP|0:DPP8|0:DPP3|0:DPP6			
GO:0004488	F:methylenetetrahydrofolate dehydrogenase (NA...; IEA:EC		0:MTHFD2|0:MTHFD1			
GO:0042228	P:interleukin-8 biosynthetic process; IDA:HGNC		0:NOD1			
GO:0006112	P:energy reserve metabolic process; TAS:ProtInc		0:ADRB3|0:LEP|0:GFPT2|0:LEPR|0:GFPT1			
GO:0043922	P:negative regulation by host of viral transc...; IMP:UniProtKB		0:TARDBP|0:POU2F3|0:TFAP4|0:HDAC1			
GO:0042288	F:MHC class I protein binding; TAS:UniProtKB		0:ATP5B|0:ATP5A1|0:DERL1|0:TUBB|0:CD8B|0:CD8A|0:TAPBP|0:TUBB2C			
GO:0008037	P:cell recognition; TAS:ProtInc		0:CRTAM|0:CADM1|0:CD5|0:CSGALNACT1|0:CNTNAP3|0:LAMA5|0:CD226|0:NCR3|0:PECAM1|0:VCAN			
GO:0061038	P:uterus morphogenesis; IMP:BHF-UCL		0:NIPBL			
GO:0045715	P:negative regulation of low-density lipoprot...; IMP:BHF-UCL		0:ADIPOQ|0:ITGB3|0:ITGAV			
GO:0043422	F:protein kinase B binding; ISS:BHF-UCL		0:APPL1|0:TRAF6|0:CCDC88A|0:BCL10|0:PDE3B			
GO:0007369	P:gastrulation; NAS:UniProtKB		0:FAM48A|0:CFC1|0:WNT8B|0:GSC|0:FGF8			
GO:0004158	F:dihydroorotate oxidase activity; IEA:InterPro		0:DPYD|0:DHODH			
GO:0050145	F:nucleoside phosphate kinase activity; EXP:Reactome		0:DTYMK			
GO:0040037	P:negative regulation of fibroblast growth fa...; IDA:BHF-UCL		0:THBS1			
GO:0032354	P:response to follicle-stimulating hormone st...; IDA:BHF-UCL		0:TGFBR3			
GO:0007202	P:activation of phospholipase C activity; TAS:UniProtKB		0:ARHGAP6|0:ADRA2A|0:GPR55|0:SELE|0:ANG|0:ADRA1A|0:RASGRP4|0:AVPR1A|0:C5AR1|0:LPAR2|0:LPAR1|0:PLCB2|0:S1PR4|0:AVPR1B|0:EGFR			
GO:0001916	P:positive regulation of T cell mediated cyto...; IDA:UniProtKB		0:IL12A			
GO:0046103	P:inosine biosynthetic process; ISS:UniProtKB		0:ADA			
GO:0030868	C:smooth endoplasmic reticulum membrane; ISS:UniProtKB		0:SVIP|0:SEC23A|0:HSD3B1|0:HSD3B2			
GO:0005026	F:transforming growth factor beta receptor ac...; IEA:InterPro		0:TGFBR2			
GO:0016080	P:synaptic vesicle targeting; TAS:UniProtKB		0:NLGN1|0:SEPT5			
GO:0015035	F:protein disulfide oxidoreductase activity; NAS:UniProtKB		0:ENOX2|0:TXNRD1|0:GLRX3|0:GLRX5|0:GLRX2|0:GLRX|0:SH3BGRL3|0:PTGES2|0:GSTK1|0:TXNRD3|0:CLIC2|0:GRXCR1|0:STAB1|0:STAB2			
GO:0008709	F:7-alpha-hydroxysteroid dehydrogenase activity; TAS:ProtInc		0:HSD17B10			
GO:0004749	F:ribose phosphate diphosphokinase activity; NAS:UniProtKB		0:PRPS1|0:PRPSAP2|0:PRPSAP1|0:PRPS2|0:PRPS1L1			
GO:0055105	F:ubiquitin-protein ligase inhibitor activity; ISS:BHF-UCL		0:CDKN2A			
GO:0031665	P:negative regulation of lipopolysaccharide-m...; TAS:HGNC		0:TRIB1|0:SIGIRR			
GO:0070287	F:ferritin receptor activity; ISS:UniProtKB		0:SCARA5			
GO:0046795	P:intracellular virion transport; TAS:UniProtKB		0:CLEC4M|0:CD209			
GO:0004810	F:tRNA adenylyltransferase activity; IDA:UniProtKB		0:TRNT1			
GO:0005254	F:chloride channel activity; TAS:ProtInc		0:APOL1|0:SLC1A4|0:SLC26A8|0:SLC26A7|0:ABCC4|0:GABRP|0:GABRR2|0:TTYH1|0:GABRB3|0:GABRG2|0:GABRA4|0:BEST2|0:ANO6|0:GABRE|0:ANO3|0:GABRG1|0:GABRA6|0:GABRR1|0:GABRA3|0:CLCA3P|0:BEST3|0:GABRD|0:ANO7|0:ANO4|0:GABRA2|0:GABRA1|0:ANO8|0:BEST4|0:GLRA4|0:ANO5|0:GABRA5|0:GABRB2|0:GABRR3|0:GABRQ|0:ANO9|0:ANO10|0:GABRG3|0:GABRB1|0:BEST1|0:TTYH2|0:TTYH3|0:FXYD1|0:CLCA2|0:FXYD3|0:CLCA1|0:CLCA4			
GO:0006583	P:melanin biosynthetic process from tyrosine; TAS:ProtInc		0:DCT|0:TYR			
GO:0060421	P:positive regulation of heart growth; ISS:BHF-UCL		0:PROX1			
GO:0034713	F:type I transforming growth factor beta rece...; ISS:BHF-UCL		0:TGFBR2|0:SMAD6|0:TGFB3|0:SMAD7|0:SMAD2|0:ENG|0:FKBP1A			
GO:0016117	P:carotenoid biosynthetic process; IEA:UniProtKB-KW		0:IDI1|0:IDI2			
GO:0007611	P:learning or memory; TAS:ProtInc		0:PAFAH1B1|0:S100B|0:GALR3|0:ACSL4|0:CRHBP|0:GALR2			
GO:0005746	C:mitochondrial respiratory chain; TAS:UniProtKB		0:COX7A2|0:COX7B|0:COX7A1|0:COX7A2P2|0:COX7A2L|0:COX7B2|0:OXA1L|0:SURF1|0:UQCRB|0:NNT|0:COX15			
GO:0032488	P:Cdc42 protein signal transduction; IMP:BHF-UCL		0:APOE|0:APOC3|0:APOA1|0:ABCA1			
GO:0070106	P:interleukin-27-mediated signaling pathway; IMP:BHF-UCL		0:IL6ST			
GO:0070741	P:response to interleukin-6; TAS:UniProtKB		0:CITED1|0:FOXA2			
GO:0008093	F:cytoskeletal adaptor activity; TAS:UniProtKB		0:ARHGAP26|0:BAIAP2L2|0:MTSS1L|0:MTSS1|0:BAIAP2L1|0:OBSL1|0:SDCBP|0:NCK1|0:BIN3|0:NCK2|0:SORBS2|0:BAIAP2|0:ANK1|0:ABI2			
GO:0000380	P:alternative nuclear mRNA splicing, via spli...; IMP:BHF-UCL		0:SLU7|0:SFPQ|0:HNRNPM			
GO:0002684	P:positive regulation of immune system process; IDA:BHF-UCL		0:AQP3			
GO:0042384	P:cilium assembly; ISS:UniProtKB		0:RAB8A|0:PCNT|0:RAB3IP|0:PCM1|0:BBS5|0:DNAI2|0:TMEM67|0:FOXJ1|0:ARL6|0:IFT172|0:TTLL3|0:PKHD1			
GO:0042166	F:acetylcholine binding; NAS:UniProtKB		0:CHRNB1|0:ACHE			
GO:0071158	P:positive regulation of cell cycle arrest; IDA:BHF-UCL		0:CDKN2A			
GO:0032401	P:establishment of melanosome localization; ISS:HGNC		0:SHROOM2			
GO:0031519	C:PcG protein complex; TAS:UniProtKB		0:PCGF6			
GO:0009309	P:amine biosynthetic process; TAS:ProtInc		0:SULT1A2			
GO:0005083	F:small GTPase regulator activity; TAS:ProtInc		0:RALGDS|0:MINK1|0:CIT|0:MAP4K4|0:NRK|0:TGFBRAP1|0:TNIK|0:GARNL3|0:MAP4K5|0:VPS39|0:MAP4K2|0:MAP4K1|0:CDC42BPG|0:CDC42BPB|0:CDC42BPA|0:MAP4K3|0:MAPRE3|0:ARL2BP|0:IPO7|0:WASL|0:KRIT1|0:WAS|0:RUNDC3A			
GO:0015018	F:galactosylgalactosylxylosylprotein 3-beta-g...; NAS:UniProtKB		0:B3GAT1|0:B3GAT2|0:B3GAT3			
GO:0004322	F:ferroxidase activity; TAS:ProtInc		0:FXN|0:FTMT|0:FTH1|0:CP			
GO:0016316	F:phosphatidylinositol-3,4-bisphosphate 4-pho...; TAS:ProtInc		0:INPP4A|0:INPP4B			
GO:0006200	P:ATP catabolic process; TAS:ProtInc		0:OLA1|0:ATP5O|0:ACLY			
GO:0046813	P:virion attachment, binding of host cell sur...; TAS:UniProtKB		0:ACE2|0:ICAM1|0:CD81			
GO:0010457	P:centriole-centriole cohesion; IMP:UniProtKB		0:SGOL1|0:CEP135|0:CEP250			
GO:0060627	P:regulation of vesicle-mediated transport; TAS:BHF-UCL		0:USP6|0:SLC30A8			
GO:0030201	P:heparan sulfate proteoglycan metabolic process; NAS:UniProtKB		0:SULF2|0:SULF1|0:HS3ST4			
GO:0030904	C:retromer complex; IEA:InterPro		0:DSCR3|0:VPS26A|0:VPS26B			
GO:0030335	P:positive regulation of cell migration; TAS:BHF-UCL		0:CCL26|0:PDGFRA|0:PDGFA|0:CDH13|0:PDGFRB|0:CCL24|0:CCL11|0:ROR2|0:PODXL|0:ANGPTL3|0:SPHK1|0:BCAR1|0:WNT5B|0:LAMB1|0:TDGF1|0:FGFR1OP|0:F2R|0:IGF1R|0:INSR|0:ADRA2A|0:CXCL16|0:APC|0:EGFR|0:WNT11|0:CREB3|0:SPAG9|0:TRIP6|0:INS|0:DRD1|0:CSF1|0:CBLL1|0:F10			
GO:0016064	P:immunoglobulin mediated immune response; TAS:UniProtKB		0:CD74|0:LY9|0:CD27|0:TLR8			
GO:0060055	P:angiogenesis involved in wound healing; TAS:BHF-UCL		0:ITGB3|0:SRF			
GO:0034362	C:low-density lipoprotein particle; IEA:UniProtKB-KW		0:APOE|0:APOB|0:APOM|0:APOC2|0:SORL1|0:LDLR|0:APOF|0:APOO|0:MSR1|0:LSR			
GO:0016538	F:cyclin-dependent protein kinase regulator a...; IEA:InterPro		0:CCNY|0:CKS1B|0:CABLES2|0:CABLES1|0:CKS2			
GO:0060087	P:relaxation of vascular smooth muscle; ISS:UniProtKB		0:KCNMA1|0:SOD1			
GO:0047555	F:3',5'-cyclic-GMP phosphodiesterase activity; IMP:BHF-UCL		0:PDE11A|0:PDE10A|0:PDE9A|0:PDE5A|0:PDE6C|0:PDE6A|0:PDE6B			
GO:0070700	F:BMP receptor binding; IPI:MGI		0:BMP4|0:BMP2|0:BMP3|0:BMP5|0:BMP6			
GO:0031306	C:intrinsic to mitochondrial outer membrane; ISS:UniProtKB		0:MFN2			
GO:0007566	P:embryo implantation; TAS:UniProtKB		0:PCSK5|0:SOD1|0:SPP1|0:IL1B|0:SCGB1A1|0:RPL29|0:TRO|0:PRLR|0:PPARD			
GO:0032760	P:positive regulation of tumor necrosis facto...; ISS:BHF-UCL		0:PF4|0:LBP|0:CD14|0:NOD2|0:TLR3|0:TLR4|0:TLR9|0:TLR2			
GO:0015186	F:L-glutamine transmembrane transporter activity; IDA:UniProtKB		0:SLC38A3			
GO:0060795	P:cell fate commitment involved in the format...; IMP:BHF-UCL		0:POU5F1			
GO:0017005	F:3'-tyrosyl-DNA phosphodiesterase activity; IDA:UniProtKB		0:TDP1			
GO:0010886	P:positive regulation of cholesterol storage; ISS:BHF-UCL		0:SCARB1|0:APOB|0:LPL|0:MSR1|0:EHD1			
GO:0032204	P:regulation of telomere maintenance; IMP:BHF-UCL		0:PIF1|0:MYC			
GO:0004465	F:lipoprotein lipase activity; TAS:ProtInc		0:LPL|0:LIPG|0:AOAH			
GO:0016847	F:1-aminocyclopropane-1-carboxylate synthase ...; IEA:InterPro		0:ACCS|0:TAT|0:CCBL1|0:GPT|0:ACCSL			
GO:0005640	C:nuclear outer membrane; TAS:ProtInc		0:GHRHR|0:PSEN1|0:EMD|0:DHCR7|0:LRPPRC|0:SIGMAR1|0:LTC4S|0:SYNE1|0:NXNL1|0:TMEM109|0:NAV3|0:SYNE2|0:C14orf49|0:ITPR3|0:RETSAT|0:GUCY2D|0:RAE1|0:GUCY2F			
GO:0030553	F:cGMP binding; IEA:UniProtKB-KW		0:PDE6G|0:PDE6H|0:CNGA3|0:PDE10A|0:PRKG2|0:CNGA1|0:PDE2A|0:PRKG1|0:PDE5A|0:CNGB3|0:PDE6C			
GO:0005785	C:signal recognition particle receptor complex; TAS:ProtInc		0:SRP9|0:SRPR			
GO:0050904	P:diapedesis; IDA:UniProtKB		0:PECAM1			
GO:0046697	P:decidualization; TAS:UniProtKB		0:GHRL|0:GHSR|0:VDR|0:CYP27B1|0:SPP1|0:PPARD			
GO:0060557	P:positive regulation of vitamin D biosynthet...; IDA:BHF-UCL		0:TNF|0:IFNG			
GO:0060022	P:hard palate development; IMP:UniProtKB		0:FOXE1			
GO:0035553	P:oxidative single-stranded RNA demethylation; IDA:BHF-UCL		0:FTO			
GO:0043981	P:histone H4-K5 acetylation; IDA:UniProtKB		0:ING4|0:MEAF6|0:PHF16|0:PHF17|0:MYST2|0:PHF15			
GO:0018094	P:protein polyglycylation; ISS:UniProtKB		0:TTLL3|0:TTLL8			
GO:0042271	P:susceptibility to natural killer cell media...; IMP:BHF-UCL		0:CADM1|0:PVRL2|0:PVR			
GO:0060402	P:calcium ion transport into cytosol; TAS:BHF-UCL		0:ADRA1A|0:JPH1|0:JPH3|0:CACNA1C|0:JPH4|0:JPH2			
GO:0006555	P:methionine metabolic process; TAS:ProtInc		0:MTHFR|0:SMS|0:MSRA			
GO:0043392	P:negative regulation of DNA binding; ISS:UniProtKB		0:TNKS|0:RSF1|0:JUN|0:TFAP4|0:MDFI			
GO:0051347	P:positive regulation of transferase activity; ISS:HGNC		0:FTMT|0:FXN|0:SERINC5|0:SERINC1			
GO:0004838	F:L-tyrosine:2-oxoglutarate aminotransferase ...; IDA:UniProtKB		0:TAT			
GO:0055088	P:lipid homeostasis; TAS:BHF-UCL		0:HNF4A|0:USF2|0:USF1|0:PPARG|0:IRS2			
GO:0008396	F:oxysterol 7-alpha-hydroxylase activity; IDA:UniProtKB		0:CYP7B1|0:CYP39A1			
GO:0006476	P:protein amino acid deacetylation; IEA:InterPro		0:SIRT3|0:SIRT5|0:SIRT6|0:SIRT4|0:SIRT7			
GO:0019773	C:proteasome core complex, alpha-subunit complex; IEA:InterPro		0:PSMA3|0:PSMA6|0:PSMA2|0:PSMA5|0:PSMA1|0:PSMA8|0:PSMA7|0:PSMA4			
GO:0030901	P:midbrain development; TAS:UniProtKB		0:WNT1|0:JHDM1D|0:SHH|0:OTX2			
GO:0032507	P:maintenance of protein location in cell; ISS:BHF-UCL		0:CD4|0:CAV1			
GO:0045744	P:negative regulation of G-protein coupled re...; IDA:UniProtKB		0:KLK14|0:RPGRIP1L|0:MGRN1			
GO:0004694	F:eukaryotic translation initiation factor 2a...; TAS:ProtInc		0:EIF2AK3|0:EIF2AK1|0:EIF2AK4|0:EIF2AK2			
GO:0005338	F:nucleotide-sugar transmembrane transporter ...; NAS:UniProtKB		0:SLC35A5|0:SLC35D2			
GO:0030296	F:protein tyrosine kinase activator activity; IMP:UniProtKB		0:NRG1|0:ERBB3|0:AFAP1L2|0:CD24|0:GHRL			
GO:0008235	F:metalloexopeptidase activity; TAS:UniProtKB		0:ERAP1|0:METAP2|0:DPEP2|0:XPNPEP2|0:DPEP3|0:RNPEP|0:LAP3|0:ZMPSTE24|0:ENPEP|0:DPEP1|0:METAP1			
GO:0019953	P:sexual reproduction; ISS:UniProtKB		0:SEMG2|0:SEMG1|0:STAT3			
GO:0010225	P:response to UV-C; IMP:UniProtKB		0:WRN|0:POLH|0:DCUN1D3|0:BCL3|0:ERCC5			
GO:0006107	P:oxaloacetate metabolic process; ISS:BHF-UCL		0:GHR|0:STAT5A|0:STAT5B			
GO:0010843	F:promoter binding; ISS:UniProtKB		0:GFI1|0:OVOL2|0:SP1|0:FOS|0:PPARG|0:SMAD7|0:CIITA|0:TAF9|0:XRCC6|0:NR5A2|0:HNF4A|0:AR|0:PROX1|0:SMAD2|0:TP53|0:MESP1|0:THRA|0:HHEX|0:XRCC5|0:POU5F1|0:NFKB1|0:SMAD4|0:NR2F2|0:GATA4|0:YY1|0:GABPB1|0:GABPB2|0:GABPA|0:GATA5|0:HMGB2|0:ZFHX3|0:TNF|0:WNT1|0:WNT11|0:RFX6|0:SOX2|0:CITED1|0:TBP|0:FOXA1|0:ETV5|0:RFX3|0:NFATC1|0:TP73|0:TBL1X|0:CEBPA|0:JUN|0:TAF5|0:ZNF281|0:TBL1XR1|0:ASH2L|0:PRDM5|0:HNF1A|0:SIX1|0:GATA6|0:HINFP|0:MLL2|0:ZNF217|0:DLX5|0:RBBP5|0:CTCFL|0:NKX2-1|0:TFEB|0:RELA|0:AIRE|0:WNT5A|0:CTNNB1|0:PAX2|0:SOX18|0:TAF7|0:WT1|0:CTCF|0:ARRB1|0:FOXA3|0:FOXA2|0:TAF2|0:TAL1|0:NCOR1|0:SOX17|0:KDM1A|0:KLF17|0:RNF10|0:BASP1|0:MSX2|0:TFE3|0:FOXI1			
GO:0051798	P:positive regulation of hair follicle develo...; IDA:MGI		0:FST			
GO:0051272	P:positive regulation of cellular component m...; TAS:HGNC		0:LYN|0:ACTN4|0:ETS1|0:TGFBR1|0:RPS19			
GO:0070307	P:lens fiber cell development; ISS:BHF-UCL		0:WNT5B|0:WNT7A|0:WNT7B			
GO:0033572	P:transferrin transport; IMP:BHF-UCL		0:DNM2|0:CLTC			
GO:0016188	P:synaptic vesicle maturation; NAS:UniProtKB		0:STXBP1|0:SYP			
GO:0007402	P:ganglion mother cell fate determination; TAS:ProtInc		0:NTF4|0:POU6F2			
GO:0016455	F:RNA polymerase II transcription mediator ac...; TAS:UniProtKB		0:MED26|0:MED14|0:MED13|0:MED17|0:MED12|0:MED24|0:PPARGC1B|0:THRAP3|0:MED1|0:MED30|0:MED4|0:MED15|0:MED31|0:MED10|0:MED19|0:MED22|0:MED18|0:MED7|0:MED6|0:MED20|0:MED12L|0:MED11|0:RBM14|0:TRERF1|0:PPARGC1A|0:CNOT2			
GO:0030594	F:neurotransmitter receptor activity; ISS:UniProtKB		0:GRIN3B			
GO:0071482	P:cellular response to light stimulus; IMP:UniProtKB		0:TRPM1			
GO:0050768	P:negative regulation of neurogenesis; ISS:UniProtKB		0:WNT7A|0:HOOK3|0:PCM1|0:DYNLT1			
GO:0005152	F:interleukin-1 receptor antagonist activity; TAS:UniProtKB		0:IL1F7|0:IL1F10|0:IL1F9|0:PXDN|0:IL1F5|0:IL1RN			
GO:0004709	F:MAP kinase kinase kinase activity; TAS:ProtInc		0:MAP3K8|0:MAP3K6|0:MAP3K7|0:MAP3K13|0:MAP3K5|0:MAP3K14|0:MAP3K15|0:MAP3K12|0:MAP3K2|0:MAP3K4|0:MAP3K3			
GO:0004958	F:prostaglandin F receptor activity; TAS:ProtInc		0:PTGFR			
GO:0043583	P:ear development; ISS:HGNC		0:ECE1|0:SHROOM2			
GO:0035385	P:Roundabout signaling pathway; IMP:BHF-UCL		0:SLIT3|0:ROBO1			
GO:0032214	P:negative regulation of telomere maintenance...; NAS:BHF-UCL		0:TERF1|0:TERF2			
GO:0001701	P:in utero embryonic development; NAS:UniProtKB		0:PTPRR|0:CHD7|0:HAND2|0:TGFB3|0:MYH6|0:MBNL1|0:ARNT2|0:LIG4|0:HINFP|0:ADAM10|0:FUT8|0:LMX1B			
GO:0090344	P:negative regulation of cell aging; IMP:UniProtKB		0:FOXM1			
GO:0061034	P:olfactory bulb mitral cell layer development; IMP:UniProtKB		0:SALL1			
GO:0022900	P:electron transport chain; IEA:UniProtKB-KW		0:ETFDH|0:ETFA|0:CYB5B|0:TXNRD1|0:NDUFA12|0:TMX1|0:FADS1|0:ERO1L|0:ENOX1|0:ERO1LB|0:CYC1|0:STEAP2|0:TMX4|0:NDUFA13|0:SDHD|0:UQCRQ|0:CYB5A|0:GLRX2|0:FDX1L|0:NOX1|0:ENOX2|0:FDX1|0:GLRX|0:NDUFB11|0:ETFB|0:TXN2|0:CYBRD1|0:STEAP1|0:CYBA|0:TXN|0:AIFM3|0:FADS2|0:CYCS|0:FRRS1|0:CYBB|0:UQCRFS1|0:CYBASC3|0:CYB561D1|0:FDXR|0:TXNRD3|0:UQCRC2|0:FA2H|0:FADS3|0:CYB561|0:NOX5|0:NDUFA11|0:CYB561D2|0:TXNL1|0:SDHC			
GO:0010829	P:negative regulation of glucose transport; ISS:BHF-UCL		0:IL1B			
GO:0019886	P:antigen processing and presentation of exog...; IDA:UniProtKB		0:CTSE			
GO:0019797	F:procollagen-proline 3-dioxygenase activity; IEA:EC		0:LEPRE1|0:LEPREL1|0:LEPREL2			
GO:0042414	P:epinephrine metabolic process; ISS:UniProtKB		0:ATP7A			
GO:0031701	F:angiotensin receptor binding; IPI:UniProtKB		0:ARRB1|0:ARRB2			
GO:0006384	P:transcription initiation from RNA polymeras...; TAS:ProtInc		0:SNAPC5|0:GTF3C4|0:BRF1			
GO:0021551	P:central nervous system morphogenesis; ISS:BHF-UCL		0:WNT1			
GO:0004513	F:neolactotetraosylceramide alpha-2,3-sialylt...; TAS:ProtInc		0:ST3GAL5			
GO:0043154	P:negative regulation of caspase activity; IMP:UniProtKB		0:SFN|0:BIRC5|0:HBXIP|0:DNAJA3|0:THBS1|0:DHCR24|0:DNAJB6|0:HSPA5|0:CDKN2D|0:GPX1|0:SMAD6|0:IFI6|0:SNCA|0:IGBP1			
GO:0004014	F:adenosylmethionine decarboxylase activity; TAS:UniProtKB		0:AMD1			
GO:0043248	P:proteasome assembly; IDA:UniProtKB		0:PSMG2|0:PSMG1|0:ADRM1			
GO:0005594	C:collagen type IX; TAS:UniProtKB		0:COL9A3|0:COL9A2|0:COL9A1			
GO:0005903	C:brush border; TAS:UniProtKB		0:SOAT2|0:PDZD3|0:MYO1A|0:ITPR3|0:ESPN|0:TMPRSS15|0:SI|0:CLIC1			
GO:0030016	C:myofibril; ISS:BHF-UCL		0:MYH3|0:MYH13|0:MYH8|0:CALD1|0:MYH15|0:MYH1|0:MYBPC1			
GO:0070141	P:response to UV-A; IDA:BHF-UCL		0:EGFR|0:AKT1|0:CCND1			
GO:0050544	F:arachidonic acid binding; ISS:HGNC		0:ALOX5AP|0:PPARG|0:STX3			
GO:0045454	P:cell redox homeostasis; TAS:UniProtKB		0:GPX1|0:DDIT3|0:EGLN2|0:GCLC|0:TXNRD1|0:AIFM1|0:PDIA5|0:GLRX3|0:TMX1|0:TXNDC3|0:TXNDC12|0:GLRX5|0:C17orf37|0:TMX4|0:TXNDC8|0:QSOX2|0:PRDX1|0:PDIA4|0:DNAJC16|0:TUSC3|0:GLRX|0:SCO2|0:SH3BGRL3|0:SEPW1|0:TXN2|0:TXNDC15|0:PRDX5|0:TXNDC5|0:TXNDC11|0:DLD|0:P4HB|0:GSR|0:TMX3|0:NXNL1|0:PTGES2|0:AIFM3|0:PRDX3|0:PRDX2|0:PDIA3|0:PRDX6|0:PDILT|0:TXNDC16|0:CLIC2|0:TXNDC6|0:DNAJC10|0:PRDX4|0:GRXCR1|0:PDIA6|0:TXNDC9|0:TMX2|0:PDIA2|0:NXN|0:NHLRC2|0:TXNRD2|0:TXNL1|0:QSOX1|0:C11orf31|0:TXNRD3|0:TXNDC2|0:GLRX2|0:ERP44			
GO:0030890	P:positive regulation of B cell proliferation; ISS:UniProtKB		0:MIF|0:IL2|0:CD74|0:PTPRC|0:TCF3|0:IRS2|0:TNFRSF4|0:IL7|0:CHRNB2|0:IL4			
GO:0060334	P:regulation of interferon-gamma-mediated sig...; IMP:MGI		0:CDC37|0:HSP90AB1			
GO:0046877	P:regulation of saliva secretion; IMP:UniProtKB		0:FGF10			
GO:0031436	C:BRCA1-BARD1 complex; IDA:UniProtKB		0:BRCA1|0:BARD1			
GO:0016125	P:sterol metabolic process; IEA:InterPro		0:EBPL			
GO:0030879	P:mammary gland development; TAS:UniProtKB		0:NOTCH4|0:TGFB3|0:NRG1|0:TDGF1			
GO:0043564	C:Ku70:Ku80 complex; IDA:UniProtKB		0:XRCC6|0:XRCC5			
GO:0034590	F:L-hydroxyproline transmembrane transporter ...; IDA:UniProtKB		0:SLC1A4			
GO:0033882	F:choloyl-CoA hydrolase activity; IEA:EC		0:ACOT8			
GO:0005856	C:cytoskeleton; TAS:UniProtKB		0:ALDOC|0:LRPPRC|0:SNTG1|0:CNN1|0:SLC30A9|0:STOM|0:LDB3|0:DGKQ|0:ELMO2|0:FARP2|0:ELMOD3|0:FRMD7|0:ARHGAP39|0:LMOD2|0:MYLIP|0:ELMO1|0:FRMD6|0:JAK1|0:EPB41L5|0:FRMPD4|0:ELMO3|0:FRMD3|0:KRIT1|0:JAK3|0:JAK2|0:PLEKHH1|0:FRMPD2|0:ELMOD1|0:FRMPD3|0:PLEKHH2|0:FRMPD1|0:ELMOD2|0:FRMD8|0:FRMD1|0:FRMD5|0:TYK2|0:PLEKHH3|0:INPP5E|0:TTC21B|0:RSPH4A|0:RSPH9|0:CYS1|0:NPHP1|0:CALCOCO2|0:ARHGAP26|0:PDLIM1|0:ABL1|0:LRRC26|0:SORBS3|0:ACTBL2|0:GPHN|0:EPB41L4A|0:TMSL3|0:FBLIM1|0:RAPH1|0:ACTL9|0:ACTRT1|0:WASF4|0:DIAPH1|0:NOS3|0:CDC42SE2|0:ANK3|0:KITLG|0:RND1|0:KIAA1949|0:CSRP3|0:CCDC6|0:DCLK2|0:RAPSN|0:DAG1|0:TRIP11|0:AKAP12|0:FGD3|0:SNTB1|0:EVL|0:MAST2|0:TMOD4|0:DOCK2|0:EPB41L1|0:CORO1B|0:TWF2|0:TRIM9|0:KY|0:FUZ|0:TMSB15A|0:SGCA|0:ABI1|0:SSH1|0:MICAL3|0:ACTG2|0:TMSB4X|0:PARD3|0:ACTR8|0:GAS2L1|0:PARVB|0:GDPD2|0:UBR4|0:PNP|0:DBNL|0:ADD3|0:CDC42SE1|0:ANK2|0:CDC42EP2|0:TNS1|0:WASF3|0:AIF1|0:ADCY10|0:ACTL8|0:TNS4|0:KLHL3|0:FGD6|0:TMSB4XP1|0:TRAF3IP1|0:FNBP1L|0:DRP2|0:FHOD3|0:FGD2|0:MPRIP|0:ANKRA2|0:SSH2|0:BIN3|0:RAI14|0:SGCB|0:RHOA|0:ACTR6|0:LMOD1|0:MAP6D1|0:SGCG|0:RIN1|0:SYMPK|0:PTPN3|0:FRMD4B|0:TMSB10|0:NOSTRIN|0:RDX|0:SNTA1|0:EPB41L3|0:SYNPO2L|0:AFAP1|0:CFL2|0:SYNE1|0:GAS2L2|0:CABYR|0:ARPC5L|0:ERMN|0:SSH3|0:ARHGAP24|0:ENAH|0:DNAJC7|0:FAAH|0:KLHL4|0:TMSB4XP2|0:S100A8|0:IVNS1ABP|0:SEPT4|0:FAM65B|0:DNMBP|0:TRAF4|0:PLEC|0:FGD5|0:PTPN13|0:BSN|0:SPIRE2|0:PPP1R9A|0:SNTG2|0:POTEKP|0:FRMD4A|0:KLHL1|0:TNKS1BP1|0:UBXN11|0:TGFB1I1|0:TRADD|0:FNBP1|0:SCIN|0:FLNC|0:TMSL6|0:ARAP3|0:DCTN6|0:JMY|0:FGD1|0:CLNS1A|0:TRIB2|0:TXNDC6|0:MICALL1|0:TAOK2|0:TMOD2|0:PTPN4|0:TRIP10|0:CDC42EP5|0:KBTBD10|0:BICD2|0:KLHL5|0:CASS4|0:ABL2|0:PARVA|0:FGD4|0:C3orf10|0:UACA|0:TRIM67|0:FHOD1|0:PPP2R2B|0:ENC1|0:SGCE|0:S100A9|0:ARHGAP21|0:LMOD3|0:ABI2|0:SGCZ|0:PTPN14|0:ERC2|0:TRIP6|0:VIL1|0:ACTR3B|0:TBCEL|0:PPP1R9B|0:SGCD|0:SHROOM4|0:TRIM36|0:SYNE2|0:WDR1|0:SH3KBP1|0:MAST1|0:TMSB4Y|0:COTL1|0:PLEK2|0:WIPF2|0:SPIRE1|0:MICAL2|0:NEXN|0:DCTN5|0:APBB1IP|0:NOS1|0:EPPK1|0:SDCBP|0:TCHH|0:PCLO|0:BICD1|0:MACF1|0:RHOF|0:CCT3|0:DMD|0:HINT1|0:PTPN21|0:PPL|0:FARP1|0:EPB41L4B|0:MCF2|0:RAE1|0:ACTL7A|0:MPZL2|0:BASP1|0:EDA|0:EPB42|0:LRRFIP1|0:DDX20|0:HIP1|0:NF2|0:STOML2|0:CDC42BPB|0:CTTN|0:UTRN|0:PTK2|0:FSCN3|0:CASP8|0:AKAP4|0:ARHGDIB|0:MSN|0:ACTG1|0:PARVG|0:ACTB|0:ARHGDIA			
GO:0015020	F:glucuronosyltransferase activity; IEA:EC		0:UGT1A8|0:UGT2B15|0:UGT2B4|0:UGT1A10|0:UGT1A9|0:UGT1A1|0:UGT2B7|0:UGT1A7|0:UGT1A3|0:UGT2A3|0:UGT2A2|0:CSGALNACT1|0:UGT2A1|0:UGT1A4|0:UGT3A2|0:UGT2B10|0:UGT2B11|0:UGT1A5|0:UGT2B28|0:UGT1A6|0:UGT2B17|0:UGT3A1			
GO:0000375	P:RNA splicing, via transesterification react...; TAS:UniProtKB		0:MPHOSPH10|0:SRSF4|0:SMNDC1|0:LSM1|0:KHSRP|0:BCAS2|0:SF3B3|0:SRRM1|0:SNRNP40			
GO:0004043	F:L-aminoadipate-semialdehyde dehydrogenase a...; IEA:EC		0:ALDH7A1			
GO:0044154	P:histone H3-K14 acetylation; IDA:UniProtKB		0:MEAF6			
GO:0046296	P:glycolate catabolic process; IDA:UniProtKB		0:HAO1			
GO:0035308	P:negative regulation of protein amino acid d...; IDA:HGNC		0:YWHAB|0:PPP2R4			
GO:0006865	P:amino acid transport; IEA:UniProtKB-KW		0:SLC6A18|0:SLC38A11|0:SLC38A9|0:SLC36A4|0:SLC38A10|0:SLC38A6|0:SLC38A7|0:XK|0:SLC38A8			
GO:0016944	F:RNA polymerase II transcription elongation ...; IEA:InterPro		0:ELP2|0:ELL3|0:ELL2|0:ELL			
GO:0008374	F:O-acyltransferase activity; EXP:Reactome		0:PIGW			
GO:0006744	P:ubiquinone biosynthetic process; IGI:UniProtKB		0:PDSS2|0:PDSS1|0:COQ2|0:COQ9|0:COQ5|0:COQ4|0:COQ7|0:COQ6|0:COQ3			
GO:0051642	P:centrosome localization; TAS:HGNC		0:NIN			
GO:0006797	P:polyphosphate metabolic process; TAS:ProtInc		0:MINPP1			
GO:0042447	P:hormone catabolic process; IDA:BHF-UCL		0:ACE			
GO:0031508	P:centromeric heterochromatin formation; ISS:UniProtKB		0:CENPV|0:HELLS			
GO:0004662	F:CAAX-protein geranylgeranyltransferase acti...; TAS:ProtInc		0:FNTA|0:PGGT1B			
GO:0030914	C:STAGA complex; IDA:UniProtKB		0:KAT2A|0:SAP130|0:TADA3|0:TAF6L|0:TAF9|0:SUPT3H|0:TAF12|0:TAF5L|0:TRRAP|0:SUPT7L|0:TAF10|0:TADA1			
GO:0004824	F:lysine-tRNA ligase activity; IDA:UniProtKB		0:KARS			
GO:0043596	C:nuclear replication fork; IDA:UniProtKB		0:PCNA|0:ZMIZ2			
GO:0072303	P:positive regulation of glomerular metanephr...; ISS:UniProtKB		0:EGR1			
GO:0034383	P:low-density lipoprotein particle clearance; TAS:BHF-UCL		0:ADIPOQ|0:LDLR|0:CD36|0:APOB|0:EHD1|0:HMOX1			
GO:0008218	P:bioluminescence; IEA:InterPro		0:HMCN1|0:NID2|0:HMCN2|0:NID1			
GO:0000254	F:C-4 methylsterol oxidase activity; EXP:Reactome		0:SC4MOL			
GO:0004164	F:diphthine synthase activity; NAS:UniProtKB		0:DPH5			
GO:0051438	P:regulation of ubiquitin-protein ligase acti...; ISS:UniProtKB		0:FEM1B|0:ZER1|0:FEM1A			
GO:0005047	F:signal recognition particle binding; TAS:ProtInc		0:SRP68|0:SRP72|0:SRP9|0:SRPR			
GO:0048070	P:regulation of developmental pigmentation; ISS:UniProtKB		0:VPS33A			
GO:0019915	P:lipid storage; ISS:BHF-UCL		0:ANGPTL3|0:CD36|0:CIDEA|0:CAV1			
GO:0051059	F:NF-kappaB binding; NAS:UniProtKB		0:COMMD7|0:BCL10|0:NPM1|0:TAF4B|0:FAF1|0:DNAJA3|0:RPS3|0:GSK3B|0:NFKBIA|0:RELA|0:MTDH|0:TP53BP2|0:RNF25|0:FOXP3			
GO:0008184	F:glycogen phosphorylase activity; TAS:ProtInc		0:PYGL|0:PYGB|0:PYGM			
GO:0043550	P:regulation of lipid kinase activity; IDA:UniProtKB		0:RBL2|0:RBL1|0:RB1			
GO:0015347	F:sodium-independent organic anion transmembr...; TAS:ProtInc		0:SLCO2B1|0:SLC22A11|0:SLCO1B1|0:SLC22A7			
GO:0010820	P:positive regulation of T cell chemotaxis; IMP:UniProtKB		0:S100A7|0:ADAM17|0:ADAM10|0:WNT5A			
GO:0046477	P:glycosylceramide catabolic process; ISS:UniProtKB		0:GBA3|0:GLA			
GO:0035417	P:negative regulation of mitotic prometaphase; IMP:UniProtKB		0:UBD			
GO:0032273	P:positive regulation of protein polymerization; IDA:HGNC		0:TPPP			
GO:0004719	F:protein-L-isoaspartate (D-aspartate) O-meth...; TAS:UniProtKB		0:PCMTD1|0:PCMTD2|0:PCMT1			
GO:0043491	P:protein kinase B signaling cascade; ISS:UniProtKB		0:TSC2			
GO:0031954	P:positive regulation of protein amino acid a...; ISS:BHF-UCL		0:RAD50|0:NBN|0:MRE11A|0:INS			
GO:0009051	P:pentose-phosphate shunt, oxidative branch; IMP:BHF-UCL		0:PGD|0:G6PD			
GO:0042130	P:negative regulation of T cell proliferation; TAS:UniProtKB		0:GLMN|0:IL10|0:SFTPD			
GO:0030393	P:fructoselysine metabolic process; NAS:UniProtKB		0:FN3K			
GO:0071568	F:UFM1 conjugating enzyme activity; IDA:UniProtKB		0:UFC1|0:KIAA0776			
GO:0008900	F:hydrogen:potassium-exchanging ATPase activity; TAS:ProtInc		0:ATP12A|0:ATP4A|0:ATP4B			
GO:0016409	F:palmitoyltransferase activity; ISS:UniProtKB		0:ZDHHC13			
GO:0017160	F:Ral GTPase binding; IPI:UniProtKB		0:RALBP1			
GO:0004871	F:signal transducer activity; TAS:UniProtKB		0:AXIN1|0:INHA|0:SHH|0:WNT10B|0:RGS16|0:NPAS4|0:RGS2|0:WNT2B|0:ARNT2|0:WNT3|0:NCOA3|0:RGS1|0:WNT1|0:WNT11|0:CBLC|0:HIF3A|0:CBLB|0:PER2|0:CBL|0:RGS6|0:NPAS3|0:GRK1|0:SNX25|0:WNT6|0:SH2B1|0:WNT16|0:RGS13|0:RGS22|0:PASK|0:SIM1|0:PASD1|0:RGS5|0:WNT8A|0:WNT5B|0:WNT3A|0:SNX13|0:WNT9A|0:WNT2|0:KCNH7|0:RGS17|0:GRK7|0:ARNTL|0:CLOCK|0:DVL3|0:WNT7A|0:RGS9|0:RGS10|0:DVL1L1|0:GRK5|0:RGS4|0:AHRR|0:DVL1|0:SIM2|0:PER1|0:WNT7B|0:AKAP10|0:ARHGEF11|0:AXIN2|0:DIXDC1|0:RGS8|0:RGS18|0:EPAS1|0:TRADD|0:GRK6|0:NPAS1|0:RGS20|0:ADRBK1|0:RGS11|0:GRK4|0:OMP|0:RGS3|0:STAT4|0:ARNTL2|0:STAT6|0:PER3|0:LSP1|0:HIF1A|0:WNT4|0:WNT9B|0:PTK2|0:RGSL1|0:WNT5A|0:NPAS2|0:NCOA2|0:ARNT|0:RGS19|0:RGS21|0:RGS7|0:SNX14|0:WNT10A|0:SH2B3|0:ADRBK2|0:GNA11|0:GNG10|0:GNAT3|0:GNB2|0:PLCD3|0:PLCXD3|0:GNA13|0:GNAI2|0:PLCB3|0:GNAQ|0:GNG13|0:PLCL2|0:PLCXD2|0:GNG11|0:GNB3|0:GNAI3|0:PLCD4|0:GNG2|0:PLCZ1|0:PLCB2|0:PLCH2|0:GNG12|0:GNB4|0:GNAI1|0:GNG7|0:PLCG2|0:GNAL|0:GNAS|0:GNAO1|0:PLCH1|0:GNG3|0:PLCD1|0:PLCB1|0:GNGT1|0:GNB1|0:GNAT1|0:PLCB4|0:GNG4|0:PLCL1|0:GNA15|0:MIER1|0:MALT1|0:ATP2C1|0:TSPAN6|0:C18orf32|0:ECM1|0:CXXC5|0:TFG|0:LGALS9|0:PPP5C|0:EEF1D|0:NDFIP2|0:BST2|0:MUL1|0:TMEM101|0:MIB2|0:NEK6|0:MAVS|0:HMOX1|0:SLC44A2|0:LGALS1|0:LITAF|0:TRIM13|0:PPM1A|0:SECTM1|0:CANT1|0:SLC35B2|0:CC2D1A|0:TRIM38|0:NDFIP1|0:GOLT1B|0:ZDHHC13|0:SHISA5|0:ZDHHC17|0:PLEKHG5|0:VOPP1|0:TMED4|0:RHOC|0:ECT2|0:TICAM1|0:GJA1|0:VAPA|0:TMEM9B|0:APOL3|0:FLNA|0:FKBP1A|0:WLS|0:PTK2B|0:YARS|0:GNA12|0:PPP1R12A|0:TRAF2|0:CTNNB1|0:CCL13|0:GNA14|0:RTN1|0:FST|0:GNGT2|0:GNG5|0:GNB5|0:TRIM63|0:FAM126A|0:TRIM55|0:ASZ1|0:CDK18|0:PSD|0:CD24|0:RTN2|0:GNG8|0:TOLLIP|0:COPS2|0:TRIM54|0:PLRG1|0:PLEKHB1|0:PRKCE|0:CCL15|0:INSL3|0:WNT8B|0:CREBBP|0:PDCD1|0:CHKA|0:CCL3|0:MAPKAPK2|0:IL18|0:IKBKAP|0:GULP1|0:CAPN3|0:TRAF3|0:RIPK2|0:BCAR1|0:ITGB3BP|0:CXCL12|0:SUFU|0:IKBKG|0:IRS2|0:IDE|0:PKP1|0:IL15|0:CCL2|0:TGFA|0:DKK1|0:PPFIA1|0:ERG|0:PWP2|0:STMN1|0:TNK1|0:CCL8|0:KL|0:CLTCL1|0:CCL14|0:CNOT7|0:CCL5|0:DKKL1|0:DVL2|0:GMFB|0:IL17B|0:PRMT2|0:SHC3|0:S100A9|0:BMX|0:TSPAN8|0:NFKBIB|0:AKAP13|0:RASGRP3|0:RAPGEF2|0:INHBA			
GO:0008137	F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB		0:NDUFA13|0:NDUFAF2|0:NDUFS4|0:NDUFV2|0:NDUFB3|0:NDUFA12|0:NDUFV3|0:MT-ND3|0:NDUFA3|0:NDUFA7|0:MT-ND4|0:NDUFB6|0:NDUFS6|0:NDUFB7|0:NDUFS3|0:NDUFB4|0:MT-ND4L|0:NDUFA2|0:MT-ND5|0:NDUFA6|0:NDUFB8|0:MT-ND6|0:NDUFA5|0:NDUFS2|0:NDUFB5|0:MT-ND1|0:NDUFA9|0:NDUFS1|0:MT-ND2|0:NDUFV1|0:NDUFA1|0:NDUFB1|0:NDUFS8|0:NDUFC2|0:NDUFS5|0:NDUFA10|0:NDUFB2|0:NDUFA4|0:NDUFB10|0:NDUFB9|0:NDUFAB1|0:NDUFA8|0:NDUFC1|0:NDUFS7			
GO:0042339	P:keratan sulfate metabolic process; IDA:UniProtKB		0:CHST1			
GO:0035567	P:non-canonical Wnt receptor signaling pathway; IMP:BHF-UCL		0:FZD6|0:FZD10|0:DVL3|0:DVL2|0:FZD7			
GO:0051693	P:actin filament capping; IEA:UniProtKB-KW		0:SPTBN2|0:CAPZA1|0:EPB49|0:SPTA1|0:SPTAN1|0:CAPZB|0:VILL|0:AVIL|0:RDX|0:SPTB|0:SPTBN4|0:CAPZA2|0:SCIN|0:SPTBN1|0:VIL1|0:CAPZA3|0:SPTBN5			
GO:0015175	F:neutral amino acid transmembrane transporte...; TAS:ProtInc		0:SLC43A1|0:SLC3A2|0:SLC7A9|0:SLC38A1|0:SLC7A8|0:SLC1A5|0:SLC7A5			
GO:0045200	P:establishment of neuroblast polarity; IMP:BHF-UCL		0:DOCK7			
GO:0051011	F:microtubule minus-end binding; IDA:UniProtKB		0:KIAA1543			
GO:0008518	F:reduced folate carrier activity; IEA:InterPro		0:SLC19A1|0:SLC19A2|0:C2orf83|0:SLC19A3			
GO:0002250	P:adaptive immune response; IMP:BHF-UCL		0:TNFRSF11A			
GO:0006979	P:response to oxidative stress; TAS:ProtInc		0:DGKK|0:ERCC8|0:NDUFA12|0:WRN|0:PNKP|0:NEIL1|0:NDUFB4|0:NDUFA6|0:GCLM|0:NDUFS2|0:NDUFS8|0:SRXN1|0:GCLC|0:MICB|0:PTGS2|0:GPX2|0:GPX7|0:PTGS1|0:GPX6|0:GPX5|0:GPX8|0:MARK2|0:TPM4|0:DHCR24|0:LRRK2|0:ERCC1|0:NAPRT1|0:ERCC3|0:CHRNA4|0:ERCC2|0:CYGB|0:PRNP|0:LIAS|0:IPCEF1|0:ETFDH|0:KRT1|0:MBL2|0:OXR1|0:VNN1|0:STK25|0:NUDT1|0:PDLIM1|0:GSS|0:SGK2|0:SCARA3|0:CCL5|0:ANGPTL7|0:SEPP1|0:OXSR1|0:ATOX1|0:MSRA			
GO:0000075	P:cell cycle checkpoint; TAS:ProtInc		0:SMC1A|0:DDB1|0:DCLRE1B|0:ERCC3|0:ERCC2|0:CCNE2|0:RBBP8|0:CCNG2|0:FANCG			
GO:0001508	P:regulation of action potential; TAS:UniProtKB		0:CLN3|0:CHRNA4|0:SRI|0:KCND2			
GO:0000224	F:peptide-N4-(N-acetyl-beta-glucosaminyl)aspa...; IEA:EC		0:NGLY1			
GO:0046328	P:regulation of JNK cascade; ISS:UniProtKB		0:MAPK8IP2|0:MAPK8IP3			
GO:0008109	F:N-acetyllactosaminide beta-1,6-N-acetylgluc...; TAS:ProtInc		0:GCNT2|0:GCNT3|0:GCNT4			
GO:0044314	P:protein K27-linked ubiquitination; IDA:UniProtKB		0:UBE2S|0:UBE2T|0:UBE2D4|0:RNF6			
GO:0010468	P:regulation of gene expression; IMP:BHF-UCL		0:CDK6|0:PTHLH|0:SORT1			
GO:0046886	P:positive regulation of hormone biosynthetic...; IDA:BHF-UCL		0:HIF1A|0:ARNT			
GO:0034435	P:cholesterol esterification; IDA:BHF-UCL		0:SOAT2|0:SOAT1|0:LCAT			
GO:0030216	P:keratinocyte differentiation; TAS:UniProtKB		0:DSP|0:TXNIP|0:CSTA|0:ANXA1|0:SCEL|0:ADAM9|0:WNT16|0:CLIC4|0:S100A7|0:CDSN|0:JAG1|0:FLG|0:EREG			
GO:0004632	F:phosphopantothenate--cysteine ligase activity; IEA:EC		0:PPCS			
GO:0004427	F:inorganic diphosphatase activity; TAS:ProtInc		0:PPA2|0:PRUNE|0:LHPP|0:PPA1			
GO:0032695	P:negative regulation of interleukin-12 produ...; IMP:UniProtKB		0:THBS1|0:IRAK3|0:TIGIT			
GO:0007632	P:visual behavior; NAS:UniProtKB		0:DYNLRB1|0:NPHP4|0:NPHP1			
GO:0061084	P:negative regulation of protein refolding; ISS:BHF-UCL		0:BAG5			
GO:0008890	F:glycine C-acetyltransferase activity; NAS:UniProtKB		0:GCAT			
GO:0047787	F:delta4-3-oxosteroid 5beta-reductase activity; IEA:EC		0:AKR1D1			
GO:0002446	P:neutrophil mediated immunity; ISS:UniProtKB		0:IL6R|0:IL6|0:ADAM17|0:PLA2G1B|0:MLL5			
GO:0042373	P:vitamin K metabolic process; IDA:UniProtKB		0:CBR1			
GO:0006119	P:oxidative phosphorylation; TAS:ProtInc		0:UQCRC2			
GO:0005681	C:spliceosomal complex; TAS:UniProtKB		0:BAT1|0:SLU7|0:U2AF2|0:HNRNPA1|0:SF3A2|0:HNRNPM|0:SF3A3|0:SNRPA|0:SF1|0:U2AF1|0:HNRNPC|0:HNRNPA2B1|0:SF3B4|0:SF3B2|0:BCAS2|0:CRNKL1|0:CWC22|0:WDR83|0:TFIP11|0:SNRNP70|0:SNW1|0:SNRPF|0:TXNL4B|0:CWC15|0:XAB2|0:PPIL1|0:PLRG1|0:HNRNPH1|0:RBM16|0:SKIV2L2|0:AQR|0:AKAP17A|0:RBM22|0:CDC5L|0:HNRNPR|0:GEMIN4|0:FRG1|0:SART1|0:RBM28|0:GEMIN8|0:PRPF19|0:C19orf29|0:STRAP|0:PRPF38B|0:DDX41|0:DDX5|0:SF3B5|0:SYF2|0:DGCR14|0:MAGOH|0:GEMIN5|0:HNRNPF|0:SREK1|0:PPIE|0:DHX35|0:NHP2L1|0:HNRPA1L3|0:SYNCRIP|0:SMN2|0:SUGP1|0:SRSF1|0:PPWD1|0:WBP4|0:EIF4A3|0:HNRNPK|0:GEMIN6|0:DHX38|0:DDX20|0:TTF2|0:PPP1R8|0:RBMX|0:RBM8A|0:PABPC1|0:PPIL3|0:LSM2|0:SRRM2|0:U2AF1L4|0:ZCCHC8|0:SMN1|0:HNRNPA3|0:RBM17|0:HNRNPU|0:RALY|0:PRPF4B|0:ISY1|0:PNN|0:LSM3|0:SRRM1|0:THOC4|0:HNRNPA1L2|0:SNRPD1|0:GEMIN7|0:PRPF38A|0:API5|0:PRPF3|0:SF3B1|0:SNRPE|0:EFTUD2|0:SMNDC1|0:SNRPD3|0:CDC40|0:PRPF18|0:IVNS1ABP|0:DHX8|0:SF3B3|0:SNRPB|0:SIP1|0:SNRPD2|0:SNRPN|0:TXNL4A|0:RBM5|0:SNRPG			
GO:0046005	P:positive regulation of circadian sleep/wake...; NAS:BHF-UCL		0:GHRH			
GO:0035379	F:carbon dioxide transmembrane transporter ac...; IDA:UniProtKB		0:AQP1			
GO:0045343	P:regulation of MHC class I biosynthetic process; NAS:UniProtKB		0:IFNB1			
GO:0045738	P:negative regulation of DNA repair; IMP:UniProtKB		0:RPS3			
GO:0043254	P:regulation of protein complex assembly; IEA:InterPro		0:PINK1|0:HCFC1|0:MDN1			
GO:0016339	P:calcium-dependent cell-cell adhesion; NAS:UniProtKB		0:CDH13|0:ATP2C1|0:NLGN1|0:PCDHB10|0:PCDHB16|0:PCDHB6|0:PCDHB9|0:PCDHB11|0:PCDHB5|0:PCDHB14|0:PCDHGC3|0:DCHS1|0:PCDHB2|0:PCDHB4|0:CDH23|0:CDHR5|0:PCDHGB4|0:PCDHB7|0:PCDHB13|0:DSG1|0:PCDHB3			
GO:0030345	F:structural constituent of tooth enamel; NAS:UniProtKB		0:AMELY|0:AMELX|0:AMBN|0:TUFT1|0:ENAM|0:STATH			
GO:0000729	P:DNA double-strand break processing; IMP:HGNC		0:UBE2N|0:UBE2V2			
GO:0045616	P:regulation of keratinocyte differentiation; TAS:BHF-UCL		0:ERRFI1|0:AQP3			
GO:0007290	P:spermatid nucleus elongation; ISS:UniProtKB		0:TNP1|0:H1FNT			
GO:0046923	F:ER retention sequence binding; NAS:UniProtKB		0:KDELR3|0:KCNIP2			
GO:0021781	P:glial cell fate commitment; NAS:UniProtKB		0:SOX2			
GO:0006054	P:N-acetylneuraminate metabolic process; TAS:ProtInc		0:GNE			
GO:0042796	P:snRNA transcription from RNA polymerase III...; IDA:UniProtKB		0:SNAPC4			
GO:0008376	F:acetylgalactosaminyltransferase activity; IDA:UniProtKB		0:B4GALNT2			
GO:0005586	C:collagen type III; IMP:UniProtKB		0:COL3A1			
GO:0000036	F:acyl carrier activity; NAS:UniProtKB		0:ALDH1L1|0:AASDH|0:ALDH1L2|0:FASN|0:NDUFAB1			
GO:0090231	P:regulation of spindle checkpoint; IMP:UniProtKB		0:USP44			
GO:0031707	F:endothelin A receptor binding; IDA:BHF-UCL		0:EDN1			
GO:0032789	P:unsaturated monocarboxylic acid metabolic p...; IDA:HGNC		0:ACOT4			
GO:0031441	P:negative regulation of mRNA 3'-end processing; NAS:UniProtKB		0:BARD1			
GO:0030643	P:cellular phosphate ion homeostasis; IMP:UniProtKB		0:ENPP1|0:SLC34A2|0:SLC34A3|0:GCM2			
GO:0060298	P:positive regulation of sarcomere organization; ISS:BHF-UCL		0:EDN1|0:PROX1			
GO:0048029	F:monosaccharide binding; ISS:UniProtKB		0:UPK1A			
GO:0003692	F:left-handed Z-DNA binding; NAS:UniProtKB		0:ZBP1			
GO:0005862	C:muscle thin filament tropomyosin; TAS:UniProtKB		0:TPM4|0:TPM2|0:TPM1|0:TPM3			
GO:0033613	F:transcription activator binding; ISS:BHF-UCL		0:PPARG|0:CIITA|0:TAF9|0:HDAC4|0:RELA|0:DGKQ|0:GATA4|0:HAND2			
GO:0010727	P:negative regulation of hydrogen peroxide me...; IC:BHF-UCL		0:HDAC6			
GO:0000159	C:protein phosphatase type 2A complex; TAS:UniProtKB		0:PPP2R2A|0:PPP2R5C|0:PPP2R1A|0:PPP2CA|0:PPP2R5A|0:PPP2R3A|0:PPP2R5D|0:PPP2R5E|0:PPP2R2D|0:PPP2R2B|0:PPP2R5B|0:PPP2R3B|0:PPP2R2C|0:PPP2R4|0:CYCS|0:PPP2CB			
GO:0030684	C:preribosome; IDA:UniProtKB		0:PIN4			
GO:0004364	F:glutathione transferase activity; TAS:ProtInc		0:GSTA4|0:GSTT1|0:MGST2|0:GSTP1|0:GSTA5|0:GSTO2|0:GSTT2|0:HPGDS|0:GSTK1|0:GSTO1|0:GSTA1|0:GSTM5|0:MGST1|0:GSTM1|0:GSTM3|0:GSTM2|0:MGST3|0:GSTA3|0:GSTA2|0:GSTM4|0:GSTZ1			
GO:0046870	F:cadmium ion binding; NAS:UniProtKB		0:NOS1|0:NOS3|0:MT1A|0:MT1L|0:MT1F|0:MT1E|0:MT1B			
GO:0042634	P:regulation of hair cycle; IMP:BHF-UCL		0:NIPBL			
GO:0006241	P:CTP biosynthetic process; IEA:InterPro		0:CTPS|0:NME5|0:TXNDC3|0:NME4|0:NME1|0:RP2|0:NME2|0:NME6|0:TXNDC6|0:NME7|0:NME2P1|0:NME3			
GO:0055014	P:atrial cardiac muscle cell development; ISS:BHF-UCL		0:NKX2-6|0:NKX2-5			
GO:0045600	P:positive regulation of fat cell differentia...; NAS:UniProtKB		0:SFRP1|0:AKT1|0:PPARG|0:ADIG|0:PPARD			
GO:0021511	P:spinal cord patterning; ISS:UniProtKB		0:RELN			
GO:0008444	F:CDP-diacylglycerol-glycerol-3-phosphate 3-p...; IEA:EC		0:PGS1			
GO:0070577	F:histone acetyl-lysine binding; ISS:UniProtKB		0:SMARCA4|0:TAF1|0:MLL|0:BAZ1B|0:BAZ2A			
GO:0005220	F:inositol 1,4,5-trisphosphate-sensitive calc...; IEA:InterPro		0:ITPR3|0:ITPR1|0:ITPR2			
GO:0043169	F:cation binding; IEA:InterPro		0:AGL|0:SLC3A2|0:GLB1L3|0:FUCA2|0:GLA|0:KLB|0:GUSB|0:CHID1|0:LCT|0:LCTL|0:IDUA|0:SLC3A1|0:CHI3L1|0:GLB1|0:GALC|0:HEXDC|0:CHIA|0:GBE1|0:OVGP1|0:HEXB|0:KL|0:CHIT1|0:CHI3L2|0:NAGA|0:CTBS|0:HEXA|0:GLB1L|0:GLB1L2|0:GBA3|0:MANBA|0:GBA			
GO:0031748	F:D1 dopamine receptor binding; IPI:BHF-UCL		0:CAV2			
GO:0050918	P:positive chemotaxis; ISS:UniProtKB		0:CORO1A|0:ANGPT1|0:SCRIB|0:TSC2			
GO:0051403	P:stress-activated MAPK cascade; TAS:UniProtKB		0:MAP2K7|0:CCM2			
GO:0010875	P:positive regulation of cholesterol efflux; ISS:BHF-UCL		0:APOE|0:NR1H3|0:PON1|0:ADIPOQ|0:NFKBIA|0:NR1H2|0:LRP1			
GO:0008781	F:N-acylneuraminate cytidylyltransferase acti...; NAS:UniProtKB		0:CMAS|0:NANS			
GO:0007041	P:lysosomal transport; TAS:ProtInc		0:PCSK9|0:USE1|0:NPC1|0:ARSB			
GO:0005310	F:dicarboxylic acid transmembrane transporter...; EXP:Reactome		0:SLC25A10			
GO:0032755	P:positive regulation of interleukin-6 produc...; TAS:BHF-UCL		0:TLR3|0:TLR4|0:TLR9|0:LBP|0:HSPD1|0:IL6R|0:IL6|0:TLR2|0:MYD88|0:IL1B			
GO:0004843	F:ubiquitin-specific protease activity; TAS:UniProtKB		0:USP15|0:USP7|0:USP4|0:USP46|0:CYLD|0:OTUB2|0:USP16|0:USP6|0:USP17L2|0:USP11|0:OTUB1|0:USP28|0:USP21|0:UCHL5|0:USP44|0:USP12|0:TNFAIP3|0:MYSM1|0:USP8|0:YOD1|0:USP10|0:USP22|0:USP1|0:BAP1|0:BRCC3|0:VCPIP1|0:USP9Y|0:UFD1L|0:USP3|0:USP25|0:USP14|0:USP18|0:USP13|0:USP33			
GO:0003944	F:N-acetylglucosamine-1-phosphodiester alpha-...; TAS:ProtInc		0:NAGPA			
GO:0016262	F:protein N-acetylglucosaminyltransferase act...; IDA:HGNC		0:B3GNT8			
GO:0048745	P:smooth muscle tissue development; ISS:UniProtKB		0:ENG|0:NF1|0:BMP4			
GO:0032388	P:positive regulation of intracellular transport; ISS:BHF-UCL		0:CAPN10			
GO:0031225	C:anchored to membrane; IEA:UniProtKB-KW		0:GML|0:CNTN2|0:BST1|0:PRND|0:CD177|0:FOLR2|0:HFE2|0:LYPD2|0:GFRA4|0:CD55|0:CEACAM8|0:SPRN|0:CD58|0:CPM|0:ACHE|0:SPACA4|0:PRSS21|0:CNTFR|0:ALPP|0:CNTN5|0:ART4|0:PSCA|0:LY6G6C|0:LY6K|0:NCAM1|0:ART1|0:NT5E|0:ULBP1|0:CNTN1|0:ITLN1|0:FOLR1|0:PRNP|0:GFRA3|0:BST2|0:ULBP2|0:DPEP2|0:MMP25|0:LYPD4|0:EFNA2|0:NTM|0:LSAMP|0:CD14|0:GPC4|0:FCGR3B|0:XPNPEP2|0:CDH13|0:MDGA2|0:SPAM1|0:ALPPL2|0:CD52|0:MMP17|0:CEACAM7|0:RGMA|0:OTOA|0:NEGR1|0:MFI2|0:NRN1L|0:RAET1L|0:LPL|0:CNTN4|0:DPEP3|0:LY6H|0:LYNX1|0:MSLN|0:TECTA|0:CEACAM6|0:GPC5|0:TNFRSF10C|0:GP2|0:GFRA2|0:LYPD6B|0:OPCML|0:DPEP1|0:PLAUR|0:BCAN|0:CD24|0:VNN1|0:LYPD5|0:ALPI|0:LY6E|0:CD109|0:VNN3|0:NRN1|0:TECTB|0:CEACAM5|0:LY6D|0:OMG|0:SEMA7A|0:LYPD1|0:CNTN3|0:TDGF1|0:EFNA3|0:GPC6|0:CNTN6|0:GPC1|0:ULBP3|0:HYAL2|0:CA4|0:UMOD|0:GFRA1|0:VNN2|0:RTN4R|0:EFNA4|0:CFC1|0:LY6G6D|0:RECK|0:GPC2|0:ART3|0:TEX101			
GO:0005436	F:sodium:phosphate symporter activity; TAS:ProtInc		0:SLC34A2|0:SLC34A3|0:SLC17A3|0:SLC17A4|0:SLC20A2|0:SLC17A2			
GO:0043497	P:regulation of protein heterodimerization ac...; IPI:HGNC		0:NRG1|0:BAK1|0:BCL2|0:BAX			
GO:0045335	C:phagocytic vesicle; IEA:UniProtKB-SubCell		0:STX12|0:ABCA1|0:ANXA11|0:RAB7A			
GO:0008305	C:integrin complex; TAS:UniProtKB		0:ITGB3|0:ITGA7|0:ITGA4|0:ITGBL1|0:ITGB5|0:ITGA2B|0:ITGB2|0:ITGAL|0:ITGAV|0:ITGB7|0:ITGAM|0:ITGB8|0:ITGA3|0:ITGAE|0:ITGB6|0:ITGA11|0:ITGA2|0:ITGA10|0:ITGAX|0:ITGA9|0:ITGA5|0:ITGB4|0:ITGAD|0:ITGA8|0:ITGA1			
GO:0050699	F:WW domain binding; ISS:HGNC		0:SCNN1G|0:NFE2|0:CDC25C|0:SCNN1A|0:NDFIP2|0:SCNN1B|0:WBP1|0:DAZAP2|0:WBP11|0:LITAF|0:KIF20B|0:PMEPA1|0:ENAH|0:TRAF4|0:SHISA5|0:FAM189B|0:WBP2NL			
GO:0006357	P:regulation of transcription from RNA polyme...; TAS:UniProtKB		0:CEBPG|0:BRD7|0:GSC2|0:MED7|0:SNF8|0:ZNF367|0:MED27|0:ARNTL2|0:BRIP1|0:MED26|0:ELP3|0:IKBKAP|0:CTDSP1|0:ELF2|0:ABCA2|0:SP4|0:ELP4|0:SUB1|0:TAF1L|0:MED15|0:MED10|0:TCEANC|0:MED19|0:TCEA3|0:SUPT6H|0:MED22|0:MED18|0:TCEA2|0:MED12L|0:MED11|0:C19orf2|0:SMARCAL1|0:SOD2|0:JMY|0:KLF17|0:TRAK1|0:TBX1|0:MED16|0:SMARCD2|0:ELP2|0:TBX10|0:CHD1|0:CIAO1|0:GATA1|0:SMARCC2|0:SMARCD1|0:KAT2A|0:FOSL2|0:HNF4G|0:DBP|0:NEUROD2|0:TCEB1|0:RBBP8|0:MYCN|0:HTATSF1|0:NFE2|0:SOX21|0:CITED1|0:TADA3|0:SOX12|0:HOXC5|0:TAF6L|0:TEF|0:CRK|0:UBP1|0:TIAL1|0:TCF19|0:SNW1|0:CHD2|0:TARBP2|0:TCF12|0:HIRA|0:SMARCA5|0:SUPT3H|0:RUVBL1|0:TFDP1|0:TFAP2C|0:SMARCE1|0:MNX1|0:IKZF3|0:TARBP1|0:SRCAP|0:SP2|0:ZNF143|0:SPIB|0:TEAD3|0:LITAF|0:ZNF76|0:PRKAR1A|0:SAP18|0:CREG1|0:STAT2|0:HOXC6|0:SMARCD3|0:BUD31|0:NFYC|0:JUND|0:SOX15|0:LRRFIP1|0:UBN1|0:HCFC2|0:BLZF1|0:TFCP2|0:DEK|0:CHD3|0:TCEB3|0:ID4|0:HTATIP2|0:FOXN1|0:TCF15|0:KLF9|0:SREBF1|0:MED20|0:ATF5|0:FOXK2|0:NRF1|0:KLF7|0:CHD4|0:ERF|0:NEUROG1|0:TCF7|0:UHRF1|0:BRD8|0:MYF6|0:TFAP2A|0:MED23|0:VEZF1|0:TBX3|0:SOX30|0:RNF14			
GO:0034364	C:high-density lipoprotein particle; IEA:UniProtKB-KW		0:APOA4|0:APOC1|0:APOC4|0:APOE|0:CETP|0:APOL1|0:APOH|0:APOA5|0:LCAT|0:SAA4|0:APOF|0:GPIHBP1|0:APOO|0:LIPC|0:SAA1|0:SAA2|0:HDLBP			
GO:0009880	P:embryonic pattern specification; ISS:UniProtKB		0:SMAD5|0:SMAD1			
GO:0004091	F:carboxylesterase activity; TAS:ProtInc		0:AADACL4|0:ABHD15|0:NCEH1|0:AADACL2|0:ACOT2|0:ACOT9|0:ACOT6|0:ABHD1|0:ACOT12|0:CES5A|0:ABHD2|0:ACOT7|0:CES3|0:ACOT11|0:ABHD3|0:BAAT|0:ACOT4|0:CES4A|0:ACOT8|0:ACOT1|0:ESD|0:CES1P1|0:CES2|0:CES1			
GO:0004373	F:glycogen (starch) synthase activity; IEA:EC		0:GYS2|0:GYS1			
GO:0018478	F:malonate-semialdehyde dehydrogenase (acetyl...; ISS:UniProtKB		0:ALDH6A1			
GO:0016509	F:long-chain-3-hydroxyacyl-CoA dehydrogenase ...; IEA:EC		0:HADHA			
GO:0004991	F:parathyroid hormone receptor activity; TAS:ProtInc		0:PTH1R|0:PTH2R			
GO:0030197	F:extracellular matrix constituent, lubricant...; NAS:UniProtKB		0:MUC4|0:MUC17|0:MUC3A|0:STATH			
GO:0015629	C:actin cytoskeleton; TAS:UniProtKB		0:FLNA|0:CDH1|0:ALDOA|0:ADAM17|0:HNRNPH1|0:SEPT2|0:PSMD10|0:TMOD3|0:STAG2|0:NFE2|0:NXF2|0:PDLIM2|0:NXF2B|0:NXF5|0:INTS6|0:TAF5|0:CROCC|0:CDC42EP4|0:H1F0|0:ZNF174|0:FHL2|0:HNRNPH2|0:APBB3|0:ACTN1|0:ZNF74|0:CDC42EP1|0:RPA1|0:PDLIM5|0:CDC42EP3|0:AIF1L|0:CTTNBP2NL|0:ABLIM2|0:SRCIN1|0:SNCA|0:MTSS1|0:CLIC5|0:DAPK1|0:CTNNAL1|0:PFN1|0:CTNNA2|0:PFN4|0:CTNNA1|0:PFN3|0:FMN1|0:CTNNA3|0:PKD2|0:USH1G|0:ABRA|0:TWF1|0:STK38L|0:SYNPO|0:TRIOBP|0:HAX1|0:TLN2|0:CORO2B|0:PFN2|0:SLC9A3R1|0:AMPH|0:KLHL20|0:WASF1|0:ARPC1A|0:FSCN1|0:SMTN|0:VASP|0:HAP1|0:CASK|0:SORBS2|0:ABLIM1|0:GSN|0:NEB|0:KPTN|0:WASL|0:VILL|0:AVIL|0:IPP|0:KALRN|0:WAS|0:WASF2|0:IQGAP2|0:DSTN|0:MYOT|0:LSP1|0:KLHL2|0:CORO1C|0:BIN1|0:FSCN2|0:ACTL7B|0:FLNB|0:MARCKS|0:CLIC4|0:EPB49			
GO:0006820	P:anion transport; TAS:ProtInc		0:TSPO|0:SLC17A5			
GO:0009912	P:auditory receptor cell fate commitment; ISS:UniProtKB		0:JAG2			
GO:0009826	P:unidimensional cell growth; IMP:UniProtKB		0:BIN3			
GO:0005634	C:nucleus; TAS:UniProtKB		0:OVOL2|0:MESP1|0:BCL9L|0:NEUROD1|0:ID3|0:ID1|0:ARID5A|0:ID4|0:ARID5B|0:ID2|0:ELK3|0:NANOG|0:TFAP2B|0:NKX2-6|0:RAG1AP1|0:FOXN3|0:HOXA7|0:SP1|0:FOXD1|0:ZNF24|0:MYOCD|0:POU6F2|0:HOXD3|0:FOXJ2|0:RFX3|0:XPO6|0:MKL2|0:SIPA1|0:RAD1|0:EHMT1|0:ENO1|0:ELF2|0:HMX1|0:ANKRD49|0:ELF1|0:ELK1|0:SP3|0:GRLF1|0:JHDM1D|0:SOX8|0:ZEB2|0:FOXK2|0:WHSC1L1|0:FOXI1|0:FOXL1|0:RAD51AP1|0:SCMH1|0:EHF|0:CREB5|0:TAL1|0:USF2|0:IGF2BP2|0:CTNND1|0:PPARG|0:CDK6|0:SOX4|0:CDKN2D|0:NR5A2|0:HNF4A|0:JAK1|0:FOXJ1|0:PICALM|0:PROX1|0:SRF|0:TARDBP|0:CDKN1C|0:HHEX|0:CTNNBIP1|0:ISOC2|0:SFRP4|0:ETS1|0:ADD1|0:TGFB1|0:NR2F2|0:TYK2|0:CDKN2C|0:PTEN|0:CDKN1B|0:CALR|0:IRAK3|0:TRIB1|0:SACS|0:PCNP|0:UPF2|0:PALLD|0:ADARB1|0:SMG7|0:S100P|0:BPY2B|0:UHMK1|0:BPTF|0:CEP290|0:TBRG1|0:MAP1S|0:NUFIP2|0:HEXIM1|0:UXT|0:S100PBP|0:ZW10|0:FBXO11|0:UBR5|0:SMG5|0:RRAGD|0:RXRB|0:CECR2|0:NFS1|0:UHRF2|0:CARD8|0:TNFAIP3|0:NR1H2|0:BPY2|0:OTUD7B|0:UBE2V2|0:PYDC1|0:BPY2C|0:CRIPAK|0:CDKL5|0:C19orf33|0:MIER1|0:FUS|0:FKBP4|0:KLF4|0:AK1|0:UCKL1|0:CAPNS1|0:SPINK4|0:BRDT|0:PGR|0:ZNF532|0:MKX|0:NCLN|0:SAFB|0:C1QC|0:NEK4|0:GPKOW|0:YY1AP1|0:ZNF516|0:ZNF267|0:ZMYM3|0:FOSL2|0:TOX4|0:IQGAP1|0:TMX1|0:ZNF680|0:RARS|0:DSN1|0:TRIM25|0:ZNF133|0:AMELY|0:ALDH9A1|0:PITPNB|0:IGF2BP1|0:GPR19|0:FUBP1|0:CSTA|0:PRPF39|0:ZNF157|0:C12orf39|0:OLIG3|0:TRIP11|0:ZFX|0:ZNF44|0:PHC1|0:MZF1|0:HTATSF1|0:PITRM1|0:NFE2|0:IKZF5|0:NR3C1|0:CHUK|0:ZNF234|0:PLEKHA1|0:STK33|0:HPGD|0:PSMC1|0:MLLT6|0:CA2|0:PDZK1|0:ZNF323|0:ZNF222|0:ZNF192|0:MSL1|0:LY6K|0:CCAR1|0:ZBTB11|0:NFIL3|0:ZNF384|0:ZMAT1|0:ZNF544|0:PTPN6|0:PTTG3P|0:OVOL1|0:PSMA6|0:TSFM|0:BRAF|0:SH3GLB1|0:ZNF540|0:SOX30|0:MYO18A|0:PASD1|0:DRG1|0:FOXD4L4|0:FOXP4|0:EAPP|0:SMC1B|0:CAMK1D|0:MLF2|0:DPP8|0:PRELID1|0:CALML6|0:MEIS2|0:ZNF75A|0:CCT8|0:POGZ|0:KCTD10|0:FOXD4L6|0:MTERFD1|0:CRABP2|0:SP2|0:UBE2Z|0:YARS|0:ZNF782|0:WDR13|0:CEBPE|0:MEF2D|0:SENP1|0:HLTF|0:PAX4|0:CNOT4|0:GON4L|0:PQBP1|0:LBP|0:PCK1|0:SH3GLB2|0:KDM3B|0:ACSS2|0:JUNB|0:FOXP1|0:SYVN1|0:SPAG7|0:FBXO18|0:ZMYM6|0:DACT1|0:XPO5|0:BBOX1|0:PTPRR|0:CDK14|0:SETDB1|0:QKI|0:ACO2|0:AHRR|0:GRHL1|0:TSHZ1|0:TAP2|0:CPA3|0:ZBTB10|0:RUNX2|0:MBNL3|0:LRG1|0:ADNP|0:C11orf41|0:NKX2-2|0:FLII|0:ZNF251|0:ASB8|0:RBBP9|0:RTN3|0:HSD17B11|0:ALDH1A2|0:MBD4|0:SDCCAG1|0:KEAP1|0:KHDRBS2|0:H1F0|0:ZNF174|0:ZNF773|0:ZFR|0:COX4I1|0:MYO18B|0:PCGF1|0:HLX|0:CERK|0:MRPL52|0:ZSCAN16|0:STON1|0:SH3D19|0:PLA2G6|0:PSMC4|0:PSMD8|0:NAV2|0:NKAP|0:PSIP1|0:BUB3|0:LIAS|0:ST6GALNAC4|0:MACC1|0:C2orf40|0:PRDX6|0:MYEF2|0:GTF3A|0:HSPA4|0:MSX2|0:SPEN|0:ZNF701|0:SFRS15|0:CSTF2|0:ZBTB33|0:STK4|0:DLX5|0:TGOLN2|0:NPSR1|0:RAD17|0:BACH1|0:ZMYND11|0:PDLIM3|0:UBAC1|0:RRP7A|0:FOXD4L1|0:SRSF11|0:ZBTB20|0:BRD4|0:SOX9|0:AMELX|0:ZNF419|0:ZFHX2|0:ZNF677|0:STX5|0:FOXP2|0:ELFN2|0:KIAA0513|0:METT11D1|0:PLEKHA2|0:C14orf43|0:LSR|0:GSTZ1|0:GATA2|0:PTPRJ|0:ZBTB7B|0:DHRS1|0:UQCRC2|0:ZSCAN30|0:RBM23|0:CCT2|0:MBTPS1|0:STAT4|0:ZNF670|0:CCNB3|0:GRHL2|0:PITPNA|0:LGALS3BP|0:PDK2|0:STAT6|0:MLLT3|0:ZNF155|0:FOXD4L2|0:PLAGL2|0:TBX19|0:MLLT10|0:S100A9|0:TPX2|0:DAZAP1|0:PPP3CA|0:NR2C2|0:KRT17|0:ZNF74|0:DUSP12|0:MPP5|0:KRT7|0:PTTG2|0:FOXD4L5|0:ZNF233|0:ME1|0:ZNF148|0:SH3KBP1|0:KIF2C|0:PBX3|0:ZNF629|0:GMEB2|0:DACH2|0:MAPKAPK5|0:KHDRBS3|0:GOLIM4|0:PSMC3|0:HKDC1|0:SALL3|0:GATAD2B|0:UAP1|0:CCNY|0:F8A1|0:SLFN11|0:TIGD6|0:SSX2|0:C11orf54|0:RNF216|0:RPL10L|0:MAT2B|0:ZNF571|0:NUDT12|0:MIS12|0:HORMAD1|0:TCF12|0:UBA3|0:USP37|0:F8A2|0:PRSS23|0:HSFX1|0:ZNF664|0:GATA3|0:ZC3HC1|0:NDUFAF3|0:HOXA9|0:REXO2|0:COQ7|0:FAM192A|0:F8A3|0:HSFX2|0:SSX2B|0:CYCS|0:GADD45A|0:ZNF471|0:SPIN1|0:KIAA1539|0:CGGBP1|0:STRBP|0:XBP1|0:ZNF572|0:C4orf27|0:SENP7|0:ZNF649|0:USP18|0:SCAND1|0:RANBP3|0:LHX6|0:KIAA1826|0:CDCA7|0:CCNDBP1|0:PRMT1|0:DCAF6|0:BRD7|0:GABPB1|0:LSM1|0:PRDX1|0:NEK1|0:POU2F2|0:RABGAP1L|0:GABPB2|0:ZNF521|0:SERTAD3|0:AIPL1|0:FGF12|0:CBX4|0:LGALS3|0:IGFBP3|0:GABPA|0:AXIN2|0:SERTAD2|0:HYLS1|0:ZNF367|0:GSK3B|0:CAMTA2|0:FGF13|0:HOPX|0:AXIN1|0:H2AFZ|0:FIBP|0:CDCA7L|0:ZRANB1|0:GATA5|0:HCFC2|0:ZHX3|0:CRYGC|0:STK17A|0:FOXE1|0:RNF4|0:ERBB2IP|0:HUS1|0:AKIRIN1|0:PAWR|0:KIAA0368|0:SNCA|0:TBPL2|0:SEPT7|0:TRAF6|0:SAMHD1|0:AKT2|0:EGFR|0:ZHX2|0:PSMD10|0:FGF10|0:RAPGEF5|0:TPPP|0:TERF1|0:METTL11A|0:MALT1|0:ZC3H3|0:PSMC6|0:STRADA|0:EYA1|0:PPP2R5C|0:ARRB1|0:PPT1|0:WDFY1|0:SERGEF|0:MOBKL1A|0:DUSP21|0:MBNL1|0:SAP30BP|0:DSCR3|0:DEAF1|0:APLF|0:APPL1|0:RASSF1|0:TCF25|0:PPP1R13B|0:CDK11A|0:SERPINB9|0:USP7|0:ADI1|0:RACGAP1|0:RBM38|0:USP4|0:ZFP36|0:PARK7|0:MEMO1|0:GLI1|0:BNIPL|0:CHD1L|0:DYRK3|0:DYNLL1|0:ZNF423|0:MYCN|0:EGLN2|0:RPS27L|0:INO80|0:RANBP9|0:TRIM68|0:SLC30A9|0:FAN1|0:NR2F1|0:UBQLN4|0:DTX3L|0:RAD9A|0:TSC2|0:CITED1|0:FGFR2|0:TNNI2|0:TBX1|0:PRMT6|0:RARA|0:CARM1|0:PML|0:TRIM21|0:FOXA1|0:CACNA1A|0:APLP2|0:TNNI3K|0:TRIP4|0:CENPV|0:ETV5|0:MAD2L1BP|0:LMX1B|0:PRDM15|0:CLN3|0:RPS6KB1|0:SRPK1|0:NFIA|0:NMNAT1|0:NEIL1|0:HIST1H1E|0:DNAJA3|0:C21orf59|0:DUSP18|0:AHR|0:SVIL|0:TLK1|0:NOTCH2|0:RRAGC|0:GCH1|0:HMBOX1|0:SPDYA|0:VCP|0:IGHMBP2|0:WDR33|0:APPL2|0:RPS6KA4|0:TBX3|0:CCNF|0:HDAC10|0:ZHX1|0:S100A7|0:WRNIP1|0:NXF5|0:ZNF675|0:TNIK|0:SOX7|0:CTNNBL1|0:PTPRE|0:CALB1|0:TBX5|0:DPH3|0:GLRX2|0:PRKCI|0:SPRYD4|0:CCDC99|0:USP16|0:PRKCD|0:RUNX1|0:DYRK2|0:ARIH2|0:DGKZ|0:CELF3|0:SETDB2|0:CTDSP1|0:C2CD2|0:SUFU|0:KHDRBS1|0:TESC|0:AR|0:TRIM33|0:RNF14|0:RAB3IP|0:HMGN1|0:UTF1|0:RARB|0:PBX1|0:NEK6|0:LANCL2|0:NFRKB|0:PCBP3|0:IKBKG|0:CREB3|0:USP11|0:BCL6|0:SREBF2|0:UBE2L3|0:SMG1|0:FOXC2|0:RBM45|0:KIAA1967|0:C21orf7|0:SHOC2|0:NR0B2|0:RBFOX2|0:CDK11B|0:GLI2|0:TMEM115|0:PSMC5|0:WDR48|0:CUTC|0:DLC1|0:RNF8|0:BCL10|0:PARP9|0:BRWD1|0:DHCR24|0:NOSIP|0:ZNF219|0:BTG1|0:RPS3|0:ZNF281|0:RSPH1|0:RNF168|0:TRERF1|0:S100A11|0:S100A4|0:CLIC3|0:JMJD6|0:CASC5|0:TSHZ3|0:CRBN|0:PKM2|0:RNF40|0:FSTL3|0:ALKBH8|0:ATE1|0:ASCL1|0:ZGPAT|0:PXK|0:SMARCAL1|0:TP63|0:S100A13|0:RPS27|0:HIC2|0:FOXP3|0:ALG2|0:MAD2L1|0:UBE2N|0:TTC3|0:HOXA5|0:TCFL5|0:CDKN2B|0:PAX6|0:VPS4B|0:PAPD7|0:DZIP1|0:NR2F6|0:THRA|0:PRDM5|0:EXO1|0:TLK2|0:NFU1|0:TWIST1|0:SAV1|0:STRADB|0:MECP2|0:RERG|0:APBB1|0:NR5A1|0:RRAGA|0:CREBZF|0:UBD|0:S100A1|0:DNAJB6|0:HNF1A|0:RFWD3|0:LYN|0:FOXO4|0:FOXL2|0:TRAF4|0:LDB2|0:MCM3AP|0:UCHL5|0:WWP2|0:TRPS1|0:USP44|0:BIRC3|0:ARRB2|0:CAND1|0:TRA2B|0:ZNF395|0:AURKAIP1|0:S100B|0:JMJD5|0:CASP8AP2|0:SPAST|0:CCS|0:YAF2|0:C15orf42|0:NAIF1|0:POU5F1|0:SREBF1|0:MUM1|0:SIK1|0:NHLRC1|0:RHOXF1|0:CENPH|0:S100A5|0:NR0B1|0:HIRIP3|0:MPHOSPH8|0:C7orf27|0:MAGEC2|0:SLC11A2|0:PNRC2|0:TRIM7|0:EDC4|0:MTMR2|0:TCF3|0:PCP4|0:UBIAD1|0:YAP1|0:BCL3|0:C21orf30|0:KDM3A|0:MEFV|0:PRKCB|0:UFM1|0:LIMD1|0:ASCL2|0:ANP32A|0:CCDC85B|0:STRN3|0:VPRBP|0:SOD1|0:MCC|0:ZBED4|0:ESRP1|0:BMI1|0:NFKBIA|0:CRTC1|0:S100A12|0:METTL1|0:MDFIC|0:RXRA|0:NEIL3|0:FAM40A|0:USP10|0:ETS2|0:BAG1|0:NUPR1|0:KDM1A|0:WWC1|0:NAA10|0:EDF1|0:CREB3L2|0:KRT14|0:FEN1|0:ZNF256|0:KIF18A|0:PKN1|0:IFI35|0:MYCBP|0:FAM107A|0:FOXO3|0:STK17B|0:KCTD1|0:C15orf48|0:BLOC1S2|0:GINS1|0:GSG2|0:FOXA2|0:NFKB2|0:MAFA|0:UMPS|0:BRSK1|0:DND1|0:ESRP2|0:THAP5|0:PTTG1IP|0:PPP2R4|0:IP6K2|0:STK36|0:TFAP4|0:TRA2A|0:DLGAP5|0:STK11|0:HNF1B|0:ZKSCAN3|0:TPRKB|0:APC|0:MGRN1|0:TP53RK|0:SOX18|0:TP53BP2|0:RNF25|0:ESX1|0:MYH9|0:C17orf79|0:NT5C|0:ZNF639|0:ZIC1|0:PIP5K1A|0:XRRA1|0:PPIA|0:NHEJ1|0:MLX|0:HSPA5|0:USP26|0:ADAP1|0:FGFR1OP|0:DBR1|0:FLNA|0:PRMT7|0:SIAH3|0:CCNB2|0:SFMBT1|0:RRAGB|0:DIP2B|0:SSX4B|0:TLE6|0:ROD1|0:SSX7|0:TCEANC|0:CBLB|0:CBL|0:TSPY4|0:SSX3|0:C10orf140|0:SHPRH|0:TSPYL3|0:SESN2|0:SCAND3|0:PNLDC1|0:SSX4|0:C1orf83|0:SIAH1L|0:NFXL1|0:TSPYL6|0:TSPY3|0:SESN3|0:SSX8|0:MBD6|0:UBTFL2|0:TCF24|0:TSPYL5|0:CCNJ|0:PHF3|0:SSX9|0:VHLL|0:CCND2|0:GTF2H2B|0:TAL2|0:FAM50B|0:DIP2C|0:PGBD1|0:SFMBT2|0:CCNJL|0:SSX5|0:SP140L|0:TSPYL4|0:HNRPLL|0:NAP1L6|0:TFAM|0:SSX6|0:GNPTAB|0:CREB3L1|0:MMP2|0:FRG2|0:TBX10|0:ZBTB12|0:CENPQ|0:CHD9|0:ARID3C|0:SPIN2B|0:IPO9|0:CHD1|0:CEP350|0:CTDSP2|0:HIST1H2AD|0:ELAC2|0:SNAPC1|0:HABP4|0:RP9|0:GFI1|0:FHL1|0:SMC6|0:LPIN3|0:RBPMS|0:IRX3|0:SEBOX|0:BTK|0:ZNF667|0:TFEC|0:HOXB5|0:ARGFX|0:CUL4B|0:ZNF568|0:LIN28B|0:C1QBP|0:TRIM45|0:CENPL|0:XAF1|0:ZNF614|0:C1orf107|0:SAFB2|0:C19orf22|0:BTBD10|0:ESRRB|0:PSMB8|0:THEG|0:PARK2|0:SSX10|0:RPAP1|0:EPN1|0:ABHD14B|0:STH|0:ZC3H14|0:BANF1|0:TDP1|0:HES2|0:ZNF775|0:USP17L7|0:TGIF2LY|0:RB1CC1|0:NEIL2|0:BATF2|0:URGCP|0:PIK3C2B|0:TCEAL2|0:COMMD1|0:HIST2H3A|0:ZNF16|0:TACC1|0:EPC2|0:IPPK|0:NDRG1|0:ZNF285|0:ZFP36L1|0:HIST1H2AJ|0:ZNF10|0:TIGD4|0:ZNF624|0:SOHLH2|0:CCNB1IP1|0:ZNF541|0:TXNRD1|0:ZNF121|0:RBMY1E|0:RNF111|0:EN2|0:TOX2|0:IRF2|0:BRMS1L|0:ZNF594|0:CDCA2|0:NEUROD6|0:FBXL3|0:ZNF830|0:ITCH|0:GTF2H2C|0:RPP25|0:HOXC11|0:HELZ|0:CAV2|0:NEK9|0:PKP3|0:HSF5|0:SORBS3|0:ZNF703|0:HIST1H1D|0:HMGXB3|0:DPPA4|0:HIST1H1C|0:ZSCAN20|0:HIST1H2BH|0:HIST1H2BO|0:ZNF57|0:FBXL4|0:BMP2K|0:ZBTB46|0:MAB21L1|0:HIST2H2BE|0:ZNF17|0:ZNF280D|0:RFX2|0:MAPK8IP1|0:DUSP8|0:KLF3|0:ANKRD37|0:ESPL1|0:ERBB4|0:DMRT1|0:ANKRD34B|0:MEX3B|0:ZNF783|0:KDM4D|0:IRF2BP2|0:ZNF230|0:ZNF434|0:ZNF347|0:KCNIP3|0:TCEB3CL|0:NFATC4|0:ZNF581|0:SPO11|0:PELO|0:POU2AF1|0:DNASE1L3|0:SRSF2IP|0:DBX2|0:IPO8|0:CLK2|0:SECISBP2|0:ZNF311|0:EHMT2|0:UFD1L|0:WTIP|0:MAMSTR|0:ZIC4|0:ZNF502|0:PPHLN1|0:HIST1H2BN|0:HIST1H2BB|0:ZNF840|0:PHF19|0:TTC5|0:MAD1L1|0:MYCL2|0:ANKRD11|0:NFKBID|0:ZNF497|0:CDY1B|0:POLR3E|0:IPMK|0:GRHL3|0:PYGO2|0:CINP|0:ZNF787|0:RQCD1|0:MTUS1|0:ACHE|0:EGR3|0:FGF14|0:DMRTA2|0:ZNF461|0:RBM12|0:H2AFJ|0:SKAP1|0:PAPD5|0:CDYL2|0:ZNF619|0:HMGB3L1|0:ZBTB1|0:ZNF876P|0:GINS4|0:GSX1|0:ZNF642|0:ZNF766|0:TBR1|0:ZNF226|0:SLC4A1AP|0:IQSEC1|0:SMU1|0:CASZ1|0:EPM2A|0:DNTTIP1|0:BEX1|0:FEZF2|0:LYL1|0:ZNF34|0:KLF14|0:SCML1|0:REXO1L1|0:NKX2-4|0:FBXW11|0:DGCR6|0:DGCR6L|0:ZNF607|0:DRAP1|0:ZNF575|0:PTBP2|0:DYX1C1|0:JUB|0:HIST2H2BF|0:HDGF|0:ZNF579|0:NOTCH3|0:HIST1H3F|0:HOXB2|0:ANP32B|0:FRG2B|0:DHX36|0:PHTF2|0:HEYL|0:ZNF816|0:CELF4|0:ARHGAP22|0:ZNF600|0:ZNF678|0:CDKL1|0:SMEK2|0:ATMIN|0:PAK2|0:ATF7IP2|0:CAMK2N2|0:SCXA|0:CDX1|0:TP53TG5|0:HSPB1|0:POLK|0:RBM15|0:DAZ3|0:SH3BP4|0:LEUTX|0:DUX4|0:ARHGAP39|0:KIAA2018|0:SRSF6|0:TRIM41|0:ZNF25|0:WBSCR22|0:HMGN4|0:MBD5|0:ZNF549|0:NACAD|0:C9orf102|0:STK40|0:PHF1|0:CSRP3|0:CBX6|0:NR1I3|0:PPL|0:NCOA3|0:ZNF107|0:KLKP1|0:ZNF417|0:MEIS1|0:NGFRAP1|0:TCEAL6|0:ZNF439|0:SH3BGRL2|0:ZNF733|0:H2AFB3|0:REXO1|0:ZNF561|0:EME2|0:ZNF362|0:ANKRD17|0:HNF4G|0:ZNF565|0:ZNF790|0:FHL5|0:SPATA2|0:EVX1|0:HIST1H2AG|0:DPRX|0:NUF2|0:ARID2|0:ZBTB4|0:WWP1|0:B9D2|0:C7orf11|0:ATXN3L|0:MRFAP1|0:ZNF862|0:BBX|0:EEF1A2|0:IRAK1BP1|0:FOXD2|0:DBP|0:UBASH3B|0:DTX2|0:H3F3A|0:SIX6|0:ARX|0:IRX6|0:INSM1|0:ZNF493|0:ZNF717|0:NEUROD2|0:HN1L|0:SBF1|0:SPI1|0:ZNF271|0:TRIM66|0:PTPN20A|0:ZNF142|0:VPS37A|0:BAZ2B|0:TAX1BP3|0:C10orf137|0:QTRT1|0:VENTX|0:MSL3L2|0:FOXB2|0:ZFP2|0:DCPS|0:DNTTIP2|0:PCBD1|0:NR2C1|0:ZSCAN23|0:ZNF628|0:ZCCHC11|0:TATDN3|0:ZNF746|0:PRKACA|0:ZNF620|0:USP17L3|0:SHOX2|0:KLF13|0:ZFAND2A|0:RNF11|0:C15orf23|0:ZNF860|0:JDP2|0:ZC3H15|0:CBLC|0:TTLL5|0:TBX6|0:ZFP42|0:MESP2|0:ZKSCAN2|0:BCAS3|0:ZNF658B|0:DONSON|0:BARHL2|0:ZFP92|0:ZSCAN18|0:ZNF837|0:TC2N|0:DCK|0:MID1IP1|0:SYNPO2|0:METTL8|0:CAMK1|0:LYRM1|0:ZNF879|0:MEOX1|0:POU1F1|0:ZC3H7A|0:KLF16|0:HIF3A|0:MAPKAP1|0:NEUROG3|0:MXD4|0:CPSF3L|0:ZNF665|0:MAGI3|0:CCHCR1|0:HIST1H2BC|0:CPSF7|0:PRDM4|0:IRF6|0:MYBL2|0:ZNF407|0:PARP14|0:HOXA3|0:ZNF343|0:TIGD1|0:HMX2|0:SOX12|0:XRCC3|0:LMO2|0:MSGN1|0:HOXC5|0:NOX4|0:OTP|0:RBMY1J|0:ZNF599|0:PRM3|0:PER2|0:DRGX|0:CXXC5|0:ZNF252|0:FANCF|0:CCNC|0:BHLHA15|0:ZNF829|0:ZNF813|0:MAZ|0:HES3|0:BATF|0:KARS|0:TEF|0:C11orf30|0:ICK|0:ZNF618|0:ZBTB42|0:DHX32|0:SCAPER|0:CBFB|0:HIST1H3H|0:ZNF276|0:EBF4|0:GSX2|0:ASCL4|0:ZNF844|0:ABI1|0:ZNF286A|0:HIST1H2AK|0:ZNF526|0:DDN|0:RASSF2|0:DLX3|0:AIMP1|0:ZNF674|0:SPC25|0:PARL|0:HSH2D|0:BANP|0:TSC22D4|0:CTDSPL|0:ZFP112|0:RAVER2|0:CRTC3|0:ZNF525|0:DMRTC2|0:PDS5A|0:PPP2R3C|0:ZNF443|0:EYA4|0:ITPKC|0:ZNF654|0:TCEA3|0:C13orf15|0:FAM9C|0:ZNF30|0:ZNF770|0:ADPRHL2|0:EPS15L1|0:MGEA5|0:HIST1H3A|0:CAPN7|0:NRG1|0:ZNF557|0:FANK1|0:PSMB10|0:ZBTB49|0:UNC45A|0:ZNF683|0:CASK|0:ZNF658|0:NPAS3|0:SMYD1|0:LANCL1|0:SPANXE|0:ZNF705F|0:PAX7|0:TUBD1|0:PDLIM2|0:DIP2A|0:ZNF510|0:LUZP1|0:ZNF623|0:CDK20|0:HES1|0:ISL1|0:C1orf61|0:ZNF385B|0:BANF2|0:SPZ1|0:ZNF284|0:DUSP5|0:BIRC7|0:HSF2|0:CIITA|0:HP1BP3|0:OSR2|0:AGTPBP1|0:STAT5A|0:KIF14|0:NFE2L2|0:MAGOHB|0:ZNF709|0:OAS1|0:HIST2H3D|0:FAM9B|0:SIX2|0:KCTD13|0:SH2B1|0:GTF2H5|0:C9orf140|0:ZNF710|0:TRIM63|0:TCF19|0:FOXN2|0:CEP164|0:ZNF136|0:NUB1|0:CUL3|0:ZNF713|0:ZNF18|0:SPIC|0:KLHDC2|0:FSD1|0:ELK4|0:TRIM47|0:ZNF846|0:ADAD1|0:GPBP1|0:SIAH2|0:RAD23A|0:RNASEH2C|0:NKX2-3|0:BIVM|0:LHX4|0:PAPOLG|0:PUS3|0:ZNF317|0:CHD2|0:ZNF763|0:HOXC10|0:MEOX2|0:FKBP3|0:KLF17|0:KLF5|0:GSC2|0:ZNF433|0:TARBP2|0:TRIOBP|0:HIST1H2AC|0:ZNF705G|0:ATXN1L|0:HIST1H2AB|0:FILIP1L|0:PRAC|0:PEG3|0:ZNF263|0:PPP6R3|0:SOHLH1|0:NCK1|0:ZNF550|0:C20orf11|0:ZNF567|0:ZNF660|0:TCEAL3|0:CENPB|0:CENPI|0:ZNF737|0:NOVA1|0:CENPK|0:FOSB|0:ZNF789|0:TCF23|0:ZNF404|0:PYGO1|0:ZNF823|0:NRBF2|0:HIST3H2BB|0:BNC2|0:ZNF486|0:UBR4|0:ZNF697|0:ZNF776|0:ZNF503|0:RYBP|0:ZNF416|0:ZNF225|0:C17orf70|0:ZNF554|0:UBTFL1|0:CCNA1|0:UBTFL5|0:PRDM14|0:MBNL2|0:NUBP2|0:FOXQ1|0:IRF1|0:ZSCAN5A|0:DUSP22|0:ZFP3|0:CRY2|0:ZNF454|0:SP6|0:NFATC1|0:SCYL1|0:SCOC|0:MEIS3P1|0:FLYWCH1|0:ACRC|0:ZNF648|0:ZNF574|0:WIZ|0:ZNF175|0:PTHLH|0:ZNF692|0:FANCL|0:ZBTB2|0:ZNF721|0:POU4F1|0:ZNF641|0:MYNN|0:ISL2|0:DCLRE1B|0:TP73|0:TSHZ2|0:CSTF2T|0:NR2E1|0:BHLHE22|0:ZNF679|0:MYPN|0:SIM1|0:ZFHX4|0:C2CD4B|0:NAA20|0:ZBTB45|0:SENP6|0:INVS|0:PHC2|0:DBX1|0:ZNF578|0:EBF3|0:CHCHD1|0:EBF1|0:RBX1|0:TSNAX|0:ZBTB7A|0:HIST1H3G|0:ZNF818P|0:PLCD4|0:PBOV1|0:ZBTB39|0:HIST1H2AI|0:PRNP|0:ZNF335|0:UBASH3A|0:TPRX1|0:CLK1|0:TNFAIP1|0:PSMA2|0:ZNF213|0:TIGD7|0:ZNF580|0:POMP|0:ZNF732|0:SUMO2|0:HIST1H2BG|0:ZNF354B|0:BCORL1|0:TCEB3C|0:MND1|0:CIC|0:TNPO3|0:HOXC9|0:KDM4C|0:ZNF777|0:TFAP2C|0:HELLS|0:IRX2|0:H2AFB1|0:PSMB5|0:MXD3|0:KHSRP|0:IBTK|0:VSX1|0:AFMID|0:NKX1-2|0:ZFP64|0:ZNF295|0:ZNF517|0:ZNF587|0:SERPINB10|0:KLF15|0:LYRM4|0:RRM2B|0:HIST1H2BM|0:ZNF77|0:EIF3K|0:CPSF4|0:ZNF613|0:ZNF490|0:CCDC89|0:ZNF324B|0:RFX7|0:MEX3C|0:ZNF341|0:SERBP1|0:ATAD5|0:TIGD5|0:TMF1|0:SCML4|0:PNKD|0:MAMLD1|0:ZNF788|0:HIST1H2BF|0:ZNF785|0:DCLK3|0:NSMCE2|0:KIAA1009|0:HOXA13|0:ZNF718|0:TSC22D1|0:PUF60|0:LIMS2|0:CLCC1|0:PIK3R5|0:ZNF702P|0:SIX5|0:ANLN|0:DLX2|0:PPIL4|0:ZNF280C|0:IPO4|0:NKX6-1|0:ZNF334|0:RANBP6|0:FOXB1|0:IKZF3|0:H3F3B|0:HINT3|0:POU6F1|0:CSDA|0:ZNF320|0:CNOT6|0:HIST1H1A|0:CDY1|0:SPG11|0:ZNF711|0:SETD8|0:ASXL2|0:MEIS3P2|0:MLL3|0:ZNF193|0:CSRP1|0:ZNF354C|0:NHLH2|0:USP17L2|0:CRCP|0:MED25|0:ZNF627|0:STK3|0:VEZT|0:ZNF468|0:ZNF740|0:NET1|0:LGALS12|0:IK|0:FAM53A|0:ZNF514|0:CAND2|0:ZWINT|0:ZNF780B|0:ZIC3|0:LMX1A|0:BTBD8|0:RBMY1D|0:CREB3L4|0:ZIK1|0:FGD2|0:ZNF548|0:NANOGP8|0:SRCAP|0:PRR13|0:RCOR1|0:ZNF806|0:SSBP3|0:ZNF322A|0:ZNF793|0:TCEAL7|0:RAX2|0:LBX2|0:ZNF408|0:ZNF426|0:PLCZ1|0:RSBN1|0:GVINP1|0:DMRT2|0:RAX|0:HIST2H2AA3|0:ZNF507|0:ZNF26|0:PPRC1|0:ZNF396|0:H2AFV|0:OAZ3|0:EIF2C2|0:ZNF143|0:ZNF560|0:ZNF438|0:SH3BGRL3|0:ZNF564|0:NLRP1|0:UPRT|0:GTF2I|0:CENPP|0:IFIH1|0:RGS17|0:ZNF671|0:DAZ2|0:DUXA|0:TAF15|0:RGS7BP|0:ZFY|0:OLIG2|0:CLASRP|0:C14orf106|0:AMIGO2|0:ADARB2|0:GINS2|0:ZNF440|0:ZBTB17|0:RLF|0:SPIB|0:RCBTB1|0:AFF1|0:ANXA1|0:ZFP28|0:ZNF826P|0:MRI1|0:POU3F4|0:ZNF397|0:HIST1H3I|0:SNTG1|0:ZNF749|0:HIST1H3B|0:BTRC|0:YEATS2|0:MUC1|0:TEAD3|0:ZNF836|0:ASF1B|0:SPOPL|0:ZNF812|0:FOXD3|0:CDY2B|0:HOXB3|0:GFI1B|0:ZNF527|0:ZNF771|0:TRIM55|0:ZNF66P|0:DUSP26|0:ZNF410|0:PHOX2B|0:DLX6|0:CUEDC2|0:ZNF76|0:ZYX|0:SOX3|0:ZNF221|0:ZFP30|0:CCDC86|0:NSL1|0:ZNF167|0:ZBTB26|0:ZNF644|0:SCAI|0:IL15|0:SPANXD|0:UBXN2B|0:DEF6|0:ZNF653|0:CDKL2|0:THRSP|0:BHLHB9|0:ZNF444|0:BEX4|0:ADRM1|0:BAT3|0:AIMP2|0:C21orf45|0:DOT1L|0:ALKBH4|0:HMGA2|0:ZNF558|0:NCAPH|0:ZNF329|0:RMI1|0:DUX3|0:ZC3H7B|0:RORA|0:RAI1|0:ZNF229|0:EPN3|0:HMGB4|0:KLF8|0:C9orf86|0:SEPX1|0:TBPL1|0:NOTO|0:VGLL2|0:CCDC101|0:ZNF449|0:HEXDC|0:ETHE1|0:IRF5|0:MSX1|0:ZNF584|0:HOXA4|0:OGFR|0:HIF1AN|0:ZNF180|0:IPO11|0:RNASEH2A|0:STAT2|0:RANGRF|0:HMX3|0:GTF2H2D|0:TJP2|0:HIVEP3|0:ZNF736|0:MIF4GD|0:CABLES1|0:ZNF791|0:PSMB1|0:SP5|0:UBE3C|0:HOXC6|0:SNRNP27|0:DCP1B|0:TADA2B|0:PRDM7|0:ZNF487P|0:ANKRD23|0:DCLRE1C|0:PNCK|0:PKNOX2|0:CLK4|0:ZNF799|0:SMYD3|0:FOXM1|0:ZBTB48|0:RFXAP|0:VAX2|0:CAMTA1|0:FAM82A2|0:CDCA4|0:ZNF534|0:BTF3|0:SETMAR|0:OFD1|0:KDM4B|0:LRRC10|0:HIST1H2BJ|0:IPO13|0:COMMD5|0:LGALS7B|0:ZNF738|0:ZNF324|0:JUND|0:R3HDM2|0:TIGD2|0:ZNF511|0:ZMYM5|0:ZNF586|0:ZNF726|0:HSFY2|0:ZNF264|0:OTUD7A|0:SCRT2|0:ZSCAN12|0:MEX3D|0:TAF1D|0:FBXO3|0:ZNF551|0:ZNF480|0:HN1|0:ZBTB41|0:UNKL|0:C12orf48|0:GBX2|0:RAVER1|0:PSMA5|0:ZNF287|0:DPPA2|0:ZNF676|0:SP7|0:UNCX|0:ZNF385C|0:TELO2|0:PSMB11|0:LRP1|0:TSPY2|0:PADI4|0:POU4F3|0:ZSCAN5B|0:ERBB2|0:GTF2IRD2B|0:DDX3Y|0:NAP1L5|0:CENPW|0:NFE2L3|0:STAT5B|0:OAS2|0:TRIM11|0:NUDC|0:PRDM10|0:MBTD1|0:BARHL1|0:UBTFL6|0:HIST1H3C|0:ZNF585A|0:CRAMP1L|0:TNIP1|0:NSFL1C|0:HEY1|0:ZNF99|0:TMUB1|0:DET1|0:CABYR|0:HIST1H3D|0:ETV3L|0:MAGEA11|0:SIM2|0:MAF|0:SSH3|0:PER1|0:TP53TG3|0:LMCD1|0:SHOX|0:BCL6B|0:NOBOX|0:ZNF689|0:TFCP2|0:ZNF570|0:DNTT|0:NCOA7|0:HIST1H3J|0:LBH|0:BHLHE23|0:DYNLT3|0:ZNF682|0:MAFF|0:ZNF445|0:XRCC2|0:ZNF485|0:LPP|0:FOXD4L3|0:SLTM|0:CCDC110|0:ZNF764|0:ZNF248|0:HIST1H2AA|0:ATOH1|0:CREB3L3|0:PRDM9|0:ZNF669|0:DDX27|0:THAP11|0:ZNF43|0:MIER3|0:PSMB6|0:PHC3|0:NOVA2|0:UBLCP1|0:ZIM2|0:ZNF318|0:NDNL2|0:ZNF609|0:RHOXF2B|0:PAN2|0:KIFC1|0:LHX5|0:ZNF543|0:ESRRG|0:C7orf70|0:ZNF566|0:MSI1|0:PLAGL1|0:FAM188A|0:ZNF778|0:DNAJC7|0:ZNF20|0:CAMKK1|0:HIST2H2AA4|0:ZC3H12A|0:C2orf51|0:NANOGP1|0:ZNF518A|0:ZSCAN29|0:ZNF296|0:HARBI1|0:IRX1|0:KLF12|0:C14orf166|0:SFN|0:PYDC2|0:CENPN|0:DAZ1|0:RFX8|0:BCL2L13|0:TCEB3B|0:ZNF260|0:ZNF429|0:MIXL1|0:TBX4|0:ZNF512|0:C8orf80|0:ZNF491|0:TATDN2|0:MTA3|0:SOX5|0:NFIX|0:ZSCAN2|0:RBM42|0:RUSC1|0:USP21|0:TBC1D1|0:GTF2IRD2|0:TP53INP1|0:ZNF300|0:ZNF460|0:NOB1|0:AEBP1|0:DCP2|0:GLYR1|0:RASD1|0:ZNF280B|0:NFATC2IP|0:USP17L5|0:UBA2|0:SUGP2|0:HIST1H2AH|0:ZNF626|0:H2AFB2|0:ZNF700|0:ELF5|0:PARP3|0:FABP4|0:DMRTB1|0:MYPOP|0:EGLN3|0:PITX3|0:AIM2|0:ZBTB44|0:ZMAT4|0:ZNF714|0:RSC1A1|0:PSMA8|0:ARID4B|0:ZNF592|0:ZNF250|0:PEG10|0:PRAME|0:ZNF12|0:SRSF5|0:HIP1|0:AHNAK2|0:RECQL4|0:LHX2|0:TRNP1|0:ZFP57|0:IWS1|0:PAPOLB|0:ZNF420|0:C2CD4A|0:HIST2H3C|0:NDN|0:TACC2|0:AES|0:HOXA1|0:ZNF181|0:ZNF48|0:ZIC2|0:CCDC106|0:DCP1A|0:DDX53|0:ZNF75CP|0:ZNF345|0:ZNF484|0:IP6K1|0:FOXI2|0:ATOH8|0:ASCL5|0:MAFK|0:PPP2R5A|0:PHF7|0:HIST1H2BL|0:ZNF467|0:DIDO1|0:CBFA2T2|0:NGDN|0:DPF2|0:ZNF322B|0:ZNF432|0:ZNF425|0:ZNF7|0:ZNF583|0:ZNF672|0:UBQLN2|0:ZNF805|0:CEBPD|0:ZNF254|0:PAX1|0:SGK1|0:ZNF827|0:NFKBIZ|0:CASP14|0:ZNF781|0:PRDM6|0:CST11|0:ZFP90|0:NACA|0:OLIG1|0:TCF15|0:HIPK3|0:ENOPH1|0:ZNF530|0:BCL11B|0:WWOX|0:KLF9|0:HIST1H2BE|0:ALKBH7|0:RBPJL|0:ZNF663|0:ZNF498|0:ZNF727|0:ZNF577|0:NCOA5|0:ZNF563|0:ZNF835|0:ZNF528|0:ZNF555|0:LGALS7|0:SYCP2L|0:SCAND2|0:HIST1H2AM|0:HOXD10|0:ZNF132|0:ZNF786|0:POLDIP2|0:ZNF56|0:NELF|0:RNASEH2B|0:EBF2|0:ZNF573|0:ZNF616|0:ZNF735|0:ZNF729|0:NSMCE1|0:CELF2|0:ZNF606|0:ESCO2|0:NRIP2|0:ZNF772|0:EID2|0:ZNF32|0:BRD2|0:FBXO38|0:NHLH1|0:SP8|0:RNF151|0:AGBL5|0:APEX2|0:UBE3A|0:RAD54L2|0:HIST2H2AB|0:NXT2|0:ADNP2|0:ZNF643|0:ZBTB25|0:NAA11|0:ETV1|0:ERGIC2|0:BACH2|0:BAT2|0:CENPT|0:ZNF235|0:TRMT61A|0:ZNF780A|0:EYA2|0:FANCG|0:ZNF224|0:ZNF652|0:CDYL|0:CCDC59|0:TIA1|0:HMGB3|0:UBE2E3|0:ZNF500|0:KDM5C|0:SSBP4|0:TEX19|0:NPAS1|0:TFCP2L1|0:TLX2|0:POLM|0:HIST1H4G|0:ZNF547|0:EVI5|0:C12orf10|0:ZNF441|0:CENPO|0:KCTD5|0:MNDA|0:DUX2|0:PIM1|0:ZC3HAV1|0:HIST3H2A|0:RORB|0:HIST2H2BD|0:PRUNE|0:PSMB2|0:PHOX2A|0:ZFPM1|0:ASPA|0:PPP2CB|0:ZGLP1|0:ZNF792|0:HSF4|0:USP25|0:ZNF124|0:NICN1|0:SPRED1|0:DMRTA1|0:REV1|0:LHX8|0:ZNF101|0:USP2|0:SPECC1|0:FOXN4|0:ZKSCAN4|0:ARHGAP19|0:TCEAL4|0:MEIS3|0:SKIV2L|0:ZNF696|0:RFXANK|0:RSBN1L|0:ZNF316|0:PHLPP1|0:SIAH1|0:LHX1|0:RXRG|0:ZNF140|0:ASXL3|0:HIST1H1B|0:ASPM|0:ZNF451|0:CDX4|0:ZNF302|0:C15orf55|0:FIP1L1|0:CCNG1|0:ZNF14|0:SIX4|0:FAM71B|0:TBX20|0:ZNF273|0:HMGB1P1|0:NEUROD4|0:USP48|0:NR1H4|0:SALL4|0:ZNF708|0:IL16|0:ZSWIM7|0:ZNF470|0:SMC5|0:TGIF2LX|0:USP17L8|0:NCAPH2|0:ZNF488|0:PAX3|0:TXNRD3|0:IRF8|0:H2BFS|0:MKL1|0:ZZZ3|0:MYOZ1|0:CLNS1A|0:SCNM1|0:FANCB|0:ZNF622|0:POLR3B|0:FEZF1|0:NARG2|0:ZNF646|0:TSPY1|0:LCORL|0:HOMEZ|0:ZNF446|0:MLF1IP|0:GEN1|0:FEV|0:VGLL3|0:SSU72|0:LCOR|0:ZNF232|0:ZNF239|0:ZNF35|0:TOX3|0:EN1|0:ZSCAN5C|0:UBTFL3|0:ZNF552|0:TKTL1|0:ZNF227|0:TRMT6|0:ETV2|0:LSMD1|0:NRF1|0:PRDM12|0:PARG|0:GPBP1L1|0:ZNF137P|0:CELF5|0:CDY2A|0:RGS20|0:TFE3|0:C11orf17|0:NAB2|0:HIST1H3E|0:NKX2-8|0:ZNF414|0:HBP1|0:JRK|0:XPO4|0:TLX1|0:BDP1|0:VAX1|0:TAOK2|0:HCFC1R1|0:CLK3|0:GCFC1|0:ZNF524|0:KDM6B|0:FKBP5|0:FLI1|0:MAB21L2|0:ZBTB47|0:ZNF681|0:YPEL1|0:ZNF536|0:SETBP1|0:ZFP1|0:SRSF3|0:SP4|0:ZNF611|0:DEPDC1|0:KIAA1429|0:ZNF695|0:MTF2|0:EGR4|0:BHLHA9|0:ZNF114|0:MAF1|0:MIER2|0:IRX4|0:PSMB7|0:TDRD3|0:EID2B|0:MYT1L|0:LPIN2|0:TNP2|0:HIST1H2BI|0:ELAC1|0:NACA2|0:UBOX5|0:CMAS|0:PRX|0:SOX14|0:ZNF688|0:HIST1H2BA|0:ZBTB8B|0:ZNF730|0:PDE4DIP|0:ZNF559|0:NHS|0:MAFG|0:RBMXL2|0:SCAF1|0:ZNF668|0:PLEKHF1|0:MUSTN1|0:ZIM3|0:PROX2|0:FTSJD2|0:RPAP2|0:TIGD3|0:CNOT3|0:ZNF821|0:HOXA6|0:COMMD6|0:ZNF391|0:USP39|0:PAX5|0:PHF11|0:USP8|0:ZBTB40|0:TFAP2E|0:CPSF2|0:HDLBP|0:ZNF519|0:ZNF304|0:DPH1|0:ZNF385D|0:WEE2|0:GINS3|0:FOXR2|0:C14orf156|0:SNIP1|0:RGS3|0:ZNF513|0:RBM24|0:RNF17|0:RBMY1F|0:SCML2|0:BCL9|0:ZNF774|0:TCEAL8|0:USP17L4|0:ZNF382|0:VPS36|0:ZNF625|0:RBMS2|0:TP53INP2|0:ALX3|0:ZNF765|0:POGK|0:ZNF366|0:ZFP36L2|0:PIK3C2A|0:ZNF595|0:ZNF724P|0:VBP1|0:EGR2|0:TMEM8B|0:RIF1|0:RFX1|0:RWDD3|0:INSM2|0:LUZP4|0:DPPA3|0:NKX6-3|0:CENPBD1|0:HMGN2L|0:DCAF7|0:SMEK1|0:MDM1|0:ALDH7A1|0:ZNF630|0:PER3|0:NFIC|0:SCXB|0:HOXD1|0:PDIK1L|0:KDM4DL|0:ZMYM1|0:ZC3H18|0:FRG2C|0:ZNF333|0:C11orf82|0:ZBTB37|0:PRDM8|0:CLSTN1|0:DDX12|0:DDX28|0:ZNF542|0:KLF7|0:CHTF8|0:OTX2|0:HOXC12|0:IRF2BP1|0:DAZL|0:PLAG1|0:ZNF841|0:ZNF784|0:GADD45GIP1|0:PURG|0:PSMA7|0:DBF4B|0:ELOF1|0:ZNF319|0:EFCAB6|0:ERF|0:ARL3|0:ANKRD12|0:HSFY1|0:ZNF185|0:UBQLN1|0:NEUROG1|0:UBA5|0:SRSF9|0:UBXN6|0:LRDD|0:NFX1|0:ZNF98|0:POLR2J2|0:CHD5|0:ZNF431|0:ZNF800|0:ZNF462|0:ZNF28|0:UBR2|0:VOPP1|0:TCF7|0:ZNF662|0:NR1I2|0:ZNF266|0:TATDN1|0:ZBTB5|0:UHRF1|0:FAM120B|0:NKX3-2|0:ECD|0:SELENBP1|0:CENPM|0:ZNF684|0:ZNF492|0:DMP1|0:IGF2BP3|0:SYCP3|0:ZNF576|0:PTPN20B|0:ZNF182|0:IRX5|0:ZFP14|0:ZNF529|0:MKNK1|0:PLEKHO1|0:ZNF556|0:HESX1|0:ZNF605|0:FRA10AC1|0:PSMC3IP|0:AKNA|0:HOXD13|0:PRRX1|0:ZFP41|0:FMN1|0:ZFPM2|0:NSD1|0:BEX2|0:ZNF518B|0:RAD54B|0:ZNF177|0:ZNF442|0:FOXR1|0:INCA1|0:CHTF18|0:TOX|0:ZNF479|0:NFATC3|0:PRKACB|0:ZNF705A|0:PRDM13|0:L3MBTL4|0:ZXDC|0:EOMES|0:PAX2|0:ZNF223|0:FAM125A|0:HIST2H2AC|0:ZBTB24|0:PRDM1|0:BIN1|0:DUSP23|0:TRIP6|0:NR3C2|0:ZFP62|0:PARP15|0:NUCKS1|0:NXN|0:FOXJ3|0:ZIC5|0:PARP12|0:ZNF582|0:HOXA2|0:ZNF430|0:ZNF691|0:ZNF808|0:MEX3A|0:PDX1|0:DCLRE1A|0:SAMD11|0:TRDMT1|0:ZNF501|0:RHOXF2|0:TCEB3CL2|0:CBX7|0:ZNF589|0:ESCO1|0:NFE2L1|0:ZNF483|0:FOXI3|0:FER|0:NPLOC4|0:HIST1H2BK|0:ISX|0:PHTF1|0:TGIF1|0:MNT|0:RELB|0:ZNF512B|0:ZNF615|0:ZNF469|0:ZMAT2|0:HMGB1P10|0:RORC|0:C2orf3|0:HIST1H2BD|0:ZNF418|0:PSMB3|0:ZBTB3|0:EIF1AD|0:DUX5|0:ALKBH6|0:C16orf75|0:ERRFI1|0:KIAA0101|0:ZNF280A|0:SIVA1|0:RUFY2|0:VGLL4|0:SPC24|0:ZFAT|0:ZNF734|0:MLXIP|0:SUPV3L1|0:TLX3|0:CTNND2|0:ZNF189|0:SETD2|0:PTPN18|0:ZBTB34|0:HES5|0:PHLPP2|0:ZNF202|0:LIN54|0:ZNF197|0:PTOV1|0:ZNF141|0:IKZF1|0:PSMC2|0:HIST1H2AE|0:SWAP70|0:ZNF596|0:SFSWAP|0:ZNF716|0:ZNF707|0:HIST1H2AL|0:DTX1|0:TTC35|0:FOXO6|0:SIX3|0:CRY1|0:NR2C2AP|0:ZNF585B|0:POU5F2|0:MARVELD1|0:AFF4|0:NCAPG2|0:NUDT6|0:REV3L|0:MYCT1|0:ZNF546|0:CRTC2|0:C1orf77|0:DQX1|0:SNX20|0:LARP6|0:ZNF621|0:LGALS14|0:ZFP82|0:ZNF292|0:TBX15|0:CCND3|0:ZBTB8A|0:ZNF761|0:FAM123B|0:PDCD2|0:NMRAL1|0:GZF1|0:PSMA4|0:ZNF45|0:ZNF610|0:KLF1|0:H2BFM|0:VEZF1|0:ZNF394|0:TREX2|0:EPB41|0:HIST2H2BC|0:SOCS7|0:HDX|0:ZFP91|0:ATAD2|0:NPEPPS|0:ZNF283|0:ZNF699|0:T|0:ZNF23|0:MAP3K2|0:DDIT3|0:ZBTB9|0:SPDEF|0:MBD3L1|0:RBM47|0:TCEAL5|0:NEUROG2|0:POLN|0:H1FX|0:EID3|0:ZNF569|0:MED28|0:DR1|0:NCKIPSD|0:JMJD1C|0:NFKBIB|0:C5orf20|0:ZNF100|0:REL|0:EWSR1|0:AKAP13|0:ZNF337|0:PADI6|0:HEY2|0:CITED4|0:SSX2IP|0:BRF2|0:RFX4|0:CLUAP1|0:KDM5D|0:PTK6|0:HOXD9|0:ZNF436|0:HES4|0:PSME3|0:ONECUT2|0:ATXN8|0:ATOH7|0:ZNF845|0:YY2|0:LHX9|0:ZNF562|0:ZNF383|0:PDGFC|0:ZNF358|0:DAZ4|0:TP53TG3B|0:ST18|0:PSMB9|0:PCIF1|0:WDR77|0:JUP|0:PDCD4|0:CITED2|0:CENPE|0:PEX19|0:TFAP2A|0:EID1|0:CSRP2BP|0:TH|0:CIDEA|0:FTO|0:NOS2|0:PSMD9|0:ALPK3|0:THYN1|0:CEP57|0:ADIG|0:HNRNPAB|0:HEXIM2|0:NF1|0:TRNAU1AP|0:SEPSECS|0:APBB2|0:DTNBP1|0:TDRD9|0:ZBTB38|0:EGR1|0:ZSCAN10|0:HUWE1|0:PPM1M|0:GLIS1|0:CEBPG|0:HNRNPUL2|0:PTGS2|0:TRIM35|0:RFX6|0:LDB1|0:SOX13|0:PSMG2|0:CSNK1D|0:PHIP|0:PIWIL4|0:TRIB3|0:IRS1|0:RTEL1|0:PHB2|0:PARD6A|0:ZC3H8|0:RNF10|0:C6orf108|0:SNAI1|0:METTL14|0:MAP2K7|0:KDM1B|0:TRAK1|0:LPIN1|0:MTL5|0:PDS5B|0:FERD3L|0:AGAP2|0:EEF1E1|0:RAG1|0:CSNK1E|0:POU3F3|0:THEMIS|0:MAGEE1|0:STAT3|0:EIF2B5|0:NASP|0:DAPK3|0:SOX10|0:IGFN1|0:RBM3|0:FBXO25|0:CDCA5|0:FIZ1|0:RIPPLY1|0:WDYHV1|0:DVL2|0:HSPA4L|0:ATF4|0:SPDYC|0:JMY|0:RHOB|0:C11orf9|0:RGN|0:SRRM4|0:TCF21|0:CTCFL|0:CSRNP1|0:PDZD2|0:ZNF496|0:LMO1|0:RIPPLY2|0:CSRNP2|0:ANP32E|0:MDFI|0:SNRK|0:DDX25|0:TESK2|0:ADAM10|0:RALGAPA1|0:HCLS1|0:ZNF212|0:ZNF83|0:ZNF257|0:EMX2|0:UPF3A|0:UNG|0:HMGXB4|0:ZNF165|0:PRMT5|0:NAA38|0:BHLHE40|0:ZRSR1|0:SOX6|0:NAB1|0:SLC2A4RG|0:TBX22|0:BRD3|0:PEX14|0:ZFP37|0:ZNF117|0:SDCBP|0:SETD7|0:HOXB9|0:GATA4|0:KNTC1|0:ZNF331|0:DMTF1|0:SSBP2|0:ZNF215|0:HOXB4|0:FOXS1|0:NKX6-2|0:HKR1|0:PCBP2|0:BHLHE41|0:FAM50A|0:IFT46|0:SOX21|0:ARID3A|0:ELF3|0:GCM2|0:SALL2|0:CUX2|0:EMX1|0:IKZF2|0:PPP2R1A|0:DNAJC2|0:NECAB3|0:C14orf4|0:C11orf1|0:ZNF93|0:ZNF282|0:SUPT6H|0:ING1|0:ZNF398|0:NCAPG|0:DSCR6|0:ZNF187|0:AHNAK|0:BTF3P13|0:SORBS2|0:HOXB8|0:RNF7|0:PKP2|0:SMURF2|0:HIC1|0:ZSCAN21|0:CABIN1|0:PPP2CA|0:SEC14L2|0:PBXIP1|0:MYCL1|0:UPF3B|0:SCRT1|0:ZNF2|0:L3MBTL2|0:ZNF72|0:NME2|0:HIVEP2|0:ARID3B|0:CDC34|0:FOXD4|0:DLX1|0:MNX1|0:MITF|0:HOXD11|0:ZNF41|0:HES7|0:TIAF1|0:ZKSCAN1|0:SNURF|0:ZNF33B|0:MOCS1|0:HOXB1|0:POLL|0:ZNF268|0:PRICKLE4|0:ZNF91|0:NAT14|0:RASSF7|0:PKP1|0:HMG20B|0:EEFSEC|0:ZNF92|0:ZXDA|0:LSM7|0:ZNF69|0:ZKSCAN5|0:ZNF205|0:ZNF253|0:RAG2|0:TULP3|0:EVX2|0:PRDM2|0:NR4A3|0:SOX15|0:ZNF3|0:LRRFIP1|0:CNOT2|0:STK39|0:BTF3P12|0:CSDC2|0:NKX3-1|0:ZNF160|0:SOX1|0:TP53TG1|0:TCF20|0:ZNF135|0:SARNP|0:BLZF1|0:TLE4|0:HOXB7|0:ZNF214|0:RBMS1|0:HOXC13|0:NGRN|0:FUBP3|0:ZNF154|0:ZNF8|0:CHD6|0:ZNF81|0:OTX1|0:CDR2|0:DENND4A|0:ZNF184|0:SEPT4|0:MDN1|0:GTF2IRD1|0:ZNF19|0:MDM4|0:ZNF200|0:ZNF208|0:DMRT3|0:APPBP2|0:ZNF79|0:ZFPL1|0:ZNF90|0:TCF7L1|0:HMGN2|0:HMG20A|0:TBX18|0:ANKRD30A|0:ZNF73|0:CELF6|0:ZNF80|0:PLCB1|0:HOXB6|0:L3MBTL3|0:C16orf5|0:ZXDB|0:ZNF33A|0:RUNX3|0:ZNF70|0:TBX21|0:KLF2|0:PARP4|0:ZNF75D|0:FOXG1|0:PPARD|0:ZNF84|0:HOXD8|0:HOXC4|0:ZNF211|0:ABCC13|0:BTAF1|0:HMGN3|0:PAX9|0:VGLL1|0:ARNTL2|0:LZTS1|0:ZNF134|0:ZNF195|0:LATS2|0:ONECUT1|0:PPP4C|0:C9orf89|0:CSRP2|0:SAE1|0:ZNF37A|0:NEK3|0:ZNF131|0:AIRE|0:CELF1|0:PCBP1|0:NKX1-1|0:MYBL1|0:ZNF169|0:CNOT8|0:NCOA2|0:HOXC8|0:ZNF207|0:ZNF277|0:HOXD4|0:ZNF138|0:DLX4|0:MYT1|0:ZNF236|0:BRIP1|0:BCL11A|0:FANCE|0:ZSCAN22|0:GLI4|0:CHD7|0:KDM5B|0:SGMS1|0:ISCU|0:TOB2|0:PIR|0:RBM6|0:CALCOCO2|0:RBMY1A1|0:PKN3|0:MAPKAPK3|0:SPANXA1|0:KIF22|0:HINT1|0:JRKL|0:HRSP12|0:HIVEP1|0:AIFM1|0:ZNF85|0:TOP3B|0:DUSP2|0:MTF1|0:TUB|0:CSE1L|0:ZBTB6|0:PTMA|0:DGKI|0:LSM5|0:MRPL40|0:AURKC|0:G3BP1|0:POLE3|0:ESRRA|0:DHX16|0:ASH1L|0:PTTG1|0:BNC1|0:RBBP8|0:VPS72|0:LDOC1|0:RAD51L1|0:PFDN5|0:PPBPL2|0:SS18|0:TLE1|0:MLLT1|0:CMPK1|0:CRK|0:NEDD9|0:DUSP9|0:ATF6B|0:ZFP161|0:MAPKAPK2|0:FANCC|0:MORC1|0:SPEG|0:DCTN4|0:PPP5C|0:SP110|0:PRC1|0:TCERG1|0:SNAPC5|0:EIF4ENIF1|0:SNAPC2|0:RECQL|0:ZBTB22|0:CSTF3|0:MPO|0:AIF1|0:EHD3|0:PPP2R5D|0:CDC14A|0:MSMB|0:HLF|0:TCF4|0:FANCA|0:WBP11|0:SLC9A3R2|0:TARBP1|0:PPP1R13L|0:NRL|0:EHD4|0:POLE4|0:HAT1|0:STK19|0:KPTN|0:SNAPC3|0:NR1H3|0:NEDD8|0:KLF10|0:SNAI2|0:NCOA4|0:ERG|0:NR4A2|0:BUD31|0:DUX1|0:RCAN1|0:EHD2|0:NFAT5|0:DUSP10|0:SESN1|0:ARL6IP4|0:STAMBP|0:PMS1|0:DEK|0:TNPO2|0:IRF9|0:NR1D1|0:AFF3|0:PSMA1|0:YBX2|0:SND1|0:ARL4C|0:CCRN4L|0:ATN1|0:CREBL2|0:DUT|0:RAD51L3|0:FOXN1|0:RBMY1C|0:PTH1R|0:BSN|0:PIN1|0:DDX39|0:PTMS|0:PPP1R7|0:MSC|0:KLF11|0:FHL2|0:CHAT|0:RAD51C|0:SSNA1|0:MX2|0:TRIM32|0:VHL|0:SPANXA2|0:THRB|0:TSN|0:LMO7|0:BLMH|0:TLE3|0:TNPO1|0:STAG1|0:PWP1|0:DDX17|0:PPM1G|0:GMEB1|0:HSBP1|0:MSL3|0:PRMT2|0:BATF3|0:TFPT|0:ZRANB2|0:DUSP11|0:PREB|0:FHOD1|0:CDK2AP1|0:LHX3|0:RAD54L|0:FRK|0:CIZ1|0:COX4NB|0:FOSL1|0:TCEAL1|0:CSTF1|0:PPP2R3B|0:FYB|0:TLE2|0:AURKA|0:RPP14|0:ETV7|0:CEBPZ|0:SRSF7|0:SPOP|0:TMBIM6|0:MXD1|0:PPM1D|0:RFX5|0:PNRC1|0:DYRK1B|0:DNMT1|0:MXI1|0:SSX1|0:SERPINA3|0:STAG2|0:SPANXB2|0:PATZ1|0:TGIF2|0:PSMB4|0:NME1|0:PSMA3|0:RPSA|0:HTRA2|0:UBP1|0:UBE2V1|0:SPANXF1|0:RANBP1|0:REST|0:GZMA|0:RBAK|0:KLF6|0:NFATC2|0:IKZF4|0:SPANXC|0:LIMK2|0:PPIL2|0:DUSP16|0:CLIC2|0:NR1D2|0:SH3BGRL|0:NOTCH1|0:POU5F1B|0:PAPOLA|0:GZMB|0:STIP1|0:SPANXB1|0:ESR2|0:SMC4|0:PPARA|0:NOTCH4|0:RBMY1B			
GO:0000244	P:assembly of spliceosomal tri-snRNP; TAS:ProtInc		0:PRPF31|0:PRPF6|0:CD2BP2|0:SRSF12|0:SRSF10|0:DDX20			
GO:0033782	F:24-hydroxycholesterol 7alpha-hydroxylase ac...; IEA:EC		0:CYP39A1			
GO:0046947	P:hydroxylysine biosynthetic process; TAS:UniProtKB		0:PLOD1			
GO:0006701	P:progesterone biosynthetic process; TAS:ProtInc		0:LHB|0:FSHB|0:ADM			
GO:0006417	P:regulation of translation; TAS:HGNC		0:KRT7|0:PPP1R15A|0:MKNK2|0:PUM2|0:LSM14B|0:GCN1L1|0:CPEB2|0:PIWIL4|0:NANOS1|0:NANOS3|0:TARBP2|0:NCK1|0:MAGOH|0:PIWIL1|0:AKT1|0:MIF4GD|0:TACO1|0:QKI|0:NCK2|0:SARNP|0:TNRC6C|0:RBM8A|0:PUM1|0:NGDN|0:TNRC6B|0:PPP1R15B|0:PIWIL3|0:MKNK1|0:CPEB1|0:IMPACT|0:LSM14A|0:CASC3|0:NANOS2|0:PA2G4|0:APP|0:DDX25|0:MTPN|0:ATXN2|0:METAP1			
GO:0001888	F:glucuronyl-galactosyl-proteoglycan 4-alpha-...; IEA:EC		0:EXTL2|0:EXTL3			
GO:0043123	P:positive regulation of I-kappaB kinase/NF-k...; ISS:UniProtKB		0:PARK2|0:TNF|0:TLR9|0:PINK1|0:TLR6|0:TRAF6|0:S100A4|0:S100A13|0:RNF31|0:NUP62|0:S100B|0:RBCK1|0:S100A12|0:NOD2|0:TAB2|0:CD40|0:HTR2B|0:NOD1|0:TNFSF10|0:MYD88|0:FADD|0:TNFRSF1A|0:RIPK2|0:FASLG|0:TNFRSF10B|0:LPAR1|0:BIRC2|0:F2R|0:CFLAR|0:BCL10|0:TBK1|0:RHOA|0:RIPK1|0:MAP3K3|0:LTBR|0:CASP1|0:TRAF3IP2|0:TRADD|0:TRAF5|0:CARD9|0:IKBKE|0:RELA|0:CASP8|0:REL|0:UBE2V1|0:UBE2N|0:MIER1|0:MALT1|0:MAP3K14|0:ATP2C1|0:TSPAN6|0:C18orf32|0:ECM1|0:CXXC5|0:TFG|0:LGALS9|0:PPP5C|0:EEF1D|0:NDFIP2|0:BST2|0:MUL1|0:TMEM101|0:MIB2|0:NEK6|0:MAVS|0:HMOX1|0:SLC44A2|0:LGALS1|0:LITAF|0:PLK2|0:TRIM13|0:PPM1A|0:SECTM1|0:CANT1|0:SLC35B2|0:CC2D1A|0:UBD|0:SLC20A1|0:TRIM38|0:NDFIP1|0:GOLT1B|0:ZDHHC13|0:MAP3K7|0:SHISA5|0:ZDHHC17|0:PLEKHG5|0:TMED4|0:RHOC|0:TICAM2|0:ECT2|0:TICAM1|0:GJA1|0:VAPA|0:TMEM9B|0:APOL3|0:FLNA|0:FKBP1A|0:WLS|0:PIM2|0:TERF2IP|0:PRKCB			
GO:0050773	P:regulation of dendrite development; NAS:UniProtKB		0:DBN1			
GO:0015433	F:peptide antigen-transporting ATPase activity; TAS:ProtInc		0:TAP2|0:TAPBP			
GO:0070022	C:transforming growth factor beta receptor co...; IC:BHF-UCL		0:TGFBR2|0:ENG|0:TGFBR1			
GO:0002368	P:B cell cytokine production; IDA:BHF-UCL		0:HSPD1			
GO:0071598	C:neuronal RNA granule; ISS:BHF-UCL		0:UHMK1			
GO:0017158	P:regulation of calcium ion-dependent exocytosis; NAS:UniProtKB		0:DOC2A|0:TRPV6			
GO:0001946	P:lymphangiogenesis; ISS:UniProtKB		0:PROX1|0:FOXC2|0:SOX18|0:CCBE1|0:PDPN			
GO:0070932	P:histone H3 deacetylation; IDA:BHF-UCL		0:HDAC1|0:HDAC4|0:HDAC9			
GO:0005025	F:transforming growth factor beta receptor ac...; IDA:BHF-UCL		0:TGFBR1			
GO:0045191	P:regulation of isotype switching; NAS:UniProtKB		0:IL10			
GO:0005345	F:purine transmembrane transporter activity; IDA:UniProtKB		0:AQP9			
GO:0000097	P:sulfur amino acid biosynthetic process; TAS:UniProtKB		0:CDO1			
GO:0031309	C:integral to nuclear outer membrane; ISS:UniProtKB		0:C19orf46			
GO:0045217	P:cell-cell junction maintenance; NAS:UniProtKB		0:PARD6A|0:NLGN2			
GO:0010510	P:regulation of acetyl-CoA biosynthetic proce...; EXP:Reactome		0:PDP1|0:PDK3|0:DLAT|0:PDHB|0:PDK4|0:DLD|0:PDK1|0:PDP2|0:PDHX|0:PDK2|0:PDHA1			
GO:0003705	F:RNA polymerase II transcription factor acti...; TAS:UniProtKB		0:HIF1A|0:USF1|0:JUN|0:RELA|0:TFAP4|0:USF2|0:SOX17|0:PROX1|0:CEBPB|0:CEBPA|0:GTF2IRD1|0:RFX3|0:NR5A2|0:MYF5|0:PURA|0:NFIX|0:EPAS1|0:IRF8|0:RFX1|0:MYOD1|0:ZFHX3			
GO:0031088	C:platelet dense granule membrane; IDA:MGI		0:SELP|0:CD63|0:ITPR1|0:LAMP2|0:ABCC4			
GO:0045445	P:myoblast differentiation; NAS:UniProtKB		0:IGF1|0:MAPK12|0:HINFP|0:RB1|0:MBNL1|0:JAG1			
GO:2000019	P:negative regulation of male gonad development; IMP:UniProtKB		0:WNT4			
GO:0031143	C:pseudopodium; TAS:UniProtKB		0:ARRB1|0:MYOZ1|0:LDB3|0:KBTBD10|0:ACTN2|0:ACTN3|0:ACTN4|0:ACTN1			
GO:0010821	P:regulation of mitochondrion organization; IDA:UniProtKB		0:GOLPH3			
GO:0010469	P:regulation of receptor activity; TAS:BHF-UCL		0:SERPINE1|0:PCSK9|0:PLAU|0:HDAC6|0:PRKCD			
GO:0008610	P:lipid biosynthetic process; IMP:UniProtKB		0:AGPS|0:LASS6|0:PC|0:MOGAT1|0:AWAT1|0:FAR2|0:MOGAT3|0:DGAT2L6|0:ACLY|0:ACSS2			
GO:0004496	F:mevalonate kinase activity; IDA:UniProtKB		0:MVK			
GO:0048247	P:lymphocyte chemotaxis; NAS:UniProtKB		0:CKLF|0:SAA1|0:SAA2|0:CXCL16			
GO:0048145	P:regulation of fibroblast proliferation; TAS:BHF-UCL		0:CTNNB1			
GO:0035267	C:NuA4 histone acetyltransferase complex; IDA:UniProtKB		0:RUVBL2|0:MEAF6|0:MORF4L1|0:KAT5|0:RUVBL1|0:DMAP1|0:EPC1|0:TRRAP|0:ING3|0:ACTB|0:YEATS4|0:EP400|0:BRD8|0:ACTL6A			
GO:0005765	C:lysosomal membrane; TAS:ProtInc		0:SLC15A3|0:SLC15A4|0:SLC11A2|0:TRIM23|0:LAMP2|0:SLC17A5|0:ABCB9|0:MYO7A|0:CLN5|0:ABCA2|0:CTNS|0:HLA-DOA|0:SLC48A1|0:HLA-DRB3|0:NPC1|0:CUBN|0:HLA-DRA|0:SPHK2|0:LMBRD1|0:PLA2G4E|0:ACP2|0:DRAM1|0:TMEM55B|0:CLCN7|0:SCARB2|0:CLN3|0:HLA-DRB4|0:MFSD8|0:VPS16|0:CCZ1|0:HLA-DOB|0:ABCA5|0:TM9SF1|0:TMEM74|0:ACPP|0:HLA-DMA|0:MMD|0:SORT1|0:HLA-DPB1|0:FAM176A|0:LITAF|0:VPS39|0:VPS18|0:PLA2G4F|0:SLC30A2|0:CD1B|0:HLA-DMB|0:VPS11|0:VPS33B|0:ITM2C|0:TMEM9|0:MCOLN1|0:HLA-DRB1|0:ROBLD3|0:VPS33A|0:HLA-DRB5|0:ARL8A|0:CD68|0:HLA-DQA2|0:PNPLA7|0:IGF2R|0:TMEM192|0:CYBASC3|0:MARCH9|0:MARCH2|0:SLC36A1|0:C7orf28B|0:C1orf85|0:NEU1|0:SLC29A3|0:HLA-DQA1|0:HPSE|0:LAMP1|0:ZNRF2|0:DRAM2|0:GAA|0:CD164|0:ARL8B|0:CD1D|0:MARCH8|0:HLA-DQB1|0:HLA-DPA1|0:GBA|0:M6PR|0:TSPAN1|0:LAPTM5|0:TMEM55A|0:HLA-DQB2|0:HGSNAT|0:MARCH1|0:VAMP7|0:RNF13|0:RILP|0:CD63|0:LAMP3			
GO:0060267	P:positive regulation of respiratory burst; IDA:BHF-UCL		0:INS|0:INSR			
GO:0008404	F:arachidonic acid 14,15-epoxygenase activity; IDA:BHF-UCL		0:CYP2J2			
GO:0007250	P:activation of NF-kappaB-inducing kinase act...; NAS:UniProtKB		0:TNFSF15|0:CARD10|0:IRAK1|0:ZFP91|0:TRAF6|0:MALT1|0:MAP3K7|0:TRAF2|0:TLR3|0:TLR6|0:TNFRSF10B|0:TNFRSF10A|0:CARD14			
GO:0043122	P:regulation of I-kappaB kinase/NF-kappaB cas...; IMP:UniProtKB		0:SQSTM1			
GO:0008608	P:attachment of spindle microtubules to kinet...; IMP:UniProtKB		0:SGOL1|0:CASC5|0:BUB3|0:NDC80			
GO:0007091	P:mitotic metaphase/anaphase transition; TAS:ProtInc		0:CDC27|0:CDC23			
GO:0006958	P:complement activation, classical pathway; TAS:ProtInc		0:C8G|0:MASP2|0:C4BPA|0:C1QC|0:CD55|0:C7|0:C3|0:SERPING1|0:CLU|0:C1QB|0:C1RL|0:C9|0:C1R|0:CD46|0:C4BPB|0:C5|0:CR1|0:C1QA|0:C8A|0:MBL2|0:C1S|0:C4A|0:CFI|0:C8B|0:C6|0:CR2|0:C2			
GO:0004078	F:biotin-[methylcrotonoyl-CoA-carboxylase] li...; IEA:EC		0:HLCS			
GO:0006418	P:tRNA aminoacylation for protein translation; TAS:ProtInc		0:AIMP1			
GO:0005585	C:collagen type II; IDA:BHF-UCL		0:COL2A1			
GO:0033205	P:cell cycle cytokinesis; IMP:BHF-UCL		0:BRCA2|0:BBS4			
GO:0033138	P:positive regulation of peptidyl-serine phos...; IMP:BHF-UCL		0:LATS1|0:MIF|0:CD44|0:AXIN1|0:CAV1|0:TGFB1|0:LIF|0:OSM|0:IL6|0:IL11|0:DOCK7			
GO:0001906	P:cell killing; IEA:InterPro		0:N4BP2L1|0:HNRNPUL2|0:N4BP2L2|0:HNRNPU|0:CNP			
GO:0032836	P:glomerular basement membrane development; ISS:UniProtKB		0:COL4A4|0:WT1|0:COL4A3|0:MPV17			
GO:0034648	F:histone demethylase activity (H3-dimethyl-K...; ISS:UniProtKB		0:KDM5B|0:KDM1A|0:KDM1B			
GO:0005816	C:spindle pole body; TAS:ProtInc		0:BUB1			
GO:0010711	P:negative regulation of collagen catabolic p...; IEP:BHF-UCL		0:CST3			
GO:0034587	P:piRNA metabolic process; ISS:UniProtKB		0:TDRD9|0:PIWIL4|0:TDRD1|0:MAEL|0:ASZ1|0:PIWIL2			
GO:0019841	F:retinol binding; IEA:UniProtKB-KW		0:RBP4|0:ADH4|0:ADH7|0:C8G|0:RBP5|0:CRABP1|0:RBP1|0:CRABP2|0:RBP7|0:RLBP1|0:RBP2			
GO:0000212	P:meiotic spindle organization; ISS:UniProtKB		0:TUBG1			
GO:0021853	P:cerebral cortex GABAergic interneuron migra...; ISS:UniProtKB		0:DRD1|0:DRD2|0:LHX6			
GO:0031755	F:Edg-2 lysophosphatidic acid receptor binding; IDA:UniProtKB		0:ADRBK1|0:RALA			
GO:0004514	F:nicotinate-nucleotide diphosphorylase (carb...; IDA:UniProtKB		0:QPRT			
GO:0022616	P:DNA strand elongation; IDA:BHF-UCL		0:TERT			
GO:0004349	F:glutamate 5-kinase activity; IEA:EC		0:ALDH18A1			
GO:0009881	F:photoreceptor activity; TAS:ProtInc		0:RRH|0:CRY2|0:RHO|0:OPN1SW|0:OPN5|0:RGR|0:OPN1LW|0:OPN1MW|0:OPN1MW2			
GO:0006043	P:glucosamine catabolic process; IMP:UniProtKB		0:GNPDA1			
GO:0033373	P:maintenance of protease location in mast ce...; ISS:UniProtKB		0:SRGN			
GO:0045407	P:positive regulation of interleukin-5 biosyn...; ISS:UniProtKB		0:IL9			
GO:0032430	P:positive regulation of phospholipase A2 act...; IMP:BHF-UCL		0:AGTR1			
GO:0006000	P:fructose metabolic process; TAS:ProtInc		0:FBP2			
GO:0008457	F:beta-galactosyl-N-acetylglucosaminylgalacto...; IDA:UniProtKB		0:B3GNT5			
GO:0007612	P:learning; TAS:ProtInc		0:SBDS|0:TH|0:DLG4|0:FYN			
GO:0007030	P:Golgi organization; TAS:ProtInc		0:BLZF1|0:SYNE1|0:DYNC2H1|0:ATL3|0:ATL2|0:COG2|0:GOLGA5|0:COG4|0:NPLOC4|0:COG1|0:SEC23IP|0:GOLGB1			
GO:0016992	F:lipoate synthase activity; IEA:EC		0:LIAS			
GO:0016922	F:ligand-dependent nuclear receptor binding; NAS:BHF-UCL		0:TRIP4|0:PROX1|0:PPARGC1A|0:NCOA3|0:TADA3|0:MED1|0:NCOA2|0:NSD1|0:BAZ2A			
GO:0000076	P:DNA replication checkpoint; TAS:ProtInc		0:CDT1|0:TIPIN|0:CDC45|0:RAD9A|0:RAD17|0:CDC6			
GO:0050152	F:omega-amidase activity; IEA:EC		0:NIT2			
GO:0060231	P:mesenchymal to epithelial transition; TAS:BHF-UCL		0:FZD7|0:CITED1			
GO:0018192	P:enzyme active site formation via L-cysteine...; IDA:UniProtKB		0:MOCS3			
GO:0060339	P:negative regulation of type I interferon-me...; IDA:UniProtKB		0:NLRC5			
GO:0006978	P:DNA damage response, signal transduction by...; TAS:UniProtKB		0:HIPK2|0:SP100|0:ING4|0:RBM38|0:KAT5|0:TFAP4|0:TP53|0:BRCA1			
GO:0004551	F:nucleotide diphosphatase activity; TAS:ProtInc		0:ENPP1|0:ENPP3|0:ENPP2			
GO:0003919	F:FMN adenylyltransferase activity; EXP:Reactome		0:FLAD1			
GO:0051482	P:elevation of cytosolic calcium ion concentr...; IDA:UniProtKB		0:DRD1|0:AGTR1|0:DRD2|0:CALCA			
GO:0000338	P:protein deneddylation; IMP:UniProtKB		0:COPS5			
GO:0030130	C:clathrin coat of trans-Golgi network vesicle; NAS:UniProtKB		0:AP1S3|0:CLTC|0:AP1S2|0:CLTCL1|0:CLTB|0:CLTA|0:AP2A1|0:NCALD			
GO:0009267	P:cellular response to starvation; ISS:UniProtKB		0:ALB|0:FADS1|0:BMPR2|0:CAV1|0:SIRT1|0:CARTPT|0:SREBF1|0:PCSK9|0:INHBB			
GO:0050201	F:fucokinase activity; NAS:UniProtKB		0:FUK			
GO:0032934	F:sterol binding; TAS:ProtInc		0:C20orf79|0:STOML1|0:HSDL2|0:HSD17B4|0:SCP2			
GO:0007006	P:mitochondrial membrane organization; TAS:ProtInc		0:MFN2|0:TIMM50|0:DNM1L			
GO:0004777	F:succinate-semialdehyde dehydrogenase activity; IDA:UniProtKB		0:ALDH5A1			
GO:0004610	F:phosphoacetylglucosamine mutase activity; IDA:UniProtKB		0:PGM3			
GO:0030137	C:COPI-coated vesicle; TAS:ProtInc		0:AP3B2			
GO:0015299	F:solute:hydrogen antiporter activity; IEA:InterPro		0:TMCO3|0:NHEDC2|0:NHEDC1|0:SLC9A10|0:SLC9A11			
GO:0051297	P:centrosome organization; IMP:UniProtKB		0:CROCC|0:PCM1|0:CKAP5|0:UXT|0:HAUS7|0:HAUS3|0:HAUS4|0:HAUS1|0:BBS4|0:HAUS8|0:HAUS5|0:HAUS2|0:HAUS6			
GO:0034372	P:very-low-density lipoprotein particle remod...; TAS:BHF-UCL		0:APOA4|0:APOE|0:CETP|0:LIPC|0:LPL|0:LCAT|0:APOC2			
GO:0004361	F:glutaryl-CoA dehydrogenase activity; TAS:ProtInc		0:GCDH			
GO:0005911	C:cell-cell junction; TAS:ProtInc		0:TLN1|0:TLN2|0:EPB41L3|0:CDH24|0:CLIC4|0:AQP3|0:CTNNA1|0:STX3|0:PTPRU|0:PTPRK|0:AQP7|0:CADM3|0:AMTN|0:CDC42BPB|0:CDC42BPA|0:PDZD2|0:CADM1|0:DLG1|0:STEAP1|0:MLLT4|0:PCDH1|0:COL17A1|0:CNN2|0:BAI1|0:CNKSR1			
GO:0004679	F:AMP-activated protein kinase activity; TAS:ProtInc		0:PRKAG3			
GO:0043189	C:H4/H2A histone acetyltransferase complex; IEA:InterPro		0:C20orf20			
GO:0032279	C:asymmetric synapse; ISS:UniProtKB		0:GRM7			
GO:0032790	P:ribosome disassembly; ISS:HGNC		0:GFM2|0:MRRF|0:MTIF3			
GO:0009086	P:methionine biosynthetic process; IEA:UniProtKB-KW		0:BHMT2|0:MTHFD1|0:APIP|0:MTHFD2L|0:MTRR|0:MRI1			
GO:0000209	P:protein polyubiquitination; TAS:ProtInc		0:STUB1|0:PRPF19|0:BCL2|0:PPIL2|0:CHFR|0:ERCC8|0:PARK2|0:TRAF6|0:LRSAM1|0:HUWE1|0:DZIP3|0:FBXW11|0:UBE2D3|0:TRIM21|0:DTL|0:ARIH2|0:FBXO4|0:CDC34|0:UBE2L3|0:BIRC2|0:UBE3C|0:RNF31|0:RNF167|0:RNF41|0:NHLRC1|0:RNF20|0:RBCK1|0:SMURF1|0:DDB2|0:AMFR|0:UBE2D1|0:UBE2E1|0:UBE2B|0:ZNF738|0:UBE2V1|0:UBE2V2			
GO:0010980	P:positive regulation of vitamin D 24-hydroxy...; IDA:UniProtKB		0:VDR|0:CYP27B1|0:FGF23			
GO:0004963	F:follicle-stimulating hormone receptor activity; TAS:ProtInc		0:FSHR			
GO:0046426	P:negative regulation of JAK-STAT cascade; IDA:HGNC		0:HGS			
GO:0060632	P:regulation of microtubule-based movement; IMP:UniProtKB		0:HDAC6|0:IGBP1			
GO:0045019	P:negative regulation of nitric oxide biosynt...; ISS:UniProtKB		0:CAV1|0:GLA			
GO:0010593	P:negative regulation of lamellipodium assembly; IDA:UniProtKB		0:SLIT2			
GO:0009214	P:cyclic nucleotide catabolic process; IEA:InterPro		0:CNP			
GO:0004146	F:dihydrofolate reductase activity; IEA:InterPro		0:DHFRP1|0:DHFR|0:DHFRL1			
GO:0008066	F:glutamate receptor activity; TAS:UniProtKB		0:GRM6|0:GRM1|0:GRM4|0:GRM5			
GO:0042176	P:regulation of protein catabolic process; TAS:HGNC		0:PSMD3|0:PSMD1|0:PSMD2|0:FAF1|0:NEDD4L|0:HGS			
GO:0008054	P:cyclin catabolic process; TAS:ProtInc		0:CUL3|0:UBE2C|0:FBXO31|0:ANAPC2			
GO:0007042	P:lysosomal lumen acidification; IMP:UniProtKB		0:PPT1|0:CLN3|0:CLN5|0:CLN6			
GO:0004098	F:cerebroside-sulfatase activity; IEA:EC		0:ARSA			
GO:0004540	F:ribonuclease activity; NAS:UniProtKB		0:DIS3L|0:DIS3|0:DIS3L2|0:AZGP1			
GO:0060192	P:negative regulation of lipase activity; IDA:BHF-UCL		0:APOA2			
GO:0019852	P:L-ascorbic acid metabolic process; NAS:UniProtKB		0:SLC23A2			
GO:0048386	P:positive regulation of retinoic acid recept...; IDA:UniProtKB		0:ESR1|0:TRIM16			
GO:0017048	F:Rho GTPase binding; NAS:UniProtKB		0:PARD6A|0:RHOH			
GO:0016422	F:mRNA (2'-O-methyladenosine-N6-)-methyltrans...; ISS:UniProtKB		0:METTL3|0:METTL14			
GO:0047894	F:flavonol 3-sulfotransferase activity; IDA:BHF-UCL		0:SULT1A1|0:SULT1A2|0:SULT1E1			
GO:0042368	P:vitamin D biosynthetic process; IDA:BHF-UCL		0:CYP27B1			
GO:0019206	F:nucleoside kinase activity; EXP:Reactome		0:AK5			
GO:0009994	P:oocyte differentiation; IEP:UniProtKB		0:NPM2			
GO:0008321	F:Ral guanyl-nucleotide exchange factor activity; NAS:UniProtKB		0:RGL1			
GO:0016567	P:protein ubiquitination; TAS:UniProtKB		0:DCAF11|0:DCAF4|0:DCAF6|0:DCAF12|0:DCAF5|0:DCAF16|0:DCAF13|0:DCAF8|0:DCAF10|0:DCAF17|0:DCAF7|0:PCNP|0:KLHL13|0:TRPC4AP|0:KCTD13|0:CUL3|0:ATG3|0:CCNF|0:RBX1|0:TNFAIP1|0:TRIM33|0:KLHL9|0:FBXW7|0:ANAPC16|0:UBD|0:CAND1|0:KLHL21|0:CUL1|0:VHLL|0:RNF14|0:ARRB1|0:NUB1|0:CRBN|0:ARRB2|0:UBA6|0:VHL|0:KCTD10|0:VCPIP1|0:VCP|0:SAE1			
GO:0003721	F:telomeric template RNA reverse transcriptas...; TAS:UniProtKB		0:TERT			
GO:0002151	F:G-quadruplex RNA binding; ISS:UniProtKB		0:AFF2			
GO:0046935	F:1-phosphatidylinositol-3-kinase regulator a...; TAS:ProtInc		0:CCKBR			
GO:0045155	F:electron transporter, transferring electron...; TAS:ProtInc		0:CYCS|0:CYC1			
GO:0009756	P:carbohydrate mediated signaling; TAS:UniProtKB		0:COLEC12|0:CLEC7A			
GO:0048278	P:vesicle docking; IEA:InterPro		0:CAV2|0:EXOC5			
GO:0034704	C:calcium channel complex; IDA:UniProtKB		0:ATP2A1|0:FKBP1B|0:AKAP6|0:RYR2|0:PPP2R4|0:TRPC4|0:TRPC5			
GO:0010611	P:regulation of cardiac muscle hypertrophy; IMP:UniProtKB		0:LMCD1			
GO:0003956	F:NAD(P)+-protein-arginine ADP-ribosyltransfe...; NAS:UniProtKB		0:ART1|0:ART5|0:ART3|0:SIRT6|0:ART4			
GO:0007186	P:G-protein coupled receptor protein signalin...; TAS:UniProtKB		0:APOE|0:AREG|0:INS|0:APOC3|0:AREGB|0:INSR|0:APOA1|0:PREX2|0:ARHGEF12|0:GNG10|0:RGS6|0:GNG11|0:GNAI3|0:GNG12|0:GNG7|0:GNAS|0:GNGT1|0:RGS11|0:RGS7|0:GNG4|0:GNA14|0:ABCA1|0:BAIAP3|0:ITPR3|0:GHRL|0:GNGT2|0:GNG5|0:GNB1L|0:APLP2|0:BCAR1|0:TULP3|0:GIPC1|0:GNG8|0:GNB2|0:CXCL1|0:C3|0:AKAP12|0:DEFB1|0:CCL3|0:IL8|0:DEFB4B|0:PTPN6|0:GNB3|0:PIK3CG|0:CXCL12|0:AKT1|0:TSHB|0:MLN|0:DEFB4A|0:ENPP2|0:GNA12|0:RAPGEFL1|0:CXCL9|0:CCL25|0:PYY|0:PIK3CB|0:C5|0:CCL23|0:VIP|0:CCL17|0:PDC|0:RASD1|0:RAPGEF4|0:GPSM2|0:CD3E|0:RGS19|0:GCG|0:SST|0:CALM2|0:CALM3|0:ARHGEF11|0:FRS2|0:CALM1			
GO:0071503	P:response to heparin; IMP:BHF-UCL		0:GPIHBP1			
GO:0032446	P:protein modification by small protein conju...; IDA:UniProtKB		0:ATG10			
GO:0047429	F:nucleoside-triphosphate diphosphatase activity; IEA:EC		0:ENPP3|0:ENPP1|0:ITPA			
GO:0004565	F:beta-galactosidase activity; TAS:UniProtKB		0:GBA3|0:GLB1			
GO:0008934	F:inositol-1(or 4)-monophosphatase activity; IMP:UniProtKB		0:IMPA2|0:IMPAD1|0:IMPA1			
GO:0004167	F:dopachrome isomerase activity; TAS:ProtInc		0:MIF|0:DCT|0:DDT			
GO:0006809	P:nitric oxide biosynthetic process; TAS:ProtInc		0:NOS3|0:NOS2|0:SPR|0:NOS1|0:GCH1|0:DDAH2|0:AKT1|0:ARG2|0:GCHFR|0:NQO1			
GO:0060809	P:mesodermal to mesenchymal transition involv...; ISS:UniProtKB		0:EOMES			
GO:0042827	C:platelet dense granule; IDA:UniProtKB		0:HPS4			
GO:0031623	P:receptor internalization; IMP:BHF-UCL		0:RAB5A|0:GHR|0:SNCA|0:NEDD4|0:GRB2|0:PICALM|0:DNM2|0:CLTC|0:CAV1			
GO:0043433	P:negative regulation of transcription factor...; TAS:BHF-UCL		0:FZD6|0:SMAD7|0:PROX1|0:SP100|0:SFRP4|0:KDM1A|0:TCF7L2|0:SIRT1|0:ID3|0:ID1|0:ID2|0:EGLN1|0:PEX14|0:MEN1|0:PBX1|0:PIM1|0:FLNA|0:HDAC2|0:HDAC4|0:CTNNBIP1|0:NR0B1|0:SFRP5|0:TRIB1|0:SIGIRR|0:SUMO1|0:TNFSF4|0:TNFRSF4|0:CEBPG|0:FOXS1|0:RB1			
GO:0048392	P:intermediate mesodermal cell differentiation; IDA:UniProtKB		0:BMP4			
GO:0005953	C:CAAX-protein geranylgeranyltransferase complex; TAS:ProtInc		0:PGGT1B			
GO:0070290	F:NAPE-specific phospholipase D activity; IEA:EC		0:PLD4|0:PLD6|0:PLD3|0:PLD2|0:PLD1			
GO:0040017	P:positive regulation of locomotion; ISS:UniProtKB		0:BVES			
GO:0008385	C:IkappaB kinase complex; TAS:HGNC		0:PYDC1|0:ERC1|0:PYCARD			
GO:0001778	P:plasma membrane repair; ISS:UniProtKB		0:TRIM72|0:MYOF			
GO:0051168	P:nuclear export; IDA:UniProtKB		0:MALT1|0:LSG1|0:ATXN1			
GO:0034516	P:response to vitamin B6; IMP:UniProtKB		0:KYNU			
GO:0051668	P:localization within membrane; IMP:BHF-UCL		0:RAC1|0:CDH13			
GO:0048842	P:positive regulation of axon extension invol...; IDA:UniProtKB		0:DSCAM			
GO:0003923	F:GPI-anchor transamidase activity; IMP:UniProtKB		0:PIGK			
GO:0030262	P:apoptotic nuclear change; IDA:UniProtKB		0:MOAP1|0:NDUFA13|0:DEDD2			
GO:0019885	P:antigen processing and presentation of endo...; TAS:HGNC		0:TAP2|0:TAPBP|0:TAPBPL|0:TAP1|0:ERAP1|0:ERAP2			
GO:0043268	P:positive regulation of potassium ion transport; ISS:BHF-UCL		0:DRD1|0:ADRA2A			
GO:0004756	F:selenide, water dikinase activity; NAS:UniProtKB		0:SEPHS1|0:SEPHS2			
GO:0012510	C:trans-Golgi network transport vesicle membrane; IDA:UniProtKB		0:RASSF9			
GO:0045355	P:negative regulation of interferon-alpha bio...; NAS:UniProtKB		0:IL10			
GO:0034612	P:response to tumor necrosis factor; TAS:BHF-UCL		0:ADIPOQ|0:ADAM9|0:ADAM10|0:CXCL16|0:GCH1|0:CYP27B1|0:NUB1|0:UBD|0:RIPK1|0:CASP8|0:IGBP1|0:TNFRSF11A|0:CASP3|0:SELE			
GO:0030198	P:extracellular matrix organization; TAS:UniProtKB		0:PXDN|0:APP|0:COL4A6|0:COL4A2|0:COL19A1|0:CSGALNACT1|0:COL6A2|0:SPOCK2|0:TMPRSS6|0:COL8A2|0:SPINK5			
GO:0006707	P:cholesterol catabolic process; TAS:ProtInc		0:SNX17|0:SCARF1|0:AKR1D1|0:CEL|0:CYP7A1|0:TRERF1|0:CYP46A1			
GO:0009642	P:response to light intensity; NAS:UniProtKB		0:SLC24A1			
GO:0004831	F:tyrosine-tRNA ligase activity; TAS:ProtInc		0:YARS2|0:YARS			
GO:0051088	P:PMA-inducible membrane protein ectodomain p...; TAS:BHF-UCL		0:ADAM9|0:ADAM17|0:ADAM10			
GO:0004655	F:porphobilinogen synthase activity; IDA:UniProtKB		0:ALAD			
GO:0014010	P:Schwann cell proliferation; IMP:HGNC		0:NF2			
GO:0016072	P:rRNA metabolic process; NAS:UniProtKB		0:MKI67IP			
GO:0042986	P:positive regulation of amyloid precursor pr...; IMP:BHF-UCL		0:SOAT1			
GO:0030970	P:retrograde protein transport, ER to cytosol; IMP:UniProtKB		0:VCP|0:DERL1|0:DERL2|0:SEC61B			
GO:0030321	P:transepithelial chloride transport; IDA:UniProtKB		0:BEST1|0:SLC12A2			
GO:0005128	F:erythropoietin receptor binding; IEA:InterPro		0:EPO			
GO:0070495	P:negative regulation of thrombin receptor si...; IDA:UniProtKB		0:SNCA			
GO:0047035	F:3-alpha(17-beta)-hydroxysteroid dehydrogena...; IDA:UniProtKB		0:DHRS9			
GO:0050687	P:negative regulation of defense response to ...; IMP:UniProtKB		0:ITCH|0:PCBP2			
GO:0033038	F:bitter taste receptor activity; IDA:HGNC		0:TAS2R16|0:TAS2R43|0:TAS2R14			
GO:0008397	F:sterol 12-alpha-hydroxylase activity; TAS:ProtInc		0:CYP8B1			
GO:0010836	P:negative regulation of protein amino acid A...; IGI:BHF-UCL		0:TINF2			
GO:0005232	F:serotonin-activated cation-selective channe...; TAS:ProtInc		0:HTR3A|0:HTR3B			
GO:0043559	F:insulin binding; IPI:BHF-UCL		0:PIK3R1|0:INSR|0:IGF1R			
GO:0031167	P:rRNA methylation; IEA:InterPro		0:FTSJ2|0:FTSJ1|0:FTSJ3			
GO:0009399	P:nitrogen fixation; TAS:UniProtKB		0:ISCU			
GO:0003874	F:6-pyruvoyltetrahydropterin synthase activity; TAS:ProtInc		0:PTS			
GO:0030220	P:platelet formation; ISS:UniProtKB		0:MYH9|0:VPS33A			
GO:0033919	F:glucan 1,3-alpha-glucosidase activity; IEA:EC		0:GANAB			
GO:0016499	F:orexin receptor activity; IEA:InterPro		0:HCRTR1			
GO:0000285	F:1-phosphatidylinositol-3-phosphate 5-kinase...; IEA:EC		0:PIKFYVE			
GO:0050333	F:thiamin-triphosphatase activity; IDA:UniProtKB		0:THTPA			
GO:0010698	F:acetyltransferase activator activity; IMP:BHF-UCL		0:AGT|0:AGTR1			
GO:0051970	P:negative regulation of transmission of nerv...; IMP:UniProtKB		0:GLRA1			
GO:0004445	F:inositol-polyphosphate 5-phosphatase activity; TAS:UniProtKB		0:INPP5K|0:INPP5J|0:INPP5B|0:INPP5A|0:INPP5D|0:SYNJ1|0:INPP5E			
GO:0035552	P:oxidative single-stranded DNA demethylation; IDA:UniProtKB		0:FTO|0:ALKBH3			
GO:0031870	F:thromboxane A2 receptor binding; IPI:UniProtKB		0:RPGRIP1L			
GO:0008761	F:UDP-N-acetylglucosamine 2-epimerase activity; TAS:ProtInc		0:GNE			
GO:0007517	P:muscle organ development; TAS:UniProtKB		0:TAGLN2|0:TAGLN3|0:FXR1|0:ZFHX3|0:FOXK1|0:UNC45A|0:UNC45B|0:TCF23|0:TWIST1|0:FAM65B|0:FOXO4|0:LBX1|0:EID2|0:USP2|0:EID2B|0:MURC|0:CENPF|0:SIRT1|0:CD164|0:SRPK3|0:FLNB|0:LMNA|0:MKX|0:TRIM72|0:CHODL|0:CACNA1H|0:FHL1|0:SOX6|0:BVES|0:MYL1|0:ANKRD2|0:MYL4|0:EVC|0:HBEGF|0:MYH3|0:EGR3|0:IGF1|0:SMTN|0:ITGA7|0:SGCA|0:MSTN|0:SPEG|0:CAPN3|0:TCF12|0:NEB|0:ITGA11|0:COL6A3|0:MAPK12|0:POU6F1|0:MEF2D|0:MEF2A|0:SGCB|0:SGCG|0:FKTN|0:MRAS|0:MEF2C|0:LAMA2|0:FHL3|0:EMD|0:AEBP1|0:ITGB1BP2|0:TEAD4|0:CTF1|0:MEF2B|0:CXCL10|0:MTM1|0:SGCE|0:UTRN|0:SGCD|0:SRI|0:TAGLN|0:ACHE|0:CAV3			
GO:0042731	F:PH domain binding; IPI:BHF-UCL		0:INPP5A			
GO:0032940	P:secretion by cell; ISS:HGNC		0:FURIN|0:PCSK6|0:CKLF|0:USE1			
GO:0010745	P:negative regulation of macrophage derived f...; TAS:BHF-UCL		0:CETP|0:NR1H3|0:NR1H2|0:CRP|0:PPARG|0:ADIPOQ|0:PPARA|0:ITGB3|0:NFKBIA|0:ITGAV|0:ABCA5|0:ABCG1|0:ABCA1			
GO:0015197	F:peptide transporter activity; IMP:UniProtKB		0:TAP1			
GO:0031576	P:G2/M transition checkpoint; ISS:UniProtKB		0:OBFC2A|0:USP17L2|0:OBFC2B|0:INTS3|0:C15orf42			
GO:0000015	C:phosphopyruvate hydratase complex; IEA:InterPro		0:ENO1|0:ENO3|0:ENO2|0:ENO4			
GO:0004506	F:squalene monooxygenase activity; NAS:UniProtKB		0:SQLE			
GO:0033630	P:positive regulation of cell adhesion mediat...; ISS:BHF-UCL		0:TGFB2|0:ADAM9|0:SFRP2			
GO:0050220	F:prostaglandin-E synthase activity; IEA:EC		0:PTGES3|0:PTGES2|0:PTGES			
GO:0004574	F:oligo-1,6-glucosidase activity; IEA:EC		0:SI			
GO:0042407	P:cristae formation; IMP:UniProtKB		0:TAZ|0:LETM1			
GO:0004561	F:alpha-N-acetylglucosaminidase activity; TAS:ProtInc		0:NAGLU			
GO:0004416	F:hydroxyacylglutathione hydrolase activity; IEA:InterPro		0:HAGH|0:PNKD			
GO:0034185	F:apolipoprotein binding; ISS:BHF-UCL		0:PLG|0:LPA|0:GPIHBP1|0:LRP1|0:LIPC|0:VLDLR			
GO:0004735	F:pyrroline-5-carboxylate reductase activity; TAS:ProtInc		0:PYCRL|0:PYCR2|0:C14orf148|0:PYCR1			
GO:0005797	C:Golgi medial cisterna; IDA:UniProtKB		0:B3GALT6			
GO:0046677	P:response to antibiotic; ISS:UniProtKB		0:CIITA|0:JAK1|0:JAK2|0:ZC3H8|0:ETS1|0:HIAT1|0:MFSD9|0:SLC22A18|0:HIATL1|0:SLC46A2|0:SKIL|0:CYB5R4			
GO:0002541	P:activation of plasma proteins involved in a...; IDA:BHF-UCL		0:F3			
GO:0046601	P:positive regulation of centriole replication; IMP:UniProtKB		0:PLK4			
GO:0030951	P:establishment or maintenance of microtubule...; IMP:HGNC		0:CKAP5|0:KIF2C			
GO:0034382	P:chylomicron remnant clearance; TAS:BHF-UCL		0:APOC1|0:APOC3|0:APOC2|0:APOE|0:LIPC			
GO:0051346	P:negative regulation of hydrolase activity; IDA:UniProtKB		0:ATPIF1			
GO:0004024	F:alcohol dehydrogenase activity, zinc-dependent; IDA:UniProtKB		0:ADH1B|0:ADH4|0:ADH1A|0:ADH7			
GO:0090081	P:regulation of canonical Wnt receptor signal...; IMP:BHF-UCL		0:POU5F1			
GO:0005165	F:neurotrophin receptor binding; IEA:InterPro		0:NTF3			
GO:0034445	P:negative regulation of plasma lipoprotein o...; IDA:BHF-UCL		0:APOA4			
GO:0004008	F:copper-exporting ATPase activity; TAS:UniProtKB		0:ATP7A|0:ATP7B			
GO:0032947	F:protein complex scaffold; TAS:UniProtKB		0:BAZ1B|0:AXIN1|0:ISCU|0:SMARCD1|0:CAV3|0:CAV1|0:EIF3B			
GO:0020037	F:heme binding; TAS:UniProtKB		0:CYP11B2|0:CYP11B1|0:NOS3|0:HMOX1|0:CYP2A6|0:CAT|0:CYP2E1|0:CYP2D6|0:PXDN|0:CYP19A1|0:CYP1A2|0:CBS|0:CYP2A13|0:ABCB6|0:AMBP|0:IDO2|0:NENF|0:CYB5B|0:HBM|0:HBB|0:MT-CO1|0:PGRMC1|0:CYP39A1|0:FADS1|0:CYP2C19|0:EPX|0:CYP7A1|0:PTGS2|0:CYP2S1|0:DOCK2|0:CYP2U1|0:GUCY1B3|0:CYC1|0:CYP7B1|0:DUOX1|0:CYGB|0:CYP51A1|0:HBG1|0:CYP11A1|0:HBZ|0:CYP4A22|0:HBE1|0:CYB5A|0:PGRMC2|0:CYP21A2|0:MPO|0:CYP3A7|0:CYP27A1|0:CYP4Z2P|0:CYP2C8|0:MT-CO2|0:CYP2B6|0:PTGIS|0:CYP27B1|0:CYP4F2|0:CYBA|0:CYP4A11|0:CYP4X1|0:TPO|0:CYP2W1|0:PTGS1|0:CYP2R1|0:CYP1A1|0:CYP3A5|0:HBQ1|0:GUCY1B2|0:FADS2|0:CYP4F3|0:CYP26C1|0:HBA2|0:LPO|0:HERC2|0:CYB5R4|0:CYP2C9|0:CYP3A43|0:CYP17A1|0:CYP8B1|0:TBXAS1|0:CYB5D2|0:CYP20A1|0:GUCY1A2|0:HBA1|0:CYP2F1|0:HBG2|0:CYP4F12|0:IDO1|0:CYP27C1|0:CYP4B1|0:CYP4V2|0:FA2H|0:NGB|0:CYP2C18|0:FADS3|0:CYP3A4|0:CYP2A7|0:CYP4F22|0:CYB5D1|0:GUCY1A3|0:DUOX2|0:CYP4F8|0:HBD|0:MB|0:CYP4Z1|0:CYP46A1|0:CYP2J2|0:CYBB|0:NOS1|0:NOS2|0:PXDNL|0:SDHD|0:SDHC|0:EIF2AK1|0:CYP26A1|0:CYP26B1|0:NOX5|0:NOX4|0:CYP1B1|0:CYP24A1|0:CYP4F11|0:CYCS			
GO:0004782	F:sulfinoalanine decarboxylase activity; IEA:EC		0:CSAD			
GO:0000432	P:positive regulation of transcription from R...; IMP:BHF-UCL		0:USF2|0:USF1			
GO:0048160	P:primary follicle stage; ISS:UniProtKB		0:EREG			
GO:0008289	F:lipid binding; TAS:UniProtKB		0:CD36|0:APOL1|0:APOC2|0:BAX|0:LTC4S|0:PPARA|0:PLTP|0:APOL4|0:C20orf114|0:C20orf186|0:APOL5|0:LBP|0:C20orf71|0:C20orf185|0:PLUNC|0:BPIL3|0:C20orf70|0:APOLD1|0:BPI|0:APOL6|0:BPIL1|0:APOL3|0:CADPS2|0:EPN1|0:SH3GL2|0:AP2A2|0:FABP9|0:SEC14L4|0:PITPNB|0:RUFY1|0:STARD4|0:CADPS|0:VCP|0:GPIHBP1|0:SH3GLB1|0:SEC14L3|0:FABP5P3|0:NR5A2|0:FNBP1L|0:FFAR2|0:EPN3|0:S100A13|0:ATP5G1|0:ATP5G2|0:FFAR3|0:NSFL1C|0:PITPNC1|0:FNBP1|0:CHMP4A|0:MTTP|0:AP2M1|0:STARD6|0:PITPNM3|0:EPN2|0:LPAR4|0:STARD5|0:SH3GL1|0:TRIP10|0:ATP5G3|0:VPS36|0:SH3GL3|0:PMP2|0:FABP12|0:GPR119|0:PITPNM2|0:PTEN|0:PRAM1|0:CLINT1|0:LIPF|0:PLIN1|0:APOL2|0:LPAR2|0:S1PR2|0:S1PR4|0:PSAP|0:S1PR3|0:RASGRP1|0:HDLBP|0:FABP7|0:MAL			
GO:0005996	P:monosaccharide metabolic process; NAS:UniProtKB		0:GAL3ST3			
GO:0008316	F:structural constituent of vitelline membrane; IEA:InterPro		0:VMO1			
GO:0032402	P:melanosome transport; ISS:BHF-UCL		0:BBS7|0:BBS4|0:ARL6|0:BBS5|0:MKKS|0:BBS2			
GO:0071472	P:cellular response to salt stress; IDA:UniProtKB		0:AQP1			
GO:0030910	P:olfactory placode formation; ISS:BHF-UCL		0:PROX1			
GO:0060197	P:cloacal septation; IEP:UniProtKB		0:WNT11			
GO:0033153	P:T cell receptor V(D)J recombination; ISS:UniProtKB		0:LIG4			
GO:0006304	P:DNA modification; IEA:UniProtKB-KW		0:DNTT			
GO:0004577	F:N-acetylglucosaminyldiphosphodolichol N-ace...; IEA:EC		0:ALG13			
GO:0009405	P:pathogenesis; IEA:InterPro		0:CARM1			
GO:0046034	P:ATP metabolic process; NAS:UniProtKB		0:AK1|0:AK5|0:NDUFS1|0:CTNS|0:FIGNL1|0:NADK			
GO:0010390	P:histone monoubiquitination; ISS:UniProtKB		0:DTX3L|0:RNF40|0:CDC73|0:PAF1|0:RNF20|0:CTR9|0:LEO1|0:UBE2E1|0:RAG1			
GO:0051983	P:regulation of chromosome segregation; IMP:UniProtKB		0:KIF2B|0:KIF2C			
GO:0035272	P:exocrine system development; ISS:UniProtKB		0:RAB26			
GO:0006284	P:base-excision repair; TAS:UniProtKB		0:WRN|0:NEIL1|0:DNA2|0:NEIL2|0:ERCC6|0:NEIL3|0:UNG|0:PRMT6|0:APEX1|0:TP53			
GO:0051303	P:establishment of chromosome localization; IMP:UniProtKB		0:BIRC5|0:NDE1			
GO:0007418	P:ventral midline development; TAS:ProtInc		0:SHH			
GO:0005464	F:UDP-xylose transmembrane transporter activity; IDA:UniProtKB		0:SLC35B4			
GO:0046316	F:gluconokinase activity; IEA:EC		0:C9orf103			
GO:0034989	F:GTP-Ral binding; IDA:BHF-UCL		0:FLNA			
GO:0008270	F:zinc ion binding; TAS:UniProtKB		0:SLC30A8|0:ZACN|0:TNKS|0:ACE|0:HDAC4|0:SLU7|0:APOBEC3F|0:MSRB3|0:SIVA1|0:SNCA|0:MDM2|0:SKI|0:PTPN1|0:BIRC5|0:SIRT2|0:LIMS1|0:RABIF|0:DHX58|0:PML|0:CA2|0:CYLD|0:LANCL1|0:GCH1|0:DHH|0:CD4|0:USP16|0:SIRT3|0:DDX58|0:BIRC2|0:PHF8|0:GLI2|0:IFIH1|0:IDE|0:CDA|0:MLL|0:ADH1B|0:S100A13|0:USP33|0:ADH4|0:RNF2|0:APOBEC3G|0:S100A5|0:JHDM1D|0:SIAH1|0:SORD|0:ADH5|0:ALAD|0:THAP1|0:SNRPC|0:SHH|0:RPS29|0:SOD1|0:BMI1|0:PDXK|0:AIRE|0:CECR1|0:RCHY1|0:PHF2|0:WT1|0:HHIP|0:ZHX3|0:SALL1|0:MMP7|0:ZBTB12|0:ADAM5P|0:PHF20|0:RFPL2|0:ZNF83|0:ZDHHC6|0:DUS3L|0:CHFR|0:FUS|0:UQCRC1|0:ADAM23|0:ZNF687|0:TRIM64C|0:RP9|0:ARAP1|0:FAM90A9|0:ZNF350|0:GFI1|0:FHL1|0:OSGEP|0:GATA1|0:RBM6|0:SYTL5|0:ZNF667|0:ZCCHC12|0:ZNF568|0:LIN28B|0:TRIM45|0:TAB2|0:GPATCH8|0:CPD|0:XAF1|0:ZDHHC22|0:SPG7|0:ZNF614|0:TRIM56|0:NEURL3|0:TRAIP|0:ESRRB|0:RNF43|0:PHF12|0:ZBTB7C|0:VAT1|0:CPO|0:PARK2|0:CGRRF1|0:ZC3H14|0:MMP24|0:ZFYVE9|0:ZNF165|0:TRIM77|0:ZNF775|0:RBM4B|0:NEIL2|0:TRAF6|0:ADAM29|0:PDLIM1|0:RNF126|0:ZNF16|0:ZDHHC3|0:CPXM1|0:ZNF285|0:ZFP36L1|0:ZNF10|0:ZHX2|0:ZNF624|0:ZNRF3|0:ENPEP|0:ZNF541|0:AGAP10|0:ZNF121|0:RAD50|0:RNF111|0:LRSAM1|0:PGR|0:ZRSR1|0:ZNF532|0:CA8|0:RNF139|0:ZNF594|0:ADAM8|0:MAN2B2|0:ZCCHC2|0:ACAP2|0:SLC2A4RG|0:CA5B|0:GTF2H2C|0:TRIM48|0:HELZ|0:DMD|0:CHURC1|0:NEURL1B|0:AGBL2|0:ZNF703|0:RSF1|0:LONRF1|0:ZSWIM3|0:ZNF804A|0:ZSCAN20|0:ZNF57|0:ZBTB46|0:DTNA|0:ADAM2|0:TRIM5|0:ZNF17|0:ZNF280D|0:ANKZF1|0:KLF3|0:HIVEP1|0:MEX3B|0:ZNF85|0:ZNF230|0:ZNF434|0:SH3RF3|0:ZNF347|0:ZFP106|0:GTF2E1|0:ZNF581|0:ZBTB38|0:FYCO1|0:FBLIM1|0:ZC3H3|0:TIPARP|0:SRSF2IP|0:TRIM72|0:CXXC1|0:ZNF311|0:EHMT2|0:WTIP|0:EGR1|0:ZIC4|0:MTF1|0:ZSCAN10|0:ZNF502|0:ZNF516|0:RNF19B|0:UNK|0:ZNF840|0:PHF19|0:CPM|0:ZNF497|0:ADAMTS20|0:ADAMTSL2|0:OVOL2|0:PYGO2|0:PPP1R10|0:MARCH7|0:ZNF787|0:PLEKHF2|0:EGR3|0:ZNF267|0:ZBTB6|0:FBXL19|0:PRICKLE2|0:TOPORS|0:RNF165|0:ZMYM3|0:CA7|0:ZNF461|0:GLIS1|0:ZDHHC11|0:DNMT3L|0:ANAPC11|0:FAM90A23|0:AGAP8|0:ZNF619|0:RREB1|0:SP1|0:ZBTB1|0:ZNF876P|0:MBNL1|0:ZNF642|0:DHX57|0:ZNF766|0:ZNF226|0:ZMYND17|0:BAZ2A|0:MARCH6|0:ING4|0:ZNF71|0:PATZ1|0:RBM22|0:CASZ1|0:PDZRN4|0:FEZF2|0:ZNF34|0:KLF14|0:DZIP3|0:ZFAND3|0:MKRN3|0:ZMYND12|0:DEAF1|0:RNF212|0:ZNF680|0:ZNF607|0:ZNF575|0:SHARPIN|0:ANKIB1|0:ZFHX3|0:RNF130|0:JUB|0:MORC2|0:ZNF579|0:CRIP3|0:ADAMTS5|0:MTMR3|0:TRIM25|0:ZNF133|0:ZNF816|0:ZNF600|0:ZNF678|0:C11orf54|0:ATMIN|0:GATA4|0:PRR3|0:AMZ1|0:CNBP|0:ZCCHC16|0:AMZ2|0:TOP3A|0:PCGF3|0:GTF2H2|0:TRIM41|0:UBR3|0:ZNF25|0:ESRRA|0:PHF16|0:ZMAT5|0:USP19|0:KDM5A|0:SUV39H2|0:ZNF549|0:PJA2|0:PHF1|0:CSRP3|0:ASH1L|0:NR1I3|0:PHF21B|0:ZNF107|0:ZFP36|0:CYHR1|0:ZNF417|0:CREBBP|0:MYST3|0:ZNF439|0:GLI1|0:ZNF157|0:ZNF733|0:ZNF561|0:ZNF362|0:ADH1C|0:DNMT3A|0:MARCH3|0:TRIM35|0:HNF4G|0:ZNF565|0:ZNF790|0:RAPSN|0:FHL5|0:RUFY1|0:ZC3H12C|0:ZFAND6|0:ARID2|0:INTS12|0:ZBTB4|0:RERE|0:BNC1|0:ZFX|0:ZCCHC6|0:DTX2|0:ZNF44|0:ZNF365|0:PHC1|0:KIAA0913|0:INSM1|0:ZNF493|0:ZNF717|0:TRIM34|0:RNF216|0:NUPL2|0:BLVRA|0:ZNF271|0:ZNF706|0:TRIM66|0:ZNF142|0:BAZ2B|0:ATF2|0:ZFYVE28|0:SYTL2|0:ZNF423|0:GTF2B|0:SUZ12|0:MZF1|0:ZFP2|0:ARFGAP3|0:TAF3|0:NR2C1|0:ZSCAN23|0:ZNF628|0:DZIP1L|0:ZCCHC11|0:ZNF746|0:TRIML1|0:PITRM1|0:FGD3|0:ZNF620|0:RNF181|0:KLF13|0:ZFAND2A|0:ZNF860|0:ZC3H15|0:ANKMY2|0:SEC24A|0:TRAFD1|0:ZFP42|0:ZKSCAN2|0:ZC3H12B|0:ZNF658B|0:LNX1|0:PDLIM5|0:FAM90A17|0:TRIM68|0:ZNF67P|0:ZFP92|0:ZSCAN18|0:ZNF837|0:APOBEC4|0:AGFG1|0:MATR3|0:CA13|0:IKZF5|0:NR2F1|0:ZNF506|0:ZNF879|0:ZCWPW1|0:ADAMDEC1|0:ZC3H7A|0:KLF16|0:PIAS3|0:DTX3L|0:NUP153|0:ZNF665|0:PPARG|0:ZNF407|0:ZNF343|0:ZCCHC24|0:DYTN|0:NR3C1|0:SF3A2|0:FAM90A20|0:LMO2|0:ZNF234|0:SALL2|0:NR6A1|0:ZNF599|0:ARFGAP2|0:TRIM9|0:ERI2|0:CXXC5|0:ZNF252|0:TADA2A|0:MAP3K1|0:ZNF829|0:ZNF813|0:MAZ|0:MKRN2|0:FBXO43|0:PARP1|0:ZNF618|0:CPA6|0:ZBTB42|0:RNF207|0:SREK1IP1|0:MYLIP|0:SCAPER|0:RARA|0:IKZF2|0:ZNF276|0:AGBL3|0:ZDHHC15|0:BPTF|0:MLLT6|0:ADAMTS1|0:ZNF571|0:TRIM21|0:CBL|0:ZNF844|0:ZNF286A|0:ZNF526|0:ZNF674|0:ZDHHC23|0:MICAL3|0:CRYZ|0:TRIM39|0:ANPEP|0:TRIP4|0:C20orf12|0:ZFP112|0:ZNF525|0:RNF121|0:CPA5|0:BRPF3|0:ZNF443|0:ZNF323|0:LMX1B|0:ZNF654|0:MICALL2|0:TCEA3|0:CLIP1|0:RBM27|0:ZNF222|0:PRDM15|0:CPXCR1|0:ADAM20|0:ZNF30|0:ZNF770|0:AGAP1|0:ZNF385A|0:TDRD1|0:ING1|0:ZNF398|0:NANOS1|0:ZFYVE19|0:MLPH|0:ZNF557|0:DDX41|0:ZBTB49|0:ZNF683|0:GIT2|0:ZNF658|0:PRKCA|0:SMYD1|0:ZNF192|0:ZNF645|0:RNF169|0:ZNF705F|0:CPXM2|0:ZSWIM1|0:ZFP161|0:PDLIM2|0:ADAM7|0:RABGGTA|0:ZNF510|0:ZNF623|0:RNF32|0:ISL1|0:NEIL1|0:RBM10|0:ZNF385B|0:ZNF284|0:WDFY2|0:BIRC7|0:ADAM32|0:ZNF187|0:ZBTB11|0:GLIS2|0:ATF7|0:NANOS3|0:OSR2|0:AGTPBP1|0:LONRF2|0:SF3A3|0:SORBS2|0:ZNF709|0:ZNRF4|0:ZNF384|0:ZNF710|0:TRIM63|0:TCF19|0:ZNF136|0:CPA4|0:TRHDE|0:MORC1|0:MAN2C1|0:ZNF713|0:ZNF18|0:AGBL1|0:ADAMTS17|0:UPF1|0:ZSWIM4|0:TRIM47|0:TRIM6|0:ZNF846|0:ADAMTS12|0:IGHMBP2|0:SIAH2|0:MMP3|0:ZFAND1|0:ANKMY1|0:SP110|0:HIC1|0:TRIM73|0:LHX4|0:ZC3H8|0:ZMAT1|0:ZNF317|0:ZNF763|0:ZSCAN21|0:ZNF544|0:KLF17|0:KLF5|0:ZNF433|0:ZNF705G|0:MECOM|0:PEG3|0:GALT|0:ZNF263|0:ZNF550|0:RNF10|0:ZNF567|0:ZNF660|0:ZCCHC13|0:ZNF737|0:ZHX1|0:OVOL1|0:ZNF789|0:SCRT1|0:ZNF404|0:PYGO1|0:ZNF823|0:BNC2|0:ZNF486|0:ADAMTSL1|0:SMAP2|0:UBR4|0:ZNF697|0:ZNF776|0:ZNF503|0:TRIM62|0:ABLIM1|0:RYBP|0:ZNF725|0:ZNF416|0:ZNF225|0:ZNF554|0:PRDM14|0:ZDHHC2|0:MBNL2|0:ZSCAN5A|0:AGAP5|0:USP20|0:L3MBTL2|0:ZFP3|0:AGAP11|0:CRYZL1|0:ZNF454|0:RFWD2|0:SP6|0:ZBTB22|0:ZNF72|0:PRKCI|0:ZNF648|0:ZNF574|0:WIZ|0:ZNF175|0:ZNF692|0:FANCL|0:ZBTB2|0:TRAF3|0:ZNF721|0:ZNF641|0:AEBP2|0:ISL2|0:RNF144A|0:MARCH5|0:TP73|0:MID1|0:DBF4|0:TSHZ2|0:ZNF540|0:NR2E1|0:PCLO|0:ZNF679|0:TRIM40|0:ZFHX4|0:CDADC1|0:ADAMTS19|0:ZBTB45|0:ADAMTS4|0:ZDHHC12|0:PHC2|0:TRIM26|0:ZNF578|0:SHPRH|0:TRIM27|0:ZDHHC19|0:RBX1|0:ZBTB7A|0:ZNF818P|0:RNFT2|0:USP45|0:ZBTB39|0:RNF138|0:LASP1|0:ZSCAN1|0:ZNF335|0:SF1|0:ACAP1|0:VDR|0:ZNF213|0:SH3RF2|0:CPA1|0:FOXP4|0:ZNF580|0:ZNF732|0:HIVEP2|0:ZNF354B|0:ZNF238|0:KDM4C|0:MUL1|0:ZNF777|0:ZDHHC5|0:ARAP2|0:NR5A2|0:SETDB2|0:HNF4A|0:ZFP64|0:ZNF295|0:ZNF517|0:LMO3|0:ZNF587|0:FAM90A22|0:PHF13|0:KLF15|0:MMP25|0:ZMIZ1|0:RNF125|0:ZNF77|0:CPSF4|0:ZNF613|0:ZNF490|0:PRICKLE1|0:ZNF324B|0:MEX3C|0:ZNF341|0:TRIM15|0:CA6|0:AR|0:FGD6|0:RNF44|0:PNKD|0:ZNF788|0:PMPCA|0:ZNF785|0:ADAM12|0:C1orf27|0:RNF14|0:NSMCE2|0:ZNF718|0:LIMS2|0:ZCCHC5|0:ZNF702P|0:MIB2|0:BHMT|0:ZNF280C|0:ZNF598|0:ZNF75A|0:ZNF41|0:ADAM19|0:DNMT3B|0:FAM90A16|0:ADAMTS16|0:POGZ|0:ZZEF1|0:ZNF334|0:IKZF3|0:ARIH1|0:ZCCHC9|0:RARB|0:ZNF320|0:APOBEC3B|0:ZNF711|0:ZNF275|0:ASAP2|0:SNAI1|0:MLL3|0:ZNF193|0:ASAP1|0:ZNF354C|0:HAGH|0:RBM26|0:SOLH|0:ZNF627|0:ZNF593|0:FAM90A14|0:RNF150|0:ZNF468|0:CA5A|0:ZNF740|0:ZNF514|0:ZKSCAN1|0:BCL6|0:DRP2|0:ZNF780B|0:ZIC3|0:LMX1A|0:NUFIP1|0:FBXO30|0:ZIK1|0:C14orf164|0:SMAP1|0:FGD2|0:ZNF33B|0:ZNF548|0:UBR1|0:ZNF664|0:KDM5B|0:PRKCZ|0:GATA3|0:ZNF806|0:ZNF322A|0:ZNF793|0:ZC3HC1|0:SEC24B|0:ADAM28|0:ZNF268|0:TRIM52|0:PRICKLE4|0:ZNF408|0:IARS|0:ZNF426|0:BMP1|0:SP2|0:DPF1|0:DNAJC21|0:MMP26|0:ZCCHC17|0:EHMT1|0:ZNF804B|0:ZNF507|0:ZNF26|0:ZNF396|0:RC3H2|0:ZNF143|0:AKAP8L|0:ZNF560|0:ZNF438|0:ZNF564|0:ZNF782|0:ADAMTSL5|0:ZC3H4|0:FAM170A|0:SIAH1L|0:NFXL1|0:ZNF671|0:RNF8|0:TAF15|0:MKRN1|0:BSPRY|0:LIMK1|0:MARCH11|0:DTX3|0:ZFY|0:ZCWPW2|0:REPIN1|0:ZNF440|0:ZBTB17|0:ZFP28|0:HLTF|0:ZNF826P|0:ZNF843|0:TRIM23|0:TRIM22|0:FASN|0:ZNF219|0:NR1H3|0:SQSTM1|0:MAN2A2|0:ZNF274|0:ZNF397|0:ZDHHC16|0:CNOT4|0:ZNF749|0:AFG3L2|0:USP49|0:TRIM3|0:REST|0:AICDA|0:RNF180|0:ZNF836|0:RNF215|0:ADAMTS9|0:ZNF812|0:GFI1B|0:ZNF527|0:ZNF771|0:TRIM55|0:ZNF66P|0:ZDHHC24|0:ZNF410|0:AGAP9|0:TCEA2|0:LIMA1|0:ZXDA|0:ZNF76|0:ZNF281|0:ZYX|0:GATAD1|0:C21orf57|0:ZNF221|0:FAM90A7|0:C11orf95|0:ZFP30|0:ZNF167|0:ZBTB26|0:ZNF644|0:AGFG2|0:RNF168|0:TRIM69|0:ANUBL1|0:RPH3AL|0:TRERF1|0:ZNF653|0:TES|0:ZNF444|0:AGAP2|0:ZNF521|0:ING2|0:ZNF558|0:ZNF329|0:TAX1BP1|0:ZDHHC18|0:SMYD4|0:PHF17|0:RNF220|0:BRAP|0:ZC3H7B|0:RORA|0:CTGLF11P|0:RAI1|0:ZNF229|0:KLF8|0:MMP21|0:SUV39H1|0:TRIM13|0:ZDHHC9|0:ZNF69|0:TSHZ3|0:RNF148|0:ZNF449|0:ZNF346|0:ZNF584|0:ADAT3|0:LNX2|0:ZNF180|0:ZC3H11A|0:RNF40|0:GTF2H2D|0:FOXP1|0:MKRN4P|0:HIVEP3|0:ZNF736|0:SYVN1|0:ZNF791|0:SP5|0:RNF157|0:MYST2|0:KLF10|0:CA1|0:ADAM15|0:SNAI2|0:ZGPAT|0:ZMYM6|0:TADA2B|0:ERVK5|0:ZNF487P|0:TP63|0:USP3|0:RFPL1|0:ZNF799|0:EP300|0:HIC2|0:TRIM74|0:NR4A2|0:FOXP3|0:SMYD3|0:ZBTB48|0:FBXO11|0:WBP4|0:CBLL1|0:SETDB1|0:ZNF534|0:SETMAR|0:MAN2B1|0:KDM4B|0:E4F1|0:LMO4|0:KIN|0:ZDHHC11B|0:ZNF324|0:TTC3|0:ZNF511|0:ZMYM5|0:ZNF586|0:ZNF726|0:LIMD2|0:TSHZ1|0:ZNF264|0:OTUD7A|0:SCRT2|0:ZSCAN12|0:MEX3D|0:ZNF750|0:FAM90A19|0:ZNF551|0:ZNF480|0:RNF175|0:ZBTB41|0:NR4A3|0:UNKL|0:ZNF839|0:PIAS1|0:TRIM16|0:C4orf23|0:ZNF287|0:ZNF676|0:SP7|0:TRMT1|0:ZNF385C|0:ZDHHC1|0:RTN4IP1|0:RNF31|0:RNF167|0:WDFY3|0:ZSCAN5B|0:DZIP1|0:RNF146|0:DNPEP|0:GTF2IRD2B|0:ZDHHC20|0:TRIM11|0:GLIS3|0:SP140|0:CPA3|0:PRDM10|0:MBTD1|0:ZBBX|0:ZBTB10|0:ZNF585A|0:OTOP3|0:ZNF160|0:ZNF99|0:ZNF474|0:MBNL3|0:NR2F6|0:ZFYVE16|0:POLE|0:THRA|0:ADAP2|0:PRDM5|0:NEURL|0:RFPL4A|0:ZMIZ2|0:TET1|0:TCF20|0:ZNF135|0:SH3RF1|0:LMCD1|0:MICAL1|0:BCL6B|0:ADNP|0:RFFL|0:ZNF689|0:ZNF814|0:ZNF570|0:PNMA3|0:C9orf3|0:ZNF682|0:NR1D1|0:ZNF251|0:ADAMTS7|0:ZNF445|0:ASTL|0:ZADH2|0:CBFA2T3|0:ZNF485|0:LPP|0:ATRX|0:POLR2L|0:APOBEC3D|0:CPSF4L|0:ZNF764|0:FHL3|0:ZNF248|0:RNF41|0:TTF2|0:PRDM9|0:ZCCHC4|0:ZNF669|0:ZNF43|0:ZRANB3|0:ZNF154|0:PHC3|0:ZNF81|0:ZNF318|0:ZNF609|0:SIRT4|0:LHX5|0:LPXN|0:RNF103|0:ZNF543|0:ESRRG|0:ZNF566|0:PLAGL1|0:ZNF778|0:KLF6|0:NR5A1|0:ZDHHC4|0:UBR5|0:ZNF20|0:RNF113A|0:MPI|0:CPN1|0:ZNF518A|0:ZSCAN29|0:ZNF296|0:VPS11|0:KLF12|0:U2AF1|0:JAZF1|0:ADAM21|0:ZNF260|0:TRIM58|0:VPS8|0:ZCCHC14|0:ZNF429|0:PHRF1|0:RFWD3|0:ZNF174|0:PEX2|0:ZNF512|0:ZNF491|0:RNFT1|0:MTA3|0:FAM90A10|0:ZSCAN2|0:SEC24C|0:ZNF773|0:TRIM75|0:GTF2IRD2|0:ZNF300|0:RNF144B|0:TRAF4|0:ZNF460|0:AEBP1|0:TRIM38|0:BIRC8|0:ADH1A|0:ZNF280B|0:FGD5|0:ZCCHC23|0:PHF14|0:TRIM10|0:PRMT3|0:ZSWIM5|0:ZNF626|0:RARG|0:RNF186|0:RNF219|0:ZNF700|0:ZFR|0:TRIM64|0:ZBTB44|0:ZMAT4|0:ZNF19|0:ZNF714|0:ZNF326|0:ZNF592|0:DCTD|0:ZNF250|0:PEG10|0:TRIM59|0:ZNF12|0:TOE1|0:RECQL4|0:LHX2|0:ZFP57|0:USP44|0:PCGF1|0:MIB1|0:ZNF420|0:ZNRF1|0:ZNF200|0:BIRC3|0:ZNF833P|0:ZNF638|0:RXRB|0:G2E3|0:ZNF181|0:POLR3K|0:HERC2|0:ZNF48|0:BSN|0:ZIC2|0:ZMYND15|0:SPIRE2|0:ZNF75CP|0:ZNF345|0:GATA6|0:ZNF484|0:ZSCAN16|0:PDZRN3|0:PHF7|0:APOBEC2|0:ZNF395|0:ZNF467|0:ZNF79|0:DIDO1|0:CBFA2T2|0:DPF2|0:ZNF322B|0:ZNF432|0:MMP27|0:MTR|0:ZNF425|0:ZNF7|0:ZNF583|0:ZNF672|0:ZNF805|0:ZC3H6|0:SYTL4|0:PXN|0:ZNF254|0:RABGEF1|0:ZNF827|0:ATXN7|0:ZNF781|0:PRDM6|0:ZFP90|0:ESR1|0:TRIM14|0:ZNF530|0:BCL11B|0:KLF9|0:CPZ|0:ZNF663|0:ZNF498|0:DTX4|0:ZNF608|0:MMP11|0:ZNF727|0:ZNF577|0:ZNF563|0:ZNF835|0:SIRT7|0:ZNF528|0:ZNF555|0:LIMS3|0:YAF2|0:BRPF1|0:ADAMTS15|0:ZNF132|0:ZNF786|0:ZNF56|0:IKZF4|0:ZNF573|0:PMPCB|0:ZNF616|0:ZNF735|0:ZNF415|0:ZDHHC13|0:TCEA1|0:ZNF729|0:TRIM28|0:RNF133|0:NSMCE1|0:RNF24|0:ZNF606|0:ADAM18|0:SP3|0:ZNF772|0:FIZ1|0:ZNF32|0:AGAP3|0:HINFP|0:PTGR2|0:MLL2|0:SP8|0:RNF151|0:AGBL5|0:APEX2|0:TGFB1I1|0:RNF114|0:ADNP2|0:ZNF643|0:ZBTB25|0:ADAM11|0:RNF123|0:ZUFSP|0:MID2|0:HGS|0:ZNF235|0:NHLRC1|0:ZNF73|0:PHF23|0:ZNF780A|0:ZNF471|0:ZNF224|0:ZNF652|0:SEC23B|0:KLF11|0:RC3H1|0:ZNF500|0:MARCH10|0:RNF141|0:TRIM43B|0:TRIM60|0:KDM5C|0:PHF3|0:LMLN|0:ADAT2|0:RBM4|0:UHRF2|0:FAM90A13|0:ZNF547|0:GTF3A|0:ZRSR2|0:ZNF441|0:CPB2|0:RNF20|0:ZC3HAV1|0:ZNF80|0:RORB|0:TLL2|0:ADH7|0:FHL2|0:ZFPM1|0:ZGLP1|0:ZNF792|0:ZNF124|0:ZNF217|0:LHX8|0:ZNF101|0:MAN2A1|0:ZKSCAN4|0:GLI3|0:ARAP3|0:MARCH9|0:ZNF696|0:SNAI3|0:ZMAT3|0:LIMK2|0:ZNF316|0:LHX1|0:ZC3H13|0:RXRG|0:ZNF140|0:MARCH2|0:ZNF701|0:RBCK1|0:ZDHHC8|0:ZNF597|0:LONRF3|0:PCGF5|0:TRIM7|0:ZSWIM2|0:RFPL4B|0:ZBTB33|0:ZNF451|0:ZNF302|0:ANKFY1|0:LIMCH1|0:FAM90A15|0:BFAR|0:ZNF14|0:ZNF367|0:FBXO41|0:FGD1|0:U2AF1L4|0:TRIM44|0:TRAF1|0:TRIM32|0:ZFYVE26|0:ZNF273|0:ZEB2|0:NR1H4|0:APOBEC3C|0:SALL4|0:ZCCHC8|0:ZNF708|0:RNF214|0:ZSWIM7|0:ZNF470|0:ZMYND11|0:ZFYVE21|0:MORC4|0:RIMS2|0:ZNF488|0:PDLIM3|0:RNF149|0:ADAMTS10|0:ZZZ3|0:RNF13|0:ZXDB|0:UBR7|0:RANBP2|0:LIG3|0:ZNF33A|0:RNF128|0:RNF183|0:HDAC6|0:ZNF622|0:FEZF1|0:TUT1|0:ZNF646|0:LDB3|0:PRKCG|0:ZNF446|0:ING3|0:RNF185|0:PRKCB|0:SUPT4H1|0:TRAF5|0:WHSC1|0:WHSC1L1|0:VAT1L|0:NR2E3|0:AGAP7|0:ING5|0:ZNF232|0:RNF166|0:ZNF239|0:ZNF35|0:XRN2|0:ZSCAN4|0:THRB|0:ZSCAN5C|0:ZNF552|0:KDM2A|0:ZNF70|0:ZNF655|0:ZNF227|0:ZBTB20|0:RBBP6|0:PRDM12|0:MICALL1|0:RNF182|0:ZNRD1|0:DTNB|0:ZNF137P|0:ZNF419|0:KLF2|0:ACAP3|0:ZNF414|0:FAM90A24P|0:XIAP|0:CA9|0:APOBEC3A|0:NRAP|0:GTF2H2B|0:ZNF524|0:ZBTB47|0:ZNF681|0:ZFHX2|0:NR1D2|0:ZNF677|0:ZNF536|0:CTCFL|0:ZFP1|0:SP4|0:TNFAIP3|0:USP51|0:ZNF611|0:ZMYND10|0:ADAMTS6|0:TP53I3|0:TRIM24|0:ZDHHC17|0:PPARD|0:KDM4A|0:ZNF695|0:MTF2|0:EGR4|0:LMO7|0:DCST1|0:FOXP2|0:ZNF114|0:ZDHHC7|0:RFPL3|0:TRIM4|0:SIRT5|0:NR4A1|0:TRIM17|0:ADAMTS8|0:MYT1L|0:RNF152|0:ZNF211|0:UBOX5|0:FAM90A8|0:RBM5|0:ZNF688|0:MTA1|0:ZBTB8B|0:ZNF730|0:ZNF559|0:ZMYM4|0:RSPRY1|0:ZDHHC21|0:TAB3|0:ZNF496|0:GATA2|0:ZNF668|0:PLEKHF1|0:ZFYVE27|0:ZIM3|0:CPE|0:TRIM46|0:ZBTB7B|0:ZNF821|0:LMO1|0:RNF222|0:LIN28A|0:ZNF391|0:ZFAND2B|0:USP39|0:NRD1|0:PHF11|0:MBD1|0:ARFGAP1|0:ZBTB40|0:UQCRC2|0:RNPEPL1|0:ZNF519|0:ZNF304|0:RNF122|0:SEC24D|0:MTA2|0:ZNF385D|0:ZNF473|0:RNF170|0:ZSCAN30|0:RXRA|0:PDLIM7|0:PRICKLE3|0:YOD1|0:ZNF513|0:RNF17|0:NEIL3|0:RNF34|0:ZNF774|0:RNF145|0:FGD4|0:ZMYND8|0:GATAD2A|0:ZNF670|0:ZNF382|0:RNF113B|0:ZNF625|0:TRIM65|0:ZNF765|0:ZNF366|0:TRIM37|0:ZFP36L2|0:ZNF595|0:ASAP3|0:CPA2|0:ZNF724P|0:MORC3|0:BHMT2|0:EGR2|0:ZBTB16|0:FAM90A18|0:EGLN1|0:ADAMTS14|0:NR1H2|0:ADAM9|0:INSM2|0:PTER|0:LTN1|0:ZCCHC3|0:ZNF134|0:ZSWIM6|0:PCGF2|0:ZNF630|0:ZNRF2|0:ZRANB2|0:BRD1|0:ZMYM1|0:ZC3H18|0:ZNF831|0:RNF213|0:ZNF333|0:ZBTB37|0:PRDM8|0:ZNF155|0:ERVK6|0:TRIM67|0:ZNF542|0:TRIM49|0:LHX3|0:TRIM64B|0:PLAG1|0:MYCBP2|0:ZNF841|0:ZNF784|0:DBF4B|0:PLAGL2|0:ZNF256|0:ZNF319|0:FAM90A1|0:TRIM71|0:MLLT10|0:BAZ1A|0:ZDHHC14|0:OTUD7B|0:NFX1|0:ZNF98|0:CHD5|0:ZNF431|0:ZNF800|0:CSRP2|0:ZNF462|0:TEX13A|0:ZC3H10|0:USP22|0:ZNF28|0:UBR2|0:RLIM|0:ZNF662|0:ADAM22|0:ZNF37A|0:NR1I2|0:ZNF266|0:ZBTB5|0:UHRF1|0:ADAMTSL3|0:SYTL3|0:TRIM50|0:ZNF684|0:ZNF492|0:RNF38|0:ZNF572|0:ZNF131|0:SP140L|0:ZNF852|0:ZNF576|0:ZNF182|0:UTRN|0:AGBL4|0:ZFP14|0:ZCRB1|0:ZNF529|0:ZNF556|0:PRDM16|0:RNF217|0:ZNF605|0:TRIM29|0:RAD18|0:NBR1|0:ADAMTS2|0:NR2C2|0:TRAF2|0:ZFP41|0:DEF8|0:NSD1|0:ZNF649|0:ZNF518B|0:BARD1|0:ZNF177|0:ZNF442|0:LENG9|0:ZCCHC10|0:AGAP4|0:ZNF479|0:TRIM42|0:APTX|0:ZNF705A|0:PRDM13|0:ZNF354A|0:RIMS1|0:CPB1|0:L3MBTL4|0:ZXDC|0:ZNF223|0:MEP1A|0:ZDBF2|0:ZNF74|0:NR2F2|0:ZBTB24|0:PRDM1|0:TRIP6|0:NR3C2|0:ZFP62|0:ZMYND19|0:ZIC5|0:PARP12|0:SRSF7|0:ZNF582|0:AMFR|0:CA4|0:ZNF430|0:ZNF691|0:ZNF808|0:MEX3A|0:MTMR4|0:AGAP6|0:PDLIM4|0:ZNF501|0:ZNF880|0:ZNF589|0:ZNF483|0:KCMF1|0:NPLOC4|0:PJA1|0:MYST4|0:PHF15|0:ZNF169|0:MLL5|0:CA3|0:ZFAND5|0:ZNF512B|0:ZNF615|0:ZNF768|0:ZNF469|0:MARCH4|0:ADAM17|0:USP5|0:ZMAT2|0:RORC|0:SIRT1|0:ZKSCAN3|0:ZNF418|0:ZBTB3|0:ZNF233|0:MECR|0:MMP19|0:MGRN1|0:ESR2|0:ZNF280A|0:TRIM36|0:RUFY2|0:ZFAT|0:ZNF734|0:L3MBTL1|0:RNF135|0:ADAMTS18|0:RNF25|0:ZNF189|0:ZBTB34|0:ZNF202|0:ZNF704|0:ZNF277|0:ZNF197|0:RNF208|0:ZNF148|0:ZNF141|0:IKZF1|0:TRIM31|0:ZNF596|0:PCGF6|0:TAF2|0:MARCH8|0:ZNF716|0:ZNF707|0:VPS41|0:ZNF639|0:DTX1|0:TRIM43|0:ZNF138|0:C1orf25|0:ZBTB43|0:FBXO40|0:BRF1|0:USP13|0:ZNF585B|0:ZNF236|0:ZIC1|0:RBM20|0:ZRANB1|0:ZCCHC7|0:ADAM10|0:ZNF546|0:RNF115|0:TRIM61|0:SCEL|0:ZNF621|0:FAM90A12|0:ZFP82|0:ZNF292|0:ZBTB8A|0:SMYD2|0:ZNF761|0:ZNF629|0:NANOS2|0:PDCD2|0:CREB5|0:ZFR2|0:GZF1|0:SEC23A|0:ZNF45|0:ZNF610|0:KLF1|0:VEZF1|0:GIT1|0:MSL2|0:ZNF394|0:MMP28|0:PPARA|0:ZFP91|0:ZNF428|0:NPEPPS|0:PHF6|0:ZNF283|0:ZNF699|0:ZNF23|0:ZC3H12D|0:OSR1|0:PTGR1|0:ZBTB9|0:APOBEC3H|0:MICAL2|0:LHX6|0:GATA5|0:ADAP1|0:ZNF569|0:ZNF100|0:CUL9|0:EWSR1|0:PEX10|0:ZNF337|0:IARS2|0:CXXC4|0:PAPLN|0:TLL1|0:BRF2|0:ZNF828|0:BCL11A|0:ZNF330|0:KDM5D|0:FAM90A5|0:ZNF436|0:CA5BP|0:PHF10|0:SALL3|0:GATAD2B|0:ZSCAN22|0:ZNF845|0:GLI4|0:YY2|0:LHX9|0:ZNF562|0:MARCH1|0:RNF6|0:ZNF383|0:ZNF358|0:PHF21A|0:ST18|0:PEX12|0:ADA|0:P2RX4|0:MSRB2|0:SEPX1|0:SIRT6|0:GRIN2A|0:ZBTB32|0:RAG2|0:RAG1|0:MT3|0:S100B|0:GRIN2B|0:ZNF212|0:ZNF257|0:KLF4|0:ACR|0:KDM2B|0:ZFP37|0:ZNF117|0:DPYS|0:WDFY1|0:MT4|0:TRIM2|0:ZNF331|0:ZNF24|0:MMP23B|0:ZNF215|0:HKR1|0:MT1A|0:RNF26|0:MT1L|0:ZNF93|0:ZNF282|0:TRAF7|0:S100A7|0:ZNF2|0:ZNF675|0:TRIM33|0:ZNF91|0:ARHGEF2|0:ERAP1|0:ZNF92|0:RNF112|0:ZFYVE20|0:ZKSCAN5|0:ZNF205|0:ZNF253|0:RPS27|0:BAZ1B|0:PRDM2|0:ZNF3|0:RNPEP|0:KNG1|0:MT1F|0:ZMYM2|0:ZNF214|0:RBAK|0:ZNF8|0:ZIM2|0:CHD3|0:ABLIM2|0:ZNF184|0:ADAM33|0:ZNF208|0:ZFPL1|0:ZNF90|0:ADAMTS3|0:LAP3|0:PAPPA2|0:MYRIP|0:MMP23A|0:MEFV|0:ZFYVE1|0:RNF39|0:ZNF75D|0:ZNF84|0:MT1E|0:PDE5A|0:ZNF195|0:SLC30A5|0:RNF19A|0:MT1B|0:RING1|0:PIAS4|0:ZNF207|0:PAPPA|0:MYT1|0:DPF3|0:TRIM54|0:POLR2H|0:ABLIM3|0:TRIM8|0:ACE2|0:CALR|0:ERAP2|0:MMP2|0:ZEB1|0:RNF4|0:MMP16|0:ZNF146|0:MMP13|0:APOBEC1|0:MMP20|0:RNF11|0:CBLC|0:PRDM4|0:YY1|0:CBLB|0:RNF7|0:MMP1|0:CA12|0:MMP14|0:ZNF22|0:MNAT1|0:MYNN|0:ARIH2|0:CSRP1|0:MMP10|0:RLF|0:PIAS2|0:TIMM8B|0:MMP17|0:BRCA1|0:MMP15|0:CHMP1A|0:CRIP1|0:LNPEP|0:TRPS1|0:MMP12|0:MEP1B|0:POLR2I|0:GDA|0:LIMD1|0:CRIP2|0:PHEX|0:ADAM30|0:RNF5|0:KLF7|0:TIMM9|0:POLR2K|0:CHD4|0:ZNF185|0:CIZ1|0:TIMM13|0:KPNB1|0:ZFPM2|0:DUSP12|0:LTA4H|0:EEA1|0:ADAMTS13|0:RASSF1|0:TP53|0:ADH6|0:MMP9|0:TIMM10|0:MDM4|0:MMP8|0:S100A12|0:CTCF			
GO:0051382	P:kinetochore assembly; NAS:UniProtKB		0:CENPA|0:MIS12|0:CENPE|0:CENPF			
GO:0047496	P:vesicle transport along microtubule; ISS:HGNC		0:PAFAH1B1|0:KIF5B|0:DYNC1I1			
GO:0042311	P:vasodilation; IEA:UniProtKB-KW		0:KNG1			
GO:0015108	F:chloride transmembrane transporter activity; TAS:ProtInc		0:SLC26A4			
GO:0060441	P:epithelial tube branching involved in lung ...; IEP:UniProtKB		0:NKX2-1			
GO:0045061	P:thymic T cell selection; IDA:UniProtKB		0:JAG2			
GO:0060430	P:lung saccule development; IMP:UniProtKB		0:FGF10			
GO:0008253	F:5'-nucleotidase activity; TAS:ProtInc		0:NT5C3|0:NT5C3L|0:NT5C1B|0:NT5C1A|0:NT5E|0:NT5C2			
GO:0006007	P:glucose catabolic process; TAS:ProtInc		0:TKTL1			
GO:0046512	P:sphingosine biosynthetic process; IDA:UniProtKB		0:ACER3|0:ACER2			
GO:0032144	C:4-aminobutyrate transaminase complex; IDA:UniProtKB		0:ABAT			
GO:0030595	P:leukocyte chemotaxis; TAS:ProtInc		0:PF4|0:SBDS|0:LYST|0:IL10			
GO:0031403	F:lithium ion binding; IDA:UniProtKB		0:PDXK			
GO:0045837	P:negative regulation of membrane potential; IDA:UniProtKB		0:BNIP3			
GO:0042471	P:ear morphogenesis; IMP:BHF-UCL		0:NIPBL			
GO:0004886	F:retinoid-X receptor activity; TAS:ProtInc		0:RXRB|0:RXRG|0:RXRA			
GO:0006552	P:leucine catabolic process; TAS:UniProtKB		0:IVD|0:MCCC1|0:MCCC2			
GO:0007343	P:egg activation; ISS:HGNC		0:WBP2NL			
GO:0007586	P:digestion; TAS:UniProtKB		0:AKR1D1|0:AKR1C2|0:C6orf127|0:C6orf126|0:CLPS|0:PRSS2|0:CTRB2|0:CTRB1|0:PRSS1|0:SULT2A1|0:UGT1A1|0:NPY|0:PGA3|0:PGA4|0:CHIA|0:UCN2|0:PGA5|0:GKN1|0:MUC5AC|0:CELA3A|0:ACSL1|0:AKR1B10|0:PPYR1|0:AMY1C|0:CTRL|0:TFF2|0:SSTR2|0:PPY|0:CTSE|0:AMY2B|0:VIPR1|0:PYY|0:AMY1B|0:HTR3A|0:GALR1|0:TFF3|0:MEP1B|0:CAPN9|0:CCKBR|0:SSTR1|0:GALR2|0:SCTR|0:BAAT|0:PGC|0:MEP1A|0:AMY1A|0:SLC15A1|0:MLNR|0:PPARGC1A|0:CYP39A1|0:SST|0:PRSS3			
GO:0080111	P:DNA demethylation; IDA:UniProtKB		0:ALKBH1			
GO:0030171	F:voltage-gated proton channel activity; IDA:HGNC		0:NOX1|0:HVCN1			
GO:0007420	P:brain development; TAS:ProtInc		0:DSCAML1|0:SHROOM4|0:ZIC1|0:PROX1|0:CLN5|0:NIPBL|0:GPR56|0:BPTF|0:SMARCA1|0:NDUFS4|0:PPT1|0:VCX3A|0:EOMES|0:CTNS|0:TGFBR2|0:MDGA1|0:MAP1S|0:SHROOM2|0:UTP3|0:PCDH18|0:NCOA6|0:PHF8|0:CNTN4|0:ECE2|0:DMBX1|0:AGTR2|0:CDK5RAP3|0:HAP1|0:CDK5R1|0:CDK5RAP2|0:CDK5RAP1|0:CA10|0:PITPNM1|0:ALX1|0:NNAT|0:POU6F1|0:UNC5C|0:NKX2-2|0:ZIC2|0:UBE3A|0:AFF2|0:PHGDH|0:FOXG1			
GO:0043923	P:positive regulation by host of viral transc...; IDA:UniProtKB		0:SP1|0:TAF11|0:JUN|0:TFAP4			
GO:0005179	F:hormone activity; TAS:UniProtKB		0:AGT|0:IGF1|0:EDN3|0:EDN2|0:EDN1|0:ADIPOQ|0:LRSAM1|0:PYY2|0:PYY3|0:LHB|0:GPHB5|0:OSTN|0:INHBE|0:PRL|0:INSL3|0:ADM|0:RETNLB|0:RLN3|0:IAPP|0:COPA|0:GPHA2|0:TTR|0:GH1|0:MLN|0:HAMP|0:CALCA|0:C1QTNF9|0:RLN2|0:ADM2|0:UCN2|0:GALP|0:EPO|0:CGB1|0:KL|0:CSH2|0:NPPC|0:INHBC|0:THPO|0:APLN|0:UCN3|0:CGB2|0:CSH1|0:UTS2D|0:TG|0:IGF2|0:INSL4|0:GCG|0:CSHL1|0:SCT|0:NPPA|0:INSL6|0:INS|0:GUCA2A|0:RETN|0:INSL5|0:PTH|0:CGB8|0:STC1|0:UTS2|0:RLN1|0:GH2|0:AMH|0:PTHLH|0:TSHB|0:GAST|0:PPY|0:GNRH2|0:CGB5|0:CCL25|0:PYY|0:CGA|0:NMB|0:CHGB|0:CGB7|0:CGB|0:POMC|0:STC2|0:GIP|0:SST|0:INHA|0:INHBA|0:INHBB			
GO:0016233	P:telomere capping; IMP:BHF-UCL		0:POT1			
GO:0010994	P:free ubiquitin chain polymerization; IDA:UniProtKB		0:UBE2S|0:UBE2C			
GO:0004920	F:interleukin-10 receptor activity; TAS:ProtInc		0:IL10RA			
GO:0004334	F:fumarylacetoacetase activity; EXP:Reactome		0:FAH			
GO:0043088	P:regulation of Cdc42 GTPase activity; ISS:UniProtKB		0:FGD1|0:BVES|0:FGD3|0:FGD6|0:FGD2|0:FGD5|0:FGD4			
GO:0030237	P:female sex determination; IMP:UniProtKB		0:WNT4			
GO:0019432	P:triglyceride biosynthetic process; ISS:UniProtKB		0:AGPAT9|0:GPAM|0:PNPLA3|0:DGAT2|0:DGAT1|0:GPAT2|0:AGPAT6			
GO:0050807	P:regulation of synapse organization; ISS:UniProtKB		0:KLK8			
GO:0005019	F:platelet-derived growth factor beta-recepto...; TAS:ProtInc		0:PDGFRB|0:PDGFRL			
GO:0031965	C:nuclear membrane; TAS:BHF-UCL		0:CAPG|0:THAP7|0:TET1|0:SCD|0:NUP62|0:WHSC1|0:MTDH|0:TRIM27|0:EPC1|0:ALOX5AP|0:TMEM97|0:TMEM18|0:PML|0:WTAP|0:BCL2|0:TAGLN2|0:PRICKLE1|0:SCRN1|0:MRPL19|0:GCHFR|0:AQP1|0:MYO6|0:ALOX5|0:SUMO1|0:NUP85|0:ABL1|0:TPR|0:LASS6|0:NUP50|0:PRICKLE2|0:NPIP|0:NOC4L|0:TEX10|0:NUPL2|0:TMEM176B|0:LASS2|0:DTL|0:CEPT1|0:IL15RA|0:TOR1A|0:QSOX2|0:TXLNG|0:INTS2|0:POM121C|0:DDX19B|0:DULLARD|0:NUP210|0:PTGDS|0:RRP12|0:TMEM48|0:RANGAP1|0:SORT1|0:LASS3|0:ATP2A3|0:AKAP6|0:HAX1|0:NUP98|0:NUP54|0:INTS1|0:PDCD6|0:PAFAH1B1|0:DDX19A|0:SLC29A2|0:POM121|0:NUP155|0:PNPLA7|0:PAXIP1|0:MYOF|0:SENP2|0:BCL2L1|0:LASS4|0:SHISA5|0:H2BFWT|0:DNAJC1|0:TSGA10|0:LASS5|0:BCL2L10|0:CLIC1|0:NUPL1|0:TMEM38B|0:TMEM38A|0:TNKS			
GO:0043542	P:endothelial cell migration; TAS:UniProtKB		0:CDH13|0:FAP|0:DPP4|0:CALCA|0:NOS3|0:S100P|0:PRSS3|0:S100A2|0:GIPC1|0:SCG2|0:TNFSF12			
GO:0001755	P:neural crest cell migration; ISS:UniProtKB		0:GDNF|0:NRTN|0:HTR2B|0:SHH			
GO:0042116	P:macrophage activation; NAS:UniProtKB		0:EDN2|0:SLC11A1|0:CD93|0:TLR1			
GO:0019003	F:GDP binding; TAS:UniProtKB		0:GEM|0:TRIM23|0:RAB5A|0:RAB28|0:RAB14|0:TGM3|0:RAB2A|0:RAP1B|0:RRAGC|0:RAB11B|0:SRP54|0:RAB9A|0:RAB21|0:RAB4A|0:RRAS|0:ARL8B|0:SEPT12|0:GNAT1|0:RERG			
GO:0014802	C:terminal cisterna; ISS:BHF-UCL		0:RYR1|0:FKBP1A			
GO:0004129	F:cytochrome-c oxidase activity; TAS:UniProtKB		0:COX4I2|0:COX7A2|0:COX8C|0:COX6A2|0:COX6C|0:COX6A1|0:COX7A2P2|0:COX6B2|0:C1orf31|0:COX7C|0:COX7B2|0:MT-CO1|0:COX6B1|0:MT-CO2|0:MT-CO3|0:SURF1|0:COX7B|0:COX11|0:CYB5A|0:COX5B|0:COX7A1|0:COX8A|0:COX5A|0:COX4I1|0:COX7A2L|0:COX15			
GO:0005622	C:intracellular; TAS:UniProtKB		0:GMIP|0:MOV10L1|0:BCO2|0:ASB1|0:OSBPL1A|0:RAB6C|0:WSB1|0:C19orf61|0:ZMYND12|0:DEPDC6|0:RAB18|0:C12orf5|0:DDX43|0:HSPB8|0:RAB17|0:UBL3|0:FAM126B|0:C6orf62|0:C11orf51|0:FAM49A|0:HPCAL4|0:MOBKL2A|0:PARP8|0:DDX59|0:RNF114|0:RSPH6A|0:NUDCD2|0:ROGDI|0:SLFN13|0:FAM119B|0:MKRN2|0:TNXB|0:RDH12|0:AVEN|0:NYX|0:TMEM102|0:USP6NL|0:PLEKHG4|0:PLXNA1|0:TRIM64C|0:REM2|0:TBC1D3B|0:GPATCH8|0:SYDE2|0:INPP5B|0:TRIM56|0:ZBTB7C|0:FAM13A|0:TRIM77|0:BIRC6|0:TBC1D3G|0:GPATCH3|0:PSD4|0:CCDC75|0:TBC1D22A|0:TRIM48|0:ZNF804A|0:CASP4|0:RHOBTB1|0:TBC1D8B|0:ARHGAP11B|0:ANKZF1|0:TBC1D19|0:C6orf103|0:TBC1D12|0:RASAL1|0:EXD2|0:TBC1D26|0:RAP2B|0:TBC1D3F|0:RHPN1|0:RIT1|0:SEC14L4|0:TBCK|0:RASA3|0:RTKN2|0:ITPK1|0:GMFG|0:RHOBTB2|0:CAPN6|0:GRTP1|0:CARD16|0:CYTH4|0:RHOD|0:ZNF365|0:ZNF706|0:ARHGEF15|0:DZIP1L|0:TRAFD1|0:ZNF67P|0:ARHGAP30|0:SIPA1L2|0:RASGEF1C|0:RGL3|0:TBC1D3C|0:ERI2|0:RNF207|0:C20orf12|0:WDR67|0:BAT4|0:SRGAP3|0:ERAS|0:TTPAL|0:CPXCR1|0:TBC1D29|0:TBC1D9|0:ZNF645|0:ERAL1|0:TBC1D3H|0:ADAMTS17|0:TBC1D3|0:TBC1D16|0:EIF2AK2|0:HMHA1|0:EXD1|0:TRIM73|0:BCR|0:ARHGEF19|0:TBC1D23|0:TRIM62|0:ZNF725|0:ARL5B|0:RASD2|0:TBC1D27|0:TRIM40|0:SEC14L3|0:TBC1D2B|0:PLEKHG3|0:TBC1D20|0:GARNL3|0:RNF138|0:ARHGAP23|0:TBC1D30|0:RNF125|0:TRIM15|0:ARHGEF10|0:ZNF598|0:ARHGEF38|0:TBC1D8|0:SOLH|0:TBC1D10A|0:ARHGEF5|0:PMS2L3|0:TRIM52|0:PLEKHG4B|0:RGL2|0:ZNF804B|0:RAPGEF2|0:FAM170A|0:ERI3|0:RALBP1|0:ARHGAP11A|0:ZNF843|0:EVI5L|0:RAPGEFL1|0:ARHGAP28|0:CARD6|0:C11orf95|0:TAX1BP1|0:SH2D3A|0:TBC1D13|0:ARHGAP9|0:ARFGEF1|0:SGSM2|0:TRIM74|0:DIRAS1|0:TBC1D17|0:PSD2|0:PREX2|0:ZNF750|0:ZNF839|0:TBC1D24|0:MRAS|0:RASGEF1B|0:SRGAP1|0:ZBBX|0:OTOP3|0:PLXNB2|0:ZNF474|0:ZNF814|0:ARL5A|0:PLXNA3|0:ARL11|0:ZRANB3|0:TRIM58|0:GPATCH1|0:CAPN13|0:TRIM75|0:NPEPL1|0:TRIM38|0:C12orf51|0:ADAD2|0:TRIM64|0:TRIM59|0:ZNF833P|0:PLEKHG7|0:RGL1|0:PLXNB3|0:CHN2|0:ARHGAP12|0:RASGEF1A|0:TRIM14|0:PLXND1|0:ZNF608|0:ARHGAP20|0:HECTD1|0:PSD|0:UBE3B|0:TBC1D7|0:C9orf100|0:ZUFSP|0:TBC1D14|0:TRIM43B|0:TRIM60|0:CARD18|0:ZNF321|0:CAPN9|0:PLXNC1|0:TOM1L2|0:GPATCH4|0:CYTH2|0:RBCK1|0:PLXNA2|0:REXO1L2P|0:TBC1D10C|0:FBXO41|0:TRIM44|0:PITPNM3|0:SPATA13|0:RIT2|0:KNDC1|0:RNF166|0:CAPN12|0:GPATCH2|0:GMFB|0:TAGAP|0:CASP5|0:ARHGAP25|0:RALB|0:PLXNA4|0:STARD8|0:TRIM17|0:ARHGAP29|0:ARL5C|0:ZNF720|0:RHOJ|0:SYDE1|0:ARHGAP36|0:TRIM46|0:FAM13B|0:DEPDC1B|0:ARL14|0:YOD1|0:TBC1D5|0:CAPN14|0:PLXNB1|0:TRIM65|0:KIAA1244|0:GNL1|0:KRBA2|0:ZNF831|0:GTPBP8|0:ARHGAP18|0:TRIM49|0:ZFC3H1|0:TRIM64B|0:EXD3|0:RASAL2|0:C1orf89|0:TBC1D25|0:TEX13A|0:MCF2L2|0:CASP12|0:PINX1|0:ZNF852|0:SYNGAP1|0:ZNF673|0:SEC14L5|0:RHOC|0:HECTD2|0:KIAA0317|0:TBC1D9B|0:ZNF747|0:NAIP|0:LENG9|0:RASAL3|0:RRAS|0:TRIM42|0:BCAR3|0:IQGAP3|0:CRADD|0:RALGAPB|0:TBC1D21|0:ZNF880|0:KCMF1|0:GTPBP6|0:RAP2C|0:PLEKHG1|0:ECT2L|0:ZNF704|0:TBC1D22B|0:TBC1D28|0:TRIM43|0:C1orf25|0:RBM20|0:SIPA1L3|0:DIRAS2|0:TRIM61|0:ZFR2|0:ARHGAP31|0:ZNF428|0:RALA|0:CAPN5|0:TBC1D10B|0:RTKN|0:ZNF828|0:CHN1|0:ARHGAP40|0:PGLYRP4|0:GSPT1|0:VPS13A|0:ZNHIT3|0:NUDT5|0:CLNK|0:PGLYRP2|0:RAB4B|0:PAPPA2|0:SLC6A16|0:GLMN|0:PGLYRP3|0:CLEC1A|0:GDA|0:HPSE2|0:PPFIBP2			
GO:0005985	P:sucrose metabolic process; IC:BHF-UCL		0:GAA			
GO:0046582	F:Rap GTPase activator activity; NAS:UniProtKB		0:RASGRP3|0:RAPGEF2|0:SIPA1			
GO:0031369	F:translation initiation factor binding; ISS:UniProtKB		0:EIF2B5|0:RPS24|0:EIF2B4			
GO:0019086	P:late viral mRNA transcription; IDA:BHF-UCL		0:USF2|0:USF1			
GO:0006364	P:rRNA processing; TAS:UniProtKB		0:RRP36|0:EXOSC3|0:UTP14C|0:NOP2|0:UTP14A|0:WDR36|0:TBL3|0:RRP1B|0:KRR1|0:FRG1|0:C18orf22|0:LSM6|0:NAF1|0:RPF1|0:UTP11L|0:UTP23|0:HEATR1|0:TSR2|0:DDX51|0:CDKN2A|0:FBLL1|0:WBP11|0:UTP18|0:GAR1|0:SUV39H1|0:NSA2|0:EXOSC6|0:EIF4A3|0:FCF1|0:DCAF13|0:DDX56|0:EXOSC10|0:C1D|0:NOP10|0:UTP15|0:EXOSC8|0:EXOSC1|0:MPHOSPH10|0:RRP1|0:UTP6|0:IMP3|0:SIRT1|0:RRP8|0:PA2G4|0:PDCD11|0:PIN4|0:RPS15|0:RPL26|0:RPS19|0:SBDS|0:RPS7|0:RPS28|0:RPL35A|0:RPS16|0:RPL14|0:RPS24|0:RPS6|0:RPL7|0:RPS17|0:RPL5|0:RPL11|0:NOC4L|0:NOL6|0:EMG1|0:WDR55|0:IMP4|0:EXOSC9|0:EXOSC5|0:EXOSC4|0:POP4|0:GEMIN4|0:RRP9|0:FBL|0:DKC1|0:EXOSC2|0:NOP56|0:NOLC1|0:EXOSC7|0:DIS3|0:NOP58			
GO:0090303	P:positive regulation of wound healing; IMP:BHF-UCL		0:VTN|0:HBEGF|0:ADRA2A			
GO:0005229	F:intracellular calcium activated chloride ch...; ISS:UniProtKB		0:NMUR2|0:ANO2|0:ANO1			
GO:0051786	F:all-trans-retinol 13,14-reductase activity; ISS:HGNC		0:RETSAT			
GO:0047131	F:saccharopine dehydrogenase (NAD+, L-glutama...; NAS:UniProtKB		0:SCCPDH|0:AASS			
GO:0019538	P:protein metabolic process; IEA:InterPro		0:NECAB3|0:NUMBL|0:COQ7			
GO:0009743	P:response to carbohydrate stimulus; TAS:UniProtKB		0:ME1			
GO:0008488	F:gamma-glutamyl carboxylase activity; TAS:ProtInc		0:GGCX			
GO:0030350	F:iron-responsive element binding; IDA:UniProtKB		0:ACO1			
GO:0008843	F:endochitinase activity; IDA:UniProtKB		0:CHIT1			
GO:0034959	P:endothelin maturation; IDA:BHF-UCL		0:ECE1			
GO:0048489	P:synaptic vesicle transport; NAS:UniProtKB		0:DNM2			
GO:0042645	C:mitochondrial nucleoid; IDA:UniProtKB		0:POLG|0:POLRMT|0:TUFM|0:SHMT2|0:HSPA9|0:ATP5B|0:ACADVL|0:SLC25A5|0:LRPPRC|0:CLPX|0:CPS1|0:DHX30|0:TFB2M|0:MTERF|0:LONP1|0:HADHB|0:LRRC59|0:POLDIP2|0:VDAC2|0:TOP1MT|0:TFB1M|0:HADHA|0:DBT|0:DDX28|0:SSBP1|0:TFAM|0:SUPV3L1|0:VDAC1|0:DNAJA3|0:C10orf2			
GO:0008146	F:sulfotransferase activity; TAS:ProtInc		0:SULT1C2|0:SULT6B1|0:DSEL|0:HS6ST2|0:WSCD1|0:HS6ST3|0:SULT4A1|0:SULT1C4|0:UST|0:HS6ST1			
GO:0005524	F:ATP binding; TAS:UniProtKB		0:P2RX7|0:P2RX4|0:UHMK1|0:AKT1|0:BRSK1|0:MTHFD1L|0:PFKM|0:CDK6|0:PRKAG2|0:ABCG1|0:ENPP1|0:INSR|0:ABCA1|0:BMPR1A|0:ACVR1|0:NLRP1|0:EIF4A3|0:ACVR1B|0:PIF1|0:NLRC4|0:ACVRL1|0:TGFBR1|0:OLA1|0:PPP2R4|0:CDKL5|0:BMPR1B|0:N4BP2|0:RAD51|0:ABCB6|0:MYH9|0:CHD8|0:MYO9B|0:STK17A|0:ATP7B|0:ABL1|0:PDK3|0:DMPK|0:ATP2C1|0:PYGL|0:TSSK1B|0:MAP4K4|0:WNK1|0:ERN1|0:CDK11A|0:ACTC1|0:DYRK3|0:MKNK2|0:MARK2|0:NME1|0:MARK1|0:TWF2|0:ICK|0:BRSK2|0:TSSK4|0:SIK3|0:SRPK1|0:ATP2B2|0:TLK1|0:IGHMBP2|0:ABCB9|0:RPS6KA4|0:TSSK6|0:DYRK2|0:ERN2|0:SMARCA5|0:SPHK1|0:MAP4K5|0:STK38|0:GSS|0:NEK6|0:EIF2B2|0:STK3|0:SIK2|0:PDK4|0:CDK11B|0:TP53|0:IDE|0:RHOBTB3|0:LONP1|0:RPS6KA5|0:MAP3K6|0:TNK1|0:TAP2|0:MAP4K2|0:TLK2|0:MAP4K1|0:DAPK2|0:LATS1|0:RECQL4|0:PINK1|0:DAPK3|0:CARS|0:PFKL|0:ABCA2|0:SIK1|0:PIM1|0:BLM|0:CDC42BPG|0:PRPS1|0:SRPK2|0:STK4|0:OXSR1|0:CDC42BPA|0:MAP4K3|0:MAP3K5|0:PDXK|0:TAP1|0:PDK2|0:NEK11|0:LATS2|0:ERCC6|0:DAPK1|0:STK17B|0:MKNK1|0:GSG2|0:GCK|0:PRKACB|0:SNRK|0:STK11|0:NUAK2|0:GALK1|0:STK38L|0:IRAK3|0:NPR1|0:REM2|0:ABCG8|0:NME5|0:N4BP2L1|0:TPR|0:ALPK2|0:SPO11|0:GUCY2D|0:PMS2L2|0:OASL|0:SCYL2|0:THNSL1|0:MORC2|0:HNRNPUL2|0:PLK5P|0:TXNDC3|0:SMCHD1|0:TRANK1|0:POTEF|0:RAB18|0:SBNO1|0:ALPK3|0:RFC3|0:ILF2|0:CETN1|0:PTK7|0:RP2|0:FASTKD3|0:ZNFX1|0:TRIB3|0:SLFN12|0:MYO15B|0:DNAJA3|0:ACTR5|0:HSP90B2P|0:MORC1|0:SYN2|0:FASTKD5|0:SUCLG2|0:POLG2|0:SCYL1|0:TDRD12|0:MLH3|0:HSP90AB4P|0:FASTKD2|0:PMS2L3|0:SLFN12L|0:AK3|0:CETN2|0:HSP90AB3P|0:PXK|0:SCYL3|0:BBS12|0:RUNX2|0:PMS1|0:XRCC2|0:C8orf45|0:SYN1|0:POTEE|0:DNAJA2|0:AARSD1|0:FDXACB1|0:FASTKD1|0:PMS2|0:GUCY2C|0:NCOA5|0:HSPE1|0:TBRG4|0:AKD1|0:MTHFSD|0:ACTL6B|0:MORC4|0:NRBP2|0:KSR2|0:NDUFA10|0:PMS2L12|0:TRIB2|0:TXNDC6|0:N4BP2L2|0:ALPK1|0:IRAK2|0:PAN3|0:MLKL|0:ABCC13|0:MLH1|0:DNAJA4|0:NRBP1|0:MORC3|0:PMS2CL|0:DALRD3|0:CTU1|0:PMS2L1|0:SPEF2|0:C3orf26|0:GUCY2F|0:NAV3|0:ACTL6A|0:DNAJA1|0:TRIB1|0:PMS2L11|0:SACS|0:PMS2L5|0:CAMKV|0:CNP|0:CHD9|0:STK16|0:NAT10|0:CHD1|0:SYN3|0:TAOK3|0:STK25|0:TEK|0:ROR2|0:CCT8L1|0:CLCN4|0:ASS1|0:UBE2W|0:SMC6|0:SRMS|0:TCP1|0:ABCC12|0:KIF4A|0:HSPA2|0:SPG7|0:UBE2J1|0:KIAA0232|0:TDRD9|0:CDK16|0:RUVBL2|0:NLRP9|0:FARS2|0:DDX50|0:RFK|0:AK1|0:ACSS3|0:FAM20B|0:UCKL1|0:CKMT1B|0:PIK3C2B|0:PKN3|0:NTRK2|0:PFKFB2|0:RIPK3|0:ATP13A2|0:IPPK|0:ABCA6|0:AKT2|0:EGFR|0:MAPKAPK3|0:SKIV2L2|0:ACSL1|0:UBE2H|0:CCT3|0:RAD50|0:MVK|0:DDX21|0:MAPK11|0:SLFN11|0:PANK2|0:HELZ|0:ADCY2|0:NEK9|0:WARS2|0:RIMKLA|0:KIF22|0:ACTBL2|0:CKMT2|0:MYLK3|0:HSP90AA2|0:BMP2K|0:MAPK4|0:ERBB4|0:GPHN|0:KIF7|0:MUSK|0:ATAD2B|0:TOP3B|0:CDK12|0:NEK4|0:PI4KA|0:MAP3K14|0:CLK2|0:PIK3C3|0:DYNC1LI2|0:SMC1A|0:KHK|0:DNAH1|0:PSMC6|0:STRADA|0:CHKB|0:CTPS|0:MAPK14|0:GTF2F2|0:MOCS3|0:MAP3K8|0:MYH3|0:CARS2|0:C9orf95|0:HK1|0:IPMK|0:RIOK3|0:RFC4|0:GLYCTK|0:KIF3B|0:DNAH2|0:PRKCE|0:MST1R|0:EPHA3|0:KIF26A|0:UBE2S|0:MSH5|0:NUBPL|0:NOD1|0:NUBP1|0:DGKI|0:HSPA9|0:MYO15A|0:ACSM2A|0:DHX57|0:FIGNL1|0:EPHA6|0:FIGNL2|0:CBWD3|0:ASNS|0:PKMYT1|0:WRN|0:ATP13A5|0:CSNK1G3|0:TGFBR2|0:DDX60L|0:CIT|0:AURKC|0:QRSL1|0:RARS|0:SETX|0:DDR2|0:KIF21B|0:CLPP|0:DHX36|0:ADCY9|0:CDKL1|0:PAK2|0:ATP2B1|0:UBE2J2|0:ITPK1|0:G3BP1|0:STK32C|0:ADCK1|0:TOP3A|0:PI4KB|0:ACSBG2|0:HYOU1|0:NLRP10|0:DNAH12|0:NLRP5|0:DHX16|0:C9orf102|0:STK40|0:DGKD|0:NUAK1|0:MTHFD1|0:PFKFB1|0:RARS2|0:DCLK2|0:PANK1|0:UBE2D3|0:ENTPD2|0:ATP6V1A|0:UBE2Q2|0:PIM3|0:UBE2K|0:TEX14|0:PIK3CD|0:PARS2|0:HUNK|0:CHD1L|0:NME4|0:WEE1|0:CCT7|0:PFAS|0:NEK5|0:MAPK1|0:ATP9A|0:KIF12|0:IKBKB|0:KIF17|0:HELB|0:MAPK8|0:KIF27|0:MAPK13|0:LIG1|0:PI4K2B|0:C10orf129|0:RTCD1|0:SBK1|0:IDH3G|0:KIF13A|0:MKI67|0:DCAKD|0:GUK1|0:FASTK|0:PIP5K1B|0:ATP8A2|0:SNRNP200|0:PFKFB4|0:DHX58|0:SGK3|0:INO80|0:NRK|0:PGS1|0:EPHB2|0:ACTG1|0:ACSL4|0:SPHK2|0:RAD51L1|0:UCK2|0:CLPB|0:AASDH|0:DCK|0:GK|0:CAMK1|0:ASCC3|0:EPHA2|0:PAK6|0:ULK1|0:KIF5B|0:ATP5B|0:MAGI3|0:ITGB1BP3|0:ACTR1A|0:BBS10|0:IP6K3|0:MAP2K6|0:MCM3|0:CSK|0:LCK|0:FGFR2|0:XRCC3|0:DDX60|0:CHUK|0:STK33|0:CLCN7|0:MAP3K10|0:CSNK1D|0:TYRO3|0:CSNK1A1|0:LONP2|0:CHKA|0:PSMC1|0:KARS|0:UBE2G2|0:DDX55|0:GLUD1|0:AARS2|0:DHX32|0:MYO1A|0:LRRK1|0:NLRC5|0:AK4|0:GALK2|0:MYO19|0:CMPK1|0:HK2|0:TNNI3K|0:HSP90B1|0:PRKACG|0:ADCY6|0:MSH2|0:PIP4K2C|0:RRM1|0:ACTG2|0:MYH8|0:TTN|0:CDK19|0:KIF20A|0:ITPKC|0:GSK3A|0:C9orf167|0:ETNK1|0:IRAK4|0:TTK|0:DDX41|0:UBE2D2|0:MYH7B|0:CASK|0:ATP10B|0:PRKCA|0:HIPK1|0:NLRP14|0:RPS6KB1|0:TOP1|0:VPS4A|0:NTRK1|0:DDX5|0:MAPKAPK2|0:NMNAT1|0:CDK20|0:ROCK2|0:GRK1|0:DNAH17|0:ETNK2|0:MYO5C|0:MAPK10|0:CIITA|0:EPHA4|0:KIF14|0:CCT4|0:KIF25|0:OAS1|0:ADCY3|0:PMVK|0:PSKH2|0:TOR2A|0:MAPK7|0:MELK|0:CCT6B|0:ITK|0:VCP|0:BLK|0:UPF1|0:UBE2QL1|0:TRPV1|0:SLC22A5|0:KIF23|0:STK24|0:SPEG|0:STK10|0:ABCD3|0:EIF2AK2|0:CHD7|0:DYNC1LI1|0:MAP3K15|0:PAPOLG|0:BCR|0:CHD2|0:ITPKB|0:CKMT1A|0:CHEK2|0:DDX43|0:MAP3K4|0:KTI12|0:CLCN3|0:DGKA|0:NADK|0:NLRP8|0:UBE2A|0:SHPK|0:DAK|0:UBE2E2|0:PAK4|0:PDGFRA|0:SLC27A2|0:WRNIP1|0:KIAA0564|0:ABCA5|0:MAP2K3|0:NARS|0:BRAF|0:PEBP1|0:AAK1|0:AMHR2|0:PASK|0:MAST3|0:ACTR2|0:KIF26B|0:RYK|0:QARS|0:NUBP2|0:RECQL|0:PTK2B|0:CDK15|0:DDX19B|0:KATNAL1|0:UBE2I|0:ATP11A|0:MYO1C|0:KIF11|0:PRKG2|0:XRCC6|0:LARS|0:PRKCD|0:ATP13A4|0:MYO10|0:MYO16|0:RIPK2|0:KIF4B|0:EARS2|0:ABCE1|0:HSPA6|0:RUVBL1|0:APAF1|0:UBA3|0:NEK1|0:MYH11|0:TNK2|0:SHPRH|0:ACVR1C|0:MYO18A|0:ATM|0:TIE1|0:CAMK1G|0:ACSL5|0:CBWD5|0:GART|0:BUB1|0:ADCY10|0:CDC7|0:CLK1|0:OPLAH|0:CDK9|0:TXK|0:FPGS|0:KIF6|0:PIK3CG|0:ERBB3|0:SYK|0:ACSM1|0:CAMK2A|0:SMC1B|0:ABCB10|0:EHD3|0:RNASEL|0:HELLS|0:DNAH9|0:CAMK1D|0:SLFNL1|0:ACSF3|0:DDX51|0:ACVR2B|0:TIMM44|0:PAICS|0:JAK1|0:HIPK2|0:DDX58|0:CDC34|0:ERCC6L|0:PIP5KL1|0:SLFN5|0:MARS|0:SEPHS2|0:LARS2|0:ATAD5|0:KIF3C|0:RPS6KC1|0:VRK1|0:AARS|0:TRAP1|0:ACSM2B|0:PAK1|0:ADCY7|0:ATP13A1|0:DHX35|0:DCLK3|0:ENTPD3|0:SMC3|0:HSP90AA4P|0:MAPK12|0:INSRR|0:ULK4|0:CCT8|0:ATAD3B|0:FGFR3|0:KIF2A|0:DHX15|0:C9orf103|0:ABCC2|0:KIT|0:EPHA7|0:SGK2|0:PIK3C2G|0:PRKDC|0:MVD|0:BCS1L|0:DNA2|0:ADCK2|0:UBE2L3|0:UCK1|0:SMG1|0:PIP5K1C|0:UBE2T|0:ATP2A3|0:RECQL5|0:NLRX1|0:ABCC9|0:MCCC1|0:SRCAP|0:FLT1|0:PRKCZ|0:CENPE|0:ABCA10|0:TEP1|0:MYLK|0:ACSBG1|0:MCM7|0:IARS|0:EHD4|0:NLRP11|0:MAP2K7|0:VARS|0:CAMK4|0:DDX10|0:NLRP4|0:UBE2Z|0:STK19|0:PSMC5|0:YARS|0:PPIP5K2|0:RPS6KA1|0:UBE2D4|0:CPS1|0:ACACB|0:IFIH1|0:ATP8B3|0:GRK7|0:LIMK1|0:EPHA10|0:MAP3K11|0:PIM2|0:PPIP5K1|0:MYO1B|0:HLTF|0:TBK1|0:CLCN6|0:DDX47|0:AFG3L2|0:UBA7|0:DNAH6|0:DHX30|0:CACNA1B|0:MMAB|0:TTBK2|0:TARS|0:OAS3|0:UBE2M|0:KIF20B|0:MYLK4|0:KIF5A|0:LIG4|0:CDKL2|0:RPS6KB2|0:DDX4|0:TRPM4|0:ACSS2|0:KIFC3|0:KDR|0:MYH15|0:PLK2|0:ACTR1B|0:TPK1|0:RIPK1|0:ABCF3|0:MYH7|0:KIF1C|0:PAPSS1|0:KIF15|0:MAT1A|0:PKM2|0:CDK5|0:JAK3|0:EPHB6|0:MYO1G|0:SMARCA2|0:ACTA2|0:DDR1|0:FBXO18|0:ATP2A2|0:UBE2Q1|0:SMARCAL1|0:DNAH5|0:TRMU|0:PNCK|0:AACS|0:CLK4|0:IRAK1|0:STYK1|0:CDK14|0:MAP3K3|0:CMPK2|0:SLK|0:BAZ1B|0:LRGUK|0:GRK5|0:CDK8|0:CDK1|0:ORC1|0:PIK3CB|0:DNAH11|0:DDX18|0:SARS|0:PCCB|0:NADSYN1|0:UBE2N|0:KIF19|0:PDGFRB|0:VRK2|0:CAMK2B|0:PSTK|0:JAK2|0:KALRN|0:YTHDC2|0:EHD2|0:MCM5|0:MAP2K4|0:MAST4|0:MAGI1|0:KIF1B|0:KIF5C|0:TK2|0:RPS6KA2|0:HLCS|0:ATP11B|0:PET112L|0:CBWD1|0:AXL|0:ATP2C2|0:CSNK1E|0:PAK7|0:ERBB2|0:FANCM|0:DDX3Y|0:DHX38|0:TARS2|0:SMARCA4|0:TTL|0:OAS2|0:MAP3K12|0:ATP2B4|0:DHX29|0:DNAH8|0:PHKG1|0:ADCY4|0:SMARCAD1|0:ATP2B3|0:NLRP12|0:MARS2|0:MYO1D|0:CSNK2A1|0:DDX56|0:DDX20|0:CCT6A|0:NEK2|0:NLRC3|0:ACTR3|0:ATRX|0:SPATA5L1|0:TTF2|0:ACACA|0:YARS2|0:DDX27|0:ZRANB3|0:ATP4A|0:CHEK1|0:CKB|0:KIF18B|0:CHD3|0:CHD6|0:PRKAA1|0:ABCA8|0:CAMKK1|0:YSK4|0:NLRP7|0:DDX52|0:DGKB|0:HSPA1A|0:LACE1|0:UBE2B|0:POLQ|0:TOR1B|0:DGKK|0:DDX19A|0:ACSS1|0:MOV10|0:SMC2|0:MYH14|0:LYN|0:MYO3A|0:MAPK6|0:UBE2R2|0:H1FNT|0:TAF1|0:ATAD3C|0:ACSM4|0:DDX6|0:NMNAT3|0:HSPH1|0:KIF24|0:UBA2|0:KIF13B|0:MYO7A|0:RAD51L3|0:MDN1|0:ACSL6|0:STARD9|0:CTPS2|0:ULK3|0:PANK4|0:MYO18B|0:PAPOLB|0:SLC27A5|0:GARS|0:CDK10|0:HELQ|0:DDX11|0:NWD1|0:CERK|0:PIKFYVE|0:DARS|0:RIOK1|0:DDX53|0:CDKL3|0:RIPK4|0:ALDH18A1|0:IP6K1|0:ATAD1|0:YME1L1|0:DDX39|0:PIP4K2B|0:HSPA8|0:ABCC11|0:MYH1|0:ATP1A1|0:ACVR2A|0:RPS6KA6|0:AURKB|0:ATP8B4|0:PSMC4|0:SGK1|0:NAV2|0:POTEKP|0:CDK4|0:EPHB3|0:PAPD4|0:FGFR4|0:ORC5|0:FIGN|0:NEK10|0:SMARCA1|0:MYO1E|0:ASNA1|0:MSH4|0:DHX8|0:CBWD6|0:HSPA14|0:DTYMK|0:HSPA12B|0:RPS6KL1|0:SRC|0:CSNK1G1|0:ABCA9|0:DDX59|0:DDX1|0:MAP3K7|0:PRKCH|0:KATNAL2|0:C1orf57|0:XRCC5|0:UBE2U|0:VRK3|0:TOP2B|0:RAD54L2|0:FUK|0:LTK|0:EPHA8|0:MCM8|0:SLFN14|0:DNAH14|0:IQCA1L|0:NLRP3|0:UBE2E3|0:FARSB|0:GRK6|0:PLK3|0:UBE2F|0:DICER1|0:MYO5B|0:C9orf98|0:CDKL4|0:KIF16B|0:DHX40|0:NEK7|0:ATP2A1|0:FES|0:MYO1H|0:WARS|0:ITPKA|0:EPRS|0:TTBK1|0:PDPK1|0:STK32A|0:RAD51C|0:PFKFB3|0:ABCB5|0:ABCG4|0:ERCC3|0:DDX46|0:AK2|0:SKIV2L|0:LIMK2|0:ACSM5|0:KCNT2|0:HSPA13|0:NSF|0:KCNJ1|0:KIF2B|0:SRXN1|0:PRKG1|0:AK4P3|0:CLCN5|0:FLT3|0:UBA6|0:GLUL|0:PRKD1|0:ADK|0:PRKY|0:FLAD1|0:STK35|0:RAD17|0:PCCA|0:SMC5|0:PDK1|0:LMTK3|0:DYRK1A|0:HSPA1B|0:DDX23|0:ATP12A|0:SCN8A|0:XYLB|0:SBK2|0:LIG3|0:SUCLA2|0:ATP8B1|0:PFKP|0:TOP1MT|0:PRKCG|0:FGR|0:THRAP3|0:MET|0:AK7|0:CCT8L2|0:UBA1|0:PRKCB|0:ACSM3|0:TRPM6|0:DGUOK|0:HSPD1|0:TOR3A|0:ENTPD8|0:MYH6|0:MAP3K13|0:ATP11C|0:ATR|0:DDX49|0:CDK17|0:MYLK2|0:ATP10A|0:NMNAT2|0:TARSL2|0:TAOK2|0:CLK3|0:GK5|0:ACLY|0:DGKQ|0:CSNK2A2|0:EEF2K|0:GSK3B|0:PANK3|0:TESK1|0:GCLC|0:MKKS|0:ADCY1|0:HFM1|0:ADRBK1|0:DNAH7|0:RAGE|0:MYO9A|0:CDK13|0:STK31|0:UBE2O|0:FARSA|0:CDK7|0:MCM2|0:HIPK4|0:DNAH10|0:CDK2|0:GRK4|0:DDX17|0:CBWD2|0:STK32B|0:KIF1A|0:KIF3A|0:EHD1|0:MYH4|0:GAK|0:NARS2|0:ROR1|0:HNRNPU|0:FLT4|0:RFC5|0:AKT3|0:BTAF1|0:ABCA13|0:DARS2|0:TRIO|0:WEE2|0:CSNK1A1L|0:MYO3B|0:ABL2|0:DGKH|0:MYO6|0:NLRP6|0:PKLR|0:CCT2|0:PI4K2A|0:EPHA5|0:MERTK|0:RET|0:MASTL|0:MAPK9|0:ABCC4|0:PIK3C2A|0:NLRP13|0:PRPF4B|0:KIF21A|0:CSNK1G2|0:ATP6AP1|0:AGK|0:PAK3|0:RIMKLB|0:KCNJ10|0:DHX37|0:ADCY8|0:VARS2|0:DHX34|0:PLK4|0:DYNC2H1|0:MYO7B|0:ATAD3A|0:PDIK1L|0:MCCC2|0:DHX9|0:PKN2|0:PRKAA2|0:DDX12|0:DDX28|0:BMPR2|0:IQCA1|0:NME7|0:UBE2C|0:PIK3CA|0:GK3P|0:KIFC2|0:TOP2A|0:IGF1R|0:RAD54L|0:ABCD1|0:TEC|0:ABCB4|0:FRK|0:CHD4|0:KIF18A|0:PKN1|0:EIF2AK4|0:ACTB|0:UBA5|0:MOS|0:C9orf96|0:CHD5|0:ULK2|0:MAPK15|0:EIF4A2|0:CAMKK2|0:MAP2K1|0:CSF1R|0:NAGK|0:DDX3X|0:UBE2G1|0:CBWD7|0:PAPOLA|0:AATK|0:MSH3|0:PAPSS2|0:ACSL3|0:HSPA1L|0:CARNS1|0:MSH6|0:EP400|0:PTK2|0:HSP90AB2P|0:LRRK2|0:DYNC1H1|0:CDC6|0:MARK3|0:AURKA|0:DDX24|0:ACSF2|0:HCK|0:FYN|0:DSTYK|0:RAD54B|0:CHTF18|0:BMS1|0:HSP90AA5P|0:KIF9|0:YES1|0:EPHB1|0:TRPM7|0:IP6K2|0:ACTR3B|0:BAT1|0:DDX31|0:TYK2|0:PIP4K2A|0:C10orf2|0:RIOK2|0:ATP1A4|0:GNE|0:NEK8|0:HSP90AB1|0:FER|0:ANKK1|0:ENTPD1|0:DNAH3|0:AK5|0:BMX|0:TESK2|0:ORC4|0:NOD2|0:CKM|0:TP53RK|0:EPHB4|0:CDK3|0:HSPA12A|0:ROS1|0:SUPV3L1|0:MATK|0:SLC22A4|0:GK2|0:PLK1|0:ATP8B2|0:PSMC2|0:ALK|0:ATP13A3|0:DCLK1|0:KATNA1|0:DHX33|0:ADCY5|0:PRKD3|0:MTOR|0:DDX42|0:RAF1|0:PIP5K1A|0:PRKX|0:KIF2C|0:MYO5A|0:OBSCN|0:DQX1|0:NTRK3|0:COASY|0:EIF2AK3|0:EPHA1|0:MTPAP|0:UBE2D1|0:DYRK1B|0:RBKS|0:ROCK1|0:TK1|0:ATP1A2|0:MAPKAPK5|0:DGKG|0:MAP2K5|0:ATAD2|0:BRIP1|0:EIF4A1|0:NLRP2|0:MAP3K2|0:MCM9|0:ABCC10|0:UBE2E1|0:MTHFS|0:SLFN13|0:DDX54|0:NME2P1|0:ABCG5|0:BUB1B|0:EIF2AK1|0:SPATA5|0:CUL9|0:NOLC1|0:IARS2|0:PKDCC|0:ADCK3|0:CCT5|0:PSMC3|0:GMPS|0:PTK6|0:TRIT1|0:HKDC1|0:NME3|0:MAT2A|0:RPS6KA3|0:ERCC2|0:ADRBK2|0:RTEL1|0:PEX1|0:VPS4B|0:PEX6|0:KCNJ11|0:CAD|0:BCKDK|0:MINK1|0:TSSK3|0:MAST2|0:SARS2|0:ATP5A1|0:PRPS1L1|0:WNK3|0:CLPX|0:NLK|0:WNK2|0:TSSK2|0:HSPA4L|0:CDC42BPB|0:SRR|0:PGK2|0:PRPS2|0:WNK4|0:DDX25|0:PGK1|0:MAST1|0:P2RX2|0:P2RX6|0:P2RX3|0:P2RX5|0:TAOK1|0:PRKD2|0:MAP2K2|0:CAMK2G|0:PIK3R4|0:MYO1F|0:MYH13|0:PRKACA|0:ATP1A3|0:PNKP|0:CAMK2D|0:MAP3K1|0:NDUFA13|0:MCM4|0:HARS2|0:TNIK|0:PHKG2|0:RUNX1|0:NME2|0:MARK4|0:MYH2|0:LANCL2|0:PNPLA8|0:LMTK2|0:ARAF|0:HK3|0:STK39|0:CDK18|0:PSKH1|0:HSPA7|0:ZAP70|0:STRADB|0:KIFC1|0:GOLGA5|0:FGFR1|0:HARS|0:HIPK3|0:SPAST|0:PRKCQ|0:ATP10D|0:HSPA4|0:NME6|0:PBK|0:MAPK3|0:RUNX3|0:DYRK4|0:MAP3K9|0:ILK|0:TRIP13|0:IKBKE|0:MCM6|0:MAK|0:NEK3|0:ATP9B|0:ABCA12|0:SRPK3|0:KSR1|0:MYH10|0:HSPA5|0:ATP8A1|0:BTK|0:ATP7A|0:ABCD4|0:SEPHS1|0:ABCC5|0:ABCB1|0:PC|0:ABCC1|0:ABCC6|0:TOR1A|0:ABCC8|0:DGKZ|0:CFTR|0:DGKE|0:PDS5B|0:RFC2|0:NVL|0:ABCB8|0:DMC1|0:EPB42|0:ABCF1|0:ABCB11|0:ABCD2|0:ABCC3|0:ABCA4|0:ABCA3|0:ABCB7|0:ABCF2|0:ABCG2|0:ABCA7|0:TPX2|0:RFC1|0:ACTA1|0:MOV10L1|0:PRKCI|0:HSP90AA1|0:STK36|0:TRNT1|0:CLP1|0:SMC4			
GO:0042541	P:hemoglobin biosynthetic process; ISS:UniProtKB		0:INHA|0:INHBA|0:ALAS2			
GO:0034190	F:apolipoprotein receptor binding; IPI:BHF-UCL		0:PCSK9|0:APOA2			
GO:0016049	P:cell growth; TAS:UniProtKB		0:SGMS1|0:NOTCH2|0:RASGRP4|0:NUPR1|0:HPN|0:EMP1|0:LEFTY2|0:TGFB3|0:LEFTY1|0:TGFB2|0:TGFB1|0:EMP3|0:ATP6V0E2|0:ATP6V0E1|0:NUBP1|0:CAV3|0:TGFBR3|0:XRN2|0:TNN|0:ERBB2IP|0:FHL1|0:SLC3A2|0:MTPN|0:DGKD|0:FGFR2|0:DDX5|0:RRAGC|0:SOCS5|0:AR|0:ENOX2|0:FGFR3|0:FGFR1|0:WHSC1L1|0:NDRG4|0:NOP58|0:MTOR			
GO:0033256	C:I-kappaB/NF-kappaB complex; TAS:BHF-UCL		0:NFKB1|0:NFKBIA			
GO:0010814	P:substance P catabolic process; IDA:BHF-UCL		0:ECE1			
GO:0008333	P:endosome to lysosome transport; TAS:ProtInc		0:SORT1|0:VAMP7|0:TRAK1|0:RHOB|0:VIPAR|0:AKTIP|0:HOOK3|0:HOOK2|0:FAM160A2|0:HOOK1|0:MGRN1|0:HMGXB4|0:ADRB2|0:M6PR			
GO:0004987	F:kappa-opioid receptor activity; TAS:ProtInc		0:OPRK1			
GO:0033180	C:proton-transporting V-type ATPase, V1 domain; IEA:InterPro		0:ATP6V1B2|0:ATP6V1A|0:ATP6V1C1|0:ATP6V1B1|0:ATP6AP1L|0:ATP6V1F|0:ATP6AP1|0:ATP6V1C2			
GO:0017101	C:aminoacyl-tRNA synthetase multienzyme complex; IDA:HGNC		0:AIMP1			
GO:0005927	C:muscle tendon junction; ISS:UniProtKB		0:NRAP			
GO:0000179	F:rRNA (adenine-N6,N6-)-dimethyltransferase a...; IEA:InterPro		0:DIMT1L|0:C1orf66|0:TFB2M|0:TFB1M			
GO:0070644	F:vitamin D response element binding; IDA:BHF-UCL		0:TCF3			
GO:0045134	F:uridine-diphosphatase activity; IDA:UniProtKB		0:ENTPD4			
GO:0048261	P:negative regulation of receptor-mediated en...; TAS:UniProtKB		0:APOC1|0:PICALM|0:APOC3|0:APOC2|0:RAC1|0:ARF6			
GO:0045794	P:negative regulation of cell volume; IDA:UniProtKB		0:KCNMA1			
GO:0055002	P:striated muscle cell development; IEP:UniProtKB		0:SDC1			
GO:0001895	P:retina homeostasis; ISS:UniProtKB		0:BBS10|0:BBS1|0:ARMS2|0:DFNB31|0:BBS4|0:SOD1			
GO:0060158	P:activation of phospholipase C activity by d...; TAS:BHF-UCL		0:DRD1|0:DRD2|0:DRD5			
GO:0017127	F:cholesterol transporter activity; IMP:BHF-UCL		0:APOA4|0:CETP|0:ABCG1|0:ABCA1|0:STARD3|0:STAR|0:APOB|0:APOA1			
GO:0046716	P:muscle cell homeostasis; ISS:UniProtKB		0:PFKM|0:ALDOA|0:CHRNA1|0:SRF|0:LARGE|0:GYLTL1B|0:SOD1			
GO:0045780	P:positive regulation of bone resorption; IMP:HGNC		0:TNFSF11|0:MC4R			
GO:0008585	P:female gonad development; ISS:UniProtKB		0:ZFP42|0:WNT4			
GO:0009019	F:tRNA (guanine-N1-)-methyltransferase activity; IEA:EC		0:TRMT5			
GO:0008431	F:vitamin E binding; TAS:ProtInc		0:SEC14L2|0:TTPA			
GO:0007039	P:vacuolar protein catabolic process; TAS:ProtInc		0:CPA2			
GO:0007309	P:oocyte axis specification; TAS:UniProtKB		0:LEFTY2|0:AXIN1			
GO:0051899	P:membrane depolarization; ISS:UniProtKB		0:P2RX7|0:KCNE1|0:KCNQ1|0:CAV1|0:BEST2|0:CHRNB2|0:CHRNA4			
GO:0004999	F:vasoactive intestinal polypeptide receptor ...; TAS:ProtInc		0:ADCYAP1R1|0:VIPR2|0:VIPR1			
GO:0005844	C:polysome; TAS:ProtInc		0:EPM2A|0:RPS4Y1|0:ATXN2|0:RPS4X|0:CALR|0:FXR1|0:PSMA1|0:EIF2S1			
GO:0030658	C:transport vesicle membrane; IEA:UniProtKB-SubCell		0:VAMP7|0:SLC30A8|0:CLCN3|0:SYCN|0:SCGN|0:RPH3AL|0:SNTB2|0:DBH|0:SPRED2|0:SYTL4|0:ICA1|0:CUZD1			
GO:0047192	F:1-alkylglycerophosphocholine O-acetyltransf...; ISS:UniProtKB		0:LPCAT1|0:LPCAT2			
GO:0033778	F:7alpha-hydroxycholest-4-en-3-one 12alpha-hy...; EXP:Reactome		0:CYP8B1			
GO:0030867	C:rough endoplasmic reticulum membrane; ISS:HGNC		0:PI4KB|0:PLOD2|0:PLOD3|0:C1orf9|0:PLOD1|0:RPN1			
GO:0008625	P:induction of apoptosis via death domain rec...; TAS:ProtInc		0:DEDD2|0:CASP8AP2|0:TNFRSF10B|0:TNFRSF10A|0:DEDD|0:FADD|0:DAXX|0:BID|0:DIABLO|0:CRADD			
GO:0006710	P:androgen catabolic process; TAS:UniProtKB		0:HSD17B11|0:HSD17B6			
GO:0004795	F:threonine synthase activity; IEA:InterPro		0:THNSL1			
GO:0042978	F:ornithine decarboxylase activator activity; NAS:UniProtKB		0:PRLR			
GO:0034976	P:response to endoplasmic reticulum stress; ISS:UniProtKB		0:ATF4|0:SCAMP5|0:OS9|0:CREB3L2|0:ATP2A1|0:FAM129A			
GO:0030054	C:cell junction; NAS:UniProtKB		0:P2RX6|0:P2RX4|0:SLC13A3|0:PTPRJ|0:BRSK1|0:DTNBP1|0:SYN3|0:UNC13B|0:ITSN1|0:CADPS2|0:SHANK3|0:GRID1|0:GRIN3A|0:AMPH|0:GABRP|0:SYT11|0:CHRM3|0:DTNA|0:SYT4|0:COLQ|0:GPHN|0:SYNGR3|0:GABRR2|0:GRIN2C|0:SV2B|0:DLG4|0:SIPA1L1|0:SCAMP5|0:ACHE|0:GLRA3|0:SNPH|0:CBLN3|0:SHC4|0:KCTD12|0:CPLX4|0:CPLX3|0:PJA2|0:SEPT3|0:CHRNA2|0:SYT7|0:RAPSN|0:OTOF|0:GRID2|0:GABRB3|0:GABRG2|0:GABBR2|0:PDLIM5|0:CADPS|0:LRFN2|0:TRIM9|0:SLC17A7|0:PICK1|0:ABI1|0:GRIN2D|0:PRR7|0:VAMP3|0:CHRM2|0:GABRA4|0:DLGAP2|0:SLC17A8|0:GRIA2|0:RPS6KB1|0:OPHN1|0:CHRM4|0:GRIP1|0:IGSF9|0:GABRE|0:GRIN2A|0:SYN2|0:UNC13A|0:GRIK3|0:SHANK2|0:SLC30A3|0:SYT10|0:GLRA2|0:GABRG1|0:PCLO|0:SVOP|0:CAMK2N1|0:GABRA6|0:STX1A|0:CAMK2A|0:GABRR1|0:CBLN4|0:SV2C|0:GABRA3|0:CHRNA5|0:DENND1A|0:CRIPT|0:GABBR1|0:RIMBP2|0:RPH3A|0:SNAP29|0:DOC2A|0:DMXL2|0:GABRD|0:CHRNB3|0:DNM2|0:DLGAP3|0:SSPN|0:CHRNA3|0:GRIA4|0:HCRT|0:CHRNG|0:CYFIP2|0:SYNGR1|0:LRFN3|0:TANC1|0:RIMS3|0:STXBP5|0:GRIA3|0:GOPC|0:SNAPIN|0:CBLN1|0:DLG2|0:GRASP|0:FAIM2|0:LRRC4B|0:CHRND|0:LGI3|0:ARC|0:KLHL17|0:CHRNA9|0:SAMD4A|0:CHRNA10|0:GRIK2|0:HTR3A|0:CHRM1|0:CHRNB1|0:SLC17A6|0:NETO1|0:SEPT11|0:SYT5|0:SYN1|0:LRRC4|0:ANKS1B|0:SHANK1|0:EGFLAM|0:GABRA2|0:NCS1|0:DNMBP|0:GRIK5|0:SHISA9|0:SYNPR|0:FBXO45|0:DOK7|0:ZNRF1|0:TPRG1L|0:CHRM5|0:BSN|0:CABP1|0:PPP1R9A|0:GAP43|0:GABRA1|0:SYP|0:CHRNA6|0:GLRA1|0:RIMS4|0:HOMER3|0:CYFIP1|0:RASGRP2|0:CHRNB4|0:SYT1|0:CHRNA1|0:GRID2IP|0:SNAP23|0:GRIN1|0:CTBP2|0:RIMS2|0:KCTD16|0:GLRA4|0:SYT12|0:CHRNB2|0:DLGAP1|0:RABAC1|0:LRFN1|0:KCTD8|0:GABRA5|0:SV2A|0:PSD3|0:CHRNA7|0:CHRNE|0:GRIK4|0:LZTS1|0:GABRB2|0:GRIN2B|0:ZNRF2|0:GABRR3|0:SRCIN1|0:CLSTN1|0:GRIK1|0:SYT6|0:SYT3|0:LGI1|0:NLGN1|0:GLRB|0:UTRN|0:CPEB1|0:GABRQ|0:PHACTR1|0:GRIA1|0:GAD2|0:GABRG3|0:ERC2|0:RIMS1|0:ARHGAP32|0:TULP1|0:PPP1R9B|0:ICA1|0:GRIN3B|0:VAMP2|0:SYT2|0:VAMP1|0:GABRB1|0:HOMER2|0:MAGI2|0:HOMER1|0:CHRNA4|0:UNC13C|0:SYT9|0:SEMA4C|0:LCP1|0:SNTB1|0:AMICA1|0:CLCA2|0:SIGMAR1|0:TBC1D2|0:CD99L2|0:PRIMA1|0:ANO7|0:SNTB2|0:SNTA1|0:PECAM1|0:ADA|0:CDHR2|0:ARHGAP21|0:XIRP2|0:LIM2			
GO:0022009	P:central nervous system vasculogenesis; ISS:UniProtKB		0:ENG|0:WNT7B			
GO:0007035	P:vacuolar acidification; NAS:UniProtKB		0:SLC11A1|0:ATP6V0E2|0:ATP6V0E1|0:ATP6V1H			
GO:0000085	P:G2 phase of mitotic cell cycle; TAS:ProtInc		0:CENPF|0:APP|0:GTSE1|0:BLM|0:FOXN3|0:KPNA2			
GO:0071502	P:cellular response to temperature stimulus; ISS:UniProtKB		0:HTR2B			
GO:0032355	P:response to estradiol stimulus; NAS:BHF-UCL		0:GHR|0:TFF1|0:RARA|0:GPR81|0:GH1|0:RNF14|0:SLC25A36|0:STAT5B|0:STAT3|0:ESR1|0:SOCS2|0:CTNNB1|0:TGFB1|0:FOXA1|0:STRN3|0:WNT8B			
GO:0031268	P:pseudopodium organization; IDA:UniProtKB		0:RAB25			
GO:0004865	F:protein serine/threonine phosphatase inhibi...; TAS:ProtInc		0:PPP1R2|0:PPP1R1A|0:PPP1R8			
GO:0032925	P:regulation of activin receptor signaling pa...; IDA:HGNC		0:SMAD7|0:FKBP1A|0:INHBA			
GO:0061044	P:negative regulation of vascular wound healing; IGI:BHF-UCL		0:SERPINE1			
GO:0047545	F:2-hydroxyglutarate dehydrogenase activity; IDA:HGNC		0:L2HGDH			
GO:0035478	F:chylomicron binding; IDA:BHF-UCL		0:GPIHBP1			
GO:0035116	P:embryonic hindlimb morphogenesis; ISS:BHF-UCL		0:RARG			
GO:0003868	F:4-hydroxyphenylpyruvate dioxygenase activity; ISS:UniProtKB		0:HPDL|0:HPD			
GO:0019722	P:calcium-mediated signaling; TAS:UniProtKB		0:EDN2|0:EDN1|0:AGTR1|0:TREML1|0:SPHK1|0:NMUR1|0:CASR|0:RCAN3|0:RCAN2|0:RCAN1|0:LAT2|0:LAT|0:HTR2B|0:EIF2AK3|0:MCTP1|0:MCTP2|0:PLA2G4B|0:SELE|0:BTK|0:PLCE1|0:NUDT4|0:IL8|0:CAMKK2			
GO:0021508	P:floor plate formation; ISS:UniProtKB		0:GLI2			
GO:0004908	F:interleukin-1 receptor activity; IEA:InterPro		0:IL18R1|0:IL1RAP|0:IL1RL1			
GO:0001541	P:ovarian follicle development; NAS:UniProtKB		0:INHBA|0:EIF2B2|0:FOXL2|0:EIF2B5|0:EIF2B4|0:SOD1|0:FSHB|0:ANG|0:INHA|0:INHBB			
GO:0051325	P:interphase; IDA:UniProtKB		0:KRT7			
GO:0016619	F:malate dehydrogenase (oxaloacetate-decarbox...; IEA:EC		0:ME2			
GO:0016481	P:negative regulation of transcription; NAS:UniProtKB		0:ZEB2|0:UIMC1|0:SNX6|0:EID2|0:NRG1|0:SUMO1|0:PDCD4|0:COMMD7|0:EREG|0:MYST3|0:PML|0:TLE1|0:DAXX|0:LANCL2|0:BRCA1|0:RUNX2|0:FOXL2|0:BCL3|0:CCDC85B|0:GCLC|0:CENPF|0:KCTD1|0:PTPRU|0:PCGF6|0:PTPRK|0:COBRA1|0:TH1L|0:ERN2|0:ATP8B1|0:DEDD|0:WWP1|0:GLIS2|0:SUDS3|0:BCL7A|0:SMURF2|0:TRIM33|0:BTAF1|0:DEDD2			
GO:0001933	P:negative regulation of protein amino acid p...; ISS:UniProtKB		0:PARK2|0:PPAP2B|0:TGFB1|0:PTEN|0:IBTK|0:IGFBP3|0:SLIT2|0:MEN1|0:TAZ|0:FAM129A			
GO:0001315	P:age-dependent response to reactive oxygen s...; IMP:UniProtKB		0:SOD2			
GO:0003988	F:acetyl-CoA C-acyltransferase activity; TAS:ProtInc		0:ACAA1|0:ACAA2|0:HADHB			
GO:0004466	F:long-chain-acyl-CoA dehydrogenase activity; TAS:ProtInc		0:ACADL|0:ACADVL			
GO:0010181	F:FMN binding; TAS:UniProtKB		0:NDOR1|0:HAO1|0:TYW1|0:POR|0:NDUFV1|0:TYW1B|0:PNPO|0:NOS1|0:NOS2|0:NOS3|0:MTRR			
GO:0003051	P:angiotensin-mediated drinking behavior; IMP:BHF-UCL		0:ACE2			
GO:0043653	P:mitochondrial fragmentation involved in apo...; IMP:HGNC		0:BAX|0:DNM1L			
GO:0019959	F:interleukin-8 binding; IPI:UniProtKB		0:A2M			
GO:0048167	P:regulation of synaptic plasticity; TAS:UniProtKB		0:YWHAG|0:GIPC1|0:YWHAH|0:CNTN4			
GO:0005967	C:mitochondrial pyruvate dehydrogenase complex; NAS:UniProtKB		0:DLAT			
GO:0016042	P:lipid catabolic process; NAS:UniProtKB		0:OC90|0:C6orf127|0:PLA2G2C|0:C6orf126|0:PLA2G12B|0:DAGLA|0:LIPK|0:PLA1A|0:LIPF|0:PNPLA5|0:PLCD3|0:PLCE1|0:PAFAH1B3|0:PLCXD3|0:ASPG|0:LGALS13|0:PLA2G2A|0:PLCB3|0:PNLIP|0:PLA2G3|0:PLD4|0:PNLIPRP1|0:CLC|0:PLCXD2|0:DAGLB|0:CLPS|0:PNPLA4|0:PLCD4|0:PNLIPRP2|0:ENPP6|0:PLB1|0:PLD6|0:ENPP2|0:PLCZ1|0:PLA2G7|0:PLCB2|0:PLCH2|0:PNPLA1|0:PNPLA8|0:PLD3|0:PLA2G2E|0:DDHD2|0:PLA2G10|0:PLBD2|0:PLA2G12A|0:PAFAH1B1|0:NCEH1|0:LIPH|0:LIPM|0:PLA2G5|0:PAFAH2|0:PLBD1|0:LIPI|0:PLA2G6|0:PLCH1|0:PLCD1|0:PLA2G2F|0:PLCB1|0:LIPN|0:APOC2|0:DDHD1|0:PLA2G16|0:ABHD4|0:PNPLA6|0:PLCB4|0:PLA2G2D|0:PNLIPRP3|0:LIPJ|0:LIPA|0:IAH1|0:PAFAH1B2|0:AZGP1			
GO:0005544	F:calcium-dependent phospholipid binding; TAS:UniProtKB		0:ANXA5|0:ANXA3|0:ANXA1|0:ANXA4|0:ANXA2|0:ANXA6|0:ANXA10|0:ANXA9|0:ANXA8|0:ANXA2P2|0:DOC2A|0:ANXA7|0:ANXA11|0:ANXA8L2|0:ANXA8L1|0:DOC2B|0:PCLO|0:PLA2G4B|0:ANXA13|0:CPNE1|0:CPNE3			
GO:0003714	F:transcription corepressor activity; TAS:UniProtKB		0:TAF9B|0:PROX1|0:SP100|0:IFNB1|0:ELK3|0:JAZF1|0:SKI|0:PEX14|0:RARA|0:TBL1X|0:HIPK2|0:SETD8|0:KDM5B|0:RBFOX2|0:TBL1XR1|0:CASP8AP2|0:YAF2|0:YAP1|0:SKIL|0:GPS2|0:NRIP1|0:SAP30|0:DDX54|0:CITED2|0:NR0B1|0:C19orf2|0:NCOR1|0:NCOR2|0:DNMT3B|0:BASP1|0:SCAI|0:HDAC3|0:NPAT|0:CRYM|0:AES|0:SIRT1|0:HDAC9|0:TRIB3|0:EID1|0:LMCD1|0:WNT4|0:NSD1|0:SRSF2|0:PBXIP1|0:L3MBTL2|0:RLIM|0:ZEB1|0:TFEC|0:PAWR|0:PLRG1|0:NFKBIL2|0:ZNF85|0:KCNIP3|0:DRAP1|0:LDB1|0:MXD4|0:E2F1|0:YY1|0:PFDN5|0:UBP1|0:ALX1|0:NFIL3|0:ZNF136|0:SIAH2|0:ZBTB32|0:RYBP|0:ID3|0:HIRA|0:SF1|0:HTT|0:MEIS2|0:CSDA|0:ZNF593|0:APEX1|0:PPP1R13L|0:NR0B2|0:ENO1|0:TRIM22|0:ZNF274|0:ATF3|0:SAP18|0:CREG1|0:JUNB|0:HOXC6|0:E4F1|0:PIAS1|0:CBX4|0:NR1D1|0:MECP2|0:KLF12|0:ID4|0:TSG101|0:E2F6|0:TRIM28|0:MSC|0:TFCP2L1|0:GRLF1|0:HSF4|0:ATF5|0:NR1H4|0:FEV|0:THRB|0:NAB2|0:HSBP1|0:MBD1|0:BATF3|0:ERF|0:TDP2|0:ZFPM2|0:NR2F2|0:TGIF1|0:MNT|0:RELB|0:MXD1|0:CIR1|0:CTCF|0:MXI1|0:DDIT3|0:SSX1|0:DR1|0:PSMC3|0:SUFU			
GO:0071385	P:cellular response to glucocorticoid stimulus; IDA:UniProtKB		0:UBE2L3			
GO:0002087	P:regulation of respiratory gaseous exchange ...; ISS:UniProtKB		0:TSHZ3			
GO:0010523	P:negative regulation of calcium ion transpor...; TAS:BHF-UCL		0:CALCA|0:NOS1			
GO:0004760	F:serine-pyruvate transaminase activity; IEA:EC		0:AGXT			
GO:0030162	P:regulation of proteolysis; NAS:UniProtKB		0:LTBP4|0:SERPINB13|0:PLAUR|0:SERPINB4			
GO:0035520	P:monoubiquitinated protein deubiquitination; IMP:UniProtKB		0:USP1			
GO:0003058	P:hormonal regulation of the force of heart c...; TAS:BHF-UCL		0:EDN2			
GO:0090042	P:tubulin deacetylation; ISS:UniProtKB		0:HDAC6			
GO:0045211	C:postsynaptic membrane; NAS:UniProtKB		0:DLG4|0:DNM2|0:SYNE1|0:HTR3E|0:HTR3B|0:CHRFAM7A|0:ZACN|0:HTR3C|0:DTNBP1|0:SHANK3|0:SIPA1L1|0:DLG1|0:PJA2|0:PDLIM5|0:DLGAP2|0:LIN7B|0:SHANK2|0:LIN7A|0:CAMK2N1|0:DLGAP3|0:TANC1|0:GOPC|0:DLG2|0:ARC|0:KLHL17|0:NETO1|0:LIN7C|0:ANKS1B|0:SHANK1|0:NCS1|0:CABP1|0:HOMER3|0:DLGAP1|0:LRFN1|0:PSD3|0:LZTS1|0:SRCIN1|0:NLGN1|0:CPEB1|0:ARHGAP32|0:HOMER2|0:HOMER1|0:MPDZ|0:SYNPO|0:SEMA4C|0:GRID1|0:GRIN3A|0:GABRP|0:CHRM3|0:GPHN|0:GABRR2|0:GRIN2C|0:GLRA3|0:SHC4|0:KCTD12|0:CHRNA2|0:RAPSN|0:GRID2|0:GABRB3|0:GABRG2|0:GABBR2|0:LRFN2|0:GRIN2D|0:PRR7|0:CHRM2|0:GABRA4|0:GRIA2|0:CHRM4|0:GRIP1|0:GABRE|0:GRIN2A|0:GRIK3|0:GLRA2|0:GABRG1|0:GABRA6|0:GABRR1|0:GABRA3|0:CHRNA5|0:GABBR1|0:GABRD|0:CHRNB3|0:SSPN|0:CHRNA3|0:GRIA4|0:CHRNG|0:LRFN3|0:GRIA3|0:GRASP|0:FAIM2|0:CHRNA9|0:CHRNA10|0:GRIK2|0:HTR3A|0:CHRM1|0:CHRNB1|0:LRRC4|0:GABRA2|0:GRIK5|0:FBXO45|0:CHRM5|0:GABRA1|0:CHRNA6|0:GLRA1|0:CHRNB4|0:GRID2IP|0:KCTD16|0:GLRA4|0:CHRNB2|0:KCTD8|0:GABRA5|0:CHRNA7|0:CHRNE|0:GRIK4|0:GABRB2|0:GRIN2B|0:GABRR3|0:CLSTN1|0:GRIK1|0:GLRB|0:UTRN|0:GABRQ|0:GRIA1|0:GABRG3|0:GRIN3B|0:GABRB1|0:CHRNA4|0:PICALM|0:GRM7|0:MAGEE1|0:GRIN1|0:KCNMA1|0:STRN|0:CHRND|0:CHRNA1|0:NLGN2			
GO:0007522	P:visceral muscle development; ISS:BHF-UCL		0:MYH6			
GO:0015662	F:ATPase activity, coupled to transmembrane m...; IEA:InterPro		0:ATP13A2|0:ATP13A5|0:ATP9A|0:ATP8A2|0:ATP10B|0:ATP11A|0:ATP13A4|0:ATP13A1|0:ATP8B3|0:ATP11B|0:ATP8B4|0:ATP10D|0:KIAA0195|0:ATP8B1|0:ATP11C|0:ATP10A|0:ATP9B|0:ATP8B2|0:ATP13A3|0:ATP8A1			
GO:0000942	C:outer kinetochore of condensed nuclear chro...; IDA:BHF-UCL		0:CCNB1|0:NDC80|0:PLK1			
GO:0051276	P:chromosome organization; ISS:UniProtKB		0:SMCHD1|0:PTTG1|0:PTTG3P|0:SMC1B|0:PTTG2|0:CDCA8|0:LIG4			
GO:0046822	P:regulation of nucleocytoplasmic transport; NAS:UniProtKB		0:AAAS			
GO:0033862	F:UMP kinase activity; IDA:MGI		0:CMPK2			
GO:0010976	P:positive regulation of neuron projection de...; ISS:UniProtKB		0:STMN2|0:NPTN			
GO:0006811	P:ion transport; NAS:UniProtKB		0:SLC22A20|0:SLC22A24|0:CNNM2|0:SLCO4A1|0:SLCO1C1|0:CNNM3|0:SLCO3A1|0:MRS2|0:CNNM1|0:SLC22A23|0:SLC22A15|0:CNNM4|0:SLCO4C1|0:WNK1|0:PDZD3			
GO:0004811	?:?; TAS:UniProtKB		0:TRIT1			
GO:0048496	P:maintenance of organ identity; IMP:HGNC		0:GPR98|0:NPHP3|0:IQCB1|0:USH2A			
GO:0043409	P:negative regulation of MAPKKK cascade; ISS:BHF-UCL		0:NF1|0:PSMD10|0:DAG1|0:P2RX7|0:CAV1			
GO:0000150	F:recombinase activity; NAS:UniProtKB		0:RBPJ			
GO:0060413	P:atrial septum morphogenesis; IMP:BHF-UCL		0:NKX2-5			
GO:0003886	F:DNA (cytosine-5-)-methyltransferase activity; TAS:ProtInc		0:TRDMT1|0:DNMT1			
GO:0004033	F:aldo-keto reductase activity; TAS:UniProtKB		0:CYB5A|0:AKR1C4|0:AKR1D1|0:MIOX|0:AKR7A3|0:AKR1B10|0:SPR|0:AKR1C1|0:AKR1C3			
GO:0003810	F:protein-glutamine gamma-glutamyltransferase...; TAS:ProtInc		0:TGM3|0:TGM1|0:TGM7|0:TGM6|0:EPB42|0:TGM2|0:TGM4|0:F13A1|0:TGM5			
GO:0045178	C:basal part of cell; TAS:BHF-UCL		0:HFE|0:SLC11A2|0:DOCK7			
GO:0005082	F:receptor signaling protein tyrosine phospha...; IDA:UniProtKB		0:CSPG4			
GO:0033179	C:proton-transporting V-type ATPase, V0 domain; IEA:InterPro		0:ATP6V0B|0:ATP6V0C|0:ATP6V0D2|0:ATP6V0E2|0:ATP6V0E1|0:ATP6V0D1			
GO:0042808	F:neuronal Cdc2-like kinase binding; NAS:UniProtKB		0:CDK5RAP2|0:CDK5RAP3|0:CDK5RAP1			
GO:0000789	C:cytoplasmic chromatin; IDA:UniProtKB		0:NPM2			
GO:0047734	F:CDP-glycerol diphosphatase activity; IEA:EC		0:C17orf48			
GO:0050922	P:negative regulation of chemotaxis; NAS:UniProtKB		0:ELANE			
GO:0042586	F:peptide deformylase activity; IDA:HGNC		0:PDF			
GO:0019166	F:trans-2-enoyl-CoA reductase (NADPH) activity; IEA:EC		0:MECR|0:PECR			
GO:0015279	F:store-operated calcium channel activity; TAS:ProtInc		0:ORAI1|0:TRPC4|0:TRPC1|0:TRPC5|0:TRPC3			
GO:0006423	P:cysteinyl-tRNA aminoacylation; IEA:InterPro		0:CARS|0:CARS2			
GO:0008201	F:heparin binding; TAS:UniProtKB		0:SELP|0:APOE|0:PCSK6|0:THBS1|0:LPL|0:SERPINE2|0:APOB|0:APOA5|0:FGF14|0:FGFBP3|0:MPO|0:LTF|0:FGF12|0:ELANE|0:CTSG|0:THBS3|0:COMP|0:FGF10|0:SLIT2|0:COL25A1|0:MDK|0:COL5A1|0:PF4|0:COL13A1|0:ANG|0:SFRP1|0:THBS4|0:VEGFA|0:FGFRL1|0:FBLN7|0:CYR61|0:VEGFB|0:RSPO4|0:FGF4|0:SERPIND1|0:CCL15|0:LIPG|0:LAMC2|0:FGFR2|0:RPL22|0:ADAMTS1|0:CXCL6|0:LIPC|0:PCOLCE2|0:SOD3|0:CTGF|0:APP|0:PGF|0:PRG2|0:RSPO1|0:VTN|0:ABP1|0:CCL23|0:IMPG2|0:CCL8|0:FGF2|0:RSPO2|0:APOH|0:ADAMTS3|0:RSPO3|0:F11|0:FGF9|0:FGF1|0:SOST|0:ADAMTS8|0:PTN|0:CCL7|0:SERPINC1|0:HRG|0:PF4V1|0:APLP1|0:C6orf25|0:HBEGF|0:PAFAH1B1|0:TGFBR3|0:TNXB|0:POSTN|0:AZU1|0:KNG1|0:FGFR1|0:FN1|0:CEL|0:SELL|0:ZNF146|0:HDGF|0:THBS2|0:RPL29|0:AAMP|0:FSTL1|0:FGFBP1|0:ODZ1|0:LRPAP1|0:SERPINA5			
GO:0006917	P:induction of apoptosis; TAS:UniProtKB		0:PPARG|0:TRADD|0:TGFB1|0:CDKN2C|0:CDKN1B|0:BBC3|0:PMAIP1|0:AIFM3|0:CD70|0:SIVA1|0:NOD1|0:BNIPL|0:TERF1|0:SAP30BP|0:PPP1R13B|0:PML|0:APOE|0:THBS1|0:TBX5|0:COL4A3|0:MUL1|0:TPD52L1|0:DLC1|0:RPS3|0:EIF5A|0:RNF41|0:HIP1|0:DAPK3|0:NAIF1|0:BNIP3L|0:INHA|0:BNIP3|0:ERCC3|0:INHBA|0:ETS1|0:IFNB1|0:GSDMA|0:DRAM2|0:TP53BP2|0:WT1|0:CIDEC|0:CDKN2A|0:RIPK1|0:BNIP1|0:UTP11L|0:IKBIP|0:ACVR1B|0:STK17A|0:LCK|0:NDUFS3|0:ERN2|0:AIFM2|0:RPS3A|0:DAPK2|0:STK17B|0:ERCC2|0:TGFB3|0:PDCD7|0:JMY|0:ERN1|0:TRIM35|0:RUNX3|0:CD27|0:NUDT2|0:PTEN|0:MAL|0:TNFRSF19|0:NLRP1|0:BCL2L13|0:NLRP3|0:FEM1B|0:NUPR1|0:NOX5|0:UNC13B|0:TRAIP|0:CASP4|0:PRKCE|0:MAPK1|0:PYCARD|0:SMNDC1|0:TNFSF10|0:MAP3K10|0:ZNF443|0:LTA|0:TNFRSF9|0:TIAL1|0:HRK|0:TRAF3|0:HTT|0:IKBKG|0:DPF1|0:DCC|0:PLAGL1|0:HTATIP2|0:CASP6|0:TNFSF12|0:TIA1|0:IFNA2|0:PDCD5|0:LALBA|0:TNFSF8|0:TFPT|0:TNFSF14|0:EI24|0:MX1|0:TLR2|0:NME3|0:BCLAF1|0:PPP2R1A|0:NOTCH2|0:PPP2CA|0:ALOX15B|0:BIK|0:CD2|0:BAK1			
GO:0008543	P:fibroblast growth factor receptor signaling...; TAS:UniProtKB		0:FGF20|0:FGF18|0:FGF17|0:FGF22|0:FGF16|0:FGF5|0:FGF4|0:FRS3|0:FGF19|0:FGF7|0:FGF3|0:FGF6|0:FGF2|0:FGF9|0:FGF1|0:FGF8|0:CEP57|0:SHOC2|0:FIBP|0:FRS2			
GO:0033017	C:sarcoplasmic reticulum membrane; TAS:BHF-UCL		0:ART1|0:JSRP1|0:ATP2A3|0:SLN|0:TMEM109|0:SYNE2|0:TRDN|0:SRI|0:ITPR2|0:TMEM38B|0:TMEM38A|0:ATP2A2|0:ATP2A1|0:RYR2			
GO:0006435	P:threonyl-tRNA aminoacylation; NAS:UniProtKB		0:TARS2|0:TARSL2|0:TARS			
GO:0045647	P:negative regulation of erythrocyte differen...; ISS:UniProtKB		0:HOXA5|0:MAFB|0:LDB1			
GO:0018024	F:histone-lysine N-methyltransferase activity; IEA:EC		0:SETD7|0:EHMT1|0:WHSC1L1|0:EZH2|0:EHMT2|0:ASH1L|0:EZH1|0:SETD8|0:MLL3|0:DOT1L|0:PRDM2|0:SMYD3|0:SETDB1|0:SETMAR|0:PRDM9|0:PRDM6|0:SETD1B|0:MLL2|0:WHSC1|0:SETD1A|0:SETD2			
GO:0016263	F:glycoprotein-N-acetylgalactosamine 3-beta-g...; IDA:UniProtKB		0:C1GALT1			
GO:0035197	F:siRNA binding; ISS:UniProtKB		0:TARBP2|0:EIF2C2|0:TLR9|0:TLR7			
GO:0010900	P:negative regulation of phosphatidylcholine ...; IDA:BHF-UCL		0:APOC1			
GO:0030977	F:taurine binding; IDA:UniProtKB		0:GLRA1			
GO:0017033	F:DNA topoisomerase I binding; IPI:UniProtKB		0:TOPORS			
GO:0042613	C:MHC class II protein complex; NAS:UniProtKB		0:HLA-DOA|0:HLA-DRB3|0:HLA-DRA|0:HLA-DRB4|0:HLA-DOB|0:HLA-DMA|0:HLA-DPB1|0:HLA-DMB|0:HLA-DRB1|0:HLA-DRB5|0:HLA-DQA2|0:HLA-DQA1|0:HLA-DQB1|0:HLA-DPA1|0:HLA-DQB2			
GO:0007271	P:synaptic transmission, cholinergic; TAS:UniProtKB		0:RAPSN|0:CHRNB1|0:CHRNA3|0:CHRNB2|0:CHRNA4|0:CHRNB3|0:NQO1|0:CHRNB4|0:CHRNE|0:APOE|0:CHRNA10			
GO:0006650	P:glycerophospholipid metabolic process; ISS:UniProtKB		0:ALDH5A1			
GO:0031334	P:positive regulation of protein complex asse...; IMP:UniProtKB		0:SUMO1|0:GSK3B|0:FAF1			
GO:0070050	P:neuron homeostasis; IMP:UniProtKB		0:CHRNA1|0:HAAO|0:FGGY			
GO:0032597	P:B cell receptor transport into membrane raft; IDA:UniProtKB		0:CD24			
GO:0032425	P:positive regulation of mismatch repair; IDA:HGNC		0:PRKCG			
GO:0019964	F:interferon-gamma binding; IDA:UniProtKB		0:KLHL20			
GO:0003130	P:BMP signaling pathway involved in heart ind...; IMP:BHF-UCL		0:BMP2|0:POU5F1			
GO:0031032	P:actomyosin structure organization; IEA:InterPro		0:CNN3|0:CNN2|0:LIMCH1|0:CNN1			
GO:0050829	P:defense response to Gram-negative bacterium; TAS:UniProtKB		0:SELP|0:TLR4|0:IL6R|0:IL6|0:SERPINE1|0:S100A7|0:LBP|0:SLC11A1|0:NOS2|0:AZU1			
GO:0007600	P:sensory perception; TAS:ProtInc		0:ARRB1|0:ARRB2|0:NTSR2|0:ADORA2A|0:TRPV2|0:SCN10A|0:OPRK1|0:PNOC|0:OPRL1|0:CCKBR|0:OPRM1|0:ACCN3			
GO:0032878	P:regulation of establishment or maintenance ...; IDA:UniProtKB		0:LLGL2			
GO:0090162	P:establishment of epithelial cell polarity; ISS:UniProtKB		0:FERMT1|0:PARD3			
GO:0034214	P:protein hexamerization; IDA:UniProtKB		0:SPAST|0:C10orf2			
GO:0070110	C:ciliary neurotrophic factor receptor complex; IDA:BHF-UCL		0:IL6ST			
GO:0070694	F:deoxyribonucleoside 5'-monophosphate N-glyc...; ISS:UniProtKB		0:C6orf108			
GO:0033364	P:mast cell secretory granule organization; ISS:UniProtKB		0:LYST			
GO:0051024	P:positive regulation of immunoglobulin secre...; ISS:BHF-UCL		0:IL6|0:TNFSF4|0:RBP4|0:TNFRSF4			
GO:0006610	P:ribosomal protein import into nucleus; NAS:UniProtKB		0:RPL23			
GO:0045817	P:positive regulation of transcription from R...; IDA:UniProtKB		0:SP1|0:TFAP2B|0:ELL3			
GO:0035377	P:transepithelial water transport; IDA:UniProtKB		0:AQP1			
GO:0008260	F:3-oxoacid CoA-transferase activity; IMP:UniProtKB		0:OXCT2|0:OXCT1			
GO:0030704	P:vitelline membrane formation; IEA:InterPro		0:VMO1			
GO:0060218	P:hemopoietic stem cell differentiation; IDA:UniProtKB		0:ACE|0:SFRP1			
GO:0035083	P:cilium axoneme assembly; IMP:BHF-UCL		0:RSPH4A|0:RSPH9			
GO:0019784	F:NEDD8-specific protease activity; IDA:UniProtKB		0:OTUB1|0:USP21			
GO:0001921	P:positive regulation of receptor recycling; ISS:UniProtKB		0:SNCA|0:ECE1|0:SCRIB|0:BVES|0:VAMP3			
GO:0042221	P:response to chemical stimulus; IEP:UniProtKB		0:RPS6KA5			
GO:0042800	F:histone methyltransferase activity (H3-K4 s...; IDA:UniProtKB		0:MLL|0:MLL5			
GO:0042578	F:phosphoric ester hydrolase activity; ISS:UniProtKB		0:PGAP1			
GO:0006356	P:regulation of transcription from RNA polyme...; TAS:ProtInc		0:POLR2L|0:POLR2K|0:TFAM			
GO:0048813	P:dendrite morphogenesis; ISS:UniProtKB		0:DVL1|0:CELSR2|0:CTNNA2			
GO:0045762	P:positive regulation of adenylate cyclase ac...; ISS:HGNC		0:CALCR|0:NF1			
GO:0006496	P:protein amino acid terminal N-glycosylation; IDA:UniProtKB		0:DDOST			
GO:0042347	P:negative regulation of NF-kappaB import int...; IDA:UniProtKB		0:NLRP3|0:CYLD			
GO:0060389	P:pathway-restricted SMAD protein phosphoryla...; ISS:BHF-UCL		0:TGFBR2|0:BMP7|0:GDF6|0:GDF7|0:BMP2|0:TGFB2|0:TGFBR1|0:GDF2|0:TGFB1|0:BMP10|0:TGFBR3|0:SMAD7			
GO:0006556	P:S-adenosylmethionine biosynthetic process; IDA:UniProtKB		0:MAT2B			
GO:0008013	F:beta-catenin binding; TAS:AgBase		0:AR|0:DVL3|0:AXIN1|0:TCF7L2|0:DLG5|0:APC2|0:SALL1|0:CHD8|0:CBY1|0:LZIC|0:CALCOCO1|0:LEF1|0:TRPC4|0:SMAD7|0:SOX17|0:CDH5|0:TCF4|0:EP300|0:CTNNA1|0:ESR1|0:CTNNBIP1|0:HDAC6|0:GSK3B|0:TBL1X|0:PSEN1|0:CDH1|0:TBL1XR1|0:PXN|0:PTPRT|0:GLI3|0:CDH24|0:PTPRU|0:APC|0:PTPRK|0:VCL|0:SHROOM2|0:AXIN2|0:CARM1|0:GRIP1|0:CDH2			
GO:0006506	P:GPI anchor biosynthetic process; ISS:UniProtKB		0:PIGY|0:DPM1|0:DPM3|0:ALG9|0:ALG12|0:CWH43|0:PGAP3|0:PIGZ|0:MPPE1|0:PGAP2			
GO:0004421	F:hydroxymethylglutaryl-CoA synthase activity; EXP:Reactome		0:HMGCS1|0:HMGCS2			
GO:0071164	F:RNA trimethylguanosine synthase activity; IDA:BHF-UCL		0:TGS1			
GO:0004951	F:cholecystokinin receptor activity; TAS:ProtInc		0:CCKAR			
GO:0005801	C:cis-Golgi network; TAS:ProtInc		0:SCYL1|0:HOOK3|0:FKTN|0:GOLGA5|0:SCFD1|0:COG3|0:TMED10|0:FAM134B|0:MPPE1|0:TRAPPC8|0:COPZ2|0:DNM1L|0:GOLIM4			
GO:0004944	F:C5a anaphylatoxin receptor activity; TAS:ProtInc		0:GPR77|0:C5AR1			
GO:0051918	P:negative regulation of fibrinolysis; TAS:BHF-UCL		0:USF1|0:PLG|0:THBS1|0:APOH|0:SERPINE1|0:THBD|0:F2			
GO:0046501	P:protoporphyrinogen IX metabolic process; IDA:BHF-UCL		0:FECH			
GO:0006826	P:iron ion transport; TAS:ProtInc		0:FTL|0:FTHL17|0:FTMT|0:FTH1P19|0:FTH1|0:TF|0:SFXN4|0:SFXN5|0:SFXN1|0:STEAP2|0:SFXN3|0:FXN|0:STEAP1|0:LTF|0:MFI2|0:SLC25A28|0:BDH2|0:STEAP4|0:HEPH|0:SFXN2|0:STEAP3|0:SLC11A1|0:TFR2|0:HFE			
GO:0015361	F:low affinity sodium:dicarboxylate symporter...; EXP:Reactome		0:SLC13A2			
GO:0006924	P:activation-induced cell death of T cells; IMP:MGI		0:SIVA1|0:AKT1			
GO:0030851	P:granulocyte differentiation; NAS:UniProtKB		0:CBFA2T3|0:CSF3			
GO:0000921	P:septin ring assembly; TAS:ProtInc		0:ANLN			
GO:0032794	F:GTPase activating protein binding; IPI:BHF-UCL		0:GAPVD1|0:PLCD1			
GO:0021631	P:optic nerve morphogenesis; ISS:UniProtKB		0:CHRNB2			
GO:0033148	P:positive regulation of estrogen receptor si...; IMP:UniProtKB		0:FOXA1|0:MLL2			
GO:0016327	C:apicolateral plasma membrane; TAS:BHF-UCL		0:NEDD4			
GO:0008424	F:glycoprotein 6-alpha-L-fucosyltransferase a...; TAS:UniProtKB		0:FUT8			
GO:0006766	P:vitamin metabolic process; TAS:ProtInc		0:RXRA			
GO:0019673	P:GDP-mannose metabolic process; IEA:InterPro		0:GMDS			
GO:0006730	P:one-carbon metabolic process; NAS:UniProtKB		0:CA8|0:CA5B|0:CA7|0:CA13|0:CA2|0:CA12|0:CA6|0:CA5A|0:CA1|0:CA9|0:CA4|0:CA3|0:CA5BP|0:AHCYL2|0:DHFRP1|0:MTHFD1L|0:MTHFD1|0:MAT2B|0:MTHFD2L|0:DHFRL1|0:FPGS|0:MTHFD2|0:MAT1A|0:DHFR|0:AHCYL1|0:MAT2A|0:AHCY			
GO:0060019	P:radial glial cell differentiation; ISS:UniProtKB		0:FGF10			
GO:0042245	P:RNA repair; IDA:UniProtKB		0:FTO|0:ALKBH1			
GO:0000213	F:tRNA-intron endonuclease activity; IEA:EC		0:TSEN2|0:TSEN34			
GO:0070773	F:protein N-terminal glutamine amidohydrolase...; ISS:UniProtKB		0:WDYHV1			
GO:0047988	F:hydroxyacid-oxoacid transhydrogenase activity; IDA:UniProtKB		0:ADHFE1			
GO:0043515	F:kinetochore binding; IMP:UniProtKB		0:CCDC99|0:CENPE|0:CENPH|0:CLASP1			
GO:0003300	P:cardiac muscle hypertrophy; ISS:UniProtKB		0:HTR2B			
GO:0070060	P:'de novo' actin filament nucleation; ISS:UniProtKB		0:JMY			
GO:0046855	P:inositol phosphate dephosphorylation; IDA:UniProtKB		0:IMPA2|0:IMPA1|0:PTEN			
GO:0043001	P:Golgi to plasma membrane protein transport; IDA:MGI		0:BLZF1			
GO:0006508	P:proteolysis; TAS:UniProtKB		0:RNPEP|0:CTSB|0:CTSH|0:PCSK2|0:REN|0:ADAMTS9|0:ASTL|0:ELANE|0:CASP3|0:ADAMTS13|0:MMP23B|0:KLK14|0:PRSS50|0:ATG4A|0:CASP7|0:PRSS2|0:BMP1|0:MMP9|0:CASP1|0:C9orf3|0:ATG4B|0:SHFM1|0:CASP6|0:PAPPA2|0:PRSS3|0:XPNPEP1|0:MMP23A|0:MMP8|0:PHEX|0:TMPRSS6|0:CTSG|0:ATG4C|0:ENDOU|0:PRSSL1|0:ADAM5P|0:MMP16|0:CELA1|0:UQCRC1|0:ADAM23|0:TFR2|0:OSGEP|0:PRSS22|0:CMA1|0:CPD|0:CTSLL6|0:CPO|0:ADAM29|0:KLK7|0:CPXM1|0:MASP2|0:ENPEP|0:CAPN11|0:F10|0:MBTPS2|0:ADAM8|0:AGBL2|0:LONRF1|0:KLK3|0:ADAM2|0:NCLN|0:SENP5|0:ESPL1|0:MALT1|0:PRSS54|0:C6orf103|0:ERMP1|0:PRSS29P|0:HPR|0:CPM|0:LPA|0:TMPRSS11F|0:NRIP3|0:OVCH1|0:PCSK5|0:TPSD1|0:CLPP|0:GZMM|0:ASPRV1|0:CTSL2|0:PRSS21|0:CAPN6|0:SENP8|0:TINAGL1|0:PIGK|0:CARD16|0:MIPEP|0:SEC11A|0:CNDP1|0:PYCARD|0:TMPRSS11B|0:HPN|0:PROZ|0:TPSG1|0:KEL|0:PRSS48|0:ADAMDEC1|0:FURIN|0:LONP2|0:AZU1|0:CPA6|0:AGBL3|0:FAP|0:ADAMTS1|0:PCSK4|0:PRTN3|0:CPA5|0:F12|0:ADAM20|0:KLK11|0:CAPN7|0:CPXM2|0:ADAM7|0:NAALADL1|0:ADAM32|0:F7|0:AGTPBP1|0:PCSK6|0:LONRF2|0:CPVL|0:TRHDE|0:AGBL1|0:ADAMTS17|0:ADAMTS12|0:DHH|0:DDI1|0:KLK6|0:ADAMTS19|0:SENP6|0:KLK2|0:TINAG|0:THOP1|0:QPCT|0:MMEL1|0:EML2|0:NLN|0:PRSS23|0:DPEP2|0:KLK10|0:CASP2|0:PRSS33|0:ADAM12|0:C1RL|0:ADAM19|0:ADAMTS16|0:SEC11C|0:SOLH|0:ACE2|0:CAPN8|0:ADAM28|0:WDR7|0:CTSE|0:CFLAR|0:PREPL|0:CTSA|0:XPNPEP2|0:C1R|0:DPP4|0:APEH|0:CASP10|0:AFG3L2|0:PRSS35|0:CTRB2|0:TYSND1|0:TMPRSS15|0:CTSL1|0:MMP21|0:MMP17|0:ADAM15|0:IMMP1L|0:PWP2|0:MMP15|0:HP|0:SCRN1|0:DDI2|0:DPP6|0:PRSS42|0:DNPEP|0:CELA2B|0:HTRA1|0:ADAMTS7|0:CTSW|0:ECE2|0:OSGEPL1|0:MST1|0:OMA1|0:ADAM21|0:CAPN13|0:TMPRSS5|0:NPEPL1|0:AEBP1|0:PRSS16|0:KLK1|0:PRSS36|0:DPP10|0:YME1L1|0:MMP27|0:MST1P9|0:CASP14|0:TMPRSS11D|0:HABP2|0:IHH|0:C1S|0:ADAMTS15|0:PRSS55|0:DPP9|0:PMPCB|0:ADAM18|0:DPEP1|0:NRIP2|0:ADAMTS3|0:CASP9|0:IMMP2L|0:RBP3|0:AGBL5|0:TMPRSS12|0:ADAM11|0:MEP1B|0:PCSK7|0:HTRA4|0:PRCP|0:CARD18|0:LMLN|0:CAPN9|0:GZMK|0:F11|0:TLL2|0:QPCTL|0:SEC11B|0:CTSD|0:TFRC|0:NSF|0:LONRF3|0:SCPEP1|0:SENP2|0:CFI|0:CFB|0:ADAMTS10|0:KLK8|0:PRSS45|0:CAPN12|0:ECEL1|0:OVCH2|0:SHH|0:PRSS37|0:SENP3|0:PCSK9|0:ADAMTS6|0:ACY1|0:ADAMTS8|0:METAP2|0:PGPEP1L|0:MASP1|0:CPE|0:CELA2A|0:UQCRC2|0:RNPEPL1|0:ADAM30|0:FOLH1B|0:SCRN2|0:CAPN14|0:F9|0:CPA2|0:ADAMTS14|0:TMPRSS9|0:PAMR1|0:PRSS8|0:ADAM22|0:CASP12|0:PYDC1|0:PRSS1|0:PRSS38|0:AGBL4|0:SENP7|0:ADAMTS2|0:NAALADL2|0:PRSS27|0:CPB1|0:MEP1A|0:METAP1|0:FAM111A|0:CRADD|0:C2|0:CARD17|0:HGF|0:LTA4H|0:TMPRSS11A|0:ADAMTS18|0:HTRA3|0:TMEM27|0:TMPRSS2|0:TPSAB1|0:NPEPPS|0:SCRN3|0:CAPN5|0:TLL1|0:PRSS53|0:CTSC|0:CAPN10|0:PITRM1|0:TPP1|0:TMPRSS7|0:TMPRSS11E|0:TMPRSS3|0:KLK15|0:NAALAD2|0:ACAN|0:FOLH1|0:PGA3|0:TMPRSS4|0:CPA4|0:KLK9|0:CELA3B|0:DPP8|0:MMP25|0:PGA4|0:MMP26|0:GZMH|0:KLK13|0:TPSB2|0:LRP8|0:ADAM33|0:KLK5|0:PGA5|0:LAP3|0:CTRB1|0:PROC|0:NRD1|0:TMPRSS13|0:KLK4|0:KLK12|0:MMP19|0:MMP28|0:MMP2|0:MMP7|0:CELA3A|0:SPG7|0:MMP24|0:CTSO|0:CASP4|0:MMP13|0:ADAMTS5|0:MMP20|0:LCN1|0:CTSK|0:CTSF|0:CTRC|0:WFDC2|0:CFD|0:DPP3|0:MMP1|0:MMP3|0:MMP14|0:CTRL|0:ADAMTS4|0:UBA3|0:CPA1|0:SUFU|0:PCSK1|0:NAPSA|0:MMP10|0:SENP1|0:KLKB1|0:FBXO3|0:MME|0:LNPEP|0:CPZ|0:MMP12|0:MMP11|0:PLAT|0:HGFAC|0:CPB2|0:CTSS|0:VHL|0:PREP|0:CASP5|0:OLR1|0:BLMH|0:TPP2|0:MBTPS1|0:FBXL2|0:ST14|0:PGC|0:CTSZ|0:F2|0:PLAU|0:FBXL6|0:FBXW2|0:RCE1|0:PEPD|0:HTRA2|0:CAPN3|0:SPCS1|0:PMPCA|0:CPA3			
GO:0008138	F:protein tyrosine/serine/threonine phosphata...; TAS:UniProtKB		0:DUSP3|0:STYXL1|0:STYX|0:EPM2A|0:SSH1|0:DUSP22|0:CDC14A|0:TPTE|0:SSH2|0:DUSP26|0:C20orf57|0:CDC14C|0:TPTE2|0:PTP4A3|0:DUSP28|0:DUPD1|0:DUSP27|0:SSH3|0:CDC14B|0:PTPDC1|0:DUSP15|0:PTPMT1|0:DUSP11|0:RNGTT|0:DUSP23|0:PTEN|0:MTMR2|0:CDKN3|0:DUSP13|0:SBF1			
GO:0006617	P:SRP-dependent cotranslational protein targe...; ISS:UniProtKB		0:SRP54			
GO:0000082	P:G1/S transition of mitotic cell cycle; TAS:UniProtKB		0:CDKN1A|0:CDKN2D|0:CDKN2C|0:CDKN1B|0:ACVR1B|0:INHBA|0:SPDYA|0:CDCA5|0:LATS2|0:CCND1|0:CDK4|0:ACVR1|0:EIF4E|0:RCC1|0:RPS6KB1|0:PHF8|0:POLE|0:EIF4EBP1|0:CDC34|0:CCNE1|0:CDKN3|0:BCAT1|0:CUL3|0:DBF4|0:CDC7|0:PPP6C|0:CUL4A|0:SKP2|0:CUL1|0:CUL5|0:CUL2|0:GSPT1			
GO:0033157	P:regulation of intracellular protein transport; IDA:UniProtKB		0:LCP1			
GO:0006207	P:'de novo' pyrimidine base biosynthetic process; NAS:UniProtKB		0:DPYD|0:UMPS|0:CAD|0:DHODH			
GO:0060315	P:negative regulation of ryanodine-sensitive ...; ISS:BHF-UCL		0:CALM2|0:CALM3|0:CALM1			
GO:0051014	P:actin filament severing; TAS:ProtInc		0:GSN|0:SCIN|0:DSTN|0:VIL1			
GO:0042993	P:positive regulation of transcription factor...; IMP:UniProtKB		0:CDH1|0:FLNA			
GO:0032074	P:negative regulation of nuclease activity; IDA:UniProtKB		0:NEIL1			
GO:0016307	F:phosphatidylinositol phosphate kinase activity; IEA:InterPro		0:PIPSL			
GO:0005148	F:prolactin receptor binding; TAS:ProtInc		0:GH1|0:SOCS2|0:PRL			
GO:0017144	P:drug metabolic process; NAS:UniProtKB		0:UGT1A1|0:UGT1A8|0:CYP2E1|0:FMO2|0:UGT1A9|0:CYP1A1|0:UGT1A7|0:CBR1|0:EPHX2			
GO:0005147	F:oncostatin-M receptor binding; IPI:BHF-UCL		0:OSM			
GO:0071277	P:cellular response to calcium ion; IMP:UniProtKB		0:ALOX5AP|0:WNT5A|0:CLIC4|0:HTR2B			
GO:0019348	P:dolichol metabolic process; IDA:UniProtKB		0:DPM1|0:SRD5A3			
GO:0004083	F:2,3-bisphospho-D-glycerate 2-phosphohydrola...; IEA:EC		0:PGAM1|0:PGAM4|0:BPGM|0:PGAM2			
GO:0042788	C:polysomal ribosome; IDA:HGNC		0:NUFIP2|0:NR0B1|0:RPL7A			
GO:0051789	P:response to protein stimulus; IDA:MGI		0:FGF10|0:NR3C1|0:NR4A2			
GO:0045823	P:positive regulation of heart contraction; ISS:BHF-UCL		0:TGFB2|0:NKX2-5			
GO:0051246	P:regulation of protein metabolic process; IEA:InterPro		0:UBE2W|0:UBE2J1|0:BIRC6|0:UBE2H|0:UBE2NL|0:UBE2J2|0:UBE2D3|0:UBE2Q2|0:UBE2K|0:UBE2G2|0:UBE2D2|0:UBE2L6|0:UBE2QL1|0:UBE2A|0:UBE2E2|0:UBE2V1|0:UBE2I|0:CDC34|0:UBE2L3|0:UBE2T|0:UBE2Z|0:UBE2D4|0:UBE2M|0:UEVLD|0:UBE2Q1|0:UBE2R2|0:TSG101|0:UBE2U|0:UBE2E3|0:UBE2F|0:UBE2DNL|0:UBE2O|0:UBE2V2|0:UBE2G1			
GO:0045162	P:clustering of voltage-gated sodium channels; TAS:UniProtKB		0:NRCAM|0:AGRN			
GO:0005890	C:sodium:potassium-exchanging ATPase complex; TAS:UniProtKB		0:ATP1A3|0:ATP1A2|0:FXYD2|0:ATP1B3|0:ATP1A1|0:ROS1|0:ATP1B1|0:ATP1A4			
GO:0042775	P:mitochondrial ATP synthesis coupled electro...; IDA:BHF-UCL		0:TAZ			
GO:0006888	P:ER to Golgi vesicle-mediated transport; TAS:UniProtKB		0:SEC13|0:SEC24B|0:PREB|0:SAR1B|0:SEC23A|0:ERGIC1|0:YKT6|0:COG3|0:NRBP1|0:TRAPPC2L|0:TRAPPC4|0:SEC23B|0:TRAPPC1|0:ZW10|0:SPAST|0:VAMP7|0:MPPE1|0:SEC24A|0:TRAPPC8|0:SAR1A|0:GOPC|0:SEC31A|0:SEC24C|0:TRAPPC2P1|0:TRAPPC2|0:SEC24D|0:LMAN1|0:RAB2A|0:SEC22A|0:SEC22B|0:SEC22C|0:GOSR2|0:BET1|0:STX18|0:TMX1|0:LMAN2L			
GO:0006278	P:RNA-dependent DNA replication; IEA:InterPro		0:ERVK2|0:ERVK6			
GO:0000308	C:cytoplasmic cyclin-dependent protein kinase...; IDA:UniProtKB		0:CCNY|0:CDK14			
GO:0004066	F:asparagine synthase (glutamine-hydrolyzing)...; IEA:InterPro		0:ASNS|0:ASNSD1			
GO:0004174	F:electron-transferring-flavoprotein dehydrog...; IDA:UniProtKB		0:AIFM2|0:ETFDH			
GO:0007205	P:activation of protein kinase C activity by ...; TAS:UniProtKB		0:PICK1|0:DGKI|0:SPHK2|0:DGKA|0:DGKZ|0:CERKL|0:SPHK1|0:DGKE|0:DGKB|0:DGKK|0:CERK|0:DGKQ|0:AGK|0:DGKG|0:DGKH|0:HTR2B|0:PLCE1|0:DGKD|0:CHRM1|0:GAP43|0:PRKD3|0:PPAP2A|0:AZU1|0:PARD3			
GO:0090201	P:negative regulation of release of cytochrom...; IMP:UniProtKB		0:PARK2|0:PSMD10|0:FXN			
GO:0050796	P:regulation of insulin secretion; TAS:UniProtKB		0:NEUROD1|0:TNF|0:IL1B|0:IFNG|0:NOS2|0:RFX6|0:RFX3|0:STX1A			
GO:0003829	F:beta-1,3-galactosyl-O-glycosyl-glycoprotein...; TAS:ProtInc		0:GCNT3|0:GCNT4|0:GCNT1			
GO:0006393	P:termination of mitochondrial transcription; TAS:ProtInc		0:MTERF			
GO:0008437	F:thyrotropin-releasing hormone activity; TAS:ProtInc		0:TRH			
GO:0018364	P:peptidyl-glutamine methylation; IDA:UniProtKB		0:TRMT112			
GO:0004346	F:glucose-6-phosphatase activity; IEA:EC		0:G6PC|0:G6PC2|0:G6PC3			
GO:0003756	F:protein disulfide isomerase activity; TAS:UniProtKB		0:ERP44|0:PDIA4|0:TMX3|0:ERP29|0:P4HB|0:PDIA3|0:PDIA6|0:PDIA2|0:PDIA5			
GO:0015078	F:hydrogen ion transmembrane transporter acti...; NAS:UniProtKB		0:ATP6V0B|0:ATP5L2|0:MT-ATP8|0:TCIRG1|0:ATP6V0A2|0:ATP5J|0:ATP5G1|0:ATP5G2|0:ATP6V0D2|0:MT-ATP6|0:ATP6V0E2|0:ATP5I|0:ATP5F1|0:ATP5H|0:ATP5G3|0:ATP5L|0:ATP6V0A1|0:ATP5S			
GO:0014704	C:intercalated disc; TAS:BHF-UCL		0:PGM5|0:OBSL1			
GO:0045381	P:regulation of interleukin-18 biosynthetic p...; NAS:UniProtKB		0:NLRP12			
GO:0016175	F:superoxide-generating NADPH oxidase activity; TAS:UniProtKB		0:NOX5|0:CYBB|0:NOX1			
GO:0019863	F:IgE binding; IEA:UniProtKB-KW		0:FCER1G|0:LGALS3|0:FCER2			
GO:0005652	C:nuclear lamina; IDA:UniProtKB		0:HLCS			
GO:0015884	P:folic acid transport; TAS:ProtInc		0:FOLR2|0:FOLR3|0:FOLR1			
GO:0048075	P:positive regulation of eye pigmentation; TAS:UniProtKB		0:HPS4			
GO:0006091	P:generation of precursor metabolites and energy; TAS:ProtInc		0:ENPP1|0:CYB5R4|0:ACOX1|0:GNPDA1|0:THTPA|0:SLC25A4|0:CROT|0:ASIP|0:SLC25A27|0:SCO1|0:AVP|0:AVPR1A|0:COX6A2|0:ISL1|0:COX17|0:CEBPA|0:COX6C|0:COX6A1|0:COX7A1|0:COX8A|0:GIPR|0:ATPIF1|0:FECH|0:COX4I1|0:MCHR1|0:XYLB|0:ADIPOQ|0:SLC25A3|0:ECH1|0:NRF1|0:GCGR|0:PPARD|0:POMC|0:ACAA1|0:PDX1|0:COX7C|0:AQP7			
GO:0070845	P:polyubiquitinated misfolded protein transport; IMP:BHF-UCL		0:HDAC6			
GO:0046882	P:negative regulation of follicle-stimulating...; NAS:UniProtKB		0:INHBB|0:FST|0:INHA|0:INHBA			
GO:0004372	F:glycine hydroxymethyltransferase activity; IDA:UniProtKB		0:SHMT2|0:SHMT1			
GO:0008544	P:epidermis development; TAS:ProtInc		0:ATP2C1|0:PLOD1|0:NTF4|0:EDA2R|0:ELF3|0:C1orf68|0:EDAR|0:KRT15|0:DCT|0:KRT34|0:KLK7|0:BTD|0:KRTAP5-9|0:KRT5|0:LAMB3|0:BNC1|0:LAMC2|0:LAMA3|0:KRT16|0:PTHLH|0:CTGF|0:ALOX12B|0:KRT1|0:ALDH3A2|0:FABP5|0:KRT83|0:CRABP2|0:HOXB13|0:EMP1|0:ATP2A2|0:GJB5|0:UGCG|0:KRT13|0:FLOT2|0:WAS|0:KLK5|0:COL17A1|0:CASP14|0:KRT85|0:KRT32|0:COL7A1|0:KRT14|0:KRT17|0:KRT31|0:CALML5|0:RBP2|0:TGM5|0:KRT10			
GO:0005216	F:ion channel activity; NAS:UniProtKB		0:TPTE|0:TPTE2|0:MCOLN3|0:PKD1L2|0:PKD2L2|0:FXYD6|0:PLLP|0:MLC1|0:PKD1L3|0:CNGA1|0:FXYD7|0:FXYD8|0:PKDREJ|0:MCOLN2|0:FXYD5|0:FXYD2			
GO:0014834	P:satellite cell maintenance involved in skel...; IDA:BHF-UCL		0:IGF1			
GO:0044240	P:multicellular organismal lipid catabolic pr...; IDA:BHF-UCL		0:APOA4|0:PLA2G1B			
GO:0018872	P:arsonoacetate metabolic process; ISS:UniProtKB		0:AS3MT			
GO:0000018	P:regulation of DNA recombination; TAS:ProtInc		0:SMARCAD1|0:KPNA2|0:IL7R|0:KPNA1			
GO:0031333	P:negative regulation of protein complex asse...; IPI:UniProtKB		0:PRKCZ|0:CDC42			
GO:0033783	F:25-hydroxycholesterol 7alpha-hydroxylase ac...; IEA:EC		0:CYP7B1			
GO:0010248	P:establishment or maintenance of transmembra...; IDA:HGNC		0:BAX|0:BAK1			
GO:0051220	P:cytoplasmic sequestering of protein; IMP:BHF-UCL		0:YWHAB|0:LATS1|0:FLNA			
GO:0031593	F:polyubiquitin binding; IPI:UniProtKB		0:VCP|0:DNAJB2|0:HDAC6|0:BRE|0:DZIP3|0:FAM175B|0:BRCC3|0:UBXN1|0:FAM175A|0:RBCK1			
GO:0019787	F:small conjugating protein ligase activity; TAS:UniProtKB		0:ATG3|0:RNF14|0:AKTIP|0:UBE2V1|0:UBE2I|0:UEVLD|0:TSG101|0:UBE2DNL|0:UBE2V2|0:UBL4A|0:ARIH1			
GO:0004357	F:glutamate-cysteine ligase activity; IDA:UniProtKB		0:GCLC			
GO:0048630	P:skeletal muscle tissue growth; IMP:BHF-UCL		0:CHRND|0:CHRNA1			
GO:0003934	F:GTP cyclohydrolase I activity; IDA:UniProtKB		0:GCH1			
GO:0030616	F:transforming growth factor beta receptor, c...; IDA:BHF-UCL		0:SMAD4			
GO:0006288	P:base-excision repair, DNA ligation; ISS:UniProtKB		0:HMGB2|0:HMGB1|0:HMGB1P10			
GO:0043047	F:single-stranded telomeric DNA binding; IMP:UniProtKB		0:HNRNPA2B1|0:OBFC1|0:POT1			
GO:0031904	C:endosome lumen; EXP:Reactome		0:APOB			
GO:0005134	F:interleukin-2 receptor binding; TAS:UniProtKB		0:TIMM50|0:IL21|0:IL2			
GO:0002502	P:peptide antigen assembly with MHC class I p...; ISS:BHF-UCL		0:CALR			
GO:0030125	C:clathrin vesicle coat; ISS:UniProtKB		0:NECAP2			
GO:0009650	P:UV protection; TAS:ProtInc		0:ERCC5|0:ERCC2|0:GPX1|0:CAT|0:SDF4|0:MC1R|0:SCARA3|0:FEN1			
GO:0008521	F:acetyl-CoA transporter activity; TAS:ProtInc		0:SLC33A1			
GO:0015680	P:intracellular copper ion transport; TAS:ProtInc		0:CCS			
GO:0004872	F:receptor activity; TAS:UniProtKB		0:CD1D|0:SEMA4D|0:AMOT|0:RTN4RL2|0:MED14|0:MED13|0:RTN4RL1|0:MED17|0:MED12|0:MED24|0:THRAP3|0:MED16|0:MED1|0:TREML2|0:MED30|0:MED4|0:SEMA6D|0:SEMA4F|0:SEMA3E|0:MEGF9|0:SEMA4B|0:SEMA4A|0:SEMA6C|0:SEMA3D|0:ANTXRL|0:SEMA3C|0:SEMA3G|0:ITGBL1|0:SEMA6B|0:PLXNC1|0:SEMA3B|0:SEMA3F|0:SEMA7A|0:SEMA5B|0:SEMA4G|0:SEMA3A|0:LAMA5|0:SEMA6A|0:SEMA4C|0:CD38|0:IGSF11|0:LILRA6|0:PTCRA|0:IL20RA|0:MS4A8B|0:KLRC4|0:FOLR2|0:FOLR4|0:TOMM22|0:ZFYVE9|0:OGFRL1|0:C5orf39|0:ITGAD|0:PDCD1LG2|0:IL28RA|0:CLEC9A|0:LBR|0:GFRA4|0:HBEGF|0:KIR3DL2|0:ITGB7|0:CD180|0:TNFRSF12A|0:TRPM5|0:GLRA3|0:ITGAM|0:OSCAR|0:PILRB|0:CD200R1L|0:PGRMC1|0:NUS1|0:PAQR5|0:CD300LB|0:FCRL4|0:PAQR9|0:NOTCH3|0:LRP11|0:MS4A14|0:LAIR1|0:CD300A|0:TRGV3|0:FCAR|0:ITGB8|0:HTR3D|0:MS4A3|0:NISCH|0:CLEC17A|0:ROBO3|0:ADIPOR1|0:CD209|0:ITGA7|0:TREML1|0:LAIR2|0:RPSA|0:IL17RE|0:MS4A6E|0:TRPM1|0:SCARB2|0:ZP4|0:CD300LF|0:ITGB3|0:CD300E|0:DGCR2|0:ITGA3|0:PHB2|0:TRB@|0:ITGB2|0:SLAMF6|0:PTPRQ|0:MRC1L1|0:TNFRSF21|0:PKHD1L1|0:SLAMF7|0:ATP6AP2|0:UNC5D|0:ITGAE|0:FOLR3|0:LRP3|0:FCGR2B|0:PAQR6|0:GLRA2|0:FCRL3|0:ITGA8|0:ANTXR2|0:MS4A6A|0:ITGB6|0:MRC2|0:MS4A15|0:KDELR3|0:TRBC2|0:GPR172B|0:ITGA11|0:RYR1|0:FCGR3A|0:TNFSF11|0:TSPO2|0:CHRNB3|0:FCGR3B|0:STRA6|0:FCGR1A|0:HTR3E|0:KIR2DL2|0:DPP4|0:FCRL2|0:ITGA4|0:KIR2DS4|0:NCR1|0:CHRND|0:MS4A4E|0:MS4A7|0:LRP4|0:CHRNA9|0:TRDC|0:CHRNA10|0:LTBR|0:CHRNB1|0:PAQR3|0:CLEC2A|0:ITGA2|0:ITGA10|0:PAQR7|0:FCGR2A|0:IMPG2|0:NETO1|0:PLXNB2|0:ILDR1|0:FCRL5|0:MS4A12|0:LDLRAD1|0:CD200R1|0:KDELR2|0:KIR2DL5A|0:ITGB5|0:LILRA4|0:TRBV12-3|0:CD226|0:ITGA2B|0:LILRB1|0:TRAC|0:GPR172A|0:ITGA9|0:ADIPOR2|0:TRBC1|0:IL20RB|0:C1orf116|0:RIPK4|0:IL17RC|0:GUCY2C|0:PLXNB3|0:NIPAL4|0:TRGC1|0:LRP5|0:GLRA1|0:SRPR|0:SLC7A1|0:CLEC12B|0:CD300LD|0:FCRL1|0:BTLA|0:KIR2DS3|0:MS4A5|0:PTPRT|0:RYR2|0:CD274|0:LMBR1|0:CD44|0:ITGA5|0:GLRA4|0:RELT|0:PAQR8|0:PILRA|0:IL23R|0:PAQR4|0:LDLRAD2|0:KDELR1|0:KIR2DL5B|0:LSR|0:KIR3DL3|0:CRLF2|0:ITGAL|0:ITGB4|0:ITGA1|0:HAVCR1|0:ZP3|0:FCGR1C|0:CLEC12A|0:IMPG1|0:GLRB|0:ADAM22|0:C10orf54|0:NOTCH1|0:MS4A10|0:CDHR1|0:ITGA6|0:SCARF2|0:LILRA5|0:HYAL2|0:IL17RD|0:MMD2|0:AMFR|0:MS4A4A|0:LRP2|0:LMBR1L|0:SRA1|0:GFRAL|0:RYR3|0:NETO2|0:FLVCR1|0:ZACN|0:HTR3C|0:NCR3|0:ITGAV|0:CD300LG|0:TNFRSF13C|0:SRPRB|0:LDLRAD3|0:FCER2|0:C6orf25|0:RAMP2|0:CLEC4F|0:NOTCH2|0:CD93|0:TNFRSF10B|0:DERL1|0:KRT1|0:VAC14|0:TMEM123|0:CD2|0:PKHD1|0:RTN4R|0:UNC13B|0:KLRG1|0:TACSTD2|0:TREM1|0:CD40|0:GUCY2D|0:LY75|0:CUBN|0:TNFRSF13B|0:GUCY1B3|0:RRBP1|0:CD244|0:ANPEP|0:TNFRSF9|0:NRXN1|0:IL10RB|0:FKBP3|0:PROCR|0:FOLR1|0:TNPO3|0:MMD|0:ATRN|0:CXADR|0:TRAM1|0:MRC1|0:SEC62|0:CD33|0:LILRB4|0:SLC1A5|0:LGTN|0:CD46|0:SLC20A2|0:LRP1|0:ITGAX|0:TNFRSF11B|0:CRLF1|0:SLC20A1|0:SIGLEC7|0:CNTNAP1|0:LRRN2|0:PLA2R1|0:SEC63|0:FCGRT|0:LILRA2|0:KIR2DL3|0:GPA33|0:KIR2DL1|0:TREM2|0:MCC|0:BTN1A1|0:CUL5|0:LILRB2|0:GUCY2F|0:NRXN3|0:TNFRSF6B|0:GUCY1A3|0:LILRA3|0:RNF139|0:ROBO4|0:CD7|0:NOTCH4			
GO:0005537	F:mannose binding; TAS:UniProtKB		0:ACR|0:CLEC17A|0:M6PR|0:CLEC4M|0:COLEC11|0:BSG|0:MBL2|0:LMAN1|0:MRC1|0:CD207|0:COLEC10|0:LMAN2L|0:CD209			
GO:0006402	P:mRNA catabolic process; NAS:UniProtKB		0:AUH|0:EIF2C3|0:HSPA1A|0:HSPA1B|0:EIF2C4|0:PNPT1|0:RNH1			
GO:0033689	P:negative regulation of osteoblast prolifera...; IMP:UniProtKB		0:EIF2AK2			
GO:0021846	P:cell proliferation in forebrain; IDA:BHF-UCL		0:WNT7A			
GO:0051149	P:positive regulation of muscle cell differen...; IMP:BHF-UCL		0:CAMK1			
GO:0019064	P:viral envelope fusion with host membrane; IDA:BHF-UCL		0:PVRL2			
GO:0048010	P:vascular endothelial growth factor receptor...; ISS:BHF-UCL		0:BMPR2			
GO:0017025	F:TATA-binding protein binding; TAS:BHF-UCL		0:THRA|0:GTF2A1|0:TAF1|0:GTF2A2|0:TAF1L|0:HHEX			
GO:0070165	P:positive regulation of adiponectin secretion; ISS:UniProtKB		0:GPR109A			
GO:0000045	P:autophagic vacuole assembly; NAS:UniProtKB		0:ATG9B|0:ATG4B|0:ATG4C|0:ATG9A|0:ATG14|0:ATG13|0:C12orf44|0:ATG3|0:MAP1LC3A|0:ATG12|0:ATG5|0:ATG16L1			
GO:0070995	P:NADPH oxidation; IDA:BHF-UCL		0:FMO2|0:FMO1			
GO:0004479	F:methionyl-tRNA formyltransferase activity; IEA:EC		0:MTFMT			
GO:0008757	F:S-adenosylmethionine-dependent methyltransf...; TAS:UniProtKB		0:NOP2|0:LCMT1|0:RRP8			
GO:0033925	F:mannosyl-glycoprotein endo-beta-N-acetylglu...; IEA:EC		0:ENGASE			
GO:0000733	P:DNA strand renaturation; IDA:UniProtKB		0:RECQL|0:RECQL4			
GO:0070579	F:methylcytosine dioxygenase activity; IDA:UniProtKB		0:TET1|0:ALKBH1			
GO:0050080	F:malonyl-CoA decarboxylase activity; IEA:EC		0:MLYCD			
GO:0030001	P:metal ion transport; IEA:InterPro		0:ARMC1			
GO:0051028	P:mRNA transport; IEA:UniProtKB-KW		0:SLBP|0:UPF3A|0:NUP85|0:TPR|0:XPO7|0:NUP93|0:TNKS|0:NUP50|0:NCBP2|0:NPIP|0:ERVK4|0:NUPL2|0:POM121B|0:NUP205|0:HNRNPA1|0:NUP214|0:NUP153|0:ENY2|0:RANBP17|0:MAGOHB|0:FMR1|0:MAGOH|0:UPF3B|0:POM121C|0:MYO1C|0:LRPPRC|0:NUP210|0:XPO1|0:KHSRP|0:TMEM48|0:NUP37|0:HNRPA1L3|0:NUP98|0:NUP188|0:NUP54|0:NUP43|0:QKI|0:EIF4A3|0:AHCTF1|0:EIF5A2|0:DDX19A|0:RBM8A|0:POM121|0:NUP62|0:NUP155|0:NUP88|0:NXT2|0:SENP2|0:RANBP2|0:SEH1L|0:EIF5AL1|0:MVP|0:NUP35|0:G3BP2|0:HNRNPA1L2|0:CASC3|0:NUPL1			
GO:0030850	P:prostate gland development; NAS:UniProtKB		0:ALOX15B			
GO:0017154	F:semaphorin receptor activity; TAS:UniProtKB		0:PLXNA1|0:PLXNB1			
GO:0010983	P:positive regulation of high-density lipopro...; IMP:BHF-UCL		0:LIPG			
GO:0017157	P:regulation of exocytosis; ISS:UniProtKB		0:RALA|0:SEPT5|0:RAB26			
GO:0007051	P:spindle organization; NAS:UniProtKB		0:METTL11A|0:CKAP5|0:PLK1S1|0:CEP72|0:ZWINT|0:CKS2|0:SPAG5|0:UBE2C|0:AURKA|0:BUB1B			
GO:0032383	P:regulation of intracellular cholesterol tra...; IMP:UniProtKB		0:ABCA2			
GO:0006821	P:chloride transport; NAS:UniProtKB		0:NMUR1|0:SLC4A10			
GO:0000832	F:inositol hexakisphosphate 5-kinase activity; ISS:UniProtKB		0:PPIP5K1|0:PPIP5K2			
GO:0034041	F:sterol-transporting ATPase activity; IDA:BHF-UCL		0:ABCG1			
GO:0032467	P:positive regulation of cytokinesis; IMP:UniProtKB		0:CENPV			
GO:0007499	P:ectoderm and mesoderm interaction; TAS:ProtInc		0:SNAI2			
GO:0034464	C:BBSome; IDA:BHF-UCL		0:BBS7|0:BBS9|0:BBS4|0:BBS1|0:BBS5|0:BBS2|0:TTC8			
GO:0009299	P:mRNA transcription; IDA:UniProtKB		0:EREG			
GO:0002001	P:renin secretion into blood stream; IEP:BHF-UCL		0:PCSK5			
GO:0061088	P:regulation of sequestering of zinc ion; TAS:BHF-UCL		0:SLC30A4|0:SLC30A3|0:AP3D1|0:SLC30A8			
GO:0003826	F:alpha-ketoacid dehydrogenase activity; IDA:HGNC		0:BCKDHA			
GO:0004092	F:carnitine O-acetyltransferase activity; IEA:EC		0:CRAT			
GO:0060394	P:negative regulation of pathway-restricted S...; IMP:BHF-UCL		0:SMAD7|0:SMAD6|0:ENG			
GO:0048015	P:phosphoinositide-mediated signaling; TAS:UniProtKB		0:IGF1|0:IGF1R|0:PLCH1|0:PTAFR|0:PIK3C2B|0:PI4KA|0:PIK3C3|0:PI4KAP2|0:PI4KB|0:PIK3CD|0:PI4KAP1|0:PIK3CG|0:PIK3C2G|0:PIK3CB|0:PIK3C2A|0:PIK3CA|0:GAB2|0:HIST1H4I|0:HIST1H4L|0:HIST1H4B|0:RFC4|0:HMGB2|0:HIST1H4E|0:HIST2H4A|0:HIST1H4H|0:HIST1H4A|0:HIST4H4|0:ZWINT|0:HIST1H4D|0:TYMS|0:CKS2|0:ERBB2|0:HIST1H4K|0:HIST1H4J|0:NDC80|0:SPAG5|0:UBE2C|0:TOP2A|0:FEN1|0:HIST1H4C|0:AURKA|0:HIST2H4B|0:PCNA|0:HIST1H4F|0:BUB1B|0:RPS6KB1			
GO:0070653	F:high-density lipoprotein receptor binding; IPI:BHF-UCL		0:APOC3|0:APOA2|0:APOA1			
GO:0005355	F:glucose transmembrane transporter activity; TAS:ProtInc		0:SLC2A14|0:SLC2A6|0:SLC2A3|0:SLC2A5|0:SLC2A8|0:PPBP			
GO:0014916	P:regulation of lung blood pressure; IMP:BHF-UCL		0:BMPR2			
GO:0042789	P:mRNA transcription from RNA polymerase II p...; IDA:MGI		0:HIF1A|0:ARNT|0:DDIT3			
GO:0042149	P:cellular response to glucose starvation; IDA:UniProtKB		0:TP53|0:ASNS|0:NUAK2|0:HSPA5			
GO:0048546	P:digestive tract morphogenesis; ISS:BHF-UCL		0:BBS7			
GO:0044258	P:intestinal lipid catabolic process; NAS:UniProtKB		0:CEL			
GO:0002376	P:immune system process; NAS:UniProtKB		0:ADSSL1|0:ADSS			
GO:0043496	P:regulation of protein homodimerization acti...; TAS:BHF-UCL		0:BAX|0:BAK1|0:BCL2|0:AIDA|0:NRG1			
GO:0060021	P:palate development; ISS:UniProtKB		0:INHBA|0:WNT11|0:CHD7|0:WNT8A|0:WNT3A|0:WNT7A|0:WNT5A|0:FOXF2|0:LEF1|0:TGFBR2|0:SMAD2|0:TGFB3|0:TGFBR3|0:TGFBR1|0:SMAD4|0:OSR1|0:PKDCC			
GO:0043843	F:ADP-specific glucokinase activity; IEA:EC		0:ADPGK			
GO:0031463	C:Cul3-RING ubiquitin ligase complex; ISS:UniProtKB		0:KLHL13|0:KLHL20|0:KCTD13|0:CUL3|0:RBX1|0:TNFAIP1|0:KLHL9|0:KLHL22|0:KLHL21|0:KCTD10			
GO:0007064	P:mitotic sister chromatid cohesion; TAS:UniProtKB		0:PDS5B|0:SMC1A			
GO:0006974	P:response to DNA damage stimulus; TAS:ProtInc		0:TAF9|0:TAF1|0:UBR5|0:MICA|0:SPDYA|0:IKBKG|0:BCL6|0:ALKBH8|0:APBB1|0:LYN|0:FBXO45|0:GNL1|0:APC|0:ATMIN|0:TLK1|0:ATAD5|0:TIMELESS|0:TLK2|0:ZMAT3|0:MCTS1|0:RIF1|0:RPS3|0:XIAP|0:AATF|0:RASSF1|0:NIPBL|0:DTX3L|0:MCM7|0:TP53TG1|0:PPP1R15A|0:SESN1|0:DDIT3			
GO:0045602	P:negative regulation of endothelial cell dif...; ISS:UniProtKB		0:NOTCH4			
GO:0047290	F:(alpha-N-acetylneuraminyl-2,3-beta-galactos...; IEA:EC		0:ST6GALNAC4			
GO:0006409	P:tRNA export from nucleus; IDA:UniProtKB		0:XPOT			
GO:0043236	F:laminin binding; TAS:UniProtKB		0:THBS1|0:BCAM|0:ADAM9|0:PLEKHA2|0:ECM1|0:AGRN			
GO:0016584	P:nucleosome positioning; IDA:UniProtKB		0:RSF1|0:SMARCA5|0:CTCF			
GO:0051380	F:norepinephrine binding; IDA:HGNC		0:ADRA2A|0:ADRB2			
GO:2000035	P:regulation of stem cell division; ISS:UniProtKB		0:SFRP2			
GO:0048387	P:negative regulation of retinoic acid recept...; TAS:BHF-UCL		0:CALR|0:PRAME|0:EZH2|0:CYP26C1|0:CYP26A1|0:CYP26B1			
GO:0008532	F:N-acetyllactosaminide beta-1,3-N-acetylgluc...; IDA:UniProtKB		0:B3GNT1			
GO:0007352	P:zygotic specification of dorsal/ventral axis; ISS:BHF-UCL		0:SMAD2|0:SMAD6|0:CXXC4			
GO:0042625	F:ATPase activity, coupled to transmembrane m...; ISS:UniProtKB		0:ATP6V0E2			
GO:0046541	P:saliva secretion; NAS:UniProtKB		0:KCNMA1|0:STATH			
GO:0004017	F:adenylate kinase activity; TAS:ProtInc		0:AK4|0:C9orf98|0:AK4P3|0:AK7|0:AK1|0:AK2|0:AK5			
GO:0050113	F:inositol oxygenase activity; IEA:EC		0:MIOX			
GO:0005858	C:axonemal dynein complex; TAS:ProtInc		0:DNAI2|0:DNAH1|0:DNAH2|0:DNAH17|0:DNAH9|0:DNAH11|0:DNAL4|0:DNAH8|0:DNAH7|0:DNAH3|0:DNALI1			
GO:0021965	P:spinal cord ventral commissure morphogenesis; ISS:UniProtKB		0:GLI2			
GO:0070370	P:cellular heat acclimation; IDA:UniProtKB		0:RBBP7			
GO:0007131	P:reciprocal meiotic recombination; TAS:ProtInc		0:KLHDC3|0:MLH3|0:RAD50|0:SPO11|0:MSH5|0:RAD51L1|0:MRE11A|0:ATM|0:SYCP1|0:RAD52|0:DMC1|0:CHEK1|0:RAD51L3|0:MSH4|0:RAD51|0:RAD21|0:LIG3|0:RAD54B|0:REC8			
GO:0045668	P:negative regulation of osteoblast different...; TAS:BHF-UCL		0:CDK6|0:SKI|0:TWIST2|0:FGF23|0:MEN1|0:HDAC7|0:CITED1|0:C14orf169|0:NOTCH1			
GO:0008180	C:signalosome; IEA:UniProtKB-KW		0:COPS5|0:COPS2|0:COPS8|0:COPS4|0:COPS6|0:COPS7B|0:COPS3|0:COPS7A|0:GPS1			
GO:0000255	P:allantoin metabolic process; ISS:BHF-UCL		0:GHR|0:STAT5A|0:STAT5B			
GO:0006154	P:adenosine catabolic process; IDA:UniProtKB		0:ADA|0:CECR1			
GO:0006796	P:phosphate metabolic process; TAS:ProtInc		0:ENPP3|0:ENPP1|0:SLC17A3|0:SLC17A4|0:ENPP2|0:SLC20A1|0:ACYP2|0:ACYP1|0:SLC17A2			
GO:0008428	F:ribonuclease inhibitor activity; TAS:ProtInc		0:RNH1|0:ABCE1			
GO:0001520	C:outer dense fiber; NAS:UniProtKB		0:ODF1			
GO:0046931	P:pore complex assembly; IDA:BHF-UCL		0:P2RX7			
GO:0000405	F:bubble DNA binding; ISS:UniProtKB		0:ERCC5|0:WRN|0:RECQL4|0:BLM|0:NEIL3			
GO:0005792	C:microsome; TAS:UniProtKB		0:TNKS2|0:UGT1A8|0:CYP2A6|0:TNKS|0:APPL1|0:CYP2C19|0:CYP2E1|0:FMO2|0:CYP2D6|0:SOAT2|0:CYP2C8|0:SORT1|0:CYP1A1|0:SOAT1|0:CYP26C1|0:CYP26A1|0:GRB14|0:CYP26B1|0:UGT1A7|0:IGF1R|0:INSR|0:CYP3A4|0:CYP2J2|0:LASS5|0:ACSBG2|0:COPA|0:POMGNT1|0:FIBP|0:DHRS9|0:HSP90B1|0:CYP1A2|0:AADAC|0:HSD3B1|0:DDOST|0:DPAGT1|0:CYP2F1|0:SLC9A6|0:MGST2|0:FMO6P|0:ACSL1|0:UGT2B15|0:UGT1A4|0:PGRMC1|0:UGT2B10|0:MGST1|0:SRD5A2|0:PTGS2|0:CYP2S1|0:SRD5A1|0:SEC11A|0:HSD17B6|0:ACSL4|0:CYP2U1|0:CYP7B1|0:EPHX1|0:CYP51A1|0:UGT2B11|0:SPCS2|0:CYP4A22|0:OAS1|0:CYB5A|0:KLK6|0:CYP21A2|0:SPCS1|0:CYP3A7|0:UGT1A10|0:SEC11C|0:VAC14|0:TCL1A|0:CYP4F2|0:ACSBG1|0:SYNCRIP|0:CYP1B1|0:HPS6|0:TAPBPL|0:FMO1|0:CYP4X1|0:CYP2R1|0:UGT2B28|0:NCEH1|0:CYP4F3|0:LRRC59|0:CYP4F11|0:UGT2B17|0:UGT1A1|0:HSD11B2|0:CYP3A43|0:PNPLA7|0:CYP8B1|0:TXNRD3|0:RDH10|0:UGT2B7|0:PTRF|0:DNAJC1|0:CYP4F12|0:FBXO2|0:CYP4B1|0:HMOX2|0:FA2H|0:CYP2A13|0:CYP2C18|0:UGT1A3|0:ACSL3|0:SPCS3|0:CYP2A7|0:CYP4F22|0:CYP4F8|0:CYP4Z1|0:C8orf17|0:CYP46A1|0:ATP2A1|0:HMOX1|0:PDE3B|0:TMED10|0:TMED2|0:LASS1|0:DCT|0:CYP7A1|0:IRS1|0:VCP|0:PTGS1|0:ATL1|0:HSD3B2|0:SQLE|0:PIK3C2B|0:FMO5|0:FADS1|0:UGT2B4|0:FMO4|0:TAPBP|0:CYP2B6|0:UGT1A5|0:UGT1A9|0:CHPT1|0:UGT1A6|0:ACSL6|0:RDH16|0:STX16|0:ERO1L|0:HSD17B3|0:COMT|0:STX2|0:OAS3|0:CYP4A11|0:LTC4S|0:ATP2A2|0:CYP3A5|0:FMO3|0:OAS2|0:SSR3|0:MGST3|0:APOB|0:HSPA13|0:SLC35B1|0:STS|0:GBA2|0:CYP39A1|0:CYP2C9			
GO:0080010	P:regulation of oxygen and reactive oxygen sp...; TAS:BHF-UCL		0:FOXM1|0:PARK2|0:RNF41|0:MPV17|0:RIPK1			
GO:0045930	P:negative regulation of mitotic cell cycle; IMP:UniProtKB		0:PTPN3|0:TGFB1|0:BTG3|0:SCRIB|0:TRIM35|0:PML|0:FOXC1|0:DGKZ|0:DLG1			
GO:0007165	P:signal transduction; TAS:UniProtKB		0:ANGPTL3|0:TGFBRAP1|0:SMC3|0:RASA1|0:TMEM102|0:ARAP1|0:UNC5CL|0:SYDE2|0:CNTNAP3B|0:ANKDD1A|0:INPP5B|0:ARHGAP26|0:BAIAP2L2|0:FAM13A|0:PPP2R2A|0:ABL1|0:ARHGAP11B|0:ARHGAP17|0:PRKAR2A|0:RAPH1|0:RHPN1|0:RIN3|0:FGA|0:GPSM3|0:FGL1|0:ANK3|0:ARHGAP22|0:RTKN2|0:ARHGAP39|0:STARD13|0:RACGAP1|0:MTSS1L|0:ROPN1|0:PDE4D|0:ANGPTL4|0:PDE4B|0:RASSF8|0:RHPN2|0:PPP1R1A|0:PCP2|0:ODZ2|0:ARHGAP30|0:SH3D20|0:GMIP|0:THOC1|0:PDE1A|0:FADD|0:RASSF2|0:SRGAP3|0:ANGPTL2|0:SNX17|0:TNXB|0:C1orf230|0:ARHGAP10|0:HMHA1|0:PDE10A|0:ITLN1|0:FGB|0:ARHGAP33|0:MYO10|0:RASA4|0:ANK2|0:ARHGAP23|0:PRKAR2B|0:DAB2IP|0:ARAP2|0:ANK1|0:PPP2R5D|0:PPP2R5E|0:ARHGAP27|0:RASSF5|0:RASSF10|0:ANGPTL1|0:ODZ3|0:DLC1|0:PDE6A|0:FGL2|0:ARHGAP11A|0:RASSF7|0:FGG|0:ARHGAP28|0:PRKAR1A|0:MFAP4|0:ARHGAP9|0:CNTNAP3|0:MTSS1|0:FCN3|0:PDE1C|0:FIBCD1|0:ARHGAP15|0:RERGL|0:GPSM1|0:CNTNAP5|0:CABYR|0:SH3BP1|0:ARHGAP24|0:SNX27|0:ANGPTL6|0:RHBDL2|0:DTHD1|0:TNR|0:ARRB2|0:PPP2R5A|0:OCRL|0:RASSF4|0:ARHGAP12|0:ROPN1L|0:PDE3A|0:ARHGAP20|0:ODZ1|0:PIK3R2|0:NFKB1|0:ANGPTL7|0:GRLF1|0:FCN2|0:CNTNAP4|0:ARHGAP19|0:ARAP3|0:GAPVD1|0:PDE2A|0:TRAF1|0:PRKAR1B|0:PPP2R2D|0:EDARADD|0:PPP1R1C|0:RASSF6|0:ANGPTL5|0:GPSM2|0:FCN1|0:RASIP1|0:TAGAP|0:ARHGAP25|0:DEPDC1|0:STARD8|0:MYO9A|0:SYDE1|0:ARHGAP36|0:ANKDD1B|0:FAM13B|0:BAIAP2|0:BAIAP2L1|0:DEPDC1B|0:RHBDL3|0:KCNH6|0:ARHGAP18|0:SPARCL1|0:CNTNAP2|0:PPP2R2B|0:ULK2|0:RADIL|0:ODZ4|0:ITLN2|0:SYNGAP1|0:ARHGAP21|0:NFKB2|0:PDE4C|0:RASAL3|0:RASSF9|0:CRADD|0:ARHGAP32|0:PPP2R5B|0:SPA17|0:PDE3B|0:MATK|0:RASSF3|0:SRGAP2|0:ANGPT1|0:TNC|0:TNN|0:PLEKHH3|0:APBB1IP|0:ARHGAP40|0:PEX11A|0:IMPA1|0:PITPNC1|0:CALCOCO1|0:RGMB|0:PEX11B|0:CASKIN1|0:GKAP1|0:TXNRD1|0:HDGF|0:PTPLA|0:CCL26|0:SCGB1A1|0:IGFBP6|0:RLN1|0:CSNK1A1|0:FGF7|0:MDK|0:AIMP1|0:GRN|0:CCL21|0:AKAP5|0:GUCA1A|0:WIF1|0:S100A10|0:GAST|0:CD2AP|0:CD53|0:KCNK10|0:NFAT5|0:CCL23|0:EPO|0:PTGES|0:HPGDS|0:NTS|0:FGFBP1|0:PMCH|0:CSH2|0:PRKCB|0:MKLN1|0:GRP|0:CNGB3|0:CSH1|0:IL13|0:IGFBP5|0:TG|0:PPP2R5C|0:AKAP17A|0:TMX1|0:WWP1|0:IGBP1|0:PPP4R1|0:TEX2|0:IL19|0:PDCL|0:DNM2|0:CLCN6|0:COL15A1|0:CABP5|0:GUCA2A|0:ZFYVE16|0:MICAL1|0:APBB1|0:KIF13B|0:PPP1R16B|0:IL21|0:NLRP3|0:HSP90AA1|0:NPHP4|0:PDE5A|0:GNL1|0:NPM1|0:NPHP1|0:PPP2R2C|0:ICOSLG|0:NOX1|0:AMELX|0:NOD1|0:LHB|0:STK25|0:GTPBP1|0:CCL19|0:CNGA3|0:ERBB2IP|0:PKN3|0:CREB1|0:CLEC5A|0:SH3GL2|0:CGB8|0:HINT1|0:NDP|0:DTNA|0:RRAGB|0:DRG2|0:KCNIP3|0:RASAL1|0:IPO8|0:DLG4|0:DPYSL5|0:INPP1|0:FGF4|0:PTPN1|0:IGFBP1|0:SMAD5OS|0:CXCL1|0:CSNK1G3|0:MPP3|0:KITLG|0:TNFSF9|0:FEZ2|0:RASA3|0:PAK2|0:ITPK1|0:GDF15|0:OXT|0:C3|0:ASIP|0:CNIH|0:ARL2BP|0:FRS3|0:HUNK|0:DLL4|0:PDE7B|0:NTF3|0:MAPRE2|0:MADCAM1|0:PPIC|0:FASTK|0:FGF21|0:KCNIP2|0:ELK3|0:AVP|0:DPYSL2|0:CAMK1|0:TNFSF10|0:PRDM4|0:CSNK1D|0:TLE1|0:TNFSF4|0:TNFSF13B|0:PDE11A|0:HBS1L|0:WISP3|0:NEDD9|0:CXCL6|0:PRKAB1|0:LTA|0:ASB2|0:ATF6B|0:PTPN22|0:OPHN1|0:CRHBP|0:CDC42EP3|0:DAPP1|0:TNFAIP6|0:CRABP1|0:CD83|0:ITK|0:TRHDE|0:STK24|0:CCL18|0:IAPP|0:BCR|0:PTPN6|0:PAK4|0:AKAP8|0:DLG5|0:MAP2K3|0:CXCL14|0:KIFAP3|0:PRKG2|0:PRKCD|0:CDC42SE1|0:CHL1|0:VEGFC|0:MPP2|0:ZNF259|0:PLAA|0:FASLG|0:INPP4B|0:IPO7|0:CAP2|0:FGF3|0:RPS6KC1|0:DPYSL3|0:RANGAP1|0:SIPA1|0:ALCAM|0:FGF6|0:IMPA2|0:NET1|0:KCNIP1|0:RHBDL1|0:EXT1|0:PRKCZ|0:CRABP2|0:GDNF|0:PGF|0:SH3BP5|0:CAMK4|0:TPTE|0:GTF2I|0:NMU|0:PDE4A|0:ARTN|0:GNRH2|0:STX2|0:BTRC|0:CGB5|0:FGF20|0:CXCL11|0:PRKAB2|0:ZYX|0:SIRPB1|0:MPP1|0:CCL20|0:CAMLG|0:NRG2|0:CCK|0:SIT1|0:CDKL2|0:ING2|0:RIN1|0:CLIC3|0:EDA|0:CXCL9|0:FGF18|0:CABP2|0:INPP5D|0:CXCL5|0:STAC|0:PKD2L1|0:TXN|0:ANKRD1|0:CACNA1I|0:CGA|0:RSU1|0:PDAP1|0:CAMK2B|0:CASP1|0:KALRN|0:HNRNPK|0:NCK2|0:FSHB|0:CSNK1E|0:WISP1|0:DEK|0:CSNK2A1|0:MLLT4|0:NMB|0:OSTF1|0:LPXN|0:SMPD1|0:CAP1|0:TNFSF18|0:SFN|0:CREBL2|0:PECAM1|0:TRAF4|0:AKAP9|0:PRKAG1|0:PSTPIP1|0:CEACAM6|0:PDIA3|0:FGF17|0:ITGB1BP2|0:PENK|0:PNOC|0:TNFSF12|0:YWHAZ|0:PXN|0:GNRH1|0:ARR3|0:RBPJL|0:CASP8AP2|0:TNFSF13|0:XCL1|0:CALCB|0:NRGN|0:COPS3|0:CD70|0:GUCA1C|0:PRKCH|0:GAS6|0:HGS|0:FGF11|0:MGST3|0:IGFALS|0:ITPKA|0:ACCN2|0:CCL24|0:CGB7|0:OGT|0:SFRP5|0:PRKG1|0:CYTL1|0:GUCY1A2|0:FGF9|0:PRKD1|0:FGD1|0:CDC42BPB|0:IGFBP4|0:WISP2|0:CCL22|0:TRAF5|0:LIMD1|0:SPRY2|0:SH3GL1|0:TRIP10|0:CCL11|0:LALBA|0:RAGE|0:TLE3|0:RASA2|0:CGB|0:TNFSF8|0:APLN|0:MTA1|0:CXCL10|0:POMC|0:AKT3|0:EXT2|0:ABL2|0:PTGES3|0:CCL7|0:SH3GL3|0:CSNK1G2|0:PKN2|0:PRKAA2|0:LRDD|0:RASAL2|0:CDS1|0:TLE2|0:ASAH2|0:CORO1C|0:CREM|0:CALML5|0:NAMPT|0:CRH|0:CCL1|0:FGF16|0:MX1|0:CD164|0:INPP4A|0:ACCN3|0:APC2|0:PLAU|0:CTNND2|0:ACTL6A|0:FLT3LG|0:RAP1GAP|0:GIP|0:TRH|0:LTB|0:PIP5K1A|0:FLNB|0:AKAP4|0:XCL2|0:ANGPT2|0:PRKRIR|0:PPP1R12B|0:MAPKAPK5|0:DGKG|0:INSL4|0:NCKIPSD|0:CAPN5|0:ATF6|0:GCG|0:TMED1|0:SERGEF|0:APPL1|0:PHB|0:ANXA5|0:APPL2|0:GDI2|0:RNF14|0:PPP1R1B|0:RANBP1|0:ANXA1|0:S100A11|0:ANXA4|0:CLIC2|0:CLIC1|0:SRI|0:S100A6			
GO:0006520	P:cellular amino acid metabolic process; TAS:UniProtKB		0:ASPG|0:HTATIP2|0:SDSL|0:ACY1|0:GOT1L1|0:CLN3|0:AGXT2L1|0:CTNS|0:GCAT|0:SLC25A15|0:GGT5|0:SCLY|0:GGT1|0:SLC7A8|0:PTS|0:SLC3A1|0:SLC7A2|0:GSS|0:QDPR|0:SLC6A14|0:MAT1A|0:SLC7A7|0:SLC7A6|0:SLC6A6|0:SLC7A9|0:SLC7A4|0:SLC7A5|0:PEPD|0:ATF4			
GO:0014068	P:positive regulation of phosphoinositide 3-k...; TAS:BHF-UCL		0:IGF1|0:GH1|0:INS|0:AGT|0:TGFB2|0:NEDD4|0:WNT16|0:ERBB3			
GO:0010551	P:regulation of gene-specific transcription f...; ISS:BHF-UCL		0:THRA|0:HNF1A|0:RAD21|0:FSTL3|0:INHBA|0:TAL1			
GO:0033605	P:positive regulation of catecholamine secretion; ISS:BHF-UCL		0:ADRBK1			
GO:0004169	F:dolichyl-phosphate-mannose-protein mannosyl...; TAS:ProtInc		0:DPM1|0:POMT1|0:POMT2|0:SDF2			
GO:0060913	P:cardiac cell fate determination; IMP:BHF-UCL		0:SOX17			
GO:0019372	P:lipoxygenase pathway; TAS:UniProtKB		0:HPGD			
GO:0002634	P:regulation of germinal center formation; NAS:UniProtKB		0:BCL6			
GO:0043020	C:NADPH oxidase complex; TAS:BHF-UCL		0:NOX1|0:CYBA|0:NOXO1|0:CYBB|0:NOXA1|0:NCF4|0:NCF1|0:NCF2			
GO:0000151	C:ubiquitin ligase complex; TAS:UniProtKB		0:CBLL1|0:RNF144B|0:BRAP|0:RNF11|0:TRAF7|0:SMURF2|0:DCUN1D1|0:RNF8|0:RNF168|0:RNF40|0:RNF2|0:CAND1|0:RNF20|0:BMI1|0:RCHY1|0:UBE2E1|0:WDSUB1|0:PRPF19|0:STUB1|0:RNF151|0:PPIL2|0:RBBP6|0:UBOX5|0:NEDD4|0:FBXL3|0:FBXL21|0:WWP1|0:FBXL7|0:FBXO8|0:TSPAN17|0:FBXO10|0:FBXO11|0:FBXO24|0:LMO7|0:FBXO9|0:FBXO21|0:FBXW4|0:FBXL4|0:FBXO7|0:WWP2|0:UBE4A|0:SUGT1|0:ARIH1|0:UBE2L3|0:UBE4B			
GO:0004862	F:cAMP-dependent protein kinase inhibitor act...; TAS:UniProtKB		0:PRKACA|0:PRKAG2|0:PKIB|0:PKIG|0:PKIA			
GO:0005298	F:proline:sodium symporter activity; EXP:Reactome		0:SLC6A7			
GO:0051726	P:regulation of cell cycle; TAS:HGNC		0:MECOM|0:BEX2|0:ESX1|0:CABLES2|0:CABLES1|0:OVOL2|0:PES1|0:BOP1|0:MADD|0:BAP1|0:UHRF2			
GO:0033682	F:ATP-dependent 5'-3' DNA/RNA helicase activity; IDA:BHF-UCL		0:PIF1			
GO:0008595	P:anterior/posterior axis specification, embryo; TAS:ProtInc		0:TBX3|0:WNT8A|0:TDGF1|0:HOXB6|0:HOXD8|0:T			
GO:0032943	P:mononuclear cell proliferation; IC:BHF-UCL		0:ACE			
GO:0003717	F:RNA polymerase II transcription termination...; TAS:ProtInc		0:TTF2			
GO:0045926	P:negative regulation of growth; IMP:UniProtKB		0:ING4|0:ALOX15B|0:ING5|0:BBC3			
GO:0070625	P:zymogen granule exocytosis; ISS:BHF-UCL		0:SDF4			
GO:0033093	C:Weibel-Palade body; IDA:UniProtKB		0:ECE1|0:VWF			
GO:0034237	F:protein kinase A regulatory subunit binding; IDA:BHF-UCL		0:RYR2			
GO:0032996	C:Bcl3-Bcl10 complex; IDA:UniProtKB		0:BCL3			
GO:0072101	P:specification of ureteric bud anterior/post...; IDA:UniProtKB		0:BMP4			
GO:0019459	P:glutamate deamidation; IDA:BHF-UCL		0:GLUD1|0:GLUD2			
GO:0047012	F:sterol-4-alpha-carboxylate 3-dehydrogenase ...; IEA:EC		0:NSDHL			
GO:0005901	C:caveola; TAS:BHF-UCL		0:CAV2|0:NOS3|0:TGFBR2|0:IRS1|0:F2R|0:CDH13|0:LRP8|0:SELE|0:SRC|0:HDAC6|0:KCNMA1|0:INSR|0:CLN3|0:PTRF|0:CAV1|0:KIF18A|0:HCK|0:CAV3|0:SDPR|0:FLOT2|0:EFNA5|0:SPRED1|0:LIPE|0:PLVAP|0:DLC1|0:MYOF|0:SCARB1			
GO:0046839	P:phospholipid dephosphorylation; TAS:UniProtKB		0:PPAP2A			
GO:0046373	P:L-arabinose metabolic process; IEA:InterPro		0:OTOG			
GO:0016591	C:DNA-directed RNA polymerase II, holoenzyme; IDA:UniProtKB		0:ELP2|0:ELP3|0:IKBKAP|0:ELP4|0:MYO6			
GO:0004408	F:holocytochrome-c synthase activity; TAS:ProtInc		0:HCCS			
GO:0001709	P:cell fate determination; TAS:UniProtKB		0:CYP26B1|0:MCL1|0:DSCAML1|0:DLL1|0:JAG1|0:NOTCH2|0:NOTCH4			
GO:0033629	P:negative regulation of cell adhesion mediat...; IDA:UniProtKB		0:PDE3B|0:SERPINE1|0:ACER2			
GO:0008475	F:procollagen-lysine 5-dioxygenase activity; TAS:ProtInc		0:PLOD1|0:PLOD2|0:PLOD3			
GO:0004645	F:phosphorylase activity; TAS:ProtInc		0:MTAP			
GO:0060299	P:negative regulation of sarcomere organization; IMP:BHF-UCL		0:CAV3			
GO:0007136	P:meiotic prophase II; TAS:ProtInc		0:MSH5			
GO:0004990	F:oxytocin receptor activity; TAS:ProtInc		0:OXTR			
GO:0030176	C:integral to endoplasmic reticulum membrane; TAS:UniProtKB		0:WFS1|0:DPM3|0:ACER3|0:DHRS9|0:ERN1|0:DERL2|0:CLN3|0:ABCB9|0:SPCS1|0:RTN4|0:DERL1|0:SLC37A4|0:DOLK|0:BSCL2|0:AMFR|0:DERL3|0:STIM1|0:HSPA5|0:ASPHD1|0:DPM2|0:ASPHD2|0:SSR3|0:ASPH|0:UPK2|0:MBOAT4|0:LRIT1|0:EXT1|0:EDEM1|0:DOLPP1|0:SEC61A1|0:RRBP1|0:SGPL1|0:DPAGT1|0:RTN2|0:SLC35D1|0:BNIP1|0:RTN1|0:G6PC			
GO:0006952	P:defense response; TAS:UniProtKB		0:CST3|0:IFNE|0:IFNA21|0:IFNA8|0:APAF1|0:IFNA7|0:NLRP1|0:IFNA10|0:IFNA14|0:IFNW1|0:IFNA6|0:IFNA5|0:IFNA16|0:IFNA13|0:IFNA4|0:IFNA17|0:IFNK|0:IFNA1|0:MLF2|0:IL31RA|0:PSG4|0:DARC|0:ICOSLG|0:IL17RB|0:MST1R|0:CLEC1A|0:LILRB3|0:TIAL1|0:CD83|0:P2RY11|0:MPO|0:CLEC1B|0:GATA3|0:CAMLG|0:ANKRD1|0:HP|0:OR2H2|0:SP140|0:LILRA1|0:TNIP1|0:PTPRCAP|0:WAS|0:FOXN1|0:TFF3|0:CSF3R|0:IL32|0:SOCS6|0:LILRA2|0:MX2|0:LILRB5|0:CD48|0:CBARA1|0:MX1|0:RNASE6|0:LILRA3|0:KCNN4|0:PSG3|0:HCP5|0:INHBA|0:CX3CL1|0:INHBB			
GO:0005784	C:Sec61 translocon complex; NAS:UniProtKB		0:SSR3|0:SSR4			
GO:0050462	F:N-acetylneuraminate synthase activity; IEA:EC		0:NANS			
GO:0046785	P:microtubule polymerization; IMP:UniProtKB		0:TPPP|0:CENPJ			
GO:0042118	P:endothelial cell activation; TAS:BHF-UCL		0:BMPER|0:P2RX4			
GO:0004459	F:L-lactate dehydrogenase activity; TAS:ProtInc		0:LDHAL6B|0:LDHAL6A|0:LDHA|0:LDHB|0:LDHC			
GO:0034737	F:ergosterol O-acyltransferase activity; IEA:EC		0:SOAT2|0:SOAT1			
GO:0008134	F:transcription factor binding; TAS:UniProtKB		0:BRD7|0:BPTF|0:SNF8|0:ERCC3|0:CEBPG|0:TLE1|0:DAXX|0:RUNX1|0:MAFB|0:STK36|0:MYST4|0:REM2|0:DIP2B|0:RAB18|0:DIP2A|0:DIP2C|0:DNMT1|0:GNPTAB|0:CAMTA2|0:GATA4|0:PARP1|0:HDAC2|0:AHR|0:TBX5|0:SOX17|0:AR|0:CSNK2B|0:PRKDC|0:GATA3|0:NIF3L1|0:HDAC5|0:GATA6|0:HHEX|0:POU5F1|0:ADD1|0:GATA2|0:NEUROD1|0:HIF1A|0:TCF7L2|0:MLXIPL|0:NKX2-5|0:TRIB1|0:MLX|0:GCM1|0:PITX2|0:E2F4|0:PSMD10|0:HDAC1|0:ARRB1|0:HOXA7|0:USP7|0:SIRT2|0:MYOCD|0:NBN|0:TBP|0:NFIA|0:IGHMBP2|0:HMGB1|0:UBE2I|0:TP73|0:CEBPA|0:PBX1|0:SMAD2|0:TP53|0:CTBP1|0:SRF|0:NLK|0:E2F2|0:THRA|0:TWIST1|0:STAT3|0:FOXO4|0:TRAPPC2P1|0:WWP2|0:FIGLA|0:TNFRSF10A|0:YWHAZ|0:TRAPPC2|0:PBX2|0:PIM1|0:STK4|0:TCF3|0:BCL3|0:FOXF2|0:E2F5|0:RBL1|0:CENPF|0:FOXC1|0:PDCD11|0:FLNA|0:TRIB2|0:APBB2|0:LMO4|0:PURA|0:APBB1|0:PURB|0:IRF4|0:ETS1|0:PARD6A|0:FOSB|0:MYBBP1A|0:DRG1|0:ENPP2|0:VHL|0:HDAC11|0:GPX3|0:HDAC8|0:RNF19A			
GO:0008393	?:?; TAS:ProtInc		0:CYP4F2|0:CYP4A11|0:CYP4F8			
GO:0043418	P:homocysteine catabolic process; IDA:UniProtKB		0:CBS			
GO:0016571	P:histone methylation; ISS:UniProtKB		0:CTCFL			
GO:0060337	P:type I interferon-mediated signaling pathway; IC:BHF-UCL		0:SP100			
GO:0010867	P:positive regulation of triglyceride biosynt...; IMP:BHF-UCL		0:NR1H3|0:NR1H2			
GO:0004909	F:interleukin-1, Type I, activating receptor ...; TAS:ProtInc		0:IL1RL2|0:IL1R1			
GO:0043666	P:regulation of phosphoprotein phosphatase ac...; IMP:UniProtKB		0:HSP90B1|0:PPP6R3|0:PPP6R1|0:PPP1R2|0:PPP1R2P3|0:PPP1R2P9|0:PPP1R2P1|0:TSC1			
GO:0003746	F:translation elongation factor activity; NAS:UniProtKB		0:TUFM|0:GFM1|0:TCEA3|0:TCEA2|0:TCEA1|0:EEF2|0:EEF1A2|0:EEF1DP3|0:HBS1L|0:EEF1D|0:TSFM|0:EEF1A1P5|0:EEF1A1|0:ABTB1|0:EIF5A2|0:EIF5AL1|0:EFTUD1|0:EIF5A|0:EEFSEC|0:EEF1G|0:EEF1B2			
GO:0006295	P:nucleotide-excision repair, DNA incision, 3...; IMP:UniProtKB		0:ERCC5|0:ERCC1|0:ERCC4			
GO:0004716	F:receptor signaling protein tyrosine kinase ...; TAS:ProtInc		0:INSR|0:EGFR|0:ERBB4|0:ERBB3|0:KDR|0:TYRO3|0:KIT|0:ERBB2|0:LYN|0:CCL4			
GO:0046952	P:ketone body catabolic process; IEA:InterPro		0:OXCT1|0:OXCT2			
GO:0018738	F:S-formylglutathione hydrolase activity; IEA:EC		0:ESD			
GO:0030426	C:growth cone; TAS:BHF-UCL		0:RAC3|0:SNCA|0:MAPT|0:APBB1|0:LRRTM1|0:OTX2|0:GDPD5|0:EXOC8|0:NGEF|0:GPRIN1|0:ABI1|0:TIAM2|0:STMN2|0:SIGMAR1|0:DPYSL3|0:KPTN|0:LIMK1|0:BASP1|0:DFNB31|0:RASGRF1|0:RUFY3|0:STX3|0:APBB2|0:DTNBP1|0:DSCAM|0:FRMD7|0:IGHMBP2|0:CDK5R1|0:THY1|0:CDK5|0:ANG|0:NRSN1|0:ERC2|0:MYO5A|0:DOCK7			
GO:0004437	F:inositol or phosphatidylinositol phosphatas...; TAS:UniProtKB		0:BPNT1|0:MTMR2			
GO:0002286	P:T cell activation involved in immune response; IDA:UniProtKB		0:LCP1			
GO:0007218	P:neuropeptide signaling pathway; TAS:ProtInc		0:SORT1|0:GRP|0:QRFP|0:GLRA2|0:GLRA1|0:GLRB|0:AGRP|0:GPR98|0:EMR1|0:CELSR3|0:GPR124|0:PKD1L2|0:LPHN1|0:GPR111|0:GPR133|0:GPR115|0:EMR2|0:GPR97|0:PKD1|0:GPR64|0:GPR112|0:GPR128|0:PKD1L3|0:ELTD1|0:BAI3|0:GPR116|0:EMR3|0:NMB|0:GPR126|0:GPR144|0:GPR113|0:LPHN2|0:BAI2|0:EMR4P|0:PKDREJ|0:GPR110|0:GPR56|0:CELSR2|0:CD97|0:GPR125|0:GPR114|0:BAI1|0:LPHN3|0:CELSR1|0:TAC1|0:GAL|0:PDYN|0:CARTPT|0:SCG5|0:NMU|0:HCRT|0:GALP|0:NMS|0:PENK|0:PNOC|0:PROK2|0:PMCH|0:NPY|0:POMC|0:NPB|0:NPW|0:TAC3|0:PCSK1N|0:PTH2|0:NPS|0:NXPH2|0:NXPH3|0:NPVF|0:NXPH4|0:CPE|0:NPFF|0:HCRTR1|0:ECEL1			
GO:0055037	C:recycling endosome; ISS:BHF-UCL		0:VAMP3|0:RAP2A|0:TF|0:VIPAR|0:HFE|0:VPS16|0:USP6|0:SLC11A2|0:SLC9A9|0:NISCH|0:RABEP1|0:RAB11FIP1|0:RABGEF1|0:UNC13D|0:TNF|0:ABCG1			
GO:0045087	P:innate immune response; TAS:UniProtKB		0:LBP|0:APOL1|0:APOBEC3F|0:APOBEC3G|0:PYDC1|0:IL1R1|0:IL18RAP|0:IL18R1|0:SIGIRR|0:IL1RAPL2|0:IL1RAP|0:IL1RAPL1|0:IL1RL1|0:IL1RL2|0:CLEC4M|0:SAMHD1|0:ITCH|0:C4BPA|0:C1QC|0:CD55|0:CD180|0:POLR3E|0:IL27|0:IFITM3|0:TRIM25|0:TNFAIP8L2|0:SERPING1|0:CD209|0:PCBP2|0:DHX58|0:TLR6|0:MYD88|0:UNC93B1|0:TLR10|0:HERC5|0:LY86|0:IRGM|0:CLU|0:C1QB|0:POLR3D|0:C1RL|0:CRCP|0:NLRX1|0:CD14|0:CLEC4D|0:FCGR1A|0:IFIH1|0:C1R|0:TBK1|0:TBKBP1|0:CD46|0:POLR3C|0:POLR3H|0:C4BPB|0:IL23A|0:POLR3G|0:TLR5|0:CR1|0:MARCO|0:C1QA|0:LY96|0:CLEC4C|0:POLR3K|0:TLR1|0:C1S|0:CLEC7A|0:TIRAP|0:IFITM1|0:CLEC10A|0:CLEC6A|0:CFI|0:TMEM173|0:MIF|0:POLR3B|0:IL23R|0:CNPY3|0:POLR3F|0:AKIRIN2|0:IFITM2|0:SPON2|0:CLEC4A|0:C6|0:TICAM2|0:LILRA5|0:TLR7|0:TOLLIP|0:RNF135|0:TICAM1|0:CD1D|0:SARM1|0:ECSIT|0:CR2|0:BCL10|0:CYBA|0:CYBB|0:NLRC5|0:DDX58|0:MAVS|0:POLR3A|0:VNN1|0:LCN2|0:TLR8|0:CORO1A|0:PGLYRP4|0:RNASE7|0:TREML1|0:DEFB1|0:S100A7|0:PGLYRP2|0:C20orf185|0:PLUNC|0:PGLYRP1|0:CRISP3|0:PGLYRP3|0:TLR3|0:PPARG|0:F12|0:TLR4|0:TLR9|0:NCF1|0:NCF2|0:TLR2|0:DEFB127|0:SFTPD|0:DEFB118|0:COLEC12|0:DMBT1			
GO:0047045	F:testosterone 17-beta-dehydrogenase (NADP+) ...; IEA:EC		0:HSD17B14|0:HSD17B3|0:AKR1C3			
GO:0005158	F:insulin receptor binding; TAS:ProtInc		0:ENPP1|0:IGF1R|0:INS|0:DOK5|0:FRS3|0:DOK1|0:DOK6|0:TLN1|0:DOK2|0:DOK7|0:TLN2|0:DOK3|0:FRS2|0:DOK4|0:IRS4|0:IGF1|0:IGF2|0:IRS1|0:SHC1|0:PIK3R1|0:GRB10|0:PHIP|0:INSL3			
GO:0045750	P:positive regulation of S phase of mitotic c...; IMP:BHF-UCL		0:PROX1|0:SMAD6			
GO:0006546	P:glycine catabolic process; TAS:ProtInc		0:SARDH|0:C9orf6|0:DMGDH|0:C1orf69|0:AMT|0:GLDC			
GO:0006090	P:pyruvate metabolic process; IDA:UniProtKB		0:ME3			
GO:0070852	C:cell body fiber; TAS:BHF-UCL		0:CNTNAP2|0:SACS			
GO:0070933	P:histone H4 deacetylation; IDA:BHF-UCL		0:HDAC1|0:HDAC4|0:HDAC9			
GO:0035499	P:carnosine biosynthetic process; IDA:UniProtKB		0:CARNS1			
GO:0005750	C:mitochondrial respiratory chain complex III; TAS:ProtInc		0:MT-CYB|0:UQCRFS1|0:BCS1L			
GO:0032855	P:positive regulation of Rac GTPase activity; ISS:BHF-UCL		0:CCL26|0:CCL24|0:CCL11|0:ALS2|0:FZD10|0:GSK3B|0:SFRP1			
GO:0006477	P:protein amino acid sulfation; TAS:ProtInc		0:HS3ST5|0:CHST5|0:UST|0:CHST4			
GO:0016032	P:viral reproduction; TAS:ProtInc		0:ERVK5|0:GFI1|0:CALCOCO2|0:PARD6A|0:HCFC2|0:CCL1			
GO:0015937	P:coenzyme A biosynthetic process; TAS:UniProtKB		0:DCAKD|0:PANK2|0:PANK1|0:PPCDC|0:PANK4|0:PANK3|0:COASY			
GO:0032349	P:positive regulation of aldosterone biosynth...; IDA:UniProtKB		0:WNT4|0:BMP6			
GO:0030911	F:TPR domain binding; ISS:UniProtKB		0:STUB1|0:HSP90AA1|0:HSP90AB1			
GO:0008022	F:protein C-terminus binding; TAS:ProtInc		0:CAV3|0:DGKZ|0:SAE1|0:PFKM|0:PDZD3|0:HRAS|0:FOXN3|0:ABL1|0:NCL|0:DLG4|0:SP1|0:CORO1A|0:SDCBP2|0:DLG1|0:USP7|0:RACGAP1|0:NIPBL|0:ERCC1|0:NEFL|0:BAT2L2|0:MKI67|0:ATXN1|0:PDZD11|0:PIAS3|0:COIL|0:CITED1|0:MRE11A|0:ECM1|0:LCK|0:PICK1|0:DAB2|0:TNNI3K|0:DST|0:MSH2|0:SNX17|0:VPS4A|0:NEIL1|0:CIITA|0:GRIP1|0:ATP2B2|0:TERF2|0:ERCC4|0:CALCOCO1|0:XRCC6|0:PRKCD|0:PEX1|0:VIM|0:CDC20|0:TBL1X|0:SDC1|0:TCF4|0:ATXN2|0:SREBF2|0:SLC9A3R2|0:PEX12|0:BCL10|0:CEP135|0:SNTG1|0:CACNA1B|0:LIG4|0:MIF4GD|0:ATP2A2|0:HIC2|0:PEX16|0:MDC1|0:VPS4B|0:ERBB2|0:PRDX3|0:PABPC1|0:PCGF1|0:MED12|0:PEX26|0:LDLRAP1|0:PEX5|0:XRCC5|0:TOP2B|0:NPAT|0:ERCC3|0:SIAH1|0:RAD51|0:HSPG2|0:CDK7|0:NCF2|0:TAF13|0:TOP2A|0:ERCC6|0:CENPF|0:CEP250|0:YEATS4|0:BLOC1S2|0:XRCC4|0:CTNNB1|0:SIRT1|0:PEX6|0:MPDZ|0:PEX10|0:ERCC2|0:EFHC1|0:PXK|0:CADM1|0:BAIAP3|0:CSK|0:ITGB3BP|0:TRIM3|0:CTBP1|0:MAGI1|0:MLLT4|0:HSPB7|0:TOPBP1|0:BAIAP2|0:MAPRE1|0:PKD2			
GO:0070059	P:apoptosis in response to endoplasmic reticu...; IMP:UniProtKB		0:BCL2|0:ATP2A1|0:CHAC1			
GO:0033962	P:cytoplasmic mRNA processing body assembly; IMP:UniProtKB		0:LSM14A|0:ATXN2			
GO:0015086	F:cadmium ion transmembrane transporter activity; IDA:UniProtKB		0:SLC11A2			
GO:0050613	F:delta14-sterol reductase activity; EXP:Reactome		0:LBR|0:TM7SF2			
GO:0004607	F:phosphatidylcholine-sterol O-acyltransferas...; NAS:UniProtKB		0:PLA2G15|0:LCAT			
GO:0045595	P:regulation of cell differentiation; TAS:UniProtKB		0:TCFL5|0:SIK1|0:FADS1|0:PPP2R1A|0:PPP2CA|0:KLK6|0:SPOCK2|0:LTBP4			
GO:0034394	P:protein localization at cell surface; IMP:UniProtKB		0:MRAP|0:EGF|0:MRAP2|0:SMURF1|0:CTNNB1|0:FLNA|0:FGF10|0:USP4|0:FGF7|0:PTPRU|0:ANGPT1|0:PTPRK|0:VCL|0:WNT11			
GO:0045022	P:early endosome to late endosome transport; NAS:UniProtKB		0:ANKRD27|0:AKTIP|0:HOOK3|0:HOOK2|0:FAM160A2|0:HOOK1|0:EEA1			
GO:0050803	P:regulation of synapse structure and activity; NAS:UniProtKB		0:APP|0:PPT1			
GO:0004829	F:threonine-tRNA ligase activity; NAS:UniProtKB		0:TARS2|0:TARSL2|0:TARS			
GO:0050872	P:white fat cell differentiation; TAS:UniProtKB		0:SIRT1|0:ADIG|0:CTBP1|0:CTBP2|0:PPARG			
GO:0032009	C:early phagosome; ISS:UniProtKB		0:UNC93B1|0:TLR9|0:TLR7			
GO:0014904	P:myotube cell development; IDA:BHF-UCL		0:IGF1			
GO:0007181	P:transforming growth factor beta receptor co...; TAS:ProtInc		0:EID2|0:ZFYVE9|0:FMOD			
GO:0002042	P:cell migration involved in sprouting angiog...; IMP:BHF-UCL		0:FGF2|0:SLIT2|0:SRF|0:ROBO1			
GO:0004986	F:delta-opioid receptor activity; TAS:ProtInc		0:OPRD1			
GO:0002369	P:T cell cytokine production; ISS:BHF-UCL		0:SLC11A1			
GO:0019780	F:FAT10 activating enzyme activity; IMP:UniProtKB		0:UBA6			
GO:0017163	F:basal transcription repressor activity; IDA:UniProtKB		0:NR0B1|0:MDM2			
GO:0006948	P:induction by virus of host cell-cell fusion; IDA:UniProtKB		0:CD4			
GO:0006470	P:protein amino acid dephosphorylation; TAS:UniProtKB		0:PTPN3|0:PPP6C|0:CTDSP2|0:PPP2R2A|0:EPM2A|0:MTMR3|0:DULLARD|0:CTDSP1|0:PTPRM|0:TIMM50|0:PTPRT|0:PTPRU|0:PTEN|0:PTPRK|0:CDC25B|0:PTP4A2|0:STYXL1|0:PTPRG|0:STYX|0:PPM1F|0:PTPN20A|0:CDC25C|0:PTPRQ|0:C2orf79|0:PPM1L|0:CDC14A|0:DUSP14|0:DUSP26|0:PTPRS|0:C20orf57|0:CDC14C|0:TPTE2|0:PTP4A3|0:PTPN23|0:DUSP28|0:DUPD1|0:DUSP27|0:ACP1|0:SSH3|0:PPM1E|0:PTPRN|0:PTPDC1|0:DUSP15|0:DUSP16|0:PTPMT1|0:CDC25A|0:DUSP11|0:PTP4A1|0:RNGTT|0:PTPN20B|0:PPM1K|0:DUSP23|0:PTPRA|0:SSH1|0:SSH2|0:CDC14B|0:PPM1M|0:PTPRC|0:PPP2R3A|0:PPP2R3B|0:DAPP1|0:MTMR6|0:PPP1R2P9|0:MTMR2|0:MTM1|0:PPP3CA|0:DUSP8|0:DUSP2|0:PTPN21|0:PTPLA|0:DUSP13|0:PTPRB|0:PPEF1|0:DUSP9|0:PTPN22|0:DUSP5|0:PTPN2|0:PTPRH|0:PPP5C|0:PTPN6|0:PTPRE|0:DUSP22|0:PTPN12|0:PTPN7|0:PPP1CA|0:TPTE|0:PTPRD|0:PPM1B|0:PTPRR|0:DUSP4|0:DUSP10|0:PTPRN2|0:PTPN13|0:MTMR7|0:PTPN4|0:CTDP1|0:PTPRJ|0:PPM1G|0:PTPRZ1|0:PTPRO|0:PPEF2|0:PTPN14|0:PTPN9|0:MTMR4|0:PPM1D|0:PTPN18|0:SBF1|0:PPP2R1A|0:PPP2CA|0:PTPN5|0:PPP2CB			
GO:0042554	P:superoxide anion generation; TAS:BHF-UCL		0:NOX1|0:CYBB|0:PRG3|0:NOX5|0:CYBA|0:NOX4|0:ALOX12|0:DUOX1|0:NCF1|0:NCF2			
GO:0043085	P:positive regulation of catalytic activity; ISS:UniProtKB		0:YWHAB|0:PSENEN|0:APH1A|0:PSEN2|0:APH1B|0:NCSTN			
GO:0005871	C:kinesin complex; TAS:ProtInc		0:KLC3|0:KLC4|0:KLC2|0:KLC1|0:KIF5B|0:KIF25|0:KIF23|0:KIF11|0:KIF3C|0:KIF5A|0:KIFC3|0:KIF5C|0:KIF2C			
GO:0015942	P:formate metabolic process; NAS:UniProtKB		0:MTHFD1L|0:MTHFS			
GO:0000386	F:second spliceosomal transesterification act...; IDA:HGNC		0:SLU7			
GO:0045598	P:regulation of fat cell differentiation; IDA:UniProtKB		0:TAF8|0:PTPRQ			
GO:0004298	F:threonine-type endopeptidase activity; IMP:UniProtKB		0:PSMB8|0:PSMB4|0:PSMA3|0:PSMB10|0:PSMA6|0:PSMA2|0:PSMB5|0:PSMB1|0:PSMA5|0:PSMB11|0:PSMA1|0:PSMB6|0:PSMA8|0:PSMB2|0:PSMB7|0:PSMA7|0:PSMB3|0:PSMA4|0:PSMB9|0:PRSS50|0:TASP1			
GO:0002039	F:p53 binding; ISS:UniProtKB		0:CDKN2AIP|0:TP53RK|0:GSK3B|0:USP7|0:RNF20|0:PSME3|0:SMARCB1|0:TAF9|0:CDKN2A|0:SMARCA4|0:TAF1|0:SIRT1|0:MDM2|0:CREBBP|0:DAXX|0:RFWD3|0:BLM|0:HSPD1|0:USP10|0:RCHY1|0:CHD8			
GO:0019992	F:diacylglycerol binding; TAS:UniProtKB		0:RASGRP3|0:DGKD|0:RAPGEF2|0:CHPT1|0:RASGRP2|0:RASGRP4			
GO:0003873	F:6-phosphofructo-2-kinase activity; TAS:UniProtKB		0:PFKFB4|0:PFKFB3|0:PFKFB2|0:PFKFB1			
GO:0004398	F:histidine decarboxylase activity; TAS:ProtInc		0:HDC			
GO:0031258	C:lamellipodium membrane; IEA:UniProtKB-SubCell		0:ANTXR1|0:SYNE2|0:VASP|0:FAP|0:CSPG4|0:DPP4|0:PDPN|0:NCKAP1|0:PLEK2			
GO:0060373	P:regulation of ventricular cardiomyocyte mem...; IC:BHF-UCL		0:SMAD7			
GO:0016539	P:intein-mediated protein splicing; IEA:InterPro		0:IHH|0:SHH			
GO:0004821	F:histidine-tRNA ligase activity; NAS:UniProtKB		0:HARS2|0:HARS			
GO:0030887	P:positive regulation of myeloid dendritic ce...; NAS:UniProtKB		0:CD2			
GO:0042791	P:5S class rRNA transcription from RNA polyme...; IC:HGNC		0:GTF3C2|0:GTF3C3|0:GTF3C5|0:GTF3C4|0:GTF3C6|0:GTF3C1			
GO:0006424	P:glutamyl-tRNA aminoacylation; IEA:InterPro		0:EARS2|0:EPRS			
GO:0043401	P:steroid hormone mediated signaling pathway; IMP:UniProtKB		0:BMP7|0:BMP4			
GO:0051058	P:negative regulation of small GTPase mediate...; IDA:UniProtKB		0:SLIT2			
GO:0004329	F:formate-tetrahydrofolate ligase activity; TAS:ProtInc		0:MTHFD1L|0:MTHFD1			
GO:0046521	P:sphingoid catabolic process; NAS:UniProtKB		0:SPHK1			
GO:0016309	F:1-phosphatidylinositol-5-phosphate 4-kinase...; IEA:EC		0:PIP4K2C|0:PIP4K2B|0:PIP4K2A			
GO:0000124	C:SAGA complex; IDA:UniProtKB		0:ATXN7L3|0:ENY2|0:USP22			
GO:0009914	P:hormone transport; NAS:UniProtKB		0:SHBG			
GO:0004556	F:alpha-amylase activity; TAS:ProtInc		0:AMY2A|0:AMY1C|0:AMY2B|0:AMY1B|0:AMY1A			
GO:0032270	P:positive regulation of cellular protein met...; IMP:BHF-UCL		0:CSF1|0:NR1H3|0:PLA2G10|0:AGTR1|0:NFKBIA|0:NR1H2			
GO:0015919	P:peroxisomal membrane transport; NAS:UniProtKB		0:ABCD1			
GO:0004896	F:cytokine receptor activity; TAS:UniProtKB		0:CD74|0:IL2RG|0:IL11RA|0:MPL|0:CSF2RB|0:CSF3R|0:CSF2RA|0:LEPR|0:IL12B|0:EBI3|0:IL17RB|0:IL31RA|0:IL15RA|0:IL12RB2|0:IL13RA2|0:IL12RB1			
GO:0017147	F:Wnt-protein binding; ISS:UniProtKB		0:APCDD1|0:FZD7|0:ROR2|0:FZD5|0:FZD3|0:FZD9|0:SFRP1|0:FZD1|0:ROR1|0:FZD6|0:FRZB			
GO:0046968	P:peptide antigen transport; NAS:UniProtKB		0:TAP2|0:CLEC4M|0:CD209			
GO:0008292	P:acetylcholine biosynthetic process; IMP:UniProtKB		0:SLC5A7			
GO:0004423	F:iduronate-2-sulfatase activity; TAS:ProtInc		0:IDS			
GO:0004482	F:mRNA (guanine-N7-)-methyltransferase activity; IMP:UniProtKB		0:RNMT			
GO:0008090	P:retrograde axon cargo transport; ISS:BHF-UCL		0:NEFL|0:PAFAH1B1			
GO:0071157	P:negative regulation of cell cycle arrest; IMP:UniProtKB		0:MDM2|0:MIF|0:FGF10|0:RASSF1|0:MLXIPL|0:TFAP4			
GO:0045759	P:negative regulation of action potential; ISS:UniProtKB		0:CHRNB2			
GO:0019556	P:histidine catabolic process to glutamate an...; IEA:InterPro		0:AMDHD1			
GO:0051800	F:phosphatidylinositol-3,4-bisphosphate 3-pho...; IDA:UniProtKB		0:PTEN			
GO:0019695	P:choline metabolic process; NAS:UniProtKB		0:DMGDH			
GO:0046390	P:ribose phosphate biosynthetic process; IMP:BHF-UCL		0:G6PD			
GO:0004773	F:steryl-sulfatase activity; TAS:ProtInc		0:STS			
GO:0010832	P:negative regulation of myotube differentiation; IMP:BHF-UCL		0:HDAC5|0:HDAC4|0:NKX2-5			
GO:0006781	P:succinyl-CoA pathway; NAS:UniProtKB		0:SUCLA2			
GO:0001917	C:photoreceptor inner segment; ISS:UniProtKB		0:ARMS2|0:MYO7A|0:GNAT2|0:GNAT1|0:PDC|0:PPEF2|0:NOS1|0:TULP1			
GO:0005892	C:nicotinic acetylcholine-gated receptor-chan...; TAS:ProtInc		0:CHRNA5|0:CHRNA2|0:CHRNA3|0:CHRNB4|0:CHRNB2|0:CHRNA7|0:CHRNA4|0:CHRNB1|0:CHRNA1|0:CHRNB3|0:CHRND|0:CHRNA6|0:CHRNE			
GO:0051610	P:serotonin uptake; IDA:UniProtKB		0:SLC6A4			
GO:0090094	P:metanephric cap mesenchymal cell proliferation; ISS:UniProtKB		0:OSR1			
GO:0004623	F:phospholipase A2 activity; TAS:ProtInc		0:PNPLA3|0:PRDX6|0:PLA2G4E|0:PLB1|0:PLA2G4F|0:PLA2G4D|0:PLA2G16|0:PROCA1|0:OC90|0:PLA2G12B|0:PLA2G2F|0:PLA2G2E|0:PLA2G10|0:PLA2G2D			
GO:0001678	P:cellular glucose homeostasis; TAS:UniProtKB		0:CARTPT|0:PPARGC1A|0:FOXA3			
GO:0042605	F:peptide antigen binding; TAS:UniProtKB		0:DHCR24|0:MAML1|0:SLC7A8|0:SLC7A9|0:SLC7A5|0:CLEC4M|0:TRGV3|0:CD209|0:TRB@|0:TRBV12-3|0:TRAC|0:TAP1|0:TAPBP			
GO:0033557	C:Slx1-Slx4 complex; IDA:UniProtKB		0:SLX1B|0:SLX1A|0:SLX4			
GO:0010458	P:exit from mitosis; IMP:UniProtKB		0:UBE2S|0:CLASP1|0:UBE2C			
GO:0090045	P:positive regulation of deacetylase activity; IDA:BHF-UCL		0:FNTA			
GO:0000050	P:urea cycle; TAS:ProtInc		0:ASL|0:ARG2|0:NAGS|0:ARG1|0:CPS1|0:OTC|0:ASS1|0:SLC25A15			
GO:0004321	F:fatty-acyl-CoA synthase activity; TAS:ProtInc		0:ACSL3			
GO:0016149	F:translation release factor activity, codon ...; IEA:InterPro		0:ETF1|0:MTRF1|0:MTRF1L			
GO:0001972	F:retinoic acid binding; IDA:UniProtKB		0:UGT1A8|0:RARA|0:UGT1A9|0:CYP26C1|0:CYP26A1|0:UGT1A1|0:CYP26B1|0:UGT1A7|0:UGT1A3|0:NR2F2			
GO:0004108	F:citrate (Si)-synthase activity; IDA:UniProtKB		0:CS			
GO:0015136	F:sialic acid transmembrane transporter activity; IDA:MGI		0:SLC17A5			
GO:0001659	P:temperature homeostasis; TAS:UniProtKB		0:ACADVL|0:ACADL|0:CIDEA|0:DRD2|0:STAT3|0:PPARGC1A			
GO:0003006	P:reproductive developmental process; ISS:BHF-UCL		0:CSF1			
GO:0044430	C:cytoskeletal part; IDA:BHF-UCL		0:IGF2BP2			
GO:0002063	P:chondrocyte development; ISS:UniProtKB		0:EIF2AK3			
GO:0015696	P:ammonium transport; IDA:UniProtKB		0:AQP1			
GO:0001567	F:cholesterol 25-hydroxylase activity; IEA:EC		0:CH25H			
GO:0090076	P:relaxation of skeletal muscle; IDA:BHF-UCL		0:ATP2A1			
GO:0035300	F:inositol-1,3,4-trisphosphate 5/6-kinase act...; IEA:EC		0:ITPK1			
GO:0016884	F:carbon-nitrogen ligase activity, with gluta...; IEA:InterPro		0:QRSL1|0:FAAH2|0:PET112L|0:FAAH			
GO:0001596	F:angiotensin type I receptor activity; IDA:BHF-UCL		0:AGTR1			
GO:0072053	P:renal inner medulla development; ISS:UniProtKB		0:WNT7B			
GO:0042056	F:chemoattractant activity; ISS:UniProtKB		0:MIF|0:SCG2|0:FGF10|0:VEGFB|0:HMGB2|0:CCL15|0:FGF7|0:CCL3|0:VEGFC|0:FIGF|0:BMP4|0:CCL5|0:VEGFA|0:CCL16|0:HMGB1			
GO:0046961	F:proton-transporting ATPase activity, rotati...; TAS:ProtInc		0:ATP6V1E2|0:ATP6V1A|0:ATP5C1|0:ATP5A1|0:ATP6V1H|0:ATP5E|0:ATP6V1B1|0:ATP6V1E1|0:ATP5EP2|0:ATP6V1D|0:ATP6AP1L|0:ATP6V1F|0:ATP6AP1|0:ATP5D|0:ATP5B|0:ATP6V1B2|0:ATP6V1C1|0:ATP6V0C|0:ATP6V0E1			
GO:0007413	P:axonal fasciculation; TAS:UniProtKB		0:CDK5R1|0:AMIGO1|0:NRCAM|0:CNTN4			
GO:0005283	F:sodium:amino acid symporter activity; NAS:UniProtKB		0:SLC38A1			
GO:0048846	P:axon extension involved in axon guidance; IDA:UniProtKB		0:SLIT2|0:SLIT3|0:SLIT1			
GO:0043525	P:positive regulation of neuron apoptosis; ISS:UniProtKB		0:BAX|0:TGFB2|0:PCSK9|0:NF1|0:CDK5R1|0:CDK5			
GO:0030667	C:secretory granule membrane; IDA:UniProtKB		0:SLC30A8|0:SLC30A5|0:VAMP2|0:ICA1			
GO:0003310	P:pancreatic A cell differentiation; ISS:UniProtKB		0:RFX6			
GO:0016532	F:superoxide dismutase copper chaperone activity; ISS:UniProtKB		0:ATP7A			
GO:0003100	P:regulation of systemic arterial blood press...; IMP:BHF-UCL		0:ECE1|0:EDN3|0:EDN2|0:EDN1|0:NOS3			
GO:0005758	C:mitochondrial intermembrane space; TAS:UniProtKB		0:PPOX|0:STAR|0:GATM|0:HTRA2|0:TIMM23|0:HSD3B1|0:NDUFS1|0:SIRT5|0:AIFM1|0:COX6B1|0:ARL2BP|0:NME4|0:CPOX|0:COX17|0:NLN|0:GOLPH3|0:COX6B2|0:CHCHD4|0:SUOX|0:AK2|0:ACN9|0:OPA1|0:HSD3B2|0:CYCS			
GO:0008281	F:sulfonylurea receptor activity; TAS:ProtInc		0:ABCC9|0:ABCC8			
GO:0032869	P:cellular response to insulin stimulus; NAS:BHF-UCL		0:PARP1|0:KAT2B|0:ENPP1|0:HDAC9|0:USF1|0:GOT1|0:PPARG|0:PRKDC|0:PDPK1|0:CAPN10|0:TRIB3|0:PRKCI|0:PLA2G1B|0:PDE3B|0:PCSK9|0:INHBB|0:HDAC5			
GO:0042612	C:MHC class I protein complex; IEA:UniProtKB-KW		0:RAET1G|0:MICA|0:ULBP1|0:PROCR|0:ULBP2|0:RAET1L|0:RAET1E|0:FCGRT|0:CD1A|0:AZGP1|0:ULBP3|0:MICB|0:B2M|0:HLA-C|0:MR1|0:HLA-F|0:HFE|0:HLA-G|0:HLA-H|0:HLA-A|0:HLA-B|0:HLA-E			
GO:0006535	P:cysteine biosynthetic process from serine; IEA:InterPro		0:CBS			
GO:0045342	P:MHC class II biosynthetic process; ISS:BHF-UCL		0:SLC11A1			
GO:0043537	P:negative regulation of blood vessel endothe...; NAS:BHF-UCL		0:APOE|0:THBS1|0:FGF2|0:TGFB1|0:VASH1|0:ANGPT4|0:ANGPT2|0:AGTR2			
GO:0009062	P:fatty acid catabolic process; TAS:ProtInc		0:FAAH|0:LPIN1|0:CEL|0:PLA2G15			
GO:0004307	F:ethanolaminephosphotransferase activity; TAS:ProtInc		0:EPT1|0:CEPT1|0:PIGF			
GO:0043068	P:positive regulation of programmed cell death; NAS:UniProtKB		0:LRRK2|0:MARK4			
GO:0050501	F:hyaluronan synthase activity; IEA:EC		0:HAS1|0:HAS2|0:HAS3			
GO:0001952	P:regulation of cell-matrix adhesion; ISS:HGNC		0:NF1			
GO:0061155	P:pulmonary artery endothelial tube morphogen...; IDA:UniProtKB		0:BMP4			
GO:0032841	F:calcitonin binding; IPI:UniProtKB		0:CALCR			
GO:0016150	F:translation release factor activity, codon ...; IDA:UniProtKB		0:ICT1			
GO:0007259	P:JAK-STAT cascade; TAS:UniProtKB		0:GH1|0:IL31RA|0:CLCF1|0:SOCS3|0:STAT5A|0:IFNAR2|0:FGFR3|0:SOCS1|0:CCL2|0:STAT2|0:IFNAR1|0:PIAS1|0:STAMBP|0:SOCS6|0:STAT4|0:SOCS2|0:CCR2|0:NMI			
GO:0005068	F:transmembrane receptor protein tyrosine kin...; TAS:UniProtKB		0:GAB2|0:TRAT1|0:BLNK|0:SHC1|0:FRS2			
GO:0031995	F:insulin-like growth factor II binding; ISS:UniProtKB		0:INSR|0:IGFBP2			
GO:0014701	C:junctional sarcoplasmic reticulum membrane; TAS:BHF-UCL		0:JPH1|0:RYR1|0:JPH3|0:JPH4|0:JPH2			
GO:0004104	F:cholinesterase activity; IDA:UniProtKB		0:ACHE|0:BCHE			
GO:0006021	P:inositol biosynthetic process; IEA:UniProtKB-KW		0:ISYNA1			
GO:0034875	F:caffeine oxidase activity; IDA:BHF-UCL		0:CYP1A2|0:CYP2C8|0:CYP2C9|0:CYP3A4			
GO:0017148	P:negative regulation of translation; TAS:BHF-UCL		0:IGF2BP1|0:IGFBP5|0:EIF4A3|0:PRG3|0:NDUFA13|0:WT1|0:ANG|0:TSC1|0:IGF2BP2|0:IGF2BP3|0:CALR			
GO:0071546	C:pi-body; ISS:UniProtKB		0:TDRD1|0:DDX4|0:ASZ1|0:PIWIL2			
GO:0046164	P:alcohol catabolic process; ISS:UniProtKB		0:ADH4			
GO:0000445	C:THO complex part of transcription export co...; IDA:UniProtKB		0:THOC7|0:THOC1|0:THOC6|0:THOC5|0:THOC2			
GO:0005507	F:copper ion binding; TAS:UniProtKB		0:APOA4|0:ATP7B|0:IL1A|0:PRNP|0:TP53|0:S100A13|0:ANG|0:S100A5|0:SOD1|0:F8|0:MOXD2P|0:F5|0:SCO1|0:AOC2|0:COX11|0:HEPHL1|0:PAM|0:MT-CO2|0:MOXD1|0:ABP1|0:SNAI3|0:LOXL2|0:HEPH|0:TYRP1|0:METT11D1|0:LOXL1|0:LOXL4|0:TYR|0:P2RX4|0:ACR|0:ALB|0:MT4|0:MT1A|0:MT1L|0:LOXL3|0:SCO2|0:CUTC|0:MT1F|0:MT1E|0:MT1B|0:DCT|0:RNF7|0:CCS|0:LOX|0:AOC3|0:MT3			
GO:0047150	F:betaine-homocysteine S-methyltransferase ac...; NAS:UniProtKB		0:BHMT2|0:BHMT			
GO:0034722	F:gamma-glutamyl-peptidase activity; IDA:UniProtKB		0:GGH			
GO:0034230	P:enkephalin processing; ISS:BHF-UCL		0:PCSK2			
GO:0032981	P:mitochondrial respiratory chain complex I a...; IMP:UniProtKB		0:TAZ|0:NDUFS4|0:NUBPL|0:BCS1L|0:NDUFAF3|0:OXA1L|0:NDUFAF4|0:NDUFS8|0:NDUFS5|0:C20orf7|0:NDUFS7			
GO:0033612	F:receptor serine/threonine kinase binding; IDA:UniProtKB		0:BMP10			
GO:0006323	P:DNA packaging; TAS:ProtInc		0:ASH1L|0:HAT1|0:NAA10			
GO:0031307	C:integral to mitochondrial outer membrane; ISS:BHF-UCL		0:RHOT1|0:FIS1|0:MUL1|0:RHOT2|0:BNIP3|0:ABCB6|0:TOMM40			
GO:0046327	P:glycerol biosynthetic process from pyruvate; ISS:BHF-UCL		0:PCK1			
GO:0034629	P:cellular protein complex localization; IDA:BHF-UCL		0:SMAD7			
GO:0030374	F:ligand-dependent nuclear receptor transcrip...; NAS:UniProtKB		0:CALCOCO1|0:PPARGC1A|0:DCAF6|0:ATXN7L3|0:SS18|0:ENY2|0:ZMIZ2|0:PPARGC1B|0:PKN1|0:WDR77|0:HMGA1|0:PRKCB|0:KDM1A|0:USP22|0:NCOA6|0:RBM14|0:MED14|0:MED13|0:TRERF1|0:MED17|0:MED12|0:MED24|0:THRAP3|0:MED1|0:MED30|0:MED4			
GO:0030354	F:melanin-concentrating hormone activity; IEA:InterPro		0:PMCHL2|0:PMCH|0:PMCHL1			
GO:0030239	P:myofibril assembly; TAS:UniProtKB		0:MYOZ1			
GO:0004035	F:alkaline phosphatase activity; NAS:UniProtKB		0:ALPP|0:ALPPL2|0:ALPI			
GO:0001787	P:natural killer cell proliferation; ISS:UniProtKB		0:ELF4			
GO:0001974	P:blood vessel remodeling; TAS:BHF-UCL		0:ACE|0:NOS3|0:ATP7A|0:AGT|0:AGTR2			
GO:0035249	P:synaptic transmission, glutamatergic; NAS:UniProtKB		0:SLC1A4			
GO:0090003	P:regulation of establishment of protein loca...; IMP:BHF-UCL		0:APPL1			
GO:0009617	P:response to bacterium; TAS:ProtInc		0:ERAP1|0:CHIT1			
GO:0006983	P:ER overload response; TAS:BHF-UCL		0:TP53|0:GSK3B|0:EIF2AK3|0:WFS1			
GO:0005930	C:axoneme; TAS:ProtInc		0:EFHC1|0:SPAG6			
GO:0004633	F:phosphopantothenoylcysteine decarboxylase a...; IEA:EC		0:PPCDC			
GO:0046449	P:creatinine metabolic process; ISS:BHF-UCL		0:GHR|0:STAT5A|0:STAT5B			
GO:0055102	F:lipase inhibitor activity; IDA:BHF-UCL		0:APOC3|0:APOA2|0:APOC2			
GO:0015254	F:glycerol channel activity; TAS:ProtInc		0:AQP3|0:AQP7			
GO:0032094	P:response to food; ISS:BHF-UCL		0:GHRH			
GO:0022625	C:cytosolic large ribosomal subunit; TAS:UniProtKB		0:RPL10|0:RPL10L|0:RPL39L|0:RPL36|0:RPL4|0:RPL38|0:RPLP0|0:RPL34|0:RPL22|0:RPL21|0:RPL18A|0:RPL3|0:RPL23A|0:RPL26|0:RPLP1|0:RPL8|0:RPL29|0:RPL31|0:RPL14|0:RPL6|0:RPL18|0:RPL41|0:RPL24|0:RPL7|0:RPL7A|0:RPLP2|0:RPL28|0:RPL5|0:RPL35|0:FXR2|0:RPL11|0:RPL27A|0:RPL37|0:RPL19|0:RPL39|0:RPL30			
GO:0005741	C:mitochondrial outer membrane; TAS:UniProtKB		0:MAOA|0:CYB5A|0:BID|0:BAX|0:MAOB|0:BAK1|0:DNM1L|0:CASP8|0:OPA1|0:MSTO1|0:BCL2|0:RAB11FIP5|0:AIFM2|0:SPATA19|0:CYB5B|0:ACSL1|0:HK1|0:GPAT2|0:TOMM6|0:AKAP1|0:PI4KB|0:MGST1|0:ACSL4|0:SLC44A1|0:CISD1|0:RPS6KB1|0:MFF|0:GPAM|0:USP30|0:SH3GLB1|0:MARCH5|0:ACSL5|0:MTX3|0:TOMM40L|0:SNN|0:MAVS|0:NLRX1|0:CPT1C|0:MFN1|0:SYNJ2BP|0:GIMAP5|0:PINK1|0:CPT1B|0:TMEM173|0:MTX1|0:CPT1A|0:PGAM5|0:MOSC2|0:ACSL3|0:CYB5R3|0:MLXIP|0:VAMP1|0:MTOR|0:KMO|0:PPP2R2B|0:CISD2|0:HK2|0:TSPO|0:GK|0:BAD|0:ACSL6|0:BCL2L1|0:GK3P|0:GK2|0:MTX2|0:TOMM34|0:VDAC2|0:VDAC3|0:RAF1|0:VDAC1|0:MCL1			
GO:0032133	C:chromosome passenger complex; IPI:UniProtKB		0:BIRC5|0:CDCA8|0:AURKB			
GO:0010509	P:polyamine homeostasis; NAS:UniProtKB		0:EIF5A2			
GO:0003279	P:cardiac septum development; TAS:BHF-UCL		0:BMP4|0:CRELD1			
GO:0018685	F:alkane 1-monooxygenase activity; IEA:EC		0:CYP4A22|0:CYP4A11			
GO:0009595	P:detection of biotic stimulus; TAS:HGNC		0:NLRP3			
GO:0005253	F:anion channel activity; TAS:ProtInc		0:CCT8L2			
GO:0043982	P:histone H4-K8 acetylation; IDA:UniProtKB		0:ING4|0:MEAF6|0:PHF16|0:PHF17|0:MYST2|0:PHF15			
GO:0000156	F:two-component response regulator activity; IEA:InterPro		0:PDE8A|0:PDE8B			
GO:0048596	P:embryonic camera-type eye morphogenesis; ISS:BHF-UCL		0:TH			
GO:0070698	F:type I activin receptor binding; IDA:BHF-UCL		0:SMAD6			
GO:0018095	P:protein polyglutamylation; TAS:UniProtKB		0:TTLL1			
GO:0010165	P:response to X-ray; ISS:BHF-UCL		0:BRCC3|0:BLM|0:XRCC4|0:XRRA1|0:IKBIP|0:LIG4|0:MSH2			
GO:0003945	F:N-acetyllactosamine synthase activity; IEA:EC		0:B4GALT1|0:B4GALT4|0:B4GALT2|0:B4GALT3			
GO:0017108	F:5'-flap endonuclease activity; IDA:UniProtKB		0:SLX1B|0:FAN1|0:DNA2|0:SLX1A|0:FEN1			
GO:0015633	F:zinc transporting ATPase activity; TAS:ProtInc		0:SLC30A3			
GO:0004489	F:methylenetetrahydrofolate reductase (NADPH)...; EXP:Reactome		0:MTHFR			
GO:0045870	P:positive regulation of retroviral genome re...; IMP:UniProtKB		0:TOP2A			
GO:0072267	P:metanephric capsule specification; ISS:UniProtKB		0:FOXD1			
GO:0045189	P:connective tissue growth factor biosyntheti...; TAS:UniProtKB		0:IL4			
GO:0045058	P:T cell selection; TAS:UniProtKB		0:CD4|0:CD1D			
GO:0050769	P:positive regulation of neurogenesis; ISS:UniProtKB		0:SERPINF1|0:LIG4			
GO:0030792	F:methylarsonite methyltransferase activity; ISS:UniProtKB		0:AS3MT			
GO:0019087	P:transformation of host cell by virus; IMP:BHF-UCL		0:INSR			
GO:0048661	P:positive regulation of smooth muscle cell p...; ISS:UniProtKB		0:IGF1|0:TNF|0:EDN1|0:IL6R|0:IL6|0:HMOX1|0:BMP4|0:ELANE|0:CDH13|0:NOX1|0:EREG			
GO:0045717	P:negative regulation of fatty acid biosynthe...; ISS:BHF-UCL		0:APOC1|0:APOC3|0:BRCA1|0:TRIB3|0:ACADVL|0:ACADL			
GO:0060201	C:clathrin sculpted acetylcholine transport v...; EXP:Reactome		0:SYT1|0:SLC18A3|0:RAB3A			
GO:0042536	P:negative regulation of tumor necrosis facto...; IDA:UniProtKB		0:GHRL|0:GHSR			
GO:0031017	P:exocrine pancreas development; ISS:UniProtKB		0:PTF1A			
GO:0017081	F:chloride channel regulator activity; IDA:UniProtKB		0:CHRNA7			
GO:0030833	P:regulation of actin filament polymerization; IEA:InterPro		0:RASA1|0:LATS1|0:ARPC1A|0:ARPC1B|0:ARPC5L|0:ARPC5|0:ARPC3|0:ACTR3B			
GO:0051541	P:elastin metabolic process; ISS:BHF-UCL		0:HIF1A			
GO:0033005	P:positive regulation of mast cell activation; IMP:BHF-UCL		0:CD226|0:PVRL2			
GO:0031860	P:telomeric 3' overhang formation; ISS:UniProtKB		0:DCLRE1B			
GO:0032715	P:negative regulation of interleukin-6 produc...; ISS:BHF-UCL		0:TNF|0:IL10|0:BPI|0:ARRB1|0:IRAK3|0:TLR4|0:TLR9			
GO:0002092	P:positive regulation of receptor internaliza...; IDA:UniProtKB		0:WNT3A|0:SELE|0:SFRP4|0:PCSK9|0:ANGPT1			
GO:0050121	F:N-acylglucosamine 2-epimerase activity; IEA:EC		0:RENBP			
GO:0071363	P:cellular response to growth factor stimulus; IMP:BHF-UCL		0:EMD|0:CTNNB1			
GO:0032911	P:negative regulation of transforming growth ...; IMP:BHF-UCL		0:FURIN			
GO:0060678	P:dichotomous subdivision of terminal units i...; ISS:UniProtKB		0:FOXD1			
GO:0055119	P:relaxation of cardiac muscle; IMP:BHF-UCL		0:P2RX4			
GO:0055099	P:response to high density lipoprotein stimulus; IDA:BHF-UCL		0:ADAM17			
GO:0045329	P:carnitine biosynthetic process; IMP:BHF-UCL		0:BBOX1|0:TMLHE|0:ACADM			
GO:0015019	F:heparan-alpha-glucosaminide N-acetyltransfe...; IEA:EC		0:HGSNAT			
GO:0043006	P:activation of phospholipase A2 activity by ...; TAS:UniProtKB		0:NMUR2|0:EGFR			
GO:0007154	P:cell communication; TAS:UniProtKB		0:GPR98|0:GJA9|0:PIK3C2B|0:SLC8A2|0:SH3PXD2B|0:SNX18|0:ZCCHC2|0:SNX8|0:FREM3|0:SNX30|0:SNX24|0:DLL4|0:NISCH|0:SGK3|0:JAG2|0:SNX3|0:FREM1|0:SNX21|0:SNX17|0:NCF4|0:SNX16|0:SNX25|0:SH3PXD2A|0:HS1BP3|0:ARHGAP33|0:SNX31|0:SNX2|0:GJB7|0:SNX7|0:RPS6KC1|0:NCF1C|0:FRAS1|0:SNX13|0:PIK3C2G|0:C6orf145|0:SLC8A3|0:GJA8|0:FREM2|0:PXK|0:NOXO1|0:SNX6|0:GJB5|0:NCF1|0:SNX32|0:SNX11|0:SNX22|0:GJB6|0:ZCCHC14|0:SNX27|0:SNX1|0:PLD2|0:GJD4|0:SNX12|0:SNX15|0:KIF16B|0:DLL1|0:SNX33|0:SLC8A1|0:SNX19|0:SNX5|0:NCF1B|0:ITGB4|0:SNX10|0:PIK3C2A|0:GJA10|0:PLD1|0:SNX29|0:ARHGAP32|0:SNX9|0:GJE1|0:JAG1|0:SNX4|0:SNX20|0:SNX14|0:PPFIA4|0:OIP5|0:INPP5A|0:GJB3|0:PPFIBP2|0:ANG|0:TRIP10|0:GJB4|0:NRG1|0:CCL19|0:SNTG1|0:DNM1L|0:GJD3|0:KREMEN1			
GO:0019907	C:cyclin-dependent protein kinase activating ...; IDA:UniProtKB		0:CCNH			
GO:0055009	P:atrial cardiac muscle tissue morphogenesis; ISS:BHF-UCL		0:MYH6|0:PROX1|0:BMP10			
GO:0046596	P:regulation of virion penetration into host ...; IDA:UniProtKB		0:HS3ST5			
GO:0046488	P:phosphatidylinositol metabolic process; IEA:InterPro		0:IP6K3|0:PIP5K1B|0:PIP4K2C|0:PIP5KL1|0:PIKFYVE|0:PIPSL|0:PIP4K2A			
GO:0016811	F:hydrolase activity, acting on carbon-nitrog...; IEA:InterPro		0:SIRT3|0:SIRT4|0:SIRT7|0:SIRT5			
GO:0015677	P:copper ion import; ISS:UniProtKB		0:ATP7B|0:ATP7A			
GO:0008649	F:rRNA methyltransferase activity; IEA:InterPro		0:GSTCD			
GO:0006929	P:substrate-bound cell migration; TAS:ProtInc		0:VEGFC			
GO:0004816	F:asparagine-tRNA ligase activity; ISS:UniProtKB		0:NARS|0:NARS2			
GO:0050764	P:regulation of phagocytosis; IC:BHF-UCL		0:SCARB1			
GO:0071285	P:cellular response to lithium ion; IDA:UniProtKB		0:CDKN1B|0:CDH1			
GO:0009115	P:xanthine catabolic process; IDA:UniProtKB		0:XDH			
GO:0005929	C:cilium; TAS:ProtInc		0:GLI3|0:OFD1|0:ENKUR|0:SPAG6|0:TEKT4|0:SLC25A31|0:FSCB|0:TTLL11|0:CATSPER1|0:TTLL9|0:ALMS1|0:CATSPER3|0:AHI1|0:TEKT2|0:CABYR|0:SPEF1|0:SPAG4|0:SPAG17|0:CC2D2A|0:CATSPER2|0:IFT57|0:CATSPER4|0:NPHP4|0:SLC9A10|0:MKS1|0:SPAG16|0:IFT20|0:CEP250|0:GAS8|0:AKAP4|0:TTLL4|0:TTLL5|0:BBS10|0:CDK20|0:C6orf170|0:MYOC|0:SNTN|0:TTC30B|0:ANXA1|0:TTLL6|0:BBS12|0:RPGRIP1|0:TTC30A|0:TTLL7|0:ODF2|0:BEST2|0:IFT172|0:DNAI1			
GO:0047750	F:cholestenol delta-isomerase activity; IEA:InterPro		0:EBP|0:EBPL			
GO:0035295	P:tube development; TAS:BHF-UCL		0:ITGB3			
GO:0005643	C:nuclear pore; TAS:ProtInc		0:AAAS|0:TPR|0:XPO7|0:TMEM48|0:EIF5A|0:NUP62|0:SENP2|0:RANBP2|0:KPNA5|0:KPNA7|0:KPNA2|0:NUP62CL|0:TMCO6|0:KPNA4|0:KPNA6|0:NUP93|0:NPIP|0:NUPL2|0:POM121B|0:POM121C|0:MYO1C|0:NUP210|0:NUP188|0:AHCTF1|0:EIF5A2|0:DDX19A|0:POM121|0:NUP155|0:EIF5AL1|0:MVP|0:NUP35|0:NUPL1|0:NUP205|0:RANBP17|0:RGPD8|0:TNKS|0:SUMO1|0:NUP50|0:GLE1|0:AGFG1|0:NUP214|0:NUP153|0:SNUPN|0:NUTF2|0:RAE1|0:DDX19B|0:IPO7|0:RANGAP1|0:KPNA1|0:NXT1|0:NUP54|0:NUP88|0:KPNB1|0:KPNA3|0:IPO5			
GO:0006333	P:chromatin assembly or disassembly; TAS:ProtInc		0:CHD8|0:CHD9|0:CHD1|0:CBX2|0:SMARCC2|0:CDY1B|0:CDYL2|0:CBX6|0:KAT5|0:CHD7|0:CHD2|0:SMARCC1|0:CBX5|0:CDY1|0:CDY2B|0:SUV39H1|0:CBX4|0:CHD3|0:CHD6|0:ARID4B|0:CBX1|0:CDYL|0:MPHOSPH8|0:CBX8|0:ARID4A|0:CDY2A|0:CBX3|0:MSL3|0:CHD4|0:CHD5|0:CBX7|0:SUV39H2|0:HDAC8|0:HIRIP3|0:MTA2			
GO:0019717	C:synaptosome; NAS:UniProtKB		0:CYFIP2|0:DTNBP1|0:ITSN1|0:SNPH|0:PDLIM5|0:SLC17A7|0:ABI1|0:VAMP3|0:SLC17A8|0:RPS6KB1|0:LIN7B|0:LIN7A|0:CAMK2N1|0:STX1A|0:SNAP29|0:DOC2A|0:SNAPIN|0:LGI3|0:SAMD4A|0:SLC17A6|0:LIN7C|0:SYNPR|0:BSN|0:PPP1R9A|0:SYP|0:RASGRP2|0:SNAP23|0:ERC2|0:VAMP2|0:VAMP1|0:SH3KBP1|0:MAGI2|0:MPDZ|0:DVL1|0:DLG4|0:SIPA1L1|0:RNF40|0:CYFIP1|0:GRIN1|0:RASGRF1			
GO:0016888	F:endodeoxyribonuclease activity, producing 5...; IEA:InterPro		0:TATDN3|0:TATDN2|0:TATDN1			
GO:0035087	P:siRNA loading onto RISC involved in RNA int...; IDA:UniProtKB		0:CLP1			
GO:0010793	P:regulation of mRNA export from nucleus; IMP:UniProtKB		0:ZC3H3			
GO:0035097	C:histone methyltransferase complex; ISS:UniProtKB		0:MEN1|0:CXXC1|0:DPY30|0:ASH2L|0:SETD1B|0:WDR82|0:SETD1A|0:MLL2|0:CBX5|0:HDAC9			
GO:0043967	P:histone H4 acetylation; ISS:UniProtKB		0:RUVBL2|0:MORF4L1|0:RUVBL1|0:DMAP1|0:EPC1|0:TRIM16|0:TRRAP|0:ING3|0:YEATS4|0:EP400|0:BRD8|0:ACTL6A|0:ARRB1|0:EP300|0:APBB1			
GO:0032810	F:sterol response element binding; IDA:UniProtKB		0:SREBF1|0:NR1H3			
GO:0043565	F:sequence-specific DNA binding; TAS:BHF-UCL		0:CALCOCO1|0:USF2|0:HDAC2|0:FOXP2|0:TCF7L2|0:BPTF|0:TFAP2B|0:NR0B1|0:POU3F1|0:GSX1|0:BCL2|0:MEOX2|0:MEIS2|0:POU2F2|0:HLX|0:MEIS3|0:POU2F3|0:DLX4|0:ESRRB|0:FOXO1|0:EGR1|0:HOXA7|0:CEBPG|0:FOXD1|0:POU2F1|0:NR2F1|0:GCM2|0:FOXJ2|0:TBX1|0:TBX3|0:TBX5|0:ZNF238|0:ZNF711|0:BCL6|0:ZIC3|0:ELF2|0:ZGPAT|0:FOXP3|0:NR2F6|0:NR1H4|0:FOXK2|0:ZNF35|0:THAP1|0:NKX2-8|0:FOXH1|0:FOXF2|0:FOXO3|0:PRDM16|0:NR2C2|0:FOXL1|0:ESX1|0:ZNF148|0:TBX2|0:CREB3L1|0:ZHX3|0:ZEB1|0:EMX2|0:IRX3|0:SEBOX|0:HOXB5|0:ARGFX|0:PITX1|0:TGIF2LY|0:BATF2|0:FOXN3|0:ZHX2|0:EN2|0:HOXC11|0:HOXA11|0:MKX|0:HSF5|0:DBX2|0:LASS6|0:FOSL2|0:NKX2-4|0:DRAP1|0:VSX2|0:HOXB9|0:HOXB2|0:CDX1|0:PROP1|0:LEUTX|0:DUX4|0:POLE3|0:ESRRA|0:NR1I3|0:MEIS1|0:TGIF2|0:HNF4G|0:FOXE3|0:EVX1|0:DPRX|0:RERE|0:FOXD2|0:DBP|0:SIX6|0:ARX|0:IRX6|0:HOXD12|0:SPI1|0:HOXB4|0:POU6F2|0:ATF2|0:VENTX|0:FOXS1|0:NKX6-2|0:FOXB2|0:HOXD3|0:NR2C1|0:SHOX2|0:JDP2|0:LASS2|0:BARHL2|0:MEOX1|0:POU1F1|0:ELF3|0:CDX2|0:HOXA3|0:NR3C1|0:HMX2|0:HOXC5|0:OTP|0:DRGX|0:CUX2|0:BATF|0:TEF|0:FOXK1|0:EMX1|0:GSX2|0:DLX3|0:LMX1B|0:ETV6|0:PAX7|0:ATF6B|0:ISL1|0:ATF7|0:NFIL3|0:NFE2L2|0:HOXB8|0:FOXN2|0:HMBOX1|0:SPIC|0:ELK4|0:NKX2-3|0:LHX4|0:HOXC10|0:GSC2|0:ZHX1|0:FOSB|0:POU4F2|0:FOXQ1|0:MEIS3P1|0:POU4F1|0:ISL2|0:TSHZ2|0:NR2E1|0:ZFHX4|0:DBX1|0:TSNAX|0:FOXD4L4|0:TPRX1|0:FOXP4|0:HOXC9|0:IRX2|0:VSX1|0:NKX1-2|0:DLX1|0:HSFX1|0:MNX1|0:HOXD11|0:DLX2|0:FOXJ1|0:NKX6-1|0:HLF|0:PBX1|0:MEIS3P2|0:FOXD4L6|0:CREB3|0:LASS3|0:LMX1A|0:CREB3L4|0:NANOGP8|0:GATA3|0:NRL|0:RAX2|0:LBX2|0:RAX|0:POLE4|0:DUXA|0:CEBPE|0:SPIB|0:MEF2D|0:PAX4|0:NANOG|0:ATF3|0:MEF2A|0:HOXB3|0:HOXB13|0:PHOX2B|0:DLX6|0:GATAD1|0:ETV4|0:DUX3|0:RORA|0:CRX|0:NOTO|0:TSHZ3|0:HOXA4|0:HOXA9|0:FOXP1|0:HOXC6|0:EVX2|0:ERG|0:NR4A2|0:HMX1|0:FOXM1|0:VAX2|0:DUX1|0:NFYC|0:JUND|0:HSFY2|0:TSHZ1|0:HOXA5|0:ELF1|0:GBX2|0:UNCX|0:ETV3|0:PAX6|0:POU4F3|0:NKX3-1|0:NFE2L3|0:BARHL1|0:BARX1|0:ETV3L|0:MAF|0:SHOX|0:NOBOX|0:ADNP|0:HOXB7|0:MAFF|0:NR1D1|0:C5orf41|0:MEF2C|0:FOXD4L3|0:HOXC13|0:CREB3L3|0:RHOXF2B|0:LHX5|0:ESRRG|0:OTX1|0:NANOGP1|0:IRX1|0:CREBZF|0:HSFX2|0:CREBL2|0:MIXL1|0:ELK1|0:MTA3|0:FOXL2|0:RARG|0:FOXN1|0:ELF5|0:PITX3|0:TRPS1|0:LHX2|0:RXRB|0:HOXA1|0:LBX1|0:FOXI2|0:MAFK|0:CEBPD|0:HOXD10|0:MAFB|0:POU5F1|0:NKX2-6|0:ADNP2|0:ETV1|0:BACH2|0:RHOXF1|0:TLX2|0:DUX2|0:PHOX2A|0:ZGLP1|0:LHX8|0:ATF5|0:FOXN4|0:ATF4|0:ONECUT3|0:LHX1|0:RXRG|0:CDX4|0:ETS1|0:HOXB6|0:ZEB2|0:BACH1|0:TGIF2LX|0:PAX3|0:LASS4|0:HOMEZ|0:FEV|0:CHRAC1|0:NR2E3|0:FOXD4L1|0:THRB|0:EN1|0:TSN|0:ETV2|0:TLX1|0:VAX1|0:ELF4|0:FLI1|0:ZFHX2|0:NR1D2|0:MEF2B|0:PRRX2|0:FOXG1|0:PPARD|0:HOXD8|0:GSC|0:IRX4|0:HOXC4|0:MTA1|0:MAFG|0:GATA2|0:NFYB|0:HOXA6|0:GBX1|0:HOPX|0:MTA2|0:FOXR2|0:GATAD2A|0:ALX3|0:LASS5|0:BATF3|0:PITX2|0:HOXA10|0:NR1H2|0:NKX6-3|0:EDF1|0:HOXD1|0:ONECUT1|0:FOXD4L2|0:OTX2|0:HOXC12|0:LHX3|0:XBP1|0:ERF|0:HSFY1|0:NR1I2|0:NKX3-2|0:FOSL1|0:POU5F1B|0:IRX5|0:HESX1|0:MAFA|0:HOXD13|0:PRRX1|0:NKX1-1|0:ETV7|0:FOXR1|0:CREM|0:NR3C2|0:FOXJ3|0:RHOXF2|0:NFE2L1|0:FOXI3|0:ISX|0:TGIF1|0:HNF1B|0:RORC|0:FOXD4L5|0:HOXC8|0:DUX5|0:SATB1|0:TLX3|0:EHF|0:HOXD4|0:FOXO6|0:POU5F2|0:PBX3|0:CREB5|0:HDX|0:DDIT3|0:SPDEF|0:LHX6|0:DR1|0:ATF6|0:HOXD9|0:GATAD2B|0:ONECUT2|0:LHX9|0:PBX4|0:TAF1|0:PPARA|0:ZSCAN10|0:ZNF24|0:SOX13|0:NR6A1|0:ZC3H8|0:FOXD4|0:FOXF1|0:RAG1|0:RORB|0:DMBX1|0:SOX14|0:NFE2			
GO:0050830	P:defense response to Gram-positive bacterium; TAS:UniProtKB		0:MBL2|0:PGLYRP4|0:PGLYRP2|0:PGLYRP1|0:PGLYRP3|0:LBP|0:IL6R|0:IL6|0:IL12A|0:PLA2G2A|0:SPACA3			
GO:0015844	P:monoamine transport; IDA:UniProtKB		0:PICK1			
GO:0060056	P:mammary gland involution; ISS:UniProtKB		0:CAV1|0:ELF3			
GO:0032801	P:receptor catabolic process; IDA:UniProtKB		0:SMURF1|0:TGFB1|0:NEDD4			
GO:0004075	F:biotin carboxylase activity; TAS:ProtInc		0:ACACB|0:ACACA|0:BTD			
GO:0034767	P:positive regulation of ion transmembrane tr...; IDA:BHF-UCL		0:PDZK1			
GO:0005098	F:Ran GTPase activator activity; TAS:ProtInc		0:RANGAP1			
GO:0045745	P:positive regulation of G-protein coupled re...; IDA:UniProtKB		0:KLK14|0:KLK6|0:KLK5			
GO:0034333	P:adherens junction assembly; IMP:BHF-UCL		0:SMAD7|0:VCL|0:CTNNB1			
GO:0010288	P:response to lead ion; IDA:UniProtKB		0:SLC34A1			
GO:0004311	F:farnesyltranstransferase activity; IDA:UniProtKB		0:GGPS1			
GO:0045046	P:protein import into peroxisome membrane; IMP:UniProtKB		0:PEX26|0:PEX16|0:PEX3			
GO:0051238	P:sequestering of metal ion; IDA:UniProtKB		0:S100A7			
GO:0070527	P:platelet aggregation; ISS:UniProtKB		0:STXBP3|0:STXBP1|0:PLEK|0:FERMT3			
GO:0008242	F:omega peptidase activity; IDA:UniProtKB		0:UCHL1			
GO:0005726	C:perichromatin fibrils; IDA:HGNC		0:NUFIP1			
GO:0051271	P:negative regulation of cellular component m...; ISS:UniProtKB		0:TGFBR3|0:SP100|0:ACTN1|0:PKHD1			
GO:0031013	F:troponin I binding; IPI:UniProtKB		0:TNNT3|0:RCAN3|0:TNNI3K|0:TNNT2|0:TNNC1			
GO:0060272	P:embryonic skeletal joint morphogenesis; ISS:BHF-UCL		0:COL2A1|0:NOG|0:WNT9A			
GO:0006879	P:cellular iron ion homeostasis; TAS:UniProtKB		0:FTMT|0:TF|0:LTF|0:MFI2|0:FTHL17|0:FTH1P19|0:FXN|0:SLC11A1|0:NUBP1|0:NDFIP1|0:ALAS2|0:SOD1|0:HP|0:TFRC|0:ABCB6|0:HFE|0:MYC|0:FTL|0:HPX|0:CP|0:TFR2			
GO:0048712	P:negative regulation of astrocyte differenti...; ISS:UniProtKB		0:F2|0:NOG			
GO:0006376	P:mRNA splice site selection; TAS:ProtInc		0:SRSF10|0:CELF1|0:SRSF6|0:SRSF1|0:SRSF5|0:SRSF9|0:SFSWAP			
GO:0015168	F:glycerol transmembrane transporter activity; IDA:UniProtKB		0:AQP2|0:AQP1			
GO:0033034	P:positive regulation of myeloid cell apoptosis; IDA:BHF-UCL		0:ADIPOQ			
GO:0015099	F:nickel ion transmembrane transporter activity; IDA:UniProtKB		0:SLC11A2			
GO:0003896	F:DNA primase activity; TAS:ProtInc		0:CCDC111|0:PRIM1|0:PRIM2			
GO:0004055	F:argininosuccinate synthase activity; IEA:EC		0:ASS1			
GO:0047710	F:bis(5'-adenosyl)-triphosphatase activity; IDA:UniProtKB		0:FHIT			
GO:0016656	F:monodehydroascorbate reductase (NADH) activity; NAS:UniProtKB		0:GSTO1			
GO:0008366	P:axon ensheathment; NAS:UniProtKB		0:PPARD|0:PRX			
GO:0006352	P:transcription initiation; NAS:UniProtKB		0:RSF1|0:SMARCA5|0:TAF6L|0:APITD1|0:TAF9B|0:RTF1|0:TAF1L|0:BRF2|0:NAT14			
GO:0030023	F:extracellular matrix constituent conferring...; NAS:UniProtKB		0:EMILIN2|0:ELN			
GO:0003964	F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW		0:ERVK2|0:ERVK6			
GO:0007015	P:actin filament organization; TAS:ProtInc		0:RND1|0:DLG1|0:BCAR1|0:RHOF|0:ARHGEF2|0:INPPL1|0:DBN1|0:SHROOM4|0:CDC42EP2|0:BIN3|0:ALDOA|0:SPTA1|0:KPTN|0:PLA2G1B			
GO:0006959	P:humoral immune response; TAS:UniProtKB		0:IL6|0:FOXJ1|0:GPR183|0:TFE3|0:TFEB|0:BST1|0:TREM1|0:POU2AF1|0:IL7|0:CCR6|0:YTHDF2|0:PDCD1|0:GPI|0:PSMB10|0:CD83|0:LY86|0:BST2|0:MNX1|0:POU2F2|0:BLNK|0:CCL2|0:LTF|0:MS4A2|0:TREM2|0:ST6GAL1|0:PAX5|0:EBI3|0:CD28|0:BCL2			
GO:0005515	F:protein binding; IPI:UniProtKB		0:KLHL13|0:KLHL14|0:ZBTB12|0:KBTBD8|0:PHF20|0:RFPL2|0:CCT8L1|0:LRRTM3|0:TRIM64C|0:UNC5CL|0:KLHL6|0:SRMS|0:TRIM45|0:LGR5|0:ANKDD1A|0:TRIM56|0:NEURL3|0:BTBD10|0:SOCS4|0:ZBTB7C|0:AP2S1|0:GPR124|0:CGRRF1|0:NLRP9|0:TRIM77|0:SHE|0:TSKU|0:KCNS2|0:ZNRF3|0:DBNDD1|0:LRRC26|0:BTBD18|0:KLHL31|0:RGS12|0:LRRIQ1|0:ZCCHC2|0:SH2D4B|0:TRIM48|0:LRRC67|0:NEURL1B|0:ACTBL2|0:TIMP4|0:LONRF1|0:LRIT3|0:CCIN|0:CIDEB|0:RHOBTB1|0:AP2A2|0:ZBTB46|0:RCBTB2|0:KCTD14|0:WWC2|0:SH2D6|0:MEX3B|0:MUSK|0:SH3RF3|0:TCEB3CL|0:ZBTB38|0:TRIM72|0:CXXC1|0:ACTL9|0:ACTRT1|0:PDZD9|0:NCCRP1|0:TLR8|0:UNK|0:PHF19|0:SIPA1L1|0:SLITRK6|0:ZBTB6|0:FBXL19|0:CHAD|0:RNF165|0:KCTD20|0:BTBD3|0:RHPN1|0:EPHA3|0:ANAPC11|0:ZBTB1|0:EPHA6|0:LRRC30|0:SNX30|0:LRRC40|0:PDZRN4|0:MKRN3|0:MOBKL2C|0:RNF212|0:KCTD7|0:RNF130|0:SNX24|0:PPP1R14C|0:TRIM25|0:AP4E1|0:WAC|0:KLHL24|0:UNC5A|0:PCGF3|0:ARHGAP39|0:NLRP10|0:NLRP5|0:PHF16|0:ERO1L|0:LGI4|0:PHF1|0:RHOBTB2|0:SEPT3|0:ASH1L|0:IFI16|0:PHF21B|0:KLHL10|0:KCNG4|0:TCEANC|0:EME2|0:TRIM35|0:SMCHD1|0:PPIL5|0:PDZD7|0:RUFY1|0:PGLYRP4|0:ZBTB4|0:CARD16|0:LINGO3|0:LRRC63|0:TRIM34|0:PPP1R14B|0:POTEF|0:LRRC23|0:TRIM66|0:LINGO2|0:KBTBD4|0:SH2D1B|0:SBK1|0:LRIT2|0:SLITRK2|0:GIPC3|0:PDZD11|0:TRIML1|0:CNDP1|0:RNF181|0:LRRC57|0:ARCN1|0:SEC24A|0:SGK3|0:MPP7|0:LRRC17|0:SIPA1L2|0:ACTR1A|0:BBS10|0:CBLB|0:RTN4RL2|0:PTK7|0:KCNC3|0:LRRC9|0:MKRN2|0:SHD|0:ZBTB42|0:RNF207|0:TAF1A|0:RNF26|0:FNBP4|0:SGCA|0:PXDNL|0:KLHL29|0:ACTG2|0:RNF121|0:BTBD7|0:TCEA3|0:SUPT6H|0:NTN5|0:ING1|0:KBTBD12|0:LRCH3|0:ZFYVE19|0:ZBTB49|0:LRRC3B|0:ZNF645|0:NLRP14|0:SNX21|0:RNF169|0:ZFP161|0:PDLIM2|0:LRRN1|0:ACTR8|0:RABGGTA|0:SNX16|0:RNF32|0:KLHL36|0:KIAA1324|0:ZBTB11|0:SNX25|0:DAPP1|0:EPHA4|0:TPBG|0:KLHL7|0:LONRF2|0:AHNAK|0:ACTR5|0:LRRC53|0:OMD|0:ZNRF4|0:KLHL28|0:TCF19|0:KCNV2|0:CEP164|0:BGN|0:SRP9L1|0:BLK|0:TRIM47|0:TRIM6|0:AP1S3|0:SP110|0:TLR10|0:TRIM73|0:TIAM2|0:LRRTM2|0:LRRC1|0:NLRP8|0:KBTBD2|0:UNC5D|0:LRRC27|0:PYGO1|0:CPN2|0:PCOLCE2|0:TRIM62|0:AP1G1|0:KBTBD13|0:RFWD2|0:SEPT10|0:ZBTB22|0:LRRC38|0:CNKSR3|0:BTBD17|0:FANCL|0:KBTBD6|0:KCTD18|0:ZBTB2|0:NACC2|0:SGIP1|0:MYNN|0:RNF144A|0:LRRC31|0:SNX31|0:PGLYRP2|0:TRIM40|0:ABTB2|0:AP2A1|0:ZBTB45|0:TRIM26|0:MPP2|0:SHPRH|0:LRRC15|0:RNFT2|0:ZBTB39|0:ARHGAP23|0:KLHL32|0:ACTL8|0:C20orf134|0:TXK|0:ZNF238|0:TCEB3C|0:SLITRK5|0:KDM4C|0:SMC1B|0:KCTD6|0:TSNARE1|0:LRWD1|0:TCERG1L|0:ZNF295|0:PHF13|0:RNF125|0:GP5|0:MEX3C|0:TRIM15|0:RNF44|0:KBTBD7|0:KCNA7|0:NCF1C|0:FBXO42|0:A2ML1|0:ZNF598|0:INSRR|0:KBTBD3|0:LRIT1|0:ZZEF1|0:CPAMD8|0:KLHL9|0:KCTD10|0:AP4M1|0:SNX13|0:RNF150|0:PIK3C2G|0:SIK2|0:BTBD8|0:C14orf164|0:ISLR|0:UNC5C|0:TRIM52|0:C1orf83|0:NLRP11|0:ACTL7A|0:DPF1|0:NLRP4|0:RC3H2|0:LRRC20|0:RAPGEF2|0:C6orf145|0:ADAMTSL5|0:GORASP2|0:SIAH1L|0:NFXL1|0:PRPF40B|0:DTX3|0:EPHA10|0:RCBTB1|0:HLTF|0:KCTD15|0:LRRC8C|0:KCND1|0:KLHL23|0:RNF215|0:SPOPL|0:LRFN3|0:LRRC69|0:TRIM55|0:ACTR6|0:CARD6|0:LRIG3|0:RNF112|0:FRMPD2P1|0:KBTBD11|0:LRRC34|0:ZBTB26|0:TRIM69|0:AP3B2|0:SRP9|0:KCNA10|0:LRRC47|0:RNF220|0:RAI1|0:RNF148|0:AP4S1|0:LRRC4B|0:KLHDC5|0:KCNC4|0:SLITRK1|0:EPHB6|0:MKRN4P|0:PDZD4|0:ACTA2|0:RNF157|0:LGR4|0:GORASP1|0:RFPL1|0:KCNG1|0:STYK1|0:KCNA6|0:TRIM74|0:DVL1L1|0:DMC1|0:BBS12|0:LRGUK|0:AP1S2|0:LGI2|0:KCNC1|0:ZBTB48|0:LRRC8A|0:SLITRK4|0:KDM4B|0:LRRC10|0:RTN4RL1|0:BICD1|0:FRMPDP2|0:MEX3D|0:RNF175|0:ZBTB41|0:MAST4|0:KCTD2|0:UNKL|0:KLHDC1|0:LRRC32|0:AXL|0:RNF146|0:SNX32|0:KLHL38|0:LRRC49|0:LRRC70|0:SP140|0:SNX11|0:ZBTB10|0:SNX22|0:SYNJ2BP|0:LRCH1|0:KCNV1|0:NEURL|0:CHADL|0:RFPL4A|0:KLHL26|0:LRG1|0:LRRC46|0:KCNC2|0:RFFL|0:ABTB1|0:INTU|0:LRRC4|0:POTEE|0:HECW2|0:BTBD16|0:RNF113A|0:NLRP7|0:TCEB3|0:PYDC2|0:KERA|0:KCTD9|0:TRIM58|0:VPS8|0:ZCCHC14|0:IVNS1ABP|0:LRRC52|0:KLHL33|0:LRRC55|0:C17orf58|0:RNFT1|0:TRIM75|0:AP3M1|0:TRIM38|0:LRRC37A3|0:PHF14|0:KCTD19|0:RNF186|0:RNF219|0:DTHD1|0:LINGO4|0:TRIM64|0:AIM2|0:ZBTB44|0:LRRIQ4|0:TRIM59|0:AHNAK2|0:LRRC37A|0:LRIG2|0:AP3S2|0:LRRN2|0:ACTR10|0:RIN2|0:PDZRN3|0:PHF7|0:DIDO1|0:DPF2|0:STON1|0:FRMPD3|0:LRTM1|0:RASSF4|0:MOBKL2A|0:POTEKP|0:LRRC61|0:ZFPL1|0:ARHGAP12|0:EPHB3|0:AMIGO3|0:PPP1R14D|0:RBPJL|0:DTX4|0:LRFN4|0:SHC2|0:BRPF1|0:COPE|0:LRRC37B|0:KCTD11|0:SRP54|0:SH2D7|0:TCEA1|0:RNF133|0:NSMCE1|0:RNF24|0:LRRC8B|0:VPS54|0:SRPR|0:KLHL34|0:RNF151|0:SNX15|0:RNF114|0:DNAL1|0:LTK|0:EPHA8|0:MID2|0:PHF23|0:SEC23B|0:KLHDC4|0:RC3H1|0:RNF141|0:TRIM43B|0:TRIM60|0:CARD18|0:PHF3|0:KIF16B|0:C4A|0:NYX|0:MNDA|0:LRRC66|0:FES|0:MAGIX|0:KCNG2|0:LRRTM1|0:RXFP1|0:LIMK2|0:SHF|0:PHLPP1|0:SFRP5|0:ARHGEF37|0:PCGF5|0:GRAPL|0:TRIM7|0:ZSWIM2|0:RFPL4B|0:ANKFY1|0:BFAR|0:KLHL8|0:KLHL22|0:RNF214|0:EDARADD|0:ZMYND11|0:LMTK3|0:BTBD19|0:RNF149|0:KCTD16|0:LRRC28|0:RNF13|0:UBR7|0:CISH|0:RNF128|0:RASSF6|0:RNF183|0:ING3|0:CCT8L2|0:RNF185|0:WHSC1|0:LRRC33|0:WHSC1L1|0:AP3M2|0:FBXL14|0:KLHL30|0:RNF166|0:RNF39|0:ZBTB20|0:C14orf166B|0:KLHL21|0:PGLYRP1|0:BTBD9|0:GALNT9|0:CD109|0:DCST1|0:ACY1|0:RFPL3|0:APBB3|0:TRIM4|0:KLHL15|0:SNX5|0:SLITRK3|0:RNF152|0:UBOX5|0:KLHL18|0:BTBD11|0:LRRCC1|0:PDZD2|0:PDHX|0:ZBTB8B|0:RSPRY1|0:BICD2|0:LRRC18|0:KCTD8|0:OMP|0:ISLR2|0:FRMPD1|0:FTSJD2|0:TRIM46|0:ANKDD1B|0:RNF222|0:OMG|0:FBXO2|0:PHF11|0:KCNS3|0:ZBTB40|0:HECW1|0:RNF122|0:SEC24D|0:LZTR1|0:RNF170|0:UNC5B|0:RGS3|0:NLRP6|0:RNF17|0:LRRC58|0:RNF34|0:LRRC37A2|0:RNF145|0:EPHA5|0:RNF113B|0:MERTK|0:TRIM65|0:SNX10|0:PIK3C2A|0:NLRP13|0:LTN1|0:ZNRF2|0:KLHL25|0:FBXL2|0:BRD1|0:RNF213|0:PODNL1|0:BTBD6|0:ZBTB37|0:KIAA1324L|0:TRIM67|0:LRRTM4|0:TRIM49|0:TRIM64B|0:PDZD8|0:TRIM71|0:EIF2AK4|0:BAZ1A|0:LRRN3|0:CHD5|0:ULK2|0:GPR125|0:SGCE|0:KCTD21|0:ZBTB5|0:MFHAS1|0:SHKBP1|0:CASP12|0:SH2D5|0:TRIM50|0:KCTD1|0:ZNF131|0:ANP32E|0:PCOLCE|0:LRFN5|0:MUDENG|0:CLTA|0:DEF8|0:LRRC2|0:FMOD|0:TRIM42|0:LRRC45|0:LRIG1|0:LRRC8E|0:SNX29|0:LRRC39|0:ANAPC10|0:ARHGAP32|0:PM20D1|0:KCTD4|0:MEX3A|0:ACTRT2|0:TCEB3CL2|0:CEP110|0:VASN|0:PHF15|0:RABEPK|0:KBTBD5|0:CARD17|0:KLHL11|0:ZBTB3|0:ARMC5|0:PRELP|0:PZP|0:PGLYRP3|0:LRTM2|0:TRIM36|0:ROS1|0:MATK|0:SETD2|0:RASSF3|0:LGR6|0:ZBTB34|0:KCNF1|0:PHLPP2|0:ACTL7B|0:RNF208|0:RTN4R|0:TRIM31|0:PM20D2|0:PCGF6|0:COPZ1|0:TRIM43|0:ZBTB43|0:BRF1|0:LRRC29|0:XRRA1|0:SIPA1L3|0:PYHIN1|0:CIDEC|0:TRIM61|0:SNX14|0:M6PR|0:ZBTB8A|0:EPHA1|0:GZF1|0:MSL2|0:DPF3|0:PHF6|0:LRCH2|0:ZBTB9|0:TRIM54|0:PIN1L|0:AP3D1|0:AP3S1|0:PTK6|0:PARD3B|0:PHF21A|0:RXFP2|0:PCIF1|0:SLC25A4|0:RAET1G|0:KCNJ9|0:TGFBR2|0:MMP20|0:KCNJ3|0:ADRA2B|0:TTN|0:SCN5A|0:TACR1|0:NOP58|0:MC3R|0:SOX4|0:TCF12|0:PPAP2B|0:RAB3IP|0:NHP2L1|0:FZD10|0:PPIH|0:DNAJB2|0:ACACB|0:MEF2D|0:MC5R|0:APOL1|0:SDF4|0:MC2R|0:ITGAX|0:FECH|0:MEF2C|0:TH|0:KCNJ5|0:RAET1E|0:PLAT|0:DRD1|0:KCNJ6|0:TAZ|0:PRPF4|0:NOP56|0:CAV1|0:ATP1B1|0:DRD2|0:POLRMT|0:TOMM22|0:MALL|0:NPHP3|0:FAM84B|0:PCNP|0:MT-CO1|0:TAF8|0:RTP3|0:MRPL12|0:TAS2R16|0:PIGA|0:CKAP5|0:RASSF1|0:KEL|0:GMIP|0:UTP11L|0:DPM2|0:RINT1|0:FMR1|0:CEP290|0:KRT16|0:ATP6AP2|0:UBE2V1|0:NUFIP2|0:NAA50|0:TRIAP1|0:RTP4|0:CDC14A|0:HEXIM1|0:GTF3C5|0:NPBWR2|0:IKBIP|0:NPBWR1|0:PAIP2B|0:LRP2BP|0:USH1C|0:TCHP|0:DPM3|0:MT-ND1|0:GTF3C4|0:HEXIM2|0:PEG10|0:IMP4|0:CECR2|0:TIPIN|0:SMARCA1|0:HNRNPA2B1|0:NLRP3|0:CDH23|0:XK|0:TMEM8B|0:NDUFB10|0:IFI6|0:SMG6|0:GTF3C6|0:PYDC1|0:MPHOSPH10|0:NPLOC4|0:IMP3|0:RPS11|0:PNMA1|0:MMP2|0:BRIX1|0:CHD9|0:STK16|0:NAT10|0:CDC25B|0:MAP1LC3C|0:NUDT1|0:CIAO1|0:SIRT6|0:ABR|0:MAOA|0:CD82|0:PTP4A2|0:EMX2|0:CXorf56|0:ELAC2|0:ASS1|0:UPF3A|0:LAGE3|0:ARAP1|0:UNG|0:GSTP1|0:ZNF350|0:UBE2W|0:KRT15|0:GFI1|0:FHL1|0:OSGEP|0:RPL4|0:PRPF3|0:RG9MTD1|0:ACOT2|0:CELSR3|0:ITSN1|0:KIF4A|0:WFIKKN1|0:DCAF11|0:B2M|0:PARD6G|0:SAFB2|0:TRAIP|0:RABGGTB|0:CDK16|0:BSDC1|0:RNF43|0:WSB1|0:PSMB8|0:TUFM|0:THEG|0:KRT34|0:SLC14A2|0:C14orf129|0:ALS2CR4|0:FOXO1|0:CBX2|0:STYXL1|0:ZNF165|0:AK1|0:USP17L7|0:UCKL1|0:SLC23A1|0:PPP1R15A|0:C12orf11|0:ALOX12|0:LMNB1|0:PIK3C2B|0:USP15|0:PKN3|0:HIST2H3A|0:RNF126|0:CEP63|0:TACC1|0:SNX18|0:NDRG1|0:LDHAL6B|0:ZFP36L1|0:CCNB2|0:ZNF10|0:NAA38|0:SKIV2L2|0:CDT1|0:QRICH2|0:CCNB1IP1|0:EIF3J|0:F10|0:CCNE2|0:CALCR|0:CWC22|0:PPP1CB|0:SYT11|0:BHLHE40|0:RNF111|0:NME5|0:DDX21|0:MTPN|0:PGR|0:RPUSD2|0:MAPK11|0:COL4A6|0:MED31|0:PANK2|0:EIF1AY|0:PPP4R2|0:HCN4|0:RPP25|0:SNX8|0:KLC2|0:SNRPB2|0:RPN2|0:C4BPA|0:KIF22|0:MYL6B|0:MON1A|0:DPPA4|0:CASP4|0:BRD3|0:RPL38|0:TMEM147|0:ARID1A|0:TPD52L3|0:RRAGB|0:HIST2H2BE|0:SHMT2|0:SAFB|0:C19orf50|0:ERGIC1|0:MAP4|0:ORC3|0:HIVEP1|0:AIFM1|0:METTL11A|0:C20orf24|0:SFPQ|0:AKR1B10|0:URB1|0:TOP3B|0:RPS23|0:EML1|0:NUP93|0:CACNB3|0:MINK1|0:SLC25A1|0:PELO|0:TIPARP|0:MAP3K14|0:PDE6D|0:ANKRD28|0:ZNF311|0:EHMT2|0:DMPK|0:TUSC2|0:KHK|0:ABCB1|0:STRADA|0:USP54|0:PRH1|0:HUWE1|0:KIAA1524|0:RRAS2|0:CTPS|0:MAPK14|0:GTF2F2|0:MAP3K8|0:YY1AP1|0:SPON1|0:MAP2K2|0:RNF19B|0:PCDHA9|0:EXOC8|0:LDHA|0:MPZL1|0:PYGO2|0:RIOK3|0:ELP3|0:CCDC130|0:RQCD1|0:GLYCTK|0:AKAP17A|0:PLEKHF2|0:CNOT10|0:KPNA5|0:MTMR9|0:MST1R|0:ASGR2|0:TUBA4A|0:EPPK1|0:EEF2|0:RBM12|0:GADD45G|0:PGRMC1|0:DNASE2|0:DGKI|0:FAM136A|0:LSM5|0:RPS15A|0:DHX57|0:CCDC33|0:SLC4A1AP|0:COG5|0:GPSM3|0:BAG2|0:PKMYT1|0:MEAF6|0:DEAF1|0:CIB1|0:C19orf60|0:VANGL1|0:UGP2|0:ANKIB1|0:TSR1|0:EIF2S2|0:KRT5|0:RARS|0:FAM48A|0:KCTD12|0:ALS2CR12|0:FEZ2|0:WNK1|0:HAS1|0:ATCAY|0:ERN1|0:ATP1B3|0:HIST1H3F|0:GATM|0:PGD|0:RND1|0:ZNF133|0:DHX36|0:EIF3G|0:SMEK2|0:C11orf54|0:GNL2|0:ITPR3|0:CBR1|0:POLR2G|0:CNBP|0:SH3BP4|0:TCF25|0:PI4KB|0:SUSD2|0:OAZ2|0:NOC4L|0:FADS1|0:RHOT1|0:CDK11A|0:BCLAF1|0:GOLGA3|0:BBS7|0:GLE1|0:GTF3C3|0:LRRC8D|0:C21orf56|0:SRSF6|0:TRIM41|0:POLE3|0:CTSL2|0:DNM1|0:HYOU1|0:HNRNPR|0:STARD13|0:PSMD3|0:MPP4|0:ZNF24|0:PHLDA1|0:SUV39H2|0:EPX|0:AFAP1L1|0:LSM12|0:CLEC3B|0:FUBP1|0:ANKRD52|0:NUAK1|0:PPL|0:LCN1|0:MTHFD1|0:S100A3|0:PAFAH1B3|0:BCKDK|0:ZFP36|0:CTAG1A|0:MEIS1|0:EDAR|0:CRYBB3|0:RARS2|0:EPS8L3|0:LRBA|0:FHIT|0:DPP7|0:SENP8|0:ASPSCR1|0:FDFT1|0:UBE2D3|0:CTSK|0:LRCH4|0:EXOSC3|0:EIF2C3|0:POP7|0:CCNDBP1|0:C1orf103|0:SRRT|0:CNTN5|0:ITGB8|0:PIK3CD|0:PLOD2|0:TTC27|0:NUF2|0:ARID2|0:COBRA1|0:CHMP4C|0:WEE1|0:GCDH|0:SSR4|0:COMMD8|0:EEF1A2|0:HRNR|0:C6orf211|0:COL4A2|0:DTX2|0:DYRK3|0:PFAS|0:RPLP0|0:HNRNPD|0:ZNF44|0:PUM2|0:ZNF365|0:SFXN1|0:RNF216|0:SF3A1|0:ANKHD1|0:BAZ2B|0:KRTAP19-5|0:RPL34|0:MARK2|0:LIPG|0:ZNF423|0:MAPK13|0:IGHG1|0:EXTL3|0:SUZ12|0:CNIH4|0:HTATSF1|0:FAM113A|0:FBXL7|0:KIF13A|0:RAC3|0:TWIST2|0:LCP2|0:TNFRSF13B|0:SEC11A|0:IGBP1|0:RHPN2|0:CD22|0:ACP6|0:PPP1R1A|0:ASXL1|0:USO1|0:FASTK|0:PIP5K1B|0:SNRNP200|0:KLF13|0:RNF11|0:C15orf23|0:POLD3|0:LOXHD1|0:PLEKHA5|0:GCN1L1|0:LDOC1|0:TRAFD1|0:HNRNPA1|0:COMT|0:PCDHA6|0:LETMD1|0:STT3B|0:LASS2|0:SMNDC1|0:CLPB|0:PNKP|0:MATR3|0:KRT82|0:GNAI2|0:SLC39A7|0:PSMA3|0:EPHA2|0:SARS2|0:ACAT1|0:TSSC1|0:FAM27E3|0:PAK6|0:MUC7|0:CSDE1|0:MAGI3|0:CCHCR1|0:HIST1H2BC|0:CPSF7|0:ITGB1BP3|0:RPS8|0:UHMK1|0:MAP2K6|0:CKS1B|0:MCM3|0:FAM110A|0:CNRIP1|0:BTBD2|0:RDBP|0:RAB33A|0:RPS26|0:C19orf29|0:CXorf40A|0:RNASEN|0:PER2|0:VPS13A|0:FANCF|0:CSNK1A1|0:CCNC|0:DIS3|0:SURF2|0:PSMC1|0:MAZ|0:C18orf56|0:RPS15|0:HIST1H3H|0:COMMD4|0:CD244|0:LSM6|0:MLLT1|0:HERPUD1|0:LRRK1|0:GSX2|0:MLLT6|0:GLTSCR1|0:REEP5|0:GRIN2D|0:RASSF2|0:PRTN3|0:TNFAIP8|0:SCARB2|0:C17orf28|0:THBS2|0:TNIP2|0:EIF3C|0:RAB1C|0:MAPKSP1|0:DDC|0:COPG|0:CAB39|0:TSC22D4|0:CHRM2|0:CCNH|0:CMBL|0:TSSK4|0:IRGQ|0:SRGAP3|0:MEST|0:ILKAP|0:BRPF3|0:PSMD13|0:CDK19|0:VWA5B2|0:KIF20A|0:SIK3|0:EIF4G2|0:ZNF385A|0:TDRD1|0:HIST1H3A|0:MED22|0:PARD3|0:DDX41|0:UNC45A|0:GIT2|0:TIFA|0:HIPK1|0:WAPAL|0:ZNF192|0:HBG1|0:PAX7|0:GNL3|0:BTG2|0:ECHS1|0:RAB1B|0:SRPK1|0:PTCD3|0:MAPKAPK2|0:PTPN22|0:EIF4G3|0:ROCK2|0:KIAA1609|0:KIAA0528|0:HIST3H3|0:HIST1H1E|0:COPS4|0:MAPK10|0:XPC|0:PTPN2|0:SF3A3|0:PTPRH|0:ATP6V1C1|0:PSMF1|0:SH3PXD2A|0:MRPS24|0:MT1G|0:MTG1|0:CATSPER1|0:FBXO46|0:HIST2H3D|0:MYCBPAP|0:CPVL|0:TLK1|0:RPN1|0:PMVK|0:EIF3D|0:RBM7|0:POLR1A|0:ATP6V0A2|0:PPFIBP1|0:TRPC1|0:MAPK7|0:MELK|0:ITK|0:PCDHA12|0:ERH|0:MAN2C1|0:OIP5|0:OTUB2|0:LIN7B|0:SLC23A3|0:KLHDC2|0:PPP4R1|0:IKBKAP|0:RPP30|0:STK24|0:EIF2AK2|0:AMY1C|0:KIAA0408|0:C7orf50|0:RAD23A|0:WDR33|0:HIC1|0:IGKC|0:EEF1D|0:MPHOSPH6|0:ATP6V0C|0:PRPF8|0:PLEKHB2|0:D2HGDH|0:RPL18A|0:BCKDHA|0:RPL3|0:EIF4ENIF1|0:TNFRSF21|0:SNCG|0:CDAN1|0:MCM4|0:IFT88|0:SLC24A1|0:CIRH1A|0:NADK|0:MCF2|0:NEURL4|0:C19orf68|0:C20orf11|0:PAK4|0:EBNA1BP2|0:RPP21|0:KRT33A|0:UPF3B|0:RPL23A|0:CNNM3|0:PSMA6|0:NRBF2|0:KCTD3|0:SERPINB3|0:TSPAN17|0:NARS|0:MAST3|0:RCN3|0:CCNA1|0:QARS|0:PKD1|0:CDK15|0:DDX19B|0:CRY2|0:HRK|0:RPP40|0:SCOC|0:TAGLN2|0:HTR2C|0:CSTF3|0:COMMD2|0:SOS2|0:LARS|0:SNRPA|0:C9orf163|0:PRDX1|0:PIWIL1|0:ARHGAP33|0:SNRPF|0:ANTXR2|0:DBF4|0:STON2|0:SCNN1D|0:PRH2|0:SLC22A1|0:TSPYL2|0:EIF2S3|0:LARP1|0:MOBKL3|0:RHEBL1|0:NEK1|0:TNK2|0:EBF3|0:DDAH2|0:ATXN3|0:PPP1R16A|0:TIE1|0:HIST1H3G|0:SLC4A7|0:GART|0:THOP1|0:CACNA1F|0:PLOD3|0:DYNLRB1|0:MAP4K5|0:KRT6A|0:RAB17|0:PTBP1|0:PTPN7|0:CDC7|0:SNX7|0:HEATR1|0:PPAN|0:ACAP1|0:PSMA2|0:EML2|0:SH3RF2|0:RPL26|0:CHCHD3|0:CD59|0:SNRPA1|0:KIF6|0:HIST1H2BG|0:PIK3CG|0:GTPBP4|0:CIC|0:HOXC9|0:TSR2|0:TDG|0:MRPS5|0:PABPC4|0:COMMD10|0:KLHL12|0:FAR1|0:SF3B1|0:MAGEA6|0:IGHA1|0:SPATA20|0:PSMB5|0:WNK3|0:RPS19|0:KHSRP|0:MLF2|0:RRP12|0:WFIKKN2|0:DNASE1L2|0:PPP2R5D|0:TIMM44|0:FLOT1|0:TOR1AIP2|0:PCDHA8|0:SLC25A12|0:ERCC6L|0:EIF3K|0:POP5|0:MARS|0:SREK1|0:C3orf15|0:PPP2R5E|0:BOLA1|0:TMEM48|0:PYGM|0:CDKN2A|0:PDIA4|0:SERBP1|0:GABRA3|0:TNFRSF10D|0:TRAF3IP1|0:VRK1|0:DPCD|0:RANGAP1|0:SRY|0:HIST1H2BF|0:PPP1R14A|0:GYS1|0:KIAA1009|0:TSC22D1|0:PUF60|0:SIX5|0:TH1L|0:MT-ND4L|0:FOXJ1|0:HTR7|0:IPO4|0:POLR1E|0:UBXN4|0:SLC22A6|0:POGZ|0:MRPS12|0:MOBKL2B|0:RPL32|0:BBS1|0:UBXN7|0:RARB|0:CNOT6|0:UBL7|0:PXMP2|0:GGA1|0:GABBR1|0:ASXL2|0:SNAI1|0:IER3|0:MLL3|0:ASAP1|0:MAGEC1|0:KIT|0:FDX1|0:CCNK|0:FSHR|0:ZNF740|0:NPY1R|0:SURF4|0:BCAS2|0:MRPS9|0:TXNL4A|0:C22orf9|0:SMCR7|0:ALG11|0:MPDU1|0:KCNIP1|0:ERGIC3|0:ATP2A3|0:ARHGEF5|0:NAP1L1|0:INPP5K|0:COPB2|0:CDC27|0:VAC14|0:INO80B|0:PCDHA5|0:TSKS|0:RHOU|0:VPREB1|0:SEC24B|0:CYP4F2|0:CSMD2|0:COPG2|0:IARS|0:EHD4|0:SYNCRIP|0:PMAIP1|0:RHOT2|0:RALGPS2|0:TRPC6|0:VARS|0:ST5|0:C21orf7|0:POLE4|0:PSMD4|0:SLC29A1|0:TMED10|0:RAB11FIP1|0:PKD1L3|0:RPA3|0:PTPLB|0:CDK11B|0:HAT1|0:EIF2C2|0:STK19|0:ATP6V1G2|0:DGKE|0:RPS6KA1|0:UBE2D4|0:RPL37A|0:EIF4H|0:SPRY4|0:KCNH7|0:CTSA|0:PCDHB5|0:MKRN1|0:SNAPC3|0:TEX11|0:APRT|0:GINS2|0:CYP1B1|0:RLF|0:TBCB|0:CEP70|0:SEPT14|0:RASSF7|0:KRTAP9-3|0:TRIM23|0:ARL1|0:NXPH3|0:RPL29|0:DDX47|0:EVI5L|0:HIST1H3I|0:BRMS1|0:HIST1H3B|0:HSD17B4|0:HTN3|0:FOXD3|0:RAI14|0:PPP2R1B|0:SLC1A5|0:GFI1B|0:NUDT18|0:MEA1|0:TCEA2|0:COG2|0:LGTN|0:CUEDC2|0:MTHFD2|0:HSPB2|0:ZYX|0:SIRPB1|0:HIGD1A|0:BZW1|0:PRKAR1A|0:PSENEN|0:OPTC|0:TUBA3D|0:SH3GLB2|0:ISG20L2|0:UTP14A|0:THRSP|0:BAT3|0:AIMP2|0:KPNA1|0:DOT1L|0:RPRD2|0:EEF1A1|0:CHAC1|0:HMGA2|0:ZNF558|0:LSM7|0:ACSS2|0:RIN1|0:TMBIM4|0:PTPRS|0:ZC3H7B|0:ZYG11B|0:RFC2|0:SERTAD3|0:RORA|0:PLK2|0:ARHGAP9|0:EIF1B|0:C20orf185|0:BACE1|0:CPSF1|0:NUP188|0:SDPR|0:RPS20|0:CTSL1|0:PPM1B|0:C9orf86|0:SRSF1|0:ACTR1B|0:SPINT1|0:LTF|0:TIMM8B|0:HOXA9|0:ERP44|0:HIF1AN|0:ZNF205|0:NEDD8|0:IPO11|0:ZC3H11A|0:PPFIBP2|0:STAT2|0:ACCN1|0:JAK3|0:TRAPPC4|0:RGS10|0:PLD3|0:SLC5A1|0:SERINC1|0:PSMD7|0:ORC6|0:CABLES1|0:P4HB|0:PSMB1|0:SPAG7|0:ARAF|0:KLF10|0:DCP1B|0:DLEU1|0:UBE2Q1|0:RPL37|0:CACNA1I|0:XPO5|0:OSBPL5|0:ERG|0:PARN|0:SOD2|0:CYTH1|0:NOSTRIN|0:MAP3K3|0:NR4A2|0:C15orf41|0:RPS6KA5|0:FAHD1|0:KIAA0090|0:ACBD3|0:SMYD3|0:ANKRD6|0:FOXM1|0:FBXO11|0:AMY1B|0:C20orf57|0:PPP1R3D|0:EPB42|0:POLR2B|0:RPS28|0:SETDB1|0:ORC1|0:FAM82A2|0:ID1|0:C2orf44|0:MMP15|0:BTF3|0:SARS|0:EML3|0:CHRM1|0:TMEM11|0:IPO13|0:COMMD5|0:SUV420H1|0:ARHGAP15|0:NADSYN1|0:ARMC6|0:PSMD5|0:RSU1|0:EIF4A3|0:CXCR7|0:GOT2|0:VRK2|0:PREX2|0:TANK|0:RCAN1|0:PELI3|0:KALRN|0:TALDO1|0:HNRNPK|0:FAM129B|0:IGHA2|0:PSMD12|0:TAF1D|0:MCM5|0:MAP2K4|0:PPP6R2|0:MME|0:KRT33B|0:CCNA2|0:RAVER1|0:C17orf62|0:KIF5C|0:LRRFIP1|0:CNOT2|0:ABI3|0:CDK18|0:DGCR8|0:CD1B|0:KRT9|0:RPE|0:CSDC2|0:F2RL2|0:CBWD1|0:TELO2|0:SRP14|0:PAK7|0:THUMPD3|0:POLR1B|0:PAX6|0:TUBB4|0:GNAI1|0:DNPEP|0:NAP1L5|0:DHX38|0:BTBD1|0:TPSB2|0:KIAA1377|0:SSB|0:TRIM11|0:DEGS1|0:NUDC|0:PAAF1|0:BARHL1|0:HIST1H3C|0:CHST12|0:TARDBP|0:C6orf167|0:PLXNB2|0:TNIP1|0:RHOG|0:NSFL1C|0:XRN1|0:ODC1|0:NR2F6|0:POLE|0:PTGES2|0:RAP2A|0:AZIN1|0:RPL35A|0:MAP4K2|0:ELOVL1|0:HIST1H3D|0:MAGEA11|0:C4orf34|0:STAMBP|0:SARNP|0:GPR63|0:AIFM3|0:RPL31|0:KDELR2|0:TLK2|0:PSPC1|0:ARHGAP24|0:EIF3CL|0:PITPNC1|0:NCOA7|0:GAGE8|0:HOXB7|0:TNPO2|0:HIST1H3J|0:DYNLT3|0:RPS16|0:CHPF|0:RPL14|0:FKBP2|0:C5orf41|0:AP1S1|0:SAT1|0:RPP38|0:CBFA2T3|0:EIF6|0:WNK2|0:HOXC13|0:POLI|0:PELP1|0:SERINC3|0:STRADB|0:DDOST|0:RAB7L1|0:CSN3|0:FUBP3|0:ARL11|0:PLN|0:YARS2|0:DDX27|0:MEPE|0:CHMP5|0:CNTN4|0:NEFM|0:CHD3|0:SPICE1|0:TRPC7|0:AHCY|0:OTX1|0:CDR2|0:EXOSC9|0:PCDHA2|0:SSR3|0:PCDHA11|0:THBD|0:DCD|0:FLOT2|0:MAP4K1|0:PDE9A|0:UBR5|0:NHP2|0:STOM|0:MBD4|0:KRT36|0:DENND4A|0:VPS11|0:TMEM214|0:DGKB|0:FBXW9|0:TCTEX1D2|0:TMED2|0:TMEM63B|0:S100A8|0:ISG15|0:TGDS|0:PRPF40A|0:CCDC149|0:P4HA2|0:PLCG2|0:PTPRN2|0:ELK1|0:HIBCH|0:COL4A4|0:DNMBP|0:SEC24C|0:AP1G2|0:CCDC82|0:HTR6|0:VPS28|0:HNRNPAB|0:EFEMP2|0:NOB1|0:LRRC7|0:SLC25A6|0:DCP2|0:COMMD3|0:DUT|0:LRRC59|0:CDC73|0:MED9|0:RPL13|0:GPRASP1|0:EXTL1|0:PSMD1|0:RBMX|0:RAD51L3|0:RPL41|0:PARP3|0:FABP4|0:CATSPER2|0:NDUFA9|0:EGLN3|0:GTF2IRD1|0:COX4I1|0:TRBC1|0:ARID4B|0:PAF1|0:ATG16L1|0:SEPN1|0:FAM64A|0:CDK10|0:ZNRF1|0:HIST2H3C|0:DCAF8|0:NUP155|0:G2E3|0:CD2BP2|0:HOXA1|0:DARS|0:HERC2|0:FAM96B|0:PDIA3|0:KIAA1715|0:RTF1|0:EXOSC2|0:MYL12A|0:OTUD4|0:SCP2|0:MZT1|0:PPP2R5A|0:RGL1|0:ATG10|0:APPBP2|0:OPRK1|0:NOMO1|0:CBFA2T2|0:AGTRAP|0:FRYL|0:MTR|0:PPP1R12A|0:PLXNB3|0:TPT1|0:GANAB|0:PSMC4|0:SGK1|0:PSMD8|0:HTR1E|0:FNTB|0:OSBPL3|0:GNS|0:MAP1A|0:EAF1|0:SLC30A7|0:PRF1|0:LST1|0:DHCR7|0:FAM127A|0:RNPC3|0:RPL24|0:HIST1H2BE|0:CNKSR2|0:BSG|0:TIMM8A|0:ZC4H2|0:KPNA4|0:WDR61|0:PKIG|0:PPIL3|0:SASH1|0:CDC14B|0:HMGN2|0:KIAA0182|0:ALDH16A1|0:HMG20A|0:TUBA1C|0:PIK3R2|0:CAMSAP1L1|0:AKR1B1|0:BZW2|0:CELF2|0:PDXDC1|0:KRTAP9-2|0:CRMP1|0:DPEP1|0:SP3|0:RNPS1|0:SLC25A10|0:C17orf81|0:SPSB4|0:ZNF32|0:PRKCQ|0:TIRAP|0:LYZ|0:PPP1R11|0:METTL13|0:TBRG4|0:MLL2|0:SNX12|0:UBE2U|0:SPHKAP|0:TDRD7|0:TSSK2|0:DKKL1|0:WDYHV1|0:AKR1A1|0:RRP15|0:RSL1D1|0:IFITM1|0:ZBTB25|0:NAA11|0:HGFAC|0:CTTNBP2NL|0:RPRM|0:PPP2R3A|0:BAT2|0:RNF123|0:SIK1|0:TCOF1|0:SLC16A1|0:SF3B3|0:TRMT61A|0:PPP1R7|0:MAGEB2|0:ZNF652|0:OAT|0:ANKS1A|0:CCDC59|0:MED20|0:CHMP4A|0:RPL36A|0:DUSP7|0:UBE2E3|0:RAB8B|0:MED29|0:CCDC50|0:SMPD4|0:WDR8|0:MTHFR|0:DACH1|0:PLK3|0:KDM5C|0:MRPS34|0:DAP3|0:UHRF2|0:EFHD1|0:TSEN15|0:TUBA3C|0:PIGR|0:RCOR3|0:GTF3A|0:ISOC2|0:SIGLEC14|0:RAB26|0:EVI5|0:GET4|0:HSPA4L|0:CENPO|0:PBRM1|0:NEK7|0:CCDC45|0:CCDC120|0:TTC25|0:MYOF|0:QPCTL|0:PRUNE|0:CDC42BPG|0:EPRS|0:RAB6B|0:TTBK1|0:INTS10|0:CYTH2|0:GPR45|0:ACCN2|0:OPRL1|0:TULP4|0:CCKBR|0:OCIAD1|0:DYNC1I2|0:SKIV2L|0:MRPL44|0:UBE4A|0:EIF2C1|0:SH2D4A|0:KRT2|0:BLOC1S1|0:TYROBP|0:PDE2A|0:TUBB2A|0:RPL36|0:AFF2|0:ACTL6B|0:PRG4|0:NFASC|0:LONRF3|0:C14orf102|0:HNRPDL|0:DENR|0:RASGRP1|0:GP9|0:FBXW5|0:SERPINB4|0:SRPK2|0:RWDD1|0:RHOB|0:NEU4|0:SLC27A4|0:HSPBP1|0:CD19|0:CHIC2|0:FBXO41|0:TGOLN2|0:EDC4|0:BCAS1|0:STAP2|0:ALPI|0:RAB5C|0:APOBEC3C|0:ZCCHC8|0:ARHGEF1|0:OPRM1|0:AQP5|0:GMCL1L|0:LRRC3|0:FAM124B|0:CTBP2|0:DDX23|0:AUP1|0:HNRNPA3|0:RNMTL1|0:SART3|0:VPS24|0:FDXR|0:PAX3|0:DUSP15|0:SF3B4|0:HIATL1|0:NUMA1|0:NAA25|0:C1orf94|0:HNRNPH2|0:KRT85|0:CAST|0:SCNM1|0:VDAC2|0:BET1|0:KRT32|0:PFKP|0:UBAC1|0:MON1B|0:COL4A5|0:LYAR|0:SNX33|0:ARL6IP1|0:CTAGE5|0:UBA1|0:ECH1|0:TRAF5|0:SMUG1|0:UFM1|0:ORM1|0:LCMT1|0:SRSF11|0:SNX19|0:XRN2|0:COG1|0:PSMD11|0:BAT5|0:LSM4|0:MTX1|0:KDM2A|0:PILRA|0:ZNF655|0:NEU1|0:TRMT6|0:KCNA4|0:RBBP6|0:TJP3|0:CASP5|0:BRD4|0:RGS20|0:LXN|0:TFE3|0:C11orf17|0:HIST1H3E|0:XIAP|0:GPS1|0:RPS29|0:MKLN1|0:NF1|0:MAP4K3|0:KDELR1|0:BEGAIN|0:FOXRED1|0:ANP32A|0:ACLY|0:FLI1|0:ELL|0:CDH11|0:PHYH|0:NELL2|0:SPNS1|0:SH3GL1|0:TNFAIP3|0:TESK1|0:SEC61A1|0:ZMYND10|0:SLC22A3|0:PROC|0:ZDHHC17|0:KDM4A|0:RAGE|0:ZDHHC7|0:BLMH|0:PNMA2|0:TFB1M|0:GOLGB1|0:NFKBIL1|0:C10orf62|0:SERTAD4|0:HDHD3|0:C19orf70|0:TNPO1|0:ATP5G3|0:EML4|0:SGTA|0:PSMD6|0:HIST1H2BI|0:RPL28|0:BIN2|0:HM13|0:CCDC136|0:PRX|0:HHLA3|0:ID2|0:ZER1|0:PDE4DIP|0:CBWD2|0:KIF3A|0:PDIA6|0:EHD1|0:ZNF496|0:TRAF3IP3|0:EIF2B1|0:GSTZ1|0:CELSR2|0:STAM2|0:PTPRJ|0:PLEKHJ1|0:MLKL|0:PLA2G16|0:KRT35|0:CPE|0:POLR3F|0:RAB10|0:LY6D|0:EIF3I|0:COMMD6|0:MT2A|0:HSD17B14|0:ZFAND2B|0:SAMD4B|0:USP39|0:CRB1|0:CTTN|0:HDLBP|0:PSPH|0:CDC25A|0:USP29|0:TPD52L2|0:FBXW8|0:PTPLAD1|0:DERA|0:ABL2|0:PTPRZ1|0:PDLIM7|0:SNIP1|0:TIMP3|0:RAC2|0:PRICKLE3|0:YIPF4|0:CCDC141|0:RPL7L1|0:TBC1D5|0:C19orf25|0:C8orf48|0:BCL9|0:FAM40A|0:STAT4|0:ZMYND8|0:ETS2|0:BCL2L2|0:OLFM1|0:TRIM37|0:IFITM2|0:ARNTL2|0:PITPNA|0:PRPF4B|0:SLC25A22|0:MRPS7|0:TFPT|0:AP4B1|0:MED11|0:DBT|0:RFX1|0:LGALS3BP|0:HOXA10|0:LZTS1|0:EGLN1|0:RWDD3|0:DYDC2|0:DUSP1|0:CD97|0:GRHPR|0:SEMA7A|0:PCID2|0:SMEK1|0:VDAC3|0:DHX37|0:FCHSD2|0:RRP1B|0:EEF1B2|0:STAT6|0:ASB16|0:MLLT3|0:PLK4|0:SHC3|0:ATAD3A|0:ZRANB2|0:FBXL8|0:MRPL43|0:NCKAP1|0:CNTN3|0:BBS2|0:PCDHA10|0:ARHGAP18|0:CACNB4|0:ATP5L|0:GCC1|0:PREB|0:CDK2AP1|0:CCDC53|0:KIFC2|0:MYCBP2|0:OPRD1|0:GADD45GIP1|0:TEC|0:KIAA1191|0:GPN1|0:TXNDC9|0:KCNIP4|0:PTPRO|0:OTUD7B|0:LIN37|0:MOS|0:UBXN6|0:CIZ1|0:NFKBIE|0:TCEB2|0:PCDHA1|0:RADIL|0:TIMM13|0:EIF4A2|0:RP1L1|0:FAM107A|0:PTP4A1|0:UBE2V2|0:IFT20|0:UHRF1|0:OLA1|0:FAM120B|0:RASGRF2|0:KPNA6|0:NAGK|0:VTA1|0:PNN|0:KIAA1267|0:DDX3X|0:SELENBP1|0:NEK3|0:C6|0:PRSS1|0:CNOT6L|0:S100A9|0:KCNJ2|0:PDHA1|0:TKT|0:DDT|0:PELI2|0:B9D1|0:HTN1|0:AATK|0:ARHGAP21|0:PAPSS2|0:ACSL3|0:SDAD1|0:RPL35|0:IMPDH2|0:ASB13|0:RHOC|0:MKNK1|0:NKD1|0:BCL2L10|0:SLCO2A1|0:FAM98B|0:TICAM2|0:TRIM29|0:RHEB|0:FYB|0:FRA10AC1|0:C16orf48|0:DYNC1H1|0:TMEM33|0:CDC6|0:IMMT|0:MARK3|0:TLE2|0:GPRC5C|0:KRT17|0:DDX24|0:LSM3|0:FTH1|0:PCBP1|0:COL23A1|0:CNDP2|0:DSTYK|0:BAI1|0:SPAG9|0:GAS8|0:RRAS|0:SPSB2|0:GIGYF2|0:SNRPG|0:SF3B2|0:BCAR3|0:SCARF2|0:KRT31|0:PCDHA7|0:PTPN9|0:YES1|0:KRT78|0:EPHB1|0:METAP1|0:KCNQ1|0:BCL2A1|0:ZBTB24|0:CCDC47|0:SRRM1|0:FAM63A|0:SIKE1|0:TTC19|0:CALML5|0:PDIA2|0:EIF5B|0:LEO1|0:AMY1A|0:TFAM|0:MZT2B|0:PLCB4|0:PPP2R5B|0:SPOP|0:FXR2|0:RHOXF2|0:NEK8|0:CRIPAK|0:ANKRD44|0:STIP1|0:CYTIP|0:GCKR|0:SNRK|0:ICA1|0:MX1|0:LOXL4|0:EXOSC4|0:EME1|0:CTAG1B|0:CNOT8|0:USP5|0:MRPS25|0:AHSG|0:C2orf3|0:TNFRSF6B|0:ZKSCAN3|0:CDKL5|0:BMX|0:HOXC8|0:CWC15|0:PSMB3|0:RPS25|0:ORC4|0:GYG1|0:SULT2B1|0:HEATR2|0:HSPB9|0:PPM1D|0:SPC24|0:GNPTG|0:LTA4H|0:MAGEA4|0:SOS1|0:EHF|0:RFX5|0:KLC4|0:MRPS14|0:ZNF277|0:MAGEB18|0:PSMC2|0:ALK|0:GAN|0:TMEM222|0:EDC3|0:SFSWAP|0:BAT2L1|0:PRKD3|0:ZNF707|0:PTRH1|0:ARF1|0:CYP4F8|0:KIAA0174|0:FBXW2|0:DLX4|0:MYT1|0:PIK3R3|0:KCNB2|0:USP13|0:KSR1|0:FBLN1|0:AFF4|0:NACAP1|0:RGS7|0:SRGAP2|0:BEND7|0:NUDT14|0:MRPS22|0:AGPAT4|0:SPINK7|0:NOC2L|0:CRTC2|0:C1orf77|0:HNRNPUL1|0:VSIG4|0:GBA|0:PNRC1|0:VDAC1|0:RGR|0:C20orf46|0:SNX20|0:HSDL1|0:HNRNPH3|0:KRT81|0:SMYD2|0:PDCD2|0:RPF2|0:UBE2D1|0:SEC23A|0:TPSAB1|0:NCKAP5|0:MAPKAPK5|0:MAP2K5|0:NPEPPS|0:HTR1B|0:CAPRIN1|0:NIN|0:ACAT2|0:TROVE2|0:UBE2E1|0:RAB3IL1|0:SRPRB|0:UBAP2L|0:MLST8|0:TCEAL5|0:RPL27A|0:LAS1L|0:POLR2H|0:ITM2A|0:PCDHA3|0:RPL23|0:GBF1|0:REL|0:CSN1S1|0:C19orf57|0:NT5C2|0:AKAP13|0:AP1M2|0:NOLC1|0:CAB39L|0:CLEC4G|0:KRT10|0:CNP|0:BRF2|0:ZNF330|0:CLUAP1|0:KDM5D|0:FANCE|0:SNRNP40|0:MUTED|0:GATAD2B|0:RPS14|0:TRPC3|0:EIF2C4|0:EAF2|0:GRIP2|0:ZHX3|0:PDCL3|0:GP1BA|0:DDB1|0:XAB2|0:CRYGC|0:TEK|0:PDCD4|0:CCNY|0:EXOSC7|0:GYPC|0:CHFR|0:FUS|0:RICTOR|0:RP9|0:KISS1R|0:HUS1|0:ATP7B|0:POLD2|0:HIST1H4I|0:DCTN1|0:LIN28B|0:SNCAIP|0:HIST1H4L|0:NUP85|0:THOC7|0:ERCC8|0:PHF12|0:PIGT|0:TDP1|0:ZFYVE9|0:WIBG|0:SEPT7|0:HIST1H4B|0:INTS7|0:HNRNPH1|0:BMF|0:RB1CC1|0:EIF4E|0:PRMT5|0:ACR|0:BIRC6|0:KLHDC3|0:AKT2|0:ZHX2|0:OBFC1|0:KCNG3|0:PPP2R2A|0:RBBP7|0:CDC45|0:ARF5|0:SLC3A2|0:MED15|0:IRF2|0:TOMM70A|0:RNF139|0:ADAM8|0:PTGFRN|0:C19orf61|0:KDM2B|0:IL28RA|0:VAMP7|0:KCNMB4|0:PDK3|0:TPR|0:SERPINA3|0:DTNA|0:PARD6B|0:SDHA|0:NCLN|0:FANCD2|0:FZR1|0:ESPL1|0:ERBB4|0:ARVCF|0:SLX1B|0:GTF2E1|0:STAG2|0:SSX2|0:SKP1|0:EZH2|0:PI4KA|0:SRSF2IP|0:PIK3C3|0:GDI1|0:EFTUD2|0:VIPAR|0:UFD1L|0:CRHR2|0:EGR1|0:CD58|0:MOCS3|0:C17orf71|0:CPSF3|0:SILV|0:PPP2R5C|0:MAD1L1|0:FBXO5|0:MTCH1|0:TNKS|0:SCAMP5|0:RBL2|0:LCA5|0:TOM1|0:RFC4|0:GNB2|0:NUP50|0:LEMD3|0:F8|0:CASP3|0:SKA3|0:PIK3R4|0:PPP1R2|0:SERGEF|0:DEDD|0:PILRB|0:CDYL2|0:CRYGD|0:NUBP1|0:DSCAM|0:MBNL1|0:NUP160|0:NTN1|0:CEP76|0:NGLY1|0:NCBP2|0:ATRIP|0:PAX8|0:SLC2A4|0:NOMO2|0:C3orf57|0:FBXW11|0:AKT1S1|0:SAP30BP|0:SETD7|0:HOXB9|0:CIRBP|0:SCRIB|0:CDC42SE2|0:ANK3|0:MT1H|0:DSN1|0:PPFIA4|0:DLAT|0:APLF|0:NOTCH3|0:FAM58A|0:CLPP|0:CDKN3|0:GAD1|0:NPC1|0:ATP2B1|0:IGF2BP1|0:G3BP1|0:RBM15|0:PAIP1|0:PPP1R13B|0:TOP3A|0:HIST1H4E|0:BBC3|0:ARL4A|0:USE1|0:DSCC1|0:KNTC1|0:LAIR1|0:SERPING1|0:ADI1|0:LRRC4C|0:ERLIN2|0:EIF3M|0:SAC3D1|0:CSRP3|0:NEDD4L|0:PARK7|0:KRT8|0:SFTPD|0:DNMT3A|0:DEPDC6|0:PRMT1|0:PIM3|0:GEMIN4|0:CTU2|0:LIMS1|0:DERL2|0:ACAN|0:PIGK|0:CD86|0:INTS12|0:CHD1L|0:WWP1|0:STAT1|0:MRFAP1|0:MS4A3|0:EFEMP1|0:RAB24|0:GGT1|0:IGF2BP2|0:USP46|0:SPI1|0:SDHAF2|0:BNIP1|0:NPHS2|0:TCEB1|0:TAX1BP3|0:CCNT1|0:MAPK8|0:RBBP8|0:ZFYVE28|0:MYCN|0:GSPT1|0:TMEM97|0:KRT18|0:MZF1|0:DCPS|0:NUP107|0:MYOZ3|0:RFX6|0:TAF3|0:EMILIN2|0:ZCCHC11|0:APH1B|0:GABRG2|0:CD47|0:NUP205|0:PHB|0:POU2F1|0:DHX58|0:TREML1|0:AMOT|0:HAP1|0:SOX2|0:AGFG1|0:C19orf40|0:NUP214|0:DPYSL2|0:RFC3|0:ILF2|0:NOM1|0:PAIP2|0:SNRNP70|0:GEMIN8|0:HIST2H4A|0:EIF2B3|0:RPA2|0:NUP153|0:PTPRB|0:IRF6|0:PSMG2|0:NR3C1|0:AASDHPPT|0:TEAD2|0:SGOL1|0:AKTIP|0:THOC1|0:ACO1|0:MAT2B|0:CSNK1D|0:TP53BP1|0:SLC7A8|0:EFCAB4B|0:UBE2G2|0:HBXIP|0:NIP7|0:PML|0:BCL2L11|0:C17orf68|0:KCNS1|0:RAP1B|0:TRIM21|0:NLRC5|0:GNAQ|0:HECTD3|0:SPC25|0:VAMP3|0:SCAMP1|0:NECAB3|0:FYTTD1|0:HFE|0:DTL|0:INTS4|0:NAF1|0:BCCIP|0:NEDD9|0:MAD2L1BP|0:LSM1|0:LMX1B|0:RPUSD4|0:MKI67IP|0:TRPC4AP|0:APITD1|0:UBE2D2|0:NCAPG|0:MAD2L2|0:RPS6KB1|0:TOP1|0:SLC15A2|0:NMNAT1|0:ITGA3|0:RFX3|0:FANCC|0:UBE2L6|0:STAT5A|0:KIF14|0:TENC1|0:NDUFA13|0:CD151|0:APBA2|0:TRAM2|0:RNF7|0:FIS1|0:NOTCH2|0:NUB1|0:FBXL5|0:NRXN1|0:IL10RB|0:MATN4|0:UPF1|0:PES1|0:PABPN1|0:KIF23|0:ABCD3|0:FIG4|0:PAM|0:NUTF2|0:XPO6|0:GP1BB|0:CDON|0:MMP14|0:APPL2|0:RAB6A|0:ZSCAN21|0:PRC1|0:MEOX2|0:MPP6|0:CHEK2|0:PTPN6|0:BAHD1|0:CACNB2|0:MAP3K4|0:INTS2|0:MECOM|0:RNH1|0:MIS12|0:RNF10|0:MAGOH|0:HIST1H4H|0:TBRG1|0:GTF2E2|0:CCNF|0:ZHX1|0:POLD1|0:POM121C|0:WRNIP1|0:ALAS2|0:NXF5|0:HIST1H4A|0:NDUFS3|0:STMN2|0:MAP2K3|0:ZNF675|0:GEMIN5|0:TNIK|0:KLK6|0:NUBP2|0:RECQL|0:MCRS1|0:MOBKL1B|0:NFATC1|0:NAPG|0:DPH3|0:MUC16|0:SLC25A5|0:PRKCI|0:TRMT112|0:CCDC99|0:TRAF3|0:TBXA2R|0:DCLRE1B|0:TP73|0:RUNX1|0:IREB2|0:ARIH2|0:SMARCA5|0:DGKZ|0:ANK2|0:SUMO3|0:ORAI1|0:RUVBL1|0:MATN3|0:ITPR1|0:TRIM27|0:SNX2|0:RBX1|0:CD9|0:CASP7|0:BUB1|0:SUV420H2|0:CD163|0:CDK9|0:NME2|0:ORC2|0:HNRNPF|0:TUBGCP2|0:TNPO3|0:DCUN1D1|0:ATP6V1H|0:XPO1|0:NR5A2|0:TUBG1|0:CTDSP1|0:FBL|0:GDI2|0:SIRT3|0:HIST4H4|0:FBXO4|0:MLH3|0:COPB1|0:MBD3|0:DDX58|0:CDC34|0:SEPT1|0:PPIE|0:LPAR1|0:TESC|0:E2F3|0:RPS6KC1|0:ATG14|0:GLS2|0:CDCA8|0:UTP20|0:ADAM12|0:CSPG4|0:GJD3|0:KRT1|0:INTS6|0:MAPK12|0:BOP1|0:FABP5|0:RPLP1|0:TRAM1|0:NUP37|0:ARIH1|0:KIF2A|0:FXN|0:ZNF711|0:TAB1|0:ASAP2|0:SSRP1|0:RAD1|0:FANCA|0:FRMPD4|0:SEC13|0:RBM26|0:EIF2B2|0:REPS2|0:USP11|0:BCS1L|0:BCL6|0:ZIC3|0:ATP6V1E1|0:NLGN3|0:TIMP1|0:MAVS|0:SMG1|0:SPINK9|0:PPP1CA|0:DOC2A|0:COPS6|0:RCOR1|0:TRPC5|0:PRSS2|0:SLC25A17|0:MCM7|0:HIST1H4D|0:PSMG1|0:KRT20|0:GOLGA2|0:FBXW7|0:LUC7L3|0:KRT19|0:TIPRL|0:GLI2|0:MAP1LC3A|0:PPP6C|0:CFLAR|0:WDR48|0:IFIH1|0:BOC|0:EXOC7|0:INADL|0:GLB1|0:USP28|0:SEPT6|0:PARP9|0:CYFIP2|0:INSIG1|0:PDE4A|0:ZBTB17|0:CNPY2|0:NDUFAF3|0:NOSIP|0:FASN|0:ZNF219|0:CNOT4|0:BTRC|0:TEAD3|0:AICDA|0:NOP2|0:BNIP2|0:SUN1|0:ZW10|0:SNRPE|0:MORF4L2|0:UBE2M|0:LYST|0:DES|0:RAD52|0:MPP1|0:SMN2|0:NSL1|0:ZFYVE20|0:OBFC2B|0:SMPDL3A|0:NXF1|0:SEC22B|0:CLTC|0:COL13A1|0:LMTK2|0:UFC1|0:INTS3|0:PHF17|0:NUP98|0:ITGB1BP1|0:DLG2|0:KRIT1|0:PTPRD|0:RBP4|0:DDRGK1|0:CLIC3|0:KLK13|0:TRIM13|0:SYMPK|0:CASC5|0:TSHZ3|0:CRBN|0:NCBP1|0:ELF2|0:PKM2|0:PPFIA1|0:MLANA|0:RPS7|0:PEX19|0:SYVN1|0:ALKBH8|0:TXN|0:ATP6V1D|0:DDR1|0:UBE3C|0:MYST2|0:NUP43|0:ZGPAT|0:MAL2|0:IRAK1|0:SCYL3|0:TERF2IP|0:CDK8|0:NTHL1|0:CBLL1|0:TAF12|0:SLX1A|0:LTBR|0:IGSF8|0:EIF4E2|0:TTC3|0:MUC2|0:WDR16|0:SIRPG|0:CASP1|0:HOXA5|0:NUP133|0:ELF1|0:GEMIN6|0:HS3ST5|0:MFI2|0:EIF3H|0:PSMA5|0:FBXO7|0:RHO|0:CSNK1E|0:RNF167|0:DPM1|0:TNK1|0:RAD9B|0:DZIP1|0:FANCM|0:RPS3A|0:TIMM23|0:ATP2B4|0:RAB22A|0:RUNX2|0:ZFYVE16|0:ASH2L|0:STRA13|0:EXO1|0:ADCY4|0:SEPT11|0:APBA3|0:NLRP12|0:NFU1|0:SESTD1|0:LY96|0:C17orf106|0:RBMS1|0:COG7|0:MYB|0:LPP|0:RNF41|0:THOC5|0:TTF2|0:PSMA1|0:ACACA|0:CHEK1|0:PPP1R8|0:GOLPH3|0:DHDDS|0:N4BP2|0:SIRT4|0:ATG4B|0:CBR4|0:RPS13|0:PRKAA1|0:RNF103|0:ABCD2|0:POLA1|0:NDUFS2|0:ANXA6|0:SHANK1|0:EIF5A2|0:SEPT9|0:N6AMT1|0:WDR4|0:VPS33B|0:CENPA|0:ATG13|0:DKC1|0:DAZ1|0:FRMPD2|0:HIST1H4K|0:SIGIRR|0:ACSS1|0:SEPT4|0:MOV10|0:PECAM1|0:PEX2|0:NCS1|0:LYN|0:SNX27|0:TPP1|0:APH1A|0:RNF144B|0:DDX6|0:KLK5|0:SHFM1|0:SSX2B|0:ADH1A|0:EIF3L|0:NFATC2|0:CDKN1C|0:AQP1|0:WDR5|0:ORAI2|0:ATP6V0D2|0:SNX1|0:RBM8A|0:KCNB1|0:FBXO45|0:SIX1|0:C9orf80|0:IFT57|0:LMNA|0:TRPS1|0:TXNDC17|0:USP44|0:PTPN13|0:PPP4R4|0:URM1|0:EEF1G|0:INCENP|0:FAM21C|0:HBA2|0:RAB7A|0:PMS2|0:BIRC3|0:VPS33A|0:GAPDHS|0:CYCS|0:NDUFS1|0:CASP6|0:PIKFYVE|0:A1CF|0:DCP1A|0:CLN5|0:TRA2B|0:SCUBE3|0:GATA6|0:CABP1|0:AVEN|0:GUCY2C|0:DDX39|0:FCGBP|0:HSPA8|0:COG3|0:AGGF1|0:ATP1A1|0:AURKB|0:DISC1|0:CLTCL1|0:NOP10|0:RABGEF1|0:MAP1LC3B|0:AURKAIP1|0:PLIN3|0:ATXN7|0:CNOT7|0:NKAP|0:NAA15|0:PEX11B|0:INTS5|0:TEAD4|0:BUB3|0:VPS35|0:SIRT7|0:HECTD1|0:RPS6|0:GLRA1|0:FNIP2|0:GADD45A|0:C15orf42|0:STIM2|0:DHX8|0:EIF3A|0:PPFIA2|0:AP1B1|0:APOD|0:COPS3|0:NTNG1|0:GFER|0:DDX1|0:CASP9|0:MAP3K7|0:USP12|0:RAB9A|0:NFKB1|0:WRAP53|0:RBM15B|0:SREBF1|0:UBTF|0:KIAA0427|0:CLTB|0:RBM25|0:TSHR|0:MUM1|0:NHLRC1|0:EYA2|0:FANCG|0:BCL2L14|0:SPINK1|0:TIA1|0:SPTLC1|0:VPS26A|0:SEPT5|0:UBE2F|0:DICER1|0:CENPH|0:ZNHIT1|0:C14orf147|0:LSM10|0:KCTD5|0:RAB21|0:MSX2|0:PIM1|0:SLBP|0:AP2M1|0:UNC13D|0:WARS|0:AP1M1|0:PDPK1|0:REV1|0:ZNF217|0:HIRIP3|0:NDOR1|0:ERLEC1|0:C7orf27|0:PRSS3|0:PBK|0:EXOSC5|0:C19orf62|0:CST5|0:FAF2|0:ADA|0:ETF1|0:SEL1L|0:TGM1|0:OGT|0:SLC11A2|0:NPHP4|0:TAF6|0:RBCK1|0:PNRC2|0:CSTF2|0:SENP2|0:KIR2DL3|0:FOXRED2|0:PEA15|0:SNAP23|0:CEP97|0:UBA6|0:CALU|0:INTS9|0:TMEM173|0:PRKD1|0:ETS1|0:TRIM44|0:TRAF1|0:RAD17|0:SMN1|0:RBBP5|0:APOA1BP|0:HSD17B8|0:RAD21|0:SNRPB|0:NLGN4Y|0:CLNS1A|0:LIG3|0:SUCLA2|0:CDHR2|0:HBA1|0:ATP5F1|0:LDB3|0:HIST1H4J|0:MET|0:TNS3|0:TEAD1|0:ATXN10|0:RUNX3|0:NOL8|0:RBM17|0:SIP1|0:RAD23B|0:KLK8|0:ING5|0:TJAP1|0:LIMD1|0:PTRF|0:DOHH|0:COL7A1|0:NFYA|0:RNF182|0:ELAVL2|0:EIF2S1|0:XPO4|0:MCM10|0:ELF4|0:NCSTN|0:CCDC85B|0:VPRBP|0:FAM160A2|0:CLIC5|0:KIAA0776|0:XRCC1|0:NDC80|0:MUS81|0:IL1RAPL1|0:NKX2-1|0:SRSF3|0:RALB|0:KIR2DL1|0:FOXG1|0:YBX1|0:ATP6V1F|0:SPAG5|0:RPS10|0:TLE3|0:PACS1|0:TRIM17|0:STAG1|0:DIABLO|0:RBM5|0:MCM2|0:MCC|0:TAB3|0:ATG12|0:MASP1|0:MIA3|0:CNOT3|0:MLH1|0:MKS1|0:KISS1|0:MAGED1|0:HNRNPU|0:AKT3|0:CPSF2|0:AGR2|0:METTL1|0:ELP4|0:ZNF473|0:SDHB|0:YOD1|0:HMOX2|0:DBNDD2|0:ITGB4|0:MYO6|0:SKP2|0:PAX9|0:LETM1|0:LIPE|0:CCM2|0:INTS8|0:BAG1|0:ORMDL3|0:MAPK9|0:DLG3|0:TIGIT|0:CD27|0:PEX13|0:PKP4|0:NAA10|0:ATP1B2|0:COL4A3BP|0:EDF1|0:GTF2H4|0:DCAF7|0:EIF3F|0:LENG8|0:NUMBL|0:RNF5|0:STATH|0:FBXO44|0:DHX9|0:KRT14|0:INSIG2|0:LATS2|0:EXOSC1|0:SLX4|0:UBE2C|0:RPL5|0:DHPS|0:BOLL|0:DAZL|0:DBC1|0:PEX3|0:FEN1|0:FANCI|0:ZNF256|0:ACAA1|0:FRK|0:CHD4|0:IKBKE|0:MATN1|0:PPP4C|0:CD48|0:MLLT10|0:IFI35|0:GLRB|0:CTU1|0:C20orf94|0:TCF7|0:GTF3C1|0:DCTN2|0:HIST1H4C|0:HNRNPL|0:NOTCH1|0:ATPAF2|0:USP1|0:CSTF1|0:IGF2BP3|0:GPR143|0:DDB2|0:RING1|0:MSH6|0:LLGL2|0:KIR2DL4|0:ORAI3|0:RAB3A|0:GCK|0:CELF1|0:PPFIA3|0:POLDIP3|0:PKHD1|0:WDR12|0:TRAF2|0:HCK|0:NPRL2|0:COG4|0:RAB9B|0:ETV7|0:HNRPLL|0:GAD2|0:PSMD2|0:RASSF9|0:ERC2|0:PCBD2|0:PSEN2|0:LCMT2|0:CLIC1|0:TREML2|0:POLD4|0:CREM|0:ECT2|0:NR3C2|0:TMEM102|0:SERPINB8|0:SRSF7|0:GTF2H1|0:FLCN|0:AMFR|0:THOC4|0:PDLIM4|0:HIST2H4B|0:CPSF6|0:EYA3|0:RFC1|0:GZMB|0:MPP5|0:ERLIN1|0:KRT7|0:DLGAP5|0:RAD51AP1|0:SETD1A|0:KIRREL3|0:KIAA0226|0:RPL11|0:CD164|0:DNM1L|0:GAPDH|0:MGRN1|0:ACOT8|0:RPS9|0:DERL3|0:VAMP2|0:RNF135|0:CTNND2|0:SERPINB5|0:SYNE2|0:LDHD|0:ALOX5|0:ARHGEF7|0:NPHP1|0:SYT2|0:ZNF148|0:THOC2|0:VAMP1|0:CDKN1B|0:TAF2|0:DCTN3|0:ZWILCH|0:ZNF639|0:RGS19|0:OGG1|0:TUBA1B|0:DDX42|0:SLC22A11|0:RAF1|0:SNX4|0:COPS2|0:SNRPD1|0:ITGAV|0:ZRANB1|0:ATG5|0:ECSIT|0:RNF115|0:TINF2|0:SCEL|0:ILF3|0:FBN1|0:SEMA6A|0:EIF4G1|0:SORCS1|0:DNM3|0:GIT1|0:LSM11|0:ODF2|0:CD80|0:BRIP1|0:GSPT2|0:EIF4A1|0:RPA1|0:GEMIN7|0:ATPAF1|0:HIST1H4F|0:PIGS|0:TTYH2|0:USP26|0:CD81|0:ADAP1|0:NXF3|0:HSF1|0:BAP1|0:BUB1B|0:SEPT8|0:PEX10|0:KLC1|0:HHIP|0:SPRR3|0:SCAMP2|0:SGOL2|0:BECN1|0:SYNPO|0:RBMY1B|0:NDUFS7|0:SPRR2E|0:VAV1|0:RAB8A|0:SNRPD2			
GO:0051977	P:lysophospholipid transport; IDA:MGI		0:PLA2G10			
GO:0009452	P:RNA capping; IEA:InterPro		0:TGS1			
GO:0000777	C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell		0:SPC25|0:BUB1|0:HJURP|0:NUP85|0:SEPT7|0:SEPT2|0:TPR|0:SMC1A|0:MAD1L1|0:KNTC1|0:NUF2|0:NUP107|0:SGOL1|0:TP53BP1|0:CSNK1A1|0:CENPV|0:SS18L1|0:DYNC1LI1|0:CENPK|0:ERCC6L|0:RANGAP1|0:NUP37|0:ZWINT|0:CENPE|0:SEPT6|0:ZW10|0:CASC5|0:NUP43|0:MAD2L1|0:NUP133|0:AHCTF1|0:NDE1|0:CLASP1|0:DYNLT3|0:NEK2|0:CENPN|0:INCENP|0:BUB3|0:CENPT|0:CENPH|0:CENPO|0:KIF2B|0:MLF1IP|0:SPAG5|0:NDEL1|0:SEH1L|0:DYNC1I1|0:CENPM|0:BOD1|0:SPC24|0:DCTN3|0:ZWILCH|0:PPP1CC|0:KIF2C|0:CLASP2|0:SGOL2|0:CENPC1			
GO:0007411	P:axon guidance; TAS:UniProtKB		0:PLA2G10|0:OTX2|0:TUBB3|0:CDK5R1|0:GLI2|0:USP33|0:SHH|0:RELN|0:C1orf187|0:TNR|0:NTN3|0:SEMA6A|0:DPYSL5|0:FEZ2|0:OPHN1|0:NRXN1|0:UNC5C|0:FEZ1|0:KAL1|0:NRP1|0:NRP2|0:SEMA3B|0:SIAH1|0:SPON2|0:NRXN3|0:CNTN4			
GO:0005776	C:autophagic vacuole; ISS:UniProtKB		0:GABARAPL1|0:ATG5|0:ULK1|0:ATG14|0:AMBRA1|0:NBR1|0:CLN3|0:ATG16L1			
GO:0030348	F:syntaxin-3 binding; IPI:UniProtKB		0:STXBP2			
GO:0018205	P:peptidyl-lysine modification; ISS:UniProtKB		0:ATP7A			
GO:0032006	P:regulation of TOR signaling cascade; IDA:UniProtKB		0:AGPAT9			
GO:0006936	P:muscle contraction; TAS:UniProtKB		0:SORBS3|0:CALM2|0:TPM4|0:VCL|0:ACTG2|0:MYL9|0:CALD1|0:TLN1|0:MYL12B|0:MYLK|0:LMOD1|0:CALM3|0:TPM3|0:ITGB5|0:PXN|0:TPM2|0:ITGA1|0:CALM1|0:CHRNB1|0:GLRA1|0:KCNIP2|0:MYH8|0:ANKRD2|0:TACR2|0:SLC6A8|0:HCN4|0:HRC|0:CKMT2|0:SCN4A|0:MYOM2|0:UTS2|0:OXTR|0:CACNA1H|0:KCNJ12|0:FXYD1|0:SNTB1|0:TMOD4|0:STBD1|0:GAMT|0:SGCA|0:SCN5A|0:PABPN1|0:CRYAB|0:P2RX6|0:RYR1|0:CLCN1|0:SSPN|0:CHRNG|0:DES|0:LTB4R|0:CHRND|0:VIPR1|0:SLMAP|0:SNTA1|0:GJC1|0:FLII|0:HCN2|0:EMD|0:GNAO1|0:KCNH2|0:MYOF|0:KCNE2|0:SLC8A1|0:GALR2|0:SCN7A|0:CACNG1|0:CHRNE|0:KCNE1|0:MYOT|0:ASPH|0:UTRN|0:KCNQ1|0:GJA5|0:GJA1|0:TRDN|0:MYH13|0:ACTA1			
GO:0003918	F:DNA topoisomerase (ATP-hydrolyzing) activity; IEA:InterPro		0:TOP2A|0:TOP2B|0:TOP1|0:TOP1MT			
GO:0006662	P:glycerol ether metabolic process; IEA:InterPro		0:TXN2			
GO:0001515	F:opioid peptide activity; IEA:UniProtKB-KW		0:PDYN|0:PENK|0:PNOC			
GO:0033270	C:paranode region of axon; ISS:BHF-UCL		0:CNTNAP1			
GO:0070830	P:tight junction assembly; NAS:UniProtKB		0:FRMPD2|0:PARD3|0:APC|0:STRN			
GO:0043932	P:ossification involved in bone remodeling; IEP:BHF-UCL		0:TGFB3|0:TGFB1			
GO:0048048	P:embryonic eye morphogenesis; ISS:BHF-UCL		0:RARG			
GO:0005811	C:lipid particle; TAS:ProtInc		0:CAV1|0:STARD13|0:PLIN5|0:PITPNM1|0:SIGMAR1|0:METTL7A|0:PLIN3|0:FAF2|0:PLIN4|0:PNPLA2|0:EHD1|0:ABHD5|0:PLIN1|0:PLIN2			
GO:0000002	P:mitochondrial genome maintenance; TAS:ProtInc		0:MPV17|0:SLC25A4|0:TYMP			
GO:0004751	F:ribose-5-phosphate isomerase activity; NAS:UniProtKB		0:RPIA			
GO:0005683	C:U7 snRNP; IDA:UniProtKB		0:SNRPD3|0:SNRPF|0:SNRPE|0:LSM10|0:SNRPB|0:SNRPG|0:LSM11			
GO:0014034	P:neural crest cell fate commitment; ISS:BHF-UCL		0:WNT8A			
GO:0030379	F:neurotensin receptor activity, non-G-protei...; IDA:BHF-UCL		0:SORT1			
GO:0000087	P:M phase of mitotic cell cycle; TAS:ProtInc		0:MPHOSPH9|0:MPHOSPH6			
GO:0001910	P:regulation of leukocyte mediated cytotoxicity; TAS:BHF-UCL		0:ICAM1			
GO:0005487	F:nucleocytoplasmic transporter activity; NAS:UniProtKB		0:NUP160|0:NUP107|0:NUP133|0:UPF3A|0:UPF3B			
GO:0007109	P:cytokinesis, completion of separation; IMP:UniProtKB		0:ANXA11|0:SPAST			
GO:0045518	F:interleukin-22 receptor binding; NAS:UniProtKB		0:IL22			
GO:0030628	F:pre-mRNA 3'-splice site binding; IDA:HGNC		0:SLU7			
GO:0005366	F:myo-inositol:hydrogen symporter activity; EXP:Reactome		0:SLC2A13			
GO:0030512	P:negative regulation of transforming growth ...; TAS:BHF-UCL		0:SMAD7|0:BAMBI|0:PIN1|0:TGFB1I1|0:SMURF1|0:SNX6|0:PEG10|0:EID2|0:SKI|0:LEMD3|0:ASPN|0:NKX2-1|0:SKIL|0:PRDM16|0:SMAD6|0:BCL9L|0:CIDEA|0:ENG			
GO:0042632	P:cholesterol homeostasis; TAS:UniProtKB		0:APOM|0:APOC2|0:APOA4|0:APOE|0:ANGPTL3|0:APOA2|0:ABCG1|0:LCAT|0:ABCA1|0:NPC1|0:TMEM97|0:NPC2|0:ABCA2|0:LDLR|0:ABCG8|0:LIPG|0:CETP|0:LIPC|0:APOC3|0:APOB|0:APOA1|0:ABCG5|0:PCSK9|0:GPIHBP1|0:SCARB1|0:EHD1|0:CAV1|0:CYP7A1|0:CD24|0:MALL|0:LDLRAP1|0:SOAT2|0:SOAT1|0:AKR1C1			
GO:0005853	C:eukaryotic translation elongation factor 1 ...; TAS:UniProtKB		0:EEF1G|0:EEF1B2|0:EEF1D|0:EEF1A1			
GO:0060595	P:fibroblast growth factor receptor signaling...; IDA:MGI		0:FGF10			
GO:0005889	C:hydrogen:potassium-exchanging ATPase complex; TAS:ProtInc		0:ATP12A			
GO:0071167	P:ribonucleoprotein complex import into nucleus; IC:BHF-UCL		0:TGS1			
GO:0017171	F:serine hydrolase activity; IDA:UniProtKB		0:ACHE|0:AADAC			
GO:0048588	P:developmental cell growth; IDA:UniProtKB		0:ARIH2			
GO:0034380	P:high-density lipoprotein particle assembly; ISS:BHF-UCL		0:APOE|0:APOA2|0:APOA1|0:ABCA1|0:APOM			
GO:0009103	P:lipopolysaccharide biosynthetic process; TAS:ProtInc		0:GLT25D1|0:CERCAM|0:CMAS|0:GNE|0:TP53RK|0:GLT25D2|0:NANS|0:ALG1			
GO:0005774	C:vacuolar membrane; IEA:UniProtKB-SubCell		0:VPS4B|0:ATP6V0B|0:ATP6V0C|0:SLC22A17|0:ATP6AP1			
GO:0000703	F:oxidized pyrimidine base lesion DNA N-glyco...; EXP:Reactome		0:NTHL1			
GO:0005123	F:death receptor binding; TAS:ProtInc		0:FEM1B|0:RIPK1|0:MYD88|0:FADD|0:BID|0:MADD|0:CASP8AP2|0:LRDD			
GO:0051604	P:protein maturation; TAS:HGNC		0:HSPD1|0:STUB1			
GO:0051138	P:positive regulation of NK T cell differenti...; ISS:BHF-UCL		0:TGFBR2			
GO:0015012	P:heparan sulfate proteoglycan biosynthetic p...; TAS:ProtInc		0:GLCE|0:NDST1			
GO:0016712	F:oxidoreductase activity, acting on paired d...; IEA:InterPro		0:CYP3A4			
GO:0045818	P:negative regulation of glycogen catabolic p...; IMP:BHF-UCL		0:INS			
GO:0032427	F:GBD domain binding; IPI:BHF-UCL		0:RHOQ			
GO:0004376	F:glycolipid mannosyltransferase activity; EXP:Reactome		0:PIGB			
GO:0060002	F:plus-end directed microfilament motor activity; IDA:UniProtKB		0:MYO3A			
GO:0005686	C:U2 snRNP; TAS:ProtInc		0:PHF5A|0:SNRPB2|0:SNRPA1			
GO:0021516	P:dorsal spinal cord development; ISS:UniProtKB		0:PROX1|0:C1orf187			
GO:0016206	F:catechol O-methyltransferase activity; EXP:Reactome		0:COMT			
GO:0004511	F:tyrosine 3-monooxygenase activity; IDA:UniProtKB		0:TH			
GO:0031424	P:keratinization; IEA:UniProtKB-KW		0:KRT2|0:LCE1E|0:PPHLN1|0:TGM3|0:LCE3C|0:PPL|0:LCE1C|0:HRNR|0:LCE2C|0:TCHH|0:SPRR2D|0:LCE4A|0:SPRR1B|0:LCE1A|0:LCE1F|0:LCE3B|0:LCE6A|0:LCE3E|0:LCE2D|0:LCE2B|0:SPRR2G|0:EVPL|0:LOR|0:SPRR2B|0:LCE3A|0:LCE1B|0:SPRR2F|0:SPRR4|0:CNFN|0:TGM1|0:LCE2A|0:LCE3D|0:SPRR2A|0:LCE5A|0:IVL|0:SPRR1A|0:SPRR3|0:LCE1D|0:SPRR2E			
GO:0000827	F:inositol 1,3,4,5,6-pentakisphosphate kinase...; ISS:UniProtKB		0:PPIP5K1|0:PPIP5K2			
GO:0005085	F:guanyl-nucleotide exchange factor activity; TAS:UniProtKB		0:ARHGAP4|0:TBXA2R|0:ANKRD27|0:RAPGEF6|0:SH2D3A|0:SH2D3C|0:DOCK8|0:RAPGEF1|0:DOCK3|0:RASGEF1C|0:RAB3IP|0:RALGPS2|0:DOCK9|0:RANGRF|0:DOCK11|0:RASGEF1B|0:RGL4|0:RASGEF1A|0:DOCK4|0:RIC8B|0:RALGDS|0:KNDC1|0:TAGAP|0:DOCK7|0:RPGR|0:RIC8A|0:BCAR3|0:DOCK6|0:DOCK1|0:RAB3IL1|0:EIF2B5|0:GAPVD1|0:DOCK5|0:RALGPS1|0:RABIF|0:HERC2|0:RAPGEFL1|0:RASGRP1|0:RAPGEF3|0:PLCE1|0:RASGRP2			
GO:0001892	P:embryonic placenta development; ISS:UniProtKB		0:TFEB			
GO:0033018	C:sarcoplasmic reticulum lumen; IEA:UniProtKB-SubCell		0:HRC|0:CASQ1|0:CASQ2|0:CALU|0:SRL			
GO:0019870	F:potassium channel inhibitor activity; NAS:UniProtKB		0:RASA1			
GO:0014873	P:response to muscle activity involved in reg...; ISS:BHF-UCL		0:AGT			
GO:0006914	P:autophagy; NAS:UniProtKB		0:MAP1LC3C|0:AMBRA1|0:ATG4D|0:RAB24|0:ULK1|0:DRAM1|0:ATG4A|0:TM9SF1|0:TMEM74|0:IRGM|0:MAP1LC3B2|0:FAM176A|0:MAP1LC3B|0:ATG7|0:ATG16L2|0:KIAA0226|0:RGS19|0:CISD2|0:WIPI1|0:GABARAPL2			
GO:0016277	F:[myelin basic protein]-arginine N-methyltra...; IDA:HGNC		0:PRMT7			
GO:0048793	P:pronephros development; ISS:HGNC		0:CEP290			
GO:0010594	P:regulation of endothelial cell migration; IDA:BHF-UCL		0:BMPER			
GO:0048754	P:branching morphogenesis of a tube; ISS:UniProtKB		0:SLIT2|0:GLI2			
GO:0042730	P:fibrinolysis; NAS:UniProtKB		0:GP1BA|0:TMPRSS6|0:F2|0:PLG|0:F12|0:KLKB1|0:PLAU|0:KRT1			
GO:0006006	P:glucose metabolic process; TAS:UniProtKB		0:AIMP1|0:PGM5|0:INS|0:PGM2L1|0:DCXR|0:PGM2|0:IGF2|0:KCNJ11|0:ADIPOQ|0:ALDH5A1|0:PGM1|0:GHRL|0:SLC37A4|0:PPARD|0:PDK3|0:IRS2|0:PDK4|0:BRS3|0:AKR1A1|0:PDK1|0:PDK2|0:SORD			
GO:0006062	P:sorbitol catabolic process; IDA:UniProtKB		0:SORD			
GO:0004504	F:peptidylglycine monooxygenase activity; NAS:UniProtKB		0:PAM			
GO:0002532	P:production of molecular mediator involved i...; IDA:UniProtKB		0:CHIA			
GO:0090263	P:positive regulation of canonical Wnt recept...; IMP:UniProtKB		0:JUP|0:WNT2B|0:WNT3A|0:SFRP1|0:WNT4|0:CSNK1D|0:CAV1|0:WNT2			
GO:0090194	P:negative regulation of glomerulus development; IDA:UniProtKB		0:BMP4			
GO:0016055	P:Wnt receptor signaling pathway; NAS:UniProtKB		0:PPM1A|0:CCNY|0:SLC9A3R1|0:HMGXB4|0:SOSTDC1|0:NDP|0:LZTS2|0:RSPO4|0:PYGO2|0:FBXW11|0:CSNK1G3|0:MESDC2|0:DKK2|0:BRD7|0:TAX1BP3|0:CTNND1|0:WLS|0:CSNK1D|0:CSNK1A1|0:TLE1|0:CYLD|0:CCDC88C|0:PORCN|0:LRRFIP2|0:SFRP2|0:WIF1|0:FZD3|0:PYGO1|0:CALCOCO1|0:TNIK|0:INVS|0:RNF138|0:NKD2|0:KLHL12|0:FZD9|0:CSNK2B|0:DKK4|0:BTRC|0:FRAT1|0:DKK1|0:DACT1|0:CDK14|0:DVL1L1|0:NLK|0:WISP1|0:TLE4|0:CSNK2A1|0:AXIN2|0:FRZB|0:AES|0:RSPO2|0:DISC1|0:DIXDC1|0:WWOX|0:CPZ|0:TCF7L1|0:HHEX|0:CTNNBIP1|0:CSNK1G1|0:TGFB1I1|0:RSPO3|0:FRAT2|0:SFRP4|0:SFRP5|0:SENP2|0:KREMEN1|0:ZBTB33|0:APCDD1|0:HBP1|0:SOST|0:CSNK2A2|0:TLE3|0:MCC|0:CSNK1A1L|0:BCL9|0:CSNK1G2|0:KREMEN2|0:TCF7|0:NKD1|0:TLE2|0:NXN|0:DKK3|0:PIAS4|0:C1orf187|0:APC2|0:FBXW4|0:ZRANB1|0:FAM123B|0:CXXC4|0:STRN|0:CELSR2|0:CD24			
GO:0008089	P:anterograde axon cargo transport; TAS:ProtInc		0:NEFL|0:KIF1B|0:KIF4A|0:KIF3B|0:KIF1A			
GO:0004497	F:monooxygenase activity; IEA:UniProtKB-KW		0:CYP2W1|0:MICAL3|0:CYP4Z2P|0:PTGIS|0:MICAL1|0:MICAL2|0:TBXAS1|0:CYP20A1|0:CYP27C1|0:CYP4V2|0:CYP4F22			
GO:0008534	F:oxidized purine base lesion DNA N-glycosyla...; EXP:Reactome		0:OGG1			
GO:0008263	F:pyrimidine-specific mismatch base pair DNA ...; TAS:ProtInc		0:TDG			
GO:0015276	F:ligand-gated ion channel activity; TAS:ProtInc		0:CNGA3			
GO:0045905	P:positive regulation of translational termin...; IEA:InterPro		0:EIF5A|0:EIF5A2|0:EIF5AL1			
GO:0030307	P:positive regulation of cell growth; TAS:UniProtKB		0:NRG1|0:TGFBR1|0:BCL2|0:N6AMT1|0:PSMD10|0:DERL2|0:SPHK1|0:AKT1|0:SFRP1|0:TGFB2|0:FGFR1OP|0:FXN|0:ADAM17|0:ADAM10|0:CXCL16|0:NOL8|0:ALOX12|0:TAF9|0:TAF9B|0:SFRP2|0:C6orf108|0:INS|0:PRSS2|0:IL2			
GO:0008202	P:steroid metabolic process; TAS:UniProtKB		0:UGT1A8|0:SULT2B1|0:AKR1C2|0:OSBPL9|0:OSBPL6|0:OSBPL11|0:OSBP2|0:OSBPL8|0:OSBP|0:OSBPL10|0:OSBPL3|0:OSBPL7|0:OSBPL2|0:SULT1A1|0:SULT4A1|0:SULT1A2|0:SULT1A3|0:SULT1A4|0:SULT1B1|0:CYP2A6|0:CYP2C19|0:CYP2E1|0:CYP2D6|0:CYP2B6|0:CYP2C9|0:TSPO|0:AKR1B10|0:UGT2B15|0:CYP3A5|0:UGT2B17|0:NR1I2|0:WWOX			
GO:0006754	P:ATP biosynthetic process; TAS:BHF-UCL		0:TGFB1|0:SLC25A13|0:ATP7B|0:ATP13A2|0:ATP2C1|0:ATP13A5|0:ATP1B3|0:ATP2B1|0:ATP9A|0:ATP8A2|0:ATP1A3|0:ATP10B|0:ATP2B2|0:ATP11A|0:ATP13A4|0:ATP13A1|0:ATP1B4|0:ATP2A3|0:ATP8B3|0:ATP2A2|0:ATP11B|0:ATP2C2|0:ATP2B4|0:ATP2B3|0:ATP4A|0:ATP1A1|0:ATP8B4|0:ATP10D|0:ATP2A1|0:KIAA0195|0:ATP12A|0:ATP8B1|0:ATP11C|0:ATP10A|0:ATP1B2|0:ATP4B|0:ATP9B|0:ATP1A4|0:ATP8B2|0:ATP1B1|0:ATP13A3|0:ATP7A|0:ATP1A2|0:ATP8A1|0:ATP5S|0:ALDOA|0:PRKAG2			
GO:0002740	P:negative regulation of cytokine secretion i...; IDA:BHF-UCL		0:TNF|0:APOA2|0:IL10|0:APOA1			
GO:0019605	P:butyrate metabolic process; NAS:UniProtKB		0:ACSM1			
GO:0042701	P:progesterone secretion; IGI:UniProtKB		0:INHBA			
GO:0051856	P:adhesion to symbiont; IMP:BHF-UCL		0:PVRL2|0:ICAM1|0:SCARB1			
GO:0071615	P:oxidative deethylation; IDA:BHF-UCL		0:CYP1A2			
GO:0047305	F:(R)-3-amino-2-methylpropionate-pyruvate tra...; IEA:EC		0:AGXT2			
GO:0032569	P:gene-specific transcription from RNA polyme...; IDA:BHF-UCL		0:GATA6			
GO:0045722	P:positive regulation of gluconeogenesis; TAS:UniProtKB		0:ARPP19|0:PPARGC1A			
GO:0043251	P:sodium-dependent organic anion transport; IDA:BHF-UCL		0:SFRP4			
GO:0060123	P:regulation of growth hormone secretion; IMP:BHF-UCL		0:CHD7			
GO:0001694	P:histamine biosynthetic process; IDA:UniProtKB		0:PRG3			
GO:0042307	P:positive regulation of protein import into ...; IDA:BHF-UCL		0:JUP			
GO:0006853	P:carnitine shuttle; EXP:Reactome		0:CPT2|0:SLC25A20|0:CPT1B			
GO:0051378	F:serotonin binding; IDA:UniProtKB		0:HTR3A|0:HTR1E|0:HTR1F|0:HTR2B|0:HTR2C|0:HTR2A			
GO:0043589	P:skin morphogenesis; ISS:UniProtKB		0:COL1A2|0:COL1A1|0:ERRFI1			
GO:0035575	F:histone demethylase activity (H4-K20 specific); IDA:UniProtKB		0:PHF8|0:JHDM1D			
GO:0006509	P:membrane protein ectodomain proteolysis; TAS:UniProtKB		0:PSEN1|0:PSENEN|0:APH1A|0:PSEN2|0:ERAP1|0:BACE2|0:MYH9|0:PRKCQ|0:NCSTN|0:BACE1			
GO:0004736	F:pyruvate carboxylase activity; EXP:Reactome		0:PC			
GO:0015350	F:methotrexate transporter activity; TAS:ProtInc		0:SLC19A1			
GO:0030049	P:muscle filament sliding; TAS:HGNC		0:TNNT2|0:MYH7|0:MYH6|0:TPM1|0:MYH2|0:MYL1|0:MYH4|0:MYL6B|0:MYL6			
GO:0008052	P:sensory organ boundary specification; ISS:UniProtKB		0:NTF4			
GO:0050880	P:regulation of blood vessel size; NAS:BHF-UCL		0:NPR1|0:HBB|0:NPPA|0:NTS|0:NPPC|0:NPPB|0:GCLM|0:GCLC|0:NOS3			
GO:0016023	C:cytoplasmic membrane-bounded vesicle; TAS:ProtInc		0:DGKD|0:DST|0:HPS1|0:CXCR4|0:USP14|0:FLG|0:ARRB1|0:RIN3|0:CCDC88A|0:DPP7|0:SLA2|0:SGK3|0:AGFG1|0:MAPKAP1|0:TRAF7|0:GRIP1|0:FAM3C|0:ATM|0:NKD2|0:TBC1D2|0:FNBP1L|0:RAB25|0:IFT74|0:ACSBG1|0:HAX1|0:NOSTRIN|0:PTPN23|0:CHIC1|0:RGL4|0:PRSS16|0:ARRB2|0:UQCC|0:WIPF1|0:FNBP1|0:PRDX6|0:RAB37|0:RAB6B|0:CHIC2|0:CORO7|0:SCN8A|0:DUSP16|0:NEU1|0:HERC3|0:SYNGR2|0:PACSIN2|0:KIAA0174|0:GGNBP2|0:DVL1|0:SPERT|0:ABCA2|0:ANP32E|0:ESD|0:ARHGDIB|0:PALM|0:ARHGDIG			
GO:0002429	P:immune response-activating cell surface rec...; IDA:UniProtKB		0:MICB			
GO:0050728	P:negative regulation of inflammatory response; NAS:UniProtKB		0:APOE|0:GHRL|0:GHSR|0:ADIPOQ|0:SAA1|0:SAA2|0:ELANE			
GO:0033130	F:acetylcholine receptor binding; IPI:UniProtKB		0:RAPSN|0:APP			
GO:0008891	F:glycolate oxidase activity; IDA:UniProtKB		0:HAO1			
GO:0005583	C:fibrillar collagen; IDA:UniProtKB		0:LUM			
GO:0055038	C:recycling endosome membrane; IEA:UniProtKB-SubCell		0:SCAMP5|0:SCAMP1|0:RAB11FIP4|0:SLC9A7|0:SLC9A6|0:SCAMP2|0:WASH4P|0:RAB11A|0:RAB11FIP2|0:SLC39A4|0:WASH2P|0:RAB11FIP5|0:WASH1|0:EHD3|0:EHD4|0:SLC26A7|0:SYT5|0:EHD1|0:WASH6P|0:RAB11FIP3|0:WASH3P			
GO:0030479	C:actin cortical patch; IEA:UniProtKB-SubCell		0:INPPL1			
GO:0002576	P:platelet degranulation; IMP:UniProtKB		0:STXBP1			
GO:0048603	F:fibroblast growth factor 2 binding; IDA:BHF-UCL		0:THBS1			
GO:0007080	P:mitotic metaphase plate congression; TAS:ProtInc		0:CDC23|0:PSRC1|0:KIF18A|0:CCNB1|0:CCDC99|0:RRS1|0:ZW10|0:CDCA5|0:SEH1L|0:CENPE			
GO:0009378	F:four-way junction helicase activity; IDA:UniProtKB		0:WRN|0:BLM			
GO:0031074	C:nucleocytoplasmic shuttling complex; NAS:UniProtKB		0:NUP62			
GO:0048669	P:collateral sprouting in the absence of injury; ISS:UniProtKB		0:APP			
GO:0004383	F:guanylate cyclase activity; TAS:ProtInc		0:NPR1|0:NPR2|0:GUCY1B2|0:GUCY2E|0:GUCY2D|0:GUCY1B3|0:GUCY2C|0:GUCY1A2|0:GUCY2F|0:GUCY1A3			
GO:0034618	F:arginine binding; TAS:BHF-UCL		0:NOS3|0:NOS2|0:NOS1			
GO:0042493	P:response to drug; TAS:UniProtKB		0:TGFBR2|0:BCL2|0:HTR2B|0:LCK|0:SLC22A12|0:PNP|0:HTR2C|0:SRP19|0:PTPRM|0:GCLM|0:SRP14|0:PAPD7|0:SRP68|0:UBE2B|0:AQP1|0:SFRP1|0:SRP54|0:SRP72|0:HTR2A|0:RAB6C|0:TOP1|0:MYC|0:THBS1|0:RPP21|0:CTNNB1|0:CCND1|0:CDK4|0:KCNJ11|0:FZD1|0:GATA6|0:DRD3|0:ADRA1A|0:DRD1|0:ADAM17|0:DRD2|0:SOD1|0:PARP4|0:CENPF|0:SCN11A|0:CTPS|0:ABCC1|0:ABCC6|0:CSAG3|0:SEMA3C|0:CSAG2|0:NAT8|0:ABCA3|0:MVP|0:BCAR3|0:ABCA2			
GO:0006669	P:sphinganine-1-phosphate biosynthetic process; NAS:UniProtKB		0:SPHK2			
GO:0005176	F:ErbB-2 class receptor binding; TAS:UniProtKB		0:CDK5|0:MUC4|0:ERBB2IP			
GO:0042296	F:ISG15 ligase activity; IDA:HGNC		0:UBE2E2|0:UBE2E1			
GO:0005834	C:heterotrimeric G-protein complex; TAS:UniProtKB		0:GNB1|0:GNG10|0:RGS6|0:GNG11|0:GNG2|0:RGS9|0:GNG12|0:GNG7|0:GNGT1|0:RGS11|0:GNG8|0:RGS7|0:GNG4|0:GNGT2|0:GNG5|0:GNB5|0:GNAT2|0:GNA15|0:GNAI1|0:GNA14|0:GNAS			
GO:0061098	P:positive regulation of protein tyrosine kin...; IDA:UniProtKB		0:SRCIN1			
GO:0043524	P:negative regulation of neuron apoptosis; ISS:UniProtKB		0:BCL2|0:VEGFB|0:GDNF|0:SOD2|0:WFS1|0:PPT1|0:MSH2|0:ERBB3|0:TGFB3|0:CLN3|0:LIG4|0:RASA1|0:NRBP2|0:SOD1			
GO:0050772	P:positive regulation of axonogenesis; TAS:UniProtKB		0:RHOA|0:NGFR|0:ARHGEF1|0:ARHGDIA|0:ROBO2|0:ROBO1|0:SKIL|0:AMIGO1|0:SLIT2			
GO:0042518	P:negative regulation of tyrosine phosphoryla...; NAS:UniProtKB		0:NF2|0:SOCS1|0:PPP2R1A|0:PPP2CA			
GO:0035258	F:steroid hormone receptor binding; IPI:UniProtKB		0:NR0B1			
GO:0018277	P:protein amino acid deamination; TAS:UniProtKB		0:LOXL1			
GO:0007631	P:feeding behavior; TAS:ProtInc		0:NPW|0:GALR3|0:PPYR1|0:HTR2C|0:MC4R|0:PYY|0:HCRTR1|0:MCHR1|0:CCKBR|0:HCRTR2|0:GALR2|0:FYN|0:GCG			
GO:0002246	P:wound healing involved in inflammatory resp...; IMP:BHF-UCL		0:HMOX1			
GO:0010898	P:positive regulation of triglyceride catabol...; ISS:UniProtKB		0:APOA4|0:APOA5|0:APOC2|0:ABHD5|0:PNPLA2|0:AADAC			
GO:0005954	C:calcium- and calmodulin-dependent protein k...; TAS:UniProtKB		0:CAMK2G|0:CAMK2D|0:CAMK1D			
GO:0004065	F:arylsulfatase activity; TAS:ProtInc		0:SULF2|0:SULF1|0:ARSG|0:ARSI|0:ARSH|0:ARSK|0:ARSJ|0:ARSB|0:ARSF|0:ARSE|0:ARSA|0:ARSD			
GO:0001931	C:uropod; IDA:MGI		0:MYH9			
GO:0032036	F:myosin heavy chain binding; NAS:BHF-UCL		0:MYBPC3|0:MYL2			
GO:0008353	F:RNA polymerase II carboxy-terminal domain k...; IEA:EC		0:CDK9|0:CDK1|0:CDK7|0:CDK8			
GO:0001961	P:positive regulation of cytokine-mediated si...; IMP:BHF-UCL		0:AGPAT2|0:AGPAT1|0:CD74			
GO:0016934	F:extracellular-glycine-gated chloride channe...; IEA:InterPro		0:GLRA2|0:GLRA1|0:GLRA3			
GO:0060316	P:positive regulation of ryanodine-sensitive ...; ISS:BHF-UCL		0:CALM2|0:CALM3|0:CALM1			
GO:0050808	P:synapse organization; ISS:UniProtKB		0:NLGN4X|0:NLGN3|0:WNT7B|0:RAB39B			
GO:0051538	F:3 iron, 4 sulfur cluster binding; ISS:UniProtKB		0:SDHB			
GO:0034505	P:tooth mineralization; IMP:UniProtKB		0:COL1A1			
GO:0030578	P:PML body organization; IDA:UniProtKB		0:ETS1|0:PML			
GO:0009586	P:rhodopsin mediated phototransduction; TAS:ProtInc		0:GRK1|0:SAG			
GO:0004820	F:glycine-tRNA ligase activity; IEA:InterPro		0:GARS|0:POLG2			
GO:0071474	P:cellular hyperosmotic response; IMP:UniProtKB		0:AQP1			
GO:0031943	P:regulation of glucocorticoid metabolic process; IDA:HGNC		0:STUB1			
GO:0017055	P:negative regulation of RNA polymerase II tr...; ISS:UniProtKB		0:HMGB1|0:THRA|0:HMGB1P10			
GO:0005666	C:DNA-directed RNA polymerase III complex; TAS:ProtInc		0:POLR3H|0:POLR3D|0:POLR3A|0:POLR3F|0:POLR3C|0:POLR3G|0:POLR3K			
GO:0010521	F:telomerase inhibitor activity; IGI:BHF-UCL		0:POT1|0:TERF1			
GO:0045730	P:respiratory burst; TAS:BHF-UCL		0:PGAM1|0:CD24|0:CYBA|0:CYBB|0:SLC11A1|0:CD55|0:CD52|0:NOX1|0:NCF1|0:NCF2			
GO:0050265	F:RNA uridylyltransferase activity; IEA:EC		0:ZCCHC6|0:ZCCHC11|0:TUT1			
GO:0007603	P:phototransduction, visible light; TAS:ProtInc		0:GNAT1|0:PDE6B|0:ABCA4|0:RP1			
GO:0016081	P:synaptic vesicle docking involved in exocyt...; NAS:UniProtKB		0:SNPH|0:PLDN			
GO:0000245	P:spliceosome assembly; TAS:UniProtKB		0:BAT1|0:CRNKL1|0:SRSF2IP|0:SRPK2|0:RBM5|0:GEMIN6|0:PRPF19|0:SNRPE|0:SMN2|0:DDX1|0:PRPF6|0:SMN1|0:SNRPG|0:SIP1|0:USP39|0:SNRPD1|0:SNRPD2|0:TXNL4A			
GO:0016805	F:dipeptidase activity; NAS:UniProtKB		0:SCRN1|0:SCRN2|0:SCRN3|0:FOLH1|0:NAALADL1|0:DPEP2|0:DPEP3|0:DPEP1|0:FOLH1B|0:PEPD|0:NAALAD2			
GO:0004940	F:beta1-adrenergic receptor activity; TAS:ProtInc		0:ADRB1			
GO:0005277	F:acetylcholine transmembrane transporter act...; EXP:Reactome		0:SLC18A3			
GO:0006383	P:transcription from RNA polymerase III promoter; TAS:ProtInc		0:TBP|0:CRCP|0:POLR3H|0:POLR3D|0:SNAPC2|0:SNAPC3|0:IVNS1ABP|0:POLR3K|0:GTF3A|0:POLR2K|0:TROVE2			
GO:0045842	P:positive regulation of mitotic metaphase/an...; NAS:UniProtKB		0:ESPL1|0:DLGAP5			
GO:0030210	P:heparin biosynthetic process; NAS:UniProtKB		0:ANGPT1|0:GLCE|0:CSGALNACT1			
GO:0007528	P:neuromuscular junction development; TAS:ProtInc		0:DNAJA3|0:MUSK|0:CHRNA1|0:DVL1|0:CACNB2|0:NRD1			
GO:0019046	P:reactivation of latent virus; TAS:UniProtKB		0:HCFC1|0:CREB3			
GO:0008140	F:cAMP response element binding protein binding; NAS:UniProtKB		0:CREB3|0:CRTC1|0:CREM			
GO:0030206	P:chondroitin sulfate biosynthetic process; NAS:UniProtKB		0:CHSY1|0:CHST7|0:CSGALNACT1|0:CHST13|0:CHST11|0:CHST3|0:SLC35D1			
GO:0050277	F:sedoheptulokinase activity; IEA:EC		0:SHPK			
GO:0032308	P:positive regulation of prostaglandin secretion; NAS:BHF-UCL		0:PLA2G10|0:TNFRSF11A|0:TNFSF11|0:IL1B|0:P2RX4			
GO:0010633	P:negative regulation of epithelial cell migr...; IMP:UniProtKB		0:MCC			
GO:0051267	F:CP2 mannose-ethanolamine phosphotransferase...; IDA:MGI		0:PIGG			
GO:0008783	F:agmatinase activity; IEA:EC		0:AGMAT			
GO:0048246	P:macrophage chemotaxis; TAS:UniProtKB		0:CCL2|0:EDN2|0:CKLF|0:SAA1|0:SAA2|0:EDNRB|0:AZU1|0:SFTPD			
GO:0047837	F:D-xylose 1-dehydrogenase (NADP+) activity; IEA:EC		0:DHDH			
GO:0000792	C:heterochromatin; IDA:UniProtKB		0:SALL1|0:MECP2			
GO:0046599	P:regulation of centriole replication; IMP:UniProtKB		0:CEP76			
GO:0046556	F:alpha-N-arabinofuranosidase activity; IEA:InterPro		0:OTOG			
GO:0031396	P:regulation of protein ubiquitination; IDA:UniProtKB		0:PINK1|0:UBQLN1|0:RNF139|0:DAXX			
GO:0005607	C:laminin-2 complex; IDA:UniProtKB		0:LAMB1			
GO:0033137	P:negative regulation of peptidyl-serine phos...; ISS:UniProtKB		0:SMAD7|0:CAV1|0:MLXIPL|0:CNKSR3			
GO:0050480	F:imidazolonepropionase activity; IEA:EC		0:AMDHD1			
GO:0002860	P:positive regulation of natural killer cell ...; IMP:BHF-UCL		0:CRTAM|0:IL12A|0:IL12B|0:PVRL2|0:CD226|0:PVR			
GO:0004149	F:dihydrolipoyllysine-residue succinyltransfe...; IEA:EC		0:DLST			
GO:0045579	P:positive regulation of B cell differentiation; NAS:UniProtKB		0:CD27			
GO:0008440	F:inositol trisphosphate 3-kinase activity; TAS:ProtInc		0:ITPKC|0:IPMK|0:IP6K3|0:IP6K1|0:IP6K2|0:ITPKB|0:ITPKA			
GO:0003983	F:UTP:glucose-1-phosphate uridylyltransferase...; TAS:UniProtKB		0:UGP2			
GO:0045010	P:actin nucleation; NAS:UniProtKB		0:SCIN|0:ARPC4			
GO:0019933	P:cAMP-mediated signaling; NAS:UniProtKB		0:GLP1R|0:NDUFS4|0:RAPGEF2			
GO:0004128	F:cytochrome-b5 reductase activity; TAS:ProtInc		0:CYB5R2|0:CYB5R4|0:CYB5R1|0:CYB5RL|0:NQO1|0:CYB561|0:CYB5R3			
GO:0033749	F:histone demethylase activity (H4-R3 specific); IDA:UniProtKB		0:JMJD6			
GO:0045662	P:negative regulation of myoblast differentia...; IMP:UniProtKB		0:BMP4|0:ZFHX3|0:TBX3|0:NOTCH1			
GO:0004596	F:peptide alpha-N-acetyltransferase activity; IEA:EC		0:NAA20|0:NAA11|0:NAA30|0:NAA10			
GO:0019310	P:inositol catabolic process; ISS:UniProtKB		0:MIOX			
GO:0001764	P:neuron migration; NAS:UniProtKB		0:TUBB2B|0:PAFAH1B1|0:DISC1|0:MDGA1|0:CDK5R1|0:CCK|0:PEX13|0:RELN|0:DNER|0:DCDC2|0:NRCAM			
GO:0006346	P:methylation-dependent chromatin silencing; ISS:UniProtKB		0:HELLS			
GO:0000407	C:pre-autophagosomal structure; ISS:UniProtKB		0:C12orf44|0:RB1CC1|0:ULK1|0:ATG13			
GO:0060157	P:urinary bladder development; ISS:BHF-UCL		0:RBP4			
GO:0003091	P:renal water homeostasis; IMP:BHF-UCL		0:CYP11B2|0:WFS1			
GO:0006561	P:proline biosynthetic process; TAS:ProtInc		0:ALDH4A1|0:C14orf148|0:PYCRL|0:PYCR2|0:PYCR1|0:ALDH18A1			
GO:0003922	F:GMP synthase (glutamine-hydrolyzing) activity; IEA:EC		0:GMPS			
GO:0042994	P:cytoplasmic sequestering of transcription f...; TAS:ProtInc		0:NFKBIL2|0:NFKBIL1|0:NFKBIE|0:MDFI|0:MXI1			
GO:0016446	P:somatic hypermutation of immunoglobulin genes; NAS:UniProtKB		0:MSH6|0:POLL			
GO:0000176	C:nuclear exosome (RNase complex); NAS:UniProtKB		0:EXOSC3|0:EXOSC10|0:EXOSC9			
GO:0051488	P:activation of anaphase-promoting complex ac...; TAS:UniProtKB		0:UBE2S|0:CDC14B|0:UBE2C			
GO:0018184	P:protein amino acid polyamination; NAS:UniProtKB		0:TGM4			
GO:0005246	F:calcium channel regulator activity; TAS:ProtInc		0:PLN|0:STIM2|0:NPY2R|0:NPY|0:SRI			
GO:0060397	P:JAK-STAT cascade involved in growth hormone...; ISS:UniProtKB		0:STAT5B|0:JAK2|0:STAT3			
GO:0010949	P:negative regulation of intestinal phytoster...; IMP:BHF-UCL		0:ABCG8|0:ABCG5			
GO:0010942	P:positive regulation of cell death; IMP:BHF-UCL		0:AXIN2			
GO:0008156	P:negative regulation of DNA replication; TAS:ProtInc		0:ENPP7|0:GMNN|0:TSPYL2|0:TTF1|0:TGFB3|0:TGFB1|0:GTPBP4|0:NF2|0:ATR|0:S100A11			
GO:0000722	P:telomere maintenance via recombination; IDA:UniProtKB		0:TEP1			
GO:0060159	P:regulation of dopamine receptor signaling p...; ISS:UniProtKB		0:DTNBP1			
GO:0070602	P:regulation of centromeric sister chromatid ...; NAS:UniProtKB		0:AXIN2|0:CTNNB1|0:CTCF			
GO:0032868	P:response to insulin stimulus; ISS:UniProtKB		0:PCK1|0:TSC1|0:SORT1|0:CITED1			
GO:0015247	F:aminophospholipid transporter activity; NAS:UniProtKB		0:ATP9B|0:ATP8A1			
GO:0051036	P:regulation of endosome size; IEP:UniProtKB		0:ALS2			
GO:0042803	F:protein homodimerization activity; TAS:UniProtKB		0:ALDH5A1|0:MTHFD1L|0:APOA4|0:BMPR1A|0:PON3|0:GHR|0:ACVR1|0:APOE|0:PDGFRA|0:HNF4A|0:EXT1|0:PDGFA|0:ADRA2C|0:APOA2|0:ABCG1|0:PON1|0:PLEK|0:CSF1|0:ABCG4|0:ENPP1|0:PDGFB|0:ABCG2|0:NOG|0:ADRA2A|0:TERT|0:TNNC1|0:FLNA|0:ADRB3|0:PRMT8|0:AGXT|0:PYCARD|0:AIMP1|0:MSH2|0:BAX|0:NFS1|0:ADRB2|0:CARD8|0:NLRC4|0:PPP2R4|0:CAV2|0:DGKD|0:HEXB|0:STK4|0:CDSN|0:CR2|0:NLGN4X|0:TBC1D22A|0:SLIT2|0:EEA1|0:SP1|0:CORO1A|0:WRN|0:SDCBP2|0:CUBN|0:BIRC5|0:GLA|0:SDS|0:CAT|0:CPOX|0:TBX1|0:ABCB9|0:DAXX|0:MECOM|0:CD4|0:RUNX1|0:GSS|0:QPRT|0:CREB3|0:MVD|0:TPD52L1|0:HMOX1|0:GDNF|0:CDA|0:MLL|0:VWF|0:S100A11|0:GZMA|0:RAB11FIP4|0:DSCAML1|0:B4GALT1|0:RRAGA|0:S100A1|0:CARS|0:ATG7|0:S100B|0:BNIP3L|0:BNIP3|0:KYNU|0:TCF3|0:MAP3K13|0:DPYD|0:CBS|0:SLC11A1|0:FOXP2|0:CHRNA7|0:TGFB2|0:TPD52L2|0:MAP3K5|0:PDXK|0:SRR|0:ZBTB16|0:SHMT1|0:NPM1|0:CLN6|0:IL17F|0:GGCT|0:ALDH1A3|0:CRYM|0:MYH9|0:RAB11FIP3|0:CISD2|0:S100A6|0:TPD52|0:FGFR1OP|0:GRPEL2|0:GRPEL1|0:GPD1L|0:GPD1|0:APOC2|0:UGT1A8|0:CALCOCO2|0:NDP|0:USF2|0:UGT1A4|0:ADD2|0:PML|0:TERF2|0:UGT1A10|0:FZD9|0:ECE1|0:PVRL2|0:UGT1A9|0:SP100|0:SRF|0:G6PD|0:FZD4|0:UGT1A6|0:UGT1A1|0:HHEX|0:ATP2A1|0:ENG|0:ADIPOQ|0:IL6R|0:ADD1|0:IRAK2|0:UGT1A7|0:SMAD4|0:UGT1A3|0:SLC4A1|0:GTF2A2|0:IRAK3|0:MLX|0:USF1|0:PDGFC|0:SH3GLB1|0:MOAP1|0:SNX6|0:IMPA2|0:IMPA1|0:RPL7|0:ERCC5|0:TERF1|0:TRIM5|0:CCDC88A|0:RAB11FIP2|0:TSC2|0:TRIM9|0:DPY30|0:BCL2|0:GCH1|0:TARBP2|0:CRYAB|0:BST2|0:CCBL1|0:RABEP1|0:FBXO4|0:CACYBP|0:CEP57|0:PRKRA|0:NR0B2|0:IDE|0:MAP3K11|0:DPP4|0:AADAT|0:RNF40|0:ATIC|0:S100A13|0:XDH|0:FOXP3|0:MAD2L1|0:GOLGA5|0:HNF1A|0:MTUS2|0:IDH1|0:NUDT21|0:S100A5|0:NR0B1|0:NAGA|0:VAPB|0:PRPS1|0:PDCD10|0:XPNPEP1|0:GCA|0:CARD9|0:SEPT12|0:SNRPC|0:TP53I3|0:CRYL1|0:MASP1|0:TOP2A|0:HPRT1|0:CENPF|0:LRRK2|0:HPS4|0:BARD1|0:NR2F2|0:ALS2|0:CECR1|0:RCHY1|0:TFAP4|0:HNF1B|0:AMBP|0:RAP1GAP|0:INHBB|0:XPA|0:ABAT|0:GALE|0:TRIM8|0:SLC30A8|0:HAND2|0:PAFAH1B1|0:CIDEA|0:GIPC1|0:NOS2|0:VEGFA|0:JUP|0:CSF1R|0:CADM3|0:PVRL3|0:PVRL1|0:HSPB6|0:LDB1|0:NR6A1|0:MAP3K10|0:PRPS1L1|0:TYR|0:STUB1|0:RAG1|0:ATPIF1|0:MAP3K12|0:UPK1A|0:TYRP1|0:MAP3K9|0:AXIN1|0:TAP1|0:NRBP1|0:PRPS2|0:ADAM10|0:CADM1|0:EIF2AK1|0:HAND1|0:ERBB3|0:P2RX7|0:P2RX4|0:ROPN1B|0:ACCS|0:OXCT1|0:ACHE|0:PYGL|0:EPHX2|0:FAP|0:CD247|0:CLCN3|0:TARS|0:IRAK1|0:APOBEC3G|0:SHBG|0:SOD1|0:PRLR|0:IL6ST|0:GYS2|0:HPGD|0:CLIP1|0:ACTN3|0:TREX1|0:AOC3|0:ACTN4|0:SLC9A7|0:HSP90AA1|0:ANXA9|0:MAFA|0:PLOD1			
GO:0030621	F:U4 snRNA binding; IDA:BHF-UCL		0:BAT1			
GO:0051577	F:MyoD binding; IDA:UniProtKB		0:CREBBP			
GO:0043087	P:regulation of GTPase activity; NAS:UniProtKB		0:RAB3GAP1|0:GDI1|0:CHM|0:GDI2|0:CHML|0:RAB3GAP2|0:ALS2CR12|0:RAPGEF6			
GO:0004527	F:exonuclease activity; IEA:UniProtKB-KW		0:AEN|0:TDP1|0:REXO1L1|0:DIS3L|0:REXO1|0:REXO4|0:ERI2|0:DIS3|0:POLD1|0:CNOT6|0:ERI3|0:ISG20L2|0:REXO1L2P|0:EXOSC1|0:CNOT6L|0:DIS3L2			
GO:0048711	P:positive regulation of astrocyte differenti...; IDA:BHF-UCL		0:SERPINE2			
GO:0031432	F:titin binding; NAS:BHF-UCL		0:ACTN2|0:TCAP|0:TRIM63|0:CALM2|0:CALM3|0:CALM1|0:OBSCN|0:MYBPC1|0:MYBPC3			
GO:0060044	P:negative regulation of cardiac muscle cell ...; ISS:UniProtKB		0:TBX5|0:RBP4|0:NOG			
GO:0000149	F:SNARE binding; TAS:ProtInc		0:CAPN10|0:GABARAPL2|0:SNAPIN			
GO:0008310	F:single-stranded DNA specific 3'-5' exodeoxy...; IDA:UniProtKB		0:ISG20			
GO:0070120	P:ciliary neurotrophic factor-mediated signal...; IMP:BHF-UCL		0:CNTFR|0:CNTF|0:IL6ST|0:LIFR|0:IL6R			
GO:0043193	P:positive regulation of gene-specific transc...; TAS:BHF-UCL		0:PPARGC1A|0:SPI1|0:POU1F1|0:IL10|0:EPO|0:TGFB3|0:IL6|0:HIF1A|0:ARNT|0:TNF|0:RARA|0:TP73|0:TP63|0:TRIM16|0:SFRP1|0:WT1|0:PROX1|0:NR2F2|0:BPTF|0:SMARCA1|0:TESC|0:MAPRE3|0:GATA4|0:SMAD2|0:PSRC1|0:HNRNPAB|0:TRIM28|0:RORB|0:PSMC5|0:NR5A2			
GO:0043069	P:negative regulation of programmed cell death; NAS:UniProtKB		0:MECOM|0:PSMC5			
GO:0000340	F:RNA 7-methylguanosine cap binding; IDA:UniProtKB		0:NCBP2|0:EIF2C2			
GO:0042109	P:lymphotoxin A biosynthetic process; NAS:UniProtKB		0:IL17F|0:BCL10			
GO:0015379	F:potassium:chloride symporter activity; TAS:ProtInc		0:SLC12A6|0:SLC12A5|0:SLC12A4|0:SLC12A7			
GO:0000932	C:cytoplasmic mRNA processing body; IEA:UniProtKB-SubCell		0:MOV10|0:PNRC2|0:LIN28A|0:LSM14A|0:TRIM5|0:MEX3B|0:EIF2C3|0:BTBD2|0:TRIM21|0:UPF1|0:EIF2C2|0:BTBD1|0:DDX6|0:DCP2|0:DCP1A|0:TNRC6B|0:EIF2C1|0:EDC4|0:BTBD6|0:PATL1|0:CPEB1|0:TNRC6A|0:MEX3A|0:EDC3|0:EIF2C4			
GO:0015410	F:manganese-transporting ATPase activity; IDA:UniProtKB		0:ATP2C1			
GO:0001959	P:regulation of cytokine-mediated signaling p...; ISS:UniProtKB		0:IRAK1|0:IRAK2|0:CD24			
GO:0001658	P:branching involved in ureteric bud morphoge...; ISS:UniProtKB		0:BMP4|0:FGF2|0:WT1|0:SALL1|0:CITED1|0:MYC|0:SIX1|0:SHH			
GO:0000710	P:meiotic mismatch repair; ISS:BHF-UCL		0:MSH6			
GO:0003991	F:acetylglutamate kinase activity; IEA:InterPro		0:NAGS			
GO:0046651	P:lymphocyte proliferation; ISS:UniProtKB		0:HELLS			
GO:0045739	P:positive regulation of DNA repair; NAS:UniProtKB		0:FGF10|0:RNF8|0:RNF168|0:CEBPG|0:TMEM161A|0:UBE2N|0:UIMC1|0:ERCC8|0:BRE|0:EYA1|0:BRCC3|0:BRCA1|0:FAM175A|0:C19orf62|0:EYA3|0:H2AFX			
GO:0043023	F:ribosomal large subunit binding; IDA:MGI		0:NPM1			
GO:0001502	P:cartilage condensation; TAS:ProtInc		0:BMPR1B|0:ALX1|0:MGP|0:BMP1			
GO:0051101	P:regulation of DNA binding; NAS:BHF-UCL		0:APEX1|0:BCL3|0:CSNK2B			
GO:0070528	P:protein kinase C signaling cascade; ISS:BHF-UCL		0:DGKQ|0:MAS1|0:HTR2B|0:PLEK			
GO:0051097	P:negative regulation of helicase activity; TAS:UniProtKB		0:SIRT1|0:TP53			
GO:0008622	C:epsilon DNA polymerase complex; NAS:UniProtKB		0:CHRAC1			
GO:0034393	P:positive regulation of smooth muscle cell a...; IDA:BHF-UCL		0:IFNG|0:IL12A|0:IL12B			
GO:0044445	C:cytosolic part; ISS:UniProtKB		0:PRDX5|0:AKT1S1			
GO:0016742	F:hydroxymethyl-, formyl- and related transfe...; IEA:InterPro		0:ALDH1L1|0:ALDH1L2			
GO:0004923	F:leukemia inhibitory factor receptor activity; IDA:MGI		0:LIFR			
GO:0005129	F:granulocyte macrophage colony-stimulating f...; TAS:ProtInc		0:CSF2			
GO:0042908	P:xenobiotic transport; IDA:UniProtKB		0:NR1I2			
GO:0033539	P:fatty acid beta-oxidation using acyl-CoA de...; ISS:BHF-UCL		0:ACADM|0:ETFDH|0:ACADVL|0:ACADL			
GO:0045235	P:protein amino acid palmitoleylation; IDA:MGI		0:CD4			
GO:0007589	P:body fluid secretion; TAS:ProtInc		0:SLC22A2|0:GUCA1B|0:VIP|0:SLC22A4			
GO:0005009	F:insulin receptor activity; IDA:UniProtKB		0:INSR			
GO:0005600	C:collagen type XIII; TAS:UniProtKB		0:COL13A1			
GO:0002086	P:diaphragm contraction; IMP:BHF-UCL		0:GAA			
GO:0004900	F:erythropoietin receptor activity; IDA:UniProtKB		0:EPOR			
GO:0002407	P:dendritic cell chemotaxis; ISS:UniProtKB		0:HMGB1			
GO:0003947	F:(N-acetylneuraminyl)-galactosylglucosylcera...; TAS:ProtInc		0:B4GALNT1			
GO:0090050	P:positive regulation of cell migration invol...; ISS:UniProtKB		0:HDAC7|0:HDAC9|0:PTGS2|0:SRPX2			
GO:0070776	C:MOZ/MORF histone acetyltransferase complex; IDA:UniProtKB		0:MEAF6|0:MYST3|0:BRPF3|0:BRPF1|0:ING5|0:BRD1|0:MYST4			
GO:0047134	F:protein-disulfide reductase activity; IEA:EC		0:TXNDC17|0:NXN			
GO:0005523	F:tropomyosin binding; TAS:ProtInc		0:TNNT2|0:S100A6|0:LMOD2|0:LMOD1|0:LMOD3|0:TNNT3|0:TNNT1|0:CNN3|0:TNNI1|0:TMOD3|0:TMOD4|0:CALD1|0:TMOD2			
GO:0022407	P:regulation of cell-cell adhesion; ISS:BHF-UCL		0:CELSR2			
GO:0016471	C:vacuolar proton-transporting V-type ATPase ...; IMP:HGNC		0:ATP6V1D|0:ATP6V0D2|0:ATP6V1F|0:ATP6V0D1|0:ATP6V1G3|0:ATP6V1G2|0:ATP6V1B1			
GO:0019373	P:epoxygenase P450 pathway; IDA:BHF-UCL		0:CYP2J2			
GO:0003727	F:single-stranded RNA binding; TAS:ProtInc		0:HNRNPA1|0:TLR8|0:HNRNPF|0:LONP1|0:A1CF|0:SNRPC|0:TLR7|0:ZFP36|0:ADARB2			
GO:0048662	P:negative regulation of smooth muscle cell p...; ISS:UniProtKB		0:IGFBP3|0:IFNG|0:IL12A|0:IGFBP5|0:IL12B|0:HMOX1|0:ANG|0:TRIB1|0:MFN2			
GO:0014050	P:negative regulation of glutamate secretion; ISS:UniProtKB		0:GRM7			
GO:0010815	P:bradykinin catabolic process; IDA:UniProtKB		0:ECE1|0:IDE|0:XPNPEP1			
GO:0002020	F:protease binding; IPI:UniProtKB		0:BCL2|0:CST3|0:CSTA|0:FURIN|0:CSTB|0:ADAMTS4|0:F3|0:CRADD|0:BDKRB2|0:POLG|0:SERPINB9|0:ECM1|0:SERPINA5|0:NFRKB|0:TP53|0:DPP4|0:VWF|0:ADRM1|0:DVL3|0:SERPINA1|0:ADAMTSL4|0:SERPINF2|0:SERPINE1|0:BRCA2|0:SERPINC1|0:THAP5|0:C10orf2			
GO:0040029	P:regulation of gene expression, epigenetic; IMP:UniProtKB		0:GPX1|0:GLMN			
GO:0030112	C:glycocalyx; IDA:UniProtKB		0:B4GALT1			
GO:0007585	P:respiratory gaseous exchange; TAS:UniProtKB		0:SFTPC|0:SFTPD|0:SFTPA2|0:SFTPA1|0:EDNRA|0:NDUFA12|0:CYSLTR1|0:UCP3|0:HNMT|0:PPBPL2|0:COX11|0:CFTR|0:COX5B|0:BPGM|0:CSF2RB|0:ELN|0:TMPRSS11D|0:SFTPB|0:COX15			
GO:0000187	P:activation of MAPK activity; TAS:UniProtKB		0:TNF|0:DRD4|0:IL1B|0:TGFA|0:FGF10|0:PLCE1|0:SHC1|0:GRM4|0:CHRNA7|0:TDGF1|0:CD81|0:THBS1|0:INSR|0:GHRL|0:MADD|0:GHR|0:TLR4|0:PLA2G1B|0:EPGN|0:SOD1|0:PRKAA1|0:C5AR1|0:S1PR2|0:ADRA2C|0:CXCR4|0:PIK3CB|0:C5|0:FPR1|0:ADORA2B|0:FGF2|0:GNG3|0:PROK2			
GO:0032391	C:photoreceptor connecting cilium; ISS:UniProtKB		0:IQCB1|0:CEP290|0:IFT122|0:WDR19|0:NPHP1			
GO:0010553	P:negative regulation of gene-specific transc...; TAS:BHF-UCL		0:NFKB1|0:GFI1|0:HDAC1|0:HAND1|0:NIPBL|0:PPARG|0:SMAD7|0:VDR|0:HEY1|0:BMP2|0:HHEX|0:HDAC4|0:ENG|0:RXRA|0:TCF7L2|0:HDAC9|0:PPARA|0:HEY2|0:YY1|0:SUFU|0:BMP4|0:PSMD10|0:TBL1X|0:TBL1XR1|0:NFIX|0:GATA6|0:ASCL2|0:SKIL|0:NFIC|0:GPS2|0:TAF7|0:HDAC2|0:CIITA|0:KAT5|0:HDAC5|0:MEF2C|0:TAF9B|0:AES|0:FOXO3|0:NKX2-5|0:NCOR1|0:IGBP1|0:NCOR2|0:HDAC3|0:FOXJ1|0:KDM1A|0:CAV1|0:SMARCA2|0:SMARCA4			
GO:0008219	P:cell death; TAS:ProtInc		0:CACNA1A|0:NDOR1|0:TGFB2|0:DBC1|0:CLUL1|0:NEFH|0:FUS|0:DCTN1|0:SNCAIP|0:SPG7|0:SNCA|0:PARK2|0:TDP1|0:SPTBN2|0:PANK2|0:FGF14|0:SETX|0:HSPB1|0:PARK7|0:GJC2|0:ATXN1|0:KCNC3|0:CYP7B1|0:TBP|0:MFSD8|0:APOE|0:FIG4|0:IGHMBP2|0:HSPB8|0:CLN8|0:FOLR1|0:ITPR1|0:ATXN3|0:NIPA1|0:TREX1|0:AR|0:SLC33A1|0:SPG11|0:ATXN2|0:AFG3L2|0:TTBK2|0:SMN2|0:KIF5A|0:FBXO7|0:DPP6|0:ATL1|0:SYNE1|0:TARDBP|0:KIAA0196|0:SMPD1|0:ATN1|0:ANG|0:TPP1|0:GARS|0:PINK1|0:CLN5|0:PLA2G6|0:ATXN7|0:REEP1|0:SPAST|0:VAPB|0:SPG21|0:ZFYVE26|0:SMN1|0:PRKCG|0:UBA1|0:ATXN10|0:SPG20|0:ZFYVE27|0:PLP1|0:FA2H|0:L1CAM|0:BSCL2|0:PNPLA6|0:GIGYF2|0:CLN6|0:APTX|0:ALS2|0:TRPM7|0:C10orf2|0:TRPV4|0:GAN|0:GBA|0:ADCK3|0:ATXN8|0:NUP62|0:PARP4|0:HMOX1|0:KLK8|0:FOSL2|0:EIF4G2|0:PTGER3			
GO:0003681	F:bent DNA binding; IDA:UniProtKB		0:PIN4			
GO:0004367	F:glycerol-3-phosphate dehydrogenase [NAD+] a...; IEA:EC		0:GPD1|0:GPD1L			
GO:0042692	P:muscle cell differentiation; IMP:UniProtKB		0:SYNE1|0:SEMA4C|0:GLMN			
GO:0030279	P:negative regulation of ossification; NAS:UniProtKB		0:SFRP1|0:SOST			
GO:0022614	P:membrane to membrane docking; IEP:BHF-UCL		0:ROCK1|0:MSN|0:EZR|0:ICAM1|0:VCAM1			
GO:0009804	P:coumarin metabolic process; IDA:BHF-UCL		0:UGT1A8|0:UGT1A7|0:CYP2D6			
GO:0000794	C:condensed nuclear chromosome; TAS:ProtInc		0:TTN|0:LRPPRC|0:RCC1|0:MKI67IP|0:RRS1|0:CHMP1A|0:NOL6|0:TUBG1|0:RAD51|0:RGS12|0:SMC1A|0:SUV39H1|0:DMC1|0:CHEK1			
GO:0004913	F:interleukin-4 receptor activity; TAS:ProtInc		0:IL4R			
GO:0000117	P:regulation of transcription involved in G2/...; ISS:BHF-UCL		0:TAF1			
GO:0051881	P:regulation of mitochondrial membrane potential; ISS:HGNC		0:BAX|0:BCL2L1|0:BAK1|0:PRDX3|0:NDUFS1|0:SOD1|0:BCL2			
GO:0017042	F:glycosylceramidase activity; IEA:EC		0:GBA3|0:LCT			
GO:0070419	C:nonhomologous end joining complex; IDA:UniProtKB		0:XRCC5|0:NHEJ1			
GO:0003847	F:1-alkyl-2-acetylglycerophosphocholine ester...; IEA:EC		0:PAFAH1B3|0:ASPG|0:PLA2G7|0:PAFAH2|0:PAFAH1B2			
GO:0043208	F:glycosphingolipid binding; TAS:BHF-UCL		0:SELL|0:SELP			
GO:0015179	F:L-amino acid transmembrane transporter acti...; EXP:Reactome		0:SLC38A1			
GO:0003720	F:telomerase activity; IDA:UniProtKB		0:DKC1|0:PTGES3			
GO:0004027	F:alcohol sulfotransferase activity; IEA:EC		0:SULT1C3|0:SULT2B1			
GO:0008584	P:male gonad development; TAS:ProtInc		0:WNT2B|0:KITLG|0:GATA4|0:ZFP42|0:TFAP2C|0:MAMLD1|0:UTF1|0:KIT|0:FSHR|0:GATA6|0:FGF9|0:WNT5A|0:WT1|0:INHBA|0:SRD5A2|0:WNT4|0:RBMY1B|0:MSH2|0:LHB|0:DMRT1|0:LHCGR|0:CSDE1|0:PRKACG|0:DMRT2|0:MEA1|0:NCOA4|0:SOX15|0:NR5A1|0:ANKRD7			
GO:0004983	F:neuropeptide Y receptor activity; TAS:ProtInc		0:PROKR1|0:PRLHR|0:QRFPR|0:PROKR2|0:GPR83|0:NPY6R			
GO:0034379	P:very-low-density lipoprotein particle assembly; TAS:BHF-UCL		0:APOB|0:SOAT2|0:SOAT1|0:DGAT1|0:APOC1|0:APOC3			
GO:0007269	P:neurotransmitter secretion; TAS:UniProtKB		0:SYN2|0:DVL1|0:RAB14|0:SYN3|0:BAIAP3|0:SNAPIN|0:HRH3|0:GRM4|0:SYT1			
GO:0019216	P:regulation of lipid metabolic process; TAS:UniProtKB		0:HNF4A|0:DRD3|0:BBS4|0:SERPINA3|0:PPAP2A|0:EDF1			
GO:0032791	F:lead ion binding; IDA:UniProtKB		0:ALAD			
GO:0009605	P:response to external stimulus; TAS:UniProtKB		0:RPS6KA5|0:EIF2AK1|0:PON3|0:PON1|0:INHA			
GO:0070053	F:thrombospondin receptor activity; ISS:BHF-UCL		0:F2|0:SDC4|0:CD47|0:CD36			
GO:0005675	C:holo TFIIH complex; NAS:UniProtKB		0:GTF2H2|0:CCNH|0:MNAT1|0:GTF2H3|0:ERCC3|0:CDK7|0:GTF2H4|0:GTF2H1|0:ERCC2|0:MMS19			
GO:0007079	P:mitotic chromosome movement towards spindle...; TAS:ProtInc		0:DLGAP5|0:CENPE			
GO:0043754	F:dihydrolipoyllysine-residue (2-methylpropan...; IEA:EC		0:DBT			
GO:0000799	C:nuclear condensin complex; IDA:UniProtKB		0:NCAPD3			
GO:0021800	P:cerebral cortex tangential migration; ISS:UniProtKB		0:RELN|0:LHX6			
GO:0015293	F:symporter activity; NAS:UniProtKB		0:SLC24A4|0:SLC45A1|0:SLC16A6|0:SLC16A14|0:SLC38A3|0:SLC24A3|0:SLC5A12|0:SLC16A3|0:SLC16A8|0:SLC17A8|0:SLC12A8|0:SLC22A5|0:SLC24A1|0:SLC16A7|0:SLC36A4|0:SLC38A4|0:SLC5A11|0:SLC16A9|0:SLC24A2|0:SLC4A10|0:SLC16A11|0:SLC17A6|0:SLC16A4|0:SLC15A5|0:SLC25A18|0:SLC16A1|0:SLC17A1|0:SLC22A18|0:SLC36A1|0:SLC25A3|0:SLC16A5|0:SLC24A5|0:SLC16A2|0:SLC5A8|0:SLC25A22|0:SLC38A2|0:KIAA1919|0:SLC5A4|0:SLC22A4|0:SLC16A12|0:SLC34A1|0:SLC16A13|0:SLC46A2			
GO:0046427	P:positive regulation of JAK-STAT cascade; IDA:UniProtKB		0:PRL|0:F2R|0:IL26			
GO:0004520	F:endodeoxyribonuclease activity; TAS:ProtInc		0:ERCC5|0:APLF|0:ERCC4|0:APEX1|0:MBD4			
GO:0008154	P:actin polymerization or depolymerization; TAS:ProtInc		0:GHRL|0:GHSR|0:EVL|0:ABI1|0:ABI2|0:WASL|0:WIPF1|0:DSTN			
GO:0000276	C:mitochondrial proton-transporting ATP synth...; NAS:UniProtKB		0:ATP5L2|0:ATP5J|0:ATP5H|0:ATP5L|0:MT-ATP8|0:MT-ATP6			
GO:0004018	F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumar...; IDA:UniProtKB		0:ADSL			
GO:0004089	F:carbonate dehydratase activity; TAS:ProtInc		0:CA13|0:CA5BP|0:CA8|0:CA5B|0:CA14|0:CA7|0:CA2|0:CA12|0:CA6|0:CA5A|0:CA1|0:CA9|0:CA4|0:CA3			
GO:0070715	P:sodium-dependent organic cation transport; IDA:BHF-UCL		0:SLC22A5			
GO:0006814	P:sodium ion transport; TAS:ProtInc		0:SLC12A5|0:SLC12A4|0:SLC12A7|0:SLC12A6|0:SLC8A2|0:SLC24A4|0:SLC5A10|0:SLC38A11|0:SLC9A5|0:SLC12A2|0:SLC38A3|0:SLC24A3|0:SLC5A12|0:NHEDC2|0:SLC17A8|0:SLC38A9|0:SLC22A5|0:SLC9A4|0:SLC12A1|0:SLC4A8|0:SLC38A10|0:SLC38A4|0:SLC38A6|0:SLC5A11|0:SLC8A3|0:SLC24A2|0:SLC4A10|0:SLC9A1|0:SLC9A8|0:SLC9A3|0:SLC17A6|0:SLC24A6|0:SLC17A1|0:SLC9A7|0:SLC38A7|0:SLC9A10|0:SLC24A5|0:SLC9A9|0:SLC9A2|0:SLC5A8|0:SLC38A2|0:SLC9A6|0:KIAA1919|0:SLC5A4|0:SLC22A4|0:SLC34A1|0:SLC38A8|0:SLC9A11|0:SLC12A3|0:NEDD4L|0:NDUFA9|0:SGK1			
GO:0070557	C:PCNA-p21 complex; IDA:UniProtKB		0:CDKN1A|0:PCNA			
GO:0043031	P:negative regulation of macrophage activation; NAS:UniProtKB		0:BPI|0:IL31RA			
GO:0007007	P:inner mitochondrial membrane organization; IDA:UniProtKB		0:OPA1			
GO:0047783	F:corticosterone 18-monooxygenase activity; IEA:EC		0:CYP11B2			
GO:0015934	C:large ribosomal subunit; TAS:ProtInc		0:MRPL15|0:MRPL32|0:RPL17|0:MRPL22|0:RPL7L1|0:RPL26L1|0:RPL13A			
GO:0004190	F:aspartic-type endopeptidase activity; TAS:UniProtKB		0:REN|0:ASPRV1|0:CTSE|0:BACE1|0:BACE2|0:NRIP3|0:DDI1|0:DDI2|0:NRIP2|0:HM13|0:NAPSA|0:CTSD|0:PGC|0:PGA3|0:PGA4|0:PGA5			
GO:0016844	F:strictosidine synthase activity; IEA:InterPro		0:C20orf3			
GO:0032700	P:negative regulation of interleukin-17 produ...; ISS:BHF-UCL		0:TLR4			
GO:0030117	C:membrane coat; IEA:InterPro		0:AP3B2|0:NCAPD2|0:AP3S2|0:AP3B1|0:AP3D1			
GO:0005041	F:low-density lipoprotein receptor activity; TAS:ProtInc		0:LDLR|0:LRP6|0:STAB1|0:STAB2|0:CD36|0:CXCL16|0:LRP12|0:VLDLR			
GO:0008343	P:adult feeding behavior; TAS:ProtInc		0:GHRL|0:LEP|0:CARTPT|0:GHSR|0:NPY|0:BRS3			
GO:0030431	P:sleep; NAS:UniProtKB		0:IL18|0:MRGPRX2			
GO:0046588	P:negative regulation of calcium-dependent ce...; NAS:UniProtKB		0:FXYD5			
GO:0042985	P:negative regulation of amyloid precursor pr...; IMP:UniProtKB		0:BACE2			
GO:0034080	P:CenH3-containing nucleosome assembly at cen...; IMP:UniProtKB		0:HJURP			
GO:0045416	P:positive regulation of interleukin-8 biosyn...; IMP:UniProtKB		0:PRG3|0:TLR4|0:APOA2|0:ELANE|0:TLR8|0:BCL10|0:TLR7			
GO:0045836	P:positive regulation of meiosis; IMP:UniProtKB		0:NPM2			
GO:0016854	F:racemase and epimerase activity; NAS:UniProtKB		0:DHRS9			
GO:0050646	F:5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid bi...; NAS:UniProtKB		0:OXER1			
GO:0001781	P:neutrophil apoptosis; IDA:UniProtKB		0:IL6|0:GPR109A			
GO:0070096	P:mitochondrial outer membrane translocase co...; IDA:BHF-UCL		0:TOMM22|0:SAMM50|0:HSPA4|0:HSP90AA1			
GO:0004683	F:calmodulin-dependent protein kinase activity; TAS:ProtInc		0:CAMKK1|0:CAMK2G|0:CAMK1|0:CAMK2D|0:CAMK1G|0:CAMK2A|0:CAMK1D|0:CAMK4|0:PNCK|0:CAMK2B|0:CAMKK2|0:MYLK2|0:DAPK2			
GO:0045209	P:MAPK phosphatase export from nucleus, lepto...; TAS:UniProtKB		0:DUSP16			
GO:0045261	C:proton-transporting ATP synthase complex, c...; IEA:InterPro		0:ATP5O			
GO:0043000	P:Golgi to plasma membrane CFTR protein trans...; IDA:UniProtKB		0:KRT18			
GO:0030261	P:chromosome condensation; IEA:UniProtKB-KW		0:AIFM2|0:HILS1|0:PRM3|0:H1FNT|0:PRM1|0:NCAPH2|0:PRM2|0:NCAPG2			
GO:0017176	F:phosphatidylinositol N-acetylglucosaminyltr...; TAS:HGNC		0:PIGP|0:PIGH|0:PIGQ|0:PIGC|0:PIGA			
GO:0060336	P:negative regulation of interferon-gamma-med...; IDA:UniProtKB		0:DNAJA3			
GO:0004654	F:polyribonucleotide nucleotidyltransferase a...; IEA:EC		0:PNPT1			
GO:0071280	P:cellular response to copper ion; IDA:UniProtKB		0:AQP2|0:AQP1			
GO:0055010	P:ventricular cardiac muscle tissue morphogen...; ISS:BHF-UCL		0:HAND1|0:MYBPC3|0:MYL3|0:TNNI3|0:MYH7|0:TNNT2|0:MYL2|0:GAA|0:TNNC1|0:TPM1|0:MYH6|0:SMAD7|0:PROX1|0:TGFBR3|0:BMP10|0:FKBP1A			
GO:0045368	P:positive regulation of interleukin-13 biosy...; IDA:UniProtKB		0:IRF4			
GO:0043552	P:positive regulation of phosphoinositide 3-k...; ISS:BHF-UCL		0:TGFB1|0:IRS1			
GO:0006994	P:positive regulation of transcription via st...; IMP:UniProtKB		0:SCAP			
GO:0005547	F:phosphatidylinositol-3,4,5-trisphosphate bi...; ISS:UniProtKB		0:ARAP1|0:BTK|0:SNX3|0:DAPP1|0:ARAP2|0:AKT1|0:ZFYVE16|0:ADAP2|0:PHLDA3|0:ARAP3|0:ZFYVE1|0:GAB2|0:PARD3|0:RAG2			
GO:0008113	F:peptide-methionine-(S)-S-oxide reductase ac...; TAS:ProtInc		0:MSRB2|0:SEPX1|0:MSRB3|0:MSRA			
GO:0019902	F:phosphatase binding; NAS:UniProtKB		0:DLG1|0:MAST2|0:MAGI2|0:CARHSP1			
GO:0045656	P:negative regulation of monocyte differentia...; IDA:UniProtKB		0:HOXA7			
GO:0005072	F:transforming growth factor beta receptor, c...; TAS:ProtInc		0:ENG|0:CDKN1B			
GO:0050885	P:neuromuscular process controlling balance; ISS:UniProtKB		0:PAFAH1B1|0:CLN3|0:TPP1|0:KCNMA1			
GO:0009966	P:regulation of signal transduction; NAS:UniProtKB		0:CDC42SE2|0:PPP1R2|0:PPP1R2P3|0:PPP1R2P9|0:SPRY3|0:CNKSR2|0:PPP1R2P1|0:MTCH1|0:YWHAG|0:GLRX2|0:TSPYL2			
GO:0012507	C:ER to Golgi transport vesicle membrane; IEA:UniProtKB-SubCell		0:SEC23IP|0:SCAP|0:SREBF2|0:SEC31B|0:SREBF1			
GO:0004671	F:protein C-terminal S-isoprenylcysteine carb...; IEA:EC		0:ICMT			
GO:0003747	F:translation release factor activity; IMP:UniProtKB		0:C12orf65|0:GSPT1			
GO:0043297	P:apical junction assembly; NAS:UniProtKB		0:VCL|0:CTNNA1			
GO:0033878	F:hormone-sensitive lipase activity; IEA:EC		0:LIPE			
GO:0015074	P:DNA integration; TAS:ProtInc		0:GIN1|0:NYNRIN|0:SCAND3|0:PPFIBP2|0:SETMAR|0:KRBA2|0:ERVK6|0:SMARCB1			
GO:0002542	P:Factor XII activation; TAS:BHF-UCL		0:F12|0:KLKB1			
GO:0035356	P:cellular triglyceride homeostasis; ISS:BHF-UCL		0:FITM2			
GO:0031125	P:rRNA 3'-end processing; ISS:UniProtKB		0:ERI1			
GO:0006104	P:succinyl-CoA metabolic process; NAS:UniProtKB		0:ACOT4|0:SUCLG2			
GO:0032510	P:endosome to lysosome transport via multives...; IMP:UniProtKB		0:LYST|0:VPS4B			
GO:0030950	P:establishment or maintenance of actin cytos...; IMP:UniProtKB		0:AQP1			
GO:0006965	P:positive regulation of biosynthetic process...; TAS:UniProtKB		0:DEFB103A|0:DEFB103B			
GO:0005795	C:Golgi stack; TAS:ProtInc		0:CLN3|0:COG2|0:ZFYVE1|0:A4GALT|0:A4GNT|0:MGAT2|0:SULF2|0:ARSE|0:NSFL1C|0:CLIP3|0:SULF1|0:DNMBP|0:RASIP1|0:TOM1L1|0:VCPIP1|0:PIP5K1A|0:RAB14|0:LPCAT2|0:TRAPPC4|0:RAB30|0:OCRL|0:GOLGB1			
GO:0050927	P:positive regulation of positive chemotaxis; IDA:BHF-UCL		0:F3|0:F2RL1|0:F7|0:CDH13|0:KDR			
GO:0016891	F:endoribonuclease activity, producing 5'-pho...; IEA:InterPro		0:ERN1|0:ERN2|0:RNASEL|0:ELAC1			
GO:0000083	P:regulation of transcription involved in G1/...; TAS:ProtInc		0:HINFP|0:NPAT|0:RB1|0:GFI1			
GO:0006102	P:isocitrate metabolic process; TAS:ProtInc		0:IDH1|0:IDH3G|0:IDH2|0:IDH3B			
GO:0046658	C:anchored to plasma membrane; TAS:UniProtKB		0:CD160|0:MDGA1|0:RTN4RL2|0:RTN4RL1|0:RHBG|0:RGMB|0:GAS1|0:NTNG2|0:NTNG1|0:LYPD3|0:EFNA5|0:TREH			
GO:0045202	C:synapse; TAS:UniProtKB		0:ACHE|0:PCDH15|0:MAP1S|0:APBB1|0:MYO7A|0:CACNB4|0:ITSN1|0:SNPH|0:ABI1|0:VAMP3|0:RPS6KB1|0:SNAP29|0:CYFIP2|0:SAMD4A|0:PPP1R9A|0:CYFIP1|0:RASGRP2|0:SNAP23|0:SH3KBP1|0:MAGI2|0:UNC13B|0:DTNA|0:COLQ|0:CBLN3|0:CPLX4|0:CPLX3|0:SEPT3|0:CADPS|0:OPHN1|0:IGSF9|0:CBLN4|0:RIMBP2|0:PRIMA1|0:RIMS3|0:CBLN1|0:SEPT11|0:ENAH|0:EGFLAM|0:DNMBP|0:DOK7|0:GAP43|0:RIMS4|0:CTBP2|0:LGI1|0:PHACTR1|0:PPP1R9B|0:DVL1|0:APBB2|0:NLGN3|0:SHISA9|0:EFNB1|0:TULP1|0:TLN2|0:CABP4			
GO:0004300	F:enoyl-CoA hydratase activity; TAS:ProtInc		0:ECHS1|0:AUH|0:HADHB|0:EHHADH|0:ECH1|0:HADHA			
GO:0045165	P:cell fate commitment; ISS:UniProtKB		0:TAL1|0:PPARG|0:SMAD2			
GO:0016620	F:oxidoreductase activity, acting on the alde...; IEA:InterPro		0:HTATIP2			
GO:0015909	P:long-chain fatty acid transport; ISS:BHF-UCL		0:PPARG			
GO:0008064	P:regulation of actin polymerization or depol...; TAS:ProtInc		0:PFN2|0:CXCL12			
GO:0035402	F:histone kinase activity (H3-T11 specific); IDA:UniProtKB		0:PKN1			
GO:0003979	F:UDP-glucose 6-dehydrogenase activity; EXP:Reactome		0:UGDH			
GO:0072180	P:mesonephric duct morphogenesis; ISS:UniProtKB		0:OSR1			
GO:0008821	F:crossover junction endodeoxyribonuclease ac...; IDA:UniProtKB		0:SLX1B|0:SLX1A			
GO:0002027	P:regulation of heart rate; ISS:BHF-UCL		0:MYH7|0:MYH6|0:DRD2			
GO:0030035	P:microspike assembly; IDA:UniProtKB		0:ACTN2			
GO:0008616	P:queuosine biosynthetic process; NAS:UniProtKB		0:QTRTD1|0:QTRT1			
GO:0001775	P:cell activation; TAS:BHF-UCL		0:CD24|0:SLURP1|0:PDGFRA|0:PDGFA			
GO:0031091	C:platelet alpha granule; NAS:UniProtKB		0:STXBP3|0:TREML1|0:VPS33B|0:STXBP1|0:SERPINE2|0:VWF			
GO:0040018	P:positive regulation of multicellular organi...; IMP:HGNC		0:GHRL|0:GH1|0:GHR|0:GHRHR|0:GHRH|0:GHSR			
GO:0006699	P:bile acid biosynthetic process; TAS:UniProtKB		0:CYP39A1|0:CYP7A1|0:AKR1D1|0:CYP7B1|0:HSD3B7			
GO:0010760	P:negative regulation of macrophage chemotaxis; IDA:BHF-UCL		0:C5			
GO:0042043	F:neurexin binding; NAS:UniProtKB		0:NLGN4X|0:SYTL2|0:SYTL1|0:SYTL4|0:NLGN1|0:NLGN2			
GO:0007095	P:mitotic cell cycle G2/M transition DNA dama...; TAS:ProtInc		0:NBN|0:CCNA2			
GO:0048365	F:Rac GTPase binding; TAS:UniProtKB		0:DOCK7|0:FLNA|0:DOCK4|0:ARHGEF2|0:PKN1|0:NOX1|0:NOXA1|0:RALBP1|0:CYFIP1|0:ARFIP2			
GO:0008458	F:carnitine O-octanoyltransferase activity; EXP:Reactome		0:CROT			
GO:0032431	P:activation of phospholipase A2 activity; TAS:BHF-UCL		0:ANG|0:PLA2G1B			
GO:0003921	F:GMP synthase activity; TAS:ProtInc		0:GMPS			
GO:0070166	P:enamel mineralization; IMP:BHF-UCL		0:AMELX			
GO:0046831	P:regulation of RNA export from nucleus; TAS:UniProtKB		0:KHDRBS1|0:NUDT4			
GO:0033344	P:cholesterol efflux; TAS:BHF-UCL		0:APOA4|0:APOC1|0:NPC1|0:APOE|0:APOC3|0:STX12|0:APOA2|0:ABCG1|0:APOM|0:APOC2|0:APOA1|0:NPC2|0:ABCA1|0:ABCG8|0:ABCG5|0:SOAT2|0:SOAT1|0:ABCA5|0:SCARB1|0:ABCG4			
GO:0006517	P:protein deglycosylation; TAS:ProtInc		0:AGA|0:MAN2B1			
GO:0043159	C:acrosomal matrix; TAS:HGNC		0:CYLC1|0:ACR			
GO:0016139	P:glycoside catabolic process; IDA:UniProtKB		0:GBA3			
GO:0019363	P:pyridine nucleotide biosynthetic process; IEA:UniProtKB-KW		0:C9orf95|0:ITGB1BP3|0:NAPRT1|0:HAAO|0:KMO|0:NAMPT			
GO:0060266	P:negative regulation of respiratory burst in...; IDA:BHF-UCL		0:INS			
GO:0010716	P:negative regulation of extracellular matrix...; IEP:BHF-UCL		0:FAP|0:DPP4|0:CST3			
GO:0006772	P:thiamin metabolic process; TAS:UniProtKB		0:TKTL1|0:THTPA			
GO:0004998	F:transferrin receptor activity; NAS:UniProtKB		0:TFR2|0:TFRC			
GO:0006683	P:galactosylceramide catabolic process; IEA:InterPro		0:GALC			
GO:0033688	P:regulation of osteoblast proliferation; ISS:UniProtKB		0:NPR3			
GO:0003989	F:acetyl-CoA carboxylase activity; TAS:ProtInc		0:ACACB|0:ACACA			
GO:0051966	P:regulation of synaptic transmission, glutam...; TAS:UniProtKB		0:GRIK1			
GO:0047497	P:mitochondrion transport along microtubule; TAS:HGNC		0:RHOT1|0:RHOT2|0:MAP1S|0:LRPPRC|0:UXT			
GO:0032057	P:negative regulation of translational initia...; TAS:UniProtKB		0:EIF2B3|0:EIF2B5|0:EIF2B4|0:EIF2AK3			
GO:0030151	F:molybdenum ion binding; NAS:UniProtKB		0:MOSC1|0:XDH|0:MOCOS|0:SUOX|0:MOSC2|0:MOCS1			
GO:0071504	P:cellular response to heparin; ISS:UniProtKB		0:SLIT2|0:EGR1			
GO:0010765	P:positive regulation of sodium ion transport; ISS:UniProtKB		0:NKX2-5|0:CNKSR3			
GO:0009298	P:GDP-mannose biosynthetic process; TAS:ProtInc		0:PMM2			
GO:0002313	P:mature B cell differentiation involved in i...; ISS:UniProtKB		0:GPR183			
GO:0042752	P:regulation of circadian rhythm; NAS:UniProtKB		0:CSNK1D|0:OPN4|0:OPN3			
GO:0035189	C:Rb-E2F complex; TAS:BHF-UCL		0:RB1			
GO:0004490	F:methylglutaconyl-CoA hydratase activity; IEA:EC		0:AUH			
GO:0031061	P:negative regulation of histone methylation; ISS:UniProtKB		0:JARID2			
GO:0010870	P:positive regulation of receptor biosyntheti...; IMP:BHF-UCL		0:HOXA5|0:HDAC1|0:HDAC2|0:HDAC6			
GO:0008147	F:structural constituent of bone; TAS:ProtInc		0:BGLAP|0:MGP			
GO:0034088	P:maintenance of mitotic sister chromatid coh...; IMP:UniProtKB		0:DSCC1|0:NIPBL|0:MAU2			
GO:0050801	P:ion homeostasis; TAS:BHF-UCL		0:AMELX			
GO:0042134	F:rRNA primary transcript binding; IDA:UniProtKB		0:PTRF			
GO:0007094	P:mitotic cell cycle spindle assembly checkpoint; TAS:ProtInc		0:APC|0:TERF1|0:TPR|0:ATM|0:CENPF|0:TTK|0:MAD2L2|0:BUB1			
GO:0020003	C:symbiont-containing vacuole; ISS:UniProtKB		0:AQP1			
GO:0071204	C:histone pre-mRNA 3'end processing complex; ISS:UniProtKB		0:SYNCRIP|0:SLBP|0:YBX1|0:ERI1|0:LSM11			
GO:0008408	F:3'-5' exonuclease activity; TAS:UniProtKB		0:REXO2|0:WRN|0:APLF|0:RAD9A|0:RAD1|0:ERI1|0:EXD2|0:EXD1|0:EXOSC10|0:EXD3|0:MRE11A|0:APEX1			
GO:0004505	F:phenylalanine 4-monooxygenase activity; TAS:ProtInc		0:PAH			
GO:0022898	P:regulation of transmembrane transporter act...; IDA:BHF-UCL		0:INS			
GO:0007189	P:activation of adenylate cyclase activity by...; TAS:ProtInc		0:ADCY2|0:ADCY9|0:ADCY6|0:ADCY3|0:ADCY10|0:ADCY7|0:ADCY4|0:GNAL|0:ADCY1|0:ADCY8|0:GHRH|0:GHRHR|0:PTHLH|0:CALCR|0:GPR26|0:GPR78|0:GPR3			
GO:0004478	F:methionine adenosyltransferase activity; TAS:ProtInc		0:MAT1A|0:MAT2A			
GO:0045954	P:positive regulation of natural killer cell ...; IMP:BHF-UCL		0:NCR3			
GO:0043325	F:phosphatidylinositol-3,4-bisphosphate binding; ISS:UniProtKB		0:PLEK|0:PLEKHA1|0:DAPP1|0:AKT1|0:SESTD1|0:PHLDA3|0:ARAP3|0:ZFYVE1|0:GAB2|0:RAG2|0:ADAP2			
GO:0006401	P:RNA catabolic process; TAS:ProtInc		0:ISG20|0:EXOSC7|0:HNRNPD|0:RNASEH1|0:ABCE1|0:PABPC4|0:RNASEH2A|0:PPP1R8|0:RNASE2|0:RNASET2|0:XRN2|0:RNASE3|0:RNASE6			
GO:0010838	P:positive regulation of keratinocyte prolife...; IDA:UniProtKB		0:FGF10|0:FGF7			
GO:0048213	P:Golgi vesicle prefusion complex stabilization; IMP:UniProtKB		0:COG4			
GO:0043462	P:regulation of ATPase activity; ISS:BHF-UCL		0:TNNT3|0:TPM2|0:MYH6|0:TNNC1			
GO:0032870	P:cellular response to hormone stimulus; IGI:BHF-UCL		0:SLIT2|0:SLIT3|0:ROBO2|0:ADRA2A			
GO:0016527	F:brain-specific angiogenesis inhibitor activity; TAS:GDB		0:BAI3|0:BAI2|0:BAI1			
GO:0006927	P:transformed cell apoptosis; ISS:UniProtKB		0:TNF|0:BAX|0:RHOB			
GO:0004333	F:fumarate hydratase activity; EXP:Reactome		0:FH			
GO:0005638	C:lamin filament; TAS:UniProtKB		0:NARF|0:LMNB1|0:LMNA			
GO:0005958	C:DNA-dependent protein kinase-DNA ligase 4 c...; NAS:UniProtKB		0:PRKDC|0:XRCC4|0:XRCC6|0:LIG4|0:XRCC6BP1			
GO:0002467	P:germinal center formation; ISS:BHF-UCL		0:ADAM17			
GO:0051393	F:alpha-actinin binding; IDA:UniProtKB		0:TTN|0:DAG1			
GO:0045444	P:fat cell differentiation; NAS:UniProtKB		0:TCF7L2|0:MED1|0:BBS7|0:BBS9|0:BBS4|0:SDF4|0:MKKS|0:BBS2|0:STEAP4|0:CBY1|0:INHBB|0:WNT5B|0:ERAP1|0:IL11			
GO:0043625	C:delta DNA polymerase complex; NAS:UniProtKB		0:POLD3			
GO:0004699	F:calcium-independent protein kinase C activity; TAS:BHF-UCL		0:PRKCD			
GO:0031966	C:mitochondrial membrane; TAS:UniProtKB		0:NDUFAF4|0:SPG7|0:COX16|0:SFXN4|0:GRAMD4|0:PEMT|0:NCRNA00219|0:STARD13|0:FKBP8|0:SMCP|0:NHEDC2|0:HTRA2|0:SFXN3|0:PLA2G4B|0:SLC27A3|0:TMEM14C|0:CYP27B1|0:FAM82A2|0:PLN|0:OMA1|0:BCL2L13|0:RNF144B|0:REEP1|0:PNPLA7|0:COX10|0:C18orf55|0:BCL2L2|0:AGK|0:RNF5|0:ROMO1|0:COQ2|0:OGDH|0:CASP7			
GO:0006789	P:bilirubin conjugation; TAS:ProtInc		0:UGT1A1			
GO:0016878	F:acid-thiol ligase activity; ISS:UniProtKB		0:ACSF3|0:AASDH			
GO:0010216	P:maintenance of DNA methylation; ISS:UniProtKB		0:DNMT1|0:HELLS			
GO:0042175	C:nuclear membrane-endoplasmic reticulum network; ISS:UniProtKB		0:NPLOC4|0:RAB14			
GO:0010667	P:negative regulation of cardiac muscle cell ...; IMP:BHF-UCL		0:NRG1|0:NKX2-5			
GO:0047933	F:glucose-1,6-bisphosphate synthase activity; IEA:EC		0:PGM2L1			
GO:0034123	P:positive regulation of toll-like receptor s...; IDA:BHF-UCL		0:TLR3|0:TLR9|0:TLR5|0:TLR2			
GO:0019205	F:nucleobase, nucleoside, nucleotide kinase a...; IEA:InterPro		0:AKD1|0:SPEF2			
GO:0016874	F:ligase activity; TAS:UniProtKB		0:NEURL3|0:RNF43|0:CCNB1IP1|0:NEURL1B|0:TRIM5|0:RNF19B|0:MARCH7|0:MARCH6|0:MKRN3|0:TRIM41|0:PJA2|0:MARCH3|0:RNF216|0:TRIML1|0:RNF181|0:CBLB|0:MKRN2|0:FANCL|0:RNF144A|0:MARCH5|0:MID1|0:SHPRH|0:RNF138|0:SH3RF2|0:RNF125|0:TRIM33|0:NSMCE2|0:SLC27A3|0:MKRN1|0:MARCH11|0:HLTF|0:TRIM22|0:UBA7|0:BTRC|0:MKRN4P|0:E4F1|0:UNKL|0:TRIM11|0:SH3RF1|0:RFFL|0:UBA2|0:ZNRF1|0:LIPT2|0:RNF133|0:RNF123|0:MID2|0:MARCH10|0:MARCH9|0:MARCH2|0:ZSWIM2|0:UBA6|0:RNF149|0:UBA1|0:XIAP|0:UBE2CBP|0:TRIML2|0:RNF34|0:TRIM37|0:LTN1|0:ZNRF2|0:MYCBP2|0:NFX1|0:SAE1|0:RNF19A|0:UHRF1|0:TRIM50|0:RAD18|0:ACSF2|0:KCMF1|0:MARCH4|0:TRIM36|0:UCHL1|0:TRIM31|0:MARCH8|0:MARCH1|0:TRIM8|0:RNF139			
GO:0032405	F:MutLalpha complex binding; IDA:MGI		0:PCNA|0:TREX1|0:ATR			
GO:0006071	P:glycerol metabolic process; IGI:UniProtKB		0:ANGPTL3|0:GDPD5|0:GPCPD1|0:GDPD3|0:GDPD4|0:GDPD2|0:DAK|0:GDE1|0:GDPD1|0:MOGAT1|0:MOGAT3|0:DGAT2|0:MOGAT2|0:COQ3|0:COQ2			
GO:0048730	P:epidermis morphogenesis; IDA:UniProtKB		0:KLK14			
GO:0072177	P:mesonephric duct development; IEP:UniProtKB		0:WNT11			
GO:0042769	P:DNA damage response, detection of DNA damage; NAS:UniProtKB		0:PNKP|0:MRPS26|0:MRPS9|0:MRPS35|0:MRPS11			
GO:0021915	P:neural tube development; ISS:UniProtKB		0:DVL1|0:ALDH1A2|0:PROX1|0:ZNF358			
GO:0004568	F:chitinase activity; IEA:InterPro		0:CHIA|0:CHID1|0:CHI3L1|0:OVGP1|0:CHI3L2			
GO:0005139	F:interleukin-7 receptor binding; TAS:ProtInc		0:IL7			
GO:0050651	P:dermatan sulfate proteoglycan biosynthetic ...; ISS:UniProtKB		0:CSGALNACT1			
GO:0021540	P:corpus callosum morphogenesis; IMP:BHF-UCL		0:PAFAH1B1			
GO:0003958	F:NADPH-hemoprotein reductase activity; TAS:UniProtKB		0:POR			
GO:0009991	P:response to extracellular stimulus; TAS:HGNC		0:RASGRP4|0:RPS19			
GO:0032972	P:regulation of muscle filament sliding speed; ISS:BHF-UCL		0:TNNC1			
GO:0051044	P:positive regulation of membrane protein ect...; ISS:BHF-UCL		0:FURIN|0:TNF|0:APOE|0:IL1B|0:IFNG|0:NRD1|0:ADRA2A|0:PACSIN3|0:SH3D19|0:ADAM9			
GO:0001556	P:oocyte maturation; NAS:UniProtKB		0:EREG|0:ANG			
GO:0006729	P:tetrahydrobiopterin biosynthetic process; TAS:UniProtKB		0:GCH1|0:PCBD1|0:QDPR|0:PCBD2|0:PTS|0:SPR			
GO:0018874	P:benzoate metabolic process; NAS:UniProtKB		0:ACSM1			
GO:0001664	F:G-protein-coupled receptor binding; TAS:UniProtKB		0:GRIK3|0:ARHGEF11|0:ARHGEF12|0:SAA1|0:SAA2|0:USP20|0:USP33|0:CORT|0:PROK2			
GO:0007052	P:mitotic spindle organization; TAS:UniProtKB		0:STMN1|0:RCC1|0:KIF2A|0:SMC3|0:SPC25|0:NDC80|0:DYNC1H1|0:TNKS|0:TTK|0:SMC1A|0:SUN2			
GO:0032993	C:protein-DNA complex; IDA:BHF-UCL		0:LEF1|0:HHEX|0:JUP|0:TCF7L2|0:CTNNB1			
GO:0004140	F:dephospho-CoA kinase activity; IEA:InterPro		0:COASY|0:DCAKD			
GO:0008273	F:calcium, potassium:sodium antiporter activity; NAS:UniProtKB		0:SLC24A1			
GO:0051089	P:constitutive protein ectodomain proteolysis; IDA:UniProtKB		0:ADAM10			
GO:0043229	C:intracellular organelle; IDA:UniProtKB		0:SLC23A1|0:BCL2L14			
GO:0004168	F:dolichol kinase activity; IDA:UniProtKB		0:DOLK			
GO:0030674	F:protein binding, bridging; TAS:UniProtKB		0:CNKSR1|0:RAD50|0:DSP|0:CSTA|0:SPRR1B|0:EVPL|0:ANXA1|0:LOR|0:GATAD2A|0:IVL|0:SPRR1A|0:FGA|0:FSCN1|0:FGB|0:FGG|0:FSCN2|0:FSCN3|0:COL1A2|0:NUFIP1|0:CRADD|0:CBX5|0:PSMC6|0:FLRT2|0:FLRT1|0:COL19A1|0:RBM14|0:ADAP2|0:COL11A1|0:MMS19|0:COL6A2|0:COL11A2|0:LDLRAP1|0:FLRT3|0:COL8A2|0:HSPA5|0:COL14A1|0:STUB1|0:FKBP4|0:ST13|0:BCL3			
GO:0046930	C:pore complex; TAS:HGNC		0:BAK1|0:TOMM40|0:TOMM40L|0:VDAC2|0:VDAC3|0:VDAC1			
GO:0009223	P:pyrimidine deoxyribonucleotide catabolic pr...; TAS:ProtInc		0:NT5C|0:NT5M			
GO:0006972	P:hyperosmotic response; NAS:UniProtKB		0:TLR3|0:ICOSLG			
GO:0016338	P:calcium-independent cell-cell adhesion; ISS:UniProtKB		0:CLDN19|0:CLDN12|0:CLDN20|0:CLDN1|0:CLDN6|0:CLDN11|0:CLDN9|0:CLDN15|0:CLDN10|0:CLDN14|0:CLDN22|0:CLDN5|0:CLDN8|0:CLDN4|0:CLDN23|0:CLDN18|0:CLDN16|0:CLDN2|0:CLDN7|0:CLDN17			
GO:0000281	P:cytokinesis after mitosis; IMP:MGI		0:NUSAP1|0:MYH10|0:APC			
GO:0033151	P:V(D)J recombination; ISS:UniProtKB		0:HMGB1|0:HMGB2|0:RAG2|0:RAG1			
GO:0019303	P:D-ribose catabolic process; NAS:UniProtKB		0:NUDT5			
GO:0030730	P:sequestering of triglyceride; IDA:BHF-UCL		0:TNF|0:IL1B|0:ENPP1			
GO:0006897	P:endocytosis; TAS:ProtInc		0:SORT1|0:STEAP2|0:ATP6V1H|0:LRP8|0:RAB22A|0:CLEC4M|0:SH3GL2|0:AP2A2|0:ASGR2|0:LY75|0:SH3BP4|0:GHR|0:RABEP2|0:DGKD|0:MARCH3|0:RUFY1|0:CD209|0:NME1|0:LRP6|0:EPS15L1|0:OPHN1|0:PACSIN3|0:SIGLEC1|0:AP1S3|0:MRC1L1|0:DBNL|0:AP1G1|0:USP20|0:STON2|0:MRC2|0:FNBP1L|0:SYNRG|0:AP3B2|0:RIN1|0:ARC|0:LRP4|0:NOSTRIN|0:AP1S2|0:USP33|0:CALY|0:HIP1|0:RIN2|0:PLA2R1|0:STON1|0:RABGEF1|0:LRP5|0:AP1B1|0:FKBP15|0:CLEC10A|0:FNBP1|0:TFRC|0:GAPVD1|0:MARCH2|0:EPN2|0:SH3GL1|0:TRIP10|0:SH3GL3|0:VLDLR|0:LRP10|0:AP3B1|0:NECAP1|0:LMBR1L|0:KIAA0226|0:PACSIN2|0:ITSN2|0:APLP1|0:SH3KBP1|0:CLINT1|0:CLEC4F|0:INPPL1|0:MYO6|0:SCARA5|0:APP|0:NECAP2|0:DNM3|0:ZFYVE9|0:TOM1|0:RIN3|0:RAB18|0:DNER|0:LRP12|0:AP2A1|0:PACSIN1|0:LDLR|0:EPN1|0:TSC2|0:SNX3|0:SNX2|0:RABEP1|0:SNX1|0:RAB7A|0:CYTH2|0:HOOK2|0:SNX4			
GO:0008607	F:phosphorylase kinase regulator activity; IMP:BHF-UCL		0:ELP3|0:IKBKAP|0:ELP4|0:PRKAG2			
GO:0030818	P:negative regulation of cAMP biosynthetic pr...; IDA:UniProtKB		0:DRD4|0:ADRA2A|0:APLP1|0:GRM7|0:GRM8|0:HTR1B			
GO:0085018	P:maintenance of symbiont-containing vacuole ...; IMP:UniProtKB		0:AQP1			
GO:0000266	P:mitochondrial fission; TAS:UniProtKB		0:FIS1|0:MUL1|0:OPA1			
GO:0070723	P:response to cholesterol; IDA:BHF-UCL		0:TGFBR2|0:SMAD2|0:TGFBR1|0:TGFB1			
GO:0015105	F:arsenite transmembrane transporter activity; TAS:ProtInc		0:OCA2|0:ASNA1			
GO:0004123	F:cystathionine gamma-lyase activity; IDA:UniProtKB		0:CTH			
GO:0042626	F:ATPase activity, coupled to transmembrane m...; TAS:ProtInc		0:ABCC1|0:ABCA8|0:ABCC12|0:ABCC5|0:ABCC8|0:ABCB10|0:ABCC9|0:ABCB8|0:ABCC11|0:ABCB5|0:ABCC13|0:TAP1|0:ABCC4|0:ABCC10|0:ABCA2|0:ABCD1|0:ABCD4|0:ABCC6|0:ABCD3|0:ABCC2|0:ABCF1|0:ABCC3|0:ABCA4|0:ABCA3|0:ABCB7			
GO:0016779	F:nucleotidyltransferase activity; IEA:UniProtKB-KW		0:MOCS3|0:GPHN|0:EIF2B3|0:OAS1|0:OAS3|0:UAP1L1			
GO:0034707	C:chloride channel complex; IEA:UniProtKB-KW		0:CLIC4|0:GABRP|0:GABRR2|0:ANO2|0:GLRA3|0:TTYH1|0:GABRB3|0:GABRG2|0:FXYD1|0:TTYH3|0:GABRA4|0:BEST2|0:ANO6|0:GABRE|0:ANO3|0:GLRA2|0:GABRG1|0:GABRA6|0:GABRR1|0:CFTR|0:GABRA3|0:CLCA3P|0:BEST3|0:CLCN1|0:GABRD|0:ANO7|0:CLIC3|0:FXYD3|0:CLCNKB|0:ANO4|0:CLCN2|0:GABRA2|0:CLIC6|0:CLCNKA|0:GABRA1|0:GLRA1|0:ANO8|0:BEST4|0:ANO1|0:CLIC2|0:GLRA4|0:ANO5|0:CLIC5|0:GABRA5|0:GABRB2|0:GABRR3|0:GLRB|0:GABRQ|0:ANO9|0:ANO10|0:GABRG3|0:CLIC1|0:GABRB1|0:BEST1|0:TTYH2			
GO:0048511	P:rhythmic process; IEA:UniProtKB-KW		0:FBXL3|0:FBXL21|0:FBXW11|0:DBP|0:ENOX1|0:TEF|0:NFIL3|0:HLF|0:SRRD|0:OPN4|0:CCRN4L|0:PER3			
GO:0018125	P:peptidyl-cysteine methylation; IDA:MGI		0:RAB6A			
GO:0007126	P:meiosis; TAS:ProtInc		0:BOLL|0:SMC3|0:STAG2|0:UTP14C|0:WBP2NL|0:NBN|0:FBXO43|0:PIWIL4|0:TDRD1|0:RBM7|0:PPP2CA|0:HORMAD1|0:PIWIL1|0:H2AFX|0:MND1|0:SMC1B|0:H1FOO|0:SLC26A8|0:RSPH1|0:EXO1|0:NEK2|0:C16orf73|0:PRDM9|0:ZNF318|0:DPEP3|0:BUB3|0:PIWIL3|0:CCNB3|0:MNS1|0:PSMC3IP|0:SMC1A|0:ZFP42|0:DMWD|0:OSGIN2|0:TOP3A|0:DUSP13|0:ZW10|0:XRCC2|0:RAD54L			
GO:0006568	P:tryptophan metabolic process; ISS:UniProtKB		0:ATP7A			
GO:0000275	C:mitochondrial proton-transporting ATP synth...; NAS:UniProtKB		0:ATP5E|0:ATP5C1|0:ATP5D			
GO:0045943	P:positive regulation of transcription from R...; ISS:UniProtKB		0:PHF8|0:RASL11A|0:UBTF			
GO:0030425	C:dendrite; TAS:BHF-UCL		0:NF1|0:TRIM9|0:DNER|0:SKOR1|0:GCHFR|0:GRIN1|0:ATXN10|0:RAB27A|0:ATXN1L|0:LRFN3|0:GOPC|0:SAMD4A|0:CNR2|0:NGDN|0:C19orf20|0:TTLL7|0:CPEB1|0:CAPRIN1|0:MPDZ|0:WFS1|0:DRD2|0:MAP1S|0:ADCY2|0:OPA1|0:CHRNA3|0:CDK5|0:TRAPPC4|0:NCDN|0:MAGEE1|0:RBM3|0:BNIP3|0:STRN3|0:SRCIN1|0:RELN|0:CHRNA4|0:APOE|0:DBN1|0:SHANK1|0:CNTNAP2|0:SACS			
GO:0051971	P:positive regulation of transmission of nerv...; IDA:HGNC		0:CARTPT			
GO:0003910	F:DNA ligase (ATP) activity; IEA:EC		0:LIG4|0:LIG1|0:LIG3			
GO:0004648	F:O-phospho-L-serine:2-oxoglutarate aminotran...; NAS:UniProtKB		0:PSAT1			
GO:0005319	F:lipid transporter activity; TAS:ProtInc		0:APOM|0:RFT1|0:MTTP|0:APOL6|0:APOC4|0:APOF|0:CFHR4|0:SFTPA1|0:LRP1|0:APOD|0:APOL3			
GO:0032588	C:trans-Golgi network membrane; IDA:UniProtKB		0:SCAMP5|0:GNAS|0:SCAMP2			
GO:0045509	F:interleukin-27 receptor activity; IC:BHF-UCL		0:IL6ST			
GO:0004016	F:adenylate cyclase activity; TAS:ProtInc		0:GNAL|0:ADCY7|0:ADCY4|0:ADCY5|0:THTPA|0:ADCY10|0:ADCY9			
GO:0048557	P:embryonic digestive tract morphogenesis; IMP:BHF-UCL		0:NIPBL			
GO:0044183	F:protein binding involved in protein folding; TAS:BHF-UCL		0:HSPA1A|0:HSPA1B|0:CALR			
GO:0006949	P:syncytium formation; TAS:ProtInc		0:ERVWE1			
GO:0070051	F:fibrinogen binding; IDA:BHF-UCL		0:THBS1			
GO:0009607	P:response to biotic stimulus; TAS:ProtInc		0:IGBP1|0:TMEM90A|0:IFITM5|0:PRRT1|0:TMEM90B|0:TMEM91|0:TUSC5|0:PRRT2|0:TMEM233|0:CCL18			
GO:0051725	P:protein amino acid de-ADP-ribosylation; IEA:InterPro		0:ADPRH|0:ADPRHL1			
GO:0042110	P:T cell activation; TAS:UniProtKB		0:CD80|0:HSPD1|0:DPP4|0:FOXP3|0:CD276|0:DDOST|0:ADA|0:TREML2|0:NLRC3|0:NCK1|0:FKBP1A|0:CD3G|0:NCK2|0:CD8B|0:IRF4|0:KIF13B|0:ICOSLG|0:PRLR|0:SLA2|0:CD2|0:CLEC7A|0:CD7			
GO:0055098	P:response to low-density lipoprotein stimulus; IDA:BHF-UCL		0:PPARG			
GO:0010536	P:positive regulation of activation of Janus ...; IDA:BHF-UCL		0:IL6R			
GO:0008021	C:synaptic vesicle; TAS:ProtInc		0:PPT1|0:CLN3|0:SEPT5|0:SYPL1|0:DOC2B|0:SYN2|0:PCLO|0:SYT17|0:SYTL4|0:SYPL2|0:TRIM9|0:STXBP5|0:LGI3|0:RABAC1|0:GIPC1|0:SYNGR3|0:TRAPPC4|0:TPRG1L|0:MT3|0:GRIN1|0:APBA1|0:HCRT|0:RAB3A			
GO:0043005	C:neuron projection; NAS:UniProtKB		0:CDH13|0:GRIN3A|0:CLN3|0:MARK4|0:INPP5K|0:GHSR|0:ATP7A|0:NRCAM			
GO:0055065	P:metal ion homeostasis; NAS:UniProtKB		0:SLC7A8			
GO:0047016	F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-de...; IEA:EC		0:HSD3B7			
GO:0010693	P:negative regulation of alkaline phosphatase...; IDA:BHF-UCL		0:TGFB2			
GO:0009450	P:gamma-aminobutyric acid catabolic process; NAS:UniProtKB		0:ALDH5A1|0:ABAT			
GO:0045590	P:negative regulation of regulatory T cell di...; IDA:BHF-UCL		0:CTLA4			
GO:0030194	P:positive regulation of blood coagulation; IDA:BHF-UCL		0:F12|0:F2R			
GO:0050906	P:detection of stimulus involved in sensory p...; IEA:InterPro		0:PPEF1|0:PPEF2			
GO:0006396	P:RNA processing; TAS:UniProtKB		0:ADARB1|0:DDX54|0:LARP7|0:MRM1|0:RTCD1|0:RNASEN|0:ADAD1|0:TARBP1|0:CHERP|0:PNPT1|0:TRMT2A|0:ADAD2|0:RSL1D1|0:MRPL44|0:RNMTL1|0:SART3|0:MRPL1|0:RPL10A|0:ZFC3H1|0:LARP6|0:ATXN1|0:DEDD2|0:RBPMS|0:RBM6|0:PABPC4|0:NUFIP1|0:BICD1|0:RBMS1|0:HNRPDL|0:DDX17|0:RBMS2|0:DUSP11|0:SETX|0:AGGF1			
GO:0006430	P:lysyl-tRNA aminoacylation; IDA:UniProtKB		0:KARS			
GO:0007059	P:chromosome segregation; TAS:ProtInc		0:PPP2R1A|0:SRPK1|0:NEK6|0:CENPH|0:CENPO|0:DSN1|0:BIRC5|0:PTTG1|0:UBE2I|0:BUB1|0:STAG3|0:NUP37|0:NSL1|0:NUP43|0:USP9X|0:RAD21|0:STAG1|0:KIF2C|0:CTCF|0:PMF1|0:METTL11A|0:SKA3|0:RCC1|0:SPC25|0:MIS12|0:SETDB2|0:HJURP|0:BRCA1|0:SKA1|0:INCENP|0:NDEL1|0:TOP2A|0:SKA2|0:ARL8B|0:ARL8A|0:NUF2|0:RIOK3			
GO:0006521	P:regulation of cellular amino acid metabolic...; IMP:BHF-UCL		0:INS			
GO:0004111	F:creatine kinase activity; TAS:ProtInc		0:CKMT1B|0:CKMT2|0:CKMT1A|0:CKB|0:CKM			
GO:0050901	P:leukocyte tethering or rolling; IMP:BHF-UCL		0:TNF|0:ROCK1|0:VCAM1|0:SELE			
GO:0061054	P:dermatome development; ISS:BHF-UCL		0:WNT1|0:WNT3A|0:WNT4|0:SFRP2			
GO:0060760	P:positive regulation of response to cytokine...; IMP:BHF-UCL		0:WNT5A|0:TAF9			
GO:0007212	P:dopamine receptor signaling pathway; IEA:InterPro		0:CALY			
GO:0007405	P:neuroblast proliferation; TAS:ProtInc		0:PAFAH1B1|0:RACGAP1|0:SHH|0:ARTN			
GO:0006525	P:arginine metabolic process; NAS:UniProtKB		0:ARG2|0:ART4			
GO:0016264	P:gap junction assembly; TAS:UniProtKB		0:GJD3|0:GJA1			
GO:0002769	P:natural killer cell inhibitory signaling pa...; IDA:UniProtKB		0:KIR2DL1			
GO:0005975	P:carbohydrate metabolic process; TAS:ProtInc		0:NEU3|0:SLC3A2|0:GLB1L3|0:B4GALT4|0:KLB|0:HYAL3|0:LCT|0:STBD1|0:LCTL|0:SLC3A1|0:C9orf103|0:GUSBP1|0:MGAT4C|0:B4GALT5|0:GLB1|0:GALC|0:HEXDC|0:MPI|0:KL|0:GANC|0:GANAB|0:GGTA1|0:GLT6D1|0:ATHL1|0:B4GALT6|0:B4GALT2|0:FGGY|0:GBGT1|0:PARG|0:HEXA|0:SI|0:GLB1L|0:ALG13|0:GLB1L2|0:KIAA1161|0:MANBA|0:GBA|0:GUSBL1|0:B4GALT3|0:MDH1B|0:NPL|0:RPE|0:PGP|0:INSR|0:MLEC|0:IDH3G|0:SLC2A3|0:ALDH1B1|0:GALNT4|0:ABCC8|0:AMY2B|0:GLO1|0:ME1|0:IDH3A|0:SLC35A1|0:ADRB3|0:SLC2A4|0:B3GAT1|0:ALDH2|0:TFF1|0:NAGPA|0:SLC2A5|0:AMY1C|0:SHPK|0:AKR7A2|0:PIGQ|0:SPAM1|0:SLC5A2|0:AMY1B|0:SLC2A2|0:CNOT7|0:HAS3|0:AKR1B1|0:B4GALNT1|0:AMY1A			
GO:0001593	F:dopamine D4 receptor activity; ISS:BHF-UCL		0:DRD4			
GO:0016561	P:protein import into peroxisome matrix, tran...; IMP:UniProtKB		0:PEX5|0:PEX6			
GO:0006471	P:protein amino acid ADP-ribosylation; TAS:ProtInc		0:TNKS2|0:PARP1|0:GNA11|0:GNAQ|0:GNA15|0:GNA14|0:SIRT6|0:SIRT2|0:ART4|0:PARP4|0:SIRT4|0:ART1|0:PARP2|0:SIRT3|0:PARP3|0:SIRT5|0:ART3			
GO:0051315	P:attachment of spindle microtubules to kinet...; IMP:UniProtKB		0:SEH1L			
GO:0030686	C:90S preribosome; ISS:UniProtKB		0:UTP20			
GO:0008135	F:translation factor activity, nucleic acid b...; TAS:ProtInc		0:SOX11|0:GCN1L1|0:GTF2H2|0:PET112L|0:ABCF1|0:GTF2H3|0:EEF2K			
GO:0016167	F:glial cell line-derived neurotrophic factor...; TAS:ProtInc		0:GFRA2|0:GFRA1			
GO:0006953	P:acute-phase response; TAS:ProtInc		0:INS|0:AHSG|0:SAAL1|0:SAA3P|0:SAA4|0:SERPINA3|0:F8|0:MRGPRX1|0:CD163|0:REG3A|0:ITIH4|0:SERPINA1|0:FN1|0:REG3G|0:SERPINF2|0:F2|0:LBP|0:SIGIRR|0:IL22|0:SAA1|0:APOL2|0:SAA2|0:CRP|0:MBL2|0:IL6R|0:IL6|0:ORM2|0:CEBPB|0:APCS|0:ORM1			
GO:0051964	P:negative regulation of synaptogenesis; ISS:UniProtKB		0:ROBO2|0:SLIT1			
GO:0004697	F:protein kinase C activity; TAS:ProtInc		0:PKN3|0:PRKD2|0:PRKCZ|0:PRKCQ|0:PRKD1|0:PKN2|0:PKN1|0:PRKCI|0:PRKCH|0:PRKCG|0:PRKCB|0:PRKD3			
GO:0006429	P:leucyl-tRNA aminoacylation; IEA:InterPro		0:LARS|0:LARS2			
GO:0007620	P:copulation; IEA:InterPro		0:PI3			
GO:0032765	P:positive regulation of mast cell cytokine p...; NAS:UniProtKB		0:BCL10			
GO:0004458	F:D-lactate dehydrogenase (cytochrome) activity; IEA:EC		0:LDHD			
GO:0032736	P:positive regulation of interleukin-13 produ...; IDA:BHF-UCL		0:RARA			
GO:0031297	P:replication fork processing; IDA:UniProtKB		0:WRN|0:BLM			
GO:0043021	F:ribonucleoprotein binding; ISS:BHF-UCL		0:PPIH|0:CD2BP2|0:PRPF6|0:SRP54|0:TIMM50|0:PRMT5|0:ITCH|0:IFIH1|0:RNF135|0:PRMT7|0:UHMK1			
GO:0035473	F:lipase binding; IPI:BHF-UCL		0:GPIHBP1			
GO:0006478	P:peptidyl-tyrosine sulfation; TAS:ProtInc		0:TPST2|0:TPST1			
GO:0005881	C:cytoplasmic microtubule; TAS:ProtInc		0:BIRC5|0:MID1|0:CLASP1|0:CLASP2|0:GTSE1|0:TUBGCP2			
GO:0006259	P:DNA metabolic process; TAS:ProtInc		0:DNASE2B|0:PTTG3P|0:MYO18A|0:PTTG2|0:SMARCAL1|0:KPNA2|0:NT5E|0:ADRA1D|0:IGFBP4			
GO:0030916	P:otic vesicle formation; ISS:HGNC		0:CEP290			
GO:0016570	P:histone modification; IEA:InterPro		0:RTF1			
GO:0005109	F:frizzled binding; NAS:BHF-UCL		0:WNT1|0:NDP|0:SDCBP|0:WNT3|0:WNT2|0:SFRP1|0:WNT5A|0:WNT8A			
GO:0005597	C:collagen type XVI; TAS:ProtInc		0:COL16A1			
GO:0032509	P:endosome transport via multivesicular body ...; IDA:BHF-UCL		0:SORT1			
GO:0050692	F:DBD domain binding; IPI:BHF-UCL		0:PROX1			
GO:0033158	P:regulation of protein import into nucleus, ...; IMP:UniProtKB		0:SIRT1			
GO:0030173	C:integral to Golgi membrane; TAS:UniProtKB		0:ACER3|0:SGMS1|0:STEAP2|0:SGMS2|0:PCSK7|0:ACER2|0:RER1|0:ENTPD4|0:QSOX1|0:ST6GALNAC2|0:CUX1|0:ST3GAL1|0:ST8SIA4|0:RFNG|0:ST6GALNAC3|0:ST3GAL5|0:ST8SIA1|0:ST3GAL2|0:ST6GAL2|0:ST6GALNAC1|0:ST8SIA5|0:ST3GAL6|0:ST3GAL3|0:MFNG|0:LFNG|0:ST6GALNAC4|0:ST8SIA2|0:ST6GAL1|0:ST6GALNAC5|0:ST8SIA6|0:B4GALNT1|0:ST3GAL4|0:B4GALNT2|0:ST8SIA3|0:ST6GALNAC6|0:GALNT2|0:CSGALNACT2|0:A4GALT|0:ABO|0:CSGALNACT1|0:CHST12|0:FUT2|0:B3GNT1|0:MAN1C1|0:LARGE			
GO:0005854	C:nascent polypeptide-associated complex; TAS:ProtInc		0:NACA			
GO:0019059	P:initiation of viral infection; EXP:Reactome		0:BANF1|0:HMGA1|0:CD4|0:XRCC6|0:LIG4|0:CXCR4|0:PSIP1|0:XRCC5|0:CCR5|0:XRCC4|0:PPIA			
GO:0005048	F:signal sequence binding; TAS:ProtInc		0:TOMM34|0:SSR3|0:SSR1|0:SSR2			
GO:0048155	F:S100 alpha binding; IPI:UniProtKB		0:AGER|0:ATP2A2|0:ANXA11|0:S100A1|0:FGF1			
GO:0008265	F:Mo-molybdopterin cofactor sulfurase activity; IMP:UniProtKB		0:MOCOS			
GO:0051156	P:glucose 6-phosphate metabolic process; IMP:BHF-UCL		0:G6PD			
GO:0016301	F:kinase activity; NAS:UniProtKB		0:MVD|0:AGPHD1|0:FAM20B|0:SGMS1|0:FN3KRP|0:PRPS1L1|0:SGMS2|0:TPK1|0:LRGUK|0:PSTK|0:PRPS1|0:FGGY|0:PMS2L1|0:PRPS2|0:PMS2L11|0:ADCK3|0:HMGXB3			
GO:0032472	P:Golgi calcium ion transport; IMP:UniProtKB		0:ATP2C1			
GO:0032223	P:negative regulation of synaptic transmissio...; IC:HGNC		0:ACHE			
GO:0019866	C:organelle inner membrane; IDA:UniProtKB		0:NEU4			
GO:0008107	F:galactoside 2-alpha-L-fucosyltransferase ac...; TAS:UniProtKB		0:CLASP2|0:FUT1|0:FUT2			
GO:0070934	P:CRD-mediated mRNA stabilization; IMP:UniProtKB		0:IGF2BP1|0:SYNCRIP|0:YBX1|0:HNRNPU|0:DHX9			
GO:0045121	C:membrane raft; TAS:HGNC		0:TNFRSF1B|0:TNF|0:FURIN|0:TNFRSF1A|0:STX12|0:ADAM17|0:ABCA1|0:BTK|0:MALL|0:PAG1|0:LAT2|0:PIKFYVE|0:TEK|0:CD55|0:MAL|0:PPT1|0:SLC6A4|0:CARD11|0:LCK|0:STOM|0:LYN|0:CD24|0:GHSR|0:PI4K2A|0:CD48|0:ANGPT1|0:EFHD2|0:PTPRC|0:IKBKB|0:PODXL|0:SMURF2|0:BCL10|0:DPP4|0:RGMB|0:GJA1|0:ITLN1|0:PRNP|0:CD79A|0:SHH|0:THY1|0:ACE2|0:CD226|0:LAT			
GO:0042825	C:TAP complex; IDA:UniProtKB		0:TAP2|0:TAP1			
GO:0030056	C:hemidesmosome; TAS:UniProtKB		0:ERBB2IP|0:COL17A1|0:DST			
GO:0006681	P:galactosylceramide metabolic process; ISS:UniProtKB		0:CLN3|0:ALDH5A1			
GO:0031579	P:membrane raft organization; IMP:UniProtKB		0:PPT1			
GO:0010734	P:negative regulation of protein amino acid g...; IMP:BHF-UCL		0:G6PD			
GO:0002018	P:renin-angiotensin regulation of aldosterone...; NAS:BHF-UCL		0:AGTR1|0:AGT			
GO:0005751	C:mitochondrial respiratory chain complex IV; IEA:InterPro		0:COX4I2|0:COX6A2|0:COX6A1			
GO:0048295	P:positive regulation of isotype switching to...; ISS:UniProtKB		0:IL4			
GO:0035555	P:initiation of Roundabout signal transduction; IC:BHF-UCL		0:SLIT2			
GO:0070935	P:3'-UTR-mediated mRNA stabilization; IMP:UniProtKB		0:TARDBP|0:RBM38|0:ELAVL1			
GO:0030502	P:negative regulation of bone mineralization; NAS:UniProtKB		0:ECM1|0:SRGN|0:FGF23|0:AHSG|0:STATH			
GO:0005545	F:phosphatidylinositol binding; TAS:UniProtKB		0:WDFY3|0:EEA1|0:WDFY1|0:ZFYVE16|0:FRMPD2|0:ZFYVE1|0:EPB41|0:PICALM|0:PLEKHA5|0:PLEKHA4|0:PIK3R1|0:SCARB1|0:CYTH3|0:SCIN|0:SYT1			
GO:0018076	P:N-terminal peptidyl-lysine acetylation; IDA:UniProtKB		0:CREBBP|0:EP300|0:KAT2B			
GO:0051057	P:positive regulation of small GTPase mediate...; ISS:UniProtKB		0:RELN			
GO:0042524	P:negative regulation of tyrosine phosphoryla...; IDA:HGNC		0:NF2			
GO:0006099	P:tricarboxylic acid cycle; TAS:UniProtKB		0:ACO2|0:SDHD|0:IDH3G|0:ACO1|0:SUCLG2|0:MDH1|0:MDH2|0:IDH2|0:FH|0:CS|0:SUCLG1|0:IDH3B|0:IDH1|0:SUCLA2|0:DLST|0:IDH3A|0:MDH1B|0:PDHB|0:SDHB|0:SDHA|0:NNT|0:SDHC			
GO:0045517	F:interleukin-20 receptor binding; TAS:UniProtKB		0:IL20			
GO:0000160	P:two-component signal transduction system (p...; NAS:UniProtKB		0:KCNH4|0:PDE8A|0:KCNH3|0:PDE8B|0:KCNH2|0:KCNH1|0:KCNH8|0:KCNH5|0:MMS19			
GO:0034381	P:plasma lipoprotein particle clearance; ISS:BHF-UCL		0:MSR1			
GO:0070508	P:cholesterol import; ISS:BHF-UCL		0:APOA1|0:SCARB1			
GO:0045409	P:negative regulation of interleukin-6 biosyn...; ISS:BHF-UCL		0:NLRP12|0:GHRL|0:GHSR|0:FOXJ1			
GO:0007191	P:activation of adenylate cyclase activity by...; IDA:UniProtKB		0:DRD3|0:DRD1|0:DRD5			
GO:0001618	F:viral receptor activity; ISS:HGNC		0:ACE2|0:SIVA1			
GO:0009435	P:NAD biosynthetic process; IEA:InterPro		0:NMNAT1|0:NMNAT3|0:NMNAT2|0:NADSYN1|0:KYNU|0:ASPDH			
GO:0016941	F:natriuretic peptide receptor activity; IDA:UniProtKB		0:NPR1|0:NPR2|0:NPR3			
GO:0090044	P:positive regulation of tubulin deacetylation; IDA:BHF-UCL		0:FNTA			
GO:0051861	F:glycolipid binding; IEA:InterPro		0:GLTP|0:PLEKHA8|0:GLTPD2|0:PLEKHA9|0:GLTPD1			
GO:0032966	P:negative regulation of collagen biosyntheti...; IDA:BHF-UCL		0:CIITA|0:IL6R|0:IL6			
GO:0001889	P:liver development; NAS:UniProtKB		0:WNT4|0:CITED2|0:TGFBR3|0:NF1|0:PCSK9|0:LSR|0:CEBPG|0:NKX2-8			
GO:0004985	F:opioid receptor activity; TAS:ProtInc		0:OGFR|0:NPBWR2|0:NPBWR1|0:OPCML			
GO:0016942	C:insulin-like growth factor binding protein ...; IC:BHF-UCL		0:IGF1|0:IGFBP3|0:IGFBP5			
GO:0050614	F:delta24-sterol reductase activity; EXP:Reactome		0:DHCR24			
GO:0045541	P:negative regulation of cholesterol biosynth...; NAS:UniProtKB		0:APOE|0:SOD1|0:SCAP			
GO:0048701	P:embryonic cranial skeleton morphogenesis; ISS:BHF-UCL		0:TGFBR2|0:TGFBR1			
GO:0045910	P:negative regulation of DNA recombination; IDA:BHF-UCL		0:MSH2|0:MSH3|0:MSH6			
GO:0010447	P:response to acidity; IDA:BHF-UCL		0:GPR65			
GO:0006644	P:phospholipid metabolic process; TAS:UniProtKB		0:PLCE1|0:PROCA1|0:OC90|0:PLA2G10|0:PLA2G12A|0:PLA2G2C|0:PLA2G2F|0:CLN8|0:LPL|0:LGALS13|0:PLA2G3|0:PLAA|0:PLCB2|0:PLA2G2E|0:PLCD1|0:PLA2G2D|0:GPX4			
GO:0006233	P:dTDP biosynthetic process; IEA:InterPro		0:DTYMK			
GO:0072233	P:metanephric thick ascending limb development; ISS:UniProtKB		0:POU3F3			
GO:0033169	P:histone H3-K9 demethylation; IDA:UniProtKB		0:KDM3A			
GO:0007268	P:synaptic transmission; TAS:UniProtKB		0:GRM7|0:PMCHL2|0:PMCH|0:PMCHL1|0:TAC1|0:PDYN|0:CARTPT|0:PNOC|0:PAFAH1B1|0:GIPC1|0:MYCBPAP|0:KCNMA1|0:GLRA3|0:SDCBP|0:KCNIP2|0:NPTX2|0:GRIK5|0:DLGAP1|0:GABRR3|0:GABRG3|0:GRM2|0:AMPH|0:LPAR3|0:MBP|0:KCNMB4|0:SLC6A2|0:CACNA1E|0:PI4KA|0:GABRR2|0:DLG4|0:NPFF|0:UTS2|0:SLC1A1|0:KCNQ2|0:UNC119|0:APBA1|0:GRM1|0:PDE7B|0:MAPK1|0:SYPL1|0:GABBR2|0:HAP1|0:AKAP5|0:GRIA2|0:KCNK3|0:GRM3|0:KCNQ3|0:NOVA1|0:HTR2C|0:SLC1A2|0:ATXN3|0:SLC6A5|0:GABRR1|0:KCNA1|0:KCNIP1|0:MPZ|0:CPNE6|0:HTR1D|0:PMP22|0:CACNA1B|0:KIF5A|0:CBLN1|0:NPBWR1|0:KCNC4|0:ACCN1|0:NPTX1|0:VIPR1|0:HTR3A|0:HCRTR1|0:SYT5|0:HTR6|0:AKAP9|0:BSN|0:OPRK1|0:HTR1E|0:SLC1A6|0:TAAR5|0:SCN1B|0:STX1B|0:GABARAP|0:CPLX1|0:HTR3B|0:HTR1F|0:RIT2|0:KCNQ5|0:NPY|0:SLC6A1|0:OMP|0:PLP1|0:GRIK4|0:GABRB2|0:GPR176|0:GRIK1|0:KCNN1|0:GRM5|0:SCN2B|0:MTNR1B|0:GRIA1|0:CRH|0:CORT|0:HTR2A|0:KCNMB1|0:HTR1B|0:HOMER1|0:CNP|0:PCDHB10|0:PCDHB16|0:SST|0:PCDHB6|0:PCDHB9|0:PCDHB11|0:PCDHB5|0:PCDHB14|0:KCND2|0:PCDHB2|0:PCDHB4|0:PCDHB13|0:PCDHB3			
GO:0051013	P:microtubule severing; IDA:UniProtKB		0:SPAST			
GO:0002309	P:T cell proliferation involved in immune res...; ISS:BHF-UCL		0:SLC11A1			
GO:0046856	P:phosphoinositide dephosphorylation; IDA:UniProtKB		0:PTEN			
GO:0030511	P:positive regulation of transforming growth ...; TAS:BHF-UCL		0:THBS1|0:TGFB1I1|0:SMAD4|0:ING2|0:CDKN2B|0:CDKN1C|0:MEN1|0:HIPK2|0:GIPC1|0:ADAM17|0:CITED2|0:CITED1			
GO:0019318	P:hexose metabolic process; IEA:InterPro		0:GALM			
GO:0001505	P:regulation of neurotransmitter levels; IMP:UniProtKB		0:GABRA2			
GO:0070740	F:tubulin-glutamic acid ligase activity; TAS:UniProtKB		0:TTLL1			
GO:0030037	P:actin filament reorganization involved in c...; TAS:UniProtKB		0:ARAP1			
GO:0032026	P:response to magnesium ion; IDA:UniProtKB		0:THBS1|0:SNCA			
GO:0035259	F:glucocorticoid receptor binding; IPI:UniProtKB		0:STAT5B|0:YWHAH|0:NRIP1			
GO:0033867	F:Fas-activated serine/threonine kinase activity; IEA:EC		0:FASTK			
GO:0019788	F:NEDD8 ligase activity; IDA:UniProtKB		0:RNF7|0:RBX1|0:UBE2M|0:UBE2F			
GO:0006654	P:phosphatidic acid biosynthetic process; IMP:UniProtKB		0:ABHD5|0:AGPAT2|0:AGPAT1|0:SLC27A1			
GO:0000268	F:peroxisome targeting sequence binding; TAS:UniProtKB		0:BRE			
GO:0042472	P:inner ear morphogenesis; ISS:UniProtKB		0:CHD7|0:SIX1|0:ZIC1			
GO:0032059	C:bleb; ISS:BHF-UCL		0:PANX1|0:TPM1|0:P2RX7			
GO:0032753	P:positive regulation of interleukin-4 produc...; IDA:BHF-UCL		0:RARA			
GO:0015297	F:antiporter activity; IEA:UniProtKB-KW		0:SLC47A1|0:SLC47A2|0:CLCN4|0:SLC24A4|0:SLC38A3|0:CLCN7|0:SLC26A10|0:CLCN3|0:CLCN6|0:SLC24A2|0:SLC24A6|0:SLC7A6|0:CLCN5|0:SLC24A5			
GO:0005592	C:collagen type XI; NAS:UniProtKB		0:COL11A1|0:COL11A2			
GO:0046629	P:gamma-delta T cell activation; IDA:UniProtKB		0:MICA|0:MICB			
GO:0032792	P:negative regulation of CREB transcription f...; IDA:UniProtKB		0:FOXP3			
GO:0009611	P:response to wounding; TAS:UniProtKB		0:TNC|0:WNT1|0:SOX2|0:PAX6|0:POU5F1|0:MDK|0:KLK8|0:ADM|0:CTGF|0:HOXB13|0:GAP43|0:LYVE1|0:CX3CR1|0:ACHE			
GO:0006747	P:FAD biosynthetic process; IEA:InterPro		0:FLAD1			
GO:0061180	P:mammary gland epithelium development; IEP:UniProtKB		0:WNT3|0:WNT2|0:WNT7B			
GO:0016337	P:cell-cell adhesion; NAS:UniProtKB		0:CD34|0:CDSN|0:DLG1|0:CRNN|0:CD93|0:CYFIP2|0:CBLL1|0:SRPX2|0:ANXA9|0:CDH24|0:ICAM3|0:ICAM4|0:ICAM5|0:ICAM2|0:COL13A1|0:SCRIB|0:CTNNB1|0:PSEN1|0:EGFR|0:CTNNA3|0:VNN1|0:CTNNA2|0:THY1|0:PKHD1|0:GPR98|0:ITGAD|0:ROPN1B|0:CD58|0:JAM2|0:CTNND1|0:SIGLEC1|0:PKP2|0:DLG5|0:ITGA8|0:COL19A1|0:ZAN|0:NLGN2|0:COL6A2|0:CD2|0:NPHP4|0:CD24|0:CD44|0:PKD1L1|0:NRCAM|0:COL8A2|0:NPHP1|0:COL14A1			
GO:0090026	P:positive regulation of monocyte chemotaxis; IMP:BHF-UCL		0:S100A14|0:S100A7|0:CXCL12|0:SERPINE1			
GO:0008442	F:3-hydroxyisobutyrate dehydrogenase activity; NAS:UniProtKB		0:HIBADH			
GO:0000046	P:autophagic vacuole fusion; ISS:UniProtKB		0:CLN3			
GO:0000077	P:DNA damage checkpoint; TAS:UniProtKB		0:H2AFX|0:RPA4|0:ATR|0:TIPRL|0:USP28|0:CHEK1|0:HINFP|0:RAD17|0:CEP63|0:BRIP1|0:HUS1|0:FOXN3|0:RAD9A|0:RAD1|0:ATRIP|0:CHEK2|0:FBXO6			
GO:0015137	F:citrate transmembrane transporter activity; TAS:UniProtKB		0:SLC13A5|0:OCA2|0:SLC25A1			
GO:0005639	C:integral to nuclear inner membrane; TAS:ProtInc		0:LBR|0:LEMD3			
GO:0044140	P:negative regulation of growth of symbiont o...; IDA:MGI		0:CAMP			
GO:0006482	P:protein amino acid demethylation; IDA:HGNC		0:PPME1			
GO:0016176	F:superoxide-generating NADPH oxidase activat...; TAS:BHF-UCL		0:NOXA1|0:NOXO1			
GO:0008907	F:integrase activity; IEA:InterPro		0:PPFIBP2|0:ERVK6			
GO:0050873	P:brown fat cell differentiation; TAS:UniProtKB		0:UCP1|0:ADIG|0:PRDM16|0:PPARGC1A			
GO:0045475	P:locomotor rhythm; ISS:UniProtKB		0:KCNMA1			
GO:0009186	P:deoxyribonucleoside diphosphate metabolic p...; IEA:InterPro		0:RRM2|0:RRM2B			
GO:0033300	F:dehydroascorbic acid transporter activity; IMP:UniProtKB		0:SLC23A1			
GO:0016281	C:eukaryotic translation initiation factor 4F...; TAS:UniProtKB		0:EIF4G2|0:EIF4EBP3|0:EIF4E|0:EIF4G3|0:EIF4H|0:EIF4B|0:EIF4A2|0:EIF4G1|0:EIF4A1			
GO:0048186	F:inhibin beta-A binding; IDA:UniProtKB		0:ACVR2A|0:IGSF1			
GO:0007200	P:activation of phospholipase C activity by G...; TAS:ProtInc		0:NMUR2|0:CXCR2|0:PLCE1|0:NMUR1|0:AGT|0:HRH1|0:P2RY6|0:TACR1|0:P2RY4|0:MC3R|0:P2RY11|0:LTB4R|0:EDNRB|0:P2RY1|0:CCKBR|0:CCKAR|0:F2RL3|0:NMBR|0:P2RY2			
GO:0043509	C:activin A complex; IDA:HGNC		0:INHBA			
GO:0032693	P:negative regulation of interleukin-10 produ...; IDA:UniProtKB		0:FOXP3			
GO:0043631	P:RNA polyadenylation; IEA:InterPro		0:PAPD4|0:PAPOLG|0:PAPOLB			
GO:0090193	P:positive regulation of glomerulus development; ISS:UniProtKB		0:NOG			
GO:0051568	P:histone H3-K4 methylation; IDA:UniProtKB		0:CXXC1|0:DPY30|0:ASH2L|0:WDR5|0:SETD1B|0:RBBP5|0:WDR82			
GO:0004371	F:glycerone kinase activity; IEA:EC		0:DAK			
GO:0003007	P:heart morphogenesis; NAS:BHF-UCL		0:CHD7|0:INSR|0:BAZ1B|0:HTR2B|0:DLC1|0:TH			
GO:0060547	P:negative regulation of necrotic cell death; IMP:BHF-UCL		0:SLC25A4			
GO:0046881	P:positive regulation of follicle-stimulating...; TAS:UniProtKB		0:INHBB|0:INHA|0:INHBA			
GO:0010880	P:regulation of release of sequestered calciu...; ISS:BHF-UCL		0:CALM2|0:CALM3|0:CALM1			
GO:0004630	F:phospholipase D activity; TAS:ProtInc		0:PLD4|0:PLD6|0:PLD3|0:PLD2|0:PLD1			
GO:0046884	P:follicle-stimulating hormone secretion; IMP:UniProtKB		0:TBX3			
GO:0032637	P:interleukin-8 production; ISS:BHF-UCL		0:PLA2G1B			
GO:0008028	F:monocarboxylic acid transmembrane transport...; TAS:ProtInc		0:SLC16A6|0:SLC16A4|0:SLC16A2			
GO:0016328	C:lateral plasma membrane; IEA:UniProtKB-SubCell		0:CDH1|0:AXIN1|0:CTNNB1|0:APC|0:BVES|0:MYO1A|0:MYO1C|0:SLCO1B3			
GO:0006883	P:cellular sodium ion homeostasis; NAS:UniProtKB		0:TMPRSS3|0:NEDD4L			
GO:0019543	P:propionate catabolic process; IEA:InterPro		0:IRG1			
GO:0009982	F:pseudouridine synthase activity; IEA:InterPro		0:PUS1|0:RPUSD2|0:PUS7|0:RPUSD1|0:NAF1|0:RPUSD4|0:TRUB2|0:TRUB1|0:GAR1|0:DKC1|0:RPUSD3|0:PUS7L|0:PUSL1			
GO:0021588	P:cerebellum formation; ISS:BHF-UCL		0:WNT1			
GO:0005135	F:interleukin-3 receptor binding; TAS:UniProtKB		0:IL3			
GO:0031703	F:type 2 angiotensin receptor binding; IPI:BHF-UCL		0:AGT			
GO:0090086	P:negative regulation of protein deubiquitina...; IMP:UniProtKB		0:DNAJB2|0:TRIM21			
GO:0014896	P:muscle hypertrophy; IMP:BHF-UCL		0:IGF1			
GO:0048535	P:lymph node development; ISS:UniProtKB		0:TGFB1			
GO:0043242	P:negative regulation of protein complex disa...; IMP:BHF-UCL		0:IRAK3			
GO:0017166	F:vinculin binding; IPI:UniProtKB		0:SYNM|0:SORBS3|0:DAG1|0:TLN1|0:C22orf28|0:CTNNA1|0:PXN|0:ACTN1			
GO:0006287	P:base-excision repair, gap-filling; IDA:MGI		0:POLG			
GO:0046899	F:nucleoside triphosphate adenylate kinase ac...; IEA:EC		0:AK3			
GO:0043048	P:dolichyl monophosphate biosynthetic process; IDA:UniProtKB		0:DOLK			
GO:0060395	P:SMAD protein signal transduction; IDA:UniProtKB		0:FOS|0:CITED1|0:JUN|0:SMAD4|0:SKI|0:BMP7|0:HIPK2|0:BMP4|0:BMP2|0:BMP6			
GO:0070858	P:negative regulation of bile acid biosynthet...; IMP:BHF-UCL		0:FGF19|0:PROX1			
GO:0060555	P:induction of necroptosis by extracellular s...; IMP:BHF-UCL		0:TNF|0:FASLG|0:RIPK1			
GO:0016500	F:protein-hormone receptor activity; IEA:InterPro		0:LGR5|0:LGR4|0:LGR6			
GO:0006493	P:protein amino acid O-linked glycosylation; TAS:ProtInc		0:POMGNT1|0:POMT2|0:TRAK1|0:GALNT9|0:LDLR|0:GCNT3|0:GALNT7|0:A4GNT|0:POMT1|0:GALNT6|0:GCNT4|0:OGT|0:GCNT1			
GO:0019104	F:DNA N-glycosylase activity; ISS:UniProtKB		0:MUTYH|0:NEIL3			
GO:0004324	F:ferredoxin-NADP+ reductase activity; TAS:ProtInc		0:FDXR			
GO:0072112	P:glomerular visceral epithelial cell differe...; ISS:UniProtKB		0:BASP1|0:WT1			
GO:0046549	P:retinal cone cell development; ISS:UniProtKB		0:THY1			
GO:0009820	P:alkaloid metabolic process; IDA:BHF-UCL		0:CYP1A2			
GO:0015911	P:plasma membrane long-chain fatty acid trans...; IDA:BHF-UCL		0:CD36			
GO:0071260	P:cellular response to mechanical stimulus; IDA:UniProtKB		0:CNN2|0:AQP1			
GO:0030395	F:lactose binding; IDA:MGI		0:LGALS12			
GO:0000023	P:maltose metabolic process; IC:BHF-UCL		0:GAA			
GO:0060502	P:epithelial cell proliferation involved in l...; IDA:MGI		0:BMP4			
GO:0047485	F:protein N-terminus binding; IPI:UniProtKB		0:ATM|0:HAX1|0:ZWINT|0:ERCC5|0:EXOC4|0:TRAF6|0:ALOX5AP|0:PEX14|0:SDCBP|0:RASSF1|0:GTF2H2|0:NIPBL|0:NCOA3|0:SLA2|0:LACRT|0:KCNIP2|0:MORF4L1|0:NBN|0:NFE2|0:ACOX1|0:PARP1|0:MEN1|0:NCOR2|0:CHMP6|0:DCTN4|0:ERCC4|0:DAXX|0:TAF11|0:MNAT1|0:SMARCC1|0:THAP7|0:SMARCE1|0:YWHAQ|0:BIRC2|0:TSC1|0:GLRX|0:TP53|0:SLC26A8|0:VWF|0:SUV39H1|0:PEX19|0:ALG2|0:RPS21|0:EIF5A|0:SMARCA4|0:TBL1XR1|0:EIF3E|0:CSNK2A1|0:MECP2|0:HSPA1A|0:GTF2H3|0:PEX5|0:SRRM2|0:NPAT|0:ERCC3|0:PDCD10|0:HSPA1B|0:CSNK2A2|0:STX5|0:RELA|0:ERCC6|0:APTX|0:MAU2|0:ERCC2			
GO:0046434	P:organophosphate catabolic process; IDA:BHF-UCL		0:PON1			
GO:0032691	P:negative regulation of interleukin-1 beta p...; IDA:UniProtKB		0:GHRL|0:GHSR			
GO:0008378	F:galactosyltransferase activity; TAS:ProtInc		0:B3GNT6|0:B3GNT3|0:B3GNT4|0:B3GALNT2|0:B3GNT7|0:B3GNT9|0:A4GNT|0:B3GNT8|0:B3GNT5|0:B4GALT5			
GO:0007292	P:female gamete generation; TAS:ProtInc		0:TOB2|0:CGB8|0:SPO11|0:DYNLL1|0:FSHR|0:CGB5|0:PARN|0:FSHB|0:USP9X|0:CGB7|0:CGB|0:BCL2L10|0:BMP15			
GO:0051793	P:medium-chain fatty acid catabolic process; IDA:BHF-UCL		0:ACADM			
GO:0030280	F:structural constituent of epidermis; NAS:UniProtKB		0:KRT82|0:PKP1|0:KRT36|0:KRTAP5-8|0:KRT84|0:KRTAP1-3|0:KRT10			
GO:0048016	P:inositol phosphate-mediated signaling; TAS:UniProtKB		0:EDN3|0:EDN2|0:EDN1|0:NMUR2|0:NMUR1|0:PLCE1			
GO:0030018	C:Z disc; TAS:BHF-UCL		0:TTN|0:TCAP|0:BMP10|0:DES|0:NEB|0:SYNE2|0:ACTN2|0:GLRX3|0:CSRP3|0:MYOZ3|0:FLNC|0:PDLIM3|0:LDB3|0:ACTN1|0:MYOT|0:MYOZ2|0:FLNB|0:TRIM54|0:OBSCN|0:KY|0:IGFN1|0:NEXN|0:SORBS2|0:OBSL1			
GO:0006903	P:vesicle targeting; TAS:ProtInc		0:YKT6|0:MAP4K2|0:LRMP|0:SNAP29|0:SNAP23|0:STX5|0:AP1M2			
GO:0032861	P:activation of Rap GTPase activity; ISS:UniProtKB		0:SIPA1L1			
GO:0004857	F:enzyme inhibitor activity; TAS:ProtInc		0:UGT1A8|0:UGT1A9|0:UGT1A1|0:UGT1A7|0:KIAA1967|0:ANGPTL4|0:SCG5|0:ARRB1|0:PRPSAP2|0:TWIST1|0:PRPSAP1|0:CABP1|0:HSPBP1|0:PDE6G|0:CSN2|0:PDE6H|0:GCKR			
GO:0045651	P:positive regulation of macrophage different...; IDA:UniProtKB		0:PF4|0:CSF1|0:LIF|0:CALCA			
GO:0033683	P:nucleotide-excision repair, DNA incision; IMP:UniProtKB		0:FAN1|0:ERCC3|0:ERCC2			
GO:0071174	P:mitotic cell cycle spindle checkpoint; IMP:BHF-UCL		0:CCNB1			
GO:0070301	P:cellular response to hydrogen peroxide; IMP:BHF-UCL		0:PLEKHA1|0:FXN|0:AQP1|0:HDAC6			
GO:0045993	P:negative regulation of translational initia...; NAS:UniProtKB		0:EIF2AK1			
GO:0032581	P:ER-dependent peroxisome organization; IDA:UniProtKB		0:PEX16			
GO:0006468	P:protein amino acid phosphorylation; TAS:UniProtKB		0:ACVR1C|0:PRKCE|0:CDK6|0:GSK3A|0:LIMK1|0:CDK4|0:BMPR1A|0:ACVR1|0:ACVRL1|0:BMPR1B|0:CREB1|0:CDK9|0:IGFBP3|0:STK17A|0:DMPK|0:GLYCTK|0:TSSK1B|0:MAP4K4|0:WNK1|0:CDK11A|0:PIM3|0:DYRK3|0:MKNK2|0:MARK2|0:MARK1|0:IP6K3|0:LCK|0:CSNK1D|0:ICK|0:BRSK2|0:TNNI3K|0:TSSK4|0:SIK3|0:SRPK1|0:TLK1|0:RPS6KA4|0:TSSK6|0:PRKCI|0:PRKCD|0:DYRK2|0:ERN2|0:CAMK2A|0:STK38|0:STK3|0:SIK2|0:CDK11B|0:PIM2|0:MAP4K2|0:TLK2|0:DAPK2|0:LATS1|0:DAPK3|0:SIK1|0:PIM1|0:CDC42BPG|0:SRPK2|0:MAPK3|0:OXSR1|0:CDC42BPA|0:MAP4K3|0:NEK11|0:LATS2|0:IKBKE|0:DAPK1|0:STK17B|0:MKNK1|0:GSG2|0:BRSK1|0:PRKACB|0:SNRK|0:STK11|0:NUAK2|0:TP53RK|0:TWF1|0:STK38L|0:DYRK1B|0:STK25|0:TEK|0:ROR2|0:NPR1|0:SRMS|0:NTRK2|0:RIPK3|0:MAPKAPK3|0:NEK9|0:MYLK3|0:BMP2K|0:ALPK2|0:MUSK|0:MAP3K14|0:CLK2|0:STRADA|0:MAPK14|0:GUCY2D|0:RIOK3|0:MST1R|0:EPHA3|0:SCYL2|0:EPHA6|0:PKMYT1|0:CSNK1G3|0:CIT|0:TBCK|0:DDR2|0:STK32C|0:STK40|0:PLK5P|0:NUAK1|0:DCLK2|0:TEX14|0:HUNK|0:WEE1|0:NEK5|0:NRK|0:ALPK3|0:EPHA2|0:PAK6|0:PTK7|0:STK33|0:LRRK1|0:PRKACG|0:TTN|0:CDK19|0:IRAK4|0:TTK|0:CASK|0:HIPK1|0:TRIB3|0:CDK20|0:EPHA4|0:PSKH2|0:MELK|0:ITK|0:BLK|0:STK24|0:SPEG|0:MAP3K15|0:CHEK2|0:PAK4|0:MAP2K3|0:AAK1|0:AMHR2|0:PASK|0:MAST3|0:PTPRE|0:CDK15|0:SCYL1|0:RIPK2|0:NEK1|0:TNK2|0:TIE1|0:BUB1|0:CDC7|0:ERBB3|0:CAMK1D|0:ACVR2B|0:RPS6KC1|0:DCLK3|0:ULK4|0:FGFR3|0:EPHA7|0:MAP2K7|0:RPS6KA1|0:GRK7|0:EPHA10|0:TBK1|0:TTBK2|0:MYLK4|0:CDKL2|0:KDR|0:PLK2|0:EPHB6|0:DDR1|0:PXK|0:PNCK|0:STYK1|0:CDK14|0:SCYL3|0:SLK|0:GRK5|0:CDK8|0:MAP2K4|0:MAST4|0:RPS6KA2|0:AXL|0:PAK7|0:STRADB|0:CHEK1|0:CAMKK1|0:YSK4|0:ULK3|0:CDK10|0:CDKL3|0:RIPK4|0:GUCY2C|0:ACVR2A|0:RPS6KA6|0:AURKB|0:EPHB3|0:FGFR4|0:NEK10|0:RPS6KL1|0:SRC|0:CSNK1G1|0:VRK3|0:GRK6|0:CDKL4|0:NEK7|0:TTBK1|0:STK32A|0:LIMK2|0:NPR2|0:STK35|0:NRBP2|0:KSR2|0:SBK2|0:TRIB2|0:MET|0:TRPM6|0:CSNK2A2|0:EEF2K|0:ALPK1|0:TESK1|0:CDK13|0:STK31|0:CDK7|0:HIPK4|0:PAN3|0:STK32B|0:MLKL|0:GAK|0:ROR1|0:FLT4|0:TRIO|0:WEE2|0:CSNK1A1L|0:MYO3B|0:MASTL|0:NRBP1|0:PAK3|0:PDIK1L|0:MOS|0:C9orf96|0:ULK2|0:CSF1R|0:MARK3|0:DSTYK|0:EPHB1|0:RIOK2|0:NEK8|0:ANKK1|0:GUCY2F|0:EPHB4|0:CDK3|0:ROS1|0:PLK1|0:OBSCN|0:TRIB1|0:EPHA1|0:MAPKAPK5|0:BUB1B|0:CAMKV|0:PKDCC|0:RPS6KA3|0:ADRBK2|0:WNT11|0:RARA|0:CCNT1|0:MINK1|0:TSSK3|0:MAST2|0:PICK1|0:PPP4R1|0:WNK3|0:APP|0:CSNK1E|0:WNK2|0:TSSK2|0:CDC42BPB|0:EIF2AK4|0:WNK4|0:TESK2|0:ADAM10|0:MAST1|0:TAOK1|0:PRKD2|0:MAP2K2|0:CAMK2G|0:PIK3R4|0:PIK3CD|0:CAMK2D|0:FGFR2|0:RYK|0:PHKG2|0:RNASEL|0:SGK2|0:ARAF|0:STK39|0:CDK18|0:PSKH1|0:GOLGA5|0:FGFR1|0:PRKCQ|0:PBK|0:PRKAR1B|0:DYRK4|0:MAK|0:NEK3|0:SRPK3|0:KSR1|0:STK16|0:CDK16|0:PKN3|0:MAPK4|0:NEK4|0:MAP3K8|0:AURKC|0:CDKL1|0:GMFG|0:C7orf16|0:FASTK|0:SGK3|0:CAMK1|0:CSK|0:CSNK1A1|0:MAPKAPK2|0:ROCK2|0:PMVK|0:STK10|0:BCR|0:BRAF|0:PRKG2|0:TXK|0:MYLK|0:CAMK4|0:STK19|0:CTBP1|0:CCL2|0:ERG|0:KALRN|0:CSNK2A1|0:MAPK6|0:PRKAG1|0:SGK1|0:PRKCH|0:LTK|0:EPHA8|0:PLK3|0:PRKG1|0:PRKD1|0:PRKY|0:PRKCG|0:FGR|0:CDK17|0:GMFB|0:CCL11|0:RAGE|0:IRAK2|0:AKT3|0:LIPE|0:MERTK|0:RET|0:PRPF4B|0:COL4A3BP|0:PLK4|0:PKN2|0:PRKAA2|0:CDK2AP1|0:TEC|0:FRK|0:FYB|0:AURKA|0:MYOD1|0:HCK|0:BMX|0:MATK|0:DCLK1|0:PRKD3|0:RAF1|0:PRKX|0:ROCK1|0:PTK6|0:MARK4|0:EPHA5|0:STK36			
GO:0051354	P:negative regulation of oxidoreductase activity; IMP:UniProtKB		0:HDAC6|0:OXA1L			
GO:0043277	P:apoptotic cell clearance; ISS:BHF-UCL		0:TGM2|0:RARA|0:NR1H3|0:LRP1			
GO:0004135	F:amylo-alpha-1,6-glucosidase activity; IEA:EC		0:AGL			
GO:0003704	F:specific RNA polymerase II transcription fa...; TAS:ProtInc		0:SRF|0:GATA4|0:GLIS1|0:GLIS3|0:ATF4|0:FOS|0:ZNF136|0:ZBTB32|0:MEIS2|0:NFRKB|0:NRL|0:ZNF143|0:GFI1B|0:ZNF281|0:DEK|0:FOXN1|0:ZNF345|0:PKNOX1|0:SOX9|0:IRF7|0:ZBTB7B|0:ETV7|0:PDX1|0:ZNF202|0:ZNF148|0:ZNF141|0:VEZF1			
GO:0046600	P:negative regulation of centriole replication; NAS:UniProtKB		0:BRCA1			
GO:0006419	P:alanyl-tRNA aminoacylation; TAS:ProtInc		0:AARS2|0:AARSD1|0:AARS			
GO:0044456	C:synapse part; ISS:BHF-UCL		0:CNTN2			
GO:0015184	F:L-cystine transmembrane transporter activity; TAS:ProtInc		0:SLC1A4|0:CTNS|0:SLC3A1|0:SLC7A9			
GO:0008047	F:enzyme activator activity; TAS:ProtInc		0:DNMT3L|0:PRKCD|0:SLX4|0:C6orf127|0:LTC4S|0:C6orf126|0:MGST2|0:PRKCE|0:MMP16|0:MMP24|0:FZR1|0:CXCL1|0:GMFG|0:PITRM1|0:DBNL|0:DBF4|0:PRKRA|0:CTSA|0:TRIM23|0:ARL1|0:HSPB2|0:MMP17|0:MMP15|0:PSAP|0:GTF3C4|0:UBA2|0:CASP9|0:CTAGE5|0:GMFB|0:SAE1|0:RFC1|0:PPP1R12B			
GO:0000444	C:MIS12/MIND type complex; IDA:UniProtKB		0:PMF1|0:DSN1|0:MIS12|0:NSL1			
GO:0060041	P:retina development in camera-type eye; ISS:UniProtKB		0:CHD7|0:NPHP1			
GO:0009952	P:anterior/posterior pattern formation; ISS:UniProtKB		0:PCSK5|0:ACVR2B|0:CYP26C1|0:TGFBR1|0:BMPR2|0:HOXD3|0:SMAD2|0:HHEX			
GO:0045116	P:protein neddylation; IEA:InterPro		0:NEDD8|0:RNF7|0:RBX1|0:UBE2M|0:UBE2F|0:NAE1|0:UBA3			
GO:0015936	P:coenzyme A metabolic process; TAS:ProtInc		0:HMGCR|0:ACLY			
GO:0042274	P:ribosomal small subunit biogenesis; ISS:UniProtKB		0:RRP36|0:RPS15|0:RPS19|0:RPS7|0:RPS28|0:RPS16|0:RPS24|0:RPS6|0:RPS17|0:EMG1|0:NOP14			
GO:0034263	P:autophagy in response to ER overload; IMP:UniProtKB		0:ATG10			
GO:0017156	P:calcium ion-dependent exocytosis; TAS:UniProtKB		0:VAMP7|0:SCIN|0:RIMS1			
GO:0007050	P:cell cycle arrest; TAS:UniProtKB		0:HRAS|0:THBS1|0:CDKN1A|0:CDKN2D|0:TP53|0:IFNG|0:IL12A|0:TGFB2|0:TGFB1|0:CDKN2C|0:IL12B|0:INHBA|0:CDKN3|0:ING4|0:WDR6|0:RBM38|0:SOX2|0:IRF6|0:PML|0:IL8|0:NOTCH2|0:MLF1|0:FOXO4|0:STK11|0:APC|0:GAS2L3|0:DST|0:GAS2L1|0:SESN2|0:SESN3|0:GAS2L2|0:MACF1|0:SGSM3|0:CGRRF1|0:VASH1|0:PRNP|0:GAS2|0:HEPACAM|0:C11orf82|0:DBC1|0:CGREF1|0:MLL5|0:MTBP|0:DDIT3|0:CALR|0:ATM|0:CDKN2A|0:CDKN2B|0:TCF7L2|0:MAP2K1|0:UHMK1|0:TBRG1|0:CDKN1B|0:RASSF1|0:APBB2|0:ERN1|0:APBB1|0:JMY|0:SKIL|0:SART1|0:DHCR24|0:KIF20B|0:HBP1|0:BARD1|0:RB1|0:PPP1R15A|0:MAP2K6|0:EIF4G2|0:CUL3|0:MYC|0:GAS1|0:AIF1|0:KHDRBS1|0:MAPK12|0:SESN1|0:PLAGL1|0:CDKN1C|0:CDC123|0:GAS7|0:GADD45A|0:IFNW1|0:RPRM|0:KAT2B|0:CUL4A|0:PPM1G|0:CUL1|0:CUL5|0:PPP2R3B|0:PA2G4|0:CUL2|0:NBN|0:TBRG4|0:INHA|0:BTG4|0:PPP1R9B			
GO:0010857	F:calcium-dependent protein kinase activity; IDA:BHF-UCL		0:PINK1			
GO:0033628	P:regulation of cell adhesion mediated by int...; IMP:UniProtKB		0:PLAU|0:TESC			
GO:0006937	P:regulation of muscle contraction; TAS:ProtInc		0:TPM3|0:MYL9|0:TNNC2|0:TPM1|0:PPP1R12B|0:MYL5			
GO:0031462	C:Cul2-RING ubiquitin ligase complex; IDA:UniProtKB		0:ZER1			
GO:0005749	C:mitochondrial respiratory chain complex II; TAS:UniProtKB		0:SDHD|0:SDHB|0:SDHC|0:SDHA			
GO:0008384	F:IkappaB kinase activity; TAS:ProtInc		0:IKBKB|0:IKBKE|0:CHUK			
GO:0045414	P:regulation of interleukin-8 biosynthetic pr...; IDA:UniProtKB		0:IL17F			
GO:0015813	P:L-glutamate transport; ISS:UniProtKB		0:ARL6IP5|0:PRAF2			
GO:0042953	P:lipoprotein transport; TAS:BHF-UCL		0:PPARG|0:ZDHHC17|0:CD36|0:PRKCB			
GO:0016533	C:cyclin-dependent protein kinase 5 holoenzym...; IEA:InterPro		0:CDK5R1|0:CDK5R2			
GO:0004407	F:histone deacetylase activity; TAS:UniProtKB		0:HDAC2|0:HDAC5|0:HDAC4|0:HDAC6|0:HDAC9|0:HDAC11|0:HDAC10|0:HDAC7|0:HDAC1|0:HDAC3|0:HDAC8			
GO:0000038	P:very long-chain fatty acid metabolic process; TAS:ProtInc		0:CYP4F2|0:ACOT2|0:ACSBG1|0:ACOT4|0:ACOT1|0:ACOX1|0:SLC27A5|0:SLC27A6			
GO:0060904	P:regulation of protein folding in endoplasmi...; TAS:BHF-UCL		0:HSPA5			
GO:0047291	F:lactosylceramide alpha-2,3-sialyltransferas...; IDA:UniProtKB		0:ST3GAL5			
GO:0034366	C:spherical high-density lipoprotein particle; IDA:BHF-UCL		0:HPR|0:CLU|0:APOC3|0:APOA2|0:PON1|0:APOM|0:APOC2|0:APOA1			
GO:0010894	P:negative regulation of steroid biosynthetic...; IDA:UniProtKB		0:WNT4			
GO:0017146	C:N-methyl-D-aspartate selective glutamate re...; NAS:UniProtKB		0:GRIN3A|0:GRIN2A|0:GRIN1|0:GRIN2B|0:GRIN3B			
GO:0046872	F:metal ion binding; TAS:UniProtKB		0:ACVR1C|0:APEX1|0:HMGCL|0:SEC23IP|0:ARMC1|0:ADD2|0:ADHFE1|0:ADD3|0:ENDOD1|0:DDHD2|0:NUDT13|0:HECTD1|0:ADD1|0:HERC2P3|0:DDHD1|0:NUDT14|0:ERCC5|0:UTY|0:PIR|0:EPT1|0:STK25|0:SIAH3|0:CTDSP2|0:COL18A1|0:ELAC2|0:CELA1|0:UNC13B|0:BTK|0:GTSF1|0:MT1DP|0:CADPS2|0:PLEKHM3|0:CLEC4M|0:RABGGTB|0:CSHL1|0:ISCA1|0:RFK|0:KIAA1045|0:THAP4|0:ATP13A2|0:PRKD2|0:CCNB1IP1|0:ATXN7L3|0:PPP1CB|0:MBTPS2|0:ADAR|0:DAGLA|0:TGM4|0:ZNF830|0:STAMBPL1|0:ADCY2|0:NEK9|0:RIMKLA|0:TIMP4|0:GALNS|0:GMPR2|0:GPHN|0:DMRT1|0:ZBED3|0:KDM4D|0:SLX1B|0:CA14|0:BMPR1A|0:NEK4|0:PELO|0:RASAL1|0:DDAH1|0:ERMP1|0:THAP8|0:DMPK|0:SMYD5|0:ATP2C1|0:CCDC76|0:ITGB7|0:EYA1|0:MOCS3|0:CPSF3|0:GGPS1|0:CARS2|0:C9orf95|0:ARSB|0:INPP1|0:FBXO5|0:PFKM|0:ELP3|0:DMRTA2|0:PRKCE|0:GLRX3|0:MOBKL1A|0:NUDT11|0:NUBP1|0:DGKI|0:ACSM2A|0:FREM3|0:GDPD3|0:NGLY1|0:ISG20|0:PC|0:FAH|0:ATP13A5|0:MOBKL2C|0:TGFBR2|0:ACMSD|0:CIT|0:UGP2|0:OVCH1|0:PPM1F|0:EIF2S2|0:MT1H|0:APLF|0:RASA3|0:ADCY9|0:CDKAL1|0:VAV3|0:ATP2B1|0:ZNHIT6|0:NAALAD2|0:NT5DC1|0:POLK|0:STK32C|0:CACNA2D1|0:PON3|0:B3GAT1|0:BIRC5|0:MGAT4B|0:ADI1|0:RACGAP1|0:ENDOG|0:CRP|0:SMPD2|0:ALPP|0:DGKD|0:NUAK1|0:NGFRAP1|0:PHOSPHO2|0:NARFL|0:RHOV|0:PDE4D|0:B4GALT4|0:MBLAC1|0:NME4|0:ZNF862|0:PDE7B|0:MIPEP|0:ADARB1|0:MKNK2|0:NEK5|0:SPRYD5|0:MUT|0:QTRT1|0:HDAC8|0:ACVR1|0:CLEC17A|0:LIG1|0:EXTL3|0:EXTL2|0:C10orf129|0:PDE4B|0:CD209|0:RPS27L|0:CNDP1|0:IMPDH1|0:ASXL1|0:NUDT4|0:ENPP3|0:PITPNM1|0:ARSF|0:ATP1A3|0:KEL|0:FBP2|0:ACAT1|0:CSGALNACT2|0:FOLH1|0:TNFSF10|0:GCM2|0:ITGB1BP3|0:MT-CYB|0:MGAT5B|0:NPTX2|0:FURIN|0:PDE8A|0:GMIP|0:DNLZ|0:CADPS|0:HR|0:RNASEN|0:ACO1|0:NAPEPLD|0:CPPED1|0:PDE1A|0:EPHX2|0:KARS|0:DPH3P1|0:APIP|0:AARS2|0:DPP3|0:EBF4|0:COPS5|0:LRRK1|0:TET2|0:TNNI3K|0:PTS|0:ADCY6|0:GLRX5|0:MGAT4A|0:CTDSPL|0:PDE11A|0:CLYBL|0:RSAD2|0:DMRTC2|0:ILKAP|0:CISD1|0:ZNHIT3|0:EYA4|0:COL10A1|0:FREM1|0:ADPRHL2|0:NUDT15|0:CEPT1|0:ZNFX1|0:FDPS|0:TGM7|0:ROCK2|0:NAALADL1|0:NUDT12|0:DNAJA3|0:TENC1|0:MT1G|0:RTEL1|0:ADCY3|0:ATP2B2|0:POLR1A|0:SUMF1|0:DAGLB|0:ITK|0:KAT5|0:NRXN1|0:NDUFV2|0:GDPD4|0:AMY1C|0:F13A1|0:FAHD2B|0:HMHA1|0:PPP5C|0:MAP3K15|0:NUDT8|0:FAHD2A|0:BCKDHA|0:HPDL|0:UNC13A|0:AMDHD1|0:CHEK2|0:PDE10A|0:MAP3K4|0:PPP2CA|0:POLH|0:RASGRP4|0:NADK|0:SGSH|0:GDPD2|0:DAK|0:CDKN1A|0:POLD1|0:WRNIP1|0:BRAF|0:AMHR2|0:ISCA2|0:NUBP2|0:CDK15|0:MOBKL1B|0:DPH3|0:SYT10|0:FLYWCH1|0:GLRX2|0:SOD3|0:ABO|0:PRKCD|0:ATP13A4|0:ANTXR2|0:PPTC7|0:IREB2|0:PGLYRP2|0:RASA4|0:DGKZ|0:MOBKL3|0:CMC1|0:NEK1|0:EBF3|0:ADO|0:EBF1|0:GART|0:THOP1|0:QPCT|0:MMEL1|0:ASGR1|0:CDC7|0:ERVK2|0:FDX1L|0:BCMO1|0:NME2|0:NLN|0:ACSM1|0:THAP7|0:IDI1|0:RNASEL|0:PPM1L|0:APCS|0:CTDSP1|0:QTRTD1|0:COX5B|0:PPAT|0:ACVR2B|0:DPEP2|0:ME3|0:HPX|0:GH1|0:ARSE|0:CACNA2D4|0:DNAJC24|0:AGMAT|0:AARS|0:ACSM2B|0:NPTXR|0:APP|0:ADCY7|0:FRAS1|0:ATP13A1|0:NT5M|0:INSRR|0:ENOSF1|0:MOBKL2B|0:RASSF5|0:CNOT6|0:ECE1|0:ASXL2|0:RPE65|0:IKBKG|0:BRCC3|0:C1GALT1|0:IMPA2|0:ENPP2|0:TIMP1|0:SMG1|0:NUDT16|0:COLEC12|0:ATP2A3|0:PPP1CA|0:INO80B|0:RHOU|0:POLL|0:MYLK|0:MGAT4C|0:SMPD3|0:PDE7A|0:DMRT2|0:CLPX|0:EIF2C2|0:PPP6C|0:GDE1|0:DGKE|0:RPL37A|0:ACACB|0:ERI3|0:C1orf124|0:ZMPSTE24|0:SOBP|0:B4GALT5|0:CYBRD1|0:ADARB2|0:PDE4A|0:XPNPEP2|0:PDE6A|0:ARL1|0:KCND1|0:HTN3|0:NUDT18|0:AFP|0:PPP3CC|0:ALPPL2|0:RSAD1|0:LIG4|0:RUFY4|0:C17orf48|0:ALKBH4|0:KDM3B|0:B3GAT2|0:ARSI|0:HPD|0:PRIM1|0:JMJD6|0:ITPA|0:CAD|0:ETHE1|0:RPAIN|0:VPS18|0:ANTXRL|0:HIF1AN|0:MAT1A|0:TKTL2|0:RNASEH2A|0:AMY2B|0:NPTX1|0:ZBED2|0:STAC|0:PDE8B|0:ALKBH8|0:ARAF|0:PHOSPHO1|0:RPL37|0:PARN|0:PDE1C|0:MAP3K3|0:FIBCD1|0:FAHD1|0:AMY1B|0:NTHL1|0:POLR2B|0:PMM1|0:ZNHIT2|0:POMT1|0:ARSH|0:ZBED1|0:KDM6A|0:SLX1A|0:TANK|0:KALRN|0:HSCB|0:ARSK|0:MME|0:GALNT10|0:RHO|0:DGCR8|0:ATP2C2|0:POLR1B|0:UPB1|0:ATP2B4|0:ARG2|0:ASH2L|0:CABYR|0:IMPA1|0:EXO1|0:ADCY4|0:STAMBP|0:AIFM3|0:ATP2B3|0:DNTT|0:CHPF|0:CISD3|0:NEK2|0:THAP9|0:NRXN2|0:ARL6|0:CHPT1|0:COX5A|0:MPPED2|0:POLI|0:BCO2|0:ACACA|0:THAP11|0:SYT5|0:B4GALT1|0:ECE2|0:PRKAA1|0:POLA1|0:PDE9A|0:NDUFS2|0:ZC3H12A|0:NT5DC4|0:HARBI1|0:DPEP3|0:NT5DC3|0:SUMF2|0:OSGEPL1|0:OMA1|0:GDPD1|0:POLB|0:CACNA2D3|0:DGKK|0:THAP2|0:DNAJA2|0:HGD|0:AARSD1|0:USP21|0:ACSM4|0:TGM6|0:NPEPL1|0:NOB1|0:UBA2|0:ACVR1B|0:DMRTB1|0:TIMP2|0:GTF2H3|0:PHYHD1|0:FXC1|0:NDUFS1|0:NUDT17|0:FRRS1|0:DMRT3|0:YME1L1|0:PCK2|0:XRCC6BP1|0:CARS|0:GTSF1L|0:ATP1A1|0:PRIM2|0:ACVR2A|0:PFKL|0:AURKB|0:PDSS1|0:FNTB|0:GNS|0:CHN2|0:MOBKL2A|0:PDE3A|0:PPM1E|0:ENOPH1|0:ALKBH7|0:NEK10|0:TIMM8A|0:VPS29|0:ASNA1|0:ZC4H2|0:ME2|0:GLO1|0:BPNT1|0:LIAS|0:NDUFV1|0:EBF2|0:PDE6B|0:DPEP1|0:ESCO2|0:DDX59|0:PRKCQ|0:PRKCH|0:MDP1|0:KCND2|0:SMPD4|0:DICER1|0:NDUFS8|0:POLM|0:ZNHIT1|0:NEK7|0:NME6|0:STAC2|0:LUC7L|0:QPCTL|0:UQCRFS1|0:ASPA|0:PPP2CB|0:B4GALT6|0:B4GALT2|0:STK32A|0:CYBASC3|0:DMRTA1|0:USP2|0:RFESD|0:VAV2|0:RXFP1|0:THAP3|0:ACSM5|0:PHLPP1|0:TGM1|0:ASXL3|0:PDE2A|0:NSF|0:CDK5RAP1|0:PRKD1|0:ADK|0:CSH2|0:ALPI|0:EXOG|0:ATP12A|0:ENPP1|0:CYB561D1|0:CHSY3|0:KSR2|0:THAP6|0:SCNM1|0:UQCRFSL1|0:POLR3B|0:KCNMA1|0:PFKP|0:LYAR|0:GEN1|0:ACSM3|0:TRPM6|0:GMPR|0:LUC7L2|0:GBGT1|0:DPYD|0:DOHH|0:TKTL1|0:ECEL1|0:MUTYH|0:NQO2|0:IDS|0:DYRK4|0:OVCH2|0:IMPAD1|0:MCM10|0:KDM6B|0:ACLY|0:DGKQ|0:SNRNP48|0:PHYH|0:MUS81|0:PDXP|0:TESK1|0:ADCY1|0:POLR3A|0:ACY1|0:MYO9A|0:MYSM1|0:RASA2|0:PDP2|0:NUDT19|0:ELAC1|0:ARHGAP29|0:MCM2|0:METAP2|0:ZBED4|0:POLR2A|0:STK32B|0:ALKBH5|0:ADAT1|0:PPM1G|0:PTX4|0:RPAP2|0:PDE1B|0:MT2A|0:GMEB1|0:ARSJ|0:ACY3|0:SDHB|0:NUDT10|0:CHSY1|0:ACVRL1|0:TIMP3|0:HMOX2|0:DGKH|0:THAP10|0:FOLH1B|0:HAGHL|0:DNAJA4|0:PAK3|0:TGFBR1|0:RIMKLB|0:ADCY8|0:MGMT|0:CSH1|0:KDM4DL|0:NEK11|0:PRKAA2|0:LATS2|0:BMPR2|0:SYT6|0:NME7|0:HCCS|0:SYT3|0:ZFC3H1|0:PDZD8|0:IGF1R|0:ELOF1|0:TEC|0:SPON2|0:ARL3|0:MBLAC2|0:UBA5|0:SMG6|0:INSR|0:PON2|0:RELN|0:NEK3|0:SAR1B|0:PRSS1|0:TKT|0:BAK1|0:TET3|0:IMPDH2|0:CARNS1|0:PDE6C|0:PPM1K|0:RHEB|0:PDE4C|0:IDI2|0:PLEKHM1P|0:LACTB2|0:CNDP2|0:FYN|0:KCND3|0:NAIP|0:CYB561|0:ANTXR1|0:KLK4|0:THAP5|0:METAP1|0:CACNA2D2|0:COL9A1|0:TRPM7|0:AMY1A|0:PM20D1|0:ATP1A4|0:EYA3|0:NEK8|0:ESCO1|0:NT5DC2|0:ARSG|0:FBP1|0:ARSD|0:STS|0:EME1|0:NRXN3|0:BMX|0:ADPGK|0:TESK2|0:ALKBH6|0:SIVA1|0:PPM1D|0:ZBED5|0:PDE3B|0:ERI1|0:PHLPP2|0:TGM2|0:ATP13A3|0:ADCY5|0:PRKD3|0:NT5C|0:MT1M|0:APLP1|0:TGM5|0:PPP1CC|0:KSR1|0:RAF1|0:REV3L|0:DNAJA1|0:ARG1|0:CYB561D2|0:CISD2|0:OBSCN|0:PSMD14|0:GMEB2|0:ROCK1|0:SAP30L|0:PRKRIR|0:ATP1A2|0:MAP2K5|0:ETFDH|0:MAP3K2|0:GALNTL6|0:SAP30|0:XPA|0:GNPTAB|0:RPA1|0:PLEKHM1|0:PRLR|0:TMPPE|0:NME2P1|0:JMJD1C|0:B4GALT7|0:B4GALT3|0:NT5C2|0:AKAP13|0:UNC13C|0:POMT2|0:BMPR1B|0:STAC3|0:TRIT1|0:DBR1|0:NME3|0:CHN1|0:SYT9|0:GPR39|0:NDUFS7|0:MAT2A|0:VAV1|0:ERCC2|0:HMGCLL1|0:CSGALNACT1|0:MTL5|0:IGFBP3|0:PPP4C|0:MT1X|0:TREX1			
GO:0033615	P:mitochondrial proton-transporting ATP synth...; IMP:UniProtKB		0:OXA1L|0:TMEM70			
GO:0032456	P:endocytic recycling; IDA:UniProtKB		0:EPS15|0:RAB11FIP3			
GO:0005222	F:intracellular cAMP activated cation channel...; NAS:UniProtKB		0:CNGB1|0:CNGA2			
GO:0001309	P:age-dependent telomere shortening; NAS:BHF-UCL		0:TERF1|0:TERF2			
GO:0004733	F:pyridoxamine-phosphate oxidase activity; IEA:EC		0:PNPO			
GO:0060412	P:ventricular septum morphogenesis; ISS:BHF-UCL		0:NKX2-5|0:SMAD7|0:PROX1			
GO:0051542	P:elastin biosynthetic process; ISS:UniProtKB		0:ATP7A			
GO:0007596	P:blood coagulation; TAS:ProtInc		0:HNF4A|0:IL20RA|0:IL28RA|0:F2RL1|0:IL10RB|0:IFNAR2|0:IFNGR2|0:IL22RA2|0:IFNAR1|0:IL10RA|0:MST1|0:EFEMP2|0:IFNGR1|0:IL20RB|0:IL22RA1|0:ANXA8|0:SERPIND1|0:SERPING1|0:PROZ|0:ANXA5|0:PROCR|0:GP5|0:KLKB1|0:KNG1|0:SERPINA1|0:TFPI2|0:P2RY1|0:PROC|0:SERPINC1|0:HRG|0:PLAU|0:PLG|0:SCUBE1|0:PLSCR4|0:PLAUR|0:F11|0:LMAN1|0:PROS1|0:F8|0:GGCX|0:F5|0:ADORA2A|0:GNAQ|0:ITGB3|0:F13A1|0:CD36|0:CD59|0:PABPC4|0:GNA12|0:C4BPB|0:ITGA2|0:F2RL2|0:THBD|0:WAS|0:PLAT|0:F13B|0:GP9|0:F2RL3|0:MMRN1|0:ENTPD1			
GO:0070989	P:oxidative demethylation; IDA:UniProtKB		0:CYP2D6|0:CYP1A2|0:CYP2C8|0:CYP3A5|0:CYP2C9|0:CYP3A4|0:ALKBH1			
GO:0008502	F:melatonin receptor activity; TAS:ProtInc		0:GPR50|0:MTNR1A|0:MTNR1B			
GO:0007021	P:tubulin complex assembly; TAS:ProtInc		0:TBCA|0:TCP1|0:ARL2			
GO:0006172	P:ADP biosynthetic process; TAS:ProtInc		0:AK5			
GO:0051584	P:regulation of dopamine uptake; IDA:UniProtKB		0:DRD3|0:DRD1|0:GDNF			
GO:0031624	F:ubiquitin conjugating enzyme binding; IPI:UniProtKB		0:ZMYM2|0:FOXL2			
GO:0016812	F:hydrolase activity, acting on carbon-nitrog...; IEA:InterPro		0:CD101			
GO:0016486	P:peptide hormone processing; NAS:UniProtKB		0:CORIN|0:ECE2|0:SCG5|0:BACE2|0:PCSK7			
GO:0008474	F:palmitoyl-(protein) hydrolase activity; NAS:UniProtKB		0:PPT1|0:PPT2			
GO:0060912	P:cardiac cell fate specification; IDA:BHF-UCL		0:POU5F1			
GO:0032800	P:receptor biosynthetic process; IMP:BHF-UCL		0:TNF|0:IL10|0:ACE2			
GO:0045039	P:protein import into mitochondrial inner mem...; IEA:InterPro		0:TIMM8B|0:TIMM10|0:FXC1|0:TIMM8A|0:TIMM9|0:TIMM13			
GO:0045898	P:regulation of RNA polymerase II transcripti...; IDA:UniProtKB		0:ATF7IP			
GO:0045084	P:positive regulation of interleukin-12 biosy...; ISS:UniProtKB		0:TLR4|0:LTB			
GO:0042802	F:identical protein binding; TAS:UniProtKB		0:TNF|0:JMJD6|0:TGFB3|0:ACADM|0:PON2|0:SCUBE1|0:NOD1|0:AMOTL1|0:CASC3|0:RUVBL2|0:ATL3|0:ATL2|0:COL1A2|0:ROBO2|0:COL1A1|0:ATL1|0:ROBO1|0:RELA|0:PCSK9|0:PFKM|0:ZNHIT6|0:PRPF19|0:P2RX2|0:P2RX6|0:NUFIP1|0:SP100|0:DVL1|0:SFRP1|0:PFKL|0:RYR2|0:APOA1|0:SMAD1|0:SIRT1|0:ALDOB|0:DTNBP1|0:STK25|0:ZNF212|0:GCC2|0:BTK|0:GYPA|0:POP4|0:COMMD1|0:MDM2|0:EGFR|0:MVK|0:NONO|0:HDAC1|0:SH3GL2|0:UPF2|0:ITGB7|0:ACTN2|0:SNRPN|0:EPM2A|0:KITLG|0:MPG|0:RASSF1|0:PAK2|0:HSPB1|0:BIRC5|0:PFKFB1|0:IKBKB|0:PCBD1|0:ATXN1|0:KCNIP2|0:ACTG1|0:NME1|0:UBQLN4|0:MAPT|0:CHUK|0:STRAP|0:PARP1|0:APIP|0:PLDN|0:FADD|0:APLP2|0:TRIM39|0:PIP4K2C|0:TTN|0:PDS5A|0:ITGB3|0:TTK|0:CHORDC1|0:EED|0:HCFC1|0:TRAF7|0:E2F7|0:SMURF2|0:HACL1|0:MKL2|0:DAXX|0:PASK|0:DBNL|0:HSPB8|0:POLG2|0:FAS|0:FTL|0:PHC2|0:MYO18A|0:ATM|0:BLOC1S3|0:PRNP|0:DFFA|0:DCTPP1|0:SUFU|0:MBIP|0:PAICS|0:AKT1|0:CASP2|0:APP|0:FGFR3|0:MED18|0:CSNK2B|0:RAB25|0:ZNF408|0:CEP170P1|0:DOK2|0:MRI1|0:ATF3|0:CASP10|0:PCMT1|0:ZXDA|0:PDS5B|0:ITGA4|0:TAX1BP1|0:BRAP|0:RALYL|0:BRCA1|0:DOM3Z|0:SCHIP1|0:PTP4A3|0:ITGA2|0:ZNF3|0:ERBB2|0:SMARCA4|0:ACP1|0:IRF9|0:DDX56|0:SAV1|0:THAP11|0:OSTF1|0:EXOSC10|0:WAS|0:DAPK2|0:C14orf166|0:PRPSAP1|0:HNRNPC|0:ITGA2B|0:GSTM3|0:GNAS|0:SOX10|0:ORC5|0:CDCA5|0:POP1|0:ELAVL1|0:TRADD|0:FNBP1|0:PHLDA3|0:DVL2|0:FHL2|0:PFKFB3|0:GSTK1|0:GLUL|0:BCL2L1|0:OXSR1|0:RAD51|0:TSPY1|0:GPSM2|0:CDC42BPA|0:RABAC1|0:POU3F2|0:TRIP10|0:CALHM1|0:CDK2|0:NFKBIA|0:PRMT2|0:NOL3|0:SH3GL3|0:EXOSC8|0:TRIP13|0:NEK11|0:IGF1R|0:PSMA7|0:ABCD1|0:MCM6|0:BAK1|0:BLOC1S2|0:RPP14|0:FYN|0:KCTD17|0:ZXDC|0:TRIP6|0:BAT1|0:TRPV4|0:FBP1|0:CASP8|0:APLP1|0:NHEJ1|0:EIF2AK3|0:PSMA4|0:RILPL2|0:ROCK1|0:KCNRG|0:ARHGDIA|0:STAC3|0:PSME3|0:ALS2CL|0:GRIN3A|0:PTPRG|0:NEFL|0:BNIPL|0:MUL1|0:HOOK3|0:TP63|0:INHBA|0:HOOK2|0:ALAD|0:HOOK1|0:CBY1|0:L3MBTL1|0:DYNLT1|0:SDF4|0:PCM1|0:AMELX|0:RGMB|0:CLDN19|0:CLDN12|0:CLDN20|0:CLDN1|0:CLDN6|0:CLDN11|0:CLDN9|0:CLDN15|0:CLDN10|0:CLDN14|0:CLDN22|0:CLDN5|0:CLDN8|0:STXBP1|0:CLDN4|0:CLDN23|0:CLDN18|0:CLDN16|0:CLDN2|0:CLDN7|0:SCAND1|0:CLDN17|0:COL2A1|0:THBS1|0:CD28|0:CNTN2|0:GLUD1|0:ALDOA|0:CD74			
GO:0016593	C:Cdc73/Paf1 complex; IDA:UniProtKB		0:CDC73|0:PAF1|0:CTR9|0:LEO1			
GO:0004064	F:arylesterase activity; TAS:ProtInc		0:PON1|0:C20orf3|0:PON3|0:PON2			
GO:0006334	P:nucleosome assembly; TAS:ProtInc		0:ASF1A|0:RSF1|0:SMARCA5|0:NPM1|0:HIST1H4I|0:HIST1H4L|0:HIST1H4B|0:HIST2H3A|0:H2AFJ|0:HIST2H2BF|0:HIST1H3F|0:HIST1H4E|0:MYST3|0:H2AFB3|0:HIST1H2AG|0:H3F3A|0:HIST2H4A|0:HIST1H3H|0:HIST1H2AK|0:HIST1H3A|0:TSPY4|0:HP1BP3|0:HIST2H3D|0:HIST1H4H|0:HIST3H2BB|0:HIST1H4A|0:TSPYL2|0:SHPRH|0:HIST1H3G|0:HIST1H2AI|0:TSPYL3|0:H2AFB1|0:HIST4H4|0:H3F3B|0:HIST1H1A|0:H2AFY2|0:HIST1H4D|0:HIST2H2AA3|0:H2AFV|0:TSPYL6|0:H1FOO|0:HIST1H3I|0:HIST1H3B|0:TSPY3|0:TSPY2|0:NAP1L5|0:TSPYL1|0:HIST1H3C|0:HIST1H3D|0:HIST1H3J|0:HIST1H2AA|0:HIST2H2AA4|0:CENPA|0:HIST1H4K|0:H1F0|0:HIST1H2AH|0:H2AFB2|0:HIST2H3C|0:TSPYL5|0:HIST1H2AM|0:HIST2H2AB|0:HIST1H4G|0:HIST3H2A|0:HIST2H2BD|0:HIST1H1T|0:H2BFS|0:TSPY1|0:HIST1H4J|0:HIST1H3E|0:H2BFWT|0:HIST1H2BA|0:H2AFZ|0:HIST1H4C|0:TSPYL4|0:NAP1L6|0:HIST2H4B|0:HIST1H2BK|0:HIST1H2BD|0:HIST1H2AL|0:H2BFM|0:HIST2H2BC|0:HIST1H4F|0:HIST1H2AD|0:HIST1H2AJ|0:HIST1H1D|0:HIST1H1C|0:HIST1H2BH|0:HIST1H2BO|0:HIST2H2BE|0:HIST1H2BN|0:HIST1H2BB|0:HMGB2|0:HIST1H2BC|0:HIST3H3|0:HIST1H1E|0:HIST1H2AC|0:HIST1H2AB|0:H2AFX|0:HIST1H2BG|0:HIST1H2BM|0:HIST1H2BF|0:HIST1H2BJ|0:H2AFY|0:HIST1H2BL|0:HIST1H2BE|0:HIST1H1B|0:HIST1H2BI|0:HIST2H2AC|0:MYST4|0:HIST1H2AE|0:H1FX|0:NAP1L3|0:NAP1L2|0:NAP1L1|0:SET|0:NAP1L4			
GO:0005488	F:binding; TAS:ProtInc		0:TM9SF3|0:SPRR2A|0:SLC25A46|0:CD38|0:AHCYL2|0:BST1|0:LCN15|0:TANC2|0:PECR|0:SPAG6|0:KIAA0368|0:KLRC4|0:SDR39U1|0:TBCCD1|0:RDH11|0:BLVRB|0:SLC25A15|0:MRO|0:HSD17B13|0:ARMCX3|0:HEATR5A|0:IFIT1B|0:GFOD1|0:PKP3|0:TTC9B|0:UCP3|0:SLC25A31|0:LCN8|0:RTDR1|0:SLC25A37|0:DHRS7C|0:ARMC8|0:DHRS13|0:TTC5|0:RDH16|0:TTC15|0:IFRD1|0:NSDHL|0:DHRS9|0:ARMC3|0:PTPN21|0:SLC25A19|0:FAM82B|0:TTC23|0:ORM2|0:DYX1C1|0:FRMD7|0:SLC25A43|0:KPNA7|0:SAAL1|0:INTS4L1|0:RDH8|0:TTC21B|0:PRPF39|0:NAPB|0:SLC25A34|0:SCCPDH|0:TEX10|0:FKBP8|0:SLC25A40|0:SCGB1A1|0:HSD17B3|0:WDR87|0:SLC25A27|0:TTI1|0:TTC29|0:TTC22|0:C7orf63|0:KDSR|0:HSD17B6|0:RGPD6|0:ZYG11A|0:SLC25A16|0:DHRSX|0:TTC18|0:IFIT2|0:TMTC3|0:ARMC4|0:HEATR4|0:LCNL1|0:PSME4|0:BDH1|0:TTC34|0:STAG3L1|0:C1orf175|0:C8orf76|0:SDR42E2|0:TTC9|0:MTHFD2L|0:UNC45B|0:LDHAL6A|0:HEATR5B|0:TMCO7|0:SDR16C5|0:RGPD2|0:DECR2|0:SCGB1D2|0:PKP2|0:SLC25A30|0:TMCO6|0:TTC39B|0:ARMCX1|0:ATXN1L|0:CDC23|0:IFRD2|0:PYCR2|0:TTC33|0:RAP1GDS1|0:NAA16|0:FRMD6|0:INTS4L2|0:STAG3|0:HSD3B7|0:MON2|0:TTC6|0:FICD|0:TTC16|0:QDPR|0:SCGBL|0:RANBP6|0:RGPD5|0:PAEP|0:TTC30B|0:TTC12|0:SEL1L2|0:C8orf73|0:SLC25A2|0:AASS|0:LCN10|0:PRMT10|0:SLC25A11|0:SLC25A20|0:SLC25A36|0:SLC25A41|0:TMTC2|0:C6orf81|0:COL15A1|0:PACRGL|0:C2orf63|0:HSD3B1|0:ARMC7|0:SH3TC1|0:BHLHB9|0:STAG3L3|0:FAM179A|0:ISYNA1|0:SLC25A47|0:RTTN|0:IFIT5|0:IFIT1|0:H6PD|0:C14orf148|0:RDH12|0:TTC21A|0:KCNU1|0:KIAA1468|0:TTC17|0:UEVLD|0:FRMD4B|0:DHRS2|0:ST13P5|0:DHRS11|0:SEL1L3|0:THADA|0:TTC13|0:KIAA0664|0:BZW1P2|0:MCAT|0:MCART1|0:SLC25A39|0:SH3TC2|0:ITGBL1|0:PLEKHH1|0:HEATR6|0:STAG3L2|0:DDO|0:EFR3A|0:NBEAL1|0:KCNT1|0:INSC|0:HSD17B11|0:SLC25A44|0:RDH5|0:FAR2|0:HSF2BP|0:RPAP3|0:PYCR1|0:C1orf163|0:TTC7A|0:FAM65B|0:LDHC|0:SERAC1|0:ANAPC5|0:LCN6|0:SLC25A28|0:HSD11B1|0:RGPD1|0:TTC9C|0:HSD17B1|0:DHRS7|0:DAO|0:SLC25A21|0:UBQLN2|0:SLC25A18|0:FRMD4A|0:ARMC2|0:SLC25A42|0:HSD3B2|0:MEI1|0:C8orf30A|0:C1orf228|0:TMTC1|0:MTCH2|0:RDH13|0:KIAA0562|0:ARMCX5|0:ANKAR|0:LCN12|0:PCYOX1|0:TTC32|0:WDFY4|0:PLEKHH2|0:RGPD4|0:NBEAL2|0:SCGB1D1|0:SLC25A33|0:HEATR7A|0:TTC30A|0:GFOD2|0:SLC25A3|0:RDH10|0:SLC25A14|0:SCGB1C1|0:C8orf30B|0:SPATA16|0:EFR3B|0:UCP2|0:DHRS12|0:ST13P4|0:ARMC9|0:MCART2|0:DCXR|0:SLC25A45|0:DHRS1|0:TTC4|0:HEATR7B1|0:FAM65A|0:KIAA1797|0:TTC24|0:RIF1|0:SLC25A29|0:ARMC10|0:TTC31|0:FRMD8|0:FRMD1|0:DHDH|0:SLC25A38|0:TTC38|0:TTC7B|0:HSD17B2|0:TTC37|0:SLC25A35|0:WDR19|0:AHCYL1|0:C17orf66|0:PTPN14|0:HSD17B7|0:DHRS7B|0:MCART6|0:TTC39A|0:TTC8|0:FAM179B|0:DHRS4L2|0:RDH14|0:DHRS4|0:SDR9C7|0:IFIT3|0:KIAA0141|0:SLC25A26|0:SLC25A32|0:SDR42E1|0:TTC35|0:FKBPL|0:SUGT1|0:SARM1|0:SGTB|0:SCGB1D4|0:HEATR7B2|0:HSD11B1L|0:NMRAL1|0:TTC28|0:PPP4R1L|0:LCN1L1|0:TMTC4|0:FAM82A1|0:HEATR3|0:MDH1B|0:SMEK3P|0:ARMCX2|0:SEC14L1|0:SMO			
GO:0048545	P:response to steroid hormone stimulus; IEP:UniProtKB		0:ABCA2			
GO:0007155	P:cell adhesion; TAS:UniProtKB		0:IZUMO1|0:COL15A1|0:GPR56|0:GP1BA|0:TINAG|0:CD9|0:POSTN|0:AOC3|0:FERMT1|0:IGFBP7|0:AGGF1|0:MAEA|0:AZGP1|0:COL16A1|0:CPXM1|0:HSPB11|0:F8|0:CTNNAL1|0:ACAN|0:C21orf29|0:F5|0:SCARB2|0:CPXM2|0:CD4|0:DCBLD2|0:SCARB1|0:HAPLN1|0:SUSD5|0:COL21A1|0:HAPLN4|0:COL24A1|0:COL11A1|0:COL20A1|0:AEBP1|0:COL11A2|0:COL27A1|0:COL22A1|0:NRP1|0:BCAN|0:LMLN|0:NRP2|0:HAPLN2|0:HSPG2|0:BTBD9|0:COL9A1|0:DCBLD1|0:HAPLN3|0:NR2C2AP|0:NELL1|0:CADM4|0:COL18A1|0:ADAM23|0:IGSF11|0:LAMB4|0:CNTNAP3B|0:SDK2|0:NLGN4X|0:COMP|0:ABL1|0:SRPX|0:COL4A6|0:FBLN7|0:SIGLEC5|0:PKP3|0:ADAM2|0:FBLIM1|0:TMEM8A|0:SPON1|0:EDIL3|0:FREM3|0:SPACA4|0:FLRT2|0:TTYH1|0:KITLG|0:CD300A|0:CD99|0:LAMB3|0:SIGLEC16|0:SPP1|0:CNTN5|0:EMILIN2|0:LAMC2|0:CD47|0:MYBPC2|0:AMICA1|0:PTK7|0:CLCA2|0:SSPO|0:AIMP1|0:THBS2|0:MPZL3|0:SIGLEC10|0:DST|0:FREM1|0:LAMA4|0:DGCR2|0:FLRT1|0:TNFAIP6|0:OMD|0:PODXL|0:PARVB|0:LAMA1|0:NRXN1|0:LAMA3|0:GP1BB|0:PGM5|0:ITGAE|0:COL12A1|0:COL4A3|0:MYBPC3|0:BCAR1|0:DPT|0:COL28A1|0:ROM1|0:COL6A3|0:APP|0:ADAM12|0:CXADR|0:NLGN3|0:LSAMP|0:CD99L2|0:BOC|0:PVRL4|0:DPP4|0:PODXL2|0:LRFN3|0:SPAM1|0:SIGLEC6|0:PTPRS|0:SYMPK|0:CNTNAP3|0:SIRPG|0:NEGR1|0:OLFM4|0:WISP1|0:CNTNAP5|0:LY9|0:HEPACAM|0:NRXN2|0:LPP|0:LAMA2|0:PECAM1|0:SIGLEC7|0:CNTNAP1|0:CSF3R|0:PERP|0:SVEP1|0:IBSP|0:COL8A1|0:AJAP1|0:SIGLEC12|0:FLRT3|0:SCARF1|0:EFS|0:IGFALS|0:SIGLEC14|0:CNTNAP4|0:ADA|0:ENG|0:NFASC|0:MAG|0:NLGN4Y|0:TGFBI|0:COL6A6|0:WISP2|0:SIGLEC8|0:CD6|0:MYBPC1|0:COL7A1|0:NPNT|0:AMTN|0:PRPH2|0:PDZD2|0:OMG|0:CASS4|0:ABL2|0:PARVA|0:LGALS3BP|0:CNTN3|0:SDK1|0:CX3CL1|0:CNTNAP2|0:SPON2|0:RADIL|0:ADAM22|0:RELN|0:SIGLEC9|0:MEGF10|0:LAMC3|0:SCARF2|0:CGREF1|0:COL6A5|0:LAMB2|0:MSLNL|0:NRXN3|0:MOG|0:APLP1|0:MYBPH|0:EGFL6|0:SSX2IP|0:SIGLEC11|0:COL5A1|0:AMBN|0:AMELX|0:RGMB|0:TNXB|0:RHOB|0:THBS1|0:CD22|0:RPSA|0:NEDD9|0:TPBG|0:CD151|0:CNTN1|0:GP5|0:NTM|0:CD33|0:CTNNA1|0:NEO1|0:LPXN|0:FLOT2|0:TNR|0:GP9|0:PKP4|0:ENTPD1|0:ERBB2IP|0:FERMT2|0:STAB1|0:SLAMF7|0:MUC16|0:PKP1|0:MFAP4|0:MTSS1|0:BGLAP|0:STAB2|0:MSLN|0:TLN2|0:KIRREL2|0:NELL2|0:MUC5AC|0:COL6A1|0:APC|0:AMBP|0:NME2|0:SELL|0:EMILIN1|0:EMR1|0:MFGE8|0:NINJ1|0:ARVCF|0:MCAM|0:DSCAM|0:DGCR6|0:CD96|0:CIB1|0:DDR2|0:HAS1|0:APBA1|0:SIRPA|0:MADCAM1|0:TYRO3|0:CASK|0:CCR3|0:PPFIBP1|0:ARHGAP5|0:FPR2|0:CD36|0:CHL1|0:ITGB3BP|0:S1PR1|0:CXCL12|0:ALCAM|0:RS1|0:ISLR|0:SSPN|0:ZYX|0:CCL2|0:TROAP|0:DDR1|0:ATP2A2|0:SEMA4D|0:MAGI1|0:ITGAX|0:MLLT4|0:CD226|0:CCR8|0:CCR1|0:RAB13|0:ITGA9|0:SPOCK1|0:PSTPIP1|0:LRRN2|0:HABP2|0:CXCR3|0:OPCML|0:FEZ1|0:KAL1|0:CCL5|0:IL32|0:TGFB1I1|0:PLXNC1|0:CHST4|0:RND3|0:LOXL2|0:SEMA5A|0:EFNB1|0:LGALS4|0:CD72|0:CCL11|0:VCAN|0:LY6D|0:CX3CR1|0:CD97|0:CLEC4A|0:MMRN1|0:PNN|0:CNTN6|0:BYSL|0:NPHS1|0:CHST10|0:BAI1|0:CCL4|0:GNE|0:C1orf38|0:TNC|0:ACHE|0:CDON|0:SLURP1|0:ARF6|0:IL2|0:INPPL1			
GO:0006198	P:cAMP catabolic process; IEP:BHF-UCL		0:PDE3B			
GO:0070848	P:response to growth factor stimulus; IMP:BHF-UCL		0:SOX2|0:SKIL|0:HDAC6			
GO:0050857	P:positive regulation of antigen receptor-med...; ISS:UniProtKB		0:PTPRC			
GO:0034187	F:apolipoprotein E binding; IPI:BHF-UCL		0:LRP8|0:MAPT			
GO:0021849	P:neuroblast division in the subventricular zone; ISS:UniProtKB		0:NUMB|0:NUMBL			
GO:0046487	P:glyoxylate metabolic process; IMP:HGNC		0:DAO|0:GRHPR|0:HAO1|0:AGXT			
GO:0000257	F:nitrilase activity; TAS:ProtInc		0:NIT1			
GO:0008330	F:protein tyrosine/threonine phosphatase acti...; TAS:ProtInc		0:PTPRZ1|0:DUSP2|0:DUSP4			
GO:0006790	P:sulfur metabolic process; NAS:UniProtKB		0:CHST2|0:CHST8|0:CHST9|0:ARSG|0:MOCS2|0:GAL3ST3|0:GAL3ST4			
GO:0031592	C:centrosomal corona; IDA:UniProtKB		0:CLASP1			
GO:0016769	F:transferase activity, transferring nitrogen...; IEA:InterPro		0:ALAS1|0:ACCS|0:SPTLC3|0:ALAS2|0:ACCSL|0:SPTLC1|0:SPTLC2|0:GCAT			
GO:0009072	P:aromatic amino acid family metabolic process; IEA:InterPro		0:TPH2|0:HPDL|0:TPH1			
GO:0004743	F:pyruvate kinase activity; TAS:UniProtKB		0:PKLR|0:PKM2			
GO:0046597	P:negative regulation of virion penetration i...; NAS:UniProtKB		0:IFNB1			
GO:0051771	P:negative regulation of nitric-oxide synthas...; IDA:BHF-UCL		0:EDN1			
GO:0033549	F:MAP kinase phosphatase activity; IMP:UniProtKB		0:DUSP3			
GO:0006829	P:zinc ion transport; IEA:UniProtKB-KW		0:SLC39A13|0:SLC30A9|0:SLC39A12|0:SLC39A8|0:SLC39A5|0:SLC30A2|0:SLC39A10|0:SLC39A14|0:SLC39A9|0:SLC30A7|0:SLC39A11|0:SLC30A10|0:SLC39A6			
GO:0004526	F:ribonuclease P activity; TAS:ProtInc		0:POP1|0:RPP25|0:RPP21|0:POP5|0:RPP14|0:POP4|0:POP7|0:RPP30|0:RPP40|0:RPP38			
GO:0055008	P:cardiac muscle tissue morphogenesis; ISS:UniProtKB		0:TTN|0:TCAP|0:MYLK2|0:ACTC1			
GO:0045773	P:positive regulation of axon extension; ISS:UniProtKB		0:MAPT|0:LIMK1|0:ISLR2			
GO:0005859	C:muscle myosin complex; TAS:UniProtKB		0:MYH1|0:MYL1|0:MYH4|0:MYH8|0:MYL4|0:MYL6B|0:MYL9|0:MYH11|0:MYLPF|0:MYL3|0:MYL5|0:MYH13|0:MYH2|0:MYH7|0:MYH6			
GO:0003836	F:beta-galactoside alpha-2,3-sialyltransferas...; TAS:ProtInc		0:ST3GAL1|0:ST3GAL2|0:ST3GAL4			
GO:0071209	F:U7 snRNA binding; IDA:UniProtKB		0:LSM11			
GO:0048168	P:regulation of neuronal synaptic plasticity; TAS:UniProtKB		0:DBN1|0:APOE			
GO:0045425	P:positive regulation of granulocyte macropha...; NAS:UniProtKB		0:CD80			
GO:0009021	F:tRNA (uracil-5-)-methyltransferase activity; IEA:EC		0:TRMT2B			
GO:0005516	F:calmodulin binding; TAS:UniProtKB		0:MYLK2|0:IQCB1|0:MYO9B|0:ATP2B2|0:SPHK1|0:DAPK2|0:MYO3A|0:TRPV6|0:DAPK1|0:CAMTA1|0:CAMTA2|0:ENKUR|0:SLC8A2|0:PHKB|0:MYH3|0:MYO15A|0:MAP2|0:NOS3|0:ADD2|0:ATP2B1|0:KCNN3|0:SNTB1|0:CAMK1|0:PHKA2|0:CAMK2D|0:SPTAN1|0:PDE1A|0:MYO1A|0:AKAP5|0:MYH8|0:ITPKC|0:CASK|0:MYO5C|0:ADCY3|0:TRPV1|0:ITPKB|0:UBR4|0:ADD3|0:PHKG2|0:MYO1C|0:INVS|0:MYH11|0:CAMK1G|0:CAMK2A|0:CAMK1D|0:MYLK|0:CAMK4|0:KCNN2|0:MYO1B|0:SLC8A3|0:PPP3CC|0:PHKA1|0:SNTB2|0:TRPM4|0:MYH15|0:MYH7|0:MYO1G|0:PNCK|0:PDE1C|0:CAMK2B|0:SNTA1|0:MAP6|0:ATP2B4|0:PHKG1|0:ATP2B3|0:MYO1D|0:NOS1|0:SPATA17|0:CAMKK1|0:MYH14|0:NDUFAF4|0:MYH1|0:RRAD|0:GAP43|0:MYO1E|0:CNN2|0:IQGAP2|0:MYO5B|0:ITPKA|0:ASPM|0:GEM|0:PCNT|0:NOS2|0:SLC8A1|0:MYH6|0:SPTBN1|0:ADD1|0:EEF2K|0:KCNH1|0:MARCKSL1|0:MYH4|0:PDE1B|0:EDF1|0:KCNN1|0:CNN1|0:IQGAP3|0:MYH9|0:MYH10|0:MYO5A|0:KCNH5|0:EWSR1|0:REM1|0:KCNN4|0:RYR2|0:MYO7A|0:TRPV4|0:USP6|0:CACNA1C|0:RYR1|0:ATPIF1|0:GRIN1|0:EEA1|0:CAMK2G|0:MYO1F|0:STRN4|0:MYH13|0:MYH2|0:CNN3|0:PPP3R1|0:STRN3|0:ADCY1|0:PPP3CA|0:STRN|0:RGS16|0:RGS2|0:IQGAP1|0:RIT1|0:RGS1|0:CALD1|0:RGS4|0:NRGN|0:RIT2|0:MARCKS|0:TTN|0:MYO6|0:CAMKK2			
GO:0006027	P:glycosaminoglycan catabolic process; TAS:ProtInc		0:FUCA1|0:GUSB|0:HYAL4|0:GNS			
GO:0046395	P:carboxylic acid catabolic process; IDA:BHF-UCL		0:PON3|0:PON1			
GO:0031012	C:extracellular matrix; TAS:UniProtKB		0:NDP|0:PCSK6|0:F3|0:TGFB3|0:SERPINE2|0:SERPINE1|0:TGFB2|0:SOD1|0:MMP14|0:MMP21|0:MMP15|0:ADAMTSL4|0:SFRP2|0:THBS1|0:PRSS2			
GO:0030617	F:transforming growth factor beta receptor, i...; IDA:BHF-UCL		0:SMAD7|0:SMAD6			
GO:0034584	F:piRNA binding; ISS:UniProtKB		0:PIWIL4|0:PIWIL1|0:PIWIL2			
GO:0019908	C:nuclear cyclin-dependent protein kinase hol...; IDA:MGI		0:BCCIP			
GO:0004817	F:cysteine-tRNA ligase activity; IEA:EC		0:CARS|0:CARS2			
GO:0060027	P:convergent extension involved in gastrulation; ISS:BHF-UCL		0:BBS4|0:MKKS			
GO:0004725	F:protein tyrosine phosphatase activity; TAS:UniProtKB		0:DUSP4|0:DUSP6|0:DUSP7|0:CDKN3|0:EYA1|0:PTPN1|0:DUSP21|0:EPM2A|0:MTMR3|0:PTPN22|0:DUSP18|0:DUSP3|0:PTPN3|0:TIMM50|0:PTPN13|0:CDC14B|0:EYA2|0:EYA3|0:PTEN|0:PTPN20A|0:DUSP13|0:SSH1|0:EYA4|0:DUSP9|0:PTPRQ|0:DUSP22|0:CDC14A|0:DUSP14|0:SSH2|0:DUSP26|0:DNAJC6|0:C20orf57|0:CDC14C|0:DUSP10|0:PTPN23|0:DUSP28|0:DUPD1|0:SSH3|0:DUSP19|0:MDP1|0:DUSP15|0:DUSP16|0:PTPMT1|0:CDC25A|0:PTPN20B|0:DUSP23|0:C2orf79|0:MTMR8|0:MTMR14|0:TPTE2|0:PTPDC1|0:MTMR2|0:RNGTT|0:MTMR1|0:PTPRT|0:CDC25C|0:DAPP1|0:MTMR6|0:MTM1|0:PTP4A1|0:DUSP8|0:DUSP2|0:PTPN21|0:PTPLA|0:DUSP5|0:PTPN6|0:PTPN7|0:TPTE|0:MTMR7|0:DUSP11|0:PTPN14|0:DUSP12|0:MTMR4|0:CDC25B|0:PTPN5			
GO:0045669	P:positive regulation of osteoblast different...; TAS:BHF-UCL		0:BMP7|0:BMP4|0:BMP2|0:WNT4|0:BMP6|0:BMPR1A|0:ACVR1|0:ACVR2B|0:ACVR2A|0:CTNNBIP1|0:BMPR2|0:IL6ST|0:BMPR1B|0:WNT7B|0:IL6R|0:IL6			
GO:0006271	P:DNA strand elongation involved in DNA repli...; TAS:ProtInc		0:RFC4|0:RFC3			
GO:0050714	P:positive regulation of protein secretion; TAS:UniProtKB		0:TGFB3|0:TGFB2|0:ADAM9|0:TGFB1|0:ANG|0:PLA2G1B|0:ACHE			
GO:0000086	P:G2/M transition of mitotic cell cycle; TAS:ProtInc		0:CCNY|0:BIRC5|0:TPD52L1|0:CDK14|0:LATS1|0:TERF1|0:CDKN1A|0:CDKN2B|0:USH1C|0:JMJD5|0:TAF2|0:KHDRBS1|0:DNM2|0:CCNB1|0:ANAPC4|0:ANAPC5|0:DDX11|0:CDK2|0:ANAPC10			
GO:0042117	P:monocyte activation; TAS:UniProtKB		0:ADAM9|0:ADAM10|0:CSF1|0:AZU1|0:SPACA3			
GO:0018206	P:peptidyl-methionine modification; TAS:HGNC		0:PDF|0:METAP2|0:METAP1			
GO:0005826	C:actomyosin contractile ring; IDA:UniProtKB		0:ANLN|0:MAEA|0:MYH9			
GO:0009384	F:N-acylmannosamine kinase activity; TAS:ProtInc		0:GNE			
GO:0007412	P:axon target recognition; ISS:UniProtKB		0:STXBP1			
GO:0004742	F:dihydrolipoyllysine-residue acetyltransfera...; NAS:UniProtKB		0:DLAT			
GO:0010951	P:negative regulation of endopeptidase activity; IDA:BHF-UCL		0:VTN			
GO:0034970	P:histone H3-R2 methylation; IMP:UniProtKB		0:CARM1			
GO:0004912	F:interleukin-3 receptor activity; TAS:ProtInc		0:IL3RA			
GO:0007016	P:cytoskeletal anchoring at plasma membrane; TAS:UniProtKB		0:TLN2|0:DAG1|0:TLN1|0:EZR|0:SHANK1|0:FLNB|0:SPTBN4			
GO:0045292	P:nuclear mRNA cis splicing, via spliceosome; IDA:UniProtKB		0:WBP4			
GO:0019509	P:L-methionine salvage from methylthioadenosine; IDA:UniProtKB		0:ADI1|0:ENOPH1			
GO:0007019	P:microtubule depolymerization; IMP:UniProtKB		0:STMN1|0:KIF18A|0:KIF2B|0:KIF2C			
GO:0006661	P:phosphatidylinositol biosynthetic process; TAS:ProtInc		0:PI4K2A|0:CD81|0:IMPA1|0:SLC27A1|0:PI4KA|0:PI4KB|0:PIK3C2A			
GO:0008252	F:nucleotidase activity; TAS:ProtInc		0:NT5M			
GO:0005684	C:U2-type spliceosomal complex; IDA:UniProtKB		0:SF3A1			
GO:0070814	P:hydrogen sulfide biosynthetic process; IDA:UniProtKB		0:CTH|0:CBS			
GO:0051605	P:protein maturation by peptide bond cleavage; ISS:UniProtKB		0:CASP2|0:ASPRV1|0:SRGN			
GO:0046969	F:NAD-dependent histone deacetylase activity ...; IDA:UniProtKB		0:SIRT6			
GO:0008038	P:neuron recognition; TAS:ProtInc		0:CNTNAP2|0:NTM|0:PCDH12|0:OPCML			
GO:0006452	P:translational frameshifting; IEA:InterPro		0:EIF5A|0:EIF5A2|0:EIF5AL1			
GO:0003215	P:cardiac right ventricle morphogenesis; ISS:BHF-UCL		0:GATA4			
GO:0033504	P:floor plate development; TAS:BHF-UCL		0:CHRD			
GO:0016126	P:sterol biosynthetic process; TAS:BHF-UCL		0:C14orf1|0:CYB5R2|0:CH25H|0:CYB5R1|0:SC4MOL|0:SC5DL|0:SQLE|0:PRKAG2			
GO:0005267	F:potassium channel activity; TAS:ProtInc		0:KCNK16|0:KCNK17|0:KCNIP3|0:KCNK12|0:KCNK15|0:KCNIP1|0:KCNIP4|0:KCNK13|0:AQP1|0:KCNK9|0:TMEM38B|0:TMEM38A|0:KCNK5|0:KCNK4|0:KCNK10|0:KCNK7			
GO:0006547	P:histidine metabolic process; IEA:UniProtKB-KW		0:FTCD			
GO:0001514	P:selenocysteine incorporation; NAS:UniProtKB		0:TRNAU1AP|0:SEPSECS|0:DIO2			
GO:0044431	C:Golgi apparatus part; IEA:InterPro		0:GGA1			
GO:0007207	P:activation of phospholipase C activity by m...; TAS:ProtInc		0:CHRM2|0:CHRM1|0:GNA15			
GO:0005768	C:endosome; TAS:ProtInc		0:RAPGEF1|0:CRK|0:NTRK1|0:NGF|0:NGFR|0:FRS2|0:ACE|0:BDKRB2|0:BET1L|0:YKT6|0:FYN|0:RNF32|0:ZNRF1|0:VPS35|0:SYT3|0:VOPP1|0:IGF2R|0:TFRC|0:EGFR|0:GIF|0:TNFAIP1|0:MLC1|0:CTSE|0:BACE1|0:DGKH|0:PKN1|0:RASSF9|0:HTR4|0:PRKCI|0:MIB2|0:PRKCZ|0:ARC|0:GOLPH3|0:OCIAD2|0:BACE2|0:SPAST|0:OCIAD1|0:GAPVD1|0:SLA|0:SNX20|0:UNC93B1|0:ATP6V1E1|0:ATP6V0A4|0:MAL|0:LHCGR|0:PI4KB|0:AVPR1A|0:CLIP1|0:VAMP4|0:ADRA2C|0:IL15|0:FPR1|0:ADRB2|0:AVPR2|0:CCR5|0:AVPR1B|0:STS			
GO:0001725	C:stress fiber; NAS:UniProtKB		0:TPM1|0:TPM4|0:TPM3|0:CNN2|0:SEPT7|0:ACTA1|0:AMOT|0:PGM5|0:LIMA1|0:ZYX|0:SEPT11|0:SEPT9|0:MYH9|0:MYH10|0:SEPT12|0:FERMT2			
GO:0010389	P:regulation of G2/M transition of mitotic ce...; IMP:UniProtKB		0:CDKN2A|0:CENPF			
GO:0001716	F:L-amino-acid oxidase activity; IEA:EC		0:IL4I1			
GO:0072054	P:renal outer medulla development; ISS:UniProtKB		0:WNT7B			
GO:0048038	F:quinone binding; IEA:InterPro		0:AOC3|0:CBR4|0:TP53I3|0:AOC2|0:ABP1|0:NDUFS2|0:NDUFS7			
GO:0001843	P:neural tube closure; ISS:UniProtKB		0:BBS4|0:DVL2|0:DEAF1|0:TSC2|0:DLC1|0:BCL10|0:LMO4|0:IFT122|0:VANGL2|0:CELSR1			
GO:0005215	F:transporter activity; TAS:UniProtKB		0:STEAP2|0:C8G|0:LCN15|0:SVOPL|0:SLC5A10|0:SYT11|0:SLC25A31|0:SLC25A23|0:FABP9|0:SYT4|0:SLC22A20|0:SV2B|0:SEC14L4|0:SLC25A43|0:OBP2A|0:LCN1|0:SYT7|0:SLC25A27|0:FABP6|0:SYPL1|0:DOC2B|0:RBP5|0:AQP10|0:CLVS2|0:SLCO4A1|0:AQP12B|0:TTPAL|0:TTPA|0:CRABP1|0:LCN9|0:SLC23A3|0:SLCO1C1|0:SEC14L2|0:SYT10|0:SLCO3A1|0:PCLO|0:SEC14L3|0:FABP5P3|0:SV2C|0:LCN2|0:RBP1|0:FABP5|0:PAEP|0:SLC17A9|0:HIATL2|0:RPH3A|0:DOC2A|0:CRABP2|0:SLC25A17|0:SLC25A36|0:SLCO5A1|0:OBP2B|0:SLC25A41|0:SLC25A47|0:SLC22A17|0:SYT17|0:AQP11|0:RBP7|0:RLBP1|0:SYT5|0:SLC25A44|0:SYNPR|0:FABP4|0:SYTL4|0:SYP|0:IGF2R|0:LCN12|0:SYT1|0:SV2A|0:SYT6|0:SYT3|0:PMP2|0:FABP12|0:CSN2|0:SEC14L5|0:AQP12A|0:SLCO6A1|0:SLC22A23|0:SLC22A15|0:RBP2|0:FABP7|0:AMBP|0:SYT2|0:SYPL2|0:CLVS1|0:LCN1L1|0:CSN1S1|0:SYT9|0:SLC22A10|0:PTGDS|0:GOLGA3|0:RASSF9|0:CUBN|0:CPNE7|0:NUP214|0:NUP153|0:KIF20A|0:SEC22A|0:NUTF2|0:SCARB1|0:HTT|0:AP4M1|0:SEC24B|0:CPNE6|0:NUP98|0:CPNE3|0:SYN1|0:NUP155|0:NUP88|0:GOSR2|0:TCOF1|0:AP2M1|0:XK|0:ABCF2|0:C16orf7|0:KLHL2|0:CPNE1|0:PACSIN2|0:FLVCR1|0:PDZK1			
GO:0071344	P:diphosphate metabolic process; EXP:Reactome		0:PPA1|0:PPA2			
GO:0051495	P:positive regulation of cytoskeleton organiz...; ISS:BHF-UCL		0:P2RX7			
GO:0005777	C:peroxisome; TAS:UniProtKB		0:AGXT|0:HACL1|0:ACOT4|0:MUL1|0:PRDX5|0:ACOXL|0:MVK|0:EPHX2|0:NUDT12|0:DECR2|0:TYSND1|0:XDH|0:DDO|0:PXT1|0:PRHOXNB|0:IDH1|0:HSDL2|0:NUDT7|0:GSTK1|0:SERHL2|0:NUDT19|0:TRIM37|0:KIAA0430|0:IDI2|0:DHRS4L2|0:DHRS4|0:ISOC1|0:ACAD11|0:ZADH2|0:SOD1|0:PECR|0:ACOX2|0:ABP1|0:DAO|0:CRAT|0:MLYCD|0:PEX7|0:AMACR|0:PMVK|0:ACOX3|0:IDI1|0:PIPOX|0:EHHADH|0:SCP2|0:ECH1|0:PHYH|0:ACOT8|0:HAO2|0:HAO1			
GO:0045869	P:negative regulation of retroviral genome re...; IDA:HGNC		0:APOBEC3F|0:APOBEC3G			
GO:0006779	P:porphyrin biosynthetic process; IEA:UniProtKB-KW		0:ABCB6|0:RSAD1			
GO:0032675	P:regulation of interleukin-6 production; IDA:HGNC		0:AFAP1L2			
GO:0043518	P:negative regulation of DNA damage response,...; IDA:UniProtKB		0:MDM2|0:CD74|0:MIF|0:CD44|0:SIRT1|0:PSMD10			
GO:0050732	P:negative regulation of peptidyl-tyrosine ph...; ISS:UniProtKB		0:SFRP1|0:PRKCZ|0:PRKCD|0:SFRP2			
GO:0030838	P:positive regulation of actin filament polym...; IMP:UniProtKB		0:CCL26|0:CCL24|0:CCL11|0:CDC42EP2|0:CDC42EP5|0:NCK1|0:ARF6|0:NCK2			
GO:0042132	F:fructose 1,6-bisphosphate 1-phosphatase act...; IEA:EC		0:FBP2|0:FBP1			
GO:0001875	F:lipopolysaccharide receptor activity; TAS:UniProtKB		0:SCARB1|0:TLR4|0:LY96|0:TLR2			
GO:0005952	C:cAMP-dependent protein kinase complex; TAS:UniProtKB		0:PRKAR1A|0:RAPGEF4|0:RAPGEF3|0:PRKACA|0:PRKAR1B|0:AKAP4|0:PRKACB			
GO:0042178	P:xenobiotic catabolic process; IDA:UniProtKB		0:CRYZ			
GO:0008480	F:sarcosine dehydrogenase activity; IEA:EC		0:SARDH			
GO:0070431	P:nucleotide-binding oligomerization domain c...; IDA:MGI		0:RELA|0:NOD2			
GO:0008479	F:queuine tRNA-ribosyltransferase activity; TAS:UniProtKB		0:QTRTD1|0:QTRT1			
GO:0060174	P:limb bud formation; IMP:BHF-UCL		0:WNT3			
GO:0005814	C:centriole; TAS:ProtInc		0:BBS4|0:CNTROB|0:CENPJ|0:CEP76|0:BIRC5|0:CCNF|0:CEP135|0:CETN2|0:OFD1|0:TUBGCP3|0:PLK4|0:SASS6|0:CEP250|0:CEP164|0:CEP192|0:FTCD|0:CEP55|0:SFI1|0:POC5|0:PARP3|0:POC1A|0:CNTLN|0:LRRCC1|0:IFT20|0:CEP170|0:ROCK1|0:ODF2|0:POC1B|0:IFT88|0:CROCC|0:TUBD1|0:CETN3			
GO:0051496	P:positive regulation of stress fiber assembly; TAS:UniProtKB		0:GPR65|0:RHOA|0:SORBS3|0:NF2|0:WNT11|0:SFRP1|0:TPM1|0:AMOT			
GO:0015085	F:calcium ion transmembrane transporter activity; TAS:ProtInc		0:ITPR1|0:SLC8A1|0:ITPR2			
GO:0006928	P:cellular component movement; TAS:UniProtKB		0:ABI1|0:CD9|0:ELMO1|0:ALOX12|0:MYLIP|0:TLN1|0:MTSS1|0:IGSF8|0:ABI3|0:ARHGEF11|0:PLAUR|0:MAPK14|0:MST1R|0:WASF1|0:IGF1|0:PTGS2|0:GNA13|0:CCR6|0:PALM|0:RAC1|0:DNALI1|0:CCL3|0:SERPINI2|0:PAK4|0:FPR2|0:CXCR5|0:DNAH9|0:ENPP2|0:ARPC1B|0:KPTN|0:WASL|0:ANXA1|0:LTB4R|0:TXN|0:PYY|0:JAK2|0:FPR1|0:AKAP3|0:ARPC5|0:STAT3|0:ARFIP2|0:SPOCK1|0:CXCR3|0:LYVE1|0:FPR3|0:CAPZA2|0:CHST4|0:ARPC2|0:VNN1|0:CERCAM|0:SPINT2|0:TUBB2C|0:NPY|0:ITGAL|0:CD97|0:LSP1|0:ADRA2A|0:ARPC3|0:CCL4|0:IL13|0:VNN2|0:SERPINB5|0:OR1D2|0:ARHGDIB|0:CAPZA1|0:HSPB1|0:ACTG1|0:TPM4|0:VCL|0:CALD1|0:ACTR2|0:VIM|0:ARF6|0:CAPZB|0:TPM3|0:ACTR3|0:TUBB|0:ACTB|0:TPM1|0:ARHGDIA			
GO:0032876	P:negative regulation of DNA endoreduplication; IMP:BHF-UCL		0:STAG2|0:SMC1A|0:MRE11A|0:SMC3|0:FBXW7			
GO:0007204	P:elevation of cytosolic calcium ion concentr...; TAS:UniProtKB		0:EDN2|0:TAC1|0:CALCR|0:NMUR2|0:CD55|0:GLP1R|0:SAA1|0:CD52|0:KNG1|0:CCKBR|0:CD24|0:SAA2|0:TRPV4|0:CHRNA9|0:CHRNA10|0:GNA15|0:OPRL1|0:C3AR1|0:ITPR3|0:CAV3|0:GHRL|0:CACNA1A|0:NPTN|0:CXCL13|0:CYSLTR1|0:CCR6|0:AVPR1A|0:C5AR1|0:F2RL1|0:CCR3|0:P2RY4|0:LPAR2|0:LPAR1|0:CCR7|0:CCR4|0:S1PR4|0:CXCR4|0:BDKRB1|0:CCR8|0:CCR1|0:CXCR3|0:S1PR3|0:MCHR1|0:CCKAR|0:CCR5|0:GALR2|0:CCR9|0:AVPR1B|0:BDKRB2|0:CCR2|0:PLCE1|0:PROK2			
GO:0000723	P:telomere maintenance; TAS:UniProtKB		0:SMG6|0:WRN|0:NBN|0:C17orf68|0:FBXO4|0:RTEL1|0:XRCC6|0:XRCC5|0:PTGES3			
GO:0005100	F:Rho GTPase activator activity; TAS:UniProtKB		0:GRLF1|0:GMIP|0:ARHGAP1|0:MYO9B|0:ARAP1|0:JUN|0:DLC1|0:CDC42EP2|0:ARHGAP6|0:SYDE2|0:THY1|0:ARAP3|0:SYDE1|0:ARHGAP26|0:ARHGAP4|0:OPHN1|0:ARHGAP5|0:ARHGAP29|0:ERRFI1|0:SOS1|0:PREX1			
GO:0002675	P:positive regulation of acute inflammatory r...; IDA:BHF-UCL		0:OSM|0:OSMR|0:IL6ST|0:IL6			
GO:0046966	F:thyroid hormone receptor binding; TAS:UniProtKB		0:MED14|0:NCOA6|0:TRIP12|0:MED13|0:MED17|0:MED12|0:MED24|0:THRAP3|0:MED16|0:MED1|0:MED30|0:MED4|0:GTF2B|0:TAF11|0:NUP62|0:TAF7|0:NSD1|0:NCOA3|0:HMGN3|0:TRIP6|0:OASL|0:ZNHIT3|0:JMJD1C			
GO:0033691	F:sialic acid binding; IDA:BHF-UCL		0:SELP|0:SELE			
GO:0001101	P:response to acid; TAS:UniProtKB		0:CHIA			
GO:0030530	C:heterogeneous nuclear ribonucleoprotein com...; TAS:ProtInc		0:HNRNPA2B1|0:HNRNPD|0:RBMX|0:HNRNPH3|0:HNRNPH1|0:HNRNPR|0:HNRNPA1|0:PTBP1|0:HNRNPF|0:HNRNPK|0:HNRPDL|0:HNRNPH2|0:HNRNPU|0:RALY|0:HNRNPL|0:HNRNPA0|0:HNRNPUL1			
GO:0003136	P:canonical Wnt receptor signaling pathway in...; IDA:BHF-UCL		0:WNT3A			
GO:0006268	P:DNA unwinding involved in replication; NAS:UniProtKB		0:PURA|0:RAD51|0:TOP3B|0:TOP3A|0:TOP1|0:TOP1MT|0:HMGA1			
GO:0045906	P:negative regulation of vasoconstriction; ISS:BHF-UCL		0:ADM|0:BMPR2			
GO:0043028	F:caspase regulator activity; IMP:UniProtKB		0:NGFRAP1|0:FOXL2			
GO:0042053	P:regulation of dopamine metabolic process; ISS:UniProtKB		0:DRD4|0:CHRNB2			
GO:0042162	F:telomeric DNA binding; TAS:ProtInc		0:XRCC5|0:PIF1|0:SMG6|0:NCL|0:TERF1|0:HNRNPD|0:TINF2|0:TERT			
GO:0008280	C:cohesin core heterodimer; TAS:UniProtKB		0:SMC1A			
GO:0060236	P:regulation of mitotic spindle organization; ISS:UniProtKB		0:PSRC1|0:C13orf34|0:TPX2			
GO:0009898	C:internal side of plasma membrane; TAS:UniProtKB		0:G6PD|0:TH|0:GEM|0:DSG1|0:PGM5|0:SHROOM4|0:JUP|0:GNB1L|0:CACNB4			
GO:0000940	C:outer kinetochore of condensed chromosome; IDA:UniProtKB		0:SKA3|0:CCDC99|0:SKA1|0:SKA2|0:CENPF|0:BUB1B			
GO:0005053	F:peroxisome matrix targeting signal-2 binding; IDA:UniProtKB		0:PEX7			
GO:0051457	P:maintenance of protein location in nucleus; NAS:UniProtKB		0:TAF8|0:TAF3|0:SUPT7L|0:PML|0:MORC3|0:TOPORS|0:BBS4|0:BCL3			
GO:0031536	P:positive regulation of exit from mitosis; IMP:UniProtKB		0:BIRC5|0:UBE2C			
GO:0015695	P:organic cation transport; NAS:UniProtKB		0:SLC22A18			
GO:0008299	P:isoprenoid biosynthetic process; IEA:UniProtKB-KW		0:PDSS2|0:PDSS1|0:MVK|0:MVD|0:HMGCR|0:HMGCS1|0:HMGCS2|0:GGPS1|0:FDFT1|0:FDPS|0:COQ2			
GO:0000793	C:condensed chromosome; ISS:UniProtKB		0:HMGB2|0:HMGB1|0:SMARCA5|0:LIG4|0:L3MBTL1|0:CTCF|0:HMGB1P10			
GO:0006457	P:protein folding; TAS:UniProtKB		0:APOA2|0:DNAJA3|0:ERP44|0:DNAJB6|0:DNAJC30|0:C19orf2|0:DNAJB4|0:GRPEL2|0:DNAJB13|0:TTC9B|0:HSP90AA2|0:CLGN|0:HSPA9|0:DNAJC5|0:PFDN5|0:HSP90B1|0:TTC9|0:GRPEL1|0:HSP90B2P|0:COPA|0:DNAJB5|0:HSP90AB4P|0:TRAP1|0:HSP90AA4P|0:CCT8|0:DNAJC16|0:UXT|0:CLPX|0:CALR3|0:DNAJB9|0:DNAJB12|0:HSP90AB3P|0:AHSP|0:SLMAP|0:AIPL1|0:HSCB|0:DNAJB11|0:DNAJC5B|0:PDRG1|0:DNAJC14|0:DNAJA2|0:CANX|0:TTC9C|0:SEC63|0:FKBP15|0:DNAJC17|0:DNAJC10|0:PFDN1|0:GRXCR1|0:DNAJB14|0:DNAJA4|0:VBP1|0:HSP90AB2P|0:HSP90AA5P|0:DNAJC5G|0:HSP90AB1|0:FKBPL|0:DNAJC18|0:CCT5|0:PPIL1|0:PPID|0:FKBP8|0:PPIC|0:PPIG|0:PIN4|0:FKBP3|0:FKBP10|0:PPIE|0:PPIL4|0:PPIAL4C|0:FKBP14|0:PPWD1|0:FKBP11|0:FKBP2|0:PPIAL4A|0:FKBP7|0:PPIB|0:PIN1|0:PPIL3|0:PPIL2|0:RANBP2|0:PPIL6|0:NKTR|0:FKBP1C|0:CWC27|0:PPIF|0:AHSA1|0:HSPA4L|0:FKBP9|0:CRYAB|0:SIL1|0:LMAN2L|0:DNAJC2|0:DNAJC19|0:BAG3|0:MPDU1|0:DNAJC21|0:ALG12|0:PFDN2|0:HSPA8|0:DNAJC4|0:CCT2|0:FUT10|0:SACS|0:PFDN6|0:LMAN1|0:FKBP4|0:TCP1|0:RUVBL2|0:CCT3|0:BAG2|0:CCT7|0:TTC1|0:CLN3|0:CCT4|0:CCT6B|0:ERP29|0:APCS|0:PPIH|0:DNAJB2|0:NFYC|0:FKBP6|0:CCT6A|0:ST13|0:HSPE1|0:BAG5|0:BAG4|0:HSPBP1|0:FKBP5|0:MKKS|0:PDIA6|0:PDIA2|0:DNAJA1|0:ATF6|0:LRPAP1|0:LTBP4|0:PDIA5|0:TBCE|0:RP2|0:PFDN4|0:TBCD|0:PPIA			
GO:0048019	F:receptor antagonist activity; TAS:UniProtKB		0:LRPAP1|0:ADH7|0:ESR2|0:AGTR2|0:IL18BP			
GO:0003729	F:mRNA binding; TAS:UniProtKB		0:CELF1|0:CALR|0:ZFP36L1|0:ZFP36|0:RPL7|0:RBM38|0:RPS26|0:FYTTD1|0:RPS3|0:RPS13|0:RBM25|0:RBM5|0:ESRP1|0:RPS5|0:ESRP2|0:HNRPLL|0:LUC7L3|0:PIWIL1|0:SRRM4|0:PURB|0:CELF3|0:RBM8A|0:ADARB1|0:FMR1|0:GRSF1|0:SSB|0:HNRNPAB|0:ELAVL1|0:RPL35|0:EIF4A1			
GO:0045736	P:negative regulation of cyclin-dependent pro...; IMP:UniProtKB		0:NR2F2|0:HEXIM1|0:HEXIM2|0:LATS1|0:CDK5RAP1|0:LATS2|0:TFAP4|0:APC|0:MEN1			
GO:0045088	P:regulation of innate immune response; NAS:UniProtKB		0:SAMHD1|0:RNF135|0:ERAP1			
GO:0060732	P:positive regulation of inositol phosphate b...; IDA:UniProtKB		0:SNCA			
GO:0004422	F:hypoxanthine phosphoribosyltransferase acti...; IEA:InterPro		0:HPRT1|0:PRTFDC1			
GO:0004622	F:lysophospholipase activity; TAS:ProtInc		0:PLA2G4A|0:ASPG|0:CLC|0:PLB1|0:PNPLA8|0:PNPLA6|0:PLA2G4B|0:LYPLAL1|0:LGALS13|0:MGLL|0:PLA2G15|0:LYPLA1			
GO:0035303	P:regulation of dephosphorylation; TAS:HGNC		0:SMG5|0:SMG7|0:SMG6			
GO:0002062	P:chondrocyte differentiation; ISS:UniProtKB		0:TGFB1|0:WNT10B|0:WNT2B|0:WNT5B|0:AMELX|0:CREB3L2			
GO:0070245	P:positive regulation of thymocyte apoptosis; IMP:UniProtKB		0:ZC3H8			
GO:0001833	P:inner cell mass cell proliferation; ISS:UniProtKB		0:SBDS			
GO:0051264	F:mono-olein transacylation activity; IDA:UniProtKB		0:PNPLA3			
GO:0045596	P:negative regulation of cell differentiation; ISS:UniProtKB		0:HOPX|0:PRAME|0:SUZ12|0:SKIL			
GO:0014824	P:artery smooth muscle contraction; IMP:BHF-UCL		0:EDN2|0:EDN1|0:EDNRA			
GO:0005141	F:interleukin-10 receptor binding; NAS:UniProtKB		0:IL10			
GO:0006412	P:translation; TAS:ProtInc		0:RPS27L|0:MRPL41|0:PTRH2|0:MRPL4|0:MRPL33|0:PELO|0:MRPL12|0:RPL36AL|0:MRPL49|0:RPL10L|0:RSL24D1|0:MRPL24|0:CYLD|0:MRPL15|0:C2orf79|0:MRPS5|0:RPS26P11|0:MRPS12|0:MRPS9|0:RPL39L|0:MRPL47|0:LRRC47|0:MRPL2|0:MRPS2|0:MRPL22|0:MRPL14|0:MRPL19|0:MRPS30|0:NCOA5|0:RSL1D1|0:MRPS11|0:MRPL17|0:METT11D1|0:RPL7L1|0:MRPL48|0:RPL39P5|0:MRPL21|0:RPS4Y2|0:MRPS10|0:MRPL30|0:PTRH1|0:RPL22L1|0:SECISBP2|0:QRSL1|0:PDF|0:AIMP2|0:EEF1E1|0:PSTK|0:MRRF|0:GSPT2|0:MRPS24|0:MRPL10|0:MRPL52|0:MRPL51|0:MRPS7|0:MRPL55|0:MRPS21|0:MRPL35|0:MRPS16|0:MRPL34|0:IGHMBP2|0:MRPS18A|0:MRPL32|0:MRPL11|0:MRPS36|0:MRPL27|0:MRPS15|0:MRPL42|0:MRPL37|0:MRPS6|0:MRPS18B|0:MRPL28|0:MRPL9|0:MRPS18C|0:MRPL13|0:MRPL36|0:MRPL43|0:MRPL18|0:MRPL45|0:MRPS25|0:MRPS14|0:MRPS17|0:MRPS33|0:EIF4EBP2|0:RRBP1|0:MRPL23|0:MRPL3|0:PABPC4|0:RPS6KB2|0:TNIP1|0:NACA|0:DPH1|0:DHPS|0:IGF2BP3|0:ASMT			
GO:0009303	P:rRNA transcription; TAS:ProtInc		0:RNASEK|0:ANG|0:SIRT7|0:POLR1E|0:MKI67IP|0:CD3EAP|0:GTF3A|0:BRF1			
GO:0043536	P:positive regulation of blood vessel endothe...; IDA:UniProtKB		0:THBS1|0:FGF2|0:VEGFA|0:PDGFB|0:TGFB1|0:AMOT|0:ANGPT4|0:ANGPT1			
GO:0002040	P:sprouting angiogenesis; ISS:UniProtKB		0:CDH13|0:ANGPT1|0:THBS1|0:CCBE1			
GO:0005891	C:voltage-gated calcium channel complex; TAS:ProtInc		0:CACNB3|0:CACNA1S|0:CACNA2D1|0:CACNA1F|0:CACNA1C|0:CACNA1D|0:CACNB4|0:CACNG6|0:CACNG7|0:CACNG3|0:CACNG8|0:CACNA1I|0:CACNA1E|0:CACNA1H|0:CACNB2|0:CACNA1B|0:CACNB1|0:CACNG2|0:CACNG1|0:CACNA1G			
GO:0006183	P:GTP biosynthetic process; IEA:InterPro		0:NME5|0:TXNDC3|0:NME4|0:NME1|0:RP2|0:NME2|0:NME6|0:TXNDC6|0:NME7|0:NME2P1|0:NME3			
GO:0005459	F:UDP-galactose transmembrane transporter act...; TAS:ProtInc		0:SLC35B1|0:SLC35A2			
GO:0004803	F:transposase activity; TAS:UniProtKB		0:C14orf115|0:ZBED1|0:SETMAR			
GO:0046108	P:uridine metabolic process; NAS:UniProtKB		0:UPP2			
GO:0016119	P:carotene metabolic process; IDA:UniProtKB		0:BCO2			
GO:0005099	F:Ras GTPase activator activity; TAS:UniProtKB		0:NF1|0:IQGAP1|0:IQGAP2|0:IQGAP3|0:WNT11|0:HTR2B|0:RASAL1|0:RASA1|0:RASA2|0:RASAL2|0:ALDH1A1			
GO:0030521	P:androgen receptor signaling pathway; NAS:UniProtKB		0:ARID1A|0:MED14|0:DAXX|0:MED13|0:MED17|0:MED12|0:MED24|0:KDM3A|0:THRAP3|0:MED16|0:MED1|0:MED30|0:MED4|0:RNF4|0:PPARGC1A|0:NCOA3|0:PPAP2A|0:GRIP1|0:KAT5|0:RNF14|0:PIAS2|0:PMEPA1|0:NCOA4|0:BRCA1|0:PIAS1|0:TGFB1I1|0:FHL2|0:CCNE1|0:CDK7|0:CTNNB1|0:RB1|0:NRIP1			
GO:0070537	P:histone H2A K63-linked deubiquitination; IMP:UniProtKB		0:BRCC3|0:UIMC1			
GO:0007223	P:Wnt receptor signaling pathway, calcium mod...; IEA:InterPro		0:FZD4|0:WNT5A|0:WNT10B|0:WNT2B|0:WNT8B|0:WNT3|0:WNT1|0:WNT11|0:WNT6|0:WNT16|0:WNT8A|0:WNT5B|0:WNT3A|0:WNT9A|0:WNT2|0:WNT7A|0:WNT7B|0:WNT4|0:WNT9B|0:WNT10A			
GO:0004105	F:choline-phosphate cytidylyltransferase acti...; TAS:ProtInc		0:PCYT1A|0:PCYT1B			
GO:0032902	P:nerve growth factor production; IDA:BHF-UCL		0:FURIN|0:PCSK6			
GO:0030371	F:translation repressor activity; NAS:UniProtKB		0:SAMD4A|0:PAIP2|0:CIRBP|0:EIF4EBP3			
GO:0006780	P:uroporphyrinogen III biosynthetic process; IDA:UniProtKB		0:UROS			
GO:0006633	P:fatty acid biosynthetic process; NAS:UniProtKB		0:LIPC|0:LPL|0:MCAT|0:C5orf4|0:CH25H|0:SC4MOL|0:SC5DL|0:TMEM195|0:DEGS2|0:PECR|0:MLYCD|0:ELOVL3|0:SCD5|0:PTPLAD2|0:PTPLA|0:PRKAG3|0:PRKAB1|0:PRKAG2|0:PTPLB|0:ACACB|0:FASN|0:ELOVL7|0:PRKAB2|0:BRCA1|0:ELOVL1|0:ACACA|0:CBR4|0:PRKAA1|0:SCD|0:PRKAG1|0:TPI1|0:FADS6|0:HSD17B8|0:PTPLAD1|0:FA2H|0:PRKAA2|0:ELOVL5|0:ELOVL2|0:MECR|0:OLAH|0:ELOVL4|0:NDUFAB1			
GO:0030308	P:negative regulation of cell growth; TAS:UniProtKB		0:CDKN1A|0:CDKN2D|0:ENPP1|0:TGFB2|0:ACVRL1|0:SMAD4|0:GDF2|0:TGFB1|0:CDKN2C|0:CDKN1B|0:ACVR1B|0:INHBA|0:SERTAD3|0:SERTAD2|0:EI24|0:RBBP7|0:PML|0:SFRP2|0:NDUFA13|0:DCBLD2|0:TSPYL2|0:MUL1|0:CAPRIN2|0:BCL6|0:OSGIN1|0:ENO1|0:CDA|0:RERG|0:FRZB|0:SFRP1|0:NME6|0:CDHR2|0:CCDC85B|0:BMPR2|0:BMP10|0:PPP1R9B|0:WT1|0:TP73|0:TP63|0:TNK1|0:DNAJB2|0:SLIT2|0:CDKN2AIP|0:SLIT3|0:SOX17|0:HNF4A|0:CYP27B1|0:MYL2|0:GNG4|0:PPT1|0:WNT11|0:NDUFS3|0:TP53|0:DCUN1D3|0:HSPA1A|0:HSPA1B|0:IP6K2|0:PSRC1|0:APBB2|0:APBB1|0:NPR1|0:SCGB3A1|0:TP53TG5|0:PPP2R1A|0:ING1|0:PPP2CA|0:SIPA1|0:BTG1|0:PHF17|0:WFDC1|0:ESR2|0:NPPB|0:NDRG3|0:AGTR2|0:RB1			
GO:0016153	F:urocanate hydratase activity; IEA:EC		0:UROC1			
GO:0008073	F:ornithine decarboxylase inhibitor activity; TAS:ProtInc		0:OAZ2|0:OAZ3|0:OAZ1			
GO:0008747	F:N-acetylneuraminate lyase activity; IEA:EC		0:NPL			
GO:0048178	P:negative regulation of hepatocyte growth fa...; IDA:UniProtKB		0:INHBB			
GO:0043034	C:costamere; ISS:UniProtKB		0:DMD|0:SVIL|0:PGM5|0:KRT19|0:SYNM|0:VCL			
GO:0005664	C:nuclear origin of replication recognition c...; TAS:ProtInc		0:ORC3|0:ORC6|0:REPIN1			
GO:0034605	P:cellular response to heat; NAS:BHF-UCL		0:IL1A|0:CLPB|0:FGF1|0:THBS1			
GO:0009330	C:DNA topoisomerase complex (ATP-hydrolyzing); IDA:UniProtKB		0:TOP2A			
GO:0000296	P:spermine transport; ISS:UniProtKB		0:TAF7			
GO:0010722	P:regulation of ferrochelatase activity; IDA:BHF-UCL		0:FXN			
GO:0051645	P:Golgi localization; IMP:UniProtKB		0:HOOK3			
GO:0007613	P:memory; TAS:ProtInc		0:CHRNB2|0:TH|0:NETO1|0:KLK8|0:CHRNA7|0:VLDLR			
GO:0035279	P:mRNA cleavage involved in gene silencing by...; IDA:UniProtKB		0:EIF2C2|0:MOV10			
GO:0004308	F:exo-alpha-sialidase activity; TAS:ProtInc		0:NEU4|0:NEU2|0:NEU3|0:NEU1			
GO:0010909	P:positive regulation of heparan sulfate prot...; IMP:BHF-UCL		0:TCF7L2|0:CTNNB1			
GO:0004109	F:coproporphyrinogen oxidase activity; TAS:ProtInc		0:RSAD1|0:CPOX			
GO:0051370	F:ZASP binding; IDA:UniProtKB		0:ACTN2			
GO:0045839	P:negative regulation of mitosis; NAS:UniProtKB		0:BMP7|0:BMP4|0:NME6|0:AURKAIP1			
GO:0004115	F:3',5'-cyclic-AMP phosphodiesterase activity; TAS:UniProtKB		0:PDE4D|0:PDE4B|0:PDE4A|0:PDE4C|0:PDE7B|0:PDE7A			
GO:0031994	F:insulin-like growth factor I binding; IPI:BHF-UCL		0:IGFBP2|0:IGFBP3|0:IGF1R|0:INSR|0:IGFBP5			
GO:0004918	F:interleukin-8 receptor activity; TAS:ProtInc		0:CXCR2|0:CXCR1			
GO:0006344	P:maintenance of chromatin silencing; IMP:BHF-UCL		0:HDAC2|0:SIRT1			
GO:0051005	P:negative regulation of lipoprotein lipase a...; IDA:BHF-UCL		0:APOC1|0:ANGPTL4|0:ANGPTL3|0:SORT1|0:APOC3			
GO:0009247	P:glycolipid biosynthetic process; TAS:UniProtKB		0:GBGT1|0:B3GNT5			
GO:0032311	C:angiogenin-PRI complex; IPI:UniProtKB		0:RNH1|0:ANG			
GO:0048210	P:Golgi vesicle fusion to target membrane; IDA:BHF-UCL		0:RAB8A			
GO:0048660	P:regulation of smooth muscle cell proliferation; IMP:BHF-UCL		0:TCF4|0:CTNNB1			
GO:0043237	F:laminin-1 binding; ISS:UniProtKB		0:ACHE|0:SLIT2|0:LACRT|0:DAG1|0:SHH			
GO:0043015	F:gamma-tubulin binding; ISS:UniProtKB		0:RACGAP1|0:RAB11FIP5|0:MARK4|0:TUBGCP3|0:BLOC1S2|0:BRCA2|0:OFD1			
GO:0046578	P:regulation of Ras protein signal transduction; IMP:BHF-UCL		0:PLCE1|0:FOXM1			
GO:0042599	C:lamellar body; TAS:UniProtKB		0:ABCA3|0:SPINK5			
GO:0004034	F:aldose 1-epimerase activity; IEA:EC		0:GALM			
GO:0005602	C:complement component C1 complex; TAS:ProtInc		0:C1QB|0:C1QA			
GO:0042734	C:presynaptic membrane; TAS:UniProtKB		0:PICK1|0:KCTD12|0:UNC13A|0:CAMK2A|0:DENND1A|0:LRFN3|0:LRRC4B|0:FBXO45|0:RIMS2|0:KCTD16|0:KCTD8|0:ZNRF2|0:GAD2|0:UNC13C|0:PICALM|0:NPTN|0:ERC2|0:SNCAIP|0:RIMS1|0:ERC1			
GO:0030387	F:fructosamine-3-kinase activity; NAS:UniProtKB		0:FN3K			
GO:0031213	C:RSF complex; IPI:UniProtKB		0:RSF1|0:SMARCA5			
GO:0016887	F:ATPase activity; TAS:UniProtKB		0:ACTC1|0:INO80|0:SMARCA5|0:KIF20B|0:RHOBTB3|0:PSMC2|0:ABCG8|0:ABCA6|0:DNAH1|0:DNAH2|0:DNAH12|0:DNAH17|0:KIAA0564|0:ABCA5|0:ABCE1|0:DNAH9|0:ABCA10|0:DNAH6|0:ABCF3|0:DNAH5|0:DNAH11|0:DNAH8|0:ABCD2|0:ABCA9|0:ABCG4|0:ABCF2|0:DNAH10|0:ABCA13|0:DYNC2H1|0:ABCA7|0:ABCA12|0:DNAH3|0:ABCA1|0:ABCG5|0:WRNIP1|0:HSPD1|0:PICK1|0:CLPX|0:KIF1B|0:ACIN1|0:MDN1|0:PSMD6|0:PSMC1|0:PSMC4|0:PSMC6|0:VCP|0:PSMC5			
GO:0005740	C:mitochondrial envelope; TAS:ProtInc		0:BNIP3L|0:CIDEA|0:ADAP2|0:ABCF2			
GO:0090004	P:positive regulation of establishment of pro...; ISS:BHF-UCL		0:AKT1|0:PDPK1|0:PRKCI|0:PIK3R1			
GO:0051717	F:inositol-1,3,4,5-tetrakisphosphate 3-phosph...; IDA:UniProtKB		0:PTEN			
GO:0006816	P:calcium ion transport; TAS:ProtInc		0:TPT1|0:NMUR2|0:NMUR1|0:CHRNA7|0:SLC8A2|0:SLC24A4|0:SLC24A3|0:BSPRY|0:SLC8A3|0:CLCA1|0:SLC24A6|0:MCOLN1|0:STIM2|0:ACCN2|0:SLC24A5|0:CACHD1|0:STIM1|0:CYP27B1|0:CAV1|0:CHRNB2|0:CHRNA4|0:SLC3A2|0:SLC24A1|0:SLN|0:FYN|0:CCL8|0:NPY|0:CSN2			
GO:0008035	F:high-density lipoprotein binding; NAS:UniProtKB		0:APOL5|0:APOL2			
GO:0009673	F:low affinity phosphate transmembrane transp...; TAS:ProtInc		0:ADAMTS8			
GO:0006536	P:glutamate metabolic process; ISS:UniProtKB		0:TAT|0:AADAT|0:GCLM|0:GCLC|0:ALDH5A1			
GO:0008091	C:spectrin; TAS:ProtInc		0:SPTBN2|0:SPTBN4|0:SPTBN5|0:SPTA1|0:SPTAN1|0:EPB41L2|0:SPTB|0:SPTBN1|0:EPB41			
GO:0043654	P:recognition of apoptotic cell; IDA:BHF-UCL		0:SCARB1			
GO:0019827	P:stem cell maintenance; TAS:UniProtKB		0:FZD7|0:ZCCHC11|0:LIN28A|0:ZNF358|0:NOTCH2			
GO:0008973	F:phosphopentomutase activity; IEA:EC		0:PGM2			
GO:0003684	F:damaged DNA binding; TAS:ProtInc		0:ALKBH3|0:ALKBH2|0:HMGB2|0:ERCC1|0:RBBP8|0:RPS3|0:APTX|0:RUVBL2|0:NEIL2|0:POLK|0:NEIL1|0:RAD23A|0:POLI|0:ESCO2|0:RAD51|0:RAD23B|0:XRCC1|0:NEIL3|0:ESCO1|0:ERCC4|0:HMGB1|0:PNKP|0:RAD1|0:GTF2H3|0:ERCC3|0:RAD18|0:DDB1|0:MPG|0:XPC|0:POLH|0:TDG|0:POLQ|0:FANCG|0:REV1|0:FEN1|0:DDB2|0:OGG1|0:XPA			
GO:0016918	F:retinal binding; ISS:UniProtKB		0:RBP5|0:CRABP1|0:RBP1|0:CRABP2|0:RBP4|0:RBP7|0:RBP3|0:RBP2|0:ALDH1A2			
GO:0031694	F:alpha-2A adrenergic receptor binding; ISS:BHF-UCL		0:ADRA2C|0:ADRB1|0:UCHL1|0:APLP1|0:ADRBK1			
GO:0030212	P:hyaluronan metabolic process; NAS:UniProtKB		0:ITIH3|0:ITIH2|0:ITIH5L|0:ITIH4|0:ITIH5|0:ITIH1			
GO:0032486	P:Rap protein signal transduction; IEP:UniProtKB		0:SGSM3			
GO:0008641	F:small protein activating enzyme activity; IEA:InterPro		0:UBA1			
GO:0008060	F:ARF GTPase activator activity; ISS:UniProtKB		0:ARAP1|0:ARFGAP3|0:ADAP1|0:AGAP10|0:ACAP2|0:AGAP8|0:AGFG1|0:ARFGAP2|0:AGAP1|0:GIT2|0:SMAP2|0:AGAP5|0:AGAP11|0:ACAP1|0:ARAP2|0:ASAP2|0:ASAP1|0:SMAP1|0:AGAP9|0:AGFG2|0:AGAP2|0:CTGLF11P|0:ADAP2|0:AGAP3|0:AGAP7|0:ACAP3|0:ARFGAP1|0:ASAP3|0:AGAP4|0:AGAP6|0:GIT1|0:ARAP3			
GO:0030238	P:male sex determination; NAS:UniProtKB		0:SRY			
GO:0019211	F:phosphatase activator activity; TAS:UniProtKB		0:BMP2|0:GTF2F1|0:FRS2			
GO:0004819	F:glutamine-tRNA ligase activity; EXP:Reactome		0:QARS			
GO:0002663	P:positive regulation of B cell tolerance ind...; ISS:BHF-UCL		0:TGFBR2			
GO:0043490	P:malate-aspartate shuttle; IDA:UniProtKB		0:SLC25A12|0:SLC25A13			
GO:0043330	P:response to exogenous dsRNA; ISS:BHF-UCL		0:IRAK3			
GO:0010459	P:negative regulation of heart rate; ISS:BHF-UCL		0:FKBP1B|0:AGTR2			
GO:0042382	C:paraspeckles; IDA:UniProtKB		0:SFPQ|0:HNRNPM|0:NONO|0:NUDT21|0:CPSF6			
GO:0048593	P:camera-type eye morphogenesis; ISS:UniProtKB		0:NF1|0:IFT122			
GO:0012505	C:endomembrane system; ISS:UniProtKB		0:RAC3|0:SLC6A4|0:CHMP1A|0:NRBP1|0:MAP1LC3C|0:GDPD5|0:SLC9A3R1|0:ITSN1|0:SNX18|0:PDCD1LG2|0:LAPTM4B|0:ATP6V1B2|0:ASPSCR1|0:MS4A3|0:PIP5K1B|0:DOCK2|0:PLDN|0:BCL2L11|0:PARD3|0:CDC42EP3|0:PCSK6|0:CHMP6|0:LAPTM4A|0:CDC42EP2|0:JAK1|0:ATP6V1B1|0:SIPA1|0:SLC9A3R2|0:LECT1|0:RC3H2|0:MAP1LC3A|0:ACACB|0:MAP1LC3B2|0:BIK|0:DOCK9|0:SNAP47|0:JAK3|0:ADAM15|0:MAL2|0:SLC2A10|0:JAK2|0:RNF167|0:CDC42EP4|0:FAAH|0:AVEN|0:MAP1LC3B|0:DOCK4|0:VAMP5|0:BCL2L14|0:RAPGEF3|0:PITPNM3|0:RNF128|0:CD274|0:FRS2|0:TNFRSF17|0:CDC42EP5|0:RNF34|0:VTI1B|0:SYTL3|0:PITPNM2|0:MPP5|0:DNM1L|0:CDC42EP1|0:FIBP|0:SLC27A1|0:PIP5K1A|0:ADAM10|0:SLC2A12|0:PARD3B|0:NBEA			
GO:0008499	F:UDP-galactose:beta-N-acetylglucosamine beta...; TAS:ProtInc		0:B3GALT1|0:B3GNT2|0:B3GALT4|0:B3GALNT1|0:B3GALT5|0:B3GALT2			
GO:0042984	P:regulation of amyloid precursor protein bio...; IDA:UniProtKB		0:NECAB3			
GO:0060484	P:lung-associated mesenchyme development; IEP:UniProtKB		0:WNT11			
GO:0006631	P:fatty acid metabolic process; TAS:ProtInc		0:UGT1A8|0:ANGPTL3|0:ACSBG2|0:ACSF3|0:PNPLA8|0:CRYL1|0:LPIN3|0:ABHD5|0:ACSL1|0:ACSM2A|0:ACAA2|0:C10orf129|0:ACSL4|0:ACOT12|0:ACSL5|0:LYPLA2|0:ACSM2B|0:SLC27A3|0:CPT1C|0:AACS|0:EHHADH|0:LYPLA1|0:ACSM4|0:ECHDC2|0:ACSM5|0:HADH|0:LPIN2|0:BAAT|0:ACSF2|0:SLC27A1|0:GHR|0:STAT5A|0:STAT5B|0:AASDH|0:ACOT11|0:PECI|0:CROT|0:ACADSB|0:GNPAT|0:ABCD2|0:PPARA			
GO:0002281	P:macrophage activation involved in immune re...; ISS:BHF-UCL		0:SBNO2|0:LBP			
GO:0030791	F:arsenite methyltransferase activity; ISS:UniProtKB		0:AS3MT			
GO:0046827	P:positive regulation of protein export from ...; NAS:BHF-UCL		0:GSK3B|0:EMD|0:TCF7L2|0:IL1B			
GO:0017113	F:dihydropyrimidine dehydrogenase (NADP+) act...; IDA:UniProtKB		0:DPYD			
GO:0070627	P:ferrous iron import; IDA:UniProtKB		0:SLC11A2			
GO:0060391	P:positive regulation of SMAD protein nuclear...; ISS:BHF-UCL		0:BMPR1A|0:BMP4|0:POU5F1|0:TGFBR1|0:TGFB1|0:RBPMS|0:TGFB3|0:SMAD4			
GO:0030169	F:low-density lipoprotein binding; ISS:BHF-UCL		0:CRP|0:THBS1|0:SCARB1|0:CDH13|0:COLEC12|0:ANKRA2|0:SCARF1|0:SORL1|0:LIPC|0:MSR1			
GO:0016235	C:aggresome; IDA:UniProtKB		0:PARK2|0:HDAC6|0:SEC62|0:CARD14|0:RNF32|0:UBD			
GO:0005388	F:calcium-transporting ATPase activity; TAS:ProtInc		0:ATP2C1|0:ATP2B2|0:ATP2A1|0:ATP2C2|0:ATP2B1|0:ATP2A3|0:ATP2A2|0:ATP2B4|0:ATP2B3			
GO:0005732	C:small nucleolar ribonucleoprotein complex; TAS:UniProtKB		0:NHP2|0:MPHOSPH10|0:SNRNP40|0:RRP9|0:NOP10			
GO:0008655	P:pyrimidine salvage; NAS:UniProtKB		0:CDA			
GO:0005024	F:transforming growth factor beta receptor ac...; NAS:UniProtKB		0:ENG|0:BMPR1A|0:BMPR2|0:LTBP4|0:LTBP1			
GO:0070212	P:protein amino acid poly-ADP-ribosylation; IDA:BHF-UCL		0:TNKS			
GO:0051281	P:positive regulation of release of sequester...; ISS:UniProtKB		0:TRPC1|0:F2R|0:DRD1|0:F2RL3|0:F2|0:SNCA|0:LACRT|0:THY1			
GO:0000125	C:PCAF complex; NAS:UniProtKB		0:TADA2A|0:TAF9|0:TAF12|0:TAF10|0:KAT2B|0:TRRAP			
GO:0043184	F:vascular endothelial growth factor receptor...; TAS:BHF-UCL		0:ITGB3|0:VEGFA|0:ITGA5			
GO:0050509	F:N-acetylglucosaminyl-proteoglycan 4-beta-gl...; NAS:BHF-UCL		0:EXT1|0:EXT2			
GO:0043198	C:dendritic shaft; ISS:UniProtKB		0:APP|0:GIPC1|0:GRM7			
GO:0042535	P:positive regulation of tumor necrosis facto...; ISS:UniProtKB		0:SPN|0:TNFRSF8|0:AZU1|0:THBS1|0:TLR4|0:TLR1			
GO:0031016	P:pancreas development; TAS:BHF-UCL		0:PROX1|0:TCF7L2			
GO:0007176	P:regulation of epidermal growth factor recep...; TAS:ProtInc		0:APP|0:SHC1|0:NCK2			
GO:0050957	P:equilibrioception; IMP:HGNC		0:USH1G|0:USH1C|0:MYO7A|0:CDH23|0:CLRN1|0:PCDH15			
GO:0070652	C:HAUS complex; IDA:UniProtKB		0:HAUS7|0:HAUS3|0:HAUS4|0:HAUS1|0:HAUS8|0:HAUS5|0:HAUS2|0:HAUS6			
GO:0070539	F:linoleic acid binding; IDA:UniProtKB		0:PPARD			
GO:0016524	F:latrotoxin receptor activity; NAS:UniProtKB		0:LPHN2			
GO:0050928	P:negative regulation of positive chemotaxis; IDA:UniProtKB		0:ANGPT2			
GO:0050815	F:phosphoserine binding; ISS:BHF-UCL		0:PIN1|0:YWHAB|0:YWHAE|0:NEDD4			
GO:0030323	P:respiratory tube development; NAS:UniProtKB		0:PCSK5|0:HECA			
GO:0042416	P:dopamine biosynthetic process; ISS:UniProtKB		0:GCH1|0:TGFB2			
GO:0004672	F:protein kinase activity; TAS:ProtInc		0:RPS6KB1|0:NPRL2|0:NPR1|0:STRADA|0:GUCY2D|0:SCYL2|0:TEX14|0:FASTKD3|0:TRIB3|0:FASTKD5|0:RNASEL|0:FASTKD2|0:PXK|0:SCYL3|0:STRADB|0:FASTKD1|0:GUCY2C|0:TBRG4|0:NPR2|0:NRBP2|0:TRIB2|0:PAN3|0:MLKL|0:NRBP1|0:C9orf96|0:GUCY2F|0:TRIB1|0:CAD|0:PKDCC|0:PACSIN1|0:CCL2|0:COL4A3BP			
GO:0031304	C:intrinsic to mitochondrial inner membrane; ISS:UniProtKB		0:PPOX			
GO:0030288	C:outer membrane-bounded periplasmic space; IEA:InterPro		0:GRID1|0:GRIN3A|0:GRIN2C|0:GRID2|0:GRIN2D|0:GRIN2A|0:GSTK1|0:GRIN1|0:GRIN2B|0:GRIN3B			
GO:0030203	P:glycosaminoglycan metabolic process; NAS:UniProtKB		0:CLN6|0:CHST9			
GO:0015742	P:alpha-ketoglutarate transport; TAS:ProtInc		0:SLC22A6			
GO:0042720	C:mitochondrial inner membrane peptidase complex; ISS:UniProtKB		0:IMMP2L			
GO:0051414	P:response to cortisol stimulus; IEP:UniProtKB		0:SLIT2|0:SLIT3			
GO:0010719	P:negative regulation of epithelial to mesenc...; TAS:BHF-UCL		0:NKX2-1|0:SMAD7			
GO:0045843	P:negative regulation of striated muscle tiss...; IDA:UniProtKB		0:BMP4|0:SIRT2			
GO:0006345	P:loss of chromatin silencing; TAS:UniProtKB		0:ASF1A|0:HMGA1			
GO:0004595	F:pantetheine-phosphate adenylyltransferase a...; IDA:UniProtKB		0:COASY			
GO:0060340	P:positive regulation of type I interferon-me...; IDA:UniProtKB		0:NLRC5			
GO:0045187	P:regulation of circadian sleep/wake cycle, s...; ISS:UniProtKB		0:PTGDS			
GO:0004691	F:cAMP-dependent protein kinase activity; TAS:ProtInc		0:PRKACB|0:PRKACA|0:PRKAA1|0:AKAP13|0:PRKACG|0:PRKAG1|0:PRKX			
GO:0045792	P:negative regulation of cell size; IMP:UniProtKB		0:AKT1S1|0:CAV3|0:DEPDC6			
GO:0046318	P:negative regulation of glucosylceramide bio...; NAS:UniProtKB		0:PRKAA1			
GO:0006098	P:pentose-phosphate shunt; IEA:UniProtKB-KW		0:HIBADH|0:GLYR1|0:TPI1			
GO:0017128	F:phospholipid scramblase activity; TAS:UniProtKB		0:PLSCR3|0:PLSCR4|0:PLSCR2|0:PLSCR1			
GO:0045663	P:positive regulation of myoblast differentia...; NAS:UniProtKB		0:ZFHX3|0:IGFBP3|0:BOC|0:BTG1			
GO:0008483	F:transaminase activity; IEA:UniProtKB-KW		0:AMT|0:AGXT2L2|0:GOT1L1			
GO:0007422	P:peripheral nervous system development; TAS:ProtInc		0:NFASC|0:SCN8A|0:ASCL2|0:UGT8|0:NEUROG3|0:GFRA3|0:ALDH3A2|0:PMP22|0:ACCN1|0:SERPINI1|0:BAI1			
GO:0008336	F:gamma-butyrobetaine dioxygenase activity; IDA:UniProtKB		0:BBOX1			
GO:0047173	F:phosphatidylcholine-retinol O-acyltransfera...; IEA:EC		0:LRAT			
GO:0014808	P:release of sequestered calcium ion into cyt...; TAS:BHF-UCL		0:RYR2			
GO:0000791	C:euchromatin; IDA:UniProtKB		0:DNMT3A			
GO:0006105	P:succinate metabolic process; ISS:UniProtKB		0:SDHA|0:GHR|0:STAT5A|0:STAT5B|0:ALDH5A1			
GO:0005245	F:voltage-gated calcium channel activity; TAS:ProtInc		0:CACNG6|0:CACNG7|0:CACNG3|0:CACNG8|0:CACNB3|0:CACNA1E|0:CACNB2|0:CACNA1B|0:CACNG2|0:CACNG5|0:CACNG4			
GO:0050729	P:positive regulation of inflammatory response; TAS:BHF-UCL		0:TLR3|0:TLR4|0:TLR9|0:TLR7|0:TLR2|0:CX3CL1|0:TNFRSF1A|0:NLRP12|0:PLA2G2A|0:AGTR1|0:AGT			
GO:0000447	P:endonucleolytic cleavage in ITS1 to separat...; ISS:UniProtKB		0:UTP20|0:NOP14			
GO:0051096	P:positive regulation of helicase activity; IDA:UniProtKB		0:POT1|0:MSH2|0:MSH3|0:MSH6|0:SSBP1			
GO:0048699	P:generation of neurons; ISS:UniProtKB		0:CIT			
GO:0042405	C:nuclear inclusion body; IDA:UniProtKB		0:STUB1|0:ATXN1|0:NBN			
GO:0000175	F:3'-5'-exoribonuclease activity; TAS:UniProtKB		0:ISG20|0:EXOSC6|0:PNPT1|0:EXOSC8|0:EXOSC3|0:EXOSC9|0:EXOSC5|0:EXOSC4|0:EXOSC2|0:EXOSC7			
GO:0030496	C:midbody; ISS:BHF-UCL		0:BIRC5|0:CLIC4|0:RACGAP1|0:VPS4A|0:KIF23|0:KLHL9|0:ANXA11|0:CDK1|0:RAB11FIP4|0:ARL8A|0:SEPT12|0:RALB|0:CENPF|0:ARL8B|0:MYH10|0:RAB11FIP3|0:ZNF330|0:MAPRE3|0:PSRC1			
GO:0031284	P:positive regulation of guanylate cyclase ac...; IMP:BHF-UCL		0:NOS3			
GO:0019934	P:cGMP-mediated signaling; NAS:UniProtKB		0:APOE|0:CD36|0:PDZD3			
GO:0006072	P:glycerol-3-phosphate metabolic process; ISS:UniProtKB		0:GK|0:GK5|0:GK3P|0:GK2|0:GPAT2			
GO:0043086	P:negative regulation of catalytic activity; ISS:UniProtKB		0:CAND1|0:PCSK9|0:CLN3			
GO:0016780	F:phosphotransferase activity, for other subs...; IEA:InterPro		0:PIGN|0:CRLS1			
GO:0002080	C:acrosomal membrane; IEA:UniProtKB-SubCell		0:C9orf11|0:RND2|0:SPACA3			
GO:0016461	C:unconventional myosin complex; TAS:UniProtKB		0:MYO18B|0:MYO1F|0:MYO9A|0:MYL6B|0:MYL6|0:MYO6			
GO:0008043	C:intracellular ferritin complex; TAS:ProtInc		0:FTL|0:FTH1			
GO:0002924	P:negative regulation of humoral immune respo...; ISS:BHF-UCL		0:FOXJ1			
GO:0042147	P:retrograde transport, endosome to Golgi; NAS:UniProtKB		0:STX16|0:VTI1A|0:BET1L|0:STX5|0:GOSR1|0:YKT6|0:VPS54|0:WASH1|0:RHOBTB3|0:FAM21C|0:PIKFYVE|0:WASH4P|0:FAM21A|0:WASH2P|0:FAM21D|0:FAM21B|0:WASH6P|0:WASH3P|0:VPS35|0:VPS26A			
GO:0032455	P:nerve growth factor processing; EXP:Reactome		0:PCSK5|0:FURIN|0:PCSK6|0:NGF			
GO:0002223	P:stimulatory C-type lectin receptor signalin...; IDA:UniProtKB		0:MICA			
GO:0005902	C:microvillus; TAS:UniProtKB		0:VCAM1|0:TEK|0:CLIC4|0:ENPP7|0:MYO1A|0:GIF|0:ANGPT1|0:SLC9A3R1|0:TBC1D10A			
GO:0006306	P:DNA methylation; TAS:UniProtKB		0:ATF7IP|0:HEMK1|0:BAZ2A|0:MLL5|0:DNMT3L|0:FOS|0:ATRX|0:DMAP1|0:GATAD2A			
GO:0035522	P:monoubiquitinated histone H2A deubiquitination; IDA:UniProtKB		0:BAP1			
GO:0005069	F:transmembrane receptor protein tyrosine kin...; ISS:BHF-UCL		0:IRS1			
GO:0050652	P:dermatan sulfate proteoglycan biosynthetic ...; TAS:UniProtKB		0:CSGALNACT2			
GO:0016492	F:neurotensin receptor activity, G-protein co...; IEA:InterPro		0:NTSR1			
GO:0035145	C:exon-exon junction complex; IDA:UniProtKB		0:WIBG|0:MAGOH|0:RBM8A			
GO:0033989	F:3alpha,7alpha,12alpha-trihydroxy-5beta-chol...; EXP:Reactome		0:HSD17B4			
GO:0018347	P:protein amino acid farnesylation; IDA:BHF-UCL		0:FNTA|0:FNTB			
GO:0008111	F:alpha-methylacyl-CoA racemase activity; IEA:EC		0:AMACR			
GO:0016250	F:N-sulfoglucosamine sulfohydrolase activity; IEA:EC		0:SGSH			
GO:0004336	F:galactosylceramidase activity; IEA:EC		0:GALC			
GO:0001537	F:N-acetylgalactosamine 4-O-sulfotransferase ...; IDA:UniProtKB		0:CHST14|0:CHST13|0:CHST8|0:CHST9|0:CHST11			
GO:0016324	C:apical plasma membrane; TAS:UniProtKB		0:NRG1|0:SLC22A5|0:TLR9|0:IL6R|0:CAV1|0:ADAM17|0:SLC22A4|0:STX3|0:EPCAM|0:UMOD|0:TEK|0:TF|0:SLC23A1|0:SLC26A4|0:PFKM|0:RHCG|0:TCIRG1|0:SLC34A2|0:AQP2|0:GIF|0:SLC22A12|0:CFTR|0:ATP6V1B1|0:DPP4|0:SLC46A1|0:AQP1|0:ATP6V0D2|0:SLC22A18|0:SLC11A2|0:AQP5|0:ATP8B1|0:KCNMA1|0:SLC30A5|0:PKHD1|0:SLC23A2|0:SLC22A11|0:ATP6V0A4|0:SLC9A3R1|0:SLC14A2|0:SLC29A4|0:SLC3A2|0:MSN|0:CIB1|0:SCNN1G|0:LCT|0:SLC5A12|0:NPC1L1|0:PROM1|0:SCNN1A|0:MREG|0:NAALADL1|0:MUC20|0:SLC9A4|0:ANK2|0:SLC4A7|0:PLB1|0:CSPG4|0:EZR|0:SLC9A3R2|0:INADL|0:OTOG|0:MUC1|0:MAL2|0:OTOA|0:CRB3|0:MGAM|0:TRPV5|0:AJAP1|0:DPEP1|0:CLCA4|0:CDHR2|0:SLC4A5|0:SCNN1B|0:CRB1|0:SI|0:SLC5A8|0:ACY3|0:MYO7B|0:KIAA1919|0:PROM2|0:DUOX2|0:CD300LG|0:SLC7A5|0:MPDZ|0:ABCG8|0:ABCG5|0:SHROOM3|0:SLC34A3|0:PODXL|0:SHROOM2|0:ATP6V1E1|0:SLC6A20|0:SLC12A3|0:VANGL2|0:SHROOM4|0:DUOX1|0:MAL			
GO:0043407	P:negative regulation of MAP kinase activity; ISS:HGNC		0:CBLC|0:APOE|0:UCHL1|0:BMP7|0:STK38|0:BMP4|0:DUSP7|0:CAV3|0:IRAK3|0:IL1B|0:NF1			
GO:0043486	P:histone exchange; ISS:UniProtKB		0:NASP			
GO:0008889	F:glycerophosphodiester phosphodiesterase act...; TAS:UniProtKB		0:GDPD5|0:GPCPD1|0:GDPD3|0:GDPD4|0:GDPD2|0:GDPD1|0:GDE1			
GO:0051739	F:ammonia transmembrane transporter activity; IDA:UniProtKB		0:SLC12A2|0:RHAG|0:RHCG|0:AQP1|0:RHBG			
GO:0033622	P:integrin activation; IMP:UniProtKB		0:FERMT3			
GO:0017071	C:intracellular cyclic nucleotide activated c...; NAS:UniProtKB		0:CNGB1|0:CNGA2			
GO:0016445	P:somatic diversification of immunoglobulins; NAS:UniProtKB		0:CTNNBL1|0:RAG2			
GO:0001819	P:positive regulation of cytokine production; TAS:BHF-UCL		0:ADRA2A|0:HTR2B|0:SOD1|0:AGPAT2|0:AGPAT1|0:CARD11|0:EREG|0:NFAM1|0:AGT			
GO:0008623	C:chromatin accessibility complex; NAS:UniProtKB		0:CHRAC1			
GO:0009988	P:cell-cell recognition; TAS:UniProtKB		0:CLEC4M|0:CD209			
GO:0051183	F:vitamin transporter activity; IEA:InterPro		0:GC			
GO:0003881	F:CDP-diacylglycerol-inositol 3-phosphatidylt...; IEA:EC		0:CDIPT			
GO:0016314	F:phosphatidylinositol-3,4,5-trisphosphate 3-...; IEA:EC		0:PTEN|0:TPTE2			
GO:0032051	F:clathrin light chain binding; IDA:UniProtKB		0:CALY			
GO:0019724	P:B cell mediated immunity; TAS:UniProtKB		0:SLA2			
GO:0002098	P:tRNA wobble uridine modification; NAS:UniProtKB		0:MOCS3|0:URM1|0:CTU2|0:CTU1			
GO:0060411	P:cardiac septum morphogenesis; IMP:BHF-UCL		0:HAND1			
GO:0001964	P:startle response; IMP:UniProtKB		0:GLRA1|0:GLRB			
GO:0046168	P:glycerol-3-phosphate catabolic process; IEA:InterPro		0:GPD1L|0:GPD1			
GO:0015174	F:basic amino acid transmembrane transporter ...; TAS:ProtInc		0:SLC3A1|0:SLC7A2|0:SLC7A4			
GO:0032320	P:positive regulation of Ras GTPase activity; IMP:UniProtKB		0:NF1|0:WNT11			
GO:0009624	P:response to nematode; ISS:UniProtKB		0:ITLN1			
GO:0060390	P:regulation of SMAD protein nuclear transloc...; IDA:UniProtKB		0:WWTR1			
GO:0042629	C:mast cell granule; ISS:UniProtKB		0:CXCR2|0:SRGN			
GO:0043259	C:laminin-10 complex; TAS:BHF-UCL		0:LAMB1|0:LAMA5|0:LAMC1			
GO:0051006	P:positive regulation of lipoprotein lipase a...; IMP:BHF-UCL		0:APOA4|0:APOH|0:APOA5|0:APOC2|0:GPIHBP1|0:NR1H3|0:NR1H2			
GO:0005183	F:gonadotropin hormone-releasing hormone acti...; TAS:ProtInc		0:GNRH1			
GO:0052106	P:quorum sensing involved in interaction with...; IMP:BHF-UCL		0:SLC22A5			
GO:0046580	P:negative regulation of Ras protein signal t...; IDA:UniProtKB		0:MFN2			
GO:0045861	P:negative regulation of proteolysis; TAS:UniProtKB		0:SERPINE2|0:PLAT|0:F2|0:INS|0:HDAC6|0:CLN3|0:CLN8|0:DNAJC1			
GO:0010878	P:cholesterol storage; IMP:BHF-UCL		0:SOAT1			
GO:0005452	F:inorganic anion exchanger activity; TAS:ProtInc		0:SLC22A6|0:SLC22A8|0:SLC22A11|0:SLC4A4|0:SLC4A7|0:SLC4A8|0:SLC4A10|0:SLC4A2|0:SLC4A11|0:SLC4A5|0:SLC4A9|0:SLC4A1|0:SLC4A3			
GO:0006370	P:mRNA capping; TAS:ProtInc		0:NCBP2|0:NCBP1|0:RNMT|0:FTSJD2|0:RNGTT			
GO:0032498	P:detection of muramyl dipeptide; IDA:MGI		0:NOD2			
GO:0004608	F:phosphatidylethanolamine N-methyltransferas...; TAS:ProtInc		0:PEMT			
GO:0051924	P:regulation of calcium ion transport; ISS:UniProtKB		0:SLN|0:PLN|0:GRIN3B			
GO:0050221	F:prostaglandin-E2 9-reductase activity; IEA:EC		0:CBR1			
GO:0007584	P:response to nutrient; TAS:UniProtKB		0:MTOR|0:STC1|0:GNAI2|0:ENSA|0:SSTR2|0:GIPR|0:TULP4|0:OGT|0:CCKAR|0:SSTR1|0:GCGR|0:STC2|0:SST			
GO:0042737	P:drug catabolic process; IDA:BHF-UCL		0:CYP2D6|0:CYP3A5			
GO:0010816	P:calcitonin catabolic process; IDA:BHF-UCL		0:ECE1			
GO:0070552	C:BRISC complex; IDA:UniProtKB		0:BRE|0:FAM175B|0:BRCC3|0:C19orf62			
GO:0008318	F:protein prenyltransferase activity; IEA:InterPro		0:PTAR1			
GO:0004343	F:glucosamine 6-phosphate N-acetyltransferase...; IEA:EC		0:GNPNAT1			
GO:0032312	P:regulation of ARF GTPase activity; IEA:InterPro		0:ARAP1|0:AGAP10|0:ACAP2|0:AGAP8|0:ARFGAP3|0:AGFG1|0:ARFGAP2|0:AGAP1|0:GIT2|0:SMAP2|0:AGAP5|0:AGAP11|0:ACAP1|0:ARAP2|0:ASAP2|0:ASAP1|0:SMAP1|0:AGAP9|0:AGFG2|0:AGAP2|0:CTGLF11P|0:ADAP2|0:AGAP3|0:ARAP3|0:AGAP7|0:ACAP3|0:ARFGAP1|0:ASAP3|0:AGAP4|0:AGAP6|0:GIT1|0:ADAP1			
GO:0015378	F:sodium:chloride symporter activity; TAS:ProtInc		0:SLC12A3			
GO:0009304	P:tRNA transcription; TAS:ProtInc		0:BRF1			
GO:0004864	F:phosphoprotein phosphatase inhibitor activity; TAS:UniProtKB		0:LMTK2|0:PPP1R10|0:PPP1R2P3|0:PPP1R14B|0:PHACTR2|0:PPP1R14A|0:PHACTR3|0:PPP1R14D|0:PPP1R11|0:PHACTR4|0:PPP1R1C|0:PHACTR1|0:PPP1R2P1|0:PPP1R2P9|0:CABIN1|0:PPP1R9B|0:SAG|0:SET|0:PTN|0:PPME1|0:PPP1R1B			
GO:0015269	F:calcium-activated potassium channel activity; TAS:ProtInc		0:KCNMB4|0:KCNMB2|0:MTMR6|0:KCNMB3|0:KCNMA1|0:KCNMB3L|0:KCNU1|0:KCNT1|0:KCNT2|0:CCT8L2|0:KCNMB1|0:KCNN4			
GO:0016592	C:mediator complex; NAS:UniProtKB		0:MED21|0:MED22|0:MED18|0:MED6|0:CDK8|0:MED29|0:MED8|0:MED11|0:MED26|0:MED14|0:MED13|0:MED17|0:MED12|0:PPARGC1B|0:THRAP3|0:MED16|0:MED1|0:MED30|0:MED4|0:MED15|0:MED31|0:MED10|0:MED7|0:MED12L|0:RBM14|0:MED24|0:MED20			
GO:0007588	P:excretion; TAS:UniProtKB		0:HMOX1|0:UGT1A7|0:ABCG8|0:ABCG5|0:ATP6V1B1|0:ATP6V0A4|0:GRHPR|0:NEDD4L|0:SLC22A18|0:UNC13B|0:TACR2|0:AQP3|0:NPHS2|0:SCNN1G|0:SCNN1A|0:KCNK5|0:AQP2|0:SLC26A3|0:AQP6|0:GUCA2B|0:NFAT5|0:CLCNKB|0:ADORA2B|0:AQP4|0:CLCNKA|0:AVPR2|0:KCNJ1|0:CLCN5|0:AQP5|0:CLDN16|0:SCNN1B|0:SCTR|0:NPHS1|0:NPHP1|0:AQP7|0:AQP9			
GO:0007520	P:myoblast fusion; TAS:ProtInc		0:NOS1|0:CACNA1H|0:ADAM12|0:KCNH1			
GO:0046340	P:diacylglycerol catabolic process; IDA:BHF-UCL		0:APOA2			
GO:0030278	P:regulation of ossification; TAS:UniProtKB		0:ZNF675			
GO:0048863	P:stem cell differentiation; ISS:UniProtKB		0:JARID2			
GO:0031093	C:platelet alpha granule lumen; EXP:Reactome		0:ALB|0:VEGFB|0:F8|0:FGA|0:IGF1|0:SERPING1|0:F5|0:CFD|0:THBS2|0:A2M|0:THBS1|0:FGB|0:VEGFC|0:APP|0:PF4|0:FIGF|0:EGF|0:PDGFA|0:FGG|0:LEFTY2|0:PPBP|0:SERPINA1|0:TGFB3|0:FN1|0:THBS4|0:SERPINF2|0:VEGFA|0:TGFB2|0:PDGFB|0:MMRN1|0:SPARC|0:HRG|0:TGFB1|0:HGF|0:THBS3			
GO:0006167	P:AMP biosynthetic process; IDA:UniProtKB		0:ADSSL1|0:ADSS|0:ADSL			
GO:0005522	F:profilin binding; TAS:ProtInc		0:RHOQ|0:VASP|0:EVL|0:PCLO|0:DBN1|0:WIPF1			
GO:0060554	P:induction of necroptosis of activated-T cells; IDA:BHF-UCL		0:FASLG			
GO:0006892	P:post-Golgi vesicle-mediated transport; TAS:ProtInc		0:DTNBP1|0:SH3GL2|0:VAMP7|0:ARRB1|0:NAPA|0:PLDN|0:AP1S3|0:AP1G1|0:FTL|0:BLOC1S3|0:DNM2|0:VAMP8|0:TXNDC5|0:CLTC|0:DNAJC6|0:AP1S2|0:AP1S1|0:PUM1|0:CNO|0:HSPA8|0:SH3D19|0:AP1B1|0:AP1M1|0:BLOC1S1|0:SNAP23|0:STX4|0:CLTA|0:FTH1|0:VAMP2|0:ARF1|0:CLINT1|0:GBF1|0:AP1M2|0:SCFD1|0:SCAMP1|0:SCAMP3|0:STX7|0:AP3B2|0:EXOC5|0:SCAMP2			
GO:0005983	P:starch catabolic process; TAS:ProtInc		0:MGAM			
GO:0005665	C:DNA-directed RNA polymerase II, core complex; TAS:UniProtKB		0:POLR2J|0:C19orf2|0:POLR2D|0:POLR2G|0:POLR2C|0:POLR2F|0:POLR2B|0:POLR2L|0:POLR2E|0:POLR2I|0:POLR2A|0:POLR2H|0:ZNF768|0:PPARGC1A			
GO:0016056	P:rhodopsin mediated signaling pathway; TAS:ProtInc		0:GRK1|0:RHO|0:SAG			
GO:0003872	F:6-phosphofructokinase activity; TAS:UniProtKB		0:PFKM|0:PFKL|0:PFKP			
GO:0006361	P:transcription initiation from RNA polymeras...; IDA:UniProtKB		0:PTRF			
GO:0060065	P:uterus development; ISS:BHF-UCL		0:RBP4			
GO:0005174	F:CD40 receptor binding; IPI:UniProtKB		0:CD40LG			
GO:0004943	F:C3a anaphylatoxin receptor activity; TAS:ProtInc		0:C3AR1			
GO:0051216	P:cartilage development; NAS:UniProtKB		0:IL17F|0:BMP3|0:BMP7|0:CHRDL2|0:LECT1|0:BMP4|0:BMP8A|0:BMP2|0:BMP5|0:NOG|0:BMP6|0:WNT5A|0:BMP8B|0:HOXD3|0:ATP7A|0:GHRL			
GO:0035375	F:zymogen binding; ISS:UniProtKB		0:DMBT1			
GO:0034738	F:lanosterol O-acyltransferase activity; IEA:EC		0:SOAT2|0:SOAT1			
GO:0019966	F:interleukin-1 binding; IPI:UniProtKB		0:A2M|0:HAX1|0:TRIM16			
GO:0010842	P:retina layer formation; ISS:UniProtKB		0:PTPRM|0:TSPAN12			
GO:0010569	P:regulation of double-strand break repair vi...; ISS:UniProtKB		0:RTEL1|0:TERF2IP			
GO:0045322	F:unmethylated CpG binding; IDA:UniProtKB		0:CXXC1|0:MLL			
GO:0008554	F:sodium-exporting ATPase activity, phosphory...; TAS:ProtInc		0:ABCB11			
GO:0004806	F:triglyceride lipase activity; TAS:UniProtKB		0:LIPC|0:LPL|0:PNPLA3|0:LIPG|0:PNPLA4|0:PNLIPRP3|0:DAGLA|0:DAGLB|0:AADAC|0:PNPLA2|0:CEL|0:PNLIP|0:PNLIPRP1|0:PNLIPRP2|0:LIPF			
GO:0047057	F:vitamin-K-epoxide reductase (warfarin-sensi...; IEA:EC		0:VKORC1			
GO:0070052	F:collagen V binding; IDA:BHF-UCL		0:THBS1			
GO:0004464	F:leukotriene-C4 synthase activity; IDA:UniProtKB		0:LTC4S|0:MGST2			
GO:0005980	P:glycogen catabolic process; NAS:UniProtKB		0:GAA|0:CPS1|0:PYGB			
GO:0043249	P:erythrocyte maturation; IMP:BHF-UCL		0:TIMP1|0:EPB42|0:EPO|0:MAEA|0:G6PD			
GO:0043171	P:peptide catabolic process; IMP:UniProtKB		0:ACE|0:ADAMTS13|0:TPP1			
GO:0035091	F:phosphoinositide binding; NAS:UniProtKB		0:CCDC88A|0:NCF1|0:HIP1R|0:HIP1|0:PIK3C2B|0:SNX18|0:ZCCHC2|0:SNX8|0:SNX30|0:SNX24|0:NISCH|0:SGK3|0:SNX21|0:SNX17|0:NCF4|0:SNX16|0:SNX25|0:SH3PXD2A|0:HS1BP3|0:ARHGAP33|0:SNX31|0:SNX2|0:SNX7|0:RPS6KC1|0:NCF1C|0:SNX13|0:PIK3C2G|0:C6orf145|0:PXK|0:NOXO1|0:SNX6|0:SNX32|0:SNX11|0:SNX22|0:ZCCHC14|0:SNX27|0:SNX1|0:PLD2|0:SNX12|0:SNX15|0:KIF16B|0:SNX33|0:SNX19|0:SNX5|0:NCF1B|0:SNX10|0:PIK3C2A|0:PLD1|0:SNX29|0:ARHGAP32|0:SNX9|0:SNX4|0:SNX20|0:SNX14|0:SEPT12			
GO:0016266	P:O-glycan processing; TAS:UniProtKB		0:GXYLT2|0:GXYLT1|0:POFUT1			
GO:0006915	P:apoptosis; TAS:UniProtKB		0:ABR|0:ITSN1|0:TRAF6|0:ARHGAP4|0:ARHGEF18|0:VAV3|0:RASGRF1|0:NGFRAP1|0:NGEF|0:APH1B|0:FGD3|0:RAC1|0:TIAM2|0:MCF2|0:SOS2|0:ITGB3BP|0:TIAM1|0:ARHGEF16|0:NET1|0:FGD2|0:NGF|0:SQSTM1|0:ARHGEF2|0:PSENEN|0:ARHGEF9|0:KALRN|0:MCF2L|0:ARHGEF4|0:PLEKHG2|0:ARHGEF11|0:APH1A|0:NGFR|0:YWHAE|0:VAV2|0:FGD1|0:NCSTN|0:PLEKHG5|0:PREX1|0:MAGED1|0:TRIO|0:ARHGEF12|0:FGD4|0:ARHGEF3|0:AATF|0:ARHGEF17|0:RASGRF2|0:PSEN2|0:ECT2|0:SOS1|0:ARHGEF7|0:OBSCN|0:AKAP13|0:VAV1|0:MAP1S|0:BNIP1|0:TRAF7|0:ING4|0:BNIPL|0:BOK|0:EPHA2|0:THOC1|0:FIS1|0:SRGN|0:MCL1|0:BLCAP|0:KIAA1967|0:BCL10|0:CYFIP2|0:SGPL1|0:UBE4B|0:NDUFS1|0:RBM25|0:BCL2L14|0:FOXO3|0:SRA1|0:BAG2|0:FASTKD3|0:FASTKD5|0:FASTKD2|0:FASTKD1|0:CASP14|0:BAG5|0:BAG4|0:TBRG4|0:CASP12|0:ELMO2|0:PDCL3|0:AEN|0:SPIN2B|0:STK17A|0:XAF1|0:RIPK3|0:BIRC6|0:FAIM|0:COMP|0:PSMD10|0:BRE|0:ITCH|0:PTRH2|0:CIDEB|0:KCNIP3|0:SGMS1|0:GRAMD4|0:TNFRSF12A|0:CSRNP3|0:DEDD|0:GADD45G|0:DNASE2|0:NTN1|0:TNFRSF1B|0:SAP30BP|0:PPM1F|0:RNF130|0:ERN1|0:DAPL1|0:PAK2|0:PPP1R13B|0:UNC5A|0:BIRC5|0:PHLDA1|0:OPA1|0:EDAR|0:FAM3B|0:UBE2D3|0:TRIM35|0:TNFRSF19|0:FKBP8|0:RNF216|0:NISCH|0:FASTK|0:USP17L3|0:SMNDC1|0:FAF1|0:AKTIP|0:DRAM1|0:APIP|0:C17orf88|0:HINT2|0:CKAP2|0:AIMP1|0:TNFAIP8|0:TRIM39|0:HTRA2|0:RPS6KB1|0:TRIB3|0:TIAL1|0:CCAR1|0:PTPRH|0:MRPL41|0:TNFRSF1A|0:SIAH2|0:API5|0:ZC3H8|0:CLPTM1L|0:MECOM|0:PEG3|0:UNC5D|0:CIAPIN1|0:RYBP|0:BCL2L12|0:CTNNBL1|0:HRK|0:C8orf4|0:SH3GLB1|0:TRAF3|0:PDCD7|0:DYRK2|0:ERN2|0:ACVR1C|0:TRIAP1|0:BUB1|0:DDIT4|0:CD5L|0:TNS4|0:RABEP1|0:HIPK2|0:LCN2|0:TNFRSF10D|0:PAK1|0:PUF60|0:RASSF5|0:BCAP29|0:NEK6|0:BCL2L15|0:TIAF1|0:USP17L2|0:STK3|0:BAG3|0:PDCD6IP|0:LGALS12|0:BIRC2|0:IL19|0:PPP1R13L|0:UNC5C|0:KRT20|0:UBE2Z|0:CFLAR|0:ELMO3|0:FAM176A|0:SLC5A11|0:MEF2D|0:BIK|0:MLL|0:ZDHHC16|0:CASP10|0:MEF2A|0:LITAF|0:CARD6|0:MFSD10|0:TRIM69|0:AIMP2|0:TAX1BP1|0:FAIM2|0:CHIA|0:INPP5D|0:TM2D1|0:DCC|0:C3orf38|0:SLK|0:FAM82A2|0:LTBR|0:LGALS7B|0:KIF1B|0:TCTN3|0:WDR92|0:USP17L1P|0:TNFRSF18|0:SULF1|0:RFFL|0:MEF2C|0:SLTM|0:RNF41|0:RTN3|0:TNFRSF11B|0:APBB1|0:BCAP31|0:PACS2|0:FAM188A|0:ZC3H12A|0:RRAGA|0:MADD|0:DAPK2|0:TP53INP1|0:RNF144B|0:HTATIP2|0:TRAF4|0:SLC25A6|0:C1D|0:BIRC8|0:USP17|0:USP17L5|0:EGLN3|0:PEG10|0:PRAME|0:BIRC3|0:G2E3|0:CASP6|0:DAD1|0:DAPK3|0:AVEN|0:DIDO1|0:DPF2|0:PERP|0:TNFSF12|0:SGK1|0:ADAMTSL4|0:TNFRSF10C|0:HIPK3|0:WWOX|0:LGALS7|0:SHB|0:NAIF1|0:BNIP3L|0:NFKB1|0:TIA1|0:KLF11|0:PHLDA3|0:FEM1B|0:NME6|0:PDCD10|0:ZMAT3|0:SHF|0:PHLPP1|0:EBAG9|0:PEA15|0:ZSWIM2|0:TMEM173|0:BFAR|0:STK4|0:TRAF1|0:RAD21|0:RASSF6|0:SHISA5|0:PRKCB|0:PDCD5|0:TRAF5|0:CARD8|0:XIAP|0:RALB|0:TNFAIP3|0:TMEM85|0:RBM5|0:PLEKHF1|0:SLC5A8|0:DNASE1|0:AXIN1|0:UNC5B|0:MAP3K5|0:RNF34|0:BCL2L2|0:BAG1|0:NOL3|0:BLID|0:CD27|0:BCL7C|0:C11orf82|0:LRDD|0:PPP2R2B|0:CSRNP2|0:DAPK1|0:STK17B|0:TPX2|0:GSDMA|0:DRAM2|0:ASAH2|0:BEX2|0:NAIP|0:BCL2A1|0:CRADD|0:NAE1|0:TMBIM6|0:NUAK2|0:SIRT1|0:TNFRSF6B|0:SIVA1|0:TP53BP2|0:PTEN|0:TICAM1|0:STEAP3|0:APLP1|0:SH3KBP1|0:ATG5|0:CIDEC|0:ROCK1|0:NLRP2|0:BUB1B|0:CADM1|0:RTKN|0:PSME3|0:NME3|0:EAF2|0:THBS1|0:DNAJB13|0:SPATA3|0:SPATA4|0:MDM4|0:C16orf5|0:CIB1|0:UBQLN1|0:PDIA2|0:RHOT1|0:RHOT2|0:LUC7L3|0:EP300|0:PPARD|0:BNIP2|0:HAND2|0:BMF|0:ACTC1|0:PDCD4|0:ARHGEF6|0:CDK11A|0:MAGI3|0:RRAGC|0:ITGB2|0:ELMO1|0:GLRX2|0:RTN4|0:CASP2|0:TNFRSF25|0:CDK11B|0:DHCR24|0:GZMH|0:PHF17|0:SEPT4|0:TAOK2|0:CSRNP1|0:ZBTB16|0:SEMA6A|0:TSPO|0:GML|0:PAWR|0:PPP1R15A|0:CGB8|0:CASP4|0:IL17A|0:CSE1L|0:FXR1|0:TNFSF9|0:IL1A|0:PDCD1|0:ADORA2A|0:E2F1|0:DDX41|0:IAPP|0:PTPN6|0:GULP1|0:PTK2B|0:DUSP22|0:LY86|0:RIPK2|0:GPR65|0:IER3|0:CD14|0:YARS|0:IL1B|0:LGALS1|0:CGB5|0:CXCR4|0:IL24|0:ADRA1A|0:CASP1|0:GADD45B|0:GAS2|0:MRPS30|0:MAGEH1|0:PRF1|0:GADD45A|0:SIAH1|0:CGB7|0:SFRP5|0:PAX3|0:CASP5|0:CGB|0:NFKBIA|0:PDE1B|0:NCKAP1|0:DOCK1|0:PHLDA2|0:RAF1|0:PDCD2|0:ESPL1|0:TP53AIP1|0:AHR|0:DAXX|0:TNFAIP1|0:BRCA1|0:VDAC1			
GO:0000084	P:S phase of mitotic cell cycle; TAS:ProtInc		0:POLD1|0:POLA1|0:LSM10|0:LSM11|0:DDX11|0:CDK2AP1			
GO:0048469	P:cell maturation; ISS:UniProtKB		0:PPARG|0:IL21|0:KCNMA1|0:LHX6			
GO:0032139	F:dinucleotide insertion or deletion binding; IDA:BHF-UCL		0:PCNA			
GO:0034699	P:response to luteinizing hormone stimulus; IDA:BHF-UCL		0:TGFBR3			
GO:0047704	F:bile-salt sulfotransferase activity; IEA:EC		0:SULT2A1			
GO:0090104	P:pancreatic E cell differentiation; ISS:UniProtKB		0:RFX6			
GO:0048755	P:branching morphogenesis of a nerve; ISS:BHF-UCL		0:DRD2			
GO:0015277	F:kainate selective glutamate receptor activity; TAS:ProtInc		0:GRIK3|0:GRIK2|0:GRIK5|0:GRIK1|0:GRIA2|0:GRIK4|0:GRIA1			
GO:0000463	P:maturation of LSU-rRNA from tricistronic rR...; IMP:UniProtKB		0:PES1|0:BOP1|0:WDR12			
GO:0003990	F:acetylcholinesterase activity; ISS:UniProtKB		0:ACHE|0:BCHE			
GO:0031092	C:platelet alpha granule membrane; IDA:MGI		0:GP1BA|0:ITGB3|0:GP1BB|0:CD36|0:CD9|0:GP5|0:PECAM1|0:ITGA2B|0:GP9|0:SELP			
GO:0070990	F:snRNP binding; IPI:BHF-UCL		0:PRPF31			
GO:0031571	P:mitotic cell cycle G1/S DNA damage checkpoint; IMP:UniProtKB		0:CCND1|0:DGKZ|0:TP53|0:RPS27L|0:RFWD3|0:FBXO31			
GO:0048675	P:axon extension; IMP:UniProtKB		0:CYFIP1			
GO:0006642	P:triglyceride mobilization; ISS:UniProtKB		0:SIRT1|0:LPIN1			
GO:0050659	F:N-acetylgalactosamine 4-sulfate 6-O-sulfotr...; IDA:UniProtKB		0:CHST15			
GO:0042345	P:regulation of NF-kappaB import into nucleus; IEP:UniProtKB		0:BCL3			
GO:0014065	P:phosphoinositide 3-kinase cascade; ISS:HGNC		0:IGF1R|0:IRS1|0:ERBB3|0:EDN1|0:ERBB2|0:PIK3R1|0:PLEKHA1|0:HTR2B|0:HTR2A|0:NF1			
GO:0043456	P:regulation of pentose-phosphate shunt; IDA:UniProtKB		0:PGAM1			
GO:0002237	P:response to molecule of bacterial origin; TAS:BHF-UCL		0:BCL10|0:CD24|0:TLR9			
GO:0007274	P:neuromuscular synaptic transmission; TAS:ProtInc		0:CHRNA1|0:CHRNB1|0:KIF1B|0:DTNA			
GO:0004726	F:non-membrane spanning protein tyrosine phos...; TAS:ProtInc		0:PTPN11|0:ACP1|0:PTPN12|0:PTPN4|0:DUSP1|0:PTPN9|0:PTPN18			
GO:0005290	F:L-histidine transmembrane transporter activity; IDA:UniProtKB		0:SLC38A3			
GO:0070688	C:MLL5-L complex; IDA:UniProtKB		0:PPP1CB|0:HCFC1|0:STK38|0:PPP1CA|0:OGT|0:ACTB|0:MLL5|0:PPP1CC			
GO:0035066	P:positive regulation of histone acetylation; TAS:UniProtKB		0:ARRB1|0:FOXP3|0:PPARGC1A			
GO:0051880	F:G-quadruplex DNA binding; IDA:UniProtKB		0:WRN|0:LONP1|0:BLM			
GO:0006625	P:protein targeting to peroxisome; NAS:UniProtKB		0:AGXT|0:PEX19|0:PEX5|0:LONP2			
GO:0006591	P:ornithine metabolic process; IMP:BHF-UCL		0:HNF4A			
GO:0032927	P:positive regulation of activin receptor sig...; IDA:HGNC		0:ACVR1B|0:ACVR2B|0:ACVR2A			
GO:0070365	P:hepatocyte differentiation; IEP:BHF-UCL		0:PROX1			
GO:0008088	P:axon cargo transport; TAS:ProtInc		0:APP|0:APBA1			
GO:0051016	P:barbed-end actin filament capping; TAS:ProtInc		0:ADD2|0:ADD1|0:TRIOBP|0:CAPG|0:GSN			
GO:0006438	P:valyl-tRNA aminoacylation; IEA:InterPro		0:VARS|0:VARS2			
GO:0046853	P:inositol and derivative phosphorylation; IDA:HGNC		0:IPPK			
GO:0032971	P:regulation of muscle filament sliding; ISS:BHF-UCL		0:MYLK2|0:MYBPC3			
GO:0045723	P:positive regulation of fatty acid biosynthe...; ISS:BHF-UCL		0:APOA4|0:APOA5|0:APOC2|0:NR1H3|0:NR1H2|0:MLXIPL			
GO:0014731	C:spectrin-associated cytoskeleton; TAS:BHF-UCL		0:SPTA1|0:ANK1|0:SPTB|0:RHBG|0:EPB41			
GO:0090200	P:positive regulation of release of cytochrom...; IMP:BHF-UCL		0:PINK1			
GO:0042383	C:sarcolemma; ISS:UniProtKB		0:DMD|0:SCN5A|0:NOS1|0:ALOX12|0:PGM5|0:AQP1|0:DLG1|0:FKRP|0:SNTB1|0:SGCA|0:CACNB2|0:SSPN|0:SGCB|0:SGCG|0:SLMAP|0:SNTA1|0:SNTG2|0:MYOT|0:SGCE|0:DYSF|0:KCND3|0:SGCZ|0:SLC27A6|0:SGCD|0:DTNBP1|0:TRIM72			
GO:0050715	P:positive regulation of cytokine secretion; ISS:UniProtKB		0:TNF|0:IL1A|0:IL10|0:MIF|0:CRTAM|0:SCAMP5|0:IL26|0:INS|0:CADM1|0:GLMN|0:HTR2B			
GO:0032722	P:positive regulation of chemokine production; TAS:BHF-UCL		0:TLR3|0:TNF|0:TLR4|0:TLR9|0:IL6R|0:IL6|0:TLR7|0:TLR2|0:ADAM17|0:HIF1A			
GO:0004503	F:monophenol monooxygenase activity; IDA:UniProtKB		0:TYR			
GO:0002686	P:negative regulation of leukocyte migration; TAS:BHF-UCL		0:HOXA7|0:HMOX1			
GO:0008168	F:methyltransferase activity; NAS:UniProtKB		0:WBSCR27|0:RG9MTD1|0:NSUN4|0:CCDC76|0:BCDIN3D|0:METT5D1|0:METTL2B|0:COQ5|0:TRMT11|0:NSUN6|0:METTL8|0:FTSJ1|0:NSUN5|0:METT5D2|0:FBL|0:TRMT12|0:METTL4|0:FBLL1|0:FTSJD1|0:METTL2A|0:NSUN7|0:METT10D|0:METTL7A|0:THUMPD2|0:METTL7B|0:METTL5|0:C4orf23|0:THUMPD3|0:ZCCHC4|0:ECE2|0:METTL10|0:MEPCE|0:METTL13|0:RG9MTD2|0:METTL11B|0:NSUN3|0:METTL6|0:METT11D1|0:N6AMT2|0:PRMT2|0:C8orf79|0:FTSJ3|0:TYW3|0:C20orf7|0:NSUN5P2|0:METTL12|0:RG9MTD3|0:LCMT2|0:WBSCR22			
GO:0004584	F:dolichyl-phosphate-mannose-glycolipid alpha...; IEA:EC		0:ALG3			
GO:0051379	F:epinephrine binding; IDA:BHF-UCL		0:ADRA2B|0:ADRA2C|0:ADRA2A			
GO:0010595	P:positive regulation of endothelial cell mig...; TAS:BHF-UCL		0:PROX1|0:AGT|0:ANXA3|0:BMP4|0:ITGB3|0:KDR|0:BMPR2|0:WNT5A|0:AAMP|0:SCARB1|0:EDN1			
GO:2000005	P:negative regulation of metanephric S-shaped...; IDA:UniProtKB		0:BMP4			
GO:0070335	F:aspartate binding; ISS:BHF-UCL		0:CAD			
GO:0034122	P:negative regulation of toll-like receptor s...; ISS:BHF-UCL		0:TLR9|0:IRAK3			
GO:0046326	P:positive regulation of glucose import; NAS:UniProtKB		0:INS|0:INSR|0:FGF21|0:FGF19|0:ITLN1|0:AKT2|0:IRS1|0:RHOQ|0:AKT1|0:IRS2|0:CAPN10|0:CLTCL1|0:PRKCI|0:PIK3R1|0:ADIPOQ|0:ARPP19			
GO:0006768	P:biotin metabolic process; NAS:UniProtKB		0:MCCC1			
GO:0071105	P:response to interleukin-11; ISS:UniProtKB		0:CITED1			
GO:0002690	P:positive regulation of leukocyte chemotaxis; TAS:BHF-UCL		0:IL6R|0:IL6|0:EDN3|0:F2RL1|0:F7|0:EDN2			
GO:0031058	P:positive regulation of histone modification; IMP:HGNC		0:UBE2N			
GO:0008112	F:nicotinamide N-methyltransferase activity; TAS:ProtInc		0:NNMT			
GO:0005546	F:phosphatidylinositol-4,5-bisphosphate binding; NAS:UniProtKB		0:RAB35|0:FRMPD4|0:SESTD1|0:PHLDA3|0:TULP1|0:SYTL2|0:PARD3|0:RAG2|0:ADAP2|0:SCIN|0:TULP3|0:PFN2			
GO:0008015	P:blood circulation; TAS:ProtInc		0:HCN4|0:KCNJ12|0:SCN5A|0:EPO|0:PLN|0:KCNH2|0:KCNE2|0:KCNE1|0:KCNQ1|0:LPA|0:HOXB2|0:SERPING1|0:DLL4|0:ADM|0:NFE2|0:GUCY1B3|0:PPYR1|0:MEOX2|0:COL4A3|0:CXCL12|0:HTR7|0:TBC1D8|0:RCAN1|0:ELN|0:MTHFR|0:MYOF|0:CLNS1A|0:OLR1|0:CXCL10|0:CYB5R3|0:GUCY1A3|0:C3AR1|0:XCL2|0:EPB41			
GO:0002448	P:mast cell mediated immunity; IEP:UniProtKB		0:SERPINB9			
GO:0031105	C:septin complex; ISS:UniProtKB		0:SEPT7|0:SEPT2|0:SEPT3|0:SEPT10|0:SEPT1|0:SEPT6|0:SEPT14|0:SEPT11|0:SEPT5|0:SEPT8|0:SEPT12			
GO:0016820	F:hydrolase activity, acting on acid anhydrid...; IEA:InterPro		0:ATP6V1G3|0:ATP6V1G2			
GO:0070411	F:I-SMAD binding; IPI:BHF-UCL		0:SMAD7|0:SMAD2|0:SMAD6|0:TGFB1I1|0:SMURF1|0:AXIN1|0:TGFBR1|0:SMAD4|0:CTNNB1|0:SMAD1			
GO:0045070	P:positive regulation of viral genome replica...; NAS:UniProtKB		0:NR5A2|0:TARBP2|0:VAPB|0:CD28			
GO:0007638	P:mechanosensory behavior; TAS:ProtInc		0:TACR1			
GO:0043129	P:surfactant homeostasis; IMP:UniProtKB		0:SFTPD			
GO:0008262	F:importin-alpha export receptor activity; TAS:ProtInc		0:CSE1L			
GO:0005921	C:gap junction; TAS:ProtInc		0:PANX1|0:PANX2|0:PANX3|0:MIP|0:DSC1			
GO:0051788	P:response to misfolded protein; IDA:BHF-UCL		0:F12|0:CLU			
GO:0042742	P:defense response to bacterium; TAS:UniProtKB		0:NLRC4|0:SPN|0:ANXA3|0:MICA|0:STAB1|0:STAB2|0:DEFB125|0:GNLY|0:HIST2H2BE|0:DEFB105B|0:DEFB131|0:LEAP2|0:DEFA6|0:DEFB121|0:RNASE7|0:DEFB1|0:DEFB116|0:HIST1H2BC|0:DEFB103A|0:DEFB104B|0:DEFB135|0:DEFA3|0:DEFB107A|0:DEFB108B|0:DEFA5|0:DEFB4B|0:DEFB108P1|0:HIST1H2BG|0:DEFB132|0:DEFB105A|0:DEFB113|0:HIST1H2BF|0:DEFB119|0:DEFB4A|0:PRG2|0:HAMP|0:DEFB129|0:DEFB107B|0:DEFB124|0:CCL20|0:LTF|0:DEFB104A|0:DEFB110|0:DEFB136|0:DEFB133|0:PPBP|0:DEFB114|0:HIST1H2BJ|0:DEFA1B|0:DCD|0:CST11|0:HIST1H2BE|0:DEFA1|0:LYZ|0:DEFB130|0:H2BFS|0:DEFB123|0:DEFB134|0:HIST1H2BI|0:DEFB115|0:S100A12|0:BPI|0:DEFB128|0:RNASE3|0:DEFB126|0:HIST1H2BK|0:DEFB112|0:DEFA4|0:DEFB103B|0:S100A14|0:MAVS|0:LYST|0:WFDC12|0:DEFB106B|0:TLR9|0:HTN3|0:DEFB106A|0:HTN1|0:TLR3|0:TLR6|0:CFP|0:LALBA|0:DEFB127|0:DEFB118			
GO:0015238	F:drug transmembrane transporter activity; TAS:ProtInc		0:SLC22A5|0:SLC47A1|0:SLC18A1|0:SLC47A2|0:EBP			
GO:0003950	F:NAD+ ADP-ribosyltransferase activity; TAS:ProtInc		0:TNKS2|0:TNKS|0:PARP1|0:SIRT4|0:PARP4|0:TIPARP|0:PARP14|0:PARP11|0:PARP6|0:PARP2|0:PARP9|0:PARP10|0:PARP3|0:PARP16|0:PARP8|0:PARP15|0:PARP12|0:ZC3HAV1|0:SIRT6|0:ART1|0:SIRT3|0:SIRT5|0:ART3			
GO:0070815	F:peptidyl-lysine 5-dioxygenase activity; IDA:UniProtKB		0:JMJD6			
GO:0042094	P:interleukin-2 biosynthetic process; TAS:UniProtKB		0:IL18			
GO:0001932	P:regulation of protein amino acid phosphoryl...; ISS:UniProtKB		0:PRKAR2A|0:PRKAR2B|0:PRKAR1A|0:RAPGEF4|0:RAPGEF3|0:PRKAR1B|0:NDUFS4|0:CCDC88A|0:PHIP|0:CCDC88C			
GO:0051066	P:dihydrobiopterin metabolic process; TAS:ProtInc		0:QDPR			
GO:0007602	P:phototransduction; TAS:ProtInc		0:OPN4|0:RRH|0:OPN1LW|0:OPN1MW|0:OPN5|0:OPN1MW2|0:RGR|0:PLEKHB1|0:GNGT2|0:OPN3|0:GNAT2|0:UNC119|0:PITPNM1|0:PDC|0:NR2E3|0:OPN1SW|0:TRPC3			
GO:0004997	F:thyrotropin-releasing hormone receptor acti...; TAS:ProtInc		0:TRHR			
GO:0043619	P:regulation of transcription from RNA polyme...; ISS:BHF-UCL		0:HIF1A|0:ARNT|0:HMOX1			
GO:0042356	F:GDP-4-dehydro-D-rhamnose reductase activity; TAS:UniProtKB		0:TSTA3			
GO:0031205	C:endoplasmic reticulum Sec complex; ISS:UniProtKB		0:SEC61B			
GO:0050920	P:regulation of chemotaxis; IMP:UniProtKB		0:CXCR4|0:USP14			
GO:0045095	C:keratin filament; TAS:UniProtKB		0:TCHP|0:KRT5|0:KRT14|0:KRT18|0:KRTAP10-8|0:KRT74|0:KRTAP4-8|0:KRTAP5-11|0:KRTAP10-5|0:KRT4|0:KRTAP5-3|0:KRTAP2-4|0:KRTAP9-9|0:KRT79|0:KRTAP5-9|0:KRTAP10-1|0:KRTAP12-1|0:KRTAP4-12|0:KRT8|0:KRTAP5-6|0:KRTAP2-1|0:KRT6C|0:KRT75|0:KRT82|0:KRTAP4-3|0:KRTAP1-1|0:KRTAP10-10|0:KRTAP10-4|0:KRTAP3-2|0:KRT6A|0:KRTAP3-1|0:KRTAP10-7|0:KRTAP9-4|0:KRTAP1-5|0:KRT83|0:KRTAP4-11|0:KRTAP12-4|0:KRTAP9-1|0:KRTAP4-4|0:KRTAP4-9|0:KRTAP5-7|0:KRTAP9-3|0:KRTAP5-4|0:KRT76|0:KRTAP9-8|0:KRT80|0:KRT72|0:KRTAP1-4|0:KRTAP10-6|0:KRTAP10-3|0:KRTAP4-1|0:KRTAP9-7|0:KRT6B|0:KRT77|0:KRTAP10-12|0:KRTAP5-8|0:KRTAP9-2|0:KRTAP12-3|0:KRT84|0:KRTAP11-1|0:KRT2|0:KRTAP4-5|0:KRT73|0:KRTAP2-3|0:KRTAP5-10|0:KRT85|0:KRTAP5-2|0:KRTAP26-1|0:KRT86|0:KRTAP1-3|0:KRTAP10-9|0:KRTAP4-7|0:KRTAP10-2|0:KRTAP9-6|0:KRTAP12-2|0:KRTAP4-2|0:KRTAP5-1|0:KRTAP2-2|0:KRT78|0:KRTAP3-3|0:KRT7|0:KRTAP4-6|0:KRT81|0:KRTAP10-11|0:KRT3			
GO:0002329	P:pre-B cell differentiation; ISS:UniProtKB		0:LRRC8A			
GO:0030949	P:positive regulation of vascular endothelial...; TAS:BHF-UCL		0:HIF1A|0:ARNT|0:FLT1|0:VEGFA|0:VEGFB|0:GRB10|0:ITGB3|0:VTN|0:ITGA5			
GO:0001669	C:acrosomal vesicle; IEA:UniProtKB-SubCell		0:CASC5|0:CAPN11|0:SV2B|0:SPACA4|0:RACGAP1|0:PATE4|0:ACRBP|0:VEZT|0:SYT8|0:ARC|0:ADAM15|0:AKAP3|0:SPESP1|0:SPAG8|0:ACRV1|0:CLK3|0:SPAG9|0:TRIM36			
GO:0060134	P:prepulse inhibition; ISS:UniProtKB		0:DRD3|0:DRD1|0:DRD2|0:CTNNA2			
GO:0019153	F:protein-disulfide reductase (glutathione) a...; IEA:EC		0:TXNDC12			
GO:0060213	P:positive regulation of nuclear-transcribed ...; IDA:UniProtKB		0:ZFP36			
GO:0046459	P:short-chain fatty acid metabolic process; ISS:UniProtKB		0:ACOT4|0:ALDH5A1			
GO:0042666	P:negative regulation of ectodermal cell fate...; IMP:BHF-UCL		0:FZD7			
GO:0034504	P:protein localization in nucleus; IMP:UniProtKB		0:MDM2|0:HHEX|0:BMP7|0:BMP4|0:SIX1|0:DVL1|0:PIKFYVE			
GO:0002378	P:immunoglobulin biosynthetic process; IMP:UniProtKB		0:GALNT2|0:PTPRC			
GO:0004148	F:dihydrolipoyl dehydrogenase activity; TAS:ProtInc		0:DLD			
GO:0071072	P:negative regulation of phospholipid biosynt...; IMP:UniProtKB		0:SLC27A1			
GO:0031625	F:ubiquitin protein ligase binding; ISS:BHF-UCL		0:CUL4B|0:C10orf46|0:CUL3|0:CUL7|0:CUL4A|0:CUL1|0:CUL5|0:ANAPC2|0:CUL9|0:CUL2|0:SMAD7|0:SMAD2|0:SMAD6|0:HSPA1A|0:ACVR1B|0:SMAD5|0:HSPA1B|0:POLR2A|0:AXIN1|0:SUMO1|0:SKI|0:ARRB1|0:TXNIP|0:USP7|0:UBE2K|0:PCBP2|0:PML|0:JKAMP|0:DAXX|0:TRIOBP|0:UBE2A|0:MID1|0:SUMO2|0:NKD2|0:MC4R|0:TP53|0:BCL10|0:MC1R|0:RNF40|0:CXCR4|0:BRCA1|0:RNF31|0:NLK|0:UBE2B|0:TSG101|0:ARRB2|0:SLC22A18|0:RNF20|0:USP2|0:SPG20|0:CBS|0:NFKBIA|0:EGR2|0:RELA|0:RAD18|0:SNX9|0:RB1|0:DTX1|0:CALR|0:HSPA5|0:PA2G4|0:TRIB3|0:BAG5|0:TRIB2|0:TRIB1			
GO:0004971	F:alpha-amino-3-hydroxy-5-methyl-4-isoxazole ...; TAS:ProtInc		0:GRIA2			
GO:0051965	P:positive regulation of synaptogenesis; IDA:MGI		0:WNT7A|0:GHRL			
GO:0008459	F:chondroitin 6-sulfotransferase activity; IDA:UniProtKB		0:CHST7|0:CHST3			
GO:0045226	P:extracellular polysaccharide biosynthetic p...; IEA:InterPro		0:MAT2B			
GO:0003920	F:GMP reductase activity; TAS:ProtInc		0:GMPR2|0:GMPR			
GO:0010766	P:negative regulation of sodium ion transport; IDA:UniProtKB		0:NEDD4			
GO:0034437	F:glycoprotein transporter activity; IDA:BHF-UCL		0:ABCG1			
GO:0030544	F:Hsp70 protein binding; IPI:UniProtKB		0:STUB1|0:DNAJB2|0:SACS|0:SNCA|0:MVD			
GO:0016404	F:15-hydroxyprostaglandin dehydrogenase (NAD+...; NAS:UniProtKB		0:HPGD|0:ABCC4			
GO:0006210	P:thymine catabolic process; ISS:UniProtKB		0:DPYD|0:DPYS			
GO:0015031	P:protein transport; TAS:ProtInc		0:SCAMP1|0:CENPF|0:SCAMP2|0:GDI1|0:RAB43|0:RAB33A|0:RAB30|0:RAB32|0:RASEF|0:GDI2|0:RAB40AL|0:RAB41|0:RAB31|0:UEVLD|0:RAB11FIP4|0:RAB40C|0:RAB40B|0:RAB27B|0:RAB44|0:RAB19|0:RAB11FIP3|0:RAB40A|0:RAB6C|0:LMAN1|0:RAB33B|0:CADPS2|0:SERP1|0:NUP85|0:RAB5A|0:SNX18|0:ARF5|0:LRSAM1|0:UNC50|0:SNX8|0:DOPEY1|0:VAMP7|0:NUP93|0:RAB14|0:LSG1|0:RAB23|0:EXOC8|0:ATG4D|0:TNKS|0:ARRB1|0:SCAMP5|0:LCA5|0:ATG9A|0:NUP50|0:TOMM6|0:NUP160|0:COG5|0:SNX30|0:NPIP|0:VPS52|0:SNX24|0:STXBP3|0:RAB2A|0:USE1|0:GLE1|0:RAB35|0:NACAD|0:RABEP2|0:DGKD|0:RUFY1|0:CHMP4C|0:RAB24|0:RABIF|0:SEC16A|0:PGAP1|0:KIF17|0:VPS37A|0:CCDC91|0:NUP107|0:KIF13A|0:POM121B|0:AFTPH|0:RAB18|0:PITPNM1|0:NUP62CL|0:NUP153|0:RAB11FIP2|0:AKTIP|0:CADPS|0:DUOXA1|0:RRBP1|0:ARFGAP2|0:VPS13A|0:RAB3B|0:RAB1C|0:SNX3|0:FAM125B|0:KIF20A|0:AGAP1|0:ARL17A|0:GABARAPL2|0:SEC22A|0:SNX21|0:RAB39|0:VPS4A|0:RAB1B|0:SLC15A2|0:SNX16|0:EXOC3|0:EXOC2|0:SNX25|0:CHMP6|0:SCAMP3|0:APBA2|0:TRAM2|0:RAB20|0:DOPEY2|0:VPS37B|0:ATG4A|0:PHAX|0:NUTF2|0:RINT1|0:SCAMP4|0:RAB2B|0:RAB6A|0:ABCB9|0:RAB11FIP5|0:POM121C|0:DDX19B|0:COG6|0:MYO1C|0:ARHGAP33|0:SNX31|0:LIN7A|0:RAB7B|0:KDELR3|0:RAB17|0:SNX7|0:NUP210|0:RAB11B|0:ACAP1|0:TNPO3|0:RAB3D|0:MON2|0:RABEP1|0:RAB12|0:TOMM40L|0:SFT2D1|0:GOLT1A|0:RAB3IP|0:ARF6|0:HOOK3|0:NUP37|0:RANBP6|0:RAB5B|0:SNX13|0:PDCD6IP|0:RAB25|0:VPS53|0:SNAP29|0:TMED3|0:TMED10|0:RAB11FIP1|0:YIF1A|0:SNF8|0:EXOC7|0:RAB3C|0:TRIM3|0:SEC31B|0:ZW10|0:VPS39|0:LYST|0:STXBP5|0:ZFYVE20|0:SEC22B|0:RAB36|0:GOPC|0:AGAP2|0:CHMP4B|0:SCFD2|0:NUP188|0:SYS1|0:VPS18|0:NUP54|0:PLEKHA8|0:RANGRF|0:NUP43|0:NMD3|0:GORASP1|0:XPO5|0:EXOC6|0:CHMP2B|0:EXOC1|0:NUP133|0:AHCTF1|0:ARL17B|0:VPS4B|0:SEC22C|0:SNX32|0:SNX11|0:RAB22A|0:CHMP1A|0:SLC15A3|0:SNX22|0:TIMM50|0:APBA3|0:LIN7C|0:TRAM1L1|0:SLC15A5|0:RAB7L1|0:CHMP5|0:ATG4B|0:EIF5A2|0:VPS11|0:TMED2|0:SEC31A|0:DDX19A|0:DNAJC14|0:VPS37C|0:SNX27|0:SFT2D3|0:VPS28|0:TSG101|0:RAB13|0:ATG16L1|0:POM121|0:NUP62|0:CHCHD4|0:GOLT1B|0:RAB7A|0:ACTN4|0:VPS33A|0:ARRB2|0:NUP155|0:BET1L|0:NASP|0:ATG10|0:NUP88|0:RABGEF1|0:ATG7|0:MCFD2|0:EPS15|0:NACA|0:SCFD1|0:RAB4B|0:VPS29|0:VPS35|0:COPE|0:GOSR2|0:VPS54|0:PEX5|0:STXBP1|0:RAB1A|0:SNX12|0:RAB9A|0:NXT2|0:ERC1|0:CHMP4A|0:EXOC5|0:RAB37|0:MYO5B|0:PRAF2|0:NECAP2|0:RAB26|0:RAB21|0:RAB6B|0:ZMAT3|0:STXBP5L|0:NSF|0:SENP2|0:SNAP23|0:RHOB|0:HOOK2|0:RAB5C|0:VPS24|0:BET1|0:C11orf2|0:CHMP1B|0:SNX19|0:COG1|0:VPS25|0:RAB15|0:XPO4|0:FAM160A2|0:COG8|0:VPS26B|0:CHMP2A|0:SNX5|0:C18orf55|0:NACA2|0:MAMDC4|0:HOOK1|0:RAB10|0:SFT2D2|0:ARFGAP1|0:DUOXA2|0:SLC15A4|0:ARF4|0:VPS36|0:SNX10|0:GOSR1|0:ATG16L2|0:SEH1L|0:EIF5AL1|0:MVP|0:LMAN2|0:STXBP2|0:PREB|0:KIF18A|0:YIPF5|0:YKT6|0:VTA1|0:SELENBP1|0:SDAD1|0:RAB3A|0:MITD1|0:COG4|0:RAB9B|0:FAM125A|0:NUP35|0:NECAP1|0:RAB34|0:SERP2|0:AP1AR|0:SEC16B|0:EXOC6B|0:ARF1|0:NUPL1|0:JAKMIP1|0:SNX4|0:VPS37D|0:SNX20|0:SNX14|0:RAB39B|0:RANBP3|0:SLC15A1|0:DMBT1|0:AAGAB|0:PKDCC|0:ARF3|0:VPS13B|0:RAB8A|0:PPT1|0:LMAN2L|0:CD3G|0:VPS33B|0:MIA3|0:MYH9|0:CEP290|0:HSP90B1|0:TMEM48|0:RAB38|0:RAB8B|0:RILP|0:LRP1B			
GO:0047804	F:cysteine-S-conjugate beta-lyase activity; IEA:EC		0:CCBL1|0:CCBL2			
GO:0016219	F:GDP-dissociation stimulator activity; IDA:UniProtKB		0:DIS3			
GO:0004563	F:beta-N-acetylhexosaminidase activity; IEA:EC		0:MGEA5|0:HEXDC|0:HEXA			
GO:0046689	P:response to mercury ion; IDA:UniProtKB		0:AQP9|0:SLC34A1			
GO:0044419	P:interspecies interaction between organisms; IEA:UniProtKB-KW		0:PDCL3|0:DDB1|0:GRB2|0:UNG|0:C1QBP|0:LDLR|0:GYPA|0:PSMB8|0:BANF1|0:UCKL1|0:EIF4E|0:MFGE8|0:MDM2|0:SLC25A4|0:CREB1|0:HLA-C|0:TRIM5|0:IL2RG|0:GTF2E1|0:KAT2A|0:TRIM25|0:PAK2|0:DLG1|0:RBM15|0:KPNA2|0:USP7|0:IRF3|0:SLAMF1|0:NEDD4L|0:CREBBP|0:KRT8|0:ANKRD17|0:CD86|0:STAT1|0:C9orf156|0:FKBP8|0:RPLP0|0:MAPK1|0:RNF216|0:TCEB1|0:CCNT1|0:PSMB4|0:GTF2B|0:KRT18|0:CLDN1|0:HNRNPA1|0:PSMA3|0:LMBRD1|0:SMARCB1|0:MAGI3|0:CDC25C|0:LCK|0:PRMT6|0:TAF4|0:TBP|0:KARS|0:CARM1|0:PML|0:FADD|0:ANPEP|0:CRTC3|0:ITGB3|0:HMGA1|0:PSMB10|0:FDPS|0:WAPAL|0:TOP1|0:SRPK1|0:EIF4G3|0:ATF7|0:CCR3|0:HCFC1|0:TNFRSF1A|0:CD93|0:KAT5|0:MMP1|0:EIF2AK2|0:RAD23A|0:SP110|0:ATP6V0C|0:DAXX|0:CD247|0:CUL7|0:UBR4|0:FCGR2B|0:PLCG1|0:UBE2I|0:SLC25A5|0:EFNB3|0:ITGB6|0:VIM|0:ABCE1|0:TBC1D20|0:RBX1|0:BUB1|0:ATP6V1H|0:SYK|0:XPO1|0:IPO7|0:PSMB5|0:CEBPA|0:COPB1|0:HPX|0:CPSF4|0:CXADR|0:TAF5|0:IKBKG|0:CREB3|0:PDCD6IP|0:MAVS|0:NLRX1|0:COPS6|0:VAC14|0:SRCAP|0:RCOR1|0:SYNCRIP|0:FBXW7|0:KRT19|0:TP53|0:CFLAR|0:WDR48|0:EIF4H|0:IFIH1|0:IDE|0:SEPT6|0:TRIM23|0:TRIM22|0:TBK1|0:BTRC|0:RHOA|0:ZYX|0:CCDC86|0:CTBP1|0:CD46|0:NXF1|0:KPNA1|0:KDR|0:NUP98|0:ZC3H7B|0:SP100|0:SUV39H1|0:SLC20A2|0:STAT2|0:F11R|0:PSMB1|0:CXCR4|0:EP300|0:LTBR|0:E4F1|0:CXCR7|0:KIN|0:APOA2|0:RAB11FIP4|0:HNRNPK|0:ITGA2|0:UBN1|0:PAAF1|0:PIK3R1|0:CD200R1|0:RTN3|0:PSMB6|0:SND1|0:PACS2|0:POLA1|0:HLA-A|0:STAT3|0:CENPA|0:ISG15|0:IVNS1ABP|0:LYN|0:TAF1|0:AP1G2|0:HTATIP2|0:EFNB2|0:TSG101|0:SLC25A6|0:APOBEC3G|0:HSPA8|0:PSIP1|0:NACA|0:TNFRSF14|0:SRC|0:BNIP3L|0:RBM15B|0:UBE3A|0:POLR2E|0:KAT2B|0:YWHAE|0:KCTD5|0:BNIP3|0:PSMB2|0:AP1M1|0:SPEN|0:ERCC3|0:TFRC|0:ATF7IP|0:RBCK1|0:MAPK3|0:APOBEC3C|0:IL16|0:ZMYND11|0:CUL4A|0:CCR5|0:ITGA5|0:MLF1IP|0:HSPD1|0:PILRA|0:IRF7|0:VPRBP|0:KDM4A|0:PSMB7|0:TNPO1|0:PACS1|0:SGTA|0:NFKBIA|0:CRTC1|0:CX3CR1|0:ACY3|0:MDFIC|0:RXRA|0:MAP3K5|0:CCNT2|0:HAVCR1|0:FBXL2|0:CUL1|0:CUL5|0:GADD45GIP1|0:CAV1|0:PSMA7|0:RELA|0:NFX1|0:HLA-B|0:EIF4A2|0:KPNB1|0:DDX3X|0:RBL1|0:RNGTT|0:NPM1|0:HCK|0:FYN|0:IPO5|0:SF3B2|0:BIN1|0:GTF2A2|0:RB1|0:KRT7|0:SIRT1|0:PSMB3|0:ACOT8|0:SIVA1|0:SATB1|0:PVR|0:CD1D|0:AMBP|0:PSMC2|0:FBLN1|0:CCR2|0:ITGAV|0:CRTC2|0:VDAC1|0:PPIA|0:EIF4G1|0:PSMA4|0:CD80|0:DMBT1|0:RALA|0:MICB|0:MPDZ|0:VCAM1|0:CUL2|0:PSMC3|0:IL2RB|0:ERCC2|0:PSMB9			
GO:0010002	P:cardioblast differentiation; ISS:UniProtKB		0:TGFB2|0:ECE2			
GO:0050512	F:lactosylceramide 4-alpha-galactosyltransfer...; IEA:EC		0:A4GALT			
GO:0033085	P:negative regulation of T cell differentiati...; ISS:BHF-UCL		0:ZC3H8|0:FOXJ1			
GO:0032494	P:response to peptidoglycan; ISS:BHF-UCL		0:IL6|0:IRAK3			
GO:0032909	P:regulation of transforming growth factor-be...; IMP:BHF-UCL		0:TGFB2|0:SMAD4|0:HIF1A			
GO:0016758	F:transferase activity, transferring hexosyl ...; IEA:InterPro		0:ALG10B|0:ALG10|0:GGTA1|0:GLT6D1			
GO:0071203	C:WASH complex; ISS:UniProtKB		0:CAPZA1|0:KIAA1033|0:WASH1|0:CAPZB|0:KIAA0196|0:FAM21C|0:CCDC53|0:WASH4P|0:FAM21A|0:WASH2P|0:FAM21D|0:FAM21B|0:WASH6P|0:WASH3P			
GO:0021892	P:cerebral cortex GABAergic interneuron diffe...; IEP:UniProtKB		0:ASCL1			
GO:0051567	P:histone H3-K9 methylation; IDA:UniProtKB		0:PRDM5			
GO:0001503	P:ossification; TAS:ProtInc		0:IBSP|0:BMP3|0:OSTN|0:TRAF6|0:BMP7|0:LRRC17|0:ECM1|0:CHRDL2|0:SORT1|0:C1orf9|0:BMP1|0:FSTL3|0:CHRDL1|0:BMP8A|0:BMP5|0:KAZALD1|0:NPR2|0:NPPC|0:PDLIM7|0:IGSF10|0:BMP8B|0:IGF2|0:PKDCC|0:EXT1|0:EXT2|0:ATP6V1B1|0:ATP6V0A4|0:EGFR|0:CDH11|0:CASR|0:MGP|0:DSPP|0:OSTF1|0:STATH|0:SPARC|0:DMP1			
GO:0005833	C:hemoglobin complex; TAS:UniProtKB		0:HBM|0:HBG1|0:HBG2|0:AHSP|0:NGB|0:HBZ|0:HBE1|0:HBQ1|0:CYB5R3|0:HBD|0:HBB|0:HBA2|0:HBA1			
GO:0048602	F:fibroblast growth factor 1 binding; IPI:UniProtKB		0:RPS2|0:S100A13			
GO:0009166	P:nucleotide catabolic process; IEA:InterPro		0:UPP1|0:UPP2			
GO:0035491	P:positive regulation of leukotriene producti...; IMP:BHF-UCL		0:SERPINE1			
GO:0034340	P:response to type I interferon; IDA:BHF-UCL		0:SP100			
GO:0005138	F:interleukin-6 receptor binding; NAS:UniProtKB		0:CNTF|0:ADAM17|0:ERAP1|0:IL6			
GO:0060422	F:peptidyl-dipeptidase inhibitor activity; IDA:UniProtKB		0:GPC3			
GO:0010881	P:regulation of cardiac muscle contraction by...; ISS:BHF-UCL		0:RYR2|0:FKBP1B			
GO:0045840	P:positive regulation of mitosis; ISS:UniProtKB		0:IGF1|0:EDN3|0:INS|0:EDN1|0:IGF2|0:EGF|0:TGFA|0:EPGN|0:NUSAP1|0:CD28|0:IL1A|0:IL1B|0:INSR|0:TERF1|0:DRD3|0:EREG|0:PHIP			
GO:0042584	C:chromaffin granule membrane; IEA:UniProtKB-SubCell		0:DBH|0:SYT1|0:SYT2|0:ATP8A1			
GO:0051903	F:S-(hydroxymethyl)glutathione dehydrogenase ...; TAS:UniProtKB		0:ADH5			
GO:0007188	P:G-protein signaling, coupled to cAMP nucleo...; TAS:UniProtKB		0:CRHR2|0:CHRM2|0:CCR3|0:CRHR1|0:ADRA1D|0:MC4R|0:GRK5|0:FPR1|0:GLP2R|0:WASF2|0:AVPR2|0:PTGER4|0:ADRA1B|0:PRKACB			
GO:0004498	F:calcidiol 1-monooxygenase activity; IDA:BHF-UCL		0:CYP27B1			
GO:0004567	F:beta-mannosidase activity; TAS:ProtInc		0:MANBA			
GO:0004696	?:?; IDA:BHF-UCL		0:GSK3A|0:GSK3B			
GO:0009649	P:entrainment of circadian clock; TAS:ProtInc		0:ARNTL2|0:PER1			
GO:0031672	C:A band; IMP:BHF-UCL		0:MYL3|0:MYL7|0:MYL4			
GO:0042379	F:chemokine receptor binding; IMP:UniProtKB		0:S100A14			
GO:0001401	C:mitochondrial sorting and assembly machiner...; IMP:BHF-UCL		0:SAMM50			
GO:0002331	P:pre-B cell allelic exclusion; ISS:UniProtKB		0:ATM|0:RAG2|0:RAG1			
GO:0014895	P:smooth muscle hypertrophy; ISS:BHF-UCL		0:CYBA			
GO:0002347	P:response to tumor cell; IEA:InterPro		0:TP73|0:TP53|0:TP63			
GO:0060603	P:mammary gland duct morphogenesis; ISS:UniProtKB		0:SCRIB			
GO:0043234	C:protein complex; NAS:UniProtKB		0:MDM2|0:CDKN2A|0:TP53|0:WIPI2|0:FAM186B|0:STRA6|0:HIGD1A|0:BTBD1|0:CCDC113|0:GPN3|0:C5orf23|0:CISD2|0:NAT9|0:SSX2IP|0:CNST|0:TRMT112|0:N6AMT1|0:ACR|0:ALB|0:HMGB2|0:CTU2|0:VPS72|0:GCH1|0:SERPINA5|0:SRCAP|0:OXA1L|0:SPTB|0:ACTN4|0:TCF3|0:SET|0:SOD1|0:PLEKHA2|0:MAGED1|0:DDB2|0:ALS2|0:EPB41|0:MSTO1|0:CEP250|0:PEX14|0:LDB1|0:BSND|0:STXBP1|0:STRN3|0:FOXP3|0:S100A1			
GO:0004491	F:methylmalonate-semialdehyde dehydrogenase (...; ISS:UniProtKB		0:ALDH6A1			
GO:0016926	P:protein desumoylation; ISS:UniProtKB		0:SENP1			
GO:0010873	P:positive regulation of cholesterol esterifi...; TAS:BHF-UCL		0:APOA4|0:APOE|0:APOA2|0:AGT|0:APOA1|0:AGTR1|0:APOC1			
GO:0055131	F:C3HC4-type RING finger domain binding; IPI:BHF-UCL		0:PINK1			
GO:0010535	P:positive regulation of activation of JAK2 k...; IDA:BHF-UCL		0:GH1			
GO:0007320	P:insemination; TAS:ProtInc		0:TAC1|0:SEMG1			
GO:0004132	F:dCMP deaminase activity; TAS:ProtInc		0:DCTD			
GO:0005375	F:copper ion transmembrane transporter activity; TAS:ProtInc		0:SLC11A2|0:SLC31A1|0:SLC31A2|0:CCS			
GO:0030660	C:Golgi-associated vesicle membrane; ISS:UniProtKB		0:GJA1|0:CSPG5|0:ZDHHC17|0:ZDHHC13			
GO:0016019	F:peptidoglycan receptor activity; TAS:ProtInc		0:PGLYRP4|0:PGLYRP2|0:PGLYRP1|0:PGLYRP3|0:CD14			
GO:0015106	F:bicarbonate transmembrane transporter activity; ISS:UniProtKB		0:SLC4A11|0:SLC26A7			
GO:0046226	P:coumarin catabolic process; IDA:BHF-UCL		0:CYP2A6			
GO:0060086	P:circadian temperature homeostasis; ISS:BHF-UCL		0:TNFRSF11A			
GO:0043116	P:negative regulation of vascular permeability; IDA:UniProtKB		0:SLIT2|0:AMOT|0:ANGPT1			
GO:0000267	C:cell fraction; NAS:UniProtKB		0:PDE7A			
GO:0060326	P:cell chemotaxis; IMP:UniProtKB		0:PDGFRB|0:HMGB2|0:AGTR1|0:ENG|0:ARRB2			
GO:0010925	P:positive regulation of inositol-polyphospha...; IDA:BHF-UCL		0:PLEK			
GO:0090136	P:epithelial cell-cell adhesion; IMP:UniProtKB		0:BVES|0:VCL|0:KIAA1543|0:KIFC3|0:PLEKHA7			
GO:0007565	P:female pregnancy; TAS:UniProtKB		0:HPGD|0:STS|0:ENDOU|0:PRL|0:RLN1|0:CRHR1|0:PSG2|0:PSG6|0:BCL2|0:AMBP|0:PAPPA|0:OXTR|0:ADM|0:PRLHR|0:CRHBP|0:ADCYAP1|0:PTHLH|0:PSG7|0:FLT1|0:TEAD3|0:RLN2|0:FSHB|0:LNPEP|0:OVGP1|0:PSG9|0:FCGRT|0:TFCP2L1|0:CSH2|0:CLIC5|0:IDO1|0:EPYC|0:PSG1|0:CSH1|0:BYSL|0:TAC3|0:CRH|0:COL16A1|0:PSG11|0:PSG5|0:INSL4|0:PSG3|0:PSG4|0:PZP			
GO:0046520	P:sphingoid biosynthetic process; IDA:MGI		0:SPTLC3			
GO:0004454	F:ketohexokinase activity; TAS:ProtInc		0:KHK			
GO:0008272	P:sulfate transport; IEA:InterPro		0:RACGAP1|0:MPST|0:TST			
GO:0000056	P:ribosomal small subunit export from nucleus; IMP:UniProtKB		0:RPS15			
GO:0033152	P:immunoglobulin V(D)J recombination; IDA:MGI		0:TCF3			
GO:0051102	P:DNA ligation involved in DNA recombination; ISS:UniProtKB		0:LIG4			
GO:0043120	F:tumor necrosis factor binding; IDA:UniProtKB		0:A2M			
GO:0007093	P:mitotic cell cycle checkpoint; TAS:ProtInc		0:ZWINT|0:KNTC1|0:ZW10|0:CHFR|0:MAD2L1BP|0:RAD17|0:ZWILCH|0:MAD1L1|0:BUB1B			
GO:0030132	C:clathrin coat of coated pit; IEA:InterPro		0:CLTC|0:CLTCL1|0:CLTB|0:AP2M1|0:CLTA			
GO:0030139	C:endocytic vesicle; TAS:UniProtKB		0:APOA1|0:TF|0:AMOT|0:DPP4|0:IGF2R|0:CD207|0:GOLIM4|0:SFTPD|0:MTSS1			
GO:0004449	F:isocitrate dehydrogenase (NAD+) activity; TAS:ProtInc		0:IDH3A|0:IDH3G|0:IDH3B			
GO:0006898	P:receptor-mediated endocytosis; TAS:UniProtKB		0:APOE|0:ADRB2|0:CLTCL1|0:PPT1|0:DNM1|0:CLN3|0:HIP1R|0:SH3D20|0:ARHGAP27|0:CUBN|0:CXCL16|0:SORL1|0:LRP1B|0:PI4KB|0:HFE|0:LRP3|0:FOLR1|0:ASGR1|0:MSR1|0:MRC1|0:RAMP3|0:IGF2R|0:PDLIM7|0:LRP2|0:RABEPK|0:M6PR|0:RAMP2|0:SFTPD|0:STAB1|0:STAB2|0:AP1S1|0:SCARF1			
GO:0030942	F:endoplasmic reticulum signal peptide binding; IEA:InterPro		0:SRP54|0:SRP14			
GO:0004122	F:cystathionine beta-synthase activity; IDA:UniProtKB		0:CBS			
GO:0030060	F:L-malate dehydrogenase activity; IDA:UniProtKB		0:MDH1|0:MDH2			
GO:0040036	P:regulation of fibroblast growth factor rece...; TAS:UniProtKB		0:OTX2			
GO:0004557	F:alpha-galactosidase activity; IDA:UniProtKB		0:GLA			
GO:0004784	F:superoxide dismutase activity; TAS:ProtInc		0:SOD2|0:SOD1|0:SOD3			
GO:0050663	P:cytokine secretion; NAS:UniProtKB		0:NOX5			
GO:0031314	C:extrinsic to mitochondrial inner membrane; ISS:UniProtKB		0:C20orf7|0:C3orf31			
GO:0006516	P:glycoprotein catabolic process; TAS:ProtInc		0:NGLY1|0:FBXO2|0:MGEA5|0:ADAMTS9			
GO:0030742	F:GTP-dependent protein binding; NAS:UniProtKB		0:EEA1|0:RAPGEF6|0:RAB5B|0:RAC1|0:RAPGEF5|0:MRAS|0:ARFIP2|0:PARD6A|0:RASGRP4			
GO:0031129	P:inductive cell-cell signaling; ISS:UniProtKB		0:SALL1			
GO:0004822	F:isoleucine-tRNA ligase activity; EXP:Reactome		0:IARS|0:IARS2			
GO:0071288	P:cellular response to mercury ion; IDA:UniProtKB		0:AQP2|0:AQP1			
GO:0070634	P:transepithelial ammonium transport; IDA:UniProtKB		0:SLC12A2|0:RHCG|0:RHBG			
GO:0030334	P:regulation of cell migration; TAS:UniProtKB		0:AMOT|0:RTN4|0:ABI3|0:ENPP2|0:NEXN|0:LAMA4|0:LAMA1|0:LAMA3|0:LAMA2|0:LAMA5|0:SRCIN1|0:JAG2|0:ROBO4|0:SERPINE2|0:JAG1|0:PARD6B			
GO:0051103	P:DNA ligation involved in DNA repair; IDA:UniProtKB		0:LIG4|0:XRCC4			
GO:0004512	F:inositol-3-phosphate synthase activity; IEA:EC		0:ISYNA1			
GO:0030264	P:nuclear fragmentation involved in apoptotic...; IMP:HGNC		0:CASP3|0:BAX			
GO:0019805	P:quinolinate biosynthetic process; NAS:UniProtKB		0:KYNU|0:HAAO			
GO:0004974	F:leukotriene receptor activity; TAS:ProtInc		0:CYSLTR1			
GO:0045184	P:establishment of protein localization; IMP:UniProtKB		0:MDM2|0:FLNA|0:RAP2A|0:PLEKHA1|0:ANK3|0:HINFP			
GO:0043495	F:protein anchor; TAS:BHF-UCL		0:ALG2|0:MYH9|0:SLC4A1			
GO:0031083	C:BLOC-1 complex; IDA:UniProtKB		0:BLOC1S3|0:BLOC1S1|0:BLOC1S2			
GO:0030182	P:neuron differentiation; TAS:UniProtKB		0:ATP2B2|0:ITM2C|0:RTN1|0:WNT7B|0:SMARCA1|0:PCSK9|0:WNT10B|0:WNT2B|0:WNT8B|0:WNT3|0:WNT11|0:BRSK2|0:WNT6|0:FZD5|0:WNT5B|0:WNT9A|0:FZD10|0:WNT2|0:FZD4|0:FZD2|0:FZD8|0:FZD1|0:FZD7|0:WNT9B|0:BRSK1|0:STMN2|0:NGRN|0:BTG4			
GO:0032415	P:regulation of sodium:hydrogen antiporter ac...; NAS:UniProtKB		0:SLC9A3R1			
GO:0006220	P:pyrimidine nucleotide metabolic process; TAS:ProtInc		0:DCK|0:TYMP|0:DCTD			
GO:0061029	P:eyelid development in camera-type eye; ISS:UniProtKB		0:INHBA			
GO:0019782	F:ISG15 activating enzyme activity; IDA:HGNC		0:UBA7			
GO:0042623	F:ATPase activity, coupled; TAS:ProtInc		0:PEX1|0:PEX6|0:VPS4A|0:DNAL4|0:VPS4B|0:HSPA8|0:DYNC1H1|0:MYL7|0:CCT8|0:MYO1E			
GO:0032592	C:integral to mitochondrial membrane; IDA:UniProtKB		0:ABCB10|0:OXA1L|0:TMEM70			
GO:0005757	C:mitochondrial permeability transition pore ...; IDA:HGNC		0:BAX			
GO:0031442	P:positive regulation of mRNA 3'-end processing; IDA:UniProtKB		0:NCBP1			
GO:0010866	P:regulation of triglyceride biosynthetic pro...; ISS:BHF-UCL		0:FITM2			
GO:0046330	P:positive regulation of JNK cascade; ISS:UniProtKB		0:SDCBP|0:TLR9|0:FZD7|0:EDA2R|0:CARD9|0:NOD2|0:FGF19|0:TPD52L1|0:TRAF4|0:TAOK2|0:WNT16|0:TAOK3|0:HIPK2|0:AXIN1|0:CD27			
GO:0031290	P:retinal ganglion cell axon guidance; ISS:UniProtKB		0:SLIT2|0:PTPRM|0:ROBO2			
GO:0015993	P:molecular hydrogen transport; NAS:UniProtKB		0:ADHFE1|0:SLC23A2			
GO:0001681	F:sialate O-acetylesterase activity; IEA:EC		0:SIAE			
GO:0004579	F:dolichyl-diphosphooligosaccharide-protein g...; IEA:EC		0:RPN2|0:STT3B|0:RPN1|0:DDOST|0:DAD1|0:STT3A			
GO:0017162	F:aryl hydrocarbon receptor binding; ISS:UniProtKB		0:ARNTL|0:ARNT|0:ARNT2			
GO:0006643	P:membrane lipid metabolic process; TAS:ProtInc		0:TMEM195|0:B4GALT4			
GO:0004339	F:glucan 1,4-alpha-glucosidase activity; IEA:InterPro		0:MGAM|0:PHKB|0:PHKA2|0:PHKA1			
GO:0003309	P:pancreatic B cell differentiation; ISS:UniProtKB		0:RFX6			
GO:0001675	P:acrosome assembly; NAS:UniProtKB		0:PAFAH1B1|0:CASC5			
GO:0005762	C:mitochondrial large ribosomal subunit; TAS:ProtInc		0:MRPL12|0:MRPL41|0:MRPL3|0:ICT1|0:MRPS24|0:MRPL10|0:MRPL52|0:MRPL51|0:MRPL55|0:MRPL27|0:MRPL13|0:MRPL36|0:MRPL23			
GO:0006544	P:glycine metabolic process; TAS:ProtInc		0:SHMT2|0:BAAT			
GO:0000186	P:activation of MAPKK activity; TAS:ProtInc		0:ADAM9|0:TGFBR1|0:LRRK2|0:BMP4|0:MAP3K13|0:TAOK2|0:CARTPT|0:MAP3K4			
GO:0006353	P:transcription termination; TAS:ProtInc		0:XRN2|0:PTRF|0:MTERFD3|0:TTF1|0:TTF2			
GO:0006813	P:potassium ion transport; IEA:UniProtKB-KW		0:SLC24A4|0:SLC12A2|0:SLC12A5|0:SLC24A3|0:SLC12A8|0:SLC12A1|0:SLC24A2|0:SLC12A4|0:SLC12A7|0:SLC24A5|0:SLC12A6			
GO:0015367	F:oxoglutarate:malate antiporter activity; TAS:ProtInc		0:SLC25A11			
GO:0008046	F:axon guidance receptor activity; TAS:ProtInc		0:ROBO2|0:ROBO1			
GO:0004040	F:amidase activity; ISS:UniProtKB		0:ACR			
GO:0030692	C:Noc4p-Nop14p complex; ISS:UniProtKB		0:NOP14			
GO:0001673	C:male germ cell nucleus; IDA:UniProtKB		0:HILS1			
GO:0048514	P:blood vessel morphogenesis; IMP:BHF-UCL		0:FZD4|0:LRP5			
GO:0002043	P:blood vessel endothelial cell proliferation...; IDA:BHF-UCL		0:BMPER|0:BMP4			
GO:0005697	C:telomerase holoenzyme complex; TAS:HGNC		0:TEP1|0:DKC1|0:WRAP53|0:PTGES3|0:TERT|0:SMG6			
GO:0006103	P:2-oxoglutarate metabolic process; ISS:UniProtKB		0:TAT|0:AADAT|0:IDH1|0:GPT2|0:GHR|0:STAT5A|0:STAT5B|0:IDH2			
GO:0050254	F:rhodopsin kinase activity; IEA:EC		0:GRK1			
GO:0030174	P:regulation of DNA-dependent DNA replication...; TAS:UniProtKB		0:WRNIP1|0:C15orf42|0:NBN			
GO:0009888	P:tissue development; IDA:UniProtKB		0:PTF1A			
GO:0043890	F:N-acetylgalactosamine-6-sulfatase activity; IEA:EC		0:GALNS			
GO:0046784	P:intronless viral mRNA export from host nucleus; IDA:UniProtKB		0:THOC7|0:THOC1|0:THOC6|0:THOC5|0:THOC3|0:BAT1|0:THOC4|0:THOC2			
GO:0000389	P:nuclear mRNA 3'-splice site recognition; TAS:HGNC		0:SLU7|0:SF3A1|0:SF3A2|0:SF3A3|0:SF1			
GO:0048002	P:antigen processing and presentation of pept...; ISS:BHF-UCL		0:SLC11A1			
GO:0016332	P:establishment or maintenance of polarity of...; ISS:UniProtKB		0:WNT7B			
GO:0005234	F:extracellular-glutamate-gated ion channel a...; TAS:ProtInc		0:GRID1|0:GRIN3A|0:GRIN2C|0:GRID2|0:GRIN2D|0:GRIA2|0:GRIK3|0:GRIA4|0:GRIA3|0:GRIK2|0:GRIK5|0:GRIN1|0:GRIK4|0:GRIK1|0:GRIA1|0:GRIN3B|0:STX1B			
GO:0048154	F:S100 beta binding; IPI:UniProtKB		0:S100A11|0:S100A1|0:S100B|0:S100A6			
GO:0035515	F:oxidative RNA demethylase activity; IDA:BHF-UCL		0:FTO			
GO:0035248	F:alpha-1,4-N-acetylgalactosaminyltransferase...; IDA:UniProtKB		0:EXTL2			
GO:0045939	P:negative regulation of steroid metabolic pr...; IC:BHF-UCL		0:UGT1A8|0:UGT1A1			
GO:0004653	F:polypeptide N-acetylgalactosaminyltransfera...; TAS:ProtInc		0:GALNT1|0:GALNT2|0:GALNT3|0:GALNT5|0:GALNT13|0:GALNT12|0:WBSCR17|0:GALNT11|0:GALNTL4|0:GALNT10|0:GALNTL1|0:GALNTL2|0:GALNT14|0:GALNTL6|0:GALNT9|0:GALNT4|0:GALNT7|0:GALNT6|0:GALNT8			
GO:0070970	P:interleukin-2 secretion; IMP:UniProtKB		0:PNP			
GO:0008633	P:activation of pro-apoptotic gene products; NAS:UniProtKB		0:DYNLL1|0:MAPK8|0:TNFSF10|0:BCL2L11|0:FADD|0:BCL2|0:BID|0:FAS|0:YWHAB|0:FASLG|0:TNFRSF10B|0:AKT1|0:PPP3CC|0:BAD|0:RIPK1|0:PPP3R1|0:TRADD|0:TRAF2|0:CASP8|0:IFI27|0:DEDD2			
GO:0006940	P:regulation of smooth muscle contraction; TAS:UniProtKB		0:NMS|0:CAV1|0:CHRNA3|0:NMUR2|0:KCNB2|0:PLCE1|0:CNN1			
GO:0005678	C:chromatin assembly complex; TAS:ProtInc		0:NAP1L3|0:CHAF1B|0:NAP1L2|0:NAP1L1|0:CHAF1A|0:NAP1L4			
GO:0006469	P:negative regulation of protein kinase activity; TAS:UniProtKB		0:TRIB3|0:PRKAG2|0:DVL1|0:PDPK1|0:PYDC1|0:CRIPAK|0:AKT1S1|0:PTPRC|0:DNAJA3|0:DBNDD2|0:TAF7|0:PKIB|0:PKIG|0:GNAQ|0:AKT1|0:CDKN2A|0:TAZ|0:TRIB1|0:DEPDC6|0:RB1|0:THY1|0:TRIB2|0:YWHAG|0:ZNF675|0:PAK2|0:SFN|0:TARBP2			
GO:0032020	P:ISG15-protein conjugation; IDA:HGNC		0:UBE2E2|0:UBA7|0:ISG15|0:UBE2E1			
GO:0004601	F:peroxidase activity; TAS:ProtInc		0:MPO|0:PXDN|0:PRDX5|0:TXNDC17|0:DUOX1|0:PTGS1|0:PRDX3|0:LPO|0:DUOX2|0:CYGB|0:PXDNL|0:IPCEF1|0:PTGS2|0:EPX|0:MGST3			
GO:0050680	P:negative regulation of epithelial cell prol...; TAS:UniProtKB		0:TGFB2|0:SOX2|0:IL26|0:MCC|0:MAGED1|0:CDK6|0:CDKN2B|0:CDKN1C|0:TGFB1|0:TINF2|0:TGFBR3|0:KRT4|0:RUNX3|0:EREG			
GO:0070493	P:thrombin receptor signaling pathway; IDA:UniProtKB		0:PLEK|0:DGKQ			
GO:0090184	P:positive regulation of kidney development; ISS:UniProtKB		0:BMP4|0:FOXD1			
GO:0030675	F:Rac GTPase activator activity; ISS:HGNC		0:DOCK4|0:ARHGAP15|0:PREX2|0:RALBP1|0:SH3D20|0:ARHGAP27			
GO:0010763	P:positive regulation of fibroblast migration; IDA:BHF-UCL		0:THBS1|0:TGFB1			
GO:0008065	P:establishment of blood-nerve barrier; TAS:ProtInc		0:GSTM3			
GO:0005938	C:cell cortex; ISS:UniProtKB		0:NEDD4|0:CTNNB1|0:CYTIP|0:CLASP2|0:CNKSR1|0:MYO9B|0:SNCA|0:NCL|0:FGFR2|0:SPINK5|0:ARF6|0:RYR1|0:TSC1|0:GRM7|0:PAFAH1B1|0:ARFIP2|0:GIPC1|0:MYH10|0:TRAF6|0:FBLIM1|0:GLRX3|0:POTEF|0:AKAP12|0:FERMT2|0:NEDD9|0:PARD3|0:FNBP1L|0:RAI14|0:PDZD4|0:CABP1|0:SPRR4|0:RIC8B|0:FNBP1|0:GPSM2|0:CLIC5|0:TRIP10|0:GRK4|0:NRBP1|0:ARHGAP32|0:FLNB|0:FLNA|0:DBNL|0:SCIN|0:CTTN|0:MYO6			
GO:0030877	C:beta-catenin destruction complex; NAS:BHF-UCL		0:CACYBP|0:SIAH1|0:GSK3B|0:AXIN1|0:APC|0:GSK3A			
GO:0016628	F:oxidoreductase activity, acting on the CH-C...; ISS:UniProtKB		0:SRD5A3|0:BDH2			
GO:0008344	P:adult locomotory behavior; TAS:BHF-UCL		0:PAFAH1B1|0:DRD4|0:NTF4|0:APP|0:GDNF			
GO:0045807	P:positive regulation of endocytosis; NAS:UniProtKB		0:SNCA|0:CALY|0:CBLL1|0:NEDD4L			
GO:0030669	C:clathrin-coated endocytic vesicle membrane; EXP:Reactome		0:LDLR|0:APOB			
GO:0004964	F:luteinizing hormone receptor activity; IEA:InterPro		0:LHCGR			
GO:0000104	F:succinate dehydrogenase activity; IEA:InterPro		0:SDHD|0:SDHC			
GO:0016602	C:CCAAT-binding factor complex; IDA:UniProtKB		0:ING2|0:NFYC|0:NFYA|0:NFYB			
GO:0046209	P:nitric oxide metabolic process; IMP:BHF-UCL		0:CPS1			
GO:0051539	F:4 iron, 4 sulfur cluster binding; ISS:UniProtKB		0:NUBPL|0:ACO1|0:MOCS1|0:NFU1|0:ETFDH|0:NUBP1|0:CDKAL1|0:NARFL|0:TYW1|0:NUBP2|0:IREB2|0:PPAT|0:RSAD1|0:NTHL1|0:ACO2|0:NDUFS2|0:NDUFS1|0:PRIM2|0:LIAS|0:NDUFV1|0:NDUFS8|0:CDK5RAP1|0:DPYD|0:MUTYH|0:TYW1B|0:NDUFS7|0:SDHB			
GO:0016579	P:protein deubiquitination; TAS:UniProtKB		0:USP15|0:USP7|0:USP4|0:USP46|0:USP6|0:USP17L2|0:USP11|0:WDR48|0:USP28|0:UCHL5|0:USP44|0:USP12|0:USP9X|0:USP2|0:USP10|0:UCHL1|0:USP26|0:USP9Y|0:USP32			
GO:0045766	P:positive regulation of angiogenesis; TAS:UniProtKB		0:HIF1A|0:F3|0:VASH2|0:ECM1|0:ANXA3|0:ANGPT4|0:ANGPTL3|0:SPHK1|0:AGGF1|0:CCR3|0:THBS1|0:SERPINE1|0:BTG1|0:AQP1|0:VEGFA|0:CHRNA7|0:WNT5A|0:NOS3|0:GATA4|0:IL1A|0:SFRP2|0:IL1B|0:RUNX1|0:RHOB|0:ANGPTL4|0:TNFSF12			
GO:0040015	P:negative regulation of multicellular organi...; ISS:UniProtKB		0:BBS2|0:PTCH1			
GO:0007599	P:hemostasis; TAS:UniProtKB		0:NFE2|0:GPI|0:AVPR2|0:FLI1|0:HPS4			
GO:0004869	F:cysteine-type endopeptidase inhibitor activity; TAS:ProtInc		0:CST3|0:CSTA|0:CSTB|0:CST5|0:FETUB|0:HRG|0:AHSG|0:BIRC6|0:BIRC5|0:CARD16|0:CST4|0:CST9L|0:KNG1|0:CST9|0:CST11|0:CARD18|0:CSTL1|0:CARD17|0:PTTG1|0:CST7|0:LCN1|0:CST8|0:CST1|0:CST6|0:CST2			
GO:0005955	C:calcineurin complex; NAS:UniProtKB		0:PPP3R1|0:PPP3CA			
GO:0071602	P:phytosphingosine biosynthetic process; IDA:UniProtKB		0:ACER3			
GO:0070097	F:delta-catenin binding; IPI:UniProtKB		0:PLEKHA7|0:PTPRT|0:CDH24			
GO:0070267	P:oncosis; IDA:UniProtKB		0:TMEM123			
GO:0050881	P:musculoskeletal movement; IMP:BHF-UCL		0:CHRND			
GO:0015248	F:sterol transporter activity; TAS:ProtInc		0:NPC1|0:HSD17B4			
GO:0010172	P:embryonic body morphogenesis; ISS:UniProtKB		0:IFT122			
GO:0060265	P:positive regulation of respiratory burst in...; ISS:BHF-UCL		0:LBP			
GO:0008053	P:mitochondrial fusion; TAS:UniProtKB		0:BAX|0:MFN2|0:OPA1			
GO:0007281	P:germ cell development; TAS:ProtInc		0:HILS1|0:MOV10L1|0:TDRD1|0:CELF4|0:DZIP1|0:OSGIN2|0:CELF1|0:DEAF1|0:DAZL			
GO:0031069	P:hair follicle morphogenesis; TAS:UniProtKB		0:WNT10A|0:FOXE1|0:TGFB2|0:ATP7A|0:TGM3			
GO:0015382	F:sodium:sulfate symporter activity; TAS:ProtInc		0:SLC13A1|0:SLC13A4			
GO:0050708	P:regulation of protein secretion; IDA:UniProtKB		0:ARFIP1|0:DNAJC1			
GO:0030233	F:deoxynucleotide transmembrane transporter a...; TAS:UniProtKB		0:SLC25A19			
GO:0004663	F:Rab geranylgeranyltransferase activity; TAS:ProtInc		0:RABGGTB|0:CHML|0:CHM|0:RABGGTA			
GO:0045932	P:negative regulation of muscle contraction; IDA:UniProtKB		0:TNNT1			
GO:0070507	P:regulation of microtubule cytoskeleton orga...; IMP:UniProtKB		0:KIAA1543|0:CYLD			
GO:0071156	P:regulation of cell cycle arrest; IMP:BHF-UCL		0:FOXM1			
GO:0044429	C:mitochondrial part; IDA:UniProtKB		0:SYNE2			
GO:0005550	F:pheromone binding; IEA:InterPro		0:LCN9			
GO:0004833	F:tryptophan 2,3-dioxygenase activity; EXP:Reactome		0:IDO1|0:TDO2			
GO:0004930	F:G-protein coupled receptor activity; TAS:UniProtKB		0:GPR65|0:RXFP1|0:GPR26|0:MRGPRX2|0:GPR35|0:GPR78|0:GPR20|0:GPR157|0:GPR84|0:GPR150|0:MRGPRX1|0:GPR179|0:FZD6|0:TAS2R20|0:GPR153|0:MRGPRD|0:PTGIR|0:TAS2R42|0:GPRC5D|0:MRGPRE|0:GABBR2|0:GPR101|0:GPR146|0:GPR61|0:GPR158|0:GPR160|0:GPR81|0:GPR97|0:FZD5|0:FZD3|0:GPR149|0:OPN1LW|0:TAS2R38|0:SMO|0:FZD9|0:MRGPRF|0:GABBR1|0:OPN1MW|0:FZD10|0:GPBAR1|0:MCHR2|0:GPR120|0:TAS2R50|0:GPR148|0:GPR88|0:MRGPRX3|0:CXCR7|0:GPR135|0:GPR161|0:GPR63|0:FZD4|0:FZD2|0:TAS2R45|0:TAS2R30|0:TAS2R39|0:GPR132|0:FZD8|0:MRGPRX4|0:GPR151|0:GPR45|0:MRGPRG|0:TAS2R40|0:FZD1|0:GPR62|0:FZD7|0:GPRC6A|0:OPN1SW|0:OPN5|0:OPN1MW2|0:GPR142|0:GPR156|0:GPR37L1|0:TAS2R12|0:TAS2R31|0:GPR162|0:TAS2R41|0:TAS2R46|0:TAS2R19|0:GPR82|0:GPR152|0:GPR98|0:GPR123|0:OXER1|0:TAS2R60|0:GPR141|0:NPVF|0:MAS1L|0:CELSR2|0:LPHN3|0:CELSR1|0:CELSR3|0:GPR124|0:LPHN1|0:GPR111|0:GPR133|0:GPR115|0:EMR2|0:GPR112|0:GPR128|0:ELTD1|0:GPR116|0:EMR3|0:TAAR1|0:TAAR8|0:GPR126|0:GPR144|0:TAAR5|0:TAAR2|0:GPR113|0:LPHN2|0:EMR4P|0:TAAR9|0:GPR110|0:TAAR6|0:GPR56|0:GPR125|0:GPR114|0:EMR1|0:CASR|0:GPR75|0:GPR22|0:FFAR1|0:GPR19|0:GPR1|0:RRH|0:GPR37|0:LANCL1|0:GPR64|0:GPER|0:FFAR2|0:GPR68|0:GPR173|0:GPR27|0:FFAR3|0:RHO|0:GLP2R|0:TPRA1|0:GPR31|0:GPR4|0:NPY|0:GPR21|0:GPR176|0:GPRC5A|0:CD97|0:XPR1|0:GPR42|0:GPR143|0:GPRC5C|0:TAAR3|0:GPR25|0:GPR52|0:APLNR|0:RGR|0:GPR39|0:GRM6|0:GRM1|0:GRM4|0:GPR85|0:GRM5			
GO:0031401	P:positive regulation of protein modification...; ISS:UniProtKB		0:ATG7|0:ATG10			
GO:0006807	P:nitrogen compound metabolic process; IEA:InterPro		0:BTD|0:NIT2|0:UPB1|0:NIT1|0:VNN1|0:VNN3|0:VNN2			
GO:0046649	P:lymphocyte activation; IEA:InterPro		0:SLAMF1			
GO:0043296	C:apical junction complex; ISS:UniProtKB		0:CDH1|0:SHROOM3			
GO:0031618	C:nuclear centromeric heterochromatin; NAS:BHF-UCL		0:CBX3|0:CBX5			
GO:0003978	F:UDP-glucose 4-epimerase activity; IDA:UniProtKB		0:GALE			
GO:0060585	P:positive regulation of prostaglandin-endope...; IMP:BHF-UCL		0:EDN2|0:EDN1			
GO:0033165	C:interphotoreceptor matrix; IEA:UniProtKB-SubCell		0:RBP3			
GO:0043306	P:positive regulation of mast cell degranulation; ISS:UniProtKB		0:GAB2			
GO:0005477	F:pyruvate secondary active transmembrane tra...; TAS:ProtInc		0:SLC16A7			
GO:0070409	P:carbamoyl phosphate biosynthetic process; IMP:UniProtKB		0:CPS1			
GO:0006968	P:cellular defense response; TAS:ProtInc		0:CXCR2|0:LBP|0:SH2D1A|0:TRAC|0:RELA|0:CD160|0:NCR2|0:KLRG1|0:KLRC4|0:GNLY|0:CLEC5A|0:KIR3DL2|0:TRAT1|0:PAGE1|0:CCR6|0:ADORA2A|0:TCIRG1|0:C5AR1|0:CCR3|0:ITK|0:CD5L|0:KLRC3|0:HLA-G|0:DCDC2|0:NCR1|0:CXCL9|0:NCF1|0:ADORA2B|0:GAGE8|0:LY96|0:CD300C|0:KLRC2|0:FAIM3|0:PRF1|0:CCL5|0:KIR2DS3|0:MNDA|0:TYROBP|0:CD19|0:CCR5|0:GAGE1|0:CX3CR1|0:CCR9|0:NCF2|0:LGALS3BP|0:LSP1|0:FOSL1|0:LILRB2|0:SPN|0:KIR2DL4|0:IL1RL2|0:IL4|0:UMOD|0:ZNF148|0:CCR2|0:VEZF1|0:BECN1			
GO:0042473	P:outer ear morphogenesis; IMP:UniProtKB		0:SALL1			
GO:0034259	P:negative regulation of Rho GTPase activity; TAS:UniProtKB		0:GMIP|0:FZD10|0:FICD			
GO:0032025	P:response to cobalt ion; ISS:HGNC		0:D2HGDH			
GO:0008191	F:metalloendopeptidase inhibitor activity; TAS:ProtInc		0:TIMP1|0:WFIKKN1|0:WFIKKN2|0:LXN|0:SPOCK3|0:TIMP4|0:COL4A3|0:TIMP3|0:TIMP2|0:RECK			
GO:0005794	C:Golgi apparatus; TAS:ProtInc		0:SLC30A7|0:SLC30A5|0:CTLA4|0:ACHE|0:DSE|0:MED15|0:NAB1|0:ZNF532|0:RRAGB|0:ATP6V1B2|0:TOX4|0:TRIP11|0:NBN|0:AGFG1|0:GOLM1|0:LCK|0:STK33|0:CCAR1|0:NUCB1|0:PASK|0:NUFIP2|0:DIAPH2|0:CD36|0:PRRG4|0:STX7|0:MYO18A|0:BST2|0:EAPP|0:FLOT1|0:PAK1|0:SIK2|0:GNG2|0:MCCC1|0:ACACB|0:FASN|0:PTGS1|0:PTPRR|0:PRDM2|0:SETDB1|0:KDM6A|0:RDX|0:GRHL1|0:CSDC2|0:CBX4|0:MBNL3|0:ATP2B3|0:C1QA|0:YIPF3|0:SND1|0:RRAGA|0:NMT2|0:H1F0|0:PSAP|0:RAB7A|0:G2E3|0:SH3D19|0:ZFPL1|0:CNKSR2|0:ZNF90|0:MYEF2|0:SDC4|0:ARPC2|0:GLUL|0:ZNF75D|0:LSR|0:DHRS1|0:KCNS3|0:IER3IP1|0:DYNC1H1|0:CDC42EP1|0:TAF7|0:ZNF148|0:MTHFS|0:RAB1B|0:NDRG2|0:CXCL14|0:OPALIN|0:TMEM22|0:TMEM43|0:ITM2C|0:SACM1L|0:ACO1|0:RABGAP1L|0:HIP1|0:IMPAD1|0:PARK2|0:ENPP7|0:ATP2C1|0:SILV|0:PPT1|0:CCDC88A|0:FKRP|0:ATP1A3|0:TSC2|0:SNX17|0:LAPTM4A|0:RNF144A|0:CERKL|0:HTT|0:CEP57|0:TMEM115|0:LITAF|0:SCYL3|0:CLASP1|0:SYNE1|0:LYN|0:AKAP9|0:KCNA5|0:CLN5|0:BACE2|0:WWOX|0:VAPB|0:USP32|0:NMNAT2|0:KCNJ6|0:STRN3|0:CLIC5|0:MYO6|0:DYNC2H1|0:GPR143|0:ABCB6|0:CLDN17|0:CLASP2|0:RAB39B|0:CLINT1|0:NAPA|0:NAPB|0:NAPG|0:STK25|0:GRB2|0:TRAPPC9|0:CALCOCO2|0:BET3L|0:ARF5|0:PTGFRN|0:JAKMIP3|0:VAMP7|0:HLA-DRB3|0:KCNIP3|0:MTUS1|0:SCYL2|0:VPS52|0:PITPNB|0:TRAPPC6B|0:FIBIN|0:PI4KB|0:HLA-DRA|0:LRBA|0:CCDC91|0:CALN1|0:WHAMM|0:LEPREL1|0:GIMAP8|0:AIMP1|0:RSAD2|0:NEDD9|0:ARL17A|0:HLA-DRB4|0:TXNDC8|0:ARFRP1|0:RAB20|0:TMEM90A|0:CUL3|0:TRAPPC6A|0:SCOC|0:JAKMIP2|0:AKR7A2|0:PPAP2B|0:FTCD|0:ARF6|0:CLCC1|0:PICALM|0:VPS53|0:SAR1A|0:ERGIC3|0:CAPN8|0:TMED3|0:HLA-DPB1|0:ARHGEF2|0:DUSP26|0:TRAPPC2L|0:GABARAPL1|0:UBXN2B|0:PRRC1|0:STX12|0:AP4S1|0:CABP2|0:RHOBTB3|0:GORASP1|0:GORAB|0:BICD1|0:MAP6|0:CABP7|0:ARL17B|0:WDR44|0:PSKH1|0:SH3RF1|0:SYN1|0:PDE9A|0:TRAPPC10|0:AP3M1|0:MSLN|0:HLA-DRB1|0:SNX1|0:DAOA|0:TRAPPC2P1|0:RSC1A1|0:HLA-DRB5|0:CABP1|0:GANAB|0:TRAPPC2|0:MCFD2|0:AP1B1|0:CD74|0:HLA-DQA2|0:FZD8|0:RAB1A|0:ERGIC2|0:DYM|0:SGSM1|0:AP1M1|0:STX11|0:C11orf2|0:AP3M2|0:TJAP1|0:RABAC1|0:TRIP10|0:SPATA16|0:HLA-DQA1|0:PDE4DIP|0:BICD2|0:GAK|0:RNF122|0:ARF4|0:PIK3C2A|0:COL4A3BP|0:GGNBP1|0:IFT20|0:TICAM2|0:GAS8|0:RAB34|0:GNPTG|0:AP1AR|0:DYNLT1|0:HLA-DQB1|0:HLA-DPA1|0:AP3S1|0:AP1M2|0:C6orf25|0:ARF3|0:HLA-DQB2|0:MARCH1|0:GLA|0:CREB3|0:PDE3B|0:FGD3|0:PICK1|0:PRNP|0:PTGDS|0:FGD6|0:APP|0:FGD2|0:FGD5|0:FGD1|0:NCSTN|0:FGD4|0:RPGR|0:GKAP1|0:PKDCC|0:SEC14L1|0:UNC13B|0:PKN3|0:KIF20A|0:F2RL1|0:PAK4|0:HERC1|0:F2R|0:IL15|0:KIF1C|0:SECTM1|0:KDELR2|0:AP3S2|0:PLIN3|0:AVPR2|0:CALU|0:OPRM1|0:NTSR1|0:SI|0:AP3B1|0:STIP1|0:STS|0:RGS19			
GO:0005608	C:laminin-3 complex; IPI:UniProtKB		0:LAMA1|0:LAMB2			
GO:0045625	P:regulation of T-helper 1 cell differentiation; IDA:UniProtKB		0:IL27			
GO:0004001	F:adenosine kinase activity; TAS:ProtInc		0:ADK			
GO:0008967	F:phosphoglycolate phosphatase activity; IEA:InterPro		0:APTX|0:PGP|0:NANP|0:ENOPH1|0:HDHD3			
GO:0009593	P:detection of chemical stimulus; TAS:ProtInc		0:UGT2A2|0:UGT2A1			
GO:0009897	C:external side of plasma membrane; NAS:UniProtKB		0:BCAM|0:CD34|0:LDLR|0:FGA|0:TGFBR2|0:SELP|0:THBS1|0:FGB|0:ACE|0:TNFRSF11A|0:TLR4|0:ECE1|0:FGG|0:ABCG1|0:TGFBR3|0:ENG|0:CTLA4|0:VCAM1|0:TAS2R16|0:ATP6AP2|0:CD28|0:SLC2A4|0:AMOT|0:GPC4|0:CCR5|0:CD3E|0:SCUBE1|0:ENOX2|0:TMEM123|0:B4GALT1|0:AQP4|0:ADA|0:SLC22A11|0:TNF|0:CLPTM1|0:IL2RG|0:CD79A|0:STAB2|0:KCNMA1|0:CHRNB2|0:CHRNA4|0:IL2RB|0:CD276|0:NRCAM			
GO:0004077	F:biotin-[acetyl-CoA-carboxylase] ligase acti...; IEA:EC		0:HLCS			
GO:0005007	F:fibroblast growth factor receptor activity; TAS:UniProtKB		0:FGFRL1|0:FGFR4|0:FGFR2|0:FGFR3|0:FGFR1			
GO:0043353	P:enucleate erythrocyte differentiation; ISS:UniProtKB		0:CEBPG			
GO:0006421	P:asparaginyl-tRNA aminoacylation; ISS:UniProtKB		0:NARS|0:NARS2			
GO:0070251	F:pristanate-CoA ligase activity; EXP:Reactome		0:SLC27A2			
GO:0001950	C:plasma membrane enriched fraction; ISS:BHF-UCL		0:ITPR2|0:STX3|0:SNAP23|0:STX4|0:RYR2			
GO:0044237	P:cellular metabolic process; ISS:UniProtKB		0:POR|0:TDH|0:TGDS|0:UXS1|0:WNT7B			
GO:0005769	C:early endosome; TAS:ProtInc		0:CD4|0:CD8B|0:LDLR|0:NOX1|0:SORT1|0:ECE1|0:HSPD1|0:NF2|0:ANKRD27|0:RABGAP1L|0:TF|0:KIAA0368|0:STX6|0:VIPAR|0:TOM1|0:WDFY1|0:PARM1|0:STEAP2|0:SNX3|0:HFE|0:DNER|0:CLN3|0:SNX17|0:VPS16|0:RPS6KC1|0:TRAK1|0:VPS4B|0:RAB22A|0:CHMP1A|0:PRDX3|0:UVRAG|0:TSG101|0:VPS33A|0:LDLRAP1|0:SLC11A2|0:USP8|0:USP10|0:ALS2|0:KIAA0226|0:MGRN1|0:PTP4A2|0:RIN3|0:RABEP2|0:NISCH|0:SGK3|0:TRAK2|0:DIAPH2|0:NIPA1|0:GRIPAP1|0:TRIM3|0:PTP4A3|0:NIPA2|0:STAMBP|0:KIFC1|0:SNX27|0:RABGEF1|0:FKBP15|0:CD1E|0:PTP4A1|0:CYTIP|0:AP1AR|0:RAB14|0:FAM21D|0:RABEP1|0:VAMP8			
GO:0030332	F:cyclin binding; IPI:UniProtKB		0:CDK6|0:CDK14|0:USP2|0:FBXO31|0:MDFIC			
GO:0001558	P:regulation of cell growth; TAS:UniProtKB		0:FAM107A|0:CYR61|0:NOV|0:IGFBP6|0:WISP3|0:IGFBP2|0:ESM1|0:CTGF|0:HTRA1|0:WISP1|0:IGFBP3|0:IGFBP7|0:HTRA4|0:KAZALD1|0:IGFBP4|0:IGFBPL1|0:IGFBP5|0:CRIM1|0:HTRA3|0:CDK11A|0:CDK11B|0:BAP1|0:AGTR1|0:ITCH|0:IL17RB|0:CHAD|0:TMEM97|0:EGLN2|0:CAMK2D|0:ABTB2|0:NET1|0:MORF4L2|0:MUC12|0:OGFR|0:NRG3|0:BLZF1|0:CHPT1|0:ARHGEF11|0:PRKCQ|0:RASGRP2|0:PAPPA2|0:EBAG9|0:CISH|0:TAOK2|0:SOCS2|0:CD320|0:FGFRL1|0:LTBP4|0:PLCE1|0:BCAR1|0:FOXM1			
GO:0005010	F:insulin-like growth factor receptor activity; TAS:ProtInc		0:IGF1R|0:IGF2R|0:CRIM1			
GO:0009263	P:deoxyribonucleotide biosynthetic process; ISS:UniProtKB		0:RRM2|0:RRM1			
GO:0031406	F:carboxylic acid binding; IDA:BHF-UCL		0:PCK1			
GO:0070369	C:beta-catenin-TCF7L2 complex; IDA:BHF-UCL		0:TCF7L2|0:CTNNB1			
GO:0002053	P:positive regulation of mesenchymal cell pro...; ISS:BHF-UCL		0:TGFBR2			
GO:0007286	P:spermatid development; TAS:ProtInc		0:BBS4|0:PVRL2|0:MKKS|0:CEP57|0:NME5|0:PIWIL1|0:DDX25|0:EDDM3B|0:SPANXB2|0:SPANXF1|0:SPANXB1|0:HSPA2|0:SPAG6			
GO:0032542	F:sulfiredoxin activity; IEA:EC		0:SRXN1			
GO:0003986	F:acetyl-CoA hydrolase activity; ISS:HGNC		0:ACOT9|0:ACOT12			
GO:0008360	P:regulation of cell shape; NAS:UniProtKB		0:KDR|0:ALDOA|0:VEGFA|0:ARHGEF18|0:ARHGAP15|0:CDC42EP2|0:CDC42EP4|0:TAOK2|0:CDC42EP5|0:CDC42EP1|0:PALMD|0:PALM2|0:FBLIM1|0:SHROOM3|0:CDC42SE2|0:PALM|0:SPTA1|0:ITGA7|0:FERMT2|0:SLC26A5|0:CDC42EP3|0:CDC42SE1|0:EZR|0:EPB42|0:GAS2|0:PDPN|0:MYH14|0:FN1|0:LST1|0:CYFIP1|0:RHOJ|0:MYH10|0:BAMBI|0:ARAP1|0:DLC1|0:MYH9|0:BVES|0:FGD3|0:FGD6|0:FGD2|0:FGD5|0:ARAP3|0:FGD1|0:FGD4|0:ITGB2|0:RASA1|0:ATP10A			
GO:0004003	F:ATP-dependent DNA helicase activity; TAS:UniProtKB		0:TRANK1|0:DNA2|0:FBXO18|0:DDX11|0:DDX12|0:ERCC2|0:RTEL1|0:BRIP1|0:CHD1|0:RUVBL2|0:G3BP1|0:CHD2|0:XRCC6|0:CHD3|0:XRCC5|0:DHX9|0:CHD4|0:CHD1L			
GO:0030101	P:natural killer cell activation; TAS:UniProtKB		0:IL21R|0:ULBP1|0:SLAMF7|0:ULBP2|0:NCR1|0:CD2|0:IFNB1|0:KIR3DS1|0:ULBP3|0:IFNK|0:KLRK1|0:IL2			
GO:0007096	P:regulation of exit from mitosis; TAS:ProtInc		0:ZW10|0:MAD2L1BP|0:NPM2|0:KNTC1|0:SIRT2|0:PPP1R9B|0:CDC23|0:ANLN			
GO:0090292	P:nuclear matrix anchoring at nuclear membrane; IDA:UniProtKB		0:SUN2|0:SUN1|0:SYNE1			
GO:0048598	P:embryonic morphogenesis; ISS:UniProtKB		0:HTR2B			
GO:0046718	P:entry of virus into host cell; TAS:UniProtKB		0:PVRL1|0:ITCH|0:WWP1|0:WWP2			
GO:0005989	P:lactose biosynthetic process; TAS:ProtInc		0:LALBA			
GO:0010920	P:negative regulation of inositol phosphate b...; IDA:BHF-UCL		0:PLEK			
GO:0015143	F:urate transmembrane transporter activity; IDA:UniProtKB		0:SLC22A12			
GO:0016709	F:oxidoreductase activity, acting on paired d...; TAS:UniProtKB		0:CYP24A1|0:COQ6|0:CYP2E1			
GO:0005663	C:DNA replication factor C complex; TAS:UniProtKB		0:RFC4|0:RFC3|0:RFC2|0:RFC5|0:RFC1|0:PCNA			
GO:0060482	P:lobar bronchus development; ISS:UniProtKB		0:WNT7B			
GO:0047638	F:albendazole monooxygenase activity; IEA:EC		0:CYP3A4			
GO:0035354	C:Toll-like receptor 1-Toll-like receptor 2 p...; IDA:MGI		0:TLR1|0:TLR2			
GO:0000115	P:regulation of transcription involved in S p...; TAS:ProtInc		0:ABL1			
GO:0005606	C:laminin-1 complex; NAS:UniProtKB		0:LAMA1|0:LAMB1|0:LAMA4|0:LAMA3|0:LAMA2|0:LAMA5|0:LAMC1			
GO:0010759	P:positive regulation of macrophage chemotaxis; ISS:BHF-UCL		0:THBS1			
GO:0045737	P:positive regulation of cyclin-dependent pro...; IDA:UniProtKB		0:PROX1|0:CCND2|0:CCND1|0:CCND3|0:CCNY|0:PSMD10			
GO:0003725	F:double-stranded RNA binding; TAS:UniProtKB		0:ADARB1|0:TLR8|0:TLR3|0:MBNL1|0:ILF2|0:ZNF346|0:DGCR8|0:DICER1|0:APTX|0:TLR7|0:ILF3|0:ADAR|0:NKRF|0:SLC4A1AP|0:CDKN2AIP|0:RNASEN|0:ADAD1|0:DUS2L|0:TARBP2|0:PRKRA|0:ADAD2|0:SON|0:MRPL44|0:DHX9|0:EIF2AK2|0:ADARB2|0:LRRFIP1|0:STAU1|0:STAU2|0:OASL			
GO:0070684	P:seminal clot liquefaction; IDA:UniProtKB		0:KLK14			
GO:0045204	P:MAPK export from nucleus; TAS:UniProtKB		0:DUSP16			
GO:0045176	P:apical protein localization; TAS:UniProtKB		0:SHROOM3|0:SHROOM2|0:VANGL2|0:GOPC|0:MAL			
GO:0060828	P:regulation of canonical Wnt receptor signal...; IMP:BHF-UCL		0:CCNY|0:SOX7|0:CDK14|0:EMD|0:LRP5			
GO:0016705	F:oxidoreductase activity, acting on paired d...; IEA:InterPro		0:C17orf101|0:P4HTM|0:OGFOD2|0:DEGS1|0:EGLN3			
GO:0071044	P:histone mRNA catabolic process; IMP:UniProtKB		0:ATM|0:PAPD5|0:LSM1|0:UPF1|0:XRN1|0:EXOSC10|0:DCP2|0:PAPD4|0:EXOSC4|0:MTPAP			
GO:0060816	P:random inactivation of X chromosome; IDA:UniProtKB		0:RLIM			
GO:0046010	P:positive regulation of circadian sleep/wake...; IDA:BHF-UCL		0:GHRL			
GO:0007072	P:positive regulation of transcription on exi...; IMP:UniProtKB		0:SIRT7			
GO:0033209	P:tumor necrosis factor-mediated signaling pa...; TAS:BHF-UCL		0:RIPK1|0:PYCARD|0:PYDC1|0:COMMD7|0:TRAF2|0:C16orf5|0:TNF|0:TXNDC17|0:TNFSF11|0:TRADD			
GO:0010040	P:response to iron(II) ion; IDA:UniProtKB		0:SNCA|0:ACO1			
GO:0000120	C:RNA polymerase I transcription factor complex; TAS:ProtInc		0:TAF1A|0:CD3EAP			
GO:0001656	P:metanephros development; TAS:BHF-UCL		0:FGF10|0:BMP7|0:FGF8|0:NF1|0:ROBO2|0:SHH|0:NIPBL|0:CITED1			
GO:0030072	P:peptide hormone secretion; ISS:UniProtKB		0:EDN3|0:EDN1|0:EXOC3L			
GO:0006990	P:positive regulation of gene-specific transc...; TAS:ProtInc		0:ATF6			
GO:0031047	P:gene silencing by RNA; ISS:UniProtKB		0:TDRD9|0:ADAR|0:NCBP2|0:RNASEN|0:NCBP1|0:XPO5|0:ASZ1|0:TNRC6C|0:TNRC6B|0:PIWIL3|0:ERI1|0:PIWIL4|0:TDRD1|0:PIWIL1|0:MAEL|0:PIWIL2			
GO:0003680	F:AT DNA binding; TAS:UniProtKB		0:MLL|0:HMGA2|0:HMGA1			
GO:0003702	F:RNA polymerase II transcription factor acti...; TAS:UniProtKB		0:NEUROD1|0:TCF7L2|0:TBX5|0:FOXM1|0:SOX8|0:ETS1|0:NKX2-8|0:SOX18|0:TBPL2|0:GTF2E1|0:TAF6L|0:TCEA3|0:GTF2E2|0:TCEA2|0:TBPL1|0:GTF2H4|0:CDK12|0:FOXE1|0:SP1|0:TBX1|0:TBX10|0:MED21|0:IRF2|0:HOXC11|0:USF2|0:PROP1|0:IRF3|0:ASH1L|0:MEIS1|0:DBP|0:ATF2|0:HTATSF1|0:VPS72|0:KLF13|0:ILF2|0:SOX21|0:PRDM4|0:SOX12|0:BATF|0:TEF|0:CBFB|0:MLLT1|0:ELL2|0:ISL1|0:TIAL1|0:CIITA|0:HOXC10|0:TCERG1|0:KLF5|0:TCF12|0:SMARCA5|0:SUPT3H|0:SF1|0:TMF1|0:MNX1|0:HMGN1|0:UTF1|0:CSDA|0:SP2|0:RAX|0:SNF8|0:SPIB|0:MLL|0:TEAD3|0:LITAF|0:CREG1|0:JUNB|0:BTF3|0:NFYC|0:JUND|0:NFAT5|0:SOX15|0:HCFC2|0:RUNX2|0:E2F2|0:MAF|0:MEF2C|0:HOXC13|0:GABPA|0:IRF4|0:GTF2A1L|0:HTATIP2|0:HOXA1|0:TCF15|0:TEAD4|0:HOXD10|0:SREBF1|0:ATF5|0:LHX1|0:FOXK2|0:SP4|0:LHX3|0:TBX19|0:TCF7|0:UHRF1|0:NKX3-2|0:TCEAL1|0:ZFPM2|0:ZNF354A|0:GMEB2|0:ATF6|0:HOXD9|0:ONECUT2|0:TBX3|0:SOX30			
GO:0042921	P:glucocorticoid receptor signaling pathway; TAS:BHF-UCL		0:NEDD4|0:ARID1A|0:YWHAH|0:NCOA6|0:RBM14|0:CALR			
GO:0004631	F:phosphomevalonate kinase activity; IDA:UniProtKB		0:PMVK			
GO:0043204	C:perikaryon; ISS:UniProtKB		0:KLHL24|0:DDN|0:CNR2|0:NDN|0:TTLL7|0:SYNPO|0:TH|0:GRIK3			
GO:0006608	P:snRNP protein import into nucleus; ISS:UniProtKB		0:NOP58			
GO:0016601	P:Rac protein signal transduction; NAS:UniProtKB		0:FARP2|0:RHOG|0:ELMO1|0:CDH13|0:DBNL|0:PTPLAD1			
GO:0032781	P:positive regulation of ATPase activity; ISS:UniProtKB		0:FGF10|0:TNNT2|0:ALDOB|0:MYL4|0:MYBPC3|0:MYL3|0:TPM1|0:GABARAPL2|0:RGN			
GO:0032568	P:general transcription from RNA polymerase I...; IDA:BHF-UCL		0:GTF2A1|0:TBP|0:GTF2A2			
GO:0032275	P:luteinizing hormone secretion; IMP:UniProtKB		0:TBX3			
GO:0060325	P:face morphogenesis; IMP:BHF-UCL		0:NIPBL			
GO:0042375	P:quinone cofactor metabolic process; NAS:UniProtKB		0:ADH4|0:CRYZL1			
GO:0070100	P:negative regulation of chemokine-mediated s...; IMP:BHF-UCL		0:SLIT2|0:SLIT3|0:ROBO1			
GO:0006885	P:regulation of pH; TAS:UniProtKB		0:SLC9A7|0:SLC9A5|0:SLC9A4|0:SLC9A8|0:SLC9A9|0:SLC9A6|0:ATP6V0A4|0:ATP6V1B1|0:SLC26A4|0:SLC9A1			
GO:0004492	F:methylmalonyl-CoA decarboxylase activity; TAS:ProtInc		0:MLYCD			
GO:0004949	F:cannabinoid receptor activity; TAS:ProtInc		0:GPR55|0:CNR1|0:CNR2			
GO:0006741	P:NADP biosynthetic process; TAS:UniProtKB		0:ME1			
GO:0007442	P:hindgut morphogenesis; ISS:UniProtKB		0:GLI2			
GO:0070628	F:proteasome binding; IPI:BHF-UCL		0:DNAJB2|0:ADRM1|0:UBD|0:UCHL5|0:USP14|0:PSMD14|0:SACS			
GO:0010626	P:negative regulation of Schwann cell prolife...; ISS:UniProtKB		0:SKI|0:RNF10			
GO:0050211	F:procollagen galactosyltransferase activity; IEA:EC		0:GLT25D1|0:GLT25D2			
GO:0003281	P:ventricular septum development; ISS:UniProtKB		0:GATA4|0:TBX5|0:SALL1			
GO:0046548	P:retinal rod cell development; ISS:BHF-UCL		0:BBS4			
GO:0045892	P:negative regulation of transcription, DNA-d...; TAS:GDB		0:UBE2I|0:YWHAQ|0:SMAD4|0:MLX|0:KDM5B|0:ARID4A|0:ZBTB16|0:PA2G4|0:ZHX3|0:PHF12|0:FOXN3|0:RSF1|0:SMARCC2|0:ING4|0:LDB1|0:POU2F1|0:PRMT6|0:NDUFA13|0:HMBOX1|0:TBX3|0:DAXX|0:MECOM|0:ZHX1|0:SMARCE1|0:ZGPAT|0:FOXP3|0:RBPJ|0:FOXG1|0:PAX9|0:GATAD2A|0:CBY1|0:ZNF639|0:CIR1|0:ILF3|0:CTCF|0:KLF4|0:SMAD2|0:BAHD1|0:HMX1|0:SBNO2|0:WNT4|0:SOX18|0:TWIST2|0:SETDB2|0:RIPPLY1|0:C14orf169|0:TCF21|0:ZNF675|0:HIC2|0:ARID5A|0:ARID5B			
GO:0004689	F:phosphorylase kinase activity; TAS:ProtInc		0:PHKG1|0:PHKA2|0:PHKG2|0:PHKA1			
GO:0046058	P:cAMP metabolic process; TAS:ProtInc		0:PTH|0:PTHLH			
GO:0051139	F:metal ion:hydrogen antiporter activity; IGI:BHF-UCL		0:SLC11A1			
GO:0008017	F:microtubule binding; TAS:UniProtKB		0:FNTA|0:MAP1S|0:POLB|0:TUBGCP5|0:TERF1|0:BIRC5|0:MAPT|0:PRNP|0:MARK4|0:HOOK3|0:SBDS|0:CDK5RAP2|0:ARHGEF2|0:TUBGCP6|0:SKA1|0:SPAST|0:MTUS2|0:SKA2|0:KATNA1|0:MAPRE2|0:APC2|0:MAPRE3|0:PSRC1|0:PAFAH1B1|0:TPPP|0:KIF5B|0:DYNC1I1|0:KIF26A|0:CCDC88A|0:RAE1|0:NDE1|0:HDAC6|0:KATNB1|0:GABARAPL2|0:DNM2|0:MACF1|0:LRPPRC|0:UXT|0:CLIP1|0:HTT|0:DCX|0:SUN2			
GO:0010641	P:positive regulation of platelet-derived gro...; IDA:BHF-UCL		0:F7|0:F3			
GO:0042609	F:CD4 receptor binding; IPI:UniProtKB		0:LCK|0:SPG21			
GO:0030817	P:regulation of cAMP biosynthetic process; IDA:UniProtKB		0:OXER1			
GO:0042100	P:B cell proliferation; NAS:UniProtKB		0:HSPD1|0:BCL2|0:CD40LG|0:PTPRC|0:CD79A|0:CD40|0:IL10|0:IFNB1			
GO:0030573	P:bile acid catabolic process; IEA:UniProtKB-KW		0:CYP39A1|0:SULT2A1|0:AKR1D1			
GO:0008148	F:negative transcription elongation factor ac...; IDA:UniProtKB		0:SUPT5H|0:SUPT4H1			
GO:0051930	P:regulation of sensory perception of pain; IDA:UniProtKB		0:PROL1			
GO:0050848	P:regulation of calcium-mediated signaling; ISS:UniProtKB		0:RGN			
GO:0003359	P:noradrenergic neuron fate commitment; IMP:UniProtKB		0:ASCL1			
GO:0004470	F:malic enzyme activity; TAS:ProtInc		0:MDH1			
GO:0006726	P:eye pigment biosynthetic process; TAS:ProtInc		0:TYR|0:OCA2|0:GPR143|0:AP3D1			
GO:0004591	F:oxoglutarate dehydrogenase (succinyl-transf...; ISS:UniProtKB		0:DHTKD1|0:OGDHL|0:OGDH			
GO:0016740	F:transferase activity; IEA:UniProtKB-KW		0:OASL|0:ILF2|0:C8orf38|0:EIF2B5|0:C1orf57|0:DCTN6|0:CDK5RAP1|0:DCTN5|0:SCLY|0:OSTCL|0:FKRP|0:NT5C3L|0:PTDSS1|0:FKTN|0:ILVBL|0:SEPSECS|0:CTU1|0:PIGO|0:C7orf10			
GO:0042359	P:vitamin D metabolic process; ISS:UniProtKB		0:CYP1A1|0:CYP3A4|0:CYP11A1			
GO:0060286	P:flagellar cell motility; IMP:UniProtKB		0:C14orf104			
GO:0007617	P:mating behavior; TAS:ProtInc		0:DRD1|0:APP|0:MTNR1A			
GO:0051084	P:'de novo' posttranslational protein folding; TAS:UniProtKB		0:UGGT1			
GO:0001522	P:pseudouridine synthesis; NAS:UniProtKB		0:RPUSD2|0:PUS7|0:RPUSD1|0:RPUSD4|0:TRUB2|0:TRUB1|0:DKC1|0:RPUSD3|0:PUS7L|0:PUSL1|0:NOP10			
GO:0008309	F:double-stranded DNA specific exodeoxyribonu...; TAS:ProtInc		0:FEN1			
GO:0033276	C:transcription factor TFTC complex; IDA:UniProtKB		0:KAT2A|0:TADA3|0:TAF4|0:TAF9|0:SUPT3H|0:TAF5|0:TAF12|0:TAF9B|0:TAF5L|0:TAF6|0:TRRAP|0:TAF10|0:TAF7|0:TAF2			
GO:0006691	P:leukotriene metabolic process; TAS:ProtInc		0:PTGR1|0:CYP4F2|0:CYP4F3			
GO:0017060	F:3-galactosyl-N-acetylglucosaminide 4-alpha-...; IEA:EC		0:FUT5|0:FUT6|0:FUT3			
GO:0003097	P:renal water transport; IDA:UniProtKB		0:AQP1			
GO:0010977	P:negative regulation of neuron projection de...; ISS:UniProtKB		0:STMN2|0:ITM2C|0:FKBP4			
GO:0032922	P:circadian regulation of gene expression; ISS:UniProtKB		0:DRD3|0:DRD2|0:CARTPT|0:CSNK1D			
GO:0002548	P:monocyte chemotaxis; NAS:BHF-UCL		0:IL6R|0:IL6|0:TNFSF11|0:CCL2|0:PDGFB|0:TNFRSF11A			
GO:0005677	C:chromatin silencing complex; NAS:UniProtKB		0:BAHD1|0:SUV39H1|0:SIRT1|0:RRP8|0:BAZ2A|0:SIRT2			
GO:0031122	P:cytoplasmic microtubule organization; ISS:HGNC		0:HOOK3|0:STMN3			
GO:0008630	P:DNA damage response, signal transduction re...; TAS:ProtInc		0:SFN|0:BRCA1|0:TOPORS|0:PML|0:CHEK2|0:IKBKE|0:MSH6|0:ABL1|0:CIDEB|0:AIFM1|0:TP73|0:CIDEA			
GO:0004652	F:polynucleotide adenylyltransferase activity; IEA:EC		0:PAPD4|0:PAPOLG|0:PAPOLB|0:PAPOLA|0:MTPAP			
GO:0005070	F:SH3/SH2 adaptor activity; TAS:UniProtKB		0:SKAP1|0:LAT|0:CD28|0:SLA2|0:BLNK|0:SH2B2|0:KHDRBS1|0:FCRL2|0:PAG1|0:CLNK|0:SH2D1A|0:GRB7|0:ARHGAP4|0:CRKL|0:VAV3|0:GRAP2|0:SH2D2A|0:SH3BGR|0:LASP1|0:STAM|0:SH2D3A|0:GAB1|0:RUSC1|0:ARHGAP6|0:CNTNAP1|0:EPS8|0:CHN2|0:ARHGAP1|0:SHB|0:SRC|0:GRB14|0:SKAP2|0:SLA|0:SH3BP2|0:IRS4|0:SH3BGRL|0:GRB10|0:SOCS2|0:TOB1|0:SH2D3C|0:GRAP|0:TP53BP2|0:ITSN2|0:CHN1|0:GRB2			
GO:0046914	F:transition metal ion binding; IEA:InterPro		0:DNHD1|0:RRM2|0:RRM2B|0:COQ7|0:SETD2			
GO:0070179	P:D-serine biosynthetic process; IDA:UniProtKB		0:SRR			
GO:0005672	C:transcription factor TFIIA complex; IEA:InterPro		0:GTF2A1|0:TBP|0:GTF2A2|0:GTF2A1L			
GO:0050031	F:L-pipecolate oxidase activity; IEA:EC		0:PIPOX			
GO:0048515	P:spermatid differentiation; ISS:UniProtKB		0:MAST2|0:NPHP1			
GO:0021702	P:cerebellar Purkinje cell differentiation; ISS:UniProtKB		0:ATP7A			
GO:0033767	F:4-hydroxyacetophenone monooxygenase activity; IEA:EC		0:CYP2C19|0:CYP2C9			
GO:0008301	F:DNA bending activity; NAS:UniProtKB		0:TERF1|0:HHEX|0:HMGB2|0:FOXD1|0:FOXC1|0:HMGB1|0:LEF1|0:FOXD4|0:HMGB3|0:TRERF1|0:FOXI1|0:FOXL1			
GO:0043482	P:cellular pigment accumulation; ISS:HGNC		0:SHROOM3|0:SHROOM2			
GO:0030048	P:actin filament-based movement; TAS:UniProtKB		0:MYH10|0:ACTC1|0:MYH9|0:MYH3|0:MYO7A|0:MYO6|0:MYO5A|0:MYL7|0:MYO9B|0:MYO1E			
GO:0004924	F:oncostatin-M receptor activity; TAS:ProtInc		0:OSMR			
GO:0008160	F:protein tyrosine phosphatase activator acti...; IDA:UniProtKB		0:PPP2R4|0:IGFBP3			
GO:0015232	F:heme transporter activity; TAS:ProtInc		0:HPX|0:ABCB7			
GO:0042423	P:catecholamine biosynthetic process; NAS:BHF-UCL		0:PNMT|0:DDC|0:HDC|0:PAH			
GO:0030748	F:amine N-methyltransferase activity; IEA:EC		0:INMT			
GO:0004134	F:4-alpha-glucanotransferase activity; IEA:EC		0:AGL			
GO:0005655	C:nucleolar ribonuclease P complex; TAS:ProtInc		0:POP1|0:POP4|0:POP7|0:RPP30|0:RPP40|0:RPP38			
GO:0030857	P:negative regulation of epithelial cell diff...; ISS:UniProtKB		0:CAV1|0:OSR1			
GO:0009258	P:10-formyltetrahydrofolate catabolic process; TAS:ProtInc		0:ALDH1L2|0:ALDH1L1			
GO:0043627	P:response to estrogen stimulus; IEP:UniProtKB		0:GHRHR|0:CRIPAK|0:CAV1|0:GHRL|0:CITED1|0:BRCA1|0:ASH2L|0:MLL2|0:RBBP5|0:BRCA2|0:CYP27B1|0:GATA3|0:KRT19|0:GSTM3|0:CD24			
GO:0034134	P:toll-like receptor 2 signaling pathway; IMP:BHF-UCL		0:RIPK2|0:IRAK1			
GO:0033627	P:cell adhesion mediated by integrin; IDA:BHF-UCL		0:VTN|0:ADAM17			
GO:0004502	F:kynurenine 3-monooxygenase activity; IDA:UniProtKB		0:KMO			
GO:0003939	F:L-iditol 2-dehydrogenase activity; IDA:UniProtKB		0:SORD			
GO:0051046	P:regulation of secretion; IMP:UniProtKB		0:MYO6			
GO:0047760	F:butyrate-CoA ligase activity; IEA:EC		0:ACSM1|0:ACSM2A|0:C10orf129|0:ACSM2B|0:ACSM4|0:ACSM5|0:ACSM3			
GO:0035085	C:cilium axoneme; ISS:UniProtKB		0:RSPH4A|0:RSPH9|0:DNAH9|0:RPGRIP1L|0:INPP5E|0:LRRC50|0:DNAH1|0:LCA5|0:DNAH2|0:DNAH12|0:TTC21B|0:B9D2|0:DNAH17|0:DNAH14|0:IFT80|0:C19orf20|0:CYS1|0:DNAH7|0:DNAH10|0:DYNC2H1|0:DYNC2LI1|0:DNAH3|0:NPHP1|0:DNAI2|0:TTLL8|0:TTLL3			
GO:0006713	P:glucocorticoid catabolic process; IDA:UniProtKB		0:YWHAH			
GO:0004499	F:flavin-containing monooxygenase activity; NAS:UniProtKB		0:FMO3|0:FMO2|0:FMO1|0:FMO6P|0:FMO5|0:FMO4			
GO:0005334	F:norephinephrine:sodium symporter activity; TAS:ProtInc		0:SLC6A2			
GO:0006703	P:estrogen biosynthetic process; TAS:UniProtKB		0:HSD17B8|0:RDH8|0:HSD17B1|0:HSD3B1			
GO:0030277	P:maintenance of gastrointestinal epithelium; NAS:UniProtKB		0:RBP4|0:TLR9|0:SERPINA3|0:MUC3A|0:MUC6			
GO:0001823	P:mesonephros development; ISS:UniProtKB		0:FGF10|0:BMP7|0:BMP4|0:FGF8|0:ZBTB16			
GO:0002725	P:negative regulation of T cell cytokine prod...; IDA:UniProtKB		0:FOXP3			
GO:0055091	P:phospholipid homeostasis; IMP:BHF-UCL		0:CETP|0:ANGPTL3|0:LIPG|0:ABCG1|0:ABCA1			
GO:0004849	F:uridine kinase activity; TAS:ProtInc		0:UCKL1|0:UCK2|0:UCK1|0:CMPK1			
GO:0050955	P:thermoception; IDA:MGI		0:TRPV1			
GO:0032376	P:positive regulation of cholesterol transport; IDA:BHF-UCL		0:LIPG			
GO:0031302	C:intrinsic to endosome membrane; TAS:BHF-UCL		0:ECE1			
GO:0008481	F:sphinganine kinase activity; NAS:UniProtKB		0:SPHK1|0:SPHK2			
GO:0017112	F:Rab guanyl-nucleotide exchange factor activity; NAS:UniProtKB		0:ALS2|0:MADD|0:RIN2			
GO:0002768	P:immune response-regulating cell surface rec...; IC:UniProtKB		0:CD24			
GO:0033177	C:proton-transporting two-sector ATPase compl...; IEA:InterPro		0:TCIRG1|0:ATP6V0A2|0:ATP6V0A1|0:ATP6V0A4			
GO:0000146	F:microfilament motor activity; TAS:UniProtKB		0:MYH10|0:MYO9B|0:MYH9|0:MYH6|0:MYH3|0:MYH7|0:MYO7A|0:MYH4|0:MYO5A|0:MYL7|0:MYH13|0:MYH2|0:MYO1E			
GO:0005520	F:insulin-like growth factor binding; TAS:ProtInc		0:CYR61|0:NOV|0:WISP3|0:ESM1|0:HTRA1|0:WISP1|0:IGFBP7|0:HTRA4|0:KAZALD1|0:WISP2|0:IGFBPL1|0:CRIM1|0:HTRA3|0:IGFBP1|0:CTGF|0:IGFALS			
GO:0004087	F:carbamoyl-phosphate synthase (ammonia) acti...; IMP:BHF-UCL		0:CPS1			
GO:0004452	F:isopentenyl-diphosphate delta-isomerase act...; TAS:ProtInc		0:IDI2|0:IDI1			
GO:0000779	C:condensed chromosome, centromeric region; ISS:UniProtKB		0:CBX3			
GO:0055114	P:oxidation reduction; TAS:UniProtKB		0:CYP2C19|0:CYP2E1|0:MPO|0:CYP2B6|0:CYP4A11|0:CYP1A1|0:CYP26C1|0:CYP26B1|0:ACADM|0:PGD|0:ALDH9A1|0:PPOX|0:BLVRA|0:CYB5R2|0:NOX4|0:PXDN|0:ME3|0:CYP24A1|0:DHRS2|0:CYB5R4|0:AKR1C1|0:ADH7|0:NDOR1|0:ALDH3A1|0:AKR1D1|0:GLUD2|0:GRHPR|0:DNHD1|0:F8|0:C5orf4|0:KCNAB1|0:F5|0:MICAL3|0:TYW1|0:FTL|0:C1orf27|0:FTHL17|0:UEVLD|0:GCLM|0:AKR1B15|0:FTH1P19|0:RTN4IP1|0:MICAL1|0:CCS|0:ALDH16A1|0:KCNAB3|0:RFESD|0:SNAI3|0:UQCRFSL1|0:TMEM195|0:CMAH|0:TYW1B|0:SETD2|0:HSDL1|0:KCNAB2|0:MICAL2|0:DECR1|0:UTY|0:MAOA|0:DUS3L|0:IDO2|0:PECR|0:SQLE|0:VAT1|0:RDH11|0:DHFRP1|0:BLVRB|0:HSD17B13|0:ALDH1L1|0:ALOX12|0:AKR1E2|0:GFOD1|0:FMO6P|0:LDHAL6B|0:DUS1L|0:KDM2B|0:AOX1|0:GMPR2|0:AIFM1|0:KDM4D|0:AKR1B10|0:LEPRE1|0:DHRS7C|0:SCD5|0:DHRS13|0:CYP2A6|0:LDHA|0:RDH16|0:NSDHL|0:DHRS9|0:PRODH|0:RRM2|0:FMO5|0:NOS3|0:GPX3|0:ACOX2|0:PDHB|0:PYCRL|0:PRODH2|0:CBR1|0:CYP39A1|0:AKR1CL1|0:ALDH2|0:ADI1|0:C17orf101|0:KDM5A|0:EPX|0:MOXD2P|0:CYP7A1|0:SRD5A2|0:RDH8|0:MTHFD1|0:ALDH6A1|0:FDFT1|0:PTGS2|0:ADH1C|0:SCCPDH|0:TXNDC12|0:PLOD2|0:GCDH|0:ALOXE3|0:HSD17B3|0:CBR3|0:SRD5A1|0:PAOX|0:EGLN2|0:IDH3G|0:CAT|0:CPOX|0:IMPDH1|0:TPH2|0:LEPREL1|0:KDSR|0:HSD17B6|0:AOC2|0:TSTA3|0:ACAD8|0:CYP2U1|0:ACOX1|0:DHRSX|0:CYP7B1|0:ALDH1B1|0:ASPHD1|0:HPGD|0:ACADS|0:GLUD1|0:BDH1|0:ACADSB|0:TET2|0:CRYZ|0:CYP51A1|0:RRM1|0:FMO2|0:SDR42E2|0:CYP11A1|0:MOSC1|0:MTHFD2L|0:LDHAL6A|0:HEPHL1|0:ALDH1L2|0:CYP4A22|0:DUS4L|0:CYP19A1|0:ACADVL|0:SDR16C5|0:SUMF1|0:GPX2|0:DECR2|0:GPD1L|0:ACOX3|0:QSOX2|0:DUS2L|0:PAM|0:ADHFE1|0:MSRB2|0:D2HGDH|0:BCKDHA|0:HPDL|0:TYR|0:HAO2|0:DIO1|0:PYCR2|0:TMLHE|0:CH25H|0:CRYZL1|0:MDH1|0:FMO4|0:SOD3|0:CYP21A2|0:ALDH4A1|0:CYP11B2|0:PRDX1|0:TECR|0:AKR7A2|0:P4HTM|0:ADO|0:PLOD3|0:HSD3B7|0:DHFRL1|0:ALOX15B|0:BCMO1|0:AIFM2|0:CYP3A7|0:KDM4C|0:CYB5R1|0:CYP27A1|0:FAR1|0:ALDH1A1|0:ACAD10|0:LOXL3|0:ALOX12B|0:GPD2|0:RRM2B|0:HSD17B12|0:PYROXD2|0:ALDH3A2|0:LEPREL2|0:QDPR|0:P4HA3|0:LDHB|0:MIOX|0:AKR1C4|0:CHDH|0:MDH2|0:HMGCR|0:KDM5B|0:HMOX1|0:AASS|0:CYP27B1|0:CYP4F2|0:GLDC|0:PHF8|0:KDM1B|0:ASPHD2|0:GPX1|0:PIPOX|0:DHCR24|0:FASN|0:GPX7|0:IDH2|0:HSD17B4|0:AOC3|0:MTHFD2|0:HSD3B1|0:CTBP1|0:RSAD1|0:PRDX5|0:FMO1|0:ALKBH4|0:KDM3B|0:HPD|0:MOXD1|0:CYP4X1|0:ACAD9|0:JMJD6|0:SEPX1|0:H6PD|0:C14orf148|0:RDH12|0:TPO|0:CYP2W1|0:HIF1AN|0:ABP1|0:ADH1B|0:ADH6|0:ALKBH8|0:PTGS1|0:CP|0:PAH|0:CYP2R1|0:BBOX1|0:XDH|0:DHRS11|0:FTMT|0:OGFOD2|0:KDM6A|0:KDM4B|0:DBH|0:ACAD11|0:GSR|0:FMO3|0:DEGS1|0:ADH4|0:TET1|0:AKR7L|0:HIBADH|0:EHHADH|0:ZADH2|0:BCO2|0:NOS1|0:HSD17B11|0:CBR4|0:CYP4F3|0:ALDH1A2|0:RDH5|0:FAR2|0:TM7SF2|0:TH|0:SCD|0:TPH1|0:PYCR1|0:PRDX3|0:P4HA2|0:HGD|0:NQO1|0:HTATIP2|0:GLYR1|0:LDHC|0:ADH1A|0:CYP11B1|0:PRDX2|0:HAAO|0:EGLN3|0:TECRL|0:HSD11B1|0:ALDH3B1|0:PHYHD1|0:SUOX|0:IDH3B|0:GAPDHS|0:CYP26A1|0:HSD17B1|0:HSD17B10|0:LPO|0:HSD11B2|0:DHRS7|0:ALDH18A1|0:SC4MOL|0:DAO|0:BDH2|0:DHFR|0:IL4I1|0:DHCR7|0:PYROXD1|0:ALKBH7|0:ME2|0:HSD3B2|0:CYP3A43|0:AKR1B1|0:CYP17A1|0:GFER|0:PCYOX1L|0:LOX|0:PTGR2|0:IDH1|0:KMO|0:CYP8B1|0:HSDL2|0:AKR1A1|0:DIO3|0:RDH13|0:PRDX6|0:MTHFR|0:KDM5C|0:C14orf169|0:STEAP4|0:JHDM1D|0:TBXAS1|0:PCYOX1|0:DHRS3|0:FADS6|0:GPX6|0:UGDH|0:SRXN1|0:LOXL2|0:FOXRED2|0:CYP20A1|0:HADH|0:IFI30|0:SORD|0:PDHA2|0:CTBP2|0:SARDH|0:HSD17B8|0:SC5DL|0:KDM3A|0:OGDHL|0:BCKDHB|0:GFOD2|0:RDH10|0:NOS2|0:MSRB3|0:HEPH|0:CYP2F1|0:VKORC1|0:VAT1L|0:GMPR|0:ADH5|0:DPYD|0:DOHH|0:KDM2A|0:PRDX4|0:L2HGDH|0:NQO2|0:TYRP1|0:PHGDH|0:FOXRED1|0:KDM6B|0:CYP4F12|0:PHYH|0:TP53I3|0:KDM4A|0:IDO1|0:DHRS12|0:SOD1|0:ASPDH|0:NOX3|0:DIO2|0:OGFOD1|0:CYP27C1|0:ALKBH5|0:ACOXL|0:DCXR|0:CRYL1|0:HADHA|0:DHRS1|0:HSD17B14|0:CYP4B1|0:HMOX2|0:DEGS2|0:ALOX15|0:CYP4V2|0:ASPH|0:KDM1A|0:EGLN1|0:CYP2A13|0:ALDH7A1|0:IVD|0:KDM4DL|0:COQ6|0:MAOB|0:CYP2C18|0:MOSC2|0:MSRA|0:IYD|0:CYB5RL|0:DHDH|0:GPX5|0:TDO2|0:PNPO|0:RNLS|0:PDHA1|0:HSD17B2|0:TET3|0:IMPDH2|0:OGDH|0:GPD1|0:AKR7A3|0:FTH1|0:CYP2A7|0:HSD17B7|0:DMGDH|0:DHRS7B|0:NXN|0:CYP4F22|0:SRD5A3|0:GPX8|0:CYB5R3|0:RDH14|0:P4HA1|0:ALDH1A3|0:SDR9C7|0:LOXL4|0:ALKBH6|0:GAPDH|0:MECR|0:ME1|0:LDHD|0:SQRDL|0:ALOX5|0:STEAP3|0:HAO1|0:SDR42E1|0:CYP4F8|0:AKR1C2|0:TXNRD2|0:SMOX|0:DHTKD1|0:ALDH3B2|0:HSD11B1L|0:IDH3A|0:CYP4Z1|0:PTGR1|0:ALDH8A1|0:JMJD1C|0:OXNAD1|0:QSOX1|0:KDM5D|0:CYP46A1|0:DHODH|0:CYP2J2|0:MDH1B|0:G6PD|0:ACADL|0:RETSAT|0:PXDNL|0:COX6B1|0:CYP2S1|0:OXA1L|0:COX4I2|0:SURF1|0:HCCS|0:GPX4|0:PDIA5|0:DUOX1|0:NCF4|0:SPR|0:MTRR|0:POR|0:SCO2|0:CYP1B1|0:DDO|0:CYP4F11|0:WWOX|0:NNT|0:CDO1|0:AKR1C3|0:LOXL1|0:DHRS4L2|0:DHRS4|0:PLOD1|0:DUOX2			
GO:0045721	P:negative regulation of gluconeogenesis; NAS:BHF-UCL		0:GCK|0:ADIPOQ|0:INS			
GO:0008116	F:prostaglandin-I synthase activity; EXP:Reactome		0:PTGIS			
GO:0051963	P:regulation of synaptogenesis; ISS:UniProtKB		0:PDLIM5|0:CHRNB2			
GO:0048733	P:sebaceous gland development; IMP:BHF-UCL		0:WNT10A			
GO:0006307	P:DNA dealkylation involved in DNA repair; TAS:ProtInc		0:FTO|0:ALKBH3|0:ALKBH1|0:ALKBH2|0:MPG			
GO:0046527	F:glucosyltransferase activity; IDA:MGI		0:ALG6			
GO:0032703	P:negative regulation of interleukin-2 produc...; IDA:UniProtKB		0:HDAC7|0:KAT5|0:FOXP3			
GO:0046579	P:positive regulation of Ras protein signal t...; IMP:UniProtKB		0:IGF1|0:EPO|0:FGF10|0:NOTCH2|0:RASGRP4|0:SHOC2			
GO:0034162	P:toll-like receptor 9 signaling pathway; IMP:UniProtKB		0:UNC93B1			
GO:0034632	F:retinol transporter activity; IC:BHF-UCL		0:RBP4			
GO:0006048	P:UDP-N-acetylglucosamine biosynthetic process; TAS:ProtInc		0:UAP1			
GO:0008887	F:glycerate kinase activity; IDA:UniProtKB		0:GLYCTK			
GO:0034616	P:response to laminar fluid shear stress; IEP:BHF-UCL		0:SMAD7|0:SMAD6			
GO:0015270	F:dihydropyridine-sensitive calcium channel a...; TAS:ProtInc		0:CACNA1S|0:CACNA1F|0:CACNA1C|0:CACNA1D|0:CACNG1			
GO:0002508	P:central tolerance induction; ISS:BHF-UCL		0:FOXJ1			
GO:0070971	C:endoplasmic reticulum exit site; ISS:UniProtKB		0:MPPE1			
GO:0008034	?:lipoprotein binding; TAS:ProtInc		0:MAPT|0:TLR6|0:LRP1|0:LRPAP1			
GO:0008352	C:katanin complex; TAS:UniProtKB		0:KATNB1			
GO:0034466	C:chromaffin granule lumen; IEA:UniProtKB-SubCell		0:DBH			
GO:0032407	F:MutSalpha complex binding; IDA:MGI		0:MUTYH|0:TREX1|0:ATR			
GO:0004441	F:inositol-1,4-bisphosphate 1-phosphatase act...; TAS:ProtInc		0:INPP1			
GO:0045545	F:syndecan binding; NAS:UniProtKB		0:TNC|0:SDCBP			
GO:0045111	C:intermediate filament cytoskeleton; IDA:HPA		0:PSMD10|0:AGBL2|0:PSMB4|0:PFDN5|0:ZNF175|0:DRG1|0:SEC62|0:BAG1			
GO:0045956	P:positive regulation of calcium ion-dependen...; ISS:UniProtKB		0:SCAMP5|0:DOC2B			
GO:0032203	P:telomere formation via telomerase; IMP:UniProtKB		0:POT1|0:TERT|0:WRAP53			
GO:0032938	P:negative regulation of translation in respo...; IDA:UniProtKB		0:PML			
GO:0051895	P:negative regulation of focal adhesion assembly; TAS:BHF-UCL		0:ARHGAP6|0:ACVRL1|0:PTEN|0:THBS1			
GO:0046688	P:response to copper ion; NAS:UniProtKB		0:ATP7B|0:IL1A|0:ATP5D			
GO:0008115	F:sarcosine oxidase activity; IEA:EC		0:PIPOX			
GO:0003952	F:NAD+ synthase (glutamine-hydrolyzing) activity; EXP:Reactome		0:NADSYN1			
GO:0035035	F:histone acetyltransferase binding; ISS:UniProtKB		0:EID1|0:FOXP3|0:SIRT2|0:TRIM68|0:TP53|0:EPAS1|0:GLI3|0:HIF1A|0:TAF7|0:ZBTB7A			
GO:0030997	P:regulation of centriole-centriole cohesion; IDA:UniProtKB		0:CEP250|0:CTNNB1			
GO:0000210	F:NAD+ diphosphatase activity; IEA:EC		0:NUDT12			
GO:0070095	F:fructose-6-phosphate binding; IDA:BHF-UCL		0:PFKL			
GO:0016242	P:negative regulation of macroautophagy; ISS:UniProtKB		0:CLN3			
GO:0016553	P:base conversion or substitution editing; TAS:HGNC		0:ADARB1|0:APOBEC3F|0:ADAR|0:APOBEC3G			
GO:0001740	C:Barr body; IDA:MGI		0:H2AFY2|0:H2AFY			
GO:0005137	F:interleukin-5 receptor binding; TAS:ProtInc		0:SDCBP|0:IL5			
GO:0005847	C:mRNA cleavage and polyadenylation specifici...; IDA:UniProtKB		0:CPSF1			
GO:0051891	P:positive regulation of cardioblast differen...; ISS:BHF-UCL		0:TBX5|0:TGFB2|0:GATA4|0:NKX2-5			
GO:0033292	P:T-tubule organization; TAS:BHF-UCL		0:CAV3			
GO:0032429	P:regulation of phospholipase A2 activity; ISS:BHF-UCL		0:LRP1			
GO:0045953	P:negative regulation of natural killer cell ...; IMP:UniProtKB		0:ARRB2			
GO:0004029	F:aldehyde dehydrogenase (NAD) activity; TAS:ProtInc		0:ALDH9A1|0:ALDH3A1|0:ALDH1B1|0:ALDH3A2|0:ALDH7A1|0:ALDH2|0:ALDH4A1|0:ALDH1A1			
GO:0042136	P:neurotransmitter biosynthetic process; TAS:BHF-UCL		0:ALDH9A1|0:GAD1|0:TH|0:CHAT|0:GAD2|0:PAH|0:NOS1			
GO:0032060	P:bleb assembly; ISS:BHF-UCL		0:P2RX7			
GO:0006359	P:regulation of transcription from RNA polyme...; TAS:UniProtKB		0:POLR3F|0:ZNF143|0:ZNF76|0:POLR3C|0:POLR3G|0:ZNF345|0:BRCA1			
GO:0032497	P:detection of lipopolysaccharide; IDA:UniProtKB		0:SCARB1|0:TLR4|0:LY96			
GO:0030154	P:cell differentiation; TAS:UniProtKB		0:ACVR1C|0:EID1|0:CAND1|0:SMURF1|0:SRA1|0:PAPPA2|0:PAPPA|0:GNPTAB|0:BMP3|0:TRAPPC9|0:FHL1|0:SPATA19|0:SEBOX|0:TDRD9|0:OSTN|0:THEG|0:ABHD5|0:NTRK2|0:SH3PXD2B|0:SOHLH2|0:ZNF541|0:TAF8|0:NEUROD6|0:CCIN|0:DMRT1|0:AMBRA1|0:NFATC4|0:HUWE1|0:TSSK3|0:C10orf27|0:FXR1|0:GADD45G|0:NUS1|0:PAQR5|0:PAX8|0:BEX1|0:TSSK1B|0:HERC4|0:DAPL1|0:ARHGAP22|0:ELAVL3|0:DAZ3|0:ACSBG2|0:SUV39H2|0:SLC22A16|0:SRD5A2|0:UTP14C|0:CSRP3|0:EDAR|0:TXNDC3|0:EDA2R|0:SPATA2|0:DLL4|0:ANGPTL4|0:NGEF|0:SRD5A1|0:MARK2|0:ZNF423|0:SEMA6D|0:TWIST2|0:NME1|0:TMEM176B|0:AGFG1|0:CYLC2|0:CAMK1|0:SEMA3E|0:CLPTM1|0:CCHCR1|0:WIPF3|0:HMX2|0:MSGN1|0:SPATA6|0:PRM3|0:SEMA4B|0:PSME4|0:FOXK1|0:PIWIL4|0:AMH|0:ANPEP|0:TSSK4|0:KRTDAP|0:DMRTC2|0:UNC45A|0:NLRP14|0:TUBD1|0:SRPK1|0:UNC45B|0:RFX3|0:GLIS2|0:NANOS3|0:SH2D2A|0:CATSPER1|0:NDRG2|0:MYCBPAP|0:RFNG|0:MGP|0:MAPK7|0:MORC1|0:CHRDL2|0:ROBO4|0:SPATA18|0:MECOM|0:SOHLH1|0:TCF23|0:ODF4|0:KIAA1279|0:DIAPH2|0:ITGA8|0:SIM1|0:CHL1|0:TSNAX|0:ZBTB7A|0:FOXA3|0:SPATA20|0:SLFN5|0:FCRLA|0:AZI1|0:SRY|0:CSPG4|0:FIGF|0:KIF2A|0:GLDN|0:NHLH2|0:COL19A1|0:C1GALT1|0:LECT1|0:FLT1|0:SLC2A14|0:PGF|0:RBM45|0:OSGIN1|0:BMP1|0:SEMA4A|0:DAZ2|0:MTL5|0:TBCB|0:PAX4|0:SQSTM1|0:SLC26A8|0:COL15A1|0:MAEL|0:MEF2A|0:ASF1B|0:MEA1|0:AIMP2|0:ZNF521|0:COL13A1|0:SUV39H1|0:AAMP|0:SEMA6C|0:CYLC1|0:EDA|0:SEMA3D|0:CATSPER3|0:IFT81|0:HMX3|0:TSNAXIP1|0:FAM82A2|0:MYF5|0:TCFL5|0:ASZ1|0:ADCYAP1R1|0:ZNF3|0:STMN1|0:GADD45B|0:PAQR7|0:UNCX|0:GPSM1|0:TSPY2|0:RPS3A|0:LGALS3|0:SIM2|0:NOBOX|0:ARHGAP24|0:YIPF3|0:TYMP|0:MEF2C|0:CHRDL1|0:THOC5|0:ODF1|0:INSC|0:ZC3H12A|0:DAZ1|0:MIXL1|0:FAM65B|0:FOXO4|0:INA|0:ZSCAN2|0:HTATIP2|0:EFNB2|0:ANGPTL6|0:TNFAIP2|0:FRZB|0:CATSPER2|0:GPM6B|0:PEG10|0:PRAME|0:HIP1|0:HLX|0:ZIC2|0:DMRT3|0:ATOH8|0:PPP1R9A|0:TNFSF12|0:C11orf20|0:CATSPER4|0:BMP8A|0:CASP14|0:SPATA9|0:GAP43|0:NAA15|0:SPAST|0:CXCL17|0:VAMP5|0:SHB|0:CSPG5|0:BZW2|0:ADAM18|0:EID2|0:NHLH1|0:RNF151|0:RNF114|0:TSSK2|0:SEMA6B|0:BMP5|0:SIK1|0:ODF3|0:TAF7L|0:SPEM1|0:KAZALD1|0:TLL2|0:PDILT|0:DMRTA1|0:SFRP4|0:PMCH|0:TCP11|0:SFRP5|0:HIST1H1T|0:RASGRP1|0:HES6|0:SRPK2|0:RHOB|0:MICALCL|0:GMCL1L|0:EDARADD|0:HEMGN|0:TXNRD3|0:KDM3A|0:SLC9A10|0:ECSCR|0:TSPY1|0:FEV|0:PIWIL3|0:PAQR8|0:GGN|0:CCDC85B|0:PPDPF|0:NPNT|0:SPATA16|0:EID2B|0:C15orf2|0:MYT1L|0:TNP2|0:APOLD1|0:CATSPERB|0:ZBTB7B|0:PAX5|0:PDLIM7|0:MURC|0:RNF17|0:NOTCH2NL|0:TTLL7|0:SEMA7A|0:SEMA5B|0:IGSF10|0:GGNBP1|0:BOLL|0:TXNDC2|0:SEMA4G|0:MAK|0:FAM120B|0:CENPF|0:DAZAP1|0:ZFP41|0:CREM|0:NXN|0:ZIC5|0:MYF6|0:PPP1R9B|0:PRM2|0:PTPRU|0:MMP19|0:BMP8B|0:GMCL1|0:SRPK3|0:CATSPERG|0:MYT1|0:ZIC1|0:FLNB|0:OBSCN|0:ANGPT1|0:NANOS2|0:ODF2|0:SLC7A5|0:TRIM54|0:EGFL6|0:CADM1|0:SPATA5|0:GGNBP2|0:PKDCC|0:TLL1|0:HES4|0:ATOH7|0:SLCO4C1|0:PRMT7|0:DAZ4|0:UHRF2|0:SRRM4|0:BHLHE41|0:MDK|0:PBXIP1|0:UBE2V1|0:GLRX2|0:KRT6A|0:FGF23|0:WHSC1L1|0:FGF22|0:NDRG4|0:ANXA13|0:NDRG3|0:MAL			
GO:0000398	P:nuclear mRNA splicing, via spliceosome; NAS:UniProtKB		0:PPIH|0:PRPF4|0:SNRPB2|0:U2AF2|0:SNRPA|0:SNRPA1|0:U2AF1|0:HNRNPC|0:HNRNPA2B1|0:SF3B4|0:SF3B2|0:WDR83|0:SNRNP70|0:SNW1|0:PHF5A|0:DHX38|0:TRA2B|0:TRA2A|0:PRPF8|0:DDX39|0:CWC15|0:PRPF3|0:NAA38|0:CELF3|0:SF3B1|0:LSM7|0:LSM2|0:HNRNPH3			
GO:0005125	F:cytokine activity; TAS:UniProtKB		0:TNF|0:OSM|0:WNT2|0:IL1B|0:WNT7A|0:CSF1|0:IL6|0:SCG2|0:INHBA|0:LIF|0:BMP4|0:IL2|0:IL26|0:MIF|0:IL17F|0:BMP3|0:GDF10|0:IFNE|0:CMTM1|0:TNFSF15|0:IL27|0:IL33|0:TNFSF9|0:IL7|0:SPP1|0:BMP7|0:IL1F8|0:IFNA21|0:TNFSF10|0:GPI|0:IL22|0:IL3|0:CMTM6|0:PPBPL2|0:TNFSF4|0:IL1F6|0:TNFSF13B|0:GRN|0:GDF5|0:MSTN|0:LTA|0:IFNA8|0:GDF3|0:CMTM3|0:AREG|0:IL25|0:IL1F7|0:IL34|0:GREM1|0:FASLG|0:CMTM2|0:NODAL|0:CMTM7|0:IL1F5|0:IL29|0:CER1|0:IFNA7|0:BMP1|0:GDF6|0:IL15|0:LEFTY2|0:IFNA10|0:IL1F10|0:IL24|0:IL17D|0:IL28B|0:IL23A|0:CMTM4|0:TSLP|0:IFNA14|0:IL9|0:GDF7|0:TNFSF18|0:IFNG|0:IL5|0:TNFSF12|0:BMP8A|0:BMP2|0:TNFSF13|0:GREM2|0:IFNW1|0:CD70|0:IL32|0:IFNA6|0:GDF1|0:IL21|0:IFNA2|0:CTF1|0:LEFTY1|0:IL12A|0:IL16|0:IFNB1|0:THPO|0:IL1F9|0:TNFSF8|0:IL28A|0:AREGB|0:IFNA5|0:IFNA16|0:IFNA13|0:IFNA4|0:IL11|0:TNFSF14|0:CD40LG|0:CMTM8|0:GDF9|0:BMP6|0:GDF2|0:IL31|0:BMP15|0:BMP10|0:EBI3|0:IL20|0:IL4|0:CMTM5|0:IL12B|0:BMP8B|0:FLT3LG|0:LTB|0:IFNA17|0:IFNK|0:IFNA1|0:CSF2|0:IL1A|0:VEGFA|0:AIMP1|0:HMGB1|0:IL1RN|0:IL10|0:ADIPOQ|0:FAM3D|0:SCGB3A1|0:FAM3B|0:FAM3C|0:GDF11|0:SLURP1|0:TNFSF11|0:CLCF1|0:BMP5|0:CSF3|0:TXLNA|0:NRG1|0:IL17A|0:GDF15|0:SECTM1|0:TNFRSF11B|0:IL17C|0:IL17B|0:IL13|0:NAMPT|0:IL18|0:IL19|0:INHA|0:TGFB2|0:INHBB			
GO:0048478	P:replication fork protection; NAS:UniProtKB		0:TIPIN|0:BLM			
GO:0045324	P:late endosome to vacuole transport; IMP:UniProtKB		0:CHMP7			
GO:0090288	P:negative regulation of cellular response to...; IDA:BHF-UCL		0:SLIT2			
GO:0032410	P:negative regulation of transporter activity; IMP:UniProtKB		0:SNCA|0:WWP2|0:NDFIP2|0:NDFIP1			
GO:0031960	P:response to corticosteroid stimulus; IEP:UniProtKB		0:SOX30			
GO:0004004	F:ATP-dependent RNA helicase activity; TAS:ProtInc		0:UPF1|0:EIF4A3|0:BAT1|0:DDX54|0:DDX25|0:MOV10L1|0:DDX24|0:DDX21|0:G3BP1|0:DDX43|0:DDX18|0:DDX56|0:DDX20|0:DHX8|0:SKIV2L|0:DDX23|0:DHX9|0:DDX3X			
GO:0004359	F:glutaminase activity; TAS:ProtInc		0:GLS|0:GLS2			
GO:0004946	F:bombesin receptor activity; TAS:ProtInc		0:GRPR|0:BRS3|0:NMBR			
GO:0010888	P:negative regulation of lipid storage; NAS:BHF-UCL		0:CRP|0:ITGB3|0:NFKBIA|0:ITGAV|0:TNF|0:IL6			
GO:0047708	F:biotinidase activity; IEA:EC		0:BTD			
GO:0008615	P:pyridoxine biosynthetic process; NAS:UniProtKB		0:PDXK|0:PNPO|0:PSAT1			
GO:0042574	P:retinal metabolic process; NAS:UniProtKB		0:SDR16C5|0:RDH10|0:ALDH1A3|0:ALDH8A1|0:BCO2			
GO:0051126	P:negative regulation of actin nucleation; IDA:UniProtKB		0:CORO1A			
GO:0010902	P:positive regulation of very-low-density lip...; IDA:BHF-UCL		0:APOC2|0:APOA5			
GO:0070188	C:Stn1-Ten1 complex; ISS:UniProtKB		0:C17orf68|0:C17orf106			
GO:0010544	P:negative regulation of platelet activation; TAS:BHF-UCL		0:APOE|0:PDGFA|0:PDGFB|0:NOS3|0:THBD|0:F2			
GO:0072227	P:metanephric macula densa development; ISS:UniProtKB		0:POU3F3			
GO:0010634	P:positive regulation of epithelial cell migr...; ISS:BHF-UCL		0:TGFB2|0:FGF10|0:BMPR2|0:HDAC6|0:HIF1A			
GO:0015195	F:L-threonine transmembrane transporter activity; IDA:UniProtKB		0:SLC1A4			
GO:0048037	F:cofactor binding; IEA:InterPro		0:BIRC5|0:ALDH1L1|0:AASDH|0:ALDH1L2|0:FASN|0:DBT|0:UBA5|0:NDUFAB1			
GO:0006637	P:acyl-CoA metabolic process; TAS:ProtInc		0:ACOT2|0:OXSM|0:ACOT4|0:ACOT1|0:AGPAT6|0:BAAT|0:ACOT9|0:ACOT12|0:ACSL6|0:MLYCD|0:GLYAT			
GO:0001836	P:release of cytochrome c from mitochondria; NAS:UniProtKB		0:CLU|0:BID|0:PMAIP1|0:BAX|0:SFN|0:BCL2L1|0:BAK1|0:TIMM50|0:BBC3|0:GPX1|0:IFI6|0:GGCT|0:SOD2|0:BCL2			
GO:0015079	F:potassium ion transmembrane transporter act...; TAS:ProtInc		0:AQP1|0:ABCC8|0:KCNA1			
GO:0045824	P:negative regulation of innate immune response; ISS:UniProtKB		0:IRAK3|0:TRAFD1			
GO:0018193	P:peptidyl-amino acid modification; IEA:InterPro		0:ASPHD1|0:ASPHD2			
GO:0050839	F:cell adhesion molecule binding; NAS:BHF-UCL		0:VCAM1|0:MSN|0:ITGB3|0:PVRL3|0:EZR|0:PVRL2|0:CD226|0:PVRL1|0:ITGAL|0:PVR|0:NPTN|0:CDH1			
GO:0005111	F:type 2 fibroblast growth factor receptor bi...; IPI:UniProtKB		0:FGF18|0:FGF17|0:FGF8|0:FGF10			
GO:0004476	F:mannose-6-phosphate isomerase activity; TAS:ProtInc		0:SPATA20|0:RENBP|0:MPI			
GO:0032805	P:positive regulation of low-density lipoprot...; IDA:BHF-UCL		0:APOE			
GO:0004614	F:phosphoglucomutase activity; IEA:EC		0:PGM1|0:PGM2			
GO:0004972	F:N-methyl-D-aspartate selective glutamate re...; TAS:ProtInc		0:GRIN3A|0:GRIN2C|0:GRIN2A|0:GRIN2B			
GO:0008275	C:gamma-tubulin small complex; NAS:UniProtKB		0:CENPJ			
GO:0042594	P:response to starvation; NAS:UniProtKB		0:PPARGC1A			
GO:0019904	F:protein domain specific binding; ISS:UniProtKB		0:MLF1|0:YWHAQ|0:SFN|0:YWHAZ|0:CASP2|0:CENPJ|0:E2F4|0:SKI|0:NEDD4|0:ESRRA|0:ERCC1|0:CALM2|0:TADA3|0:RARA|0:HNRNPM|0:ETV6|0:VPS4A|0:NFE2L2|0:VCP|0:YWHAB|0:TBL1X|0:TFDP1|0:IKBKG|0:CSNK2B|0:CNTROB|0:HOXB1|0:MRPS31|0:NR0B2|0:NLRP1|0:IL1B|0:BASP1|0:TNNI3|0:CTBP1|0:ZNF521|0:CALM3|0:CHMP2B|0:ARHGEF4|0:CHMP1A|0:THRA|0:TFDP2|0:MECP2|0:ATN1|0:MED12|0:HGS|0:NR0B1|0:MRPL17|0:CHMP1B|0:CHMP2A|0:CBX3|0:FOXH1|0:SKIL|0:KPNB1|0:CALM1|0:XPA|0:STMN3|0:YWHAH			
GO:0019254	P:carnitine metabolic process, CoA-linked; ISS:BHF-UCL		0:ACADM|0:ACADL			
GO:0010519	P:negative regulation of phospholipase activity; IDA:BHF-UCL		0:ANGPTL3			
GO:0050662	F:coenzyme binding; TAS:UniProtKB		0:TDH|0:TSTA3|0:EHHADH|0:TGDS|0:NQO1|0:GLYR1|0:UXS1|0:HADH|0:NQO2|0:GMDS|0:GALE|0:GCLC|0:ALAS2|0:WWOX			
GO:0006360	P:transcription from RNA polymerase I promoter; TAS:ProtInc		0:TAF1A|0:TAF1C|0:POLR1C			
GO:0060836	P:lymphatic endothelial cell differentiation; ISS:BHF-UCL		0:SOX18			
GO:0002262	P:myeloid cell homeostasis; ISS:UniProtKB		0:SOD1			
GO:0003955	F:NAD(P)H dehydrogenase (quinone) activity; TAS:ProtInc		0:NQO1			
GO:0014740	P:negative regulation of muscle hyperplasia; ISS:BHF-UCL		0:NOS3			
GO:0048487	F:beta-tubulin binding; ISS:UniProtKB		0:BBS4|0:MAP1S|0:LRPPRC|0:UXT|0:RACGAP1|0:EMD|0:GABARAP|0:VAPB|0:ARL8B|0:B4GALT1|0:SPAST|0:GABARAPL2|0:GABARAPL1|0:ARL8A			
GO:0042495	P:detection of triacylated bacterial lipopeptide; IDA:MGI		0:TLR1|0:TLR2			
GO:0009749	P:response to glucose stimulus; ISS:UniProtKB		0:THBS1|0:APOA2|0:MAFA|0:SLC30A8|0:NEUROD1|0:IRS2|0:ADIPOQ|0:TCF7L2|0:GYS2|0:EIF2B3|0:EIF2B2|0:EIF2B5|0:EIF2B1|0:EIF2B4			
GO:0046619	P:optic placode formation involved in camera-...; ISS:BHF-UCL		0:PROX1			
GO:0003842	F:1-pyrroline-5-carboxylate dehydrogenase act...; TAS:ProtInc		0:ALDH4A1			
GO:0005654	C:nucleoplasm; TAS:ProtInc		0:ERCC5|0:DDB1|0:XAB2|0:CDC25B|0:POLD2|0:HIST1H4I|0:HIST1H4L|0:ERCC8|0:FOXO1|0:HIST1H4B|0:CDT1|0:CCNE2|0:CDC45|0:MAPK11|0:TERF1|0:TPR|0:FANCD2|0:FZR1|0:DFFB|0:GTF2E1|0:SKP1|0:MAPK14|0:FBXO5|0:CDC26|0:RFC4|0:NUP50|0:CAMK2G|0:HMGB2|0:CASP3|0:ANAPC11|0:ATRIP|0:POLR1D|0:PKMYT1|0:MPG|0:HIST1H4E|0:IRF3|0:ERCC1|0:CALM2|0:COBRA1|0:WEE1|0:POT1|0:MAPK1|0:TCEB1|0:ATF2|0:CCNT1|0:MAPK8|0:GTF2B|0:LIG1|0:CLSPN|0:POLD3|0:POLA2|0:NBN|0:RFC3|0:HIST2H4A|0:RPA2|0:NUP153|0:CAMK2D|0:CDC25C|0:CKS1B|0:MCM3|0:ANAPC7|0:RDBP|0:TP53BP1|0:SNRPD3|0:GMNN|0:KIF20A|0:ANAPC4|0:HIST3H3|0:MAPK10|0:XPC|0:POLR1A|0:TERF2|0:MAPK7|0:SUPT16H|0:PABPN1|0:KIF23|0:STK24|0:DUSP3|0:ERCC4|0:MCM4|0:CDC23|0:CDKN1A|0:HIST1H4H|0:TAF1C|0:RNMT|0:POLD1|0:HIST1H4A|0:ZBTB32|0:HMGB1|0:SUPT5H|0:SNRPF|0:DBF4|0:ATM|0:CASP7|0:CDC20|0:PRKAG2|0:H2AFX|0:CDC7|0:ITGB3BP|0:DFFA|0:TDG|0:CAMK2A|0:HIST4H4|0:AKT1|0:TH1L|0:SSRP1|0:DNA2|0:APEX1|0:CDC27|0:HIST1H4D|0:CAMK4|0:RPA3|0:RPS6KA1|0:RRN3|0:SQSTM1|0:TAF1B|0:MEF2A|0:SNRPE|0:PRKAB2|0:RAD52|0:RPS6KB2|0:KPNA1|0:RFC2|0:PRIM1|0:NCBP1|0:CALM3|0:RPS6KA5|0:BRCA1|0:TERF2IP|0:DUSP4|0:CDK1|0:NTHL1|0:CAMK2B|0:MYF5|0:MCM5|0:CCNA2|0:RPS6KA2|0:MDC1|0:POLR1B|0:POLE|0:CHEK1|0:HIST1H4K|0:POLB|0:DUSP6|0:ANAPC5|0:CDC16|0:CASP6|0:PRIM2|0:RPS6KA6|0:NGFR|0:TCEA1|0:XRCC5|0:NFKB1|0:UBTF|0:MCM8|0:DUSP7|0:WHSC2|0:MAPK3|0:TCF3|0:SNRPB|0:ACD|0:NUMA1|0:ALKBH3|0:LIG3|0:HIST1H4J|0:CCNB1|0:SUPT4H1|0:RAD23B|0:CCNE1|0:SMUG1|0:PTRF|0:ATR|0:MUTYH|0:IRF7|0:MCM10|0:XRCC1|0:CTDP1|0:BRCA2|0:NR4A1|0:RFC5|0:CDC25A|0:POLR1C|0:MAPK9|0:CCNT2|0:MGMT|0:CUL1|0:PRKAA2|0:ANAPC2|0:PALB2|0:POLR2K|0:UBE2C|0:FANCI|0:TTF1|0:TCEB2|0:MCM6|0:KPNB1|0:HIST1H4C|0:USP1|0:RNGTT|0:DDB2|0:ALKBH2|0:GCK|0:CDC6|0:CCND1|0:ANAPC1|0:SNRPG|0:POLD4|0:ANAPC10|0:HIST2H4B|0:MYF6|0:RFC1|0:GCKR|0:TERT|0:MYOG|0:CALM1|0:PLK1|0:OGG1|0:SNRPD1|0:PCNA|0:TINF2|0:UBE2D1|0:POLE2|0:XPA|0:UBE2E1|0:HIST1H4F|0:RPS6KA3|0:SNRPD2|0:CDKN2AIP|0:CDKN2A|0:CD2BP2|0:HNRNPA1|0:MYO16|0:CCNO|0:SIVA1|0:WRN|0:IFI16|0:TRIM27|0:PARP2|0:AEN|0:SIRT6|0:MDM2|0:NCBP2|0:SETX|0:DSCC1|0:DAG1|0:ATXN1|0:PHB|0:MKI67IP|0:GIT2|0:TOP1|0:NDUFA13|0:PES1|0:FBXW7|0:USP28|0:RPS2|0:KIF20B|0:SYMPK|0:ANXA11|0:POLA1|0:WDR4|0:XPOT|0:CDC14B|0:RBM15B|0:TOP2B|0:STRN3|0:TOP2A|0:WDR12|0:APTX|0:L3MBTL1|0:MAU2|0:WT1|0:CTCF|0:LARP7|0:WIBG|0:HNRNPH1|0:ANKRD28|0:HAND1|0:CIRBP|0:HNRNPR|0:ATF7|0:MYO1C|0:LRPPRC|0:MCL1|0:HNRNPF|0:BOP1|0:NUDT16|0:SYNCRIP|0:LOR|0:ESF1|0:NMD3|0:E4F1|0:AHCTF1|0:UBN1|0:LIN9|0:CBFA2T3|0:RTF1|0:HNRNPA2B1|0:C14orf169|0:HNRNPH2|0:THAP1|0:KDM2A|0:VPS25|0:SET|0:ZCRB1|0:SYNE2|0:CIB1|0:PPP1R9B|0:RPS19BP1|0:SRSF12|0:PAX8|0:SRRT|0:RBM19|0:UTP20|0:BNIP3|0:RPS15|0:RECQL5|0:EIF3E|0:SMARCC2|0:SMARCD1|0:CPSF3|0:KPNA2|0:RTCD1|0:SMARCB1|0:MRE11A|0:FMR1|0:POLH|0:SMARCC1|0:SMARCA5|0:ATXN3|0:PTBP1|0:NUP98|0:NUP54|0:SMARCA2|0:SMARCD3|0:HNRNPK|0:SP140|0:POLI|0:POLQ|0:CBX1|0:PRM1|0:WDHD1|0:HNRNPL|0:PRM2|0:ATF6			
GO:0006458	P:'de novo' protein folding; TAS:BHF-UCL		0:HSPD1|0:FKBP1B|0:FKBP1A			
GO:0047498	F:calcium-dependent phospholipase A2 activity; TAS:UniProtKB		0:PLA2G1B|0:PLA2G4B|0:PLA2G12A|0:PLA2G3|0:PLA2G5|0:PLA2G2A			
GO:0007507	P:heart development; TAS:UniProtKB		0:ADAP2|0:ECE1|0:TBX1|0:CITED2|0:COL3A1|0:FBN1|0:TGFBR2|0:PCSK5|0:SOX4|0:ERBB3|0:DVL2|0:TGFBR1|0:HDAC9|0:ALPK3|0:NF1|0:TSC2|0:NCOA6|0:GLI2|0:OSR1|0:DVL1L1|0:TCF25|0:SHOX2|0:POU6F1|0:DVL3|0:FGF12|0:CASQ2|0:IRX4|0:SRI|0:PLCE1|0:ERBB2			
GO:0048742	P:regulation of skeletal muscle fiber develop...; ISS:UniProtKB		0:HDAC9			
GO:0031902	C:late endosome membrane; ISS:UniProtKB		0:SLC9A9|0:SLC11A2|0:CLCN4|0:HLA-DRB3|0:NPC1|0:HLA-DRA|0:CHMP4C|0:VPS37A|0:TMEM55B|0:MAPKSP1|0:FAM125B|0:VPS4A|0:HLA-DRB4|0:CHMP6|0:VPS16|0:VPS37B|0:CLCN3|0:ABCA5|0:HLA-DMA|0:MMD|0:SNF8|0:VPS39|0:STARD3|0:STARD3NL|0:CHMP4B|0:VPS18|0:CHMP2B|0:VPS4B|0:HLA-DMB|0:VPS11|0:VPS33B|0:TMEM9|0:VPS37C|0:MCOLN1|0:VPS28|0:TSG101|0:HLA-DRB1|0:ROBLD3|0:VPS33A|0:HLA-DRB5|0:ARL8A|0:CHMP4A|0:CYBASC3|0:RHOB|0:VPS24|0:CHMP1B|0:SLC29A3|0:CHMP2A|0:CD63|0:PLD1|0:MITD1|0:FAM125A|0:ARL8B|0:VPS37D|0:RILP|0:TMEM55A|0:MARCH1|0:VAMP7|0:RNF13			
GO:0031018	P:endocrine pancreas development; ISS:UniProtKB		0:IL6R|0:HNF1B|0:EIF2AK3|0:IL6|0:RFX3			
GO:0009408	P:response to heat; TAS:UniProtKB		0:NOS1|0:CRNN|0:MICA|0:GCLC|0:MICB|0:HSPB6|0:HSPB1|0:DNAJA3|0:HSPB8|0:CRYAB|0:CRYAA|0:DNAJA2|0:HSPB7|0:HSPB3|0:DNAJA4|0:DNAJA1|0:EIF2B5|0:SOD1|0:NOS3|0:DNAJB4|0:AKT1|0:EIF2B3|0:EIF2B2|0:EIF2B1|0:EIF2B4			
GO:0048170	P:positive regulation of long-term neuronal s...; ISS:HGNC		0:NPTN			
GO:0043531	F:ADP binding; TAS:UniProtKB		0:GLUD1|0:PRKAG2|0:ABCG1|0:GLUD2|0:MYH9|0:MYH10|0:MYO9B|0:LONP1|0:MYO3A|0:GCLC|0:TAP1|0:MYO6|0:ACTA1|0:ME1			
GO:0043029	P:T cell homeostasis; NAS:UniProtKB		0:ZC3H8|0:FOXP3|0:TNFSF14			
GO:0018105	P:peptidyl-serine phosphorylation; ISS:UniProtKB		0:TGFBR2|0:PRKDC|0:PRKCZ|0:TAF1|0:PINK1|0:GSK3B|0:TGFBR1|0:LRRK2|0:TNKS|0:MORC3|0:AKT1|0:NEK6|0:SMG1|0:MAP4K1|0:STK4|0:TDGF1|0:MTOR|0:ADRBK1|0:UHMK1|0:MAP3K12|0:HIPK3			
GO:0042450	P:arginine biosynthetic process via ornithine; IEA:InterPro		0:ASL			
GO:0007220	P:Notch receptor processing; TAS:HGNC		0:APH1A|0:PSEN1|0:PSENEN|0:NCSTN|0:PSEN2			
GO:0043138	F:3'-5' DNA helicase activity; IDA:UniProtKB		0:ERCC3			
GO:0019103	F:pyrimidine nucleotide binding; IDA:UniProtKB		0:NT5C			
GO:0045918	P:negative regulation of cytolysis; IDA:BHF-UCL		0:PF4|0:CSF2			
GO:0004966	F:galanin receptor activity; TAS:ProtInc		0:GALR3|0:GALR1|0:GALR2			
GO:0046903	P:secretion; TAS:UniProtKB		0:PRKCI|0:TPD52			
GO:0021775	P:smoothened signaling pathway involved in ve...; ISS:UniProtKB		0:GLI2			
GO:0051782	P:negative regulation of cell division; IMP:UniProtKB		0:BLM			
GO:0048185	F:activin binding; TAS:BHF-UCL		0:ACVR1|0:ACVRL1|0:SMAD7|0:SMURF1|0:FKBP1A|0:FST|0:FSTL3|0:ENG			
GO:0051929	P:positive regulation of calcium ion transpor...; ISS:BHF-UCL		0:NKX2-5			
GO:0045921	P:positive regulation of exocytosis; IMP:UniProtKB		0:UNC13D			
GO:0006116	P:NADH oxidation; IDA:BHF-UCL		0:ALDOB			
GO:0005275	F:amine transmembrane transporter activity; TAS:UniProtKB		0:AQP9			
GO:0045726	P:positive regulation of integrin biosyntheti...; IMP:BHF-UCL		0:TGFB2|0:NOX1			
GO:0016045	P:detection of bacterium; TAS:UniProtKB		0:NOD1|0:NLRC4|0:NOD2|0:PGLYRP4|0:PGLYRP2|0:PGLYRP1|0:PGLYRP3|0:CD1D			
GO:0047874	F:dolichyldiphosphatase activity; ISS:UniProtKB		0:DOLPP1			
GO:0035573	P:N-terminal peptidyl-serine trimethylation; IDA:UniProtKB		0:METTL11A			
GO:0043257	C:laminin-8 complex; IDA:UniProtKB		0:LAMB1			
GO:0043221	F:SMC protein binding; TAS:UniProtKB		0:PAPD7			
GO:0005353	F:fructose transmembrane transporter activity; IEA:InterPro		0:SLC2A5|0:SLC2A7			
GO:0060669	P:embryonic placenta morphogenesis; ISS:UniProtKB		0:WNT7B			
GO:0048536	P:spleen development; ISS:BHF-UCL		0:NKX2-5|0:ADAM17			
GO:0007163	P:establishment or maintenance of cell polarity; TAS:UniProtKB		0:CD3G|0:CLASP1|0:CAP2|0:CAP1|0:SFRP5|0:CDC42BPB|0:CRB1|0:SPN|0:MAP7|0:CCL4|0:PARD6B|0:DLG1|0:CDC42|0:CLASP2			
GO:0030183	P:B cell differentiation; TAS:UniProtKB		0:ITGA4|0:VCAM1|0:TPD52|0:NHEJ1|0:MSH2|0:HHEX|0:ADAM17|0:NFAM1|0:CEBPG|0:CD79A|0:BLNK|0:AICDA|0:IL10|0:KLF6|0:IL11|0:HDAC5|0:HDAC4|0:IL4|0:HDAC9			
GO:0051371	F:muscle alpha-actinin binding; TAS:HGNC		0:NRAP|0:PALLD			
GO:0004348	F:glucosylceramidase activity; IEA:EC		0:GBA2|0:GBA			
GO:0004462	F:lactoylglutathione lyase activity; IDA:UniProtKB		0:GLO1			
GO:0030218	P:erythrocyte differentiation; NAS:UniProtKB		0:DYRK3|0:ACIN1|0:RPS19|0:SLC25A38|0:RPS14|0:TAL1|0:JAK2|0:LYN|0:MLL5|0:HCLS1|0:ALAS2|0:INHA|0:INHBA			
GO:0003883	F:CTP synthase activity; TAS:ProtInc		0:CTPS|0:CTPS2			
GO:0045765	P:regulation of angiogenesis; TAS:BHF-UCL		0:IL6|0:RNH1|0:HTATIP2|0:WARS|0:NF1|0:SFRP1|0:TSPAN12|0:KRT1|0:ERBB2|0:EPHB4|0:HMOX1|0:CTNNB1			
GO:0042523	P:positive regulation of tyrosine phosphoryla...; ISS:BHF-UCL		0:IGF1|0:IL3|0:GH1|0:EPO|0:CSF2|0:IL31RA|0:GHR|0:JAK2			
GO:0008081	F:phosphoric diester hydrolase activity; ISS:UniProtKB		0:MPPE1			
GO:0016312	F:inositol bisphosphate phosphatase activity; IDA:UniProtKB		0:INPP5K			
GO:0042835	F:BRE binding; ISS:UniProtKB		0:CELF1|0:CELF4			
GO:0033632	P:regulation of cell-cell adhesion mediated b...; IMP:UniProtKB		0:DPP4|0:ADA|0:FERMT3			
GO:0004063	F:aryldialkylphosphatase activity; IEA:EC		0:PON1|0:PON2			
GO:0007346	P:regulation of mitotic cell cycle; TAS:HGNC		0:AFAP1L2|0:ZNF655|0:C12orf11|0:PIM3|0:CYLD|0:THAP1|0:PLK1|0:CDC123|0:FBXO5|0:DYNLT3|0:SIK1|0:MAEA|0:TMEM8B			
GO:0006260	P:DNA replication; TAS:UniProtKB		0:HUS1|0:ORC3|0:ATRIP|0:CLSPN|0:RAD9A|0:CDC25C|0:DBF4|0:CDC7|0:RAD1|0:RPA3|0:RFC2|0:ORC6|0:RAD9B|0:CHEK1|0:MCM8|0:RAD17|0:ATR|0:MCM10|0:CDK2|0:CDC25A|0:CDC6|0:ING4|0:MYST2|0:KIN|0:ING5|0:NAE1|0:KRT7|0:RECQL|0:DNTT|0:C8orf45|0:POLQ|0:POLM|0:MCM9|0:CDT1|0:RBBP7|0:CINP|0:PAPD5|0:GINS4|0:CHAF1B|0:CCDC88A|0:POLK|0:DSCC1|0:LIG1|0:PHB|0:NFIA|0:SUPT16H|0:CTGF|0:SSRP1|0:GINS2|0:RBBP4|0:LIG4|0:RMI1|0:PAPD7|0:LIN9|0:POLI|0:NFIX|0:STRA8|0:LIG3|0:GINS3|0:NFIC|0:CHTF8|0:SSBP1|0:CENPF|0:GINS1|0:CHAF1A|0:CHTF18|0:C16orf75|0:TK1|0:NFIB|0:POLN|0:UPF1|0:TBRG1|0:NOL8|0:NUP98|0:KCTD13|0:TNFAIP1|0:NASP|0:C15orf42|0:RRM2|0:TMX1|0:POLA2|0:RRM1|0:NCOA6|0:TREX1|0:RBM14|0:POLL|0:TYMS|0:RBMS1|0:RFC5|0:TOP2A|0:SIRT1|0:SPHAR|0:IGF1|0:POLE3|0:IGHMBP2|0:NT5M|0:EGF|0:NAP1L1|0:REPIN1|0:RNASEH2A|0:TYMP|0:DUT|0:MCM3AP|0:PTMS|0:SET|0:ACHE			
GO:0007512	P:adult heart development; NAS:UniProtKB		0:HAND2|0:TCAP|0:NKX2-5|0:MYH7|0:MYH6|0:BMP10|0:SCUBE1			
GO:0035019	P:somatic stem cell maintenance; ISS:UniProtKB		0:SOX2|0:POU5F1|0:NOG|0:NANOG|0:LIG4			
GO:0001890	P:placenta development; NAS:UniProtKB		0:PLAC1|0:PPARG|0:ANG|0:SOD1			
GO:0071672	P:negative regulation of smooth muscle cell c...; IDA:BHF-UCL		0:SLIT2			
GO:0005087	F:Ran guanyl-nucleotide exchange factor activity; TAS:UniProtKB		0:RCC1|0:ALS2|0:RCBTB2|0:SERGEF			
GO:0008406	P:gonad development; TAS:ProtInc		0:SALL1|0:FGF8|0:HMGCR|0:MKKS			
GO:0019815	C:B cell receptor complex; ISS:UniProtKB		0:CD79A			
GO:0043014	F:alpha-tubulin binding; ISS:UniProtKB		0:BBS4|0:FNTA|0:HDAC6|0:RACGAP1|0:WASH1|0:B4GALT1|0:ARL8B|0:SNCA|0:SPAST|0:WASH4P|0:WASH2P|0:OFD1|0:ARL8A|0:WASH6P|0:WASH3P			
GO:0031234	C:extrinsic to internal side of plasma membrane; ISS:UniProtKB		0:CAV2|0:TGM3|0:CYLD|0:S100A6|0:ERRFI1			
GO:0000177	C:cytoplasmic exosome (RNase complex); IDA:UniProtKB		0:EXOSC3			
GO:0001758	F:retinal dehydrogenase activity; ISS:UniProtKB		0:ALDH8A1|0:ALDH1A1|0:ALDH1A2			
GO:0051299	P:centrosome separation; IMP:HGNC		0:NEK2|0:CNTROB			
GO:0004176	F:ATP-dependent peptidase activity; IEA:InterPro		0:LONP1|0:LONRF1|0:LONP2|0:LONRF2|0:CRBN|0:NSF|0:LONRF3			
GO:0005309	F:creatine:sodium symporter activity; TAS:ProtInc		0:SLC6A8			
GO:0070728	F:leucine binding; IDA:BHF-UCL		0:GLUD1|0:GLUD2			
GO:0030170	F:pyridoxal phosphate binding; NAS:UniProtKB		0:ALB|0:SDS|0:CTH|0:CBS|0:PDXK|0:SHMT1|0:ABAT|0:ALAS1|0:SHMT2|0:SCLY|0:PYGL|0:THNSL1|0:GAD1|0:PDXDC2P|0:TAT|0:DDC|0:MOSC1|0:SPTLC3|0:ALAS2|0:CCBL1|0:GPT|0:GLDC|0:ACCSL|0:SGPL1|0:AADAT|0:AGXT2L2|0:GOT2|0:MOCOS|0:CCBL2|0:PSAT1|0:GOT1|0:AGXT2L1|0:PDXDC1|0:NFS1|0:OAT|0:SPTLC1|0:GADL1|0:SDSL|0:GOT1L1|0:AGXT2|0:MOSC2|0:GAD2|0:PYGB|0:SPTLC2|0:CSAD|0:GCAT|0:GPT2|0:AGXT|0:SRR|0:ACCS			
GO:0006576	P:cellular biogenic amine metabolic process; TAS:ProtInc		0:SULT1B1			
GO:0003419	P:growth plate cartilage chondrocyte prolifer...; ISS:UniProtKB		0:NPPC			
GO:0055007	P:cardiac muscle cell differentiation; ISS:UniProtKB		0:NRG1|0:CBY1			
GO:0007321	P:sperm displacement; TAS:ProtInc		0:EDDM3A			
GO:0071104	P:response to interleukin-9; ISS:UniProtKB		0:CITED1			
GO:0046475	P:glycerophospholipid catabolic process; IDA:UniProtKB		0:PLA2G4B|0:PLA2G4C			
GO:0016255	P:attachment of GPI anchor to protein; TAS:UniProtKB		0:PGAP1|0:PLAUR|0:PIGT|0:PIGK|0:PIGU|0:GPAA1|0:PIGS			
GO:0043292	C:contractile fiber; ISS:UniProtKB		0:CDK5R1			
GO:0060729	P:intestinal epithelial structure maintenance; ISS:BHF-UCL		0:TLR4			
GO:0005916	C:fascia adherens; ISS:UniProtKB		0:CTNNA3|0:NRAP			
GO:0030187	P:melatonin biosynthetic process; TAS:UniProtKB		0:AANAT|0:ASMT|0:ASMTL			
GO:0042033	P:chemokine biosynthetic process; TAS:UniProtKB		0:IL18			
GO:0008131	F:primary amine oxidase activity; IEA:EC		0:MAOA|0:MAOB|0:ABP1|0:AOC3|0:AOC2			
GO:0050748	P:negative regulation of lipoprotein metaboli...; IMP:BHF-UCL		0:ITGB3|0:ITGAV			
GO:0007275	P:multicellular organismal development; TAS:UniProtKB		0:SIAH3|0:MST1R|0:VANGL1|0:SIAH2|0:SIAH1L|0:GNRH2|0:SEMA3G|0:SPRED2|0:LDB2|0:PLXNB3|0:PLXNC1|0:SPRED1|0:MET|0:PROX2|0:SPRED3|0:SPATA19|0:IRX3|0:SEBOX|0:C1orf107|0:GPX4|0:TDRD9|0:THEG|0:TBPL2|0:LCLAT1|0:SOHLH2|0:ZNF541|0:RNF111|0:NME5|0:TAF8|0:CHURC1|0:CCIN|0:RTL1|0:TCTN1|0:TSSK3|0:C10orf27|0:IFRD1|0:EDIL3|0:GADD45G|0:PAQR5|0:NKX2-4|0:AMN|0:TSSK1B|0:SCXA|0:DAZ3|0:DKK2|0:ACSBG2|0:USP7|0:KDM5A|0:DPPA5|0:SLC22A16|0:UTP14C|0:MEIS1|0:TXNDC3|0:SPATA2|0:RERE|0:PHC1|0:LSM14B|0:MARK2|0:VENTX|0:NKX6-2|0:TWIST2|0:TRIML1|0:WLS|0:DONSON|0:AGFG1|0:CYLC2|0:CCHCR1|0:WIPF3|0:SPATA6|0:PRM3|0:DRGX|0:PSME4|0:ICK|0:EBF4|0:PIWIL4|0:DLX3|0:BANP|0:TSSK4|0:EYA4|0:FREM1|0:TDRD1|0:FMN2|0:NLRP14|0:TUBD1|0:DIP2A|0:CDK20|0:TXNDC8|0:ISL1|0:NANOS3|0:CATSPER1|0:MYCBPAP|0:WIF1|0:MORC1|0:SPDYA|0:C6orf170|0:ADAD1|0:FAM3C|0:SPATA18|0:SOHLH1|0:UNC5D|0:CFDP1|0:TSSK6|0:ODF4|0:DIAPH2|0:PIWIL1|0:RBM19|0:TSHZ2|0:PHC2|0:DBX1|0:EBF3|0:EBF1|0:TSNAX|0:ZBTB7A|0:MCL1|0:FOXA3|0:HOXC9|0:SPATA20|0:NKX1-2|0:TMEFF1|0:AZI1|0:POGZ|0:DKK4|0:CENPE|0:SLC2A14|0:OSGIN1|0:PLCZ1|0:SMPD3|0:TDRD6|0:KDM1B|0:SPRY4|0:DAZ2|0:KIAA1598|0:MTL5|0:PKP1|0:SLC26A8|0:MAEL|0:ASF1B|0:IFITM5|0:GFI1B|0:HILS1|0:DDX4|0:AIMP2|0:ZNF521|0:CYLC1|0:BICC1|0:CATSPER3|0:IFT81|0:TSNAXIP1|0:DACT1|0:HMX1|0:GRHL1|0:TCFL5|0:ASZ1|0:ADCYAP1R1|0:ZNF3|0:GADD45B|0:PAQR7|0:LRP1|0:DZIP1|0:GPR161|0:PIWIL2|0:MBNL3|0:LBH|0:FLII|0:ODF1|0:PHC3|0:DAZ1|0:ZNF260|0:SPESP1|0:H1FNT|0:ZSCAN2|0:ZFR|0:CATSPER2|0:SHISA2|0:GTF2IRD1|0:FIGLA|0:DMRT3|0:CATSPER4|0:DIXDC1|0:SPATA9|0:PRM1|0:C14orf39|0:EBF2|0:ADAM18|0:OLFML3|0:RNF114|0:TSSK2|0:SIK1|0:PRTG|0:ODF3|0:DACH1|0:TAF7L|0:SPEM1|0:LEFTY1|0:TLL2|0:ZGLP1|0:PDILT|0:SPIN1|0:HHAT|0:C19orf20|0:SFRP5|0:HIST1H1T|0:MICALCL|0:FAT3|0:GMCL1L|0:HEMGN|0:TXNRD3|0:SLC9A10|0:ZAR1|0:NRARP|0:PIWIL3|0:PAQR8|0:GGN|0:PPDPF|0:NPNT|0:SPATA16|0:C15orf2|0:TNP2|0:CATSPERB|0:HOOK1|0:SHISA3|0:RNF17|0:POGK|0:NOTCH2NL|0:KDM1A|0:PAK3|0:DCAF7|0:SCXB|0:DYNC2H1|0:GGNBP1|0:STIL|0:HOXC12|0:BOLL|0:DAZL|0:STRBP|0:TXNDC2|0:TRIM71|0:RADIL|0:CSRP2|0:PTP4A1|0:MAK|0:DAZAP1|0:ZFP41|0:DND1|0:CREM|0:BIN1|0:NXN|0:EYA3|0:DYNC2LI1|0:NDRG4|0:PRM2|0:DDX25|0:SCMH1|0:TNP1|0:CTNND2|0:LSM14A|0:GMCL1|0:CATSPERG|0:DLX4|0:OBSCN|0:NANOS2|0:DACH2|0:ODF2|0:PRR15|0:TRIM54|0:EGFL6|0:SPATA5|0:GGNBP2|0:SLCO4C1|0:DAZ4|0:NXF5|0:DDX1|0:RPS4Y1|0:RPS4X|0:NXF2|0:NXF2B|0:DGKD|0:HKR1|0:DOPEY2|0:HIC1|0:PBXIP1|0:FOXD4|0:TRERF1|0:ST6GAL2|0:SPRY3|0:APOL2|0:ERC1|0:RHOXF1|0:PHF3|0:FRAT2|0:CECR1|0:C19orf57|0:BST1|0:GATA1|0:ARHGDIB|0:RBBP7|0:KLF3|0:ARVCF|0:ZNF267|0:ZMYM3|0:RREB1|0:PTPLA|0:NGFRAP1|0:CHST2|0:HUNK|0:PDCD1|0:C16orf80|0:NFE2|0:CLPTM1|0:ANGPTL2|0:DDX41|0:CLC|0:CRABP1|0:FOSB|0:RYBP|0:DUSP22|0:DRG1|0:GPR65|0:BST2|0:PRELID1|0:HLF|0:PAEP|0:RS1|0:ADRA1D|0:TCL1A|0:REG3A|0:ADAMTS9|0:HMGA2|0:CREG1|0:HOXA9|0:ZMYM6|0:ERG|0:POMT1|0:GNRHR|0:NUDC|0:AFF3|0:CCL17|0:ZNF7|0:GNRH1|0:MMP11|0:ELAVL1|0:HMGB3|0:EVI5|0:PIM1|0:FES|0:WHSC2|0:ACRV1|0:LENEP|0:LIMD1|0:ATR|0:TNFRSF17|0:CDK13|0:ZMYM4|0:LMO1|0:MSL3|0:MYCNOS|0:ZNF256|0:CSF1R|0:PCOLCE|0:ZNF74|0:TGIF1|0:MNT|0:MXD1|0:DNM1L|0:CCBP2|0:ZNF45|0:SPDEF|0:INSL4|0:LTBP4|0:TBX22|0:TCP11|0:TBX21			
GO:0006627	P:protein processing involved in protein targ...; TAS:ProtInc		0:IMMP2L|0:MIPEP			
GO:0000247	F:C-8 sterol isomerase activity; IEA:InterPro		0:SIGMAR1			
GO:0047376	F:all-trans-retinyl-palmitate hydrolase activity; IEA:EC		0:RPE65			
GO:0014826	P:vein smooth muscle contraction; IMP:BHF-UCL		0:EDN3|0:EDN2|0:EDN1|0:EDNRB			
GO:0032534	P:regulation of microvillus assembly; ISS:UniProtKB		0:PODXL			
GO:0004758	F:serine C-palmitoyltransferase activity; IDA:UniProtKB		0:SPTLC3|0:SPTLC1|0:SPTLC2			
GO:0010269	P:response to selenium ion; IMP:BHF-UCL		0:GPX1			
GO:0016021	C:integral to membrane; TAS:UniProtKB		0:AQP3|0:TAAR1|0:TAAR8|0:TAAR2|0:TAAR9|0:TAAR6|0:TAS2R43|0:NPBWR2|0:NPBWR1|0:TAS2R14|0:TAS2R4|0:TLR8|0:TAS2R16|0:CD86|0:TAS1R3|0:TAS1R1|0:TAS2R3|0:CD93|0:MRGPRX2|0:TNFRSF10B|0:LRP8|0:QRFPR|0:TNFRSF10A|0:TAS2R5|0:TAS1R2|0:CD80|0:GHRHR|0:SORT1|0:ECE1|0:PVRL2|0:CDH1|0:CD74|0:PVR|0:LAT|0:MCTP1|0:IZUMO1|0:MCTP2|0:NFAM1|0:LAX1|0:HVCN1|0:APH1B|0:SLC17A7|0:KISS1R|0:GBA2|0:NMUR2|0:PLEKHB1|0:SCAMP5|0:SLC26A11|0:ATL3|0:CKLF|0:SLC22A16|0:BVES|0:AMOT|0:NPC1L1|0:SCAMP1|0:ATL2|0:SLC22A12|0:ADCY7|0:CREB3|0:C1GALT1|0:AOC3|0:LMTK2|0:PEX19|0:IGSF8|0:ATL1|0:SLC5A7|0:SYNE1|0:MADD|0:GOLGA5|0:BCL2L13|0:CLN5|0:LST1|0:ABCA2|0:SCARF1|0:SLC9A7|0:CDHR2|0:KCNMA1|0:RDH10|0:FXYD5|0:MIA3|0:TMPRSS6|0:CX3CL1|0:B4GALT7|0:SCAMP2|0:TCEB3CL|0:FREM3|0:KCNAB1|0:FREM1|0:TCEB3C|0:IL22RA2|0:ZNF219|0:TCEB3|0:TCEB3B|0:KCNAB3|0:AADACL2|0:STXBP5L|0:STXBP6|0:TCEB3CL2|0:TECPR1|0:KCNAB2|0:CREB3L1|0:TMEM216|0:GGT3P|0:CADM4|0:SLC10A7|0:OR2K2|0:UQCR11|0:FAT4|0:OR2V2|0:EVC|0:OR7A17|0:C9orf11|0:EPT1|0:OR10X1|0:TMEM180|0:HIGD1B|0:SLC25A46|0:GDPD5|0:OR10A2|0:OR8J3|0:OR6C1|0:GBP7|0:OR9G1|0:PCDHA13|0:CNGA3|0:CD38|0:ZDHHC6|0:PGBD5|0:MAOA|0:PLXNA1|0:HS2ST1|0:PIRT|0:LIM2|0:OR4M2|0:CLCN4|0:IGSF11|0:CHST6|0:LRRTM3|0:OR4C13|0:IZUMO2|0:NCRNA00052|0:TMEM125|0:OR4A4P|0:FUT4|0:CDH8|0:LILRA6|0:OR2T29|0:ELFN1|0:UNC5CL|0:PIGL|0:CASC4|0:GJA9|0:TMED7|0:PTCRA|0:ABCC12|0:ASTN2|0:CPD|0:HLA-DOA|0:OR11L1|0:UGT1A8|0:SERP1|0:CNTNAP3B|0:SVOPL|0:PIGG|0:C7orf53|0:LRP1B|0:ABCG8|0:ZDHHC22|0:OR8K3|0:SQLE|0:SPG7|0:UBE2J1|0:IL20RA|0:UTS2R|0:DNAJC25|0:MS4A8B|0:GYPA|0:GPR157|0:CTAGE4|0:ALG9|0:SDK2|0:SLC48A1|0:PRCD|0:KLRC4|0:JAGN1|0:RNF43|0:OR1L3|0:TOMM22|0:OR1B1|0:TMEM132A|0:RDH11|0:ALS2CR4|0:OR5W2|0:C20orf107|0:OR13F1|0:OR8B4|0:TMEM49|0:GRID1|0:SLC25A24|0:NDUFB3|0:GRAMD1C|0:ARMCX3|0:FAM20B|0:FAM73B|0:COX16|0:MAN1A1|0:NKAIN1|0:SIGLEC15|0:SLC29A4|0:EMB|0:FAM19A5|0:ST7L|0:OR5K4|0:LCLAT1|0:KRTCAP3|0:ALOX5AP|0:C19orf18|0:RFT1|0:SLC8A2|0:ATP13A2|0:PCDH20|0:KCNK9|0:OR2C1|0:ABCA6|0:GCNT6|0:EGFR|0:ZDHHC3|0:CYB5B|0:CDHR4|0:OR5L2|0:FMO6P|0:OR4C3|0:TMEM175|0:FAM134A|0:C9orf57|0:C4orf32|0:MCOLN3|0:ZNRF3|0:ENPP7|0:OR52E1|0:SHISA4|0:SEC61G|0:AWAT2|0:FAM134C|0:ACSL1|0:LRRC26|0:FAM156A|0:SLC24A4|0:SLC5A10|0:OR13A1|0:OR2A25|0:CXorf59|0:C11orf92|0:P2RY10|0:UNC50|0:MT-CO1|0:SDC3|0:TMEM218|0:TOMM70A|0:C4orf49|0:TSPAN18|0:GPR150|0:TMEM78|0:PTGFRN|0:OR4D5|0:SIGLEC5|0:LRRN4CL|0:DAGLA|0:HCN4|0:CEACAM19|0:TMEM133|0:MPEG1|0:TMCO5B|0:TMIE|0:FNDC3B|0:VMA21|0:PCDHGB3|0:ATRNL1|0:SUN3|0:C8orf49|0:PDCD1LG2|0:MBOAT7|0:OR2M3|0:RPN2|0:JPH1|0:NINJ1|0:SEC61A2|0:UCP3|0:SFXN4|0:TREM1|0:VAMP7|0:OR52E6|0:SLC13A3|0:LRIT3|0:SLC25A31|0:STX6|0:OR2T6|0:SLC45A1|0:CLEC9A|0:UGT8|0:SLC25A23|0:SFXN5|0:ADCK5|0:RELL2|0:LAPTM4B|0:TMEM147|0:SYT4|0:SLC38A11|0:NCLN|0:KLRB1|0:CCDC51|0:SLC44A4|0:ERGIC1|0:ERBB4|0:OR2T33|0:RTP3|0:CLGN|0:SLC25A37|0:OR5AS1|0:OR10D3|0:FAM75A1|0:OR4C46|0:RTL1|0:MRVI1|0:ELOVL3|0:OR51Q1|0:OR9G9|0:GALNT13|0:OR5AU1|0:CMTM1|0:SLC25A1|0:RNASEK|0:TMEM66|0:ACBD5|0:TMC2|0:UGT2B15|0:PPAP2C|0:PAG1|0:C11orf34|0:ESYT3|0:RAET1G|0:OR2W3|0:ERMP1|0:C3orf20|0:SCD5|0:LASS6|0:C17orf60|0:SLC47A1|0:CCDC155|0:SLC22A20|0:THSD1|0:OR1G1|0:PROKR1|0:CDH17|0:CD180|0:TMPO|0:KIAA1524|0:SV2B|0:PKD1L2|0:KCNJ9|0:TMEM14A|0:FAM18A|0:OR2A5|0:C19orf42|0:RNF19B|0:PCDHA9|0:OR2AK2|0:XKR5|0:SILV|0:PLD5|0:MTCH1|0:GALNT12|0:C2orf24|0:SLC30A4|0:MCAM|0:OR7C1|0:CD8BP|0:DENND5B|0:CLMN|0:UGT1A4|0:RDH16|0:GRAMD4|0:ATG9A|0:TMEM40|0:GPAT2|0:HIAT1|0:SLC35C2|0:MR1|0:SLITRK6|0:TNFRSF12A|0:ACCN5|0:PPP1R3A|0:PRRT3|0:ATG9B|0:OR5M11|0:NSDHL|0:MYADML|0:MRGPRX1|0:CLDN19|0:TMEM67|0:CLDN12|0:OR51L1|0:OR4A5|0:ASGR2|0:FAM119A|0:ZDHHC11|0:TMEM150C|0:B3GALT4|0:OSCAR|0:IFITM3|0:DSC3|0:GPR179|0:CD200R1L|0:HTR2B|0:PGRMC1|0:NUS1|0:OR5M8|0:C10orf57|0:B3GALNT1|0:OR13C8|0:SNPH|0:B3GNT4|0:CDH22|0:AKAP1|0:PIGA|0:SLC35E4|0:SURF1|0:GDPD3|0:MARCH6|0:OR2A42|0:MT-ND3|0:FMO5|0:TNFRSF1B|0:FAM69A|0:PAQR5|0:CORIN|0:CD300LB|0:GJD2|0:OR51E1|0:TMEM116|0:FAM74A2|0:SLC26A9|0:SLC25A19|0:FCRL4|0:C9orf125|0:NOMO2|0:RHBDF2|0:OR2G3|0:C3orf57|0:TMEM201|0:TMEM121|0:TMX1|0:TMEM198|0:SLC39A3|0:DISP2|0:C3orf18|0:ATP13A5|0:SLC41A3|0:TMEM128|0:TSPAN6|0:FAM162A|0:GNRHR2|0:AMN|0:CLDN20|0:PEMT|0:C10orf111|0:VANGL1|0:NDUFA3|0:RNF130|0:TMEM93|0:PTPLAD2|0:KITLG|0:OR1S1|0:TNFSF9|0:CNIH3|0:STX16|0:PAQR9|0:TMEM119|0:ST7|0:TM4SF19|0:MFSD9|0:NOTCH3|0:CALHM2|0:PCDHGA6|0:OR10G2|0:SLC22A9|0:TAS2R20|0:CDKAL1|0:TARM1|0:LRP11|0:PARM1|0:MS4A14|0:SLC25A43|0:UBE2J2|0:OR4F6|0:SGPP1|0:SLC35B4|0:UGT3A2|0:C6orf162|0:PTPLA|0:PIGX|0:NCRNA00185|0:TMEM139|0:SLC38A5|0:SLC16A14|0:FXYD6|0:UNC5A|0:NCRNA00219|0:SUSD2|0:NOC4L|0:GPR153|0:TMEM14E|0:USE1|0:TMCO3|0:CLEC4E|0:MGAT4B|0:OR6M1|0:LAIR1|0:LRRC8D|0:MRAP|0:UBR3|0:MRGPRD|0:UGT2B10|0:TPCN1|0:AADACL4|0:C4orf52|0:KLRG2|0:SLC7A3|0:SLC36A3|0:SLC35D2|0:ERLIN2|0:CEACAM16|0:C17orf101|0:TMEM200A|0:ADCK4|0:EBPL|0:SLAMF1|0:USP19|0:TMEM87B|0:CD300A|0:CNIH|0:SLC35A5|0:SLC10A4|0:EFHA2|0:TMED9|0:UGT2B4|0:SRD5A2|0:ALPP|0:C5orf4|0:OPA1|0:MMP23B|0:TMEM140|0:TMEM212|0:G6PC2|0:OR13H1|0:TMEM82|0:SPACA1|0:LRBA|0:SIGLEC16|0:TMIGD2|0:C1GALT1C1|0:HS3ST6|0:AMAC1L1|0:CCDC90B|0:SLC25A34|0:ENTPD2|0:COX7B|0:MARCH3|0:UGT2A3|0:SYT7|0:KCNN3|0:DPY19L3|0:TEX10|0:OR10A6|0:GXYLT2|0:MFAP3L|0:CWH43|0:CHST2|0:TNFRSF8|0:GLCE|0:DAG1|0:OR4D2|0:C19orf38|0:OR4F29|0:OR52E5|0:FUT8|0:TMEM62|0:SERINC4|0:DLL4|0:HTR3D|0:SSR4|0:OR4A16|0:MS4A3|0:LINGO3|0:FKBP8|0:KIAA1109|0:GSG1L|0:SLC25A40|0:C2orf18|0:XKRY|0:GGT1|0:SLC7A13|0:UGT2A2|0:OR1D5|0:ALG10B|0:PCDHGB7|0:SFXN1|0:TEDDM1|0:ATP9A|0:TAS2R42|0:C10orf128|0:FAM176B|0:GPRC5D|0:BTN2A2|0:PGAP1|0:TMEM136|0:SIRPA|0:SRD5A1|0:SLC37A2|0:LINGO2|0:SLC25A27|0:SLC39A13|0:ITFG3|0:ARL6IP5|0:CLDN25|0:KCNJ12|0:KLB|0:OR6T1|0:CALN1|0:CLEC17A|0:SEMA6D|0:EXTL3|0:TMEM97|0:EXTL2|0:OR51F2|0:CNIH4|0:C18orf26|0:OR1F2P|0:MRGPRE|0:TMEM14B|0:GRINA|0:LRIT2|0:SLITRK2|0:CD209|0:GJC2|0:SEZ6L|0:SEC11A|0:OR2AP1|0:SLC7A5P1|0:PDCD1|0:OR5P2|0:TMEM229B|0:OR51D1|0:LAMP2|0:SLC2A7|0:MADCAM1|0:GCNT3|0:TMEM120A|0:SLC35F2|0:OR56A5|0:OR2A14|0:TRPV3|0:SHISA7|0:OR4Q3|0:LMF2|0:ATP8A2|0:SLC24A3|0:SLC22A24|0:OR5H15|0:TMEM184C|0:CNNM2|0:GALNT1|0:KNCN|0:HIGD2A|0:PEAR1|0:FAM36A|0:OR1S2|0:KDSR|0:HAVCR2|0:LPCAT1|0:TMC7|0:C14orf176|0:OR10J4|0:IFI27L2|0:ACSL4|0:TMEM176B|0:COMT|0:GPR108|0:TMEM54|0:LETMD1|0:STT3B|0:TMEM63A|0:LASS2|0:WLS|0:AGPAT9|0:OR52H1|0:SLC30A9|0:TSPAN11|0:YIF1B|0:OR1L6|0:C5orf50|0:AMICA1|0:ODZ2|0:NUP210L|0:GPR101|0:SLC39A7|0:OR14A16|0:OR7C2|0:DNAJC22|0:TMEM18|0:TMEM86A|0:CYP2U1|0:TMEM45A|0:SLC2A13|0:AQP10|0:GREB1|0:REEP3|0:LMBRD1|0:SLC25A16|0:SLC2A3|0:NDST4|0:AGPAT3|0:OR10G7|0:OR2AE1|0:OR13C4|0:CCDC108|0:LAG3|0:TMEM44|0:OR10H4|0:CTAG2|0:MT-CYB|0:MGAT5B|0:C10orf76|0:IL17RE|0:OR4N4|0:TMEM171|0:MT-ATP8|0:COX8C|0:TMTC3|0:FURIN|0:RHBDD2|0:OR11H6|0:TMEM57|0:LPCAT2|0:DUOXA1|0:CYC1|0:NYNRIN|0:DISP1|0:DCST2|0:TNMD|0:MT-ND4|0:FAM18B2|0:LRRN4|0:C1orf159|0:TMC1|0:DRAM1|0:TSPAN33|0:C10orf35|0:LRFN2|0:MEGF9|0:ITPRIPL1|0:C1orf210|0:TMEM55B|0:OSTM1|0:CLCN7|0:PCDHGA9|0:LCTL|0:SLC5A9|0:FAM118A|0:NDUFB6|0:CSMD1|0:CMTM6|0:KCNK12|0:C3orf43|0:SEMA4B|0:NIPAL2|0:OR12D2|0:OR5B21|0:HEG1|0:OR2T34|0:AMAC1L3|0:MS4A6E|0:GALNT4|0:GPR26|0:FAM151A|0:THSD7B|0:DUOX1|0:OR9K2|0:CD34|0:SLCO4A1|0:HLA-F|0:PCDHGA2|0:TMEM158|0:CD244|0:ZDHHC15|0:SLC5A12|0:HERPUD1|0:JKAMP|0:CADM3|0:CDH16|0:PCSK4|0:CLECL1|0:PPAPDC1A|0:SGCA|0:YIPF1|0:UCP1|0:PLD4|0:TNFSF13B|0:EPHX1|0:TMEM35|0:C19orf77|0:TMEM188|0:C17orf28|0:ZDHHC23|0:AQP12B|0:PRR7|0:MPZL3|0:KCNK15|0:GPR146|0:ZP4|0:PARL|0:TMEM231|0:ADCY6|0:CYP51A1|0:SIGLEC10|0:FAM26E|0:C1orf175|0:MGAT4A|0:OR5K2|0:NHEDC2|0:FAM23B|0:VN1R1|0:OR4C6|0:TMEM163|0:FMO2|0:MOGAT1|0:TMEM191A|0:LPAR6|0:SLC26A5|0:PLLP|0:RNF121|0:TMEM219|0:MEST|0:HTRA2|0:TMEM30A|0:CD300LF|0:OR51A4|0:UGT2B11|0:COX11|0:NPTN|0:OR7G3|0:CISD1|0:SYT14|0:UNC93B1|0:SPCS2|0:OR6V1|0:ALG10|0:PI16|0:C9orf167|0:PVRL3|0:ADAM20|0:TMEM199|0:C2orf28|0:B3GALNT2|0:DNER|0:C19orf28|0:CD300E|0:NRG1|0:OR2L3|0:MARVELD2|0:DGCR2|0:VSIG10|0:C6orf72|0:FAM155B|0:SLC17A8|0:OR51G1|0:ATP10B|0:C1orf130|0:KHDC1|0:LRRC3B|0:C3orf21|0:SEC22A|0:GRIA2|0:GPR61|0:RPRML|0:PLSCR3|0:C12orf69|0:FAM38B|0:SLC18A1|0:ATF6B|0:ABCC6|0:OTOP2|0:OR13C2|0:FAM134B|0:SIRPB2|0:SLC2A5|0:OR5L1|0:TMX4|0:HLA-DRB4|0:OR9I1|0:ADAM7|0:SLC12A8|0:TMEM174|0:LRRN1|0:IGSF3|0:LHFPL2|0:SLC26A10|0:MANEA|0:OR2J1|0:MFF|0:MFSD8|0:TM4SF4|0:B3GNT7|0:BCL2|0:KIAA1324|0:TIMM22|0:ADAM32|0:AQP2|0:B3GALT5|0:SAMM50|0:MFN2|0:TLCD2|0:RHBDF1|0:PCDH18|0:TM6SF1|0:SEZ6|0:CLDN6|0:AWAT1|0:CMTM3|0:HEPHL1|0:YIPF2|0:LRRC53|0:TMCO7|0:OR2B2|0:RIC3|0:NDUFA13|0:TOMM20L|0:SCAMP3|0:GPR158|0:CATSPER1|0:ERMAP|0:IGSF9|0:ATP2B2|0:TRAM2|0:ZNRF4|0:OR52K1|0:RPN1|0:CSMD3|0:XKR9|0:SLC38A9|0:PCDHGA10|0:MIR17HG|0:SDR16C5|0:GPR174|0:ATP6V0A2|0:KIAA0319L|0:FAM75A4|0:XKRX|0:SDHD|0:DAGLB|0:TMEM90A|0:OR4F17|0:SYNGR4|0:OR11H12|0:OR11H4|0:SLC44A5|0:IL15RA|0:COMTD1|0:PCDHA12|0:AREG|0:SLC37A1|0:SPTLC3|0:OR6C4|0:DPY19L2P2|0:SLC23A3|0:GPR160|0:GPR81|0:GPM6A|0:SFXN3|0:IL18RAP|0:SLAMF6|0:AVL9|0:SLCO1C1|0:SLC25A30|0:SLC22A5|0:QSOX2|0:C9orf46|0:PAM|0:SLC39A4|0:GPIHBP1|0:GRAMD1B|0:FNDC4|0:GDPD4|0:OR8J2|0:ENTPD6|0:OR2V1|0:SCAMP4|0:FAM171B|0:TLR10|0:SLC30A8|0:RXFP4|0:CDON|0:SLC10A6|0:PTPRQ|0:LRRTM2|0:TMEM181|0:CLPTM1L|0:TMC5|0:OR4D6|0:MRC1L1|0:TMEM126A|0:TMEM221|0:OR4S2|0:APOO|0:ARMCX1|0:TNFRSF21|0:LY6G6F|0:TMPRSS7|0:CD247|0:CDAN1|0:PKHD1L1|0:P2RX2|0:OR5D18|0:SLC9A4|0:GPAM|0:ESYT2|0:SLAMF7|0:INTS2|0:TYR|0:ATP6AP2|0:GDPD2|0:SLC35C1|0:ILDR2|0:TTTY13|0:OR8H2|0:UNC5D|0:DIO1|0:HIGD2B|0:FZD3|0:C10orf105|0:ASTN1|0:TMEM135|0:SLC27A2|0:C17orf78|0:HLA-DOB|0:AIG1|0:TMED6|0:CNNM3|0:ABHD14A|0:CYB5A|0:ABCA5|0:TSPAN17|0:ABCC8|0:XKR4|0:ALG1|0:TMEM215|0:ODF4|0:UBR4|0:KCNE4|0:CH25H|0:RHBDD1|0:PIGM|0:SOAT2|0:OR10AD1|0:USP30|0:OR52P1P|0:OR2S2|0:ZDHHC2|0:TMEM111|0:FCRL6|0:OR5AK3P|0:CD4|0:PTPRE|0:OR6C70|0:IFI27L1|0:JAM3|0:LAPTM4A|0:DIRC2|0:TRPM8|0:FCGR2B|0:CLDN11|0:MXRA8|0:C6orf192|0:B3GNT9|0:HTR2C|0:SYT10|0:FMO4|0:PAQR6|0:LRRC38|0:ATP11A|0:MUC16|0:FAS|0:BTN3A2|0:PCDHGA7|0:SLC26A3|0:OR7D4|0:OR2L5|0:TMCO5A|0:LMF1|0:SLCO3A1|0:GALNT5|0:ALG14|0:TEX261|0:OR2G2|0:C7orf42|0:FCRL3|0:TMCC2|0:TECR|0:RNF144A|0:MARCH5|0:DULLARD|0:NDUFB4|0:ATP13A4|0:ANTXR2|0:TMEM74|0:FAM69B|0:MAGT1|0:MS4A6A|0:SCNN1D|0:SLC32A1|0:ERN2|0:BTN2A3|0:CXorf66|0:CDH18|0:OR1J1|0:DPCR1|0:SLC1A2|0:PCDHGC4|0:P4HTM|0:TMEM209|0:OR4F5|0:ZDHHC12|0:SVOP|0:SLC36A4|0:ITPR1|0:TBC1D20|0:OR10P1|0:STX7|0:ZDHHC19|0:MRC2|0:C10orf112|0:TM4SF18|0:TMEM169|0:OR2T2|0:C18orf62|0:FAM69C|0:LRRC15|0:WBSCR17|0:RNFT2|0:PCDHGB2|0:NDFIP2|0:TMEM75|0:OR4C45|0:MS4A15|0:TMEM106A|0:ACSL5|0:GPR149|0:TMEM129|0:SLC35B3|0:GJB7|0:SUN2|0:KDELR3|0:MMEL1|0:MFSD1|0:TRBC2|0:HCN3|0:MCL1|0:OPALIN|0:C5orf40|0:TMEM154|0:HSD3B7|0:ACE|0:MFSD2B|0:FMR1NB|0:SGPP2|0:GIMAP2|0:CD37|0:C9orf4|0:OSTC|0:TMEM51|0:WDR11|0:CMTM2|0:FITM1|0:STX1A|0:OR2A12|0:SERINC5|0:FAM198B|0:C7orf66|0:GAL3ST2|0:AIFM2|0:SLITRK5|0:S1PR1|0:CD79A|0:OR10G3|0:OR10G8|0:C16orf91|0:CYB5R1|0:CALHM3|0:AGPAT2|0:SLC12A1|0:LEMD1|0:ZDHHC5|0:CYP4Z2P|0:FAR1|0:KLRC3|0:TSNARE1|0:OR11H1|0:KIAA1409|0:OR4K17|0:TM2D2|0:PPM1L|0:C6orf10|0:SPNS3|0:PPAP2B|0:TMEM22|0:SLC41A2|0:TNFRSF11A|0:OXER1|0:RTP4|0:RRP12|0:MRS2|0:NIPA1|0:IL7R|0:OR5AR1|0:C11orf24|0:DSEL|0:C19orf24|0:TLR9|0:HLA-DMA|0:GPR137|0:PTCHD3|0:FAM74A1|0:SLC35A3|0:TCTN2|0:MT-CO2|0:GALNT11|0:TOR1AIP2|0:ENPP6|0:ERVWE1|0:TMEFF1|0:HSD17B12|0:PLB1|0:OR52N2|0:C20orf108|0:CLRN3|0:OR11A1|0:TMEM132B|0:KCNK18|0:SV2C|0:CACNA2D4|0:SFT2D1|0:FICD|0:TAS2R38|0:TMEM31|0:PCNXL2|0:TMEM101|0:C14orf165|0:CDH5|0:TNFRSF10D|0:UGT1A5|0:NPTXR|0:OR10A7|0:CMTM7|0:SLC16A10|0:TMEM178|0:PTGIS|0:CEACAM3|0:C10orf26|0:MLC1|0:GOLT1A|0:MMGT1|0:ADAM12|0:FRAS1|0:OR2B6|0:ATP13A1|0:SIDT1|0:TMCC3|0:C1orf27|0:SLC4A8|0:COX6C|0:SLC13A1|0:S1PR2|0:OR5AC1|0:CLCC1|0:ENTPD3|0:ALDH3A2|0:MT-ND4L|0:SLC27A3|0:SLC38A10|0:BTN3A1|0:UGT1A10|0:OR14K1|0:TMEM120B|0:ALCAM|0:ADAM19|0:PNLDC1|0:TMEM92|0:OR2B8P|0:OR2C3|0:BAMBI|0:MRGPRF|0:KCNE3|0:PLD6|0:NKAIN3|0:TMEM14C|0:SEC11C|0:SLC38A4|0:VTCN1|0:ARL6IP6|0:VSIG8|0:PAPPAS|0:C12orf59|0:SPG11|0:VN1R4|0:OR10J3|0:OR52E2|0:PXMP2|0:VAMP4|0:BCAP29|0:SLC39A12|0:SNN|0:OR5K1|0:YIPF6|0:MOGS|0:TP53I13|0:CLDN9|0:SLC17A9|0:C9orf7|0:IER3|0:MOSPD1|0:TMEM170A|0:TM4SF20|0:GLDN|0:EGF|0:VSIG1|0:HIATL2|0:CTAGE9|0:TMEM79|0:DNAJC16|0:OR1J2|0:KIT|0:MARVELD3|0:OR8K1|0:OR52A4|0:FTSJD1|0:MUC3B|0:FCGR3A|0:VEZT|0:RNF150|0:C1orf66|0:ORMDL1|0:OR51S1|0:GCNT2|0:SURF4|0:C1orf91|0:BCS1L|0:C20orf141|0:ACE2|0:SEL1L2|0:C17orf95|0:CDRT15L1|0:ADCK2|0:OR4K3|0:OR6Y1|0:OR3A1|0:TMEM225|0:SMCR7|0:ALG11|0:USMG5|0:MPDU1|0:LASS3|0:NLGN3|0:TPST2|0:OR1N2|0:MAVS|0:TSPAN14|0:OR5H14|0:C17orf56|0:ERGIC3|0:CREB3L4|0:C1orf9|0:SLC2A1|0:OR13C5|0:ATP2A3|0:EPCAM|0:OR5T2|0:PTDSS1|0:SLC38A6|0:B3GALT2|0:HMGCR|0:EMCN|0:OR6P1|0:LECT1|0:SLC25A2|0:TMED3|0:GALNTL4|0:CLEC4D|0:ODZ3|0:TMEM68|0:SLC2A14|0:OR52B2|0:ABCA10|0:FAAH2|0:OR4K14|0:KIDINS220|0:NKAIN4|0:CD99L2|0:ICMT|0:ADAM28|0:UNC5C|0:PRIMA1|0:OR14I1|0:OR2L2|0:GPBAR1|0:CSMD2|0:CEACAM21|0:SORCS3|0:TMIGD1|0:PIGQ|0:CLSTN3|0:BLCAP|0:HLA-DPB1|0:OR52N5|0:MGAT4C|0:TUSC3|0:CD163L1|0:TSPO2|0:MCHR2|0:HYAL4|0:TMEM38B|0:SMPD3|0:CCDC56|0:HLA-G|0:SLC25A20|0:SYT8|0:TRPC6|0:OR56B1|0:PIGY|0:STRA6|0:LHFP|0:C6orf174|0:C22orf32|0:MT-ND5|0:C20orf103|0:OR11H7|0:SLC25A36|0:PKD1L3|0:YIF1A|0:PCDH17|0:PTPLB|0:TMEM108|0:PQLC1|0:NKPD1|0:OR5B17|0:NDUFB11|0:SLC39A8|0:LHFPL5|0:TMEM115|0:SLC10A5|0:OR13J1|0:DGKE|0:OR6C68|0:ALG5|0:GPR120|0:PCDHGB6|0:AGPAT5|0:OR6N1|0:FCGR1A|0:KCNH7|0:SEMA4A|0:BOC|0:TIMM23B|0:NFXL1|0:TMEM211|0:SLCO5A1|0:ZMPSTE24|0:TMEM107|0:CPT1C|0:PMP22|0:HTR3E|0:PIGC|0:B4GALT5|0:LRAT|0:IL18R1|0:MARCH11|0:ARMCX4|0:CTXN3|0:CYBRD1|0:OR2Z1|0:TMEM88|0:SLC25A41|0:OR14J1|0:TAS2R50|0:AMIGO2|0:TMEM26|0:PVRL4|0:INSIG1|0:FAM176A|0:XYLT1|0:TMTC2|0:SLFN12L|0:FAM165B|0:ACER1|0:KCNMB3L|0:NAT14|0:SLC5A11|0:DHCR24|0:ZPLD1|0:VAMP8|0:TAS2R60|0:PANX1|0:OR2T7|0:DCHS2|0:MPZL2|0:FRMD3|0:SUSD5|0:KIR2DL2|0:TXNDC15|0:TMEM204|0:GPR180|0:BIK|0:B4GALNT4|0:STX2|0:MPPE1|0:AADAC|0:LRRC8C|0:MAN2A2|0:ZDHHC16|0:TAPBPL|0:DPP4|0:OR5H1|0:SLC26A8|0:TMEM159|0:GPR173|0:EVC2|0:AFG3L2|0:C5orf15|0:LILRB4|0:ADIG|0:SLC8A3|0:STOML1|0:OR5K3|0:RNF180|0:GPR148|0:RNF215|0:IFITM5|0:LRFN3|0:PPAPDC3|0:SUN1|0:ZP1|0:GJB3|0:LRRC37BP1|0:ZDHHC24|0:OR56A4|0:ELOVL7|0:CCDC109B|0:C8orf83|0:IL13RA2|0:OR5M9|0:LRIG3|0:STARD3|0:CRB2|0:SLC16A9|0:ANKRD46|0:TMC8|0:HIGD1A|0:TMEM191B|0:HSD3B1|0:CD207|0:STARD3NL|0:OR2I1P|0:MEGF8|0:CAMLG|0:CDH26|0:SCAI|0:NRG2|0:LAT2|0:SLCO1A2|0:GALNT7|0:FAM155A|0:DPY19L2|0:CDHR3|0:OR5H6|0:SLC24A2|0:SEC22B|0:C17orf87|0:C1orf185|0:GRIA3|0:PNPLA8|0:FMO1|0:SLC35F3|0:SGCG|0:TMEM184B|0:FREM2|0:RGS9BP|0:TMEM41B|0:FAM26F|0:GPR88|0:COL13A1|0:KCNK4|0:B3GALTL|0:TMPRSS15|0:TRPM4|0:GJC3|0:OR56B2P|0:B3GAT2|0:EPS15L2|0:C1orf95|0:OR9A2|0:OR2G6|0:SLC35A4|0:DSG4|0:TMEM86B|0:OR2AT4|0:C14orf135|0:ZDHHC18|0:TMBIM4|0:MOXD1|0:SLC25A47|0:TMEM45B|0:SMCR7L|0:CNNM1|0:IKBIP|0:CLDN15|0:OR51A2|0:UGT1A9|0:LIME1|0:GPR137C|0:OR2A2|0:C5orf43|0:GPR27|0:TRIM13|0:SLC35D3|0:ZDHHC9|0:IL3RA|0:TSPO|0:TSPAN10|0:SEMA6C|0:STX12|0:OR8H3|0:C11orf87|0:OR7G2|0:FNDC5|0:SYS1|0:RNF148|0:FAIM2|0:LRRC4B|0:SLC22A25|0:KIAA1549|0:PCDH10|0:KIAA1467|0:MRGPRX3|0:TMEM138|0:TMEM131|0:KCNU1|0:ANTXRL|0:TGFA|0:MS4A4E|0:CATSPER3|0:TMEM144|0:C1orf70|0:DSG3|0:SLC46A1|0:COX7A1|0:TMEM17|0:XKR8|0:MS4A7|0:OR1F1|0:C1orf151|0:TXNDC11|0:TMEM220|0:ROBO2|0:TM7SF3|0:OR10H3|0:OR5AK2|0:SLITRK1|0:GXYLT1|0:REEP4|0:DNAJB12|0:KIAA0319|0:OR5V1|0:PLD3|0:SERINC1|0:SLC9A8|0:LRP4|0:C3orf35|0:SYVN1|0:FUT5|0:CLDND2|0:F11R|0:DCC|0:C5orf62|0:FAM75A7|0:ADAM15|0:LGR4|0:TRDC|0:FAM38A|0:G6PC3|0:ABCB8|0:MAL2|0:OR5D13|0:ATP5G1|0:NHEDC1|0:CXCR4|0:PTPRR|0:ESYT1|0:TMC4|0:OR7A10|0:STYK1|0:OR2W1|0:REEP6|0:ATP5G2|0:TMEM42|0:SEMA4D|0:AGPAT1|0:FER1L5|0:TMEM132E|0:FIBCD1|0:SLCO2B1|0:KIAA0090|0:TMEM52|0:OR4A15|0:SEL1L3|0:OR8J1|0:NAT8L|0:GRAMD2|0:FAM174A|0:C6orf70|0:ALG2|0:FAM75A3|0:INTS1|0:FAM82A2|0:OR4N5|0:COX8A|0:TMEM59|0:TMEM104|0:OR10J6P|0:OR4D10|0:LRRC8A|0:ARSH|0:SLITRK4|0:CDC14C|0:CD53|0:DBH|0:C6orf105|0:LTBR|0:ANKLE2|0:SLC9A3|0:SLC39A5|0:OR4S1|0:C16orf62|0:KCNK10|0:OR6A2|0:C19orf6|0:ZDHHC11B|0:ZAN|0:ENTPD7|0:GJB5|0:ATP6AP1L|0:OR56B4|0:VRK2|0:SLC34A3|0:NDUFB8|0:STOML3|0:PAQR3|0:PSD2|0:TMEM189|0:CLEC2A|0:GPR135|0:TM9SF4|0:SIRPG|0:PRRT1|0:TPTE2|0:AQP11|0:TLR5|0:CLDN10|0:MEGF11|0:KCNK7|0:OR6S1|0:DSC1|0:OR2L13|0:SLC16A11|0:RTP1|0:RNF175|0:OR2A7|0:PPAPDC1B|0:OR52Z1|0:OR52N1|0:MCART1|0:MT-ND6|0:NIPA2|0:SLC30A2|0:SLC25A39|0:C17orf62|0:C9orf135|0:GYLTL1B|0:TMEM134|0:FKTN|0:DPP6|0:GALNT10|0:OR9A1P|0:XKR3|0:TCTN3|0:CABP7|0:PAQR7|0:BRI3BP|0:FCGR2A|0:ATP11B|0:C17orf74|0:OR6B2|0:TMBIM1|0:ZDHHC1|0:IMPG2|0:SLC35F5|0:ATP2C2|0:PNPLA3|0:C6orf89|0:CEND1|0:ESAM|0:TMEM182|0:RNF167|0:OR8H1|0:SLC17A6|0:FMO3|0:NETO1|0:GALNT6|0:OR2H2|0:DPY19L2P1|0:TMX3|0:GPR161|0:TMEM196|0:MXRA7|0:GLT8D1|0:CLDN14|0:AQP7P3|0:ZDHHC20|0:TMEM43|0:OR10H5|0:LRRC70|0:TMEM50B|0:C12orf67|0:MUC17|0:SCARA3|0:LPCAT4|0:NPIPL3|0:LILRA1|0:FUT11|0:CMTM4|0:OTOP3|0:CRB3|0:B3GALT6|0:PLXNB2|0:ILDR1|0:SLC15A3|0:CANT1|0:FCRL5|0:SYNJ2BP|0:PTGES2|0:TMUB1|0:TRPM3|0:C16orf79|0:IL10RA|0:TMEM64|0:C16orf58|0:CNTNAP5|0:SLC1A3|0:PCDHGA11|0:TOMM5|0:SLC41A1|0:C20orf30|0:ELOVL1|0:SLC39A10|0:B3GNT6|0:C1orf223|0:GJC1|0:KIRREL|0:C4orf34|0:ADCY4|0:SLC46A3|0:OR6C65|0:MS4A12|0:C9orf123|0:LDLRAD1|0:TIMM50|0:GPR63|0:PCDHGC3|0:TMEM232|0:OR10G4|0:TMEM183B|0:DCHS1|0:CD200R1|0:NIPAL1|0:ATP2B3|0:LY9|0:C12orf23|0:C11orf41|0:OR4L1|0:C7orf23|0:SLC26A7|0:PTDSS2|0:FKBP11|0:TMEM30C|0:CHPF|0:TMEM88B|0:OR4F16|0:TRAM1L1|0:TMEM208|0:KIR2DL5A|0:HEPACAM|0:YIPF3|0:TMEM110|0:PCDHGA3|0:FLVCR2|0:TMEM206|0:OR2AJ1|0:NRXN2|0:UGT2B28|0:PLXNA3|0:CHPT1|0:OR6X1|0:UGCG|0:OR4P4|0:PTPRCAP|0:ARV1|0:C14orf109|0:LILRA4|0:SLC15A5|0:OR10G9|0:C16orf92|0:NDST1|0:C11orf75|0:DDOST|0:KCNT1|0:SLC39A14|0:TMEM60|0:CREB3L3|0:TMEM127|0:DSCAML1|0:PLN|0:APCDD1L|0:GJB6|0:PLP2|0:OR10J5|0:C1orf101|0:OR56A1|0:SYT5|0:RTN3|0:C6orf191|0:PCDHB8|0:OR13G1|0:B4GALT1|0:SLC25A44|0:CLDN22|0:FAT2|0:OR4C16|0:NCRNA00116|0:LRRC4|0:OR52I1|0:OR2W6P|0:ECE2|0:NCEH1|0:OR4E1|0:OR8A1|0:SLC7A14|0:TRPC7|0:C3orf33|0:FCGR1B|0:CYP4F3|0:RNF103|0:ALG12|0:SELE|0:NLGN2|0:FAR2|0:TM2D3|0:CLEC4C|0:PLAC2|0:FAAH|0:OR5M1|0:ZDHHC4|0:ABCA8|0:OR14A2|0:TMEM132C|0:TMEM47|0:MFSD2A|0:C10orf72|0:HLA-DMB|0:KCNK17|0:HLA-A|0:OR9G4|0:SCD|0:TPCN2|0:SLAMF8|0:PTCHD2|0:SEZ6L2|0:NDUFB5|0:TMEM214|0:ITM2C|0:TMED5|0:CDH6|0:TNFSF18|0:OR5AN1|0:OR10K2|0:UGT1A6|0:OR4A8P|0:FXYD4|0:OMA1|0:TMEM63B|0:FAM173A|0:SPAG4|0:SOAT1|0:GTSCR1|0:MT-ND1|0:OR2T11|0:ADAM21|0:GDPD1|0:UGT2A1|0:TMEM100|0:GAPT|0:CACNA2D3|0:OR10S1|0:MGAM|0:OR5A2|0:SIGIRR|0:DNAJC14|0:IL1RAPL2|0:PECAM1|0:TMEM9|0:LRRC52|0:B3GNT8|0:KIAA0247|0:LRRC55|0:CYP26C1|0:PCDH11Y|0:SLC24A6|0:RNFT1|0:LRRC24|0:C11orf90|0:OR52M1|0:TAS2R45|0:SFT2D3|0:CLEC14A|0:GJA3|0:TMPRSS5|0:ENPP5|0:SPNS2|0:ORMDL2|0:GGT7|0:C1orf98|0:EMD|0:RNF144B|0:FXYD7|0:OR10W1|0:LHFPL1|0:OR2B11|0:C19orf12|0:PGAP3|0:FAM23A|0:C8orf40|0:ABHD3|0:PIGN|0:GALNTL1|0:OR9Q1|0:TMCC1|0:SLC25A6|0:TMEM177|0:LRRC37A3|0:BTN3A3|0:C12orf51|0:LRRC59|0:OR2L8|0:PANX2|0:SERAC1|0:FAM55B|0:C12orf53|0:GCNT4|0:RHBDL2|0:XG|0:SYNPR|0:PCDH9|0:ITFG1|0:EXTL1|0:GBP3|0:ILVBL|0:RNF186|0:ORAI2|0:OR4K5|0:HLA-DRB1|0:OR2T3|0:LINGO4|0:ACSL6|0:CANX|0:SLC25A28|0:ADIPOR2|0:TMEM150A|0:CATSPER2|0:CLDN8|0:TMEM126B|0:DPY19L4|0:GIMAP5|0:OR5H2|0:OR52E8|0:SHISA2|0:OR2F2|0:TECRL|0:TMEM141|0:CTAGE1|0:HSD11B1|0:OR14C36|0:TRBC1|0:LHFPL3|0:IL20RB|0:TRIM59|0:FAM70A|0:RAET1E|0:AMAC1L2|0:LRRC37A|0:CYP4F11|0:TMEM90B|0:TMEM168|0:NDFIP1|0:DPP10|0:GOLT1B|0:PCDHGB1|0:OR11H2|0:SUSD1|0:TMEM106B|0:LRIG2|0:SLC27A5|0:HHATL|0:C19orf59|0:OR52K2|0:PCNXL3|0:PINK1|0:C16orf54|0:UGT2B17|0:HLA-DRB5|0:UGT1A1|0:LRRN2|0:OR5D14|0:OR10AG1|0:BET1L|0:FRY|0:OR6B3|0:DAD1|0:HCST|0:OR8D4|0:MT-ATP6|0:OR5AP2|0:PARP16|0:TAS2R30|0:FITM2|0:TAS2R39|0:TMEM63C|0:EVI2A|0:IL17RC|0:GIMAP1|0:TMEM191C|0:GJB1|0:FRRS1|0:GPR89C|0:MFSD11|0:FAM162B|0:TMEM151B|0:C14orf132|0:GUCY2C|0:PEX11G|0:HHLA2|0:SLC25A21|0:CLSTN2|0:PTGES|0:LEMD2|0:NOMO1|0:OR4X1|0:OR1I1|0:YIPF7|0:ABCC11|0:AGTRAP|0:OR8D1|0:OR13D1|0:MT-ND2|0:GPR132|0:OR2T12|0:PLXNB3|0:FAIM3|0:SORCS2|0:TMPRSS11BNL|0:TMEM25|0:NIPAL4|0:ALG6|0:CATSPER4|0:LRTM1|0:SLC25A18|0:IGHD|0:TRGC1|0:SEC63|0:TOR1AIP1|0:OR6N2|0:ATP8B4|0:OR10T2|0:OR5B2|0:P2RY8|0:DSE|0:SLC39A9|0:PQLC2|0:BTNL3|0:TMEM69|0:EPHX4|0:SLC30A7|0:ZFPL1|0:LRRC19|0:PRF1|0:SPATA9|0:OR6C76|0:OR8U9|0:PDE3A|0:XYLT2|0:AMIGO3|0:DHCR7|0:OR10H2|0:FAM165A|0:VN1R3|0:OR10A4|0:OR8B12|0:REEP1|0:SPAST|0:PLXND1|0:INTS5|0:BSG|0:TMEM89|0:C14orf180|0:AJAP1|0:SLC25A42|0:LRFN4|0:GPR155|0:AMAC1|0:OR10Z1|0:CD302|0:ERAP2|0:FCGRT|0:MFSD7|0:OR1P1|0:OR1M1|0:OR4F4|0:GJD4|0:C19orf26|0:FAM57A|0:STIM2|0:MOGAT3|0:OR1F12|0:ODZ1|0:B4GALNT3|0:TMEM203|0:UBAC2|0:IZUMO3|0:OR1E3|0:OR10V1|0:TMEM91|0:LRRC37B|0:PLSCR1|0:SLC35E1|0:SIGLEC12|0:SCN1B|0:TMEM114|0:UXS1|0:NDUFA1|0:GGTA1|0:PCDHGA8|0:SLC43A2|0:ZDHHC13|0:OR2F1|0:SUSD4|0:C22orf24|0:C3orf45|0:RNF133|0:RNF24|0:FAM163B|0:ADAM18|0:LRRC8B|0:C14orf118|0:ABCA9|0:TMEM87A|0:GPR85|0:GOSR2|0:SLC25A10|0:KIAA1024|0:UNC80|0:IMMP2L|0:TMEM186|0:BNIP3L|0:GALNT8|0:C12orf62|0:FXYD8|0:PNPLA7|0:C12orf70|0:KMO|0:MUC13|0:TMEM192|0:TPST1|0:SREBF1|0:CLEC12B|0:CD300LD|0:TMPRSS12|0:CYP8B1|0:SEMA6B|0:GPR139|0:OR7G1|0:IFITM1|0:CLEC10A|0:TMTC1|0:ADAM11|0:ERGIC2|0:MTCH2|0:RPRM|0:ZP2|0:FCRL1|0:GLT6D1|0:C1orf43|0:C3orf71|0:DCAF17|0:TMEM130|0:NDUFB1|0:DIO3|0:PRTG|0:DGAT2L6|0:TOMM20|0:OR8B2|0:SPTLC1|0:NRP1|0:TUSC5|0:SMPD4|0:PIGZ|0:LYSMD4|0:CRLS1|0:MFAP3|0:MOSPD2|0:MGST3|0:CSF1|0:MBOAT1|0:MRGPRX4|0:ANKAR|0:TMCO2|0:TMEM217|0:NRP2|0:CDH2|0:FUT6|0:ACPT|0:PRAF2|0:C14orf147|0:GPR151|0:DSG2|0:SIGLEC14|0:PRRT4|0:SPEM1|0:PLXNC1|0:TMEM165|0:SERINC2|0:OR2T27|0:LRRC66|0:C2orf82|0:STEAP4|0:OR6C74|0:VAPB|0:IGHM|0:LILRA2|0:MYOF|0:QPCTL|0:UQCRFS1|0:CLDN23|0:NALCN|0:CHST4|0:CLDND1|0:C2orf89|0:B4GALT6|0:XKR7|0:FER1L4|0:B4GALT2|0:HS6ST2|0:SEC11B|0:CPT1B|0:MS4A5|0:CYBASC3|0:TBXAS1|0:OR6J1|0:GPR45|0:MT-CO3|0:CNTNAP4|0:WDFY4|0:SLC4A2|0:OR4C12|0:JPH4|0:MAN2A1|0:ABCG4|0:CD3D|0:PLEKHH2|0:LRRTM1|0:TMEM80|0:TMEM210|0:RXFP1|0:DHRS3|0:CDRT15L2|0:MARCH9|0:CLEC6A|0:FADS6|0:TMEM194B|0:GRAMD1A|0:FAM75A6|0:ELOVL4|0:HHAT|0:NDUFC2|0:C7orf13|0:STX3|0:SLC25A25|0:OR9Q2|0:C7orf45|0:OR2M5|0:SYT1|0:MARCH2|0:KCNT2|0:TCP11|0:OR4K13|0:OR4F15|0:OR56A3|0:ZDHHC8|0:PLXNA2|0:IL2RA|0:NFASC|0:OR2J3|0:BTNL8|0:TMEM95|0:SLC36A1|0:MRGPRG|0:CYP20A1|0:C9orf174|0:UMODL1|0:KREMEN1|0:MAG|0:DLK2|0:CLEC2L|0:UPK3A|0:CTXN2|0:LPAR5|0:TMEM173|0:TMEM71|0:C20orf165|0:SLC27A4|0:GJB2|0:KIAA0195|0:BCL2L1|0:PCDHGB5|0:OR52B6|0:TGOLN2|0:SLC25A33|0:OR8K5|0:SIDT2|0:OR2B3|0:SLC45A4|0:NPR2|0:TMEM170B|0:TAS2R40|0:OR5I1|0:OR2T8|0:ALPI|0:FAT3|0:NPSR1|0:WSCD2|0:OR7A2P|0:LILRB5|0:C9orf79|0:PPAPDC2|0:FAM189A1|0:SLC13A5|0:LRRC3|0:OR2AG2|0:OR1N1|0:CDH23|0:TREML3|0:LMTK3|0:C3orf1|0:SLC39A11|0:S1PR5|0:AUP1|0:OR5T3|0:UBIAD1|0:CYB561D1|0:TMEM145|0:RNF149|0:MUC21|0:CDCP1|0:CHSY3|0:LASS4|0:SC5DL|0:NNT|0:CD164L2|0:TLCD1|0:SEMA5A|0:HIATL1|0:HEPACAM2|0:OR4N2|0:MFSD5|0:NLGN4Y|0:OR6K6|0:FZD1|0:TMEM185A|0:C1orf186|0:RNF13|0:TM6SF2|0:OR8S1|0:SLC4A11|0:SLC38A7|0:CLDN18|0:RNF128|0:ABHD6|0:ATP6V0E1|0:CD274|0:SLC9A10|0:SLC35F4|0:OR4K2|0:OR2Y1|0:GHSR|0:RNF183|0:STX4|0:ECSCR|0:C11orf9|0:DPY19L1|0:LMBR1|0:MMP23A|0:GALNTL5|0:BET1|0:OTOP1|0:VSTM1|0:SHISA5|0:KRTCAP2|0:C15orf27|0:ABCB7|0:C9orf91|0:TMEM195|0:COX15|0:HEPH|0:WSCD1|0:RNF185|0:C4orf3|0:C7orf44|0:ARL6IP1|0:TMEM184A|0:CACNG5|0:TMEM19|0:RELT|0:VKORC1|0:TRPM6|0:UGT2B7|0:CLDN16|0:FAM73A|0:OR6B1|0:DNAJC15|0:LRRC33|0:PKDREJ|0:GPR78|0:OR4A47|0:FAM74A3|0:OR5R1|0:PANX3|0:CDIPT|0:ENTPD8|0:SYT12|0:SLC24A5|0:FAM159A|0:TMEM156|0:ATP11C|0:SLC9A9|0:BAT5|0:PAQR8|0:GBGT1|0:OR10K1|0:C18orf45|0:ABHD12|0:PILRA|0:COX10|0:GLG1|0:MCOLN2|0:CDHR5|0:NRG4|0:PIGF|0:C6orf35|0:CCDC109A|0:OR2W5|0:IL23R|0:MUC15|0:PAQR4|0:RNF182|0:PCDHGB4|0:LDLRAD2|0:MS4A13|0:JPH2|0:C19orf75|0:UPK3B|0:RELL1|0:TYRP1|0:C1orf115|0:GPR62|0:OR2M2|0:FAM70B|0:TSPAN19|0:SLC29A3|0:USH2A|0:IMPAD1|0:TAOK2|0:GPR33|0:PCDHGA5|0:GALNT9|0:FOXRED1|0:SLC35B1|0:FAM180B|0:DNAJC1|0:CYP4F12|0:OR51G2|0:TMEM106C|0:KIAA1024L|0:RABAC1|0:DNAJC4|0:STX5|0:NRSN1|0:C1orf212|0:OR1L8|0:TMEM207|0:GGT6|0:CHPF2|0:SPNS1|0:IL1RAPL1|0:PCDHGA4|0:CBLN2|0:TMEM205|0:C11orf64|0:PQLC3|0:OR2T5|0:C11orf10|0:UCP2|0:FER1L6|0:OR2AG1|0:PLXNA4|0:OR2T4|0:ZDHHC17|0:FAM87A|0:DCST1|0:HIGD1C|0:FAM8A1|0:CXCR1|0:ZDHHC7|0:SLC44A3|0:OR4K15|0:ELFN2|0:MYO9A|0:OCLN|0:TREM2|0:RTP2|0:TMEM38A|0:CALHM1|0:THSD7A|0:NDST3|0:KIR2DL5B|0:FAM187B|0:LRFN1|0:OR4D11|0:ATP5G3|0:C7orf68|0:C14orf37|0:UGT1A7|0:FUT3|0:SLITRK3|0:C18orf55|0:HM13|0:APOLD1|0:PROKR2|0:TMEM167A|0:TMEM39B|0:OR7E24|0:SLC30A1|0:TAZ|0:CHRFAM7A|0:BTBD11|0:DIO2|0:CCDC136|0:TMEM85|0:CRELD1|0:OR5G3|0:KIAA0922|0:CATSPERB|0:ZDHHC21|0:OR2A1|0:TM9SF3|0:ALKBH5|0:MCART2|0:TMEM41A|0:MAMDC4|0:TRAF3IP3|0:LSR|0:FAM75A5|0:ISLR2|0:SV2A|0:C18orf19|0:GSG1|0:TMEM50A|0:PLA2G16|0:ZFYVE27|0:RPAP2|0:KIR3DL3|0:SLC25A45|0:ABCC13|0:SFT2D2|0:CPT1A|0:C20orf106|0:PLP1|0:RNF222|0:PTCHD1|0:CRLF2|0:DNAJB14|0:WRB|0:KIAA1432|0:OR52N4|0:OR52L1|0:GJB4|0:CRB1|0:SI|0:TMEM37|0:C1orf162|0:SLC5A8|0:CHST3|0:FAM171A2|0:OR2A4|0:ABCA13|0:OR12D3|0:FAM174B|0:MFSD3|0:B3GNT5|0:STT3A|0:RNF122|0:TMEM160|0:GPR107|0:ENPP4|0:RNF170|0:SLC37A3|0:NRM|0:UNC5B|0:CLRN1|0:UGT3A1|0:MFSD6|0:PTPLAD1|0:CHSY1|0:GPR83|0:EXT2|0:LASS1|0:NCRNA00169|0:SHISA3|0:YIPF4|0:TMEM150B|0:C5orf28|0:TMEM30B|0:DUOXA2|0:TMEM223|0:CEACAM20|0:SLC15A4|0:CYSLTR2|0:KIAA1797|0:LRRC37A2|0:MBTPS1|0:LETM1|0:CNGB3|0:RNF145|0:CLDN2|0:OR4B1|0:DEGS2|0:FAM156B|0:SPACA3|0:CEACAM18|0:ORMDL3|0:DSC2|0:RET|0:AREGB|0:IL1RL1|0:LRRC25|0:LASS5|0:ABCC4|0:FAM171A1|0:PCNX|0:CYP4V2|0:IFITM2|0:OR6C6|0:PVRIG|0:LEPR|0:OR8I2|0:C16orf42|0:SLC43A3|0:SLC25A22|0:OR1L1|0:OR1K1|0:VANGL2|0:TIGIT|0:FA2H|0:MPV17L2|0:GPRC6A|0:TMEM8B|0:VLDLR|0:C21orf63|0:RHBDL3|0:KIAA1244|0:ATP6AP1|0:C3orf17|0:SLC38A2|0:SLC25A29|0:OR2M7|0:ADAM9|0:TMUB2|0:TMEM146|0:SLC45A2|0:POMGNT1|0:ATP1B2|0:TMEM183A|0:OR51T1|0:C19orf56|0:LHFPL4|0:ADCY8|0:PCDHGA12|0:ARMC10|0:ITPR2|0:OR6K3|0:GOSR1|0:IGSF5|0:HAVCR1|0:RNF5|0:LRP10|0:CHODL|0:TSPAN5|0:AMIGO1|0:DARC|0:ZP3|0:OR8G5|0:NCKAP1|0:OR5P3|0:L1CAM|0:CREB3L2|0:OR6F1|0:KIAA1324L|0:PGAM5|0:KREMEN2|0:CLSTN1|0:LMAN2|0:C17orf61|0:SEMA5B|0:VN1R5|0:TMEM65|0:LRRTM4|0:MAOB|0:FCGR1C|0:TMEM149|0:STX17|0:IFI6|0:MGAT2|0:CNIH2|0:KCNH8|0:OR9A4|0:SYT6|0:OPN5|0:PREB|0:OR3A3|0:OR6K2|0:TMEM8C|0:OR5D16|0:FAM173B|0:SYT3|0:IL1R2|0:SLAMF9|0:SLC9A6|0:BRI3|0:SDK1|0:FUT9|0:SLC4A9|0:OR4E2|0:TMCO4|0:TMEM190|0:FADS3|0:PKD1L1|0:DGAT2|0:C20orf123|0:TMEM109|0:IL22RA1|0:ATP4B|0:FAM75A2|0:OR6Q1|0:SEMA4G|0:OR4C15|0:OR52I2|0:ARMCX6|0:SLC47A2|0:TMC3|0:LRRN3|0:CLEC12A|0:ZDHHC14|0:GPR109A|0:IYD|0:XKR6|0:NKAIN2|0:GPR142|0:CCDC90A|0:CD320|0:TMEM213|0:GLIPR1|0:IER3IP1|0:C6orf129|0:PIGO|0:SLC35E3|0:TMX2|0:OR1L4|0:HS6ST3|0:GPR156|0:VOPP1|0:PIGW|0:YIPF5|0:PRSS8|0:RNF19A|0:VTI1B|0:OR10Q1|0:SLC25A38|0:C10orf54|0:HS3ST4|0:TOMM7|0:TNFSF14|0:PRRT2|0:PLXDC1|0:OR51A7|0:TMED4|0:UGT1A3|0:CYP3A4|0:MBOAT2|0:ODZ4|0:KCNK16|0:CMTM8|0:TMEM151A|0:HERPUD2|0:CRTAM|0:HSD17B2|0:OR4F3|0:AATK|0:MS4A10|0:TMEM39A|0:ELOVL5|0:GGT2|0:LRFN5|0:ITM2B|0:ACSL3|0:KIAA1919|0:GLT8D2|0:DYSF|0:CXorf61|0:LMAN1L|0:BCL2L10|0:GJA10|0:TMEM98|0:FRMD5|0:RNF217|0:LAMP3|0:OR2T1|0:FAM163A|0:SLC25A35|0:ORAI3|0:TMEM99|0:MYADML2|0:CDS1|0:CDH15|0:TMEM117|0:TMEM202|0:C3orf52|0:PCDHGA1|0:KIAA0317|0:TMEM33|0:NDUFC1|0:PKHD1|0:VSIG10L|0:DRAM2|0:ITPRIPL2|0:NAALADL2|0:ASAH2|0:TBC1D9B|0:PNPLA6|0:PCDHB18|0:TAAR3|0:CDH24|0:SLC35E2|0:RGSL1|0:PCDHGC5|0:MEGF10|0:GPR119|0:OR13C9|0:SPCS3|0:SLC35F1|0:KIAA1161|0:OR2H1|0:COL23A1|0:TMEM179|0:OR10AC1P|0:CHST10|0:TAS2R12|0:ANTXR1|0:DGAT1|0:HRCT1|0:FAM74A7|0:GALNTL2|0:C17orf80|0:TMEM176A|0:TMEM185B|0:OR5AL1|0:TMEM229A|0:TMEM72|0:PCDH15|0:SGCZ|0:CLRN2|0:AQP12A|0:LRIG1|0:HSD17B7|0:TMC6|0:OR10H1|0:LRRC8E|0:SCARF2|0:DHRS7B|0:TMEM53|0:OR5M3|0:PPP1R3F|0:OR10C1|0:LILRA5|0:TREML2|0:GREB1L|0:SLCO6A1|0:OR7D2|0:CCDC47|0:SLC26A6|0:CACNA2D2|0:FATE1|0:CDH3|0:EI24|0:PDZK1IP1|0:OR8U1|0:CCDC107|0:PTTG1IP|0:OR4X2|0:SLC27A6|0:TRPM7|0:TAS2R31|0:TMEM102|0:VSTM2B|0:FAM200A|0:MCART6|0:IL17RD|0:KLHDC7A|0:SLC22A23|0:VKORC1L1|0:CTNS|0:MMD2|0:ROMO1|0:KIAA1644|0:FAM172B|0:MS4A4A|0:SUSD3|0:TLR7|0:SLC22A15|0:ABHD13|0:STX18|0:CCPG1|0:DCBLD1|0:SLC2A6|0:OR52W1|0:SLC35A2|0:MGST2|0:NOX5|0:EMP3|0:ELOVL2|0:XKRY2|0:SRD5A3|0:LRP2|0:MTDH|0:LMBR1L|0:C2CD2L|0:OR6C75|0:OR5M10|0:GALNT14|0:LYSMD3|0:ERLIN1|0:GPX8|0:TP53I11|0:ALG8|0:TMEM200B|0:VASN|0:GLIPR1L2|0:CBARA1|0:TMEM14D|0:SGCD|0:CMTM5|0:STX10|0:C5orf60|0:STS|0:BTNL2|0:MSLNL|0:ATP6V0A1|0:IGSF9B|0:MARCH4|0:NF1L5|0:OR51H1P|0:MANSC1|0:OR2T10|0:TMEM167B|0:FAM57B|0:GFRAL|0:TMEM61|0:PLVAP|0:SERP2|0:COX7C|0:TIMD4|0:C6orf138|0:TMEM56|0:C2orf85|0:LRTM2|0:GJA5|0:REEP2|0:GJE1|0:SLC5A4|0:TMEM81|0:MYADM|0:PDE3B|0:NPDC1|0:RYR3|0:SLC28A3|0:LGR6|0:OR52J3|0:SYNE2|0:NETO2|0:PROM2|0:GPR162|0:SFXN2|0:BTNL9|0:SLC25A26|0:MANBAL|0:OR4D9|0:ZACN|0:NDUFA11|0:SYT2|0:VN1R2|0:OR52E4|0:OR2J2|0:LPGAT1|0:SLC16A12|0:CACHD1|0:HLA-E|0:SLC25A32|0:FLT3LG|0:TMEM222|0:STEAP3|0:OR51F1|0:PLSCR2|0:C9orf71|0:TSPAN8|0:IGSF1|0:TMEM143|0:FAM26D|0:ATP13A3|0:CADM2|0:SDR42E1|0:TMEM233|0:TAS2R41|0:MARCH8|0:TMEM161B|0:SYPL2|0:ADCY5|0:DUOX2|0:COX7B2|0:MOG|0:ATP7A|0:CATSPERG|0:C13orf36|0:OR52L2P|0:CYP4F8|0:HTR3C|0:MPV17L|0:CASD1|0:SMAGP|0:CTXN1|0:HLA-DQB1|0:APLP1|0:VAPA|0:OR4C5|0:TAS2R46|0:SLC27A1|0:TAS2R19|0:MARVELD1|0:RAG1AP1|0:CD248|0:LMBRD2|0:SYT15|0:CTAGE6P|0:LTB|0:C13orf16|0:C20orf3|0:SLC38A8|0:TMEM9B|0:OR14L1P|0:NPR3|0:CYB561D2|0:CNNM4|0:P2RY12|0:AGPAT4|0:OR13C3|0:LINGO1|0:CD300LG|0:VSIG4|0:OR5C1|0:CISD2|0:GCNT7|0:SLC9A11|0:OR4Q2|0:C6orf64|0:FCAMR|0:CLDN17|0:OR10D4P|0:DSG1|0:TMEM27|0:C20orf46|0:DNAJC18|0:MANEAL|0:TMEM20|0:SNX14|0:TMEM187|0:TNFRSF13C|0:NOMO3|0:FUT10|0:MOGAT2|0:EIF2AK3|0:OR10R2|0:FAM87B|0:ATP6V0A4|0:FGFRL1|0:GPR82|0:OR10G6|0:MFSD6L|0:LETM2|0:SORCS1|0:OR4K1|0:LAYN|0:MOSPD3|0:SHISA6|0:C14orf49|0:OR5B12|0:BTC|0:SLC2A12|0:GPR77|0:PLXDC2|0:SLC7A5|0:CYP4Z1|0:SPTLC2|0:PCDH19|0:LEPROTL1|0:SLC16A13|0:GPR152|0:GALNTL6|0:IGDCC4|0:GNPTAB|0:ABCC10|0:FNDC3A|0:SLC30A10|0:OR5J2|0:TMEM164|0:SRPRB|0:MFSD4|0:SLC30A6|0:OR5A1|0:TMCO1|0:OR8D2|0:TMEM105|0:KCNK13|0:LDLRAD3|0:NIPAL3|0:SLC36A2|0:PRLR|0:TMPPE|0:TMEM161A|0:ITM2A|0:OR11G2|0:ABCG5|0:C18orf15|0:KCNH5|0:FAM189A2|0:OR52B4|0:CADM1|0:OR5B3|0:ATF6|0:B4GALT3|0:VCAM1|0:ALG3|0:OR52R1|0:PCDHB1|0:OR2D3|0:MLEC|0:FAM18B1|0:SLC45A3|0:KIAA2013|0:OR4F21|0:DENND4C|0:WBSCR28|0:OR1J4|0:TMEM55A|0:OR4C11|0:CLEC4G|0:C6orf25|0:OR4M1|0:TMEM179B|0:FAM159B|0:TMTC4|0:HLA-DQB2|0:C1orf204|0:POMT2|0:OR8U8|0:RHBDD3|0:LPCAT3|0:FAM82A1|0:SIGLEC11|0:OR2T35|0:C19orf63|0:CLEC4F|0:CYP46A1|0:HGSNAT|0:TMED1|0:OR8B3|0:DHODH|0:SYT9|0:OR5T1|0:SLC22A10|0:FAM119B|0:SLCO4C1|0:C2orf74|0:SEMA4C|0:KLRD1|0:MARCH1|0:ARMCX2|0:PNPLA2|0:CNST|0:C14orf101|0:SLC2A11|0:RXFP2|0:PIK3IP1|0:SLC39A6|0:TMED10|0:TMED2|0:PEX14|0:UPK1A|0:C1orf85|0:KIRREL3|0:RARG|0:CD276|0:CHST15|0:UPK1B|0:INPP5B|0:MALL|0:TAS2R9|0:TMPRSS3|0:SLC3A2|0:GPR84|0:PRRG3|0:ADCY2|0:OR6C3|0:TSPAN32|0:OR51V1|0:GAL3ST3|0:ATP2C1|0:PLA2G4A|0:TEX28|0:C14orf1|0:PCDHB10|0:FCGR2C|0:UNC93A|0:PCDHB16|0:SLC12A5|0:C9orf5|0:CDH12|0:OR51B5|0:POPDC3|0:B3GALT1|0:NPFFR1|0:NAALAD2|0:FADS1|0:LRRC4C|0:OR52D1|0:PIGP|0:EDAR|0:IL21R|0:TNFRSF19|0:GPR18|0:AGPAT6|0:PIGB|0:OR8G1|0:OR51B4|0:KIR2DS2|0:OR52A5|0:ROBO3|0:ADIPOR1|0:TAS2R8|0:TAS2R13|0:ICOS|0:TREML1|0:ABHD1|0:ADAMDEC1|0:IL31RA|0:FGFR2|0:CHST14|0:TM7SF4|0:OR1Q1|0:OR2D2|0:FAP|0:REEP5|0:APLP2|0:GPR87|0:DNAJC19|0:NAALADL1|0:TMPRSS4|0:SIGLEC1|0:KCNH3|0:GHITM|0:OR6C2|0:PCDHB9|0:TMEM132D|0:SCAP|0:GPR123|0:CLN8|0:PRRG4|0:SLC4A7|0:DLL3|0:CHST5|0:SLC25A12|0:OR51I2|0:OR4D1|0:ABHD2|0:TAS2R7|0:TEX2|0:TMEFF2|0:P2RY14|0:EGFL8|0:OR8B8|0:TMEM123|0:SLN|0:KIR2DS1|0:KCNN2|0:PCDHB5|0:SLC19A2|0:OR1E1|0:TAS2R10|0:CLCN6|0:CHST1|0:COL15A1|0:ERAP1|0:CHST13|0:FCRL2|0:OR2M4|0:SLC4A10|0:CNTNAP3|0:OR1A2|0:PKD2L1|0:PMEPA1|0:JPH3|0:CXCR7|0:PLSCR4|0:SLC2A10|0:HS3ST5|0:CDH20|0:PCDHB14|0:ERBB2|0:MFN1|0:CDH19|0:CHST8|0:PTGDR|0:SLC35B2|0:OR51J1|0:PIGV|0:SAMD8|0:GPR141|0:OR5AC2|0:OR51M1|0:OR51I1|0:OR3A4|0:ADAM33|0:GRIK5|0:C15orf24|0:SLC38A1|0:GPM6B|0:SMAD5|0:NRSN2|0:KIAA1715|0:CDH10|0:BACE2|0:OR51B6|0:NAT8B|0:KIRREL2|0:HSD3B2|0:OR1C1|0:ATP10D|0:SEC61B|0:ATP6V0E2|0:LPHN2|0:PLAUR|0:B3GNT2|0:SCN3B|0:PVRL1|0:NAT8|0:SLC22A18|0:SLC19A3|0:PTPRT|0:OR5F1|0:SEL1L|0:SLC37A4|0:P2RY13|0:EBAG9|0:CHST9|0:OR1A1|0:OR10A3|0:CHST11|0:ATP10A|0:IFI27|0:SLC46A2|0:SLC4A5|0:MAS1L|0:CDH11|0:CDS2|0:ADCY1|0:OR51B2|0:GAL3ST4|0:CDH7|0:CELSR2|0:MUC3A|0:HRH4|0:SLC12A6|0:TAS2R1|0:POPDC2|0:PCDHB7|0:C18orf1|0:ADAM22|0:NOTCH1|0:B3GAT3|0:ATP9B|0:HCN1|0:GPR37L1|0:SLC1A7|0:GPR171|0:OR8G2|0:FAM189B|0:TMPRSS13|0:CLN6|0:PITPNM2|0:PCDHB13|0:ABCA12|0:LPHN3|0:SMAD1|0:TRPV4|0:OR51E2|0:OR10A5|0:SUCNR1|0:MGAT5|0:OR7A5|0:CUZD1|0:ADAM10|0:FLNB|0:CYYR1|0:ICOSLG|0:SEMA6A|0:CDH9|0:ATP8A1|0:TMEM194A|0:CR2|0:CXCL16|0:SLC10A3|0:VNN1|0:GPR98|0:CELSR3|0:GPR124|0:LPHN1|0:GPR111|0:GPR133|0:GPR115|0:EMR2|0:GPR97|0:GPR112|0:GPR128|0:ELTD1|0:BAI3|0:GPR116|0:EMR3|0:GPR126|0:GPR144|0:GPR113|0:BAI2|0:EMR4P|0:GPR110|0:GPR125|0:GPR114|0:KEL|0:XK|0:LMAN1|0:ABCD4|0:DCT|0:KLRG1|0:VAT1|0:SLC14A2|0:SLC25A15|0:GALR3|0:NCAM2|0:MBTPS2|0:MGAT3|0:CD101|0:GGT5|0:SLC9A5|0:CA14|0:BMPR1A|0:ATP6V0B|0:ABCB1|0:SLC26A4|0:TRPM5|0:TMEM2|0:B3GAT1|0:EMP2|0:FDFT1|0:OTOF|0:TSPAN2|0:B4GALT4|0:GGCX|0:ACP2|0:LRP6|0:VAMP3|0:CEPT1|0:NAGPA|0:HS3ST3A1|0:TOMM34|0:NCAM1|0:PKP2|0:CA12|0:MAN1A2|0:ATP6V0C|0:HS3ST2|0:FPR2|0:LRP3|0:TM9SF1|0:TSPAN3|0:PGRMC2|0:GLP1R|0:CHL1|0:ICAM4|0:SLC5A5|0:FLOT1|0:F3|0:SMO|0:FZD9|0:TRAM1|0:FSHR|0:MC4R|0:SEC62|0:TPTE|0:BRS3|0:EMP1|0:MFSD10|0:SLC12A9|0:CEACAM7|0:SLC5A2|0:LTC4S|0:A4GNT|0:POMT1|0:GIPR|0:SECTM1|0:FPR1|0:CD1B|0:PXMP4|0:SEC22C|0:TIMM23|0:RARRES1|0:UST|0:KDELR2|0:GLP2R|0:SERINC3|0:MGAT1|0:PGAP2|0:GALR1|0:TSPAN16|0:TRAPPC10|0:TPRA1|0:CLDN5|0:PSAP|0:LILRB1|0:HS3ST1|0:SC4MOL|0:IL5RA|0:LRP5|0:SLC7A11|0:CD68|0:SSR1|0:SRPR|0:TIMM17B|0:SLC16A1|0:CKAP4|0:FPR3|0:ENPP1|0:SPINT2|0:GCNT1|0:ABCA3|0:GALNT3|0:SIGLEC8|0:MTX1|0:GALR2|0:TNFRSF17|0:CA9|0:KDELR1|0:GCGR|0:SLC9A2|0:PRPH2|0:GOLGB1|0:SSR2|0:ADAM30|0:CLDN7|0:FZD7|0:ABCG2|0:NDST2|0:ABCA7|0:OCA2|0:GPR143|0:TIMM17A|0:SPAG9|0:SLC7A4|0:GPR182|0:PTGER4|0:ACP5|0:TMEM59L|0:DLK1|0:FUT7|0:SLC39A1|0:PKD2|0:TRDN|0:CRIM1|0:GOLIM4|0:TSPAN1|0:LRPAP1|0:RNF139|0:PKD2L2|0:LMAN2L|0:SBF1|0:CHST7|0:SLC44A1|0:NOX4|0:ROBO4|0:CLCN3|0:OXGR1|0:COLEC12|0:MAN1B1|0:GDE1|0:SLC44A2|0:SLC9A1|0:PTPN5|0:OPN4|0:KL|0:CLEC7A|0:FZD8|0:CD7|0:PITPNM3|0:TAPT1|0:SLC26A1|0:C11orf2|0:MFRP|0:SDHC			
GO:0034983	P:peptidyl-lysine deacetylation; IMP:BHF-UCL		0:HDAC4|0:SIRT1|0:HDAC9|0:HDAC6			
GO:0019843	F:rRNA binding; TAS:UniProtKB		0:SBDS|0:MRPL20|0:RPL9|0:MRPS6|0:MRPL16|0:RPS11|0:RPS18|0:KDM2B|0:RPS4Y1|0:RPF1|0:RPL23A|0:RPL8|0:RPL37|0:NOL12|0:RPS4Y2|0:RPL11|0:IMP3|0:RPS9|0:MRPS17|0:RPS4X|0:ERI1|0:ANG			
GO:0060761	P:negative regulation of response to cytokine...; IMP:BHF-UCL		0:AES			
GO:0014032	P:neural crest cell development; TAS:BHF-UCL		0:HAND2|0:CYP26C1|0:NRG1			
GO:0018279	P:protein amino acid N-linked glycosylation v...; TAS:HGNC		0:OSTC|0:DDOST|0:DAD1|0:STT3B|0:STT3A|0:RPN2|0:RPN1|0:MAGT1|0:TUSC3			
GO:0019237	F:centromeric DNA binding; TAS:ProtInc		0:CENPB|0:ZW10|0:KIF2C			
GO:0010596	P:negative regulation of endothelial cell mig...; IMP:UniProtKB		0:APOH|0:ACVRL1|0:GDF2|0:BMP10|0:SLIT2|0:NR2F2|0:PTPRM			
GO:0051990	F:(R)-2-hydroxyglutarate dehydrogenase activity; ISS:HGNC		0:D2HGDH			
GO:0004181	F:metallocarboxypeptidase activity; TAS:UniProtKB		0:CPD|0:CPO|0:CPXM1|0:AGBL2|0:AGBL3|0:CPA5|0:CPXM2|0:AGTPBP1|0:AGBL1|0:AEBP1|0:AGBL5|0:CPE|0:AGBL4|0:CPB1|0:CPA6|0:CPA4|0:CPM|0:CPA1|0:CPN1|0:CPZ|0:CPB2|0:CPA2|0:PEPD|0:CPA3			
GO:0045075	P:regulation of interleukin-12 biosynthetic p...; ISS:UniProtKB		0:MAST2			
GO:0006873	P:cellular ion homeostasis; TAS:ProtInc		0:RHAG|0:RHCG|0:SLC4A1			
GO:0019210	F:kinase inhibitor activity; NAS:UniProtKB		0:RHOH|0:AHSG			
GO:0008179	F:adenylate cyclase binding; IPI:UniProtKB		0:AKAP12|0:AKAP5			
GO:0010613	P:positive regulation of cardiac muscle hyper...; TAS:BHF-UCL		0:EDN1|0:BMP10|0:AGT|0:IL6ST			
GO:0016788	F:hydrolase activity, acting on ester bonds; IMP:UniProtKB		0:C11orf54|0:SUPT6H|0:SRBD1|0:C3orf33|0:DTD1|0:C14orf126|0:ASPA|0:ACY3|0:RNF17|0:PTER|0:IAH1|0:PGAP3			
GO:0042703	P:menstruation; IMP:UniProtKB		0:FOXL2			
GO:0031264	C:death-inducing signaling complex; IDA:BHF-UCL		0:FADD|0:FAS|0:RIPK1|0:CASP8			
GO:0050905	P:neuromuscular process; NAS:BHF-UCL		0:CHRNA1|0:CHRND			
GO:0032235	P:negative regulation of calcium ion transpor...; IDA:UniProtKB		0:STIM2			
GO:0018345	P:protein palmitoylation; IDA:UniProtKB		0:WNT4			
GO:0032453	F:histone demethylase activity (H3-K4 specific); ISS:UniProtKB		0:C14orf169			
GO:0002089	P:lens morphogenesis in camera-type eye; ISS:HGNC		0:SHROOM2			
GO:0004835	F:tubulin-tyrosine ligase activity; IEA:InterPro		0:TTL|0:TTLL4|0:TTLL8|0:TTLL11|0:TTLL5|0:TTLL9|0:TTLL6|0:TTLL13|0:TTLL1|0:TTLL3|0:TTLL7|0:TTLL2|0:TTLL10|0:TTLL12			
GO:0009117	P:nucleotide metabolic process; TAS:ProtInc		0:GMPR2|0:GMPR|0:NT5C3L|0:NT5C3|0:ITPA|0:NT5C1A|0:NT5C1B|0:NT5C2|0:SMARCAD1|0:FHIT|0:REXO2			
GO:0048280	P:vesicle fusion with Golgi apparatus; IEA:InterPro		0:USO1			
GO:0008158	F:hedgehog receptor activity; IEA:InterPro		0:NPC1|0:DISP1|0:PTCH1|0:NPC1L1|0:PTCHD3|0:PTCH2|0:PTCHD2|0:PTCHD1|0:C6orf138			
GO:0021761	P:limbic system development; IEP:BHF-UCL		0:CNTNAP2			
GO:0005581	C:collagen; TAS:ProtInc		0:COL24A1|0:COL27A1|0:COL19A1|0:COL18A1|0:COL10A1			
GO:0002005	P:angiotensin catabolic process in blood; IC:UniProtKB		0:ACE2|0:ACE			
GO:0006909	P:phagocytosis; TAS:ProtInc		0:ANXA3|0:PECAM1|0:ELMOD3|0:ELMOD1|0:ELMOD2|0:ELMO2|0:TUB|0:CDC42SE2|0:CDC42SE1|0:ELMO3|0:GATA2|0:ABCA7|0:MEGF10|0:TULP1|0:ANXA11|0:SLC11A1|0:CD93|0:ADORA2A|0:CD14|0:ADORA1|0:CORO1C			
GO:0001937	P:negative regulation of endothelial cell pro...; TAS:HGNC		0:APOE|0:THBS1|0:APOH|0:AIMP1|0:GHRL|0:VASH1|0:ATPIF1|0:ENG|0:NR2F2|0:NF1|0:ATP5A1|0:PTPRM|0:CAV1|0:CAV2|0:SCG2			
GO:0006605	P:protein targeting; TAS:UniProtKB		0:PML|0:HPS4|0:AKAP12|0:AKAP5|0:TOMM20L|0:RPL11|0:GIPC1|0:TRAK1|0:NLGN1|0:KATNB1|0:AKAP6|0:RASSF9|0:FUT10|0:LTBP2|0:GABARAP|0:CDC37|0:AP1M2|0:KIF13B|0:HOMER3			
GO:0032600	P:chemokine receptor transport out of membran...; ISS:UniProtKB		0:CD24			
GO:0004586	F:ornithine decarboxylase activity; TAS:UniProtKB		0:ODC1			
GO:0006432	P:phenylalanyl-tRNA aminoacylation; IEA:InterPro		0:FARS2|0:FDXACB1|0:FARSB|0:FARSA			
GO:0005786	C:signal recognition particle, endoplasmic re...; NAS:UniProtKB		0:SRP19|0:SRP14|0:SRP68|0:SRP54|0:SRP72|0:SRP9L1|0:SRP9			
GO:0043266	P:regulation of potassium ion transport; ISS:BHF-UCL		0:DRD2			
GO:0031849	F:olfactory receptor binding; IMP:HGNC		0:RTP1|0:REEP1|0:RTP2			
GO:0005549	F:odorant binding; NAS:UniProtKB		0:OBP2A|0:OBP2B			
GO:0004522	F:pancreatic ribonuclease activity; TAS:ProtInc		0:RNASE8|0:RNASE2|0:EDDM3B|0:RNASE9|0:RNASE13|0:RNASE7|0:RNASE10|0:ANG|0:EDDM3A|0:RNASE11|0:RNASE3|0:RNASE12|0:RNASE6|0:RNASE4|0:RNASE1			
GO:0010940	P:positive regulation of necrotic cell death; IMP:BHF-UCL		0:FAS			
GO:0042107	P:cytokine metabolic process; IDA:MGI		0:TNFSF15			
GO:0030014	C:CCR4-NOT complex; NAS:UniProtKB		0:CNOT7			
GO:0032575	F:ATP-dependent 5'-3' RNA helicase activity; IDA:UniProtKB		0:IGHMBP2			
GO:0032039	C:integrator complex; IDA:HGNC		0:INTS7|0:INTS12|0:INTS4|0:INTS2|0:INTS6|0:INTS3|0:INTS1|0:INTS5|0:INTS10|0:INTS9|0:INTS8			
GO:0009101	P:glycoprotein biosynthetic process; IDA:UniProtKB		0:TNIP1			
GO:0005791	C:rough endoplasmic reticulum; TAS:ProtInc		0:FKRP|0:TMEM97|0:PTGDS|0:PSEN1|0:MYOC|0:HCRT|0:RAB14|0:SEC62|0:LRAT|0:STAU1			
GO:0050925	P:negative regulation of negative chemotaxis; IDA:UniProtKB		0:ROBO2|0:ROBO1			
GO:0033326	P:cerebrospinal fluid secretion; IEP:UniProtKB		0:AQP1			
GO:0003715	F:transcription termination factor activity; TAS:ProtInc		0:MTERF			
GO:0004418	F:hydroxymethylbilane synthase activity; IDA:UniProtKB		0:HMBS			
GO:0008535	P:respiratory chain complex IV assembly; TAS:ProtInc		0:SCO2|0:COX18|0:COX15|0:COX10|0:SURF1|0:SCO1|0:COX11			
GO:0070078	P:histone H3-R2 demethylation; IDA:BHF-UCL		0:JMJD6			
GO:0070327	P:thyroid hormone transport; IMP:UniProtKB		0:CRYM			
GO:0050693	F:LBD domain binding; IPI:UniProtKB		0:CITED1|0:PROX1|0:CITED2			
GO:0043331	P:response to dsRNA; IDA:HGNC		0:PMAIP1			
GO:0008277	P:regulation of G-protein coupled receptor pr...; TAS:ProtInc		0:RIC8B|0:PLCE1|0:RAMP3|0:RAMP2|0:USP20|0:USP33|0:DYNLT1|0:RGS6|0:RASGRP4|0:RGS7|0:RGS16|0:RGS2|0:RAMP1|0:GIT2|0:GRK1|0:RGS5|0:RGS9|0:GRK5|0:RGS4|0:RGS14|0:GNG7|0:GRK6|0:RGS20|0:RGS11|0:RGS3|0:GNG4|0:GIT1			
GO:0019725	P:cellular homeostasis; NAS:UniProtKB		0:RHOT1|0:RHOT2|0:SLC22A12|0:MCL1|0:ABCA12|0:DEDD2			
GO:0045069	P:regulation of viral genome replication; TAS:ProtInc		0:PPIA|0:CCL3			
GO:0032420	C:stereocilium; TAS:HGNC		0:MYO15A|0:SLC4A7|0:KPTN|0:MPP1|0:ESPN|0:DOCK4|0:CDH23|0:PCDH15|0:LOXHD1|0:TPRN|0:DFNB31|0:GRXCR1|0:USH1C			
GO:0005798	C:Golgi-associated vesicle; TAS:ProtInc		0:ADAM10|0:VPS41|0:SCFD1|0:PI4KA|0:TYR|0:OCRL			
GO:0003311	P:pancreatic D cell differentiation; ISS:UniProtKB		0:RFX6			
GO:0070761	C:pre-snoRNP complex; IDA:BHF-UCL		0:PIH1D1|0:ZNHIT6|0:NOP58|0:TAF9|0:NUFIP1|0:NOP56			
GO:0008228	P:opsonization; TAS:ProtInc		0:LBP|0:CRP|0:MBL2|0:FCN2|0:FCN1			
GO:0071732	P:cellular response to nitric oxide; IDA:UniProtKB		0:AQP1			
GO:0047865	F:dimethylglycine dehydrogenase activity; IMP:UniProtKB		0:DMGDH			
GO:0005753	C:mitochondrial proton-transporting ATP synth...; TAS:ProtInc		0:ATP5J2|0:ATP5O|0:ATP5G1|0:ATP5G2|0:ATP5G3			
GO:0008173	F:RNA methyltransferase activity; IEA:InterPro		0:FTSJ2|0:MRM1|0:TARBP1|0:TRMT2A|0:RNMTL1			
GO:0009305	P:protein amino acid biotinylation; IDA:UniProtKB		0:HLCS			
GO:0006686	P:sphingomyelin biosynthetic process; NAS:UniProtKB		0:SGMS1|0:SGMS2|0:SAMD8			
GO:0043368	P:positive T cell selection; ISS:UniProtKB		0:THEMIS			
GO:0002224	P:toll-like receptor signaling pathway; IC:UniProtKB		0:BCL10			
GO:0034235	F:GPI anchor binding; TAS:BHF-UCL		0:THY1|0:MPPE1|0:VNN1			
GO:0007128	P:meiotic prophase I; TAS:ProtInc		0:SYCE1|0:SYCE2|0:SYCP2|0:RAD1			
GO:0043586	P:tongue development; ISS:BHF-UCL		0:WNT10A|0:NKX2-6|0:NKX2-5			
GO:0001869	P:negative regulation of complement activatio...; IDA:UniProtKB		0:SERPING1|0:A2M			
GO:0016768	F:spermine synthase activity; EXP:Reactome		0:SMS			
GO:0006540	P:glutamate decarboxylation to succinate; TAS:ProtInc		0:GAD1|0:GAD2			
GO:0042517	P:positive regulation of tyrosine phosphoryla...; TAS:UniProtKB		0:LIF|0:GH1|0:CNTF|0:IL6|0:IL31RA|0:IL6R|0:IL6ST|0:GHR|0:JAK2|0:CLCF1|0:IL20			
GO:0030870	C:Mre11 complex; NAS:BHF-UCL		0:TERF2|0:TERF2IP|0:RAD50|0:NBN|0:MRE11A			
GO:0000089	P:mitotic metaphase; TAS:ProtInc		0:CDCA8|0:MAD1L1|0:CENPE			
GO:0090084	P:negative regulation of inclusion body assembly; IMP:BHF-UCL		0:DNAJB2|0:HSPA1A|0:HSPA1B|0:SACS			
GO:0042351	P:'de novo' GDP-L-fucose biosynthetic process; TAS:UniProtKB		0:TSTA3|0:GMDS			
GO:0007265	P:Ras protein signal transduction; TAS:UniProtKB		0:HRAS|0:MAPKAPK3|0:MAPK11|0:MAPK14|0:MAP2K2|0:MAPK1|0:MAPK13|0:NTRK1|0:MAPKAPK2|0:YWHAB|0:SHC1|0:MAPK12|0:NGF|0:SHC2|0:SRC|0:KRAS|0:RALGDS|0:MAPK3|0:RALB|0:SHC3|0:MAP2K1|0:SOS1|0:NRAS|0:RAF1|0:RALA|0:BRAP|0:RASSF1|0:CDKN1A|0:TP53|0:CCNA2|0:CDK2|0:RB1|0:LAT|0:NF1|0:RAPGEF6|0:RGL2|0:SHOC2|0:RASGRP2|0:G3BP2|0:KSR1|0:RREB1|0:CRKL|0:GRAP2|0:IGF1|0:G3BP1|0:MRAS|0:FGF2|0:RASGRP1|0:GNB1|0:PLD1|0:RRAS|0:GRAP|0:GRB2|0:PLCE1			
GO:0045859	P:regulation of protein kinase activity; TAS:UniProtKB		0:TSPYL2|0:TTN|0:C17orf71|0:CAMKK2			
GO:0030412	F:formimidoyltetrahydrofolate cyclodeaminase ...; IEA:EC		0:FTCD			
GO:0008217	P:regulation of blood pressure; TAS:ProtInc		0:NPPA|0:HBB|0:TAC4|0:PPARG|0:CYP11B1|0:P2RX4|0:ACVRL1|0:GCH1|0:COL1A2|0:MYH6|0:PTGS2|0:PTGS1|0:SOD1|0:NPR3|0:NPR1|0:EPHX2|0:ERAP1|0:NPPC|0:ACSM3|0:NPPB|0:ERAP2|0:UTS2|0:GNB3|0:BRS3|0:CHGA|0:RENBP|0:NPR2|0:GCGR			
GO:0051155	P:positive regulation of striated muscle cell...; ISS:BHF-UCL		0:NRG1			
GO:0006069	P:ethanol oxidation; IDA:UniProtKB		0:ADH1C|0:ADH1B|0:ADH6|0:ADH4|0:ADH7			
GO:0042253	P:granulocyte macrophage colony-stimulating f...; TAS:UniProtKB		0:IL18			
GO:0008588	P:release of cytoplasmic sequestered NF-kappaB; NAS:UniProtKB		0:NLRP12|0:TNFSF14|0:TRIP6|0:CD27			
GO:0043405	P:regulation of MAP kinase activity; ISS:UniProtKB		0:TRIB3|0:TRIB1|0:TRIB2			
GO:0005160	F:transforming growth factor beta receptor bi...; TAS:ProtInc		0:TGFBRAP1|0:LEFTY2|0:LEFTY1|0:INHBC			
GO:0006783	P:heme biosynthetic process; TAS:UniProtKB		0:HMBS|0:UROD|0:PPOX|0:UROS|0:ALAD|0:TMEM14C|0:SLC25A39|0:C1orf69|0:FXN|0:ALAS2|0:TSPO|0:ALAS1|0:CPOX|0:FECH|0:NFE2L1|0:SLC25A38			
GO:0021795	P:cerebral cortex cell migration; ISS:UniProtKB		0:PEX13			
GO:0019534	F:toxin transporter activity; IDA:UniProtKB		0:ABCG1|0:SLC7A8			
GO:0050681	F:androgen receptor binding; NAS:UniProtKB		0:CALR|0:KDM3A|0:PRKCB|0:KDM1A|0:WIPI1|0:PKN1|0:NSD1|0:PRPF6|0:TRIM68|0:DAXX|0:RNF14|0:TGFB1I1|0:RNF6|0:RNF4|0:PPARGC1A|0:NCOA3|0:GRIP1|0:KAT5|0:PIAS2|0:NCOA4|0:BRCA1|0:PIAS1|0:FHL2|0:CCNE1|0:CDK7|0:CTNNB1|0:RB1|0:NRIP1			
GO:0048864	P:stem cell development; IDA:BHF-UCL		0:WNT7A			
GO:0010807	P:regulation of synaptic vesicle priming; ISS:UniProtKB		0:STXBP1			
GO:0048468	P:cell development; ISS:UniProtKB		0:CYB5R4			
GO:0031115	P:negative regulation of microtubule polymeri...; IDA:UniProtKB		0:STMN2|0:MAPRE1			
GO:0004798	F:thymidylate kinase activity; IDA:MGI		0:DTYMK			
GO:0016540	P:protein autoprocessing; NAS:UniProtKB		0:F12|0:FXN|0:PCSK9|0:KLK6			
GO:0016616	F:oxidoreductase activity, acting on the CH-O...; IEA:InterPro		0:CTBP1|0:UEVLD|0:CTBP2|0:UBA5			
GO:0060447	P:bud outgrowth involved in lung branching; IDA:MGI		0:FGF10			
GO:0051289	P:protein homotetramerization; ISS:UniProtKB		0:DECR1|0:ACTN2|0:GPX3|0:CDA|0:ALDH5A1|0:HPRT1|0:ACOT13|0:CRYZ|0:USP16|0:GNMT|0:TP63|0:SOD2|0:CBR4|0:CTH|0:DPYS|0:ATPIF1|0:SRR			
GO:0042267	P:natural killer cell mediated cytotoxicity; NAS:UniProtKB		0:LYST|0:CEBPG|0:SLAMF7|0:TUBB2C|0:TUBB			
GO:0000796	C:condensin complex; IDA:UniProtKB		0:NCAPG|0:NCAPH|0:SMC2|0:SMC4			
GO:0003973	F:(S)-2-hydroxy-acid oxidase activity; TAS:UniProtKB		0:HAO2			
GO:0003865	F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; IEA:EC		0:SRD5A1|0:SRD5A3|0:SRD5A2			
GO:0042805	F:actinin binding; ISS:UniProtKB		0:PDLIM5			
GO:0032770	P:positive regulation of monooxygenase activity; IDA:BHF-UCL		0:POR|0:GDNF			
GO:0004598	F:peptidylamidoglycolate lyase activity; IEA:EC		0:PAM			
GO:0045719	P:negative regulation of glycogen biosyntheti...; TAS:BHF-UCL		0:ENPP1|0:GRB10			
GO:0000724	P:double-strand break repair via homologous r...; TAS:UniProtKB		0:BRCA1|0:UBE2N|0:SLX1B|0:OBFC2A|0:FAN1|0:ERCC4|0:OBFC2B|0:SLX1A|0:SLX4|0:BLM|0:RAD51AP1|0:RAD51			
GO:0017056	F:structural constituent of nuclear pore; NAS:UniProtKB		0:NUP62CL|0:NUP62|0:NUP155|0:TMEM48|0:NUP98			
GO:0006406	P:mRNA export from nucleus; TAS:UniProtKB		0:NUP160|0:NUP107|0:NXF5|0:NUP133|0:DDX39|0:FYTTD1|0:NCBP1|0:EIF5A|0:DDX25|0:NXF2|0:NXF2B|0:SRSF10|0:UPF2|0:SMG7|0:UPF1|0:SMG5|0:SMG6|0:AGFG1|0:RAE1|0:DDX19B|0:SMG1			
GO:0004044	F:amidophosphoribosyltransferase activity; TAS:ProtInc		0:PPAT			
GO:0006369	P:termination of RNA polymerase II transcription; TAS:ProtInc		0:MAZ			
GO:0051497	P:negative regulation of stress fiber assembly; IMP:UniProtKB		0:DLC1|0:ARHGAP6|0:ARAP1			
GO:0070551	F:endoribonuclease activity, cleaving siRNA-p...; IDA:UniProtKB		0:EIF2C2			
GO:0061133	F:endopeptidase activator activity; IMP:UniProtKB		0:ADRM1|0:PSME3|0:PSMD14			
GO:0003997	F:acyl-CoA oxidase activity; TAS:ProtInc		0:ACOX1|0:ACOXL|0:ACOX2|0:ACOX3			
GO:0004392	F:heme oxygenase (decyclizing) activity; IMP:UniProtKB		0:HMOX2|0:HMOX1			
GO:0034142	P:toll-like receptor 4 signaling pathway; IDA:UniProtKB		0:S100A14			
GO:0005244	F:voltage-gated ion channel activity; IEA:UniProtKB-KW		0:KCNK9|0:KCNIP3|0:TRPM5|0:TPCN1|0:KCNK12|0:KCNK15|0:KCNK5|0:CACNA2D4|0:CLCA3P|0:KCNIP1|0:KCNK4|0:KCNU1|0:CATSPER3|0:KCNK10|0:KCNK7|0:KCNK17|0:TPCN2|0:CATSPER2|0:CATSPER4|0:CYBB|0:NALCN|0:TMEM37|0:KCNIP4|0:KCNK16|0:CACNA2D2|0:KCNK13			
GO:0016458	P:gene silencing; ISS:UniProtKB		0:CHMP1A|0:UTP3|0:SCMH1			
GO:0033699	F:DNA 5'-adenosine monophosphate hydrolase ac...; IDA:UniProtKB		0:APTX			
GO:0005200	F:structural constituent of cytoskeleton; TAS:UniProtKB		0:ACTG1|0:NEFL|0:VIM|0:SPTB|0:TLN2|0:SYNM|0:ERBB2IP|0:CCIN|0:CTNNA2|0:KRT16|0:KRT6A|0:TLN1|0:KRT20|0:TUBGCP3|0:TUBGCP4|0:YEATS4|0:TPM1|0:KRT15|0:DMD|0:SORBS3|0:DSP|0:MSN|0:KRT5|0:PPL|0:CCDC6|0:SPTA1|0:BFSP1|0:CYLC2|0:SPTAN1|0:MAPT|0:EPB41L4B|0:SORBS2|0:ADD3|0:PLS1|0:TUBG1|0:ANK1|0:KRT1|0:BFSP2|0:ACTL7A|0:ARPC1B|0:KRT19|0:VILL|0:DES|0:CD2AP|0:LOR|0:EPB42|0:BICD1|0:KRT9|0:NEFM|0:ARPC5|0:TUBE1|0:INA|0:GFAP|0:KRT6B|0:HIP1|0:KRT2|0:ARPC2|0:ACTL6B|0:SPTBN1|0:KRT14|0:ARPC3|0:KRT17|0:KRT31|0:ACTL7B|0:EPB41|0:SPTBN2|0:ACTA1|0:AGRN|0:SPTBN4|0:ACTB			
GO:0019894	F:kinesin binding; TAS:UniProtKB		0:KIFAP3|0:SNCA|0:MAPK8IP1|0:KIAA1279|0:NEK6|0:ACTB|0:MAPK8IP3|0:CROCC|0:MAPK8IP2|0:KIF1B			
GO:0004163	F:diphosphomevalonate decarboxylase activity; IDA:UniProtKB		0:MVD			
GO:0004385	F:guanylate kinase activity; TAS:ProtInc		0:GUK1|0:CARD11|0:MAGI3|0:DLG3|0:MPP3|0:DLG1|0:CASK|0:MPP2|0:MPP1|0:DLG2|0:TJP2			
GO:0009000	F:selenocysteine lyase activity; TAS:ProtInc		0:SCLY			
GO:0034447	P:very-low-density lipoprotein particle clear...; IGI:BHF-UCL		0:APOE|0:VLDLR|0:APOC1			
GO:0070374	P:positive regulation of ERK1 and ERK2 cascade; NAS:BHF-UCL		0:BMPER|0:TNFSF11|0:CD74|0:MIF|0:CD44|0:ST5|0:TEK|0:FGF10|0:VEGFB|0:FGF4|0:ARRB1|0:FGF21|0:FGF19|0:S100A7|0:IL26|0:GPR55|0:FGF2|0:ARRB2|0:ANGPT1|0:TNFRSF11A|0:ADRA1A|0:TNF			
GO:0042413	P:carnitine catabolic process; ISS:BHF-UCL		0:ACADL			
GO:0007032	P:endosome organization; NAS:UniProtKB		0:VPS18|0:RAB22A|0:ALS2CL|0:AKTIP|0:HOOK3|0:HOOK2|0:FAM160A2|0:HOOK1|0:USP8|0:ALS2			
GO:0046978	F:TAP1 binding; ISS:UniProtKB		0:TAPBP|0:TAP2|0:TAP1			
GO:0010744	P:positive regulation of macrophage derived f...; TAS:BHF-UCL		0:PLA2G10|0:LPL|0:NFKB1|0:AGTR1|0:AGT|0:PF4|0:CSF1|0:APOB|0:CSF2|0:CD36|0:MAPK9|0:MSR1|0:PLA2G2A			
GO:0007443	P:Malpighian tubule morphogenesis; TAS:ProtInc		0:TINAG			
GO:0030199	P:collagen fibril organization; NAS:UniProtKB		0:TGFB2|0:COL11A2|0:COL2A1|0:COL1A2|0:COL5A1|0:COL1A1|0:COL3A1|0:COL5A2|0:TGFBR1|0:NF1|0:ATP7A|0:COL5A3|0:LUM|0:COL12A1|0:COL11A1|0:ADAMTS3|0:COL14A1			
GO:0043568	P:positive regulation of insulin-like growth ...; NAS:BHF-UCL		0:IGF1|0:WNT1|0:GH1|0:PHIP|0:GHRHR|0:GHRH			
GO:0006289	P:nucleotide-excision repair; TAS:UniProtKB		0:POLL|0:RPA4|0:NEIL2|0:NEIL1|0:GTF2H5|0:SLK|0:NEIL3|0:OGG1|0:TP53|0:BRCA2|0:SLX4|0:SLC30A9|0:RAD23A|0:ATXN3|0:MMS19			
GO:0002034	P:regulation of blood vessel size by renin-an...; IC:BHF-UCL		0:AGTR1			
GO:0042813	F:Wnt receptor activity; TAS:UniProtKB		0:FZD3|0:FZD6|0:FZD4|0:FZD1|0:FZD9|0:FZD10|0:FZD7|0:FZD8			
GO:0005105	F:type 1 fibroblast growth factor receptor bi...; ISS:UniProtKB		0:FGF18|0:FGF17|0:FGF8|0:NPTN			
GO:0045742	P:positive regulation of epidermal growth fac...; NAS:UniProtKB		0:AGT|0:AFAP1L2|0:NUP62			
GO:0005496	F:steroid binding; TAS:UniProtKB		0:UGT1A8|0:UGT1A1|0:CYP3A4|0:SCGB2A2|0:PGR|0:PAQR5|0:NR3C1|0:CYP21A2|0:PAQR7|0:ESR1|0:SULT1E1|0:PAQR8|0:NR3C2|0:PDIA2|0:SERPINA6|0:PGRMC1|0:PGRMC2|0:AKR1D1|0:ESR2			
GO:0070536	P:protein K63-linked deubiquitination; TAS:UniProtKB		0:CYLD|0:OTUB2|0:USP20|0:USP33|0:TNFAIP3|0:USP8|0:YOD1|0:C19orf62|0:ZRANB1|0:PSMD14			
GO:0005513	P:detection of calcium ion; TAS:UniProtKB		0:RYR2|0:KCNMB4|0:KCNMB2|0:KCNMB3|0:STIM1|0:CASR|0:KCNIP2|0:KCNIP1|0:SYT1			
GO:0035315	P:hair cell differentiation; TAS:UniProtKB		0:ERCC3|0:ERCC2|0:SPINK5			
GO:0006184	P:GTP catabolic process; IDA:UniProtKB		0:GCH1			
GO:0051877	P:pigment granule aggregation in cell center; ISS:BHF-UCL		0:BBS7|0:BBS4|0:MKKS			
GO:0005787	C:signal peptidase complex; TAS:UniProtKB		0:SPCS2|0:SPCS3|0:SPCS1			
GO:0000126	C:transcription factor TFIIIB complex; NAS:UniProtKB		0:BRF1			
GO:0009306	P:protein secretion; TAS:ProtInc		0:STEAP3|0:ERP29|0:ARFGAP3|0:NECAB3|0:LTBP2|0:PDIA4|0:PPY|0:ARL4D|0:SCG2|0:CANX			
GO:0090181	P:regulation of cholesterol metabolic process; ISS:BHF-UCL		0:ACADVL|0:ACADL			
GO:0061188	P:negative regulation of chromatin silencing ...; IMP:UniProtKB		0:PHF8|0:PHF2			
GO:0047718	F:indanol dehydrogenase activity; IEA:EC		0:AKR1C1|0:AKR1C3			
GO:0032454	F:histone demethylase activity (H3-K9 specific); IDA:UniProtKB		0:KDM4C|0:PHF8|0:JHDM1D|0:KDM1A			
GO:0005003	F:ephrin receptor activity; TAS:ProtInc		0:EPHA6|0:EPHA2|0:EPHA4|0:EPHA7|0:EPHA10|0:EPHB3|0:EPHA8|0:EPHB1|0:EPHB4|0:EPHA1|0:EPHB6			
GO:0005743	C:mitochondrial inner membrane; TAS:UniProtKB		0:SLC25A4|0:PRODH|0:SLC25A5|0:SLC25A20|0:CYP24A1|0:ALDH18A1|0:SLC25A21|0:SLC25A10|0:CYP11B2|0:AIFM3|0:ALAS2|0:NDUFAF3|0:HSD3B1|0:LGALS3|0:ABCB7|0:LETM1|0:SLC25A22|0:MPV17|0:CBARA1|0:SLC25A26|0:SCO1|0:SLC25A17|0:SCO2|0:C3orf1|0:UQCR11|0:SLC25A46|0:SLC25A24|0:CKMT1B|0:MT-CO1|0:CKMT2|0:SLC25A31|0:SLC25A23|0:SLC25A37|0:ATP5S|0:MTCH1|0:GATM|0:SLC25A43|0:SLC25A34|0:SLC25A40|0:COX8C|0:CYC1|0:PARL|0:COX11|0:DNAJC19|0:TIMM22|0:COQ10B|0:ACADVL|0:UQCRQ|0:SLC25A30|0:CKMT1A|0:ABCB10|0:COX5B|0:MRS2|0:MT-CO2|0:SLC25A12|0:COX6C|0:SLC25A2|0:SLC25A36|0:COQ4|0:SLC25A41|0:SLC25A47|0:ABCB8|0:COX8A|0:IMMP1L|0:COQ10A|0:MCART1|0:SLC25A39|0:FECH|0:COX5A|0:COQ7|0:SLC25A44|0:SLC25A28|0:COX4I1|0:FXC1|0:SLC25A18|0:CRAT|0:TIMM8A|0:SLC25A42|0:MTCH2|0:CRLS1|0:MT-CO3|0:SLC25A25|0:SLC25A33|0:EXOG|0:SLC25A14|0:SPNS1|0:UQCR10|0:MCART2|0:PTPMT1|0:SLC25A45|0:SLC25A29|0:SLC25A38|0:SLC25A35|0:MCART6|0:COX7C|0:LETM2|0:HSPD1|0:PHB2|0:CLPX|0:SLC25A13|0:HSD3B2|0:SLC25A27|0:UCP1|0:UCP2|0:SLC25A19|0:SLC25A16|0:CPT2|0:CDS2|0:SLC25A32|0:DHODH|0:CYP11B1|0:SLC25A15|0:UCP3|0:SLC25A11|0:SLC25A3|0:HCCS|0:SLC25A1|0:PHB|0:PMPCA			
GO:0051099	P:positive regulation of binding; IMP:UniProtKB		0:PON1|0:DPH3|0:RARA			
GO:0030518	P:steroid hormone receptor signaling pathway; NAS:UniProtKB		0:CALCOCO1|0:RHOXF1			
GO:0017069	F:snRNA binding; IDA:UniProtKB		0:HEXIM1|0:HEXIM2|0:GEMIN5			
GO:0090205	P:positive regulation of cholesterol metaboli...; IC:BHF-UCL		0:LDLRAP1			
GO:0051051	P:negative regulation of transport; IDA:MGI		0:TRAT1|0:YRDC|0:RSC1A1			
GO:0000138	C:Golgi trans cisterna; TAS:ProtInc		0:SGMS1|0:B4GALT1|0:AP4M1			
GO:0006878	P:cellular copper ion homeostasis; TAS:UniProtKB		0:SCO1|0:SCO2|0:ATP7A|0:APP|0:PRNP|0:MT2A|0:ATOX1|0:ATP7B			
GO:0040014	P:regulation of multicellular organism growth; ISS:UniProtKB		0:PRL|0:IGF1|0:DRD3|0:APP|0:SOD1			
GO:0045654	P:positive regulation of megakaryocyte differ...; IMP:UniProtKB		0:HMGB2|0:TESC|0:SCIN			
GO:0032929	P:negative regulation of superoxide anion gen...; IDA:UniProtKB		0:AATF			
GO:0070164	P:negative regulation of adiponectin secretion; ISS:BHF-UCL		0:IL1B			
GO:0033076	P:isoquinoline alkaloid metabolic process; IDA:BHF-UCL		0:CYP2D6			
GO:0015093	F:ferrous iron transmembrane transporter acti...; IDA:UniProtKB		0:SLC11A2			
GO:0017111	F:nucleoside-triphosphatase activity; IEA:InterPro		0:C1orf57|0:SPG7|0:ATAD2B|0:NUBP1|0:FIGNL1|0:FIGNL2|0:CLPB|0:MCM3|0:C9orf167|0:TOR2A|0:NAV1|0:ATAD5|0:ATAD3B|0:BCS1L|0:AFG3L2|0:NVL|0:ORC1|0:SPATA5L1|0:TOR1B|0:ATAD3C|0:ATAD1|0:YME1L1|0:FIGN|0:SRP54|0:MCM8|0:AKD1|0:MMAA|0:RAD17|0:ATAD3A|0:TRIP13|0:RNF213|0:GPN1|0:CDC6|0:NAIP|0:CHTF18|0:NAV3|0:ORC4|0:MCM9|0:SPATA5|0:PSMC3			
GO:0004037	F:allantoicase activity; IEA:EC		0:ALLC			
GO:0008746	F:NAD(P) transhydrogenase activity; TAS:ProtInc		0:DHDH			
GO:0001773	P:myeloid dendritic cell activation; ISS:UniProtKB		0:HMGB1			
GO:0030282	P:bone mineralization; NAS:UniProtKB		0:ASPN|0:CYP27B1|0:SBDS|0:EIF2AK3|0:AMBN|0:TUFT1|0:MINPP1|0:BGLAP|0:ENAM			
GO:0046967	P:cytosol to ER transport; IMP:UniProtKB		0:TAP2|0:TAP1			
GO:0008298	P:intracellular mRNA localization; NAS:UniProtKB		0:BICD1			
GO:0015801	P:aromatic amino acid transport; TAS:HGNC		0:SLC16A10			
GO:0060080	P:regulation of inhibitory postsynaptic membr...; ISS:UniProtKB		0:DRD4|0:CHRNA4			
GO:0042063	P:gliogenesis; IMP:BHF-UCL		0:CDK6			
GO:0007267	P:cell-cell signaling; TAS:UniProtKB		0:CD86|0:IL22|0:INS|0:IL10|0:IL11|0:IL13|0:CD80|0:AIMP1|0:EREG|0:STAB1|0:SH2D1A|0:TBX5|0:DHH|0:DLGAP3|0:DLGAP4|0:DLGAP5|0:GATA4|0:SFRP2|0:FADS1|0:WNT6|0:ITGB2|0:WNT9A|0:FCRL2|0:WNT7B|0:ISG15|0:IHH|0:GAL3ST4|0:WNT9B|0:SH3KBP1|0:ADAM10|0:CXCL13|0:LHB|0:BMP3|0:TEK|0:ENPEP|0:PTH|0:PGR|0:CGB8|0:NDP|0:TUSC2|0:IL17A|0:STC1|0:MPZL1|0:FGF4|0:FGF14|0:PCSK5|0:CCL15|0:TNFSF9|0:IL7|0:INSL3|0:GRAP2|0:GDF15|0:ASIP|0:ASH1L|0:CCL26|0:PTGIR|0:SEMA4F|0:ADM|0:FGF21|0:AVP|0:TNFSF10|0:IL3|0:ADRA2B|0:AMH|0:PCDH8|0:GDF5|0:CCL21|0:WISP3|0:CXCL6|0:LTA|0:CCL3|0:TNFAIP6|0:IL18|0:TRHDE|0:AREG|0:CCL18|0:ADCYAP1|0:IAPP|0:FAT1|0:IL26|0:CXCL14|0:PTHLH|0:EFNB3|0:EFNA1|0:FASLG|0:BST2|0:TFAP2C|0:GPR50|0:TNFRSF11A|0:TSHB|0:AR|0:PCSK1|0:GUCA1B|0:FGF6|0:MLN|0:EFNA2|0:IK|0:ADRA1D|0:IFNA7|0:PGF|0:IL1B|0:ADRA2C|0:CD33|0:CGB5|0:FGF20|0:CALCA|0:CXCL11|0:ZYX|0:CCL20|0:IL15|0:SIGLEC6|0:CXCL9|0:FGF18|0:CXCL5|0:TXN|0:KLF10|0:PYY|0:ADRA1A|0:SIRPG|0:FGF12|0:MME|0:CCL23|0:WISP1|0:C1QA|0:MLLT4|0:NMB|0:LNPEP|0:CCL17|0:NR5A1|0:TNFSF18|0:NUDT3|0:PCDH1|0:CCR1|0:GJA3|0:HCN2|0:CCL8|0:EFNB2|0:CEACAM6|0:FGF17|0:GJB1|0:GNRH1|0:FGFBP1|0:XCL1|0:EFNA5|0:FGF5|0:CD70|0:CCL5|0:TSHR|0:NRP1|0:FGF11|0:IFNA2|0:CTF1|0:CHST4|0:SEMA3B|0:CCL24|0:VIPR2|0:CGB7|0:FGF9|0:GJB2|0:CCR5|0:SEMA5A|0:WISP2|0:CCL22|0:EFNB1|0:AGT|0:SPRY2|0:IL17C|0:IL1F9|0:LALBA|0:CGB|0:TNFSF8|0:GPR56|0:PHEX|0:CXCL10|0:FGF13|0:PTPRJ|0:IL17B|0:POMC|0:CRB1|0:TGFB2|0:MERTK|0:CCL7|0:AREGB|0:CD97|0:CCL16|0:EFNA3|0:STC2|0:S100A9|0:LILRB2|0:CCL4|0:NAMPT|0:FGF16|0:GRAP|0:TOLLIP|0:ESR2|0:CCL13|0:GJA1|0:EFNA4|0:TRH|0:CCL27|0:ADRA1B|0:LTB|0:INSL4|0:TMED1|0:GRB2|0:TSPAN32|0:SRD5A2|0:IL2|0:ECE2|0:INHA			
GO:0009236	P:cobalamin biosynthetic process; IEA:InterPro		0:MMAB			
GO:0002526	P:acute inflammatory response; ISS:BHF-UCL		0:VNN1			
GO:0004314	F:[acyl-carrier-protein] S-malonyltransferase...; IDA:UniProtKB		0:FASN|0:MCAT			
GO:0008033	P:tRNA processing; TAS:ProtInc		0:FARS2|0:FBL|0:FBLL1|0:FDXACB1|0:DUS3L|0:ELAC2|0:RG9MTD1|0:MTO1|0:RPP25|0:DUS1L|0:CCDC76|0:PUS7|0:POP7|0:TRMT11|0:LSM6|0:DUS4L|0:RPP30|0:DUS2L|0:RPP21|0:TYW1|0:RPP40|0:TRMT12|0:POP5|0:TRUB2|0:TRUB1|0:PUS10|0:ADAT3|0:C4orf23|0:RPP38|0:HSD17B10|0:KIAA0391|0:ADAT2|0:TSEN15|0:TRMT6|0:PUS7L|0:TYW3|0:TYW1B|0:RPP14|0:LCMT2|0:PUSL1|0:ADAT1|0:KARS|0:TRIT1|0:POP4|0:AARS|0:SARS			
GO:0031386	F:protein tag; IEA:InterPro		0:RNF41			
GO:0006590	P:thyroid hormone generation; TAS:UniProtKB		0:FOXE1|0:DIO1|0:DIO2			
GO:0019448	P:L-cysteine catabolic process; IDA:UniProtKB		0:CBS			
GO:0032435	P:negative regulation of proteasomal ubiquiti...; ISS:UniProtKB		0:TAF9|0:UBXN1|0:HSP90AB1|0:GIPC1|0:N4BP1			
GO:0002687	P:positive regulation of leukocyte migration; TAS:BHF-UCL		0:MIA3|0:VEGFA			
GO:0005250	F:A-type (transient outward) potassium channe...; TAS:UniProtKB		0:KCND3|0:KCNIP2			
GO:0030855	P:epithelial cell differentiation; TAS:UniProtKB		0:UPK1B|0:UPK1A|0:UPK3A|0:UPK2|0:ELF3|0:EHF|0:PPARG|0:KRT4|0:SIX1|0:KRT3|0:DHRS9|0:RHCG|0:SPINK5|0:DMBT1			
GO:0042780	P:tRNA 3'-end processing; IDA:UniProtKB		0:TRNT1			
GO:0000003	P:reproduction; IEP:UniProtKB		0:MMP23B|0:MMP23A			
GO:0030384	P:phosphoinositide metabolic process; TAS:UniProtKB		0:PLEK|0:DRD2|0:PITPNM3			
GO:0008817	F:cob(I)yrinic acid a,c-diamide adenosyltrans...; IEA:EC		0:MMAB			
GO:0046983	F:protein dimerization activity; TAS:UniProtKB		0:ATM|0:ACTN2|0:TFAP2C|0:TAF5|0:TFAP2B|0:GARS|0:TFAP2A|0:CREB3L1|0:POLR2J|0:BATF2|0:CREB1|0:POLR2J3|0:FOSL2|0:POLR1D|0:ZNF862|0:DBP|0:ATF2|0:NFE2|0:BATF|0:TEF|0:ATF6B|0:ATF7|0:NFIL3|0:NFE2L2|0:FOSB|0:POLR2C|0:SCAND3|0:HLF|0:CREB3|0:CREB3L4|0:ATF3|0:JUNB|0:ZBED1|0:JUND|0:NFE2L3|0:CREB3L3|0:CREBZF|0:CREBL2|0:CEBPD|0:BACH2|0:ATF5|0:ATF4|0:BACH1|0:ZBED4|0:POLR1C|0:BATF3|0:ZMYM1|0:CREB3L2|0:XBP1|0:POLR2J2|0:FOSL1|0:SPEF2|0:CREM|0:NFE2L1|0:CREB5|0:PRKRIR|0:DDIT3|0:ATF6|0:HPS1|0:STK3|0:STAT3|0:TCF21|0:AR|0:CELSR1|0:NCF4|0:WWOX			
GO:0071354	P:cellular response to interleukin-6; IDA:MGI		0:SELPLG			
GO:0051747	F:cytosine C-5 DNA demethylase activity; IDA:UniProtKB		0:ALKBH2			
GO:0090096	P:positive regulation of metanephric cap mese...; ISS:UniProtKB		0:MYC			
GO:0046590	P:embryonic leg morphogenesis; IMP:BHF-UCL		0:WNT7A			
GO:0007158	P:neuron cell-cell adhesion; TAS:UniProtKB		0:CDK5R1|0:ASTN1|0:CTNND2|0:NCAM2|0:NINJ2|0:CNTN4			
GO:0070561	P:vitamin D receptor signaling pathway; IEP:BHF-UCL		0:CYP24A1			
GO:0004117	F:calmodulin-dependent cyclic-nucleotide phos...; TAS:ProtInc		0:PDE1A|0:PDE1C|0:PDE1B			
GO:0005922	C:connexon complex; TAS:ProtInc		0:GJD3|0:GJA9|0:GJD2|0:GJC2|0:GJB7|0:GJB3|0:GJC3|0:GJB5|0:GJC1|0:GJB6|0:GJA3|0:GJD4|0:GJB4|0:GJA10|0:GJE1|0:GJA8|0:GJB1|0:GJB2|0:GJA1			
GO:0042743	P:hydrogen peroxide metabolic process; IDA:BHF-UCL		0:NOX1			
GO:0032490	P:detection of molecule of bacterial origin; IDA:BHF-UCL		0:LBP			
GO:0004118	F:cGMP-stimulated cyclic-nucleotide phosphodi...; TAS:ProtInc		0:PDE2A			
GO:0042392	F:sphingosine-1-phosphate phosphatase activity; IDA:UniProtKB		0:PPAP2C|0:PPAP2A|0:PPAP2B|0:SGPP2			
GO:0000062	F:acyl-CoA binding; TAS:ProtInc		0:SOAT2|0:SOAT1|0:PECI|0:ACBD5|0:DBI|0:ACBD6|0:ACBD3|0:ACBD7|0:ACBD4|0:ALDH6A1|0:ACOT7			
GO:0015211	F:purine nucleoside transmembrane transporter...; TAS:ProtInc		0:SLC28A2			
GO:0015245	F:fatty acid transporter activity; TAS:ProtInc		0:SLC27A4			
GO:0005332	F:gamma-aminobutyric acid:sodium symporter ac...; IEA:InterPro		0:SLC6A12			
GO:0071208	F:histone pre-mRNA DCP binding; ISS:UniProtKB		0:SNRPD3|0:LSM10|0:SLBP			
GO:0070254	P:mucus secretion; ISS:UniProtKB		0:AGR2			
GO:0004708	F:MAP kinase kinase activity; TAS:ProtInc		0:LRRK2|0:TGFA|0:MAP2K7|0:EPGN|0:MAP3K9|0:MAPKAPK3|0:MAPK14|0:MAP2K6|0:MAPK10|0:MAP2K3|0:MAP2K1|0:MAPKAPK5			
GO:0047977	F:hepoxilin-epoxide hydrolase activity; ISS:UniProtKB		0:ALOX12			
GO:0016155	F:formyltetrahydrofolate dehydrogenase activity; IEA:EC		0:ALDH1L1|0:ALDH1L2			
GO:0032717	P:negative regulation of interleukin-8 produc...; IMP:BHF-UCL		0:TLR9|0:BPI|0:ARRB1|0:IL6R|0:ADAM17			
GO:0010501	P:RNA secondary structure unwinding; IDA:BHF-UCL		0:BAT1			
GO:0051451	P:myoblast migration; ISS:UniProtKB		0:THBS4|0:SIX1			
GO:0007168	P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc		0:PDZD3|0:NPR1|0:NPPA|0:NPR2|0:NPPC|0:NPPB|0:GUCY2D|0:GUCA1B|0:GUCY2C|0:GUCY2F			
GO:0033981	F:D-dopachrome decarboxylase activity; IEA:EC		0:DDT			
GO:0032797	C:SMN complex; IDA:UniProtKB		0:GEMIN8			
GO:0010575	P:positive regulation vascular endothelial gr...; TAS:BHF-UCL		0:C3|0:C5|0:HIF1A|0:ARNT|0:NOX1|0:GATA4|0:IL1A|0:PTGS2|0:IL1B|0:IL6ST			
GO:0050919	P:negative chemotaxis; IDA:UniProtKB		0:PDGFA|0:SLIT3|0:SLIT1			
GO:0042018	F:interleukin-22 receptor activity; IDA:UniProtKB		0:IL22RA2			
GO:0006414	P:translational elongation; TAS:ProtInc		0:RPS11|0:RPS18|0:RPL4|0:RPL27|0:RPL38|0:RPS23|0:RPS15A|0:RPS4Y1|0:RPLP0|0:RPL34|0:RPSA|0:RPS8|0:RPL22|0:RPS26|0:RPS15|0:RPL21|0:RPL18A|0:RPL3|0:RPL9|0:RPL23A|0:RPL12|0:RPL26|0:RPS12|0:RPS19|0:RPLP1|0:RPL32|0:RPL17|0:RPL37A|0:RPL8|0:RPL29|0:RPS3|0:RPS20|0:RPS7|0:RPL37|0:RPS27|0:RPS28|0:RPS21|0:RPS3A|0:RPL35A|0:RPL31|0:RPS16|0:RPL14|0:RPS13|0:RPL6|0:RPL18|0:RPL13|0:RPL41|0:RPL10|0:RPS24|0:RPL24|0:RPS6|0:RPL36A|0:RPL7|0:RPL36|0:RPL13A|0:RPS17|0:RPL19|0:RPL7A|0:FAU|0:RPS29|0:RPL39|0:RPLP2|0:RPS10|0:RPL15|0:RPL28|0:RPL10A|0:RPL30|0:RPL5|0:RPL3L|0:RPL26L1|0:RPS5|0:RPL35|0:RPL11|0:RPS25|0:RPS9|0:RPS4X|0:RPL27A|0:RPL23|0:RPS14|0:RPS2|0:VARS|0:EEF2K			
GO:0050766	P:positive regulation of phagocytosis; TAS:UniProtKB		0:TUB|0:AZU1|0:TULP1|0:AHSG|0:SLC11A1|0:CALR|0:GATA2|0:SFTPD|0:SPACA3			
GO:0007179	P:transforming growth factor beta receptor si...; TAS:UniProtKB		0:FOS|0:TGFBR2|0:CITED1|0:JUN|0:SMAD2|0:TGFB3|0:ARRB2|0:TGFBR3|0:ENG|0:TGFB2|0:TGFBR1|0:SMAD4|0:ACVRL1|0:ACVR1|0:HPGD|0:COL1A2|0:COL3A1|0:PTPRK|0:SMAD6|0:SMAD9|0:FSHB|0:ADAM9|0:NLK|0:USP9X|0:USP9Y|0:TGFB1|0:SMAD5|0:SMAD1|0:ID1|0:GDF10|0:BMPR1A|0:LTBP2|0:GDF15|0:GDF5|0:FNTA|0:LEFTY2|0:KLF10|0:MAP3K7|0:LEFTY1|0:GDF9|0:TGFBRAP1|0:FOXH1			
GO:0050783	P:cocaine metabolic process; TAS:UniProtKB		0:BCHE			
GO:0035173	F:histone kinase activity; IDA:UniProtKB		0:BAZ1B			
GO:0005829	C:cytosol; TAS:UniProtKB		0:CDC25B|0:ABR|0:RICTOR|0:HABP4|0:CENPJ|0:ITSN1|0:DCTN1|0:PGM1|0:HRAS|0:AP2S1|0:RPL27|0:FOXO1|0:BANF1|0:RFK|0:BMF|0:EIF4E|0:TRAF6|0:PFKFB2|0:CEP63|0:MDM2|0:AKT2|0:MAPKAPK3|0:CCNB2|0:CD28|0:EIF3J|0:ACSL1|0:ABL1|0:TXNRD1|0:CCNE2|0:SPTBN2|0:MAPK11|0:SRM|0:TUBGCP5|0:SH3GL2|0:AP2A2|0:FZR1|0:DFFB|0:MALT1|0:CACNB3|0:PRKAR2A|0:SKP1|0:FBLIM1|0:MAP3K14|0:ARHGAP4|0:MAPK14|0:RAPGEF1|0:MAP3K8|0:MAP2K2|0:MAD1L1|0:FBXO5|0:CDC26|0:ARHGEF18|0:ACTN2|0:CAMK2G|0:PIK3R4|0:TUBA4A|0:PTPN1|0:ANAPC11|0:CEP76|0:NCBP2|0:ASNS|0:FAH|0:NOS3|0:ARHGEF6|0:EIF2S2|0:CKAP5|0:KRT5|0:RARS|0:RND1|0:VAV3|0:EIF3G|0:PAK2|0:DLG1|0:GRAP2|0:IRF3|0:NGFRAP1|0:TUBA1A|0:PANK1|0:NEFL|0:PDE4D|0:GEMIN4|0:LIMS1|0:CALM2|0:GYG2|0:PTTG1|0:YWHAG|0:NGEF|0:MAPK1|0:NUPL2|0:DOK1|0:TCEB1|0:DYNLL1|0:MAPK8|0:SPTA1|0:PDE4B|0:LCP2|0:VASP|0:FGD3|0:IMPDH1|0:PRKACA|0:PFKFB4|0:ARCN1|0:NAT1|0:ACTG1|0:EVL|0:COMT|0:RAC1|0:DOCK2|0:NUP214|0:SDCCAG8|0:GK|0:CARD11|0:MAPKAP1|0:PNMT|0:AGPAT3|0:CAMK2D|0:PLCB3|0:CDC25C|0:SPTAN1|0:ACTR1A|0:MAPT|0:EPB41L1|0:AASDHPPT|0:ANAPC7|0:CSK|0:LCK|0:SMAD7|0:SULT2A1|0:GAMT|0:SNUPN|0:CSNK1D|0:PRKAG3|0:CSNK1A1|0:MAP3K1|0:PDE1A|0:KARS|0:FERMT2|0:MYD88|0:BCL2L11|0:CEP78|0:CBL|0:FADD|0:AIMP1|0:EIF3C|0:PRKACG|0:COPG|0:VCL|0:AKAP5|0:TTN|0:CRK|0:BRPF3|0:SNRPD3|0:PRKAB1|0:CEP152|0:BCAT1|0:HMGA1|0:IRAK4|0:RPS6KB1|0:ANAPC4|0:MAPKAPK2|0:ROCK2|0:IRS1|0:CD151|0:GRIP1|0:EIF3D|0:CEP164|0:SMS|0:ITK|0:PARVB|0:PHAX|0:STK24|0:AP1S3|0:EEF1D|0:TIAM2|0:ELMO1|0:AMDHD1|0:CEP192|0:RPL9|0:PTPN6|0:GPAM|0:MCF2|0:GALT|0:CDC23|0:NCK1|0:CDKN1A|0:UBE2V1|0:ALMS1|0:NARS|0:AANAT|0:GEMIN5|0:CH25H|0:DBNL|0:QARS|0:BID|0:AP1G1|0:RFWD2|0:TSGA14|0:MDH1|0:RPL12|0:COPA|0:SOS2|0:LARS|0:SNRPF|0:PRKCD|0:RIPK2|0:FTL|0:DYNLL2|0:EIF2S3|0:AP2A1|0:APAF1|0:BCAR1|0:CASP7|0:CDC20|0:PRKAG2|0:ITGB3BP|0:YWHAB|0:PRKAR2B|0:DFFA|0:TUBGCP2|0:ATP6V1H|0:AGPAT2|0:XPO1|0:CAMK2A|0:IDI1|0:TUBG1|0:COPB1|0:AKT1|0:EIF3K|0:MARS|0:PYGM|0:CASP2|0:AZI1|0:CEP57|0:PAK1|0:TLN1|0:SHC1|0:LIMS2|0:PIK3R5|0:QPRT|0:RPL32|0:TIAM1|0:ARHGEF16|0:PPP1R1B|0:ADC|0:AKR1C4|0:NET1|0:IRS2|0:RPL17|0:BIRC2|0:FGD2|0:PPP1CA|0:COPB2|0:CDC27|0:SMAD2|0:PRKCZ|0:KIDINS220|0:MYLK|0:NAT2|0:SFI1|0:IARS|0:VARS|0:FNTA|0:RPS6KA1|0:RPL37A|0:ACACB|0:AGPAT5|0:EIF4H|0:GPX1|0:APRT|0:PDE4A|0:CEP70|0:PLCB2|0:NOSIP|0:CDK5RAP2|0:CEP135|0:FASN|0:STAM|0:PTPN11|0:BTRC|0:ARHGEF2|0:PPP3CC|0:TARS|0:SNRPE|0:PRKAB2|0:PRKAR1A|0:SMN2|0:PCK1|0:BAD|0:AIMP2|0:KPNA1|0:EEF1A1|0:ACSS2|0:HPD|0:EEF1E1|0:RIPK1|0:NCBP1|0:DSG3|0:INPP5D|0:CALM3|0:ACIN1|0:CDK5|0:CETN2|0:TUBGCP6|0:TXN|0:GAB1|0:GORASP1|0:HAUS2|0:IRAK1|0:PDE1C|0:AGPAT1|0:NINL|0:AP1S2|0:ARHGEF9|0:CDK1|0:ORC1|0:SARS|0:OFD1|0:NADSYN1|0:RSU1|0:UBE2N|0:CAMK2B|0:KALRN|0:EIF5A|0:GEMIN6|0:EIF3H|0:RPS6KA2|0:NDE1|0:MCF2L|0:GSR|0:CSNK1E|0:TUBB4|0:GBE1|0:CLASP1|0:UPB1|0:ARHGEF4|0:RHOG|0:RPL35A|0:EIF3E|0:EIF3CL|0:PIK3R6|0:DDX20|0:NEK2|0:AP1S1|0:SMAD6|0:MLLT4|0:RPTOR|0:ZAP70|0:TUBGCP3|0:CKB|0:BCAP31|0:PLEKHG2|0:PRKAA1|0:ENAH|0:CAMKK1|0:TH|0:TPH1|0:EIF5A2|0:WAS|0:ARHGEF11|0:LYN|0:AKAP9|0:SPTB|0:PCM1|0:PLEC|0:ANAPC5|0:RPL13|0:CDC16|0:TUBG2|0:PABPC1|0:APOBEC3G|0:PRKAG1|0:EEF1G|0:SMAD5|0:GARS|0:PUM1|0:GOT1|0:CASP6|0:DARS|0:SMAD9|0:NUP88|0:CARS|0:MTR|0:RPS6KA6|0:SH3D19|0:NGFR|0:HARS|0:EPS15|0:POTEKP|0:PSIP1|0:AP2B1|0:CDK4|0:BUB3|0:BPNT1|0:PPP3R1|0:COPE|0:EIF3A|0:DTYMK|0:AP1B1|0:AKR1B1|0:SRC|0:CASP9|0:MAP3K7|0:KMO|0:NFKB1|0:SPTBN4|0:HGS|0:TRADD|0:RPL36A|0:PLEK|0:FARSB|0:MTHFR|0:YWHAE|0:FLNC|0:GRLF1|0:FES|0:AP2M1|0:AP1M1|0:EPRS|0:CHAT|0:PDPK1|0:PRPS1|0:PFKFB3|0:RALGDS|0:VAV2|0:DYNC1I2|0:ADA|0:SSNA1|0:PHLPP1|0:EIF4B|0:SULT1E1|0:RPIA|0:NSF|0:UGDH|0:PLCB1|0:GLUL|0:PRKD1|0:MAPK3|0:FGD1|0:FLAD1|0:PRKAR1B|0:SMN1|0:RPL13A|0:SNRPB|0:NUMA1|0:RANBP2|0:AMD1|0:STX4|0:PCNT|0:PRKCG|0:CCNB1|0:PRKCB|0:STARD5|0:SIP1|0:CCNE1|0:TUBB2C|0:TUBB|0:EIF1AX|0:ALAD|0:SPTBN1|0:SPRY2|0:IRF7|0:EIF2S1|0:XIAP|0:ADD1|0:ACLY|0:EEF2K|0:CEP72|0:GSK3B|0:TESK1|0:IDO1|0:ADRBK1|0:SPRY1|0:PACS1|0:RPL15|0:DIABLO|0:FARSA|0:PLEKHG5|0:TUBGCP4|0:CDK2|0:GSTZ1|0:STAM2|0:NMT1|0:HMGCS1|0:NFKBIA|0:EIF3I|0:ACTN1|0:PDE1B|0:RPL10A|0:RAP1A|0:AXIN1|0:TRIO|0:ABL2|0:ARHGEF12|0:RAC2|0:MYO6|0:PARVA|0:FGD4|0:PTGES3|0:HAL|0:ILK|0:ARHGEF3|0:CSNK1G2|0:CDC42|0:COL4A3BP|0:EIF3F|0:SMAD4|0:EEF1B2|0:PLK4|0:CUL1|0:PRKAA2|0:KRT14|0:CACNB4|0:CUL5|0:ANAPC2|0:UBE2C|0:DHPS|0:RPL3L|0:HPRT1|0:RELA|0:ACTB|0:TCEB2|0:ARHGEF17|0:EIF4A2|0:MAP2K1|0:TDO2|0:KPNB1|0:DCTN2|0:RASGRF2|0:RPL26L1|0:CEP250|0:TKT|0:IMPDH2|0:PPP3CA|0:PTK2|0:RHEB|0:GPD1|0:GCK|0:PDE4C|0:MAPRE1|0:DYNC1H1|0:CDC6|0:IDI2|0:TRAF2|0:FTH1|0:FYN|0:DGAT1|0:CCND1|0:ANAPC1|0:SNRPG|0:PRKACB|0:YES1|0:ANAPC10|0:ECT2|0:NAMPT|0:ACP5|0:PLCB4|0:SMAD1|0:CEP110|0:GZMB|0:EIF4EBP1|0:GCKR|0:AK5|0:BMX|0:DNM1L|0:ASMT|0:GYG1|0:APC|0:SULT2B1|0:CALM1|0:CKM|0:SOS1|0:PTEN|0:TICAM1|0:GALK1|0:EIF3B|0:ARHGEF7|0:PLK1|0:WDR1|0:CDKN1B|0:COPZ1|0:CASP8|0:ARF1|0:DCTN3|0:RAF1|0:SH3KBP1|0:SNRPD1|0:AGPAT4|0:SPTBN5|0:OBSCN|0:DSG1|0:NEDD1|0:EIF4G1|0:UBE2D1|0:PGM2|0:ROCK1|0:ODF2|0:EIF4A1|0:CLINT1|0:UBE2E1|0:GEMIN7|0:MLST8|0:FGFR1OP|0:ADSL|0:BUB1B|0:RPL23|0:AKAP13|0:ARHGDIA|0:AP1M2|0:APBB1IP|0:FLNA|0:VAV1|0:RPS6KA3|0:GRIP2|0:SNRPD2|0:FKBP1B|0:URM1|0:PARK2|0:CASP3|0:APPL1|0:NISCH|0:FXN|0:CAD|0:BAX|0:G6PD|0:SERPINE2|0:PINK1|0:CTNNBIP1|0:FKBP1A|0:ACOT6|0:ACO1|0:CEP290|0:MAP1S|0:ITGB1BP1|0:NFS1|0:ISCU|0:TOM1L1|0:HSD17B14|0:BCL2L10|0:NOD2|0:ACOT1|0:CIDEB|0:CTNNAL1|0:ZFP36|0:ARFGEF2|0:BAG3|0:ARFIP1|0:PPP6C|0:CABLES1|0:VPS28|0:RIC8B|0:ABI2|0:PDCD4|0:BTK|0:SNCA|0:BLVRB|0:ALOX12|0:CLIC4|0:HDAC1|0:EEA1|0:ATP6V1G3|0:MOCS3|0:TOM1|0:WDFY1|0:DNMT3L|0:NUBP1|0:EPM2A|0:ACMSD|0:STXBP3|0:CCDC88A|0:PLCE1|0:BIRC5|0:SERPINB9|0:C21orf96|0:RBM38|0:PGAM1|0:IL1A|0:MEMO1|0:GLI1|0:BNIPL|0:CBR3|0:ZFYVE28|0:KRTAP6-1|0:ARFGAP3|0:PDZD11|0:LCP1|0:AFTPH|0:SOX2|0:SPHK2|0:SLC6A4|0:ULK1|0:CITED1|0:FAF1|0:UBE2G2|0:HBXIP|0:MEN1|0:CRYZ|0:HSP90B1|0:STEAP2|0:CYLD|0:NAPRT1|0:PRKCA|0:NCF4|0:FANCC|0:C21orf59|0:SPINK5|0:GCH1|0:VCP|0:ATG3|0:DUSP3|0:SH3BGR|0:S100A7|0:IL26|0:CRYZL1|0:PLCG1|0:PRKCI|0:PEX1|0:GSN|0:VIM|0:UBASH3A|0:AIFM2|0:C2CD2|0:PRICKLE1|0:PLA2G4B|0:GSTT1|0:RAB3IP|0:CCT8|0:EZR|0:LANCL2|0:PCBP3|0:MVD|0:INPP5K|0:C21orf7|0:MAP1LC3A|0:BCL10|0:MOCS2|0:PPIP5K1|0:ANKRA2|0:RSPH1|0:CHAC1|0:SDPR|0:CPNE3|0:FERMT1|0:ALKBH8|0:S100A13|0:MAD2L1|0:PSRC1|0:HLCS|0:VPS4B|0:THRA|0:NFU1|0:RERG|0:GOLPH3|0:PDE9A|0:HSF2BP|0:FOXO4|0:MYO7A|0:HAAO|0:MCM3AP|0:UCHL5|0:TXNDC17|0:VPS35|0:LDLRAP1|0:PEX5|0:AKR1C1|0:POU5F1|0:TOP2B|0:BCL2L14|0:DUSP7|0:AKAP7|0:VPS26A|0:RASGRP2|0:KCTD5|0:KYNU|0:NDOR1|0:GLI3|0:PDCD10|0:GAPVD1|0:SRXN1|0:SPG21|0:PCP4|0:HSPD1|0:DPYD|0:FGF1|0:CBS|0:GCFC1|0:DGKQ|0:SOD1|0:AKR1D1|0:PREX1|0:USP8|0:PDXK|0:ANXA9|0:RRP1B|0:SHMT1|0:STXBP2|0:GBA3|0:NBR1|0:XRCC4|0:RASSF9|0:ALS2|0:SERPINB8|0:GGCT|0:MX1|0:TPRKB|0:RNF25|0:ALOX5|0:MYH9|0:VPS41|0:CALR|0:CIDEC|0:PPIA|0:S100A6|0:PEX6|0:PRMT7|0:FHL1|0:TAB2|0:RB1CC1|0:UFD1L|0:SDCBP|0:COG5|0:HERC4|0:APLF|0:CAMK2N2|0:G3BP1|0:RILPL1|0:CHMP4C|0:RAB24|0:USO1|0:ENGASE|0:PLA2G4E|0:ICK|0:CDCA3|0:RAP1B|0:TRIM39|0:ANPEP|0:PDE11A|0:CMBL|0:C17orf37|0:NFE2L2|0:TXLNG|0:DIAPH2|0:RASA4|0:POMP|0:AHSA1|0:AFMID|0:HPS5|0:SPG11|0:PDCD6IP|0:HERC1|0:UBR1|0:PDE7A|0:GVINP1|0:PREPL|0:EXOC7|0:LPIN1|0:HPS6|0:PCYT1A|0:UBXN2B|0:ANO7|0:CHMP4B|0:PLA2G4F|0:AACS|0:CHMP2B|0:HERC6|0:GPSM1|0:WDR44|0:ILDR1|0:CHMP5|0:PDC|0:ATG13|0:GCHFR|0:SNX27|0:INPPL1|0:DPP9|0:CPLX1|0:RASGRP1|0:RUSC2|0:CORO7|0:VPS24|0:CHMP1B|0:PTRF|0:SET|0:MKKS|0:LPIN2|0:PLA2G4D|0:FRMPD1|0:LIPE|0:ALDH7A1|0:NIPSNAP3A|0:STIL|0:YKT6|0:FOXO3|0:SELENBP1|0:GAD2|0:DUSP23|0:NXN|0:NPLOC4|0:CPLX2|0:MGRN1|0:ZFAT|0:ATP7A|0:COX19|0:RILPL2|0:SLC7A5|0:CAPRIN1|0:CTNND1|0:NOS2|0:DNAJA3|0:CREB3|0:CYCS|0:NEDD4|0:PPARG|0:PAFAH1B1|0:CAPN10|0:KLC2|0:RASGRF1|0:ACOT12|0:KLC1|0:FKBP4|0:DCT|0:ABHD5|0:NBEA|0:RAB14|0:DPYS|0:C10orf27|0:PPT1|0:ATP6V1B2|0:ATP6V1A|0:GYS2|0:PDLIM5|0:UBQLN4|0:GABARAPL2|0:MFN2|0:RBX1|0:DCTPP1|0:ATP6V1E1|0:PPIP5K2|0:NCDN|0:MAP3K12|0:WDYHV1|0:AS3MT|0:ALDH3A1|0:ATP6V1G1|0:HDAC6|0:VPS26B|0:CRYL1|0:FBXO2|0:ATG4C|0:CTU1|0:ICA1|0:ME1|0:RNF115|0:PLA2G4A|0:SULT4A1|0:EPHX2|0:UPP2|0:NDRG2|0:PHPT1|0:PBXIP1|0:FAS|0:ADCY10|0:TNFRSF25|0:ERAP1|0:PKM2|0:NCALD|0:OSBPL5|0:GCLM|0:UROS|0:SNX15|0:PRDX6|0:HSP90AA1|0:NT5C1A|0:TAP1|0:PGK2|0:EIF5|0:C9orf89|0:MTHFS|0:SULT1B1|0:GSK3A|0:GRB2|0:BEST1|0:AIP|0:TACSTD2|0:LDHA|0:SCLY|0:UNC119|0:OTOF|0:CADPS|0:ABI1|0:NUTF2|0:CCNA1|0:FPGS|0:CCBL1|0:ENOX2|0:HSPB2|0:SERPINB6|0:NCF1|0:NUCB2|0:IDH1|0:OGT|0:VHL|0:LGALS4|0:ACY1|0:S100A12|0:BAAT|0:RGS3|0:NOL3|0:EGLN1|0:RABGAP1|0:AKR7A3|0:TCP10|0:SEC23A|0:NPEPPS|0:PDZD3|0:SART1|0:HPGD|0:PPP2R1A|0:PPP2CA|0:NADK|0:SPHK1|0:MTRR|0:GLRX|0:CDA|0:SQSTM1|0:PLA2G4C|0:NRD1|0:ATOX1|0:CDO1|0:PCTP			
GO:0043206	P:fibril organization; IMP:UniProtKB		0:FKBP1A|0:MUC5AC|0:CST3|0:COL5A1|0:COL3A1|0:B4GALT7			
GO:0004776	F:succinate-CoA ligase (GDP-forming) activity; NAS:UniProtKB		0:SUCLG1|0:SUCLG2			
GO:0016165	F:lipoxygenase activity; TAS:ProtInc		0:ALOX12|0:ALOXE3|0:ALOX12B|0:ALOX5|0:ALOX15B|0:ALOX15			
GO:0060348	P:bone development; IMP:UniProtKB		0:FGF8			
GO:0009890	P:negative regulation of biosynthetic process; IEA:InterPro		0:GCHFR			
GO:0016799	F:hydrolase activity, hydrolyzing N-glycosyl ...; IEA:InterPro		0:NEIL2			
GO:0016998	P:cell wall macromolecule catabolic process; TAS:UniProtKB		0:LYZL6|0:LYZL2|0:LYSMD2|0:SPACA5|0:LYSMD1|0:LYG1|0:LYZL4|0:NCOA7|0:OXR1|0:SPACA5B|0:LYZL1|0:LYZ|0:LYSMD4|0:LYG2|0:LYSMD3|0:SPACA3			
GO:0006549	P:isoleucine metabolic process; ISS:BHF-UCL		0:GHR|0:STAT5A|0:STAT5B			
GO:0004301	F:epoxide hydrolase activity; TAS:UniProtKB		0:EPHX2|0:RNPEP|0:EPHX1|0:LTA4H			
GO:0007618	P:mating; TAS:ProtInc		0:OR2H2			
GO:0010718	P:positive regulation of epithelial to mesenc...; TAS:BHF-UCL		0:TGFB3|0:TGFB1I1|0:TGFB2|0:TGFB1|0:WWTR1|0:BAMBI|0:AXIN2|0:BCL9L|0:TCF7L2|0:CTNNB1|0:SMAD2|0:SMAD4|0:SNAI1			
GO:0060059	P:embryonic retina morphogenesis in camera-ty...; ISS:BHF-UCL		0:PROX1|0:RBP4			
GO:0006189	P:'de novo' IMP biosynthetic process; NAS:UniProtKB		0:GART|0:PAICS|0:PFAS			
GO:0070362	F:mitochondrial heavy strand promoter anti-se...; IDA:UniProtKB		0:LONP1			
GO:0032963	P:collagen metabolic process; ISS:BHF-UCL		0:TNXB|0:HIF1A			
GO:0004965	F:GABA-B receptor activity; TAS:ProtInc		0:GPR156|0:GABBR2|0:GABBR1			
GO:0018146	P:keratan sulfate biosynthetic process; IDA:UniProtKB		0:CHST6			
GO:0042095	P:interferon-gamma biosynthetic process; TAS:UniProtKB		0:IL18|0:IL12B			
GO:0001736	P:establishment of planar polarity; ISS:UniProtKB		0:VANGL2|0:CELSR1			
GO:0050051	F:leukotriene-B4 20-monooxygenase activity; IEA:EC		0:CYP4F2|0:CYP4F3			
GO:0048589	P:developmental growth; ISS:UniProtKB		0:NIPBL|0:GLI2|0:DMBX1			
GO:0008482	F:sulfite oxidase activity; TAS:ProtInc		0:SUOX			
GO:0045875	P:negative regulation of sister chromatid coh...; NAS:UniProtKB		0:ESPL1			
GO:0009968	P:negative regulation of signal transduction; NAS:UniProtKB		0:ERBB3|0:BRAP|0:HHIP|0:DDIT4L|0:DDIT4|0:SOCS4|0:SOCS3|0:RGS12|0:RGS16|0:ARRB1|0:RGS2|0:RGS1|0:RGS6|0:RGS13|0:RGS22|0:RGS5|0:SNX13|0:RGS17|0:RGS7BP|0:RGS9BP|0:RGS9|0:RGS10|0:RGS4|0:RGS14|0:ARRB2|0:RGS8|0:RGS18|0:SOCS6|0:CISH|0:RGS20|0:RGS11|0:RGS3|0:SOCS2|0:PAK1IP1|0:RGS19|0:RGS21|0:RGS7|0:SOCS7|0:ACVR1|0:KIF26A|0:SOCS5|0:IGFBP3			
GO:0015467	F:G-protein activated inward rectifier potass...; TAS:UniProtKB		0:KCNJ9|0:KCNJ3|0:KCNJ6|0:KCNJ5			
GO:0046321	P:positive regulation of fatty acid oxidation; TAS:UniProtKB		0:PPARGC1A			
GO:0030835	P:negative regulation of actin filament depol...; IDA:UniProtKB		0:LIMA1			
GO:0003841	F:1-acylglycerol-3-phosphate O-acyltransferas...; NAS:UniProtKB		0:ABHD5|0:LCLAT1|0:MBOAT2|0:AGPAT1|0:AGPAT3|0:AGPAT2|0:AGPAT5|0:AGPAT4			
GO:0050892	P:intestinal absorption; TAS:BHF-UCL		0:ADRA2A			
GO:0033265	F:choline binding; TAS:BHF-UCL		0:CRP			
GO:0000188	P:inactivation of MAPK activity; TAS:UniProtKB		0:DUSP6|0:LAX1|0:DUSP3|0:CAV1|0:SPRED2|0:SPRED1|0:PPP2R1A|0:PPP2CA|0:DUSP8|0:DUSP2|0:DUSP9|0:DUSP22|0:RGS4|0:GPS1|0:RGS3|0:GPS2|0:DUSP16			
GO:0008654	P:phospholipid biosynthetic process; TAS:UniProtKB		0:PIP5K1A|0:EPT1|0:LCLAT1|0:MBOAT7|0:GPAT2|0:SERINC4|0:PGS1|0:AGPAT9|0:GPAM|0:SERINC5|0:ISYNA1|0:SERINC1|0:LPCAT4|0:CRLS1|0:MBOAT1|0:CDIPT|0:PISD|0:MBOAT2|0:LPGAT1|0:LPCAT3|0:LPCAT1|0:AGPAT3|0:AGPAT5|0:CDS2|0:AGPAT4|0:DGKE|0:FADS1|0:PCYT2			
GO:0004693	F:cyclin-dependent protein kinase activity; TAS:ProtInc		0:CDK5|0:CDK2|0:CDK6|0:CDK4|0:CDK1|0:CDK16|0:CDK12|0:CDK11A|0:ICK|0:CDK19|0:CDK20|0:CDK15|0:CDK11B|0:CDKL2|0:CDK8|0:CDK18|0:CDKL3|0:CDKL4|0:CDK17|0:RAGE|0:CDK13|0:MAK|0:CDKL5|0:CDK14|0:CDKL1|0:CDK9|0:CDK10|0:CDK7|0:CDK3			
GO:0045008	P:depyrimidination; EXP:Reactome		0:TDG|0:NTHL1|0:MBD4|0:CCNO|0:SMUG1			
GO:0016485	P:protein processing; TAS:UniProtKB		0:PSENEN|0:APH1A|0:METAP2|0:APH1B|0:PTCH1|0:CLN3|0:NCSTN|0:ADAMTS13			
GO:0031996	F:thioesterase binding; IPI:UniProtKB		0:ADRA2A|0:HAUS7|0:CALM2|0:RAC1|0:ARF6|0:CALM3|0:CDC42|0:CALM1			
GO:0047499	F:calcium-independent phospholipase A2 activity; IDA:UniProtKB		0:PNPLA8|0:PLA2G4C			
GO:0043308	P:eosinophil degranulation; ISS:UniProtKB		0:VAMP7			
GO:0005778	C:peroxisomal membrane; TAS:ProtInc		0:SLC27A2|0:AP2M1|0:PEX1|0:PNPLA8|0:PEX19|0:ABCD4|0:AGPS|0:ACSL1|0:ACSL4|0:FAR1|0:GNPAT|0:PXMP2|0:HMGCR|0:SLC25A17|0:FNDC5|0:FAR2|0:ABCD2|0:PEX11G|0:PEX5|0:ACSL3|0:DHRS7B|0:MPV17L|0:PEX6|0:PEX10|0:PEX14|0:CAT|0:ACSL6|0:PXMP4			
GO:0030520	P:estrogen receptor signaling pathway; TAS:UniProtKB		0:RARA|0:ARID1A|0:RBFOX2|0:PPARGC1B|0:EGLN2|0:NCOA6|0:RBM14|0:TADA3|0:DDX54			
GO:0034101	P:erythrocyte homeostasis; IMP:UniProtKB		0:HMOX1|0:RPS24|0:RPS17			
GO:0047730	F:carnosine synthase activity; IDA:UniProtKB		0:CARNS1			
GO:0048703	P:embryonic viscerocranium morphogenesis; IMP:UniProtKB		0:TBX1			
GO:0070889	P:platelet alpha granule organization; IMP:UniProtKB		0:VPS33B			
GO:0055117	P:regulation of cardiac muscle contraction; TAS:BHF-UCL		0:NKX2-5|0:NOS1			
GO:0034417	F:bisphosphoglycerate 3-phosphatase activity; IDA:BHF-UCL		0:MINPP1			
GO:0004613	F:phosphoenolpyruvate carboxykinase (GTP) act...; ISS:BHF-UCL		0:PCK2|0:PCK1			
GO:0006534	P:cysteine metabolic process; IEA:InterPro		0:GCLC|0:NFS1			
GO:0035042	P:fertilization, exchange of chromosomal prot...; TAS:UniProtKB		0:TNP1			
GO:0043012	P:regulation of fusion of sperm to egg plasma...; NAS:UniProtKB		0:NOX5			
GO:0004411	F:homogentisate 1,2-dioxygenase activity; TAS:ProtInc		0:HGD			
GO:0005789	C:endoplasmic reticulum membrane; TAS:UniProtKB		0:PIGG|0:SQLE|0:CYP2A6|0:PLA2G4A|0:NSDHL|0:CYP39A1|0:CYP2C19|0:CYP7A1|0:FDFT1|0:CYP2S1|0:KDSR|0:SLC39A7|0:CYP2U1|0:CYP7B1|0:CYP51A1|0:CD4|0:CYP1A2|0:CYP3A7|0:PPM1L|0:CYP2C8|0:CYP2B6|0:HMGCR|0:CYP4F2|0:CYP1B1|0:ACER1|0:CYP4A11|0:CYP2W1|0:CYP2R1|0:CYP3A5|0:BCAP31|0:CYP4F3|0:TM7SF2|0:CYP26C1|0:PIGN|0:HSD11B1|0:CYP4F11|0:SLC27A5|0:CYP26A1|0:GJB1|0:SC4MOL|0:CYP2C9|0:DHCR7|0:CYP17A1|0:CYP8B1|0:SLC37A4|0:CYP26B1|0:CYP2F1|0:CYP4F12|0:CYP4B1|0:DEGS2|0:COL4A3BP|0:CYP2A13|0:CYP2C18|0:PIGW|0:CYP3A4|0:HSD17B7|0:VAPA|0:SOAT2|0:SOAT1|0:PIGA|0:BAX|0:DPM1|0:TMPRSS3|0:PIGY|0:VMA21|0:SILV|0:TMEM67|0:NOMO2|0:TMX1|0:ERLIN2|0:LMAN2L|0:AGPAT9|0:HERPUD1|0:HSP90B1|0:NECAB3|0:SPINK5|0:SDR16C5|0:DULLARD|0:ORMDL1|0:AADAC|0:TRIM13|0:ERP44|0:MLANA|0:POMT1|0:PEX16|0:PIGV|0:ATP2A1|0:VAPB|0:MIA3|0:SLC9A6|0:ERLIN1|0:CISD2|0:ALG3|0:DUOXA1|0:CREB3L1|0:PIGL|0:TMED7|0:UGT1A8|0:SERP1|0:UBE2J1|0:JAGN1|0:RNF43|0:TMEM132A|0:RDH11|0:LCLAT1|0:ALOX5AP|0:SEC61G|0:AWAT2|0:ACSL1|0:RNF139|0:PTGFRN|0:SEC61A2|0:HLA-DRB3|0:NCLN|0:ERGIC1|0:CLGN|0:ELOVL3|0:UGT2B15|0:ERMP1|0:SCD5|0:LASS6|0:UGT1A4|0:RDH16|0:SLC26A11|0:ATL3|0:TLR3|0:PTPN1|0:PGRMC1|0:SDCBP|0:C14orf1|0:MARCH6|0:PKMYT1|0:RHBDF2|0:PEMT|0:PTPLAD2|0:UBE2J2|0:SGPP1|0:ITPR3|0:RAB2A|0:PTPLA|0:DLG1|0:PIGX|0:FADS1|0:USE1|0:UGT2B10|0:HLA-DRA|0:SLC17A3|0:EBPL|0:USP19|0:ERO1L|0:CNIH|0:TMED9|0:UGT2B4|0:PJA2|0:SRD5A2|0:G6PC2|0:PTGS2|0:OTOF|0:AGPAT6|0:SEC16A|0:PGAP1|0:SRD5A1|0:ARL6IP5|0:ERO1LB|0:GGCX|0:SEZ6L|0:SEC11A|0:LMF2|0:SEC24A|0:LPCAT1|0:ACSL4|0:LASS2|0:PITPNM1|0:LPCAT2|0:NOX4|0:LCTL|0:GPR37|0:JKAMP|0:DDN|0:EPHX1|0:MOGAT1|0:RSAD2|0:MEST|0:UGT2B11|0:UNC93B1|0:ALG10|0:CEPT1|0:ATF6B|0:HLA-DRB4|0:CYP2D6|0:ATL2|0:BCL2|0:RHBDF1|0:AWAT1|0:CYP4A22|0:RIC3|0:IL15RA|0:EBP|0:RINT1|0:RAB2B|0:DIO1|0:SLC27A2|0:POM121C|0:TMED6|0:CYB5A|0:ALG1|0:SCAP|0:CH25H|0:PIGM|0:CLN8|0:CYP21A2|0:LMF1|0:ALG14|0:TECR|0:MARCH5|0:ANTXR2|0:ERN2|0:P4HTM|0:ITPR1|0:ACSL5|0:KDELR3|0:SIGMAR1|0:NUP210|0:HSD3B7|0:SGPP2|0:SERINC5|0:TLR9|0:TOR1AIP2|0:GPER|0:HSD17B12|0:PSEN1|0:UGT1A5|0:PTGIS|0:MMGT1|0:ALDH3A2|0:UGT1A10|0:SORT1|0:TRAM1|0:UBXN4|0:SEC11C|0:PAPPAS|0:BCAP29|0:MOGS|0:CREB3|0:SURF4|0:POR|0:ERGIC3|0:CREB3L4|0:ICMT|0:SEC24B|0:CLSTN3|0:HLA-DPB1|0:TSPO2|0:YIF1A|0:PTPLB|0:SEC62|0:MAN1B1|0:ALG5|0:ZMPSTE24|0:LPIN1|0:LRAT|0:INSIG1|0:FAM176A|0:XYLT1|0:LRRC8C|0:ZDHHC16|0:TAPBPL|0:SEC31B|0:PPAPDC3|0:ERAP1|0:ZW10|0:ELOVL7|0:C8orf83|0:TMC8|0:PSENEN|0:SEC22B|0:PNPLA8|0:B3GALTL|0:MOXD1|0:IKBIP|0:CYP4X1|0:UGT1A9|0:ZDHHC9|0:TXNDC11|0:PLD3|0:SYVN1|0:LTC4S|0:PTGS1|0:FAM38A|0:G6PC3|0:CYP1A1|0:TMEM189|0:TPTE2|0:EIF5A|0:PDCD6|0:GPSM1|0:TMX3|0:SEC22C|0:DEGS1|0:SCARA3|0:LPCAT4|0:PSKH1|0:CANT1|0:ELOVL1|0:KDELR2|0:TRAM1L1|0:FKBP2|0:UGT2B28|0:UGCG|0:ABCG1|0:CREB3L3|0:RTN3|0:FADS2|0:RNF103|0:FAR2|0:MFSD2A|0:SCD|0:EIF5A2|0:SEZ6L2|0:TMED5|0:UGT1A6|0:SEC31A|0:LSS|0:DNAJC14|0:SEC24C|0:ORMDL2|0:APH1A|0:LRRC59|0:HLA-DRB1|0:ACSL6|0:CANX|0:SHISA2|0:POM121|0:SEPN1|0:HHATL|0:UGT2B17|0:HLA-DRB5|0:UGT1A1|0:GIMAP1|0:PIP4K2B|0:CLSTN2|0:YIPF7|0:AGTRAP|0:ALG6|0:SEC63|0:SCFD1|0:XYLT2|0:ERAP2|0:STIM2|0:MOGAT3|0:CD74|0:HLA-DQA2|0:CYP3A43|0:CSPG5|0:RNF133|0:SSR1|0:RAB9A|0:ERGIC2|0:DRD1|0:DGAT2L6|0:SEC23B|0:SMPD4|0:MGST3|0:RAB21|0:LRRTM1|0:ELOVL4|0:HHAT|0:SEL1L|0:MARCH2|0:RASGRP1|0:UPK3A|0:TMEM173|0:BFAR|0:AUP1|0:LASS4|0:SC5DL|0:RNF13|0:BET1|0:SHISA5|0:RDH10|0:VKORC1|0:UGT2B7|0:ANO5|0:CDIPT|0:KDELR1|0:SLC35B1|0:DNAJC1|0:TMEM106C|0:HLA-DQA1|0:CALHM1|0:LPIN2|0:HM13|0:SSR2|0:GSG1|0:SEC24D|0:PTPLAD1|0:LASS1|0:SHISA3|0:DUOXA2|0:MBTPS1|0:LASS5|0:CYP4V2|0:FA2H|0:ARMC10|0:RNF5|0:EIF5AL1|0:CREB3L2|0:CLSTN1|0:LMAN2|0:CNIH2|0:PREB|0:FADS3|0:DGAT2|0:IER3IP1|0:YIPF5|0:RASGRF2|0:TMED4|0:UGT1A3|0:SAR1B|0:ELOVL5|0:ACSL3|0:CDS1|0:C3orf52|0:PLD1|0:PNPLA6|0:DGAT1|0:GRIA1|0:CYP2A7|0:CLN6|0:TMC6|0:PSEN2|0:NR3C2|0:ARHGAP32|0:CYP4F22|0:TLR7|0:STX18|0:MGST2|0:ELOVL2|0:SRD5A3|0:MTDH|0:ALG8|0:CYB5R3|0:STS|0:SERP2|0:SLC39A1|0:LPGAT1|0:SEC16B|0:CYP4F8|0:HLA-DQB1|0:MTOR|0:HLA-DPA1|0:MOGAT2|0:CYP4Z1|0:SRPRB|0:RCE1|0:TMCO1|0:C8orf17|0:MLEC|0:HLA-DQB2|0:POMT2|0:LPCAT3|0:CYP46A1|0:CYP2J2|0:FITM1|0:FITM2|0:SERINC1|0:RETSAT|0:DTNBP1|0:VAMP7|0:UBQLN4|0:ATL1|0:PGAP2|0:PIGF|0:PIGO|0:UGT1A7|0:MPDU1|0:DHCR24|0:APOL2|0:EIF2AK3|0:LMAN1|0:LRMP|0:KTN1|0:MRVI1|0:SEC22A|0:SLC33A1|0:PIGC|0:PLP2|0:SREBF1|0:HSD17B2|0:ATF6|0:HTRA2|0:CASP7			
GO:0016564	F:transcription repressor activity; TAS:UniProtKB		0:SCMH1|0:TBX22|0:HAND1|0:NIPBL|0:CIITA|0:KAT5|0:KDM1A|0:HDAC9|0:CALR|0:ID1|0:ARID4A|0:ID2|0:HEXIM2|0:SNW1|0:NR1I2|0:SALL1|0:ZNF350|0:KLF4|0:PHF12|0:FOXN3|0:RSF1|0:HOXA7|0:DNMT3L|0:ZFHX3|0:ZNF24|0:IFI16|0:TNF|0:ZNF423|0:ATXN1|0:PHB|0:POU2F1|0:ELF3|0:CITED1|0:PML|0:RFX3|0:HMBOX1|0:SOX7|0:THAP7|0:JUN|0:ZNF219|0:ZNF281|0:BMP4|0:EPC1|0:TSHZ3|0:ELF2|0:TP63|0:FOXP3|0:THRA|0:PRAME|0:GATA6|0:NKAP|0:ZNF217|0:GLI3|0:LIMD1|0:SET|0:STRN3|0:FOXG1|0:KDM4A|0:PAX9|0:GATAD2A|0:RELA|0:RING1|0:DKK3|0:RB1|0:MYST4|0:L3MBTL1|0:ZNF148|0:TBX2|0:WT1|0:ILF3|0:CHD8|0:TRAF6|0:EZH2|0:WNT11|0:DAP|0:BCL6|0:HMX1|0:CDKN1C|0:SBNO2|0:MLXIPL|0:NKX2-5|0:FOXE1|0:ZSCAN10|0:TWIST2|0:ZBTB7A|0:ZNF238|0:KHDRBS1|0:CTBP1|0:FERD3L|0:POU3F3|0:MSX2|0:CTBP2|0:DMBX1|0:PPARD|0:SOX14|0:PRDM16|0:MBD2|0:CBX2|0:NAB1|0:TSC22D4|0:EED|0:ZNF675|0:ZNF253|0:LRRFIP1|0:SP3|0:YBX1|0:C2orf3|0:ARID5A|0:ARID5B|0:PATZ1|0:BCLAF1|0:ZNF282|0:REST|0:RBAK|0:IKZF4			
GO:0006310	P:DNA recombination; TAS:ProtInc		0:WRN|0:RDM1|0:RECQL|0:RECQL5|0:RECQL4|0:SMC6|0:NONO|0:SFPQ|0:EME2|0:LIG1|0:RPA2|0:RUVBL1|0:ERVK2|0:MND1|0:NSMCE2|0:RPA3|0:DCLRE1C|0:KIN|0:NSMCE1|0:ZSWIM7|0:SMC5|0:MUS81|0:ERVK6|0:PSMC3IP|0:EME1|0:RAG1AP1|0:RPAIN|0:HMGB3|0:NCOA6|0:TREX1|0:RBM14|0:RBPJ|0:RUVBL2|0:XRCC3|0:IGHMBP2|0:ATRX|0:TSN			
GO:0005131	F:growth hormone receptor binding; NAS:UniProtKB		0:GH1|0:TYK2|0:JAK1|0:JAK2|0:SOCS2			
GO:0002355	P:detection of tumor cell; IDA:HGNC		0:CRTAM			
GO:0045085	P:negative regulation of interleukin-2 biosyn...; TAS:UniProtKB		0:FOXP3|0:SFTPD			
GO:0043004	P:cytoplasmic sequestering of CFTR protein; NAS:UniProtKB		0:GOPC			
GO:0042980	F:cystic fibrosis transmembrane conductance r...; IPI:UniProtKB		0:USP10|0:GOPC			
GO:0001944	P:vasculature development; IDA:UniProtKB		0:CALCA			
GO:0004483	F:mRNA (nucleoside-2'-O-)-methyltransferase a...; IDA:UniProtKB		0:FTSJD2			
GO:0004745	F:retinol dehydrogenase activity; TAS:ProtInc		0:DHRS9|0:SDR16C5|0:RDH12|0:ADH4|0:ADH7|0:RDH10|0:HSD17B6|0:RDH11|0:RDH16|0:RDH8|0:RDH5			
GO:0050571	F:1,5-anhydro-D-fructose reductase activity; IEA:EC		0:AKR1E2			
GO:0045294	F:alpha-catenin binding; IPI:UniProtKB		0:PTPRT|0:CDH2|0:JUP|0:CTNNB1|0:VCL|0:CDH24			
GO:0046928	P:regulation of neurotransmitter secretion; TAS:UniProtKB		0:SNCAIP|0:CHRNB4|0:KCNMB4			
GO:0006907	P:pinocytosis; NAS:UniProtKB		0:PPT1|0:AHSG			
GO:0005720	C:nuclear heterochromatin; TAS:ProtInc		0:FOXC1|0:ATRX|0:CBX1			
GO:0007040	P:lysosome organization; TAS:ProtInc		0:ABCA1|0:VPS18|0:MYO7A|0:HPS4|0:GBA|0:GAA|0:AKTIP|0:HOOK3|0:HOOK2|0:FAM160A2|0:HOOK1|0:CLVS2|0:TPP1|0:CLVS1|0:ARSB|0:NAGPA|0:HPS1			
GO:0006922	P:cleavage of lamin; IMP:HGNC		0:GZMA|0:GZMB|0:BAX			
GO:0033596	C:TSC1-TSC2 complex; IDA:UniProtKB		0:TSC2|0:TSC1			
GO:0019530	P:taurine metabolic process; ISS:BHF-UCL		0:GHR|0:STAT5A|0:STAT5B			
GO:0007497	P:posterior midgut development; TAS:ProtInc		0:RET			
GO:0016525	P:negative regulation of angiogenesis; TAS:UniProtKB		0:FASLG|0:HHEX|0:APOH|0:AMOT|0:SERPINF1|0:VASH1|0:COL4A2|0:ANGPT4|0:THBS1|0:COL4A3|0:PF4|0:FOXO4|0:IL17F|0:THBS4|0:PML|0:STAB1|0:PTPRM|0:HOXA5|0:KLK3|0:GHRL|0:NPR1|0:SPINK5|0:NPPB			
GO:0002060	F:purine binding; IDA:UniProtKB		0:PYGL|0:PNP			
GO:0031726	F:CCR1 chemokine receptor binding; IDA:UniProtKB		0:CREB3			
GO:0015051	F:X-opioid receptor activity; IEA:InterPro		0:OPRL1			
GO:0016573	P:histone acetylation; NAS:UniProtKB		0:CREBBP|0:KAT5|0:HAT1|0:KAT2B|0:CPA4			
GO:0004842	F:ubiquitin-protein ligase activity; TAS:UniProtKB		0:RFWD2|0:NEDD4|0:CBLC|0:TRIM23|0:UHRF2|0:PPIL2|0:CHFR|0:UBE2W|0:PARK2|0:TRAF6|0:MDM2|0:UBE2H|0:LRSAM1|0:ITCH|0:KLHL20|0:MALT1|0:SKP1|0:HUWE1|0:TOPORS|0:UBE2S|0:DZIP3|0:FBXW11|0:RNF130|0:UBE2D3|0:UBE2Q2|0:TRIM68|0:DTX3L|0:TRIM9|0:UBE2G2|0:MYLIP|0:TRIM21|0:HECTD3|0:UBE2D2|0:TRAF7|0:SMURF2|0:UBE2A|0:UBE2E2|0:ARIH2|0:MUL1|0:FBXO4|0:CDC34|0:UBE2L3|0:BIRC2|0:UBE2T|0:UBE2D4|0:RNF8|0:CNOT4|0:RNF168|0:BRAP|0:TRIM13|0:UBE3C|0:BRCA1|0:UBE2N|0:TTC3|0:RNF31|0:RNF167|0:RNF41|0:RNF103|0:UBE2B|0:RFWD3|0:UBE2R2|0:RNF144B|0:WWP2|0:BIRC3|0:UBE3A|0:NHLRC1|0:UBE2E3|0:RNF20|0:RBCK1|0:SMURF1|0:TRIM32|0:RNF182|0:TNFAIP3|0:TRIM17|0:RNF5|0:UBE2C|0:UBE2G1|0:TRAF2|0:AMFR|0:RCHY1|0:MGRN1|0:RNF135|0:RNF115|0:UBE2D1|0:ZFP91|0:UBE2E1|0:UBE2J1|0:TRIM25|0:UBE2J2|0:UBE2QL1|0:UBE2Z|0:UBE2Q1|0:UBE2U|0:UBE2O|0:WDSUB1|0:SIAH2|0:UBR4|0:MIB2|0:SIAH1L|0:MIB1|0:HERC2|0:HECTD1|0:RNF151|0:UBR7|0:RBBP6|0:HERC2P3|0:RNF111|0:UBE2M|0:FEM1B|0:ZER1|0:RNF6|0:RNF4|0:UBR3|0:RNF220|0:RAG1|0:ZNF738|0:PDZRN3|0:SIAH1|0:RNF13|0:RLIM|0:RNF217|0:RNF25|0:FEM1A|0:FBXL3|0:FBXL21|0:NEDD4L|0:FBXL7|0:FBXL5|0:TSPAN17|0:TRIP12|0:FBXO10|0:FBXO11|0:FBXO25|0:FBXO24|0:LMO7|0:FBXO9|0:FBXO21|0:BARD1|0:CBL|0:ANAPC4|0:UBE2L6|0:FBXO3|0:FBXO7|0:FBXO22|0:UBR5|0:ANAPC5|0:FBXO2|0:FBXL2|0:ANAPC2|0:ANAPC10|0:FBXL6|0:FBXW2|0:WWP1|0:CDC23|0:CBLL1			
GO:0016671	F:oxidoreductase activity, acting on sulfur g...; IEA:InterPro		0:ERO1L|0:ERO1LB			
GO:0010507	P:negative regulation of autophagy; IMP:UniProtKB		0:HTR2B|0:DAP|0:KIAA0226			
GO:0005112	F:Notch binding; TAS:ProtInc		0:DTX1|0:JAG2|0:NCOR2|0:SNW1|0:DLL1|0:DLL3|0:JAG1|0:DLL4			
GO:0050868	P:negative regulation of T cell activation; IMP:UniProtKB		0:LAX1|0:DUSP3|0:TIGIT			
GO:0003069	P:vasodilation by acetylcholine involved in r...; ISS:BHF-UCL		0:SOD2			
GO:0051636	F:Gram-negative bacterial cell surface binding; NAS:UniProtKB		0:LBP|0:STAB2|0:DMBT1|0:PRB3			
GO:0046121	P:deoxyribonucleoside catabolic process; IDA:UniProtKB		0:DERA			
GO:0005096	F:GTPase activator activity; TAS:ProtInc		0:ARHGAP9|0:RACGAP1|0:TSC2|0:GNAQ|0:RASA4|0:LRRK2|0:GPSM3|0:RABEP2|0:PCP2|0:RABEP1|0:GPSM1|0:GPSM2|0:FAM13A|0:ARHGDIB|0:ARHGAP11B|0:ARHGAP17|0:GDI1|0:SIPA1L1|0:CHM|0:RIN3|0:PLEKHG6|0:ARHGAP22|0:STARD13|0:ARHGEF15|0:ARHGAP30|0:SIPA1L2|0:SRGAP3|0:HMHA1|0:ARHGEF19|0:GARNL3|0:ARHGAP23|0:DAB2IP|0:GDI2|0:ANKRD27|0:RANBP1|0:ARHGDIG|0:ARHGAP11A|0:ARHGAP28|0:RIN1|0:SH3BP1|0:ARHGAP24|0:RAP1GAP2|0:ARHGEF11|0:RIN2|0:ARHGAP12|0:ARHGAP20|0:RINL|0:ARHGAP19|0:GAPVD1|0:ARHGEF1|0:ARHGAP25|0:DEPDC1|0:STARD8|0:MYO9A|0:CHML|0:ARHGAP36|0:FAM13B|0:DEPDC1B|0:ARHGEF12|0:ARHGAP18|0:SYNGAP1|0:ARHGAP21|0:RASAL3|0:ARHGAP32|0:SRGAP2|0:SIPA1L3|0:ARHGAP31|0:ALS2CL|0:ARHGDIA|0:CHN1|0:ARHGAP40|0:ARRB1|0:ARHGEF6|0:RAP1GDS1|0:ABR|0:RGS12|0:RGS16|0:RGS2|0:RASA3|0:VAV3|0:RGS1|0:RGS6|0:BCR|0:RGS5|0:BNIP2|0:RGS9|0:RGS4|0:RGS14|0:CHN2|0:RAB3GAP2|0:RGS20|0:RGS11|0:PTPLAD1|0:RGS3|0:DOCK1|0:RAP1GAP			
GO:0006685	P:sphingomyelin catabolic process; TAS:ProtInc		0:SMPD4|0:SMPDL3B|0:SMPDL3A|0:SMPD1|0:SMPD3			
GO:0042030	F:ATPase inhibitor activity; IDA:UniProtKB		0:ATPIF1			
GO:0035242	F:protein-arginine omega-N asymmetric methylt...; IDA:UniProtKB		0:PRMT8|0:PRMT6			
GO:0070119	F:ciliary neurotrophic factor binding; IPI:BHF-UCL		0:IL6R			
GO:0045347	P:negative regulation of MHC class II biosynt...; TAS:UniProtKB		0:HDAC2|0:PF4|0:IL10			
GO:0000090	P:mitotic anaphase; TAS:ProtInc		0:CUL3|0:SKA1|0:SKA2|0:MAD1L1|0:ANAPC4|0:ANAPC5|0:NUMA1|0:ANAPC10			
GO:0061001	P:regulation of dendritic spine morphogenesis; ISS:UniProtKB		0:SRCIN1|0:SIPA1L1|0:PDLIM5			
GO:0042177	P:negative regulation of protein catabolic pr...; NAS:UniProtKB		0:PRKCG|0:INS|0:SMAD4|0:IRAK3|0:FLNA|0:MDM4|0:SERPINB12			
GO:0031490	F:chromatin DNA binding; IDA:UniProtKB		0:RARA|0:FOXC2			
GO:0030895	C:apolipoprotein B mRNA editing enzyme complex; TAS:HGNC		0:A1CF|0:APOBEC3F|0:APOBEC3G			
GO:0070836	P:caveola assembly; IMP:BHF-UCL		0:CAV2|0:CAV1			
GO:0017015	P:regulation of transforming growth factor be...; TAS:UniProtKB		0:TGFB1|0:ENG|0:TRIM33|0:IL17F|0:SMAD2|0:SMURF2|0:LTBP4			
GO:0032811	P:negative regulation of epinephrine secretion; NAS:BHF-UCL		0:ADRA2B|0:ADRA2C|0:ADRA2A			
GO:0005869	C:dynactin complex; TAS:ProtInc		0:DCTN2|0:DCTN3|0:ACTR1A|0:ACTR1B			
GO:0032816	P:positive regulation of natural killer cell ...; IDA:UniProtKB		0:IL12A|0:IL12B			
GO:0045124	P:regulation of bone resorption; TAS:BHF-UCL		0:NF1|0:BGLAP|0:ITGB3|0:SRC			
GO:0003032	P:detection of oxygen; NAS:UniProtKB		0:SLC11A2|0:CYB5R4			
GO:0050765	P:negative regulation of phagocytosis; IDA:BHF-UCL		0:ADIPOQ			
GO:0031669	P:cellular response to nutrient levels; IMP:UniProtKB		0:RPTOR			
GO:0090331	P:negative regulation of platelet aggregation; ISS:BHF-UCL		0:SERPINE2			
GO:0000578	P:embryonic axis specification; IMP:BHF-UCL		0:WNT7A			
GO:0043408	P:regulation of MAPKKK cascade; IDA:UniProtKB		0:ATP6AP2|0:REN|0:CD24			
GO:0060707	P:trophoblast giant cell differentiation; ISS:UniProtKB		0:PLK4			
GO:0006335	P:DNA replication-dependent nucleosome assembly; TAS:ProtInc		0:CHAF1B|0:CHAF1A			
GO:0033523	P:histone H2B ubiquitination; ISS:UniProtKB		0:RNF40|0:CDC73|0:PAF1|0:RNF20|0:CTR9|0:LEO1|0:UBE2E1|0:RNF8			
GO:0005851	C:eukaryotic translation initiation factor 2B...; IDA:UniProtKB		0:EIF2B3|0:EIF2B2|0:EIF2B5|0:EIF2B1|0:EIF2B4			
GO:0034046	F:poly(G) RNA binding; IDA:UniProtKB		0:ATXN1			
GO:0004981	F:muscarinic acetylcholine receptor activity; TAS:ProtInc		0:CHRM3|0:CHRM2|0:CHRM4|0:CHRM1|0:CHRM5			
GO:0043162	P:ubiquitin-dependent protein catabolic proce...; NAS:HGNC		0:TSG101|0:TOM1L1			
GO:0016986	F:transcription initiation factor activity; NAS:UniProtKB		0:TAF10|0:TAF4|0:TAF6L|0:TAF12|0:TAF6|0:TAF4B|0:SUPT3H			
GO:0004335	F:galactokinase activity; IDA:UniProtKB		0:GALK2|0:GALK1			
GO:0031397	P:negative regulation of protein ubiquitination; ISS:UniProtKB		0:GTPBP4|0:PRKCG|0:ARRB1|0:TSC1|0:UBXN1|0:VPS28|0:ARRB2|0:USP4|0:N4BP1			
GO:0030309	P:poly-N-acetyllactosamine metabolic process; NAS:UniProtKB		0:GAL3ST3			
GO:0008995	F:ribonuclease E activity; TAS:ProtInc		0:PPP1R8			
GO:0051000	P:positive regulation of nitric-oxide synthas...; TAS:BHF-UCL		0:APOE|0:SCARB1|0:FCER2|0:HTR2B|0:GCH1|0:AKT1|0:AGTR2|0:INS|0:HIF1A			
GO:0035335	P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB		0:DUSP21|0:DUSP18|0:DUSP3|0:DUSP6|0:DUSP7			
GO:0001706	P:endoderm formation; ISS:UniProtKB		0:SOX7|0:SOX17|0:EOMES			
GO:0042624	F:ATPase activity, uncoupled; NAS:UniProtKB		0:ATAD2|0:ATP6V1F			
GO:0015166	F:polyol transmembrane transporter activity; TAS:UniProtKB		0:AQP9			
GO:0007243	P:intracellular protein kinase cascade; TAS:ProtInc		0:PFKFB1|0:PRKACA|0:PRKACG|0:MLXIPL|0:PRKACB|0:SRC|0:DRD2|0:STK17A|0:MAPK11|0:MAPK14|0:MAP4K4|0:WNK1|0:MKNK2|0:MARK2|0:MAPK13|0:MARK1|0:ICK|0:SRPK1|0:RPS6KA4|0:STK38|0:STK3|0:SIK2|0:RPS6KA5|0:DAPK2|0:PINK1|0:DAPK3|0:SIK1|0:SRPK2|0:STK4|0:OXSR1|0:NEK11|0:LATS2|0:DAPK1|0:STK17B|0:MKNK1|0:GSG2|0:STK38L|0:TXK|0:RPS6KA1|0:RPS6KA6|0:TYK2|0:RPS6KA3|0:PRKAG2|0:TGFBR3|0:MC1R|0:AGTR2|0:WNK3|0:WNK2|0:WNK4|0:MAST1|0:PRKCSH|0:ZAP70|0:HMOX1|0:C7orf16|0:PRKAG3|0:BLK|0:SGK2|0:AKAP11|0:ITGB1BP1|0:ADRA1A|0:RPS6KA2|0:TEC|0:FYB|0:FYN|0:ADRA1B			
GO:0004177	F:aminopeptidase activity; TAS:UniProtKB		0:ERAP2|0:ERAP1|0:C9orf3|0:METAP2|0:PEPD|0:DPP7|0:XPNPEP3|0:DPP3|0:DPP8|0:DPP4|0:NPEPL1|0:DPP9|0:PHEX|0:RNPEPL1|0:TPP2|0:RNPEP|0:LAP3|0:LNPEP|0:ANPEP|0:TRHDE|0:XPNPEP2|0:DNPEP|0:BLMH|0:NPEPPS|0:ENPEP|0:METAP1			
GO:0034341	P:response to interferon-gamma; ISS:UniProtKB		0:CALCOCO2|0:CIITA|0:CYP27B1|0:SP100|0:CXCL16|0:SNCA|0:DNAJA3|0:GCH1|0:KYNU|0:NUB1|0:UBD|0:SLC11A1|0:CITED1			
GO:0015057	F:thrombin receptor activity; TAS:UniProtKB		0:F2R|0:F2RL1|0:F2RL2|0:F2RL3|0:GP1BA			
GO:0007004	P:telomere maintenance via telomerase; TAS:ProtInc		0:TERF2|0:RAD50|0:POT1|0:TERT|0:TERF1|0:TNKS1BP1|0:MRE11A|0:TERF2IP|0:DKC1|0:RFC1			
GO:0017049	F:GTP-Rho binding; NAS:UniProtKB		0:KCTD13|0:TNFAIP1|0:PKN1|0:RTKN|0:CDC42EP2|0:CDC42EP5|0:TRIOBP|0:CDC42EP4			
GO:0044224	C:juxtaparanode region of axon; TAS:BHF-UCL		0:CNTN2|0:KCNA1|0:KCNA2|0:KCNAB2|0:CNTNAP2			
GO:0031648	P:protein destabilization; ISS:UniProtKB		0:MDM2|0:CDKN2A|0:SOX17|0:ISOC2|0:TRIM21|0:CTSH|0:CCDC88C			
GO:0015992	P:proton transport; TAS:ProtInc		0:ATP6V1G3|0:ATP6V1G2|0:UCP2			
GO:0051219	F:phosphoprotein binding; ISS:BHF-UCL		0:RRAGA|0:IGF2R|0:TBK1|0:RB1|0:MTOR|0:PAFAH1B1			
GO:0050832	P:defense response to fungus; IEA:UniProtKB-KW		0:S100A12|0:GNLY|0:DEFA6|0:DEFA3|0:DEFA5|0:HAMP|0:HTN3|0:DEFA1B|0:DCD|0:DEFA1|0:HTN1|0:DEFA4			
GO:0007018	P:microtubule-based movement; TAS:UniProtKB		0:DNHD1|0:KIF22|0:KIF7|0:DNAH2|0:TUBA4A|0:KIF26A|0:TUBB6|0:KIF21B|0:DNAH12|0:TUBA1A|0:KIF12|0:KIF17|0:KIF27|0:KIF13A|0:TUBB4Q|0:KIF20A|0:TUBB1|0:TUBD1|0:DNAH17|0:TUBA3E|0:KIF14|0:KIF25|0:KIF23|0:KIF26B|0:KIF11|0:KIF4B|0:KIF6|0:DNAH9|0:KIF3C|0:KIF2A|0:CENPE|0:DNAH6|0:KIF20B|0:TUBA3D|0:TUBB3|0:KIFC3|0:KIF1C|0:KIF15|0:DNAH5|0:DNAH11|0:KIF19|0:KIF5C|0:TUBB2B|0:TUBB4|0:DNAH8|0:KIF18B|0:KIFC1|0:TUBE1|0:KIF24|0:STARD9|0:TUBA1C|0:TUBA4B|0:DNAH14|0:TUBA3C|0:KIF16B|0:TUBB2A|0:KIF2B|0:TUBB2C|0:TUBB|0:DNAH7|0:DNAH10|0:KIF3A|0:TUBAL3|0:KIF21A|0:DYNC2H1|0:TUBA8|0:KIFC2|0:KIF18A|0:KIF9|0:DNAH3|0:TUBA1B|0:KIF2C|0:KTN1|0:DYNLRB2|0:DYNLRB1|0:DNAL4|0:DYNC1I2|0:DYNC1H1|0:KIF5A|0:KIF13B			
GO:0019882	P:antigen processing and presentation; NAS:UniProtKB		0:RAET1G|0:CD1C|0:MICA|0:ULBP1|0:PROCR|0:ULBP2|0:CD1B|0:RAET1L|0:RAET1E|0:FCGRT|0:CD1A|0:AZGP1|0:CD1E|0:ULBP3|0:MICB|0:CD8A			
GO:0051265	F:diolein transacylation activity; IDA:UniProtKB		0:PNPLA3			
GO:0034112	P:positive regulation of homotypic cell-cell ...; IDA:BHF-UCL		0:TNFSF11			
GO:0009409	P:response to cold; TAS:ProtInc		0:ACOT11|0:CIRBP|0:CSDA|0:GMPR			
GO:0042219	P:cellular amino acid derivative catabolic pr...; IDA:UniProtKB		0:A2LD1			
GO:0006890	P:retrograde vesicle-mediated transport, Golg...; TAS:UniProtKB		0:ARCN1|0:COPG|0:COPA|0:COPB1|0:COPE|0:ARFGAP1|0:ARF1|0:GBF1|0:SCYL1|0:RER1|0:COG7|0:COG3|0:COG4|0:SCFD1|0:PICK1|0:TAPBP|0:RAB6B|0:KIF1C|0:COPB2|0:COPG2|0:COPZ1			
GO:0005687	C:U4 snRNP; IDA:BHF-UCL		0:PRPF31			
GO:0032100	P:positive regulation of appetite; ISS:HGNC		0:GHRL|0:GHSR|0:NPY			
GO:0071506	P:cellular response to mycophenolic acid; ISS:UniProtKB		0:EGR1			
GO:0031365	P:N-terminal protein amino acid modification; TAS:HGNC		0:PDF|0:METAP2|0:METAP1			
GO:0009056	P:catabolic process; TAS:ProtInc		0:PTER|0:CES2			
GO:0042981	P:regulation of apoptosis; TAS:UniProtKB		0:P2RX4|0:ACVR1C|0:TRAF1|0:BEX2|0:TMEM102|0:NAE1|0:PSME3|0:PECR|0:CARD16|0:CARD11|0:CARD10|0:DLG5|0:IFIH1|0:CARD6|0:TRAF4|0:CARD14|0:BCL2L14|0:CARD18|0:TRAF5|0:CASP5|0:CARD9|0:CASP12|0:CARD17|0:NOD2|0:WRN|0:DEPDC6|0:TRAF7|0:CD3G|0:BTG1|0:MADD|0:BLOC1S2|0:SIRT1|0:LCN2|0:ZNF738|0:SKIL|0:ACTN2|0:ACTN3|0:RTN4|0:SEPT4|0:ACTN4|0:ACTN1|0:IL6R|0:CTSB|0:PHB|0:NME1|0:BCAR1|0:LGALS1|0:CALR			
GO:0004852	F:uroporphyrinogen-III synthase activity; IDA:UniProtKB		0:UROS			
GO:0007049	P:cell cycle; TAS:UniProtKB		0:HHEX|0:MAP3K8|0:NCRNA00266|0:SEPT7L|0:SEPT8|0:SPIN2B|0:PARD6G|0:RB1CC1|0:URGCP|0:TACC1|0:PCNP|0:CDT1|0:CCNE2|0:CDC45|0:PPP1CB|0:MAPK4|0:PARD6B|0:SENP5|0:PELO|0:TUSC2|0:STRADA|0:RBL2|0:CINP|0:TXNIP|0:RGS2|0:FBXW11|0:RAB11A|0:CHAF1B|0:AURKC|0:JUB|0:CDC5L|0:APPL1|0:ARL2|0:SEPT3|0:RBM38|0:CCNDBP1|0:PIM3|0:DMTF1|0:MAPK1|0:CCNT1|0:MAPK13|0:LIG1|0:KRT18|0:CLSPN|0:E2F8|0:SMARCB1|0:CKS1B|0:MCM3|0:CABLES2|0:TRIM21|0:CKAP2|0:TET2|0:RASSF2|0:BANP|0:CYLD|0:WTAP|0:CCNH|0:BCCIP|0:GMNN|0:C13orf15|0:ING1|0:PARD3|0:VPS4A|0:CCAR1|0:HCFC1|0:MRPL41|0:TLK1|0:TERF2|0:MAPK7|0:PARD6A|0:ERH|0:E2F7|0:SIAH2|0:RINT1|0:TXLNG|0:APPL2|0:CHEK2|0:SEPT10|0:TSPYL2|0:RAB11B|0:TFDP1|0:KLK10|0:SEPT1|0:E2F3|0:CDC14A|0:USP17L2|0:PDCD6IP|0:PPP1CA|0:SPIN2A|0:EID1|0:MCM7|0:BLCAP|0:SMPD3|0:SEPT6|0:RCBTB1|0:SEPT14|0:HMG20B|0:CROCC|0:BIN3|0:RBBP4|0:LIG4|0:SUV39H1|0:HJURP|0:CABLES1|0:ANXA11|0:EP300|0:BRCA1|0:AHCTF1|0:MDC1|0:VPS4B|0:LIN9|0:E2F2|0:SEPT11|0:TLK2|0:TFDP2|0:STRADB|0:POC5|0:SEPT9|0:CREBL2|0:SEPT4|0:MAPK6|0:CDC73|0:TRNP1|0:PIN1|0:RASSF4|0:CASP8AP2|0:SPAST|0:C15orf42|0:KCTD11|0:ESCO2|0:MCM8|0:SIK1|0:SEPT5|0:UHRF2|0:EVI5|0:PIM1|0:USP2|0:SPIN1|0:SPDYC|0:SIAH1|0:MCTS1|0:MAPK3|0:RAD17|0:ZMYND11|0:CCND2|0:VPS24|0:FBXO31|0:CHMP1B|0:THAP1|0:SEPT12|0:CTCFL|0:RALB|0:GAK|0:USP8|0:MAEA|0:RIF1|0:LZTS1|0:DUSP1|0:G0S2|0:CCNT2|0:NEK11|0:DDX12|0:CHTF8|0:GADD45GIP1|0:FANCI|0:DBF4B|0:ARL3|0:MCM6|0:USP22|0:PTP4A1|0:UHRF1|0:RBL1|0:SPECC1L|0:GSG2|0:LLGL2|0:CHAF1A|0:BEX2|0:THAP5|0:CHTF18|0:NAE1|0:CCPG1|0:CEP110|0:ESCO1|0:ARL8B|0:TP53BP2|0:TMPRSS11A|0:LIN54|0:IKZF1|0:STEAP3|0:KIAA0174|0:CUZD1|0:PPP1CC|0:AVPI1|0:RAB11FIP3|0:PYHIN1|0:GSPT2|0:RALA|0:PARD3B|0:UPF1|0:NASP|0:ERBB2IP|0:CUL4B|0:JAG2|0:SUPT5H|0:MPHOSPH8|0:DTYMK|0:ATR|0:GPS1|0:PFDN1|0:MCM2|0:RABGAP1|0:GPS2|0:EGFL6|0:AHR|0:FOXM1			
GO:0051015	F:actin filament binding; TAS:ProtInc		0:ADD2|0:TTN|0:ADD1|0:FLNA|0:MAP1S|0:MYH10|0:EGFR|0:CORO1A|0:SVIL|0:AIF1|0:EZR|0:LIMA1|0:AIF1L|0:SPTB|0:ACTN4|0:MYO6|0:ANTXR1|0:TULP1|0:MYH9|0:FSCN1|0:MYO5C|0:FSCN2|0:FSCN3|0:MYO5A|0:MYL4|0:NEXN|0:TNNC1|0:MYO16|0:SLC6A4|0:SHROOM2|0:SHROOM1|0:CYFIP1|0:SCIN|0:ESPN|0:SHROOM4|0:MACF1|0:SPTA1|0:PLS1|0:MARCKS			
GO:0006801	P:superoxide metabolic process; TAS:UniProtKB		0:CYB5R4|0:SOD3|0:NOS2|0:CCS|0:PREX1			
GO:0055075	P:potassium ion homeostasis; IMP:BHF-UCL		0:CYP11B2			
GO:0008449	F:N-acetylglucosamine-6-sulfatase activity; TAS:ProtInc		0:GNS			
GO:0045145	F:single-stranded DNA specific 5'-3' exodeoxy...; IDA:UniProtKB		0:EXO1			
GO:0007598	P:blood coagulation, extrinsic pathway; EXP:Reactome		0:F10|0:TFPI|0:F7|0:F3|0:F9			
GO:0046854	P:phosphoinositide phosphorylation; ISS:UniProtKB		0:SMG1|0:IP6K1|0:IP6K2|0:PI4KAP2|0:PI4KAP1|0:PIK3R1			
GO:0047598	F:7-dehydrocholesterol reductase activity; IDA:UniProtKB		0:DHCR7			
GO:0004996	F:thyroid-stimulating hormone receptor activity; TAS:ProtInc		0:PAX8|0:TSHR			
GO:0016504	F:peptidase activator activity; ISS:BHF-UCL		0:CLPX|0:CAV1			
GO:0005412	F:glucose:sodium symporter activity; IDA:MGI		0:SLC5A1			
GO:0061154	P:endothelial tube morphogenesis; IMP:BHF-UCL		0:CTNNB1			
GO:0030500	P:regulation of bone mineralization; TAS:UniProtKB		0:ENPP1|0:MGP|0:BGLAP|0:IFITM5|0:CYP27B1|0:ANKH			
GO:0070062	C:extracellular vesicular exosome; IDA:BHF-UCL		0:ALDOA			
GO:0032003	F:interleukin-28 receptor binding; IPI:UniProtKB		0:IL29			
GO:0030036	P:actin cytoskeleton organization; TAS:UniProtKB		0:ARHGEF18|0:RHOG|0:ARHGEF17|0:RAC3|0:FGD1|0:TAOK2|0:CDC42|0:NUAK2|0:FMNL1|0:TMSL3|0:CAPZA1|0:TMSB15A|0:PFN1|0:TMSB4X|0:FMN2|0:DIAPH2|0:TMSB4XP1|0:DAAM1|0:PFN4|0:FHOD3|0:CAPZB|0:INF2|0:FMNL3|0:TMSB10|0:FHDC1|0:DAAM2|0:TMSB4XP2|0:DIAPH3|0:PFN3|0:CAPZA2|0:TMSL6|0:GRID2IP|0:FMNL2|0:FHOD1|0:FMN1|0:CAPZA3|0:PFN2|0:TMSB4Y|0:XIRP2|0:ELMO1|0:NF2|0:SSH1|0:SSH2|0:ARFIP2|0:RHOJ|0:FOXJ1|0:PAFAH1B1|0:NF1|0:ABL1|0:FGD3|0:TNXB|0:FGD6|0:FGD2|0:DLC1|0:FGD5|0:FGD4|0:TESK2|0:ARHGAP26|0:SDCBP|0:FERMT2|0:INPP5K|0:ARHGEF11|0:KLHL1|0:NPHP4|0:TRIP10|0:CORO2B|0:NPHP1|0:SPTBN5|0:ARHGDIB|0:CXCL1|0:ARPC1A|0:DYNLL1|0:CRK|0:LIMK1|0:MRAS|0:ARPC5|0:WASF2|0:PDPK1|0:CYTH2|0:RND3|0:PRKG1|0:ADRA2A|0:PACSIN2|0:FLNB|0:ROCK1|0:PLEK2|0:AMOT|0:DOCK2|0:MTSS1			
GO:0030148	P:sphingolipid biosynthetic process; TAS:UniProtKB		0:C3orf57|0:SPTLC1|0:C14orf147			
GO:0003824	F:catalytic activity; IEA:InterPro		0:SYN3|0:SDR39U1|0:SLC3A2|0:RIMKLA|0:HDDC3|0:C3orf48|0:TDH|0:PLD5|0:CDYL2|0:DIP2B|0:GTF2F1|0:CDKAL1|0:FAM111B|0:STBD1|0:RSAD2|0:LANCL1|0:DIP2A|0:SLC3A1|0:SYN2|0:ECHDC1|0:HHIPL2|0:HDHD1|0:TAB1|0:LANCL2|0:MOCS1|0:ISOC1|0:KCNU1|0:HHIPL1|0:AZIN1|0:C10orf52|0:KCNT1|0:SYN1|0:CWF19L1|0:LANCL3|0:PSTPIP1|0:HDDC2|0:AKAP7|0:ISOC2|0:KCNT2|0:KCNMA1|0:ECHDC3|0:DIP2C|0:RIMKLB|0:LENG9|0:NAE1|0:CRYM|0:NMRAL1|0:HHIP			
GO:0005175	F:CD27 receptor binding; IPI:HGNC		0:SIVA1			
GO:0030375	F:thyroid hormone receptor coactivator activity; IDA:UniProtKB		0:MED16			
GO:0010314	F:phosphatidylinositol-5-phosphate binding; ISS:UniProtKB		0:LANCL2|0:SESTD1|0:PHLDA3|0:SH3PXD2B			
GO:0014069	C:postsynaptic density; ISS:UniProtKB		0:DTNBP1|0:CACNA1C|0:CABP1|0:SHANK3|0:GRIN3A|0:DLG1|0:PJA2|0:DLGAP2|0:LIN7B|0:SHANK2|0:LIN7A|0:CAMK2N1|0:DNM2|0:DLGAP3|0:TANC1|0:GOPC|0:DLG2|0:ARC|0:KLHL17|0:LIN7C|0:ANKS1B|0:SHANK1|0:NCS1|0:HOMER3|0:DLGAP1|0:LRFN1|0:PSD3|0:LZTS1|0:NLGN1|0:CPEB1|0:ARHGAP32|0:HOMER2|0:HOMER1|0:MPDZ|0:SYNPO|0:DLG4|0:SIPA1L1|0:PDLIM5|0:CHRNA3|0:NETO1|0:GRIN1|0:SRCIN1|0:DNM3|0:STRN|0:SEMA4C			
GO:0016563	F:transcription activator activity; TAS:UniProtKB		0:HDAC2|0:PBX4|0:HDAC1|0:CDH1|0:KDM5A|0:CEP290|0:TAF8|0:GABPB1|0:BCL2|0:GABPB2|0:HIVEP3|0:ELK1|0:NFATC2|0:SALL1|0:CHD8|0:FOXO1|0:FGF10|0:RSF1|0:ARID1A|0:CXXC1|0:HMGB2|0:SP1|0:PAX8|0:TNF|0:GLI1|0:ZNF423|0:RFX6|0:PHB|0:FOXJ2|0:RFX3|0:MYC|0:NFATC1|0:TP73|0:RUNX1|0:TBL1X|0:AR|0:MITF|0:FOXC2|0:GLI2|0:ZNF281|0:BMP4|0:ING2|0:FOXF1|0:ELF2|0:TP63|0:ANKRD49|0:TRIM16|0:TBL1XR1|0:RUNX2|0:FUBP3|0:APBB1|0:IRF4|0:SFRP1|0:BMP2|0:BRPF1|0:SP3|0:DLX5|0:ELF4|0:CTCFL|0:PPARD|0:BRCA2|0:FOXH1|0:FOXF2|0:RELA|0:WNT4|0:FOXO3|0:AIRE|0:YWHAH|0:ZXDC|0:TGFB1|0:PAX2|0:NR2F2|0:TFAP4|0:MYST4|0:ZKSCAN3|0:WT1|0:TAF1L|0:ILF3|0:PPARA|0:CHURC1|0:HOXB9|0:HMBOX1|0:HOXC9|0:HOXA9|0:HNF1B|0:BRF1|0:HOXD9|0:CDKN1C|0:XRCC6|0:FOXP3|0:SMARCA4|0:SKAP1|0:WNT1|0:WNT11|0:TP53|0:ATF4|0:WNT5A|0:CTCF|0:RNF6|0:PPARG|0:HDAC4|0:TCF3|0:MLXIPL|0:NKX2-5|0:POU3F1|0:SS18L1|0:GLIS2|0:CAND2|0:SMAD2|0:POU3F3|0:ESRRG|0:STAT3|0:INHBA|0:NKX2-1|0:EOMES|0:KLF4|0:CD86|0:HNRNPD|0:IKBKB|0:TP53BP1|0:ZNF398|0:ZSCAN21|0:SEC14L2|0:SRY|0:DNM2|0:NAT14|0:ETV4|0:HMGN5|0:IRAK1|0:ELF1|0:MYB|0:SMAD5|0:KLF2|0:ONECUT1|0:MYBL1|0:FOXC1|0:CD80|0:RREB1|0:UBE2V1|0:EPC1|0:KLF6			
GO:0019276	P:UDP-N-acetylgalactosamine metabolic process; IDA:UniProtKB		0:EXTL2|0:CSGALNACT1|0:B4GALNT2			
GO:0060575	P:intestinal epithelial cell differentiation; IDA:MGI		0:GATA4|0:GATA6|0:GATA5			
GO:0042327	P:positive regulation of phosphorylation; TAS:BHF-UCL		0:SDCBP|0:FZD7|0:EGFR|0:EREG|0:DSCAM|0:BCL10|0:ANG|0:GLMN|0:THBS1|0:GRB10			
GO:0071547	C:piP-body; ISS:UniProtKB		0:TDRD9|0:PIWIL4|0:MAEL|0:DDX4			
GO:0016459	C:myosin complex; TAS:BHF-UCL		0:MYO15B|0:CGN|0:CGNL1|0:MYO9B|0:MYO15A|0:MYO1A|0:MYO19|0:MYO5C|0:MYO10|0:MYO16|0:MYO18A|0:MYL12B|0:MYO1B|0:MYO1G|0:MYO1D|0:MYH14|0:MYO3A|0:MYO7A|0:MYL12A|0:MYO1E|0:MYO5B|0:MYO1H|0:MYO3B|0:MYO7B|0:MYH9|0:MYO5A|0:BMF|0:DYNLL2|0:FILIP1L|0:MYH10|0:MYL7|0:MYL2			
GO:0005771	C:multivesicular body; TAS:HGNC		0:TPT1|0:STEAP3|0:CD79A|0:LRAT|0:TSG101			
GO:0008104	P:protein localization; TAS:UniProtKB		0:TNS4|0:STK11IP|0:CUTA|0:NR0B1|0:DDX42|0:CD81|0:VPS13C|0:VPS13D|0:ULK1|0:CROCC|0:BIN3|0:ERCC3|0:CBY1|0:CEP250|0:DRD2|0:DOC2B|0:AKAP10|0:SQSTM1			
GO:0008553	F:hydrogen-exporting ATPase activity, phospho...; IEA:InterPro		0:ATP5B			
GO:0031638	P:zymogen activation; IDA:UniProtKB		0:F12|0:PRSS3			
GO:0005662	C:DNA replication factor A complex; TAS:ProtInc		0:RPA4|0:RPA2|0:RPA1|0:PURA|0:PURB|0:RPA3			
GO:0050908	P:detection of light stimulus involved in vis...; NAS:UniProtKB		0:CACNA1F|0:GNAT2|0:GNAT1|0:SDR16C5			
GO:0005506	F:iron ion binding; TAS:UniProtKB		0:ACO2|0:FBXL5|0:PHF8|0:TET1|0:NFU1|0:JHDM1D|0:ALOX12|0:AOX1|0:LEPRE1|0:SCD5|0:C17orf101|0:C5orf4|0:PLOD2|0:ALOXE3|0:TPH2|0:LEPREL1|0:PPEF1|0:STEAP2|0:TYW1|0:TMLHE|0:CH25H|0:P4HTM|0:PLOD3|0:ALOX15B|0:ALOX12B|0:NOX1|0:PDF|0:LEPREL2|0:MTRR|0:P4HA3|0:MIOX|0:POR|0:STEAP1|0:BBOX1|0:XDH|0:OGFOD2|0:SCD|0:TPH1|0:P4HA2|0:EGLN3|0:SC4MOL|0:STEAP4|0:NDOR1|0:SC5DL|0:NOX3|0:OGFOD1|0:ALOX15|0:EGLN1|0:TYW1B|0:PPEF2|0:P4HA1|0:PLOD1|0:ALOX5|0:STEAP3|0:KDM3A|0:TMEM195|0:LCN2|0:C14orf169|0:FDX1|0:ISCU			
GO:0006121	P:mitochondrial electron transport, succinate...; IMP:UniProtKB		0:SDHAF2			
GO:0051561	P:elevation of mitochondrial calcium ion conc...; IMP:UniProtKB		0:ATP2A1|0:CBARA1			
GO:0042608	F:T cell receptor binding; NAS:UniProtKB		0:DOCK2|0:CD3G|0:CD3E			
GO:0031461	C:cullin-RING ubiquitin ligase complex; IEA:InterPro		0:C10orf46|0:CUL7|0:CUL5|0:ANAPC2|0:CUL9|0:CUL2			
GO:0001616	F:growth hormone secretagogue receptor activity; IDA:HGNC		0:GHSR			
GO:0015837	P:amine transport; NAS:UniProtKB		0:RHCG			
GO:0050720	P:interleukin-1 beta biosynthetic process; IDA:BHF-UCL		0:CMA1			
GO:0002017	P:regulation of blood volume by renal aldoste...; IMP:BHF-UCL		0:CYP11B2			
GO:0006081	P:cellular aldehyde metabolic process; TAS:ProtInc		0:ALDH9A1|0:ADH4|0:ALDH3A1|0:ALDH3A2|0:ALDH3B1|0:ALDH3B2|0:ALDH7A1|0:AKR1B10|0:AKR7A2|0:ALDH1A1|0:AKR7A3			
GO:0006941	P:striated muscle contraction; TAS:UniProtKB		0:ALDOA|0:PGAM2|0:MYH6|0:ARHGEF11|0:ID2B|0:DTNA|0:SMPX|0:CASQ2|0:KBTBD10|0:TTN			
GO:0032913	P:negative regulation of transforming growth ...; IMP:UniProtKB		0:CD24			
GO:0043044	P:ATP-dependent chromatin remodeling; IMP:UniProtKB		0:BAZ1B|0:SMARCA1|0:SMARCA5|0:CHD8			
GO:0005739	C:mitochondrion; TAS:UniProtKB		0:MTHFD1L|0:CYP2D6|0:NDFIP2|0:CLU|0:GPX1|0:RIPK1|0:ARMS2|0:TAZ|0:SACS|0:ACOT2|0:TRIAP1|0:PDF|0:PMAIP1|0:MSRB3|0:IFI6|0:BCL2L10|0:SIVA1|0:TAOK3|0:HMBS|0:PTRH2|0:NEK9|0:GCET2|0:CASP3|0:CHAF1B|0:CCDC90B|0:TNFRSF19|0:CHCHD10|0:ELK3|0:E2F1|0:RDBP|0:GABPB1|0:LRRK1|0:MLLT6|0:MPST|0:CHRDL2|0:PSMA6|0:TSFM|0:PRDX1|0:FRMD6|0:PNKD|0:MTERFD1|0:ZNF782|0:IDH2|0:MRPL2|0:ACO2|0:MCF2L|0:GLT8D1|0:APOBEC3G|0:PSMC4|0:LIMK2|0:ALKBH3|0:ECH1|0:DIABLO|0:METT11D1|0:CDK7|0:AATK|0:BRD8|0:P4HA1|0:ILF3|0:RALGAPA1|0:HKDC1|0:FAM110B|0:PECI|0:MYL10|0:C3orf23|0:PTS|0:MRPL15|0:ABHD10|0:AGPAT5|0:SMCR7L|0:ACAD9|0:FAHD1|0:PTGES2|0:BRP44|0:THG1L|0:TMEM186|0:FUNDC2|0:FOXRED1|0:C10orf10|0:COQ6|0:KIAA1683|0:TMEM143|0:MTRF1L|0:ACSBG2|0:CMPK2|0:OXCT2|0:ESR2|0:SLC22A4|0:CLIC4|0:NUBPL|0:BBC3|0:SDHAF2|0:TMEM126A|0:KIAA1279|0:NAPG|0:GLRX2|0:ABCE1|0:CAPRIN2|0:BZRAP1|0:DNA2|0:TP53|0:TRAK1|0:HAX1|0:PRDX5|0:DHRS2|0:MCAT|0:ATPIF1|0:NFU1|0:PYCR1|0:PRDX3|0:NMNAT3|0:FANCG|0:NME6|0:KYNU|0:SUCLA2|0:PTRF|0:IFI27|0:ISCU|0:ALKBH1|0:FEN1|0:TRNT1|0:MECR|0:KIAA0141|0:TXNRD2|0:ECSIT|0:GLYATL3|0:C9orf6|0:CA5BP|0:COQ9|0:UNG|0:ATP7B|0:RG9MTD1|0:XAF1|0:ISCA1|0:ACSS3|0:MRPL46|0:MTO1|0:C21orf33|0:PANK2|0:CHCHD2|0:STARD7|0:MLYCD|0:MRPL4|0:MRPL33|0:TDH|0:MRPL50|0:GLYCTK|0:MTUS1|0:HEBP2|0:FAM136A|0:MRPL49|0:ENDOG|0:PPL|0:COQ5|0:GTPBP5|0:GLOD4|0:ACOT13|0:MRM1|0:YRDC|0:QTRT1|0:DYNLL1|0:C10orf129|0:MMADHC|0:PGS1|0:LACTB|0:GIMAP8|0:ACAD8|0:MRPL24|0:MRPL54|0:C18orf22|0:DHX32|0:BCL2L11|0:NDUFAF2|0:ELOVL6|0:TRIM39|0:CLYBL|0:PTCD3|0:MTG1|0:OAS1|0:LIPT1|0:NUDT8|0:RAB32|0:SUCLG2|0:GDF5OS|0:ISCA2|0:KLK6|0:CMC1|0:GLYATL1|0:MRPS5|0:RNASEL|0:ACSF3|0:LYRM4|0:NCRNA00188|0:C3orf15|0:AGMAT|0:TRAP1|0:MRPL53|0:MAPK12|0:ENOSF1|0:ACOT7|0:SH3BP5|0:RAB40AL|0:GLDC|0:C22orf32|0:C2orf56|0:TXN2|0:MMAB|0:C15orf62|0:MTFMT|0:RSAD1|0:AADAT|0:CCDC19|0:C8orf38|0:MRPS27|0:MRPS2|0:AGXT2L2|0:TACO1|0:PDSS2|0:REXO2|0:ACBD3|0:FTMT|0:CXorf23|0:KIF1B|0:HLCS|0:GSR|0:RTN4IP1|0:MRPL14|0:OAS2|0:MRPS6|0:CISD3|0:MRPL19|0:GTPBP3|0:PACS2|0:AKAP10|0:OXR1|0:MRPS30|0:GFM2|0:FAM65B|0:MRPS23|0:NIT1|0:ECHDC2|0:LIPT2|0:MRPL38|0:YME1L1|0:SCP2|0:DHDPSL|0:PDSS1|0:AGXT2L1|0:WWOX|0:KIAA0391|0:C2orf47|0:MRPS34|0:ISOC2|0:C12orf10|0:C14orf159|0:MRPL44|0:MMAA|0:GLUL|0:GLYATL2|0:DLST|0:ECHDC3|0:NUDT19|0:C14orf2|0:C14orf156|0:MRPL48|0:PUS1|0:MRPS7|0:BLID|0:TMEM8B|0:MCCD1|0:ALDH7A1|0:VARS2|0:AGXT2|0:NUDT9|0:CCDC90A|0:MRPL21|0:MYCBP|0:C1orf31|0:ATPAF2|0:PISD|0:CHCHD9|0:METTL12|0:ACSF2|0:MRPS10|0:KIAA0101|0:MRPL30|0:MTFR1|0:TRIM31|0:OGG1|0:MRRF|0:NUDT6|0:GFM1|0:DHTKD1|0:CCDC123|0:MTERFD3|0:C1orf69|0:MCEE|0:HSDL1|0:MTPAP|0:IDH3A|0:ATPAF1|0:SPATA5|0:ADCK3|0:TRIT1|0:HCLS1|0:OXSM|0:ACOT9|0:MSRB2|0:D2HGDH|0:MTIF2|0:MTIF3|0:AUH|0:NLRP5|0:IDH3G|0:HINT2|0:GBAS|0:GLRX5|0:ADHFE1|0:CHCHD3|0:QTRTD1|0:BPHL|0:PRELID1|0:MTHFD2|0:TRMU|0:ALDH5A1|0:MRPL22|0:UROS|0:LIAS|0:STXBP1|0:GSTZ1|0:NOP14|0:DHRS4L2|0:DHRS4|0:DECR1|0:ALDH6A1|0:GLS|0:PPP2R1A|0:OPA3|0:PPP2CA|0:SLIT3|0:SEPT4|0:VHL|0:C12orf65|0:GCAT|0:HSCB|0:CA5B|0:AMT|0:MTHFD1|0:ACP6|0:AMACR|0:CLN3|0:FPGS|0:GLS2|0:NT5M|0:MRPS31|0:GCSH|0:PET112L|0:BCAT2|0:ARG2|0:DUT|0:IDH3B|0:PCK2|0:DGUOK|0:MTRF1|0:COX4NB|0:ASAH2|0:FIBP|0:CRY1|0:GLYAT|0:TP53AIP1|0:AASS|0:HSPA1A|0:HSPA1B			
GO:0050431	F:transforming growth factor beta binding; TAS:BHF-UCL		0:TGFBR2|0:TGFB3|0:TGFBR3|0:TGFBR1|0:LTBP4|0:ACVR1|0:ENG|0:ACVRL1|0:CD36|0:THBS1			
GO:0070574	P:cadmium ion transmembrane transport; ISS:BHF-UCL		0:SLC11A1|0:SLC30A1			
GO:0048041	P:focal adhesion assembly; NAS:UniProtKB		0:TAOK2|0:ACTN2|0:ACTN3|0:ACTN1|0:PTPRK|0:THY1|0:DLC1|0:TESK2|0:TRIP6|0:LAMA5			
GO:0042552	P:myelination; TAS:UniProtKB		0:EIF2B2|0:EIF2B5|0:EIF2B4|0:SCN2A|0:NFASC|0:SCN8A|0:ZNF24|0:AMIGO1|0:ACSBG1|0:KLK6|0:SBF2|0:MAL			
GO:0006529	P:asparagine biosynthetic process; IEA:UniProtKB-KW		0:ASNS|0:ASNSD1			
GO:0050434	P:positive regulation of viral transcription; IDA:UniProtKB		0:RSF1|0:MDFIC			
GO:0005915	C:zonula adherens; ISS:BHF-UCL		0:KIAA1543|0:KIFC3|0:PLEKHA7|0:PVRL2|0:JUP			
GO:0050790	P:regulation of catalytic activity; IEA:InterPro		0:CTSB			
GO:0006437	P:tyrosyl-tRNA aminoacylation; TAS:ProtInc		0:YARS2|0:YARS			
GO:0019706	F:protein-cysteine S-palmitoleyltransferase a...; IDA:UniProtKB		0:YKT6|0:ZDHHC17			
GO:0007387	P:anterior compartment pattern formation; TAS:ProtInc		0:PBX3			
GO:0060228	F:phosphatidylcholine-sterol O-acyltransferas...; TAS:BHF-UCL		0:APOA4|0:APOE|0:APOA2|0:APOA1|0:APOC1			
GO:0047015	F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase...; IEA:EC		0:HSD17B10			
GO:0032448	F:DNA hairpin binding; IDA:HGNC		0:NR0B1			
GO:0047280	F:nicotinamide phosphoribosyltransferase acti...; EXP:Reactome		0:NAMPT			
GO:0072060	P:outer medullary collecting duct development; ISS:UniProtKB		0:WNT7B			
GO:0003418	P:growth plate cartilage chondrocyte differen...; ISS:UniProtKB		0:NPPC			
GO:0008519	F:ammonium transmembrane transporter activity; IEA:InterPro		0:RHAG|0:RHCG|0:RHBG|0:RHD|0:RHCE			
GO:0006097	P:glyoxylate cycle; IEA:UniProtKB-KW		0:IDH2|0:IDH1			
GO:0019835	P:cytolysis; IEA:UniProtKB-KW		0:APOL1|0:MMD|0:MMD2|0:C8G|0:C7|0:GZMM|0:MICA|0:C9|0:GZMH|0:GZMA|0:C5|0:C8A|0:PRF1|0:LYZ|0:C8B|0:C6|0:GZMB|0:MICB			
GO:0009720	P:detection of hormone stimulus; NAS:UniProtKB		0:ABCG1			
GO:0090234	P:regulation of kinetochore assembly; IMP:UniProtKB		0:RNF4			
GO:0060318	P:definitive erythrocyte differentiation; ISS:BHF-UCL		0:TGFBR3			
GO:0018112	F:proline racemase activity; IEA:EC		0:C14orf149			
GO:0046696	C:lipopolysaccharide receptor complex; IDA:UniProtKB		0:HSPD1|0:TLR4|0:LY96			
GO:0046898	P:response to cycloheximide; IDA:BHF-UCL		0:GHR			
GO:0021983	P:pituitary gland development; NAS:UniProtKB		0:SALL1|0:GLI2|0:NR0B1			
GO:0000105	P:histidine biosynthetic process; IEA:UniProtKB-KW		0:MTHFD1|0:MTHFD2L			
GO:0043587	P:tongue morphogenesis; IMP:BHF-UCL		0:GAA			
GO:0002052	P:positive regulation of neuroblast prolifera...; ISS:BHF-UCL		0:DISC1|0:DRD2			
GO:0033577	P:protein amino acid glycosylation in endopla...; IGI:UniProtKB		0:ALG2			
GO:0004714	F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc		0:ALK|0:NTRK2|0:ERBB3|0:RET|0:ROS1|0:NTRK3|0:INSRR|0:TEK|0:ROR2|0:ERBB4|0:MUSK|0:DDR2|0:PTK7|0:TYRO3|0:NTRK1|0:RYK|0:TRIM27|0:TIE1|0:DDR1|0:AXL|0:LTK|0:ROR1|0:MERTK			
GO:0032440	F:2-alkenal reductase activity; IEA:EC		0:PTGR1			
GO:0046873	F:metal ion transmembrane transporter activity; IEA:InterPro		0:SLC39A13|0:SLC39A12|0:SLC39A8|0:SLC39A5|0:SLC39A10|0:SLC39A14|0:SLC39A9|0:SLC39A11|0:SLC39A6			
GO:0008892	F:guanine deaminase activity; TAS:ProtInc		0:GDA			
GO:0010670	P:positive regulation of oxygen and reactive ...; IDA:UniProtKB		0:THBS1|0:ROMO1			
GO:0006479	P:protein amino acid methylation; TAS:ProtInc		0:GSPT1|0:ETF1|0:BHMT|0:PRMT2			
GO:0010043	P:response to zinc ion; ISS:HGNC		0:HVCN1|0:ZACN|0:HAAO|0:SLC30A5|0:D2HGDH			
GO:0000739	F:DNA strand annealing activity; IDA:UniProtKB		0:RECQL|0:TP53|0:RECQL4|0:BLM			
GO:0005680	C:anaphase-promoting complex; TAS:ProtInc		0:CDC26|0:UBE2S|0:ANAPC11|0:ANAPC7|0:ANAPC4|0:CDC23|0:ANAPC13|0:CDC27|0:ANAPC16|0:ANAPC5|0:CDC16|0:ANAPC2|0:UBE2C|0:ANAPC1|0:ANAPC10|0:HECTD3|0:ZZEF1|0:HERC2|0:MYCBP2|0:CUL9|0:CUL7|0:FZR1|0:BUB1B			
GO:0071564	C:npBAF complex; ISS:UniProtKB		0:ARID1A|0:SMARCC2|0:SMARCD1|0:SMARCB1|0:SMARCC1|0:SMARCE1|0:SMARCA2|0:SMARCD3|0:SMARCA4|0:ACTL6A|0:PHF10			
GO:0032348	P:negative regulation of aldosterone biosynth...; IDA:UniProtKB		0:DKK3			
GO:0018107	P:peptidyl-threonine phosphorylation; ISS:UniProtKB		0:TGFBR2|0:TAF1|0:PDPK1|0:TGFBR1|0:TNKS|0:ACVR1B|0:CAD|0:NLK|0:MAP3K12|0:HIPK3			
GO:0031931	C:TORC1 complex; IDA:UniProtKB		0:RPTOR|0:MTOR			
GO:0010735	P:positive regulation of transcription via se...; ISS:BHF-UCL		0:SRF|0:NKX2-5			
GO:0032880	P:regulation of protein localization; TAS:UniProtKB		0:PICALM|0:RABGAP1L|0:RSL1D1|0:C13orf34|0:SLC26A4|0:SUMO1			
GO:0004531	F:deoxyribonuclease II activity; TAS:ProtInc		0:DNASE2B|0:DNASE2			
GO:0006461	P:protein complex assembly; TAS:UniProtKB		0:ZW10|0:LAMC1|0:MDM2|0:PARD6B|0:LLGL1|0:PML|0:MLL|0:MDM4|0:RIMS1|0:TFAP4|0:APC|0:ATPAF1|0:CD74|0:CAPG|0:MAGI1|0:KCNQ5|0:TUBGCP4|0:NDUFAF1|0:KNTC1|0:MKI67IP|0:CARD10|0:MPP6|0:NAPG|0:CD3G|0:MDN1|0:GPAA1|0:STK16|0:SLC9A3R1|0:CD40|0:DLG4|0:CAPZA1|0:CHAF1B|0:APBA1|0:CREBBP|0:RANBP9|0:VAMP3|0:HFE|0:PARD3|0:FANCC|0:IKBKAP|0:SH3BGR|0:FAS|0:KIFAP3|0:TAPBP|0:LIN7A|0:TUBGCP2|0:SYK|0:FANCA|0:REPS2|0:SLC9A3R2|0:PPIH|0:WASL|0:CD2AP|0:PTCH2|0:CLDN14|0:SLC7A7|0:LPXN|0:SLC7A6|0:DARS|0:NFS1|0:WIPF1|0:TSPAN4|0:SF3B3|0:CAPZA2|0:EPRS|0:IL1RAP|0:TRAF1|0:SKAP2|0:OCLN|0:SLC7A9|0:MATN1|0:TCEB2|0:KPNA3|0:CHAF1A|0:VIL1|0:APC2|0:IL2RB|0:PPP2R1A|0:HMGA1|0:GEMIN5			
GO:0030957	F:Tat protein binding; IDA:UniProtKB		0:MDFIC|0:NPM1			
GO:0008542	P:visual learning; ISS:UniProtKB		0:CHRNB2|0:DRD3|0:DRD1|0:DRD2|0:NF1|0:APP|0:NETO1|0:GRIN1			
GO:0043049	P:otic placode formation; ISS:BHF-UCL		0:PROX1			
GO:0045767	P:regulation of anti-apoptosis; IMP:UniProtKB		0:RTKN|0:DDX42			
GO:0035051	P:cardiac cell differentiation; NAS:UniProtKB		0:BMP2|0:MYOCD			
GO:0031072	F:heat shock protein binding; TAS:UniProtKB		0:LIMK1|0:PDXP|0:FAF1|0:DNAJC30|0:DNAJC9|0:DNAJB4|0:DNAJC25|0:DNAJB13|0:DNAJB8|0:DNAJC5|0:DNAJC8|0:DNAJB1|0:DNAJC22|0:DNAJC12|0:DNAJC2|0:DNAJC19|0:DNAJA3|0:DNAJB5|0:DNAJC24|0:DNAJC16|0:DNAJC21|0:DNAJB2|0:DNAJC3|0:DNAJC6|0:DNAJC28|0:DNAJB9|0:DNAJB12|0:DNAJC13|0:HSCB|0:DNAJB11|0:DNAJC5B|0:DNAJC14|0:DNAJA2|0:SEC63|0:DNAJC27|0:DNAJC17|0:DNAJC10|0:SLC8A1|0:DNAJC15|0:DNAJB3|0:DNAJC1|0:DNAJC4|0:GRXCR1|0:GAK|0:DNAJB14|0:DNAJA4|0:DNAJC11|0:DNAJC5G|0:DNAJB7|0:DNAJA1|0:DNAJC18|0:FKBP4|0:PPID|0:TOMM34|0:DNAJC7|0:DNAJB6|0:FKBP5|0:CDC37|0:DAXX			
GO:0000248	F:C-5 sterol desaturase activity; TAS:ProtInc		0:FADS1|0:SC5DL			
GO:0005956	C:protein kinase CK2 complex; NAS:UniProtKB		0:CSNK2B			
GO:0017129	F:triglyceride binding; IDA:BHF-UCL		0:CETP			
GO:0016192	P:vesicle-mediated transport; TAS:UniProtKB		0:CHMP1A|0:AP4E1|0:STX19|0:GGA2|0:SGIP1|0:TSNARE1|0:SFT2D1|0:GOLT1A|0:GGA1|0:VAMP4|0:STX12|0:SFT2D3|0:AP3M1|0:NCAPD2|0:GOLT1B|0:AP3S2|0:AP2B1|0:VAMP5|0:CLTB|0:AP2M1|0:STX11|0:STXBP6|0:AP3M2|0:SFT2D2|0:AP4B1|0:STX17|0:MUDENG|0:GGA3|0:VAMP1|0:VPS41|0:AP3D1|0:AP3S1|0:BET3L|0:ARF5|0:TRAPPC6B|0:USE1|0:CNIH|0:NAPB|0:TRAPPC5|0:SEC16A|0:BNIP1|0:ARFGAP2|0:ARL17A|0:TRAPPC6A|0:RINT1|0:RAB2B|0:RAB6A|0:KDELR3|0:BCAP29|0:ERGIC3|0:YIF1A|0:SEC31B|0:ARL17B|0:KDELR2|0:RTN3|0:BCAP31|0:TMED2|0:TRAPPC10|0:MCFD2|0:ZFPL1|0:ERGIC2|0:COPZ2|0:KDELR1|0:ARF4|0:YIPF5|0:SEC16B|0:ARF3|0:MAPK8IP1|0:BVES|0:MAPK8IP3|0:RAB39B|0:ARFGAP3|0:NCALD|0:AP1G2|0:CECR2|0:RAB4B|0:OSBPL1A|0:ACTR1A|0:KIF20A|0:AP4M1|0:CPNE6|0:CPNE3|0:CYTH3|0:CYTH1|0:KALRN|0:RAB13|0:PLIN3|0:RAB1A|0:GOLGA4|0:CPNE1|0:LRPAP1|0:PRKCI|0:ARF6|0:SPTBN4|0:ARAP3			
GO:0005132	F:interferon-alpha/beta receptor binding; TAS:ProtInc		0:IFNK|0:IFNB1|0:IFNA7|0:IFNA2|0:IFNA16|0:IFNA13|0:IFNA4|0:IFNA17|0:IFNA1			
GO:0007256	P:activation of JNKK activity; IMP:UniProtKB		0:TNIK			
GO:0005977	P:glycogen metabolic process; TAS:ProtInc		0:GSK3B|0:PPP1CB|0:PPP1R3A|0:PPP1R2|0:PPP1R2P3|0:PPP1R1A|0:PHKA2|0:PPP1R3B|0:PPP1CA|0:PPP1R3D|0:PPP1R3E|0:PPP1R2P1|0:PPP1CC|0:PRKAG2|0:EPM2A|0:PHKB|0:PHKA1			
GO:0003940	F:L-iduronidase activity; TAS:ProtInc		0:IDUA			
GO:0015914	P:phospholipid transport; TAS:HGNC		0:NPC2			
GO:0008267	F:poly-glutamine tract binding; TAS:ProtInc		0:RERE			
GO:0030505	P:inorganic diphosphate transport; IDA:BHF-UCL		0:ENPP1			
GO:0016410	F:N-acyltransferase activity; IDA:MGI		0:BAAT			
GO:0043175	F:RNA polymerase core enzyme binding; IPI:UniProtKB		0:RBM16			
GO:0005242	F:inward rectifier potassium channel activity; TAS:ProtInc		0:KCNJ16|0:KCNJ13|0:KCNK1|0:KCNJ12|0:KCNJ4|0:KCNJ14|0:KCNJ1|0:KCNK6|0:KCNQ5|0:KCNJ2|0:KCNJ15			
GO:0005763	C:mitochondrial small ribosomal subunit; TAS:UniProtKB		0:MRPS22|0:MRPS21|0:MRPS16|0:MRPS18A|0:MRPS36|0:MRPS15|0:MRPL42|0:MRPS18C|0:MRPS11|0:MRPS26|0:MRPS24|0:MRPS9|0:MRPS18B|0:MRPS35|0:MRPS25|0:MRPS17|0:MRPS33|0:MRPS28			
GO:0018350	P:protein amino acid esterification; NAS:UniProtKB		0:CEL			
GO:0008527	F:taste receptor activity; TAS:UniProtKB		0:TAS1R3|0:TAS1R1|0:TAS1R2|0:TAS2R4|0:TAS2R9|0:TAS2R8|0:TAS2R13|0:TAS2R3|0:TAS2R7|0:TAS2R10|0:TAS2R1|0:TAS2R5			
GO:0051536	F:iron-sulfur cluster binding; NAS:UniProtKB		0:ABCE1|0:ISCU|0:ISCA1|0:ELP3|0:GLRX3|0:RSAD2|0:RTEL1|0:ISCA2|0:ERCC2|0:RPS3			
GO:0050870	P:positive regulation of T cell activation; ISS:UniProtKB		0:MALT1|0:MAP3K7|0:TRAF2|0:TNFSF11|0:HSPD1|0:CD47|0:LCK|0:SIRPG|0:THY1			
GO:0016798	F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW		0:SMPDL3B|0:SMPDL3A|0:SMPD1|0:ATHL1			
GO:0007062	P:sister chromatid cohesion; TAS:UniProtKB		0:STAG2|0:MRE11A|0:FBXW7|0:SMC3|0:REC8|0:PAPD7			
GO:0046404	F:ATP-dependent polydeoxyribonucleotide 5'-hy...; IEA:EC		0:N4BP2|0:PNKP|0:CLP1			
GO:0030343	F:vitamin D3 25-hydroxylase activity; IDA:BHF-UCL		0:CYP2R1|0:CYP3A4			
GO:0045901	P:positive regulation of translational elonga...; ISS:UniProtKB		0:EIF5A2|0:EIF5AL1|0:EIF5A			
GO:0019864	F:IgG binding; IEA:UniProtKB-KW		0:FCGR2C|0:FCGR2B|0:FCGR3A|0:FCGR3B|0:FCGR1A|0:FCGR2A|0:FCGR1B|0:FCGRT|0:FCGR1C			
GO:0004642	F:phosphoribosylformylglycinamidine synthase ...; IDA:UniProtKB		0:PFAS			
GO:0045666	P:positive regulation of neuron differentiation; NAS:UniProtKB		0:ADRA2B|0:ADRA2C|0:NKX2-5|0:RHOA|0:VWC2|0:HOXD3|0:NRCAM			
GO:0004647	F:phosphoserine phosphatase activity; TAS:ProtInc		0:PSPH|0:VPS29|0:PSPHL			
GO:0015182	F:L-asparagine transmembrane transporter acti...; IDA:UniProtKB		0:SLC38A3			
GO:0050902	P:leukocyte adhesive activation; TAS:UniProtKB		0:CX3CL1			
GO:0019838	F:growth factor binding; IPI:UniProtKB		0:FLT4|0:LTBP2|0:FGFBP2|0:LTBP3|0:LTBP1|0:GHR|0:GHRHR|0:ERBB3|0:KDR|0:OSMR|0:LIFR|0:ACVR2B|0:FLT1|0:NRP1			
GO:0015252	F:hydrogen ion channel activity; IDA:UniProtKB		0:SLC4A11|0:NOX5			
GO:0071560	P:cellular response to transforming growth fa...; IEP:UniProtKB		0:WNT2|0:WNT7A|0:WNT4|0:WNT5A|0:WNT10A			
GO:0042598	C:vesicular fraction; IDA:UniProtKB		0:STEAP2			
GO:0005887	C:integral to plasma membrane; TAS:UniProtKB		0:FZD4|0:P2RX7|0:DRD1|0:AGTR1|0:P2RX4|0:AGTR2|0:DRD2|0:TNFRSF14|0:NPR1|0:SLC6A4|0:SLC1A4|0:ABCG1|0:CCKBR|0:IGF1R|0:BMPR1B|0:DRD3|0:ITPR3|0:GHR|0:TNF|0:F2RL1|0:DRD4|0:PDGFRA|0:ADRA2C|0:ADRB2|0:BMPR2|0:SLC4A1|0:ADRA2A|0:ADAM17|0:ABCA1|0:PHB|0:PSEN1|0:PSENEN|0:APH1A|0:EPGN|0:YKT6|0:PSEN2|0:CAV2|0:TRPC3|0:NLGN4X|0:NPC1|0:C20orf54|0:TM4SF1|0:RHCG|0:MICA|0:NOTCH2|0:STAB1|0:GRIK3|0:LRP12|0:DCBLD2|0:ORAI1|0:SGMS2|0:GPR172B|0:TLR4|0:SLC22A17|0:GPR55|0:STAB2|0:BCAP31|0:STOM|0:CALY|0:GPR172A|0:GRM4|0:TRPV5|0:GLRA1|0:GPR35|0:ABCB5|0:APCDD1|0:CD72|0:RHBG|0:GPR20|0:MAEA|0:ACVRL1|0:PI4K2A|0:ALK|0:STIM1|0:SLC22A11|0:CD81|0:SLC6A8|0:EPHA6|0:TMPRSS11F|0:EDA2R|0:EPHB2|0:SLC6A17|0:TMPRSS11B|0:SLC6A11|0:SLC6A18|0:SLC6A5|0:EPHA7|0:EPHA10|0:SLC6A14|0:EPHB6|0:PDGFRB|0:TNFRSF18|0:SLC6A12|0:SLC6A20|0:SLC6A19|0:SLC6A15|0:SLC6A6|0:EPHA8|0:ABCA4|0:SLC6A1|0:EPHA5|0:TMPRSS9|0:SLC6A16|0:SLC6A3|0:TMPRSS11A|0:SLC6A13|0:FZD6|0:TGFBR3|0:PTPRC|0:SLC38A3|0:JAG2|0:SCARA5|0:BSND|0:NCSTN|0:TMPRSS11E|0:NLGN1|0:TSPAN12|0:MICB|0:GP1BB|0:TFR2|0:SDC2|0:CALCR|0:RASGRP3|0:HLA-C|0:HLA-DRB3|0:CD58|0:TMEM8A|0:PILRB|0:JAM2|0:FLRT2|0:HLA-DRA|0:CEACAM1|0:PPAP2A|0:KIR3DL1|0:CD5|0:SLC34A2|0:FLRT1|0:KIR2DS5|0:CACNB2|0:DRD5|0:GLRA2|0:CD9|0:CD3G|0:INSRR|0:TNFSF11|0:GRM7|0:RAPGEF2|0:PTPRM|0:MUC12|0:NCR1|0:TMEM11|0:SLC22A13|0:NRG3|0:HLA-H|0:SLC25A13|0:MCOLN1|0:TRAC|0:CD2|0:HLA-DQA2|0:FLRT3|0:DLL1|0:SDC4|0:ATP8B1|0:CD44|0:TRGC2|0:CD1A|0:SLC22A14|0:CD8A|0:SLC11A1|0:HLA-DQA1|0:PLXNB1|0:CD27|0:KIR3DS1|0:CD1E|0:GLRB|0:HLA-B|0:NRCAM|0:SIGLEC9|0:IL17RA|0:CD164|0:PTPRU|0:CD3E|0:JAG1|0:SLC34A1|0:LEPROT|0:HLA-DPA1|0:SLC7A10|0:PTPRK|0:CD36|0:SIT1|0:RXFP3|0:GP1BA|0:GRM2|0:SORL1|0:SLC22A2|0:TEK|0:SELL|0:ROR2|0:GYPC|0:CD82|0:MMP16|0:ADAM23|0:NCR2|0:EMR1|0:XCR1|0:LDLR|0:TACR2|0:LGR5|0:CLEC4M|0:OR52A1|0:MAS1|0:SLC35A1|0:MMP24|0:SLC23A1|0:HTR4|0:LPAR3|0:PTGER2|0:SLC31A1|0:ADAM29|0:NTRK2|0:CLDN3|0:SLC25A4|0:CYSLTR1|0:ENPEP|0:TACSTD2|0:ABCC5|0:PTPRG|0:HRH1|0:NTSR2|0:LRMP|0:P2RX1|0:TM9SF2|0:CASR|0:ICAM3|0:ADAM8|0:GPR32|0:CLEC5A|0:ADRB3|0:CHRM3|0:IGSF6|0:SLC4A4|0:IL1R1|0:KTN1|0:ADAM2|0:GPR75|0:IL2RG|0:SLC6A2|0:MUSK|0:CD55|0:SYNGR3|0:CEACAM8|0:TNFSF15|0:GABRR2|0:CD40|0:MAL|0:GPR22|0:CRHR2|0:KIR3DL2|0:SLC12A2|0:TRAT1|0:GP6|0:RHAG|0:MPZL1|0:GUCY2D|0:IL17RB|0:SSTR3|0:MUC4|0:FFAR1|0:TLR3|0:KLRF1|0:MST1R|0:EPHA3|0:B3GNT3|0:LHCGR|0:DSCAM|0:SLC16A6|0:LY75|0:SLC1A1|0:CLEC1A|0:SLC2A4|0:CD96|0:MPP3|0:DDR2|0:HAS1|0:ADCY9|0:ATP2B1|0:BCAM|0:SLC17A3|0:GPR19|0:OXTR|0:CD99|0:IL27RA|0:SMPD2|0:RDH8|0:GRM6|0:SELP|0:TRPA1|0:ATP6V1A|0:FCAR|0:SLCO1B1|0:GPR1|0:GRM1|0:RRH|0:SLC19A1|0:PTGIR|0:ACCN4|0:PCDHB6|0:CCR6|0:PALM|0:LILRB3|0:NPHS2|0:GRID2|0:GABRB3|0:TNFRSF13B|0:IL4R|0:SYPL1|0:GABRG2|0:SEMA4F|0:CD47|0:FXYD1|0:VSIG2|0:CLDN1|0:ABCC1|0:GABBR2|0:FCER1G|0:SCNN1G|0:ENPP3|0:PCDHA6|0:CD1C|0:HPN|0:TPSG1|0:GOLM1|0:EPHA2|0:LCT|0:FOLH1|0:TNFSF10|0:CLPTM1|0:TLR6|0:ADORA2A|0:PTPRB|0:STBD1|0:RAMP1|0:PTK7|0:CLCA2|0:PTCH1|0:TYRO3|0:SLC7A8|0:PRLHR|0:GPR37|0:TNFSF4|0:P2RY6|0:ADRA2B|0:TRPM1|0:HNRNPM|0:AVPR1A|0:CALCRL|0:SCARB2|0:SLC16A3|0:GBAS|0:PCDH8|0:TCIRG1|0:ANPEP|0:PROM1|0:CHRM2|0:PPYR1|0:GABRA4|0:TSPAN9|0:HFE|0:SLC6A9|0:SLC16A8|0:KCNK5|0:LANCL1|0:IL11RA|0:NTRK1|0:KCNK3|0:AQP9|0:SLC15A2|0:STX8|0:C5AR1|0:TNFRSF9|0:NPY6R|0:SLC13A4|0:TSPAN7|0:TACR1|0:EPHA4|0:TPBG|0:CCR3|0:SLC3A1|0:PTPRH|0:CHRM4|0:ART1|0:CD151|0:NPFFR2|0:HRH2|0:ADCY3|0:HPS1|0:TNFRSF1A|0:OPN3|0:AGER|0:GABRE|0:CD83|0:TRPC1|0:PODXL|0:TRHDE|0:NRXN1|0:EBP|0:P2RY4|0:TRPV1|0:GRM3|0:CRHR1|0:SLC10A1|0:MMP14|0:FZD5|0:GPR6|0:SLC24A1|0:MC3R|0:CCRL1|0:FAT1|0:GPC3|0:ST3GAL5|0:IFNAR2|0:P2RY11|0:SLC30A3|0:PROCR|0:PTGER3|0:RYK|0:PKD1|0:RHD|0:SLC16A7|0:SLC25A5|0:SLC40A1|0:FOLR1|0:TBXA2R|0:PCDHB11|0:GPR64|0:EFNB3|0:CNR1|0:GJA4|0:TRPV2|0:P2RX6|0:EFNA1|0:MPP2|0:IFNGR2|0:TRIM27|0:TIE1|0:PCDHAC2|0:GABRA6|0:SIGMAR1|0:ASGR1|0:LPAR2|0:SLC7A2|0:CXCR5|0:FASLG|0:CD163|0:GPR65|0:FUT1|0:BST2|0:GPR183|0:SLC5A6|0:IL12RB2|0:ERBB3|0:SDC1|0:GPR50|0:GABRR1|0:OPN1LW|0:ACVR2B|0:ROM1|0:MMD|0:GPER|0:PCDHA8|0:GP5|0:LPAR1|0:GABRA3|0:APP|0:ATRN|0:MPL|0:CSPG4|0:SLC33A1|0:CXADR|0:SSTR2|0:CLEC1B|0:OR1D4|0:HTR7|0:PCDH7|0:ATP1B4|0:SLC22A6|0:RYR1|0:FGFR3|0:OR1E2|0:GABBR1|0:OPN1MW|0:ABCC2|0:THY1|0:CD200|0:MSR1|0:SLC17A4|0:NPY1R|0:CD79B|0:ENPP2|0:SLC31A2|0:ADRA1D|0:FZD10|0:TMEM5|0:AQP6|0:MRC1|0:RHBDL1|0:TNFRSF25|0:CCR7|0:CCR4|0:GPC4|0:FLT1|0:PCDHA5|0:MPZ|0:TRPC5|0:SLC25A17|0:CLCN1|0:GABRD|0:EVI2B|0:SLC25A11|0:F2R|0:SLC29A1|0:HTR1D|0:GPR17|0:FFAR2|0:SSPN|0:GPR68|0:SLC17A5|0:SYNGR1|0:STEAP1|0:CNPY2|0:CD33|0:JTB|0:CLEC2B|0:MUC1|0:SLC4A3|0:PODXL2|0:SGCB|0:GJA8|0:SLC1A5|0:NKG7|0:SLC2A8|0:KLRK1|0:ZYX|0:CEACAM4|0:SIRPB1|0:NEU3|0:S1PR4|0:MPP1|0:IL15|0:MC1R|0:CD46|0:ADRM1|0:SIGLEC6|0:LTB4R|0:NMUR1|0:KIR2DS4|0:KDR|0:PTPRS|0:PTPRD|0:BACE1|0:ADORA1|0:CD52|0:SLC20A2|0:TPO|0:MC5R|0:MMP17|0:CCR10|0:PTAFR|0:ACCN1|0:MLANA|0:NPY2R|0:SLC5A1|0:VIPR1|0:DDR1|0:ATP2A2|0:FXYD3|0:PTCH2|0:SLMAP|0:FFAR3|0:SLC12A4|0:P2RX3|0:BDKRB1|0:MMP15|0:HTR3A|0:CHRM1|0:ADRA1A|0:CLCA1|0:HCRTR1|0:IFNAR1|0:CMKLR1|0:MME|0:MFI2|0:CLCNKB|0:ADCYAP1R1|0:RHO|0:CR1|0:SLC12A7|0:HTR1A|0:PCDH12|0:F2RL2|0:LRRC32|0:AXL|0:LRP1|0:NEO1|0:DEGS1|0:SLC16A4|0:MC2R|0:GRPR|0:SLC26A2|0:ATP2B4|0:NUMB|0:ADORA2B|0:GPR109B|0:SLC7A7|0:CLEC2D|0:CD8B|0:SLC2A2|0:ABCB11|0:MARCO|0:IL12RB1|0:CD300C|0:GPR137B|0:LNPEP|0:ATP4A|0:FZD2|0:AQP4|0:FADS2|0:CNGA1|0:PTGFR|0:KLRC2|0:GPR12|0:PCDHA2|0:PCDHA11|0:THBD|0:ABCD2|0:TM7SF2|0:ABCC3|0:EDNRB|0:CD226|0:ROBO1|0:CCRL2|0:NPY5R|0:PDPN|0:CCR8|0:CNR2|0:PCDH1|0:HRH3|0:CCR1|0:PTPRN2|0:IL9R|0:HTR6|0:GPR34|0:SLC20A1|0:EFNB2|0:AQP1|0:COL17A1|0:IFNGR1|0:SLC29A2|0:SIGLEC7|0:PTH1R|0:SSTR5|0:ICAM5|0:SLC7A6|0:CEACAM6|0:CHRM5|0:FGFR1|0:CLCNKA|0:CSF3R|0:GPC5|0:TLR1|0:TSPAN13|0:MS4A2|0:KL|0:EDNRA|0:OPRK1|0:PLA2R1|0:PRRG1|0:TNFSF12|0:ACVR2A|0:NGFR|0:AQP8|0:HTR1E|0:RHCE|0:HAS2|0:HTR5A|0:EPHB3|0:RAMP3|0:TNFRSF10C|0:GAL3ST1|0:FGFR4|0:TMPRSS11D|0:SLC5A3|0:TSPAN31|0:GABRA1|0:HAS3|0:SLC1A6|0:SLC22A7|0:CXCR3|0:LYVE1|0:TAAR5|0:SELPLG|0:OPCML|0:CSPG5|0:PTPRN|0:CD70|0:PCDHB12|0:SLC7A1|0:STX1B|0:IGF2R|0:TSPAN4|0:LTK|0:OR3A2|0:TSHR|0:MEP1B|0:S1PR3|0:SLC17A1|0:SLCO1B3|0:GPR3|0:KIR2DS3|0:CLDN4|0:GRM8|0:PCDHA4|0:PIGR|0:HTR3B|0:P2RY1|0:PCDHB2|0:PCDHB4|0:MCHR1|0:ACCN2|0:OPRL1|0:IL1RAP|0:GPR44|0:TFRC|0:AVPR2|0:SLC10A2|0:VIPR2|0:GPR31|0:TYROBP|0:CLCA4|0:HTR1F|0:SLC28A2|0:KIR2DL3|0:GP9|0:GPR4|0:CLCN5|0:FLT3|0:SLC18A2|0:CCKAR|0:PTH2R|0:BFAR|0:PRKD1|0:ICAM1|0:CD19|0:SSTR1|0:OPRM1|0:AQP5|0:LY6E|0:CCR5|0:CSF2RA|0:F2RL3|0:CD69|0:GPA33|0:TM4SF5|0:PCDHB15|0:NMBR|0:SLC25A3|0:NTSR1|0:MET|0:SLC25A14|0:LPAR4|0:EFNB1|0:SLC8A1|0:SLC6A7|0:SLC16A5|0:HCRTR2|0:CD6|0:ECEL1|0:PTGER1|0:OLR1|0:SLC16A2|0:ICAM2|0:KIR2DL1|0:APOM|0:SLC22A3|0:SCTR|0:GPR21|0:SLC12A3|0:CEACAM5|0:TRHR|0:HS6ST1|0:TNFSF8|0:GPR56|0:PHEX|0:TACR3|0:GABRA5|0:PTPRJ|0:CXCR6|0:CX3CR1|0:BPI|0:ROR1|0:FLT4|0:PTPRZ1|0:LAMP1|0:CCR9|0:SLC18A3|0:MERTK|0:SYNGR2|0:SLC22A8|0:SLC13A2|0:GABRB2|0:GPR176|0:P2RY2|0:GPRC5A|0:CD97|0:NINJ2|0:KCNJ10|0:SLC28A1|0:MTNR1A|0:EPOR|0:XPR1|0:OPN1SW|0:PCDHA10|0:TSPAN15|0:MS4A1|0:BTN1A1|0:GRIK1|0:GPR42|0:SLC7A9|0:GRM5|0:OPRD1|0:CD63|0:GYPB|0:ABCB4|0:CD48|0:ST14|0:SLC39A2|0:PTPRO|0:OPN1MW2|0:PCDHA1|0:EFNA3|0:CLEC4A|0:SGCE|0:GPC6|0:CSF1R|0:SSTR4|0:CD40LG|0:GPC1|0:KCNJ2|0:LILRB2|0:BTN2A1|0:MTNR1B|0:SPN|0:PCDHAC1|0:AVPR1B|0:SLCO2A1|0:KIR2DL4|0:NPHS1|0:GABRQ|0:GPRC5C|0:KLRC1|0:IL1RL2|0:ADRB1|0:CYB561|0:BAI1|0:MIP|0:UPK2|0:TRPM2|0:PCDH11X|0:MEP1A|0:PCDHA7|0:EPHB1|0:HS3ST3B1|0:PTPRF|0:CTLA4|0:NCKAP1L|0:ADORA3|0:TMBIM6|0:GUCY2F|0:ENTPD1|0:GPR25|0:NRXN3|0:HTR2A|0:TLR2|0:ACCN3|0:EPHB4|0:VAMP2|0:SLC22A4|0:FLVCR1|0:CCBP2|0:SLC23A2|0:VAMP1|0:C3AR1|0:EFNA4|0:BDKRB2|0:DCLK1|0:TRO|0:GPR52|0:GYPE|0:APLNR|0:CACNG4|0:OR1D2|0:TNFRSF4|0:GABRB1|0:P2RX5|0:LTB4R2|0:NCR3|0:CCR2|0:FCER1A|0:ADRA1B|0:OR10J1|0:RGR|0:NTRK3|0:M6PR|0:TMPRSS2|0:EPHA1|0:HTR1B|0:CAPRIN1|0:SLC15A1|0:LIFR|0:HOMER1|0:PRRG2|0:RCE1|0:PTPRA|0:SLC17A2|0:PCDHA3|0:PCDHB3|0:FCER2|0:LAPTM5|0:ART3|0:MLNR|0:RAMP2|0:SLC14A1|0:KCNJ15|0:GPR39|0:IL2RB|0:GPR15|0:AQP7|0:ATP7B|0:CD28|0:HBEGF|0:CXCR2|0:EREG|0:SLC43A1|0:SLC22A1|0:GJD3|0:GNRHR|0:TRPV6|0:FRS2|0:SLC30A5|0:CD1D|0:GJA1|0:CELSR1|0:NOTCH4			
GO:0008705	F:methionine synthase activity; EXP:Reactome		0:MTR			
GO:0021999	P:neural plate anterior/posterior regionaliza...; ISS:BHF-UCL		0:CELSR2			
GO:0032023	P:trypsinogen activation; ISS:UniProtKB		0:CUZD1			
GO:0030688	C:preribosome, small subunit precursor; ISS:UniProtKB		0:RRP1B|0:RRP1|0:UTP20			
GO:0018675	F:(S)-limonene 6-monooxygenase activity; IEA:EC		0:CYP2C19|0:CYP2C9			
GO:0034360	C:chylomicron remnant; TAS:BHF-UCL		0:APOB			
GO:0006746	P:FADH2 metabolic process; NAS:UniProtKB		0:NOX1			
GO:0019858	P:cytosine metabolic process; TAS:UniProtKB		0:CDA			
GO:0031770	F:growth hormone-releasing hormone receptor b...; IPI:BHF-UCL		0:GHRH			
GO:0033673	P:negative regulation of kinase activity; ISS:BHF-UCL		0:PRDX3|0:CDKN1C|0:NPRL2|0:CDKN1B|0:IRS2			
GO:0008379	F:thioredoxin peroxidase activity; TAS:ProtInc		0:PRDX1|0:PRDX2|0:PRDX4			
GO:0000155	F:two-component sensor activity; IEA:InterPro		0:PDK3|0:BCKDK|0:KCNH4|0:KCNH3|0:PDK4|0:CNTLN|0:KCNH2|0:PDK1|0:KCNH1|0:CASS4|0:PDK2|0:KCNH8|0:KCNH5			
GO:0032804	P:negative regulation of low-density lipoprot...; IDA:HGNC		0:FURIN			
GO:0008768	F:UDP-sugar diphosphatase activity; IEA:EC		0:NUDT14			
GO:0007519	P:skeletal muscle tissue development; TAS:UniProtKB		0:SKIL|0:TAZ|0:SVIL|0:MYLPF|0:CAV1|0:ZNF238|0:SIX1|0:IGSF8|0:MYL6B|0:CSRP3|0:MYF5|0:MYOD1|0:MYF6|0:MYL6			
GO:0050851	P:antigen receptor-mediated signaling pathway; TAS:UniProtKB		0:SPG21|0:SLA2			
GO:0030324	P:lung development; ISS:UniProtKB		0:PROX1|0:RBP4|0:GLI2			
GO:0031526	C:brush border membrane; NAS:UniProtKB		0:SLC22A5|0:ATP6V0A4|0:B4GALT1|0:AQP1|0:PDZK1|0:SLC34A2|0:ITLN1|0:PEX19|0:CUBN|0:SLC22A12|0:SLC34A1			
GO:0000354	P:cis assembly of pre-catalytic spliceosome; IC:HGNC		0:SNRNP200|0:DDX23			
GO:0000966	P:RNA 5'-end processing; ISS:UniProtKB		0:PIWIL2			
GO:0004530	F:deoxyribonuclease I activity; IEA:EC		0:DNASE1			
GO:0007216	P:metabotropic glutamate receptor signaling p...; TAS:ProtInc		0:GRM6|0:HOMER3|0:HOMER2			
GO:0007406	P:negative regulation of neuroblast prolifera...; ISS:HGNC		0:NF1			
GO:0010700	P:negative regulation of norepinephrine secre...; TAS:BHF-UCL		0:ADRA2B|0:ADRA2C|0:ADRA2A			
GO:0072097	P:negative regulation of branch elongation in...; IDA:UniProtKB		0:BMP4			
GO:0042643	C:actomyosin, actin part; IDA:UniProtKB		0:ACTC1			
GO:0008426	F:protein kinase C inhibitor activity; TAS:ProtInc		0:YWHAG|0:SFN			
GO:0071318	P:cellular response to ATP; IDA:MGI		0:SSH1|0:HSP90B1|0:PDXP			
GO:0034747	C:Axin-APC-beta-catenin-GSK3B complex; NAS:BHF-UCL		0:CTNNBIP1|0:GSK3B|0:AXIN1|0:CTNNB1|0:APC|0:AXIN2			
GO:0008853	F:exodeoxyribonuclease III activity; IEA:EC		0:RAD9A|0:TREX1|0:RAD1|0:TREX2			
GO:0004058	F:aromatic-L-amino-acid decarboxylase activity; IDA:UniProtKB		0:DDC			
GO:0051123	P:RNA polymerase II transcriptional preinitia...; ISS:BHF-UCL		0:GTF2A2|0:TAF1			
GO:0006880	P:intracellular sequestering of iron ion; TAS:ProtInc		0:FTH1|0:SRI			
GO:0030424	C:axon; TAS:BHF-UCL		0:NF1|0:SNCA|0:PPT1|0:GHRL|0:MAPT|0:LRRTM1|0:KLHL24|0:OPHN1|0:STMN2|0:KIAA1598|0:LRFN3|0:ATL1|0:SEPT11|0:NGDN|0:FKBP15|0:C19orf20|0:AMIGO1|0:UHMK1|0:DRD2|0:DSCAM|0:CTNNA2|0:IGHMBP2|0:CDK5R1|0:APP|0:GRM7|0:CDK5|0:TGFB2|0:SRCIN1|0:RNF6|0:CNTN4|0:SEMA6A|0:DOCK7|0:SACS			
GO:0006397	P:mRNA processing; TAS:UniProtKB		0:NUDT21|0:CPSF6|0:ROD1|0:ERN1|0:RBM27|0:ERN2|0:RNASEL|0:RBM26|0:RBM23|0:HNRNPL|0:HNRPLL|0:PDCD11|0:XAB2|0:PPIL1|0:THOC7|0:PLRG1|0:TSEN54|0:HNRNPH1|0:RBM4B|0:RBMY1A1|0:RBM16|0:SKIV2L2|0:CWC22|0:RBMY1E|0:ADAR|0:PPP4R2|0:AQR|0:AKAP17A|0:SRSF8|0:APOBEC1|0:RBM22|0:PTBP2|0:CDC5L|0:TFIP11|0:ZMAT5|0:DHX16|0:RBM38|0:PRPF39|0:ADARB1|0:FRG1|0:TXNL4B|0:RBM28|0:APOBEC4|0:CPSF7|0:THOC1|0:C19orf29|0:RBMY1J|0:STRAP|0:PRPF38B|0:SREK1IP1|0:LSM6|0:WTAP|0:DDX41|0:DDX5|0:SRPK1|0:RBM10|0:MAGOHB|0:SF3B5|0:CDC40|0:PABPN1|0:PAPOLG|0:SYF2|0:DGCR14|0:MAGOH|0:MBNL2|0:CSTF2T|0:HNRNPF|0:THOC6|0:CPSF4|0:SREK1|0:PPIE|0:DHX35|0:PUF60|0:NHP2L1|0:WBP11|0:BCAS2|0:RBMY1D|0:HNRPA1L3|0:SYNCRIP|0:RBFOX2|0:LUC7L3|0:RBM39|0:PRPF40B|0:CLASRP|0:ADARB2|0:AICDA|0:SUGP1|0:JMJD6|0:TSEN2|0:SYMPK|0:SNRNP27|0:PPWD1|0:QKI|0:EIF4A3|0:HNRNPK|0:TARDBP|0:MBNL3|0:THOC5|0:TTF2|0:PPP1R8|0:PRPF40A|0:SUGP2|0:RBMX|0:RBM8A|0:RBMY1C|0:PAPOLB|0:A1CF|0:APOBEC2|0:PAPD4|0:RNPC3|0:PPIL3|0:DHX8|0:CELF2|0:SNRNP35|0:RNPS1|0:RBM15B|0:RBM25|0:SRRM2|0:RBM4|0:TSEN15|0:CELF6|0:LSM10|0:DDX46|0:THOC3|0:AFF2|0:FIP1L1|0:U2AF1L4|0:ZCCHC8|0:HNRNPA3|0:SCNM1|0:RBM17|0:SSU72|0:XRN2|0:LSM4|0:CELF5|0:SNRNP48|0:SRSF3|0:KIAA1429|0:YBX1|0:ESRP1|0:SCAF1|0:HNRNPU|0:RALY|0:RBMY1F|0:NOL3|0:PRPF4B|0:ZRANB2|0:ISY1|0:TSEN34|0:PNN|0:CNOT6L|0:ZCRB1|0:CPEB1|0:ESRP2|0:SRRM1|0:THOC4|0:SNRNP25|0:HNRNPA1L2|0:THOC2|0:CASC3|0:CIR1|0:MTPAP|0:PRPF38A|0:RBMY1B|0:SNRNP40|0:SRRM4|0:NONO|0:EFTUD2|0:LSM5|0:HNRNPR|0:SMNDC1|0:SRSF2|0:LSM1|0:PTBP1|0:KHSRP|0:KHDRBS1|0:DHX15|0:ELAVL4|0:PRPF18|0:SF3B3|0:SRSF11|0:SRSF4|0:HNRNPA0|0:SRSF7|0:SPOP|0:PPARGC1A|0:KIN|0:LSM3			
GO:0016070	P:RNA metabolic process; NAS:UniProtKB		0:NOM1|0:EIF4G2|0:EIF4G3|0:MIF4GD|0:AKAP7|0:LENG9|0:EIF4G1|0:CNP|0:ATXN2|0:DDX24			
GO:0004113	F:2',3'-cyclic-nucleotide 3'-phosphodiesteras...; TAS:ProtInc		0:CNP			
GO:0004712	F:protein serine/threonine/tyrosine kinase ac...; ISS:UniProtKB		0:RELN			
GO:0005224	F:ATP-binding and phosphorylation-dependent c...; TAS:ProtInc		0:CFTR			
GO:0006256	P:UDP catabolic process; IDA:UniProtKB		0:ENTPD4			
GO:0006298	P:mismatch repair; TAS:ProtInc		0:PCNA|0:PMS2|0:MSH2|0:EXO1|0:PMS2L2|0:TDG|0:MSH4|0:PMS2L12|0:PMS2L1|0:PMS2L11|0:PMS2L5|0:MSH3|0:POLD3|0:MLH3|0:TREX1|0:ABL1|0:MSH5|0:TP73|0:PMS1|0:MUTYH|0:MLH1			
GO:0008193	F:tRNA guanylyltransferase activity; TAS:ProtInc		0:THG1L|0:USP14			
GO:0030234	F:enzyme regulator activity; NAS:UniProtKB		0:BRCC3|0:PSMD3|0:SLN|0:PSMD1|0:RGN|0:PSMD2|0:CPN2|0:ATP6V1H			
GO:0047325	F:inositol tetrakisphosphate 1-kinase activity; IEA:EC		0:ITPK1			
GO:0044212	F:transcription regulatory region DNA binding; IDA:UniProtKB		0:LEF1|0:CALCOCO1			
GO:0043507	P:positive regulation of JUN kinase activity; NAS:UniProtKB		0:TLR9|0:EDN1|0:TLR6|0:MAP3K7|0:TRAF2|0:TNFRSF11A|0:FZD10|0:DVL3|0:DVL2|0:PAK1|0:MAP3K4|0:TRAF6			
GO:0070702	C:inner mucus layer; ISS:UniProtKB		0:MUC2			
GO:0007568	P:aging; TAS:ProtInc		0:KL|0:ADRA1A|0:TPRA1|0:LOXL2			
GO:0033617	P:mitochondrial respiratory chain complex IV ...; IMP:UniProtKB		0:BCS1L			
GO:0008460	F:dTDP-glucose 4,6-dehydratase activity; IEA:EC		0:TGDS			
GO:0003943	F:N-acetylgalactosamine-4-sulfatase activity; TAS:ProtInc		0:ARSB|0:GALNS			
GO:0060084	P:synaptic transmission involved in micturition; ISS:UniProtKB		0:CHRNA3|0:CHRNB4|0:CHRNB2			
GO:0034198	P:cellular response to amino acid starvation; IDA:UniProtKB		0:DAP			
GO:0016323	C:basolateral plasma membrane; TAS:HGNC		0:EGFR|0:ERBB4|0:TRPC4|0:ERBB3|0:TLR9|0:CAV1|0:STX2|0:STX4|0:CLDN19|0:EPCAM|0:TJP1|0:TEK|0:NOD1|0:ANK3|0:DLG1|0:PDZD11|0:RHCG|0:ANK2|0:MLC1|0:SLC22A6|0:B4GALT1|0:FRMPD2|0:RHBG|0:CEACAM5|0:SLC22A8|0:SLC4A1|0:ATP7A|0:BEST1|0:CHRM3|0:SLC4A4|0:SLCO1B1|0:OTOF|0:AQP3|0:SLC7A8|0:LIN7B|0:SLC9A4|0:SLC22A1|0:LIN7A|0:SLC4A7|0:CXADR|0:ANXA1|0:SLC39A5|0:MEGF11|0:SLC7A7|0:MAP4K2|0:LIN7C|0:SLC7A6|0:AJAP1|0:SLC22A7|0:IL6R|0:MEGF10|0:MAP7|0:PROM2|0:CD300LG|0:SLCO4C1|0:SLC26A7|0:BSND|0:CADM1|0:ENPP1|0:ANK1|0:CFTR|0:ADRA2A|0:SLC16A10|0:SLC4A11			
GO:0008057	P:eye pigment granule organization; ISS:HGNC		0:SHROOM2			
GO:0061101	P:neuroendocrine cell differentiation; IMP:UniProtKB		0:WNT11			
GO:0019028	C:viral capsid; IEA:InterPro		0:ERV3|0:ERVWE1|0:ERVK5			
GO:0030863	C:cortical cytoskeleton; TAS:HGNC		0:SELE|0:GYPC|0:DLG4|0:TRPC4|0:SLC4A1|0:EZR			
GO:0033735	F:aspartate dehydrogenase activity; IEA:EC		0:ASPDH			
GO:0035516	F:oxidative DNA demethylase activity; IDA:UniProtKB		0:FTO			
GO:0016817	F:hydrolase activity, acting on acid anhydrides; IEA:InterPro		0:IRGM|0:IRGC			
GO:0031000	P:response to caffeine; ISS:BHF-UCL		0:RYR2|0:RYR1			
GO:0008016	P:regulation of heart contraction; TAS:UniProtKB		0:KCNE1|0:KCNQ1|0:DMPK|0:TNNT2|0:TH|0:S100A1|0:CACNA1H|0:KCNJ12|0:KCNE1L|0:CHRM2|0:SCN5A|0:DES|0:CELF2|0:HSPB7|0:KCNH2|0:KCNG2|0:KCNE2|0:ADORA3|0:SRI|0:CYP2J2|0:KCNIP2			
GO:0042168	P:heme metabolic process; ISS:UniProtKB		0:BDH2			
GO:0032465	P:regulation of cytokinesis; IMP:UniProtKB		0:BBS4|0:CALM2|0:CALM3|0:CETN2|0:CALM1			
GO:0032835	P:glomerulus development; IMP:HGNC		0:PLCE1			
GO:0006342	P:chromatin silencing; TAS:ProtInc		0:HILS1|0:SIRT6|0:SIRT3|0:SIRT7|0:TNP1|0:HDAC5|0:SIRT4|0:SIRT5			
GO:0034725	P:DNA replication-dependent nucleosome disass...; IMP:BHF-UCL		0:BAZ1B			
GO:0048013	P:ephrin receptor signaling pathway; IDA:MGI		0:EFNB3			
GO:0007398	P:ectoderm development; TAS:UniProtKB		0:KRT6A|0:STX2|0:VAX2|0:KRT6B|0:ZBTB7B|0:TFAP2A|0:SMURF1			
GO:0002077	P:acrosome matrix dispersal; NAS:UniProtKB		0:ACR			
GO:0004326	F:tetrahydrofolylpolyglutamate synthase activity; TAS:ProtInc		0:FPGS			
GO:0032980	P:keratinocyte activation; IDA:UniProtKB		0:KRT2			
GO:0032154	C:cleavage furrow; ISS:UniProtKB		0:RAB11A|0:MEN1|0:RAB11FIP4|0:MYH9|0:MYH10|0:RAB11FIP3|0:RALA|0:SEPT12			
GO:0005590	C:collagen type VII; TAS:ProtInc		0:COL7A1			
GO:0060047	P:heart contraction; ISS:BHF-UCL		0:SOD1|0:GPX1|0:MYL2			
GO:0009987	P:cellular process; IEA:InterPro		0:XPNPEP3|0:XPNPEP2			
GO:0070172	P:positive regulation of tooth mineralization; TAS:BHF-UCL		0:TFAP2A|0:WNT6|0:AMELX			
GO:0004365	F:glyceraldehyde-3-phosphate dehydrogenase (p...; TAS:UniProtKB		0:GAPDH|0:GAPDHS			
GO:0010494	C:stress granule; ISS:UniProtKB		0:MBNL1|0:IGF2BP1|0:ATXN2|0:DDX6|0:DDX1|0:YBX1|0:LIN28A|0:LSM14A|0:CIRBP			
GO:0043271	P:negative regulation of ion transport; ISS:UniProtKB		0:PXK			
GO:0046628	P:positive regulation of insulin receptor sig...; ISS:BHF-UCL		0:INS|0:IGF2|0:IRS1			
GO:0043539	F:protein serine/threonine kinase activator a...; IDA:UniProtKB		0:STK3|0:STK4|0:ALS2			
GO:0000717	P:nucleotide-excision repair, DNA duplex unwi...; IMP:UniProtKB		0:ERCC3			
GO:0015827	P:tryptophan transport; ISS:UniProtKB		0:SLC3A2			
GO:0007195	P:inhibition of adenylate cyclase activity by...; IMP:BHF-UCL		0:DRD3|0:DRD4|0:DRD2|0:FLNA			
GO:0004537	F:caspase-activated deoxyribonuclease activity; TAS:ProtInc		0:DFFB|0:DFFA			
GO:0017168	F:5-oxoprolinase (ATP-hydrolyzing) activity; IEA:EC		0:OPLAH			
GO:0050869	P:negative regulation of B cell activation; TAS:UniProtKB		0:FOXJ1|0:SLA2			
GO:0032735	P:positive regulation of interleukin-12 produ...; ISS:BHF-UCL		0:HSPD1|0:IFNG|0:CD40LG|0:TLR3|0:TLR4|0:TLR9|0:TLR2			
GO:0070208	P:protein heterotrimerization; IPI:UniProtKB		0:SKI|0:SKIL			
GO:0021819	P:layer formation in the cerebral cortex; ISS:BHF-UCL		0:PAFAH1B1			
GO:0005302	F:L-tyrosine transmembrane transporter activity; TAS:ProtInc		0:OCA2			
GO:0016290	F:palmitoyl-CoA hydrolase activity; IEA:EC		0:PPT1|0:ACOT2|0:ACOT7|0:BAAT|0:ACOT4|0:ACOT1			
GO:0030976	F:thiamin pyrophosphate binding; IEA:InterPro		0:HACL1|0:ILVBL|0:OGDHL|0:OGDH|0:DHTKD1			
GO:0015651	F:quaternary ammonium group transmembrane tra...; IDA:MGI		0:SLC22A3			
GO:0004638	F:phosphoribosylaminoimidazole carboxylase ac...; IEA:EC		0:PAICS			
GO:0004351	F:glutamate decarboxylase activity; IEA:EC		0:GAD1|0:GLUL|0:GAD2			
GO:0006388	P:tRNA splicing, via endonucleolytic cleavage...; IDA:UniProtKB		0:TSEN54|0:TSEN2|0:CLP1			
GO:0003834	F:beta-carotene 15,15'-monooxygenase activity; IDA:UniProtKB		0:BCMO1			
GO:0060155	P:platelet dense granule organization; NAS:UniProtKB		0:F2R|0:F2RL3|0:ABCA1|0:BLOC1S3|0:BLOC1S1|0:BLOC1S2			
GO:0032313	P:regulation of Rab GTPase activity; ISS:UniProtKB		0:USP6NL|0:TBC1D3B|0:SGSM3|0:TBC1D3G|0:TBC1D22A|0:TBC1D8B|0:TBC1D19|0:TBC1D12|0:TBC1D26|0:TBC1D3F|0:TBCK|0:GRTP1|0:TBC1D3C|0:TBC1D4|0:WDR67|0:TBC1D29|0:TBC1D9|0:TBC1D3H|0:C6orf170|0:TBC1D3|0:TBC1D16|0:TBC1D23|0:TBC1D27|0:TBC1D2B|0:TBC1D20|0:USP6|0:TBC1D30|0:TBC1D2|0:TBC1D8|0:TBC1D10A|0:RABGAP1L|0:EVI5L|0:TBC1D13|0:SGSM2|0:TBC1D17|0:TBC1D24|0:TBC1D1|0:TBC1D7|0:TBC1D14|0:EVI5|0:SGSM1|0:TBC1D10C|0:TBC1D5|0:RABGAP1|0:TBC1D25|0:TBC1D9B|0:TBC1D21|0:TBC1D22B|0:TBC1D28|0:TBC1D10B|0:TBC1D15			
GO:0005578	C:proteinaceous extracellular matrix; TAS:UniProtKB		0:SFRP1|0:AMELX|0:ADAMTS9|0:LTBP4|0:ASPN|0:TIMP4|0:ADAMTSL2|0:GPC3|0:TIMP1|0:GPC4|0:ADAMTSL5|0:NTNG2|0:GPC5|0:NTNG1|0:GPC6|0:GPC1|0:GPC2|0:PAPLN|0:MMP2|0:MMP7|0:MMP16|0:EMILIN1|0:WNT10B|0:CRTAP|0:MMP24|0:FBLN7|0:MMP13|0:LEPRE1|0:SPON1|0:ADAMTS20|0:FREM3|0:WNT2B|0:AMELY|0:UCMA|0:WNT8B|0:WNT3|0:MMP20|0:SFTPD|0:ACAN|0:WNT1|0:ANGPTL4|0:WNT11|0:EMILIN2|0:ZP4|0:RPTN|0:PODN|0:PXDN|0:OMD|0:WNT6|0:COCH|0:ADAMTS17|0:MMP1|0:WNT16|0:ADAMTS12|0:MMP3|0:EMID2|0:OGN|0:DCN|0:ADAMTSL1|0:ADAMTS19|0:CHL1|0:ADAMTS4|0:DPT|0:SFTPA2|0:WNT5B|0:ADAMTS16|0:WNT3A|0:WNT9A|0:WNT2|0:LGALS1|0:COL21A1|0:ZP1|0:VWF|0:BMP4|0:WNT7A|0:MMP17|0:EMILIN3|0:MMP9|0:HAPLN4|0:OTOA|0:SFTPA1|0:CHADL|0:WNT7B|0:NTN3|0:ADAMTS7|0:SERPINA1|0:EMID1|0:PRSS36|0:THSD4|0:TNR|0:SPOCK1|0:TECTA|0:MMP27|0:FBN3|0:CPZ|0:MMP12|0:ADAMTS15|0:ZP2|0:COL22A1|0:CILP|0:BCAN|0:NYX|0:HAPLN2|0:ADAMTS10|0:TGFBI|0:COL6A6|0:GFOD2|0:NPNT|0:ADAMTS6|0:MMP8|0:TECTB|0:ADAMTS8|0:EPYC|0:SPOCK3|0:LGALS3BP|0:ADAMTS14|0:ZP3|0:PODNL1|0:SPARCL1|0:SPON2|0:CRTAC1|0:WNT4|0:CTHRC1|0:WNT9B|0:RELN|0:ADAMTSL3|0:ADAMTS2|0:VIT|0:WNT5A|0:CILP2|0:COL6A5|0:HAPLN3|0:ADAMTS18|0:CALR|0:WNT10A|0:TNN|0:WNT8A|0:POSTN|0:TGFB1|0:MUC4|0:FLRT2|0:MATN2|0:MMP23B|0:AMBN|0:ECM1|0:FLRT1|0:TNXB|0:BGN|0:MMP25|0:MMP26|0:COL6A2|0:ELN|0:KERA|0:SPOCK2|0:FN1|0:FLRT3|0:ADAMTS3|0:ENAM|0:MMP23A|0:CRISP3|0:LTBP1|0:MMP19|0:MMP28|0:COMP|0:LTBP2|0:DGCR6|0:ADAMTS5|0:PI3|0:EFEMP1|0:FBN2|0:MGP|0:FBLN2|0:MATN3|0:CTGF|0:DSPP|0:HAPLN1|0:CHI3L1|0:MMP10|0:OPTC|0:MEPE|0:TFPI2|0:FBLN5|0:MMP11|0:KAL1|0:VCAN|0:MATN1|0:IMPG1|0:DMP1|0:FMOD|0:PRELP|0:FBLN1|0:CHAD|0:ADAMTS13|0:IMPG2|0:CD248			
GO:0032473	C:external side of mitochondrial outer membrane; IDA:UniProtKB		0:LRRK2			
GO:0008415	F:acyltransferase activity; IEA:UniProtKB-KW		0:TMEM68|0:PDHX|0:GGT3P|0:ZDHHC6|0:ZDHHC22|0:ZDHHC3|0:TGM4|0:MBOAT7|0:GGT5|0:TGM3|0:ZDHHC11|0:GGT1|0:A2LD1|0:ZDHHC23|0:PORCN|0:TGM7|0:LIPT1|0:F13A1|0:ZDHHC12|0:ZDHHC19|0:QPCT|0:ZDHHC5|0:ZDHHC16|0:ZDHHC24|0:ZDHHC9|0:ATE1|0:ZDHHC11B|0:ZDHHC20|0:LPCAT4|0:ZDHHC4|0:GGT7|0:TGM6|0:ESCO2|0:DGAT2L6|0:MBOAT1|0:QPCTL|0:HHAT|0:TGM1|0:ZDHHC8|0:GGT6|0:ZDHHC7|0:ZDHHC21|0:DBT|0:ZDHHC14|0:GGT2|0:ESCO1|0:GGCT|0:TGM2|0:LPGAT1|0:TGM5			
GO:0032470	P:elevation of endoplasmic reticulum calcium ...; IMP:BHF-UCL		0:ATP2A1			
GO:0032331	P:negative regulation of chondrocyte differen...; ISS:BHF-UCL		0:PTHLH|0:WNT9A			
GO:0004814	F:arginine-tRNA ligase activity; IEA:InterPro		0:RARS|0:RARS2|0:DALRD3			
GO:0005262	F:calcium channel activity; TAS:ProtInc		0:TRPV6|0:TRPV4|0:TPCN1|0:TRPV3|0:TRPV2|0:CACNA2D4|0:CLCA3P|0:CATSPER3|0:CHRNA9|0:CHRNA10|0:TRPM3|0:TRPC7|0:TPCN2|0:CATSPER2|0:CATSPER4|0:TRPM6|0:CALHM1|0:TMEM37|0:CACNA2D2|0:TRPM7|0:HTR2B|0:PSEN1|0:TRPV5|0:TRPM1|0:TRPV1|0:MS4A2|0:CUL5|0:TRPM2			
GO:0006012	P:galactose metabolic process; TAS:ProtInc		0:CHST1|0:GALK2|0:GALK1|0:GALT|0:SLC35A2			
GO:0051586	P:positive regulation of dopamine uptake; ISS:BHF-UCL		0:DRD4|0:DRD2			
GO:0046943	F:carboxylic acid transmembrane transporter a...; TAS:UniProtKB		0:AQP9			
GO:0051537	F:2 iron, 2 sulfur cluster binding; ISS:UniProtKB		0:FXN|0:XDH|0:CISD2|0:CMAH|0:AOX1|0:GLRX5|0:CISD1|0:NDUFV2|0:GLRX2|0:FDX1L|0:FDX1|0:FECH|0:AIFM3|0:CISD3|0:NDUFS1|0:UQCRFS1|0:RFESD|0:UQCRFSL1|0:SDHB			
GO:0048617	P:embryonic foregut morphogenesis; ISS:BHF-UCL		0:GATA4			
GO:0048008	P:platelet-derived growth factor receptor sig...; ISS:UniProtKB		0:PDGFA|0:VEGFA|0:PDGFB|0:PDGFC|0:BCAR1			
GO:0015961	P:diadenosine polyphosphate catabolic process; TAS:ProtInc		0:NUDT3			
GO:0060311	P:negative regulation of elastin catabolic pr...; IMP:BHF-UCL		0:CST3			
GO:0034453	P:microtubule anchoring; ISS:BHF-UCL		0:C16orf63|0:FGFR1OP|0:DAG1|0:KIAA1543|0:HOOK3|0:PCM1			
GO:0002575	P:basophil chemotaxis; IDA:UniProtKB		0:VEGFA			
GO:0031848	P:protection from non-homologous end joining ...; ISS:BHF-UCL		0:TERF2|0:TERF2IP|0:DCLRE1B|0:ACD			
GO:0008831	F:dTDP-4-dehydrorhamnose reductase activity; IEA:InterPro		0:MAT2B			
GO:0070905	F:serine binding; IDA:UniProtKB		0:GRM7			
GO:0042593	P:glucose homeostasis; TAS:BHF-UCL		0:SLC2A4|0:RBP4|0:TCF7L2|0:SLC37A4|0:PPARG|0:WFS1|0:INS|0:INSR|0:ADRA2A|0:PYGL|0:RFX6|0:HNF1A|0:G6PC|0:GCK|0:PCK1|0:ADIPOQ|0:NEUROD1|0:MLXIPL|0:STAT3|0:CYB5R4|0:RPS6|0:IRS1|0:CYP11B1|0:USF1			
GO:0048407	F:platelet-derived growth factor binding; IPI:BHF-UCL		0:COL2A1|0:COL1A2|0:COL5A1|0:COL1A1|0:COL3A1|0:COL6A1|0:COL4A1|0:PDGFRA|0:PDGFA|0:PDGFRB|0:PDGFB			
GO:0001640	F:adenylate cyclase inhibiting metabotropic g...; IDA:UniProtKB		0:GRIK3			
GO:0050251	F:retinol isomerase activity; IEA:EC		0:RPE65			
GO:0048604	F:fibroblast growth factor 3 binding; IPI:UniProtKB		0:RPS2			
GO:0008171	F:O-methyltransferase activity; TAS:ProtInc		0:COMTD1|0:COQ3			
GO:0060178	P:regulation of exocyst localization; ISS:UniProtKB		0:RALB			
GO:0007635	P:chemosensory behavior; TAS:ProtInc		0:CASR|0:TRPV1|0:OBP2B|0:TAS2R1|0:TAS2R5			
GO:0060279	P:positive regulation of ovulation; ISS:UniProtKB		0:INHBA|0:INHBB			
GO:0016939	C:kinesin II complex; ISS:UniProtKB		0:KIFAP3			
GO:0033819	F:lipoyl(octanoyl) transferase activity; IEA:EC		0:LIPT2			
GO:0031301	C:integral to organelle membrane; IDA:UniProtKB		0:SLC22A17			
GO:0030276	F:clathrin binding; TAS:UniProtKB		0:HIP1|0:AFTPH|0:NCALD|0:LDLRAP1|0:AP2B1|0:DNER			
GO:0051894	P:positive regulation of focal adhesion assembly; ISS:BHF-UCL		0:KDR|0:TSC1|0:SFRP1			
GO:0051020	F:GTPase binding; IPI:UniProtKB		0:DOCK8|0:DOCK3|0:DOCK2|0:DOCK5|0:DOCK9|0:DOCK11|0:DOCK6|0:DOCK1|0:RASA1			
GO:0005924	C:cell-substrate adherens junction; ISS:UniProtKB		0:CTNNB1|0:NEXN			
GO:0052548	P:regulation of endopeptidase activity; IDA:BHF-UCL		0:NRD1			
GO:0045945	P:positive regulation of transcription from R...; IMP:UniProtKB		0:FOXA3|0:CEBPA|0:CHD8			
GO:0010008	C:endosome membrane; NAS:UniProtKB		0:LDLR|0:TAB2|0:TRAF6|0:TLR8|0:TLR3|0:IRF3|0:TLR9|0:TAB1|0:TBK1|0:MAP3K7|0:APOB|0:IRF7|0:TAB3|0:IKBKE|0:INSR|0:TLR7|0:TICAM1|0:FIG4|0:VAC14|0:WIPI1|0:DTNBP1|0:HLA-DOA|0:SLC48A1|0:TM9SF2|0:SLC30A4|0:SCYL2|0:VPS52|0:PARM1|0:CUBN|0:UBE2D3|0:RHOV|0:LAMP2|0:CD1C|0:SLC6A4|0:STEAP2|0:GGA2|0:ATP6V0A2|0:HLA-DOB|0:SUN2|0:ARF6|0:SORT1|0:GGA1|0:VPS53|0:HLA-DPB1|0:STEAP1|0:CLCN6|0:EHD2|0:CD1B|0:WDR44|0:RAB22A|0:CHMP1A|0:CHMP5|0:AP1G2|0:SNX1|0:NDFIP1|0:PLIN3|0:CD68|0:VPS29|0:HLA-DQA2|0:DIO3|0:VPS26A|0:PRAF2|0:GRB14|0:MARCH2|0:CLCN5|0:SPG21|0:GNPNAT1|0:CD1A|0:VPS25|0:HLA-DQA1|0:TOM1L1|0:USP8|0:LAMP1|0:ZNRF2|0:ABCA7|0:VTA1|0:ARHGAP32|0:RABEPK|0:CD164|0:VPS45|0:CD1D|0:GGA3|0:STEAP3|0:HLA-DQB1|0:LEPROT|0:HLA-DPA1|0:GOLIM4|0:HLA-DQB2|0:ANKFY1|0:SLA2			
GO:0046674	P:induction of retinal programmed cell death; IMP:HGNC		0:BAX			
GO:0015139	F:alpha-ketoglutarate transmembrane transport...; EXP:Reactome		0:SLC25A21			
GO:0043588	P:skin development; NAS:UniProtKB		0:KRT9|0:WNT10A|0:COL5A1|0:COL3A1|0:COL5A2|0:ASPRV1|0:DHCR24|0:ATP7A|0:COL5A3			
GO:0001670	F:dopamine D2 receptor activity; IDA:BHF-UCL		0:DRD2			
GO:0051087	F:chaperone binding; TAS:UniProtKB		0:AHSA1|0:VWF|0:DNAJB6|0:SACS|0:PFDN6|0:GRPEL2|0:GRPEL1|0:HSCB|0:AHSA2|0:PARK2|0:ALB|0:FGB|0:CP|0:BAG5|0:BIRC5|0:TSC1|0:TP53|0:HSPE1|0:HSPD1|0:SOD1|0:CALR|0:HSPA5|0:TBCE|0:TBCA|0:TBCD|0:TBCC|0:PFDN4			
GO:0021575	P:hindbrain morphogenesis; ISS:UniProtKB		0:DLC1			
GO:0015320	F:phosphate carrier activity; TAS:ProtInc		0:SLC25A3			
GO:0048870	P:cell motility; IMP:BHF-UCL		0:SRPX2|0:ETS1			
GO:0004955	F:prostaglandin receptor activity; TAS:BHF-UCL		0:PPARG			
GO:0033342	P:negative regulation of collagen binding; IMP:HGNC		0:GTPBP4			
GO:0009168	P:purine ribonucleoside monophosphate biosynt...; IEA:InterPro		0:PPAT|0:AMPD1|0:AMPD2|0:AMPD3|0:ADA|0:CECR1|0:ADAL			
GO:0042582	C:azurophil granule; IDA:UniProtKB		0:AZU1|0:ANXA11|0:STX3|0:SNAP23|0:STXBP2			
GO:0030145	F:manganese ion binding; TAS:UniProtKB		0:GALNT1|0:GALNT2|0:PCK1|0:GALNT3|0:ABL1|0:ATP2C1|0:WRN|0:DYRK2|0:SOD2|0:PIM1|0:XPNPEP1|0:ABL2|0:ME1|0:XPNPEP3|0:MRE11A|0:PPEF1|0:PPM1B|0:PPM1A|0:DCP2|0:NUDT7|0:PRUNE|0:PPEF2|0:PEPD|0:PPM1M|0:MPPE1|0:LAP3|0:B3GAT3|0:ENDOU			
GO:0051571	P:positive regulation of histone H3-K4 methyl...; IMP:UniProtKB		0:DNMT3B|0:DNMT1			
GO:0051291	P:protein heterooligomerization; ISS:BHF-UCL		0:SEPT7|0:SEPT11|0:SEPT9|0:SCUBE3|0:ITPR3			
GO:0042766	P:nucleosome mobilization; TAS:UniProtKB		0:ARID1A			
GO:0003953	F:NAD+ nucleosidase activity; IEA:EC		0:CD38|0:BST1			
GO:0015271	F:outward rectifier potassium channel activity; NAS:UniProtKB		0:KCNK2			
GO:0050883	P:musculoskeletal movement, spinal reflex action; ISS:BHF-UCL		0:DRD3			
GO:0032375	P:negative regulation of cholesterol transport; IMP:BHF-UCL		0:NFKB1|0:APOC1|0:APOC2			
GO:0032874	P:positive regulation of stress-activated MAP...; IMP:UniProtKB		0:TGFB2|0:CARD9|0:NOD2|0:IL26|0:SEMA4C|0:MID1			
GO:0048040	F:UDP-glucuronate decarboxylase activity; IEA:EC		0:UXS1			
GO:0032050	F:clathrin heavy chain binding; IDA:BHF-UCL		0:PICALM			
GO:0030432	P:peristalsis; ISS:BHF-UCL		0:DRD2			
GO:0004674	F:protein serine/threonine kinase activity; TAS:UniProtKB		0:ATRIP|0:RIPK2|0:RPS6KA1|0:RPS6KA2|0:CHEK1|0:MAP2K1|0:RPS6KA3|0:RIPK1|0:ATR|0:TAOK3|0:UHMK1|0:PAK2|0:STK17A|0:DMPK|0:TSSK1B|0:MAP4K4|0:WNK1|0:ERN1|0:PIM3|0:MKNK2|0:MARK2|0:MARK1|0:BRSK2|0:TSSK4|0:TTN|0:SIK3|0:SRPK1|0:TLK1|0:TSSK6|0:TNIK|0:DYRK2|0:ERN2|0:MAP4K5|0:MARK4|0:AKT1|0:STK38|0:NEK6|0:STK3|0:SIK2|0:SMG1|0:PIM2|0:LMTK2|0:CPNE3|0:RPS6KA5|0:MAP4K2|0:TLK2|0:TAF1|0:LATS1|0:PINK1|0:DAPK3|0:SIK1|0:PIM1|0:CDC42BPG|0:SRPK2|0:STK4|0:OXSR1|0:CDC42BPA|0:TAOK2|0:MAP4K3|0:ILK|0:NEK11|0:LATS2|0:STK17B|0:MKNK1|0:BRSK1|0:SNRK|0:STK11|0:NUAK2|0:TP53RK|0:MTOR|0:STK38L|0:IRAK3|0:WEE1|0:KSR2|0:KSR1|0:CAMKV|0:STK25|0:MAPKAPK3|0:NEK9|0:BMP2K|0:ADCK5|0:ALPK2|0:RIOK3|0:PIK3R4|0:PKMYT1|0:CSNK1G3|0:AURKC|0:STK32C|0:ADCK1|0:ADCK4|0:STK40|0:NUAK1|0:DCLK2|0:DYRK3|0:NEK5|0:SBK1|0:NRK|0:MAST2|0:ALPK3|0:PAK6|0:MAP2K6|0:STK33|0:CSNK1D|0:CSNK1A1|0:LRRK1|0:TNNI3K|0:IRAK4|0:CASK|0:HIPK1|0:PSKH2|0:MELK|0:STK24|0:SPEG|0:PAK4|0:MAP2K3|0:AAK1|0:PASK|0:MAST3|0:NEK1|0:BUB1|0:CDC7|0:HIPK2|0:DCLK3|0:ULK4|0:ADCK2|0:MAP2K7|0:TBK1|0:TTBK2|0:MYLK4|0:CLK4|0:SLK|0:MAP2K4|0:MAST4|0:PAK7|0:YSK4|0:MYO3A|0:ULK3|0:RIOK1|0:RIPK4|0:RPS6KA6|0:AURKB|0:NEK10|0:RPS6KL1|0:CSNK1G1|0:VRK3|0:NEK7|0:TTBK1|0:STK32A|0:STK35|0:LMTK3|0:SBK2|0:TRPM6|0:CSNK2A2|0:ALPK1|0:STK31|0:HIPK4|0:STK32B|0:AKT3|0:WEE2|0:CSNK1A1L|0:MYO3B|0:MASTL|0:PRPF4B|0:PAK3|0:PDIK1L|0:MOS|0:ULK2|0:DAPK1|0:AATK|0:GSG2|0:MARK3|0:AURKA|0:DSTYK|0:TRPM7|0:RIOK2|0:NEK8|0:ANKK1|0:DCLK1|0:RAF1|0:OBSCN|0:DYRK1B|0:MAP2K5|0:BUB1B|0:BCKDK|0:MINK1|0:TSSK3|0:CIT|0:WNK3|0:WNK2|0:HIPK3|0:TSSK2|0:DYRK1A|0:CDC42BPB|0:PLK4|0:WNK4|0:TESK2|0:TAF1L|0:MAST1|0:TAOK1|0:MAP2K2|0:ULK1|0:HSPB8|0:ARAF|0:PSKH1|0:NUP62|0:DYRK4|0:NEK3|0:SRPK3|0:PAK1|0:STK16|0:AKT2|0:BRDT|0:NEK4|0:CLK2|0:HUNK|0:SGK3|0:TTK|0:MAPKAPK2|0:ROCK2|0:STK10|0:BCR|0:CLK1|0:RPS6KC1|0:VRK1|0:SGK2|0:STK19|0:LIMK1|0:RPS6KB2|0:VRK2|0:KALRN|0:NEK2|0:EXOSC10|0:SGK1|0:BRD2|0:PRKY|0:CLK3|0:TESK1|0:GAK|0:TRIO|0:ROCK1|0:MAPKAPK5|0:LGMN|0:CHEK2|0:CSNK1E|0:CSNK2A1|0:PBK|0:LIMK2|0:CSNK1G2|0:STK36			
GO:0032233	P:positive regulation of actin filament bundl...; ISS:UniProtKB		0:LIMK1|0:PLEK|0:SYNPO			
GO:0034651	P:cortisol biosynthetic process; IDA:BHF-UCL		0:CYP11B1			
GO:0030490	P:maturation of SSU-rRNA; ISS:UniProtKB		0:RPS14			
GO:0004074	F:biliverdin reductase activity; IDA:UniProtKB		0:BLVRB|0:BLVRA			
GO:0004052	F:arachidonate 12-lipoxygenase activity; TAS:ProtInc		0:ALOX12|0:ALOX12B			
GO:0001512	F:dihydronicotinamide riboside quinone reduct...; IEA:EC		0:NQO2			
GO:0009348	C:ornithine carbamoyltransferase complex; NAS:UniProtKB		0:OTC			
GO:0035064	F:methylated histone residue binding; ISS:UniProtKB		0:CHD8|0:L3MBTL2|0:CBX5|0:NCAPD3|0:PHF8|0:WDR92|0:JHDM1D|0:PHF2|0:L3MBTL1|0:NCAPG2|0:RRP8|0:RAG2			
GO:0045776	P:negative regulation of blood pressure; ISS:BHF-UCL		0:CALCA|0:DRD3|0:DRD2			
GO:0045947	P:negative regulation of translational initia...; NAS:UniProtKB		0:PAIP2B|0:PAIP2|0:EIF2C2|0:EIF4EBP2|0:FMR1|0:EIF4EBP3|0:EIF3E			
GO:0008188	F:neuropeptide receptor activity; TAS:ProtInc		0:KISS1R|0:NPFFR2|0:NPFFR1|0:SORCS3|0:SORCS2|0:SORCS1|0:MCHR1|0:HCRTR2			
GO:0016415	F:octanoyltransferase activity; IEA:InterPro		0:LIPT2			
GO:0002328	P:pro-B cell differentiation; ISS:UniProtKB		0:SOX4|0:LIG4			
GO:0004161	F:dimethylallyltranstransferase activity; IEA:EC		0:GGPS1|0:FDPS			
GO:0001550	P:ovarian cumulus expansion; ISS:UniProtKB		0:EREG|0:BMPR1B			
GO:0048814	P:regulation of dendrite morphogenesis; ISS:UniProtKB		0:CHRNA3|0:CHRNB2			
GO:0032211	P:negative regulation of telomere maintenance...; IMP:BHF-UCL		0:TERF1|0:TINF2|0:POT1|0:ACD			
GO:0018293	P:protein-FAD linkage; IMP:UniProtKB		0:SDHAF2			
GO:0046655	P:folic acid metabolic process; IDA:UniProtKB		0:SHMT1			
GO:0034339	P:regulation of transcription from RNA polyme...; ISS:BHF-UCL		0:DGKQ|0:PKN1|0:PRKCB|0:KDM1A|0:SIRT1			
GO:0050682	F:AF-2 domain binding; ISS:UniProtKB		0:PPARGC1B|0:NR0B1|0:ESRRG			
GO:0045909	P:positive regulation of vasodilation; NAS:UniProtKB		0:HMOX1|0:NOS1|0:AGTR2|0:CALCA|0:CPS1|0:NOS3|0:EPHX2|0:INS			
GO:0006011	P:UDP-glucose metabolic process; TAS:ProtInc		0:UGP2|0:UGDH			
GO:0060428	P:lung epithelium development; ISS:UniProtKB		0:WNT7B|0:ERRFI1			
GO:0004615	F:phosphomannomutase activity; TAS:ProtInc		0:PMM1|0:PMM2			
GO:0009410	P:response to xenobiotic stimulus; IDA:UniProtKB		0:AHR			
GO:0034553	P:mitochondrial respiratory chain complex II ...; IMP:UniProtKB		0:SDHAF1			
GO:0004345	F:glucose-6-phosphate dehydrogenase activity; TAS:ProtInc		0:G6PD|0:H6PD			
GO:0015222	F:serotonin transmembrane transporter activity; IDA:UniProtKB		0:SLC6A4			
GO:0051908	F:double-stranded DNA specific 5'-3' exodeoxy...; IDA:UniProtKB		0:EXO1			
GO:0034115	P:negative regulation of heterotypic cell-cel...; IDA:BHF-UCL		0:ADIPOQ			
GO:0008409	F:5'-3' exonuclease activity; ISS:UniProtKB		0:DCLRE1C|0:FAN1|0:DCLRE1B|0:FEN1|0:XRN1|0:CPSF3			
GO:0018153	P:isopeptide cross-linking via N6-(L-isogluta...; TAS:UniProtKB		0:IVL			
GO:0033700	P:phospholipid efflux; IMP:BHF-UCL		0:APOA4|0:APOC1|0:APOE|0:APOC3|0:APOA2|0:APOC2|0:APOA1|0:ABCA1|0:ABCG1			
GO:0031427	P:response to methotrexate; IEA:UniProtKB-KW		0:DHFRP1|0:DHFR			
GO:0003870	F:5-aminolevulinate synthase activity; IEA:EC		0:ALAS2|0:ALAS1			
GO:0008628	P:induction of apoptosis by hormones; TAS:UniProtKB		0:PTH|0:SSTR3|0:SST			
GO:0003938	F:IMP dehydrogenase activity; TAS:ProtInc		0:IMPDH1|0:IMPDH2			
GO:0035243	F:protein-arginine omega-N symmetric methyltr...; IMP:UniProtKB		0:PRMT7|0:PRMT5			
GO:0004019	F:adenylosuccinate synthase activity; IDA:UniProtKB		0:ADSSL1|0:ADSS			
GO:0004028	F:3-chloroallyl aldehyde dehydrogenase activity; TAS:ProtInc		0:ALDH1A2|0:ALDH3A2|0:ALDH3B1|0:ALDH3B2			
GO:0001822	P:kidney development; ISS:UniProtKB		0:PROX1|0:PCSK5|0:WFS1|0:ACE|0:AGTR1|0:AGT|0:C1GALT1|0:HNF1B|0:TGFBR1|0:PCSK9|0:GLI2|0:SIX1|0:PKHD1			
GO:0031146	P:SCF-dependent proteasomal ubiquitin-depende...; ISS:UniProtKB		0:SKP1|0:FBXW11|0:FBXL5|0:CCNF|0:RBX1|0:FBXO4|0:FBXW7|0:FBXO31|0:FBXO6|0:CUL1|0:FBXO2			
GO:0004605	F:phosphatidate cytidylyltransferase activity; NAS:UniProtKB		0:CDS1|0:CDS2			
GO:0070072	P:vacuolar proton-transporting V-type ATPase ...; IGI:BHF-UCL		0:VMA21|0:ALDOB			
GO:0051781	P:positive regulation of cell division; ISS:UniProtKB		0:VEGFB|0:FGF4|0:EREG|0:IL1A|0:CAT|0:FGF7|0:MDK|0:OSM|0:VEGFC|0:FGF3|0:FIGF|0:FGF6|0:PGF|0:PDGFA|0:IL1B|0:TGFA|0:PPBP|0:TGFB3|0:FGF2|0:PDGFD|0:MACC1|0:FGF5|0:FGF9|0:GKN1|0:FGF1|0:VEGFA|0:PTN|0:TGFB2|0:PDGFB|0:FGF8|0:TGFB1|0:BTC|0:IGF2|0:PROK1|0:PDGFC|0:HTR2B			
GO:0032496	P:response to lipopolysaccharide; TAS:BHF-UCL		0:SELP|0:ADAM17|0:SNCA|0:GCH1|0:CPS1|0:IL12A|0:CYP27B1|0:S100A14|0:S100A7|0:SRR|0:TRIB1|0:TNFRSF11A|0:SLC11A1|0:IRAK3|0:CITED1|0:PRDX3|0:LIAS|0:SELE			
GO:0006368	P:RNA elongation from RNA polymerase II promoter; TAS:ProtInc		0:POLR2J|0:TAF4B|0:GTF2E1|0:GTF2F2|0:POLR2D|0:GTF2F1|0:POLR2G|0:GTF2H2|0:GTF2B|0:GTF2A1|0:TAF4|0:TBP|0:CCNH|0:TAF9|0:TAF11|0:GTF2E2|0:MNAT1|0:POLR2C|0:TAF5|0:POLR2F|0:POLR2B|0:TAF12|0:POLR2L|0:TAF1|0:GTF2H3|0:POLR2E|0:POLR2I|0:ERCC3|0:TAF6|0:CDK7|0:POLR2A|0:GTF2H4|0:TAF13|0:POLR2K|0:TAF10|0:GTF2H1|0:GTF2A2|0:POLR2H|0:ERCC2|0:SUPT5H|0:ELL3|0:SUPT4H1|0:ADRM1|0:ELL2|0:CDK9|0:ELL|0:TCEB2			
GO:0005761	C:mitochondrial ribosome; TAS:ProtInc		0:MRPL47|0:DAP3|0:MRPL40|0:MRPL35|0:MRPL32|0:MRPL39|0:MRPL37|0:MRPL28|0:MRPL9|0:MRPL43|0:MRPL18|0:MRPS14|0:MRPS12			
GO:0005136	F:interleukin-4 receptor binding; TAS:UniProtKB		0:IL4			
GO:0033033	P:negative regulation of myeloid cell apoptosis; IDA:UniProtKB		0:APOH|0:MAEA			
GO:0070064	F:proline-rich region binding; ISS:BHF-UCL		0:SH3D19|0:ABL1|0:NEDD4|0:CYLD|0:PFN1|0:WBP4|0:APBB1|0:ABI2|0:GHR			
GO:0031572	P:G2/M transition DNA damage checkpoint; NAS:UniProtKB		0:FZR1|0:CLSPN|0:CDC14B|0:BRSK1|0:PLK1|0:ATM|0:RINT1|0:UIMC1|0:BRE|0:DTL|0:BRCC3|0:BRCA1|0:FAM175A|0:C19orf62|0:BLM			
GO:0070207	P:protein homotrimerization; ISS:UniProtKB		0:ALOX5AP|0:SKI|0:MIF|0:SKIL|0:TRAF2|0:SCARA5			
GO:0031081	P:nuclear pore distribution; IMP:UniProtKB		0:TMEM48			
GO:0005011	F:macrophage colony-stimulating factor recept...; TAS:ProtInc		0:MST1R|0:CSF1R			
GO:0008898	F:homocysteine S-methyltransferase activity; TAS:ProtInc		0:MTR|0:BHMT2|0:BHMT			
GO:0032727	P:positive regulation of interferon-alpha pro...; ISS:BHF-UCL		0:HSPD1|0:DDX58|0:MAVS|0:TLR4			
GO:0005793	C:ER-Golgi intermediate compartment; TAS:ProtInc		0:GJB2|0:MAN1A1|0:TMED9|0:SERPINH1|0:ANPEP|0:NUCB1|0:SCYL1|0:TMED10|0:YIF1A|0:ERP44|0:P4HB|0:TMED5|0:TMED2|0:NUCB2|0:FN1|0:RAB37|0:KDELR1|0:GOLGB1|0:PDIA6|0:KIAA0174|0:HSPA5|0:KIAA0368|0:UGGT2|0:WHAMM|0:C19orf10|0:MYO18A|0:MCFD2|0:RGMB|0:UGGT1|0:ATP2A1|0:SEC23IP			
GO:0050891	P:multicellular organismal water homeostasis; IEP:UniProtKB		0:AQP4|0:AQP1			
GO:0033345	P:asparagine catabolic process via L-aspartate; ISS:UniProtKB		0:ASRGL1			
GO:0030326	P:embryonic limb morphogenesis; NAS:UniProtKB		0:CYP26B1|0:MBNL1|0:PTCH1|0:FBXW4			
GO:0050661	F:NADP or NADPH binding; TAS:UniProtKB		0:NOX1|0:G6PD|0:CAT|0:NDOR1|0:NNT|0:CRYM|0:DHFRP1|0:FMO6P|0:TXNRD1|0:FMO5|0:PGD|0:FMO2|0:FMO4|0:DHFRL1|0:HMGCR|0:FMO1|0:DHFR|0:TXNRD3|0:ASPDH|0:TXNRD2|0:NOS1|0:DPYD|0:NOS3|0:DUOX1|0:CRYZL1|0:NOX5|0:NOS2|0:SPR|0:MTRR|0:ME1			
GO:0045523	F:interleukin-27 receptor binding; ISS:UniProtKB		0:IL27			
GO:0016480	P:negative regulation of transcription from R...; IEA:InterPro		0:MAF1			
GO:0033178	C:proton-transporting two-sector ATPase compl...; IEA:InterPro		0:ATP6V1E2|0:ATP6V1E1|0:ATP6V1D			
GO:0008274	C:gamma-tubulin ring complex; NAS:UniProtKB		0:TUBGCP5|0:TUBGCP6|0:MZT1|0:MZT2B|0:MZT2A|0:BRCA1|0:TUBGCP4			
GO:0070407	P:oxidation-dependent protein catabolic process; IMP:UniProtKB		0:LONP1			
GO:0060356	P:leucine import; ISS:UniProtKB		0:SLC3A2			
GO:0031627	P:telomeric loop formation; ISS:UniProtKB		0:TERF2|0:DCLRE1B			
GO:0008514	F:organic anion transmembrane transporter act...; TAS:ProtInc		0:ABCC5|0:ABCC2|0:SLCO1A2|0:ABCC3|0:SLCO1B3|0:SLC22A8			
GO:0051795	P:positive regulation of catagen; IDA:UniProtKB		0:TGFB2			
GO:0060355	P:positive regulation of cell adhesion molecu...; NAS:BHF-UCL		0:IL1B			
GO:0010751	P:negative regulation of nitric oxide mediate...; IDA:BHF-UCL		0:THBS1			
GO:0006607	P:NLS-bearing substrate import into nucleus; TAS:ProtInc		0:KPNA5|0:KPNA2|0:RERE|0:CBLB|0:KPNA1|0:TRPS1|0:KPNA4|0:KPNB1|0:KPNA6|0:KPNA3|0:FYB|0:IPO5|0:NCKIPSD			
GO:0003774	F:motor activity; TAS:ProtInc		0:MYO15B|0:CGN|0:CGNL1|0:DCTN1|0:TCTE3|0:DYNC1LI2|0:MYO15A|0:MYO1F|0:DNM1|0:MYO1A|0:MYO19|0:MYH8|0:SLC26A5|0:MYH7B|0:MYO5C|0:DYNC1LI1|0:MYL9|0:MYO1C|0:MYO10|0:MYO16|0:MYH11|0:MYO18A|0:MYLPF|0:MYL12B|0:MYL3|0:DNM2|0:MYO1B|0:MYH15|0:MYO1G|0:DYNLT3|0:MYL1|0:MYH14|0:MYO18B|0:MYL12A|0:MYH1|0:MYL4|0:MYO5B|0:MYO1H|0:MYO9A|0:MYO3B|0:MYO7B|0:DCTN2|0:MYL2|0:DYNC2LI1|0:DYNLT1|0:DNM3|0:MYL5|0:MYL6B|0:MYL6|0:DNAI1			
GO:0060561	P:apoptosis involved in morphogenesis; IMP:UniProtKB		0:SCRIB			
GO:0048179	C:activin receptor complex; IDA:UniProtKB		0:ACVR1|0:ACVR1C			
GO:0048666	P:neuron development; TAS:UniProtKB		0:TGFB2|0:SRF|0:PPT1			
GO:0016361	F:activin receptor activity, type I; TAS:HGNC		0:ACVRL1|0:ACVR1C|0:ACVR1B			
GO:0019005	C:SCF ubiquitin ligase complex; ISS:UniProtKB		0:FBXO27|0:SKP1|0:FBXW11|0:FBXO17|0:FBXL5|0:CCNF|0:RBX1|0:FBXO4|0:FBXW7|0:FBXO31|0:FBXO6|0:SKP2|0:FBXO44|0:CUL1|0:FBXO25|0:FBXO2			
GO:0045216	P:cell-cell junction organization; NAS:UniProtKB		0:TGFB3|0:TGFB2|0:TGFB1|0:PRKCI|0:NLGN4X			
GO:0070890	F:sodium-dependent L-ascorbate transmembrane ...; IDA:UniProtKB		0:SLC23A1|0:SLC23A2			
GO:0010833	P:telomere maintenance via telomere lengthening; ISS:UniProtKB		0:TINF2|0:OBFC1|0:ZSCAN4			
GO:0008142	F:oxysterol binding; TAS:ProtInc		0:OSBPL5|0:OSBP			
GO:0045348	P:positive regulation of MHC class II biosynt...; ISS:UniProtKB		0:CIITA|0:AZU1|0:IL4			
GO:0005008	F:hepatocyte growth factor receptor activity; TAS:ProtInc		0:MET			
GO:0008531	F:riboflavin kinase activity; NAS:UniProtKB		0:RFK			
GO:0006519	P:cellular amino acid and derivative metaboli...; TAS:ProtInc		0:OTUB2|0:YOD1|0:BPHL			
GO:0003701	F:RNA polymerase I transcription factor activity; TAS:ProtInc		0:TAF1A|0:TAF1C|0:UBTF			
GO:0002543	P:activation of blood coagulation via clottin...; IC:BHF-UCL		0:F3			
GO:0009395	P:phospholipid catabolic process; NAS:BHF-UCL		0:ANGPTL3|0:APOA2|0:PRDX6|0:PLA2G4A|0:PLA2G4E|0:PLCG1|0:PLA2G4F|0:PLCG2|0:PLA2G4D|0:NAPEPLD|0:LIPG			
GO:0003987	F:acetate-CoA ligase activity; IEA:EC		0:ACSS2|0:ACSS1|0:ACSS3			
GO:0071712	P:ER-associated misfolded protein catabolic p...; IMP:UniProtKB		0:RNF5			
GO:0043205	C:fibril; IDA:UniProtKB		0:MUC5AC|0:SNCA|0:ODAM			
GO:0051262	P:protein tetramerization; TAS:UniProtKB		0:TGM3|0:CAT|0:PEX5|0:IGF1R|0:ADSL|0:TRPV5|0:AASS|0:TP53			
GO:0030673	C:axolemma; TAS:BHF-UCL		0:ROBO2|0:CNTNAP2			
GO:0042589	C:zymogen granule membrane; ISS:UniProtKB		0:TMED10|0:TMED2|0:CUZD1|0:DMBT1			
GO:0014806	P:smooth muscle hyperplasia; TAS:BHF-UCL		0:NOS3|0:HMOX1			
GO:0048304	P:positive regulation of isotype switching to...; ISS:UniProtKB		0:IL4			
GO:0006665	P:sphingolipid metabolic process; NAS:UniProtKB		0:FA2H|0:SFTPB|0:ASAH2C|0:ARV1|0:PSAPL1|0:GBA|0:SERINC1|0:TEX2			
GO:0070996	F:type 1 melanocortin receptor binding; IPI:BHF-UCL		0:POMC|0:MRAP|0:MRAP2			
GO:0061205	P:paramesonephric duct development; IMP:UniProtKB		0:WNT4			
GO:0047936	F:glucose 1-dehydrogenase activity; IEA:EC		0:H6PD			
GO:0021891	P:olfactory bulb interneuron development; ISS:UniProtKB		0:ROBO2			
GO:0016291	F:acyl-CoA thioesterase activity; TAS:UniProtKB		0:ACSBG2|0:ACOT13|0:ACOT8|0:ACOT11			
GO:0045833	P:negative regulation of lipid metabolic process; IDA:BHF-UCL		0:APOC2			
GO:0032525	P:somite rostral/caudal axis specification; ISS:UniProtKB		0:RIPPLY1|0:RIPPLY2			
GO:0030219	P:megakaryocyte differentiation; NAS:UniProtKB		0:CDKN2B|0:IL11			
GO:0000318	F:protein-methionine-R-oxide reductase activity; ISS:HGNC		0:MSRB3|0:MSRB2			
GO:0010903	P:negative regulation of very-low-density lip...; IDA:BHF-UCL		0:APOC3|0:APOA2|0:APOA1			
GO:0048477	P:oogenesis; ISS:UniProtKB		0:SOHLH2|0:PAQR5|0:NANOS3|0:SOHLH1|0:DIAPH2|0:PAQR7|0:NOBOX|0:PAQR8|0:FMN2|0:PIWIL2			
GO:0030666	C:endocytic vesicle membrane; EXP:Reactome		0:MDM2|0:DLG4|0:CAMK2G|0:CAMK2D|0:PICK1|0:CACNG3|0:GRIA2|0:CAMK2A|0:GRIA4|0:GRIA3|0:CACNG8|0:CAMK2B|0:CACNG2|0:AP2B1|0:AP2M1|0:SYT1|0:GRIA1|0:SYT2|0:CACNG4			
GO:0047105	F:4-trimethylammoniobutyraldehyde dehydrogena...; IEA:EC		0:ALDH9A1			
GO:0008290	C:F-actin capping protein complex; TAS:ProtInc		0:ADD2|0:ADD1|0:CAPG|0:CAPZA1|0:CAPZB|0:CAPZA2			
GO:0001539	P:ciliary or flagellar motility; NAS:UniProtKB		0:DNAH1|0:DNAH2|0:DNAH17|0:DNAH8|0:DNAH7|0:DNAH3			
GO:0090118	P:receptor-mediated endocytosis of low-densit...; IMP:BHF-UCL		0:LDLRAP1			
GO:0015116	F:sulfate transmembrane transporter activity; IDA:UniProtKB		0:SLC26A8|0:SLC26A7			
GO:0004850	F:uridine phosphorylase activity; TAS:ProtInc		0:UPP2|0:UPP1			
GO:0006740	P:NADPH regeneration; EXP:Reactome		0:IDH1			
GO:0016853	F:isomerase activity; IEA:UniProtKB-KW		0:TXNDC5|0:ITPK1|0:TSTA3|0:DSEL|0:ENOSF1|0:HSD17B4|0:PUS10|0:PDILT|0:ECH1|0:PBLD			
GO:0030131	C:clathrin adaptor complex; IEA:InterPro		0:ARCN1|0:GGA2|0:AP1S3|0:AP1G1|0:SGIP1|0:STON2|0:GGA1|0:AP4M1|0:AP1S2|0:AP3M1|0:STON1|0:AP2B1|0:AP1B1|0:AP2M1|0:AP1M1|0:AP3M2|0:AP4B1|0:MUDENG|0:GGA3|0:AP1M2			
GO:0004463	F:leukotriene-A4 hydrolase activity; TAS:ProtInc		0:LTA4H			
GO:0006351	P:transcription, DNA-dependent; TAS:ProtInc		0:NKX2-6|0:AR|0:ZNF219|0:TAF1B|0:POLR3A|0:PTGER3|0:MYNN|0:ESR1|0:ZNF217|0:THRB			
GO:0030272	F:5-formyltetrahydrofolate cyclo-ligase activity; IEA:InterPro		0:MTHFS|0:MTHFSD			
GO:0004059	F:aralkylamine N-acetyltransferase activity; EXP:Reactome		0:AANAT			
GO:0017089	F:glycolipid transporter activity; IEA:InterPro		0:GLTP|0:PLEKHA8|0:GLTPD2|0:PLEKHA9|0:GLTPD1			
GO:0000305	P:response to oxygen radical; TAS:UniProtKB		0:TXNRD2			
GO:0045175	P:basal protein localization; NAS:UniProtKB		0:ERBB2IP			
GO:0006693	P:prostaglandin metabolic process; TAS:UniProtKB		0:HPGD|0:AKR1C2|0:TNFRSF1A|0:ACOX1|0:PTGES|0:CYP4F8|0:AKR1C3			
GO:0030133	C:transport vesicle; TAS:UniProtKB		0:CAV2|0:PLEKHF2|0:C14orf1|0:APH1B|0:YIPF1|0:YIPF2|0:BGN|0:SSPN|0:SYT13|0:YIPF3|0:TMEM168|0:CRISPLD2|0:GALNTL2|0:AP1AR|0:TMEM187|0:CNST|0:C12orf39|0:AIMP1|0:PCSK1|0:PRG2|0:VGF|0:NPTX1|0:CPA3|0:OVGP1|0:NTS|0:PCSK2|0:C2orf40|0:NRSN2|0:TGOLN2|0:AP3S1|0:NRSN1			
GO:0042551	P:neuron maturation; NAS:UniProtKB		0:CLN5			
GO:0000795	C:synaptonemal complex; TAS:ProtInc		0:UBE2I|0:STAG3			
GO:0042403	P:thyroid hormone metabolic process; IDA:UniProtKB		0:SULT1B1			
GO:0031123	P:RNA 3'-end processing; IMP:UniProtKB		0:ZCCHC6|0:ZCCHC11|0:LIN28B|0:LIN28A			
GO:0030546	F:receptor activator activity; IMP:BHF-UCL		0:PPARGC1B|0:BAZ1B			
GO:0004471	F:malate dehydrogenase (decarboxylating) acti...; TAS:ProtInc		0:ME2			
GO:0070079	P:histone H4-R3 demethylation; IDA:BHF-UCL		0:JMJD6			
GO:0042102	P:positive regulation of T cell proliferation; IMP:UniProtKB		0:IL1B|0:IL6|0:VCAM1|0:CD276|0:PNP|0:CD28|0:IL21|0:IL6ST|0:NCK1|0:NCK2			
GO:0031124	P:mRNA 3'-end processing; TAS:UniProtKB		0:CLP1			
GO:0015520	F:tetracycline:hydrogen antiporter activity; IEA:InterPro		0:HIAT1|0:MFSD9|0:SLC22A18|0:HIATL1|0:SLC46A2			
GO:0033634	P:positive regulation of cell-cell adhesion m...; IDA:UniProtKB		0:PODXL			
GO:0050124	F:N-acylneuraminate-9-phosphatase activity; IDA:UniProtKB		0:NANP			
GO:0001774	P:microglial cell activation; IEP:UniProtKB		0:AZU1			
GO:0004368	F:glycerol-3-phosphate dehydrogenase activity; TAS:ProtInc		0:GPD2			
GO:0001786	F:phosphatidylserine binding; ISS:UniProtKB		0:CPNE1|0:THBS1|0:SDPR|0:ANXA9|0:SYTL2|0:SCARB1|0:TRIM72|0:SCIN			
GO:0060307	P:regulation of ventricular cardiomyocyte mem...; IMP:BHF-UCL		0:CAV3			
GO:0001599	F:endothelin-A receptor activity; NAS:UniProtKB		0:EDNRA			
GO:0031210	F:phosphatidylcholine binding; TAS:BHF-UCL		0:APOA4|0:CETP|0:APOA2|0:APOA5|0:PCTP|0:APOC1			
GO:0043032	P:positive regulation of macrophage activation; TAS:UniProtKB		0:THBS1|0:LBP|0:HSPD1|0:SPACA3			
GO:0008361	P:regulation of cell size; TAS:BHF-UCL		0:RPTOR|0:RARG			
GO:0006805	P:xenobiotic metabolic process; TAS:ProtInc		0:UGT1A8|0:SULT1A1|0:FMO2|0:SULT1A3|0:SULT1A4|0:UGT1A7|0:UGT1A3|0:SULT1B1|0:UGT2B4|0:UGT1A9|0:UGT2B28|0:UGT1A6|0:S100A12|0:NR1I2|0:HNF4A|0:EPHX2|0:FMO4|0:UGT1A5|0:AKR1C1|0:CYP2D6|0:CYP2J2|0:UGT2B15|0:UGT2B11|0:NQO1			
GO:0034968	P:histone lysine methylation; IDA:UniProtKB		0:WDR92			
GO:0033150	C:cytoskeletal calyx; IEA:UniProtKB-SubCell		0:CCIN|0:CYLC2|0:CYLC1			
GO:0032795	F:heterotrimeric G-protein binding; IDA:BHF-UCL		0:ADRA2A			
GO:0007257	P:activation of JUN kinase activity; TAS:ProtInc		0:WNT5A|0:MUL1|0:MAP3K11|0:MDFIC|0:MAP3K10|0:MAP3K9|0:MDFI|0:BIRC7|0:RIPK1|0:DAXX|0:DBNL|0:MAP4K5|0:MAP3K6|0:MAP4K1|0:PTPLAD1|0:MAP3K5|0:PKN1|0:MAP3K2			
GO:0005865	C:striated muscle thin filament; IDA:UniProtKB		0:TTN|0:ACTA1			
GO:0046380	P:N-acetylneuraminate biosynthetic process; IDA:UniProtKB		0:NANP			
GO:0001523	P:retinoid metabolic process; IDA:UniProtKB		0:BCMO1|0:ADH7|0:RARRES2			
GO:0045023	P:G0 to G1 transition; IEP:UniProtKB		0:MDM4			
GO:0032040	C:small-subunit processome; ISS:UniProtKB		0:UTP14C|0:UTP11L|0:UTP14A|0:WDR36|0:TBL3|0:UTP20|0:NOP14			
GO:0048704	P:embryonic skeletal system morphogenesis; ISS:UniProtKB		0:DSCAML1|0:HOXD3			
GO:0032982	C:myosin filament; IEA:UniProtKB-KW		0:MYH3|0:MYOM2|0:MYH13|0:MYBPC2|0:MYH8|0:MYH7B|0:MYH11|0:MYH2|0:MYH15|0:MYH7|0:MYH1|0:MYH6|0:MYBPC1|0:MYH4|0:MYBPH			
GO:0031528	C:microvillus membrane; ISS:UniProtKB		0:MSN|0:PROM1|0:MUC20|0:EZR|0:PDPN|0:DPEP1|0:CA9|0:PROM2|0:PODXL			
GO:0008195	F:phosphatidate phosphatase activity; ISS:UniProtKB		0:PPAP2C|0:PPAP2B|0:PPAP2A|0:LPIN3|0:PPAPDC1A|0:LPIN1|0:PPAPDC1B|0:LPIN2			
GO:0031233	C:intrinsic to external side of plasma membrane; ISS:BHF-UCL		0:F10|0:F3|0:ADAM9			
GO:0016585	C:chromatin remodeling complex; NAS:UniProtKB		0:ASF1A|0:RBM10|0:KIF11|0:KAT2B|0:MYSM1|0:SMARCA1|0:ESR1			
GO:0030292	F:protein tyrosine kinase inhibitor activity; IDA:UniProtKB		0:IBTK|0:FGFR1OP			
GO:0004801	F:transaldolase activity; TAS:ProtInc		0:TALDO1			
GO:0008349	F:MAP kinase kinase kinase kinase activity; IDA:UniProtKB		0:MAP4K1			
GO:0051085	P:chaperone mediated protein folding requirin...; IEA:InterPro		0:ERO1L|0:C9orf167|0:TOR2A|0:TOR1A|0:TOR1B|0:TOR3A			
GO:0060965	P:negative regulation of gene silencing by miRNA; IMP:UniProtKB		0:DND1|0:POU5F1			
GO:0031295	P:T cell costimulation; TAS:BHF-UCL		0:CARD11|0:DPP4|0:CD24|0:CAV1|0:KLRK1			
GO:0010768	P:negative regulation of transcription from R...; IMP:BHF-UCL		0:NEDD4			
GO:0007616	P:long-term memory; NAS:UniProtKB		0:NTF4|0:RASGRF1			
GO:0009264	P:deoxyribonucleotide catabolic process; IEA:InterPro		0:DERA			
GO:0004882	F:androgen receptor activity; TAS:ProtInc		0:AR|0:NR1I3			
GO:0004651	F:polynucleotide 5'-phosphatase activity; IEA:EC		0:RNGTT			
GO:0007338	P:single fertilization; TAS:ProtInc		0:MFGE8|0:ZP4|0:BSPH1|0:ZP1|0:CD46|0:OVGP1|0:LCN6|0:OR1D2|0:ELSPBP1|0:SLC22A16|0:NPM2|0:IGSF8|0:TUBGCP3|0:CLGN|0:MST1R|0:XKRY|0:SPAG1|0:BPY2B|0:DNALI1|0:ADAM20|0:DAZ2|0:GNPDA1|0:ADAM21|0:UBXN8|0:BPY2|0:BPY2C|0:OR10J1|0:AKAP4			
GO:0043488	P:regulation of mRNA stability; NAS:HGNC		0:ZFP36L1|0:SERBP1			
GO:0008574	F:plus-end-directed microtubule motor activity; TAS:ProtInc		0:KIF18A|0:KIF3B			
GO:0017061	F:S-methyl-5-thioadenosine phosphorylase acti...; IEA:EC		0:MTAP			
GO:0090169	P:regulation of spindle assembly; IMP:UniProtKB		0:RNF4			
GO:0008631	P:induction of apoptosis by oxidative stress; TAS:ProtInc		0:PRODH|0:TP53I3|0:RNF7			
GO:0034645	P:cellular macromolecule biosynthetic process; IDA:MGI		0:PTH			
GO:0051938	P:L-glutamate import; IDA:UniProtKB		0:SLC1A1|0:SLC1A2|0:SLC1A3			
GO:0032463	P:negative regulation of protein homooligomer...; IMP:BHF-UCL		0:CLU			
GO:0005839	C:proteasome core complex; NAS:UniProtKB		0:PSMB8|0:PSMB4|0:PSMB10|0:PSMB5|0:PSMB1|0:PSMB11|0:PSMB2|0:PSMB7|0:PSMB3|0:PSMB9|0:PSMF1|0:PSMB6			
GO:0050727	P:regulation of inflammatory response; TAS:UniProtKB		0:CMA1|0:ACE2|0:SBNO2|0:AHSG|0:MYD88|0:SELE|0:IL20			
GO:0070839	P:divalent metal ion export; ISS:BHF-UCL		0:SLC11A1			
GO:0046790	F:virion binding; TAS:UniProtKB		0:HSP90B1|0:HIPK2|0:PPIA|0:CLEC4M|0:CD209			
GO:0032591	C:dendritic spine membrane; ISS:UniProtKB		0:DDN|0:SHISA9			
GO:0022857	F:transmembrane transporter activity; IC:UniProtKB		0:ATP5J2			
GO:0080008	C:CUL4 RING ubiquitin ligase complex; IDA:UniProtKB		0:DCAF11|0:DCAF4|0:DCAF6|0:DCAF12|0:DCAF5|0:DCAF16|0:DCAF13|0:DCAF8|0:DCAF10|0:DCAF17|0:DCAF7			
GO:0050850	P:positive regulation of calcium-mediated sig...; NAS:BHF-UCL		0:CDH13|0:P2RX4|0:TRAT1|0:P2RX2|0:P2RX3|0:P2RX5			
GO:0002528	P:regulation of vascular permeability involve...; IMP:BHF-UCL		0:CTNNBIP1			
GO:0007171	P:activation of transmembrane receptor protei...; TAS:ProtInc		0:NRG1|0:ANGPT1|0:PRLR|0:CHRNA3|0:PILRB|0:ADRB2			
GO:0044421	C:extracellular region part; IDA:HGNC		0:C19orf24			
GO:0005626	C:insoluble fraction; TAS:ProtInc		0:GPC4|0:MDM2|0:PML|0:TP53|0:CLIC5|0:NAE1|0:GYS2|0:CCDC88C|0:PDE4D|0:PDE4B|0:LOR|0:S100A12|0:TMBIM6			
GO:0009116	P:nucleoside metabolic process; NAS:UniProtKB		0:PRPS1L1|0:PPAT|0:UPRT|0:PRPS1|0:PRPS2|0:MTAP|0:NT5C1A			
GO:0045321	P:leukocyte activation; TAS:BHF-UCL		0:TMX1|0:ZNF3|0:TOLLIP|0:ITIH1|0:EDN1			
GO:0032038	F:myosin II heavy chain binding; NAS:BHF-UCL		0:MYL3|0:MYL4			
GO:0050713	P:negative regulation of interleukin-1 beta s...; IDA:BHF-UCL		0:APOA1			
GO:0035054	P:embryonic heart tube anterior/posterior pat...; ISS:BHF-UCL		0:GATA4			
GO:0002606	P:positive regulation of dendritic cell antig...; ISS:BHF-UCL		0:SLC11A1			
GO:0006096	P:glycolysis; TAS:UniProtKB		0:ALDOB|0:PFKL|0:MDH1|0:MDH2|0:UEVLD|0:ENO4|0:ALDOC|0:LDHAL6B|0:DLAT|0:PDHB|0:PGAM1|0:GPI|0:HK2|0:LDHAL6A|0:LDHB|0:BPGM|0:ENO1|0:ENO3|0:LDHC|0:GAPDHS|0:TPI1|0:ENO2|0:PDHA2|0:OGDHL|0:PKLR|0:PDHA1|0:OGDH|0:GCK|0:ADPGK|0:PGK1|0:DHTKD1|0:HKDC1|0:ALDOA|0:PFKM|0:PGAM2|0:LDHA|0:PGAM4|0:PKM2|0:HK3|0:PFKP|0:PGK2|0:GAPDH|0:HK1|0:PFKFB1			
GO:0035088	P:establishment or maintenance of apical/basa...; NAS:UniProtKB		0:CLIC4			
GO:0004521	F:endoribonuclease activity; ISS:UniProtKB		0:RNASEK|0:ENDOU|0:CPSF3			
GO:0005391	F:sodium:potassium-exchanging ATPase activity; TAS:UniProtKB		0:ATP1B4|0:ATP4B|0:ATP1A3|0:ATP1A2|0:FXYD2|0:ATP1B3|0:ATP1A1|0:ATP1B2|0:ATP1B1|0:ATP1A4			
GO:0090002	P:establishment of protein localization in pl...; IDA:UniProtKB		0:WNT4			
GO:0050998	F:nitric-oxide synthase binding; ISS:UniProtKB		0:CAV1|0:ACTB|0:DMD|0:NOS1AP			
GO:0002903	P:negative regulation of B cell apoptosis; NAS:UniProtKB		0:IL2|0:IRS2|0:BCL6			
GO:0045716	P:positive regulation of low-density lipoprot...; NAS:UniProtKB		0:SCAP			
GO:0021764	P:amygdala development; IMP:BHF-UCL		0:AXIN2			
GO:0035117	P:embryonic arm morphogenesis; IMP:UniProtKB		0:NIPBL|0:TBX3|0:TBX5			
GO:0030832	P:regulation of actin filament length; TAS:ProtInc		0:NEB|0:NEBL			
GO:0004585	F:ornithine carbamoyltransferase activity; NAS:UniProtKB		0:OTC			
GO:0002088	P:lens development in camera-type eye; ISS:BHF-UCL		0:WNT2B|0:WNT2|0:WNT5A			
GO:0015100	F:vanadium ion transmembrane transporter acti...; IDA:UniProtKB		0:SLC11A2			
GO:0015380	F:anion exchanger activity; IEA:UniProtKB-KW		0:SLC26A11|0:SLC26A8|0:SLC26A7			
GO:0016075	P:rRNA catabolic process; NAS:UniProtKB		0:ERN2|0:RNASEN|0:DEDD2			
GO:0050690	P:regulation of defense response to virus by ...; EXP:Reactome		0:AP2S1|0:CD28|0:AP2A2|0:AP2A1|0:ATP6V1H|0:CD8B|0:AP2B1|0:AP2M1			
GO:0048562	P:embryonic organ morphogenesis; ISS:UniProtKB		0:RBP4|0:NEUROD1|0:FOXE1			
GO:0042180	P:cellular ketone metabolic process; IDA:BHF-UCL		0:CYP2B6			
GO:0030175	C:filopodium; ISS:HGNC		0:MSN|0:EZR|0:VCAM1|0:ACTN2|0:DAG1|0:ABI1|0:PODXL|0:MYO3A|0:CDC42|0:ABI2|0:WASH3P|0:SLC9A3R1|0:RAPH1|0:CIB1|0:TIAM2|0:ARL4C|0:ENAH|0:FAM65B|0:NGDN|0:BAIAP2|0:FGD4|0:LY6G6D|0:RUFY3			
GO:0000506	C:glycosylphosphatidylinositol-N-acetylglucos...; TAS:HGNC		0:PIGA|0:PIGY|0:DPM2			
GO:0010800	P:positive regulation of peptidyl-threonine p...; IMP:BHF-UCL		0:AXIN1|0:TGFB1|0:PRKAG2			
GO:0016831	F:carboxy-lyase activity; TAS:HGNC		0:SGPL1|0:PDXDC2P|0:PRHOXNB|0:PDXDC1|0:GADL1|0:BCKDHA|0:BCKDHB			
GO:0015758	P:glucose transport; NAS:UniProtKB		0:GH1|0:INS|0:PLA2G1B|0:EDNRA|0:SLC2A10|0:PPARD			
GO:0004419	F:hydroxymethylglutaryl-CoA lyase activity; ISS:UniProtKB		0:HMGCL|0:HMGCLL1			
GO:0008536	F:Ran GTPase binding; TAS:ProtInc		0:BIRC5|0:RGPD8|0:IPO8|0:RANBP9|0:IPO7|0:RANBP1|0:RANBP2|0:IPO5|0:RANBP3			
GO:0033141	P:positive regulation of peptidyl-serine phos...; IDA:MGI		0:IFNG			
GO:0004597	F:peptide-aspartate beta-dioxygenase activity; TAS:ProtInc		0:HIF1AN|0:ASPHD1|0:ASPHD2|0:ASPH			
GO:0018272	P:protein-pyridoxal-5-phosphate linkage via p...; IDA:UniProtKB		0:CTH			
GO:0042641	C:actomyosin; NAS:UniProtKB		0:DBN1			
GO:0004968	F:gonadotropin-releasing hormone receptor act...; TAS:ProtInc		0:GNRHR2|0:GNRHR			
GO:0006431	P:methionyl-tRNA aminoacylation; IEA:InterPro		0:MARS2|0:MARS			
GO:0060849	P:regulation of transcription involved in lym...; IMP:BHF-UCL		0:PROX1|0:NR2F2			
GO:0045749	P:negative regulation of S phase of mitotic c...; TAS:BHF-UCL		0:CHMP1A|0:DCUN1D3|0:MYO16|0:APBB2|0:APBB1|0:GAS1|0:BCL6|0:SMARCA4|0:RB1			
GO:0005548	F:phospholipid transporter activity; IDA:BHF-UCL		0:CETP|0:ABCG1|0:ABCA1			
GO:0018243	P:protein amino acid O-linked glycosylation v...; IDA:UniProtKB		0:GALNT1|0:GALNT2|0:GALNT3			
GO:0002244	P:hemopoietic progenitor cell differentiation; IEP:BHF-UCL		0:FST|0:BMP4|0:FSTL3|0:SFRP1|0:INHBA|0:TGFB1|0:PLEK			
GO:0006047	P:UDP-N-acetylglucosamine metabolic process; TAS:ProtInc		0:GNE|0:SLC35A3			
GO:0051322	P:anaphase; IMP:UniProtKB		0:USP44|0:KLHL21			
GO:0045893	P:positive regulation of transcription, DNA-d...; TAS:UniProtKB		0:SOX4|0:NIF3L1|0:F2R|0:DVL3|0:SP100|0:PPM1A|0:ETS2|0:MRPL12|0:AFAP1L2|0:TAF8|0:FOXE1|0:ATXN7L3|0:SMARCC2|0:PAX8|0:ILF2|0:FOXJ2|0:ENY2|0:KAT5|0:MAP2K3|0:TCF4|0:BCL10|0:TRERF1|0:FOXF1|0:SMARCD3|0:ANKRD49|0:ARHGEF11|0:HNF1A|0:NAA15|0:ATF7IP|0:MYSM1|0:MDFIC|0:PRDM16|0:NSD1|0:PCBD2|0:HNF1B|0:EHF|0:ILF3|0:CTCF|0:CREB5|0:DYRK1B|0:USP16|0:ZNF711|0:MMS19|0:JMJD5|0:TASP1|0:MLL5|0:SOX17|0:NAA16|0:PHF5A|0:ESRRG|0:USP21|0:C11orf9|0:TCF21|0:ZNF496|0:TMX1|0:IL31RA|0:TP53BP1|0:GRIP1|0:SEC14L2|0:RNF14|0:NCOA4|0:PIAS1|0:TGFB1I1|0:FHL2|0:CCNE1|0:YEATS4|0:NOTCH4			
GO:0042254	P:ribosome biogenesis; IEA:UniProtKB-KW		0:RPLP0|0:NHP2L1|0:MRPL10|0:RPL7A|0:BRIX1|0:GNL2|0:ZNHIT6|0:GTPBP5|0:RSL24D1|0:RNASEN|0:EBNA1BP2|0:RRS1|0:GNL3L|0:GTPBP4|0:ISG20L2|0:MRTO4|0:RCL1|0:GTPBP10|0:BYSL|0:MINA			
GO:0007169	P:transmembrane receptor protein tyrosine kin...; TAS:UniProtKB		0:NTRK2|0:ADORA2A|0:NTRK1|0:ADCYAP1|0:NGF|0:ADCYAP1R1|0:NRG1|0:ROR2|0:ERBB4|0:MST1R|0:EPHA3|0:EPHA6|0:EPHA4|0:TIE1|0:KIT|0:EPHA7|0:EPHA10|0:EPHB6|0:DDR1|0:AXL|0:EPHB3|0:LTK|0:EPHA8|0:EPHA5|0:CSF1R|0:EPHB1|0:EPHB4|0:ROS1|0:ALK|0:EPHA1|0:PTPRT|0:ERBB3|0:IL31RA|0:RASGRP4|0:CD4|0:INSRR|0:CD8B|0:CD7|0:CD8A|0:TEK|0:PTPRG|0:MUSK|0:RAPGEF1|0:MPZL1|0:DOK1|0:LCP2|0:CD3EAP|0:ABI1|0:GFRA2|0:PTPRJ|0:ROR1|0:NRTN|0:BDKRB2|0:NTRK3|0:CNKSR1|0:MTSS1			
GO:0009100	P:glycoprotein metabolic process; NAS:UniProtKB		0:PCSK6|0:ERP44|0:ADAMTS13			
GO:0070626	F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imida...; IEA:EC		0:ADSL			
GO:0030618	F:transforming growth factor beta receptor, p...; TAS:BHF-UCL		0:SMAD2|0:SMAD5|0:SMAD9|0:SMAD1			
GO:0030504	F:inorganic diphosphate transmembrane transpo...; IDA:UniProtKB		0:ANKH			
GO:0060291	P:long-term synaptic potentiation; ISS:UniProtKB		0:NPTN			
GO:0007264	P:small GTPase mediated signal transduction; TAS:UniProtKB		0:RIT1|0:BRAF|0:RASD2|0:ARHGEF18|0:RAB33B|0:REM2|0:RAB5A|0:ARF5|0:RAB28|0:RHOBTB1|0:RAPGEF1|0:RAB23|0:RAP2B|0:IQGAP1|0:RAB11A|0:RASL11A|0:RND1|0:RAB43|0:RAB2A|0:ARL2|0:RHOT1|0:ARL4A|0:RASGRF1|0:RAB35|0:RHOBTB2|0:RALGPS1|0:RHOV|0:RAB24|0:RABIF|0:RASL12|0:RAC3|0:RAC1|0:RASGEF1C|0:RGL3|0:RAB33A|0:LRRK1|0:RAB3B|0:RAB1C|0:RAB30|0:ERAS|0:AGAP1|0:RAB39|0:RAB1B|0:RHOH|0:ARFRP1|0:RAB20|0:RAB2B|0:RAB6A|0:RAB32|0:RHOQ|0:RASGRP4|0:RND2|0:RAB42|0:ARL5B|0:RASEF|0:RHEBL1|0:RAB7B|0:RAB17|0:RAB11B|0:RAB3D|0:RAB12|0:RABL2A|0:ARF6|0:RAB5B|0:RAB25|0:ARL4D|0:RAB40AL|0:RHOT2|0:RALGPS2|0:TRIM23|0:ARL1|0:RAB3C|0:RAB41|0:RAPGEFL1|0:RAB36|0:RAB31|0:AGAP2|0:SH2D3A|0:C9orf86|0:DIRAS1|0:RASGEF1B|0:RAB22A|0:RAP2A|0:RAB40C|0:ARL5A|0:RGL4|0:ARL6|0:RAB7L1|0:ARL11|0:ARL4C|0:RASD1|0:RAB13|0:RAB7A|0:RAB40B|0:RASGEF1A|0:RAB4B|0:ARL8A|0:DNAJC27|0:AGAP3|0:RAB1A|0:RAB9A|0:NKIRAS2|0:IQGAP2|0:RAB8B|0:RASL10B|0:RAB37|0:RAB26|0:RAB21|0:RAB27B|0:RAB6B|0:RND3|0:RAPGEF4|0:RAPGEF3|0:RAB5C|0:GEM|0:KNDC1|0:RAB15|0:RAB44|0:RAB4A|0:ARL5C|0:RAB10|0:RHOF|0:ARL14|0:RAC2|0:ARF4|0:CDC42|0:ARL3|0:RABL3|0:C1orf89|0:RASGRF2|0:RAB19|0:RHOC|0:RHEB|0:RAB3A|0:LRRK2|0:RAB9B|0:NKIRAS1|0:SH2D3C|0:BCAR3|0:IQGAP3|0:RASL11B|0:RAB34|0:IFT27|0:RABL2B|0:RAP2C|0:ARL8B|0:ARF1|0:DIRAS2|0:RAB39B|0:RAB40A|0:RAB27A|0:ARF3|0:REM1|0:RAB8A|0:RALBP1|0:RAPGEF5|0:RAB14|0:RAB18|0:SOS2|0:RAB38|0:RERG|0:RIN2|0:RGL1|0:RIT2|0:ABR|0:DIRAS3|0:VAV3|0:SIAH2|0:TNK2|0:KRIT1|0:ARFIP2|0:RRAD|0:PLD2|0:RASL10A|0:PDK1|0:RUNDC3A|0:DOCK1|0:RGS19|0:RRAGC|0:RAPGEF2|0:RAB6C			
GO:0001938	P:positive regulation of endothelial cell pro...; TAS:UniProtKB		0:HIF1A|0:ARNT|0:CCL26|0:F3|0:PROX1|0:CCL24|0:VEGFA|0:CCL11|0:PDGFB|0:SCG2|0:VASH2|0:VEGFB|0:HMGB2|0:ECM1|0:BMP4|0:ANG|0:AGGF1|0:BMP2|0:THBS4|0:ITGB3|0:CDH13|0:KDR|0:HTR2B|0:BMPR2|0:WNT5A|0:TNFSF12			
GO:0015130	F:mevalonate transmembrane transporter activity; TAS:ProtInc		0:SLC16A1			
GO:0030110	F:HLA-C specific inhibitory MHC class I recep...; NAS:UniProtKB		0:KIR2DS5			
GO:0001958	P:endochondral ossification; ISS:UniProtKB		0:COL13A1|0:DLX5			
GO:0030856	P:regulation of epithelial cell differentiation; NAS:UniProtKB		0:ALOX15B|0:CD24			
GO:0034384	P:high-density lipoprotein particle clearance; ISS:BHF-UCL		0:APOA1|0:APOE|0:SCARB1|0:APOA2|0:APOC2|0:APOM			
GO:0004799	F:thymidylate synthase activity; IEA:EC		0:TYMS			
GO:0070492	F:oligosaccharide binding; IDA:BHF-UCL		0:SELP|0:SELE			
GO:0008172	F:S-methyltransferase activity; EXP:Reactome		0:ASMT			
GO:0048484	P:enteric nervous system development; ISS:UniProtKB		0:KIF26A			
GO:0004571	F:mannosyl-oligosaccharide 1,2-alpha-mannosid...; TAS:UniProtKB		0:KIAA2018|0:EDEM1|0:EDEM3|0:EDEM2|0:MAN1A1|0:MAN1A2|0:MAN1C1|0:MAN1B1			
GO:0043457	P:regulation of cellular respiration; TAS:BHF-UCL		0:PRDM16|0:NOS2			
GO:0006312	P:mitotic recombination; TAS:ProtInc		0:ERCC1|0:RAD52|0:RAD51|0:RAD54B			
GO:0006427	P:histidyl-tRNA aminoacylation; IEA:InterPro		0:HARS2|0:HARS			
GO:0001963	P:synaptic transmission, dopaminergic; NAS:UniProtKB		0:TH|0:DRD5			
GO:0001614	F:purinergic nucleotide receptor activity; NAS:BHF-UCL		0:P2RX7|0:P2RX4|0:P2RX1|0:P2RX2|0:P2RX6|0:P2RX3|0:P2RX5			
GO:0035003	C:subapical complex; IDA:UniProtKB		0:PDZD3			
GO:0008589	P:regulation of smoothened signaling pathway; TAS:UniProtKB		0:PTCH1|0:ZIC1|0:GLI1|0:OTX2			
GO:0060552	P:positive regulation of fructose 1,6-bisphos...; IDA:BHF-UCL		0:IFNG			
GO:0007162	P:negative regulation of cell adhesion; TAS:ProtInc		0:ERBB3|0:CDH13|0:MIA3|0:RND1|0:KNG1|0:ADAM10|0:DSCAM|0:CBLL1|0:ADAMDEC1|0:SIPA1|0:ADAM22|0:CD164|0:ARHGDIB|0:ARHGDIG|0:TGFBI|0:SPN|0:ARHGDIA			
GO:0071109	P:superior temporal gyrus development; IMP:BHF-UCL		0:CNTNAP2|0:EMX2|0:TSC2|0:MAPT|0:NR3C1|0:NFATC2|0:GSK3B			
GO:0005102	F:receptor binding; TAS:UniProtKB		0:HNF4A|0:PLA2G1B|0:CD160|0:SEMA4D|0:GLA|0:RARA|0:ARPP19|0:ANG|0:CNTNAP3B|0:FGA|0:FGL1|0:ANGPTL4|0:LAMA4|0:LAMA1|0:LAMA3|0:ITLN1|0:FGB|0:FGL2|0:FGG|0:MFAP4|0:CNTNAP3|0:FCN3|0:FIBCD1|0:CNTNAP5|0:LAMA2|0:ANGPTL6|0:TNR|0:CNTNAP1|0:ANGPTL7|0:FCN2|0:CNTNAP4|0:ANGPTL5|0:FCN1|0:CNTNAP2|0:ITLN2|0:TRDN|0:TNC|0:CNTFR|0:FKBP1B|0:LRP6|0:CDH5|0:CSNK2B|0:AKAP6|0:F2R|0:LPL|0:SERPINE2|0:FZD1|0:C7orf68|0:CAV1|0:PPP2R4|0:PGR|0:MSN|0:NCK1|0:WNT5B|0:AR|0:PANX1|0:DPP4|0:MTSS1|0:KNG1|0:RASA1|0:MBL2|0:SRPX2|0:GIPC1|0:CRTAM|0:CADM1|0:LBP|0:P2RX7|0:P2RX4|0:PICK1|0:FIZ1|0:CD276|0:DIAPH1|0:S100A10|0:SELPLG|0:GNB2L1|0:BCAP31|0:APOL2|0:C3|0:APOF|0:ENSA|0:ANGPTL2|0:F2RL1|0:DIAPH2|0:GFRA3|0:ALCAM|0:ANGPTL1|0:ANXA1|0:AKAP9|0:GAS6|0:PLXNC1|0:CYTL1|0:STOML2|0:GLG1|0:CD72|0:TAC3|0:PCSK1N|0:GFRA1|0:SRI|0:TMED1|0:CHRNA10|0:ICOSLG			
GO:0030073	P:insulin secretion; NAS:UniProtKB		0:NEUROD1|0:MAFA|0:PDX1|0:FAM3B|0:SLC30A8|0:HNF1A|0:CYB5R4|0:EIF2AK3|0:GAL|0:CAMK2G			
GO:0044267	P:cellular protein metabolic process; ISS:HGNC		0:L2HGDH|0:CCT8L1|0:BBS10|0:BBS12|0:PIKFYVE|0:CCT8L2|0:D2HGDH			
GO:0005900	C:oncostatin-M receptor complex; IDA:BHF-UCL		0:OSM|0:OSMR|0:IL6ST			
GO:0048205	P:COPI coating of Golgi vesicle; EXP:Reactome		0:ARCN1|0:COPG|0:COPA|0:COPB1|0:COPB2|0:COPE|0:ARFGAP1|0:COPZ1|0:ARF1|0:GBF1			
GO:0002674	P:negative regulation of acute inflammatory r...; IDA:BHF-UCL		0:INS			
GO:0042511	P:positive regulation of tyrosine phosphoryla...; IMP:BHF-UCL		0:IFNG|0:IL6ST			
GO:0004720	F:protein-lysine 6-oxidase activity; TAS:ProtInc		0:LOXL3|0:LOX			
GO:0003878	F:ATP citrate synthase activity; TAS:ProtInc		0:SUCLG1|0:ACLY			
GO:0007031	P:peroxisome organization; TAS:ProtInc		0:ACOT8|0:PEX19|0:PEX2|0:ABCD1|0:ABCD3			
GO:0017140	F:lipoic acid synthase activity; ISS:UniProtKB		0:LIAS			
GO:0032147	P:activation of protein kinase activity; ISS:BHF-UCL		0:TGFB2|0:AXIN1|0:STRADA|0:STRADB|0:TPX2|0:ITGB3|0:TGFBR2|0:SLC11A1			
GO:0000910	P:cytokinesis; TAS:UniProtKB		0:ANLN|0:VPS4A|0:RALB|0:DCTN3|0:RALA|0:ROCK1|0:CNTROB|0:KLHL13|0:RAB11A|0:BIRC5|0:RAB35|0:CUL3|0:KLHL9|0:RAB11FIP4|0:AHCTF1|0:INCENP|0:KLHL21|0:MYH9|0:RAB11FIP3|0:RASA1|0:ROCK2|0:ROPN1B|0:ESPL1|0:SEPT3|0:ARHGEF11|0:CECR2|0:NOX5|0:SEPT7|0:AURKC|0:PRC1|0:DIAPH2|0:SEPT4|0:SEPT5|0:SEPT6			
GO:0008276	F:protein methyltransferase activity; IEA:InterPro		0:TRMT112|0:N6AMT1|0:METTL11A|0:C12orf72|0:HEMK1|0:PRMT10|0:C1orf156			
GO:0070373	P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB		0:DUSP3|0:DUSP6|0:TLR4|0:CNKSR3			
GO:0007548	P:sex differentiation; TAS:ProtInc		0:DMRTA2|0:DMRTB1|0:SRD5A1|0:DMRTC2|0:SRY|0:PBX1|0:DMRTA1|0:DMRT3|0:RQCD1|0:IDE|0:CDKL2|0:WNT7A|0:CYP17A1			
GO:0009584	P:detection of visible light; TAS:ProtInc		0:GRM6			
GO:0070670	P:response to interleukin-4; ISS:UniProtKB		0:CITED1			
GO:0046631	P:alpha-beta T cell activation; IDA:UniProtKB		0:INS			
GO:0048270	F:methionine adenosyltransferase regulator ac...; IDA:UniProtKB		0:MAT2B			
GO:0003108	P:negative regulation of the force of heart c...; IMP:BHF-UCL		0:ADRBK1			
GO:0004750	F:ribulose-phosphate 3-epimerase activity; IEA:EC		0:RPE			
GO:0044323	F:retinoic acid-responsive element binding; IDA:UniProtKB		0:RARA			
GO:0032848	P:negative regulation of cellular pH reduction; IDA:UniProtKB		0:BCL2			
GO:0021836	P:chemorepulsion involved in postnatal olfact...; IDA:UniProtKB		0:SLIT2|0:ROBO1			
GO:0005243	F:gap junction channel activity; NAS:UniProtKB		0:GJB1|0:GJA10|0:GJD2|0:GJB3|0:GJB4			
GO:0043547	P:positive regulation of GTPase activity; ISS:UniProtKB		0:TSC2|0:THY1			
GO:0004386	F:helicase activity; TAS:ProtInc		0:CHD9|0:HELZ|0:DHX58|0:DHX32|0:CHD7|0:SHPRH|0:HELLS|0:ERCC6L|0:SRCAP|0:IFIH1|0:HLTF|0:SMARCAD1|0:ZRANB3|0:MOV10|0:NAV2|0:RAD54L2|0:BTAF1|0:RAD54L|0:ERCC6|0:EP400|0:DQX1|0:SMARCA5|0:SMARCA2|0:SMARCA4|0:SMARCA1			
GO:0003078	P:regulation of natriuresis; NAS:BHF-UCL		0:AGTR1|0:AGT			
GO:0006405	P:RNA export from nucleus; IC:HGNC		0:HNRNPA1			
GO:0016529	C:sarcoplasmic reticulum; ISS:UniProtKB		0:NOS1|0:AKAP6|0:S100A1|0:MRVI1|0:ANK1|0:HAX1|0:PLN|0:ATP2A1			
GO:0050178	F:phenylpyruvate tautomerase activity; IDA:MGI		0:MIF			
GO:0030718	P:germ-line stem cell maintenance; ISS:UniProtKB		0:PIWIL2			
GO:0030828	P:positive regulation of cGMP biosynthetic pr...; IDA:BHF-UCL		0:APOE			
GO:0008312	F:7S RNA binding; TAS:ProtInc		0:SRP19|0:SRP54|0:SRP9L1|0:SRP9|0:SRP72|0:SRP14|0:EXOSC2			
GO:0047493	F:ceramide cholinephosphotransferase activity; IDA:UniProtKB		0:SGMS1|0:SGMS2			
GO:0001918	F:farnesylated protein binding; IDA:MGI		0:AIPL1			
GO:0071110	P:histone biotinylation; IDA:UniProtKB		0:HLCS			
GO:0004477	F:methenyltetrahydrofolate cyclohydrolase act...; TAS:ProtInc		0:MTHFD2L|0:MTHFD2|0:MTHFD1			
GO:0045236	F:CXCR chemokine receptor binding; IPI:UniProtKB		0:ITCH			
GO:0043406	P:positive regulation of MAP kinase activity; TAS:BHF-UCL		0:EDN3|0:PDGFB|0:ADRA2A|0:TGFB1|0:EGF|0:EGFR|0:HTR2B|0:TPD52L1|0:ERBB2|0:PDCD10|0:CD24|0:ELANE|0:GH1			
GO:0006641	P:triglyceride metabolic process; TAS:ProtInc		0:CEL|0:APOE|0:CETP|0:APOH|0:CAV1|0:LIPF|0:APOA2|0:PNLIPRP2			
GO:0017050	F:D-erythro-sphingosine kinase activity; IDA:UniProtKB		0:SPHK1			
GO:0004375	F:glycine dehydrogenase (decarboxylating) act...; TAS:ProtInc		0:GLDC			
GO:0004045	F:aminoacyl-tRNA hydrolase activity; IEA:InterPro		0:ICT1|0:PTRH2|0:PTRH1|0:C2orf79			
GO:0000114	P:regulation of transcription involved in G1 ...; TAS:ProtInc		0:GFI1B			
GO:0005540	F:hyaluronic acid binding; TAS:UniProtKB		0:LAYN|0:ACAN|0:STAB1|0:SUSD5|0:HAPLN1|0:NCAN|0:HAPLN4|0:BCAN|0:HAPLN2|0:HAPLN3|0:HMMR|0:STAB2|0:CD44|0:TNFAIP6|0:VCAN|0:IMPG2			
GO:0001965	F:G-protein alpha-subunit binding; IMP:UniProtKB		0:RIC8B|0:HTR2B			
GO:0005688	C:U6 snRNP; TAS:ProtInc		0:LSM4			
GO:0012501	P:programmed cell death; NAS:UniProtKB		0:PKM2|0:TOP1			
GO:0042732	P:D-xylose metabolic process; IEA:UniProtKB-KW		0:XYLB|0:DCXR			
GO:0000387	P:spliceosomal snRNP assembly; TAS:UniProtKB		0:NCBP2|0:GEMIN4|0:WDR77|0:SNUPN|0:SNRPD3|0:PHAX|0:TGS1|0:SNRPF|0:SNRPE|0:SMN2|0:NCBP1|0:SMN1|0:SNRPB|0:CLNS1A|0:SIP1|0:SNRPG|0:SNRPD1|0:SNRPD2|0:GEMIN8|0:SNRPC|0:PRMT5|0:PRMT7|0:SART1|0:GEMIN5|0:GEMIN6|0:GEMIN7			
GO:0003975	F:UDP-N-acetylglucosamine-dolichyl-phosphate ...; IDA:UniProtKB		0:DPAGT1			
GO:0042795	P:snRNA transcription from RNA polymerase II ...; IDA:UniProtKB		0:SNAPC4			
GO:0004967	F:glucagon receptor activity; TAS:ProtInc		0:GLP1R|0:GCGR			
GO:0006308	P:DNA catabolic process; IEA:InterPro		0:DNASE1L2|0:DNASE1L1|0:DNASE1			
GO:0045014	P:negative regulation of transcription by glu...; IDA:UniProtKB		0:CHMP1A			
GO:0004839	F:ubiquitin activating enzyme activity; TAS:UniProtKB		0:ATG7|0:SAE1			
GO:0046703	F:natural killer cell lectin-like receptor bi...; IDA:UniProtKB		0:MICA|0:MICB			
GO:0046848	F:hydroxyapatite binding; NAS:UniProtKB		0:AMELX|0:BGLAP|0:STATH			
GO:0006422	P:aspartyl-tRNA aminoacylation; TAS:ProtInc		0:NARS|0:NARS2|0:DARS2|0:DARS			
GO:0014894	P:response to denervation involved in regulat...; ISS:BHF-UCL		0:HDAC4			
GO:0051923	P:sulfation; IDA:BHF-UCL		0:SULT1A1|0:SULT2A1|0:SULT1C2|0:SULT1A2|0:SULT1A3|0:SULT1C4|0:SULT1A4|0:SULT1E1|0:SULT1B1			
GO:0008080	F:N-acetyltransferase activity; NAS:UniProtKB		0:SMARCE1|0:NAT10|0:SATL1|0:CSRP2BP|0:NAA50|0:NAA40|0:NAT14|0:NAT8L|0:NAT15|0:NAT6|0:C7orf52|0:NAT9|0:NAT8B|0:NAT8			
GO:0016013	C:syntrophin complex; TAS:ProtInc		0:SNTG1|0:SNTG2			
GO:0004827	F:proline-tRNA ligase activity; IEA:EC		0:EPRS|0:PARS2			
GO:0045919	P:positive regulation of cytolysis; ISS:BHF-UCL		0:RRAGA|0:P2RX7			
GO:0046456	P:icosanoid biosynthetic process; TAS:UniProtKB		0:FADS1			
GO:0008209	P:androgen metabolic process; TAS:ProtInc		0:DHRS9|0:AKR1D1|0:SHH|0:CYP3A4|0:AKR1C4			
GO:0070491	F:transcription repressor binding; ISS:BHF-UCL		0:HHEX|0:HDAC9|0:PRDM5|0:HDAC7|0:KAT5|0:HDAC5|0:HDAC4|0:RELA|0:SKI|0:HMGB1|0:NFYB|0:CBX5			
GO:0071726	P:cellular response to diacylated bacterial l...; IDA:MGI		0:TLR6|0:TLR2			
GO:0070080	F:titin Z domain binding; IPI:BHF-UCL		0:ACTN2|0:TCAP			
GO:0014819	P:regulation of skeletal muscle contraction; IMP:BHF-UCL		0:CAV3			
GO:0004941	F:beta2-adrenergic receptor activity; IDA:HGNC		0:ADRB2			
GO:0015966	P:diadenosine tetraphosphate biosynthetic pro...; IDA:UniProtKB		0:GARS			
GO:0033188	F:sphingomyelin synthase activity; IMP:HGNC		0:SGMS2|0:SGMS1			
GO:0003985	F:acetyl-CoA C-acetyltransferase activity; TAS:ProtInc		0:ACAT1|0:ACAT2|0:HADHA			
GO:0005528	F:FK506 binding; TAS:UniProtKB		0:FKBP1B|0:FKBP1A|0:FKBP3|0:NFATC1|0:FKBP6|0:FKBP2|0:FKBP5|0:FKBP4			
GO:0014067	P:negative regulation of phosphoinositide 3-k...; ISS:UniProtKB		0:TSC2			
GO:0016531	F:copper chaperone activity; IEA:InterPro		0:ATOX1|0:COX17			
GO:0071103	P:DNA conformation change; IDA:BHF-UCL		0:HHEX			
GO:0002437	P:inflammatory response to antigenic stimulus; IEP:UniProtKB		0:HMGB1			
GO:0000400	F:four-way junction DNA binding; IDA:UniProtKB		0:MEN1			
GO:0016322	P:neuron remodeling; ISS:UniProtKB		0:FARP2|0:RND1|0:APP			
GO:0016988	F:transcription initiation factor antagonist ...; IDA:UniProtKB		0:THRA			
GO:0031659	P:positive regulation of cyclin-dependent pro...; IDA:UniProtKB		0:EGFR|0:AKT1|0:ADAM17|0:FGF10|0:PIM1			
GO:0004337	F:geranyltranstransferase activity; IEA:EC		0:GGPS1|0:FDPS			
GO:0009159	P:deoxyribonucleoside monophosphate catabolic...; ISS:UniProtKB		0:C6orf108			
GO:0051298	P:centrosome duplication; ISS:UniProtKB		0:BRCA2|0:CEP192|0:NDE1			
GO:0050653	P:chondroitin sulfate proteoglycan biosynthet...; TAS:UniProtKB		0:CSGALNACT1|0:CSGALNACT2			
GO:0051373	F:FATZ binding; IDA:UniProtKB		0:MYOZ1			
GO:0042992	P:negative regulation of transcription factor...; ISS:HGNC		0:NF1			
GO:0030528	F:transcription regulator activity; NAS:UniProtKB		0:ADH1A|0:NUP62|0:HES2|0:SOHLH2|0:NEUROD6|0:RFX2|0:TCEB3CL|0:LYL1|0:SCXA|0:KIAA2018|0:OLIG3|0:SSBP2|0:MSGN1|0:HES3|0:EBF4|0:ASCL4|0:NPAS3|0:SOHLH1|0:TCF23|0:EBF3|0:TCEB3C|0:MXD3|0:ZNF711|0:NHLH2|0:SSBP3|0:C1orf83|0:ZFY|0:CAMTA1|0:AHRR|0:TCF24|0:POLR3K|0:FIGLA|0:ATOH8|0:ASCL5|0:OLIG1|0:EBF2|0:NHLH1|0:SSBP4|0:POLR2I|0:RPL7|0:NEUROD4|0:VGLL3|0:ZNRD1|0:TAL2|0:BHLHA9|0:MAF1|0:CAMTA2|0:PROX2|0:CNOT3|0:RPL7L1|0:SCXB|0:TCEB3CL2|0:MLXIP|0:HES5|0:NEUROG2|0:CITED4|0:BRF2|0:HES4|0:ATOH7|0:BPTF|0:SMARCA1|0:THAP1|0:BAZ2B|0:BAZ1B|0:BAZ1A|0:BAZ2A|0:ASH2L			
GO:0000780	C:condensed nuclear chromosome, centromeric r...; IDA:BHF-UCL		0:AURKB|0:CENPC1			
GO:0004815	F:aspartate-tRNA ligase activity; TAS:ProtInc		0:DARS2|0:NARS|0:NARS2|0:DARS			
GO:0045727	P:positive regulation of translation; NAS:UniProtKB		0:THBS1|0:SAMD4A|0:WIBG|0:CIRBP|0:IL6|0:EIF4A3|0:BCL3|0:POLDIP3|0:RPS4X|0:FAM129A|0:PIWIL2|0:RBM3|0:CD28			
GO:0014056	P:regulation of acetylcholine secretion; ISS:UniProtKB		0:CHRNA3			
GO:0033088	P:negative regulation of immature T cell prol...; ISS:BHF-UCL		0:CDKN2A			
GO:0030184	F:nitric oxide transmembrane transporter acti...; IDA:UniProtKB		0:AQP1			
GO:0051091	P:positive regulation of transcription factor...; TAS:UniProtKB		0:PPARGC1A|0:SMARCB1|0:PPARG|0:LRP6|0:PPAP2B|0:WNT2|0:SP100|0:IL10|0:SMARCA4|0:FZD4|0:FZD1|0:JUP|0:IL6|0:GTF2A2|0:NFAM1|0:ANXA3|0:EP300|0:HDAC5|0:HDAC4|0:PTEN|0:FOXA1|0:ABRA|0:JMY|0:CEBPG			
GO:0005993	P:trehalose catabolic process; TAS:ProtInc		0:TREH			
GO:0015101	F:organic cation transmembrane transporter ac...; TAS:UniProtKB		0:SLC22A2|0:SLC7A8|0:SLC22A13|0:SLC22A14|0:SLC22A1			
GO:0004155	F:6,7-dihydropteridine reductase activity; TAS:ProtInc		0:QDPR			
GO:0005159	F:insulin-like growth factor receptor binding; TAS:ProtInc		0:INSR|0:IGF1|0:INS|0:ARRB1|0:YWHAG|0:IRS1|0:SHC1|0:SOCS1|0:PIK3R1|0:SOCS2|0:YWHAH|0:IGF2|0:INSL4			
GO:0016491	F:oxidoreductase activity; TAS:UniProtKB		0:ETFA|0:APEX1|0:NDOR1|0:KDM1A|0:AGPS|0:DNHD1|0:DCT|0:F8|0:C5orf4|0:KCNAB1|0:F5|0:C20orf79|0:NECAB3|0:NECAB2|0:TYW1|0:FTL|0:C1orf27|0:FTHL17|0:GCLM|0:AKR1B15|0:FTH1P19|0:RTN4IP1|0:COQ7|0:SCP2|0:ALDH16A1|0:KCNAB3|0:RFESD|0:NECAB1|0:C9orf21|0:TYW1B|0:SETD2|0:HSDL1|0:KCNAB2|0:VAT1|0:HSD17B13|0:GFOD1|0:AIFM1|0:DHRS7C|0:DHRS13|0:AKR1CL1|0:FDFT1|0:ENOX1|0:DHRSX|0:STEAP2|0:MOSC1|0:HEPHL1|0:SUMF1|0:PYROXD2|0:KDM1B|0:STEAP1|0:ALKBH8|0:DHRS11|0:AIFM3|0:AKR7L|0:ZADH2|0:DHRS7|0:PYROXD1|0:HSDL2|0:RDH13|0:STEAP4|0:CYBASC3|0:DHRS3|0:FADS6|0:FOXRED2|0:IFI30|0:GFOD2|0:HEPH|0:VAT1L|0:FOXRED1|0:DHRS12|0:DHRS1|0:FA2H|0:MOSC2|0:IYD|0:RNLS|0:DHRS7B|0:RDH14|0:SDR9C7|0:SQRDL|0:SMOX|0:HSD11B1L|0:OXNAD1|0:PDIA5|0:WWOX			
GO:0051425	F:PTB domain binding; IPI:UniProtKB		0:INSR			
GO:0043231	C:intracellular membrane-bounded organelle; IDA:UniProtKB		0:SLC9A3R1|0:THSD1|0:ANGPTL4|0:MMP3|0:MMEL1|0:EML2|0:PPP2R5E|0:TLN1|0:PHKA1|0:G6PD|0:GJB6|0:ARHGAP1|0:TGFBR3|0:TAOK1|0:SLIT1|0:SLC30A1|0:CCDC80|0:PITPNM2|0:AQP9|0:GLRA1			
GO:0004175	F:endopeptidase activity; TAS:ProtInc		0:PSENEN|0:PSEN1|0:SENP1			
GO:0051100	P:negative regulation of binding; IDA:BHF-UCL		0:CYP2D6			
GO:0047196	F:long-chain-alcohol O-fatty-acyltransferase ...; IEA:EC		0:AWAT2|0:AWAT1			
GO:0042975	F:peroxisome proliferator activated receptor ...; IPI:UniProtKB		0:HMGA1|0:MED1			
GO:0003099	P:positive regulation of the force of heart c...; TAS:BHF-UCL		0:EDN2			
GO:0001530	F:lipopolysaccharide binding; NAS:UniProtKB		0:HSPD1|0:BPI|0:CD14|0:SELP|0:LBP|0:P2RX7|0:BPIL2			
GO:0016303	F:1-phosphatidylinositol-3-kinase activity; TAS:ProtInc		0:PIK3CA|0:PIK3C2B|0:ATM|0:PIK3CD|0:PIK3C2G|0:PIK3C3|0:PIK3CG|0:PIK3CB|0:PIK3C2A|0:PIK3R3			
GO:0004727	F:prenylated protein tyrosine phosphatase act...; TAS:ProtInc		0:PTP4A2|0:PTP4A3			
GO:0001501	P:skeletal system development; TAS:UniProtKB		0:PTHLH|0:CHD7|0:TBX3|0:COL1A2|0:DLL3|0:FBN1|0:NPR3|0:ACAN|0:ANKH|0:AHSG|0:PTH|0:UFD1L|0:IGF1|0:CLEC3B|0:SPP2|0:SHOX2|0:LECT2|0:COL10A1|0:EBP|0:COL12A1|0:PRDX1|0:ADAMTS4|0:MATN3|0:SUFU|0:ARSE|0:HOXA13|0:FGFR3|0:GUSBP1|0:COL19A1|0:POSTN|0:DLX6|0:PAPSS1|0:CMKLR1|0:ANXA2|0:SHOX|0:MEPE|0:TNFRSF11B|0:AEBP1|0:EXTL1|0:FRZB|0:TRAPPC2P1|0:TRPS1|0:PTH1R|0:COL9A2|0:TRAPPC2|0:TEAD4|0:INHA|0:TCOF1|0:IGFBP4|0:EN1|0:PHEX|0:ETS2|0:PAPSS2|0:HOXD13|0:PRELP|0:CLEC3A|0:TLL1|0:RPS6KA3|0:GDF11			
GO:0051018	F:protein kinase A binding; TAS:ProtInc		0:AKAP4|0:AKAP6|0:AKAP12|0:AKAP11|0:AKAP3			
GO:0010859	F:calcium-dependent cysteine-type endopeptida...; IEA:InterPro		0:CAST			
GO:0050508	F:glucuronosyl-N-acetylglucosaminyl-proteogly...; ISS:UniProtKB		0:EXTL1|0:EXT2|0:EXT1			
GO:0005086	F:ARF guanyl-nucleotide exchange factor activity; TAS:ProtInc		0:GBF1|0:PSD4|0:IQSEC1|0:ARFGEF2|0:ARFGEF1|0:PSD2|0:PSD|0:IQSEC3|0:KIAA1244|0:IQSEC2|0:FBXO8|0:CYTH4|0:HERC1|0:CYTH3|0:CYTH1|0:CYTH2			
GO:0010273	P:detoxification of copper ion; ISS:UniProtKB		0:ATP7A			
GO:0014909	P:smooth muscle cell migration; IMP:BHF-UCL		0:AAMP|0:ITGB3			
GO:0071535	F:RING-like zinc finger domain binding; IPI:UniProtKB		0:RNF2|0:BMI1			
GO:0016787	F:hydrolase activity; NAS:UniProtKB		0:SBNO1|0:C13orf27|0:IDI1|0:ACAD10|0:ADAT3|0:HDHD2|0:CECR5|0:CPSF2|0:IDI2|0:DCLRE1A|0:PM20D2|0:ABHD14B|0:SAMHD1|0:ABHD8|0:LIPK|0:HINT1|0:SPO11|0:LSG1|0:PNPLA5|0:ITPK1|0:NT5DC1|0:RHOT1|0:MBLAC1|0:C9orf156|0:DCPS|0:SPAG1|0:LACTB|0:CPSF3L|0:NDST4|0:TMEM55B|0:CPPED1|0:HINT2|0:CMBL|0:MEST|0:NUDT15|0:FAHD2B|0:NUDT8|0:FAHD2A|0:ABHD14A|0:CDADC1|0:LYPLA2|0:BPHL|0:SERHL|0:PDE12|0:EPHX3|0:HINT3|0:NUDT16|0:FAAH2|0:THEM5|0:RHOT2|0:PPAPDC3|0:NUDT18|0:PNPLA1|0:ETHE1|0:ABHD11|0:DCP1B|0:FAHD1|0:DDHD2|0:ENTPD7|0:PLBD2|0:FAM108A3P|0:NUDT13|0:MPPED2|0:NDST1|0:RBBP9|0:GNPDA1|0:LIPH|0:NT5DC4|0:NT5DC3|0:LIPM|0:AADACL3|0:ENPP5|0:FAM108A2|0:PLBD1|0:DCP2|0:NUDT17|0:DCP1A|0:LIPI|0:EPHX4|0:ASNA1|0:PNPLA7|0:ADAT2|0:FAM108C1|0:SERHL2|0:PPAPDC2|0:LIPN|0:FAM108A1|0:NDST3|0:NUDT19|0:DDHD1|0:ENPP4|0:ABHD4|0:HAGHL|0:MPPED1|0:NDST2|0:GNPDA2|0:ABHD12B|0:MBLAC2|0:OLA1|0:LACTB2|0:INPP5F|0:NAAA|0:ABHD13|0:NT5DC2|0:ENTPD1|0:LIPJ|0:FAM108B1|0:NOTUM|0:NUDT6|0:MANEAL|0:TMEM55A|0:OVCA2			
GO:0071614	F:linoleic acid epoxygenase activity; IDA:BHF-UCL		0:CYP2J2			
GO:0016971	F:flavin-linked sulfhydryl oxidase activity; IGI:UniProtKB		0:QSOX1			
GO:0071207	F:histone pre-mRNA stem-loop binding; ISS:UniProtKB		0:SLBP|0:ERI1			
GO:0046826	P:negative regulation of protein export from ...; IDA:UniProtKB		0:BARD1			
GO:0031103	P:axon regeneration; TAS:UniProtKB		0:RTN4RL2|0:RTN4RL1			
GO:0030126	C:COPI vesicle coat; NAS:UniProtKB		0:SCYL1|0:COPB2|0:COPG2|0:COPZ1|0:AP4E1|0:ARCN1|0:COPG|0:COPA|0:COPB1|0:COPE|0:COPZ2			
GO:0060287	P:cilium movement involved in determination o...; ISS:UniProtKB		0:RFX3|0:OFD1			
GO:0005276	F:hydrogen:vesicular amine antiporter activity; EXP:Reactome		0:SLC32A1			
GO:0046902	P:regulation of mitochondrial membrane permea...; TAS:UniProtKB		0:BCL2L1|0:BAK1|0:BNIP3|0:BCL2|0:TP53			
GO:0060001	F:minus-end directed microfilament motor acti...; NAS:UniProtKB		0:MYO6			
GO:0001891	C:phagocytic cup; ISS:BHF-UCL		0:CORO1A|0:TNF			
GO:0045987	P:positive regulation of smooth muscle contra...; IDA:UniProtKB		0:MYOCD|0:SRF|0:SPHK1|0:PROK2			
GO:0031053	P:primary microRNA processing; TAS:BHF-UCL		0:DGCR8|0:SRRT|0:SMAD2|0:SMAD1			
GO:0004948	F:calcitonin receptor activity; NAS:UniProtKB		0:CALCR|0:CRCP			
GO:0035025	P:positive regulation of Rho protein signal t...; TAS:UniProtKB		0:GPR55|0:ARRB1|0:ABRA|0:RAC1			
GO:0008429	F:phosphatidylethanolamine binding; TAS:ProtInc		0:MAP1LC3A|0:PEBP1			
GO:0003777	F:microtubule motor activity; TAS:ProtInc		0:DNHD1|0:KLC2|0:KIF7|0:KIF26A|0:KIF21B|0:DNAH12|0:KIF12|0:DYNLL1|0:KIF27|0:KIF13A|0:KIF20A|0:KIF14|0:KIF25|0:KIF26B|0:KIF4B|0:DYNLL2|0:KIF6|0:KIF3C|0:KIF2A|0:KIF20B|0:KIF5A|0:KIF1C|0:KIF15|0:KIF19|0:KIF18B|0:KIF24|0:STARD9|0:DNAH14|0:KIF16B|0:KLC3|0:KIF2B|0:DNAH10|0:KIF1A|0:KIF3A|0:KIF21A|0:DYNC2H1|0:KIFC2|0:KIF9|0:KLC4|0:KLC1|0:DNAI2|0:BBS4|0:CENPE|0:KIF5B|0:DYNC1I1|0:KIF1B|0:SMC1A|0:DNAH1|0:DYNLRB2|0:DNAH2|0:DNAH17|0:DYNLRB1|0:DNAH9|0:SMC3|0:DNAH6|0:DNAH5|0:DNAH11|0:DNAL4|0:DNAH8|0:KIFC1|0:KIF13B|0:DYNC1I2|0:DNAH7|0:DYNC1H1|0:DNAH3|0:KIF4A|0:KIF22|0:DNALI1|0:KIF23|0:KIF11|0:KIFC3|0:KIF5C|0:APPBP2|0:KIF2C			
GO:0016174	F:NAD(P)H oxidase activity; TAS:UniProtKB		0:CYB5R4|0:KMO|0:DUOX2|0:DUOX1|0:NOX4			
GO:0050648	F:5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetra...; NAS:UniProtKB		0:OXER1			
GO:0045089	P:positive regulation of innate immune response; TAS:UniProtKB		0:TLR8|0:POLR3D|0:POLR3C|0:POLR3G|0:POLR3B|0:POLR3F|0:EREG|0:IFNB1|0:CD1D|0:IFNK			
GO:0031673	C:H zone; IDA:UniProtKB		0:ATP2A1			
GO:0004569	F:glycoprotein endo-alpha-1,2-mannosidase act...; IEA:EC		0:MANEA			
GO:0008420	F:CTD phosphatase activity; ISS:UniProtKB		0:CTDSP2|0:CTDSP1|0:CTDP1|0:PPM1M			
GO:0042834	F:peptidoglycan binding; TAS:HGNC		0:TLR2|0:NOD1|0:NLRP3			
GO:0051823	P:regulation of synapse structural plasticity; ISS:UniProtKB		0:CTNNA2			
GO:0001582	P:detection of chemical stimulus involved in ...; IDA:HGNC		0:TAS1R3|0:TAS1R2			
GO:0004629	F:phospholipase C activity; TAS:ProtInc		0:PLCXD3|0:PLCXD2|0:ACAP1|0:PLCXD1|0:PDIA3			
GO:0042700	P:luteinizing hormone signaling pathway; ISS:UniProtKB		0:EREG			
GO:0031514	C:motile secondary cilium; ISS:UniProtKB		0:RSPH4A|0:RSPH9|0:BBS4|0:BBS2|0:TAS2R43|0:NPHP1|0:MKKS|0:WDR19			
GO:0045860	P:positive regulation of protein kinase activity; TAS:BHF-UCL		0:TAB2|0:MAP2K3|0:CD4|0:TRAF4|0:ALS2|0:PRKAG2|0:CENPE|0:CSF1|0:RELN|0:PRKAG1			
GO:0005819	C:spindle; TAS:ProtInc		0:FBXO5|0:PIN4|0:KIF23|0:KIF11|0:CLTC|0:ANXA11|0:INCENP|0:MZT1|0:CLTCL1|0:CBX1|0:SEPT12|0:CBX3|0:MAEA|0:MZT2B|0:CEP350|0:NUP85|0:SEPT7|0:SEPT2|0:HAUS7|0:TERF1|0:HAUS3|0:MAP7D1|0:MTUS1|0:MAP9|0:HSPB1|0:BIRC5|0:RACGAP1|0:SAC3D1|0:PRPF19|0:MAD2L1BP|0:KIF14|0:HAUS4|0:SNCG|0:MAP1S|0:MID1|0:INVS|0:CDCA8|0:KIAA1009|0:CDC14A|0:CSPP1|0:CENPE|0:SEPT6|0:ARHGEF2|0:KIF20B|0:KIF15|0:HAUS5|0:HAUS2|0:KIFC1|0:RCC2|0:AURKB|0:SPAST|0:CRMP1|0:HAUS6|0:EVI5|0:KIF2B|0:MAP7D3|0:NDEL1|0:RIF1|0:ARL3|0:PTP4A1|0:CEP170|0:DCTN3|0:MZT2A|0:MAD1L1|0:NEDD9|0:TTK|0:CDC20			
GO:0016311	P:dephosphorylation; IDA:UniProtKB		0:THTPA			
GO:0019049	P:evasion of host defenses by virus; IDA:BHF-UCL		0:TGFB1			
GO:0007276	P:gamete generation; TAS:ProtInc		0:SPIN2B|0:SPIN4|0:SPIN3|0:SPIN2A|0:SPIN1|0:RHOXF1|0:CHEK1			
GO:0045076	P:regulation of interleukin-2 biosynthetic pr...; IDA:UniProtKB		0:IL17F			
GO:0048488	P:synaptic vesicle endocytosis; TAS:ProtInc		0:SNCA|0:ITSN1|0:SYNJ1			
GO:0015459	F:potassium channel regulator activity; TAS:ProtInc		0:ADRB2|0:KCNE1|0:KCNS1|0:SGK2|0:ARPP19|0:ABCC9|0:DRD4|0:DRD2|0:DLG1|0:KCNMB3|0:KCNMB2|0:KCNAB1|0:KCNJ12|0:KCNV1|0:KCNAB3|0:KCNS3|0:KCNMB1|0:KCNAB2			
GO:0042779	P:tRNA 3'-trailer cleavage; IEA:InterPro		0:ELAC1			
GO:0055090	P:acylglycerol homeostasis; IDA:BHF-UCL		0:ANGPTL3|0:APOA5			
GO:0004493	F:methylmalonyl-CoA epimerase activity; IDA:UniProtKB		0:MCEE			
GO:0042346	P:positive regulation of NF-kappaB import int...; NAS:UniProtKB		0:TLR3|0:TNF|0:TLR4|0:TLR9|0:TLR7|0:TLR2|0:SPHK1|0:RHOA			
GO:0016238	P:chaperone-mediated autophagy; TAS:BHF-UCL		0:SQSTM1			
GO:0035257	F:nuclear hormone receptor binding; IPI:UniProtKB		0:TACC2|0:NCOA2|0:TCF7L2|0:SMARCD3			
GO:0010614	P:negative regulation of cardiac muscle hyper...; ISS:UniProtKB		0:CAV3|0:P2RX4|0:BMP10|0:GLRX3			
GO:0004861	F:cyclin-dependent protein kinase inhibitor a...; TAS:ProtInc		0:CDKN1A|0:CDKN2D|0:CDKN2B|0:CDKN2C|0:HEXIM1|0:HEXIM2|0:KAT2B|0:CDKN1C|0:CDKN1B			
GO:0070324	F:thyroid hormone binding; IDA:UniProtKB		0:THRA|0:CRYM			
GO:0051864	F:histone demethylase activity (H3-K36 specific); ISS:UniProtKB		0:PHF8|0:JMJD5|0:JHDM1D|0:KDM4A|0:KDM2B|0:KDM2A|0:C14orf169			
GO:0009967	P:positive regulation of signal transduction; NAS:UniProtKB		0:CDKN2AIP|0:HDAC6|0:CD80			
GO:0030047	P:actin modification; NAS:UniProtKB		0:TRIOBP			
GO:0046847	P:filopodium assembly; ISS:UniProtKB		0:FGD1|0:ARHGAP26|0:BAIAP2L2|0:MTSS1L|0:MTSS1|0:BAIAP2|0:BAIAP2L1|0:FGD3|0:FGD6|0:FGD2|0:FGD5|0:FGD4|0:DNM3			
GO:0035299	F:inositol pentakisphosphate 2-kinase activity; IDA:HGNC		0:IPPK			
GO:0004828	F:serine-tRNA ligase activity; ISS:UniProtKB		0:SARS|0:TPR|0:ZNFX1|0:SARS2			
GO:0042851	P:L-alanine metabolic process; IDA:UniProtKB		0:GPT2			
GO:0004137	F:deoxycytidine kinase activity; TAS:ProtInc		0:DCK			
GO:0006672	P:ceramide metabolic process; TAS:UniProtKB		0:SGPL1|0:ACER3|0:ACER2|0:ORMDL1|0:ORMDL2|0:ORMDL3|0:PPP2R1A|0:PPP2CA|0:ASAH1|0:NSMAF|0:ASAH2|0:CERK			
GO:0005052	F:peroxisome matrix targeting signal-1 binding; IDA:UniProtKB		0:PEX5			
GO:0070826	C:paraferritin complex; IDA:UniProtKB		0:SLC11A2			
GO:0070328	P:triglyceride homeostasis; NAS:BHF-UCL		0:CETP|0:LPL|0:APOC4|0:GPIHBP1|0:LIPC|0:APOC3|0:APOA5|0:APOC2|0:ANGPTL4|0:ANGPTL3|0:SCARB1|0:MLXIPL			
GO:0008434	F:vitamin D3 receptor activity; IDA:BHF-UCL		0:VDR			
GO:0045161	P:neuronal ion channel clustering; TAS:UniProtKB		0:MTCH1|0:PICK1			
GO:0034418	P:urate biosynthetic process; IMP:UniProtKB		0:PNP|0:PRPS1			
GO:0031674	C:I band; TAS:BHF-UCL		0:MYL3|0:CACNA1S|0:RYR1|0:ATP2A1|0:ACTC1|0:ALDOA			
GO:0031064	P:negative regulation of histone deacetylation; IGI:BHF-UCL		0:FOXP3			
GO:0003735	F:structural constituent of ribosome; TAS:UniProtKB		0:RPL10|0:MRPS22|0:RPS15A|0:MRPL41|0:RPS19|0:RPS3|0:RPS2|0:RPS20|0:FAU|0:RPS29|0:RPS5|0:RPS11|0:RPS18|0:MRPL4|0:RPS23|0:MRPL33|0:RPL36AL|0:MRPL49|0:RPS27L|0:RPL10L|0:RSL24D1|0:MRPL24|0:RPSA|0:RPS8|0:RPS26|0:RPS15|0:CYLD|0:MRPL15|0:RPL12|0:MRPL3|0:MRPS5|0:RPS12|0:RPS26P11|0:RPL32|0:MRPS9|0:RPL17|0:RPL37A|0:RPL39L|0:MRPL47|0:MRPL2|0:MRPS2|0:RPS7|0:RPS27|0:RPS28|0:RPS21|0:MRPL22|0:RPS3A|0:MRPL14|0:RPL35A|0:RPS16|0:MRPL19|0:RPS13|0:MRPS30|0:RPS6|0:RSL1D1|0:RPL36A|0:MRPS11|0:MRPL17|0:MRPL36|0:RPL10A|0:RPL7L1|0:MRPL48|0:RPL39P5|0:MRPL21|0:RPL26L1|0:RPS4Y2|0:MRPS10|0:MRPL30|0:RPS9|0:RPL22L1|0:RPS14|0:RPS4Y1|0:RPS4X|0:MRPS24|0:MRPL10|0:MRPL52|0:MRPL51|0:MRPS7|0:MRPL55|0:MRPS21|0:MRPL35|0:MRPS16|0:MRPL34|0:MRPS18A|0:MRPL32|0:MRPL11|0:MRPS36|0:MRPL27|0:MRPS15|0:MRPL42|0:MRPL37|0:MRPS6|0:MRPS18B|0:MRPL28|0:RPS24|0:MRPL9|0:RPL36|0:RPS17|0:MRPS18C|0:MRPL13|0:MRPL43|0:MRPL18|0:MRPL45|0:MRPS25|0:MRPS17|0:MRPS33|0:RPL23|0:RPL4|0:RPL38|0:MRPL12|0:RPLP0|0:RPL34|0:RPL22|0:RPL21|0:RPL18A|0:RPL3|0:RPL9|0:RPL23A|0:MRPL23|0:RPL26|0:RPLP1|0:MRPS12|0:RPL8|0:RPL29|0:RPL31|0:RPL14|0:RPL6|0:RPL18|0:RPL13|0:RPL41|0:RPL24|0:RPL7|0:RPL13A|0:RPL7A|0:RPLP2|0:RPL15|0:RPL28|0:RPL5|0:RPL3L|0:RPL35|0:RPL11|0:RPL27A|0:RPL27|0:RPL37|0:RPL19|0:RPL39|0:RPL30|0:MRPS14			
GO:0070564	P:positive regulation of vitamin D receptor s...; IDA:BHF-UCL		0:CYP27B1			
GO:0032228	P:regulation of synaptic transmission, GABAergic; ISS:UniProtKB		0:DRD2|0:USP46			
GO:0060674	P:placenta blood vessel development; TAS:BHF-UCL		0:ITGB8			
GO:0045927	P:positive regulation of growth; NAS:UniProtKB		0:TMX1			
GO:0017110	F:nucleoside-diphosphatase activity; IEA:EC		0:ENTPD5|0:ENTPD6|0:CANT1			
GO:0070389	P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB		0:DNAJB1|0:DNAJC7|0:PTGES3|0:BAG1			
GO:0034356	P:NAD biosynthesis via nicotinamide riboside ...; IGI:UniProtKB		0:PNP			
GO:0010466	P:negative regulation of peptidase activity; IDA:UniProtKB		0:ECM1			
GO:0070888	F:E-box binding; IDA:UniProtKB		0:MYC|0:ASCL1|0:TCF3|0:ASCL2|0:TFAP4			
GO:0019829	F:cation-transporting ATPase activity; NAS:UniProtKB		0:ATP9B|0:ATP8A1			
GO:0005779	C:integral to peroxisomal membrane; TAS:ProtInc		0:FIS1|0:PEX12|0:PEX11A|0:PEX16|0:PEX13|0:PEX3|0:PEX10|0:PEX26|0:PEX2|0:PEX11B|0:ABCD1|0:MPV17|0:ABCD3			
GO:0019985	P:translesion synthesis; IDA:UniProtKB		0:DTL|0:PCNA			
GO:0005113	F:patched binding; NAS:UniProtKB		0:IHH			
GO:0043383	P:negative T cell selection; ISS:UniProtKB		0:THEMIS			
GO:0000774	F:adenyl-nucleotide exchange factor activity; IEA:InterPro		0:GRPEL2|0:GRPEL1			
GO:0032859	P:activation of Ral GTPase activity; ISS:UniProtKB		0:RALGAPA2|0:RALGAPB|0:RALGAPA1			
GO:0046889	P:positive regulation of lipid biosynthetic p...; NAS:BHF-UCL		0:AKT1|0:INS			
GO:0045423	P:regulation of granulocyte macrophage colony...; IDA:UniProtKB		0:IL17F			
GO:0001976	P:neurological system process involved in reg...; ISS:BHF-UCL		0:CALCA|0:DRD2			
GO:0005945	C:6-phosphofructokinase complex; NAS:UniProtKB		0:PFKM|0:PFKL|0:PFKP			
GO:0006488	P:dolichol-linked oligosaccharide biosyntheti...; TAS:UniProtKB		0:ALG12|0:ALG2|0:SRD5A3|0:MPDU1			
GO:0043114	P:regulation of vascular permeability; TAS:UniProtKB		0:BDKRB2|0:AZU1|0:SRC|0:YES1|0:NPR1|0:NPPB			
GO:0033693	P:neurofilament bundle assembly; IDA:UniProtKB		0:NEFL			
GO:0046320	P:regulation of fatty acid oxidation; TAS:BHF-UCL		0:ACSL1|0:STRADA|0:PRKAG3|0:CAB39|0:PRKAB1|0:CPT2|0:SLC25A20|0:ACACB|0:PRKAB2|0:STRADB|0:PRKAA1|0:PRKAG1|0:CPT1B|0:PRKAA2|0:STK11|0:CAB39L|0:PRKAG2			
GO:0006212	P:uracil catabolic process; IDA:UniProtKB		0:DPYS|0:DPYD			
GO:0032786	P:positive regulation of RNA elongation; IDA:UniProtKB		0:ERCC6			
GO:0031095	C:platelet dense tubular network membrane; ISS:BHF-UCL		0:ITPR3|0:ITPR1|0:ITPR2|0:EHD1			
GO:0008441	F:3'(2'),5'-bisphosphate nucleotidase activity; EXP:Reactome		0:BPNT1			
GO:0045047	P:protein targeting to ER; ISS:UniProtKB		0:SEC61G|0:SEC61A1			
GO:0003689	F:DNA clamp loader activity; TAS:UniProtKB		0:RFC4|0:RFC2|0:RFC5|0:RFC1|0:RFC3			
GO:0005730	C:nucleolus; TAS:UniProtKB		0:ELP2|0:NBN|0:CBX5|0:CDKN2A|0:SP100|0:FAM64A|0:SIRT1|0:ELP3|0:IKBKAP|0:RPS19|0:NUFIP1|0:NF2|0:IMP4|0:SMUG1|0:SPTBN1|0:IMP3|0:UTY|0:ZNF687|0:GATA1|0:ZNF146|0:PITX1|0:SEPT2|0:ADAR|0:AGBL2|0:MSN|0:NKRF|0:CAPG|0:ACTN2|0:HMGB2|0:CSRNP3|0:PGRMC1|0:ZNF71|0:VSX2|0:CDC5L|0:BCLAF1|0:STAT1|0:IDH3G|0:HNRNPA1|0:PNKP|0:SMARCB1|0:FOXK1|0:ETV6|0:KIAA0020|0:URB2|0:RPL9|0:CSTB|0:ZNF22|0:HMGB1|0:STON2|0:SMARCA5|0:ZSCAN1|0:MBIP|0:VRK1|0:MYH2|0:ZNF275|0:HNRPA1L3|0:POLR2F|0:CAMK4|0:WASL|0:ATF3|0:DDX47|0:ETV4|0:HMGN5|0:MYH7|0:SOX11|0:PARN|0:MLF1|0:KDM6A|0:NLK|0:SSB|0:SP140|0:CC2D1A|0:DKC1|0:TSG101|0:LRRC7|0:SIX1|0:ACTN4|0:MED12|0:MYH1|0:PPM1E|0:HNRNPA2B1|0:ZNF415|0:FKBP15|0:USP36|0:NLE1|0:RCOR3|0:ZNF597|0:SRPK2|0:HNRNPA3|0:WHSC1|0:MYH6|0:CBS|0:KDM4A|0:TWISTNB|0:ACTN1|0:WRB|0:RRP1B|0:STX17|0:HIF1A|0:NFKBIE|0:EP400|0:DDX24|0:NOL11|0:KIAA0415|0:MTDH|0:MINA|0:ZBTB43|0:SUB1|0:PRKRIR|0:PHF6|0:NFIB|0:OSR1|0:CCT5|0:UTP3|0:REXO4|0:ZNF506|0:KLHL7|0:FAM32A|0:FGF18|0:DDX56|0:THAP2|0:RPL36|0:LYAR|0:SENP3|0:C15orf29|0:ABL1|0:IFI16|0:PARP2|0:SRP19|0:S100A16|0:TCOF1|0:AEN|0:MDM2|0:NCL|0:RRP36|0:VCX|0:WRN|0:MEAF6|0:FTSJ2|0:ARL4A|0:MKI67|0:ILF2|0:NOM1|0:COIL|0:PIN4|0:PARP1|0:PML|0:MKI67IP|0:RPF1|0:TOP1|0:KAT5|0:MYC|0:CIRH1A|0:CIAPIN1|0:RBM19|0:TSPYL2|0:CERKL|0:RRS1|0:UTP20|0:FBXW7|0:PHF8|0:SBDS|0:TP53|0:MORF4L2|0:KIF20B|0:NSUN2|0:ZNF346|0:HJURP|0:RPS7|0:WDR74|0:RPS3A|0:RPS13|0:POLA1|0:PNO1|0:RBPJ|0:CDC14B|0:RPS6|0:RNF20|0:BLM|0:NOL8|0:XRN2|0:ZNF655|0:RPS10|0:MDFIC|0:NEK11|0:EXOSC1|0:ERCC6|0:SDAD1|0:APTX|0:MPHOSPH10|0:RRP1|0:PHF2|0:RPL11|0:DEDD2|0:RPS25|0:RPS9|0:ERI1|0:PPP1CC|0:CTCF|0:RRP8|0:DDX54|0:PA2G4|0:ZNF330|0:RPS14|0:BRIX1|0:NAT10|0:DIMT1L|0:EXOSC7|0:TSEN54|0:DDX50|0:MRO|0:WIBG|0:RBM4B|0:SKIV2L2|0:PPP1CB|0:PRKRIP1|0:MAFIP|0:NOL7|0:KDM2B|0:SENP5|0:ZFP106|0:HAND1|0:KRR1|0:SETX|0:GNL2|0:PHLDA1|0:KDM5A|0:UTP14C|0:GRWD1|0:EXOSC3|0:ERVK4|0:TEX10|0:RBM34|0:FRG1|0:RBM28|0:DNAJB1|0:RSL24D1|0:WDR43|0:RRP9|0:MIDN|0:RNASEN|0:DIS3|0:NIP7|0:YPEL4|0:HNRNPM|0:WTAP|0:ZNF385A|0:UTP11L|0:NUSAP1|0:DDX5|0:MPHOSPH6|0:DAXX|0:EBNA1BP2|0:RPP21|0:WDR3|0:RDM1|0:KLK6|0:MCRS1|0:MYO1C|0:WDR75|0:UTP23|0:HEATR1|0:PPAN|0:GNL3L|0:GTPBP4|0:XPO1|0:RRP12|0:DDX51|0:CDCA8|0:NOC3L|0:FBLL1|0:ZNF593|0:BCAS2|0:ABT1|0:NUDT16|0:PPP1CA|0:INO80B|0:UTP18|0:ARL4D|0:ZCCHC17|0:YPEL3|0:RRN3|0:ISG20L2|0:UTP14A|0:TSEN2|0:ESF1|0:PARP10|0:NSA2|0:NVL|0:EXOSC6|0:NMD3|0:PWP2|0:CDC14C|0:MRTO4|0:DGCR8|0:FCF1|0:USP17L1P|0:TSPYL1|0:DCAF13|0:FAM9A|0:PSPC1|0:PNMA3|0:NEK2|0:YPEL2|0:CBFA2T3|0:EIF6|0:RCC2|0:NHP2|0:DDX52|0:NOP16|0:C16orf88|0:C1D|0:USP17|0:NOL9|0:TOE1|0:G2E3|0:TBL3|0:EXOSC2|0:NOP10|0:ATXN7|0:TOP2B|0:RSL1D1|0:NOL10|0:DCAF17|0:RBM4|0:TSEN15|0:C14orf169|0:ZMAT3|0:GTPBP10|0:STK35|0:TUT1|0:STOX1|0:STAU2|0:MAK16|0:RBBP6|0:ZNRD1|0:CA9|0:MUS81|0:PNMA2|0:LIN28A|0:UTP15|0:AATF|0:FTSJ3|0:EXOSC8|0:DHX9|0:NOL12|0:RPL5|0:TTF1|0:TSEN34|0:SMG6|0:KIAA0649|0:BYSL|0:GLTSCR2|0:IPO5|0:PAK1IP1|0:DDX31|0:UTP6|0:TERT|0:EME1|0:DHX33|0:NOC2L|0:SIN3A|0:ILF3|0:RPF2|0:SAP30L|0:LAS1L|0:POLR2H|0:PDCD11|0:RPS19BP1|0:POLR1E|0:DEDD|0:BAZ2A|0:TSR1|0:RASL11A|0:NOC4L|0:NLRP5|0:N4BP1|0:NOL6|0:GNL3|0:VCX3A|0:MYBBP1A|0:EMG1|0:DNAJB9|0:ANG|0:VCX3B|0:UBTF|0:WDR55|0:PLK4|0:BMS1|0:URB1|0:RCL1|0:EXOSC5|0:EXOSC4|0:FMR1|0:PNMA1|0:DDX21|0:FXR1|0:GEMIN4|0:RPL3|0:ZNF259|0:PTBP1|0:ZNF274|0:NOP2|0:EXOSC10|0:EXOSC9|0:SRP68|0:SLC29A2|0:DDX11|0:ASNA1|0:NOL4|0:NOL3|0:RPL35|0:NOLC1|0:OASL			
GO:0006935	P:chemotaxis; TAS:UniProtKB		0:RNASE2|0:PROK2|0:GPR77|0:CYR61|0:CMTM1|0:SERPIND1|0:ROBO3|0:CCL4L1|0:CMTM6|0:CMTM3|0:CMTM2|0:CMTM7|0:CREB3|0:CCL4L2|0:ROBO2|0:PPBP|0:CMTM4|0:TYMP|0:S100A8|0:CXCL17|0:FPR3|0:ECSCR|0:S100A9|0:CMTM8|0:CCL4|0:CMTM5|0:C3AR1|0:OR1D2|0:XCL2|0:CCL3L1|0:ENPP2|0:CCL3L3|0:PLP2|0:CCR1|0:CXCL13|0:CCL19|0:XCR1|0:HRAS|0:MAPK14|0:CXCL1|0:CCL26|0:CCR6|0:MAPK1|0:DEFB1|0:AIMP1|0:LECT2|0:CCL21|0:CXCL6|0:CCR3|0:CCL18|0:CXCL2|0:DEFB4B|0:CCRL1|0:FPR2|0:CXCL14|0:CXCL12|0:DEFB4A|0:CCR7|0:CCR4|0:RALBP1|0:CXCL11|0:CCL20|0:CXCL9|0:PTAFR|0:CXCL5|0:CCL25|0:PIK3CB|0:C5|0:DEFA1B|0:CMKLR1|0:FPR1|0:CCL23|0:CCL17|0:CCRL2|0:CCR8|0:CCL8|0:FGF2|0:XCL1|0:CXCR3|0:DEFA1|0:KAL1|0:PLAUR|0:CCL24|0:CCR5|0:CCL22|0:CCL11|0:CXCR1|0:CXCL10|0:CCR9|0:CCL7|0:MAP2K1|0:FOSL1|0:SPN|0:PLD1|0:IL4|0:CCL1|0:CCL13|0:PLAU|0:CCBP2|0:CCL27|0:LTB4R2|0:CCR2|0:RALA|0:CCL28			
GO:0031527	C:filopodium membrane; IEA:UniProtKB-SubCell		0:ANTXR1|0:SYNE2|0:VASP|0:PDPN|0:NF2			
GO:0004484	F:mRNA guanylyltransferase activity; TAS:ProtInc		0:RNGTT			
GO:0006874	P:cellular calcium ion homeostasis; TAS:ProtInc		0:DRD4|0:TPT1|0:DRD3|0:CHERP|0:ATP2C1|0:GCM2|0:STIM2|0:CHRNA7|0:SLC30A1|0:TNNI3|0:RGN|0:PTH|0:EPHX2|0:ELANE|0:DRD5|0:CCL19|0:CASR|0:STC1|0:CCL15|0:CCL3|0:CXCL12|0:CCL2|0:CCL23|0:CCL14|0:XCL1|0:CALCB|0:CCL5|0:CCL11|0:CCL7|0:CCL1|0:CCL13			
GO:0030057	C:desmosome; NAS:UniProtKB		0:JUP|0:B4GALT1|0:PKP3|0:DSP|0:DSC3|0:PPL|0:EVPL|0:DSG4|0:DSG3|0:DSC1|0:PERP|0:DSG2|0:DSC2|0:PKP4|0:PNN|0:PKP2|0:PKP1|0:CDSN|0:DSG1			
GO:0000836	C:Hrd1p ubiquitin ligase complex; NAS:UniProtKB		0:OS9			
GO:0005529	F:sugar binding; TAS:UniProtKB		0:CLEC7A|0:GFPT2|0:GFPT1|0:ZG16|0:SELL|0:SIGLEC5|0:CLEC5A|0:ATRNL1|0:CLEC9A|0:GALNT13|0:PKD1L2|0:GALNT12|0:KLRF1|0:ASGR2|0:LY75|0:LPHN1|0:OS9|0:CLEC1A|0:LGALS9C|0:CLEC18A|0:KLRG2|0:CLEC3B|0:PRG3|0:SIGLEC16|0:ACAN|0:LGALS13|0:CD22|0:GALNT1|0:NPTX2|0:GALNT4|0:CLECL1|0:SIGLEC10|0:FREM1|0:DGCR2|0:GRIFIN|0:CLC|0:CD93|0:MRC1L1|0:ITLN1|0:PKD1|0:GALNT5|0:REG1B|0:MRC2|0:CLEC18B|0:WBSCR17|0:ASGR1|0:KLRC3|0:APCS|0:SFTPA2|0:GALNT11|0:ATRN|0:CLEC1B|0:CHI3L1|0:GALNT2|0:GALNTL4|0:CLEC4D|0:PKD1L3|0:NCAN|0:CALR3|0:CD33|0:KLRK1|0:GALNT7|0:SIGLEC6|0:CLEC19A|0:CLEC2A|0:GALNT10|0:SFTPA1|0:GALNT6|0:CLEC2D|0:KLRC2|0:CLEC4C|0:CLEC14A|0:GALNTL1|0:CANX|0:PLA2R1|0:LGALS9B|0:CD302|0:SIGLEC12|0:GALNT8|0:CLEC12B|0:LPHN2|0:BCAN|0:AIM1L|0:SIGLEC14|0:CRYBG3|0:REG3G|0:CLEC6A|0:MAG|0:CLEC2L|0:CD69|0:GALNT3|0:OLR1|0:GALNT9|0:CD72|0:VCAN|0:FBXO2|0:AIM1|0:C21orf63|0:CHODL|0:LMAN2|0:REG4|0:CLEC12A|0:CLEC4A|0:ITLN2|0:LMAN1L|0:KLRC1|0:GALNTL2|0:LPHN3|0:GALNT14|0:REG1A|0:CLEC18C|0:NCRNA00083|0:CD248|0:CALR|0:ZG16B|0:LGALS14|0:LAYN|0:GALNTL6|0:FCER2|0:CLEC4G|0:SIGLEC11|0:CLEC4F|0:KLRD1|0:KRT1|0:SIGLEC1|0:CHIA|0:SORD|0:SIGLEC9|0:CLEC11A|0:KLRG1|0:KLRB1|0:CLEC4E|0:PRG2|0:REG3A|0:CLEC2B|0:FCN3|0:LGALS7B|0:LGALS3|0:SIGLEC7|0:LGALS7|0:CLEC10A|0:FCN2|0:SIGLEC8|0:FCN1|0:LGALS4|0:CLEC3A|0:LGALS8|0:SFTPD			
GO:0047395	F:glycerophosphoinositol glycerophosphodieste...; IEA:EC		0:GDE1			
GO:0046825	P:regulation of protein export from nucleus; IMP:BHF-UCL		0:UHMK1|0:CDKN2A			
GO:0031274	P:positive regulation of pseudopodium assembly; IMP:MGI		0:CDC42EP2|0:CDC42EP4|0:CDC42EP5|0:CDC42|0:CDC42EP1|0:APC			
GO:0015014	P:heparan sulfate proteoglycan biosynthetic p...; NAS:UniProtKB		0:EXT1|0:EXT2|0:CSGALNACT1			
GO:0030163	P:protein catabolic process; TAS:UniProtKB		0:SPG7|0:FBXO27|0:NCCRP1|0:FBXO17|0:AFG3L2|0:YME1L1|0:FBXO44|0:LRSAM1|0:USE1|0:PPT1|0:CLN3|0:TPP1|0:PRSS16|0:CLN5|0:ELANE|0:CLN6|0:TPRKB|0:MTOR			
GO:0042328	F:heparan sulfate N-acetylglucosaminyltransfe...; NAS:BHF-UCL		0:EXT1|0:EXT2			
GO:0006913	P:nucleocytoplasmic transport; NAS:UniProtKB		0:AAAS|0:ANP32A|0:NUP155|0:MYBBP1A|0:SET			
GO:0010871	P:negative regulation of receptor biosyntheti...; IDA:BHF-UCL		0:PPARG|0:PPARA			
GO:0043461	P:proton-transporting ATP synthase complex as...; NAS:UniProtKB		0:ATPAF2			
GO:0004528	F:phosphodiesterase I activity; TAS:UniProtKB		0:ENPP1|0:ENPP3|0:ENPP2|0:APEX1			
GO:0030156	F:benzodiazepine receptor binding; TAS:ProtInc		0:BZRAP1|0:DBI			
GO:0009812	P:flavonoid metabolic process; IDA:BHF-UCL		0:SULT1A1|0:SULT1A3|0:SULT1A4|0:UGT1A3|0:SULT1B1			
GO:0048255	P:mRNA stabilization; TAS:UniProtKB		0:E2F1|0:GDNF|0:CIRBP|0:AXIN2|0:SLC11A1|0:PAIP1|0:PABPC1			
GO:0005852	C:eukaryotic translation initiation factor 3 ...; TAS:ProtInc		0:EIF3J|0:EIF3G|0:EIF3M|0:EIF3C|0:EIF3D|0:EIF3K|0:EIF3H|0:EIF3E|0:EIF3CL|0:EIF3L|0:EIF3A|0:EIF3I|0:EIF3F|0:EIF3B|0:COPS5			
GO:0072162	P:metanephric mesenchymal cell differentiation; NAS:UniProtKB		0:PAX2|0:WNT4			
GO:0005097	F:Rab GTPase activator activity; ISS:UniProtKB		0:RABGAP1L|0:RAB3GAP1|0:USP6NL|0:TBC1D3B|0:SGSM3|0:TBC1D3G|0:TBC1D22A|0:TBC1D8B|0:TBC1D19|0:TBC1D12|0:TBC1D26|0:TBC1D3F|0:TBCK|0:GRTP1|0:TBC1D3C|0:TBC1D4|0:WDR67|0:TBC1D29|0:TBC1D9|0:TBC1D3H|0:C6orf170|0:TBC1D3|0:TBC1D16|0:TBC1D23|0:TBC1D27|0:TBC1D2B|0:TBC1D20|0:USP6|0:TBC1D30|0:TBC1D2|0:TBC1D8|0:TBC1D10A|0:EVI5L|0:TBC1D13|0:SGSM2|0:TBC1D17|0:TBC1D24|0:TBC1D1|0:TBC1D7|0:TBC1D14|0:EVI5|0:SGSM1|0:TBC1D10C|0:TBC1D5|0:RABGAP1|0:TBC1D25|0:TBC1D9B|0:TBC1D21|0:TBC1D22B|0:TBC1D28|0:TBC1D10B|0:TBC1D15			
GO:0005790	C:smooth endoplasmic reticulum; TAS:UniProtKB		0:TH|0:PSEN1|0:CASQ1|0:RYR1|0:SLMAP|0:GBA2			
GO:0045630	P:positive regulation of T-helper 2 cell diff...; NAS:UniProtKB		0:RARA|0:CD86			
GO:0019369	P:arachidonic acid metabolic process; NAS:UniProtKB		0:PLA2G10|0:PLA2G4B|0:PLA2G4C			
GO:0048406	F:nerve growth factor binding; IPI:BHF-UCL		0:FURIN|0:PCSK6|0:SORT1			
GO:0048251	P:elastic fiber assembly; ISS:UniProtKB		0:TNXB|0:MYH11|0:ATP7A			
GO:0019901	F:protein kinase binding; NAS:UniProtKB		0:PRKAG3|0:PRKAG2|0:PRKAG1|0:LAX1|0:IBTK|0:LLGL1|0:FAF1|0:SRCIN1|0:ADIPOR1|0:PRKACA|0:CDKN2D|0:CDKN2B|0:CD226|0:CCND2|0:ADRA2A|0:CCND1|0:CDKN2C|0:CCND3|0:USF1|0:SKI|0:NEK9|0:SKAP1|0:DLG1|0:PGAM1|0:PTPRC|0:RAD9A|0:LCK|0:MSH2|0:CYLD|0:TRIB3|0:DNAJA3|0:PLK1S1|0:ITGB2|0:SPDYA|0:CD4|0:KIF11|0:BCAR1|0:RNF138|0:NEK6|0:ZC3HC1|0:MAP2K7|0:SOCS1|0:TP53|0:RPS3|0:TNNI3|0:BAD|0:STK11IP|0:MAP3K12|0:C13orf34|0:PRDX3|0:LATS1|0:KIF13B|0:SPDYC|0:CD24|0:MAPK8IP2|0:RELA|0:TCF7L2|0:FOXO3|0:CEP250|0:TPX2|0:AURKA|0:MAML1|0:SMAD1|0:TPRKB|0:NOD2|0:ERRFI1|0:APC|0:TICAM1|0:PLK1|0:PPP1CC|0:PTPRK|0:MAP3K2|0:FGFR1OP|0:GHR|0:MAPK8IP3|0:PTPRR|0:STAT3|0:FIZ1|0:KAT2B|0:MAP3K13|0:GNAT1|0:ADAM10|0:IL31RA|0:CD3E			
GO:0006541	P:glutamine metabolic process; ISS:UniProtKB		0:GLS2|0:CPS1|0:GGH|0:ASNSD1|0:CTPS|0:ASNS|0:PFAS|0:PPAT|0:CTPS2|0:GFPT2|0:GFPT1|0:GMPS|0:CAD|0:ALDH5A1			
GO:0050435	P:beta-amyloid metabolic process; IDA:UniProtKB		0:IDE|0:BACE1			
GO:0046627	P:negative regulation of insulin receptor sig...; TAS:BHF-UCL		0:ENPP1|0:GSK3A|0:PRKCZ|0:IRS1|0:IL1B|0:GRB10|0:PTPRE|0:SOCS1|0:PTPN1|0:AHSG|0:PRKCD			
GO:0033555	P:multicellular organismal response to stress; IMP:BHF-UCL		0:NOS1			
GO:0004914	F:interleukin-5 receptor activity; TAS:ProtInc		0:IL5RA			
GO:0009791	P:post-embryonic development; NAS:UniProtKB		0:BMP4|0:STK36|0:SCUBE1			
GO:0003823	F:antigen binding; TAS:UniProtKB		0:IGHG3|0:IGHG4|0:IGHG2|0:IGLC6|0:IGHM|0:IGLC7|0:TOPORS|0:SKAP1|0:PPP2R1A|0:IGKC|0:IGKV1-5|0:IGHA1|0:IGKV4-1|0:IGHV@|0:VPREB1|0:IGJ|0:IGLC1|0:IGHD|0:IGHE|0:SLAMF1|0:LAG3|0:IL7R|0:LILRB4|0:LILRA1|0:FCN2|0:LILRA2|0:KIR2DL3|0:FCN1|0:LILRA3|0:IGHG1|0:IGHA2			
GO:0004919	F:interleukin-9 receptor activity; TAS:ProtInc		0:IL9R			
GO:0050718	P:positive regulation of interleukin-1 beta s...; NAS:UniProtKB		0:PANX1|0:P2RX7|0:PYCARD|0:NLRP3|0:CARD8|0:PYDC1|0:NOD2|0:NLRP2|0:TRIM16|0:NLRP12			
GO:0042974	F:retinoic acid receptor binding; IPI:UniProtKB		0:PRAME|0:MED1			
GO:0001654	P:eye development; TAS:ProtInc		0:TGFB2|0:BLOC1S3|0:PAX6			
GO:0008970	F:phospholipase A1 activity; TAS:ProtInc		0:LIPG|0:PLA1A			
GO:0047747	F:cholate-CoA ligase activity; IEA:EC		0:SLC27A5			
GO:0045086	P:positive regulation of interleukin-2 biosyn...; NAS:UniProtKB		0:CD28|0:IRF4|0:IL1A|0:IL1B|0:GLMN|0:CD86|0:CD4|0:CD80			
GO:0051466	P:positive regulation of corticotropin-releas...; ISS:BHF-UCL		0:TNFSF11			
GO:0043624	P:cellular protein complex disassembly; IGI:MGI		0:NRG1			
GO:0035414	P:negative regulation of catenin protein nucl...; IMP:BHF-UCL		0:AXIN2|0:EMD|0:SFRP5|0:TAZ			
GO:0000250	F:lanosterol synthase activity; TAS:ProtInc		0:LSS			
GO:0031692	F:alpha-1B adrenergic receptor binding; ISS:BHF-UCL		0:ADRA2A			
GO:0030534	P:adult behavior; ISS:BHF-UCL		0:BBS4|0:BBS2			
GO:0016818	F:hydrolase activity, acting on acid anhydrid...; IEA:InterPro		0:NUDT7			
GO:0047223	F:beta-1,3-galactosyl-O-glycosyl-glycoprotein...; NAS:UniProtKB		0:POMGNT1|0:B3GNT6			
GO:0043011	P:myeloid dendritic cell differentiation; ISS:BHF-UCL		0:DHRS2|0:UBD|0:TGFBR2			
GO:0070914	P:UV-damage excision repair; IDA:BHF-UCL		0:MC1R			
GO:0045127	F:N-acetylglucosamine kinase activity; IEA:EC		0:NAGK			
GO:0005788	C:endoplasmic reticulum lumen; TAS:UniProtKB		0:APOA4|0:PTGS2|0:PTGIS|0:FMO1|0:APOA2|0:APOB|0:APOA1|0:OS9|0:HSP90B1|0:ERP44|0:ERLEC1|0:FOXRED2|0:CLN6|0:CALR|0:RCN2|0:ENTPD5|0:SIL1|0:HYOU1|0:TXNDC12|0:POGLUT1|0:GLT25D1|0:SERPINH1|0:SUMF1|0:TOR1A|0:MINPP1|0:RCN3|0:FKBP10|0:ERP29|0:P4HA3|0:KDELC1|0:CES3|0:UGGT1|0:CALR3|0:KDELC2|0:FKBP14|0:TXNDC5|0:H6PD|0:P4HB|0:DNAJB11|0:SDF2L1|0:FKBP7|0:PACS2|0:SUMF2|0:TOR1B|0:P4HA2|0:PDIA3|0:CES2|0:EDEM3|0:CERCAM|0:DNAJC10|0:ERP27|0:PDIA6|0:OLFM1|0:EDEM2|0:CES1|0:PDIA2|0:P4HA1|0:GLT25D2|0:UGGT2|0:NTF4|0:PPIB|0:ERAP1|0:ERAP2|0:PDIA4|0:MBTPS1|0:RCN1|0:PDIA5|0:HSPA5			
GO:0006704	P:glucocorticoid biosynthetic process; TAS:ProtInc		0:HSD11B2			
GO:0016287	F:glycerone-phosphate O-acyltransferase activity; IEA:EC		0:GNPAT			
GO:0006565	P:L-serine catabolic process; IDA:UniProtKB		0:SDS|0:CBS|0:SHMT1			
GO:0046982	F:protein heterodimerization activity; TAS:UniProtKB		0:DVL3|0:PRMT8|0:PDSS2|0:PDSS1|0:DGKD|0:GABPB1|0:GABPB2|0:HEXB|0:GABPA|0:TLR1|0:BMP2|0:VEGFA|0:HEXA|0:BMP6|0:TLR2|0:EGFR|0:TERF1|0:SCUBE1|0:CEBPG|0:BIRC5|0:RARA|0:PML|0:CLCN3|0:RUNX1|0:ERBB3|0:TPD52L1|0:ERBB2|0:HNF1A|0:BNIP3L|0:BNIP3|0:RXRA|0:TPD52|0:NPM1|0:UGT1A8|0:ABCG8|0:USF2|0:UGT1A4|0:ADD2|0:GTF2A1|0:APOE|0:UGT1A10|0:FZD9|0:EXT1|0:PDGFA|0:ADRA2C|0:CYBA|0:UGT1A9|0:IRAK1|0:FZD4|0:ABCG1|0:UGT1A6|0:UGT1A1|0:CYBB|0:EPAS1|0:APOB|0:AGTR1|0:ABCG4|0:ADD1|0:IRAK2|0:UGT1A7|0:EXT2|0:PDGFB|0:NEUROD1|0:MLXIPL|0:UGT1A3|0:ADRA2A|0:ADRB1|0:GTF2A2|0:ARNT|0:BDKRB2|0:IRAK3|0:MLX|0:ABCG5|0:USF1|0:BAX|0:ROPN1B|0:SMC1A|0:SDCBP|0:SDCBP2|0:ARNT2|0:KATNB1|0:PPP2R1A|0:BCL2|0:RRAGC|0:SUPT5H|0:UBA3|0:MCL1|0:CD3G|0:SMC3|0:TP53|0:ALG2|0:APOA2|0:PEF1|0:RRAGA|0:SMC2|0:UBA2|0:RRAGD|0:TOP2B|0:VAPB|0:CD3D|0:IL12A|0:SUPT4H1|0:TOP2A|0:HIF1A|0:SAE1|0:BAK1|0:BARD1|0:RALGAPB|0:NAE1|0:IL12B|0:CD3E|0:KATNA1|0:SMC4|0:VAPA|0:RALGAPA1|0:NKX2-5|0:RALGAPA2|0:TYR|0:RAB3GAP2|0:TYRP1|0:TAS1R3|0:TAS1R1|0:TCF4|0:FSHB|0:TCF3|0:MAFA|0:TAS1R2|0:PPP2R4|0:TGFB2|0:NOTCH4			
GO:0045785	P:positive regulation of cell adhesion; TAS:UniProtKB		0:NRG1|0:CHRD|0:ERBB2|0:AZU1|0:SAA1|0:IL12A|0:SAA2|0:IL12B|0:ALOX12|0:TPM1|0:TGM2|0:PRSS2			
GO:0008328	C:ionotropic glutamate receptor complex; ISS:UniProtKB		0:SHISA9			
GO:0004428	F:inositol or phosphatidylinositol kinase act...; IEA:InterPro		0:PI4KAP2|0:PI4KAP1|0:RNPEPL1			
GO:0006450	P:regulation of translational fidelity; IGI:UniProtKB		0:GATC|0:RPS5			
GO:0003913	F:DNA photolyase activity; IEA:InterPro		0:CRY2|0:CRY1			
GO:0015094	F:lead ion transmembrane transporter activity; IDA:UniProtKB		0:SLC11A2			
GO:0048284	P:organelle fusion; ISS:BHF-UCL		0:CYP26C1			
GO:0048268	P:clathrin coat assembly; TAS:UniProtKB		0:EPS15|0:CALY|0:HIP1|0:PICALM|0:AP2S1			
GO:0042982	P:amyloid precursor protein metabolic process; TAS:UniProtKB		0:KLK6|0:ACHE			
GO:0035280	P:miRNA loading onto RISC involved in gene si...; IDA:UniProtKB		0:TARBP2			
GO:0003214	P:cardiac left ventricle morphogenesis; IMP:BHF-UCL		0:SFRP2|0:NPY2R|0:NPY5R|0:CPE			
GO:0051773	P:positive regulation of nitric-oxide synthas...; IDA:BHF-UCL		0:FCER2			
GO:0006684	P:sphingomyelin metabolic process; TAS:ProtInc		0:ENPP7|0:CLN3|0:SMPD2			
GO:0015087	F:cobalt ion transmembrane transporter activity; IDA:UniProtKB		0:SLC11A2			
GO:0051569	P:regulation of histone H3-K4 methylation; IMP:UniProtKB		0:CTCFL			
GO:0060171	C:stereocilium membrane; IEA:UniProtKB-SubCell		0:MYO1C|0:USH2A			
GO:0016363	C:nuclear matrix; NAS:UniProtKB		0:NONO|0:SFPQ|0:GHRHR|0:HNRNPM|0:CAD|0:NUFIP1|0:ERCC8|0:TEP1|0:CLIC4|0:DNMT3A|0:ATXN1|0:MEN1|0:PML|0:SMC3|0:AKAP8L|0:TP53|0:KIN|0:HLCS|0:CHMP1A|0:POLA1|0:PRPF40A|0:SPTBN4|0:BLM|0:MAEA|0:CENPF|0:ALOX5|0:ZNF350|0:KIF4A|0:RUVBL2|0:SATB2|0:MATR3|0:PPIG|0:YY1|0:THOC1|0:KIF4B|0:RUVBL1|0:ATXN3|0:PHACTR3|0:AHCTF1|0:CFL2|0:PSPC1|0:ZNF326|0:ATXN7|0:TGFB1I1|0:GMCL1L|0:ENC1|0:SRRM1|0:CFL1|0:SATB1|0:GMCL1|0:RBM16|0:AKAP8|0:FIGN|0:SMARCAD1|0:MYB|0:YEATS4			
GO:0042169	F:SH2 domain binding; TAS:HGNC		0:PAG1|0:LAX1|0:SKAP1|0:SQSTM1|0:NUP62|0:LAT2|0:AFAP1L2|0:LCK|0:CRK|0:ARHGAP5|0:DLC1|0:JAK2|0:INPPL1|0:SRC|0:INSR|0:PTK2|0:SH3PXD2B|0:IRS1|0:NLK|0:SIT1			
GO:0035098	C:ESC/E(Z) complex; IDA:UniProtKB		0:RBBP7|0:EZH2|0:SUZ12|0:HDAC2|0:EED|0:AEBP2|0:EZH1|0:RBBP4			
GO:0070545	C:PeBoW complex; IDA:UniProtKB		0:PES1|0:BOP1|0:WDR12			
GO:0060706	P:cell differentiation involved in embryonic ...; ISS:UniProtKB		0:EOMES			
GO:0031647	P:regulation of protein stability; ISS:BHF-UCL		0:APOA2|0:USP4|0:USP3|0:FBXO7|0:CDKN2AIP|0:AURKA|0:APTX|0:DPM2|0:DPM3|0:GIPC1			
GO:0001657	P:ureteric bud development; ISS:UniProtKB		0:SLIT2|0:ROBO2|0:BMP7|0:OSR1			
GO:0003996	F:acyl-CoA ligase activity; IDA:UniProtKB		0:ACSM1			
GO:0005685	C:U1 snRNP; IDA:UniProtKB		0:SNRPC			
GO:0060076	C:excitatory synapse; ISS:UniProtKB		0:NETO1			
GO:0015562	F:efflux transmembrane transporter activity; IDA:UniProtKB		0:ABCB5|0:ABCB6			
GO:0009917	F:sterol 5-alpha reductase activity; IDA:UniProtKB		0:SRD5A2			
GO:0015054	F:gastrin receptor activity; IDA:UniProtKB		0:CCKBR			
GO:0006145	P:purine base catabolic process; IMP:UniProtKB		0:DPYD			
GO:0015935	C:small ribosomal subunit; NAS:UniProtKB		0:MRPS12|0:MRPS2|0:DAP3|0:MRPS6			
GO:0032964	P:collagen biosynthetic process; IMP:UniProtKB		0:TRAM2|0:COL5A1|0:COL1A1|0:COL3A1			
GO:0006839	P:mitochondrial transport; TAS:UniProtKB		0:UCP3|0:SLC25A30|0:SLC25A10|0:SLC25A14|0:KIAA1279|0:STARD3|0:HSP90AA1			
GO:0071346	P:cellular response to interferon-gamma; IEP:UniProtKB		0:AQP4|0:WNT5A			
GO:0031698	F:beta-2 adrenergic receptor binding; IPI:UniProtKB		0:NEDD4|0:SLC9A3R1			
GO:0031419	F:cobalamin binding; IEA:UniProtKB-KW		0:GIF|0:TCN1|0:CUBN|0:MUT|0:LMBRD1|0:MTR|0:MMACHC			
GO:0070102	P:interleukin-6-mediated signaling pathway; IMP:BHF-UCL		0:STAT3|0:IL6|0:IL6R			
GO:0006428	P:isoleucyl-tRNA aminoacylation; IEA:InterPro		0:IARS|0:IARS2			
GO:0007108	P:cytokinesis, initiation of separation; IMP:UniProtKB		0:RACGAP1			
GO:0010574	P:regulation of vascular endothelial growth f...; IDA:BHF-UCL		0:IL6			
GO:0030819	P:positive regulation of cAMP biosynthetic pr...; IMP:UniProtKB		0:MRAP|0:GHRHR|0:GHRH|0:MC3R|0:GPR65|0:MC4R|0:MC1R|0:MC5R|0:MC2R|0:MRAP2|0:DRD1|0:ADRB1|0:PTH|0:PTHLH|0:ADCY7|0:ABCA1|0:AKAP12|0:AKAP5			
GO:0016572	P:histone phosphorylation; ISS:UniProtKB		0:RPS6KA5|0:MAP3K12			
GO:0032914	P:positive regulation of transforming growth ...; ISS:BHF-UCL		0:ATP6AP2|0:THBS1			
GO:0019883	P:antigen processing and presentation of endo...; NAS:UniProtKB		0:CD74			
GO:0043209	C:myelin sheath; ISS:BHF-UCL		0:CNTN2|0:ITPR3			
GO:0003408	P:optic cup formation involved in camera-type...; ISS:BHF-UCL		0:WNT16|0:WNT5A			
GO:0005251	F:delayed rectifier potassium channel activity; TAS:ProtInc		0:KCNQ1|0:KCNS1|0:KCNA3|0:KCNA1|0:KCNA2|0:KCNA5|0:KCNH2|0:KCNG2|0:KCNH1|0:KCNS3|0:KCNE1|0:KCNB2			
GO:0050104	F:L-gulonate 3-dehydrogenase activity; IDA:UniProtKB		0:CRYL1			
GO:0031639	P:plasminogen activation; IDA:BHF-UCL		0:KLKB1|0:APOH|0:F11			
GO:0006413	P:translational initiation; TAS:UniProtKB		0:RPS5|0:RPS3|0:RPS17|0:PAIP1|0:RPS3A			
GO:0005742	C:mitochondrial outer membrane translocase co...; TAS:BHF-UCL		0:TOMM22|0:TOMM40|0:TOMM7|0:TOMM5|0:TOMM20L|0:TOMM20|0:TOMM70A			
GO:0030229	F:very-low-density lipoprotein receptor activity; IDA:BHF-UCL		0:LDLR|0:LRP8|0:VLDLR			
GO:0017119	C:Golgi transport complex; IDA:UniProtKB		0:COG5|0:GOLGA3|0:COG6|0:COG2|0:COG7|0:COG3|0:COG1|0:COG8|0:COG4			
GO:0048024	P:regulation of nuclear mRNA splicing, via sp...; IMP:UniProtKB		0:CWC22|0:JMJD6			
GO:0042393	F:histone binding; TAS:UniProtKB		0:PRMT7|0:ASF1A|0:BRD7|0:UIMC1|0:SNCA|0:RSF1|0:RCC1|0:DTX3L|0:PRMT6|0:USP16|0:TBL1X|0:RNF8|0:HILS1|0:RNF168|0:JAK2|0:TBL1XR1|0:DEK|0:NCAPD2|0:RNF20|0:PRKCB|0:MYSM1|0:PKN1|0:AIRE|0:NPM1|0:C17orf79|0:SIRT1|0:H2AFX|0:HJURP|0:USP3|0:APBB1|0:HINFP|0:IPO9|0:RAG1|0:CTCFL|0:RBBP4|0:CHAF1B|0:NPM2|0:SET			
GO:0005759	C:mitochondrial matrix; TAS:ProtInc		0:FARS2|0:WARS2|0:OXCT1|0:PC|0:RARS2|0:SARS2|0:ACAT1|0:KARS|0:ATP5C1|0:ECHS1|0:ATP5A1|0:HARS2|0:TMLHE|0:QARS|0:CYP27A1|0:LARS2|0:ATP5E|0:MDH2|0:GOT2|0:FH|0:FECH|0:HIBADH|0:YARS2|0:HIBCH|0:GARS|0:PPA2|0:HADH|0:HMGCL|0:HMGCS2|0:ATP5D|0:IARS2|0:NFS1|0:PITRM1|0:PIN4|0:GRPEL1|0:DNAJA3|0:ACSM1|0:HAGH|0:KIAA1967|0:MARS2|0:CS|0:SIRT4|0:CBR4|0:ACSS1|0:NDUFA9|0:HSD17B8|0:SIRT5|0:PDP1|0:C1QBP|0:GRPEL2|0:ALAS1|0:PDK3|0:CARS2|0:ACSM2A|0:PRODH|0:PDHB|0:CLPP|0:ALDH2|0:PARS2|0:GCDH|0:MIPEP|0:MUT|0:AGXT|0:ALDH1B1|0:ACADS|0:GLUD1|0:AARS2|0:ACADSB|0:AK4|0:ALAS2|0:EARS2|0:FDX1L|0:SIRT3|0:ME3|0:ACSM2B|0:PMPCA|0:SHC1|0:FDX1|0:SDHAF1|0:PDK4|0:AK3|0:ETHE1|0:DLD|0:ACADL|0:PCCB|0:TARS2|0:NAGS|0:ACSM4|0:CYCS|0:ME2|0:HSPE1|0:PMPCB|0:COQ3|0:ACSM5|0:AK4P3|0:PDHA2|0:PCCA|0:PDK1|0:SARDH|0:FDXR|0:NDUFA10|0:OGDHL|0:ACSM3|0:ACADM|0:PDP2|0:PDHX|0:NARS2|0:DARS2|0:GLUD2|0:PDK2|0:MCCC2|0:PDHA1|0:OGDH|0:PPM1K|0:PPIF|0:ABAT|0:IVD|0:NDUFAB1|0:FXN|0:CA5A|0:TST|0:OAT|0:OTC|0:BDH1|0:MCCC1|0:ATP5F1|0:SOD1|0:DCI|0:DMGDH|0:SOD2|0:HSPD1|0:ETFA|0:CASQ1|0:NR3C1|0:ALDH4A1|0:TIMM44|0:ETFB			
GO:0034392	P:negative regulation of smooth muscle cell a...; IDA:BHF-UCL		0:IGF1|0:APOH			
GO:0033077	P:T cell differentiation in the thymus; ISS:UniProtKB		0:ADAM17|0:LIG4|0:RAG2|0:RAG1			
GO:0031557	P:induction of programmed cell death in respo...; NAS:UniProtKB		0:GRIK2			
GO:0005126	F:cytokine receptor binding; TAS:ProtInc		0:IFNE|0:IL15|0:IFNA10|0:IL9|0:MIF|0:IFNA6|0:IFNA21|0:IFNA8|0:IFNA14|0:IFNW1|0:IFNA5			
GO:0051098	P:regulation of binding; ISS:UniProtKB		0:SMAD2			
GO:0045988	P:negative regulation of striated muscle cont...; IMP:UniProtKB		0:ADRBK1|0:ATP2A1			
GO:0012506	C:vesicle membrane; NAS:UniProtKB		0:APPL1|0:GIPC1|0:GAD1			
GO:0034501	P:protein localization to kinetochore; IPI:UniProtKB		0:CDK1|0:CCDC99|0:ZW10|0:AURKB|0:BUB1B			
GO:0030517	P:negative regulation of axon extension; ISS:UniProtKB		0:RTN4|0:RNF6			
GO:0008745	F:N-acetylmuramoyl-L-alanine amidase activity; TAS:UniProtKB		0:PGLYRP4|0:PGLYRP1|0:PGLYRP3|0:PGLYRP2			
GO:0004707	F:MAP kinase activity; TAS:ProtInc		0:MAPK15|0:MAPK6|0:NLK|0:MAPK3|0:MAPK4|0:MAPK7|0:MAPK12			
GO:0006942	P:regulation of striated muscle contraction; TAS:ProtInc		0:TNNT3|0:MYL3|0:MYBPC3|0:TNNI1|0:MYL2|0:SRI|0:MYBPH			
GO:0010754	P:negative regulation of cGMP-mediated signaling; IDA:BHF-UCL		0:THBS1			
GO:0010989	P:negative regulation of low-density lipoprot...; IMP:BHF-UCL		0:PCSK9|0:APOC3			
GO:0015386	F:potassium:hydrogen antiporter activity; IDA:UniProtKB		0:SLC9A7			
GO:0017121	P:phospholipid scrambling; TAS:UniProtKB		0:PLSCR3|0:PLSCR4|0:PLSCR2|0:PLSCR1			
GO:0048681	P:negative regulation of axon regeneration; ISS:UniProtKB		0:KLK8			
GO:0002302	P:CD8-positive, alpha-beta T cell differentia...; IMP:UniProtKB		0:EOMES			
GO:0043195	C:terminal button; TAS:UniProtKB		0:GHRH|0:GRIK3|0:KCNMA1|0:CABP4			
GO:0006171	P:cAMP biosynthetic process; TAS:ProtInc		0:UCN2|0:ADM|0:ADORA2A			
GO:0045743	P:positive regulation of fibroblast growth fa...; ISS:UniProtKB		0:FGFBP3|0:NPTN			
GO:0042269	P:regulation of natural killer cell mediated ...; TAS:UniProtKB		0:NCR1			
GO:0004062	F:aryl sulfotransferase activity; TAS:ProtInc		0:SULT1A1|0:SULT1A2|0:SULT1A3|0:SULT1A4			
GO:0035093	P:spermatogenesis, exchange of chromosomal pr...; IMP:UniProtKB		0:SYCP3			
GO:0006325	P:chromatin organization; TAS:UniProtKB		0:MUM1|0:SOX6|0:SOX2|0:SOX21|0:SOX15|0:SOX1|0:TCF7L1|0:HMGN2|0:SAFB|0:HMGA2|0:VCX			
GO:0046332	F:SMAD binding; NAS:UniProtKB		0:TGFBR2|0:BMP2|0:BMPR1A|0:ACVR1|0:STUB1|0:ACVR1B|0:EID2|0:ACVRL1|0:BMPR1B|0:TGFBRAP1|0:TGFBR3|0:SMURF2|0:FKBP1A|0:SKI|0:SKOR1|0:HIPK2|0:SKIL|0:ZEB2			
GO:0005198	F:structural molecule activity; TAS:UniProtKB		0:LAMA5|0:CDC42SE2|0:CSTA|0:BVES|0:SPRR1B|0:EVPL|0:ANXA1|0:IVL|0:SPRR1A|0:ISCA1|0:CLDN3|0:KRT79|0:CLDN12|0:TUBA4A|0:TUBB6|0:CLDN20|0:CTNNAL1|0:AP4E1|0:KRT26|0:TUBA1A|0:CLDN25|0:C21orf29|0:KRT18|0:CLDN1|0:CCDC108|0:EPB41L1|0:ERV3|0:THBS2|0:COPG|0:VCL|0:TUBD1|0:LMNB2|0:KRT71|0:CLDN6|0:KRT222|0:TUBA3E|0:THBS1|0:SEMG2|0:KRT33A|0:ISCA2|0:CLDN11|0:COPA|0:SYNC|0:KRTAP3-2|0:KRTAP3-1|0:COPB1|0:ERVWE1|0:KRT40|0:KRT23|0:CLDN9|0:MOSPD1|0:KRT83|0:COPB2|0:COPG2|0:COL21A1|0:TUBA3D|0:TUBB3|0:CLDN15|0:KRT27|0:EPB41L2|0:ERVK5|0:CLDN10|0:EPB41L3|0:KRT33B|0:KRT80|0:KRT72|0:TUBB2B|0:CTNNA1|0:TUBB4|0:CLDN14|0:SEMG1|0:COL20A1|0:KRT13|0:CLDN22|0:KRT24|0:CLDN5|0:CLDN8|0:LMNA|0:CLTCL1|0:KRT77|0:COPE|0:THBS4|0:FLG2|0:TUBA1C|0:CLTB|0:TUBA4B|0:COL22A1|0:CLDN4|0:KRT39|0:KRT28|0:MOSPD2|0:KRTAP11-1|0:TUBA3C|0:VAPB|0:CLDN23|0:TUBB2A|0:KRT73|0:CLDN18|0:KRT32|0:CLDN16|0:TUBB2C|0:OCLN|0:KRT35|0:TUBAL3|0:CLDN2|0:CLDN7|0:IFLTD1|0:TUBA8|0:NES|0:CLTA|0:KRT78|0:KRTAP3-3|0:COL16A1|0:KRT25|0:THBS3|0:TUBA1B|0:VAPA|0:CLDN17|0:CTNNA3|0:KRT81|0:MOSPD3|0:NELL1|0:KRT3|0:CROCC|0:KRT34|0:MAP2|0:LAMB3|0:ROCK2|0:LAMA3|0:MPZ|0:KRT12|0:MAP1B|0:MAP1A|0:PRPH|0:PNN|0:LAMB2|0:UPK1B|0:KRT4|0:EPPK1|0:KRT8|0:KRT6C|0:PGM5|0:KRT76|0:MEGF8|0:CLTC|0:CYLC1|0:ODF1|0:EIF3A|0:NPHP4|0:NELL2|0:KRT86|0:GNL1|0:KRT7|0:NPHP1|0:JAG1|0:FLG|0:SEPT7|0:LMNB1|0:MAP4|0:LLGL1|0:MPZL1|0:KRT37|0:LAD1|0:KRT75|0:MATR3|0:TUBB4Q|0:MYOC|0:KLHL3|0:LAMA2|0:SPAG4|0:SEPT4|0:TUBG2|0:SEPT5|0:BFAR|0:NUMA1|0:KRT85|0:MAP7|0:LAMC3|0:KRT38|0:DCTN3|0:ODF2|0:SPRR3|0:SPRR2E			
GO:0008493	F:tetracycline transporter activity; TAS:ProtInc		0:MFSD10			
GO:0045415	P:negative regulation of interleukin-8 biosyn...; IMP:UniProtKB		0:ELANE|0:BCL3			
GO:0042026	P:protein refolding; TAS:UniProtKB		0:HSPA1A|0:HSPA1B|0:HSPD1|0:FKBP1B|0:FKBP1A|0:HSP90AA1			
GO:0015171	F:amino acid transmembrane transporter activity; TAS:ProtInc		0:SLC38A4|0:SLC6A15|0:SLC6A6|0:SLC43A2|0:SLC38A2|0:SLC6A20|0:SLC7A13|0:SLC7A5P1|0:SLC7A7|0:SLC7A14|0:SLC6A14|0:SLC7A6			
GO:0060433	P:bronchus development; IDA:MGI		0:BMP4			
GO:0006343	P:establishment of chromatin silencing; IDA:BHF-UCL		0:SIRT1			
GO:0010839	P:negative regulation of keratinocyte prolife...; IDA:UniProtKB		0:PTPRK			
GO:0042602	F:flavin reductase activity; IDA:UniProtKB		0:BLVRB			
GO:0051603	P:proteolysis involved in cellular protein ca...; IMP:BHF-UCL		0:CLPX|0:PSMB11|0:CASP8			
GO:0000466	P:maturation of 5.8S rRNA from tricistronic r...; IMP:UniProtKB		0:PES1|0:WDR12			
GO:0015327	F:cystine:glutamate antiporter activity; TAS:ProtInc		0:SLC7A11			
GO:0007206	P:activation of phospholipase C activity by m...; TAS:ProtInc		0:GRM5|0:HOMER1			
GO:0015721	P:bile acid and bile salt transport; TAS:UniProtKB		0:ATP8B1|0:AKR1C1			
GO:0019408	P:dolichol biosynthetic process; IDA:UniProtKB		0:DPAGT1			
GO:0070371	P:ERK1 and ERK2 cascade; IMP:UniProtKB		0:FGF10|0:HTR2B|0:HTR2C|0:HTR2A			
GO:0007518	P:myoblast cell fate determination; TAS:ProtInc		0:IFRD1			
GO:0001980	P:regulation of systemic arterial blood press...; ISS:UniProtKB		0:TNNI3			
GO:0004860	F:protein kinase inhibitor activity; TAS:UniProtKB		0:SH3BP5|0:WNK1|0:CAMK2N2|0:TRIB3|0:TRIB2|0:TRIB1|0:TAOK3|0:SOCS3|0:MAPK8IP1|0:GMFG|0:MBIP|0:SOCS1|0:DNAJC3|0:GMFB|0:PPP1R1B			
GO:0060048	P:cardiac muscle contraction; ISS:BHF-UCL		0:MYLK2|0:TCAP|0:MYL3|0:MYL4|0:RYR2|0:ADRBK1|0:TAZ|0:GAA|0:TNNC1|0:TPM1|0:TNNI3|0:MYBPC3			
GO:0050913	P:sensory perception of bitter taste; NAS:UniProtKB		0:TAS2R60			
GO:0015333	F:peptide:hydrogen symporter activity; TAS:ProtInc		0:SLC15A3|0:SLC15A4|0:SLC15A2|0:SLC15A1			
GO:0016604	C:nuclear body; ISS:UniProtKB		0:NCOR2|0:CREBBP|0:NACC1|0:HIPK2|0:NACC2			
GO:0017080	F:sodium channel regulator activity; NAS:UniProtKB		0:TMPRSS3|0:NEDD4L|0:CAV3|0:SGK2			
GO:0001912	P:positive regulation of leukocyte mediated c...; TAS:BHF-UCL		0:NOS2			
GO:0033791	F:3alpha,7alpha,12alpha-trihydroxy-5beta-chol...; IEA:EC		0:ACOX2			
GO:0032583	P:regulation of gene-specific transcription; NAS:BHF-UCL		0:RNF14|0:UBE2L3|0:INSR|0:RNF20|0:RNF6|0:CELSR2|0:INS|0:IGF2			
GO:0005104	F:fibroblast growth factor receptor binding; IPI:UniProtKB		0:FGF5|0:FRS3|0:FGF2|0:FRS2|0:FGF1|0:FGF19			
GO:0004775	F:succinate-CoA ligase (ADP-forming) activity; TAS:UniProtKB		0:ACLY|0:SUCLA2			
GO:0015205	F:nucleobase transmembrane transporter activity; TAS:ProtInc		0:SLC23A1|0:SLC23A2			
GO:0019115	F:benzaldehyde dehydrogenase activity; IDA:UniProtKB		0:ADH4			
GO:0046403	F:polynucleotide 3'-phosphatase activity; IDA:UniProtKB		0:PNKP|0:APTX			
GO:0005161	F:platelet-derived growth factor receptor bin...; TAS:ProtInc		0:PDGFA|0:IL1R1|0:PDGFRA|0:PDGFRB|0:VEGFA|0:PDGFC|0:PDGFB|0:ITGB3|0:ITGA5|0:FIGF|0:TYMP			
GO:0046100	P:hypoxanthine metabolic process; IMP:UniProtKB		0:HPRT1			
GO:0015908	P:fatty acid transport; TAS:UniProtKB		0:GOT2|0:PPARD|0:PPARA			
GO:0050884	P:neuromuscular process controlling posture; IMP:MGI		0:GCH1			
GO:0070535	P:histone H2A K63-linked ubiquitination; IDA:UniProtKB		0:RNF168			
GO:0000064	F:L-ornithine transmembrane transporter activity; TAS:ProtInc		0:SLC25A2|0:SLC25A15			
GO:0071397	P:cellular response to cholesterol; ISS:UniProtKB		0:LRP6|0:CYP7A1			
GO:0042133	P:neurotransmitter metabolic process; TAS:ProtInc		0:CLN3|0:GCHFR			
GO:0008643	P:carbohydrate transport; IEA:UniProtKB-KW		0:C10orf125|0:RFT1|0:SLC37A2|0:SLC37A1|0:SLC35C1|0:SLC5A11|0:SLC35D3|0:PEA15|0:SLC37A3|0:KIAA1919|0:SLC5A4|0:SLC2A12|0:SLC2A11			
GO:0034454	P:microtubule anchoring at centrosome; IMP:BHF-UCL		0:BBS4			
GO:0033595	P:response to genistein; IDA:UniProtKB		0:BRCA2			
GO:0008753	F:NADPH dehydrogenase (quinone) activity; TAS:ProtInc		0:CBR4|0:NQO2			
GO:0009059	P:macromolecule biosynthetic process; IEA:InterPro		0:AASDHPPT			
GO:0010801	P:negative regulation of peptidyl-threonine p...; IDA:BHF-UCL		0:SMAD7			
GO:0003867	F:4-aminobutyrate transaminase activity; IEA:EC		0:ABAT			
GO:0032301	C:MutSalpha complex; IDA:HGNC		0:MSH2|0:MSH6			
GO:0019836	P:hemolysis by symbiont of host erythrocytes; TAS:ProtInc		0:ALB|0:C9			
GO:0048786	C:presynaptic active zone; ISS:UniProtKB		0:NUFIP1|0:GRM7			
GO:0032350	P:regulation of hormone metabolic process; IDA:BHF-UCL		0:TCF7L2			
GO:0032024	P:positive regulation of insulin secretion; TAS:BHF-UCL		0:TCF7L2|0:GLUD1|0:RBP4|0:CAPN10|0:GCK|0:IRS2|0:PSMD9|0:GHRL|0:DOC2B|0:SLC30A8			
GO:0033864	P:positive regulation of NAD(P)H oxidase acti...; TAS:BHF-UCL		0:AGTR1|0:AGT			
GO:0050327	F:testosterone 17-beta-dehydrogenase activity; IEA:EC		0:HSD17B2|0:HSD17B6|0:HSD17B8|0:AKR1C3			
GO:0048156	F:tau protein binding; ISS:UniProtKB		0:HDAC6|0:SNCA|0:APOE|0:S100B			
GO:0000139	C:Golgi membrane; TAS:ProtInc		0:B2M|0:NOS3|0:PDGFD|0:BSG|0:GJB2|0:ARFGAP1|0:ARF1|0:SLC30A6|0:GBF1|0:PDGFC|0:MALL|0:TRIM23|0:CAV1|0:ARFGEF2|0:ATP2C1|0:CLN3|0:TAPBP|0:ARFIP1|0:ICA1|0:SLC35A5|0:SLC35A4|0:RAB33B|0:CHST15|0:GCC2|0:HS2ST1|0:CHST6|0:TNKS2|0:GLIPR2|0:HRAS|0:TMEM132A|0:SLC35A1|0:FAM20B|0:MAN1A1|0:GCNT6|0:ZDHHC3|0:UNC50|0:MPHOSPH9|0:MGAT3|0:CAV2|0:STX6|0:ERGIC1|0:GALNT13|0:GALNT12|0:TNKS|0:SLC26A11|0:B3GALT4|0:B3GNT3|0:B3GALNT1|0:B3GNT4|0:COG5|0:PKMYT1|0:STX16|0:B3GALT1|0:PARM1|0:SLC35B4|0:RAB2A|0:PLCE1|0:B3GAT1|0:MGAT4B|0:SLC35D2|0:CNIH|0:PJA2|0:CAV3|0:LMAN2L|0:HS3ST6|0:GLCE|0:SEC16A|0:CHST7|0:ARFGAP3|0:GCNT3|0:SEC24A|0:LPCAT1|0:WLS|0:NDST4|0:MGAT5B|0:LPCAT2|0:CHST14|0:ARFGAP2|0:GALNT4|0:MGAT4A|0:B3GALNT2|0:HS3ST3A1|0:MANEA|0:B3GNT7|0:B3GALT5|0:RHBDF1|0:RIC3|0:IL15RA|0:MAN1A2|0:ENTPD6|0:RAB2B|0:RAB6A|0:FZD5|0:CLCN3|0:SLC35C1|0:HS3ST2|0:ABCA5|0:SCAP|0:COG6|0:B3GNT9|0:SH3GLB1|0:GALNT5|0:WBSCR17|0:NDFIP2|0:CAMK1G|0:SLC35B3|0:FAM198B|0:IRGM|0:RAB12|0:SLC35A3|0:GALNT11|0:GPER|0:PSEN1|0:TMF1|0:GOLT1A|0:MMGT1|0:SVIP|0:GCNT2|0:SURF4|0:SREBF2|0:TPST2|0:CREB3L4|0:B3GALT2|0:GALNTL4|0:RHOU|0:SEC24B|0:CLSTN3|0:MGAT4C|0:SMPD3|0:TMED10|0:YIF1A|0:GORASP2|0:ZMPSTE24|0:XYLT1|0:DHCR24|0:ARL1|0:CHST1|0:CHST13|0:GALNT7|0:SEC22B|0:RAB36|0:PNPLA8|0:GOPC|0:B3GAT2|0:ZDHHC9|0:SYS1|0:SLC9A8|0:A4GNT|0:ACBD3|0:TMEM59|0:OSBP|0:PAQR3|0:HS3ST5|0:GYLTL1B|0:FKTN|0:GALNT10|0:ATL1|0:GPSM1|0:GALNT6|0:SCARA3|0:PTGES2|0:B3GNT6|0:UST|0:CBFA2T3|0:COG7|0:CHPT1|0:CHST8|0:NDST1|0:ABCG1|0:MGAT1|0:SLC35B2|0:RTN3|0:ECE2|0:B3GNT8|0:SEC24C|0:PGAP3|0:GALNTL1|0:GCNT4|0:NDFIP1|0:GOLT1B|0:BET1L|0:CLSTN2|0:AGTRAP|0:LST1|0:XYLT2|0:GAL3ST1|0:RNF24|0:GOSR2|0:GALNT8|0:RAB9A|0:TPST1|0:SREBF1|0:ERC1|0:B3GNT2|0:TMEM130|0:SEC23B|0:GABARAP|0:SMPD4|0:RAB21|0:STEAP4|0:RAB6B|0:MAN2A1|0:RND3|0:GRB14|0:MARCH9|0:PDCD10|0:GOLGA7|0:EBAG9|0:RASGRP1|0:CHST9|0:CLCN5|0:GNPNAT1|0:CORO7|0:RNF13|0:GCNT1|0:GALNTL5|0:CDIPT|0:COG1|0:CHST11|0:GBGT1|0:GALNT9|0:STX5|0:COG8|0:GOLGA7B|0:NDST3|0:TMEM167A|0:CHST3|0:B3GNT5|0:SEC24D|0:EXT2|0:LASS1|0:MBTPS1|0:POMGNT1|0:GOSR1|0:CLSTN1|0:LMAN2|0:GCC1|0:MGAT2|0:NDST2|0:ARL3|0:CD1E|0:ABCA7|0:YKT6|0:HS3ST4|0:GOLGA4|0:ARHGAP21|0:ITM2B|0:PLD1|0:COG4|0:CHST10|0:GALNTL2|0:GAD2|0:PSEN2|0:ARHGAP32|0:IL17RD|0:HS3ST3B1|0:STX18|0:SLC35A2|0:GALNT14|0:TMEM59L|0:MARCH4|0:TMEM167B|0:VPS45|0:APC2|0:SEC16B|0:RAP1GAP|0:NRAS|0:MTOR|0:LEPROT|0:GCNT7|0:MANEAL|0:SEC23A|0:ROCK1|0:GALNTL6|0:GNPTAB|0:FNDC3A|0:TMCO1|0:AP3D1|0:DOPEY2|0:GABARAPL2|0:MAPK8IP3|0:PGAP2|0:MAN2A2|0:B3GAT3|0:MGAT5|0:EXT1|0:LMAN1|0:USO1|0:VAMP4|0:COG2|0:MAP4K2|0:BET1|0:GLG1|0:GOLGB1|0:STX10			
GO:0032302	C:MutSbeta complex; IDA:HGNC		0:MSH2|0:MSH3			
GO:0031932	C:TORC2 complex; IDA:UniProtKB		0:RICTOR|0:MTOR			
GO:0006921	P:cellular component disassembly involved in ...; IDA:HGNC		0:PMAIP1			
GO:0030665	C:clathrin coated vesicle membrane; IEA:UniProtKB-SubCell		0:DAB2|0:AP1G1|0:DENND1A|0:AP3B2|0:HIP1R|0:HIP1|0:AP1B1|0:AP1M1|0:MYO6|0:AP3B1|0:AP1M2			
GO:0005923	C:tight junction; TAS:ProtInc		0:AMOTL1|0:PARD6B|0:BVES|0:AMOT|0:PARD3|0:FRMPD2|0:APC|0:STRN|0:PARD6G|0:CLDN3|0:ARHGAP17|0:JAM2|0:CLDN25|0:MPP7|0:MAGI3|0:MARVELD2|0:LIN7B|0:LIN7A|0:CXADR|0:INADL|0:ARHGEF2|0:SYMPK|0:TJP2|0:F11R|0:MAGI1|0:UBN1|0:ESAM|0:CRB3|0:LIN7C|0:TRAF4|0:TJAP1|0:TJP3|0:OCLN|0:IGSF5|0:CGNL1|0:MTDH|0:MPP5|0:MPDZ|0:SYNPO|0:PARD3B|0:CLDN19|0:CLDN12|0:CLDN20|0:CLDN1|0:CLDN6|0:PARD6A|0:CLDN11|0:SHROOM2|0:CLDN9|0:CLDN15|0:CLDN10|0:CLDN14|0:CLDN22|0:CLDN5|0:CLDN8|0:CLDN4|0:CLDN23|0:CLDN18|0:CLDN16|0:CLDN2|0:CLDN7|0:WNK4|0:CLDN17|0:CGN|0:ASH1L|0:RAB13|0:TJP1			
GO:0051450	P:myoblast proliferation; IDA:BHF-UCL		0:IGF1			
GO:0042119	P:neutrophil activation; TAS:UniProtKB		0:CXCR2|0:PRG3|0:MLL5|0:IL8|0:PREX1			
GO:0030368	F:interleukin-17 receptor activity; NAS:UniProtKB		0:IL17RA			
GO:0072284	P:metanephric S-shaped body morphogenesis; IGI:UniProtKB		0:WT1			
GO:0045627	P:positive regulation of T-helper 1 cell diff...; NAS:UniProtKB		0:SOCS5|0:CD80			
GO:0045768	P:positive regulation of anti-apoptosis; TAS:UniProtKB		0:BRE|0:OPA1|0:RASA1|0:IL6R|0:IL6|0:CTNNB1|0:RPS27L|0:SFRP2|0:PRKAA1|0:MAPK8IP2|0:SMAD7|0:RIPK1|0:IL6ST|0:SIRT1|0:CD28|0:ERC1			
GO:0000127	C:transcription factor TFIIIC complex; IDA:HGNC		0:GTF3C2|0:GTF3C3|0:GTF3C5|0:GTF3C4|0:GTF3C6|0:GTF3C1			
GO:0042637	P:catagen; IDA:UniProtKB		0:TGFB2			
GO:0019236	P:response to pheromone; IEA:UniProtKB-KW		0:VN1R1|0:VN1R4|0:VN1R3|0:VN1R5|0:VN1R2			
GO:0007626	P:locomotory behavior; TAS:ProtInc		0:DRD3|0:TH|0:QRFP|0:CHRNA3|0:CHRNB2|0:SOD1|0:PEX13|0:ATP7A|0:STRN|0:ANKH|0:C1QL1|0:NOVA1|0:NPY2R|0:HPGDS			
GO:0045657	P:positive regulation of monocyte differentia...; ISS:BHF-UCL		0:ACIN1|0:CTNNBIP1|0:CSF1			
GO:0000137	C:Golgi cis cisterna; ISS:UniProtKB		0:NECAB3|0:ATL1			
GO:0007379	P:segment specification; TAS:ProtInc		0:DVL2|0:BMI1			
GO:0000718	P:nucleotide-excision repair, DNA damage removal; NAS:UniProtKB		0:ERCC5|0:DDB1|0:GTF2H2|0:ERCC1|0:RPA2|0:CCNH|0:XPC|0:ERCC4|0:MNAT1|0:RPA3|0:GTF2H3|0:ERCC3|0:RAD23B|0:CDK7|0:GTF2H4|0:DDB2|0:GTF2H1|0:XPA|0:RPA1|0:ERCC2|0:PNKP			
GO:0032190	F:acrosin binding; IPI:UniProtKB		0:ZP4|0:SERPINA5|0:ZP2|0:ZP3			
GO:0043265	C:ectoplasm; ISS:UniProtKB		0:GYS2			
GO:0004021	F:L-alanine:2-oxoglutarate aminotransferase a...; NAS:UniProtKB		0:GPT2|0:GPT			
GO:0006296	P:nucleotide-excision repair, DNA incision, 5...; IMP:UniProtKB		0:NTHL1|0:ERCC1|0:ERCC4			
GO:0042418	P:epinephrine biosynthetic process; IDA:BHF-UCL		0:TH			
GO:0033235	P:positive regulation of protein sumoylation; ISS:UniProtKB		0:PIAS3|0:PIAS1|0:HDAC4|0:PIAS4|0:RASD2			
GO:0008354	P:germ cell migration; TAS:ProtInc		0:TGFBR1|0:PPAP2A|0:PPAP2B|0:HMGCR			
GO:0006666	P:3-keto-sphinganine metabolic process; IDA:MGI		0:KDSR			
GO:0060083	P:smooth muscle contraction involved in mictu...; IDA:UniProtKB		0:KCNMA1			
GO:0008287	C:protein serine/threonine phosphatase complex; IEA:InterPro		0:PPP4R4|0:PDP1|0:PPM1F|0:ILKAP|0:PPM1L|0:PPM1B|0:PPM1A|0:PPM1E|0:PDP2|0:PPM1G|0:PPM1K|0:PPM1D			
GO:0072205	P:metanephric collecting duct development; ISS:UniProtKB		0:WNT7B			
GO:0060766	P:negative regulation of androgen receptor si...; IDA:UniProtKB		0:PIAS2|0:SFRP1			
GO:0033484	P:nitric oxide homeostasis; ISS:BHF-UCL		0:CAV1			
GO:0032116	C:cohesin loading complex; IDA:UniProtKB		0:NIPBL|0:MAU2			
GO:0018676	F:(S)-limonene 7-monooxygenase activity; IEA:EC		0:CYP2C19|0:CYP2C9			
GO:0000293	F:ferric-chelate reductase activity; ISS:UniProtKB		0:CYBRD1|0:CYB561|0:FRRS1			
GO:0004641	F:phosphoribosylformylglycinamidine cyclo-lig...; IEA:EC		0:GART			
GO:0009441	P:glycolate metabolic process; TAS:ProtInc		0:IGF1			
GO:0042719	C:mitochondrial intermembrane space protein t...; IEA:InterPro		0:TIMM8B|0:TIMM10|0:FXC1|0:TIMM8A|0:TIMM9|0:TIMM13			
GO:0030070	P:insulin processing; IDA:BHF-UCL		0:PCSK2			
GO:0006559	P:L-phenylalanine catabolic process; TAS:ProtInc		0:FAH|0:HPD|0:PAH|0:TAT|0:HGD|0:GSTZ1			
GO:0016344	P:meiotic chromosome movement towards spindle...; ISS:BHF-UCL		0:FMN2			
GO:0007193	P:inhibition of adenylate cyclase activity by...; TAS:ProtInc		0:ADCY2|0:ADCY9|0:ADCY6|0:ADCY3|0:ADCY10|0:ADCY7|0:GNAI1|0:ADCY4|0:GNAL|0:ADCY1|0:ADCY8|0:APLP1|0:ADRA2A|0:RGS1|0:NPY1R|0:NPY2R|0:OPRK1|0:MCHR1|0:OPRL1|0:CORT			
GO:0031783	F:type 5 melanocortin receptor binding; IPI:BHF-UCL		0:MRAP|0:MRAP2			
GO:0050774	P:negative regulation of dendrite morphogenesis; ISS:UniProtKB		0:YWHAH			
GO:0035413	P:positive regulation of catenin protein nucl...; IMP:BHF-UCL		0:WNT3A|0:EGF|0:POU5F1|0:EGFR			
GO:0007178	P:transmembrane receptor protein serine/threo...; TAS:ProtInc		0:IRAK1|0:ACVR1B			
GO:0043985	P:histone H4-R3 methylation; NAS:UniProtKB		0:C17orf79|0:PRMT5			
GO:0006788	P:heme oxidation; IEA:InterPro		0:HMOX1|0:HMOX2			
GO:0030325	P:adrenal gland development; ISS:UniProtKB		0:SALL1|0:WNT11|0:WNT4|0:DKK3|0:WT1|0:NR0B1|0:NF1|0:MDK			
GO:0005637	C:nuclear inner membrane; TAS:ProtInc		0:GHRHR|0:ATP1B4|0:PSEN2|0:SMAD1|0:LMNB1|0:UNC50|0:TMPO|0:TMEM201|0:LMNB2|0:LRPPRC|0:SUN2|0:SIGMAR1|0:SUN1|0:TMEM43|0:LEMD2|0:TOR1AIP1|0:RNF13|0:NRM|0:EMD|0:ATP11B|0:CBX3|0:MATR3			
GO:0017002	F:activin receptor activity; IEA:InterPro		0:ACVR2B			
GO:0030423	P:targeting of mRNA for destruction involved ...; IMP:UniProtKB		0:TARBP2|0:DICER1|0:CLP1			
GO:0007219	P:Notch signaling pathway; NAS:UniProtKB		0:MAML3|0:HES1|0:MAML2|0:ASCL1|0:MAML1|0:NOTCH3|0:HEYL|0:DLL4|0:DTX2|0:APH1B|0:MESP2|0:DNER|0:NOTCH2|0:CNTN1|0:DLL3|0:PSEN1|0:APP|0:MIB2|0:DTX3|0:PSENEN|0:POFUT1|0:TP63|0:MESP1|0:HEY1|0:APH1A|0:MIB1|0:RBPJ|0:NKAP|0:DTX4|0:SPEN|0:SEL1L|0:NCSTN|0:NOTCH2NL|0:CNTN6|0:PSEN2|0:ADAM17|0:DTX1|0:NOTCH4|0:HEY2|0:HOXD3|0:NRG1|0:BMP10|0:ADAM10|0:JAG2|0:DLL1|0:JAG1			
GO:0035517	C:PR-DUB complex; IDA:UniProtKB		0:ASXL1|0:BAP1			
GO:0030574	P:collagen catabolic process; NAS:UniProtKB		0:PRSS2|0:MMP2|0:MMP7|0:MMP16|0:MMP13|0:PRTN3|0:MMP1|0:MMP3|0:MMP26|0:MMP10|0:ADAM15|0:MMP9|0:MMP27|0:MMP11|0:MMP8|0:ADAMTS14|0:ADAMTS2|0:MMP19|0:PEPD|0:KLK6|0:ADAMTS3			
GO:0007399	P:nervous system development; TAS:UniProtKB		0:MARK4|0:GDPD5|0:NTRK2|0:NEUROD6|0:ARID1A|0:SMARCC2|0:AMBRA1|0:SMARCD1|0:BEX1|0:ELAVL3|0:NGEF|0:ZNF423|0:SEMA6D|0:NME1|0:CAMK1|0:SEMA3E|0:SMARCB1|0:SEMA4B|0:GLIS2|0:NDRG2|0:RFNG|0:KIAA1279|0:SMARCC1|0:CHL1|0:SMARCE1|0:KIF2A|0:GLDN|0:SEMA4A|0:TBCB|0:MEF2D|0:MEF2A|0:SEMA6C|0:SEMA3D|0:SMARCA2|0:SMARCD3|0:ARID1B|0:STMN1|0:GPSM1|0:SMARCA4|0:CHRDL1|0:INSC|0:INA|0:EFNB2|0:FBXO45|0:ATOH8|0:PPP1R9A|0:GAP43|0:SPAST|0:BZW2|0:SEMA6B|0:CYB5D2|0:ACTL6B|0:NRBP2|0:FEV|0:MYT1L|0:PAX5|0:TTLL7|0:SEMA7A|0:SEMA5B|0:SEMA4G|0:PPP1R9B|0:ACTL6A|0:MYT1|0:DPF3|0:SLC7A5|0:HES4|0:PHF10|0:ATOH7|0:SEMA4C|0:UTP11L|0:SDHA|0:MYLIP|0:NDUFV2|0:TPP1|0:PRPS1|0:GLRB|0:MBNL1|0:DGCR14|0:RBM45|0:DPF1|0:SRRM4|0:NRSN1|0:NEFH|0:DCTN1|0:ARHGAP26|0:RAPGEF5|0:SDCBP2|0:EVL|0:MDK|0:AHNAK|0:NOTCH2|0:CSGALNACT1|0:IGSF8|0:CHD6|0:GPM6B|0:INHA|0:INHBA|0:FUT10|0:NRG1|0:SPG7|0:MOBP|0:CHRM3|0:NINJ1|0:NDP|0:DLG4|0:FGF14|0:KCNQ2|0:CXCL1|0:HEYL|0:APBA1|0:CNTFR|0:PAFAH1B3|0:LRCH4|0:SHOX2|0:PCDHA6|0:FGF19|0:IL3|0:CHRM2|0:ST8SIA4|0:APBA2|0:NR2E1|0:SIM1|0:ATXN3|0:PCDHAC2|0:GREM1|0:PPP2R5D|0:PCDHA8|0:DPYSL3|0:GSS|0:GUSBP1|0:LSAMP|0:DOC2A|0:PCDHA5|0:TRPC5|0:CPNE6|0:TRIM3|0:RAPGEFL1|0:SCRG1|0:DLX6|0:AVIL|0:CBLN1|0:DVL3|0:ADORA1|0:CHERP|0:CHRM1|0:TFAP2B|0:DPYSL4|0:FGF12|0:FKTN|0:HEY1|0:NEURL|0:SIM2|0:MEF2C|0:MPPED2|0:AQP4|0:PCDHA2|0:MSI1|0:PCDHA11|0:SMPD1|0:PCDH1|0:LY6H|0:SPOCK1|0:FGF17|0:GJB1|0:SERF1A|0:MTR|0:TIMM8A|0:BPNT1|0:ODZ1|0:NRGN|0:CRMP1|0:PCDHB12|0:C4orf6|0:FGF11|0:PCDHA4|0:DYRK1A|0:ST8SIA2|0:PCDHB15|0:GDA|0:GMFB|0:TMOD2|0:MAB21L2|0:PHYH|0:NAGLU|0:FGF13|0:PTN|0:OLFM1|0:VLDLR|0:NINJ2|0:PCDHA10|0:LGI1|0:PCDHA1|0:ENC1|0:PCDHAC1|0:ITM2B|0:NR2C2|0:NAIP|0:PCDHA7|0:FABP7|0:APLP1|0:P2RX5|0:SERF1B|0:CRIM1|0:NELL1|0:PCDHA3|0:HEY2|0:CYP46A1|0:HDAC4|0:CSPG5|0:SOX14			
GO:0060091	C:kinocilium; ISS:UniProtKB		0:GRXCR1			
GO:0035403	F:histone kinase activity (H3-T6 specific); IDA:UniProtKB		0:PRKCA|0:PRKCB			
GO:0032580	C:Golgi cisterna membrane; IEA:UniProtKB-SubCell		0:FUT4|0:ARAP1|0:GAL3ST3|0:INPP5E|0:GOLGA3|0:B4GALT4|0:FUT8|0:GALNT1|0:PITPNM1|0:CSGALNACT2|0:ST3GAL1|0:GOLGA8A|0:NAGPA|0:ABO|0:MOBKL3|0:FUT1|0:GAL3ST2|0:SORT1|0:ASAP2|0:GALNT2|0:CSGALNACT1|0:GOLGA2|0:B4GALT5|0:GOLPH3L|0:B4GALNT4|0:PSENEN|0:ST3GAL2|0:ST6GAL2|0:FUT5|0:FUT11|0:B3GALT6|0:CANT1|0:FUT2|0:CHPF|0:GOLPH3|0:B4GALT1|0:NCS1|0:APH1A|0:ST3GAL3|0:COG3|0:SCFD1|0:B4GALNT3|0:UXS1|0:GGTA1|0:FUT6|0:B4GALT6|0:B4GALT2|0:CHSY3|0:GALNT3|0:CHPF2|0:FUT3|0:GAL3ST4|0:ST6GAL1|0:CHSY1|0:FUT9|0:YIPF5|0:SAR1B|0:ST3GAL4|0:FUT7|0:GOLGA1|0:FUT10|0:GOLIM4|0:B4GALT7|0:B4GALT3|0:GOLGA8B			
GO:0031854	F:orexigenic neuropeptide QRFP receptor binding; ISS:UniProtKB		0:QRFP			
GO:0010792	P:DNA double-strand break processing involved...; IMP:UniProtKB		0:SLX1B|0:RBBP8|0:SLX1A|0:SLX4			
GO:0047444	F:N-acylneuraminate-9-phosphate synthase acti...; IEA:EC		0:NANS			
GO:0032184	F:SUMO polymer binding; ISS:UniProtKB		0:RNF4			
GO:0006869	P:lipid transport; TAS:ProtInc		0:APOA5|0:APOLD1|0:SORL1|0:PLTP|0:APOL4|0:LPA|0:STARD4|0:OSBPL9|0:OSBPL6|0:OSBPL11|0:APOO|0:OSBP2|0:GULP1|0:SIGMAR1|0:SPNS3|0:APOL5|0:LBP|0:OSBPL8|0:OSBP|0:APOL1|0:SPNS2|0:SCP2|0:OSBPL10|0:OSBPL3|0:STARD6|0:C11orf2|0:STARD5|0:SPNS1|0:OSBPL7|0:HDLBP|0:VLDLR|0:COL4A3BP|0:SLC27A6|0:OSBPL1A|0:OSBPL2|0:CLN8|0:APOL2|0:ABCA12|0:CHKA|0:PSAP			
GO:0004517	F:nitric-oxide synthase activity; ISS:BHF-UCL		0:NOS3|0:NOS2|0:NOS1			
GO:0005223	F:intracellular cGMP activated cation channel...; IDA:UniProtKB		0:AQP1			
GO:0006398	P:histone mRNA 3'-end processing; NAS:UniProtKB		0:CPSF3|0:CPSF2|0:ZNF473|0:SLBP|0:LSM11|0:CSDC2			
GO:0090024	P:negative regulation of neutrophil chemotaxis; IDA:UniProtKB		0:SLIT2			
GO:0005591	C:collagen type VIII; TAS:ProtInc		0:COL8A1			
GO:0008076	C:voltage-gated potassium channel complex; TAS:ProtInc		0:KCNE1|0:KCNQ1|0:KCNMB4|0:KCNMB2|0:KCNS1|0:KCNMB3|0:KCNMA1|0:KCNS2|0:KCNG3|0:KCTD14|0:KCTD20|0:KCTD7|0:KCTD12|0:KCNG4|0:KCTD13|0:KCNV2|0:KCTD3|0:KCTD18|0:TNFAIP1|0:KCTD6|0:KCNA7|0:KCTD10|0:KCTD15|0:KCND1|0:KCNA10|0:KCNG1|0:KCTD2|0:KCNQ4|0:KCNV1|0:KCNC2|0:KCTD9|0:KCTD19|0:KCNB1|0:KCTD11|0:KCTD5|0:KCTD16|0:KCTD8|0:KCNS3|0:KCTD21|0:SHKBP1|0:KCTD1|0:KCTD17|0:KCTD4|0:KCNF1|0:KCNRG|0:KCNJ16|0:KCNIP2|0:KCNJ13|0:CNTNAP2|0:KCNA3|0:KCNK1|0:KCNQ2|0:KCNH4|0:KCNJ3|0:KCNC3|0:KCNE1L|0:KCNQ3|0:KCNJ4|0:KCNA1|0:KCNA2|0:KCNC4|0:KCNA6|0:KCNC1|0:HCN2|0:KCNA5|0:KCNJ5|0:KCNJ8|0:KCNH2|0:KCNG2|0:KCNJ14|0:KCNJ1|0:KCNE2|0:KCNK6|0:KCNQ5|0:KCNA4|0:KCNJ6|0:KCNH1|0:KCNN1|0:KCND3|0:KCNB2|0:KCNN4			
GO:0007498	P:mesoderm development; TAS:UniProtKB		0:MESDC2|0:HES7|0:BTK|0:MEST|0:TIE1|0:IKZF3|0:JAK2|0:SECTM1|0:TCF21|0:HCK|0:BMX|0:MATK|0:IKZF1|0:T|0:GDF11			
GO:0030881	F:beta-2-microglobulin binding; TAS:UniProtKB		0:CD1D			
GO:0048148	P:behavioral response to cocaine; ISS:UniProtKB		0:DRD3|0:DRD4|0:DRD2|0:ABAT			
GO:0010508	P:positive regulation of autophagy; ISS:UniProtKB		0:PIM2			
GO:0007020	P:microtubule nucleation; TAS:UniProtKB		0:TUBGCP5|0:TUBGCP6|0:RANBP9|0:TUBGCP3|0:TUBGCP4|0:BLOC1S2|0:TUBGCP2|0:CENPJ			
GO:0006228	P:UTP biosynthetic process; IEA:InterPro		0:NME5|0:TXNDC3|0:NME4|0:NME1|0:RP2|0:NME2|0:NME6|0:TXNDC6|0:NME7|0:NME2P1|0:NME3			
GO:0007130	P:synaptonemal complex assembly; TAS:ProtInc		0:SYCP1|0:SYCP2|0:STAG3			
GO:0015250	F:water channel activity; TAS:ProtInc		0:AQP9|0:AQP1|0:AQP5|0:AQP3|0:AQP2|0:AQP6|0:AQP8|0:AQP7			
GO:0033119	P:negative regulation of RNA splicing; IDA:UniProtKB		0:RPS26|0:RPS13			
GO:0003180	P:aortic valve morphogenesis; IMP:BHF-UCL		0:NOTCH1			
GO:0019213	F:deacetylase activity; IDA:UniProtKB		0:AADAC			
GO:0006164	P:purine nucleotide biosynthetic process; IMP:UniProtKB		0:MTHFD1|0:MTHFD2L|0:PRPS1|0:HPRT1			
GO:0006297	P:nucleotide-excision repair, DNA gap filling; IDA:UniProtKB		0:POLD2|0:RFC4|0:LIG1|0:POLD3|0:RFC3|0:RPA2|0:POLD1|0:RPA3|0:RFC2|0:POLE|0:RFC5|0:POLD4|0:RFC1|0:PCNA|0:POLE2|0:RPA1|0:LIG4			
GO:0031021	C:interphase microtubule organizing center; IDA:UniProtKB		0:BIRC5			
GO:0051344	P:negative regulation of cyclic-nucleotide ph...; ISS:UniProtKB		0:GNAT1			
GO:0042640	P:anagen; TAS:UniProtKB		0:SPINK5			
GO:0034736	F:cholesterol O-acyltransferase activity; IDA:BHF-UCL		0:SOAT2|0:SOAT1			
GO:0014047	P:glutamate secretion; ISS:BHF-UCL		0:GIPC1			
GO:0043687	P:post-translational protein modification; ISS:UniProtKB		0:AKTIP|0:UBE2I|0:UEVLD|0:UBE2DNL|0:ATG5			
GO:0005078	F:MAP-kinase scaffold activity; NAS:UniProtKB		0:MAPK8IP1|0:MAPK8IP3|0:MAPK8IP2			
GO:0085020	P:protein K6-linked ubiquitination; ISS:UniProtKB		0:UBE2S|0:UBE2T|0:UBE2D4|0:BRCA1|0:BARD1|0:RNF6|0:RNF4			
GO:0014002	P:astrocyte development; IMP:UniProtKB		0:EIF2B5			
GO:0046485	P:ether lipid metabolic process; IDA:UniProtKB		0:TMEM195			
GO:0003941	F:L-serine ammonia-lyase activity; IEA:EC		0:SDS|0:SRR|0:SDSL			
GO:0000731	P:DNA synthesis involved in DNA repair; TAS:UniProtKB		0:WRN|0:POLH|0:POLD1|0:WRNIP1|0:POLA1|0:CDKN2D|0:POLE|0:POLD3|0:RFC3			
GO:0003682	F:chromatin binding; TAS:UniProtKB		0:UPF1|0:TP53|0:CAMTA2|0:NKX2-5|0:KLHDC3|0:SMC1A|0:C19orf40|0:APITD1|0:TOP1|0:BAHD1|0:POLD1|0:PHF8|0:RNF8|0:RNF168|0:TSHZ3|0:BAZ1B|0:FANCM|0:POLE|0:APBB1|0:POLA1|0:NKAP|0:JMJD5|0:C15orf42|0:TOP2B|0:PRKCB|0:KDM1A|0:TOP2A|0:PKN1|0:ERCC6|0:AIRE|0:APTX|0:ZKSCAN3|0:BAP1|0:CHD8|0:CHD9|0:CHD1|0:TIGD4|0:SMARCC2|0:CDY1B|0:CDYL2|0:CBX6|0:KAT5|0:CHD2|0:HIRA|0:CDY1|0:CDY2B|0:CHD3|0:ARID4B|0:CDYL|0:MPHOSPH8|0:CBX8|0:ARID4A|0:CDY2A|0:CBX3|0:MSL3|0:CHD4|0:CHD5|0:CBX7|0:NCOA6|0:RAG2|0:SKIL|0:NSD1|0:JARID2|0:ASF1A|0:CENPB|0:HMGN5|0:CHD6|0:NUP62|0:PBRM1|0:CENPF|0:CHD7|0:CHAF1B|0:MPO|0:EZH1|0:SMARCE1|0:ING2|0:SUV39H1|0:CENPA|0:CBX1|0:CHAF1A|0:ACTL6A|0:VCX|0:CDCA5			
GO:0044420	C:extracellular matrix part; IDA:BHF-UCL		0:AMELY|0:AMELX|0:CILP			
GO:0034109	P:homotypic cell-cell adhesion; IDA:BHF-UCL		0:PPAP2B			
GO:0045597	P:positive regulation of cell differentiation; NAS:UniProtKB		0:SRF|0:INS|0:VHL			
GO:0043163	P:cell envelope organization; TAS:UniProtKB		0:TGM3|0:TGM1			
GO:0051646	P:mitochondrion localization; IMP:UniProtKB		0:MFN2|0:MUL1			
GO:0008045	P:motor axon guidance; IMP:UniProtKB		0:SLIT2|0:SLIT1			
GO:0016078	P:tRNA catabolic process; IDA:UniProtKB		0:POP1			
GO:0000049	F:tRNA binding; TAS:ProtInc		0:AIMP1|0:FARS2|0:IGHMBP2|0:CARS|0:XPOT|0:TRNT1|0:FDXACB1|0:FARSA|0:AARS2|0:MARS|0:YARS|0:NSUN2|0:TRMU|0:XPO5|0:RPL35A|0:METTL1|0:CTU1|0:EIF2A|0:SEPSECS|0:KARS|0:AARS|0:SSB			
GO:0032471	P:reduction of endoplasmic reticulum calcium ...; IMP:BHF-UCL		0:ATP2A1			
GO:0004325	F:ferrochelatase activity; IDA:BHF-UCL		0:FECH			
GO:0007409	P:axonogenesis; TAS:UniProtKB		0:ULK2|0:DOCK7|0:DRD2|0:CTNNA2|0:NTNG2|0:CCK|0:ATL1|0:NTNG1|0:DSCAML1|0:APBB1|0:RTN4R|0:S100A6|0:POU4F1|0:S100B|0:BAIAP2|0:BAI1|0:PAX2|0:PARD6B|0:PARD3			
GO:0042287	F:MHC protein binding; NAS:UniProtKB		0:TRGV3|0:TRB@|0:TRBV12-3|0:TRAC|0:CLEC7A			
GO:0031901	C:early endosome membrane; IEA:UniProtKB-SubCell		0:B2M|0:ZFYVE9|0:ZFYVE16|0:ZFYVE28|0:PIKFYVE|0:SLC9A6|0:CLCN4|0:RAB5A|0:EEA1|0:REP15|0:WASH4P|0:APPL1|0:MARCH3|0:RUFY1|0:FAM21A|0:HSD17B6|0:CLVS2|0:APPL2|0:WASH2P|0:CLCN3|0:WASH1|0:STX7|0:CFTR|0:PLA2G4B|0:MMGT1|0:RAB5B|0:FGD2|0:EHD4|0:STAM|0:HPS6|0:ZFYVE20|0:TMEM90B|0:FAM21C|0:EPS15|0:HGS|0:RAB21|0:RAB5C|0:SH3GL1|0:EHD1|0:STAM2|0:FAM21B|0:SH3GL3|0:WASH6P|0:MARCH8|0:CLVS1|0:WASH3P|0:MARCH1			
GO:0048239	P:negative regulation of DNA recombination at...; ISS:UniProtKB		0:TERF2IP			
GO:0004639	F:phosphoribosylaminoimidazolesuccinocarboxam...; TAS:ProtInc		0:PAICS			
GO:0050674	P:urothelial cell proliferation; IDA:UniProtKB		0:FGF10			
GO:0050750	F:low-density lipoprotein receptor binding; IPI:BHF-UCL		0:APOE|0:HSP90B1|0:LANCL1|0:DKK1|0:SYT1|0:DNAJA1|0:LRPAP1|0:SNX17|0:APOB|0:APOA5|0:PCSK9			
GO:0008157	F:protein phosphatase 1 binding; TAS:ProtInc		0:PPP1R9B|0:AKAP11|0:LILRB1			
GO:0009822	P:alkaloid catabolic process; IDA:BHF-UCL		0:CYP2D6|0:CYP3A5|0:CYP3A4			
GO:0031711	F:bradykinin receptor binding; IPI:BHF-UCL		0:ACE|0:AGTR1			
GO:0051665	P:membrane raft localization; IDA:UniProtKB		0:RALA			
GO:0042335	P:cuticle development; ISS:UniProtKB		0:DUOX1|0:DUOX2			
GO:0003696	F:satellite DNA binding; TAS:ProtInc		0:CENPB|0:MBD2|0:MLH3|0:MBD4			
GO:0032807	C:DNA ligase IV complex; IMP:UniProtKB		0:XRCC4|0:LIG4			
GO:0021562	P:vestibulocochlear nerve development; ISS:UniProtKB		0:CHRNB2			
GO:0005185	F:neurohypophyseal hormone activity; IEA:InterPro		0:OXT|0:AVP			
GO:0016044	P:cellular membrane organization; NAS:UniProtKB		0:DTNBP1|0:SEC24A|0:FTL|0:BLOC1S3|0:SEC13|0:SEC24B|0:TXNDC5|0:DNAJC6|0:SEC31A|0:SEC24C|0:PUM1|0:CNO|0:HSPA8|0:SH3D19|0:AP1M1|0:BLOC1S1|0:SEC24D|0:PREB|0:SAR1B|0:FTH1|0:VAMP2|0:SEC23A|0:AP1M2|0:CCDC88A|0:UPK2|0:LPCAT2|0:PRKCI			
GO:0009396	P:folic acid and derivative biosynthetic process; IEA:InterPro		0:MTHFD1L|0:MTHFD1|0:MTHFD2L|0:FPGS|0:MTHFD2|0:MTHFSD|0:MTHFS			
GO:0042438	P:melanin biosynthetic process; ISS:UniProtKB		0:SILV|0:TYRP1|0:SLC45A2|0:DDT|0:CITED1			
GO:0030134	C:ER to Golgi transport vesicle; NAS:UniProtKB		0:KIAA0368|0:YIPF5|0:LMAN2L			
GO:0043400	P:cortisol secretion; NAS:UniProtKB		0:GHRL			
GO:0042301	F:phosphate binding; NAS:UniProtKB		0:SLC34A2|0:PNP|0:MTHFD2|0:RELA|0:G6PC|0:CHST14|0:ADSSL1|0:ADSS			
GO:0016594	F:glycine binding; ISS:UniProtKB		0:GRIN3A|0:GLRA2|0:GNMT|0:GLRA1|0:GRIN1|0:GRIN2B|0:ALAS2|0:SRR|0:GRIN3B			
GO:0070171	P:negative regulation of tooth mineralization; ISS:UniProtKB		0:ASPN			
GO:0006600	P:creatine metabolic process; ISS:BHF-UCL		0:CKMT1B|0:CKMT2|0:CKMT1A|0:CKB|0:CKM|0:GHR|0:STAT5A|0:STAT5B			
GO:0007194	P:negative regulation of adenylate cyclase ac...; TAS:ProtInc		0:GRM7|0:GALR3|0:GABBR2|0:GNAI3|0:GABBR1|0:GALR1|0:EDNRB|0:LTB4R2|0:CCR2			
GO:0004352	F:glutamate dehydrogenase activity; IDA:UniProtKB		0:GLUD1|0:GLUD2			
GO:0008048	F:calcium sensitive guanylate cyclase activat...; TAS:ProtInc		0:GUCA1A|0:GUCA1B|0:GUCA2B|0:RCVRN|0:GUCA1C			
GO:0019826	F:oxygen sensor activity; TAS:UniProtKB		0:EGLN2|0:NOX4			
GO:0021528	P:commissural neuron differentiation in the s...; ISS:UniProtKB		0:C1orf187			
GO:0003009	P:skeletal muscle contraction; IMP:BHF-UCL		0:TNNT3|0:TNNI2|0:TNNC2|0:TCAP|0:CHRNA1			
GO:0046833	P:positive regulation of RNA export from nucleus; ISS:UniProtKB		0:NCBP2			
GO:0005497	F:androgen binding; TAS:ProtInc		0:AR|0:SCGB2A1|0:ALDH1A1|0:SHBG			
GO:0033522	P:histone H2A ubiquitination; IMP:UniProtKB		0:UBE2A|0:RNF8|0:UBE2B			
GO:0030111	P:regulation of Wnt receptor signaling pathway; NAS:UniProtKB		0:MDFIC|0:FOXL1|0:PPP2R1A|0:PPP2CA|0:TCF7L1|0:SENP2			
GO:0006491	P:N-glycan processing; TAS:UniProtKB		0:MGAT4B|0:MGAT4A|0:ST8SIA4|0:MAN1A2|0:ST8SIA2|0:ST8SIA3|0:FUT8			
GO:0045123	P:cellular extravasation; NAS:UniProtKB		0:AZU1			
GO:0032314	P:regulation of Rac GTPase activity; ISS:UniProtKB		0:STMN3|0:BVES			
GO:0015893	P:drug transport; NAS:UniProtKB		0:PDZK1			
GO:0005579	C:membrane attack complex; TAS:ProtInc		0:C8A|0:C8G|0:C9|0:C5|0:C8B|0:C6|0:C7			
GO:0007249	P:I-kappaB kinase/NF-kappaB cascade; TAS:ProtInc		0:IRF3|0:MAP3K1|0:MYD88|0:IRAK4|0:TLR10|0:TBK1|0:RIPK1|0:TLR5|0:LY96|0:TIRAP|0:TICAM2|0:TICAM1|0:TLR8|0:ZNF675|0:TIAF1|0:NLRC3|0:BCL3|0:MAP3K14|0:IRAK1BP1|0:NKIRAS2|0:NKIRAS1|0:STAT1|0:IRAK2|0:PTPLAD1			
GO:0008023	C:transcription elongation factor complex; TAS:ProtInc		0:NUFIP1|0:ELP2|0:ELP3|0:IKBKAP|0:ELP4|0:ERCC6|0:ELL|0:ELL3|0:TCEA2|0:ELL2|0:CDK9|0:TTF2			
GO:0046964	F:3'-phosphoadenosine 5'-phosphosulfate trans...; IDA:UniProtKB		0:SLC35B2			
GO:0007605	P:sensory perception of sound; TAS:UniProtKB		0:STRC|0:TMC1|0:MARVELD2|0:SLC17A8|0:OTOA|0:DFNB59|0:MYO6|0:ESPN|0:NIPBL|0:COL2A1|0:WFS1|0:USH1G|0:USH1C|0:DFNB31|0:USH2A|0:CLRN1|0:ATP6V0A4|0:ATP6V1B1|0:CDH23|0:PCDH15|0:C20orf54|0:LOXHD1|0:MYO1A|0:SLC26A5|0:ATP2B2|0:TBL1X|0:GRM7|0:TPRN|0:COL1A1|0:MYO3A|0:MYO7A|0:COL11A2|0:CRYM|0:CHRNB2|0:SOD1|0:GRXCR1|0:NDP|0:KPTN|0:EYA1|0:SLC26A4|0:MYO15A|0:DIAPH1|0:OTOF|0:COCH|0:OTOR|0:COL4A3|0:EML2|0:POU3F4|0:TIMM8B|0:KCNQ4|0:POU4F3|0:GJB6|0:DFNA5|0:TECTA|0:GJB2|0:PAX3|0:KCNE1|0:ALDH7A1|0:TIMM9|0:TIMM13|0:NDUFB9|0:ZNF354A|0:KCNQ1|0:WDR1|0:TIMM10			
GO:0048025	P:negative regulation of nuclear mRNA splicin...; ISS:UniProtKB		0:SRSF10|0:SRSF12			
GO:0034378	P:chylomicron assembly; TAS:BHF-UCL		0:APOA4			
GO:0022627	C:cytosolic small ribosomal subunit; NAS:UniProtKB		0:RPS11|0:RPS18|0:RPS23|0:RPS15A|0:RPSA|0:RPS8|0:RPS26|0:RPS15|0:RPS12|0:RPS19|0:RPS3|0:RPS2|0:RPS20|0:RPS7|0:RPS27|0:RPS28|0:RPS21|0:RPS3A|0:RPS16|0:RPS13|0:HBA2|0:RPS24|0:RPS6|0:HBA1|0:RPS17|0:FAU|0:RPS29|0:RPS10|0:RPS5|0:RPS25|0:RPS9|0:RPS4X|0:RPS14|0:MRPS7|0:RPS4Y1			
GO:0008296	F:3'-5'-exodeoxyribonuclease activity; TAS:ProtInc		0:TREX1|0:TREX2			
GO:0016012	C:sarcoglycan complex; TAS:ProtInc		0:SGCA|0:SGCB|0:SGCG|0:SGCE|0:SGCD			
GO:0072061	P:inner medullary collecting duct development; ISS:UniProtKB		0:WNT7B			
GO:0051552	P:flavone metabolic process; IDA:BHF-UCL		0:UGT1A7|0:UGT1A8|0:UGT1A10|0:UGT1A9|0:UGT1A1			
GO:0002230	P:positive regulation of defense response to ...; IMP:UniProtKB		0:APOBEC3F|0:APOBEC3G|0:PML|0:DDX58|0:MAVS			
GO:0090051	P:negative regulation of cell migration invol...; IMP:BHF-UCL		0:HDAC5			
GO:0046620	P:regulation of organ growth; NAS:UniProtKB		0:SOD1			
GO:0030349	F:syntaxin-13 binding; TAS:UniProtKB		0:ABCA1|0:PLDN			
GO:0034755	P:iron ion transmembrane transport; ISS:UniProtKB		0:SCARA5			
GO:0005914	C:spot adherens junction; IDA:UniProtKB		0:PGM5			
GO:0008448	F:N-acetylglucosamine-6-phosphate deacetylase...; IEA:EC		0:AMDHD2			
GO:0014902	P:myotube differentiation; IMP:BHF-UCL		0:SKI|0:SORT1			
GO:0016791	F:phosphatase activity; IEA:InterPro		0:MTMR9|0:MTMR11|0:MTMR10|0:MTMR12|0:SBF2			
GO:0016503	F:pheromone receptor activity; IEA:InterPro		0:VN1R1|0:VN1R4|0:VN1R3|0:VN1R5|0:VN1R2			
GO:0044236	P:multicellular organismal metabolic process; IMP:BHF-UCL		0:GHR			
GO:0006449	P:regulation of translational termination; TAS:ProtInc		0:UPF1|0:HRSP12			
GO:0042320	P:regulation of circadian sleep/wake cycle, R...; ISS:UniProtKB		0:CHRNB2			
GO:0031573	P:intra-S DNA damage checkpoint; TAS:UniProtKB		0:NEK11|0:TIPIN|0:MDC1			
GO:0006824	P:cobalt ion transport; IEA:UniProtKB-KW		0:SLC30A5|0:GIF|0:TCN2|0:TCN1			
GO:0050780	F:dopamine receptor binding; IEA:InterPro		0:CALY			
GO:0009055	F:electron carrier activity; TAS:UniProtKB		0:ETFA|0:ADH6|0:TXNDC17|0:KMO|0:HMOX2|0:ETFDH|0:COX7A2|0:TXNRD1|0:MT-CO1|0:NDUFA12|0:AOX1|0:SDHA|0:CYP2A6|0:GLRX3|0:CYP39A1|0:CYP2C19|0:CYP7A1|0:CYP2S1|0:DOCK2|0:CYP2U1|0:CYP7B1|0:CYP2E1|0:DUOX1|0:NDUFAF2|0:STEAP2|0:CYP51A1|0:GLRX5|0:CYP11A1|0:CYP2D6|0:CYP4A22|0:CYP21A2|0:CYP11B2|0:ABCE1|0:FDX1L|0:CYP3A7|0:CYP27A1|0:CYP4Z2P|0:CYP2C8|0:NOX1|0:MT-CO2|0:CYP2B6|0:PTGIS|0:CYP27B1|0:CYP4F2|0:GLRX|0:SH3BGRL3|0:TXN2|0:CYP1B1|0:STEAP1|0:CYP4A11|0:CYP4X1|0:CYP2W1|0:COX7A1|0:CYP24A1|0:CYP2R1|0:XDH|0:CYP1A1|0:CYP3A5|0:PTGES2|0:CYP4F3|0:COX7A2P2|0:CYP26C1|0:NQO1|0:CYP11B1|0:CYP4F11|0:SUOX|0:CYP26A1|0:COX7A2L|0:CYP2C9|0:CYP3A43|0:CYBB|0:CYP17A1|0:CYP8B1|0:NDUFS8|0:STEAP4|0:TBXAS1|0:CYP20A1|0:CYP26B1|0:TXNRD3|0:CLIC2|0:RETSAT|0:CYP2F1|0:DPYD|0:CYP4F12|0:NOX3|0:GRXCR1|0:CYP27C1|0:CYP4B1|0:SDHB|0:CYP4V2|0:CYP2A13|0:CYP2C18|0:CYP3A4|0:CYP2A7|0:CYP4F22|0:NOX5|0:STEAP3|0:DUOX2|0:CYP4F8|0:CYP4Z1|0:SDHC|0:CYP46A1|0:CYP2J2|0:NDUFS6|0:NDUFV2|0:NDUFS3|0:GLRX2|0:NDUFS2|0:HAAO|0:NDUFS1|0:DMGDH|0:AIFM1|0:FDX1|0:ETFB|0:UQCR11|0:RDH16|0:ALDH2|0:SRD5A1|0:HSD17B6|0:AOC2|0:TSTA3|0:NOX4|0:COX11|0:CYP19A1|0:SDHD|0:GPX2|0:ALDH4A1|0:AKR7A2|0:CYP1A2|0:QDPR|0:AKR1C4|0:GLDC|0:CYBA|0:NCF1|0:GSR|0:DEGS1|0:COX5A|0:P4HA2|0:IDH3B|0:ME2|0:AKR1B1|0:AKR1A1|0:DHRS3|0:UGDH|0:LOXL2|0:ADH5|0:NQO2|0:PHGDH|0:PHYH|0:IDO1|0:NCF2|0:ASPH|0:MAOB|0:DHDH|0:AKR7A3|0:ME1			
GO:0008105	P:asymmetric protein localization; TAS:ProtInc		0:COLQ			
GO:0004555	F:alpha,alpha-trehalase activity; IDA:UniProtKB		0:TREH			
GO:0006975	P:DNA damage induced protein phosphorylation; TAS:ProtInc		0:ATM|0:MAP2K6|0:MAPK12			
GO:0034197	P:triglyceride transport; ISS:BHF-UCL		0:APOH			
GO:0007099	P:centriole replication; IMP:UniProtKB		0:CNTROB|0:CENPJ|0:CEP135|0:CETN2|0:SASS6			
GO:0048014	P:Tie receptor signaling pathway; IDA:UniProtKB		0:ANGPT1|0:ANGPT2			
GO:0004430	F:1-phosphatidylinositol 4-kinase activity; TAS:ProtInc		0:PI4K2A|0:PI4K2B|0:PI4KA|0:PI4KB			
GO:0047042	F:3-alpha-hydroxysteroid dehydrogenase (B-spe...; IEA:EC		0:AKR1C1|0:AKR1C4			
GO:0006749	P:glutathione metabolic process; TAS:UniProtKB		0:GPX1|0:GSTA1|0:GSTT1|0:G6PD|0:CTNS|0:ALDH5A1|0:SOD1|0:GLRX2			
GO:0007266	P:Rho protein signal transduction; TAS:UniProtKB		0:MYO9B|0:CTNNAL1|0:RHOG|0:TAX1BP3|0:COL1A2|0:ARHGEF11|0:AGTR1|0:RTKN|0:CDH13|0:CNKSR1|0:ARHGAP6|0:ARHGDIB|0:ARHGAP4|0:RHOD|0:ARHGAP5|0:ARHGDIG|0:LIMK1|0:ARHGAP1|0:ARHGEF1|0:ARHGAP29|0:ARHGEF3|0:ADRA2A|0:CFL1|0:ROCK1|0:ARHGDIA|0:ROPN1B|0:RHOA|0:RHOB			
GO:0034619	P:cellular chaperone-mediated protein complex...; IDA:BHF-UCL		0:HSPA4|0:HSP90AA1			
GO:0006261	P:DNA-dependent DNA replication; TAS:ProtInc		0:POLE2|0:RPAIN|0:PNKP|0:RPA2|0:POLG2|0:POLB|0:CDK2AP1|0:TFAM|0:RFC1|0:REV3L|0:RPA1			
GO:0008617	P:guanosine metabolic process; TAS:ProtInc		0:DGUOK			
GO:0005133	F:interferon-gamma receptor binding; TAS:ProtInc		0:DNAJA3|0:IFNG			
GO:0016505	F:apoptotic protease activator activity; NAS:UniProtKB		0:MAL|0:EBAG9			
GO:0019428	P:allantoin biosynthetic process; IEA:InterPro		0:PRHOXNB			
GO:0006656	P:phosphatidylcholine biosynthetic process; TAS:ProtInc		0:APOA2|0:LCAT|0:APOA1|0:AGPAT6|0:SLC27A1|0:PEMT			
GO:0072092	P:ureteric bud invasion; ISS:UniProtKB		0:SALL1			
GO:0002741	P:positive regulation of cytokine secretion i...; IMP:UniProtKB		0:WNT5A			
GO:0007595	P:lactation; TAS:ProtInc		0:PRL|0:AGPAT6|0:PRLR|0:OXTR|0:APLN			
GO:0046037	P:GMP metabolic process; IMP:BHF-UCL		0:PDE6A|0:PDE6B			
GO:0030146	P:diuresis; TAS:UniProtKB		0:DRD2|0:NPR3|0:NPR1|0:KNG1|0:NPPB			
GO:0006616	P:SRP-dependent cotranslational protein targe...; ISS:UniProtKB		0:SRP54			
GO:0005536	F:glucose binding; NAS:UniProtKB		0:G6PD|0:GCK|0:PYGL			
GO:0055074	P:calcium ion homeostasis; NAS:UniProtKB		0:CYP27B1|0:GRIN1|0:S100A14			
GO:0007339	P:binding of sperm to zona pellucida; TAS:ProtInc		0:ZPBP2|0:ZPBP|0:SPA17|0:ZAN|0:SPAM1|0:ZP2			
GO:0005055	F:laminin receptor activity; IMP:BHF-UCL		0:BCAM			
GO:0019763	F:immunoglobulin receptor activity; NAS:UniProtKB		0:FCGR1B			
GO:0034714	F:type III transforming growth factor beta re...; IDA:BHF-UCL		0:TGFBR2			
GO:0000166	F:nucleotide binding; TAS:ProtInc		0:CHFR|0:APLF|0:POLA1|0:LARP7|0:UPF3A|0:RBPMS|0:PPARGC1A|0:SAFB2|0:RBMXL1|0:HNRNPH1|0:RBM4B|0:RBMY1A1|0:RBM16|0:SKI|0:RBMY1E|0:NCL|0:ZRSR1|0:NONO|0:SNRPB2|0:PABPC1L2B|0:SAFB|0:SRSF12|0:SFPQ|0:PABPC3|0:LEMD3|0:SRSF8|0:POLR2D|0:RBM12|0:RBM11|0:NCBP2|0:RBM22|0:RBMS3|0:PTBP2|0:CIRBP|0:ROD1|0:CELF4|0:EIF3G|0:IGF2BP1|0:ELAVL3|0:RBM15|0:DAZ3|0:SRSF6|0:HNRNPR|0:RBM44|0:RBM38|0:HNRNPD|0:RBM34|0:U2AF2|0:IGF2BP2|0:ENOX1|0:HTATSF1|0:RBM28|0:HNRNPA1|0:SLC30A9|0:MATR3|0:SNRNP70|0:NXF2|0:CPSF7|0:RDBP|0:RBMY1J|0:CPEB2|0:HNRNPM|0:SRSF2|0:RAVER2|0:MKI67IP|0:RBM27|0:RBM10|0:TIAL1|0:RBM7|0:PABPN1|0:NXF2B|0:CPEB4|0:RBMX2|0:RBM41|0:UPF3B|0:RPL23A|0:POLD1|0:MRPL23|0:NXF5|0:RDM1|0:KIAA2022|0:SNRPA|0:RBM19|0:CSTF2T|0:C10orf140|0:CELF3|0:PTBP1|0:HNRNPF|0:PABPC1L|0:SKOR1|0:PABPC4|0:NAV1|0:SREK1|0:PPIE|0:PUF60|0:ENOX2|0:PPIL4|0:RBM26|0:CRCP|0:HNRNPCL1|0:RBMY1D|0:HNRPA1L3|0:RBM45|0:RBM14|0:SYNCRIP|0:RBFOX2|0:PPRC1|0:EIF4H|0:RBM39|0:DAZ2|0:CNOT4|0:NXF1|0:ELAVL4|0:SRSF10|0:MRPL39|0:SRSF1|0:ACIN1|0:RALYL|0:PARN|0:PABPC5|0:CPEB3|0:RAVER1|0:SSB|0:TARDBP|0:POLE|0:PSPC1|0:TRMT2A|0:SLTM|0:MSI1|0:U2AF1|0:DAZ1|0:PABPC4L|0:HNRNPC|0:RBM42|0:HNRNPAB|0:TNRC6C|0:RBM18|0:RBMX|0:RBM8A|0:PABPC1|0:RBMY1C|0:SRSF5|0:A1CF|0:TRA2B|0:TDRD10|0:RBM3|0:RNPC3|0:RPS24|0:TNRC6B|0:HNRNPA2B1|0:CELF2|0:SETD1B|0:SNRNP35|0:RNPS1|0:ELAVL1|0:RBM15B|0:RBM25|0:PPARGC1B|0:TIA1|0:DACH1|0:RBM4|0:RBMXL3|0:MYEF2|0:CELF6|0:ZRSR2|0:SPEN|0:RBM46|0:RBM12B|0:RBPMS2|0:EIF4B|0:SFRS15|0:HNRPDL|0:CSTF2|0:U2AF1L4|0:HNRNPA3|0:SART3|0:SF3B4|0:HNRNPH2|0:TUT1|0:NOL8|0:RBM17|0:SRSF11|0:CELF5|0:ELAVL2|0:SRSF3|0:RBM5|0:ESRP1|0:RBMXL2|0:SKIL|0:C14orf156|0:RALY|0:RBM24|0:RBM23|0:TRNAU1AP|0:RBMY1F|0:RBMS2|0:PABPC1L2A|0:SRSF4|0:RNF213|0:BOLL|0:DAZL|0:MSI2|0:SRSF9|0:KIAA0430|0:HNRNPL|0:DAZAP1|0:IGF2BP3|0:ZCRB1|0:CELF1|0:POLDIP3|0:HNRNPA0|0:NAIP|0:DND1|0:ESRP2|0:HNRPLL|0:SRSF7|0:G3BP2|0:TNRC6A|0:THOC4|0:CPSF6|0:TRA2A|0:SETD1A|0:HNRNPA1L2|0:EIF3B|0:NCBP2L|0:REV3L|0:NT5C1B|0:HNRNPH3|0:DACH2|0:XPA|0:NXF3|0:EWSR1|0:RBMY1B|0:DAZ4|0:HDGF|0:NT5C3L|0:NT5E|0:NT5C3|0:CRY2|0:NT5M|0:SLC27A3|0:MOCS2|0:VPS11|0:SLC27A4|0:NT5C1A|0:VDAC2|0:VDAC3|0:SLC27A6|0:CRY1|0:SLC27A1|0:NT5C2|0:TINAG|0:LTB4R|0:DHRS3			
GO:0035241	F:protein-arginine omega-N monomethyltransfer...; IDA:UniProtKB		0:PRMT8|0:PRMT6|0:PRMT7			
GO:0051318	P:G1 phase; TAS:UniProtKB		0:ZNF655|0:RB1			
GO:0046979	F:TAP2 binding; IPI:UniProtKB		0:TAPBP|0:TAP1			
GO:0000072	P:M phase specific microtubule process; TAS:ProtInc		0:KPNA2			
GO:0006004	P:fucose metabolic process; TAS:ProtInc		0:FUCA2|0:FUCA1|0:POFUT2|0:B3GALTL|0:POFUT1|0:FPGT			
GO:0031642	P:negative regulation of myelination; ISS:UniProtKB		0:KLK8|0:EIF2AK3			
GO:0018108	P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB		0:PDGFRA|0:PDGFRB|0:INSR|0:ABI1|0:ABI2|0:ABL1|0:ABL2|0:ERBB4|0:FLT1|0:LYN|0:FES|0:TYK2|0:FER|0:DYRK1A|0:RELN			
GO:0008593	P:regulation of Notch signaling pathway; IGI:UniProtKB		0:DTX1			
GO:0004715	F:non-membrane spanning protein tyrosine kina...; TAS:ProtInc		0:DYRK1A|0:BTK|0:SRMS|0:ABL1|0:WEE1|0:CSK|0:LCK|0:BLK|0:SYK|0:JAK1|0:JAK3|0:STYK1|0:BAZ1B|0:JAK2|0:ZAP70|0:LYN|0:FES|0:FGR|0:WEE2|0:ABL2|0:PTK2|0:HCK|0:FER|0:BMX|0:MATK|0:TNK1|0:FYN|0:SRC|0:YES1|0:ITK|0:PTK2B|0:TNK2|0:CLK1|0:TXK|0:TEC|0:FRK|0:TYK2|0:PTK6			
GO:0048854	P:brain morphogenesis; ISS:UniProtKB		0:PAFAH1B1|0:BBS4|0:MKKS|0:BBS2|0:CTNNA2			
GO:0000785	C:chromatin; TAS:ProtInc		0:NEDD4|0:ARRB1|0:UPF1|0:OIP5|0:STAG2|0:DSCC1|0:MEN1|0:PDS5A|0:SMC3|0:PDS5B|0:HLCS|0:STAG1|0:APTX|0:L3MBTL1|0:MAU2|0:CHD8|0:CHD9|0:CHD1|0:CBX2|0:SMARCC2|0:CDY1B|0:CDYL2|0:HMGN4|0:CBX6|0:HMGA1|0:KAT5|0:CHD7|0:CHD2|0:CDY1|0:CDY2B|0:HMGA2|0:HMGN5|0:CBX4|0:CHD3|0:CHD6|0:ARID4B|0:HMGN2|0:CDYL|0:MPHOSPH8|0:CBX8|0:ARID4A|0:CDY2A|0:MSL3|0:HMGN3|0:HMGN2L|0:CHD4|0:CHD5|0:CBX7|0:MYCN|0:HMGN1|0:MCM7|0:JUNB|0:JUND|0:MAF|0:MCM2|0:RB1			
GO:0004984	F:olfactory receptor activity; TAS:ProtInc		0:OR1D2|0:OR2K2|0:OR2V2|0:OR7A17|0:OR10X1|0:OR10A2|0:OR8J3|0:OR6C1|0:OR9G1|0:OR4M2|0:OR4C13|0:OR4A4P|0:OR2T29|0:OR11L1|0:OR8K3|0:OR52A1|0:OR1L3|0:OR1B1|0:OR5W2|0:OR13F1|0:OR8B4|0:OR5K4|0:OR5L2|0:OR4C3|0:OR52E1|0:OR13A1|0:OR2A25|0:OR4D5|0:OR2M3|0:OR52E6|0:OR2T6|0:OR2T33|0:OR5AS1|0:OR10D3|0:OR4C46|0:OR51Q1|0:OR9G9|0:OR5AU1|0:OR2W3|0:OR1G1|0:OR2A5|0:OR2AK2|0:OR7C1|0:OR5M11|0:OR51L1|0:OR4A5|0:OR5M8|0:OR13C8|0:OR2A42|0:OR51E1|0:OR2G3|0:OR1S1|0:OR10G2|0:OR4F6|0:OR6M1|0:OR13H1|0:OR10A6|0:OR4D2|0:OR4F29|0:OR52E5|0:OR4A16|0:OR6T1|0:OR51F2|0:OR1F2P|0:OR2AP1|0:OR5P2|0:OR51D1|0:OR56A5|0:OR2A14|0:OR4Q3|0:OR5H15|0:OR1S2|0:OR10J4|0:OR52H1|0:OR1L6|0:OR14A16|0:OR7C2|0:OR10G7|0:OR2AE1|0:OR13C4|0:OR10H4|0:OR4N4|0:OR11H6|0:OR12D2|0:OR5B21|0:OR2T34|0:OR9K2|0:OR5K2|0:OR4C6|0:OR51A4|0:OR7G3|0:OR6V1|0:OR2L3|0:OR51G1|0:OR13C2|0:OR5L1|0:OR9I1|0:OR2J1|0:OR2B2|0:OR52K1|0:OR4F17|0:OR11H12|0:OR11H4|0:OR6C4|0:OR8J2|0:OR2V1|0:OR4D6|0:OR4S2|0:OR5D18|0:OR8H2|0:OR10AD1|0:OR52P1P|0:OR5AK3P|0:OR6C70|0:OR7D4|0:OR2L5|0:OR2G2|0:OR1J1|0:OR4F5|0:OR10P1|0:OR2T2|0:OR4C45|0:OR2A12|0:OR10G3|0:OR10G8|0:OR11H1|0:OR4K17|0:OR5AR1|0:OR52N2|0:OR11A1|0:OR10A7|0:OR2B6|0:OR5AC1|0:OR1D4|0:OR14K1|0:OR2B8P|0:OR2C3|0:OR1E2|0:OR10J3|0:OR52E2|0:OR5K1|0:OR1J2|0:OR8K1|0:OR52A4|0:OR51S1|0:OR4K3|0:OR6Y1|0:OR1N2|0:OR5H14|0:OR13C5|0:OR5T2|0:OR6P1|0:OR52B2|0:OR4K14|0:OR14I1|0:OR2L2|0:OR52N5|0:OR56B1|0:OR11H7|0:OR5B17|0:OR13J1|0:OR6C68|0:OR6N1|0:OR2Z1|0:OR14J1|0:OR2T7|0:OR5H1|0:OR5K3|0:OR56A4|0:OR5M9|0:OR2I1P|0:OR5H6|0:OR56B2P|0:OR9A2|0:OR2G6|0:OR2AT4|0:OR51A2|0:OR2A2|0:OR8H3|0:OR7G2|0:OR1F1|0:OR10H3|0:OR5AK2|0:OR5V1|0:OR5D13|0:OR7A10|0:OR2W1|0:OR4A15|0:OR8J1|0:OR4N5|0:OR10J6P|0:OR4D10|0:OR4S1|0:OR6A2|0:OR56B4|0:OR6S1|0:OR2L13|0:OR2A7|0:OR52Z1|0:OR52N1|0:OR9A1P|0:OR6B2|0:OR8H1|0:OR10H5|0:OR6C65|0:OR10G4|0:OR4L1|0:OR4F16|0:OR2AJ1|0:OR6X1|0:OR4P4|0:OR10G9|0:OR10J5|0:OR56A1|0:OR13G1|0:OR4C16|0:OR52I1|0:OR2W6P|0:OR4E1|0:OR8A1|0:OR5M1|0:OR14A2|0:OR9G4|0:OR5AN1|0:OR10K2|0:OR4A8P|0:OR2T11|0:OR10S1|0:OR5A2|0:OR52M1|0:OR10W1|0:OR2B11|0:OR9Q1|0:OR2L8|0:OR4K5|0:OR2T3|0:OR5H2|0:OR52E8|0:OR2F2|0:OR14C36|0:OR11H2|0:OR52K2|0:OR5D14|0:OR10AG1|0:OR6B3|0:OR8D4|0:OR5AP2|0:OR4X1|0:OR1I1|0:OR8D1|0:OR13D1|0:OR2T12|0:OR6N2|0:OR10T2|0:OR5B2|0:OR6C76|0:OR8U9|0:OR10H2|0:OR10A4|0:OR8B12|0:OR10Z1|0:OR1P1|0:OR1M1|0:OR4F4|0:OR1F12|0:OR1E3|0:OR10V1|0:OR2F1|0:OR3A2|0:OR7G1|0:OR8B2|0:OR2T27|0:OR6C74|0:OR6J1|0:OR4C12|0:OR9Q2|0:OR2M5|0:OR4K13|0:OR4F15|0:OR56A3|0:OR2J3|0:OR52B6|0:OR8K5|0:OR2B3|0:OR5I1|0:OR2T8|0:OR7A2P|0:OR2AG2|0:OR1N1|0:OR5T3|0:OR4N2|0:OR6K6|0:OR8S1|0:OR4K2|0:OR2Y1|0:OR6B1|0:OR4A47|0:OR5R1|0:OR10K1|0:OR2W5|0:OR2M2|0:OR51G2|0:OR1L8|0:OR2T5|0:OR2AG1|0:OR2T4|0:OR4K15|0:OR4D11|0:OR7E24|0:OR5G3|0:OR2A1|0:OR52N4|0:OR52L1|0:OR2A4|0:OR12D3|0:OR4B1|0:OR6C6|0:OR8I2|0:OR1L1|0:OR1K1|0:OR2M7|0:OR51T1|0:OR6K3|0:OR8G5|0:OR5P3|0:OR6F1|0:OR9A4|0:OR3A3|0:OR6K2|0:OR5D16|0:OR4E2|0:OR6Q1|0:OR4C15|0:OR52I2|0:OR1L4|0:OR10Q1|0:OR51A7|0:OR4F3|0:OR2T1|0:OR13C9|0:OR2H1|0:OR10AC1P|0:OR5AL1|0:OR10H1|0:OR5M3|0:OR10C1|0:OR7D2|0:OR8U1|0:OR4X2|0:OR52W1|0:OR6C75|0:OR5M10|0:OR51H1P|0:OR2T10|0:OR52J3|0:OR4D9|0:OR52E4|0:OR2J2|0:OR51F1|0:OR52L2P|0:OR4C5|0:OR10J1|0:OR14L1P|0:OR13C3|0:OR5C1|0:OR4Q2|0:OR10D4P|0:OR10R2|0:OR10G6|0:OR4K1|0:OR5B12|0:OR5J2|0:OR5A1|0:OR8D2|0:OR11G2|0:OR52B4|0:OR5B3|0:OR52R1|0:OR2D3|0:OR4F21|0:OR1J4|0:OR4C11|0:OR4M1|0:OR8U8|0:OR2T35|0:OR8B3|0:OR5T1|0:OR6C3|0:OR51V1|0:OR51B5|0:OR52D1|0:OR8G1|0:OR51B4|0:OR52A5|0:OR1Q1|0:OR2D2|0:OR6C2|0:OR51I2|0:OR4D1|0:OR8B8|0:OR1E1|0:OR2M4|0:OR1A2|0:OR51J1|0:OR5AC2|0:OR51M1|0:OR51I1|0:OR3A4|0:OR51B6|0:OR1C1|0:OR5F1|0:OR1A1|0:OR10A3|0:OR51B2|0:OR8G2|0:OR51E2|0:OR10A5|0:OR7A5|0:OR2C1|0:OR1D5|0:OR2S2|0:OR3A1|0:OR2H2			
GO:0015980	P:energy derivation by oxidation of organic c...; TAS:ProtInc		0:ACSM1|0:ACADVL|0:CRAT			
GO:0060122	P:inner ear receptor stereocilium organization; ISS:UniProtKB		0:DFNB31|0:GRXCR1			
GO:0003341	P:cilium movement; IMP:BHF-UCL		0:RSPH4A|0:RSPH9			
GO:0019478	P:D-amino acid catabolic process; IEA:InterPro		0:DTD1|0:C14orf126			
GO:0070506	F:high-density lipoprotein receptor activity; IDA:BHF-UCL		0:SCARB1			
GO:0070842	P:aggresome assembly; IMP:BHF-UCL		0:UBD|0:PARK2|0:HDAC6			
GO:0045814	P:negative regulation of gene expression, epi...; IEP:UniProtKB		0:TRIM27|0:EPC1|0:CREBZF			
GO:0042421	P:norepinephrine biosynthetic process; IDA:BHF-UCL		0:TH			
GO:0045059	P:positive thymic T cell selection; ISS:UniProtKB		0:ZAP70|0:CD3D			
GO:0032449	C:CBM complex; NAS:UniProtKB		0:MALT1|0:CARD10|0:BCL10			
GO:0006082	P:organic acid metabolic process; IDA:BHF-UCL		0:FMO2|0:CYP2C8|0:FMO1			
GO:0047522	F:15-oxoprostaglandin 13-oxidase activity; IEA:EC		0:PTGR2|0:PTGR1			
GO:0032217	F:riboflavin transporter activity; IDA:UniProtKB		0:C20orf54|0:GPR172B|0:GPR172A			
GO:0004995	F:tachykinin receptor activity; TAS:ProtInc		0:TACR2|0:TACR3			
GO:0043522	F:leucine zipper domain binding; NAS:UniProtKB		0:PMF1|0:PAWR|0:DAPK3|0:AATF|0:ERC1			
GO:0045298	C:tubulin complex; IDA:UniProtKB		0:MAPT			
GO:0060317	P:cardiac epithelial to mesenchymal transition; IDA:BHF-UCL		0:BMP2|0:TGFBR3|0:TGFB2			
GO:0007159	P:leukocyte cell-cell adhesion; TAS:ProtInc		0:APOA4|0:ITGA4|0:ITGB2|0:SYK|0:CALCA|0:MSN|0:EZR|0:ICAM1|0:ITGAL|0:FERMT3|0:CLEC4M|0:CD209|0:TSTA3|0:GMDS|0:CD40LG|0:CERCAM			
GO:0061090	P:positive regulation of sequestering of zinc...; IDA:BHF-UCL		0:SLC30A2			
GO:0031410	C:cytoplasmic vesicle; ISS:UniProtKB		0:LRP6|0:HFE|0:GCH1|0:GRM4|0:SLC11A2|0:SOD1|0:MAP1LC3C|0:AMBRA1|0:ATG9A|0:ATG9B|0:TM9SF1|0:TMEM74|0:MAP1LC3A|0:MAP1LC3B2|0:MAP1LC3B|0:ENTPD4|0:NBR1|0:RHCG			
GO:0046874	P:quinolinate metabolic process; IDA:UniProtKB		0:ACMSD			
GO:0008124	F:4-alpha-hydroxytetrahydrobiopterin dehydrat...; IEA:EC		0:PCBD1|0:PCBD2			
GO:0034188	F:apolipoprotein A-I receptor activity; IDA:BHF-UCL		0:ABCA1			
GO:0045471	P:response to ethanol; ISS:UniProtKB		0:TH|0:GRIN3A|0:GRIN2A|0:ADH6|0:GOT2|0:ADH7|0:GRIN1|0:GRIN2B|0:SDF4|0:CHRNB2|0:SOD1			
GO:0030003	P:cellular cation homeostasis; IDA:HGNC		0:SLC4A11			
GO:0051637	F:Gram-positive bacterial cell surface binding; TAS:BHF-UCL		0:LBP|0:TLR2|0:DMBT1|0:CRP			
GO:0000242	C:pericentriolar material; TAS:ProtInc		0:TNKS2|0:LCK|0:BBS4|0:HOOK3|0:PCM1|0:TNKS|0:TUBE1			
GO:0005172	F:vascular endothelial growth factor receptor...; IPI:UniProtKB		0:VEGFA			
GO:0008513	F:secondary active organic cation transmembra...; TAS:ProtInc		0:SLC22A4			
GO:0070063	F:RNA polymerase binding; ISS:UniProtKB		0:TAF10|0:NEDD4|0:PHRF1			
GO:0000738	P:DNA catabolic process, exonucleolytic; IDA:UniProtKB		0:ISG20|0:XRN2			
GO:0048187	F:inhibin beta-B binding; IDA:UniProtKB		0:IGSF1			
GO:0019911	F:structural constituent of myelin sheath; IDA:UniProtKB		0:MAL			
GO:0045110	P:intermediate filament bundle assembly; IMP:UniProtKB		0:KRT14			
GO:0005503	F:all-trans retinal binding; IDA:UniProtKB		0:ADH4			
GO:0005596	C:collagen type XIV; NAS:UniProtKB		0:COL14A1			
GO:0030247	F:polysaccharide binding; IEA:InterPro		0:SUSD2|0:TINAGL1|0:ENPP3|0:TINAG|0:ENPP2|0:PRG4|0:ENPP1|0:C8orf84|0:ENDOU			
GO:0006270	P:DNA-dependent DNA replication initiation; TAS:ProtInc		0:POLA1|0:MCM4|0:MCM7|0:MCM5|0:MCM2|0:MCM6|0:ORC4|0:CDC34|0:CDC45|0:MCM3|0:ORC2|0:ORC1|0:PURA|0:RPA4|0:ORC5			
GO:0060393	P:regulation of pathway-restricted SMAD prote...; IDA:BHF-UCL		0:BMPER|0:PIN1			
GO:0050871	P:positive regulation of B cell activation; IDA:BHF-UCL		0:IL6			
GO:0008106	F:alcohol dehydrogenase (NADP+) activity; IEA:EC		0:ALDH3A1|0:AKR1A1			
GO:0044130	P:negative regulation of growth of symbiont i...; IDA:MGI		0:MBL2			
GO:0008266	F:poly(U) RNA binding; TAS:ProtInc		0:PABPC4|0:ATXN1|0:HNRNPH1			
GO:0051919	P:positive regulation of fibrinolysis; IDA:BHF-UCL		0:PLG|0:F12|0:KLKB1|0:F11			
GO:0032767	F:copper-dependent protein binding; IPI:UniProtKB		0:ATOX1|0:ATP7A			
GO:0004666	F:prostaglandin-endoperoxide synthase activity; IDA:BHF-UCL		0:PTGS2|0:PTGS1			
GO:0000917	P:barrier septum formation; IEA:UniProtKB-KW		0:BIN3			
GO:0048227	P:plasma membrane to endosome transport; NAS:UniProtKB		0:SORT1|0:RAB11A			
GO:0031433	F:telethonin binding; IPI:BHF-UCL		0:TTN			
GO:0070936	P:protein K48-linked ubiquitination; ISS:UniProtKB		0:UBE2H|0:ITCH|0:UBE2D3|0:UBE2Q2|0:UBE2K|0:UBE2G2|0:UBE2D2|0:UBE2A|0:UBE2E2|0:ARIH2|0:CDC34|0:UBE2T|0:UBE2D4|0:TTC3|0:UBE2B|0:UBE2R2|0:UBE3A|0:UBE2E3|0:TNFAIP3|0:RNF5|0:UBE2C|0:UBE2G1|0:UBE2D1|0:UBE2E1|0:RNF4|0:RNF6			
GO:0048791	P:calcium ion-dependent exocytosis of neurotr...; ISS:UniProtKB		0:DOC2B			
GO:0034465	P:response to carbon monoxide; IDA:UniProtKB		0:KCNMA1			
GO:0031594	C:neuromuscular junction; ISS:UniProtKB		0:CAV3|0:SERPINE2|0:CHRNA1|0:CDK5R1|0:CDK5			
GO:0007183	P:SMAD protein complex assembly; TAS:ProtInc		0:SMAD2|0:SMAD4|0:TGFB1|0:SMAD1|0:FKBP1A|0:EID2|0:ZFYVE9			
GO:0045948	P:positive regulation of translational initia...; ISS:BHF-UCL		0:DAZ1|0:BOLL|0:DAZL|0:RPS6KB1|0:RPS6KB2|0:UHMK1			
GO:0003851	F:2-hydroxyacylsphingosine 1-beta-galactosylt...; IEA:EC		0:UGT8			
GO:0007063	P:regulation of sister chromatid cohesion; IDA:UniProtKB		0:BUB1			
GO:0010736	F:serum response element binding; ISS:BHF-UCL		0:SRF|0:NKX2-5			
GO:0005219	F:ryanodine-sensitive calcium-release channel...; TAS:BHF-UCL		0:RYR2|0:RYR1|0:RYR3			
GO:0005582	C:collagen type XV; TAS:UniProtKB		0:COL15A1			
GO:0033961	F:cis-stilbene-oxide hydrolase activity; IEA:EC		0:EPHX1			
GO:0043312	P:neutrophil degranulation; ISS:UniProtKB		0:ANXA3|0:STXBP3|0:STXBP2|0:VAMP7			
GO:0001504	P:neurotransmitter uptake; TAS:ProtInc		0:SLC1A3			
GO:0008528	F:peptide receptor activity, G-protein coupled; NAS:UniProtKB		0:GLP1R|0:NPR2|0:NPR3|0:NPR1			
GO:0030342	F:1-alpha,25-dihydroxyvitamin D3 24-hydroxyla...; IDA:UniProtKB		0:CYP24A1			
GO:0070846	P:Hsp90 deacetylation; IMP:BHF-UCL		0:HDAC6			
GO:0002166	F:beta-dystroglycan binding; IPI:UniProtKB		0:MAP2|0:VCL			
GO:0050429	F:calcium-dependent phospholipase C activity; IDA:MGI		0:PLCH1			
GO:0045359	P:positive regulation of interferon-beta bios...; IDA:UniProtKB		0:TLR8|0:TLR3|0:TLR9|0:TLR7			
GO:0002074	P:extraocular skeletal muscle development; IMP:UniProtKB		0:FOXL2			
GO:0033883	F:pyridoxal phosphatase activity; IEA:EC		0:PHOSPHO2|0:PDXP			
GO:0002026	P:regulation of the force of heart contraction; ISS:UniProtKB		0:MYL3|0:MYL4|0:MYH6|0:GLRX3			
GO:0010552	P:positive regulation of gene-specific transc...; TAS:BHF-UCL		0:HDAC1|0:LEF1|0:HAND1|0:MYOCD|0:SMARCB1|0:PPARG|0:TAF9|0:RHOQ|0:GDNF|0:TP53|0:NR1H3|0:SMARCA4|0:MEF2C|0:TAF1|0:BMP2|0:HHEX|0:POU5F1|0:ENG|0:ETS1|0:TCF3|0:GATA2|0:POMC|0:NR1H2|0:TCF7L2|0:CTNNB1|0:GTF2A2|0:PTH|0:GABPB1|0:GABPB2|0:BMP4|0:GABPA|0:FOXF2|0:FOXA1|0:IL26|0:BRCA1|0:NFIX|0:GATA6|0:NKX2-1|0:TFEB|0:NFIC|0:SOX18|0:USF2|0:ARRB1|0:HDAC2|0:TBX5|0:XRCC6|0:HNF4A|0:PRKDC|0:HDAC5|0:FOXP3|0:HDAC4|0:NFKBIA|0:BCL9L|0:USF1|0:AR|0:MLL2|0:GLI3|0:TAF2|0:TLR3|0:CITED2|0:TLR4|0:TLR9|0:MC1R|0:MLXIPL|0:PLA2G1B|0:TLR2|0:TFE3|0:SMARCA2			
GO:0051131	P:chaperone-mediated protein complex assembly; TAS:ProtInc		0:PFDN6|0:HSPD1|0:THEG|0:CCT6B|0:APCS			
GO:0042058	P:regulation of epidermal growth factor recep...; IMP:BHF-UCL		0:CDH13			
GO:0007288	P:sperm axoneme assembly; ISS:BHF-UCL		0:BBS2			
GO:0050473	F:arachidonate 15-lipoxygenase activity; IEA:EC		0:ALOX15B|0:ALOX15			
GO:0033578	P:protein amino acid glycosylation in Golgi; IEA:InterPro		0:FUT8			
GO:0021952	P:central nervous system projection neuron ax...; ISS:UniProtKB		0:CHRNB2			
GO:0004095	F:carnitine O-palmitoyltransferase activity; TAS:ProtInc		0:CPT1C|0:CPT2|0:CPT1B|0:CPT1A			
GO:0021756	P:striatum development; ISS:BHF-UCL		0:CNTNAP2|0:BBS4|0:MKKS|0:BBS2			
GO:0046929	P:negative regulation of neurotransmitter sec...; ISS:BHF-UCL		0:SLC30A1			
GO:0031957	F:very long-chain fatty acid-CoA ligase activity; IDA:HGNC		0:ACSBG1			
GO:0008083	F:growth factor activity; TAS:UniProtKB		0:LIF|0:NRG1|0:OSM|0:ANGPTL3|0:CNTF|0:VEGFA|0:IL6|0:IGF2|0:TGFA|0:EPGN|0:EGF|0:REG1A|0:FGF10|0:LACRT|0:JAG2|0:OSGIN1|0:TDGF1|0:IL11|0:FGF8|0:CLEC11A|0:RABEP2|0:RABEP1|0:IL1B|0:BMP3|0:INHBE|0:VEGFB|0:HBEGF|0:EREG|0:CXCL1|0:NOV|0:KITLG|0:HDGF|0:IGF1|0:GDF15|0:GMFG|0:BMP7|0:NTF3|0:FGF21|0:TFF1|0:GPI|0:FGF19|0:IL3|0:AMH|0:WISP3|0:GDF3|0:OGN|0:GDF11|0:VEGFC|0:IL34|0:NODAL|0:CXCL12|0:CDNF|0:FIGF|0:PDGFA|0:BMP1|0:VGF|0:ARTN|0:NGF|0:GDF6|0:FGF20|0:PSPN|0:NRG2|0:BMP4|0:LEFTY2|0:PPBP|0:MANF|0:IL9|0:GDF7|0:TYMP|0:TGFB3|0:FGF2|0:IL5|0:BMP8A|0:PDGFD|0:BMP2|0:MIA|0:MACC1|0:FGF5|0:GDF1|0:BMP5|0:LEFTY1|0:CSF3|0:IL12A|0:INHBC|0:FGF23|0:GMFB|0:NRG4|0:FGF22|0:PTN|0:TGFB2|0:PDGFB|0:CD320|0:BMP6|0:GDF2|0:BMP15|0:TGFB1|0:NRTN|0:BMP10|0:BMP8B|0:INHBB|0:PROK1|0:PDGFC|0:CSF2|0:GH1|0:AMBN|0:AMELX|0:IL7|0:MDK|0:ESM1|0:GDNF|0:TDGF3|0:IL10|0:NRG3|0:CSF1|0:ENDOU|0:CECR1|0:IL4|0:HGF|0:JAG1|0:AGT|0:F2|0:CLCF1|0:GDF10|0:NDP|0:FGF4|0:FGF14|0:FGF7|0:GRN|0:GDF5|0:MSTN|0:AREG|0:NTF4|0:FGF3|0:FGF6|0:PGF|0:FGF18|0:DKK1|0:FGF12|0:FGF17|0:FGF11|0:BDNF|0:FGF9|0:FGF1|0:THPO|0:FGF13|0:AREGB|0:GDF9|0:FGF16|0:BTC|0:IL2|0:CSPG5|0:INHA|0:INHBA|0:NUDT6			
GO:0042562	F:hormone binding; ISS:UniProtKB		0:ADIPOR1|0:AMHR2|0:UCN2|0:ADIPOR2			
GO:0032436	P:positive regulation of proteasomal ubiquiti...; ISS:UniProtKB		0:MDM2|0:SMAD7|0:VCP|0:DNAJB2|0:TAF1|0:HSPBP1|0:STUB1|0:SUMO1|0:PSMD10|0:SUMO2|0:RCHY1|0:NUB1|0:USP5|0:PLK1|0:TRIB2|0:TRIB1|0:CSNK1D|0:CSNK1E			
GO:0006066	P:alcohol metabolic process; TAS:ProtInc		0:CHDH|0:ADH1A|0:ALDH2|0:ALDH3B1|0:ALDH3B2			
GO:0004379	F:glycylpeptide N-tetradecanoyltransferase ac...; IEA:EC		0:NMT2|0:NMT1			
GO:0055062	P:phosphate ion homeostasis; IDA:UniProtKB		0:SFRP4|0:SLC34A1			
GO:0051443	P:positive regulation of ubiquitin-protein li...; ISS:BHF-UCL		0:PIN1|0:BMI1|0:AXIN1|0:UBE2N|0:TRIB3			
GO:0030185	P:nitric oxide transport; NAS:UniProtKB		0:EDN1|0:HBB			
GO:0051865	P:protein autoubiquitination; ISS:UniProtKB		0:PARK2|0:UHRF2|0:ERCC8|0:TRAF6|0:LRSAM1|0:TRIM68|0:TRIM21|0:UBE2A|0:STUB1|0:CNOT4|0:TRIM13|0:BRCA1|0:UBE2B|0:TRIM17|0:DDB2|0:TRAF2|0:RCHY1|0:RNF115|0:RNF4|0:RNF220|0:RAG1|0:RNF13			
GO:0042797	P:tRNA transcription from RNA polymerase III ...; IC:HGNC		0:GTF3C2|0:GTF3C3|0:GTF3C5|0:GTF3C4|0:GTF3C6|0:GTF3C1			
GO:0070891	F:lipoteichoic acid binding; IDA:MGI		0:CD14|0:LBP			
GO:0009913	P:epidermal cell differentiation; IDA:UniProtKB		0:GLI1|0:GLI2			
GO:0050847	P:progesterone receptor signaling pathway; IDA:HGNC		0:NEDD4|0:UBR5			
GO:0001525	P:angiogenesis; TAS:UniProtKB		0:EGF|0:SCG2|0:EPGN|0:NCL|0:IL18|0:PROK2|0:MYH9|0:MMP2|0:MFGE8|0:EREG|0:TNFRSF12A|0:NUS1|0:VAV3|0:ARHGAP22|0:COL4A2|0:ANGPTL4|0:EPHA2|0:GPI|0:PTPRB|0:ECM1|0:AIMP1|0:ANPEP|0:SH2D2A|0:EFNA1|0:VEGFC|0:CSPG4|0:FIGF|0:FGF6|0:HAND2|0:PGF|0:COL15A1|0:ADAM15|0:ARHGAP24|0:TYMP|0:ZC3H12A|0:HTATIP2|0:ANGPTL6|0:TNFAIP2|0:AGGF1|0:TNFSF12|0:FN1|0:NAA15|0:COL8A1|0:CXCL17|0:SRPX2|0:SHB|0:EPAS1|0:EGFL7|0:WARS|0:VAV2|0:PDCD10|0:RHOB|0:HSPG2|0:ECSCR|0:FGF1|0:APOLD1|0:TSPAN12|0:COL4A1|0:COL8A2|0:MMP19|0:ANGPT2|0:PROK1|0:HOXA7|0:HOXA3|0:HOXB3|0:HOXB13|0:SOX18|0:ROBO4|0:NOX1|0:ACVRL1|0:ATP5B|0:C1GALT1|0:ANG|0:HAND1|0:SOX17|0:THY1|0:CEACAM1|0:S100A7|0:AAMP|0:STAB2|0:SLC12A6|0:TMPRSS6|0:PLXDC1|0:JAG1|0:LAMA5|0:HMOX1|0:KDR|0:ID1|0:ITGA5|0:ERAP1|0:IL8|0:ATPIF1|0:TGFB2			
GO:0033871	F:[heparan sulfate]-glucosamine 3-sulfotransf...; IEA:EC		0:HS3ST2			
GO:0030136	C:clathrin-coated vesicle; TAS:UniProtKB		0:MALL|0:VAMP3|0:GGA2|0:SCYL2|0:SH3BP4|0:PICALM|0:EPN3|0:PIK3C2A|0:WIPI1|0:CLINT1|0:CLVS2|0:CLVS1|0:STX6			
GO:0006499	P:N-terminal protein myristoylation; NAS:UniProtKB		0:NMT2|0:NMT1			
GO:0051974	P:negative regulation of telomerase activity; IMP:UniProtKB		0:POT1|0:PIF1|0:TERF1|0:MEN1			
GO:0070086	P:ubiquitin-dependent endocytosis; IDA:UniProtKB		0:LRSAM1			
GO:0032400	P:melanosome localization; ISS:UniProtKB		0:VPS33B|0:VPS33A|0:GPR143			
GO:0010107	P:potassium ion import; ISS:BHF-UCL		0:KCNJ11|0:ABCC9			
GO:0008603	F:cAMP-dependent protein kinase regulator act...; TAS:ProtInc		0:ROPN1B|0:ROPN1|0:C1orf230|0:CABYR|0:ROPN1L|0:RAPGEF4|0:RAPGEF3|0:SPA17|0:PRKAG2|0:PRKAR2A|0:PRKAR1B|0:PRKAG1|0:PRKAR2B|0:PRKAR1A|0:CXCL10			
GO:0009790	P:embryo development; TAS:UniProtKB		0:NRG1|0:NRG2|0:NANOG|0:NPM2|0:LSR|0:RICTOR|0:UBR3|0:RACGAP1|0:ATP5A1|0:TNFAIP1|0:CDK5R1|0:CDK5|0:RASA1|0:SCEL|0:NOTCH4|0:EDA2R|0:CELF4|0:MFRP|0:USP22|0:CELF1|0:RAI2|0:FUT10|0:PDGFA|0:NR5A2|0:TGFB2			
GO:0002367	P:cytokine production involved in immune resp...; IMP:UniProtKB		0:NOD2			
GO:0008206	P:bile acid metabolic process; TAS:ProtInc		0:GBA2|0:AKR1C1|0:NPC1|0:ACOX2|0:ACOX3|0:NR1H4|0:BAAT			
GO:0043533	F:inositol 1,3,4,5 tetrakisphosphate binding; TAS:UniProtKB		0:ADAP2|0:ITPR3|0:ADAP1			
GO:0006930	P:substrate-bound cell migration, cell extension; TAS:ProtInc		0:SDCBP|0:OPHN1|0:CD2AP			
GO:0031252	C:cell leading edge; ISS:UniProtKB		0:HDAC6|0:CXCR4|0:CDC42BPG|0:JMY|0:CDC42BPB|0:CDC42BPA			
GO:0048485	P:sympathetic nervous system development; NAS:UniProtKB		0:NF1|0:ASCL1			
GO:0045815	P:positive regulation of gene expression, epi...; ISS:HGNC		0:RAG1AP1			
GO:0004198	F:calcium-dependent cysteine-type endopeptida...; TAS:ProtInc		0:C6orf103|0:CAPN7|0:CAPN8|0:CAPN13|0:CAPN12|0:CAPN14|0:CAPN10|0:CAPNS1|0:CAPN11|0:CAPN6|0:CAPN3|0:SOLH|0:CAPN9|0:CAPN5			
GO:0003677	F:DNA binding; TAS:UniProtKB		0:SETX|0:ANG|0:RAD50|0:GTF2A1|0:ARID2|0:ARID1B|0:ARID5B|0:MAP1S|0:BCLAF1|0:CCNT1|0:SPHK1|0:CDK9|0:PLAGL1|0:RPL7|0:ZNF350|0:ALB|0:TLR8|0:TOPORS|0:INO80|0:ILF2|0:APITD1|0:POLD1|0:RUNX1|0:SMARCA5|0:AIFM2|0:APEX1|0:RC3H2|0:LIG4|0:ING2|0:TAF12|0:TRIM16|0:POLE|0:STRA13|0:POLA1|0:ZNF395|0:TAF6|0:ERCC6|0:ILF3|0:DNMT1|0:MIER1|0:POLR2J|0:POLD2|0:POLRMT|0:LIN28B|0:ZNF541|0:POLR2J3|0:TAF8|0:MED26|0:ZBED3|0:SMARCC2|0:TCEB3CL|0:FBXL19|0:POLR1D|0:GIN1|0:ZFAND3|0:HEMK1|0:MBD5|0:ASH1L|0:MYST3|0:TCEANC|0:EME2|0:TRANK1|0:ZFAND6|0:CHD1L|0:TAF3|0:SBNO1|0:DHX58|0:POLA2|0:FAN1|0:CSDE1|0:NYNRIN|0:CXXC5|0:DNAJC2|0:BANF2|0:TNRC18|0:POLR1A|0:GTF2H5|0:UPF1|0:BOD1L|0:FAM171B|0:BAHD1|0:TBRG1|0:WRNIP1|0:MYBBP1A|0:SMARCC1|0:SOS2|0:ABTB2|0:SUPT3H|0:SHPRH|0:MYO18A|0:EZH1|0:TCEB3C|0:HELLS|0:SETDB2|0:DMAP1|0:POLR2C|0:POLR3D|0:SCML4|0:BAHCC1|0:POLR1E|0:POGZ|0:EEPD1|0:RCOR1|0:POLR2F|0:C1orf83|0:C14orf115|0:AKAP8L|0:IFIH1|0:C1orf124|0:GON4L|0:CCDC79|0:POLR3C|0:MBD6|0:POLR3H|0:PPFIBP2|0:ZBED2|0:TADA2B|0:SMARCAL1|0:SLK|0:TERF2IP|0:SETDB1|0:OTUD7A|0:CSDC2|0:POLR1B|0:SMARCA4|0:UBTFL2|0:SMARCAD1|0:DNTT|0:POLR2L|0:C8orf45|0:ZRANB3|0:MIER3|0:TCEB3|0:RFX8|0:GLYR1|0:TAF9B|0:POLR3K|0:RTF1|0:RABGEF1|0:SMARCA1|0:CARHSP1|0:APEX2|0:POLR2E|0:CENPT|0:KDM5C|0:POLM|0:POLR2I|0:RCOR3|0:SRXN1|0:POLR3B|0:GEN1|0:PDCD5|0:BDP1|0:MUS81|0:POLR3A|0:MIER2|0:BTBD11|0:ZBED4|0:POLR3F|0:LIN28A|0:POLR1C|0:POGK|0:KRBA2|0:POLR2K|0:OTUD7B|0:POLR2J2|0:PRR12|0:XRCC4|0:TRDMT1|0:TCEB3CL2|0:CXorf27|0:MYST4|0:ZFAND5|0:EME1|0:ZBED5|0:SOS1|0:JARID2|0:CXXC4|0:KDM5D|0:PHF21A|0:ZBTB12|0:CHD9|0:ARID3C|0:CHD1|0:PHF20|0:FUS|0:POLG|0:SNAPC1|0:ZNF687|0:ZNF667|0:ZNF568|0:KIF4A|0:ZNF614|0:SAFB2|0:RPAP1|0:CBX2|0:BANF1|0:ZNF775|0:THAP4|0:HIST2H3A|0:ZNF16|0:ZNF285|0:ZNF10|0:TIGD4|0:ZNF624|0:SOHLH2|0:ZNF121|0:ADAR|0:TOX2|0:ZNF532|0:ZNF594|0:NEUROD6|0:NONO|0:HMGXB3|0:ZNF57|0:JRKL|0:ZNF17|0:ZNF280D|0:AIFM1|0:ZNF783|0:ZNF230|0:ZNF434|0:ZNF347|0:SFPQ|0:TIGD6|0:ZNF581|0:NKRF|0:ZNF311|0:THAP8|0:ZIC4|0:TMPO|0:ZNF502|0:GTF2F2|0:ZNF516|0:ZNF840|0:NPAS4|0:ZNF497|0:GRHL3|0:OVOL2|0:RBL2|0:PPP1R10|0:ZNF787|0:LEMD3|0:ZNF267|0:ZNF461|0:GLIS1|0:H2AFJ|0:PAPD5|0:ZNF619|0:HMGB3L1|0:RREB1|0:TOX4|0:ZBTB1|0:GTF2F1|0:ZNF876P|0:ZNF642|0:ZNF766|0:ZNF226|0:BAZ2A|0:CASZ1|0:FEZF2|0:ZNF34|0:KLF14|0:ZNF680|0:ZNF607|0:ZNF575|0:HIST2H2BF|0:HDGF|0:ZNF579|0:HIST1H3F|0:PHTF2|0:ZNF816|0:ZNF600|0:ZNF678|0:SCXA|0:G3BP1|0:DSCC1|0:KIAA2018|0:GTF3C3|0:ZNF25|0:HMGN4|0:ZNF549|0:C9orf102|0:ZNF107|0:ZFP36|0:ZNF417|0:ZNF439|0:ZNF733|0:H2AFB3|0:ZNF561|0:ZNF362|0:ZNF565|0:ZNF790|0:OLIG3|0:HIST1H2AG|0:ZBTB4|0:BBX|0:H3F3A|0:ZNF44|0:PHC1|0:INSM1|0:ZNF493|0:ZNF717|0:MAPK1|0:ZNF271|0:BAZ2B|0:ZFP2|0:HKR1|0:CLSPN|0:ZNF620|0:PCBP2|0:KLF13|0:ZNF860|0:ZNF658B|0:ZFP92|0:ZNF837|0:AGFG1|0:C19orf40|0:IKZF5|0:ZNF506|0:ZNF879|0:PRPF19|0:MXD4|0:NUP153|0:ZNF665|0:PRDM4|0:ZNF407|0:ZNF343|0:TIGD1|0:SOX12|0:XRCC3|0:MSGN1|0:ZNF234|0:THOC1|0:ZNF599|0:PRM3|0:ZNF252|0:BHLHA15|0:ZNF829|0:ZNF813|0:MAZ|0:PIN4|0:HES3|0:ZNF618|0:ZBTB42|0:IKZF2|0:PML|0:TAF1A|0:HIST1H3H|0:ZNF276|0:EBF4|0:ZNF571|0:TRIM21|0:ASCL4|0:ZNF844|0:ZNF286A|0:HIST1H2AK|0:ZNF526|0:ZNF674|0:BANP|0:ZFP112|0:ZNF525|0:ZNF443|0:ZNF654|0:TCEA3|0:ZNF282|0:ZNF222|0:ZNF30|0:ZNF770|0:ZNF385A|0:HIST1H3A|0:ZNF398|0:ZNF557|0:ZBTB49|0:ZNF683|0:ZNF658|0:NPAS3|0:SMYD1|0:NUSAP1|0:ZNF705F|0:ZFP161|0:ZNF510|0:ZNF623|0:NCOR2|0:SPZ1|0:ZNF284|0:ZBTB11|0:GLIS2|0:HP1BP3|0:RTEL1|0:ZNF709|0:HIST2H3D|0:ZNF384|0:ZNF710|0:ZNF136|0:ZNF713|0:ZNF846|0:GPBP1|0:CHD7|0:ZMAT1|0:ZNF317|0:ZNF763|0:ZNF544|0:ZNF433|0:ZNF705G|0:SOHLH1|0:ZNF550|0:ZNF567|0:ZNF660|0:TAF1C|0:GTF2E2|0:ZNF737|0:OVOL1|0:ZNF789|0:ZNF404|0:ZNF2|0:ZNF823|0:HIST3H2BB|0:ZNF486|0:ZNF697|0:ZNF776|0:RYBP|0:RDM1|0:ZNF416|0:ZNF225|0:C17orf70|0:ZNF554|0:UBTFL1|0:UBTFL5|0:PRDM14|0:ZFP3|0:ZNF454|0:SP6|0:SCYL1|0:FLYWCH1|0:ZNF648|0:ZNF574|0:ZNF692|0:ZBTB2|0:ZNF721|0:ZNF641|0:AEBP2|0:KIF4B|0:ZNF540|0:ZNF679|0:ZBTB45|0:PHC2|0:ZNF578|0:EBF3|0:TRIM27|0:ATM|0:HIST1H3G|0:ZNF818P|0:PARP2|0:ZBTB39|0:HIST1H2AI|0:ZNF335|0:ERVK2|0:TIGD7|0:ZNF580|0:ZNF732|0:ZNF354B|0:MND1|0:CIC|0:THAP7|0:ZNF777|0:H2AFB1|0:MXD3|0:KHSRP|0:ZFP64|0:ZNF295|0:ZNF517|0:ZNF587|0:ERCC6L|0:ZNF77|0:ZNF613|0:ZNF490|0:ZNF324B|0:CDKN2A|0:RFX7|0:ZNF341|0:TIGD5|0:TMF1|0:SMARCE1|0:ZNF788|0:ZNF785|0:TRIM33|0:ZNF718|0:PUF60|0:ZNF702P|0:ZNF280C|0:ZNF75A|0:ZNF334|0:H3F3B|0:ZNF320|0:HIST1H1A|0:ZNF275|0:MLL3|0:NFRKB|0:PCBP3|0:ZNF354C|0:NHLH2|0:GTF3C5|0:ZNF627|0:ZNF593|0:H2AFY2|0:ZNF468|0:PRKDC|0:DNA2|0:ZNF514|0:ZNF780B|0:ABT1|0:ZIK1|0:ZNF548|0:ZNF664|0:SRCAP|0:ZNF806|0:ZNF322A|0:ZNF793|0:ZNF408|0:ZNF426|0:SP2|0:HIST2H2AA3|0:ZNF507|0:ZNF26|0:LUC7L3|0:H2AFV|0:ZNF143|0:ZNF560|0:ZNF438|0:ZNF564|0:ZNF782|0:ZNF671|0:TAF15|0:ZFY|0:C14orf106|0:ZNF440|0:NAT14|0:ZFP28|0:ZNF826P|0:H1FOO|0:HIST1H3I|0:ZNF749|0:HIST1H3B|0:MAEL|0:ZNF836|0:ZNF812|0:GFI1B|0:ZNF527|0:ZNF771|0:ZNF66P|0:ZNF410|0:HILS1|0:TCEA2|0:ZNF76|0:ZNF221|0:ZFP30|0:ZBTB26|0:ZNF644|0:ZNF653|0:FERD3L|0:DOT1L|0:ZNF521|0:ZNF558|0:ZNF329|0:HMGN5|0:PIAS2|0:SP100|0:ZNF229|0:HMGB4|0:KLF8|0:TBPL1|0:ZNF584|0:ZNF180|0:HJURP|0:ORC6|0:ZNF253|0:ZNF736|0:SMARCA2|0:ZNF791|0:SP5|0:FBXO18|0:SNAI2|0:ZNF487P|0:ZNF799|0:ZNF534|0:ZBED1|0:SETMAR|0:ZNF738|0:AHRR|0:ZNF324|0:GRHL1|0:TIGD2|0:ZNF511|0:ZNF586|0:ZNF726|0:ZNF264|0:SCRT2|0:HNRNPK|0:TAF1D|0:MCM5|0:ZNF551|0:ZBTB41|0:C12orf48|0:PIAS1|0:LRRFIP1|0:ZNF676|0:SP7|0:C17orf49|0:PAPD7|0:ERBB2|0:GTF2IRD2B|0:FANCM|0:DDX3Y|0:CENPW|0:PRDM10|0:UBTFL6|0:HIST1H3C|0:ZBTB10|0:CRAMP1L|0:ZNF160|0:XRN1|0:ZNF99|0:HIST1H3D|0:SARNP|0:ZNF689|0:ZNF570|0:DEK|0:HIST1H3J|0:BHLHE23|0:ZNF682|0:DDX20|0:C17orf106|0:THAP9|0:ZNF251|0:AFF3|0:MYB|0:XRCC2|0:ZNF485|0:ATRX|0:ZNF764|0:ZNF248|0:HIST1H2AA|0:TTF2|0:YBX2|0:FUBP3|0:ZNF669|0:THAP11|0:PHC3|0:PPP1R8|0:CHD6|0:ZNF543|0:ZNF566|0:CC2D1A|0:ZNF778|0:ZNF20|0:HIST2H2AA4|0:ZNF518A|0:ZNF296|0:CENPA|0:ZNF260|0:H1F0|0:ZNF429|0:THAP2|0:ZNF512|0:ZNF491|0:H1FNT|0:GTF2A1L|0:ZNF773|0:GTF2IRD2|0:ZNF300|0:ZNF460|0:GTF3C4|0:ZNF280B|0:HIST1H2AH|0:ZNF626|0:H2AFB2|0:ZNF700|0:ZFR|0:ZBTB44|0:ZMAT4|0:ZNF714|0:ARID4B|0:ZNF326|0:IFT57|0:ZNF592|0:ZNF250|0:PEG10|0:ZNF12|0:ZFP57|0:ZNF420|0:HIST2H3C|0:NDN|0:DDX11|0:ZNF181|0:ZNF48|0:ZIC2|0:FIGLA|0:ZNF345|0:ZNF484|0:ATOH8|0:ASCL5|0:PCBP4|0:ZNF467|0:ZNF79|0:ZNF322B|0:ZNF432|0:ZNF425|0:ZNF583|0:ZNF672|0:PRIM2|0:ZNF805|0:ZNF254|0:PAX1|0:ZNF827|0:ZNF781|0:PSIP1|0:ZFP90|0:NACA|0:OLIG1|0:ZNF530|0:ZNF663|0:ZNF727|0:ZNF577|0:ZNF563|0:ZNF835|0:ZNF528|0:ZNF555|0:BRPF1|0:HIST1H2AM|0:ZNF786|0:ZNF56|0:EBF2|0:ZNF573|0:ZNF616|0:ZNF735|0:ZNF415|0:TCEA1|0:ZNF729|0:ZNF606|0:ZNF772|0:ZNF32|0:NHLH1|0:SP8|0:RAD54L2|0:UBTF|0:HIST2H2AB|0:ZNF643|0:MCM8|0:ZNF235|0:ZNF780A|0:ZNF471|0:ZNF224|0:ZNF652|0:TOPBP1|0:UHRF2|0:HIST1H4G|0:MYEF2|0:ZNF547|0:GTF3A|0:ZNF441|0:MNDA|0:PBRM1|0:HIST3H2A|0:HIST2H2BD|0:ZFPM1|0:ZNF792|0:ZNF101|0:THAP3|0:ZNF696|0:ZNF316|0:ZNF701|0:ZNF597|0:HIST1H1T|0:ZBTB33|0:ZNF451|0:ZNF302|0:ZNF14|0:ZNF273|0:HMGB1P1|0:NEUROD4|0:SALL4|0:ZNF708|0:ZNF470|0:ZMYND11|0:ZNF488|0:ACD|0:H2BFS|0:ZZZ3|0:THAP6|0:FEZF1|0:STOX1|0:ZNF646|0:LCORL|0:WHSC1|0:SMUG1|0:TOX3|0:UBTFL3|0:ATR|0:ZNF552|0:KDM2A|0:ZNF655|0:ZNF227|0:ZBTB20|0:NRF1|0:PRDM12|0:GPBP1L1|0:ZNF419|0:HIST1H3E|0:ZNF414|0:HBP1|0:JRK|0:H2BFWT|0:ZNF524|0:DNAJC1|0:ZBTB47|0:ZNF681|0:ZNF677|0:ZNF536|0:SETBP1|0:ZFP1|0:TNFAIP3|0:ZNF611|0:MTF2|0:BHLHA9|0:ZNF114|0:TFB1M|0:MYSM1|0:TNP2|0:ZNF688|0:HIST1H2BA|0:ZBTB8B|0:ZNF730|0:ZNF559|0:C14orf43|0:ZNF668|0:ZIM3|0:PROX2|0:TIGD3|0:ZNF821|0:ZNF391|0:ZBTB40|0:ZNF519|0:ZNF304|0:ZNF473|0:THAP10|0:ZNF513|0:HMGN3|0:ZNF774|0:ZNF670|0:ZNF382|0:ZNF625|0:ZNF765|0:ZNF366|0:ZNF595|0:ZNF724P|0:INSM2|0:CENPBD1|0:HMGN2L|0:ZNF630|0:H2AFZ|0:SCXB|0:DHX9|0:ZNF333|0:ZBTB37|0:PRDM8|0:DDX12|0:ERVK6|0:ZNF542|0:CHTF8|0:PREB|0:ZNF841|0:MED1|0:ZNF784|0:PURG|0:STRBP|0:TTF1|0:RAD54L|0:ZNF319|0:ZNF98|0:CHD5|0:ZNF431|0:ZNF800|0:ZNF462|0:ZNF28|0:GTF3C6|0:TCF7|0:ZNF662|0:GTF3C1|0:ZNF266|0:ZBTB5|0:PNN|0:DDX3X|0:ZNF684|0:ZNF492|0:AHDC1|0:ZNF572|0:SP140L|0:SYCP3|0:ZNF576|0:ZNF182|0:ZFP14|0:ZNF529|0:ZNF556|0:EP400|0:ZNF605|0:PSMC3IP|0:AKNA|0:ZFP41|0:ZFPM2|0:ZNF649|0:ZNF518B|0:RAD54B|0:ZNF177|0:ZNF442|0:THAP5|0:CHTF18|0:TOX|0:ZNF479|0:ZNF705A|0:PRDM13|0:ZNF223|0:ZNF74|0:ZBTB24|0:SRRM1|0:MYBL1|0:ZIC5|0:ZNF582|0:ZNF430|0:ZNF691|0:ZNF808|0:ZNF501|0:ZNF589|0:HIST1H2BK|0:ZNF512B|0:ZNF615|0:ZNF768|0:ZNF469|0:PIAS4|0:ZMAT2|0:HMGB1P10|0:HIST1H2BD|0:ZNF418|0:DEDD2|0:ZBTB3|0:C16orf75|0:ZNF233|0:ZNF280A|0:ZFAT|0:ZNF734|0:MLXIP|0:SETD2|0:ZBTB34|0:ASCL3|0:LIN54|0:ZNF141|0:SWAP70|0:ZNF596|0:ZNF716|0:ZNF707|0:HIST1H2AL|0:ZBTB43|0:REV3L|0:ZNF546|0:TAF1L|0:NHEJ1|0:ZNF621|0:ZFP82|0:ZNF292|0:ZBTB8A|0:ZNF761|0:ZNF629|0:GMEB2|0:PDCD2|0:GZF1|0:DACH2|0:ZNF610|0:SAP30L|0:H2BFM|0:VEZF1|0:PRKRIR|0:HIST2H2BC|0:ZFP91|0:ZNF283|0:ZNF699|0:ZNF23|0:POLE2|0:MCM9|0:SAP30|0:ZBTB9|0:POLN|0:ZNF569|0:ZNF100|0:ZNF337|0:RFX4|0:ZNF436|0:HES4|0:SALL3|0:ATOH7|0:ZNF845|0:GLI4|0:YY2|0:ZNF562|0:ZNF383|0:ZNF358|0:ERCC2|0:CHD8|0:TNP1|0:SUPV3L1|0:CDT1|0:HUWE1|0:DEDD|0:ZBTB32|0:ZNF22|0:ZBTB7A|0:APP|0:MLF1|0:SURF6|0:ZNF212|0:ZNF257|0:HIST1H2AD|0:HMGXB4|0:ACR|0:HIST1H2AJ|0:ABL1|0:KDM2B|0:HIST1H1D|0:HIST1H1C|0:HIST1H2BH|0:HIST1H2BO|0:ARID1A|0:HIST2H2BE|0:HIST1H2BN|0:HIST1H2BB|0:PATZ1|0:CDC5L|0:ZNF331|0:HIST1H2BC|0:RPS15|0:APLP2|0:PRDM15|0:HIST3H3|0:HIST1H1E|0:HIST1H2AC|0:HIST1H2AB|0:ZNF675|0:SOX30|0:TRIM26|0:HIST1H2BG|0:ARID3B|0:HIST1H2BM|0:HIST1H2BF|0:HES7|0:NUFIP1|0:POLL|0:RASSF7|0:ZNF205|0:RAG2|0:RPS27|0:HIC2|0:HIST1H2BJ|0:ZDHHC1|0:TCF20|0:ZNF214|0:ZNF8|0:ZIM2|0:DENND4A|0:ZNF184|0:H2AFY|0:ZNF208|0:HIST1H2BL|0:ZFPL1|0:HIST1H2BE|0:HMGN2|0:HIST1H1B|0:SYCP2|0:ZNF84|0:HIST1H2BI|0:POLR2A|0:PAX9|0:ZNF195|0:HIST2H2AC|0:HIST1H2AE|0:CALR|0:BRIP1|0:H1FX|0:ARID5A|0:RBM6|0:ZNF146|0:KIF22|0:RFX2|0:LBR|0:HIVEP1|0:KCNIP3|0:SPO11|0:EZH2|0:DNASE1L3|0:ZBTB6|0:ZMYM3|0:DNASE2|0:LYL1|0:ZFX|0:LIG1|0:RNF11|0:RAD51L1|0:MCM3|0:TAF6L|0:PARP1|0:MLLT1|0:NUCB1|0:SP110|0:CHD2|0:ZBTB22|0:DNASE1L2|0:MBD3|0:KHDRBS1|0:HMGN1|0:SSRP1|0:LHFP|0:SNAPC3|0:REPIN1|0:HLTF|0:PQBP1|0:SYCP1|0:SOX3|0:RAD52|0:PDS5B|0:KIF15|0:ANKRD1|0:ZMYM6|0:DMC1|0:BRCA1|0:POLR2B|0:ORC1|0:DNASE1L1|0:ZNF43|0:CHD3|0:RPL6|0:NUCB2|0:TRAF4|0:TSG101|0:C1D|0:RAD51L3|0:MCM3AP|0:SON|0:ZNF7|0:PRM1|0:GRLF1|0:ZNF124|0:RAD51C|0:LENEP|0:WDHD1|0:LIG3|0:ZNF239|0:PARP4|0:TAL2|0:RBM5|0:ZMYM4|0:HNRNPU|0:MGMT|0:CDK2AP1|0:CHD4|0:ABI2|0:CEBPZ|0:PRM2|0:CRY1|0:MXI1|0:CENPC1|0:HIST1H4I|0:PPARGC1A|0:HIST1H4L|0:HIST1H4B|0:SERPINA3|0:OASL|0:HIST1H4E|0:HIST2H4A|0:HIST1H4H|0:HIST1H4A|0:HIVEP2|0:HIST4H4|0:HIST1H4D|0:HIST1H4K|0:HIST1H4J|0:HIST1H4C|0:HIST2H4B|0:HIST1H4F			
GO:0043027	F:caspase inhibitor activity; IMP:UniProtKB		0:TRIAP1|0:XIAP|0:SNCA|0:SERPINB9|0:CD27|0:TNFSF14|0:HSPA5|0:BIRC5|0:TNFAIP8|0:PRDX5|0:PRDX3			
GO:0048009	P:insulin-like growth factor receptor signali...; ISS:UniProtKB		0:GHR|0:AKT1|0:PIK3R1|0:TSC2|0:EIF2AK3			
GO:0003844	F:1,4-alpha-glucan branching enzyme activity; EXP:Reactome		0:GBE1			
GO:0005461	F:UDP-glucuronic acid transmembrane transport...; EXP:Reactome		0:SLC35D1			
GO:0019343	P:cysteine biosynthetic process via cystathio...; IEA:InterPro		0:CBS			
GO:0042866	P:pyruvate biosynthetic process; IDA:UniProtKB		0:SDS|0:SRR			
GO:0051353	P:positive regulation of oxidoreductase activity; IMP:BHF-UCL		0:ABL1|0:FTMT|0:ABL2|0:ATP7A|0:FXN			
GO:0010506	P:regulation of autophagy; IMP:UniProtKB		0:ULK1|0:CISD2			
GO:0017124	F:SH3 domain binding; NAS:UniProtKB		0:CBLC|0:DRD4|0:ARHGAP26|0:BAIAP2L2|0:MTSS1L|0:MTSS1|0:BAIAP2|0:BAIAP2L1|0:ELMO2|0:ENKUR|0:SHANK3|0:ARHGAP17|0:RAPGEF1|0:CIT|0:DOCK3|0:CCDC6|0:SH3BGRL2|0:FUT8|0:PTTG1|0:SIRPA|0:VASP|0:PLSCR3|0:SH2D2A|0:PTTG3P|0:SHANK2|0:SH3BGR|0:BCAR1|0:KHDRBS1|0:ADAM19|0:SH3BP5|0:ELMO3|0:DNAJC6|0:INPP5D|0:QKI|0:PLSCR4|0:SH3BP1|0:ENAH|0:KHDRBS2|0:ARHGAP6|0:CNTNAP1|0:ITGB1BP2|0:INPP5J|0:EPS15|0:DOCK4|0:INPPL1|0:ARHGAP1|0:PLSCR1|0:EFS|0:SH3BP2|0:TOM1L1|0:USP8|0:SH3BGRL|0:PAK3|0:SYNGAP1|0:FAM125A|0:DOCK1|0:LRP2|0:PTTG2|0:TP53BP2|0:DTX1|0:SH3KBP1|0:KHDRBS3|0:NCKIPSD|0:CBL|0:ADAM12|0:GPX1|0:CYBA|0:ADAM15|0:NCF1|0:ADAM9|0:ADAM17|0:ADAM10|0:AFAP1L2|0:ABL1|0:RAD9A|0:MAPT|0:LANCL1|0:ELMO1|0:PTPN12|0:CD2AP|0:MICAL1|0:ABI2|0:CD3E|0:SH3D20|0:ARHGAP27|0:EVL|0:ESPN|0:MAPK15|0:SOCS7			
GO:0043280	P:positive regulation of caspase activity; IMP:UniProtKB		0:CARD8|0:NLRP2|0:HMGB1|0:SOX7|0:FOXL2			
GO:0006810	P:transport; TAS:UniProtKB		0:RALBP1|0:TMED7|0:TMED9|0:TMED6|0:AFP|0:BICD1|0:TMED5|0:BICD2|0:TMED4|0:PITPNM2|0:TMED1|0:NDUFS4|0:ETFA|0:SLC48A1|0:NDUFB3|0:ABCA6|0:CYB5B|0:TXNRD1|0:TCTE3|0:NDUFA12|0:LAPTM4B|0:LCN8|0:SDHA|0:ACBD5|0:DYNC1LI2|0:CROT|0:SLC35C2|0:DYNLRB2|0:NDUFV3|0:MT-ND3|0:NDUFA3|0:ATCAY|0:PITPNB|0:G3BP1|0:FADS1|0:ERO1L|0:ENOX1|0:DYNLL1|0:ERO1LB|0:NDUFA7|0:SLC35F2|0:LMBRD1|0:CYC1|0:MT-ND4|0:NDUFB6|0:NDUFS6|0:TMX4|0:SDHD|0:NDUFV2|0:NDUFB7|0:DYNC1LI1|0:DBI|0:NDUFS3|0:LAPTM4A|0:DIRC2|0:GLRX2|0:NDUFB4|0:DYNLL2|0:MOBKL3|0:DYNLRB1|0:MFSD2B|0:FDX1L|0:ENOX2|0:MT-ND4L|0:NDUFA2|0:FDX1|0:HERC1|0:ABCA10|0:LCN10|0:TSPO2|0:STRA6|0:MT-ND5|0:GLRX|0:NDUFB11|0:ETFB|0:TXN2|0:CYBRD1|0:CYBA|0:NDUFA6|0:SLC35F3|0:OSCP1|0:TXN|0:NDUFB8|0:MT-ND6|0:SLC35F5|0:AIFM3|0:DYNLT3|0:NDUFA5|0:ARL4C|0:FADS2|0:NDUFS2|0:NDUFB5|0:MT-ND1|0:TMEM9|0:CYCS|0:NDUFS1|0:SPIRE2|0:FRRS1|0:MT-ND2|0:CRAT|0:LYVE1|0:NDUFV1|0:SLC35E1|0:NDUFA1|0:ABCA9|0:RBP3|0:NDUFB1|0:NDUFS8|0:CYBASC3|0:DYNC1I2|0:NDUFC2|0:CYB561D1|0:NDUFS5|0:FDXR|0:TXNRD3|0:MFSD5|0:NDUFA10|0:SLC35F4|0:STAU2|0:NDUFB2|0:CPT1A|0:UQCRC2|0:ABCA13|0:SDHB|0:FA2H|0:NDUFA4|0:AFM|0:NDUFB10|0:CNIH2|0:FADS3|0:NDUFB9|0:NDUFA8|0:DYNC1H1|0:NDUFC1|0:SLC35F1|0:CYB561|0:SERPINA6|0:CYB561D2|0:TXNL1|0:ETFDH|0:SPIRE1|0:GOLIM4|0:SDHC|0:LAPTM5|0:NDUFS7|0:TTR|0:GJC1|0:PARP4|0:TM9SF2|0:ENSA|0:STX8|0:NNAT|0:AR|0:NPTX1|0:ABCD2|0:AKAP9|0:RSC1A1|0:ALB			
GO:0023034	P:intracellular signaling pathway; TAS:UniProtKB		0:PAG1|0:NOD1|0:GMIP|0:NFAM1|0:DGKK|0:NOD2|0:ARFGEF2|0:NFATC1|0:SH3BP5|0:PDPK1|0:TLK1|0:CLNK|0:BLNK|0:TLK2|0:SH2B2|0:KALRN|0:SMAD2|0:APBB2|0:CLEC4M|0:PRKD2|0:SDCBP2|0:TP53TG5|0:CD209|0:MAGI3|0:GNB1L|0:SHANK2|0:DLG5|0:SIPA1|0:INADL|0:PLA2G4C|0:ACOT11|0:ARHGEF4|0:RASA1|0:APBA3|0:TRAF3IP2|0:S100A1|0:PRKCQ|0:CISH|0:PLXNB1|0:TMPRSS6|0:DEDD2|0:TOLLIP|0:CD80|0:STYXL1|0:TREM1|0:DFFB|0:PRKAR2A|0:CXCL1|0:FKBP8|0:CORO2A|0:DGKA|0:PRKAR2B|0:DFFA|0:PRKAR1A|0:CAPS|0:SIRPG|0:STMN1|0:CARHSP1|0:EFS|0:YWHAE|0:TYROBP|0:ZBTB33|0:ANP32A|0:FER|0:PLCL1|0:HCLS1|0:SQSTM1			
GO:0030327	P:prenylated protein catabolic process; NAS:UniProtKB		0:PCYOX1			
GO:0006939	P:smooth muscle contraction; TAS:UniProtKB		0:BDKRB2|0:NMUR1|0:MYH11|0:CHRNB2|0:GAL|0:CNN3|0:MYL7|0:SMTN|0:ADRA1A|0:KNG1			
GO:0004977	F:melanocortin receptor activity; TAS:ProtInc		0:MC5R			
GO:0031491	F:nucleosome binding; ISS:UniProtKB		0:MUM1|0:SMARCA5|0:SMARCA1|0:RNF4			
GO:0000019	P:regulation of mitotic recombination; TAS:ProtInc		0:RAD50|0:MRE11A			
GO:0016300	F:tRNA (uracil) methyltransferase activity; IDA:UniProtKB		0:ALKBH8			
GO:0045670	P:regulation of osteoclast differentiation; NAS:UniProtKB		0:BGLAP			
GO:0032976	P:release of matrix enzymes from mitochondria; IDA:HGNC		0:BAX			
GO:0005682	C:U5 snRNP; TAS:ProtInc		0:CD2BP2|0:PRPF6|0:SNRNP200|0:DDX23|0:PRPF8|0:SNRNP40			
GO:0016310	P:phosphorylation; NAS:UniProtKB		0:TOLLIP|0:HTR2B|0:UGP2|0:TOP1|0:ALPPL2|0:ALPI			
GO:0042036	P:negative regulation of cytokine biosyntheti...; NAS:UniProtKB		0:ASB1			
GO:0006349	P:regulation of gene expression by genetic im...; TAS:UniProtKB		0:ZFP57|0:KDM1B|0:CTCFL|0:PRMT7|0:DNMT3L|0:DIRAS3|0:IGF2|0:DNMT3A			
GO:0035022	P:positive regulation of Rac protein signal t...; IC:UniProtKB		0:ALS2			
GO:0015026	F:coreceptor activity; TAS:UniProtKB		0:ACVR2A|0:TGFBR3|0:CD86|0:CD4|0:CD8B|0:CD8A|0:CD80|0:PVRL2|0:CXCR4|0:LY96|0:CCR8|0:ZP2|0:PVRL1|0:CCR5|0:CXCR6|0:CD28			
GO:0004859	F:phospholipase inhibitor activity; TAS:ProtInc		0:APOC1|0:ANGPTL3|0:ANXA2P2|0:ANXA4|0:ANXA5|0:ANXA2|0:PDC|0:SNCB			
GO:0033746	F:histone demethylase activity (H3-R2 specific); IDA:UniProtKB		0:JMJD6			
GO:0022408	P:negative regulation of cell-cell adhesion; IMP:BHF-UCL		0:TGFB1|0:GTPBP4|0:NF2|0:B4GALNT2|0:WNT1			
GO:0005895	C:interleukin-5 receptor complex; ISS:UniProtKB		0:SDCBP			
GO:0001915	P:negative regulation of T cell mediated cyto...; ISS:UniProtKB		0:PTPRC			
GO:0004888	F:transmembrane receptor activity; TAS:UniProtKB		0:CD3D|0:NFAM1|0:ANTXR1|0:TLR8|0:FCER1G|0:TLR6|0:MYD88|0:IL18RAP|0:CD247|0:FAS|0:CD79A|0:TLR9|0:CD79B|0:TLR5|0:THBD|0:SIGIRR|0:EFEMP2|0:TIRAP|0:IL1RAPL1|0:TICAM2|0:TLR7|0:TLR2|0:SARM1|0:SELE|0:CD3G|0:SLC22A17|0:ENG|0:GP1BB|0:TLR3|0:FCGR2C|0:EDAR|0:KIR2DS2|0:TLR4|0:KIR2DS1|0:PLXNA3|0:TLR1|0:EVI2A|0:TRGC2|0:CD72|0:CD27|0:CD3E|0:SORL1|0:NCR2|0:CLDN3|0:IGSF6|0:KLRB1|0:GP6|0:CLEC1A|0:SLAMF1|0:LILRB3|0:AGER|0:EBP|0:CD4|0:KLRC3|0:TNFRSF10D|0:INTS6|0:CLEC1B|0:LILRA1|0:CLEC2D|0:CD300C|0:KLRC2|0:TNFRSF10C|0:CLDN4|0:ICAM1|0:LILRB5|0:CD69|0:SIGLEC8|0:CLEC4A|0:SPN|0:KIR2DL4|0:KLRC1|0:M6PR|0:KLRD1|0:DNER|0:TLR10			
GO:0032395	F:MHC class II receptor activity; TAS:UniProtKB		0:HLA-DRB3|0:HLA-DRA|0:HLA-DQA2|0:HLA-DQB1|0:HLA-DPA1|0:HLA-DQB2|0:HLA-DOA|0:HLA-DOB|0:HLA-DQA1			
GO:0072089	P:stem cell proliferation; IEP:UniProtKB		0:WNT7B			
GO:0005173	F:stem cell factor receptor binding; NAS:UniProtKB		0:SPRED2|0:SPRED1|0:KITLG			
GO:0043584	P:nose development; IMP:BHF-UCL		0:CHD7			
GO:0009653	P:anatomical structure morphogenesis; TAS:ProtInc		0:CSGALNACT1|0:TBX10|0:MAS1|0:CASR|0:MAB21L1|0:CPM|0:MCAM|0:RCAN3|0:PAX8|0:MRPL40|0:SCML1|0:ROD1|0:IGF2BP2|0:DYNLL1|0:LIG1|0:KRT18|0:RAC1|0:SOX13|0:EYA4|0:CES1P1|0:MYOC|0:GSC2|0:FAT1|0:SLC40A1|0:EZH1|0:TSHB|0:IER3|0:GPC4|0:GATA3|0:F2R|0:MPZL2|0:TRIM13|0:NEDD8|0:BICD1|0:CLTCL1|0:SOX10|0:LYVE1|0:POU5F1|0:DKKL1|0:S1PR3|0:PHLDA3|0:SFRP5|0:WHSC1|0:KRT35|0:RPL10A|0:LZTR1|0:SCML2|0:CST6|0:TBX19|0:MLXIPL|0:IGF2BP3|0:DKK3|0:EYA3|0:NFE2L1|0:SCMH1|0:FSCN2|0:ZNF141|0:TPD52			
GO:0016520	F:growth hormone-releasing hormone receptor a...; TAS:UniProtKB		0:GHSR|0:MLNR|0:GHRHR|0:TAPT1			
GO:0004221	F:ubiquitin thiolesterase activity; TAS:UniProtKB		0:USP46|0:USP20|0:USP16|0:USP33|0:USP21|0:USP12|0:USP2|0:USP14|0:USP32|0:MYSM1|0:USP1|0:USP42|0:USP9Y|0:USP38|0:USP15|0:STAMBPL1|0:USP31|0:USP19|0:ATXN3L|0:USP17L3|0:USP34|0:CYLD|0:USP41|0:USP30|0:ATXN3|0:USP45|0:USP37|0:USP6|0:OTUD5|0:USP11|0:USP49|0:USP24|0:USP17L1P|0:STAMBP|0:USP17|0:USP17L5|0:USP40|0:USP36|0:USP27X|0:USP9X|0:USP25|0:USP48|0:USP43|0:USP51|0:USP8|0:USP22|0:USP47|0:USP35|0:USP13|0:USP26|0:USP17L7|0:USP50|0:USP54|0:USP53|0:PAN2|0:UCHL5|0:USP17L8|0:USP39|0:USP17L4|0:USP18|0:USPL1|0:USP7|0:USP4|0:BRCC3|0:USP17L2|0:USP28|0:USP3|0:USP44|0:TNFAIP3|0:USP10|0:ZRANB1|0:BAP1|0:USP5|0:UCHL3|0:USP29|0:UCHL1|0:PSMD14			
GO:0002605	P:negative regulation of dendritic cell antig...; IDA:BHF-UCL		0:THBS1			
GO:0050647	F:5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic aci...; NAS:UniProtKB		0:OXER1			
GO:0045724	P:positive regulation of flagellum assembly; ISS:BHF-UCL		0:BBS4			
GO:0043420	P:anthranilate metabolic process; IDA:UniProtKB		0:KYNU			
GO:0016226	P:iron-sulfur cluster assembly; TAS:UniProtKB		0:NFU1|0:ISCA1|0:ISCA2|0:CIAO1|0:NUBP1|0:NARFL|0:SDHAF1|0:ISCU			
GO:0047743	F:chlordecone reductase activity; IEA:EC		0:AKR1C4			
GO:0048806	P:genitalia development; IMP:UniProtKB		0:WNT5A|0:DNAJC19|0:FOXF2|0:HNF1B			
GO:0005504	F:fatty acid binding; TAS:ProtInc		0:UGT1A8|0:APOC1|0:HNF4A|0:ALB|0:ADH5|0:NDUFAB1|0:AZGP1|0:FABP2|0:FABP5|0:FABP4			
GO:0003995	F:acyl-CoA dehydrogenase activity; TAS:ProtInc		0:ACOX2|0:ACOX1|0:ACOX3|0:ACAD10|0:ACAD9|0:ACAD11|0:ACOXL|0:ACAD8			
GO:0043809	F:methylthioribulose 1-phosphate dehydratase ...; IEA:EC		0:APIP			
GO:0031781	F:type 3 melanocortin receptor binding; IPI:BHF-UCL		0:MRAP|0:MRAP2|0:POMC			
GO:0030898	F:actin-dependent ATPase activity; ISS:HGNC		0:MYH9|0:MYH10|0:MYO3A|0:MYH7|0:MYH6|0:MYL6			
GO:0005005	F:transmembrane-ephrin receptor activity; TAS:UniProtKB		0:EFNB3|0:EFNA3|0:EFNA4|0:EPHB2|0:EPHA5			
GO:0015300	F:solute:solute antiporter activity; NAS:UniProtKB		0:SLC25A16			
GO:0019627	P:urea metabolic process; IDA:BHF-UCL		0:CYP2C9			
GO:0033599	P:regulation of mammary gland epithelial cell...; IMP:BHF-UCL		0:DEAF1|0:GPX1			
GO:0010991	P:negative regulation of SMAD protein complex...; IDA:BHF-UCL		0:SMAD6			
GO:0001849	F:complement component C1q binding; TAS:BHF-UCL		0:CD93|0:CALR			
GO:0060501	P:positive regulation of epithelial cell prol...; IDA:MGI		0:FGF7			
GO:0042733	P:embryonic digit morphogenesis; ISS:UniProtKB		0:ECE1|0:WNT7A|0:NOG|0:SALL1|0:TBX3|0:SHH			
GO:0045796	P:negative regulation of intestinal cholester...; IMP:BHF-UCL		0:ABCG8|0:ABCG5			
GO:0000183	P:chromatin silencing at rDNA; NAS:UniProtKB		0:SUV39H1|0:SIRT1|0:RRP8|0:BAZ2A|0:SIRT2			
GO:0009312	P:oligosaccharide biosynthetic process; TAS:ProtInc		0:MGAT2|0:FUT8|0:COG2|0:ST8SIA2			
GO:0060907	P:positive regulation of macrophage cytokine ...; IMP:UniProtKB		0:WNT5A			
GO:0016142	P:O-glycoside catabolic process; IDA:UniProtKB		0:GBA2			
GO:0043137	P:DNA replication, removal of RNA primer; IDA:UniProtKB		0:DNA2|0:FEN1			
GO:0031262	C:Ndc80 complex; IDA:UniProtKB		0:NUF2|0:SPC25|0:NDC80|0:SPC24			
GO:0050479	F:glyceryl-ether monooxygenase activity; IDA:UniProtKB		0:TMEM195			
GO:0048659	P:smooth muscle cell proliferation; ISS:UniProtKB		0:NAA35			
GO:0043484	P:regulation of RNA splicing; ISS:UniProtKB		0:HNRNPH1|0:RBM38|0:MBNL2|0:HNRNPF|0:MBNL3|0:ESRP1|0:CELF1|0:ESRP2|0:SNRNP70|0:AFF2|0:SRRM4			
GO:0030195	P:negative regulation of blood coagulation; TAS:UniProtKB		0:VTN|0:SERPINE1|0:SERPINE2|0:APOH|0:KNG1|0:EDN1|0:PROC			
GO:0070325	F:lipoprotein receptor binding; IC:BHF-UCL		0:LRP1			
GO:0032266	F:phosphatidylinositol-3-phosphate binding; ISS:UniProtKB		0:BBS5|0:ZFYVE28|0:LANCL2|0:SESTD1|0:PHLDA3|0:WIPI1|0:SH3PXD2B|0:PARD3			
GO:0000014	F:single-stranded DNA specific endodeoxyribon...; TAS:ProtInc		0:DCLRE1C|0:RBBP8|0:MRE11A			
GO:0015272	F:ATP-activated inward rectifier potassium ch...; TAS:ProtInc		0:KCNJ11|0:KCNJ10			
GO:0005021	F:vascular endothelial growth factor receptor...; TAS:ProtInc		0:PDGFRA|0:FLT1|0:KDR|0:FLT4|0:PDGFRB|0:NRP1|0:NRP2|0:FLT3			
GO:0030246	F:carbohydrate binding; NAS:UniProtKB		0:CD34|0:MAN2B2|0:GPCPD1|0:EPM2A|0:NOMO2|0:STBD1|0:MAN2A2|0:NOMO1|0:GALM|0:MAN2A1|0:ALG13|0:NOMO3|0:MLEC|0:GAL3ST3			
GO:0032012	P:regulation of ARF protein signal transduction; IEA:InterPro		0:PSD4|0:IQSEC1|0:ARFGEF2|0:CYTH4|0:FBXO8|0:CYTH3|0:ARFGEF1|0:CYTH1|0:PSD2|0:PSD|0:IQSEC3|0:CYTH2|0:PSD3|0:KIAA1244|0:IQSEC2|0:GBF1			
GO:0000403	F:Y-form DNA binding; IDA:UniProtKB		0:WRN|0:MEN1|0:RAD18			
GO:0016442	C:RNA-induced silencing complex; IEA:InterPro		0:TARBP2|0:EIF2C2|0:DICER1|0:SND1			
GO:0050819	P:negative regulation of coagulation; IEA:InterPro		0:HS3ST5|0:ANXA5			
GO:0045923	P:positive regulation of fatty acid metabolic...; ISS:BHF-UCL		0:ADIPOQ			
GO:0000178	C:exosome (RNase complex); TAS:UniProtKB		0:EXOSC6|0:C1D|0:EXOSC2|0:EXOSC5|0:EXOSC8|0:EXOSC4|0:EXOSC1|0:EXOSC7|0:DIS3			
GO:0043148	P:mitotic spindle stabilization; IMP:BHF-UCL		0:SBDS|0:CCNB1			
GO:0070553	F:nicotinic acid receptor activity; ISS:UniProtKB		0:GPR109A			
GO:0030259	P:lipid glycosylation; NAS:UniProtKB		0:ALG13|0:B4GALNT1|0:B4GALNT2|0:B3GALT1			
GO:0010430	P:fatty acid omega-oxidation; IDA:UniProtKB		0:ADH7			
GO:0050861	P:positive regulation of B cell receptor sign...; ISS:HGNC		0:NFAM1			
GO:0001568	P:blood vessel development; ISS:UniProtKB		0:TCF7L2|0:COL1A2|0:COL1A1|0:FOXS1			
GO:0030853	P:negative regulation of granulocyte differen...; IMP:UniProtKB		0:C1QC|0:ADIPOQ|0:RARA|0:PRDM16|0:RUNX1			
GO:0070603	C:SWI/SNF-type complex; IDA:BHF-UCL		0:BAZ1B|0:TOP2B|0:CHAF1A			
GO:0005984	P:disaccharide metabolic process; TAS:ProtInc		0:IDUA			
GO:0004926	F:non-G-protein coupled 7TM receptor activity; IEA:InterPro		0:FZD6|0:FZD5|0:FZD3|0:SMO|0:FZD9|0:FZD10|0:FZD4|0:FZD2|0:FZD8|0:FZD1|0:FZD7			
GO:0051709	P:regulation of killing of cells of another o...; NAS:BHF-UCL		0:P2RX7			
GO:0045182	F:translation regulator activity; ISS:BHF-UCL		0:IGF2BP1|0:AIRE|0:RPS9|0:RPS14|0:IGF2BP2|0:IGF2BP3			
GO:0033185	C:dolichol-phosphate-mannose synthase complex; IDA:UniProtKB		0:DPM2|0:DPM1|0:DPM3			
GO:0050710	P:negative regulation of cytokine secretion; ISS:UniProtKB		0:FOXP3|0:CIDEA|0:SRGN			
GO:0006358	P:regulation of transcription from RNA polyme...; NAS:UniProtKB		0:CNOT2			
GO:0008798	F:beta-aspartyl-peptidase activity; TAS:ProtInc		0:BACE1			
GO:0051409	P:response to nitrosative stress; IEP:UniProtKB		0:DUSP6			
GO:0070215	F:MDM2 binding; IPI:UniProtKB		0:PSME3|0:CDKN2A|0:RFWD3			
GO:0050810	P:regulation of steroid biosynthetic process; TAS:UniProtKB		0:NR5A1			
GO:0005669	C:transcription factor TFIID complex; IEA:InterPro		0:TAF1|0:TAF8|0:TAF4|0:TAF12|0:TAF6|0:TAF3|0:TBP|0:TAF9|0:TAF11|0:TAF5|0:TAF9B|0:TAF13|0:TAF10|0:TAF7|0:TAF2|0:TAF4B|0:TAF7L|0:TAF1L			
GO:0005625	C:soluble fraction; TAS:UniProtKB		0:CALCOCO2|0:PCSK6|0:PCSK2|0:PLEK|0:COPA|0:SPHK1|0:ERCC8|0:FARS2|0:CLIC4|0:GGPS1|0:CRYGD|0:ASNS|0:CTU2|0:MEN1|0:CRYBA1|0:RASGRP4|0:GSTT1|0:CSGALNACT1|0:RAB3GAP1|0:GCLM|0:ALDH5A1|0:TPP1|0:HAAO|0:KYNU|0:SORD|0:GIPC1|0:SRR|0:ERCC6|0:CRYBA4|0:KLK12|0:CLIC1|0:SDF4|0:TPPP|0:PYGL|0:GYS2|0:SYTL1|0:TEP1|0:MTL5|0:RAB3GAP2|0:CORO7|0:CYB5R2|0:THTPA|0:EPHX2|0:PPP2R1A|0:PPP2CA|0:STMN2|0:EBAG9|0:CXCL13|0:LHB|0:CTDSP2|0:MOBP|0:CGB8|0:CD55|0:NPFF|0:UNC119|0:RARS|0:INSL3|0:SELP|0:PDE4D|0:GYG2|0:C7orf16|0:PDE4B|0:ADM|0:FGF21|0:COMT|0:AVP|0:TNFSF10|0:EDN3|0:KARS|0:ABI1|0:TNFSF13B|0:WISP3|0:MED22|0:CCL3|0:CRHBP|0:SH2D2A|0:HPS1|0:FMR1|0:ADCYAP1|0:IAPP|0:CXCL2|0:NARS|0:IL26|0:PTPN12|0:FAS|0:SOD3|0:FGB|0:ADCY10|0:HTT|0:IPO7|0:AARS|0:RANGAP1|0:MLN|0:IK|0:IARS|0:YARS|0:HAX1|0:IDE|0:REG3A|0:PDE4A|0:GNRH2|0:STX2|0:PCYT1A|0:CGB5|0:FGF20|0:IL13RA2|0:CCDC19|0:STAC|0:CCL25|0:GRK5|0:PYY|0:CGA|0:DBH|0:NCF1|0:FSHB|0:ANXA2|0:WISP1|0:MAP4K2|0:ACP1|0:NMB|0:RLBP1|0:UBR5|0:FABP4|0:GARS|0:FBLN5|0:DARS|0:KL|0:GNRH1|0:ARR3|0:NTS|0:ASNA1|0:CCS|0:CALCB|0:ST6GALNAC4|0:PPP1R11|0:LTK|0:FARSB|0:IGFALS|0:WARS|0:EPRS|0:CGB7|0:CYTL1|0:SPINT2|0:WISP2|0:EFNB1|0:AGT|0:IL17C|0:ADRBK1|0:CGB|0:FARSA|0:POMC|0:NSMAF|0:HMGCS1|0:CTTN|0:MERTK|0:AP4B1|0:RNASE3|0:TAC3|0:F2|0:MEP1A|0:IL13|0:PCSK1N|0:PPP2R4|0:CRH|0:CORT|0:TNFRSF6B|0:DLK1|0:FLT3LG|0:GIP|0:TRH|0:FBLN1|0:CCR2|0:BTC|0:INSL4|0:GCG|0:ARRB1|0:FCRL2|0:CD40LG			
GO:0016830	F:carbon-carbon lyase activity; IDA:HGNC		0:HACL1			
GO:0046777	P:protein amino acid autophosphorylation; TAS:UniProtKB		0:PDGFRA|0:ATM|0:RIPK1|0:PDGFRB|0:ERBB2|0:TAOK3|0:CDK12|0:UHMK1|0:CDKL5|0:PAK2|0:MAP3K3|0:STK4|0:MTOR|0:MOBKL1A|0:TNIK|0:PAK1|0:SMG1|0:MAP3K11|0:LMTK2|0:TNK1|0:MYO3A|0:ACVR1B|0:MAP3K13|0:MAP3K9|0:IGF1R|0:MAPK15|0:CAMKK2|0:LRRK2|0:ALK|0:EIF2AK3|0:INSRR|0:LMTK3|0:AATK|0:EIF2AK2|0:NEK2|0:PIM1|0:INSR|0:CAD|0:MEX3B|0:MAP3K10|0:JAK2|0:MAP3K12|0:DYRK1A|0:EIF2AK1|0:IRAK1|0:AKT1|0:TAF1			
GO:0032873	P:negative regulation of stress-activated MAP...; IMP:UniProtKB		0:FOXO1|0:FOXM1|0:IGBP1			
GO:0006893	P:Golgi to plasma membrane transport; TAS:BHF-UCL		0:STEAP2|0:GOPC|0:OSBPL5|0:RAB3IP			
GO:0070703	C:outer mucus layer; ISS:UniProtKB		0:MUC2			
GO:0004340	F:glucokinase activity; IDA:UniProtKB		0:GCK			
GO:0045077	P:negative regulation of interferon-gamma bio...; TAS:UniProtKB		0:INHA|0:INHBA			
GO:0004588	F:orotate phosphoribosyltransferase activity; IDA:UniProtKB		0:UMPS			
GO:0019212	F:phosphatase inhibitor activity; ISS:UniProtKB		0:TESC|0:ANP32E			
GO:0031054	P:pre-microRNA processing; IMP:UniProtKB		0:TARBP2|0:EIF2C2|0:DICER1|0:LIN28B|0:ZCCHC11|0:LIN28A			
GO:0006629	P:lipid metabolic process; TAS:UniProtKB		0:ACAT2|0:GDPD5|0:LCN15|0:GPCPD1|0:GDPD3|0:PLCL2|0:GDPD4|0:GDPD2|0:ACAP1|0:GDPD1|0:PLCXD1|0:TECRL|0:PNPLA7|0:LCN12|0:NAAA|0:PLCL1|0:CIDEA|0:ATP5A1|0:LPA|0:PITPNB|0:PITPNM1|0:CD36|0:CLU|0:PITPNA|0:GPX5|0:APOL4|0:APOL5|0:LRP8|0:ABCA2|0:PLTP|0:RDH16|0:APOBEC1|0:APOC4|0:UGT2B10|0:ACP6|0:CPNE7|0:ACAD8|0:MGLL|0:TTPA|0:LIPT1|0:ALDH3A2|0:BTN3A1|0:FABP5|0:CPNE6|0:ANXA1|0:THRSP|0:CPNE3|0:LRP1|0:TPRA1|0:TPP1|0:ALDH3B1|0:HSD17B10|0:BTNL3|0:LRP5|0:PDE3A|0:APOD|0:RBP3|0:MGST3|0:MTTP|0:UGT2B7|0:PHYH|0:ABCB4|0:AOAH|0:BTN2A1|0:NR2F2|0:LRP2|0:CPNE1|0:ZNF202|0:ALDH3B2|0:GDE1			
GO:0001575	P:globoside metabolic process; IMP:UniProtKB		0:CLN3			
GO:0071108	P:protein K48-linked deubiquitination; IMP:UniProtKB		0:OTUB2|0:USP20|0:OTUB1|0:USP33|0:USP8|0:YOD1|0:USP5|0:BAP1			
GO:0001968	F:fibronectin binding; ISS:BHF-UCL		0:THBS1|0:VEGFA|0:LACRT|0:PLEKHA2|0:FSTL3|0:SFRP2			
GO:0001642	F:group III metabotropic glutamate receptor a...; IDA:UniProtKB		0:GRM7			
GO:0031232	C:extrinsic to external side of plasma membrane; NAS:UniProtKB		0:PCSK9|0:PLG|0:SERPINE2|0:CUBN			
GO:0034509	P:centromeric core chromatin assembly; IMP:UniProtKB		0:HJURP			
GO:0030314	C:junctional membrane complex; NAS:UniProtKB		0:JPH1			
GO:0005149	F:interleukin-1 receptor binding; TAS:UniProtKB		0:TRIP6|0:IL1A|0:TLR9|0:TLR5|0:IL1F8|0:IL1F6|0:IL1B|0:IL1F7			
GO:0090009	P:primitive streak formation; NAS:BHF-UCL		0:T			
GO:0071425	P:hemopoietic stem cell proliferation; ISS:UniProtKB		0:WNT10B|0:WNT2B|0:WNT5A|0:ARIH2|0:SFRP2|0:MECOM			
GO:0004731	F:purine-nucleoside phosphorylase activity; IDA:UniProtKB		0:PNP			
GO:0050853	P:B cell receptor signaling pathway; ISS:UniProtKB		0:LAT2|0:PLEKHA1|0:BCAR1|0:PTPRC|0:CD79A|0:PRKCB			
GO:0006101	P:citrate metabolic process; TAS:ProtInc		0:ACO2|0:ACO1|0:GHR|0:STAT5A|0:STAT5B|0:ACLY			
GO:0001671	F:ATPase activator activity; TAS:UniProtKB		0:DNAJB6|0:AHSA2|0:MYBPC3|0:AHSA1|0:DNAJC1			
GO:0016202	P:regulation of striated muscle tissue develo...; NAS:UniProtKB		0:CENPF|0:TGFB1|0:MTPN			
GO:0071727	P:cellular response to triacylated bacterial ...; IDA:MGI		0:TLR1|0:TLR2			
GO:0001920	P:negative regulation of receptor recycling; IDA:MGI		0:PCSK9|0:TRAT1			
GO:0051574	P:positive regulation of histone H3-K9 methyl...; ISS:UniProtKB		0:JARID2			
GO:0032237	P:activation of store-operated calcium channe...; IMP:UniProtKB		0:STIM2|0:STIM1|0:EFCAB4B			
GO:0005543	F:phospholipid binding; TAS:UniProtKB		0:ABCG1|0:ABCA1|0:F10|0:PLA2G2A|0:APOE|0:F3|0:APOC3|0:PON1|0:APOH|0:APOB|0:APOA1|0:PRKCI|0:PTAFR|0:NR5A1|0:PLEKHA3|0:MYOF|0:PREX1|0:DYSF|0:SYTL4|0:BPIL2|0:SEC14L2|0:PLA2G4C|0:OSBPL1A|0:RASAL1|0:PLA2G7|0:PLA2G15|0:GRK5|0:PAFAH2|0:SHC1			
GO:0004518	F:nuclease activity; ISS:UniProtKB		0:RAD50|0:SLK|0:FANCM|0:SND1|0:ASTE1|0:HARBI1|0:TDP2|0:PGAP1			
GO:0006954	P:inflammatory response; TAS:UniProtKB		0:BDKRB2|0:IL1RN|0:IL10|0:AFAP1L2|0:MEFV|0:RELA|0:CD40LG|0:IL17A|0:IL1F6|0:IL17D|0:IL17B|0:IL17F|0:CXCL13|0:CCL19|0:CD180|0:TLR8|0:NFKBID|0:IL27|0:TLR3|0:TLR6|0:CCL4L1|0:MYD88|0:CCL18|0:TLR10|0:STAB1|0:LY86|0:IRGM|0:TLR9|0:ATRN|0:CD14|0:CCL4L2|0:CHST1|0:CCL2|0:CCL25|0:CXCL3|0:IL23A|0:TLR5|0:LY96|0:NDST1|0:CCL17|0:CNR2|0:CCL8|0:TLR1|0:CLEC7A|0:TIRAP|0:CHST4|0:MIF|0:IL23R|0:OLR1|0:KDM6B|0:CCL7|0:CCL16|0:TICAM2|0:TLR7|0:C1orf38|0:TLR2|0:TICAM1|0:ELF3|0:CYBA|0:PXK|0:NLRP3|0:PARP4|0:SLC11A1|0:TNFRSF1A|0:LIAS|0:NFAM1|0:LTA4H|0:ITCH|0:SCUBE1|0:AZU1|0:EPHX2|0:SIGLEC1|0:ITGB2|0:MMP25|0:PLA2G4B|0:PLA2G4C|0:PROK2|0:CARD18|0:ITGAL|0:TOLLIP|0:NCR3|0:NOX1|0:NOD1|0:SCG2|0:XCR1|0:KLRG1|0:HRH1|0:AOX1|0:NFATC4|0:CXCR2|0:CD40|0:PTX3|0:LY75|0:FOS|0:CXCL1|0:CCL26|0:CHST2|0:RAC1|0:ADORA2A|0:MGLL|0:AIMP1|0:CCL21|0:CXCL6|0:CCL3|0:CCR3|0:TNFAIP6|0:AGER|0:IL10RB|0:IL18RAP|0:CXCL2|0:FPR2|0:RIPK2|0:AIF1|0:NFRKB|0:CCR7|0:CCR4|0:BLNK|0:PLA2G7|0:GPR68|0:ANXA1|0:CXCL11|0:CCL20|0:LTB4R|0:ADORA1|0:CXCL9|0:PTAFR|0:F11R|0:PLA2G2E|0:CXCR4|0:CCL23|0:ABCF1|0:IL9|0:S100A8|0:CCR1|0:IL5|0:CYBB|0:TPST1|0:S1PR3|0:IFNA2|0:IL1RAP|0:CCL24|0:CCR5|0:CCL22|0:IL17C|0:CCL11|0:CXCR1|0:IRAK2|0:CXCL10|0:S100A12|0:ALOX15|0:CD97|0:NFX1|0:AOAH|0:S100A9|0:CCL4|0:NFATC3|0:IL13|0:PLA2G2D|0:ADORA3|0:NFE2L1|0:CCL13|0:C3AR1|0:CCR2|0:NMI|0:APOL3|0:NOX4|0:IL8|0:CCL3L1|0:CCL3L3|0:HDAC5|0:AOC3|0:PRDX5|0:KNG1|0:CYP4F11|0:HDAC4|0:LYZ|0:NFKB1|0:CDO1|0:HDAC9			
GO:0003999	F:adenine phosphoribosyltransferase activity; EXP:Reactome		0:APRT			
GO:0001941	P:postsynaptic membrane organization; IMP:UniProtKB		0:CHRNB1			
GO:0017059	C:serine C-palmitoyltransferase complex; IDA:UniProtKB		0:C3orf57|0:SPTLC3|0:C14orf147|0:SPTLC2			
GO:0060230	F:lipoprotein lipase activator activity; IDA:BHF-UCL		0:APOH|0:APOA5|0:APOC2			
GO:0050999	P:regulation of nitric-oxide synthase activity; IDA:UniProtKB		0:EGFR			
GO:0008177	F:succinate dehydrogenase (ubiquinone) activity; IEA:EC		0:SDHA|0:SDHB			
GO:0005089	F:Rho guanyl-nucleotide exchange factor activity; TAS:UniProtKB		0:ARHGEF1|0:FARP2|0:ABR|0:PLEKHG4|0:ITSN1|0:ARHGEF18|0:PLEKHG6|0:RASGRF1|0:NGEF|0:ARHGEF15|0:FGD3|0:TTN|0:BCR|0:TIAM2|0:MCF2|0:ARHGEF19|0:SOS2|0:PLEKHG3|0:ARHGEF10|0:FGD6|0:ARHGEF38|0:ARHGEF16|0:NET1|0:ARHGEF5|0:FGD2|0:PLEKHG4B|0:ARHGEF9|0:KALRN|0:MCF2L|0:PLEKHG2|0:DNMBP|0:FGD5|0:PLEKHG7|0:C9orf100|0:VAV2|0:ARHGEF37|0:FGD1|0:SPATA13|0:PLEKHG5|0:ARHGEF10L|0:TRIO|0:ARHGEF12|0:FGD4|0:ARHGEF17|0:MCF2L2|0:RASGRF2|0:ECT2|0:PLEKHG1|0:ECT2L|0:ARHGEF7|0:ITSN2|0:OBSCN|0:AKAP13|0:VAV1|0:ARHGEF6|0:ARHGEF4|0:FARP1|0:TIAM1|0:ARHGEF3|0:SOS1|0:ARHGEF11|0:PREX1			
GO:0002891	P:positive regulation of immunoglobulin media...; IMP:BHF-UCL		0:CD226|0:PVRL2			
GO:0046425	P:regulation of JAK-STAT cascade; IDA:HGNC		0:PIGU			
GO:0005783	C:endoplasmic reticulum; TAS:UniProtKB		0:PRKCE|0:MRAP|0:PRKCA|0:PRKCD|0:NDFIP2|0:MRAP2|0:TAS2R16|0:AIFM3|0:DSE|0:MSRB3|0:CAV1|0:UBQLN1|0:YKT6|0:CRIPAK|0:ARSG|0:FNDC3B|0:DUSP9|0:CLCC1|0:DNAJB12|0:LRG1|0:EMD|0:CTSH|0:STX17|0:LAMB2|0:TMEM49|0:APOC1|0:PHTF2|0:CNIH4|0:SEMA4F|0:PGS1|0:PLA2G2A|0:CYP19A1|0:MAMDC2|0:YIPF6|0:THY1|0:FAM19A1|0:TPST2|0:EHD4|0:TMTC2|0:DNAJB9|0:RGMA|0:NDUFB8|0:DNASE1L1|0:TMEM50B|0:GOLT1B|0:RPL10|0:C7orf58|0:SLC36A1|0:ALDH3A1|0:CCDC3|0:SV2A|0:TMEM50A|0:DHRS1|0:PTN|0:YIPF4|0:FAM172A|0:CD320|0:CTSZ|0:TMEM98|0:TMEM117|0:FATE1|0:RDH14|0:FAM57B|0:RTN4R|0:ANKRD13C|0:GPC2|0:ACO1|0:INPP5K|0:CAMLG|0:KIAA0368|0:KCNG3|0:LSG1|0:MAL|0:NPC1|0:CCDC88A|0:VASH1|0:AGA|0:ATP1A3|0:AGPAT3|0:PRSS50|0:KIAA0020|0:PXDN|0:B3GALT5|0:VCP|0:NT5C3|0:S100A7|0:CERKL|0:IFNGR2|0:HMOX1|0:PSMG1|0:VWF|0:DDRGK1|0:CLDN14|0:CLDN8|0:CLN5|0:CYB5R4|0:BNIP3L|0:SREBF1|0:TMEM195|0:ZFYVE1|0:SET|0:ANP32A|0:KIAA0776|0:ATP7A|0:TTC35|0:TPD52|0:FAM134A|0:NAPA|0:C5orf4|0:NAPB|0:C9orf167|0:FAM134B|0:TOR2A|0:NAPG|0:COPA|0:PRR18|0:HSD17B6|0:KLK6|0:VAC14|0:HPS6|0:NCEH1|0:PNPLA7|0:FBXO2|0:TRAPPC9|0:CRELD2|0:SEC23IP|0:PARK2|0:PPP1R15A|0:PIK3C2B|0:BET3L|0:KCNIP3|0:LEPRE1|0:HACE1|0:MR1|0:EPM2A|0:TRAPPC6B|0:CNBP|0:MESDC2|0:MGST1|0:LRBA|0:TRAPPC5|0:LEPREL1|0:GIMAP8|0:PRKCSH|0:SCAPER|0:LRP6|0:AIMP1|0:PCSK6|0:OAS1|0:GRIP1|0:SULF2|0:ULBP1|0:TRAPPC6A|0:DUS2L|0:NCK1|0:PLCD4|0:AHSA1|0:ATG14|0:LEPREL2|0:POFUT2|0:TCL1A|0:ACSBG1|0:SYNCRIP|0:TP53|0:TRAPPC3|0:CNPY2|0:TRAPPC2L|0:GABARAPL1|0:UBXN2B|0:ARSI|0:BACE1|0:METTL7A|0:TRAPPC4|0:CHERP|0:POFUT1|0:NCK2|0:PCYT1B|0:TMEM43|0:OAS2|0:SULF1|0:PDE9A|0:TRAPPC2P1|0:HSD11B2|0:A1CF|0:BACE2|0:GANAB|0:SGK1|0:TRAPPC2|0:MCFD2|0:LRP5|0:GHDC|0:SPAST|0:ASNA1|0:RAB1A|0:NHLRC1|0:MTTP|0:PDILT|0:FAF2|0:HSPA13|0:TXNRD3|0:STAU2|0:TOR3A|0:PTRF|0:CNPY3|0:RNF122|0:HMOX2|0:ALG13|0:TMEM8B|0:TRAPPC1|0:PTP4A1|0:AHCYL1|0:FCRLB|0:EPM2AIP1|0:VCPIP1|0:PKD2|0:C6orf25|0:CIB1|0:CREB3|0:PDE3B|0:NPLOC4|0:PRNP|0:AGPAT2|0:UPK1A|0:NCSTN|0:PDZD2|0:AGR2|0:FKBP9|0:RRAS2|0:CRAT|0:VPREB3|0:VHL|0:SGMS1|0:MAN1A1|0:ABI1|0:CES1P1|0:STX8|0:KIFAP3|0:PLIN2|0:PIGH|0:CTSA|0:PCMT1|0:KIF1C|0:AGPAT1|0:BDKRB1|0:SRP68|0:GNAZ|0:SEMA3B|0:AVPR2|0:OPRM1|0:NTSR1|0:TMBIM6|0:DNM1L|0:APEX1|0:HSPA1A|0:HSPA1B			
GO:0045884	P:regulation of survival gene product expression; ISS:UniProtKB		0:AKT1S1			
GO:0007263	P:nitric oxide mediated signal transduction; TAS:ProtInc		0:APOE|0:CD36|0:NEUROD1|0:MAFA|0:PDX1|0:AGT|0:AGTR2|0:DDAH1|0:GUCY1B3|0:DDAH2|0:FPR1|0:GUCY1A3			
GO:0016274	F:protein-arginine N-methyltransferase activity; NAS:UniProtKB		0:FBXO11|0:PRMT3			
GO:0016972	F:thiol oxidase activity; IEA:EC		0:QSOX2|0:GFER			
GO:0046878	P:positive regulation of saliva secretion; IMP:UniProtKB		0:AQP1			
GO:0043183	F:vascular endothelial growth factor receptor...; IPI:UniProtKB		0:VEGFA|0:VEGFB			
GO:0043065	P:positive regulation of apoptosis; NAS:UniProtKB		0:SOD1|0:SFRP4|0:AGT|0:BMP2|0:ING4|0:TNFRSF8|0:DNAJA3|0:HMGB1|0:CTNNBL1|0:BCL6|0:BMP4|0:HOXA5|0:APBB1|0:DUSP6|0:SFRP1|0:ADAMTSL4|0:RPS6|0:STK4|0:ING3|0:RBM5|0:TOP2A|0:CTNNB1|0:PPP2R4|0:TFAP4|0:MTCH1|0:WNT10B|0:SFRP2|0:SOX4|0:CAPN10|0:HDAC6|0:HSPD1|0:AGTR2|0:NLRC4|0:APC|0:SLIT2|0:SCRIB|0:KIAA1967|0:IGFBP3|0:DCUN1D3|0:UBD|0:SCIN|0:KCNMA1|0:BARD1|0:IP6K2|0:RARG|0:CSRNP3|0:STK3|0:EEF1E1|0:PAWR|0:FAF1|0:DNM2|0:KNG1			
GO:0004721	F:phosphoprotein phosphatase activity; TAS:UniProtKB		0:PDXP|0:DLGAP5|0:PGAM5|0:CTDSPL|0:TENC1|0:PHPT1|0:PPP2CA|0:CTDSPL2|0:PPTC7|0:PPP3CC|0:PPM1H|0:UBLCP1|0:SSU72|0:RPAP2|0:PHLPP2|0:PPAP2C|0:PPAP2B|0:DLG1			
GO:0001600	F:endothelin-B receptor activity; IPI:BHF-UCL		0:EDNRB			
GO:0043517	P:positive regulation of DNA damage response,...; ISS:UniProtKB		0:CDKN2A|0:ATM|0:ATR|0:EEF1E1			
GO:0030149	P:sphingolipid catabolic process; TAS:UniProtKB		0:SGPL1|0:PPT1			
GO:0009612	P:response to mechanical stimulus; TAS:UniProtKB		0:DNAH1|0:TRPV4			
GO:0004590	F:orotidine-5'-phosphate decarboxylase activity; IDA:UniProtKB		0:UMPS			
GO:0048273	F:mitogen-activated protein kinase p38 binding; IGI:UniProtKB		0:RPS6KA4			
GO:0031575	P:mitotic cell cycle G1/S transition checkpoint; TAS:BHF-UCL		0:HRAS|0:TGFB1|0:NBN|0:WNT9A|0:CDKN2B|0:USP17L2|0:DLG1|0:RB1			
GO:0030414	F:peptidase inhibitor activity; IEA:UniProtKB-KW		0:WFDC10B|0:SSPO|0:UMODL1|0:WFDC13|0:PI16|0:PI15|0:R3HDML			
GO:0001666	P:response to hypoxia; TAS:UniProtKB		0:ITPR1|0:RYR1|0:TH|0:ITPR2|0:ADAM17|0:ARNT|0:NARFL|0:EGLN1|0:EPAS1|0:ARNT2|0:EGLN2|0:PML|0:HSP90B1|0:CITED2|0:ALAS2|0:DPP4|0:EP300|0:ANG|0:MT3|0:ADA|0:KCNMA1|0:CHRNB2|0:CHRNA7|0:HMOX2|0:HIF1A|0:CHRNA4|0:NOS1|0:CLDN3|0:PLOD2|0:CXCR4|0:LONP1|0:SLC11A2|0:CD24|0:ASCL2|0:PLOD1|0:TGFB2|0:SMAD4|0:USF1|0:UBQLN1|0:PDIA2|0:RYR2|0:CAV1|0:NF1|0:BNIP3|0:THBS1|0:ANGPTL4|0:PRKAA1|0:CREBBP			
GO:0015234	F:thiamin transmembrane transporter activity; TAS:UniProtKB		0:SLC19A2			
GO:0018343	P:protein farnesylation; IDA:MGI		0:AIPL1			
GO:0010042	P:response to manganese ion; ISS:HGNC		0:ADAM9|0:D2HGDH			
GO:0000801	C:central element; ISS:HGNC		0:SYCE1|0:SYCE2			
GO:0031235	C:intrinsic to internal side of plasma membrane; TAS:BHF-UCL		0:RASA3|0:SPTA1|0:SPTB			
GO:0031616	C:spindle pole centrosome; ISS:UniProtKB		0:AURKA|0:NPM1|0:DLGAP5|0:NDE1			
GO:0006367	P:transcription initiation from RNA polymeras...; TAS:UniProtKB		0:POLR2J|0:TAF4B|0:GTF2E1|0:GTF2F2|0:POLR2D|0:GTF2F1|0:POLR2G|0:GTF2H2|0:GTF2B|0:GTF2A1|0:CCNH|0:TAF9|0:GTF2E2|0:MNAT1|0:POLR2C|0:POLR2F|0:POLR2B|0:POLR2L|0:GTF2H3|0:POLR2E|0:POLR2I|0:ERCC3|0:CDK7|0:POLR2A|0:GTF2H4|0:POLR2K|0:GTF2H1|0:POLR2H|0:ERCC2|0:TBP|0:TAF11|0:TAF13|0:TAF4|0:MED14|0:TAF5|0:MED13|0:TAF12|0:MED17|0:MED12|0:MED24|0:TAF6|0:THRAP3|0:MED16|0:MED1|0:TAF10|0:TAF7|0:TAF2|0:MED30|0:MED4|0:TBPL2|0:TBPL1|0:GTF2A1L|0:TAF7L|0:NCOA6|0:MED26|0:MAZ|0:CDK9|0:E2F3|0:MED7|0:GTF2I|0:E2F2|0:MED27|0:MED23|0:PPARGC1A			
GO:0002227	P:innate immune response in mucosa; NAS:BHF-UCL		0:APOA4|0:NOS2			
GO:0043874	F:acireductone synthase activity; IDA:UniProtKB		0:ENOPH1			
GO:0032148	P:activation of protein kinase B activity; ISS:UniProtKB		0:ADRA2B|0:INS|0:ADRA2C|0:PDPK1|0:INSR|0:ADRA2A|0:WNT5A|0:ANG|0:CCDC88A			
GO:0033116	C:ER-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell		0:LMAN1|0:TMEM49|0:VMA21|0:ERGIC1|0:RAB2A|0:CLN8|0:SURF4|0:ERGIC3|0:TMED3|0:MPPE1|0:SEC22B|0:FAM38A|0:BCAP31|0:ERGIC2|0:CKAP4|0:SEC23B|0:STX5|0:LMAN2			
GO:0000171	F:ribonuclease MRP activity; IDA:UniProtKB		0:POP1			
GO:0051150	P:regulation of smooth muscle cell differenti...; TAS:BHF-UCL		0:MYOCD|0:SRF			
GO:0042497	F:triacylated lipopeptide binding; IDA:MGI		0:TLR2			
GO:0050995	P:negative regulation of lipid catabolic process; NAS:BHF-UCL		0:TNF|0:IL1B|0:APOA2|0:ADRA2A|0:CIDEA|0:PDE3B|0:GPR109A|0:INS			
GO:0030026	P:cellular manganese ion homeostasis; IDA:UniProtKB		0:ATP2C1			
GO:0008526	F:phosphatidylinositol transporter activity; TAS:UniProtKB		0:PITPNC1|0:PITPNM1|0:CDIPT|0:PITPNA|0:PITPNM3			
GO:0060416	P:response to growth hormone stimulus; IDA:UniProtKB		0:TRIM16			
GO:0001934	P:positive regulation of protein amino acid p...; ISS:UniProtKB		0:TNF|0:WNT3A|0:IL1B|0:CCND2|0:INSR|0:F2|0:CCND1|0:CCND3|0:AKTIP|0:ITLN1|0:IL34|0:CARD14|0:CSNK1D|0:DVL3|0:AXIN2|0:DVL2|0:ADAM17|0:ACVR2A|0:FAM129A|0:NPTN			
GO:0047560	F:3-dehydrosphinganine reductase activity; IDA:MGI		0:KDSR			
GO:0005018	F:platelet-derived growth factor alpha-recept...; IDA:BHF-UCL		0:PDGFRA			
GO:0016618	F:hydroxypyruvate reductase activity; IDA:UniProtKB		0:GRHPR			
GO:0060370	P:susceptibility to T cell mediated cytotoxicity; IDA:BHF-UCL		0:PVRL2|0:PVR			
GO:0030827	P:negative regulation of cGMP biosynthetic pr...; TAS:UniProtKB		0:PDZD3			
GO:0042660	P:positive regulation of cell fate specification; IDA:MGI		0:FGF2			
GO:0032549	F:ribonucleoside binding; IEA:InterPro		0:POLR2B|0:POLR1B|0:POLR3B			
GO:0001533	C:cornified envelope; TAS:UniProtKB		0:CNFN|0:CDSN|0:DSP|0:CSTA|0:SPRR1B|0:EVPL|0:ANXA1|0:LOR|0:IVL|0:SPRR1A|0:SPRR2D|0:SPRR2G|0:SPRR2B|0:SPRR2F|0:SPRR2A|0:SPRR2E|0:TGM1|0:SCEL			
GO:0004069	F:L-aspartate:2-oxoglutarate aminotransferase...; IDA:UniProtKB		0:GOT2|0:GOT1			
GO:0004061	F:arylformamidase activity; IEA:EC		0:AFMID			
GO:0000800	C:lateral element; IDA:UniProtKB		0:BLM			
GO:0009374	F:biotin binding; TAS:ProtInc		0:HLCS|0:ACACB|0:MCCC1|0:PC|0:PCCA			
GO:0055005	P:ventricular cardiac myofibril development; ISS:BHF-UCL		0:PROX1			
GO:0007034	P:vacuolar transport; IEA:InterPro		0:DSCR3|0:VPS26A|0:VPS26B			
GO:0016670	F:oxidoreductase activity, acting on sulfur g...; IEA:InterPro		0:PCYOX1L			
GO:0046322	P:negative regulation of fatty acid oxidation; ISS:BHF-UCL		0:ACADVL|0:ACADL			
GO:0021942	P:radial glia guided migration of Purkinje cell; ISS:UniProtKB		0:CTNNA2			
GO:0006366	P:transcription from RNA polymerase II promoter; TAS:UniProtKB		0:PBX4|0:HAND1|0:USF1|0:FOXE3|0:AHR|0:FOXM1|0:DVL1|0:THRA|0:ARRB2|0:DVL2|0:ETS1|0:NKX2-8|0:ZNF768|0:BMPR2|0:ARRB1|0:GATA4|0:LMO4|0:ERCC6|0:PIR|0:PMF1|0:NCOR1|0:NFATC4|0:POU2AF1|0:KAT2A|0:RREB1|0:DEAF1|0:ZFHX3|0:IRF3|0:KDM5A|0:FUBP1|0:ASH1L|0:STAT1|0:PTTG1|0:TRIP11|0:POU6F2|0:CCNT1|0:KLF13|0:POU1F1|0:ELF3|0:CDX2|0:PRDM4|0:NR3C1|0:TADA2A|0:PARP1|0:PPBPL2|0:TAF1A|0:CBFB|0:MLLT1|0:COPS5|0:TRIP4|0:CEBPB|0:ALX1|0:HSF2|0:NFIL3|0:HCFC1|0:NFE2L2|0:SUPT16H|0:TCERG1|0:KLF5|0:SNAPC5|0:SNAPC2|0:TAF1C|0:IRF1|0:NFATC1|0:SUPT3H|0:CEBPA|0:TMF1|0:TSC22D1|0:HLF|0:NFRKB|0:CCNK|0:APEX1|0:ABT1|0:POU2F2|0:GATA3|0:NRL|0:PSMC5|0:SNAPC3|0:MLL|0:MAX|0:BTF3|0:DUX1|0:TCFL5|0:NFAT5|0:NFE2L3|0:TARDBP|0:ASH2L|0:MAF|0:SHOX|0:IRF9|0:MAFF|0:YBX2|0:ATOH1|0:CCRN4L|0:HSF2BP|0:TCEB3B|0:GABPA|0:FOXO4|0:SOX5|0:NFIX|0:ELF5|0:TRPS1|0:CEBPD|0:PAX1|0:TCEA1|0:TGFB1I1|0:EPAS1|0:ETV1|0:TAF5L|0:MSC|0:KLF11|0:ARID4A|0:PAX3|0:RUNX3|0:FEV|0:NR2E3|0:NFYA|0:TRIM24|0:YBX1|0:PAX5|0:MBD1|0:MSL3|0:BATF3|0:NFIC|0:CCNT2|0:TRIP13|0:NFX1|0:NKX3-2|0:ECD|0:FOSL1|0:TRIM29|0:HOXD13|0:ETV7|0:CEBPZ|0:NFATC3|0:PAX2|0:NFE2L1|0:MNT|0:DTX1|0:AFF4|0:GMEB2|0:CREB5|0:PPARA|0:NMI|0:NFKB1|0:COPS2			
GO:0004031	F:aldehyde oxidase activity; TAS:ProtInc		0:ADH7|0:AOX1			
GO:0042098	P:T cell proliferation; NAS:UniProtKB		0:TNFRSF4|0:TNFSF14			
GO:0001928	P:regulation of exocyst assembly; ISS:UniProtKB		0:RALB			
GO:0060563	P:neuroepithelial cell differentiation; IDA:UniProtKB		0:FGF8			
GO:0016890	F:site-specific endodeoxyribonuclease activit...; IDA:UniProtKB		0:DNA2			
GO:0006518	P:peptide metabolic process; TAS:ProtInc		0:PAM|0:DNPEP			
GO:0004363	F:glutathione synthase activity; TAS:ProtInc		0:GSS			
GO:0031116	P:positive regulation of microtubule polymeri...; ISS:BHF-UCL		0:TERF1|0:MAPT|0:CAV3|0:PSRC1			
GO:0034644	P:cellular response to UV; IMP:BHF-UCL		0:TMEM161A|0:AQP1|0:PTPRK|0:ATR			
GO:0045007	P:depurination; EXP:Reactome		0:MPG|0:MUTYH|0:OGG1			
GO:0005362	F:low-affinity glucose:sodium symporter activity; TAS:ProtInc		0:SLC5A9|0:SLC5A2			
GO:0042474	P:middle ear morphogenesis; ISS:UniProtKB		0:NOG|0:OSR1			
GO:0004792	F:thiosulfate sulfurtransferase activity; TAS:ProtInc		0:MOCS3|0:MPST|0:TST			
GO:0004621	F:glycosylphosphatidylinositol phospholipase ...; IEA:EC		0:GPLD1			
GO:0002082	P:regulation of oxidative phosphorylation; ISS:UniProtKB		0:ATP7A			
GO:0008307	F:structural constituent of muscle; TAS:UniProtKB		0:MYH7|0:MYL6|0:MYH6|0:DMD|0:KRT19|0:SYNM|0:TTN|0:MYBPC3|0:DAG1|0:MYH11|0:NEXN|0:MYLPF|0:OBSCN|0:MYH2|0:MYL1|0:MYH4|0:MYL2|0:MYH8|0:ANKRD2|0:MYL4|0:MYL6B|0:ACTN2|0:MYOM2|0:NEBL|0:SMTN|0:MYBPC2|0:TPM4|0:SORBS2|0:MYL9|0:ACTN3|0:MYOM1|0:NEB|0:MYL3|0:TCAP|0:PLEC|0:TPM2|0:MYBPC1|0:MYOT|0:ASPH|0:MYBPH|0:TPM1|0:MYL5			
GO:0005604	C:basement membrane; TAS:ProtInc		0:USH2A|0:DAG1|0:TINAG|0:THBS4|0:FBN1|0:LAMB4|0:HMCN1|0:LAD1|0:LAMC2|0:FREM1|0:COL28A1|0:ANXA2P2|0:VWC2|0:SMOC1|0:NTN4|0:SMOC2|0:ANXA2|0:NID1|0:COL17A1|0:VWA1|0:COL8A1|0:HSPG2|0:SPARC|0:LAMC3|0:EGFL6|0:COL8A2|0:ERBB2IP|0:NID2|0:DST|0:SMC3|0:EFEMP2|0:COL7A1|0:APLP1			
GO:0007610	P:behavior; TAS:ProtInc		0:CNTNAP2|0:AGTR2|0:HPRT1|0:USP46|0:ZIC1|0:KISS1R|0:PMCHL1|0:MAOA|0:C7orf16|0:FOSB|0:HTR1A|0:CNR2|0:OPRK1			
GO:0042826	F:histone deacetylase binding; ISS:UniProtKB		0:HDAC9|0:CAMTA2|0:HDAC10|0:GLI3|0:PKN2|0:PKN1|0:TAL1|0:NCOR1|0:HDAC1|0:SP1|0:KPNA2|0:NIPBL|0:YWHAB|0:SP2|0:RBBP4|0:FOXP3|0:HDAC3|0:HDAC4|0:YWHAE|0:MEF2B|0:USF1|0:TRAF6|0:KAT2A|0:SIRT2|0:RAD9A|0:GMNN|0:NCOR2|0:TOP2B|0:NUDT21|0:KAT2B|0:HDAC6|0:TOP2A|0:TFAP4|0:SUDS3			
GO:0031512	C:motile primary cilium; ISS:BHF-UCL		0:PAFAH1B1			
GO:0045494	P:photoreceptor cell maintenance; TAS:UniProtKB		0:BBS10|0:BBS1|0:GPR98|0:NPHP3|0:IQCB1|0:USH1G|0:USH1C|0:CDH23|0:USH2A|0:CLRN1|0:PCDH15|0:BBS4|0:MKKS|0:BBS2|0:TULP1|0:RDH12			
GO:0032099	P:negative regulation of appetite; TAS:HGNC		0:LEP|0:PPARA|0:CARTPT			
GO:0005721	C:centromeric heterochromatin; ISS:UniProtKB		0:INCENP|0:HELLS			
GO:0010742	P:macrophage derived foam cell differentiation; TAS:BHF-UCL		0:TGFB1|0:SOAT1|0:SOAT2			
GO:0031080	C:Nup107-160 complex; IDA:UniProtKB		0:NUP85|0:NUP160|0:NUP107|0:NUP37|0:SEC13|0:NUP98|0:NUP43|0:NUP133|0:SEH1L			
GO:0030250	F:guanylate cyclase activator activity; NAS:UniProtKB		0:GUCA2A			
GO:0021769	P:orbitofrontal cortex development; IMP:BHF-UCL		0:FZD3|0:TCF4|0:WNT7A|0:CLASP2			
GO:0034213	P:quinolinate catabolic process; IDA:UniProtKB		0:QPRT			
GO:0004802	F:transketolase activity; TAS:ProtInc		0:TKT|0:TKTL2|0:TKTL1			
GO:0034993	C:SUN-KASH complex; IDA:UniProtKB		0:SUN2|0:SUN1|0:SYNE1|0:SYNE2|0:C14orf49			
GO:0000262	C:mitochondrial chromosome; TAS:ProtInc		0:POLG2			
GO:0000502	C:proteasome complex; TAS:UniProtKB		0:VCP|0:PSMC6|0:PSMC5|0:ADRM1|0:SHFM1|0:PSMC2|0:KIAA0368|0:PSME4|0:POMP|0:TRIP12|0:UBE3C|0:PAAF1|0:UCHL5|0:UBE3A|0:RAD23B|0:USP14|0:UBQLN1|0:PSMC1|0:PSMD6|0:PSMD3|0:PSMD4|0:PSMD5|0:PSMC4|0:PSMD11|0:PSMC3|0:PSMD14			
GO:0033842	F:N-acetyl-beta-glucosaminyl-glycoprotein 4-b...; IEA:EC		0:B4GALNT4|0:B4GALNT3			
GO:0005873	C:plus-end kinesin complex; TAS:ProtInc		0:KIF3B|0:KIF15			
GO:0000302	P:response to reactive oxygen species; NAS:UniProtKB		0:S100A7|0:PTPRN|0:APOE			
GO:0000122	P:negative regulation of transcription from R...; TAS:ProtInc		0:TBX22|0:PROX1|0:SP100|0:CALR|0:HEXIM1|0:HEXIM2|0:BPTF|0:ALX1|0:TRIM27|0:EID1|0:EPC1|0:KLF12|0:JAZF1|0:WT1|0:PHF21A|0:SALL1|0:FST|0:MDM2|0:SKI|0:HOXA7|0:TCF25|0:SLA2|0:NR2F1|0:MEN1|0:HDAC10|0:SUPT5H|0:BCL6|0:NR2F6|0:TRPS1|0:MDM4|0:GLI3|0:SUPT4H1|0:STRN3|0:PRDM16|0:NR2F2|0:MTDH|0:NRIP1|0:RPS14|0:ZFHX3|0:CITED2|0:SATB1|0:TRAF6|0:GLI2|0:USP2|0:CRYM|0:RARG|0:GLIS1|0:NR6A1|0:FOXD3|0:GLIS3|0:PPARD|0:SOX14|0:NSD1|0:MDFI|0:FOXE1|0:ZEB1|0:PAWR|0:IRF2|0:DRAP1|0:ZNF157|0:SPI1|0:HDAC8|0:VPS72|0:MXD4|0:E2F1|0:ZFP161|0:ZNF136|0:FOSB|0:ZBTB32|0:RYBP|0:POU4F2|0:ORC2|0:MEIS2|0:CSDA|0:ZNF593|0:NR0B2|0:ENO1|0:GFI1B|0:ZNF281|0:KLF10|0:SNAI2|0:TWIST1|0:MECP2|0:STAT3|0:ZNF174|0:E2F6|0:ZNF345|0:ZNF254|0:KLF11|0:ZMYND11|0:IRF8|0:VHL|0:IRF7|0:HSBP1|0:NFX1|0:TCEAL1|0:ZNF177|0:PRDM1|0:TGIF1|0:ZNF189|0:ZNF202|0:ZNF148|0:DNMT1|0:DR1			
GO:0004553	F:hydrolase activity, hydrolyzing O-glycosyl ...; IEA:InterPro		0:GLB1L3|0:KLB|0:LCTL|0:GUSBP1|0:GBE1|0:GLB1L|0:GLB1L2|0:KIAA1161|0:GUSBL1			
GO:0010862	P:positive regulation of pathway-restricted S...; TAS:BHF-UCL		0:BMPR1A|0:GDF6|0:GDF7|0:ENG|0:TGFBR1|0:GDF2|0:TGFB1|0:BMP10|0:RBPMS|0:BMP7|0:BMP4|0:BMP2|0:BMP6|0:BMPR2|0:TGFB3|0:SMAD4|0:TTK			
GO:0048265	P:response to pain; ISS:UniProtKB		0:GCH1|0:RELN			
GO:0043202	C:lysosomal lumen; IEA:UniProtKB-SubCell		0:PSAP|0:ACP2|0:PLBD2|0:NEU4|0:NEU1|0:CD1E			
GO:0045198	P:establishment of epithelial cell apical/bas...; ISS:UniProtKB		0:C19orf46			
GO:0050900	P:leukocyte migration; NAS:UniProtKB		0:AIMP1|0:MSN|0:ICAM1|0:FOXJ1|0:CD34|0:MYH9			
GO:0051090	P:regulation of transcription factor activity; NAS:UniProtKB		0:USP7|0:CREBZF|0:STK36|0:TAF6L|0:TAF6|0:C14orf39			
GO:0032526	P:response to retinoic acid; NAS:BHF-UCL		0:AQP3|0:RBP4|0:SP100|0:RARG|0:HSD17B2|0:TMEM161A|0:OVCA2|0:ACER2|0:MICB|0:ASCL1|0:TRIM16|0:CDKN2D|0:RXRA|0:MLL5|0:WNT8A			
GO:0006596	P:polyamine biosynthetic process; TAS:ProtInc		0:ADC|0:AZIN1|0:ODC1|0:OAZ1			
GO:0016494	F:C-X-C chemokine receptor activity; NAS:UniProtKB		0:CXCR5|0:CXCR3|0:CCBP2|0:CXCR4			
GO:0031404	F:chloride ion binding; IDA:UniProtKB		0:ACE|0:NLGN4X|0:AMY2A			
GO:0051987	P:positive regulation of attachment of spindl...; IMP:BHF-UCL		0:CCNB1			
GO:0006464	P:protein modification process; TAS:ProtInc		0:TTLL4|0:RIMKLA|0:HACE1|0:HERC4|0:TTLL11|0:TTLL5|0:TTLL9|0:HERC5|0:HERC1|0:TTLL6|0:HERC6|0:TTL|0:TTLL13|0:HECW2|0:C12orf51|0:LIPT2|0:UBE3B|0:UBA1|0:HERC3|0:HECW1|0:TTLL7|0:TTLL2|0:RIMKLB|0:TTLL10|0:HECTD2|0:KIAA0317|0:TTLL12|0:WDYHV1|0:RABGGTB|0:PPT2|0:GNMT|0:CPE|0:USP29|0:RNF19A|0:MANBA|0:PLOD1|0:SEPHS1|0:SLC35A1|0:PPP4R2|0:CHRM3|0:PLOD2|0:PHKA2|0:NAGPA|0:PAM|0:MCRS1|0:QPCT|0:PLOD3|0:MMP15|0:CHRM1|0:PLAT|0:LOX|0:UBL4A|0:USP25|0:LOXL2|0:PHEX|0:MSRA|0:B4GALT7			
GO:0046370	P:fructose biosynthetic process; IDA:UniProtKB		0:SORD			
GO:0051047	P:positive regulation of secretion; ISS:UniProtKB		0:LACRT|0:SCIN			
GO:0004676	F:3-phosphoinositide-dependent protein kinase...; IDA:BHF-UCL		0:PDPK1			
GO:0005587	C:collagen type IV; TAS:UniProtKB		0:COL4A3|0:COL4A4|0:COL4A6|0:COL4A5|0:COL4A2			
GO:0001609	F:adenosine receptor activity, G-protein coupled; IEA:InterPro		0:ADORA3			
GO:0005674	C:transcription factor TFIIF complex; TAS:ProtInc		0:GTF2F2|0:GTF2F1			
GO:0042127	P:regulation of cell proliferation; TAS:UniProtKB		0:ERBB3|0:EID2|0:INHA|0:CDCA7|0:JAG2|0:TEK|0:TCFL5|0:SIRT1|0:CREB3|0:CCDC88A|0:GNL3|0:AGTR1|0:SCGB3A1|0:FOXM1|0:PPP1R9B|0:JAG1|0:ACE2|0:ENG|0:RBFOX2|0:ARHGEF2|0:CHRNA10|0:BRCA1|0:TPD52L2			
GO:0006283	P:transcription-coupled nucleotide-excision r...; IMP:UniProtKB		0:XAB2|0:ERCC3|0:ERCC2|0:ERCC5|0:ERCC8|0:ERCC6			
GO:0043303	P:mast cell degranulation; NAS:UniProtKB		0:LAT|0:LAT2|0:CPLX2|0:S100A13			
GO:0032042	P:mitochondrial DNA metabolic process; NAS:UniProtKB		0:LONP1			
GO:0033144	P:negative regulation of steroid hormone rece...; IDA:UniProtKB		0:CALR|0:NR0B1			
GO:0043125	F:ErbB-3 class receptor binding; TAS:ProtInc		0:NRG1|0:PIK3R1|0:CDK5|0:ERBB2			
GO:0042312	P:regulation of vasodilation; NAS:UniProtKB		0:ACE|0:ACE2|0:AGTR1|0:NPR1|0:NPPB			
GO:0033780	F:taurochenodeoxycholate 6alpha-hydroxylase a...; IEA:EC		0:CYP3A4			
GO:0042101	C:T cell receptor complex; NAS:UniProtKB		0:TRAT1|0:SYK|0:ZAP70|0:CD4|0:CD8B|0:CD8A			
GO:0010922	P:positive regulation of phosphatase activity; IDA:MGI		0:BMP2			
GO:0050688	P:regulation of defense response to virus; IEA:UniProtKB-KW		0:IL27			
GO:0008613	F:diuretic hormone activity; TAS:UniProtKB		0:NPPB			
GO:0010039	P:response to iron ion; IMP:BHF-UCL		0:BCL2|0:SLC11A2|0:FXN			
GO:0010628	P:positive regulation of gene expression; ISS:UniProtKB		0:PF4|0:CSF1|0:SFRP4|0:AVP|0:WNT6|0:WNT16|0:MAPK9|0:HOXD3|0:DNMT3B|0:DNMT1|0:FOXD1|0:AVPR2|0:OSR1			
GO:0004788	F:thiamin diphosphokinase activity; IEA:EC		0:TPK1			
GO:0015879	P:carnitine transport; IDA:BHF-UCL		0:PDZK1			
GO:0051622	P:negative regulation of norepinephrine uptake; IDA:UniProtKB		0:SNCA			
GO:0008380	P:RNA splicing; TAS:UniProtKB		0:FUS|0:POLR2J|0:HNRNPH1|0:EFTUD2|0:SMC1A|0:GTF2F2|0:CPSF3|0:POLR2D|0:GTF2F1|0:POLR2G|0:HNRNPR|0:HNRNPD|0:DNAJC8|0:PCBP2|0:CPSF7|0:PCF11|0:SRSF2|0:CCAR1|0:SF3B5|0:CDC40|0:PABPN1|0:MAGOH|0:UPF3B|0:CSTF3|0:PTBP1|0:HNRNPF|0:POLR2C|0:NHP2L1|0:POLR2F|0:SUGP1|0:CPSF1|0:POLR2B|0:HNRNPK|0:POLR2L|0:RBMX|0:RBM8A|0:RNPS1|0:POLR2E|0:NUDT21|0:POLR2I|0:CSTF2|0:HNRNPA3|0:HNRNPH2|0:SRSF11|0:SRSF3|0:YBX1|0:POLR2A|0:HNRNPU|0:CPSF2|0:DHX9|0:POLR2K|0:HNRNPL|0:CSTF1|0:PAPOLA|0:HNRNPA0|0:PCBP1|0:SRSF7|0:THOC4|0:HNRNPUL1|0:POLR2H|0:ZMAT5|0:PDCD7|0:DHX15|0:SNRNP35|0:ZRSR2|0:SNRNP48|0:ZCRB1|0:SNRNP25|0:RNPC3|0:TARDBP|0:RBMY1B|0:XAB2|0:PPIL1|0:THOC7|0:PLRG1|0:RBM4B|0:RBMY1A1|0:RBM16|0:SKIV2L2|0:CWC22|0:RBMY1E|0:PPP4R2|0:AQR|0:AKAP17A|0:SRSF8|0:LSM5|0:RBM22|0:PTBP2|0:CDC5L|0:TFIP11|0:RBM38|0:PRPF39|0:FRG1|0:TXNL4B|0:RBM28|0:THOC1|0:C19orf29|0:RBMY1J|0:STRAP|0:PRPF38B|0:SREK1IP1|0:WTAP|0:DDX41|0:DDX5|0:RBM10|0:MAGOHB|0:SYF2|0:DGCR14|0:MBNL2|0:THOC6|0:SREK1|0:PPIE|0:DHX35|0:PUF60|0:WBP11|0:RBMY1D|0:HNRPA1L3|0:RBFOX2|0:RBM39|0:PRPF40B|0:CLASRP|0:JMJD6|0:SNRNP27|0:PPWD1|0:QKI|0:EIF4A3|0:MBNL3|0:THOC5|0:TTF2|0:PPP1R8|0:PRPF40A|0:SUGP2|0:PABPC1|0:RBMY1C|0:PPIL3|0:RBM15B|0:RBM25|0:SRRM2|0:RBM4|0:LSM10|0:DDX46|0:THOC3|0:AFF2|0:U2AF1L4|0:ZCCHC8|0:SCNM1|0:RBM17|0:SRRM4|0:KIAA1429|0:ESRP1|0:SCAF1|0:RALY|0:RBMY1F|0:ISY1|0:PNN|0:LSM3|0:ESRP2|0:HNRNPA1L2|0:THOC2|0:CASC3|0:CIR1|0:PRPF38A|0:LUC7L3|0:PPP2R1A|0:RRAGC|0:PPP2CA|0:PPP1R9B|0:NONO|0:DHX16|0:PPIG|0:SRPK1|0:NOVA1|0:PPAN|0:SYNCRIP|0:PRPF18|0:ARL6IP4|0:IVNS1ABP|0:ZNF638|0:DHX8|0:LSM4|0:NOL3|0:PRPF4B|0:ZRANB2|0:RP9|0:PPARGC1A|0:SNRPN|0:LSM6			
GO:0045787	P:positive regulation of cell cycle; TAS:UniProtKB		0:RPS15A|0:TBX3|0:TCF3|0:CALR|0:RARA|0:TRIM21|0:CITED2|0:TGFB2|0:HCFC1			
GO:0070682	P:proteasome regulatory particle assembly; TAS:UniProtKB		0:PSMD10|0:PSMD9|0:PSMD5			
GO:0008143	F:poly(A) RNA binding; TAS:UniProtKB		0:EIF4A3|0:PABPC4|0:RBPMS|0:PABPC3|0:TIA1|0:HNRPDL|0:PABPC1			
GO:0003723	F:RNA binding; TAS:UniProtKB		0:ADARB1|0:APOBEC3F|0:NUFIP2|0:NUFIP1|0:HNRNPA2B1|0:NR0B1|0:BRCA1|0:BARD1|0:JAKMIP1|0:CRNKL1|0:LIN28B|0:CWC22|0:NCL|0:DZIP3|0:HNRNPD|0:SF3A1|0:PCBP2|0:HSP90B1|0:MKI67IP|0:NXF5|0:KHDRBS1|0:RBM45|0:RBFOX2|0:KIN|0:RPS16|0:APOBEC3G|0:WRAP53|0:ENDOU|0:PCBP1|0:RAD51AP1|0:RPUSD2|0:EIF1AY|0:PUS7|0:FUBP1|0:MRM1|0:NSUN6|0:RPUSD1|0:RPS15|0:RPUSD4|0:SUPT6H|0:PUS3|0:MRPS5|0:TRUB2|0:TRUB1|0:ZCCHC17|0:NOP2|0:LGTN|0:RPS2|0:SUGP1|0:LRRC47|0:RNASEH2A|0:CHERP|0:TRMT1|0:FUBP3|0:UBR5|0:SUGP2|0:ASCC1|0:DHX8|0:RSL1D1|0:FARSB|0:ZBP1|0:MCTS1|0:RNASET2|0:RNMTL1|0:MRPL1|0:RPUSD3|0:TTC14|0:RPL10A|0:PUS1|0:PUS7L|0:ERVK6|0:MRPL21|0:PUSL1|0:C1orf25|0:PDCD11|0:DIMT1L|0:LARP7|0:PDCD4|0:UPF3A|0:THOC7|0:SAFB2|0:ZC3H14|0:DDX50|0:WIBG|0:RBM4B|0:RBM16|0:RBMY1E|0:DDX21|0:UNC50|0:NONO|0:RPP25|0:SNRPB2|0:UPF2|0:PABPC1L2B|0:SAFB|0:MEX3B|0:SFPQ|0:AQR|0:PPP1R10|0:AKAP17A|0:SRSF8|0:RBM12|0:RBM11|0:RBM22|0:SNRPN|0:ISG20|0:KRR1|0:RBMS3|0:DDX60L|0:PTBP2|0:DIS3L|0:CDC5L|0:EIF3G|0:POLR2G|0:G3BP1|0:RBM15|0:DAZ3|0:SRSF6|0:DPPA5|0:RBM44|0:RBM38|0:ANKRD17|0:EXOSC3|0:EIF2C3|0:ERVK4|0:RBM34|0:U2AF2|0:PUM2|0:SPI1|0:ANKHD1|0:HTATSF1|0:DHX58|0:RBM28|0:MATR3|0:CSDE1|0:CPSF7|0:RRP9|0:UHMK1|0:DDX60|0:THOC1|0:DIS3|0:MAZ|0:DDX55|0:NIP7|0:LSM6|0:CPEB2|0:TRIM21|0:SRSF2|0:RAVER2|0:LSM1|0:RBM27|0:NANOS1|0:DDX41|0:KHDC1|0:DDX5|0:KIAA0020|0:NANOS3|0:MAGOHB|0:OAS1|0:RBM7|0:PHAX|0:ZC3H8|0:PAPOLG|0:PRPF8|0:CPEB4|0:RBMX2|0:RBM41|0:MAGOH|0:UPF3B|0:RDM1|0:MBNL2|0:RBM33|0:RPL12|0:SNRPA|0:RBM19|0:CSTF2T|0:EARS2|0:LARP1|0:SRBD1|0:ERVK2|0:SNRPA1|0:PABPC1L|0:XPO1|0:KHSRP|0:THOC6|0:DDX51|0:DDX58|0:CPSF4|0:MEX3C|0:PUF60|0:PPIL4|0:CNOT6|0:APOBEC3B|0:FBLL1|0:RBM26|0:ABT1|0:NUDT16|0:RBMY1D|0:C14orf21|0:HNRPA1L3|0:PRPF31|0:DDX10|0:PPRC1|0:IFIH1|0:RBM39|0:LARP4|0:TAF15|0:DDX47|0:CNOT4|0:DHX30|0:SNRPE|0:OAS3|0:SMN2|0:SRSF1|0:BICC1|0:EIF4E3|0:ALKBH8|0:EXOSC6|0:LARP4B|0:METTL3|0:RALYL|0:PNPT1|0:PABPC5|0:CPEB3|0:DDX18|0:QKI|0:TDRKH|0:MEX3D|0:RAVER1|0:THUMPD3|0:DDX3Y|0:OAS2|0:XRN1|0:SARNP|0:TIMM50|0:PSPC1|0:DDX56|0:TRMT2A|0:SLTM|0:CPSF4L|0:THOC5|0:EXOSC10|0:SRP68|0:SYNJ2|0:DDX52|0:EIF5A2|0:U2AF1|0:DAZ1|0:PABPC4L|0:DDX19A|0:MOV10|0:RBM42|0:DDX6|0:DCP2|0:C1D|0:LARP1B|0:TNRC6C|0:RBM18|0:ZFR|0:PNO1|0:SRSF5|0:PAPOLB|0:PUM1|0:DDX11|0:DDX53|0:TRA2B|0:TDRD10|0:RNPC3|0:TNRC6B|0:SETD1B|0:SNRNP35|0:PABPN1L|0:DDX59|0:DDX1|0:DNAJC17|0:SRRM2|0:RC3H1|0:RBMXL3|0:MTHFSD|0:MYEF2|0:GTF3A|0:ZRSR2|0:ZC3HAV1|0:EPRS|0:SPEN|0:RBM46|0:RBM12B|0:DDX46|0:EXOSC5|0:SKIV2L|0:ZMAT3|0:EIF2C1|0:THOC3|0:SFRS15|0:FIP1L1|0:U2AF1L4|0:SMN1|0:SART3|0:SNRPB|0:SF3B4|0:TUT1|0:RRP7A|0:NOL8|0:RBM17|0:PIWIL3|0:EIF1AX|0:SRSF11|0:LSM4|0:DDX49|0:CELF5|0:FAM120A|0:EIF2S1|0:RBMXL2|0:SCAF1|0:CPSF2|0:HDLBP|0:C14orf156|0:RBM24|0:RBM23|0:TRNAU1AP|0:ZFP36L2|0:PABPC1L2A|0:DHX34|0:EXOSC8|0:SRSF4|0:EIF5AL1|0:DDX12|0:DDX28|0:BOLL|0:SRSF9|0:SYNJ1|0:EIF4A2|0:KIAA0430|0:RBM43|0:DDX3X|0:ZCRB1|0:POLDIP3|0:DDX24|0:LSM3|0:EIF4E1B|0:SNRPG|0:ZNF74|0:SRRM1|0:SRSF7|0:DDX31|0:TNRC6A|0:THOC4|0:MEX3A|0:TRDMT1|0:CPSF6|0:TRA2A|0:EXOSC4|0:SETD1A|0:DDX25|0:EIF1AD|0:HNRNPA1L2|0:EIF3B|0:THOC2|0:SFSWAP|0:CASC3|0:WT1|0:DDX42|0:RBM20|0:LARP6|0:DIS3L2|0:NANOS2|0:EIF4G1|0:MTPAP|0:RBM47|0:DDX54|0:PA2G4|0:DAZ4|0:EIF2C4|0:SNRNP70|0:RNMT|0:SNRPF|0:ADAT1|0:CPSF3|0:BAZ2A|0:NOL6|0:EMG1|0:TEP1|0:MRPS7|0:SURF6|0:CWC15|0:HNRNPM|0:HNRNPC|0:ZRSR1|0:SRSF12|0:RPS15A|0:NXF2|0:RDBP|0:RBMY1J|0:ERAL1|0:RBM10|0:UPF1|0:NXF2B|0:PSMA6|0:LRPPRC|0:PCBP3|0:ATXN2|0:RBM14|0:RPS20|0:SRSF10|0:RPS7|0:CSDC2|0:RPS3A|0:RBMS1|0:NOVA2|0:EXOSC9|0:RBMX|0:PCBP4|0:RBM15B|0:PPARGC1B|0:CELF6|0:RBMY1H|0:YBX1|0:RBMY1F|0:EXOSC1|0:PAPOLA|0:G3BP2|0:RPS25|0:HNRNPH3|0:RBMY1B|0:FUS|0:RPL4|0:RBM6|0:POP4|0:RBMY1A1|0:RPL38|0:MRPL12|0:RCAN3|0:AKAP1|0:LSM5|0:EIF2S2|0:ROD1|0:PAIP1|0:HNRNPR|0:RPLP0|0:RPL34|0:RTCD1|0:RNASEH1|0:AGFG1|0:RPL22|0:RPL21|0:TIAL1|0:PABPN1|0:RPL18A|0:RPL3|0:DDX43|0:NOVA1|0:MRPL23|0:RAE1|0:DDX19B|0:CSTF3|0:RPL26|0:MRPL3|0:RPS19|0:FBL|0:RPLP1|0:NHP2L1|0:TARBP1|0:EIF4H|0:DAZ2|0:RPL29|0:SARS|0:HNRNPK|0:RPL31|0:RPL14|0:PSMA1|0:PPP1R8|0:DKC1|0:RPL6|0:RPL18|0:RPL13|0:RPL41|0:RBMY1C|0:ZNF638|0:APOBEC2|0:RBM3|0:RPL24|0:NOL4|0:CELF2|0:RNPS1|0:RBM4|0:ETF1|0:EIF4B|0:CSTF2|0:HNRNPA3|0:HNRNPH2|0:RPL7A|0:ZNF239|0:FAU|0:RPLP2|0:SRSF3|0:RPL15|0:RPL28|0:DDX17|0:HNRNPU|0:RALY|0:RBMS2|0:NOL3|0:ZRANB2|0:DUSP11|0:DAZL|0:RPL3L|0:HNRNPL|0:DAZAP1|0:CSTF1|0:RPP14|0:HNRNPA0|0:FXR2|0:SUPV3L1|0:SNRPD1|0:HNRNPUL1|0:TROVE2|0:RPL27A|0:EWSR1|0:EXOSC7|0:PPARGC1A|0:MOV10L1|0:SF1|0:PPIE|0:RPL19|0:RPL39|0:RPL30			
GO:0016576	P:histone dephosphorylation; IDA:UniProtKB		0:EYA1|0:EYA2|0:EYA3			
GO:0017172	F:cysteine dioxygenase activity; ISS:UniProtKB		0:CDO1			
GO:0051224	P:negative regulation of protein transport; IMP:UniProtKB		0:NDFIP2|0:WWP2|0:NDFIP1			
GO:0060710	P:chorio-allantoic fusion; ISS:UniProtKB		0:WNT7B			
GO:0060560	P:developmental growth involved in morphogenesis; ISS:UniProtKB		0:WNT7B			
GO:0060302	P:negative regulation of cytokine activity; IPI:BHF-UCL		0:NOG			
GO:0035162	P:embryonic hemopoiesis; TAS:UniProtKB		0:TGFBR2|0:MLL			
GO:0004494	F:methylmalonyl-CoA mutase activity; TAS:ProtInc		0:MUT			
GO:0009294	P:DNA mediated transformation; TAS:ProtInc		0:SMC3			
GO:0030031	P:cell projection assembly; IDA:UniProtKB		0:RAC3			
GO:0051835	P:positive regulation of synapse structural p...; IMP:UniProtKB		0:FRMPD4			
GO:0004535	F:poly(A)-specific ribonuclease activity; IEA:EC		0:PARN|0:PAN2			
GO:0006694	P:steroid biosynthetic process; TAS:ProtInc		0:HSD17B3|0:CYP19A1|0:CYP21A2|0:HSD11B1|0:STARD5|0:NR0B1|0:HSD3B2|0:SDR42E2|0:SDR42E1|0:HINT2|0:TECR|0:HSD17B12|0:PBX1|0:STARD3|0:ACBD3|0:HSD17B11|0:HSD17B2|0:HSD17B7|0:TRERF1|0:PRLR|0:SCP2|0:TFCP2L1|0:FDXR			
GO:0010874	P:regulation of cholesterol efflux; IMP:BHF-UCL		0:CETP			
GO:0015036	F:disulfide oxidoreductase activity; IDA:UniProtKB		0:TMX1|0:TXNL1			
GO:0006843	P:mitochondrial citrate transport; TAS:UniProtKB		0:SLC25A1			
GO:0008656	F:caspase activator activity; TAS:ProtInc		0:AIFM3|0:CARD8|0:SIVA1|0:TERF1|0:RPS27L|0:TPD52L1|0:MAP3K5|0:CASP8AP2|0:PYCARD|0:APAF1|0:TNFRSF10B|0:NLRP1|0:NLRP12|0:BCL2L13|0:TNFRSF10A|0:NOD1|0:CASP1			
GO:0019208	F:phosphatase regulator activity; NAS:UniProtKB		0:ZEB2			
GO:0009925	C:basal plasma membrane; ISS:UniProtKB		0:MUC20|0:MET|0:TF|0:MYO1C|0:AQP1|0:LDLRAP1|0:CLCA2|0:OSCP1|0:KCNQ4|0:SLCO1B3|0:SHROOM4			
GO:0050917	P:sensory perception of umami taste; IDA:UniProtKB		0:TAS1R3|0:TAS1R1			
GO:0019047	P:provirus integration; EXP:Reactome		0:BANF1|0:HMGA1|0:XRCC6|0:LIG4|0:PSIP1|0:XRCC5|0:XRCC4|0:PPIA			
GO:0033011	C:perinuclear theca; ISS:HGNC		0:WBP2NL			
GO:0047915	F:ganglioside galactosyltransferase activity; IEA:EC		0:B3GALT4			
GO:0030338	F:CMP-N-acetylneuraminate monooxygenase activity; NAS:UniProtKB		0:CMAH			
GO:0019976	F:interleukin-2 binding; ISS:UniProtKB		0:IL2RG			
GO:0005719	C:nuclear euchromatin; IDA:UniProtKB		0:CBX3			
GO:0044444	C:cytoplasmic part; IDA:UniProtKB		0:WDFY3|0:SLC22A18			
GO:0035024	P:negative regulation of Rho protein signal t...; ISS:UniProtKB		0:KCTD13|0:CUL3|0:TNFAIP1|0:DLC1|0:ADRA1A|0:SCAI|0:ARAP3			
GO:0031513	C:nonmotile primary cilium; ISS:BHF-UCL		0:BBS4|0:RAB8A|0:SSTR3|0:MCHR1			
GO:0004576	F:oligosaccharyl transferase activity; TAS:ProtInc		0:ALG5			
GO:0000103	P:sulfate assimilation; IEA:InterPro		0:PAPSS1|0:PAPSS2			
GO:0007098	P:centrosome cycle; TAS:ProtInc		0:NPM1|0:CETN3|0:TUBE1			
GO:0031090	C:organelle membrane; ISS:UniProtKB		0:FAAH			
GO:0018242	P:protein amino acid O-linked glycosylation v...; IDA:BHF-UCL		0:GALNT1|0:GALNT2|0:GALNT3			
GO:0004602	F:glutathione peroxidase activity; TAS:UniProtKB		0:GPX1|0:GPX3|0:GSTT1|0:GPX7|0:GPX6|0:GPX5|0:GPX8|0:GPX2|0:GSTZ1|0:GPX4			
GO:0003709	F:RNA polymerase III transcription factor act...; TAS:ProtInc		0:ZNF143|0:ZNF345|0:GTF3A|0:BRF1			
GO:0000900	F:translation repressor activity, nucleic aci...; NAS:UniProtKB		0:PAIP2B|0:CELF4|0:CELF1			
GO:0043569	P:negative regulation of insulin-like growth ...; IDA:BHF-UCL		0:CILP|0:IGFBP5			
GO:0004144	F:diacylglycerol O-acyltransferase activity; IEA:EC		0:DGAT1|0:DGAT2|0:MOGAT3			
GO:0015193	F:L-proline transmembrane transporter activity; IDA:UniProtKB		0:SLC1A4			
GO:0048144	P:fibroblast proliferation; IEP:UniProtKB		0:WNT7B			
GO:0072201	P:negative regulation of mesenchymal cell pro...; IMP:BHF-UCL		0:WNT5A|0:CTNNBIP1			
GO:0070358	P:actin polymerization-dependent cell motility; ISS:UniProtKB		0:JMY			
GO:0030433	P:ER-associated protein catabolic process; TAS:UniProtKB		0:DNAJB2|0:ERLIN2|0:JKAMP|0:DERL1|0:TRIM13|0:SYVN1|0:RNF103|0:SEC61B|0:ERLEC1|0:AMFR|0:ERLIN1|0:KIAA0368|0:TMEM67|0:OS9|0:DERL2|0:HSP90B1|0:FOXRED2|0:YOD1|0:NPLOC4|0:EDEM1|0:FBXO6|0:DERL3|0:HSPA5|0:VCP			
GO:0048039	F:ubiquinone binding; ISS:UniProtKB		0:ETFDH|0:SDHD|0:SDHB			
GO:0051736	F:ATP-dependent polyribonucleotide 5'-hydroxy...; IDA:UniProtKB		0:CLP1			
GO:0042171	F:lysophosphatidic acid acyltransferase activity; IDA:UniProtKB		0:ABHD5			
GO:0004450	F:isocitrate dehydrogenase (NADP+) activity; ISS:UniProtKB		0:IDH1|0:IDH2			
GO:0046686	P:response to cadmium ion; IDA:UniProtKB		0:HAAO|0:SLC34A1			
GO:0042428	P:serotonin metabolic process; ISS:UniProtKB		0:ATP7A			
GO:0004085	F:butyryl-CoA dehydrogenase activity; IEA:EC		0:ACADS			
GO:0042723	P:thiamin and derivative metabolic process; EXP:Reactome		0:SLC19A2|0:SLC19A3			
GO:0004970	F:ionotropic glutamate receptor activity; IEA:InterPro		0:GRID1|0:GRID2|0:GRIN1|0:GRIN3B			
GO:0043691	P:reverse cholesterol transport; TAS:BHF-UCL		0:CETP|0:LIPC|0:ABCA5|0:APOC3|0:APOC2|0:APOA4|0:APOE|0:APOA2|0:LCAT|0:SCARB1|0:LIPG|0:APOA1|0:ABCA1|0:ABCG1|0:APOM|0:CLU			
GO:0008118	F:N-acetyllactosaminide alpha-2,3-sialyltrans...; TAS:ProtInc		0:ST3GAL3			
GO:0045132	P:meiotic chromosome segregation; IEA:InterPro		0:SGOL1			
GO:0030241	P:skeletal muscle myosin thick filament assembly; ISS:UniProtKB		0:TTN|0:TCAP|0:MYH11			
GO:0005827	C:polar microtubule; IDA:UniProtKB		0:CUL3|0:TUBG1|0:TUBGCP3|0:KLHL21			
GO:0007252	P:I-kappaB phosphorylation; TAS:ProtInc		0:TLR3|0:TLR4|0:TLR9|0:TLR7|0:TLR2|0:MAP3K7|0:ERC1|0:CHUK|0:PRDX4			
GO:0034614	P:cellular response to reactive oxygen species; ISS:UniProtKB		0:FOS|0:CRYGD|0:PTPRK|0:PXN|0:TPM1|0:PRDX5|0:ROMO1|0:MPV17			
GO:0070904	P:transepithelial L-ascorbic acid transport; IDA:UniProtKB		0:SLC23A1|0:SLC23A2			
GO:0048639	P:positive regulation of developmental growth; IMP:BHF-UCL		0:INSR			
GO:0030295	F:protein kinase activator activity; TAS:UniProtKB		0:MAPK8IP2|0:FGF13|0:PRKAG2|0:WNT11|0:MADD			
GO:0047840	F:dCTP diphosphatase activity; IEA:EC		0:DCTPP1			
GO:0006664	P:glycolipid metabolic process; TAS:ProtInc		0:ST3GAL6|0:ST6GALNAC4			
GO:0032212	P:positive regulation of telomere maintenance...; IMP:BHF-UCL		0:TNKS2|0:TNKS|0:POT1			
GO:0006511	P:ubiquitin-dependent protein catabolic process; TAS:UniProtKB		0:UHRF2|0:DTL|0:TRPC4AP|0:FBXO4|0:TTC3|0:UBD|0:SIAH3|0:USP42|0:CUL4B|0:USP9Y|0:USP38|0:USP17L7|0:USP15|0:USP50|0:USP54|0:USP31|0:USP7|0:USP4|0:USP46|0:TCEB1|0:USP17L3|0:C10orf46|0:USP34|0:CYLD|0:USP41|0:CUL7|0:USP30|0:USP20|0:USP16|0:USP45|0:USP53|0:USP37|0:USP6|0:USP17L2|0:USP11|0:SIAH1L|0:USP28|0:USP49|0:USP24|0:USP3|0:USP17L1P|0:PAN2|0:USP21|0:USP17|0:USP17L5|0:UCHL5|0:PSMA8|0:USP44|0:USP40|0:USP36|0:USP12|0:USP27X|0:USP9X|0:USP25|0:USP2|0:USP48|0:USP17L8|0:CUL4A|0:USP14|0:USP32|0:USP43|0:USP51|0:USP39|0:USP8|0:USP29|0:USP10|0:USP17L4|0:CUL5|0:USP22|0:USP1|0:USP47|0:USP35|0:USP18|0:USP5|0:UCHL1|0:USPL1|0:USP13|0:USP26|0:BAP1|0:CUL9|0:CUL2|0:NUB1|0:RNF20|0:UBA6|0:UBR3|0:RNF40|0:RLIM|0:RNF6|0:UCHL3|0:FBXL7|0:FBXO8|0:UBE2A|0:FBXO11|0:FBXO21|0:FBXW4|0:UBE2H|0:FBXL4|0:UFD1L|0:UBE2K|0:UBE2D2|0:SIAH2|0:UBE2I|0:SQSTM1|0:BTRC|0:NEDD8|0:FBXO7|0:FBXO22|0:UBR5|0:UBE3A|0:UBE4A|0:UBE2G1|0:ARIH1|0:UBE2L3|0:USP33			
GO:0006636	P:unsaturated fatty acid biosynthetic process; TAS:ProtInc		0:FADS3|0:DEGS1|0:FADS2			
GO:0051348	P:negative regulation of transferase activity; IMP:BHF-UCL		0:GSK3A			
GO:0051384	P:response to glucocorticoid stimulus; ISS:HGNC		0:TNF|0:IL1RN|0:GHRHR|0:IL10|0:IL6|0:CALCR|0:GOT1|0:ADAM9|0:PDCD7			
GO:0032374	P:regulation of cholesterol transport; TAS:HGNC		0:TSPO			
GO:0002792	P:negative regulation of peptide secretion; IDA:BHF-UCL		0:CD74			
GO:0051186	P:cofactor metabolic process; IMP:UniProtKB		0:PPT1			
GO:0042832	P:defense response to protozoan; NAS:UniProtKB		0:SLC11A1|0:LYST|0:CLEC7A			
GO:0032268	P:regulation of cellular protein metabolic pr...; IDA:MGI		0:SSH1			
GO:0008484	F:sulfuric ester hydrolase activity; IEA:InterPro		0:SGSH			
GO:0008454	F:alpha-1,3-mannosylglycoprotein 4-beta-N-ace...; TAS:ProtInc		0:MGAT4C|0:MGAT4B|0:MGAT4A			
GO:0021871	P:forebrain regionalization; IEP:UniProtKB		0:WNT2B|0:WNT7B			
GO:0007254	P:JNK cascade; TAS:ProtInc		0:MAP3K13|0:TRIB1|0:FGF14|0:FGF12|0:MAP3K12|0:ARHGEF6|0:TNFRSF19|0:MINK1|0:CRKL|0:DUSP9|0:MAP3K4|0:SH2D3A|0:MAP2K4|0:DUSP10|0:ADORA2B|0:MAP4K2|0:GPS1|0:MAP4K3|0:SH2D3C|0:GPS2			
GO:0060914	P:heart formation; TAS:BHF-UCL		0:SOX17			
GO:0032232	P:negative regulation of actin filament bundl...; IDA:BHF-UCL		0:PARK2			
GO:0004956	F:prostaglandin D receptor activity; NAS:UniProtKB		0:PTGDR			
GO:0016051	P:carbohydrate biosynthetic process; ISS:UniProtKB		0:CHST14|0:UST|0:CHST8|0:HS6ST2|0:CHST9|0:GFPT2|0:HS6ST1|0:HS6ST3|0:CHST10|0:GFPT1|0:B3GAT2			
GO:0034374	P:low-density lipoprotein particle remodeling; TAS:BHF-UCL		0:CETP|0:MPO|0:APOA2|0:LIPC|0:APOB|0:ABCG1|0:AGTR1|0:AGT|0:PLA2G2A			
GO:0006725	P:cellular aromatic compound metabolic process; IEA:InterPro		0:CLYBL			
GO:0005838	C:proteasome regulatory particle; TAS:ProtInc		0:PSMD9|0:PSMD10|0:PSMD13|0:PSMD7|0:PSMD12|0:PSMD1|0:PSMD8|0:PSMD2			
GO:0034048	P:negative regulation of protein phosphatase ...; IDA:UniProtKB		0:TIPRL			
GO:0006687	P:glycosphingolipid metabolic process; TAS:ProtInc		0:PSAP			
GO:0045779	P:negative regulation of bone resorption; ISS:BHF-UCL		0:CALCA|0:CARTPT|0:P2RX7			
GO:0008320	F:protein transmembrane transporter activity; TAS:BHF-UCL		0:AZGP1|0:TOMM22|0:TOMM70A|0:TOMM40			
GO:0022904	P:respiratory electron transport chain; ISS:UniProtKB		0:SDHA|0:ALDH5A1			
GO:0051017	P:actin filament bundle assembly; TAS:UniProtKB		0:ADD2|0:ADD1|0:AIF1|0:EZR|0:LIMA1|0:SHROOM1|0:NEDD9|0:FSCN1|0:FSCN2|0:EPB49			
GO:0006613	P:cotranslational protein targeting to membrane; TAS:ProtInc		0:SSR3|0:TRAM1|0:SEC62|0:SSR1|0:SSR2			
GO:0016004	F:phospholipase activator activity; IDA:BHF-UCL		0:ARHGAP6|0:APOC2			
GO:0002827	P:positive regulation of T-helper 1 type immu...; ISS:BHF-UCL		0:SLC11A1			
GO:0006564	P:L-serine biosynthetic process; NAS:UniProtKB		0:PHGDH|0:PSPH|0:PSAT1			
GO:0004447	F:iodide peroxidase activity; IEA:EC		0:TPO			
GO:0061056	P:sclerotome development; ISS:BHF-UCL		0:SHH|0:SFRP2			
GO:0006998	P:nuclear envelope organization; IGI:MGI		0:DULLARD|0:SUN2			
GO:0090191	P:negative regulation of branching involved i...; IDA:UniProtKB		0:BMP4			
GO:0031087	P:deadenylation-independent decapping of nucl...; TAS:UniProtKB		0:PNRC2			
GO:0016180	P:snRNA processing; IDA:HGNC		0:INTS7|0:INTS12|0:INTS4|0:INTS2|0:INTS6|0:INTS3|0:INTS1|0:INTS5|0:INTS10|0:INTS9|0:INTS8			
GO:0044425	C:membrane part; IDA:UniProtKB		0:LRSAM1			
GO:0030670	C:phagocytic vesicle membrane; IEA:UniProtKB-SubCell		0:SLC11A1|0:ANXA3|0:DMBT1|0:VAMP7|0:CORO1A|0:TLR6|0:IRGM|0:RAB11FIP1|0:TLR1|0:RILP			
GO:0042326	P:negative regulation of phosphorylation; TAS:UniProtKB		0:BMP7|0:DYNLL1|0:BMP4|0:INHA|0:INHBA			
GO:0007185	P:transmembrane receptor protein tyrosine pho...; TAS:UniProtKB		0:PTPRU|0:PTPRD|0:PTN|0:TRIO|0:PTPRF|0:FRS2			
GO:0046934	F:phosphatidylinositol-4,5-bisphosphate 3-kin...; IEA:EC		0:TRAT1|0:PIK3CG|0:PIK3CA|0:PIK3CD|0:PIK3CB			
GO:0002029	P:desensitization of G-protein coupled recept...; ISS:BHF-UCL		0:ADRBK1			
GO:0008629	P:induction of apoptosis by intracellular sig...; TAS:ProtInc		0:BAX|0:LGALS12|0:SART1|0:CD24|0:CUL3|0:CDKN1A|0:CUL4A|0:CUL1|0:CUL5|0:CUL2			
GO:0015701	P:bicarbonate transport; NAS:UniProtKB		0:SLC4A10			
GO:0070260	F:5'-tyrosyl-DNA phosphodiesterase activity; IDA:UniProtKB		0:TDP2			
GO:0006003	P:fructose 2,6-bisphosphate metabolic process; NAS:UniProtKB		0:PFKFB1|0:PFKFB2|0:PFKFB4|0:PFKFB3			
GO:0042765	C:GPI-anchor transamidase complex; TAS:UniProtKB		0:PIGK|0:PIGU|0:PIGT|0:GPAA1|0:PIGS			
GO:0046654	P:tetrahydrofolate biosynthetic process; IEA:InterPro		0:GCH1			
GO:0061028	P:establishment of endothelial barrier; IMP:UniProtKB		0:SOX18			
GO:0042923	F:neuropeptide binding; IPI:UniProtKB		0:MC3R|0:MRGPRX2|0:MC4R			
GO:0005689	C:U12-type spliceosomal complex; IDA:UniProtKB		0:ZMAT5|0:PDCD7|0:DHX15|0:SNRNP35|0:ZRSR2|0:SNRNP48|0:ZCRB1|0:SNRNP25|0:RNPC3			
GO:0034371	P:chylomicron remodeling; IC:BHF-UCL		0:APOA4|0:LPL|0:APOC2			
GO:0004519	F:endonuclease activity; TAS:ProtInc		0:N4BP2|0:ZRANB3|0:APEX2|0:MUTYH|0:ELAC2|0:HRSP12|0:PELO|0:G3BP1|0:ENDOG|0:ERCC1|0:EME2|0:ZC3H12C|0:ZC3H12B|0:ENDOD1|0:DNASE1L2|0:SETMAR|0:DNASE1L1|0:PPP1R8|0:ZC3H12A|0:PMS2|0:GEN1|0:SMG6|0:EME1|0:ZC3H12D|0:RPS3|0:RAG1|0:PNKP|0:RAG2|0:EXOG|0:NTHL1|0:OGG1			
GO:0000059	P:protein import into nucleus, docking; TAS:UniProtKB		0:NUP98|0:NUP205			
GO:0005657	C:replication fork; IDA:UniProtKB		0:UBE2B|0:RAD18			
GO:0030729	F:acetoacetate-CoA ligase activity; IEA:EC		0:AACS			
GO:0051897	P:positive regulation of protein kinase B sig...; ISS:BHF-UCL		0:F10|0:F7|0:INS|0:TGFBR1|0:TGFB1|0:IGF2|0:TEK|0:VEGFB|0:THBS1|0:IL26|0:ANGPT1|0:EGFR|0:HBEGF|0:F3|0:INSR|0:TCF7L2|0:MC1R			
GO:0010916	P:negative regulation of very-low-density lip...; IDA:BHF-UCL		0:APOC1|0:APOC3|0:APOC2|0:LRPAP1			
GO:0008637	P:apoptotic mitochondrial changes; NAS:UniProtKB		0:CDKN2A|0:ATP2A1|0:AIFM2			
GO:0033031	P:positive regulation of neutrophil apoptosis; IDA:UniProtKB		0:GPR109A			
GO:0032741	P:positive regulation of interleukin-18 produ...; ISS:BHF-UCL		0:TLR9|0:TLR2			
GO:0003858	F:3-hydroxybutyrate dehydrogenase activity; IDA:UniProtKB		0:BDH2|0:BDH1			
GO:0043546	F:molybdopterin cofactor binding; IDA:UniProtKB		0:XDH			
GO:0019887	F:protein kinase regulator activity; NAS:UniProtKB		0:APC|0:FAF1|0:CSNK2B			
GO:0031228	C:intrinsic to Golgi membrane; NAS:UniProtKB		0:CHST2|0:CHST5|0:CHST4			
GO:0032205	P:negative regulation of telomere maintenance; IMP:UniProtKB		0:TERF2IP|0:ERCC1|0:ERCC4			
GO:0042508	P:tyrosine phosphorylation of Stat1 protein; IDA:UniProtKB		0:IFNG			
GO:0046525	F:xylosylprotein 4-beta-galactosyltransferase...; IDA:UniProtKB		0:B4GALT7			
GO:0032728	P:positive regulation of interferon-beta prod...; ISS:BHF-UCL		0:POLR3D|0:DDX58|0:MAVS|0:POLR3C|0:POLR3G|0:POLR3B|0:POLR3A|0:POLR3F|0:RNF135|0:TLR3|0:TLR4|0:TLR9|0:TLR2			
GO:0042755	P:eating behavior; ISS:UniProtKB		0:CCK|0:STAT3			
GO:0042572	P:retinol metabolic process; TAS:UniProtKB		0:SDR16C5|0:RDH12|0:ADH4|0:RDH10|0:RBP4|0:RETSAT|0:RDH11|0:DHRS9|0:DHRS3			
GO:0042997	P:negative regulation of Golgi to plasma memb...; ISS:UniProtKB		0:PKDCC			
GO:0042581	C:specific granule; IDA:UniProtKB		0:STXBP3|0:ANXA3|0:ANXA11|0:STX3|0:SNAP23|0:STX4|0:CRISP3|0:STXBP2			
GO:0006108	P:malate metabolic process; IEA:InterPro		0:ME3|0:MDH2|0:ME1|0:ME2|0:MDH1B			
GO:0008792	F:arginine decarboxylase activity; EXP:Reactome		0:ADC			
GO:0051128	P:regulation of cellular component organization; ISS:UniProtKB		0:STK38L			
GO:0090286	P:cytoskeletal anchoring at nuclear membrane; IDA:UniProtKB		0:SUN2|0:SUN1|0:SYNE1|0:SYNE2|0:C14orf49			
GO:0008170	F:N-methyltransferase activity; TAS:ProtInc		0:HEMK1|0:PRMT1			
GO:0015180	F:L-alanine transmembrane transporter activity; IDA:UniProtKB		0:SLC38A3|0:SLC1A4			
GO:0042622	C:photoreceptor outer segment membrane; ISS:UniProtKB		0:RHO|0:GNAT2|0:GNAT1			
GO:0019867	C:outer membrane; TAS:UniProtKB		0:SLC24A1|0:ANKH			
GO:0048853	P:forebrain morphogenesis; NAS:UniProtKB		0:NF1|0:SLIT1			
GO:0045980	P:negative regulation of nucleotide metabolic...; IEA:InterPro		0:CDA|0:ATPIF1			
GO:0005737	C:cytoplasm; TAS:UniProtKB		0:ELP2|0:PAIP2B|0:TSTA3|0:XPO6|0:ACOT11|0:ARAP3|0:GMDS|0:TOLLIP|0:HAND1|0:WNT1|0:IGF2BP2|0:ADM|0:CDK6|0:WNT16|0:FZD3|0:SOX4|0:CDKN2D|0:STUB1|0:P2RX6|0:NR5A2|0:HNF4A|0:JAK1|0:YWHAQ|0:PROX1|0:CSNK2B|0:ZWINT|0:FZD10|0:PPIH|0:LIMK1|0:HDAC5|0:SP100|0:EDN1|0:CDKN2B|0:FZD2|0:CDKN1C|0:HHEX|0:SFRP4|0:SMURF1|0:HIF1A|0:IGF2BP3|0:ADRA2A|0:TYK2|0:CDKN2C|0:TLR2|0:IRAK3|0:TRIB1|0:ACAT2|0:GPR98|0:FAM84B|0:RTP3|0:SMG7|0:HNRNPA1|0:UTP11L|0:NAA50|0:SNX2|0:CDC7|0:RTP4|0:ACVR2B|0:C19orf24|0:HEXIM1|0:SH3GLB2|0:CRYAA|0:USH1C|0:FBXO11|0:SNX6|0:EIF4A3|0:HSD17B11|0:DFNB31|0:SMG5|0:RRAGD|0:PEG10|0:BDH2|0:ACVR2A|0:SPINT2|0:CARD8|0:USH2A|0:METAP2|0:NR1H2|0:OTUD7B|0:SMG6|0:RCHY1|0:SNX4|0:AFAP1L2|0:NLRP2|0:ZHX3|0:NUDT1|0:ZNF350|0:ZNF146|0:FMNL1|0:AK1|0:UCKL1|0:HNRNPH1|0:MFGE8|0:PRMT5|0:CAPNS1|0:NDRG1|0:EIF1AY|0:AGBL2|0:TMOD3|0:C1QC|0:MSN|0:NKRF|0:SMC1A|0:HUWE1|0:LEF1|0:YY1AP1|0:ZNF516|0:ZMYM3|0:GLIS1|0:IQGAP1|0:DSN1|0:TRIM25|0:ZNF133|0:ZMAT5|0:KDM5A|0:IFI16|0:CSTA|0:CCDC6|0:ZNF157|0:OLIG3|0:STAT1|0:ZNF44|0:PI4K2B|0:IL1RN|0:GTF2A1|0:ELF3|0:PARP14|0:TAF4|0:PSMC1|0:CKAP2|0:ZNF323|0:ETV6|0:ZNF192|0:LY6K|0:NFIA|0:ATF7|0:PABPN1|0:TBX3|0:POLH|0:PTTG3P|0:CSTB|0:BRAF|0:ZNF22|0:MNAT1|0:L3MBTL2|0:ZNF540|0:SOX30|0:PASD1|0:DRG1|0:FOXP4|0:NME2|0:HNRNPF|0:SDC1|0:SMC1B|0:MLF2|0:MBIP|0:AMOTL1|0:CBX5|0:PPP2R5E|0:VRK1|0:NPTXR|0:SRY|0:TAF5|0:MEIS2|0:DNMT3B|0:POGZ|0:SSRP1|0:KCTD10|0:LASS3|0:NLGN3|0:HNRPA1L3|0:FLT1|0:CRABP2|0:MCM7|0:CAMK4|0:RBFOX2|0:RPA3|0:UBE2Z|0:YARS|0:WDR13|0:MEF2D|0:WASL|0:SENP1|0:CNOT4|0:GPR173|0:GON4L|0:PQBP1|0:REST|0:ZYX|0:PHKA1|0:ELF2|0:HJURP|0:TJP2|0:SOX11|0:DACT1|0:PNCK|0:EP300|0:PARN|0:MAX|0:DMC1|0:SLK|0:TAF12|0:CAPN1|0:KLKB1|0:SCHIP1|0:ELF1|0:ARID1B|0:KLHDC1|0:PADI4|0:AFAP1|0:DDX3Y|0:SSB|0:SP140|0:ARHGAP24|0:C11orf41|0:NKX2-2|0:IRF9|0:ZNF251|0:LPP|0:TTF2|0:ASB8|0:RBBP9|0:CC2D1A|0:POLA1|0:WDR4|0:TCEB3|0:SFN|0:SDCCAG1|0:KHDRBS2|0:IRF4|0:ZNF174|0:NQO1|0:ZNF773|0:LRRC7|0:WWTR1|0:SIX1|0:HLX|0:POLR3K|0:RTF1|0:UBQLN2|0:SVEP1|0:PSMD8|0:ATG7|0:NKAP|0:GP2|0:HNRNPA2B1|0:MACC1|0:ZNF415|0:CSNK1G1|0:MAFB|0:CCDC50|0:LMLN|0:RCOR3|0:MSX2|0:BLM|0:ASPA|0:TJP1|0:ATF7IP|0:TAF6|0:ZNF597|0:ZBTB33|0:STK4|0:NPSR1|0:RAD17|0:ARHGEF1|0:HNRNPA3|0:HNRNPH2|0:UBAC1|0:RRP7A|0:MED27|0:BRD4|0:ZNF419|0:ZFHX2|0:CTCFL|0:KDM4A|0:KIAA0513|0:APBB3|0:KBTBD10|0:MTA1|0:CDC37|0:CNOT3|0:BAIAP2|0:HDLBP|0:ZSCAN30|0:ZNF670|0:BAG1|0:GRHL2|0:PITPNA|0:NEUROD1|0:STAT6|0:MLLT3|0:MVP|0:ISY1|0:ZNF155|0:TOP2A|0:PLAGL2|0:MLLT10|0:CAMKK2|0:S100A7A|0:S100A9|0:DAZAP1|0:RING1|0:KRT17|0:DDX24|0:ACTRT2|0:PHF2|0:FER|0:MPP5|0:MINA|0:PTTG2|0:SIRT1|0:LTA4H|0:SWAP70|0:TWF1|0:ZIC1|0:KIF2C|0:CIR1|0:TMPRSS2|0:PBX3|0:GMEB2|0:GIT1|0:MED4|0:MAPKAPK5|0:RPA1|0:KHDRBS3|0:HSF1|0:PSMC3|0:SALL3|0:UAP1|0:PNMA6B|0:ZCCHC2|0:GDI1|0:C3orf20|0:KHK|0:KIAA1524|0:PRICKLE2|0:CTAG1A|0:COBRA1|0:SSBP2|0:IFT46|0:TUFT1|0:UBAP1|0:COMMD4|0:MTMR6|0:NRBF2|0:GPRASP2|0:MOAP1|0:SESN2|0:RCBTB1|0:C12orf68|0:TKTL2|0:CCDC135|0:DGCR8|0:C11orf20|0:NRIP2|0:AGBL5|0:RNF123|0:TTC25|0:PLEKHH2|0:UBA6|0:LRRC48|0:ZMYND10|0:SGTA|0:UTP15|0:GRHPR|0:KLHL25|0:UBA5|0:OLA1|0:CTAG1B|0:TXLNB|0:PHLPP2|0:TXLNA|0:AAGAB|0:SNCAIP|0:FARP2|0:NOD1|0:BTG3|0:LSM1|0:CD247|0:TGS1|0:NEK1|0:PABPC4|0:IBTK|0:FCRLA|0:IMPA2|0:TEP1|0:RPAIN|0:TP63|0:CYTH1|0:AIPL1|0:POLB|0:PRSS36|0:INPP5J|0:SERTAD2|0:PLCH1|0:PLCD1|0:HYLS1|0:TULP4|0:BOLL|0:VASH2|0:BAALC|0:CCR2|0:ZRANB1|0:BRIP1|0:TP53BP1|0:PDCL3|0:SALL1|0:DDB1|0:IPO9|0:CRYGC|0:RNF4|0:HDAC7|0:ERBB2IP|0:PAWR|0:TBPL2|0:TDP1|0:KLHDC3|0:ROPN1B|0:AGL|0:MBTPS2|0:PSMD10|0:LRSAM1|0:BRE|0:ADCY2|0:SLIT2|0:XPO7|0:TRIM5|0:STRADA|0:EYA1|0:TGM3|0:ELP3|0:SERGEF|0:SKAP1|0:MOBKL1A|0:HTR2B|0:DUSP21|0:NGLY1|0:DZIP3|0:DEAF1|0:RNF130|0:SETX|0:WNK1|0:MTMR3|0:SDCBP2|0:BIRC5|0:TRIM2|0:ADI1|0:WDR6|0:SIRT2|0:DNMT3A|0:SPATA2|0:RCC1|0:TRIM34|0:AQP3|0:WNT11|0:KIAA1543|0:TWIST2|0:ZCCHC11|0:ATXN1|0:PCBP2|0:KCNIP2|0:AMOT|0:ZFP42|0:FAM129A|0:PAIP2|0:GEMIN8|0:SPRR2D|0:DTX3L|0:IRF6|0:IP6K3|0:RALGAPA2|0:THOC1|0:PLEKHA1|0:GAB2|0:PIN4|0:EFCAB4B|0:RARA|0:CARM1|0:PML|0:NLRC5|0:CACNA1A|0:SSH1|0:TNFAIP8|0:TNNI3K|0:TRIP4|0:MAD2L1BP|0:MKI67IP|0:CTNNA2|0:TUBB1|0:RPS6KB1|0:SRPK1|0:NEIL1|0:PODN|0:RHOH|0:HCFC1|0:DUSP18|0:ADCY3|0:MYCBPAP|0:ATP2B2|0:TRIM63|0:RRAGC|0:HMBOX1|0:PODXL|0:IKBKAP|0:TRIM6|0:MEOX2|0:C14orf104|0:RNF10|0:CIAPIN1|0:HDAC10|0:NXF5|0:ZNF675|0:PNP|0:TNIK|0:SOX7|0:PTPRE|0:SH2D1A|0:TBX5|0:DPH3|0:MYO1C|0:DYRK2|0:ARIH2|0:RHEBL1|0:TRIM27|0:CDC42EP2|0:CELF3|0:MAP4K5|0:DDIT4|0:SUFU|0:STK38|0:AR|0:RNF14|0:SMC3|0:BAMBI|0:PBX1|0:NEK6|0:HAGH|0:UBE2L3|0:SMG1|0:RBM45|0:WNT2|0:KRT20|0:SBDS|0:PSMC5|0:CUTC|0:PARP9|0:TRIM22|0:BASP1|0:SNTG1|0:AICDA|0:CALCA|0:BZW1|0:S100A11|0:NSUN2|0:STK11IP|0:PHF17|0:BRAP|0:C20orf185|0:CLIC3|0:TRIM13|0:SYMPK|0:CRBN|0:UBXN1|0:ATE1|0:PXK|0:OVCA2|0:DLEC1|0:PEF1|0:WDR26|0:TRIM16|0:RNF167|0:TNK1|0:PAX6|0:DZIP1|0:HCFC2|0:IMPA1|0:ADCY4|0:MICAL1|0:NLRP12|0:PITPNC1|0:SAV1|0:NLRC3|0:STRADB|0:TMEM127|0:APBB1|0:AQP4|0:DNAJC7|0:ROBO1|0:DAPK2|0:UBE2B|0:HNF1A|0:SMC2|0:DUSP6|0:HTATIP2|0:AQP1|0:KIF13B|0:CDC123|0:PTPN13|0:PPP4R4|0:BIRC3|0:SH2B2|0:ZNF395|0:CARD14|0:XPOT|0:TRIM14|0:NAA15|0:CASP8AP2|0:CCS|0:KLHL1|0:FNIP2|0:SRPX2|0:ELAVL1|0:PRKCH|0:ZBTB25|0:NR0B1|0:PIM1|0:USP9X|0:SLBP|0:MPHOSPH8|0:ADSSL1|0:C19orf62|0:MAGEC2|0:TRIM7|0:SRPK2|0:TCF3|0:UBIAD1|0:YAP1|0:KLK8|0:UFM1|0:LIMD1|0:SPG20|0:ZNF655|0:RNF182|0:CARD9|0:ASCL2|0:PARP4|0:STRN3|0:MAPK8IP2|0:TRIM4|0:UBL5|0:CDC42EP5|0:MCC|0:ZBED4|0:PLEKHA2|0:TFEB|0:SKIL|0:FBXO6|0:ELP4|0:MACF1|0:MDFIC|0:CCM2|0:SRR|0:GSDMC|0:NAA10|0:EDF1|0:SRCIN1|0:COLEC10|0:DBC1|0:SPRR2A|0:TXNDC2|0:DDX3X|0:ENDOU|0:GINS1|0:UTRN|0:LLGL2|0:NFKB2|0:UMPS|0:BRSK1|0:BARD1|0:DND1|0:CLIC1|0:PTTG1IP|0:PPP2R4|0:STK36|0:PYGB|0:KRT7|0:ALDH1A3|0:STK11|0:IVL|0:RNF135|0:ERI1|0:SERPINB5|0:ESX1|0:HDAC9|0:PPP1CC|0:STK38L|0:DDX42|0:COPS2|0:XRRA1|0:MYO5A|0:TXNL1|0:SCEL|0:MLX|0:ADAP1|0:NXF3|0:BAP1|0:PA2G4|0:NMI|0:SPRR2E|0:NDRG3|0:RNF6|0:AQP7|0:LDHAL6B|0:DBNDD1|0:TPR|0:DDAH1|0:C12orf72|0:SNX30|0:KPNA7|0:RDH8|0:PRMT8|0:EEF1A2|0:PDCD2L|0:PRMT6|0:GALK2|0:UPP1|0:ZNFX1|0:FARP1|0:GSTCD|0:TMCO6|0:CNKSR3|0:DDAH2|0:GART|0:SYK|0:PRMT10|0:FRMD3|0:GSTO2|0:EIF4E3|0:EIF4E2|0:GLTPD2|0:SH3BP1|0:FDXACB1|0:TECRL|0:C1orf156|0:ASMTL|0:FUK|0:ARHGEF37|0:CDK5RAP1|0:GFPT2|0:PLEKHA9|0:DERA|0:DBNDD2|0:PRTFDC1|0:PRMT2|0:BHMT2|0:DALRD3|0:KPNA6|0:AHSA2|0:FRMD5|0:EIF4E1B|0:GFPT1|0:PDCD2|0:GLTPD1|0:SPAG6|0:ARHGAP26|0:LRRC26|0:SORBS3|0:TERF1|0:ACTBL2|0:MAP7D1|0:GPHN|0:EPB41L4A|0:TMSL3|0:RAPH1|0:ACTL9|0:ACTRT1|0:DNAH1|0:SIPA1L1|0:DNAH2|0:SKA3|0:EPPK1|0:MYO15A|0:PTPN21|0:DIAPH1|0:SHROOM3|0:MAP2|0:CDC42SE2|0:ANK3|0:KITLG|0:TTLL8|0:ADD2|0:KIAA1949|0:PALLD|0:DNAH12|0:TTC21B|0:DCLK2|0:ARPC1A|0:ARPC4|0:SMTN|0:SNTB1|0:MAST2|0:TMOD4|0:CORO1B|0:KIAA0284|0:TMSB15A|0:SGCA|0:ACTG2|0:CENPV|0:PFN1|0:MICALL2|0:TMSB4X|0:EPB41L4B|0:ACTR8|0:DNAH17|0:GAS2L1|0:RSPH4A|0:CDC42EP3|0:KIF23|0:PARVG|0:TRIOBP|0:ACTR2|0:CDC42SE1|0:TNS1|0:WASF3|0:AIF1|0:ACTL8|0:TNS4|0:C18orf10|0:KLHL3|0:TMSB4XP1|0:TRAF3IP1|0:DRP2|0:PFN4|0:FHOD3|0:CENPE|0:ACTL7A|0:ARPC1B|0:MPRIP|0:EVPL|0:SSH2|0:BIN3|0:SGCB|0:ACTR6|0:AVIL|0:SGCG|0:PTPN3|0:FRMD4B|0:TMSB10|0:SHROOM1|0:EPB42|0:IPP|0:SNTA1|0:EPB41L3|0:AIF1L|0:SYNPO2L|0:CTNNA1|0:CFL2|0:LRRC49|0:GAS2L2|0:GAS2|0:CDC42EP4|0:ARPC5L|0:ERMN|0:SSH3|0:TTLL1|0:RCC2|0:FAAH|0:TMSB4XP2|0:SPAG4|0:SKA1|0:MYO3A|0:RSPH9|0:INCENP|0:ACTR10|0:SPIRE2|0:PPP1R9A|0:AURKB|0:SNTG2|0:PXN|0:FRMD4A|0:MTUS2|0:TLN2|0:UBXN11|0:TGFB1I1|0:PFN3|0:DNAH14|0:TMSL6|0:DCTN6|0:JMY|0:CYS1|0:TTLL3|0:MAP7D3|0:MEFV|0:MICALL1|0:KLHL21|0:TMOD2|0:DNAH7|0:DNAH10|0:CASS4|0:RHOF|0:MYO3B|0:CORO2B|0:C3orf10|0:RIF1|0:ENC1|0:SGCE|0:ESPN|0:SKA2|0:KLHL2|0:TPX2|0:LMOD3|0:ARPC3|0:SGCZ|0:TPPP3|0:PTPN14|0:VIL1|0:ACTR3B|0:TBCEL|0:SGCD|0:DNAH3|0:ACTL7B|0:NPHP1|0:GAN|0:PFN2|0:JAKMIP1|0:CTNNA3|0:MAST1|0:COTL1|0:PLEK2|0:WIPF2|0:SYNPO|0:DCTN5|0:ELMO2|0:SUMO1|0:CRNKL1|0:MIER1|0:CHD9|0:TOB2|0:CHD1|0:WDR34|0:CST7|0:AGPHD1|0:CCT8L1|0:C11orf73|0:TFR2|0:SLC9A3R1|0:RBPMS|0:UNC5CL|0:HUS1|0:LIN28B|0:TRIM45|0:DNAJB4|0:NUP85|0:THOC7|0:PARD6G|0:PPID|0:SAFB2|0:PRCD|0:PSMB8|0:VAT1|0:SHANK3|0:SGSM3|0:RUVBL2|0:NLRP9|0:EPN1|0:C14orf129|0:ABHD14B|0:STH|0:WIBG|0:URGCP|0:AKR1E2|0:COMMD1|0:PDLIM1|0:RIPK3|0:IPPK|0:PRKD2|0:SCLT1|0:NUDT16L1|0:RNF111|0:TCTE3|0:MTPN|0:PGR|0:MAFIP|0:CAPSL|0:SLC2A4RG|0:FBXL3|0:GSTM5|0:WDR83|0:FBXL4|0:HINT1|0:AOX1|0:DTNA|0:ANKRD37|0:HIVEP1|0:ANKRD34B|0:TAF4B|0:NBPF5|0:ARHGAP17|0:AKR1B10|0:NFATC4|0:LRTOMT|0:EML1|0:PELO|0:IPO8|0:HEPN1|0:PSMC6|0:GNAT3|0:EPS8L1|0:SERPINB2|0:PPHLN1|0:SULT1A1|0:GGPS1|0:SAMD1|0:TTC5|0:DPYSL5|0:SPANXB2|0:PPP1R12C|0:KPNA5|0:MTMR9|0:CA7|0:EEF2|0:SLU7|0:PAPD5|0:NUDT11|0:SP1|0:GINS4|0:FCGR2C|0:SLC4A1AP|0:COPS8|0:GPSM3|0:ASB6|0:IQSEC1|0:RBM22|0:PLEKHG6|0:SMU1|0:BEX1|0:REXO1L1|0:FBXW11|0:ETAA1|0:MAP9|0:RBMS3|0:CSNK1G3|0:TLE6|0:CIT|0:PLCD3|0:SHARPIN|0:SCRIB|0:PPP1R14C|0:STRN4|0:PPFIA4|0:DOCK3|0:KIF21B|0:CDC5L|0:CRIP3|0:PGD|0:DHX36|0:CELF4|0:ARHGAP22|0:CDKL1|0:NBPF15|0:KLHL24|0:CBR1|0:TP53TG5|0:TFIP11|0:DAZ3|0:PADI1|0:HNMT|0:CDK11A|0:BCLAF1|0:AKR1CL1|0:BBS7|0:GLE1|0:KNTC1|0:TRIM41|0:USP7|0:HNRNPR|0:MPP4|0:PIK3AP1|0:DPPA5|0:NACAD|0:STK40|0:RALGPS1|0:PAFAH1B3|0:KLKP1|0:KLHL10|0:NEDD4L|0:TXNDC3|0:EPS8L3|0:KRT8|0:EPB49|0:C7orf49|0:ADH1C|0:ANKRD17|0:UBE2Q2|0:CCNDBP1|0:ERVK4|0:KCNAB1|0:THEM4|0:UBE2K|0:TEX14|0:CTU2|0:CLLU1|0:TNFRSF8|0:WWP1|0:TULP2|0:BNC1|0:SDS|0:IRAK1BP1|0:UBASH3B|0:DTX2|0:PUM2|0:TBCE|0:HN1L|0:RNF216|0:PPP1R14B|0:BLVRA|0:FSCN1|0:PTPN20A|0:ANKHD1|0:SEMA6D|0:PCMTD1|0:GSDMB|0:EGLN2|0:DCPS|0:SBK1|0:MAPRE2|0:RAC3|0:NACC1|0:PCBD1|0:BFSP1|0:SPAG1|0:NUDT4|0:GSTA5|0:ZFAND2A|0:RNF11|0:ZC3H15|0:DHX58|0:RANBP9|0:LNX1|0:RGPD6|0:AOC2|0:NFE2|0:MID1IP1|0:SYNPO2|0:DNAJB1|0:METTL8|0:CAMK1|0:ILF2|0:ASCC3|0:HIF3A|0:FOLH1|0:C20orf186|0:ARID3A|0:CSDE1|0:CPSF3L|0:GPI|0:CCHCR1|0:SH3D20|0:WIPF3|0:IL17RE|0:CDC37L1|0:THTPA|0:NBPF20|0:CBLB|0:STRAP|0:PER2|0:CXXC5|0:CHKA|0:DIS3|0:SPATS2|0:FUZ|0:SLC7A8|0:ZBTB42|0:TBC1D4|0:APIP|0:MYLIP|0:DPP3|0:AGBL3|0:LSM6|0:CPEB2|0:CYGB|0:MYO19|0:ENSA|0:LGALS9|0:MICAL3|0:RANBP17|0:TNIP2|0:NBPF11|0:HSH2D|0:CAB39|0:PIP4K2C|0:RAVER2|0:CRTC3|0:RGS6|0:NAF1|0:ILKAP|0:PPP2R3C|0:PDZK1|0:NT5C3L|0:EYA4|0:ITPKC|0:SIK3|0:RBM27|0:AGAP1|0:ADPRHL2|0:ZNF385A|0:PEX5L|0:MGEA5|0:FANK1|0:PSMB10|0:NCAPG|0:SDCCAG3|0:SMYD1|0:BEX5|0:NUSAP1|0:LANCL1|0:SPANXE|0:CAPNS2|0:PDLIM2|0:PTPN22|0:CDK20|0:RAPGEF6|0:BANF2|0:COPS4|0:MYO15B|0:SPZ1|0:PLCL2|0:BIRC7|0:HSF2|0:LDHAL6A|0:GLIS2|0:DAPP1|0:AGTPBP1|0:STAT5A|0:PTPN2|0:KIF14|0:AHR|0:PTPRH|0:SH3PXD2A|0:CRABP1|0:NECAB2|0:MTMR12|0:FBF1|0:SERPINB13|0:FBXL20|0:SH2B1|0:C9orf140|0:SAT2|0:MICA|0:MAPK7|0:MELK|0:CCT6B|0:CSRP2BP|0:AGBL1|0:CEMP1|0:C6orf170|0:GBP4|0:TRIM47|0:SMURF2|0:GPBP1|0:F13A1|0:GIPC2|0:BIVM|0:FAM19A2|0:PRC1|0:TGFBRAP1|0:MPHOSPH6|0:SPATA18|0:UNC13A|0:PDE10A|0:RHOQ|0:FILIP1L|0:RASGRP4|0:LRRC1|0:PEG3|0:NLRP8|0:GDPD2|0:SHPK|0:RNH1|0:PPP6R3|0:SHANK2|0:SOHLH1|0:CUL7|0:MAGOH|0:ABHD14A|0:SERPINB3|0:SMAP2|0:CALCOCO1|0:UBR4|0:GULP1|0:ABLIM1|0:RYBP|0:RDM1|0:KANK1|0:MBNL2|0:CAPN3|0:DUSP22|0:CRY2|0:ZNF175|0:FANCL|0:TRAF3|0:TSPYL2|0:NAA20|0:PLS1|0:DGKZ|0:CERKL|0:INVS|0:SUMO3|0:SPR|0:VMAC|0:LYPLA2|0:THOP1|0:PBOV1|0:EHBP1|0:PSMA2|0:EML2|0:ALOX15B|0:TTR|0:TXK|0:NBPF4|0:TNPO3|0:DAB2IP|0:ARAP2|0:IPO7|0:SPANXF1|0:PSMB5|0:KHSRP|0:CAMK1D|0:PPP2R5D|0:FBXO4|0:SERPINB10|0:CDV3|0:ZMIZ1|0:DDX58|0:CDC34|0:RRM2B|0:PLEKHA4|0:PIP5KL1|0:PGLS|0:BSND|0:CCDC89|0:MEX3C|0:RBP1|0:HSFX1|0:EPB41L5|0:CALML6|0:DAAM1|0:EEF1A1P5|0:ARHGAP27|0:DPYSL3|0:CDCA8|0:GLTP|0:NCF1C|0:PPP1R14A|0:DCLK3|0:HMGN1|0:TSC22D1|0:SIX5|0:C6orf108|0:BHMT|0:HSP90AA4P|0:IPO4|0:RANBP6|0:CRIPT|0:RASSF5|0:HINT3|0:ARIH1|0:BBS1|0:RGPD5|0:RARB|0:CNOT6|0:PPIAL4C|0:SULT1A2|0:RPE65|0:TP53I13|0:ASAP1|0:BFSP2|0:WBP11|0:STK3|0:REPS2|0:USP11|0:UBL4B|0:POU2F2|0:NNMT|0:SNAP29|0:BLNK|0:COPS6|0:PPP1R13L|0:FAM126A|0:FEM1C|0:GSTM1|0:ZNF322A|0:APOL5|0:EID1|0:TNFSF11|0:DPF1|0:RALGPS2|0:SERPINA9|0:FBXW7|0:ZNF396|0:HAT1|0:OAZ3|0:TIPRL|0:AKAP8L|0:OTUB1|0:GDE1|0:SH3BGRL3|0:NLRP1|0:UPRT|0:GTF2I|0:SPRY4|0:IFIH1|0:RGS17|0:SPRR2G|0:DAZ2|0:ELMO3|0:BSPRY|0:TRIM16L|0:DTX3|0:RGS7BP|0:OLIG2|0:BRWD1|0:TBCB|0:RAB3GAP1|0:H1FOO|0:MRI1|0:ZNF397|0:APEH|0:GSTA4|0:ACBD6|0:CABP5|0:MUC1|0:COL21A1|0:FRAT1|0:PLCH2|0:CCNG2|0:TRIM55|0:NBPF1|0:CUEDC2|0:LIMA1|0:LYST|0:LMOD1|0:GDAP1|0:CTBP1|0:LOR|0:SCAI|0:SPANXD|0:DEF6|0:NXF1|0:CDKL2|0:TES|0:BHLHB9|0:BEX4|0:ADRM1|0:AGAP2|0:ALKBH4|0:ISYNA1|0:COPS7B|0:RIN1|0:CLOCK|0:NCAPH|0:DVL3|0:KRT27|0:RAI1|0:AAMP|0:C9orf86|0:SEPX1|0:TBPL1|0:ARRDC3|0:ITPA|0:SAP18|0:HEXDC|0:SRSF1|0:ANAPC16|0:ZNF346|0:PARP10|0:FGFR1OP2|0:OGFR|0:PADI2|0:MAGEA1|0:IPO11|0:STAT2|0:PLEKHA8|0:ADH1B|0:RANGRF|0:STAC|0:FAM114A1|0:HIVEP3|0:MIF4GD|0:ADH6|0:PSMB1|0:EXOSC6|0:LRP2BP|0:NMD3|0:CA1|0:DCP1B|0:TULP3|0:NPL|0:IFI44|0:XPO5|0:SAMD4A|0:ERG|0:ST13P5|0:CAPS|0:RPS6KA5|0:SMYD3|0:PABPC5|0:C20orf57|0:PMM1|0:CAMTA1|0:DDHD2|0:QKI|0:EML3|0:IPO13|0:ARHGAP15|0:NBPF3|0:E4F1|0:DCX|0:KIN|0:LGALS7B|0:AHRR|0:C19orf6|0:SCRN1|0:WDR16|0:TANK|0:HSFY2|0:DPYSL4|0:CASP1|0:OTUD7A|0:MEX3D|0:RBP7|0:PPP6R2|0:AHCTF1|0:MAST4|0:UNKL|0:SULT6B1|0:CCNA2|0:C12orf48|0:RAVER1|0:PSMA5|0:CNOT2|0:STMN1|0:C4orf23|0:SERPINB11|0:TELO2|0:CR1L|0:DUPD1|0:PSMB11|0:TSPY2|0:NLK|0:GUCY1B2|0:PALMD|0:TRIM11|0:ADH4|0:TNIP1|0:XRN1|0:TMUB1|0:CABYR|0:ACP1|0:MAGEA11|0:PER1|0:TP53TG3|0:LMCD1|0:PSPC1|0:NBPF14|0:STAB2|0:C9orf3|0:LBH|0:ABTB1|0:HEPACAM|0:SAT1|0:EIF6|0:PPIAL4A|0:RLBP1|0:SPATA5L1|0:PELP1|0:THOC5|0:PSMA1|0:C16orf73|0:THAP11|0:SPATA17|0:OSTF1|0:INSC|0:PSMB6|0:PPP1R8|0:N4BP2|0:NDNL2|0:EXOSC10|0:PAN2|0:LPXN|0:EXOSC9|0:MSI1|0:HECW2|0:ANKS1B|0:ZC3H12A|0:KLHDC8B|0:PLEKHA3|0:ARPP19|0:SPEF1|0:MPI|0:SHANK1|0:HARBI1|0:DGKB|0:GSTT2|0:PYDC2|0:DAZ1|0:FRMPD2|0:S100A8|0:HSFX2|0:GDPD1|0:NUDT3|0:DGKK|0:DTD1|0:DDX19A|0:IVNS1ABP|0:SPAG17|0:AARSD1|0:RBM42|0:RUSC1|0:PAFAH2|0:AEBP1|0:C1D|0:LDHC|0:ADH1A|0:GSTM3|0:SPRY3|0:NFATC2IP|0:GPRASP1|0:GFAP|0:GAS7|0:ZFR|0:EGLN3|0:PSMA8|0:ARID4B|0:PANK4|0:RECQL4|0:C1orf116|0:SULT1C4|0:LRIG2|0:CLIC6|0:GAPDHS|0:BSN|0:NASP|0:C14orf126|0:CDKL3|0:RIPK4|0:DAPK3|0:IP6K1|0:CNO|0:RIN2|0:ASCC1|0:PCBP4|0:ATG10|0:NTAN1|0:DIDO1|0:NGDN|0:DPF2|0:PPP1R12A|0:EML5|0:TIPIN|0:SPRR2F|0:DIXDC1|0:SOX10|0:CASP14|0:ATXN7|0:CST11|0:CNFN|0:PAPD4|0:HIPK3|0:PPP1R14D|0:PPM1E|0:ENOPH1|0:PLS3|0:RGS18|0:DTX4|0:CARHSP1|0:KPNA4|0:SIRT7|0:LIMS3|0:LGALS7|0:HMGN2|0:BRPF1|0:RAB3GAP2|0:CLEC7A|0:SHB|0:CELF2|0:PABPN1L|0:C20orf203|0:RNPS1|0:IQSEC3|0:C17orf81|0:SPSB4|0:BAG4|0:AGAP3|0:TIRAP|0:SPSB1|0:FBXO38|0:SPHKAP|0:WRAP53|0:RNF151|0:SPANXC|0:TSSK2|0:NXT2|0:RBM25|0:NAA11|0:GSTM2|0:BAT2|0:PHLDB2|0:MID2|0:NBPF7|0:NKIRAS2|0:TRMT5|0:EYA2|0:ANKS1A|0:COL22A1|0:HOMER3|0:KCNAB3|0:PHLDA3|0:ODF3|0:UBE2E3|0:RC3H1|0:WDR8|0:KRT28|0:TAF7L|0:RBM4|0:FNIP1|0:FEM1B|0:CDKL4|0:SERPINB7|0:SPEM1|0:MNDA|0:NEK7|0:ZC3HAV1|0:ANO1|0:ADH7|0:NAT6|0:PRUNE|0:PSMB2|0:CDC42BPG|0:PPP2CB|0:TTBK1|0:USP25|0:GALM|0:ATF5|0:CTH|0:SH2D4A|0:MCTS1|0:ASPM|0:STXBP5L|0:HNRPDL|0:CABP4|0:SENP2|0:PEA15|0:GUCY1A2|0:UMODL1|0:STXBP6|0:STRA8|0:DOK3|0:C15orf55|0:NECAB1|0:GSTA3|0:BCAS1|0:STAP2|0:STK35|0:USP48|0:NAA30|0:IL16|0:PPP2R2D|0:EDARADD|0:PPP1R1C|0:CDC42BPB|0:SART3|0:KSR2|0:MIF|0:DUSP15|0:WDR55|0:NBPF9|0:NAA25|0:LRRC16A|0:FMNL2|0:KDM3A|0:TAOK1|0:TPPP2|0:TXNDC6|0:ZNF622|0:STOX1|0:TSPY1|0:ZAR1|0:IFT122|0:LRRC6|0:MLF1IP|0:CCT8L2|0:COPS7A|0:RELT|0:TRAF5|0:WHSC1|0:RAD23B|0:SSU72|0:GSTA2|0:FBXL14|0:PIWIL3|0:C5orf13|0:MAP3K13|0:RNF39|0:GSTM4|0:CDC42BPA|0:TKTL1|0:NQO2|0:TSN|0:LSMD1|0:SKAP2|0:DYRK4|0:DTNB|0:NOXA1|0:CELF5|0:RGS20|0:NBPF16|0:LXN|0:FAM120A|0:TARSL2|0:SULT1C3|0:XPO4|0:GPS1|0:MKLN1|0:HCFC1R1|0:BEGAIN|0:FKBP5|0:VPRBP|0:IL1RAPL1|0:PANK3|0:SPAG5|0:PSMB7|0:TDRD3|0:ST13P4|0:CAPN2|0:IPCEF1|0:BIN2|0:NACA2|0:PRX|0:HIPK4|0:STXBP4|0:PAN3|0:UBE2CBP|0:DDHD1|0:LRRC18|0:DDTL|0:OMP|0:PPM1G|0:BMI1|0:ADSS|0:CRTC1|0:COMMD6|0:GOT1L1|0:MAGED1|0:GMEB1|0:AKT3|0:LYPLAL1|0:ACY3|0:HECW1|0:DPH1|0:ARHGEF10L|0:PCMTD2|0:CSNK1A1L|0:NLRC4|0:PADI3|0:NUDT10|0:PDLIM7|0:SPAG16|0:FOLH1B|0:RBM24|0:HSPBAP1|0:NLRP6|0:TRNAU1AP|0:RNF17|0:PPP6R1|0:NCF2|0:PI4K2A|0:STAT4|0:TSGA10|0:ASAP3|0:NBPF6|0:NOTCH2NL|0:HPS3|0:LZTS1|0:RWDD3|0:DPPA3|0:PER3|0:NUMBL|0:ATG16L2|0:EXOSC8|0:PIPSL|0:PKN2|0:C11orf82|0:TRIM67|0:NBPF10|0:IFI44L|0:GNPDA2|0:STRBP|0:PSMA7|0:MSI2|0:TEC|0:GPN1|0:FRK|0:TRIM71|0:HSFY1|0:FAM83D|0:LRDD|0:SYNJ1|0:SAMD9|0:AKR1C3|0:KPRP|0:TNFSF14|0:PLXDC1|0:HNRNPL|0:ECD|0:DAPK1|0:CENPM|0:CNOT6L|0:TRIM50|0:DDT|0:DMP1|0:NBPF12|0:PTPN20B|0:AGBL4|0:KPNA3|0:MKNK1|0:NKD1|0:PLEKHO1|0:AIRE|0:FOXA2|0:HSP90AB2P|0:TRIM29|0:CELF1|0:FYB|0:PPFIA3|0:NBPF8|0:PPEF2|0:PHACTR1|0:IQSEC2|0:HCK|0:FMN1|0:CNDP2|0:BEX2|0:DSTYK|0:NKIRAS1|0:RIC8A|0:SPSB2|0:SH2D3C|0:HSP90AA5P|0:NFATC3|0:ERC2|0:PTPN9|0:SSFA2|0:BCL2A1|0:TRIP6|0:SIKE1|0:ZMYND19|0:EIF5B|0:FLCN|0:TULP1|0:TACC3|0:THOC4|0:MTMR4|0:RBP2|0:EML6|0:EYA3|0:NEK8|0:PID1|0:MTAP|0:TERT|0:PHLDA2|0:CA3|0:EPS8L2|0:SDR9C7|0:SPANXB1|0:SRA1|0:DYNC2LI1|0:CNOT8|0:CARD17|0:KRT25|0:AZI2|0:PSMB3|0:CLEC11A|0:ALKBH6|0:ACCN3|0:SIVA1|0:HNRNPA1L2|0:PGK1|0:MATK|0:RASSF3|0:PTPN18|0:FABP7|0:IKZF1|0:AKAP14|0:PRKD3|0:ITSN2|0:AKR1C2|0:SMC4|0:FOXO6|0:TGM5|0:STAP1|0:FBXO40|0:CDCA7L|0:WT1|0:KSR1|0:SMOX|0:SARM1|0:FEM1A|0:LRRC50|0:NUDT14|0:CRTC2|0:NT5C1B|0:SPRR1A|0:LARP6|0:COASY|0:CCND3|0:FAM123B|0:RANBP3|0:PSMA4|0:TAGLN|0:TK1|0:C11orf21|0:PPP1R12B|0:SOCS7|0:DGKG|0:HOMER2|0:GSPT2|0:KCNAB2|0:PLCL1|0:ALDH8A1|0:TROVE2|0:PLEKHM1|0:MICAL2|0:EID3|0:SLC36A2|0:MED28|0:INMT|0:UBTD2|0:CUL9|0:EWSR1|0:NT5C2|0:HHIP|0:PADI6|0:HMMR|0:SPRR3|0:UNC13C|0:CITED4|0:FAM82A1|0:LGALS8|0:PTK6|0:PSME3|0:PMM2|0:STRN|0:APOL3|0:ZNF383|0:DAZ4|0:TP53TG3B|0:PSMB9|0:WDR77|0:ARHGAP6|0:CITED2|0:BTG1|0:FGF13|0:MAPRE3|0:P2RX7|0:CELSR2|0:MLXIPL|0:STMN3|0:TESC|0:ADIG|0:HNRNPAB|0:HEXIM2|0:NF1|0:SEPSECS|0:IDO2|0:USP9Y|0:DDIT4L|0:SH3PXD2B|0:EGR1|0:ATG4D|0:ASRGL1|0:DEDD|0:TRIM35|0:SRRT|0:MARK1|0:NXF2|0:GNB2L1|0:PACSIN3|0:ATG4A|0:NXF2B|0:MYBBP1A|0:EMG1|0:RBM19|0:NAA16|0:PTF1A|0:NAA35|0:DOCK5|0:HIPK2|0:UTP20|0:MIOX|0:SNAI1|0:MAP2K7|0:MTL5|0:RNF220|0:SLC46A1|0:TERF2IP|0:MLF1|0:THEMIS|0:ARL6|0:GNPDA1|0:ATG4B|0:STAT3|0:KLHL4|0:UBD|0:UBE4B|0:TRIM10|0:CDCA5|0:FIZ1|0:DVL2|0:HSPA4L|0:ATF4|0:CASKIN1|0:XPNPEP1|0:MICALCL|0:NRBP2|0:TRIB2|0:RGN|0:CASKIN2|0:KIAA1217|0:RELN|0:YWHAH|0:SHROOM4|0:DDX25|0:ERRFI1|0:UPF3A|0:CLEC4M|0:PABPC3|0:MT4|0:SERPINB1|0:RRM2|0:UGP2|0:SERPINB12|0:UCHL3|0:PFAS|0:TAX1BP3|0:CD209|0:MT1A|0:RBP5|0:TFG|0:MT1L|0:GSTO1|0:ETNK1|0:RNF7|0:API5|0:UPF3B|0:DBN1|0:DPP8|0:GPT|0:RECQL5|0:DNM2|0:SEPW1|0:GZMH|0:SRSF10|0:IFIT1|0:CHIA|0:DVL1L1|0:FOXP3|0:SPRR2B|0:ABI3|0:STK39|0:MT1F|0:RASA1|0:GSTA1|0:ABLIM2|0:ISG15|0:C15orf24|0:PRMT3|0:RBM8A|0:NUP62|0:CARS|0:TNKS1BP1|0:CELF6|0:HSPA4|0:CD3D|0:EXOSC5|0:SERPINB4|0:MT1E|0:EML4|0:KLHL5|0:SOCS2|0:MT1B|0:PCBP1|0:G3BP2|0:EXOSC4|0:NDRG4|0:APOL6|0:PTGR1|0:ABLIM3|0:BCL11A|0:SRF|0:S100P|0:FMR1|0:NLRP3|0:UBE2V2|0:METAP1|0:PNMA1|0:EIF1|0:FPGT|0:GNA11|0:KIF4A|0:SPANXA1|0:DUSP8|0:NFKBIL2|0:TUB|0:CSE1L|0:DGKI|0:HDGF|0:PAIP1|0:KPNA2|0:PRSS21|0:CD99|0:CREBBP|0:PRMT1|0:BRD7|0:PPIC|0:BPTF|0:CMPK1|0:GNAQ|0:LECT2|0:MED22|0:SPRR1B|0:SH2D2A|0:GPX2|0:SIAH2|0:ARHGAP5|0:DLG5|0:RAE1|0:MCRS1|0:DDX19B|0:NFATC1|0:PTHLH|0:USP16|0:ATXN3|0:ZNF259|0:ALDH1A1|0:AARS|0:SULT1C2|0:CSDA|0:FANCA|0:ASL|0:SULT1A3|0:SOCS1|0:CDK11B|0:REG3A|0:LGTN|0:NXT1|0:TROAP|0:NUP54|0:PPFIA1|0:GRK5|0:HNRNPK|0:DUSP10|0:LRRFIP1|0:CRIP1|0:TNPO2|0:YBX2|0:ARPC5|0:ATN1|0:MADD|0:HSPH1|0:ST13|0:PTH1R|0:ZNF638|0:HSD17B1|0:CD2BP2|0:EXOSC2|0:PPP2R5A|0:ARR3|0:HPGDS|0:PPFIA2|0:CXCR3|0:COPS3|0:RPRM|0:PPP1R7|0:EFS|0:EXOC5|0:SULT1A4|0:SOCS6|0:ETF1|0:MX2|0:WDHD1|0:TRAF1|0:SPANXA2|0:GCA|0:PTPN4|0:LMO7|0:RAGE|0:BLMH|0:TNPO1|0:NSMAF|0:ROR1|0:TPP2|0:FBXL2|0:GRB10|0:CMAH|0:FHOD1|0:CDK2AP1|0:DAZL|0:BYSL|0:IPO5|0:MDFI|0:DOCK1|0:NAE1|0:PPP2R5B|0:GRAP|0:SLC6A3|0:PVR|0:CTNND2|0:DTX1|0:ARG1|0:NAP1L4|0:NOLC1|0:GSTP1|0:ADAR|0:OASL|0:RREB1|0:PPA1|0:PPP1R13B|0:HDAC8|0:NME1|0:PSMA3|0:ANXA5|0:TBCA|0:HDAC2|0:CRNN|0:PSME1|0:GDI2|0:FABP5|0:RANBP1|0:SPIB|0:ANXA1|0:LGALS1|0:ANXA4|0:HDAC3|0:GLO1|0:WARS|0:CLIC2|0:SH3BGRL|0:DCAF7|0:PAPOLA|0:POLDIP3|0:UCHL1|0:PSMC2|0:PAFAH1B2			
GO:0043734	F:DNA-N1-methyladenine dioxygenase activity; IDA:UniProtKB		0:FTO|0:ALKBH3|0:ALKBH2			
GO:0030377	F:U-plasminogen activator receptor activity; NAS:UniProtKB		0:PLAUR			
GO:0005863	C:striated myosin muscle thick filament; TAS:ProtInc		0:MYBPC3|0:MYOM1			
GO:0007197	P:inhibition of adenylate cyclase activity by...; TAS:ProtInc		0:CHRM5			
GO:0003085	P:negative regulation of systemic arterial bl...; IMP:BHF-UCL		0:BMPR2			
GO:0007182	P:common-partner SMAD protein phosphorylation; IDA:MGI		0:SMAD2			
GO:0008199	F:ferric iron binding; IEA:InterPro		0:FXN|0:ACP5|0:TF|0:FTL|0:FTHL17|0:LTF|0:FTMT|0:FTH1P19|0:MFI2|0:FTH1			
GO:0033897	F:ribonuclease T2 activity; IEA:InterPro		0:RNASET2			
GO:0003151	P:outflow tract morphogenesis; ISS:BHF-UCL		0:NIPBL|0:SFRP2|0:NPY1R|0:NPY2R|0:NPY5R|0:SOX17|0:SOX18			
GO:0018298	P:protein-chromophore linkage; IEA:UniProtKB-KW		0:HMCN1|0:NID2|0:HMCN2|0:NID1|0:RRH|0:OPN3|0:CRY2|0:IGHA1|0:OPN1LW|0:OPN1MW|0:RHO|0:OPN4|0:OPN1SW|0:OPN5|0:OPN1MW2|0:AMBP|0:CRY1|0:RGR			
GO:0015491	F:cation:cation antiporter activity; IDA:BHF-UCL		0:SLC22A4			
GO:0070061	F:fructose binding; IMP:BHF-UCL		0:ALDOA|0:ALDOB			
GO:0043566	F:structure-specific DNA binding; IDA:UniProtKB		0:TET1			
GO:0005845	C:mRNA cap binding complex; ISS:UniProtKB		0:EIF4E|0:NCBP2|0:EIF2C2|0:NCBP1|0:EIF4E2|0:FMR1|0:EIF4E3|0:CYFIP1|0:EIF4E1B			
GO:0016581	C:NuRD complex; NAS:BHF-UCL		0:CSNK2A1|0:CHD3|0:RBBP7|0:HDAC1|0:HDAC2|0:RBBP4|0:MTA2|0:GATAD2A|0:CHD4|0:MBD3			
GO:0001302	P:replicative cell aging; IMP:UniProtKB		0:ROMO1			
GO:0008517	F:folic acid transporter activity; TAS:ProtInc		0:SLC46A1|0:SLC19A2|0:SLC25A32|0:SLC19A1			
GO:0006014	P:D-ribose metabolic process; IEA:InterPro		0:RBKS			
GO:0030240	P:skeletal muscle thin filament assembly; ISS:UniProtKB		0:TTN|0:TCAP|0:ACTA1|0:PROX1|0:ACTC1			
GO:0008897	F:holo-[acyl-carrier-protein] synthase activity; IDA:UniProtKB		0:AASDHPPT			
GO:0005840	C:ribosome; TAS:UniProtKB		0:RSL24D1|0:CYLD|0:RSL1D1|0:MRPL46|0:MRPL4|0:MRPL33|0:MRPL50|0:RPL36AL|0:MRPL49|0:RPS27L|0:MRPL24|0:MRPL54|0:RPL12|0:MRPS5|0:RPS26P11|0:MRPL53|0:RPL32|0:MRPS31|0:RPS10P5|0:RPL37A|0:MRPL2|0:MRPS27|0:MRPL14|0:RPL35A|0:MRPL19|0:MRPS30|0:MRPS23|0:MRPL38|0:RPS6KL1|0:MRPS34|0:MRPL17|0:MRPL44|0:METT11D1|0:RPL10A|0:MRPL48|0:RPL39P5|0:MRPL21|0:MRPL45|0:RPS4Y2|0:MRPS10|0:MRPL30|0:RPL22L1|0:QTRT1|0:GCN1L1|0:SF1|0:DNAJC21|0:RPL36A|0:RPL23|0:SERP1|0:RRBP1|0:RPL9|0:SRP68|0:RPL15|0:RPL3L|0:RPL27|0:APEX1			
GO:0000287	F:magnesium ion binding; TAS:UniProtKB		0:STK36|0:PCK1|0:GEM|0:PIF1|0:SNCA|0:ABL1|0:TGM3|0:WRN|0:TSSK1B|0:ERN1|0:DYRK3|0:MARK2|0:NME1|0:MARK1|0:AASDHPPT|0:ICK|0:BRSK2|0:TSSK4|0:SIK3|0:NUDT5|0:SRPK1|0:TSSK6|0:DYRK2|0:ERN2|0:SPHK1|0:STK38|0:GSS|0:MAPK12|0:NEK6|0:STK3|0:SIK2|0:MAP2K7|0:MTHFD2|0:MAP3K6|0:NUDT3|0:LATS1|0:PINK1|0:CERK|0:IDH1|0:SIK1|0:EYA2|0:CDC42BPG|0:SRPK2|0:STK4|0:OXSR1|0:FOXK2|0:CDC42BPA|0:GCLC|0:ABL2|0:MAP3K5|0:PDXK|0:HPRT1|0:BRSK1|0:PRKACB|0:SNRK|0:STK11|0:NUAK2|0:STK38L|0:IRAK3|0:PGM1|0:FARS2|0:MAP3K8|0:PPA1|0:ITPK1|0:WEE1|0:ATP9A|0:IDH3G|0:ATP8A2|0:COMT|0:RNASEH1|0:MAP3K1|0:ADPRH|0:NT5C3L|0:IRAK4|0:ATP10B|0:HACL1|0:PRPS1L1|0:RPS6KA4|0:PGM5|0:MAST3|0:ATP11A|0:TNK2|0:ADCY10|0:ENO1|0:PRPSAP2|0:RPS6KA1|0:ATP8B3|0:ADPRHL1|0:PPM1B|0:PKM2|0:RPS6KA5|0:PPM1A|0:MAST4|0:RPS6KA2|0:ATP11B|0:MAP3K12|0:ENO3|0:ATP4A|0:PRPSAP1|0:FDXACB1|0:ILVBL|0:IDH3B|0:RPS6KA6|0:ATP8B4|0:ENO2|0:PPA2|0:MAP3K7|0:FARSB|0:NUDT7|0:REV1|0:PRPS1|0:ADSSL1|0:PGM3|0:NT5C1A|0:ATP8B1|0:MAP3K13|0:ATP11C|0:ATP10A|0:ENO4|0:ADSS|0:WEE2|0:PKLR|0:ATP9B|0:PRPS2|0:PTEN|0:ATP8B2|0:NT5C1B|0:IDH3A|0:PGM2|0:ATP8A1|0:RPS6KA3|0:TESC|0:TSSK3|0:FIGNL1|0:MAST2|0:DCTPP1|0:IDH2|0:NLK|0:TSSK2|0:CDC42BPB|0:MAST1|0:OPA1|0:RRAGC|0:NT5C3|0:ATP10D|0:LAP3|0:PI4K2A|0:S100P|0:NLRC4|0:FAN1|0:MOV10L1|0:TDP2			
GO:0042325	P:regulation of phosphorylation; NAS:UniProtKB		0:SRPX2|0:PPP1R14C|0:PPP1R14B|0:PPP1R14A|0:PPP1R14D|0:MCM7|0:RAD17|0:BARD1|0:SIRT2			
GO:0000472	P:endonucleolytic cleavage to generate mature...; ISS:UniProtKB		0:UTP20|0:NOP14			
GO:0008123	F:cholesterol 7-alpha-monooxygenase activity; ISS:UniProtKB		0:CYP7A1			
GO:0003827	F:alpha-1,3-mannosylglycoprotein 2-beta-N-ace...; IEA:InterPro		0:MGAT1|0:POMGNT1			
GO:0019307	P:mannose biosynthetic process; IEA:InterPro		0:PMM1			
GO:0060621	P:negative regulation of cholesterol import; IMP:BHF-UCL		0:APOA2|0:APOC3			
GO:0004550	F:nucleoside diphosphate kinase activity; TAS:ProtInc		0:NME1|0:NME2|0:NME6|0:NME7|0:NME2P1|0:NME3|0:TXNDC3|0:RP2|0:TXNDC6|0:NME5|0:NME4			
GO:0015015	P:heparan sulfate proteoglycan biosynthetic p...; TAS:ProtInc		0:HS3ST5|0:HS6ST1|0:HS3ST3B1			
GO:0004667	F:prostaglandin-D synthase activity; TAS:ProtInc		0:PTGDS|0:HPGDS			
GO:0006051	P:N-acetylmannosamine metabolic process; TAS:ProtInc		0:NAGK			
GO:0051010	F:microtubule plus-end binding; IDA:UniProtKB		0:DST|0:CLASP1|0:KIF18A|0:MAPRE1|0:APC|0:STIM1|0:KIF2C|0:CLASP2			
GO:0006659	P:phosphatidylserine biosynthetic process; IMP:UniProtKB		0:PTDSS1|0:SLC27A1			
GO:0031532	P:actin cytoskeleton reorganization; ISS:UniProtKB		0:GPR65|0:PLEK|0:RALA|0:FLNA|0:FGF10|0:FGF7|0:CDC42BPA|0:ANTXR1|0:RICTOR|0:ATP2C1|0:MYH9|0:CAPN10|0:DTNBP1|0:SIPA1L1|0:CDC42BPG|0:CDC42BPB			
GO:0000165	P:MAPKKK cascade; TAS:UniProtKB		0:INS|0:SCG2|0:BRAP|0:FGF13|0:MEN1|0:TAOK3|0:NF1|0:RASGRP3|0:IL31RA|0:RAPGEF2|0:MAPKAPK2|0:FGFR3|0:MAP3K3|0:DUSP4|0:FGFR1|0:NRTN|0:CAMKK2			
GO:0034597	F:phosphatidylinositol-4,5-bisphosphate 4-pho...; IEA:EC		0:INPP4B|0:INPP4A			
GO:0030429	F:kynureninase activity; IDA:UniProtKB		0:KYNU			
GO:0030854	P:positive regulation of granulocyte differen...; IMP:UniProtKB		0:RUNX1			
GO:0030061	C:mitochondrial crista; IDA:UniProtKB		0:COX6B2|0:OPA1			
GO:0045603	P:positive regulation of endothelial cell dif...; IMP:UniProtKB		0:BTG1			
GO:0047631	F:ADP-ribose diphosphatase activity; IEA:EC		0:NUDT5|0:C17orf48|0:NUDT9|0:TRPM2			
GO:0005315	F:inorganic phosphate transmembrane transport...; IEA:InterPro		0:ANKH|0:SLC20A2|0:SLC20A1			
GO:0014912	P:negative regulation of smooth muscle cell m...; IMP:BHF-UCL		0:IGFBP3|0:SERPINE1|0:IGFBP5|0:TRIB1			
GO:0008969	F:phosphohistidine phosphatase activity; TAS:ProtInc		0:PHPT1|0:MINPP1			
GO:0005658	C:alpha DNA polymerase:primase complex; TAS:ProtInc		0:POLA1|0:PRIM1|0:PRIM2|0:MCM3			
GO:0019441	P:tryptophan catabolic process to kynurenine; IEA:InterPro		0:IDO2|0:TDO2			
GO:0048599	P:oocyte development; NAS:UniProtKB		0:FIGLA			
GO:0033120	P:positive regulation of RNA splicing; IDA:UniProtKB		0:HNRPLL			
GO:0016925	P:protein sumoylation; ISS:UniProtKB		0:SUMO1|0:TOPORS|0:SUMO3|0:SUMO2|0:UBA2|0:SAE1|0:PIAS3|0:BCL11A			
GO:0002028	P:regulation of sodium ion transport; ISS:BHF-UCL		0:P2RX7|0:P2RX4|0:DRD2			
GO:0008327	F:methyl-CpG binding; NAS:UniProtKB		0:MBD2|0:MBD1			
GO:0008495	F:protoheme IX farnesyltransferase activity; IEA:InterPro		0:COX10			
GO:0007389	P:pattern specification process; TAS:ProtInc		0:RFNG|0:SHROOM3|0:SIX1|0:ZIC1|0:MID1|0:MFNG			
GO:0016272	C:prefoldin complex; NAS:UniProtKB		0:PFDN6|0:C19orf2|0:PFDN5|0:UXT|0:PFDN4|0:SLMAP|0:PDRG1|0:PFDN1|0:VBP1|0:PFDN2			
GO:0005744	C:mitochondrial inner membrane presequence tr...; TAS:UniProtKB		0:TIMM23B|0:MRPL45|0:TIMM50|0:TIMM8B|0:TIMM23|0:TIMM17B|0:TIMM9|0:TIMM13|0:TIMM17A|0:TIMM10|0:SLC25A6			
GO:0005044	F:scavenger receptor activity; TAS:UniProtKB		0:STAB1|0:STAB2|0:SCARF1|0:TMPRSS3|0:CORIN|0:SUSD2|0:TINAGL1|0:ENPP3|0:HPN|0:SCARA5|0:CD5|0:TMPRSS4|0:TINAG|0:CD5L|0:LOXL3|0:ENPP2|0:CD163L1|0:VTN|0:TMPRSS15|0:HHIPL1|0:MARCO|0:TMPRSS5|0:PRG4|0:PRSS12|0:LOXL2|0:CFI|0:ENPP1|0:C8orf84|0:CD6|0:PGBD1|0:ENDOU|0:TMPRSS13|0:SRCRB4D|0:LOXL4|0:TMPRSS2|0:CD163|0:MSR1|0:SCARA3|0:LGALS3BP|0:COLEC12|0:DMBT1|0:CXCL16			
GO:0004056	F:argininosuccinate lyase activity; TAS:ProtInc		0:ASL			
GO:0000145	C:exocyst; NAS:UniProtKB		0:EXOC4|0:EXOC7|0:EXOC6|0:EXOC6B|0:EXOC3L|0:EXOC1			
GO:0042369	P:vitamin D catabolic process; NAS:BHF-UCL		0:FGF23|0:CYP24A1			
GO:0007173	P:epidermal growth factor receptor signaling ...; TAS:UniProtKB		0:AREG|0:AREGB|0:TGFB1|0:ADAM17|0:HBEGF|0:EREG|0:BCAR1|0:PLCE1|0:DGKD|0:CBL|0:GRB7|0:SHC1|0:REPS2|0:GAB1|0:NCK2|0:EPS8|0:EPS15|0:SHC3|0:GRB2|0:ERBB2IP|0:RPS6KA5			
GO:0044030	P:regulation of DNA methylation; ISS:UniProtKB		0:KDM1B			
GO:0033884	F:phosphoethanolamine/phosphocholine phosphat...; IEA:EC		0:PHOSPHO1			
GO:0032344	P:regulation of aldosterone metabolic process; ISS:UniProtKB		0:KCNMA1			
GO:0051898	P:negative regulation of protein kinase B sig...; ISS:UniProtKB		0:PHLDA3|0:SFRP5|0:DAG1|0:PLEKHA1|0:PTEN|0:DRD3|0:DRD2|0:TSC2			
GO:0009187	P:cyclic nucleotide metabolic process; TAS:ProtInc		0:PDE8A|0:PDE8B|0:NUDT4			
GO:0019862	F:IgA binding; IEA:UniProtKB-KW		0:AMBP|0:FCAR			
GO:0031227	C:intrinsic to endoplasmic reticulum membrane; IEA:InterPro		0:PGAP3|0:ALG9|0:FMO6P|0:FMO5|0:PIGB|0:EXTL3|0:EXTL2|0:FMO2|0:FMO4|0:FMO1|0:FMO3|0:ALG12|0:EXTL1|0:PIGZ|0:EXT2			
GO:0005828	C:kinetochore microtubule; TAS:UniProtKB		0:KNTC1|0:ZW10|0:KIF18A|0:CLASP1|0:CLASP2			
GO:0004994	F:somatostatin receptor activity; TAS:ProtInc		0:SSTR1|0:SSTR3|0:SSTR2|0:SSTR5|0:SSTR4			
GO:0008139	F:nuclear localization sequence binding; TAS:ProtInc		0:BRAP|0:NFKBIA|0:KPNA2|0:KPNA1|0:TNPO2|0:TNPO1|0:TFPT|0:KPNB1|0:KPNA3			
GO:0004620	F:phospholipase activity; TAS:BHF-UCL		0:LPL|0:LIPC			
GO:0006474	P:N-terminal protein amino acid acetylation; TAS:HGNC		0:NAA15|0:NAA10|0:NAA16|0:NAA50			
GO:0010518	P:positive regulation of phospholipase activity; IDA:BHF-UCL		0:APOC2			
GO:0042089	P:cytokine biosynthetic process; TAS:UniProtKB		0:PCSK5|0:CD28			
GO:0048298	P:positive regulation of isotype switching to...; IDA:MGI		0:TNFSF13|0:TGFB1			
GO:0021972	P:corticospinal neuron axon guidance through ...; IMP:BHF-UCL		0:SLIT2			
GO:0009308	P:amine metabolic process; TAS:ProtInc		0:AOC3|0:ABP1|0:SULT1C2			
GO:0006986	P:response to unfolded protein; TAS:ProtInc		0:HSPD1|0:ERP44|0:HSPA1A|0:HSPA1B|0:CREB3L1|0:UBE2J2|0:JKAMP|0:ATF6B|0:UBXN4|0:CREB3L4|0:DNAJC3|0:CHAC1|0:MANF|0:CREB3L3|0:EDEM1|0:EDEM3|0:FAF2|0:FBXO6|0:EDEM2|0:CREB3L2|0:HERPUD2|0:DNAJB5|0:HSPA4L|0:HSPB2|0:HSPB1|0:HSPA7|0:DNAJB6|0:HSPA8|0:HSPA4|0:HSP90AA1|0:HSP90AB1|0:DNAJB4|0:HSPA2|0:DNAJB1|0:SERPINH1|0:TOR1A|0:HSPA6|0:DNAJB2|0:TOR1B|0:HSPH1|0:HSPE1|0:HSPB7|0:HSPB3|0:DNAJC4|0:HSPA1L|0:DNAJA1			
GO:0030172	F:troponin C binding; NAS:UniProtKB		0:TNNT3|0:TNNI3|0:TNNT2|0:CNN3			
GO:0045629	P:negative regulation of T-helper 2 cell diff...; ISS:UniProtKB		0:SOCS5			
GO:0000028	P:ribosomal small subunit assembly; IMP:UniProtKB		0:RPS14			
GO:0006635	P:fatty acid beta-oxidation; TAS:UniProtKB		0:BDH2|0:DECR1|0:ACOX3|0:ACOXL|0:ADIPOQ|0:CPT2|0:DCI|0:ACADS|0:ECHS1|0:HADHB|0:CPT1B|0:ECH1|0:CPT1A|0:PPARD			
GO:0032970	P:regulation of actin filament-based process; IDA:MGI		0:CNN2			
GO:0004096	F:catalase activity; IDA:UniProtKB		0:CAT			
GO:0000225	F:N-acetylglucosaminylphosphatidylinositol de...; NAS:UniProtKB		0:PIGL			
GO:0043046	P:DNA methylation involved in gamete generation; TAS:UniProtKB		0:TDRD9|0:PIWIL4|0:TDRD1|0:MAEL|0:ASZ1|0:PIWIL2|0:CTCFL|0:PRMT7|0:PICK1			
GO:0034138	P:toll-like receptor 3 signaling pathway; IMP:UniProtKB		0:UNC93B1			
GO:0004360	F:glutamine-fructose-6-phosphate transaminase...; TAS:ProtInc		0:GFPT2|0:GFPT1			
GO:0045606	P:positive regulation of epidermal cell diffe...; IDA:BHF-UCL		0:SFRP4			
GO:0071566	F:UFM1 activating enzyme activity; IDA:UniProtKB		0:UBA5			
GO:0051722	F:protein C-terminal methylesterase activity; IDA:HGNC		0:PPME1			
GO:0030275	F:LRR domain binding; IPI:UniProtKB		0:POLR2J|0:LRRFIP2|0:ROBO1|0:ZXDC			
GO:0006882	P:cellular zinc ion homeostasis; ISS:BHF-UCL		0:SLC30A5|0:LCK|0:SLC30A1			
GO:0017034	F:Rap guanyl-nucleotide exchange factor activity; IDA:UniProtKB		0:RAPGEF5|0:RAPGEF2			
GO:0031953	P:negative regulation of protein amino acid a...; IDA:UniProtKB		0:ENG|0:ENPP1|0:NLRP12|0:ERRFI1			
GO:0005802	C:trans-Golgi network; TAS:ProtInc		0:FURIN|0:TAS2R16|0:SMPD4|0:RAB11A|0:GCC2|0:ATP2C1|0:CHST2|0:SCAMP1|0:GGA2|0:CLN3|0:DPY30|0:ATXN2|0:BACE1|0:MLANA|0:GOLPH3|0:CLTCL1|0:SLC9A7|0:CHST4|0:SLC11A2|0:WIPI1|0:CBY1|0:GGA3|0:ATP7A|0:CNST|0:NBEA|0:CLVS2|0:CLVS1|0:TGOLN2|0:AP4B1|0:GOLGA4			
GO:0030177	P:positive regulation of Wnt receptor signali...; ISS:UniProtKB		0:PPM1A|0:DVL1|0:SALL1|0:DISC1|0:ZRANB1|0:SOX4|0:HHEX			
GO:0016913	F:follicle-stimulating hormone activity; NAS:UniProtKB		0:FSHB			
GO:0015798	P:myo-inositol transport; ISS:UniProtKB		0:PGAP1			
GO:0015707	P:nitrite transport; ISS:BHF-UCL		0:SLC11A1			
GO:0032090	F:Pyrin domain binding; IPI:HGNC		0:PYCARD|0:NLRP2			
GO:0046513	P:ceramide biosynthetic process; NAS:UniProtKB		0:LASS5|0:LASS1|0:CLN8			
GO:0051533	P:positive regulation of NFAT protein import ...; IDA:UniProtKB		0:LACRT			
GO:0000309	F:nicotinamide-nucleotide adenylyltransferase...; IEA:EC		0:NMNAT1|0:NMNAT3|0:NMNAT2			
GO:0008286	P:insulin receptor signaling pathway; TAS:ProtInc		0:FOXC2|0:FOXO4|0:AKT2|0:RHOQ|0:AKT1|0:GRB2|0:IRS1|0:PIK3R1|0:GSK3A|0:SHC1|0:IRS2|0:SH2B2|0:BCAR1|0:PHIP|0:APPL1|0:GRB10|0:GAB1|0:BAIAP2|0:IGF1R|0:PIK3R3|0:IGF2|0:AP3S1			
GO:0048011	P:nerve growth factor receptor signaling pathway; ISS:UniProtKB		0:UTP11L|0:BCAR1			
GO:0048747	P:muscle fiber development; IMP:UniProtKB		0:CHRNB1			
GO:0004825	F:methionine-tRNA ligase activity; IDA:UniProtKB		0:MARS|0:MARS2			
GO:0006742	P:NADP catabolic process; IEA:InterPro		0:ASPDH			
GO:0003968	F:RNA-directed RNA polymerase activity; IEA:EC		0:POLR2A			
GO:0045637	P:regulation of myeloid cell differentiation; NAS:UniProtKB		0:PURB			
GO:0031305	C:integral to mitochondrial inner membrane; NAS:HGNC		0:COX18|0:ETFDH|0:IMMT|0:L2HGDH			
GO:0007067	P:mitosis; TAS:UniProtKB		0:USP16|0:CLTCL1|0:TXNL4B|0:HORMAD1|0:HORMAD2|0:WEE2|0:KLHL13|0:PMF1|0:CHFR|0:SEPT7|0:C12orf11|0:CEP63|0:CCNB2|0:SEPT2|0:CDCA2|0:ZNF830|0:NEK9|0:HAUS7|0:TERF1|0:HAUS3|0:LZTS2|0:FZR1|0:STAG2|0:NEK4|0:MAPRE3|0:CDC26|0:PAPD5|0:MAP9|0:CKAP5|0:DSN1|0:BIRC5|0:KATNB1|0:KNTC1|0:SAC3D1|0:SIRT2|0:NUF2|0:RCC1|0:PTTG1|0:C7orf11|0:WEE1|0:MAPRE2|0:CDC25C|0:ANAPC7|0:CETN1|0:SGOL1|0:CSNK1A1|0:CDCA3|0:SPC25|0:CENPV|0:PDS5A|0:NEDD9|0:HAUS4|0:CEP164|0:OIP5|0:FSD1|0:KIF23|0:HAUS1|0:DYNC1LI1|0:MIS12|0:CCNF|0:CCNA1|0:UBE2I|0:ANAPC13|0:RUVBL1|0:NEK1|0:CDC20|0:BUB1|0:HELLS|0:ERCC6L|0:KIAA1009|0:ANLN|0:NUP37|0:KIF2A|0:NEK6|0:SETD8|0:KLHL9|0:CCNK|0:ZC3HC1|0:CEP55|0:TIMELESS|0:RNF8|0:C14orf106|0:ARHGEF2|0:CCNG2|0:KIF20B|0:CD2AP|0:NSL1|0:HAUS8|0:C21orf45|0:HMGA2|0:CASC5|0:ANAPC16|0:HAUS5|0:NUP43|0:HAUS2|0:CETN3|0:CDK1|0:E4F1|0:CCNA2|0:NDE1|0:CLASP1|0:NUDC|0:C13orf34|0:DYNLT3|0:PAFAH1B1|0:RCC2|0:LATS1|0:USP44|0:INCENP|0:AURKB|0:TIPIN|0:ARL8A|0:LMLN|0:HAUS6|0:USP9X|0:ASPM|0:KIF2B|0:CCNG1|0:RAD21|0:KLHL21|0:SPAG5|0:STAG1|0:LRRCC1|0:CDK2|0:CDC25A|0:LATS2|0:ANAPC2|0:UBE2C|0:FAM83D|0:CENPF|0:MAPRE1|0:CDC6|0:BOD1|0:ANAPC1|0:DCLRE1A|0:CDK3|0:SPC24|0:DYNLT1|0:KATNA1|0:ZWILCH|0:NCAPG2|0:NEDD1|0:CLASP2|0:SKA3|0:SETDB2|0:CLTC|0:DCTN2|0:CIT|0:DCTN1|0:MAD2L2|0:CDK11A|0:TXNL4A|0:CDK11B|0:CETN2|0:PBK|0:EML4|0:NEK3|0:YEATS4|0:HGF|0:BUB1B|0:CDC25B|0:KIF22|0:PKMYT1|0:SSSCA1|0:PPP5C|0:SMC3|0:KIF15|0:CDC16|0:TPX2|0:AURKA|0:DCTN3|0:SUGT1|0:KIF2C|0:NOLC1|0:ANAPC11|0:CLIP1|0:PBRM1			
GO:0006390	P:transcription from mitochondrial promoter; TAS:ProtInc		0:MRPL12|0:TFB2M|0:C10orf2|0:POLRMT|0:TFAM			
GO:0001534	C:radial spoke; ISS:UniProtKB		0:RSPH4A			
GO:0006196	P:AMP catabolic process; TAS:ProtInc		0:AMPD3			
GO:0009058	P:biosynthetic process; IEA:InterPro		0:ALDH1L1|0:ALDH1L2|0:GMPPB|0:GAL3ST2|0:ALG11|0:AADAT|0:C8orf38|0:GMPPA|0:C10orf52|0:CCBL2|0:GLT1D1|0:PBLD|0:GOT1L1|0:HAL|0:C20orf3|0:GTDC1|0:GCAT|0:GPT2			
GO:0019956	F:chemokine binding; IPI:UniProtKB		0:PLP2			
GO:0042415	P:norepinephrine metabolic process; ISS:UniProtKB		0:ATP7A			
GO:0030968	P:endoplasmic reticulum unfolded protein resp...; TAS:UniProtKB		0:DERL2|0:DERL1|0:DERL3|0:EIF2AK3|0:VAPB|0:YOD1|0:AMFR|0:VCP			
GO:0001729	F:ceramide kinase activity; IDA:UniProtKB		0:CERK			
GO:0030166	P:proteoglycan biosynthetic process; NAS:UniProtKB		0:CHST8|0:CHST9|0:FOXL1|0:GAL3ST3|0:GAL3ST4			
GO:0019060	P:intracellular transport of viral proteins i...; TAS:UniProtKB		0:TAP2|0:TAP1|0:DYNLT1|0:DERL1			
GO:0035412	P:regulation of catenin protein nuclear trans...; IMP:BHF-UCL		0:GNAQ			
GO:0005885	C:Arp2/3 protein complex; TAS:UniProtKB		0:ARPC4|0:ARPC1B|0:ARPC5|0:ARPC2|0:ARPC3|0:ACTR2|0:ACTR3			
GO:0045345	P:positive regulation of MHC class I biosynth...; IDA:UniProtKB		0:IL29			
GO:0004710	F:MAP/ERK kinase kinase activity; NAS:UniProtKB		0:EGFR			
GO:0030422	P:production of siRNA involved in RNA interfe...; IDA:UniProtKB		0:TARBP2|0:PRKRA|0:DICER1			
GO:0046824	P:positive regulation of nucleocytoplasmic tr...; IDA:BHF-UCL		0:NEDD4			
GO:0001975	P:response to amphetamine; ISS:BHF-UCL		0:DRD4|0:DRD2			
GO:0050777	P:negative regulation of immune response; TAS:UniProtKB		0:COL3A1|0:AMBP|0:SPINK5|0:TGFB2			
GO:0045922	P:negative regulation of fatty acid metabolic...; IMP:BHF-UCL		0:UGT1A8|0:UGT1A9|0:UGT1A7|0:INS			
GO:0016615	F:malate dehydrogenase activity; IEA:InterPro		0:MDH1B			
GO:0010827	P:regulation of glucose transport; ISS:BHF-UCL		0:TRIB3			
GO:0060052	P:neurofilament cytoskeleton organization; ISS:UniProtKB		0:SOD1			
GO:0006083	P:acetate metabolic process; ISS:UniProtKB		0:ALDH5A1			
GO:0019896	P:axon transport of mitochondrion; TAS:UniProtKB		0:NEFL|0:OPA1			
GO:0019395	P:fatty acid oxidation; NAS:UniProtKB		0:ADIPOR1|0:ALOX12|0:ADIPOR2|0:PPARGC1A|0:ACSM1			
GO:0070937	C:CRD-mediated mRNA stability complex; IDA:UniProtKB		0:IGF2BP1|0:SYNCRIP|0:YBX1|0:HNRNPU|0:DHX9			
GO:0034012	F:FAD-AMP lyase (cyclizing) activity; IEA:EC		0:DAK			
GO:0070857	P:regulation of bile acid biosynthetic process; IDA:UniProtKB		0:CYP7A1			
GO:0019825	F:oxygen binding; TAS:UniProtKB		0:CYP2C19|0:CYP2U1|0:CYP2E1|0:CYP1A2|0:CYP3A7|0:CYP2C8|0:CYP2B6|0:CYP4F2|0:CYP4A11|0:CYP3A5|0:CYP4F3|0:CYP2C9|0:CYP2F1|0:CYP4F12|0:CYP4B1|0:CYP2C18|0:CYP3A4|0:HBB|0:HBM|0:CYGB|0:HBG1|0:HBZ|0:HBE1|0:HBQ1|0:HBA2|0:HBA1|0:HBG2|0:NGB|0:HBD|0:CYP19A1|0:CYP1A1|0:CYP26A1|0:CYP17A1|0:CYP8B1|0:CYP2A7|0:CYP1B1			
GO:0047298	F:(S)-3-amino-2-methylpropionate transaminase...; IEA:EC		0:ABAT			
GO:0030020	F:extracellular matrix structural constituent...; NAS:UniProtKB		0:COL9A3|0:COL2A1|0:COL9A2|0:COL9A1|0:COL12A1|0:COL11A2			
GO:0005875	C:microtubule associated complex; TAS:ProtInc		0:FNTA|0:FNTB|0:HDAC6|0:PAFAH1B1|0:MEFV|0:KIF1B|0:KIFC1|0:PEA15|0:MAP4|0:EML1|0:MAP2|0:RANBP9|0:MAPT|0:MID1|0:EML2|0:MAP1B|0:DCX|0:STAU1|0:APPBP2|0:PXN|0:MAP1A|0:CLIP2|0:RABGAP1|0:MAP7			
GO:0032769	P:negative regulation of monooxygenase activity; IDA:BHF-UCL		0:SNCA			
GO:0005576	C:extracellular region; TAS:UniProtKB		0:LHB|0:C8G|0:HABP4|0:MASP2|0:CGB8|0:VEGFB|0:FGF4|0:C7|0:TUBA4A|0:PDYN|0:INSL3|0:CALM2|0:FGF19|0:THBS2|0:RLN3|0:VCL|0:TTN|0:BRPF3|0:F13A1|0:IGKC|0:PNLIPRP2|0:FGF3|0:APP|0:TLN1|0:MLN|0:ANXA1|0:CGB5|0:FGF20|0:RLN2|0:CALM3|0:CGA|0:CHRDL1|0:PNOC|0:PDGFD|0:POTEKP|0:C1S|0:SCG3|0:PLEK|0:CGB7|0:CFB|0:CGB|0:POMC|0:MMRN1|0:FGF8|0:CALM1|0:WDR1|0:SEMA3A|0:THBS3|0:TRH|0:PPIA|0:PROK1|0:NPS|0:FLNA|0:FGFBP3|0:GPHA2|0:PTGFR|0:PPT1|0:A1BG|0:GLA|0:LACRT|0:SPINK5|0:S100A7|0:KLK6|0:PTGDS|0:GDNF|0:ERAP1|0:PLUNC|0:DCD|0:AGGF1|0:CST5|0:PROL1|0:APOA1BP|0:C2orf7|0:ATG4C|0:CLEC11A|0:PAPPA|0:GLIPR2|0:LRSAM1|0:PRRG3|0:TMPRSS11F|0:SAAL1|0:PROCA1|0:TMPRSS11B|0:SCGB2A2|0:PI16|0:PRRG4|0:APOL5|0:SCGB2A1|0:MFI2|0:APOL2|0:PRRG1|0:HTRA4|0:UMODL1|0:APOLD1|0:GLIPR1|0:PON2|0:GLIPR1L2|0:TMPRSS11A|0:APOL6|0:PRRG2|0:APOL3|0:PRSSL1|0:ZG16|0:SFTA2|0:C3orf39|0:CST7|0:KIAA0100|0:FNDC1|0:CRELD2|0:CELA1|0:ADAM23|0:FAM24A|0:GPHB5|0:BAGE4|0:DEFB125|0:C10orf99|0:C6orf27|0:C17orf77|0:MIA2|0:PRSS22|0:LCN15|0:CMA1|0:VWCE|0:WFIKKN1|0:DAND5|0:CLEC4M|0:FOLR2|0:LYZL6|0:CSHL1|0:FOLR4|0:CPO|0:ACPL2|0:GAL|0:HSD17B13|0:FAM19A5|0:GFOD1|0:TSKU|0:KLK7|0:SCT|0:SPINK4|0:VMO1|0:INHBE|0:MAN2B2|0:SOSTDC1|0:LIPK|0:WFDC10B|0:PDCD1LG2|0:TREM1|0:CYR61|0:LCN8|0:RNASE4|0:IGFL1|0:FAM20A|0:EPDR1|0:PRSS54|0:GFRA4|0:PRL|0:DHRS7C|0:APOL4|0:CD40|0:DEFB105B|0:DHRS13|0:THSD1|0:PRSS29P|0:PLA1A|0:CLUL1|0:SAMD1|0:RSPO4|0:C8orf55|0:SILV|0:TCTN1|0:CRISPLD1|0:RNASE9|0:TUB|0:IL17RB|0:C1orf191|0:DEFB131|0:MR1|0:C1QL4|0:LIPF|0:C1QTNF4|0:EPHA3|0:MUC19|0:EDIL3|0:NPFF|0:TMEM155|0:LEAP2|0:DSCAM|0:PSG2|0:KIAA0495|0:TNFRSF1B|0:ISM2|0:DEFB127|0:CXorf36|0:CBLN3|0:DEAF1|0:CLEC18A|0:PATE3|0:OVCH1|0:C19orf76|0:LYZL2|0:C1orf134|0:TPSD1|0:TEPP|0:C6orf186|0:NXPH1|0:C2orf66|0:FIBIN|0:GZMM|0:ADCK1|0:OBP2A|0:FUCA2|0:BAGE|0:COLEC11|0:IGLL1|0:LCN1|0:DPP7|0:CST8|0:FCAR|0:C12orf39|0:NF1L4|0:MXRA5|0:DEFB121|0:PGLYRP4|0:C6orf57|0:TULP2|0:C12orf28|0:RNASE13|0:SCGB1A1|0:C21orf29|0:NTF3|0:IGHG1|0:EXTL2|0:DEFB118|0:IGHG3|0:CD209|0:IL4R|0:SPP2|0:PDZD11|0:CNDP1|0:ACP6|0:ICOS|0:CEACAM1|0:GALNT1|0:SPINK8|0:ENPP3|0:KCP|0:PCDHA6|0:HYAL3|0:ARSF|0:PROZ|0:FAM5C|0:CHID1|0:PRSS48|0:DEFB1|0:ADAMDEC1|0:DEFB116|0:FAM150B|0:LAIR2|0:ST3GAL1|0:C20orf186|0:MUC7|0:RLN1|0:IL17RE|0:FSTL4|0:NPTX2|0:KIR3DX1|0:FGFR2|0:GH2|0:ACRBP|0:PRB2|0:CCDC134|0:SPATA6|0:DEFB104B|0:QRFP|0:CLCA2|0:RETNLB|0:FAM55D|0:DEFB135|0:HEG1|0:C4orf40|0:KARS|0:CPA6|0:DEFB107A|0:PGA3|0:STRCP1|0:MDK|0:LGALS9|0:SIGLEC10|0:DEFB108B|0:PYY2|0:MGAT4A|0:KRTDAP|0:CPA5|0:WISP3|0:C7orf34|0:NTN5|0:KLK11|0:LRCH3|0:SERPINI2|0:CES1P1|0:OLFML1|0:GLIPR1L1|0:NPIPL1|0:C1QTNF8|0:ITIH5L|0:VSIG6|0:LY6K|0:C19orf10|0:ISM1|0:BSPH1|0:FAM19A4|0:C17orf99|0:C4orf29|0:NCAM1|0:ENHO|0:C6orf1|0:CLPS|0:SIGLEC1|0:TOR2A|0:LCN9|0:WIF1|0:CPA4|0:SPINT4|0:MUC20|0:VWA3A|0:QSOX2|0:CST4|0:PAM|0:C12orf49|0:AMY1C|0:ADCYAP1|0:IAPP|0:SERPINA11|0:CHRDL2|0:C2orf72|0:DEFB4B|0:VSTM2A|0:C3orf58|0:RTBDN|0:NBL1|0:KIAA0564|0:PCOLCE2|0:CCDC126|0:LTBP3|0:FOLR3|0:C15orf61|0:ITLN1|0:PSG8|0:FAM5B|0:OTOR|0:FAS|0:BTBD17|0:C1QTNF5|0:FOLR1|0:ANTXR2|0:PGLYRP2|0:EFNA1|0:REG1B|0:CST9L|0:CLEC18B|0:TFF2|0:HHIPL2|0:ACPP|0:MMEL1|0:LY6G5C|0:SPACA5|0:CD59|0:DEFB108P1|0:STX1A|0:ICAM4|0:DEFB132|0:ENDOD1|0:DEFB105A|0:PRSS23|0:SPATA20|0:CBLN4|0:C2CD2|0:IL7R|0:WFIKKN2|0:DNASE1L2|0:DEFB113|0:ENPP6|0:CES5A|0:CDNF|0:FCRLA|0:BOLA1|0:TSHB|0:C4orf26|0:CA6|0:SCG5|0:SCGB3A2|0:C12orf73|0:ADAM12|0:LYG1|0:IZUMO4|0:MSMP|0:CXADR|0:IGHG4|0:EPHX3|0:PGA4|0:IGHG2|0:SCGBL|0:DEFB119|0:IGFL4|0:PAEP|0:GABBR1|0:DEFB4A|0:FAM19A1|0:GALNT2|0:FCGR3A|0:DKK4|0:LUZP2|0:ENPP2|0:LPAL2|0:GAST|0:TMEFF2|0:TNFRSF25|0:SPINK9|0:PSG7|0:IGSF21|0:OLFM2|0:INSL6|0:EMCN|0:LECT1|0:PPY|0:EGFL8|0:ISLR|0:ADAM28|0:LCN10|0:NAPSA|0:CD163L1|0:FCGR3B|0:SERPINA9|0:C6orf127|0:RNASE1|0:PLGLA|0:NMU|0:WFDC8|0:PLAC1L|0:EPHA10|0:OBP2B|0:DEFB129|0:PVRL4|0:XYLT1|0:C9|0:ART5|0:ARTN|0:GNRH2|0:TEX264|0:C17orf67|0:GPX7|0:C7orf69|0:C1QL3|0:DPP4|0:MUC1|0:C1orf56|0:CHGA|0:PRSS35|0:RNASE10|0:ABHD15|0:DEFB107B|0:DEFB124|0:CRB2|0:CFHR4|0:SCGN|0:C20orf71|0:TREML4|0:NRG2|0:C1QTNF9|0:SIGLEC6|0:BAGE5|0:ARSI|0:ST3GAL2|0:PDGFRL|0:CBLN1|0:GUCA2B|0:C20orf185|0:ADM2|0:GZMA|0:PLA2G15|0:EDA|0:CREG1|0:CNTNAP3|0:METRNL|0:IGLON5|0:LTF|0:C10orf58|0:SEMA3D|0:DKK1|0:LGI3|0:EYS|0:CLEC19A|0:WFDC3|0:AMY2B|0:DEFB104A|0:EPHB6|0:TXN|0:DDR1|0:C18orf54|0:TULP3|0:DEFB110|0:FAM132B|0:DEFB136|0:FAM180A|0:FAM55C|0:C10orf25|0:XDH|0:DEFB133|0:SERPINA12|0:DHRS11|0:CA11|0:LGI2|0:PYY|0:CNPY4|0:AMY1B|0:LYZL4|0:FAM198A|0:DEFB114|0:FSTL5|0:MANF|0:SEMA3G|0:HHIPL1|0:ARSK|0:C6orf120|0:FAM108A3P|0:CR1L|0:ITGBL1|0:NETO1|0:PLGLB2|0:FAM150A|0:GALP|0:MUC17|0:C14orf93|0:VIP|0:WISP1|0:TNFRSF18|0:C13orf28|0:LY6G5B|0:CD8B|0:CCBE1|0:WFDC12|0:CD200R1|0:CGB1|0:NMB|0:ITIH5|0:UCN|0:NMS|0:CDCP2|0:NGRN|0:LNPEP|0:CNTN4|0:C3orf64|0:ZPBP2|0:HSD17B11|0:CECR9|0:B4GALT1|0:C10orf31|0:BPIL3|0:LIPH|0:CST9|0:BAGE2|0:MST1|0:S100A8|0:SPINLW1|0:SPACA5B|0:LYPD6|0:SPINK2|0:LIPM|0:PSG9|0:VWDE|0:TCN1|0:ENPP5|0:OTOS|0:FAM108A2|0:PLBD1|0:FAM3A|0:ITFG1|0:IGFL3|0:PSORS1C2|0:LCN6|0:MSLN|0:ST3GAL3|0:SNED1|0:NDFIP1|0:PLA2G2C|0:C18orf20|0:CSF3R|0:LYZL1|0:SCUBE3|0:C6orf126|0:PENK|0:FCGBP|0:RSPO2|0:LIPI|0:TMEM25|0:C6orf58|0:IGHD|0:MST1P9|0:SVEP1|0:C5orf46|0:PLAC9|0:SPAG11A|0:PRF1|0:NTS|0:GP2|0:ALKBH7|0:C11orf83|0:WFDC9|0:CXCL17|0:CHGB|0:CALCB|0:C1QL2|0:SRPX2|0:FAM132A|0:C1QTNF6|0:C11orf45|0:C1orf54|0:PGA5|0:C5orf55|0:PCYOX1L|0:PLGLB1|0:OLFML3|0:MUC13|0:SBSN|0:NPVF|0:RSPO3|0:PLAUR|0:C2orf40|0:DEFB130|0:SPINK1|0:PVRL1|0:AGR3|0:AADACL2|0:NRP1|0:WFDC5|0:CREG2|0:BDNF|0:LCN12|0:ANGPTL7|0:CSTL1|0:PIGR|0:GZMK|0:IGHM|0:TLL2|0:INSL5|0:NF1L6|0:SLPI|0:PAPPA2|0:CYB5D2|0:IL1RAP|0:SEMA3B|0:REG3G|0:TXNDC16|0:FAM131A|0:GPX6|0:PRG4|0:CLCA4|0:SCPEP1|0:RARRES2|0:CHST9|0:C11orf94|0:CALU|0:RNASE11|0:WFDC11|0:CSH2|0:C20orf70|0:SPINK6|0:C8orf84|0:CDCP1|0:CSF2RA|0:DEFB123|0:C9orf47|0:ZPBP|0:DNAJC10|0:GLT1D1|0:NHLRC3|0:WISP2|0:LIPN|0:C1QTNF3|0:SCGB1C1|0:SERPINE3|0:GKN1|0:C1QL1|0:NPIPL2|0:PILRA|0:EPGN|0:FAM108A1|0:NRG4|0:MUC15|0:PI15|0:OVCH2|0:CD8A|0:OLR1|0:PRSS37|0:C2orf69|0:PLA2G12B|0:CCDC3|0:TREM2|0:SERPINI1|0:DEFB134|0:APOOL|0:BAGE3|0:DEFB115|0:PLAC1|0:APLN|0:RSPRY1|0:UCN3|0:PTX4|0:BOLA3|0:CPE|0:HPSE|0:ST6GAL1|0:KISS1|0:CRLF2|0:FAM20C|0:BPI|0:WFDC6|0:R3HDML|0:CRB1|0:ARSJ|0:CELA2A|0:GKN2|0:AGR2|0:DEFB128|0:NPB|0:TMPRSS11E|0:FAM55A|0:PLXNB1|0:FAM24B|0:CST1|0:GLB1L|0:TAC4|0:CPA2|0:FNDC7|0:NOTCH2NL|0:VSIG7|0:WFDC10A|0:GLB1L2|0:PRLH|0:CGB2|0:EDEM2|0:WFDC13|0:PSG1|0:IGFL2|0:SIRPD|0:CSH1|0:EPOR|0:PCDHA10|0:BTN1A1|0:IGSF10|0:LYG2|0:REG4|0:COLEC10|0:PDDC1|0:PAMR1|0:CST6|0:C16orf89|0:DEFB126|0:IL6ST|0:FAM172A|0:CFHR2|0:SERPINA13|0:PCDHA1|0:SCUBE2|0:GPX5|0:STC2|0:CSN2|0:C14orf144|0:CES4A|0:IGFBPL1|0:AOAH|0:PLXDC1|0:S100A9|0:RNLS|0:PRSS38|0:ITLN2|0:NPC2|0:NPW|0:C17orf69|0:CDSN|0:VWA2|0:KIR3DP1|0:C4orf7|0:C11orf44|0:PCDH15|0:PRSS27|0:CPB1|0:PRNT|0:LILRA5|0:NRTN|0:MEGF6|0:CGREF1|0:AMY1A|0:PM20D1|0:CRH|0:CORT|0:TULP1|0:MUCL1|0:PATE1|0:SRCRB4D|0:ST3GAL4|0:PF4V1|0:REG1A|0:HHLA1|0:VASN|0:DEFB112|0:PNLIPRP3|0:UMOD|0:TNFRSF6B|0:CD164|0:ADPGK|0:KLHL11|0:RNASE12|0:FAM108B1|0:PSG11|0:PSAPL1|0:RNASE8|0:CLEC18C|0:PGLYRP3|0:SERPINA10|0:GNPTG|0:C5orf38|0:PTH2|0:IGSF1|0:EFNA4|0:NOTUM|0:GIP|0:SPINT3|0:VWA5B1|0:PYY3|0:SCGB1D4|0:CFC1|0:PSG5|0:CRIM1|0:SPINK7|0:HTRA3|0:PRAP1|0:CCDC70|0:ZG16B|0:C5orf53|0:FAM19A3|0:TMPRSS2|0:HSD11B1L|0:UTS2D|0:CLEC3A|0:LIFR|0:NELL1|0:BPIL1|0:ELSPBP1|0:PRLR|0:OLFML2B|0:LCN1L1|0:CSN1S1|0:HHIP|0:FCER2|0:GCG|0:LILRA3|0:TLL1|0:CST2|0:C19orf63|0:PRSS53|0:NTF4|0:LCN2|0:PDZD2|0:KIRREL3|0:C1orf187|0:CFHR5|0:TF|0:FST|0:EDDM3B|0:PROS1|0:DEFB106B|0:F10|0:C4BPA|0:SERPINA3|0:FAM3D|0:KLK3|0:C1QC|0:MAP2K2|0:SERPIND1|0:KLK15|0:LPA|0:GNGT2|0:SERPING1|0:NPPA|0:ITIH3|0:TINAGL1|0:RNASE7|0:F5|0:NXPH2|0:BPIL2|0:TUFT1|0:DEFB103A|0:AZU1|0:PRB3|0:KRTAP1-1|0:ITIH2|0:PSG6|0:NRG1|0:PSG3|0:RFNG|0:TNFRSF1A|0:KLK9|0:FAM3C|0:CELA3B|0:CPN2|0:IGKV1-5|0:ESM1|0:ABO|0:CD163|0:TTR|0:TLR9|0:IGKV4-1|0:IGHV@|0:SAA3P|0:VPREB1|0:HAMP|0:ITIH4|0:C1R|0:NXPH3|0:HTN3|0:CTSL1|0:PRB1|0:C4BPB|0:P4HB|0:SPAG11B|0:DBH|0:PSG4|0:HP|0:FETUB|0:UCN2|0:GUCA2A|0:FSHB|0:TPSB2|0:NRG3|0:LRG1|0:PLA2G12A|0:CSN3|0:IGJ|0:SEPN1|0:FGFR1|0:LFNG|0:KRTAP5-8|0:F13B|0:DLL1|0:CTSS|0:NXPH4|0:DEFB106A|0:PLA2G2F|0:CABP4|0:SEPP1|0:PIP|0:ELANE|0:SHBG|0:PGLYRP1|0:NELL2|0:PROC|0:KRTAP1-3|0:PRB4|0:GNG8|0:MUC3A|0:F9|0:PDGFB|0:CD27|0:UACA|0:STATH|0:AZGP1|0:MAPK15|0:HS3ST4|0:HRG|0:HTN1|0:KLK12|0:MUC6|0:PMCHL1|0:AMBP|0:JAG1|0:TXLNA|0:ITIH1|0:DEFB103B|0:PLTP|0:PTX3|0:FGF21|0:MATN4|0:KLK10|0:PLIN2|0:PRG2|0:SPINT1|0:PLA2G2E|0:PLA2G10|0:CELA2B|0:RNASE2|0:SMR3A|0:PLA2G5|0:TMPRSS11D|0:ODZ1|0:IFI30|0:RNASET2|0:INHBC|0:SPINT2|0:DNASE1|0:RNASE3|0:KLK4|0:PLA2G2D|0:RNASE6|0:SERPINA5|0:PLA2G4B|0:CDA|0:IL18BP|0:PROK2|0:SPACA3|0:INHBB|0:DMBT1			
GO:0004687	F:myosin light chain kinase activity; TAS:ProtInc		0:MYLK2|0:MYLK3|0:MYLK			
GO:0030318	P:melanocyte differentiation; NAS:UniProtKB		0:CITED1|0:MITF			
GO:0010038	P:response to metal ion; TAS:ProtInc		0:NEDD4L|0:CUTA|0:MTL5|0:NDRG1|0:MT1X			
GO:0090308	P:regulation of methylation-dependent chromat...; IDA:BHF-UCL		0:POU5F1			
GO:0018106	P:peptidyl-histidine phosphorylation; IEA:InterPro		0:PDK3|0:BCKDK|0:PDK4|0:PDK1|0:PDK2			
GO:0021860	P:pyramidal neuron development; ISS:UniProtKB		0:ATP7A			
GO:0005588	C:collagen type V; NAS:UniProtKB		0:COL5A1|0:COL5A2|0:COL5A3			
GO:0060082	P:eye blink reflex; ISS:UniProtKB		0:KCNMA1			
GO:0031435	F:mitogen-activated protein kinase kinase kin...; IPI:UniProtKB		0:TRAF6|0:STK38			
GO:0045664	P:regulation of neuron differentiation; NAS:UniProtKB		0:YWHAG|0:NLGN1|0:CDK5RAP3|0:CDK5R1|0:CDK5RAP2|0:CDK5RAP1			
GO:0032707	P:negative regulation of interleukin-23 produ...; ISS:BHF-UCL		0:TLR4			
GO:0047620	F:acylglycerol kinase activity; IEA:EC		0:AGK			
GO:0015204	F:urea transmembrane transporter activity; TAS:ProtInc		0:SLC14A2|0:SLC14A1			
GO:0043091	P:L-arginine import; ISS:BHF-UCL		0:SLC11A1			
GO:0016342	C:catenin complex; IDA:MGI		0:CDH1|0:CTNNA1|0:CDH2|0:JUP|0:CTNNB1|0:APC2			
GO:0004649	F:poly(ADP-ribose) glycohydrolase activity; IEA:EC		0:PARG|0:ADPRHL2			
GO:0010621	P:negative regulation of transcription by tra...; TAS:BHF-UCL		0:HHEX|0:ID1			
GO:0051082	F:unfolded protein binding; TAS:UniProtKB		0:HSPD1|0:TOMM20|0:AIP|0:GRPEL1|0:SCG5|0:UGGT1|0:PTGES3|0:NPM1|0:DNAJC30|0:C19orf2|0:DNAJB13|0:HSP90AA2|0:DNAJC5|0:DNAJB1|0:PFDN5|0:TBCA|0:HSP90B1|0:HSP90B2P|0:COPA|0:DNAJB5|0:HSP90AB4P|0:TRAP1|0:HSP90AA4P|0:CCT8|0:DNAJC16|0:UXT|0:CLPX|0:PFDN4|0:CALR3|0:DNAJB9|0:DNAJB12|0:HSP90AB3P|0:SLMAP|0:DNAJC5B|0:PDRG1|0:DNAJC14|0:DNAJA2|0:SEC63|0:DNAJC17|0:HSP90AA1|0:DNAJC10|0:DNAJC1|0:PFDN1|0:GRXCR1|0:DNAJB14|0:DNAJA4|0:VBP1|0:HSP90AB2P|0:HSP90AA5P|0:DNAJC5G|0:HSP90AB1|0:DNAJA1|0:DNAJC18|0:CCT5|0:CRYAA|0:TMEM67|0:CRYAB|0:NDUFAF1|0:SRSF12|0:SIL1|0:ERO1LB|0:DNAJC2|0:HTRA2|0:SCAP|0:SRSF10|0:AHSP|0:MDN1|0:CANX|0:PFDN2|0:HSPE1|0:TUBB2C|0:DNAJC4|0:CCT2|0:PFDN6|0:CALR|0:LMAN1|0:TCP1|0:DNAJB4|0:HSPA2|0:SPG7|0:RUVBL2|0:CCT3|0:CLGN|0:CHAF1B|0:CCT7|0:PPIC|0:RP2|0:TTC1|0:CLN3|0:CCT4|0:CCT6B|0:TOR1A|0:APCS|0:DNAJB2|0:AFG3L2|0:AIPL1|0:CCT6A|0:PPIB|0:TOR1B|0:MKKS|0:CDC37|0:CHAF1A|0:NAP1L4|0:LRPAP1|0:HSPA9|0:TAPBP|0:HSPA1A|0:HSPA1B|0:PPIA|0:HSPA5			
GO:0005905	C:coated pit; TAS:UniProtKB		0:LDLR|0:SORT1|0:SELE|0:HSPD1|0:TF|0:RAB35|0:DAB2|0:PICALM|0:TFRC|0:EPN1|0:ARRB1|0:SH3BP4|0:EPS15L1|0:AP1S3|0:LRP12|0:AAK1|0:LRP3|0:APP|0:AP4M1|0:AP4S1|0:AP1S2|0:LRP1|0:AP1S1|0:ARRB2|0:AP2B1|0:MYO6|0:VLDLR|0:LRP10|0:SNAP91|0:LRP2|0:NECAP2|0:HIP1R|0:RAMP2|0:EPS15			
GO:0016641	F:oxidoreductase activity, acting on the CH-N...; IEA:InterPro		0:LOXL2			
GO:0015375	F:glycine:sodium symporter activity; TAS:ProtInc		0:SLC6A9|0:SLC6A5			
GO:0009615	P:response to virus; TAS:UniProtKB		0:IRAK3|0:TNF|0:IFNG|0:RPS15A|0:ISG20|0:CREBZF|0:BCL3|0:DUOX2|0:IFNE|0:ITCH|0:TRIM5|0:POLR3E|0:IFITM3|0:TRIM25|0:IRF3|0:STAT1|0:PCBP2|0:IFNA21|0:DEFA3|0:UNC93B1|0:IFNA8|0:EIF2AK2|0:HERC5|0:ZNF175|0:RNASEL|0:DDX58|0:POLR3D|0:CRCP|0:MAVS|0:IFIH1|0:TBK1|0:DNAJC3|0:POLR3C|0:POLR3H|0:STAT2|0:IFNA10|0:IL28B|0:IL23A|0:POLR3G|0:DEFA1B|0:TRIM11|0:IFNA14|0:IRF9|0:ISG15|0:APOBEC3G|0:POLR3K|0:DEFA1|0:PLSCR1|0:IFITM1|0:IFNA2|0:ZC3HAV1|0:MX2|0:POLR3B|0:POLR3A|0:IL28A|0:POLR3F|0:IFITM2|0:IFNA5|0:IFNA16|0:IFNA13|0:MX1|0:DMBT1|0:IFNA1|0:BECN1|0:CCDC130|0:GTF2F1|0:HSPB1|0:CDK6|0:CHRM2|0:PSMA2|0:CLU|0:ENO1|0:PIM2|0:ACTA2|0:STMN1|0:ODC1|0:AP1S1|0:EEF1G|0:TPT1|0:APOB|0:IL12A|0:NPC2|0:CFL1|0:DCLK1|0:IFNK|0:CCT5|0:C19orf2|0:IFI16|0:IFNA6|0:IFNB1|0:IFI35|0:CCL19|0:BANF1|0:HBXIP|0:IFNAR2|0:ABCE1|0:IFNGR2|0:CXCL12|0:PRKRA|0:IFNA7|0:TRIM22|0:IFI44|0:CXCR4|0:IFNAR1|0:IVNS1ABP|0:LILRB1|0:CCL8|0:IFNGR1|0:IFNW1|0:CCL5|0:FGR|0:CCL22|0:IRF7|0:CCL11|0:IFNA4|0:FOSL1|0:CCL4|0:HNRNPUL1|0:IFNA17|0:SPACA3			
GO:0070840	F:dynein complex binding; IDA:BHF-UCL		0:HDAC6			
GO:0060170	C:cilium membrane; IEA:UniProtKB-SubCell		0:BBS4|0:TMEM67|0:TAS2R4|0:BBS7|0:BBS9|0:TAS2R43|0:BBS1|0:BBS5|0:BBS2|0:TTC8|0:PROM2|0:TAS2R46			
GO:0060425	P:lung morphogenesis; ISS:UniProtKB		0:WNT7B			
GO:0035539	F:8-oxo-7,8-dihydrodeoxyguanosine triphosphat...; IDA:UniProtKB		0:NUDT1			
GO:0007214	P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc		0:GABRG1|0:GABRA6|0:GABRA5|0:GABRG3|0:GABRA2|0:GABRR3|0:GABRG2|0:GABRA4|0:GABRE|0:GABRR1|0:GABRA3|0:GABBR1|0:GABRA1|0:GABRB2			
GO:0070182	F:DNA polymerase binding; IPI:UniProtKB		0:ACD|0:LONP1			
GO:0060335	P:positive regulation of interferon-gamma-med...; IDA:UniProtKB		0:NLRC5			
GO:0035092	P:sperm chromatin condensation; ISS:UniProtKB		0:TSSK6|0:H1FNT			
GO:0030955	F:potassium ion binding; TAS:BHF-UCL		0:HDAC4|0:PDXK|0:PKM2|0:KCNA4|0:PKLR|0:KCNJ11			
GO:0010966	P:regulation of phosphate transport; IDA:UniProtKB		0:FGF23			
GO:0006597	P:spermine biosynthetic process; NAS:UniProtKB		0:SMS|0:AMD1			
GO:0008803	F:bis(5'-nucleosyl)-tetraphosphatase (symmetr...; TAS:ProtInc		0:NUDT2			
GO:0019207	F:kinase regulator activity; IDA:MGI		0:BCCIP			
GO:0060381	P:positive regulation of single-stranded telo...; IDA:BHF-UCL		0:ACD			
GO:0022011	P:myelination in the peripheral nervous system; ISS:HGNC		0:NF1			
GO:0004165	F:dodecenoyl-CoA delta-isomerase activity; NAS:UniProtKB		0:PECI|0:EHHADH|0:DCI			
GO:0001759	P:induction of an organ; ISS:UniProtKB		0:SIX1			
GO:0003700	F:sequence-specific DNA binding transcription...; TAS:UniProtKB		0:TAL1|0:FOS|0:SPI1|0:POU1F1|0:PPARG|0:SOX4|0:TCF12|0:HNF4A|0:SMAD2|0:MEF2A|0:SRF|0:MESP1|0:MEF2C|0:ETS1|0:TCF3|0:FOXP2|0:ETS2|0:NEUROD1|0:TCF7L2|0:SMAD1|0:NANOG|0:TFAP2B|0:POU5F1|0:NKX2-6|0:SREBF1|0:ATF2|0:AHR|0:GSC2|0:TP73|0:RORA|0:GCM1|0:KLF12|0:ZNF367|0:RXRA|0:PITX2|0:NFIC|0:FOXO3|0:PA2G4|0:ZHX3|0:FOXE1|0:E2F4|0:ZHX2|0:EGR1|0:HMGB2|0:SP1|0:TCF25|0:SOX2|0:NR2F1|0:E2F1|0:TEAD2|0:RARA|0:ETV5|0:LMX1B|0:HES1|0:MECOM|0:ZHX1|0:HMGB1|0:SOX7|0:TBX5|0:RUNX1|0:FOXA3|0:AR|0:TCF4|0:CREB3|0:ZIC3|0:GLI2|0:TP53|0:ZBTB17|0:ZNF219|0:TEAD3|0:ZNF281|0:TRERF1|0:ELF2|0:ASCL1|0:ZGPAT|0:FOXP3|0:FOXM1|0:HOXA5|0:ELF1|0:NR2F6|0:THRA|0:HNF1A|0:ELK1|0:FOXO4|0:GATA6|0:TEAD4|0:NPAT|0:GLI3|0:TAF6|0:TEAD1|0:ZNF35|0:STRN3|0:PPARD|0:FOXI1|0:GATA2|0:TFEB|0:FOXF2|0:EGR2|0:AATF|0:NKX2-5|0:NR2C2|0:NR2F2|0:HNF1B|0:EHF|0:PCGF6|0:ZNF639|0:CTCF|0:CREB5|0:CREB3L1|0:TBX10|0:EMX2|0:IRX3|0:SEBOX|0:ARGFX|0:ESRRB|0:TGIF2LY|0:BATF2|0:FOXN3|0:EN2|0:PGR|0:HOXC11|0:HOXA11|0:MKX|0:HSF5|0:ZSCAN20|0:TAF4B|0:NFATC4|0:DBX2|0:LASS6|0:SATB2|0:DMRTA2|0:GSX1|0:CEBPG|0:NKX2-4|0:VSX2|0:HOXB2|0:CDX1|0:PROP1|0:LEUTX|0:DUX4|0:ZNF24|0:IRF3|0:MEIS1|0:DPRX|0:RERE|0:DBP|0:SIX6|0:ARX|0:IRX6|0:VENTX|0:FOXB2|0:HOXD3|0:NR2C1|0:ZSCAN23|0:VPS72|0:SHOX2|0:TBX6|0:NRK|0:ZKSCAN2|0:LASS2|0:E2F8|0:ZSCAN18|0:HOXA3|0:FOXJ2|0:HMX2|0:SMAD7|0:TBX1|0:NR6A1|0:OTP|0:TAF4|0:DRGX|0:TEF|0:FOXK1|0:EMX1|0:GSX2|0:TSC22D4|0:DMRTC2|0:ZNF323|0:ZNF192|0:PBX4|0:ISL1|0:HMBOX1|0:ZNF18|0:SPIC|0:NKX2-3|0:LHX4|0:ZSCAN21|0:HOXC10|0:MEOX2|0:PEG3|0:FOSB|0:FOXQ1|0:ZSCAN5A|0:MEIS3P1|0:ISL2|0:TSHZ2|0:NR2E1|0:ZFHX4|0:DBX1|0:FOXD4L4|0:ZSCAN1|0:TPRX1|0:VDR|0:ZNF213|0:FOXP4|0:HOXC9|0:IRX2|0:NKX1-2|0:DLX1|0:HSFX1|0:SRY|0:SCAND3|0:TSC22D1|0:SIX5|0:FOXB1|0:HLF|0:MEIS3P2|0:ZNF193|0:FOXD4L6|0:LASS3|0:LMX1A|0:CREB3L4|0:NANOGP8|0:RAX2|0:LBX2|0:RAX|0:NR0B2|0:ZNF396|0:NFXL1|0:DUXA|0:CEBPE|0:PAX4|0:NR1H3|0:ZNF397|0:HOXB3|0:HOXB13|0:GATAD1|0:ETV4|0:TFAP2D|0:ZNF167|0:ZNF444|0:DUX3|0:NOTO|0:TSHZ3|0:ZNF449|0:IRF5|0:MSX1|0:FOXF1|0:HOXA4|0:HOXA9|0:STAT2|0:HMX3|0:FOXP1|0:HOXC6|0:MYST2|0:EVX2|0:PKNOX2|0:ERG|0:NR4A2|0:HMX1|0:DUX1|0:JUND|0:HSFY2|0:TSHZ1|0:ZSCAN12|0:NR4A3|0:ZNF287|0:UNCX|0:ETV3|0:ZSCAN5B|0:BARHL1|0:ETV3L|0:MAF|0:ADNP|0:MAFF|0:C5orf41|0:SMAD6|0:ZNF445|0:CBFA2T3|0:FOXD4L3|0:CREB3L3|0:MRPL28|0:RHOXF2B|0:LHX5|0:ESRRG|0:NANOGP1|0:ZSCAN29|0:IRX1|0:CREBZF|0:HSFX2|0:MIXL1|0:MTA3|0:ZSCAN2|0:FOXN1|0:ELF5|0:DMRTB1|0:PITX3|0:LHX2|0:SMAD5|0:HLX|0:HOXA1|0:ZNF75CP|0:FOXI2|0:DMRT3|0:ZSCAN16|0:SMAD9|0:CBFA2T2|0:CEBPD|0:ZNF498|0:SCAND2|0:TSC22D2|0:MAFB|0:ADNP2|0:ZNF500|0:TLX2|0:NR0B1|0:MSX2|0:DUX2|0:ZGLP1|0:DMRTA1|0:LHX8|0:ATF5|0:FOXN4|0:ZKSCAN4|0:MEIS3|0:RXRG|0:MGA|0:CDX4|0:DLX5|0:ZEB2|0:TGIF2LX|0:LASS4|0:C11orf9|0:HOMEZ|0:ZNF446|0:ZNF232|0:FOXD4L1|0:ZSCAN4|0:EN1|0:ZSCAN5C|0:ETV2|0:IRF7|0:NKX2-8|0:TLX1|0:GCFC1|0:ZFHX2|0:ZNF75D|0:FOXG1|0:GSC|0:IRX4|0:NR4A1|0:MYT1L|0:MTA1|0:ZNF496|0:HOXA6|0:TFAP2E|0:HOPX|0:MTA2|0:FOXR2|0:ZSCAN30|0:GATAD2A|0:ALX3|0:LASS5|0:PGBD1|0:HOXA10|0:NKX6-3|0:SMAD4|0:HOXD1|0:CREB3L2|0:FOXD4L2|0:HOXC12|0:LHX3|0:ERF|0:HSFY1|0:NR1I2|0:NKX3-2|0:IRX5|0:HESX1|0:PRRX1|0:NKX1-1|0:ETV7|0:FOXR1|0:L3MBTL4|0:EOMES|0:CREM|0:FOXJ3|0:HOXA2|0:RHOXF2|0:ZNF483|0:FOXI3|0:ISX|0:RORC|0:C2orf3|0:FOXD4L5|0:ZKSCAN3|0:DUX5|0:L3MBTL1|0:TLX3|0:TFDP3|0:ESX1|0:FOXO6|0:POU5F2|0:TBX15|0:PBX3|0:ZNF394|0:HDX|0:SPDEF|0:GATAD2B|0:ZSCAN22|0:LHX9|0:ST18|0:IRF2|0:HMGA1|0:ZC3H8|0:TAF5|0:BCL6|0:ZXDA|0:HINFP|0:ZXDC|0:RARG|0:PPARA|0:ZBTB38|0:ZSCAN10|0:CSRNP3|0:ARNT2|0:IRF6|0:CITED2|0:KLF17|0:FOXD3|0:PHF5A|0:SIX1|0:RORB|0:TCF21|0:TFE3|0:CSRNP1|0:DMBX1|0:CSRNP2|0:FOXL1|0:SCAND1|0:ESR1|0:MLXIPL|0:ZFP36L1|0:KLF3|0:HEYL|0:GTF2H2|0:MZF1|0:ELK3|0:ATF7|0:HCFC1|0:SIX2|0:ELK4|0:VSX1|0:MEIS2|0:CSDA|0:PBX1|0:GTF2I|0:MEF2D|0:MLL|0:CRX|0:RFXAP|0:VAX2|0:RUNX2|0:E2F2|0:TFDP2|0:RXRB|0:MAFK|0:PHOX2A|0:RFXANK|0:LHX1|0:THRB|0:MEF2B|0:EGR4|0:MAFG|0:E2F5|0:MLLT10|0:TCEAL1|0:TFAP2A|0:RFX5|0:T|0:DDIT3|0:REL|0:SALL1|0:ZNF83|0:KLF4|0:ZNF165|0:BHLHE40|0:SOX6|0:ZFP37|0:ZNF117|0:ZNF71|0:HOXB9|0:TGIF2|0:DMTF1|0:ZNF215|0:HOXD12|0:HOXB4|0:REXO4|0:NKX6-2|0:ZFP42|0:BHLHE41|0:SLC30A9|0:SOX21|0:ARID3A|0:ELF3|0:CITED1|0:HR|0:SALL2|0:CUX2|0:ZNF93|0:NFIA|0:ZNF187|0:BTF3P13|0:HOXB8|0:MYCL1|0:SCRT1|0:ZNF72|0:MNX1|0:HOXD11|0:FOXJ1|0:ZNF41|0:ZKSCAN1|0:ZNF33B|0:HOXB1|0:ZNF268|0:ZNF91|0:HMG20B|0:TAF1B|0:ZNF92|0:ZNF69|0:ZKSCAN5|0:PRDM2|0:SOX15|0:ZNF3|0:BTF3P12|0:NKX3-1|0:BARX1|0:SOX1|0:ZNF135|0:BLZF1|0:HOXB7|0:HOXC13|0:ZNF154|0:ZNF81|0:OTX1|0:IRF4|0:FOXL2|0:ZNF19|0:GTF2H3|0:ZNF90|0:TCF7L1|0:HMG20A|0:TBX18|0:ANKRD30A|0:ZNF73|0:RHOXF1|0:ZNF80|0:TULP4|0:HOXB6|0:ZNF33A|0:FOXK2|0:ZNF70|0:KLF2|0:ASCL2|0:ELF4|0:PRRX2|0:HOXD8|0:HOXC4|0:ZNF211|0:BTAF1|0:GBX1|0:ARNTL2|0:ZNF134|0:TAF13|0:OTX2|0:ZNF37A|0:ZNF131|0:BRD8|0:ZNF169|0:CNOT8|0:HOXC8|0:ZNF207|0:ZNF277|0:HOXD4|0:ZNF138|0:DLX4|0:MYT1|0:WT1|0:ZNF236|0:MLX|0:LHX6|0:PDX1|0:ZEB1|0:POU3F1|0:RNF4|0:GATA1|0:TFEC|0:HDAC1|0:DMRT1|0:ZNF85|0:USF2|0:MTF1|0:MYCL2|0:EGR3|0:FOSL2|0:TBR1|0:PAX8|0:SCML1|0:DRAP1|0:FOXD1|0:TRIM25|0:ZNF133|0:CNBP|0:KDM5A|0:PHF1|0:FUBP1|0:NR1I3|0:CREBBP|0:ZNF157|0:HNF4G|0:EVX1|0:STAT1|0:PTTG1|0:BNC1|0:FOXD2|0:NEUROD2|0:ZNF142|0:MYCN|0:POU2F1|0:NFE2|0:SOX13|0:CDX2|0:MYBL2|0:TADA3|0:NR3C1|0:YY1|0:HOXC5|0:GABPB1|0:TADA2A|0:BATF|0:PPBPL2|0:CBFB|0:CBL|0:FOXA1|0:DLX3|0:UBP1|0:SUPT6H|0:ETV6|0:PAX7|0:ATF6B|0:ALX1|0:HSF2|0:NFIL3|0:STAT5A|0:NFE2L2|0:TCF19|0:FOXN2|0:MYC|0:MSRB2|0:SNAPC5|0:SNAPC2|0:ZNF263|0:POU4F2|0:NFATC1|0:SLC26A3|0:ZNF175|0:POU4F1|0:HIRA|0:MYNN|0:SIM1|0:ZNF238|0:TFDP1|0:TFAP2C|0:E2F3|0:DLX2|0:IKZF3|0:POU6F1|0:SOLH|0:POU2F2|0:KDM5B|0:GATA3|0:DMRT2|0:ENO1|0:RLF|0:AFF1|0:TRIM22|0:POU3F4|0:ZNF274|0:ATF3|0:PHOX2B|0:DLX6|0:CLOCK|0:KLF10|0:MAX|0:ZBTB48|0:BUD31|0:E4F1|0:NFYC|0:RCAN1|0:TCFL5|0:NFAT5|0:GBX2|0:UBN1|0:PAX6|0:POU4F3|0:NFE2L3|0:STAT5B|0:SP140|0:TARDBP|0:HEY1|0:SIM2|0:SHOX|0:TFCP2|0:IRF9|0:ATOH1|0:CCRN4L|0:STAT3|0:GABPA|0:CREBL2|0:ZNF174|0:SOX5|0:AEBP1|0:GAS7|0:TRPS1|0:CNOT7|0:TCF15|0:KLF9|0:RBPJL|0:ZNF132|0:TRIM28|0:NFKB1|0:ZBTB25|0:ETV1|0:TAF5L|0:MSC|0:KLF11|0:NPAS1|0:TFCP2L1|0:SNAPC4|0:HSF4|0:ZNF217|0:ZNF140|0:HES6|0:NR1H4|0:ARID4A|0:BACH1|0:PAX3|0:RUNX3|0:FEV|0:SUPT4H1|0:NFYA|0:ZNF137P|0:FLI1|0:POU3F2|0:YBX1|0:PFDN1|0:NFYB|0:LMO1|0:MBD1|0:LZTR1|0:MSL3|0:SCML2|0:STAT4|0:ZFP36L2|0:BATF3|0:LZTS1|0:GTF2H4|0:PCGF2|0:STAT6|0:ZRANB2|0:ZNF155|0:KLF7|0:PLAG1|0:PLAGL2|0:ZNF256|0:XBP1|0:NEUROG1|0:NFX1|0:UHRF1|0:FOSL1|0:YEATS4|0:NFKB2|0:TRIM29|0:PRDM1|0:NPAS2|0:NR3C2|0:TFAM|0:MYF6|0:NFE2L1|0:RB1|0:PHTF1|0:TGIF1|0:MNT|0:RELB|0:MYOG|0:MXD1|0:SCMH1|0:ESR2|0:ZNF189|0:ZNF202|0:ZNF197|0:ARNT|0:TSC22D3|0:AFF4|0:CIR1|0:ZNF45|0:KLF1|0:NFIB|0:HSF1|0:ATF6|0:HEY2|0:VAV1|0:HCLS1|0:SLC2A4RG|0:TBX22|0:FOXE3|0:POU6F2|0:FOXS1|0:HIC1|0:NME2|0:FOXD4|0:LMO4|0:TBX4|0:NFATC2|0:RBPJ|0:IKZF4|0:ATF4|0:TBX21|0:POU5F1B|0:MAFA|0:ZIC1			
GO:0004603	F:phenylethanolamine N-methyltransferase acti...; EXP:Reactome		0:PNMT			
GO:0033993	P:response to lipid; ISS:BHF-UCL		0:ABCG1|0:VPS4B|0:PPARG			
GO:0046885	P:regulation of hormone biosynthetic process; NAS:UniProtKB		0:TRERF1			
GO:0035176	P:social behavior; NAS:BHF-UCL		0:NLGN4X|0:NLGN3|0:MKKS|0:CHRNB2|0:DRD3|0:DRD4			
GO:0009268	P:response to pH; TAS:ProtInc		0:NOX1|0:HVCN1|0:ACCN2			
GO:0001867	P:complement activation, lectin pathway; IPI:UniProtKB		0:MASP2|0:FCN3|0:FCN2|0:MASP1|0:KRT1|0:MBL2			
GO:0032757	P:positive regulation of interleukin-8 produc...; IMP:BHF-UCL		0:TLR3|0:TLR4|0:TLR9|0:LBP|0:TLR5|0:TLR7|0:TLR2|0:AFAP1L2|0:CALCA|0:SERPINE1			
GO:0007549	P:dosage compensation; IDA:MGI		0:H2AFY2|0:H2AFY			
GO:0006148	P:inosine catabolic process; IDA:MGI		0:PNP			
GO:0001750	C:photoreceptor outer segment; ISS:UniProtKB		0:PCDH15|0:MYO7A|0:RPGR|0:C2orf71|0:PDC|0:PPEF2|0:TULP1			
GO:0004969	F:histamine receptor activity; TAS:ProtInc		0:ZNF219|0:HRH4|0:HRH1|0:HRH2|0:HRH3|0:HTR6			
GO:0051592	P:response to calcium ion; TAS:BHF-UCL		0:FGA|0:ITPR3|0:CALM2|0:TTN|0:TRPC1|0:THBS1|0:FGB|0:FGG|0:CALM3|0:CALM1|0:SLC25A12|0:ANXA11|0:ALG2|0:SLC25A13|0:SEC31A|0:KCNMA1|0:TNNT2|0:ADAM9|0:PEF1|0:CAV1|0:PDCD6|0:NEDD4|0:AQP3			
GO:0017151	F:DEAD/H-box RNA helicase binding; TAS:UniProtKB		0:POT1|0:AKAP8L			
GO:0004353	F:glutamate dehydrogenase [NAD(P)+] activity; IDA:BHF-UCL		0:GLUD1|0:GLUD2			
GO:0016260	P:selenocysteine biosynthetic process; NAS:UniProtKB		0:SEPHS2			
GO:0009434	C:microtubule-based flagellum; ISS:UniProtKB		0:OXCT2|0:AKAP4|0:GAS8			
GO:0043623	P:cellular protein complex assembly; NAS:BHF-UCL		0:AXIN1|0:CSNK2B			
GO:0050702	P:interleukin-1 beta secretion; IMP:BHF-UCL		0:NLRC4|0:ABCA1			
GO:0043260	C:laminin-11 complex; TAS:BHF-UCL		0:LAMB2|0:LAMA5|0:LAMC1			
GO:0032049	P:cardiolipin biosynthetic process; IMP:UniProtKB		0:PLA2G6|0:TAZ|0:SLC27A1			
GO:0019433	P:triglyceride catabolic process; IMP:BHF-UCL		0:LIPC|0:APOC3|0:LPL|0:PNPLA3|0:CPS1|0:APOA5			
GO:0004634	F:phosphopyruvate hydratase activity; TAS:ProtInc		0:ENO4|0:ENO1|0:ENO3|0:ENO2			
GO:0070206	P:protein trimerization; IDA:UniProtKB		0:TRIM5|0:TRIM34|0:TRIM21|0:TRIM6|0:TRIM27|0:TRIM22|0:TRIM4			
GO:0006214	P:thymidine catabolic process; IDA:UniProtKB		0:DPYD			
GO:0015892	P:siderophore-iron transport; ISS:UniProtKB		0:LCN2|0:SLC22A17			
GO:0042092	P:T-helper 2 type immune response; TAS:UniProtKB		0:IL18|0:IL10|0:IL4			
GO:0004467	F:long-chain fatty acid-CoA ligase activity; TAS:ProtInc		0:ACSL1|0:SLC27A5|0:ACSBG1|0:ACSBG2|0:ACSL4|0:ACSL5|0:ACSL3|0:ACSL6|0:SLC27A2|0:SLC27A6			
GO:0006542	P:glutamine biosynthetic process; IEA:InterPro		0:LGSN|0:GLUL			
GO:0046836	P:glycolipid transport; TAS:HGNC		0:NPC2			
GO:0043395	F:heparan sulfate proteoglycan binding; IEA:InterPro		0:COMP|0:GPC3|0:GPC4|0:GPC5|0:GPC6|0:GPC1|0:GPC2			
GO:0055089	P:fatty acid homeostasis; IMP:BHF-UCL		0:INS			
GO:0003957	F:NAD(P)+ transhydrogenase (B-specific) activity; TAS:UniProtKB		0:NNT			
GO:0016050	P:vesicle organization; NAS:UniProtKB		0:SORT1|0:CAV1|0:ZFYVE16			
GO:0032261	P:purine nucleotide salvage; IMP:UniProtKB		0:ADA			
GO:0004866	F:endopeptidase inhibitor activity; TAS:ProtInc		0:GPX1|0:PROL1|0:C3|0:C5|0:C4A|0:UCHL5|0:USP14|0:PSMF1|0:PROS1|0:LPA|0:SPP2|0:RENBP			
GO:0016286	F:small conductance calcium-activated potassi...; TAS:UniProtKB		0:KCNN1|0:KCNN2			
GO:0016428	F:tRNA (cytosine-5-)-methyltransferase activity; IEA:EC		0:NSUN2|0:TRDMT1			
GO:0018348	P:protein amino acid geranylgeranylation; TAS:ProtInc		0:CHM|0:PGGT1B|0:FNTA			
GO:0090023	P:positive regulation of neutrophil chemotaxis; IDA:UniProtKB		0:THBS4			
GO:0035196	P:production of miRNAs involved in gene silen...; IMP:UniProtKB		0:SNIP1			
GO:0046626	P:regulation of insulin receptor signaling pa...; ISS:UniProtKB		0:TSC2|0:SIK2			
GO:0005595	C:collagen type XII; NAS:UniProtKB		0:COL12A1			
GO:0005154	F:epidermal growth factor receptor binding; TAS:UniProtKB		0:CBLC|0:EPGN|0:TGFA|0:GRB2|0:SHC1|0:HBEGF|0:BTC|0:EREG|0:EGF			
GO:0048269	C:methionine adenosyltransferase complex; IDA:UniProtKB		0:MAT2B			
GO:0016595	F:glutamate binding; IDA:UniProtKB		0:GRM7|0:GRIN1|0:GCLC			
GO:0009986	C:cell surface; TAS:UniProtKB		0:RARA|0:GHR|0:TRPC4|0:GHRHR|0:FURIN|0:PROM1|0:PCSK6|0:MICA|0:AREG|0:ULBP2|0:SORT1|0:ACE2|0:FZD10|0:PDGFA|0:PVRL2|0:TGFA|0:THBD|0:CD226|0:PLAT|0:APOH|0:SFRP4|0:ENG|0:CHRNA1|0:ENPP1|0:MIF|0:VEGFA|0:C7orf68|0:AREGB|0:PDGFB|0:BMP10|0:ADAM17|0:PVR|0:PLAU|0:GPR98|0:RTP1|0:ACVR1B|0:GHSR|0:RTP2|0:TMEM8B|0:ACVRL1|0:TEK|0:HSPA2|0:NLGN4X|0:CLIC4|0:SLC3A2|0:SRPX|0:FGF10|0:DMD|0:KLHL20|0:SLIT2|0:CXCR2|0:ABCB1|0:PGRMC1|0:HSPA9|0:MPP3|0:HSPB1|0:ALPP|0:CLEC17A|0:TREML1|0:AMOT|0:ATP5B|0:FGFR2|0:TM7SF4|0:PDLIM2|0:NOTCH2|0:SULF2|0:GPM6A|0:CEP290|0:HMGB1|0:DCBLD2|0:MPP2|0:LPAR2|0:GDI2|0:ACVR2B|0:MMP25|0:LPAR1|0:APP|0:GJD3|0:NLGN3|0:RC3H2|0:DPP4|0:AOC3|0:AAMP|0:ROBO2|0:P4HB|0:CXCR4|0:PTPRR|0:AQP11|0:ATPIF1|0:SULF1|0:DSCAML1|0:FLOT2|0:ROBO1|0:SPTB|0:SFRP1|0:SCUBE3|0:HSPA8|0:KCND2|0:IGF2R|0:PLAUR|0:PTPRT|0:SLC11A2|0:STX4|0:ELANE|0:USP14|0:HSPD1|0:IRAK2|0:ANXA9|0:TIGIT|0:CX3CL1|0:TDGF1|0:CYP3A4|0:TREML2|0:TMEM102|0:NOD2|0:EPHB4|0:C20orf3|0:ADAM10|0:M6PR|0:PTPRK|0:HSPA5|0:RALA|0:PRLR|0:NOTCH4|0:ELFN2|0:MMP16|0:PPFIA4|0:STRC|0:PSEN1|0:IDE|0:BACE1|0:TPO|0:BACE2|0:PPFIA2|0:KAL1|0:HNRNPU|0:CTSG|0:PPFIA3|0:HMMR|0:LRPAP1|0:LAYN|0:SLC9A3|0:SHH|0:HM13|0:ISLR2|0:WNT4|0:HBEGF|0:ADAMTS13|0:CLCN3|0:CSPG4|0:NRD1			
GO:0003713	F:transcription coactivator activity; TAS:UniProtKB		0:HAND1|0:SP100|0:TAF1|0:JUP|0:GTF2A2|0:MED21|0:MED6|0:RBPMS|0:MAML3|0:KAT2A|0:SAP130|0:ING4|0:CREBBP|0:ELF3|0:CITED1|0:TAF6L|0:RARA|0:PML|0:TAF9|0:KAT5|0:CITED2|0:MKL2|0:TAF11|0:MAML2|0:USP16|0:SUPT3H|0:JUN|0:UTF1|0:APEX1|0:UBE2L3|0:BCL10|0:EP300|0:TAF12|0:WWTR1|0:YAF2|0:HINFP|0:TGFB1I1|0:KAT2B|0:TAF5L|0:NPAT|0:RNF20|0:YAP1|0:MED27|0:MYSM1|0:WWC1|0:MYCBP|0:SUPT7L|0:NPM1|0:TAF10|0:MAML1|0:TAF7|0:NRIP1|0:SUB1|0:TADA1|0:DYRK1B|0:CBFB|0:PRPF6|0:PMF1|0:HCFC1|0:MMS19|0:EDF1|0:CTNNB1|0:MLL5|0:HAND2|0:PSMD9|0:JMY|0:CARM1|0:USP21|0:MKL1|0:LPIN2|0:PRDM16|0:BCL9L|0:RNF4|0:IL31RA|0:GRIP1|0:PIAS2|0:NCOA4|0:BRCA1|0:ARID1B|0:PIAS1|0:TCF20|0:FHL2|0:CCNE1|0:CDK7|0:RB1|0:NCOA2|0:SMARCD2|0:ZEB1|0:TFEC|0:RIPK3|0:BRDT|0:MED26|0:SMARCC2|0:SMARCD1|0:NFATC4|0:POU2AF1|0:MTF1|0:GTF2F1|0:NR1I3|0:TRIP11|0:ZFX|0:ATF2|0:PCBD1|0:NFE2|0:GTF2A1|0:NR2F1|0:YY1|0:TAF4|0:COPS5|0:TRIP4|0:HSF2|0:CIITA|0:TCERG1|0:SMARCC1|0:TFDP1|0:SMARCE1|0:ABT1|0:SRCAP|0:MED7|0:NR1H3|0:PQBP1|0:JUNB|0:SMARCA2|0:SMARCD3|0:MAX|0:RFXAP|0:TFAP2B|0:E4F1|0:NFYC|0:NFE2L3|0:HCFC2|0:NR5A1|0:GABPA|0:GTF2A1L|0:HTATIP2|0:RXRB|0:SOX10|0:EPAS1|0:TRIM32|0:NR1H4|0:SP4|0:TRIM24|0:GMEB1|0:RXRA|0:KLF7|0:NR1I2|0:ECD|0:NFKB2|0:NR2C2|0:PRRX1|0:MYOD1|0:TFAP2A|0:MNT|0:ESR2|0:ARNT|0:DTX1|0:AIP|0:MED23|0:NFKBIB|0:ATF6|0:PSMC3|0:MYST3|0:RNF14|0:TBPL1|0:VGLL1			
GO:0043560	F:insulin receptor substrate binding; ISS:BHF-UCL		0:PRKCZ|0:GRB2|0:IGF1R|0:INSR|0:PRKCD|0:PIK3R1			
GO:0046911	F:metal chelating activity; IDA:BHF-UCL		0:APOE			
GO:0022601	P:menstrual cycle phase; NAS:BHF-UCL		0:TGFB3|0:TGFB2|0:SFRP4			
GO:0021757	P:caudate nucleus development; IMP:UniProtKB		0:FOXP2			
GO:0004644	F:phosphoribosylglycinamide formyltransferase...; TAS:ProtInc		0:GART			
GO:0019290	P:siderophore biosynthetic process; ISS:UniProtKB		0:BDH2			
GO:0004659	F:prenyltransferase activity; IEA:InterPro		0:UBIAD1|0:COQ2			
GO:0019079	P:viral genome replication; TAS:ProtInc		0:CLEC4M|0:CD209|0:NFIA|0:HTATSF1|0:HBXIP|0:UBP1|0:CTBP1|0:CCL2|0:DEK|0:OPRK1|0:CTBP2|0:CXCR6|0:CCL4			
GO:0033857	F:diphosphoinositol-pentakisphosphate kinase ...; ISS:UniProtKB		0:PPIP5K1|0:PPIP5K2			
GO:0003912	F:DNA nucleotidylexotransferase activity; TAS:ProtInc		0:POLM|0:DNTT			
GO:0019903	F:protein phosphatase binding; NAS:UniProtKB		0:HSP90B1|0:SHOC2|0:VCP|0:PPP6R3|0:PPP6R1|0:EGFR|0:IQGAP1|0:GNB2L1|0:SNX3|0:BCAR1|0:ERBB2|0:PIK3R1|0:NEK2|0:JUP|0:AP3B1|0:CTNNB1|0:PPP1R16B			
GO:0008398	F:sterol 14-demethylase activity; EXP:Reactome		0:CYP51A1			
GO:0070498	P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL		0:IL1R1|0:IRAK1|0:IRAK2|0:IRAK3			
GO:0051973	P:positive regulation of telomerase activity; ISS:UniProtKB		0:POT1|0:ACD|0:WRAP53|0:PARM1			
GO:0001733	F:galactosylceramide sulfotransferase activity; IEA:InterPro		0:GAL3ST1|0:GAL3ST3|0:GAL3ST2|0:GAL3ST4			
GO:0007166	P:cell surface receptor linked signaling pathway; TAS:UniProtKB		0:CD3D|0:EDN3|0:F2|0:KHDRBS1|0:NUP62|0:MIF|0:FCER1G|0:CBLC|0:CBLB|0:CD79B|0:CD3G|0:P2RX7|0:LAMA1|0:TSPAN12|0:GP1BB|0:EVL|0:CABIN1|0:COL4A3|0:CDA|0:CD27|0:SIGLEC9|0:SEMA6A|0:CD160|0:KLRG1|0:HRAS|0:TACSTD2|0:IGSF6|0:CD101|0:KLRB1|0:PRL|0:MAPK14|0:STC1|0:KLRF1|0:ASGR2|0:CLEC1A|0:PRMT1|0:MKNK2|0:LILRB3|0:TNFRSF13B|0:MYD88|0:AGER|0:IL18RAP|0:TRPV1|0:CD59|0:TNFRSF10B|0:CLEC1B|0:BIRC2|0:CD14|0:ANXA1|0:SIRPB1|0:MAGI1|0:LILRA1|0:CLEC2D|0:MARCO|0:IRF9|0:MADD|0:IFNG|0:BIRC3|0:PIP4K2B|0:BSG|0:IFITM1|0:IFNA2|0:LILRB5|0:LY6E|0:IFNB1|0:GEM|0:CD274|0:IL17C|0:CXCL10|0:MERTK|0:BAG1|0:CLEC4A|0:STC2|0:TDP2|0:LILRB2|0:BRD8|0:KLRC1|0:ADAP1|0:KLRD1|0:CD28|0:CD2|0:INHA|0:INHBA			
GO:0014059	P:regulation of dopamine secretion; ISS:UniProtKB		0:DRD3|0:CHRNA4			
GO:0005754	C:mitochondrial proton-transporting ATP synth...; NAS:UniProtKB		0:ATP5B			
GO:0033754	F:indoleamine 2,3-dioxygenase activity; IEA:EC		0:IDO2|0:IDO1			
GO:0050877	P:neurological system process; IMP:BHF-UCL		0:KCNJ11			
GO:0015377	F:cation:chloride symporter activity; TAS:ProtInc		0:SLC12A9			
GO:0040009	P:regulation of growth rate; IDA:UniProtKB		0:BNIPL			
GO:0016605	C:PML body; ISS:UniProtKB		0:TP53|0:SP100|0:SIRT1|0:LRCH4|0:RPAIN|0:MORC3|0:RPA1|0:CHFR|0:SKI|0:KLHL20|0:TOPORS|0:ISG20|0:TOP3A|0:PML|0:DAXX|0:CHEK2|0:UBE2I|0:TRIM16|0:ZMYM2|0:SPTBN4|0:TOPBP1|0:BLM|0:RAD51|0:ELF4|0:SKIL|0:ZBTB16|0:IKBKE|0:TDP2|0:RB1|0:TRIM8|0:N4BP1			
GO:0015439	F:heme-transporting ATPase activity; IMP:UniProtKB		0:ABCB6			
GO:0046965	F:retinoid X receptor binding; TAS:UniProtKB		0:PPARG|0:HMGA1|0:VDR|0:RARG|0:NSD1|0:NCOA6			
GO:0016005	F:phospholipase A2 activator activity; TAS:ProtInc		0:PLAA			
GO:0015920	P:lipopolysaccharide transport; IDA:BHF-UCL		0:SCARB1|0:LBP			
GO:0006919	P:activation of caspase activity; TAS:ProtInc		0:TNF|0:PPARG|0:MOAP1|0:F3|0:F2R|0:HSPD1|0:PMAIP1|0:NLRC4|0:TNFSF15|0:NOD1|0:IFT57|0:HIP1|0:TERF1|0:BBC3|0:LCK|0:DNAJA3|0:COL4A3|0:MUL1|0:DLC1|0:RPS3|0:SLC11A2|0:IFNB1|0:IFI27|0:FASLG|0:CDKN2A|0:MTCH1|0:DAP|0:SENP1|0:ROBO1|0:VCP|0:CASP8AP2|0:EIF2AK3|0:PYCARD|0:TNFRSF10B|0:NLRP1|0:NLRP12|0:BCL2L13|0:TNFRSF10A|0:HSPE1|0:STAT1|0:BCL2L10|0:F2			
GO:0022626	C:cytosolic ribosome; TAS:ProtInc		0:NUFIP1|0:EIF2AK4|0:RPL13			
GO:0005335	F:serotonin:sodium symporter activity; IDA:UniProtKB		0:SLC6A4			
GO:0009620	P:response to fungus; TAS:UniProtKB		0:CHIA			
GO:0004796	F:thromboxane-A synthase activity; IEA:EC		0:TBXAS1			
GO:0004559	F:alpha-mannosidase activity; TAS:ProtInc		0:MAN2B2|0:MAN2C1|0:MAN2A2|0:MAN2A1|0:MAN2B1			
GO:0007210	P:serotonin receptor signaling pathway; IMP:UniProtKB		0:HTR2B|0:HTR2C			
GO:0008665	F:2'-phosphotransferase activity; TAS:UniProtKB		0:NT5C3			
GO:0008815	F:citrate (pro-3S)-lyase activity; IEA:InterPro		0:ACLY|0:CLYBL			
GO:0046473	P:phosphatidic acid metabolic process; IDA:BHF-UCL		0:PLA2G2A			
GO:0045078	P:positive regulation of interferon-gamma bio...; TAS:UniProtKB		0:CD276|0:TLR8|0:IL27|0:TLR3|0:TLR9|0:TLR7|0:CEBPG|0:IL21|0:EBI3|0:IL12B			
GO:0004303	F:estradiol 17-beta-dehydrogenase activity; TAS:ProtInc		0:HSD17B14|0:HSD17B8|0:HSD17B2|0:HSD17B6|0:HSD17B12|0:HSD17B11|0:HSD17B1|0:RDH8|0:HSD17B4|0:HSD17B7			
GO:0051341	P:regulation of oxidoreductase activity; IDA:UniProtKB		0:ECSIT			
GO:0043388	P:positive regulation of DNA binding; IDA:UniProtKB		0:SKI|0:HMGB2|0:NME1|0:HMGB1|0:EDF1			
GO:0040030	P:regulation of molecular function, epigenetic; IMP:UniProtKB		0:CTCF			
GO:0044295	C:axonal growth cone; ISS:UniProtKB		0:FKBP4			
GO:0004380	F:glycoprotein-fucosylgalactoside alpha-N-ace...; NAS:UniProtKB		0:ABO			
GO:0060045	P:positive regulation of cardiac muscle cell ...; ISS:BHF-UCL		0:NRG1|0:FGF2|0:BMP10			
GO:0032516	P:positive regulation of phosphoprotein phosp...; IDA:HGNC		0:AGTR2|0:PPP2R4			
GO:0001672	P:regulation of chromatin assembly or disasse...; IDA:UniProtKB		0:TLK1|0:TLK2			
GO:0014805	P:smooth muscle adaptation; NAS:BHF-UCL		0:IL1B			
GO:0071624	P:positive regulation of granulocyte chemotaxis; IDA:UniProtKB		0:S100A14|0:S100A7			
GO:0070695	C:FHF complex; IDA:UniProtKB		0:AKTIP|0:HOOK3|0:HOOK2|0:FAM160A2|0:HOOK1			
GO:0005088	F:Ras guanyl-nucleotide exchange factor activity; NAS:UniProtKB		0:RASGRP4|0:RAPGEF4|0:RGL2			
GO:0002682	P:regulation of immune system process; IEA:InterPro		0:ORM2|0:ORM1			
GO:0004082	F:bisphosphoglycerate mutase activity; TAS:ProtInc		0:PGAM1|0:PGAM4|0:PGAM2|0:BPGM			
GO:0050862	P:positive regulation of T cell receptor sign...; NAS:UniProtKB		0:TRAT1|0:LCK			
GO:0046339	P:diacylglycerol metabolic process; NAS:UniProtKB		0:DGKK|0:DGKD			
GO:0001942	P:hair follicle development; IMP:UniProtKB		0:INHBA|0:APCDD1			
GO:0071481	P:cellular response to X-ray; IMP:UniProtKB		0:NIPBL			
GO:0010891	P:negative regulation of sequestering of trig...; IDA:UniProtKB		0:PPARG|0:PPARA|0:ABHD5|0:PNPLA2			
GO:0018160	P:peptidyl-pyrromethane cofactor linkage; IEA:InterPro		0:HMBS			
GO:0072218	P:metanephric ascending thin limb development; ISS:UniProtKB		0:POU3F3			
GO:0006275	P:regulation of DNA replication; TAS:ProtInc		0:PCNA|0:CCDC88A|0:PPP2R1A|0:PPP2CA|0:CDK2			
GO:0032956	P:regulation of actin cytoskeleton organization; TAS:BHF-UCL		0:RHOQ|0:FZD10|0:RICTOR|0:CCDC88A|0:MLST8|0:PDGFA			
GO:0005184	F:neuropeptide hormone activity; TAS:ProtInc		0:GRP|0:QRFP|0:AGRP|0:NPFF|0:NTS|0:TRH|0:CCK|0:GAL|0:ADCYAP1|0:VIP|0:UCN|0:PENK|0:PNOC|0:CALCB|0:NPY|0:CRH|0:CORT			
GO:0008236	F:serine-type peptidase activity; TAS:ProtInc		0:PRSS3|0:ENDOU|0:SEC11A|0:SEC11C|0:IMMP1L|0:IMMP2L|0:RBP3|0:SEC11B|0:PARL|0:ABHD10|0:RHBDD1|0:DPP8|0:DPP9|0:RELN|0:ZFYVE9|0:NAALAD2|0:PRSS16|0:DPP7			
GO:0045821	P:positive regulation of glycolysis; TAS:UniProtKB		0:HIF1A|0:ARNT|0:IGF1|0:INS|0:INSR|0:MLXIPL|0:GAPDHS			
GO:0055072	P:iron ion homeostasis; ISS:UniProtKB		0:HMOX1|0:FBXL5|0:BDH2			
GO:0007538	P:primary sex determination; TAS:ProtInc		0:NR5A1			
GO:0070742	F:C2H2 zinc finger domain binding; IPI:UniProtKB		0:THAP7|0:SRRM2|0:TAF9|0:MBD2|0:ZXDA|0:ZXDC|0:WT1			
GO:0032968	P:positive regulation of RNA elongation from ...; IEA:InterPro		0:SUPT5H			
GO:0070584	P:mitochondrion morphogenesis; IMP:UniProtKB		0:NUBPL			
GO:0047394	F:glycerophosphoinositol inositolphosphodiest...; IEA:EC		0:GDPD2			
GO:0055106	F:ubiquitin-protein ligase regulator activity; ISS:BHF-UCL		0:TRIB3|0:TRIB2|0:TRIB1			
GO:0032582	P:negative regulation of gene-specific transc...; TAS:BHF-UCL		0:PROX1|0:FOXP2|0:NR2F2|0:PEX14|0:TNF|0:BMP7|0:RARA|0:GMNN|0:BASP1|0:ASCL1|0:CDKN1C|0:SFRP1|0:RELA|0:WNT5A|0:CDKN1B|0:WT1|0:PFDN5|0:TFAP4|0:TNFSF4|0:TNFRSF4|0:FOXD1|0:NOTCH1			
GO:0015095	F:magnesium ion transmembrane transporter act...; TAS:ProtInc		0:ZDHHC17|0:MMGT1|0:ZDHHC13|0:CLDN16			
GO:0015267	F:channel activity; TAS:ProtInc		0:MAL|0:STEAP1|0:GJA8			
GO:0051259	P:protein oligomerization; TAS:HGNC		0:PFKL|0:NPM1|0:TEK|0:MALT1|0:QPRT|0:BLM|0:NBR1|0:AMFR|0:IRAK1|0:DGKH|0:MAP3K11|0:SLC6A4|0:DPAGT1|0:UPK1A|0:NOD1|0:NLRP3|0:NOD2			
GO:0006301	P:postreplication repair; NAS:UniProtKB		0:BRCA1|0:MSH2|0:UBE2B|0:UBE2N|0:WDR33|0:UBE2A			
GO:0007368	P:determination of left/right symmetry; TAS:ProtInc		0:BBS7|0:ARL6|0:MKKS|0:CITED2|0:CFC1|0:KIF3B|0:ZIC3|0:PITX2			
GO:0030284	F:estrogen receptor activity; TAS:UniProtKB		0:ESR1|0:ESR2			
GO:0042771	P:DNA damage response, signal transduction by...; ISS:UniProtKB		0:IFI16|0:TP53|0:AEN|0:RPS27L|0:DYRK2|0:USP28|0:PHLDA3|0:BCL3|0:C16orf5|0:PPP2R5C|0:PML			
GO:0009386	P:translational attenuation; TAS:ProtInc		0:YBX2			
GO:0045740	P:positive regulation of DNA replication; ISS:BHF-UCL		0:HRAS|0:KITLG|0:IGF1|0:IL3|0:PDGFRA|0:INS|0:PDGFA|0:EPO|0:PDGFB|0:PLA2G1B|0:PDGFC|0:CSF2|0:EREG|0:GLI1|0:DNA2|0:GLI2|0:CALR|0:AREG|0:TGFB3|0:AREGB|0:IGF1R|0:INSR|0:FGF10|0:SHC1			
GO:0010149	?:senescence; NAS:BHF-UCL		0:HRAS|0:CHEK2|0:CDKN1A|0:CHEK1|0:ATR|0:ATM|0:CALR|0:WNT16|0:PRKCD|0:CDKN2A|0:TP53|0:SRF|0:MAP2K1|0:TERT|0:TERF2			
GO:0045296	F:cadherin binding; TAS:UniProtKB		0:CDH13|0:PTPRM|0:FXYD5|0:CTNNAL1|0:CTNNA2|0:TRPC4|0:P2RX4|0:JUP|0:CTNND1|0:CTNNA1|0:PTPRT|0:CTNNB1|0:VCL|0:CDK5R1|0:CTNNA3			
GO:0016603	F:glutaminyl-peptide cyclotransferase activity; IEA:EC		0:QPCT			
GO:0006182	P:cGMP biosynthetic process; IDA:UniProtKB		0:HTR2B|0:NPPA|0:HTR2C|0:AQP1|0:NPPC|0:NPPB			
GO:0046323	P:glucose import; NAS:BHF-UCL		0:SORT1|0:SLC2A4			
GO:0030900	P:forebrain development; TAS:UniProtKB		0:DLC1|0:C1orf187|0:OTX2			
GO:0060588	P:negative regulation of lipoprotein lipid ox...; IDA:BHF-UCL		0:APOM			
GO:0005883	C:neurofilament; TAS:ProtInc		0:NEFL|0:NEFH|0:DLGAP2|0:GAN|0:NEFM|0:INA			
GO:0005968	C:Rab-protein geranylgeranyltransferase complex; TAS:ProtInc		0:CHML|0:CHM			
GO:0001953	P:negative regulation of cell-matrix adhesion; TAS:HGNC		0:HOXA7|0:RASA1|0:ACER2|0:NF2			
GO:0030331	F:estrogen receptor binding; TAS:UniProtKB		0:PPARGC1B|0:WIPI1|0:TAF10|0:DDX54|0:CTNNB1|0:MMS19|0:MED1|0:NRIP1|0:STRN|0:NSD1|0:PHB2|0:RERG|0:NCOA6			
GO:0002489	P:antigen processing and presentation of endo...; IMP:UniProtKB		0:TAP2			
GO:0006065	P:UDP-glucuronate biosynthetic process; EXP:Reactome		0:UGP2|0:UGDH|0:SLC35D1			
GO:0005151	F:interleukin-1, Type II receptor binding; TAS:HGNC		0:ERAP1			
GO:0031247	P:actin rod assembly; IDA:MGI		0:HSP90B1			
GO:0009231	P:riboflavin biosynthetic process; NAS:UniProtKB		0:RFK			
GO:0032788	P:saturated monocarboxylic acid metabolic pro...; IDA:HGNC		0:ACOT4			
GO:0060296	P:regulation of cilium beat frequency involve...; ISS:BHF-UCL		0:BBS4|0:MKKS|0:BBS2			
GO:0046904	F:calcium oxalate binding; NAS:UniProtKB		0:AMBP			
GO:0005796	C:Golgi lumen; TAS:ProtInc		0:PCSK5|0:FURIN|0:PCSK6|0:NGF|0:PPIL2|0:TGFB1|0:AGRP|0:BLZF1|0:SDF4|0:HS3ST1|0:GOLIM4			
GO:0000172	C:ribonuclease MRP complex; TAS:ProtInc		0:POP1|0:POP4			
GO:0017183	P:peptidyl-diphthamide biosynthetic process f...; NAS:UniProtKB		0:DPH3|0:DPH5			
GO:0045900	P:negative regulation of translational elonga...; IEA:InterPro		0:SRP9L1|0:SRP9|0:SRP14			
GO:0009892	P:negative regulation of metabolic process; IDA:BHF-UCL		0:CYP2D6			
GO:0001519	P:peptide amidation; NAS:UniProtKB		0:PGLYRP2			
GO:0048705	P:skeletal system morphogenesis; IMP:UniProtKB		0:TBX4			
GO:0005249	F:voltage-gated potassium channel activity; TAS:UniProtKB		0:KCNMA1|0:KCNS2|0:HCN4|0:KCTD14|0:KCTD20|0:KCTD7|0:KCTD12|0:KCNG4|0:KCNAB1|0:KCTD13|0:KCNV2|0:KCTD3|0:KCNE4|0:KCTD18|0:HCN3|0:TNFAIP1|0:KCTD6|0:KCNA7|0:KCNE3|0:KCTD10|0:KCTD15|0:KCNA10|0:KCNG1|0:KCTD2|0:KCNV1|0:KCNC2|0:KCTD9|0:HCN2|0:KCTD19|0:KCNB1|0:KCTD11|0:KCNAB3|0:KCTD5|0:KCTD16|0:KCTD8|0:KCTD21|0:SHKBP1|0:KCTD1|0:HCN1|0:KCTD17|0:KCTD4|0:KCNF1|0:KCNAB2|0:KCNH5|0:KCNRG|0:KCND1|0:KCNQ2|0:KCNH4|0:KCNC3|0:KCNQ3|0:KCNC4|0:KCNA6|0:KCNC1|0:KCNE2|0:KCNA4|0:KCNH3			
GO:0004581	F:dolichyl-phosphate beta-glucosyltransferase...; IEA:EC		0:ALG5			
GO:0005001	F:transmembrane receptor protein tyrosine pho...; TAS:ProtInc		0:PTPRM|0:PTPRU|0:PTPRK|0:PTPRG|0:PTPRC|0:PTPRB|0:PTPRH|0:PTPRE|0:PTPRS|0:PTPRD|0:PTPRR|0:PTPRN2|0:PTPRN|0:PTPRJ|0:PTPRZ1|0:PTPRO|0:PTPRF|0:PTPRA			
GO:0004402	F:histone acetyltransferase activity; TAS:ProtInc		0:NCOA3|0:CREBBP|0:MYST3|0:EP300|0:TAF1|0:MYST4|0:CDY1B|0:ELP3|0:MGEA5|0:KAT5|0:CDY1|0:CDY2B|0:CLOCK|0:MYST2|0:KAT2B|0:CDYL|0:CDY2A|0:TAF1L|0:SRCAP|0:HAT1|0:GTF3C4			
GO:0001847	F:opsonin receptor activity; TAS:BHF-UCL		0:CD14			
GO:0055096	P:low-density lipoprotein mediated signaling; IDA:BHF-UCL		0:CDH13			
GO:0051453	P:regulation of intracellular pH; IMP:UniProtKB		0:ATP5B			
GO:0030516	P:regulation of axon extension; TAS:UniProtKB		0:NRCAM|0:APOE			
GO:0048565	P:digestive tract development; ISS:BHF-UCL		0:NKX2-6			
GO:0004879	F:ligand-dependent nuclear receptor activity; TAS:ProtInc		0:AHR|0:PTGER3			
GO:0051145	P:smooth muscle cell differentiation; IMP:UniProtKB		0:GATA6			
GO:0001731	P:formation of translation preinitiation complex; ISS:UniProtKB		0:C15orf42			
GO:0043473	P:pigmentation; TAS:BHF-UCL		0:NF1|0:ATP7A|0:C12orf10|0:MC1R|0:TH			
GO:0070273	F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB		0:LANCL2|0:SESTD1			
GO:0006876	P:cellular cadmium ion homeostasis; IGI:BHF-UCL		0:SLC11A1			
GO:0003960	F:NADPH:quinone reductase activity; NAS:UniProtKB		0:CRYZ|0:TP53I3|0:ADH4|0:CRYZL1			
GO:0008525	F:phosphatidylcholine transmembrane transport...; TAS:ProtInc		0:PCTP|0:PITPNA			
GO:0006887	P:exocytosis; TAS:ProtInc		0:SYTL1|0:UNC13B|0:CADPS2|0:TRIM72|0:LLGL1|0:EXOC8|0:SCAMP5|0:CPLX4|0:EXOC3|0:EXOC2|0:LIN7B|0:UNC13A|0:RAB3D|0:NKD2|0:SLC17A9|0:SYCN|0:EXOC7|0:STXBP5|0:SNAPIN|0:LGI3|0:LIN7C|0:RIMS4|0:EXOC5|0:STXBP5L|0:SRCIN1|0:LLGL2|0:TXLNA|0:RALA|0:UNC13C|0:MIA3|0:SCRN1|0:EXOC3L|0:SYTL4|0:ANK1|0:EXOC1|0:ARFGEF2|0:CADPS|0:CCL3|0:LIN7A|0:SNAP29|0:RPH3AL|0:ARFGEF1|0:CCL8|0:CCL5|0:CPLX1			
GO:0043783	F:oxidoreductase activity, oxidizing metal io...; ISS:UniProtKB		0:ETFDH			
GO:0070016	F:armadillo repeat domain binding; ISS:BHF-UCL		0:LEF1|0:TCF4|0:CTNNBIP1|0:STRN4|0:CALCOCO1|0:STRN3|0:STRN|0:AXIN1			
GO:0006123	P:mitochondrial electron transport, cytochrom...; NAS:UniProtKB		0:COX15|0:COX10|0:MT-CO1|0:MT-CO2|0:MT-CO3			
GO:0090090	P:negative regulation of canonical Wnt recept...; ISS:UniProtKB		0:AXIN2|0:SFRP4|0:SOX2|0:SFRP1|0:GLI3|0:MCC|0:WNT4|0:WNT5A|0:SIAH2|0:APC|0:FZD6|0:CTNND1|0:PFDN5|0:SOX17|0:STK3|0:LATS1|0:SFRP5|0:STK4|0:TAZ|0:LATS2|0:WNT11|0:CYLD|0:NKX2-5|0:CAV1|0:C1orf187			
GO:0016095	P:polyprenol catabolic process; IDA:UniProtKB		0:SRD5A3			
GO:0060675	P:ureteric bud morphogenesis; IEP:UniProtKB		0:WNT11			
GO:0047696	F:beta-adrenergic receptor kinase activity; IEA:EC		0:ADRBK1|0:ADRBK2			
GO:0060314	P:regulation of ryanodine-sensitive calcium-r...; TAS:BHF-UCL		0:FKBP1A|0:FKBP1B|0:JPH1|0:JPH3|0:JPH4|0:JPH2			
GO:0051546	P:keratinocyte migration; IDA:UniProtKB		0:FERMT1|0:KRT2			
GO:0071584	P:negative regulation of zinc ion import; ISS:BHF-UCL		0:SLC30A1			
GO:0006282	P:regulation of DNA repair; TAS:ProtInc		0:USP1|0:POLH|0:UBE2V1|0:UBE2V2			
GO:0000066	P:mitochondrial ornithine transport; TAS:ProtInc		0:SLC25A2|0:SLC25A15			
GO:0015055	F:secretin receptor activity; TAS:ProtInc		0:SCTR			
GO:0005925	C:focal adhesion; NAS:UniProtKB		0:PXN|0:TRIM25|0:VASP|0:PDLIM2|0:LASP1|0:SDC1|0:MLF2|0:MYH2|0:MYH7|0:AFAP1|0:LPP|0:MYH1|0:FHL2|0:EBAG9|0:MYH6|0:PDLIM7|0:PARVA|0:PTK2|0:GIT1|0:AIF1L|0:TENC1|0:PGM5|0:TNS4|0:DLC1|0:LIMA1|0:ZYX|0:TRIP6|0:SYNE2|0:ARHGAP26|0:FBLIM1|0:SDCBP|0:LIMS1|0:NOX4|0:FERMT2|0:NEDD9|0:PARVB|0:PARVG|0:TNS1|0:PAK1|0:LIMS2|0:RHOU|0:TES|0:FERMT1|0:ARHGAP24|0:ENAH|0:DIXDC1|0:TLN2|0:TGFB1I1|0:PRUNE|0:TNS3|0:STARD8|0:GAK|0:CASS4|0:ILK|0:SH3KBP1|0:ARHGAP31|0:APBB1IP|0:ACTN2|0:ACTN3|0:ACTN1|0:PTPRC|0:EVL|0:VCL|0:BCAR1|0:S100A7|0:TLN1			
GO:0008187	F:poly-pyrimidine tract binding; TAS:ProtInc		0:PTBP1			
GO:0033261	P:regulation of S phase; IMP:UniProtKB		0:CDC7|0:TIMELESS|0:PTPRC|0:SLBP			
GO:0005114	F:type II transforming growth factor beta rec...; TAS:BHF-UCL		0:TGFB3|0:TGFBR3|0:TGFB2|0:TGFBR1|0:TGFB1|0:ENG|0:BAMBI			
GO:0045404	P:positive regulation of interleukin-4 biosyn...; NAS:UniProtKB		0:IRF4|0:CD86			
GO:0005127	F:ciliary neurotrophic factor receptor binding; TAS:ProtInc		0:IL6ST|0:LIFR|0:CNTF			
GO:0010465	F:nerve growth factor receptor activity; IDA:BHF-UCL		0:SORT1			
GO:0051290	P:protein heterotetramerization; IDA:UniProtKB		0:INSR			
GO:0009107	P:lipoate biosynthetic process; IEA:InterPro		0:LIPT2|0:LIAS			
GO:0042272	C:nuclear RNA export factor complex; NAS:UniProtKB		0:NXF3|0:NXF2|0:NXF2B			
GO:0007033	P:vacuole organization; TAS:ProtInc		0:NDP			
GO:0006487	P:protein amino acid N-linked glycosylation; TAS:UniProtKB		0:MGAT3|0:MGAT1|0:POMGNT1|0:ALG6|0:ALG8|0:DOLPP1|0:MAN1B1|0:MGAT5|0:MOGS|0:GAL3ST1|0:MAN1C1			
GO:0009954	P:proximal/distal pattern formation; ISS:UniProtKB		0:CYP26B1|0:GLI2			
GO:0070887	P:cellular response to chemical stimulus; IMP:BHF-UCL		0:SERPINE1			
GO:0034241	P:positive regulation of macrophage fusion; IMP:BHF-UCL		0:ADAM9			
GO:0030836	P:positive regulation of actin filament depol...; IDA:BHF-UCL		0:PLEK			
GO:0042445	P:hormone metabolic process; TAS:UniProtKB		0:KLK6|0:ALDH9A1			
GO:0006910	P:phagocytosis, recognition; IDA:UniProtKB		0:COLEC12|0:CLEC7A			
GO:0032369	P:negative regulation of lipid transport; IMP:BHF-UCL		0:ITGB3|0:NR1H3|0:NR1H2|0:ITGAV			
GO:0030866	P:cortical actin cytoskeleton organization; IMP:UniProtKB		0:PLEK|0:LLGL1|0:DLG1|0:EPB41L1|0:EPB41L2|0:EPB41L3|0:EPB41|0:RHOQ|0:ARF6			
GO:0016234	C:inclusion body; ISS:UniProtKB		0:DNAJB2|0:HSPA1A|0:BAG5|0:HSPA1B|0:MIOX			
GO:0004748	F:ribonucleoside-diphosphate reductase activity; NAS:UniProtKB		0:RRM2B|0:RRM2|0:RRM1			
GO:0047238	F:glucuronosyl-N-acetylgalactosaminyl-proteog...; IEA:EC		0:CHSY1|0:CSGALNACT1|0:CHPF|0:CHSY3			
GO:0004315	F:3-oxoacyl-[acyl-carrier-protein] synthase a...; IDA:HGNC		0:FASN|0:OXSM			
GO:0016298	F:lipase activity; IDA:UniProtKB		0:LIPA			
GO:0033267	C:axon part; ISS:UniProtKB		0:DTNBP1			
GO:0048149	P:behavioral response to ethanol; TAS:BHF-UCL		0:DRD2|0:DRD4			
GO:0010155	P:regulation of proton transport; NAS:UniProtKB		0:SLC30A5|0:NOX5			
GO:0051208	P:sequestering of calcium ion; TAS:BHF-UCL		0:ATP7B|0:HSP90B1|0:CALR			
GO:0043434	P:response to peptide hormone stimulus; ISS:UniProtKB		0:EIF2B3|0:EIF2B2|0:EIF2B5|0:EIF2B1|0:EIF2B4			
GO:0004020	F:adenylylsulfate kinase activity; IEA:EC		0:PAPSS1|0:PAPSS2			
GO:0008097	F:5S rRNA binding; IEA:InterPro		0:RPL5			
GO:0043142	F:single-stranded DNA-dependent ATPase activity; IDA:UniProtKB		0:RAD51			
GO:0004875	F:complement receptor activity; TAS:ProtInc		0:CR2|0:CR1			
GO:0005773	C:vacuole; TAS:HGNC		0:DNPEP|0:STX4			
GO:0004618	F:phosphoglycerate kinase activity; NAS:UniProtKB		0:PGK1|0:PGK2			
GO:0048256	F:flap endonuclease activity; IDA:UniProtKB		0:EXO1			
GO:0033391	C:chromatoid body; ISS:UniProtKB		0:PIWIL1|0:TDRD6|0:PIWIL2|0:TDRD7|0:DDX25			
GO:0005942	C:phosphoinositide 3-kinase complex; NAS:UniProtKB		0:PIK3C2B|0:PIK3C3|0:PIK3CG|0:PIK3C2G|0:PIK3CB|0:PIK3R2|0:PIK3C2A|0:PIK3R3|0:PIK3CD|0:MTOR			
GO:0035068	C:micro-ribonucleoprotein complex; IDA:UniProtKB		0:EIF2C2|0:TNRC6A			
GO:0071062	C:alphav-beta3 integrin-vitronectin complex; TAS:BHF-UCL		0:ITGB3|0:VTN|0:ITGA5			
GO:0007029	P:endoplasmic reticulum organization; ISS:UniProtKB		0:ATL1|0:BNIP1|0:ATL3|0:ATL2|0:DOPEY2|0:CAV2|0:EIF2AK3			
GO:0008509	F:anion transmembrane transporter activity; ISS:BHF-UCL		0:ABCA1			
GO:0018191	P:peptidyl-serine octanoylation; IDA:UniProtKB		0:MBOAT4			
GO:0070534	P:protein K63-linked ubiquitination; ISS:UniProtKB		0:PARK2|0:TRAF6|0:ITCH|0:UBE2S|0:UBE2E2|0:ARIH2|0:UBE2T|0:UBE2D4|0:UBE2N|0:UBE2B|0:UBE2E3|0:RNF5|0:UBE2G1|0:TRAF2|0:ZFP91|0:RNF4|0:WWP2			
GO:0004765	F:shikimate kinase activity; IEA:InterPro		0:THNSL1|0:C9orf103			
GO:0000784	C:nuclear chromosome, telomeric region; ISS:UniProtKB		0:TNKS2|0:PURA|0:RAD50|0:TNKS|0:NBN|0:PIF1|0:ERCC1|0:ERCC4|0:ZSCAN4			
GO:0043010	P:camera-type eye development; IMP:UniProtKB		0:CRYBA4			
GO:0031695	F:alpha-2B adrenergic receptor binding; IPI:BHF-UCL		0:APLP1			
GO:0004485	F:methylcrotonoyl-CoA carboxylase activity; NAS:UniProtKB		0:MCCC1|0:MCCC2			
GO:0043949	P:regulation of cAMP-mediated signaling; ISS:UniProtKB		0:PEX5L			
GO:0031782	F:type 4 melanocortin receptor binding; IPI:BHF-UCL		0:MRAP|0:MRAP2|0:POMC			
GO:0004706	F:JUN kinase kinase kinase activity; ISS:UniProtKB		0:MAP3K10|0:MAP3K11|0:MAP3K9			
GO:0004319	F:enoyl-[acyl-carrier-protein] reductase (NAD...; EXP:Reactome		0:FASN			
GO:0071356	P:cellular response to tumor necrosis factor; IDA:UniProtKB		0:SFRP1			
GO:0050730	P:regulation of peptidyl-tyrosine phosphoryla...; IMP:UniProtKB		0:ITGB2|0:EGFR			
GO:0004854	F:xanthine dehydrogenase activity; TAS:ProtInc		0:AOX1|0:XDH			
GO:0021527	P:spinal cord association neuron differentiation; ISS:HGNC		0:MDGA1			
GO:0008332	F:low voltage-gated calcium channel activity; TAS:ProtInc		0:CACNA1I|0:CACNA1H|0:CACNA1G			
GO:0017017	F:MAP kinase tyrosine/serine/threonine phosph...; IEA:InterPro		0:DUSP6|0:DUSP7|0:DUSP8|0:DUSP2|0:DUSP21|0:DUSP18|0:DUSP14|0:DUSP10|0:DUSP16|0:DUSP1			
GO:0010905	P:negative regulation of UDP-glucose cataboli...; IC:BHF-UCL		0:GSK3A			
GO:0030663	C:COPI coated vesicle membrane; IEA:UniProtKB-SubCell		0:TMED2			
GO:0005094	F:Rho GDP-dissociation inhibitor activity; TAS:ProtInc		0:ARHGDIB|0:ARHGDIG|0:ARHGDIA			
GO:0005815	C:microtubule organizing center; TAS:ProtInc		0:CHMP1A|0:CDC25B|0:CEP350|0:TACC1|0:HAUS7|0:HAUS3|0:LZTS2|0:MTUS1|0:JUB|0:RASSF1|0:SMEK2|0:ARL2|0:ARL2BP|0:PDE4D|0:C7orf11|0:ACTR1A|0:FAM110A|0:CSNK1A1|0:CEP57L1|0:CEP78|0:CEP152|0:C13orf15|0:FAM110C|0:CCT4|0:HAUS4|0:FSD1|0:BBS9|0:HAUS1|0:SNCG|0:NUBP2|0:SCYL1|0:CCDC99|0:RUVBL1|0:SEPT1|0:AZI1|0:KIAA1009|0:CDC14A|0:CCT8|0:KIF2A|0:CSPP1|0:PDCD6IP|0:CEP68|0:AKAP11|0:CEP70|0:HAUS8|0:ACTR1B|0:HAUS5|0:SLMAP|0:NINL|0:PSKH1|0:MCPH1|0:CHEK1|0:KIFC1|0:C14orf166|0:LATS1|0:TACC2|0:SPAST|0:CRMP1|0:TOPBP1|0:HAUS6|0:EVI5|0:SSNA1|0:KIF2B|0:HOOK2|0:CCNB1|0:CLIC5|0:MKKS|0:PDE4DIP|0:SMEK1|0:LATS2|0:KIF18A|0:UBXN6|0:MAPRE1|0:BOD1|0:FAM125A|0:TTC8|0:DCTN3|0:CLASP2|0:BUB1B|0:CCT5|0:FAM110B|0:ABCA2|0:TUBGCP2|0:KPTN			
GO:0005642	C:annulate lamellae; IDA:UniProtKB		0:XPO1|0:EIF5A			
GO:0015630	C:microtubule cytoskeleton; TAS:ProtInc		0:NDRG1|0:GTF2F2|0:ALDH9A1|0:ZNF44|0:MAPK1|0:DPYSL2|0:PSMA3|0:SPTAN1|0:SULT1C2|0:SPIB|0:CDC42EP4|0:ZNF415|0:MAPK3|0:ACTRT2|0:GNE|0:CCNB2|0:CCNA1|0:C1orf49|0:THAP6|0:C16orf48|0:RASSF1|0:LYST|0:PPP2R1A|0:MARK1			
GO:0004053	F:arginase activity; TAS:ProtInc		0:ARG2|0:ARG1			
GO:0071542	P:dopaminergic neuron differentiation; IDA:UniProtKB		0:FGF8			
GO:0060956	P:endocardial cell differentiation; ISS:BHF-UCL		0:SOX17|0:SOX18			
GO:0007606	P:sensory perception of chemical stimulus; TAS:ProtInc		0:C5AR1			
GO:0000808	C:origin recognition complex; IDA:UniProtKB		0:ORC1|0:ORC5|0:ORC4			
GO:0043425	F:bHLH transcription factor binding; ISS:BHF-UCL		0:USF2|0:HAND1|0:TCF3|0:USF1|0:ASCL1|0:PSMD9			
GO:0043281	P:regulation of caspase activity; IDA:UniProtKB		0:SOX2			
GO:0030299	P:intestinal cholesterol absorption; TAS:UniProtKB		0:ABCG8|0:SOAT2|0:ABCG5|0:LDLR|0:NPC1L1|0:CEL|0:AKR1C1			
GO:0004079	F:biotin-[methylmalonyl-CoA-carboxytransferas...; IEA:EC		0:HLCS			
GO:0060152	P:microtubule-based peroxisome localization; ISS:UniProtKB		0:PEX1|0:PEX13			
GO:0032418	P:lysosome localization; IMP:BHF-UCL		0:VPS33B|0:VPS33A|0:HDAC6			
GO:0034145	P:positive regulation of toll-like receptor 4...; IDA:BHF-UCL		0:LBP			
GO:0006833	P:water transport; TAS:ProtInc		0:PDZD3|0:AVP			
GO:0046491	P:L-methylmalonyl-CoA metabolic process; IDA:UniProtKB		0:MCEE			
GO:0051434	F:BH3 domain binding; IPI:UniProtKB		0:BAX|0:BCL2			
GO:0030158	F:protein xylosyltransferase activity; TAS:UniProtKB		0:XYLT2|0:XYLT1			
GO:0032730	P:positive regulation of interleukin-1 alpha ...; IDA:UniProtKB		0:CALCA			
GO:0030099	P:myeloid cell differentiation; TAS:UniProtKB		0:MYST3|0:NCOA6|0:RUNX1|0:PRDX3|0:RASGRP4|0:ZBTB16|0:SNRK			
GO:0045092	C:interleukin-18 receptor complex; NAS:UniProtKB		0:TOLLIP			
GO:0022417	P:protein maturation by protein folding; TAS:BHF-UCL		0:WFS1|0:AIP|0:FKBP1B|0:CALR|0:FKBP1A			
GO:0070876	C:SOSS complex; IDA:UniProtKB		0:OBFC2A|0:OBFC2B|0:INTS3|0:C9orf80			
GO:0031418	F:L-ascorbic acid binding; IEA:UniProtKB-KW		0:C17orf101|0:TMLHE|0:LEPRE1|0:PLOD2|0:EGLN2|0:LEPREL1|0:PAM|0:P4HTM|0:PLOD3|0:LEPREL2|0:P4HA3|0:OGFOD2|0:DBH|0:P4HA2|0:EGLN3|0:ALKBH3|0:PHYH|0:OGFOD1|0:EGLN1|0:P4HA1|0:PLOD1			
GO:0016566	F:specific transcriptional repressor activity; TAS:UniProtKB		0:UBE2I|0:BMP2|0:TCF7L2|0:HDAC9|0:SUFU|0:ZBTB16|0:HDAC1|0:NKRF|0:PHB2|0:ZC3H8|0:HDAC10|0:EID1|0:BASP1|0:PRDM5|0:SFRP1|0:HINFP|0:WNT5A|0:TFAP4|0:ESX1|0:TAF7|0:WT1|0:PFDN5|0:HDAC2|0:HDAC4|0:NACC1|0:CREBZF|0:PPARG|0:FOXS1|0:NACC2|0:HDAC6|0:UBP1|0:HDAC5			
GO:0004143	F:diacylglycerol kinase activity; TAS:UniProtKB		0:DGKK|0:DGKZ|0:DGKQ|0:DGKB|0:AGK|0:SPHK2|0:CERKL|0:SPHK1|0:CERK|0:DGKH|0:DGKI|0:DGKA|0:DGKE|0:DGKG|0:DGKD			
GO:0060038	P:cardiac muscle cell proliferation; ISS:UniProtKB		0:TGFB2|0:TGFBR3|0:BMP10			
GO:0051879	F:Hsp90 protein binding; TAS:BHF-UCL		0:AHR|0:STUB1|0:ARNTL|0:HDAC6|0:HIF1A|0:NPAS2|0:NASP|0:KDR			
GO:0032229	P:negative regulation of synaptic transmissio...; ISS:UniProtKB		0:ADRA1A|0:STXBP1			
GO:0051204	P:protein insertion into mitochondrial membrane; IGI:UniProtKB		0:COX18			
GO:0046592	F:polyamine oxidase activity; EXP:Reactome		0:PAOX			
GO:0016401	F:palmitoyl-CoA oxidase activity; ISS:BHF-UCL		0:ACADL			
GO:0051927	P:negative regulation of calcium ion transpor...; ISS:UniProtKB		0:DRD4|0:DRD2|0:ADRA2A|0:NCS1|0:IL1RAPL1			
GO:0008469	F:histone-arginine N-methyltransferase activity; IEA:EC		0:PRMT8|0:PRMT5|0:CARM1			
GO:0015711	P:organic anion transport; IEA:InterPro		0:SLC16A3|0:SLC10A1|0:SLC16A1|0:SLC10A2|0:SLC16A5|0:SLC10A3			
GO:0019855	F:calcium channel inhibitor activity; NAS:UniProtKB		0:TNNI3|0:SLC30A1|0:AMBP			
GO:0033089	P:positive regulation of T cell differentiati...; ISS:BHF-UCL		0:VNN1			
GO:0006585	P:dopamine biosynthetic process from tyrosine; NAS:BHF-UCL		0:TH			
GO:0015853	P:adenine transport; TAS:ProtInc		0:VDAC3			
GO:0051287	F:NAD or NADH binding; TAS:UniProtKB		0:BDH2|0:ADH4|0:SORD|0:AOX1|0:IDH3G|0:GPD1L|0:NDUFV2|0:ME3|0:IDH2|0:HIBADH|0:NDUFS2|0:HTATIP2|0:IDH3B|0:GAPDHS|0:ME2|0:NDUFV1|0:IDH1|0:UGDH|0:CTBP2|0:PHGDH|0:GAPDH|0:IDH3A|0:CTBP1|0:NNT|0:GRHPR|0:ME1			
GO:0005351	F:sugar:hydrogen symporter activity; TAS:ProtInc		0:SLC35A1|0:SLC35A5|0:SLC35A3|0:SLC35A4|0:SLC4A11|0:SLC35A2|0:SLC2A10|0:SLC2A9|0:SLC17A5			
GO:0032579	C:apical lamina of hyaline layer; IEA:UniProtKB-SubCell		0:TFF3			
GO:0000492	P:box C/D snoRNP assembly; IMP:BHF-UCL		0:PIH1D1|0:ZNHIT6|0:NUFIP1			
GO:0006173	P:dADP biosynthetic process; TAS:ProtInc		0:AK5			
GO:0035313	P:wound healing, spreading of epidermal cells; IMP:UniProtKB		0:ITGA5|0:ADAM17|0:ACVRL1|0:COL5A1			
GO:0050679	P:positive regulation of epithelial cell prol...; TAS:HGNC		0:IGF1|0:TGFA|0:EGFR|0:LACRT|0:ERBB2|0:NME1|0:NME2|0:EPGN|0:LAMB1|0:LAMC1			
GO:0032202	P:telomere assembly; IMP:BHF-UCL		0:ACD|0:TINF2			
GO:0051349	P:positive regulation of lyase activity; IDA:UniProtKB		0:FTMT|0:FXN			
GO:0001967	P:suckling behavior; ISS:UniProtKB		0:UBR3|0:PEX13			
GO:0050577	F:GDP-L-fucose synthase activity; IEA:EC		0:TSTA3			
GO:0005542	F:folic acid binding; TAS:ProtInc		0:SLC19A2|0:C2orf83|0:SLC19A3|0:FOLR4|0:SLC19A1|0:FTCD|0:GNMT|0:SLC46A1|0:MTHFS|0:FOLR1|0:FOLR2|0:FOLR3			
GO:0010748	P:negative regulation of plasma membrane long...; IMP:BHF-UCL		0:THBS1|0:AKT2|0:AKT1|0:IRS2			
GO:0070555	P:response to interleukin-1; ISS:UniProtKB		0:IL1R1|0:SELE|0:AES|0:SNCA|0:TRAF6|0:RELA|0:MYD88|0:PRKCA|0:TAF9|0:IRAK1|0:HDAC4|0:SRC|0:IRAK2|0:IRAK3|0:IGBP1|0:TNFRSF11A|0:CITED1			
GO:0050711	P:negative regulation of interleukin-1 secretion; IDA:HGNC		0:NLRP12			
GO:0034617	F:tetrahydrobiopterin binding; NAS:BHF-UCL		0:NOS3|0:NOS2|0:NOS1			
GO:0032091	P:negative regulation of protein binding; TAS:BHF-UCL		0:AES|0:CTNNBIP1|0:GSK3B|0:CAV1|0:LRPAP1|0:PARK7|0:PRKCD			
GO:0003998	F:acylphosphatase activity; TAS:ProtInc		0:ACYP2|0:ACYP1			
GO:0043152	P:induction of bacterial agglutination; TAS:UniProtKB		0:DMBT1			
GO:0008176	F:tRNA (guanine-N7-)-methyltransferase activity; IDA:UniProtKB		0:METTL1			
GO:0022891	F:substrate-specific transmembrane transporte...; IEA:InterPro		0:ABCB9|0:SLC2A12|0:SLC2A11			
GO:0000252	F:C-3 sterol dehydrogenase (C-4 sterol decarb...; EXP:Reactome		0:NSDHL			
GO:0016269	P:O-glycan processing, core 3; NAS:UniProtKB		0:B3GNT6			
GO:0006094	P:gluconeogenesis; TAS:UniProtKB		0:PC|0:G6PC2|0:SDS|0:FBP2|0:GPI|0:G6PC3|0:TPI1|0:PCK2|0:FBP1|0:RBP4|0:G6PC|0:PCK1|0:ATF4|0:PPARGC1A|0:GPT|0:SLC25A10|0:PFKFB1			
GO:0004925	F:prolactin receptor activity; NAS:UniProtKB		0:PRLR			
GO:0042516	P:regulation of tyrosine phosphorylation of S...; ISS:UniProtKB		0:IL22RA2			
GO:0050996	P:positive regulation of lipid catabolic process; ISS:BHF-UCL		0:ANGPTL3|0:APOA2|0:IL1B			
GO:0030027	C:lamellipodium; NAS:UniProtKB		0:PXN|0:NME2|0:ITGB1BP1|0:PTPRM|0:ABI3|0:WASF2|0:CORO1A|0:CCDC88A|0:DAG1|0:AMOT|0:ABI1|0:PODXL|0:DGKZ|0:TESC|0:TSC1|0:SCYL3|0:APBB1|0:ABI2|0:PIP5K1A|0:WASH3P|0:ITSN1|0:RAPH1|0:IGF2BP1|0:RAC3|0:SSH1|0:NEDD9|0:TIAM2|0:CDK5|0:SH3RF1|0:SLC39A14|0:ENAH|0:PSTPIP1|0:NRBP1|0:SWAP70|0:ARHGAP31|0:APBB1IP|0:APBB2|0:FGD3|0:EVL|0:DBNL|0:FGD6|0:FGD2|0:FGD5|0:CYFIP1|0:ARAP3|0:FGD1|0:CTTN|0:FGD4|0:ALS2|0:SPRY1			
GO:0071253	F:connexin binding; ISS:UniProtKB		0:CNST			
GO:0048199	P:vesicle targeting, to, from or within Golgi; ISS:HGNC		0:TMED10			
GO:0032137	F:guanine/thymine mispair binding; IMP:MGI		0:MSH2			
GO:0007160	P:cell-matrix adhesion; TAS:UniProtKB		0:VTN|0:HOXD3|0:ITGB1BP1|0:COL3A1|0:EPDR1|0:RAPH1|0:ITGB7|0:MUC4|0:ITGB8|0:ITGB3|0:ITGB2|0:ITGB6|0:ITGBL1|0:ITGB5|0:NID1|0:SNED1|0:TECTA|0:PXN|0:ITGB4|0:BCAM|0:ADAM9|0:TMEM8B|0:TSC1|0:ANGPTL3|0:COL13A1|0:RAC1|0:ITGAD|0:ADAMTS13|0:DEFB118|0:SIGLEC1|0:ITGA8|0:C22orf28|0:CD44|0:ITGA1|0:ILK|0:THBS3|0:ITGAV|0:VCL|0:ITGA7|0:ITGA3|0:ITGA11|0:PPFIA1|0:ADAM15|0:ITGA2|0:ITGA10|0:COL17A1|0:FBLN5|0:FXC1|0:PPFIA2|0:LYVE1|0:SGCE|0:PKD2|0:ECM2|0:PARVG			
GO:0019531	F:oxalate transmembrane transporter activity; IDA:UniProtKB		0:SLC26A8|0:SLC26A7			
GO:0005337	F:nucleoside transmembrane transporter activity; IEA:InterPro		0:SLC29A1|0:SLC29A2|0:SLC29A4			
GO:0032145	F:succinate-semialdehyde dehydrogenase binding; ISS:UniProtKB		0:ABAT			
GO:0006606	P:protein import into nucleus; TAS:ProtInc		0:RPAIN|0:IPO13|0:PTTG1IP|0:KPNA7|0:SNUPN|0:TMCO6|0:TSC2|0:IPO9|0:RANBP17|0:NDUFA13|0:TPR|0:PPP1R10|0:MCM3AP|0:PDIA3|0:RANBP2			
GO:0045177	C:apical part of cell; ISS:BHF-UCL		0:VCAM1|0:USH1C|0:PDZD3|0:CLIC4|0:CA2|0:HFE|0:CLCN5|0:ITPR3			
GO:0003688	F:DNA replication origin binding; TAS:ProtInc		0:ORC4|0:HSPD1|0:ORC3|0:ORC2|0:ORC5			
GO:0007262	P:STAT protein nuclear translocation; TAS:ProtInc		0:F2R|0:F2			
GO:0042998	P:positive regulation of Golgi to plasma memb...; IMP:UniProtKB		0:CNST			
GO:0043394	F:proteoglycan binding; TAS:BHF-UCL		0:CECR1|0:SLIT2|0:COL5A1|0:THBS1			
GO:0016209	F:antioxidant activity; NAS:UniProtKB		0:APOE|0:APOA4|0:C9orf21|0:SRXN1|0:ALB|0:MT3			
GO:0004800	F:thyroxine 5'-deiodinase activity; TAS:UniProtKB		0:DIO3|0:DIO1|0:DIO2			
GO:0007026	P:negative regulation of microtubule depolyme...; NAS:UniProtKB		0:STMN2|0:APC|0:MAP4|0:MAP2|0:MAPT|0:KATNB1|0:ARHGEF2|0:CLASP1|0:MID1IP1|0:CLASP2|0:TRIM54			
GO:0060053	C:neurofilament cytoskeleton; TAS:UniProtKB		0:SYNM			
GO:0006611	P:protein export from nucleus; TAS:ProtInc		0:SMURF1|0:TGFB1|0:XPO7|0:STRADA|0:XPO6|0:STRADB|0:CALR|0:NUP214|0:EIF5A|0:NUPL2			
GO:0051106	P:positive regulation of DNA ligation; IDA:UniProtKB		0:RAD51			
GO:0015068	F:glycine amidinotransferase activity; IDA:MGI		0:GATM			
GO:0048807	P:female genitalia morphogenesis; ISS:BHF-UCL		0:RBP4			
GO:0000786	C:nucleosome; TAS:UniProtKB		0:HILS1|0:TNP1|0:MYST3|0:HP1BP3|0:SHPRH|0:HIST1H1A|0:H1FOO|0:H1F0|0:HIST1H1T|0:HIST2H3A|0:H2AFJ|0:HIST2H2BF|0:HIST1H3F|0:H2AFB3|0:HIST1H2AG|0:H3F3A|0:PRM3|0:HIST1H3H|0:HIST1H2AK|0:HIST1H3A|0:HIST2H3D|0:HIST3H2BB|0:HIST1H3G|0:HIST1H2AI|0:H2AFB1|0:H3F3B|0:H2AFY2|0:HIST2H2AA3|0:H2AFV|0:HIST1H3I|0:HIST1H3B|0:HIST1H3C|0:HIST1H3D|0:HIST1H3J|0:HIST1H2AA|0:HIST2H2AA4|0:CENPA|0:HIST1H2AH|0:H2AFB2|0:HIST2H3C|0:PRM1|0:HIST1H2AM|0:HIST2H2AB|0:HIST1H4G|0:HIST3H2A|0:HIST2H2BD|0:H2BFS|0:HIST1H3E|0:H2BFWT|0:TNP2|0:HIST1H2BA|0:H2AFZ|0:HIST1H2BK|0:PRM2|0:HIST1H2BD|0:HIST1H2AL|0:H2BFM|0:HIST2H2BC|0:HIST1H2AD|0:HIST1H2AJ|0:HIST1H1D|0:HIST1H1C|0:HIST1H2BH|0:HIST1H2BO|0:HIST2H2BE|0:HIST1H2BN|0:HIST1H2BB|0:HIST1H2BC|0:HIST3H3|0:HIST1H1E|0:HIST1H2AC|0:HIST1H2AB|0:H2AFX|0:HIST1H2BG|0:HIST1H2BM|0:HIST1H2BF|0:HIST1H2BJ|0:H2AFY|0:HIST1H2BL|0:HIST1H2BE|0:HIST1H1B|0:HIST1H2BI|0:HIST2H2AC|0:MYST4|0:HIST1H2AE|0:H1FX|0:HIST1H4I|0:HIST1H4L|0:HIST1H4B|0:HIST1H4E|0:HIST2H4A|0:HIST1H4H|0:HIST1H4A|0:HIST4H4|0:HIST1H4D|0:HIST1H4K|0:HIST1H4J|0:HIST1H4C|0:HIST2H4B|0:HIST1H4F			
GO:0017075	F:syntaxin-1 binding; TAS:UniProtKB		0:STXBP1|0:SNPH|0:SYT1			
GO:0050811	F:GABA receptor binding; NAS:UniProtKB		0:JAKMIP1|0:GABARAP|0:GABARAPL1|0:TRAK2|0:GABARAPL2			
GO:0004867	F:serine-type endopeptidase inhibitor activity; TAS:UniProtKB		0:FURIN|0:SERPINE2|0:SERPINE1|0:SERPINB9|0:SERPING1|0:A2M|0:SPINK5|0:SERPINA5|0:APP|0:SPINK9|0:SERPINA9|0:SERPINB8|0:SERPINB5|0:CRIM1|0:WFIKKN1|0:SPINK4|0:SERPINB2|0:SERPIND1|0:ITIH3|0:WFDC2|0:TFPI|0:SPINK8|0:APLP2|0:ITIH2|0:ITIH5L|0:SPINT4|0:SERPINA11|0:PEBP1|0:COL28A1|0:WFIKKN2|0:COL6A3|0:A2ML1|0:CPAMD8|0:WFDC8|0:ITIH4|0:WFDC3|0:SERPINA12|0:SERPINB11|0:ITIH5|0:SPINLW1|0:SPINK2|0:TFPI2|0:KAL1|0:SPINK1|0:WFDC5|0:SLPI|0:SPINK6|0:SERPINE3|0:COL7A1|0:CD109|0:WFDC6|0:WFDC10A|0:SERPINA13|0:WFDC1|0:PZP|0:SPINT3|0:SPINK7|0:RECK|0:ITIH1|0:PAPLN|0:SERPINB12|0:SERPINB1|0:SERPINB13|0:WFDC12|0:SERPINA1|0:SERPINF2|0:SERPINB4|0:SERPINC1|0:SERPINF1|0:PI3|0:SERPINH1|0:SERPINI2|0:SERPINA2|0:SERPINB3|0:SERPINB10|0:SERPINB6|0:SPINT1|0:SERPINA4|0:SERPINB7|0:SERPINA7|0:SPINT2|0:AGT|0:SERPINI1|0:SERPINA10|0:SERPINA6|0:SERPINA3|0:AMBP			
GO:0033182	P:regulation of histone ubiquitination; IMP:HGNC		0:UBE2N			
GO:0030122	C:AP-2 adaptor complex; TAS:UniProtKB		0:AP2A2|0:AP2A1|0:AP2S1			
GO:0030983	F:mismatched DNA binding; IEA:InterPro		0:PMS2L2|0:MSH5|0:TDG|0:MLH3|0:PMS1|0:MSH4|0:PMS2L12|0:PMS2CL|0:PMS2L1|0:MSH3|0:PMS2L11|0:PMS2L5			
GO:0016320	P:endoplasmic reticulum membrane fusion; IMP:HGNC		0:BNIP1			
GO:0018467	F:formaldehyde dehydrogenase activity; IDA:UniProtKB		0:ADH5			
GO:0019674	P:NAD metabolic process; EXP:Reactome		0:NAPRT1|0:NADK|0:NAMPT			
GO:0061136	P:regulation of proteasomal protein catabolic...; IMP:UniProtKB		0:GPX1|0:PSME3|0:UCHL5|0:USP14|0:PSMD14			
GO:0035115	P:embryonic forelimb morphogenesis; ISS:UniProtKB		0:WNT7A|0:ZNF358			
GO:0006337	P:nucleosome disassembly; TAS:UniProtKB		0:TNP1|0:NFE2|0:SUPT16H|0:SMARCE1|0:HMGA1|0:SET			
GO:0007231	P:osmosensory signaling pathway; TAS:UniProtKB		0:TRPV4			
GO:0009063	P:cellular amino acid catabolic process; IEA:InterPro		0:ENOSF1			
GO:0033588	C:Elongator holoenzyme complex; IDA:HGNC		0:ELP4			
GO:0070469	C:respiratory chain; IEA:UniProtKB-KW		0:UQCR11|0:MT-CO1|0:CYC1|0:UQCRQ|0:MT-CO2|0:CYCS|0:UQCR10			
GO:0060548	P:negative regulation of cell death; IMP:BHF-UCL		0:PARK2|0:FGF2|0:WNT16			
GO:0042806	F:fucose binding; ISS:UniProtKB		0:SELP|0:CLEC17A|0:ACR			
GO:0001574	P:ganglioside biosynthetic process; NAS:UniProtKB		0:ST3GAL5			
GO:0000079	P:regulation of cyclin-dependent protein kina...; TAS:UniProtKB		0:CDKN2D|0:CDKN2B|0:CDKN2C|0:GTPBP4|0:BCCIP|0:BLM|0:CDK5RAP3|0:CCNE2|0:DIRAS3|0:PKMYT1|0:CDKN3|0:CCNT1|0:CKS1B|0:C13orf15|0:HERC5|0:MNAT1|0:CDK5R1|0:CCNK|0:CKS2|0:CHEK1|0:CDK5R2|0:CDKN1C|0:GADD45A|0:CCNG1|0:CDK7|0:CDC37|0:CCNT2|0:ANAPC2|0:CDC6|0:SERTAD1|0:GTF2H1|0:CDKN1B|0:CDC25C|0:CDC25A|0:PTEN			
GO:0030235	F:nitric-oxide synthase regulator activity; NAS:UniProtKB		0:AKT1|0:HSP90AA1|0:HSP90AB1|0:ESR1			
GO:0050929	P:induction of negative chemotaxis; IDA:UniProtKB		0:SLIT2			
GO:0042987	P:amyloid precursor protein catabolic process; TAS:HGNC		0:ABCG1|0:CLN3|0:APH1A|0:PSEN1|0:PSENEN|0:NCSTN|0:PSEN2			
GO:0000080	P:G1 phase of mitotic cell cycle; TAS:UniProtKB		0:CDC23|0:FOXO4|0:TCF3|0:CDK6|0:TAF1|0:MAP3K11|0:E2F1|0:CDKN1C|0:TBRG4			
GO:0004060	F:arylamine N-acetyltransferase activity; TAS:ProtInc		0:NAT1|0:NAT2			
GO:0035021	P:negative regulation of Rac protein signal t...; ISS:HGNC		0:STMN3			
GO:0050660	F:FAD binding; TAS:UniProtKB		0:ETFA|0:AIFM2|0:XDH|0:KMO|0:NDOR1|0:FOXRED2|0:KDM1A|0:DUS3L|0:AGPS|0:SQLE|0:FMO6P|0:TXNRD1|0:MTO1|0:DUS1L|0:AOX1|0:SDHA|0:AIFM1|0:FMO5|0:ERO1L|0:GCDH|0:ERO1LB|0:ACAD8|0:ACOX1|0:ACADS|0:DUOX1|0:ACADSB|0:STEAP2|0:FMO2|0:DUS4L|0:ACADVL|0:ACOX3|0:DUS2L|0:D2HGDH|0:FMO4|0:ACAD10|0:NOX1|0:CHDH|0:STEAP1|0:DHCR24|0:FMO1|0:ACAD9|0:ACADL|0:ACAD11|0:FMO3|0:AIFM3|0:STEAP4|0:TXNRD3|0:ACADM|0:NOX3|0:ACOXL|0:IVD|0:COQ6|0:LDHD|0:STEAP3|0:DUOX2|0:TXNRD2|0:CYBB|0:NOS1|0:NOS2|0:DPYD|0:ETFDH|0:NOS3|0:NOX5|0:PPOX|0:NOX4|0:MTRR			
GO:0008331	F:high voltage-gated calcium channel activity; IDA:UniProtKB		0:CACNA1S			
GO:0004722	F:protein serine/threonine phosphatase activity; TAS:ProtInc		0:PPM1L|0:PHLPP1|0:CDKN3|0:PPP6C|0:PPP2R2A|0:EPM2A|0:MTMR3|0:LCK|0:PPM1A|0:TIMM50|0:CDC14B|0:PTEN|0:PPM1F|0:PPM1E|0:PPM1K|0:DULLARD|0:PPP1CC|0:PPP2R3B|0:MTMR6|0:MTM1|0:PPP4C|0:PPEF1|0:PPP5C|0:PPP1CA|0:PPM1B|0:PPP1R3C|0:PPP1R3D|0:PPM1G|0:PPEF2|0:PPM1D			
GO:0035276	F:ethanol binding; IDA:UniProtKB		0:ADH7			
GO:0004509	F:steroid 21-monooxygenase activity; IEA:EC		0:CYP21A2			
GO:0010310	P:regulation of hydrogen peroxide metabolic p...; TAS:BHF-UCL		0:NOXA1|0:RAC1|0:NOXO1|0:RAC2			
GO:0047372	F:acylglycerol lipase activity; IEA:EC		0:PNLIPRP2|0:CEL|0:MGLL|0:ABHD6|0:ABHD12			
GO:0015030	C:Cajal body; TAS:ProtInc		0:PRPF3|0:EFTUD2|0:SART1|0:NOP58|0:FBL|0:PRPF4|0:OIP5|0:PRPF31|0:LSG1|0:COIL|0:HINFP|0:WRAP53|0:SRRM2|0:NPAT|0:LSM10|0:SNRPC|0:ZNF473|0:GEMIN4|0:FRG1|0:SMNDC1|0:GEMIN8|0:PHAX|0:TGS1|0:GEMIN5|0:RDM1|0:XPO1|0:TRIM22|0:GAR1|0:GEMIN6|0:DDX20|0:NHP2|0:ANKS1B|0:DKC1|0:NOP10|0:EAF1|0:DDX46|0:SIP1|0:ELL|0:DDX42|0:GEMIN7|0:SMN2|0:SMN1|0:U2AF1			
GO:0030825	P:positive regulation of cGMP metabolic process; IMP:BHF-UCL		0:WNT5A|0:FZD2			
GO:0035086	C:flagellar axoneme; IEA:UniProtKB-SubCell		0:SPAG4|0:SPAG17|0:C19orf20|0:SPAG16			
GO:0042412	P:taurine biosynthetic process; TAS:UniProtKB		0:CDO1			
GO:0000170	F:sphingosine hydroxylase activity; EXP:Reactome		0:DEGS2			
GO:0030208	P:dermatan sulfate biosynthetic process; IDA:UniProtKB		0:CHST12|0:DSE			
GO:0070979	P:protein K11-linked ubiquitination; ISS:UniProtKB		0:UBE2W|0:UBE2H|0:CDC26|0:UBE2S|0:ANAPC11|0:UBE2D3|0:ANAPC7|0:ANAPC4|0:UBE2A|0:UBE2E2|0:CDC23|0:ANAPC13|0:UBE2L3|0:UBE2T|0:CDC27|0:UBE2D4|0:UBE2B|0:ANAPC5|0:CDC16|0:UBE2E3|0:ANAPC2|0:UBE2C|0:ANAPC1|0:ANAPC10|0:RNF4			
GO:0005499	F:vitamin D binding; TAS:ProtInc		0:S100G|0:CALB1|0:KL|0:IRX5|0:GC			
GO:0035005	F:phosphatidylinositol-4-phosphate 3-kinase a...; NAS:UniProtKB		0:PIK3C2G|0:PIK3C2A|0:PIK3C2B			
GO:0030526	C:granulocyte macrophage colony-stimulating f...; TAS:UniProtKB		0:CSF2RB			
GO:0042744	P:hydrogen peroxide catabolic process; TAS:UniProtKB		0:PRDX1|0:MPO|0:GPX1|0:APOA4|0:CAT|0:PXDN|0:EPX|0:DUOX1|0:TPO|0:LPO|0:DUOX2|0:PRDX3|0:PXDNL|0:PRDX2|0:GPX3			
GO:0051928	P:positive regulation of calcium ion transport; IMP:UniProtKB		0:WFS1|0:ORAI1|0:CREB3			
GO:0033025	P:regulation of mast cell apoptosis; ISS:BHF-UCL		0:ADAM17			
GO:0004587	F:ornithine-oxo-acid transaminase activity; TAS:ProtInc		0:OAT			
GO:0050804	P:regulation of synaptic transmission; ISS:UniProtKB		0:PXK			
GO:0004791	F:thioredoxin-disulfide reductase activity; NAS:UniProtKB		0:TXNRD1|0:TXNDC2|0:TXNRD2|0:TXNRD3			
GO:0009582	P:detection of abiotic stimulus; TAS:ProtInc		0:TAC1|0:TACR1|0:NPFFR2|0:TIMELESS			
GO:0007416	P:synapse assembly; TAS:UniProtKB		0:DRD1|0:DRD2|0:NLGN1|0:DNM3|0:DNER|0:NLGN2|0:SPOCK2|0:POU4F1|0:ACHE|0:PCDHB10|0:PCDHB16|0:PCDHB6|0:PCDHB9|0:PCDHB11|0:PCDHB5|0:PCDHB14|0:PCDHB2|0:PCDHB4|0:NRCAM|0:PCDHB13|0:PCDHB3			
GO:0035235	P:ionotropic glutamate receptor signaling pat...; ISS:UniProtKB		0:CLN3|0:CDK5R1|0:APP|0:GRIN1|0:GRIN3B			
GO:0007340	P:acrosome reaction; TAS:ProtInc		0:STX2|0:ROPN1B|0:CRCP|0:AKAP3|0:PKDREJ			
GO:0042531	P:positive regulation of tyrosine phosphoryla...; ISS:UniProtKB		0:IL29|0:LYN|0:HCLS1			
GO:0060754	P:positive regulation of mast cell chemotaxis; IDA:UniProtKB		0:VEGFB|0:VEGFC|0:FIGF|0:VEGFA			
GO:0010033	P:response to organic substance; TAS:UniProtKB		0:CREB1|0:DGKD|0:GLRX2|0:PPP2R1A|0:PPP2CA|0:SUPT5H			
GO:0004910	F:interleukin-1, Type II, blocking receptor a...; IEA:InterPro		0:IL1RAPL2|0:IL1R2			
GO:0006163	P:purine nucleotide metabolic process; IDA:UniProtKB		0:GUK1			
GO:0051329	P:interphase of mitotic cell cycle; IMP:UniProtKB		0:KATNA1			
GO:0008278	C:cohesin complex; TAS:BHF-UCL		0:SMC3|0:RAD21			
GO:0014911	P:positive regulation of smooth muscle cell m...; IDA:BHF-UCL		0:IGF1|0:VTN|0:PDGFB			
GO:0005201	F:extracellular matrix structural constituent; TAS:UniProtKB		0:COL15A1|0:LAMB1|0:PXDN|0:FBN1|0:COL18A1|0:COL4A3|0:COL24A1|0:FBN3|0:COL27A1|0:COL4A5|0:COL5A2|0:COL4A1|0:LAMC1|0:COL3A1|0:COL4A4|0:LAMA1|0:COL4A6|0:CHAD|0:TINAGL1|0:COL5A3|0:LUM|0:BGN|0:COL1A2|0:CD4|0:WNT3A|0:WNT9A|0:COL19A1|0:MUC8|0:COL13A1|0:COL11A1|0:WNT7B|0:COL6A2|0:FN1|0:WNT4|0:WNT9B|0:MUC6|0:COL8A2|0:COL14A1|0:COMP|0:MFAP5|0:FBN2|0:LAMA4|0:MGP|0:FBLN2|0:MATN3|0:DSPP|0:CHI3L1|0:OPTC|0:MEPE|0:EFEMP2|0:TFPI2|0:KAL1|0:MATN1|0:IMPG1|0:PRELP|0:FBLN1|0:ACAN|0:COL4A2|0:IMPG2|0:MUC5AC			
GO:0046888	P:negative regulation of hormone secretion; ISS:UniProtKB		0:LIF|0:OSM|0:IL11|0:FGF23			
GO:0045618	P:positive regulation of keratinocyte differe...; TAS:UniProtKB		0:TRIM16|0:CYP27B1|0:NME2|0:IL20			
GO:0004961	F:thromboxane A2 receptor activity; TAS:ProtInc		0:TBXA2R			
GO:0016493	F:C-C chemokine receptor activity; NAS:UniProtKB		0:CCR6|0:CCRL1|0:CXCR4|0:CCRL2|0:CCR1|0:CXCR3|0:CXCR6|0:CCR2|0:CCR5			
GO:0032066	P:nucleolus to nucleoplasm transport; IDA:HGNC		0:TBRG1			
GO:0005385	F:zinc ion transmembrane transporter activity; TAS:ProtInc		0:SLC39A7|0:SLC30A1|0:SLC30A6|0:SLC30A8|0:SLC11A2|0:SLC30A5|0:SLC30A4|0:SLC39A2			
GO:0051920	F:peroxiredoxin activity; IEA:EC		0:PRDX5|0:PRDX3|0:PRDX6			
GO:0045885	P:positive regulation of survival gene produc...; ISS:UniProtKB		0:IL2RB|0:CDH13|0:MEF2C|0:TGFBR1|0:NKX2-5|0:IL3			
GO:0001726	C:ruffle; TAS:HGNC		0:CDK6|0:NME2|0:ITGB1BP1|0:AMOT|0:INPP5K|0:INPP5J|0:PODXL|0:BCAR1|0:ARF6|0:CD2AP|0:S100A11|0:MTMR14|0:S100B|0:KIF18A|0:MYH9|0:MYO5A|0:S100A6|0:TLN2|0:SLC9A3R1|0:PARD6A|0:KBTBD10|0:BAIAP2|0:ARFIP2|0:TESC|0:LAYN|0:FGD3|0:FGD6|0:FGD5|0:CYFIP1|0:ARAP3|0:FGD1|0:CTTN|0:FGD4|0:ALS2|0:MTSS1|0:ITGA5			
GO:0046974	F:histone methyltransferase activity (H3-K9 s...; IDA:UniProtKB		0:SUV39H2|0:SETDB2|0:SUV39H1			
GO:0042496	P:detection of diacylated bacterial lipopeptide; IDA:MGI		0:TLR6|0:TLR2			
GO:0004947	F:bradykinin receptor activity; TAS:ProtInc		0:BDKRB2|0:BDKRB1			
GO:0001665	F:alpha-N-acetylgalactosaminide alpha-2,6-sia...; IEA:EC		0:ST6GALNAC1			
GO:0003948	F:N4-(beta-N-acetylglucosaminyl)-L-asparagina...; ISS:UniProtKB		0:AGA|0:ASRGL1			
GO:0015362	F:high affinity sodium:dicarboxylate symporte...; EXP:Reactome		0:SLC13A3			
GO:0060564	P:negative regulation of mitotic anaphase-pro...; IMP:UniProtKB		0:USP44			
GO:0006955	P:immune response; TAS:UniProtKB		0:ZAP70|0:HLA-DOA|0:B2M|0:HLA-DRB3|0:TNFSF15|0:RAET1G|0:OASL|0:CXCL1|0:CCL15|0:TNFSF9|0:SUSD2|0:LIF|0:PRG3|0:IL1A|0:TINAGL1|0:ENPP3|0:CD1C|0:ILF2|0:TNFSF10|0:CCL4L1|0:IL3|0:HLA-F|0:TNFSF4|0:HFE|0:CXCL6|0:CCL3|0:HLA-DRB4|0:OAS1|0:IL8|0:OSM|0:ULBP1|0:CXCL2|0:CCL3L1|0:HLA-DOB|0:PROCR|0:CXCL14|0:FAS|0:TINAG|0:FASLG|0:ULBP2|0:HLA-DMA|0:PF4|0:ENPP2|0:PRG2|0:HLA-DPB1|0:HLA-G|0:CCL4L2|0:CCL3L3|0:OAS3|0:EDA|0:CXCL9|0:CXCL5|0:CXCL3|0:PPBP|0:CD1B|0:RAET1L|0:OAS2|0:IL9|0:CCL17|0:HLA-DMB|0:HLA-A|0:TNFSF18|0:IFNG|0:CCL8|0:CCL28|0:HLA-DRB1|0:RAET1E|0:HLA-DRB5|0:IL5|0:TNFSF12|0:CCL14|0:TNFSF13|0:XCL1|0:CD70|0:IL21|0:CSF3|0:PRG4|0:ENPP1|0:C8orf84|0:CCL11|0:TNFSF8|0:CCL7|0:AZGP1|0:CCL16|0:TNFSF14|0:ENDOU|0:ULBP3|0:IL13|0:CCL1|0:PF4V1|0:CCL13|0:HLA-E|0:LTB|0:XCL2|0:MICB|0:CSF2|0:THBS1|0:TNFAIP1|0:BMPR1A|0:SMAD6|0:TGFBR3|0:IGF1R|0:BMP6|0:WAS|0:PNP|0:MAP3K14|0:FTH1|0:ITGAD|0:PDCD1LG2|0:HLA-C|0:FCGR2C|0:HLA-DRA|0:IGLL1|0:TRGV3|0:KIR2DS2|0:IGHG1|0:IL1F8|0:IGHG3|0:IL1RN|0:ICOS|0:KIR3DL1|0:IL1F6|0:PXDN|0:TRB@|0:KIR2DS5|0:CLNK|0:IGKC|0:IGKV1-5|0:CD4|0:IL1F7|0:IGHA1|0:IGKV4-1|0:IGHV@|0:IGHG4|0:IGHG2|0:IL19|0:VPREB1|0:TNFSF11|0:KIR2DS1|0:CHIA|0:IGHA2|0:CD276|0:CD8B|0:HLA-H|0:BCAP31|0:FCGR1B|0:EXOSC9|0:TRBV12-3|0:IGJ|0:IGLC1|0:TRBC1|0:IGHD|0:LST1|0:CHIT1|0:HLA-DQA2|0:KAAG1|0:PVRL1|0:IGHM|0:SERPINB4|0:TRGC2|0:CD1A|0:HLA-DQA1|0:CYSLTR2|0:COL4A3BP|0:KIR3DS1|0:IKBKE|0:IFI35|0:CD1E|0:HLA-B|0:NOTCH1|0:HLA-DQB1|0:NCR3|0:HLA-DPA1|0:HLA-DQB2|0:IGHE|0:CYP11B1|0:ZEB1|0:CXCL13|0:GTPBP1|0:CST7|0:CCL19|0:C1QBP|0:ARHGDIB|0:MBP|0:IGSF6|0:IL2RG|0:CEACAM8|0:IL17A|0:MR1|0:LY75|0:CD96|0:CNIH|0:IL27RA|0:CCL26|0:FCAR|0:RGS1|0:LCP2|0:IL4R|0:MADCAM1|0:CHUK|0:CCL21|0:CEBPB|0:AQP9|0:C5AR1|0:NFIL3|0:HRH2|0:ATP6V0A2|0:IL10RB|0:IKBKAP|0:CRHR1|0:CCL18|0:DEFB4B|0:CCRL1|0:FCGR2B|0:TCF12|0:TAPBP|0:GBP2|0:GPR65|0:CXCL12|0:PRELID1|0:PRKRA|0:DEFB4A|0:IKBKG|0:FCGR3A|0:IK|0:CD79B|0:CCR4|0:FCGR3B|0:SP2|0:TRIM22|0:S1PR4|0:CCL20|0:VTN|0:IL15|0:LTB4R|0:PTAFR|0:CCL25|0:VIPR1|0:SEMA3C|0:SEMA4D|0:RAG1|0:DEFA1B|0:SECTM1|0:CMKLR1|0:CCL23|0:MAP4K2|0:CTSW|0:CCR8|0:CNR2|0:CCR1|0:AIM2|0:OPRK1|0:FCGRT|0:ODZ1|0:DEFA1|0:TNFRSF14|0:CCL5|0:IL32|0:CTSS|0:CHST4|0:GPR44|0:CCL24|0:KIR2DL3|0:ETS1|0:IL16|0:CCR5|0:IRF8|0:GEM|0:CD274|0:CCL22|0:KIR2DL1|0:APLN|0:IL17B|0:CCR9|0:RFX1|0:CD97|0:SEMA7A|0:MS4A1|0:IFI6|0:IL1R2|0:OPRD1|0:XBP1|0:TCF7|0:LILRB2|0:SPN|0:FYB|0:CCL4|0:PTGER4|0:CTLA4|0:CD164|0:CCBP2|0:CCL27|0:TNFRSF4|0:CCR2|0:CTSC|0:NCF4|0:DPP8|0:HAMP|0:GZMA|0:IL2|0:CD7|0:IL12A|0:CX3CL1			
GO:0035023	P:regulation of Rho protein signal transduction; NAS:UniProtKB		0:ABR|0:PLEKHG4|0:ITSN1|0:FARP2|0:ARHGEF18|0:PLEKHG6|0:ARHGEF6|0:VAV3|0:NGEF|0:ARHGEF15|0:TTN|0:FARP1|0:BCR|0:TIAM2|0:MCF2|0:ARHGEF19|0:SOS2|0:PLEKHG3|0:ARHGEF10|0:ARHGEF38|0:TIAM1|0:ARHGEF16|0:NET1|0:ARHGEF5|0:PLEKHG4B|0:ARHGEF9|0:PREX2|0:KALRN|0:MCF2L|0:ARHGEF4|0:PLEKHG2|0:ARHGEF11|0:DNMBP|0:PLEKHG7|0:C9orf100|0:VAV2|0:ARHGEF37|0:ARHGEF1|0:SPATA13|0:PLEKHG5|0:PREX1|0:ARHGEF10L|0:TRIO|0:ARHGEF12|0:ARHGEF3|0:ARHGEF17|0:MCF2L2|0:RASGRF2|0:ECT2|0:PLEKHG1|0:ECT2L|0:SOS1|0:ARHGEF7|0:ITSN2|0:OBSCN|0:AKAP13|0:VAV1|0:ARHGEF2			
GO:0005325	F:peroxisomal fatty acyl CoA transporter acti...; EXP:Reactome		0:ABCD1			
GO:0044111	P:development involved in symbiotic interaction; IMP:UniProtKB		0:NEDD4			
GO:0001532	F:interleukin-21 receptor activity; NAS:UniProtKB		0:IL21R			
GO:0016020	C:membrane; TAS:UniProtKB		0:GLTP|0:NPHP4|0:PCSK2|0:ATXN2L|0:FIBP|0:TOM1|0:CYB5R2|0:CRNN|0:TGFBRAP1|0:SERPINA5|0:KHDRBS1|0:RALBP1|0:ANKRA2|0:POFUT1|0:TNK1|0:CUTA|0:OGFRL1|0:VEGFB|0:LZTS2|0:SDF2|0:RASL11A|0:KIAA2018|0:RASL12|0:NID2|0:SEMA3E|0:NDUFAF2|0:BCHE|0:CNKSR3|0:VEGFC|0:CD5L|0:LOXL3|0:DPP8|0:MAMDC2|0:FIGF|0:PGF|0:PDGFA|0:SEMA3D|0:OGFR|0:C2orf83|0:SEMA3C|0:SEMA3G|0:HHIPL1|0:RERGL|0:PALMD|0:IRGC|0:SDF2L1|0:NID1|0:RERG|0:EFEMP2|0:YME1L1|0:TNFSF13|0:CNTLN|0:DPP9|0:AGAP3|0:EDEM3|0:LMLN|0:PAPPA2|0:SEMA3B|0:PRSS12|0:LOXL2|0:CFI|0:NPNT|0:VEGFA|0:SEMA3F|0:PGBD1|0:PDGFB|0:LGALS3BP|0:EDEM2|0:TYK2|0:RASL11B|0:SRCRB4D|0:LOXL4|0:IL12B|0:TP53RK|0:SEMA3A|0:MRPS17|0:PAPPA|0:EGFL6|0:REM1|0:SNX18|0:ASPSCR1|0:TRIP11|0:RAC3|0:PIP5K1B|0:DOCK2|0:PLDN|0:CDC42EP3|0:NUCB1|0:PCSK6|0:JAK1|0:SIPA1|0:RC3H2|0:ACACB|0:DOCK9|0:SNAP47|0:JAK3|0:GORASP1|0:CDC42EP4|0:AVEN|0:DOCK4|0:BCL2L14|0:RAPGEF3|0:FBXO2|0:RNF34|0:NRBP1|0:SYTL3|0:BECN1|0:STK16|0:SYTL5|0:RUVBL2|0:PRKD2|0:TCTE3|0:PLCD3|0:PPP1R14C|0:STRN4|0:MTMR3|0:PAK2|0:HPSE2|0:ACSBG2|0:DNAJC5|0:STX19|0:NAPB|0:PDE4D|0:RAB24|0:YRDC|0:CCDC91|0:PI4K2B|0:BFSP1|0:PLA2G2A|0:SH3D20|0:NAPEPLD|0:RAB1C|0:PIP4K2C|0:GUCA1A|0:LTA|0:PEX5L|0:MYH7B|0:C17orf37|0:RAB1B|0:GRK1|0:CYP19A1|0:MYCBPAP|0:SH2B1|0:PLEKHB2|0:ARHGAP5|0:FILIP1L|0:LRRC1|0:MCF2|0:OSBP2|0:STMN2|0:RAB42|0:NAPG|0:INVS|0:RUVBL1|0:PLCD4|0:EHBP1|0:DAB2IP|0:IBTK|0:GDI2|0:PLEKHA4|0:PIP5KL1|0:RPS6KC1|0:ARHGAP27|0:PNKD|0:PIK3R5|0:ASAP1|0:BFSP2|0:PIK3C2G|0:HERC1|0:FAM126A|0:TSC1|0:RGS17|0:REN|0:GRK7|0:BSPRY|0:PCYT1A|0:LGTN|0:GABARAPL1|0:KRIT1|0:CRBN|0:METTL7A|0:SYT17|0:ARHGAP15|0:RGS14|0:PEF1|0:TELO2|0:CR1L|0:DNAJC5B|0:GAS2|0:STAMBP|0:RFFL|0:LIPH|0:RDH5|0:AKAP10|0:PLEKHA3|0:DNAJA2|0:CERK|0:RIPK4|0:PLA2G6|0:SVEP1|0:CHN2|0:VPS35|0:PLCH1|0:PDE6B|0:PHLDB2|0:GRK6|0:PLK3|0:UNC13D|0:STX11|0:PHLPP1|0:GAPVD1|0:PDE2A|0:KSR2|0:VHL|0:MAP3K13|0:USP32|0:C1orf58|0:RGS20|0:BEGAIN|0:CYP27C1|0:DCXR|0:AKT3|0:ARHGEF12|0:DNAJA4|0:VPS36|0:FBXL2|0:PSTPIP2|0:DCTN2|0:SELENBP1|0:NKTR|0:SH2D3C|0:DOCK1|0:DNAJC5G|0:MTMR4|0:MUCL1|0:SPA17|0:PHLDA2|0:BAALC|0:GAPDH|0:PHLPP2|0:PRKD3|0:RGS19|0:KSR1|0:JAKMIP1|0:DNAJA1|0:SCEL|0:MARCKS|0:DGKG|0:CLINT1|0:MED28|0:AKAP13|0:HCLS1|0:CDK5|0:ARL6|0:APBB2|0:IGLL1|0:PGLYRP4|0:PPP2R1A|0:SNX17|0:MPP6|0:IL25|0:PGLYRP2|0:INPP5A|0:ITGB1BP1|0:HK3|0:LRG1|0:APBA3|0:SPRY3|0:SPAG8|0:SNX15|0:NPVF|0:F11|0:CORO2B|0:PGLYRP3|0:SPTBN5|0:SEC14L1|0:SRPX|0:PTPN6|0:TBC1D8|0:OAS2|0:FRZB|0:LAMC3|0:PLA2G4C			
GO:0046717	P:acid secretion; IDA:UniProtKB		0:SLC22A16			
GO:0003012	P:muscle system process; ISS:UniProtKB		0:TRIM72			
GO:0006408	P:snRNA export from nucleus; TAS:BHF-UCL		0:NCBP2|0:PHAX			
GO:0034695	P:response to prostaglandin E stimulus; IDA:BHF-UCL		0:TGFBR3			
GO:0009008	F:DNA-methyltransferase activity; TAS:ProtInc		0:MGMT			
GO:0030160	F:GKAP/Homer scaffold activity; NAS:UniProtKB		0:SHANK2			
GO:0019888	F:protein phosphatase regulator activity; TAS:UniProtKB		0:SHOC2			
GO:0031429	C:box H/ACA snoRNP complex; IEA:InterPro		0:NAF1|0:GAR1			
GO:0002581	P:negative regulation of antigen processing a...; IDA:BHF-UCL		0:THBS1			
GO:0019145	F:aminobutyraldehyde dehydrogenase activity; IDA:UniProtKB		0:ALDH9A1			
GO:0042904	P:9-cis-retinoic acid biosynthetic process; IDA:UniProtKB		0:DHRS9			
GO:0033872	F:[heparan sulfate]-glucosamine 3-sulfotransf...; IEA:EC		0:HS3ST3A1|0:HS3ST3B1			
GO:0060550	P:positive regulation of fructose 1,6-bisphos...; IDA:BHF-UCL		0:IFNG			
GO:0004047	F:aminomethyltransferase activity; TAS:ProtInc		0:AMT|0:SARDH|0:DMGDH|0:C1orf69|0:GCSH			
GO:0032399	F:HECT domain binding; IPI:HGNC		0:BPY2B|0:BPY2|0:BPY2C			
GO:0030071	P:regulation of mitotic metaphase/anaphase tr...; IEA:InterPro		0:CDC23|0:NEK6|0:HECTD3|0:CUL7|0:ZZEF1|0:HERC2|0:MYCBP2|0:ANAPC10|0:CUL9			
GO:0004347	F:glucose-6-phosphate isomerase activity; IEA:EC		0:GPI			
GO:0007199	P:G-protein signaling, coupled to cGMP nucleo...; TAS:ProtInc		0:AGTR2|0:AGT|0:TBL3			
GO:0043532	F:angiostatin binding; IDA:UniProtKB		0:AMOT|0:ATPIF1			
GO:0004729	F:oxygen-dependent protoporphyrinogen oxidase...; IDA:UniProtKB		0:PPOX			
GO:0015809	P:arginine transport; IDA:UniProtKB		0:CLN3			
GO:0016765	F:transferase activity, transferring alkyl or...; IEA:InterPro		0:NUS1|0:DHDDS			
GO:0001652	C:granular component; ISS:UniProtKB		0:CDKN2AIP|0:SURF6			
GO:0045585	P:positive regulation of cytotoxic T cell dif...; IDA:UniProtKB		0:SART1			
GO:0045648	P:positive regulation of erythrocyte differen...; ISS:BHF-UCL		0:HIF1A|0:ARNT|0:ACVR1B|0:ACVR2A|0:INHBA|0:FOXO3|0:ETS1|0:HMGB2|0:TAL1			
GO:0050771	P:negative regulation of axonogenesis; ISS:UniProtKB		0:RHOA|0:NGFR|0:MAG|0:ARHGEF1|0:OMG|0:RTN4R|0:LINGO1|0:ARHGDIA|0:RUFY3|0:THY1			
GO:0019344	P:cysteine biosynthetic process; IDA:UniProtKB		0:CTH			
GO:0060262	P:negative regulation of N-terminal protein p...; ISS:UniProtKB		0:HHATL			
GO:0005947	C:mitochondrial alpha-ketoglutarate dehydroge...; TAS:ProtInc		0:BCKDHA|0:BCKDHB|0:BCKDK|0:DBT			
GO:0070087	F:chromo shadow domain binding; IPI:BHF-UCL		0:LBR|0:NIPBL|0:SP100|0:ATRX|0:TRIM28|0:CHAF1A			
GO:0010369	C:chromocenter; IDA:UniProtKB		0:SALL1			
GO:0050591	F:quinine 3-monooxygenase activity; IEA:EC		0:CYP3A4			
GO:0042035	P:regulation of cytokine biosynthetic process; IC:BHF-UCL		0:IGF2BP1|0:IGF2BP2|0:IGF2BP3			
GO:0005157	F:macrophage colony-stimulating factor recept...; TAS:UniProtKB		0:IL34|0:CSF1			
GO:0034097	P:response to cytokine stimulus; IMP:BHF-UCL		0:PML|0:SP100|0:IL6R|0:OSMR|0:IL6ST|0:LIFR|0:BCL2|0:MCL1|0:BCL2L1|0:DDOST|0:ALDH1A2|0:COL3A1|0:TMEM102|0:SRF			
GO:0001882	F:nucleoside binding; IEA:InterPro		0:PNP|0:CDA|0:ACTN4|0:POLA1|0:SLC28A2|0:SLC28A1|0:SLC28A3			
GO:0019067	P:viral assembly, maturation, egress, and rel...; IEP:BHF-UCL		0:PCSK5|0:FURIN			
GO:0003994	F:aconitate hydratase activity; IEA:EC		0:ACO1|0:ACO2			
GO:0015129	F:lactate transmembrane transporter activity; TAS:ProtInc		0:BSG|0:SLC16A8			
GO:0031372	C:UBC13-MMS2 complex; IDA:HGNC		0:UBE2N|0:UBE2V2			
GO:0006420	P:arginyl-tRNA aminoacylation; TAS:ProtInc		0:RARS2|0:DALRD3|0:RARS			
GO:0050816	F:phosphothreonine binding; ISS:BHF-UCL		0:PIN1|0:NEDD4			
GO:0003337	P:mesenchymal to epithelial transition involv...; ISS:UniProtKB		0:BMP4|0:SALL1|0:PAX2			
GO:0003937	F:IMP cyclohydrolase activity; TAS:ProtInc		0:ATIC			
GO:0016052	P:carbohydrate catabolic process; IDA:UniProtKB		0:AMY2A|0:NAGA			
GO:0016254	P:preassembly of GPI anchor in ER membrane; EXP:Reactome		0:PIGL|0:PIGG|0:PIGA|0:PIGX|0:PIGP|0:PIGB|0:DPM2|0:PIGM|0:PIGH|0:PIGQ|0:PIGC|0:PIGV|0:PIGN|0:PIGF|0:PIGO|0:PIGW			
GO:0007608	P:sensory perception of smell; TAS:UniProtKB		0:OR2K2|0:OR2V2|0:OR7A17|0:OR10X1|0:OR10A2|0:OR8J3|0:OR6C1|0:OR9G1|0:OR4M2|0:OR4C13|0:OR4A4P|0:OR2T29|0:OR11L1|0:OR8K3|0:OR1L3|0:OR1B1|0:OR5W2|0:OR13F1|0:OR8B4|0:OR5K4|0:OR2C1|0:OR5L2|0:OR4C3|0:OR52E1|0:OR13A1|0:OR2A25|0:OR4D5|0:OR2M3|0:OR52E6|0:OR2T6|0:OR2T33|0:OR5AS1|0:OR10D3|0:OR4C46|0:OR51Q1|0:OR9G9|0:OR5AU1|0:OR2W3|0:OR1G1|0:OR2A5|0:OR2AK2|0:OR7C1|0:OR5M11|0:OR51L1|0:OR4A5|0:OR5M8|0:OR13C8|0:OR2A42|0:OR51E1|0:OR2G3|0:OR1S1|0:OR10G2|0:OR4F6|0:OR6M1|0:OBP2A|0:OR13H1|0:OR10A6|0:OR4D2|0:OR4F29|0:OR52E5|0:OR4A16|0:UGT2A2|0:OR6T1|0:OR51F2|0:OR1F2P|0:OR2AP1|0:OR5P2|0:OR51D1|0:OR2A14|0:OR4Q3|0:OR5H15|0:OR1S2|0:OR10J4|0:OR52H1|0:OR1L6|0:OR14A16|0:OR7C2|0:OR10G7|0:OR2AE1|0:OR13C4|0:OR10H4|0:OR4N4|0:OR11H6|0:OR12D2|0:OR5B21|0:OR2T34|0:OR9K2|0:OR5K2|0:OR4C6|0:OR51A4|0:OR7G3|0:OR6V1|0:OR2L3|0:OR51G1|0:OR13C2|0:CNGB1|0:OR5L1|0:OR9I1|0:OR2J1|0:OR2B2|0:ADCY3|0:OR52K1|0:OR4F17|0:OR11H12|0:OR11H4|0:OR6C4|0:OR8J2|0:OR2V1|0:OR4D6|0:OR4S2|0:OR5D18|0:OR8H2|0:OR10AD1|0:OR52P1P|0:OR2S2|0:OR5AK3P|0:OR6C70|0:OR7D4|0:OR2L5|0:OR2G2|0:OR1J1|0:OR4F5|0:OR10P1|0:OR2T2|0:OR4C45|0:OR2A12|0:OR10G3|0:OR10G8|0:OR11H1|0:CNGA4|0:OR4K17|0:OR5AR1|0:OR52N2|0:OR11A1|0:OR10A7|0:OR2B6|0:OR5AC1|0:OR1D4|0:OR14K1|0:OR2B8P|0:OR2C3|0:OR1E2|0:OR10J3|0:OR52E2|0:OR5K1|0:OR1J2|0:OR8K1|0:OR52A4|0:OR51S1|0:OR4K3|0:OR6Y1|0:OR3A1|0:OR1N2|0:OR5H14|0:OR13C5|0:OR5T2|0:OR6P1|0:OR52B2|0:OR4K14|0:OR14I1|0:OR2L2|0:OR52N5|0:OR56B1|0:OR5B17|0:GRM7|0:OR13J1|0:OR6C68|0:OR6N1|0:OR2Z1|0:OR14J1|0:OR2T7|0:OR5H1|0:OR5K3|0:OR56A4|0:OR5M9|0:OR2I1P|0:OR5H6|0:OR56B2P|0:OR9A2|0:OR2G6|0:OR2AT4|0:OR51A2|0:OR2A2|0:OR8H3|0:OR7G2|0:OR1F1|0:OR10H3|0:OR5AK2|0:OR5V1|0:OR5D13|0:OR7A10|0:OR2W1|0:OR4A15|0:OR8J1|0:OR4N5|0:OR10J6P|0:OR4D10|0:OR4S1|0:OR6A2|0:OR56B4|0:OR6S1|0:OR2L13|0:OR2A7|0:OR52Z1|0:OR52N1|0:OR6B2|0:OR8H1|0:OR2H2|0:OR10H5|0:OR6C65|0:OR10G4|0:OR4L1|0:OR4F16|0:OR2AJ1|0:OR6X1|0:OR4P4|0:OR10G9|0:OR10J5|0:OR56A1|0:OR13G1|0:OR4C16|0:OR52I1|0:OR2W6P|0:OR4E1|0:OR8A1|0:OR5M1|0:OR14A2|0:OR9G4|0:OR5AN1|0:OR10K2|0:OR2T11|0:UGT2A1|0:OR10S1|0:OR5A2|0:OR52M1|0:OR10W1|0:OR2B11|0:OR9Q1|0:OR2L8|0:OR4K5|0:OR2T3|0:OR5H2|0:OR52E8|0:OR2F2|0:OR14C36|0:OR11H2|0:OR52K2|0:OR5D14|0:OR10AG1|0:OR6B3|0:OR8D4|0:OR5AP2|0:OR4X1|0:OR1I1|0:OR8D1|0:OR13D1|0:OR2T12|0:OR6N2|0:OR10T2|0:OR5B2|0:OR6C76|0:OR8U9|0:OR10H2|0:OR10A4|0:OR8B12|0:OR10Z1|0:OR1P1|0:OR1M1|0:OR4F4|0:OR1F12|0:OR1E3|0:OR10V1|0:OR2F1|0:OR3A2|0:OR7G1|0:OR8B2|0:GRM8|0:OR2T27|0:OR6C74|0:OR6J1|0:OR4C12|0:OR9Q2|0:OR2M5|0:OR4K13|0:OR4F15|0:OR56A3|0:OR2J3|0:OR52B6|0:OR8K5|0:OR2B3|0:OR5I1|0:OR2T8|0:OR7A2P|0:OR2AG2|0:OR1N1|0:OR5T3|0:OR4N2|0:OR6K6|0:OR8S1|0:OR4K2|0:OR2Y1|0:OR6B1|0:OR4A47|0:OR5R1|0:OR10K1|0:OR2W5|0:OR2M2|0:OR51G2|0:OR1L8|0:OR2T5|0:OR2AG1|0:OR2T4|0:OR4K15|0:OR4D11|0:OR7E24|0:OR2A1|0:OR52N4|0:OR52L1|0:OR2A4|0:OR12D3|0:OR4B1|0:OR6C6|0:OR8I2|0:OR1L1|0:OR1K1|0:OR2M7|0:OR51T1|0:OR6K3|0:OR8G5|0:OR5P3|0:OR6F1|0:OR9A4|0:OR3A3|0:OR6K2|0:OR5D16|0:OR4E2|0:OR6Q1|0:OR4C15|0:OR52I2|0:OR1L4|0:OR10Q1|0:OR51A7|0:OR4F3|0:OR2T1|0:OR13C9|0:OR2H1|0:OR10AC1P|0:OR5AL1|0:OR10H1|0:OR5M3|0:OR10C1|0:OR7D2|0:OR8U1|0:OR4X2|0:OR52W1|0:OR6C75|0:OR5M10|0:OR51H1P|0:OR2T10|0:OR52J3|0:OR4D9|0:OR52E4|0:OR2J2|0:OR51F1|0:OR52L2P|0:OR4C5|0:OR10J1|0:OR14L1P|0:OR13C3|0:OR5C1|0:OR4Q2|0:OR10D4P|0:OR10R2|0:OR10G6|0:OR4K1|0:OR5B12|0:OR5J2|0:OR5A1|0:OR8D2|0:OR11G2|0:OR52B4|0:OR5B3|0:OR52R1|0:OR2D3|0:OR4F21|0:OR1J4|0:OR4C11|0:OR4M1|0:OR8U8|0:OR2T35|0:OR8B3|0:OR5T1|0:BBS4|0:MKKS|0:DRD2|0:BEST2|0:UBR3|0:OR6C3|0:OR51V1|0:OR51B5|0:OR52D1|0:OR8G1|0:OR51B4|0:OR52A5|0:OR1Q1|0:OR2D2|0:OR6C2|0:OR51I2|0:OR4D1|0:OR8B8|0:OBP2B|0:OR1E1|0:OR2M4|0:OR1A2|0:OR51J1|0:OR5AC2|0:OR51M1|0:OR51I1|0:OR3A4|0:OR51B6|0:OR1C1|0:OR5F1|0:OR1A1|0:OR10A3|0:OR51B2|0:OR8G2|0:CNGA2|0:OR51E2|0:OR10A5|0:OR7A5|0:OR52A1|0:OR1D5|0:OMP|0:OR1D2|0:GNAS			
GO:0003726	F:double-stranded RNA adenosine deaminase act...; NAS:UniProtKB		0:ADARB1|0:ZBP1|0:ADAR			
GO:0009566	P:fertilization; NAS:UniProtKB		0:KLK14|0:TDRD9|0:FUT10			
GO:0051302	P:regulation of cell division; IEA:InterPro		0:CABLES2|0:CABLES1			
GO:0004766	F:spermidine synthase activity; TAS:ProtInc		0:SRM|0:SMS			
GO:0033162	C:melanosome membrane; IEA:UniProtKB-SubCell		0:TH|0:DTNBP1|0:DCT|0:TYR|0:TYRP1|0:SLC45A2|0:OCA2|0:GPR143			
GO:0048715	P:negative regulation of oligodendrocyte diff...; ISS:HGNC		0:DRD3|0:NF1			
GO:0031581	P:hemidesmosome assembly; IMP:HGNC		0:KRT5|0:LAMB3|0:LAMC2|0:CD151|0:LAMA3|0:PLEC|0:COL17A1|0:ITGB4|0:KRT14|0:ITGA6|0:LAMC1			
GO:0043140	F:ATP-dependent 3'-5' DNA helicase activity; IMP:UniProtKB		0:WRN|0:RECQL|0:BLM|0:RECQL4			
GO:0005456	F:CMP-sialic acid transmembrane transporter a...; TAS:ProtInc		0:SLC35A1			
GO:0050427	P:3'-phosphoadenosine 5'-phosphosulfate metab...; IDA:BHF-UCL		0:ENPP1			
GO:0043648	P:dicarboxylic acid metabolic process; IDA:HGNC		0:ACOT4			
GO:0000182	F:rDNA binding; NAS:UniProtKB		0:TSPYL2			
GO:0016477	P:cell migration; TAS:UniProtKB		0:THBS1|0:BAMBI|0:ENPEP|0:TMEM18|0:BCAR1|0:IL12A|0:WWC1|0:IL12B|0:NOX1|0:JUP|0:LAMC1|0:SCRIB|0:CCDC88A|0:KCTD13|0:CUL3|0:TNFAIP1|0:ANG|0:PTPRK|0:TGFBR3|0:FOXE1|0:SHROOM2|0:USP33|0:CD24|0:TNN|0:PSG2|0:CEACAM1|0:ASTN1|0:DGKZ|0:BTG1|0:SCYL3|0:FN1|0:TAOK2|0:PLXNB1|0:PIP5K1A|0:ITGB1BP1|0:PARP9|0:NRD1|0:ABI2			
GO:0071459	P:protein localization to chromosome, centrom...; IDA:BHF-UCL		0:CENPA			
GO:0045786	P:negative regulation of cell cycle; TAS:UniProtKB		0:HDAC1|0:PRDM4|0:HDAC2|0:NGF|0:HDAC3|0:NGFR|0:BMP2|0:CDK6|0:HPGD|0:GMNN|0:ALOX15B|0:TAF6|0:ETS1|0:PTPRK|0:RNF167|0:THAP5|0:RHOB|0:RUNX3|0:PDCD4|0:TSPYL2|0:SIPA1|0:CREB3|0:PPP1R13B|0:ZBTB17|0:TP53BP2			
GO:0015669	P:gas transport; IMP:HGNC		0:RPS19			
GO:0040008	P:regulation of growth; NAS:UniProtKB		0:IGSF11|0:SOCS4|0:SOCS3|0:RUVBL2|0:BRMS1L|0:PAK2|0:MORF4L1|0:NEDD9|0:OSM|0:KAT5|0:SOCS5|0:RUVBL1|0:DMAP1|0:SHC1|0:ENOX2|0:SOCS1|0:EPC1|0:HMGA2|0:ING2|0:CREG1|0:E4F1|0:HEPACAM|0:NDNL2|0:PRAME|0:NDN|0:GAP43|0:KCTD11|0:CSPG5|0:GAS6|0:UBE2E3|0:SOCS6|0:ZMAT3|0:MCTS1|0:ING3|0:TMEM8B|0:ARMC10|0:YEATS4|0:BRD8|0:C20orf20|0:ACTL6A|0:SOCS7|0:LRP12			
GO:0005896	C:interleukin-6 receptor complex; IDA:BHF-UCL		0:IL6R|0:IL6|0:IL6ST			
GO:0032570	P:response to progesterone stimulus; TAS:BHF-UCL		0:NR1H3|0:TGFB3|0:TGFB2|0:TGFB1|0:CAV1|0:THBS1			
GO:0042564	C:NLS-dependent protein nuclear import complex; ISS:UniProtKB		0:MYBBP1A			
GO:0006302	P:double-strand break repair; TAS:ProtInc		0:TDP1|0:SETX|0:NBN|0:VCP|0:RNF8|0:RNF168|0:TDP2|0:APTX|0:UIMC1|0:RAD50|0:BRE|0:EYA1|0:APLF|0:KAT5|0:BRCC3|0:FAM175A|0:C19orf62|0:EYA3|0:BAZ1B|0:SOD1|0:PAPD7|0:BRIP1|0:CIB1|0:RAD21|0:FEN1			
GO:0034986	F:iron chaperone activity; IDA:BHF-UCL		0:FXN			
GO:0004507	F:steroid 11-beta-monooxygenase activity; IDA:BHF-UCL		0:CYP11B2|0:CYP11B1			
GO:0004917	F:interleukin-7 receptor activity; TAS:ProtInc		0:IL7R			
GO:0035572	P:N-terminal peptidyl-serine dimethylation; IDA:UniProtKB		0:METTL11A			
GO:0048638	P:regulation of developmental growth; IMP:BHF-UCL		0:NIPBL			
GO:0048625	P:myoblast cell fate commitment; IDA:BHF-UCL		0:TCF7L2			
GO:0071218	P:cellular response to misfolded protein; IDA:BHF-UCL		0:STUB1			
GO:0008903	F:hydroxypyruvate isomerase activity; IEA:EC		0:HYI			
GO:0001935	P:endothelial cell proliferation; TAS:BHF-UCL		0:DLG1|0:CALCA|0:THAP1|0:HMOX1			
GO:0005462	F:UDP-N-acetylglucosamine transmembrane trans...; TAS:ProtInc		0:SLC35B4|0:SLC35A3			
GO:0045862	P:positive regulation of proteolysis; IMP:UniProtKB		0:AURKAIP1|0:HDAC2|0:CLN6			
GO:0005694	C:chromosome; IEA:UniProtKB-KW		0:SPO11|0:TOP3A|0:TOP1|0:TOP2B|0:TOP1MT|0:TOP2A|0:SMC6|0:KIF4A|0:BANF1|0:CCNB1IP1|0:TMPO|0:SETD7|0:HNRNPD|0:CLSPN|0:CD3EAP|0:TADA2A|0:NUSAP1|0:EED|0:CEP164|0:SUPT16H|0:PES1|0:BAHD1|0:RBM19|0:THAP7|0:SETD8|0:SSRP1|0:AKAP8L|0:RNF8|0:HMG20B|0:RNF168|0:SP100|0:HMGB4|0:RNF40|0:PRDM7|0:SETDB1|0:NSFL1C|0:PRDM9|0:PRPF40A|0:ZFR|0:PRDM6|0:HMGB3|0:RNF20|0:GTPBP10|0:HMGB1P1|0:SMC5|0:NCAPH2|0:NUMA1|0:RBBP6|0:MBD1|0:FANCI|0:MPHOSPH10|0:ESCO1|0:LIN54			
GO:0033280	P:response to vitamin D; TAS:BHF-UCL		0:SPP1|0:CYP27B1|0:CDKN2D|0:AQP3			
GO:0006886	P:intracellular protein transport; TAS:UniProtKB		0:ARFIP1|0:TLK1|0:SYTL5|0:AP2S1|0:STX6|0:IPO8|0:CSE1L|0:TOM1|0:CHM|0:STX16|0:AP4E1|0:STX19|0:NAPB|0:SYTL2|0:SEC24A|0:RAMP1|0:COPG|0:VPS16|0:AP1S3|0:NAPG|0:COPA|0:SGIP1|0:STON2|0:STX7|0:SNX2|0:STX1A|0:XPO1|0:COPB1|0:IPO4|0:SYTL1|0:BCAP29|0:VTI1A|0:AP4M1|0:SAR1A|0:RPH3A|0:COPB2|0:SEC24B|0:COPG2|0:TIMM23B|0:STAM|0:STX2|0:RPH3AL|0:AP3B2|0:STX12|0:AP1S2|0:TNPO2|0:AP1S1|0:BCAP31|0:SEC24C|0:AP1G2|0:NCAPD2|0:SNX1|0:COG3|0:STON1|0:CLTCL1|0:SYTL4|0:AP2B1|0:RAMP3|0:XPOT|0:AP1B1|0:STX1B|0:HGS|0:SEC23B|0:TOM1L2|0:AP2M1|0:AP1M1|0:STX11|0:STX3|0:MYRIP|0:RIMS2|0:STX4|0:AP3M2|0:STX5|0:CHML|0:TOM1L1|0:STAM2|0:SEC24D|0:AP4B1|0:STX17|0:VTI1B|0:SYTL3|0:SAR1B|0:MRPL45|0:MUDENG|0:RIMS1|0:STX18|0:STX10|0:COPZ1|0:VPS41|0:SEC23A|0:EXPH5|0:AP3S1|0:RAMP2|0:ACD|0:VIPAR|0:COG7|0:UNC93B1|0:SCG5|0:CD74|0:YWHAH|0:AP2A2|0:SIL1|0:SSR4|0:ARFGAP3|0:GGA2|0:SNX17|0:AP2A1|0:SEC13|0:ARHGEF2|0:CLTC|0:SNX6|0:HERC2|0:SNX15|0:CLTB|0:COPZ2|0:CLTA|0:VPS45|0:GGA3|0:SEC23IP|0:APBA1|0:ARCN1|0:AP1G1|0:ERP29|0:CTSA|0:COG2|0:LGTN|0:SYNRG|0:SNAPIN|0:KDELR2|0:AP3S2|0:APPBP2|0:RAB3GAP2|0:KDELR1|0:RPGR|0:KLHL2|0:STAP1|0:AP3D1|0:GGA1|0:NPM1			
GO:0018406	P:protein amino acid C-linked glycosylation v...; TAS:HGNC		0:DPM3			
GO:0045725	P:positive regulation of glycogen biosyntheti...; IMP:UniProtKB		0:INS|0:INSR|0:DYRK2|0:AKT2|0:IRS1|0:AKT1|0:IRS2|0:GCK			
GO:0009311	P:oligosaccharide metabolic process; TAS:ProtInc		0:GLA|0:ST6GAL2|0:MOGS|0:GAL3ST3|0:GAL3ST4|0:MAN1B1			
GO:0050754	P:positive regulation of fractalkine biosynth...; IDA:UniProtKB		0:AZU1			
GO:0050655	P:dermatan sulfate proteoglycan metabolic pro...; IDA:UniProtKB		0:CHST14			
GO:0045671	P:negative regulation of osteoclast different...; TAS:HGNC		0:ZNF675|0:CALCA|0:FSTL3|0:GPR55|0:LRRC17|0:IL4|0:TLR3|0:TLR4|0:CARTPT			
GO:0004180	F:carboxypeptidase activity; TAS:ProtInc		0:ACE2|0:CNDP1|0:FOLH1|0:NAALADL1|0:ACE|0:CNDP2|0:NAALAD2|0:BLMH			
GO:0033553	C:rDNA heterochromatin; ISS:UniProtKB		0:SUV39H1|0:SIRT1|0:RRP8|0:BAZ2A			
GO:0051764	P:actin crosslink formation; IDA:BHF-UCL		0:FLNA			
GO:0004937	F:alpha1-adrenergic receptor activity; TAS:UniProtKB		0:ADRA1D|0:ADRA1B|0:ADRA1A			
GO:0010629	P:negative regulation of gene expression; ISS:UniProtKB		0:MIF|0:VEGFB|0:NDFIP2|0:WWP2|0:NDFIP1|0:UPK3B|0:SFRP2			
GO:0017136	F:NAD-dependent histone deacetylase activity; IDA:UniProtKB		0:SIRT1|0:SIRT2			
GO:0071320	P:cellular response to cAMP; IEP:UniProtKB		0:AQP1|0:AQP9|0:AQP8			
GO:0006434	P:seryl-tRNA aminoacylation; ISS:UniProtKB		0:TPR|0:ZNFX1|0:SARS|0:SARS2			
GO:0060285	P:ciliary cell motility; ISS:UniProtKB		0:C14orf104|0:RFX3			
GO:0048861	P:leukemia inhibitory factor signaling pathway; IGI:BHF-UCL		0:LIF|0:LIFR|0:IL6ST			
GO:0004887	F:thyroid hormone receptor activity; TAS:ProtInc		0:THRA|0:NR1H3|0:NR4A3|0:NR2F6|0:THRB|0:BRD8			
GO:0004704	F:NF-kappaB-inducing kinase activity; TAS:ProtInc		0:IKBKE|0:MAP3K14|0:PPP4C|0:IRAK1|0:IRAK2			
GO:0043983	P:histone H4-K12 acetylation; IDA:UniProtKB		0:ING4|0:MEAF6|0:PHF16|0:PHF17|0:MYST2|0:PHF15			
GO:0005624	C:membrane fraction; TAS:UniProtKB		0:CAV2|0:WNT3|0:ACE|0:FLOT1|0:ECE1|0:FLOT2|0:DRD1|0:PLEK|0:ENG|0:WNT5A|0:ABCA1|0:MCTP2|0:NR0B1|0:RPL7A|0:ZACN|0:GP1BA|0:HTR4|0:ABCC5|0:SELP|0:LAMP2|0:A4GALT|0:INPP5K|0:DPM1|0:DPP10|0:BFAR|0:EIF2B1|0:ABCC4|0:VLDLR|0:PDZD3|0:ARRB1|0:TMX1|0:MTMR3|0:PLCE1|0:AGPAT6|0:SPHK2|0:PPAP2A|0:GABARAPL2|0:CLN3|0:RASGRP4|0:BCAR1|0:RC3H2|0:PNPLA8|0:NMUR1|0:ALG2|0:SHANK1|0:AVEN|0:SORD|0:GIPC1|0:ATP8B1|0:MAP3K13|0:GAL3ST4|0:MAEA|0:DOLK|0:PEX13|0:HPS4|0:CLIC1|0:VPS41|0:MCTP1|0:RAB14|0:PPT1|0:SYTL2|0:MAP3K12|0:CHRNA4|0:KCNK9|0:IGHG1|0:IGHG3|0:SLC18A1|0:STMN2|0:NAPG|0:IGHG4|0:IGHG2|0:IGHA2|0:FGFR1|0:IGHM|0:ATP6V1F|0:FADS3|0:SLC30A5|0:SLC22A2|0:FUT4|0:GYPA|0:FOLR2|0:SLC14A2|0:SLC23A1|0:MAN1A1|0:CYSLTR1|0:EEA1|0:KTN1|0:SLC6A2|0:PRKAR2A|0:SLC12A2|0:ABCB1|0:LEMD3|0:DSC3|0:DSCAM|0:SLC16A6|0:SLC1A1|0:PKMYT1|0:SLC17A3|0:PRSS21|0:SLCO1B1|0:OTOF|0:SLC19A1|0:GGCX|0:MADCAM1|0:GCNT3|0:VSIG2|0:ABCC1|0:CEACAM1|0:PITPNM1|0:SLC39A7|0:LCT|0:FOLH1|0:ADORA2A|0:SPTAN1|0:STBD1|0:SCARB2|0:SLC16A3|0:GBAS|0:TSPAN9|0:SLC6A9|0:SLC16A8|0:SLC3A1|0:CD151|0:CYP19A1|0:ARFRP1|0:HPS1|0:NT5E|0:MAN1A2|0:CNTN1|0:SLC24A1|0:MCF2|0:EBNA1BP2|0:SLC30A3|0:FOLR3|0:BID|0:SLC16A7|0:SLC26A3|0:CD36|0:XRCC6|0:FOLR1|0:SLC1A2|0:MPP2|0:TRIM27|0:ITGB3BP|0:SLC7A2|0:FUT1|0:CD59|0:SLC5A6|0:SLC12A1|0:MMD|0:CDH5|0:SLC33A1|0:ARF6|0:SLC22A6|0:RAB5B|0:MOGS|0:SLC17A4|0:TPST2|0:RHBDL1|0:SLC2A1|0:ICMT|0:SLC29A1|0:SLC17A5|0:PDE4A|0:VAMP8|0:JTB|0:SLC4A3|0:RAPGEFL1|0:SLC1A5|0:EMP1|0:CEACAM4|0:LMOD1|0:MPP1|0:KIF5A|0:IL15|0:ADRM1|0:SNTB2|0:SIGLEC6|0:EDA|0:CD52|0:SLC20A2|0:SPINT1|0:CYTH3|0:ABCB8|0:A4GNT|0:SLC12A4|0:CHRM1|0:DBH|0:DSC1|0:PXMP4|0:LRP1|0:DEGS1|0:SLC16A4|0:SLC26A2|0:SLC1A3|0:CLEC2D|0:SLC2A2|0:ABCB11|0:UGCG|0:GPR137B|0:PLP2|0:FADS2|0:ABCC3|0:HIP1|0:TSPAN13|0:KL|0:GAL3ST1|0:TSPAN31|0:CD68|0:SLC1A6|0:SLC22A7|0:LYVE1|0:SELPLG|0:CSPG5|0:ADAM18|0:TPST1|0:SLC16A1|0:CKAP4|0:SLC17A1|0:NRP2|0:CD7|0:CYTH2|0:SLC4A2|0:RAPGEF4|0:SLC28A2|0:RASGRP1|0:SLC18A2|0:RAPGEF3|0:ABCA4|0:ATP6V0E1|0:ABCA3|0:GALNT3|0:FRS2|0:SLC6A7|0:SLC16A5|0:OLR1|0:KDELR1|0:SLC16A2|0:DNAJC4|0:SLC22A3|0:SLC12A3|0:FUT3|0:LY6D|0:LAMP1|0:SLC18A3|0:SLC22A8|0:SLC13A2|0:ADCY8|0:SLC28A1|0:TSPAN15|0:MGAT2|0:ABCB4|0:LILRB2|0:GPR143|0:B4GALNT1|0:UTRN|0:BCL2L10|0:SLCO2A1|0:CHST10|0:TSPAN12|0:CA4|0:NCKAP1L|0:TMEM59L|0:SLC39A1|0:ROS1|0:SLC23A2|0:RGS19|0:BEST1|0:SLC15A1|0:PPIF|0:SLC17A2|0:AKAP13|0:SLC22A1|0:SPHK1|0:KREMEN1			
GO:0030097	P:hemopoiesis; TAS:UniProtKB		0:BMI1|0:L3MBTL1|0:TAZ|0:NKX2-5|0:GLRX5|0:TGFB2|0:KIRREL3|0:KITLG|0:ZNF675|0:AHSP|0:ZNF160|0:ASH2L|0:DLL1|0:CD164|0:JAG1|0:FUT10|0:BCL11A|0:NOTCH2|0:NOTCH4			
GO:0002439	P:chronic inflammatory response to antigenic ...; IMP:BHF-UCL		0:TNF			
GO:0010001	P:glial cell differentiation; ISS:UniProtKB		0:RELN			
GO:0071107	P:response to parathyroid hormone stimulus; ISS:UniProtKB		0:CITED1			
GO:0048332	P:mesoderm morphogenesis; IMP:UniProtKB		0:TBX3			
GO:0005227	F:calcium activated cation channel activity; NAS:UniProtKB		0:PKD2L1			
GO:0070435	C:Shc-EGFR complex; ISS:BHF-UCL		0:EGFR|0:SHC1			
GO:0050983	P:spermidine catabolic process to deoxyhypusi...; TAS:ProtInc		0:DHPS			
GO:0043139	F:5'-3' DNA helicase activity; IDA:UniProtKB		0:C10orf2|0:ERCC2			
GO:0033136	P:serine phosphorylation of STAT3 protein; ISS:UniProtKB		0:NLK			
GO:0051902	P:negative regulation of mitochondrial depola...; TAS:UniProtKB		0:IFI6|0:BCL2			
GO:0035110	P:leg morphogenesis; IMP:UniProtKB		0:TBX4			
GO:0071391	P:cellular response to estrogen stimulus; IEP:UniProtKB		0:RARA|0:SFRP1|0:SERPINB9			
GO:0001948	F:glycoprotein binding; ISS:UniProtKB		0:FLNA|0:FBXO27|0:OS9|0:LACRT|0:FBXO17|0:VWF|0:IGF2R|0:ERLEC1|0:F7|0:ITGB2|0:ACE2|0:APOH|0:FYN|0:LCK|0:CD4|0:RASA1|0:FBXO6			
GO:0006977	P:DNA damage response, signal transduction by...; TAS:ProtInc		0:CDKN1A|0:PPP2R5C|0:RBM38|0:PML|0:GTSE1|0:TRIAP1|0:GML			
GO:0014827	P:intestine smooth muscle contraction; IMP:UniProtKB		0:HTR2B|0:HTR1D			
GO:0090321	P:positive regulation of chylomicron remnant ...; ISS:BHF-UCL		0:GPIHBP1			
GO:0000109	C:nucleotide-excision repair complex; IDA:UniProtKB		0:ERCC8|0:ERCC1|0:ERCC4			
GO:0007506	P:gonadal mesoderm development; IEA:UniProtKB-KW		0:AMH|0:TSPY2|0:TSPY1			
GO:0008251	F:tRNA-specific adenosine deaminase activity; IMP:UniProtKB		0:ADAT1			
GO:0045295	F:gamma-catenin binding; IPI:UniProtKB		0:PTPRT|0:LEF1|0:DSC3|0:CDH1|0:CTNNA1|0:CDH2|0:TCF7L2|0:APC|0:DSG1|0:PTPRK			
GO:0003708	F:retinoic acid receptor activity; TAS:ProtInc		0:RARA|0:RARG|0:RARB			
GO:0015052	F:beta3-adrenergic receptor activity; IMP:HGNC		0:ADRB3			
GO:0051896	P:regulation of protein kinase B signaling ca...; IDA:UniProtKB		0:RICTOR			
GO:0000093	P:mitotic telophase; NAS:UniProtKB		0:MAD1L1			
GO:0070326	F:very-low-density lipoprotein receptor binding; IPI:BHF-UCL		0:APOE|0:PCSK9|0:LRPAP1			
GO:0046080	P:dUTP metabolic process; IEA:InterPro		0:DUT			
GO:0005521	F:lamin binding; TAS:ProtInc		0:SUN2|0:BNIP3L|0:NARF|0:SYNE1|0:LBR|0:TMPO			
GO:0034126	P:positive regulation of MyD88-dependent toll...; ISS:BHF-UCL		0:MOG			
GO:0030274	F:LIM domain binding; NAS:UniProtKB		0:LDB1|0:RIPK2|0:LPAR2|0:TLN1|0:LDB2|0:CSRP2BP			
GO:0021987	P:cerebral cortex development; ISS:HGNC		0:FOXP2|0:LEF1|0:FZD3|0:TCF4|0:WNT7A|0:AXIN2|0:DVL2|0:ZEB2|0:CLASP2|0:BBS4|0:MKKS|0:BBS2|0:NF1			
GO:0006002	P:fructose 6-phosphate metabolic process; TAS:ProtInc		0:PFKM|0:PFKL|0:GFPT2|0:GFPT1			
GO:0046685	P:response to arsenic; NAS:UniProtKB		0:SRRT			
GO:0047800	F:cysteamine dioxygenase activity; IEA:EC		0:ADO			
GO:0032897	P:negative regulation of viral transcription; IDA:BHF-UCL		0:SP100|0:IFNB1			
GO:0031293	P:membrane protein intracellular domain prote...; IMP:UniProtKB		0:TRAF6|0:APH1B|0:PSEN1|0:PSENEN|0:NGFR|0:NFKB1|0:NCSTN|0:RELA|0:PSEN2|0:ADAM17|0:APH1A			
GO:0005736	C:DNA-directed RNA polymerase I complex; TAS:ProtInc		0:POLR1A|0:POLR1C			
GO:0015194	F:L-serine transmembrane transporter activity; TAS:ProtInc		0:SLC1A4|0:SERINC1|0:SLC7A10			
GO:0048549	P:positive regulation of pinocytosis; IMP:UniProtKB		0:PPT1			
GO:0090281	P:negative regulation of calcium ion import; ISS:BHF-UCL		0:SLC30A1			
GO:0034446	P:substrate adhesion-dependent cell spreading; NAS:UniProtKB		0:LAMB1|0:FN1|0:LAMA5|0:LAMC1|0:ANTXR1|0:SRCIN1|0:BVES|0:VAMP3|0:C22orf28			
GO:0009032	F:thymidine phosphorylase activity; TAS:ProtInc		0:TYMP			
GO:0004332	F:fructose-bisphosphate aldolase activity; IDA:UniProtKB		0:ALDOA|0:ALDOB|0:ALDOC			
GO:0006663	P:platelet activating factor biosynthetic pro...; NAS:UniProtKB		0:CHPT1|0:LPCAT2|0:PLA2G4A			
GO:0071333	P:cellular response to glucose stimulus; IMP:BHF-UCL		0:CYP7A1|0:ADRA2A			
GO:0060305	P:regulation of cell diameter; IDA:BHF-UCL		0:PLEK			
GO:0010997	F:anaphase-promoting complex binding; IPI:UniProtKB		0:CLSPN|0:PLK1			
GO:0060173	P:limb development; ISS:UniProtKB		0:COMP|0:IFT122			
GO:0015440	F:peptide-transporting ATPase activity; IDA:UniProtKB		0:ABCB9			
GO:0031201	C:SNARE complex; TAS:HGNC		0:BNIP1|0:STX3|0:VAMP7|0:STX16|0:VTI1A|0:BET1L|0:STX5|0:GOSR1|0:YKT6			
GO:0010957	P:negative regulation of vitamin D biosynthet...; IC:BHF-UCL		0:GFI1|0:NFKB1			
GO:0018931	P:naphthalene metabolic process; IDA:UniProtKB		0:CYP2F1			
GO:0045197	P:establishment or maintenance of epithelial ...; TAS:UniProtKB		0:MARK2|0:ERBB2IP|0:PRKCI			
GO:0008117	F:sphinganine-1-phosphate aldolase activity; NAS:UniProtKB		0:SGPL1			
GO:0032733	P:positive regulation of interleukin-10 produ...; ISS:BHF-UCL		0:HSPD1|0:TIGIT|0:TLR4|0:TLR9			
GO:0016565	F:general transcriptional repressor activity; IMP:BHF-UCL		0:TBX3|0:ZNF256|0:HMGB2|0:CBX5|0:SP100|0:CBX3			
GO:0017091	F:AU-rich element binding; IDA:UniProtKB		0:ELAVL3|0:ZFP36|0:ELAVL4|0:NUDT21|0:DND1			
GO:0046653	P:tetrahydrofolate metabolic process; IEA:InterPro		0:MTHFD1L|0:DHFRP1|0:MTHFD2|0:DHFR|0:MTHFS|0:PIPOX			
GO:0046641	P:positive regulation of alpha-beta T cell pr...; TAS:UniProtKB		0:EBI3			
GO:0005035	F:death receptor activity; TAS:ProtInc		0:TNFRSF10A			
GO:0006548	P:histidine catabolic process; IEA:InterPro		0:MOXD2P|0:C9orf4|0:UROC1|0:MOXD1|0:DBH|0:FRRS1			
GO:0005501	F:retinoid binding; ISS:UniProtKB		0:APOD|0:PTGDS			
GO:0030492	F:hemoglobin binding; NAS:UniProtKB		0:HBB|0:HP|0:HPR|0:AHSP			
GO:0001619	F:lysosphingolipid and lysophosphatidic acid ...; IEA:InterPro		0:S1PR1|0:LPAR1|0:S1PR2|0:S1PR4|0:S1PR3|0:S1PR5			
GO:0050684	P:regulation of mRNA processing; IDA:UniProtKB		0:CDK11A|0:SRPK1|0:CDK11B			
GO:0051573	P:negative regulation of histone H3-K9 methyl...; IMP:UniProtKB		0:DNMT3B|0:DNMT1			
GO:0032451	F:demethylase activity; IDA:UniProtKB		0:CYP1A2			
GO:0070034	F:telomeric RNA binding; IDA:BHF-UCL		0:TERT			
GO:0045622	P:regulation of T-helper cell differentiation; NAS:UniProtKB		0:IRF4			
GO:0005964	C:phosphorylase kinase complex; TAS:ProtInc		0:PHKA2			
GO:0004957	F:prostaglandin E receptor activity; TAS:ProtInc		0:HPGD|0:PTGER3|0:PTGER2|0:PTGER1|0:PTGER4			
GO:0032747	P:positive regulation of interleukin-23 produ...; ISS:BHF-UCL		0:MYD88			
GO:0032269	P:negative regulation of cellular protein met...; IC:BHF-UCL		0:NFKB1			
GO:0000095	F:S-adenosylmethionine transmembrane transpor...; IMP:UniProtKB		0:SLC25A26			
GO:0018958	P:phenol metabolic process; IDA:UniProtKB		0:SULT1B1			
GO:0000439	C:core TFIIH complex; IEA:InterPro		0:GTF2H3			
GO:0048006	P:antigen processing and presentation, endoge...; IDA:UniProtKB		0:CD1D			
GO:0043130	F:ubiquitin binding; TAS:HGNC		0:NEDD4|0:UBE2N|0:SIRT2|0:UCHL3|0:FAN1|0:USP16|0:OTUB1|0:BCL10|0:SQSTM1|0:RNF168|0:CXCR4|0:NUP62|0:TRIM32|0:KIF18A|0:NBR1|0:UCHL1|0:TOP2A|0:CIITA|0:POU5F1|0:MARK4|0:TSG101|0:TOM1L1			
GO:0090083	P:regulation of inclusion body assembly; IMP:BHF-UCL		0:SNCAIP|0:BAG5			
GO:0051535	F:syntaxin-5 binding; ISS:UniProtKB		0:SCFD1			
GO:0002821	P:positive regulation of adaptive immune resp...; IC:BHF-UCL		0:IL6ST			
GO:0004739	F:pyruvate dehydrogenase (acetyl-transferring...; TAS:ProtInc		0:PDHA1|0:PDHB|0:PDHA2			
GO:0060039	P:pericardium development; ISS:BHF-UCL		0:TBX5|0:NKX2-6			
GO:0043149	P:stress fiber assembly; IMP:UniProtKB		0:ARRB1|0:KCTD13|0:CUL3|0:TNFAIP1			
GO:0032342	P:aldosterone biosynthetic process; IDA:BHF-UCL		0:CYP11B2|0:CYP11B1			
GO:0045920	P:negative regulation of exocytosis; IMP:UniProtKB		0:IL1RAPL1|0:SNCA			
GO:0033540	P:fatty acid beta-oxidation using acyl-CoA ox...; IMP:BHF-UCL		0:HSD17B4|0:CRAT|0:ABCD1|0:ACAA1|0:ACOT8|0:ACOX1			
GO:0060161	P:positive regulation of dopamine receptor si...; ISS:BHF-UCL		0:CAV2|0:DRD3			
GO:0032740	P:positive regulation of interleukin-17 produ...; ISS:BHF-UCL		0:TGFB1|0:NOD2|0:MYD88			
GO:0031574	P:S-M checkpoint; ISS:UniProtKB		0:NAE1|0:C15orf42			
GO:0004560	F:alpha-L-fucosidase activity; TAS:UniProtKB		0:FUCA2|0:FUCA1			
GO:0007253	P:cytoplasmic sequestering of NF-kappaB; NAS:UniProtKB		0:PSMD10|0:NFKBIA|0:FAF1|0:IL10|0:G3BP2			
GO:0008612	P:peptidyl-lysine modification to hypusine; IMP:UniProtKB		0:EIF5A|0:EIF5A2|0:DHPS|0:EIF5AL1|0:DOHH			
GO:0045778	P:positive regulation of ossification; IMP:BHF-UCL		0:TGFB2|0:WNT5A			
GO:0050860	P:negative regulation of T cell receptor sign...; ISS:UniProtKB		0:PTPN22|0:DUSP3|0:THY1			
GO:0042573	P:retinoic acid metabolic process; NAS:UniProtKB		0:UGT1A8|0:UGT1A9|0:UGT1A1|0:UGT1A7|0:UGT1A3|0:BCO2			
GO:0033081	P:regulation of T cell differentiation in the...; NAS:UniProtKB		0:CLPTM1|0:SOD1			
GO:0072236	P:metanephric loop of Henle development; ISS:UniProtKB		0:WNT7B			
GO:0021794	P:thalamus development; IMP:UniProtKB		0:CNTNAP2|0:SLC6A4			
GO:0048306	F:calcium-dependent protein binding; TAS:UniProtKB		0:TNNT3|0:S100A11|0:S100B|0:S100A6|0:ALG2|0:S100P|0:S100PBP|0:MASP2|0:RBM22|0:PLSCR3|0:PDCD6IP|0:ANXA7|0:TNNI3|0:ANXA11|0:PDCD6|0:MBL2|0:SEC31A|0:TSG101|0:CABP1|0:FCN2|0:MASP1|0:TNNC1|0:STX2|0:DMBT1			
GO:0016776	F:phosphotransferase activity, phosphate grou...; IEA:InterPro		0:CMPK1			
GO:0032802	P:low-density lipoprotein receptor catabolic ...; IDA:HGNC		0:PCSK9			
GO:0032729	P:positive regulation of interferon-gamma pro...; ISS:BHF-UCL		0:HSPD1|0:IL12A|0:IL12B|0:TLR4|0:SLC11A1			
GO:0030330	P:DNA damage response, signal transduction by...; TAS:UniProtKB		0:MYO6|0:USP10|0:NBN			
GO:0002326	P:B cell lineage commitment; NAS:UniProtKB		0:TCF3			
GO:0008455	F:alpha-1,6-mannosylglycoprotein 2-beta-N-ace...; TAS:ProtInc		0:MGAT2			
GO:0060697	P:positive regulation of phospholipid catabol...; IDA:BHF-UCL		0:APOC2			
GO:0034370	P:triglyceride-rich lipoprotein particle remo...; IDA:BHF-UCL		0:APOA2			
GO:0007089	P:traversing start control point of mitotic c...; TAS:ProtInc		0:CDC25C|0:CDK10|0:CDK2|0:CDC6			
GO:0008241	F:peptidyl-dipeptidase activity; IEA:InterPro		0:ACE|0:ACE2|0:TMEM27			
GO:0047130	F:saccharopine dehydrogenase (NADP+, L-lysine...; IEA:EC		0:AASS			
GO:0006711	P:estrogen catabolic process; IDA:UniProtKB		0:UGT2B4			
GO:0030981	C:cortical microtubule cytoskeleton; IDA:UniProtKB		0:CLASP1|0:MAPRE1			
GO:0004572	F:mannosyl-oligosaccharide 1,3-1,6-alpha-mann...; TAS:ProtInc		0:MAN2A2|0:MAN2A1			
GO:0001662	P:behavioral fear response; NAS:BHF-UCL		0:DRD4			
GO:0015464	F:acetylcholine receptor activity; TAS:ProtInc		0:CHRNA2|0:CHRNA5|0:CHRNA3|0:CHRNB4|0:CHRNB2|0:CHRNA7|0:ANXA9|0:CHRNA4|0:CHRNG|0:CHRNA6|0:CHRNA1|0:CHRNE			
GO:0045844	P:positive regulation of striated muscle tiss...; IDA:UniProtKB		0:MKL2			
GO:0030328	P:prenylcysteine catabolic process; IEA:InterPro		0:PCYOX1L			
GO:0090190	P:positive regulation of branching involved i...; ISS:UniProtKB		0:GDNF|0:NOG			
GO:0009191	P:ribonucleoside diphosphate catabolic process; IDA:UniProtKB		0:NUDT5			
GO:0006350	P:transcription; TAS:UniProtKB		0:XAB2|0:CREB3|0:FUBP3|0:CREBZF|0:POLR2J3|0:PPP1R10|0:TCEANC|0:SPOCD1|0:PAPOLG|0:C1orf83|0:PAPOLB|0:DIDO1|0:PHF3|0:PAPOLA|0:CREB3L1|0:ZHX3|0:SALL1|0:CHD8|0:TBX10|0:ZBTB12|0:ZEB1|0:MIER1|0:CHD9|0:ARID3C|0:CHD1|0:POU3F1|0:PHF20|0:ZNF212|0:ZNF83|0:ZNF257|0:RNF4|0:HDAC7|0:SNAPC1|0:ZNF687|0:HABP4|0:ZNF350|0:GFI1|0:GATA1|0:RBPMS|0:IRX3|0:KLF4|0:SEBOX|0:UIMC1|0:ZNF667|0:ZCCHC12|0:TFEC|0:HOXB5|0:ARGFX|0:PITX1|0:ZNF568|0:PAWR|0:ZNF614|0:SAFB2|0:E2F4|0:ESRRB|0:PHF12|0:RUVBL2|0:SSX10|0:RPAP1|0:MBD2|0:FOXO1|0:CBX2|0:ZNF165|0:HES2|0:ZNF775|0:TGIF2LY|0:RB1CC1|0:TCEAL2|0:FOXN3|0:PRMT5|0:ZNF16|0:EPC2|0:ZNF285|0:ZNF10|0:ZHX2|0:ZNF624|0:SOHLH2|0:ATXN7L3|0:ZNF541|0:TAL1|0:RBBP7|0:BRDT|0:ZNF121|0:MED21|0:BHLHE40|0:KLHL31|0:HDAC11|0:TOX2|0:MED15|0:IRF2|0:PGR|0:SOX6|0:NAB1|0:MED31|0:MAFIP|0:ZNF532|0:BRMS1L|0:TAF8|0:ZNF594|0:NEUROD6|0:SLC2A4RG|0:NONO|0:GTF2H2C|0:HOXC11|0:CHURC1|0:HDAC1|0:KDM2B|0:TBX22|0:ASF1A|0:HOXA11|0:HSF5|0:ZNF703|0:ZSCAN20|0:ZNF57|0:ZBTB46|0:ARID1A|0:ZNF17|0:ZNF280D|0:SAFB|0:RFX2|0:KLF3|0:ERBB4|0:HIVEP1|0:DMRT1|0:ZNF783|0:ZNF85|0:KDM4D|0:SMARCC2|0:USF2|0:IRF2BP2|0:ZNF230|0:ZNF434|0:ZNF347|0:KCNIP3|0:SFPQ|0:TCEB3CL|0:SSX2|0:ZNF581|0:ZBTB38|0:EZH2|0:ZFP37|0:ZNF117|0:NKRF|0:CXXC1|0:ZNF311|0:VIPAR|0:MED10|0:WTIP|0:MAMSTR|0:EGR1|0:MTF1|0:ZSCAN10|0:ZNF502|0:LEF1|0:EYA1|0:SATB2|0:ZNF516|0:MAML3|0:ZNF840|0:PHF19|0:NPAS4|0:ZNF497|0:POLR3E|0:CDCA7|0:GRHL3|0:OVOL2|0:RBL2|0:ELP3|0:ZNF787|0:RQCD1|0:HOXA7|0:EGR3|0:ZNF267|0:ZBTB6|0:TXNIP|0:CSRNP3|0:ZNF461|0:GLIS1|0:DEDD|0:SAP130|0:ZNF619|0:CCNL1|0:SP1|0:ZBTB1|0:ZNF876P|0:GSX1|0:ZNF642|0:ZNF766|0:TBR1|0:ZNF226|0:BAZ2A|0:ZNF71|0:CEBPG|0:PATZ1|0:ALX4|0:POLR1D|0:CASZ1|0:PAX8|0:FEZF2|0:LYL1|0:ZNF34|0:KLF14|0:SCML1|0:SAP30BP|0:MEAF6|0:SSX4B|0:ZNF680|0:ZNF607|0:DRAP1|0:ZNF575|0:VSX2|0:SETD7|0:HOXB9|0:CHAF1B|0:FOXD1|0:RASL11A|0:HDGF|0:ZNF579|0:CDC5L|0:ERN1|0:NOTCH3|0:HOXB2|0:ZNF133|0:PHTF2|0:HEYL|0:ZNF816|0:ARHGAP22|0:ZNF600|0:ZNF678|0:ATF7IP2|0:SCXA|0:ARNT2|0:CNBP|0:TCF25|0:PCGF3|0:DUX4|0:BCLAF1|0:ZNF25|0:SSX7|0:ZNF331|0:ZNF24|0:ESRRA|0:SUV39H2|0:ZNF549|0:PHF1|0:CBX6|0:NR1I3|0:IFI16|0:NCOA3|0:ZNF107|0:ZNF417|0:MEIS1|0:CREBBP|0:TCEAL6|0:MYST3|0:ZNF439|0:GLI1|0:ZNF157|0:ZNF733|0:ZNF561|0:ZNF362|0:TGIF2|0:ZNF565|0:ZNF790|0:OLIG3|0:DMTF1|0:DPRX|0:ARID2|0:ZBTB4|0:COBRA1|0:ATXN3L|0:MYOCD|0:ZNF215|0:ZNF862|0:BBX|0:RERE|0:BNC1|0:ZFX|0:IRAK1BP1|0:FOXD2|0:DBP|0:HNRNPD|0:ZNF44|0:ARX|0:INSM1|0:ZNF493|0:ZNF717|0:NEUROD2|0:MAPK1|0:HOXD12|0:SPI1|0:HOXB4|0:ZNF271|0:ZNF142|0:BAZ2B|0:TCEB1|0:ATF2|0:C10orf137|0:DYNLL1|0:HDAC8|0:FOXS1|0:ZNF423|0:MSL3L2|0:FOXB2|0:SUZ12|0:MZF1|0:ZFP2|0:HTATSF1|0:RFX6|0:HKR1|0:NACC1|0:TWIST2|0:DNTTIP2|0:PCBD1|0:TAF3|0:HOXD3|0:NR2C1|0:ZSCAN23|0:ZNF628|0:ZNF746|0:CTNND1|0:VPS72|0:ASXL1|0:ZNF620|0:MED19|0:ZNF860|0:JDP2|0:MORF4L1|0:POU2F1|0:ELK3|0:TTLL5|0:TBX6|0:ZFP42|0:MESP2|0:BHLHE41|0:ZKSCAN2|0:ZNF658B|0:SOX2|0:BARHL2|0:SLC30A9|0:ZFP92|0:E2F8|0:ZSCAN18|0:ZNF837|0:NFE2|0:SOX13|0:IKZF5|0:NR2F1|0:ACAD8|0:ILF2|0:ZNF506|0:ASCC3|0:SOX21|0:ZNF879|0:KLF16|0:PIAS3|0:NEUROG3|0:MXD4|0:SMARCB1|0:ARID3A|0:ZNF665|0:GCM2|0:E2F1|0:PPARG|0:IRF6|0:MYBL2|0:ZNF407|0:PARP14|0:HOXA3|0:FOXJ2|0:ZNF343|0:TADA3|0:YY1|0:MCM3|0:HMX2|0:TEAD2|0:SOX12|0:SMAD7|0:RDBP|0:HR|0:MSGN1|0:HOXC5|0:ZNF234|0:THOC1|0:TBX1|0:SALL2|0:NR6A1|0:OTP|0:ZNF599|0:PER2|0:PRMT6|0:GABPB1|0:DRGX|0:ZNF252|0:TP53BP1|0:TBL1Y|0:CUX2|0:CCNC|0:BHLHA15|0:ZNF829|0:ZNF813|0:HES3|0:BATF|0:TEF|0:FOXK1|0:C11orf30|0:ZNF618|0:ZBTB42|0:RARA|0:SS18|0:CARM1|0:IKZF2|0:PML|0:ZNF276|0:TLE1|0:EBF4|0:BPTF|0:GSX2|0:ZNF571|0:ASCL4|0:FOXA1|0:ZNF844|0:ZNF286A|0:ENY2|0:ZNF526|0:ZNF674|0:HDAC2|0:BANP|0:TSC22D4|0:ZFP112|0:CRTC3|0:ZNF525|0:ZNF93|0:DMRTC2|0:ZNF443|0:ZNF323|0:EYA4|0:LMX1B|0:ZNF654|0:SS18L1|0:UBP1|0:ZNF282|0:ZNF222|0:PRDM15|0:SUPT6H|0:ZNF30|0:ZNF770|0:ZNF385A|0:MED22|0:ETV6|0:ZNF398|0:HMGA1|0:ZNF557|0:ZBTB49|0:ZNF683|0:ZNF658|0:NPAS3|0:HIPK1|0:SMYD1|0:ZNF192|0:ZNF705F|0:DPY30|0:PAX7|0:BTG2|0:TRIB3|0:ZFP161|0:NFIA|0:ZNF510|0:ZNF623|0:EED|0:HES1|0:NCOR2|0:CCAR1|0:RFX3|0:SPZ1|0:ZNF284|0:ZNF187|0:CNOT1|0:ZBTB11|0:GLIS2|0:ATF7|0:CIITA|0:STAT5A|0:ACTR5|0:TRAF7|0:ZNF709|0:HOXB8|0:PHB2|0:ZNF384|0:GTF2H5|0:ZNF710|0:TCF19|0:FOXN2|0:NOTCH2|0:ZNF136|0:HMBOX1|0:KAT5|0:ZNF713|0:ZNF18|0:SPIC|0:E2F7|0:IKBKAP|0:ZNF846|0:GPBP1|0:SSX3|0:IGHMBP2|0:CITED2|0:TXLNG|0:SP110|0:CHD7|0:HIC1|0:NKX2-3|0:LHX4|0:ZC3H8|0:ZNF317|0:ZNF763|0:ZSCAN21|0:HOXC10|0:ZNF544|0:KLF17|0:ZNF433|0:MKL2|0:TBX3|0:DAXX|0:ZNF705G|0:TGS1|0:MCM4|0:BAHD1|0:SEC14L2|0:MECOM|0:ZNF263|0:SOHLH1|0:ZNF550|0:RNF10|0:ZNF567|0:ZNF660|0:TCEAL3|0:ZNF737|0:HDAC10|0:ZHX1|0:OVOL1|0:ZNF789|0:SCRT1|0:ZNF404|0:ZNF2|0:ZNF823|0:NRBF2|0:BNC2|0:ZNF486|0:ZNF675|0:ZBTB32|0:MYBBP1A|0:ZNF697|0:ZNF776|0:ZNF503|0:RYBP|0:ZNF22|0:ZNF416|0:ZNF225|0:ZNF554|0:SOX7|0:PRDM14|0:POU4F2|0:SMARCC1|0:FOXQ1|0:ZSCAN5A|0:SOX4|0:L3MBTL2|0:ZFP3|0:CRY2|0:ZNF454|0:MAML2|0:SP6|0:SCYL1|0:TBX5|0:ZBTB22|0:ZNF648|0:ZNF574|0:ZNF175|0:ZNF692|0:USP16|0:ZBTB2|0:TCF12|0:ZNF721|0:POU4F1|0:ZNF641|0:HIRA|0:AEBP2|0:TP73|0:RUNX1|0:TSHZ2|0:ZNF540|0:NR2E1|0:BHLHE22|0:ERN2|0:ZNF679|0:CCNL2|0:SIM1|0:ZFHX4|0:TSPYL2|0:SOX30|0:ZBTB45|0:ZNF578|0:RUVBL1|0:EBF3|0:ATXN3|0:TRIM27|0:SOX17|0:LRPPRC|0:EBF1|0:ZBTB7A|0:ZNF818P|0:ZBTB39|0:FOXD4L4|0:PTF1A|0:ZSCAN1|0:FOXA3|0:ZNF335|0:SUV420H2|0:SF1|0:ITGB3BP|0:DMRTC1|0:VDR|0:ZNF213|0:FOXP4|0:TBL1X|0:ZNF580|0:EZH1|0:ZNF732|0:NME2|0:HIVEP2|0:ZNF354B|0:BCORL1|0:ZNF238|0:TCEB3C|0:TFDP1|0:SKOR1|0:CIC|0:HOXC9|0:KDM4C|0:THAP7|0:ZNF777|0:TFAP2C|0:NR5A2|0:HELLS|0:MXD3|0:HNF4A|0:KHSRP|0:VSX1|0:ARID3B|0:ZFP64|0:DMAP1|0:ZNF295|0:ZNF517|0:LMO3|0:ZNF587|0:MBD3|0:KLF15|0:HIPK2|0:ZMIZ1|0:SUDS3|0:ZNF77|0:ZNF613|0:FOXD4|0:ZNF490|0:KHDRBS1|0:ZNF324B|0:CDKN2A|0:ZNF341|0:HSFX1|0:SCML4|0:MNX1|0:MAMLD1|0:ZNF788|0:SRY|0:ZNF785|0:MITF|0:HOXD11|0:TRIM33|0:RNF14|0:HOXA13|0:ZNF718|0:UTF1|0:PUF60|0:ZNF702P|0:SIX5|0:TH1L|0:FOXJ1|0:ZNF280C|0:ZNF75A|0:NKX6-1|0:ATP1B4|0:ZNF41|0:ZNF334|0:FOXB1|0:IKZF3|0:HES7|0:POU6F1|0:CSDA|0:RARB|0:ZNF320|0:CNOT6|0:TCF4|0:PBX1|0:ZNF711|0:ZNF275|0:SETD8|0:HEXIM1|0:MED18|0:PROX1|0:SSRP1|0:ASXL2|0:MLL3|0:ZNF193|0:ZNF354C|0:IKBKG|0:SSX4|0:NHLH2|0:FOXD4L6|0:HAND2|0:MED25|0:ZNF627|0:ZNF593|0:ZNF468|0:ZNF740|0:ZNF514|0:ZKSCAN1|0:BSX|0:CAND2|0:BCL6|0:SREBF2|0:ZNF780B|0:ZIC3|0:UBE2L3|0:LMX1A|0:CREB3L4|0:ZIK1|0:ZNF33B|0:ZNF548|0:NANOGP8|0:HOXB1|0:ZNF664|0:SRCAP|0:KDM5B|0:PPP1R13L|0:PRR13|0:RCOR1|0:SMAD2|0:ZNF806|0:SSBP3|0:FOXC2|0:ZNF322A|0:ZNF793|0:TCEAL7|0:EID1|0:RBM14|0:RAX2|0:ZNF268|0:LBX2|0:MCM7|0:ZNF408|0:ZNF426|0:SP2|0:DPF1|0:DMRT2|0:RAX|0:NR0B2|0:TIMELESS|0:ZNF507|0:ZNF26|0:PPRC1|0:PHF8|0:ZNF396|0:SNF8|0:EIF2C2|0:ZNF143|0:ENO1|0:GLI2|0:ZNF560|0:ZNF438|0:ZNF564|0:ZNF782|0:KDM1B|0:RBM39|0:ZNF671|0:ELP2|0:DUXA|0:ZNF91|0:LPIN1|0:ZFY|0:CEBPE|0:OLIG2|0:ZNF440|0:BRWD1|0:ZBTB17|0:RLF|0:RRN3|0:SPIB|0:MEF2D|0:RCBTB1|0:WASL|0:ZFP28|0:HLTF|0:HMG20B|0:ZNF826P|0:PAX4|0:NANOG|0:TRIM22|0:NR1H3|0:GABPB2|0:ZNF274|0:ATF3|0:ZNF397|0:CNOT4|0:ZNF749|0:HDAC5|0:PQBP1|0:REST|0:TEAD3|0:MEF2A|0:ZNF836|0:ASF1B|0:ZNF812|0:FOXD3|0:HOXB3|0:HOXB13|0:GFI1B|0:ZNF527|0:ZNF771|0:ZNF66P|0:LITAF|0:ZNF410|0:PHOX2B|0:HILS1|0:ZNF92|0:ZXDA|0:MORF4L2|0:ZNF76|0:ZNF281|0:SOX3|0:BZW1|0:ZNF221|0:RBBP4|0:ETV4|0:TFAP2D|0:ZFP30|0:CTBP1|0:ASCC2|0:ZNF167|0:ZBTB26|0:ZNF644|0:SCAI|0:MED6|0:TRERF1|0:ZNF653|0:FERD3L|0:ZNF444|0:POLR3C|0:ARNTL|0:ZNF521|0:KDM3B|0:HMGA2|0:ING2|0:ZNF558|0:CLOCK|0:PHF5A|0:ZNF329|0:HMGN5|0:PHF17|0:SERTAD3|0:RORA|0:CRX|0:PRIM1|0:SSX8|0:ZNF229|0:KLF8|0:JMJD6|0:SUV39H1|0:NOTO|0:VGLL2|0:CCDC101|0:ZNF69|0:SAP18|0:ZKSCAN5|0:TSHZ3|0:ZNF449|0:IRF5|0:MSX1|0:ESF1|0:ZNF584|0:FOXF1|0:HOXA4|0:ELF2|0:HOXA9|0:HIF1AN|0:ZNF180|0:ZNF205|0:STAT2|0:HMX3|0:FSTL3|0:GTF2H2D|0:FOXP1|0:ZNF253|0:SOX11|0:HIVEP3|0:ZNF736|0:SMARCA2|0:ZNF791|0:SP5|0:HOXC6|0:MYST2|0:KLF10|0:ASCL1|0:SNAI2|0:ZGPAT|0:TADA2B|0:NCOA4|0:SRF|0:SIN3B|0:ZNF487P|0:TP63|0:ABRA|0:SMARCD3|0:ZNF799|0:EP300|0:HIC2|0:ERG|0:NR4A2|0:HMX1|0:BAZ1B|0:TERF2IP|0:PRDM2|0:FOXP3|0:FOXM1|0:ZBTB48|0:CDK8|0:VAX2|0:SETDB1|0:CAMTA1|0:ZNF534|0:KDM4B|0:TFAP2B|0:SUV420H1|0:E4F1|0:ARID5A|0:HDAC3|0:NFYC|0:ZNF738|0:AHRR|0:ZNF324|0:JUND|0:GRHL1|0:ZNF511|0:ZNF586|0:POLR3G|0:ZNF726|0:HSFY2|0:TSHZ1|0:ZNF264|0:SCRT2|0:HOXA5|0:GCM1|0:ELF1|0:ZSCAN12|0:TAF1D|0:MCM5|0:ZNF551|0:ZNF480|0:ZBTB41|0:NR4A3|0:ARID1B|0:GBX2|0:PIAS1|0:ZNF3|0:LRRFIP1|0:CNOT2|0:ZNF287|0:ZNF676|0:SP7|0:UNCX|0:CBX4|0:ETV3|0:PAX6|0:PADI4|0:NLK|0:ZSCAN5B|0:NKX3-1|0:PURA|0:ERBB2|0:GTF2IRD2B|0:SMARCA4|0:GLIS3|0:TBL1XR1|0:PRDM10|0:MBTD1|0:BARHL1|0:ZBTB10|0:ZNF585A|0:CHMP1A|0:ZNF160|0:BARX1|0:MESP1|0:HEY1|0:RUNX2|0:SOX1|0:ZNF99|0:NR2F6|0:PRDM5|0:ZMYM2|0:ETV3L|0:SIM2|0:ZMIZ2|0:TCF20|0:ZNF135|0:SARNP|0:PER1|0:LMCD1|0:NOBOX|0:ADNP|0:ZNF689|0:TFCP2|0:ZNF570|0:TLE4|0:PSPC1|0:POU3F3|0:NCOA7|0:HOXB7|0:LBH|0:BHLHE23|0:FLII|0:ZNF214|0:TWIST1|0:ZNF682|0:RBAK|0:NR1D1|0:SMAD6|0:ZNF251|0:ZNF445|0:MEF2C|0:CBFA2T3|0:AFF3|0:MYB|0:ZNF485|0:SLTM|0:HOXC13|0:TFDP2|0:ZNF764|0:ZNF248|0:PELP1|0:MECP2|0:CREB3L3|0:PRDM9|0:ZNF669|0:THAP11|0:ZNF43|0:ZNF154|0:MIER3|0:ZNF8|0:PPP1R8|0:ZIM2|0:APBB1|0:SND1|0:CHD3|0:CHD6|0:ZNF81|0:ZNF318|0:LHX5|0:ZNF543|0:ESRRG|0:ZNF566|0:CC2D1A|0:PLAGL1|0:ZNF778|0:RNF2|0:KLF6|0:ZNF20|0:NANOGP1|0:ZNF518A|0:ZSCAN29|0:ZNF296|0:DENND4A|0:KLF12|0:RFX8|0:KEAP1|0:JAZF1|0:KHDRBS2|0:HSFX2|0:ZNF184|0:ZNF260|0:ZNF429|0:IRF4|0:MOV10|0:MIXL1|0:ZNF174|0:TBX4|0:ZNF512|0:ELK1|0:ZNF491|0:ZSCAN2|0:USP21|0:ZNF773|0:GTF2IRD2|0:ZNF300|0:FOXL2|0:ZNF460|0:AEBP1|0:C1D|0:SSX2B|0:CDC73|0:ZNF280B|0:NFATC2|0:MED9|0:ZNF626|0:HEXIM2|0:WDR5|0:RARG|0:ZNF700|0:WWTR1|0:FOXN1|0:DMRTB1|0:MYPOP|0:E2F6|0:ZBTB44|0:GTF2IRD1|0:ZNF19|0:TRAPPC2P1|0:ZNF714|0:RSC1A1|0:ARID4B|0:ZNF326|0:PAF1|0:IFT57|0:ZNF592|0:ZNF250|0:PRAME|0:ZNF12|0:HIP1|0:LHX2|0:ZFP57|0:PCGF1|0:ZNF420|0:SMAD5|0:HLX|0:ZNF200|0:NDN|0:RXRB|0:AES|0:ZNF208|0:HOXA1|0:ZNF181|0:FRY|0:LBX1|0:ZNF48|0:CAND1|0:FIGLA|0:ZNF75CP|0:ZNF345|0:RBPJ|0:ZNF484|0:FOXI2|0:DMRT3|0:ATOH8|0:ASCL5|0:ZSCAN16|0:ASCC1|0:MAFK|0:SBNO2|0:BARX2|0:SMAD9|0:ZNF395|0:ZNF467|0:ZNF79|0:DPF2|0:ZNF322B|0:FRYL|0:ZNF432|0:ZNF425|0:ZNF7|0:ZNF583|0:SERTAD2|0:ZNF672|0:PRIM2|0:ZNF805|0:ZNF254|0:SOX10|0:ZNF827|0:TRAPPC2|0:NFKBIZ|0:DMRTC1B|0:ATXN7|0:ZNF781|0:PRDM6|0:CNOT7|0:NKAP|0:EAF1|0:PSIP1|0:ZFP90|0:NACA|0:OLIG1|0:TCF15|0:HIPK3|0:ZNF530|0:NAA15|0:BCL11B|0:KLF9|0:ZNF90|0:RBPJL|0:ZNF663|0:CASP8AP2|0:SMARCA1|0:TEAD4|0:ZNF498|0:ZNF727|0:ZNF577|0:NCOA5|0:ZNF563|0:TCF7L1|0:ZNF835|0:ZNF528|0:ZNF555|0:HHEX|0:HDAC4|0:YAF2|0:BRPF1|0:HOXD10|0:ZNF132|0:ZNF786|0:ZNF56|0:HMG20A|0:EBF2|0:IKZF4|0:ZNF573|0:TBX18|0:ZNF616|0:MACC1|0:ZNF735|0:ZNF415|0:ZNF729|0:TRIM28|0:SETD1B|0:ZNF606|0:MAFB|0:NRIP2|0:SP3|0:ZNF772|0:FIZ1|0:C17orf81|0:RIPPLY1|0:EID2|0:ZNF32|0:HINFP|0:POU5F1|0:MLL2|0:NHLH1|0:SP8|0:RBM15B|0:SREBF1|0:UBTF|0:ADNP2|0:ZNF643|0:ZBTB25|0:BACH2|0:PPARGC1B|0:MCM8|0:PBX2|0:ZNF235|0:KAT2B|0:ZNF73|0:ZNF780A|0:EYA2|0:ZNF471|0:ZNF224|0:ZNF652|0:CDYL|0:CCDC59|0:RHOXF1|0:MED29|0:ZNF500|0:DACH1|0:KDM5C|0:NPAS1|0:TFCP2L1|0:MYEF2|0:NPAT|0:NR0B1|0:ZNF547|0:RCOR3|0:ARID5B|0:C14orf169|0:ZNF441|0:SSX9|0:MNDA|0:MSX2|0:PBRM1|0:ZNF80|0:RORB|0:FHL2|0:PHOX2A|0:ZFPM1|0:ZGLP1|0:JHDM1D|0:ZNF792|0:HSF4|0:ZNF124|0:DMRTA1|0:SPEN|0:LHX8|0:ZNF101|0:ATF5|0:CBX8|0:FOXN4|0:ZKSCAN4|0:GLI3|0:TCEAL4|0:ATF4|0:ZNF696|0:WHSC2|0:RFXANK|0:SNAI3|0:ONECUT3|0:ATF7IP|0:ZNF316|0:EIF2C1|0:LHX1|0:MCTS1|0:RXRG|0:ZNF140|0:ASXL3|0:ZNF701|0:ACTL6B|0:PNRC2|0:ZNF597|0:HNRPDL|0:PCGF5|0:ZBTB33|0:MGA|0:ZNF451|0:HES6|0:CDX4|0:ZNF302|0:ZNF14|0:SOX8|0:DLX5|0:ZNF367|0:ETS1|0:HOXB6|0:TRRAP|0:TBX20|0:ZNF273|0:ZEB2|0:NEUROD4|0:NR1H4|0:SALL4|0:ZNF708|0:YLPM1|0:IL16|0:TCF3|0:ZNF470|0:POU2F3|0:BACH1|0:TGIF2LX|0:CTBP2|0:ZMYND11|0:RBBP5|0:ZNF488|0:YAP1|0:L3MBTL3|0:IRF8|0:BCL3|0:MKL1|0:ZZZ3|0:ZXDB|0:KDM3A|0:ZNF33A|0:C11orf9|0:HDAC6|0:POLR3B|0:FEZF1|0:ZNF646|0:HOMEZ|0:ZNF446|0:MLF1IP|0:ING3|0:MED13L|0:TEAD1|0:PRKCB|0:FOXK2|0:VGLL3|0:WHSC1|0:WHSC1L1|0:ING5|0:ZNF232|0:FOXD4L1|0:ZNF239|0:ZNF35|0:LIMD1|0:ZSCAN4|0:ZSCAN5C|0:THAP1|0:ZNF552|0:KDM2A|0:VPS25|0:ZNF70|0:ZNF655|0:ZNF227|0:ZBTB20|0:NRF1|0:PRDM12|0:GPBP1L1|0:TBX21|0:SOX9|0:ZNRD1|0:ZNF137P|0:TCF21|0:ZNF419|0:KLF2|0:TFE3|0:IRF7|0:NAB2|0:ZNF414|0:HBP1|0:BDP1|0:VAX1|0:ELF4|0:GCFC1|0:ZNF524|0:TAL2|0:ANP32A|0:CCDC85B|0:FLI1|0:ZBTB47|0:ZNF681|0:ZFHX2|0:NR1D2|0:ZNF677|0:ZNF536|0:MEF2B|0:CTCFL|0:CSRNP1|0:DMBX1|0:POU3F2|0:ZFP1|0:NKX2-1|0:SP4|0:ZNF611|0:ZNF75D|0:FOXG1|0:PPARD|0:KDM4A|0:EGR4|0:BHLHA9|0:ZNF84|0:HOXD8|0:FOXP2|0:ZNF114|0:MAF1|0:MIER2|0:TFB1M|0:TLE3|0:MYSM1|0:EID2B|0:TWISTNB|0:NR4A1|0:HOXC4|0:MYT1L|0:LPIN2|0:ZNF211|0:FOXI1|0:MCM2|0:SOX14|0:ZNF688|0:ZBTB8B|0:ZNF730|0:CAMTA2|0:ZNF559|0:MED12L|0:MAFG|0:C14orf43|0:CBX3|0:ZNF496|0:GATA2|0:ZNF668|0:FOXH1|0:NFYB|0:TFEB|0:BMI1|0:ZIM3|0:PROX2|0:POLR3F|0:ZBTB7B|0:CNOT3|0:ZNF821|0:HOXA6|0:CRTC1|0:FOXF2|0:ZNF391|0:GMEB1|0:PHF11|0:ZBTB40|0:TFAP2E|0:GBX1|0:ZNF519|0:HOPX|0:ZNF304|0:ELP4|0:MDFIC|0:FOXR2|0:ZSCAN30|0:C14orf156|0:RXRA|0:ZNF513|0:MURC|0:AKIRIN2|0:PAX9|0:SCML2|0:ZNF774|0:MED8|0:STAT4|0:TCEAL8|0:GATAD2A|0:ZNF670|0:ZNF382|0:VPS36|0:ZNF625|0:BCL9L|0:ALX3|0:ZNF765|0:ZNF366|0:GRHL2|0:VGLL1|0:ARNTL2|0:ZNF595|0:KDM1A|0:ZNF724P|0:EGR2|0:MED11|0:WWC1|0:CGGBP1|0:ZBTB16|0:RFX1|0:HOXA10|0:NR1H2|0:INSM2|0:NKX6-3|0:EDF1|0:NEUROD1|0:ZNF134|0:PCGF2|0:ZNF630|0:E2F5|0:SMAD4|0:STAT6|0:ZNF195|0:PER3|0:MLLT3|0:SCXB|0:HOXD1|0:KDM4DL|0:ZNF333|0:CREB3L2|0:ZBTB37|0:PRDM8|0:ZNF155|0:ZNF542|0:ONECUT1|0:KLF7|0:FOXD4L2|0:HELT|0:PREB|0:HOXC12|0:LHX3|0:IRF2BP1|0:PLAG1|0:MYCBP2|0:ZNF841|0:ZNF784|0:ELOF1|0:PLAGL2|0:ZNF256|0:ZNF319|0:TBX19|0:CHD4|0:RELA|0:PKN1|0:XBP1|0:EFCAB6|0:ERF|0:MLLT10|0:BAZ1A|0:HSFY1|0:NEUROG1|0:SRFBP1|0:ZNF98|0:POLR2J2|0:TCF7L2|0:CHD5|0:ZNF431|0:ZNF800|0:MYCBP|0:ZNF462|0:MCM6|0:USP22|0:MLXIPL|0:ZNF28|0:VOPP1|0:TCF7|0:RLIM|0:ZNF662|0:ZNF37A|0:NR1I2|0:ZNF266|0:FOXO3|0:ZBTB5|0:UHRF1|0:FAM120B|0:CSRNP2|0:SUPT7L|0:PNN|0:NOTCH1|0:SSX5|0:RBL1|0:POU5F1B|0:TCEAL1|0:KCTD1|0:ZNF684|0:ZNF492|0:ZNF572|0:ZNF131|0:ZNF576|0:YEATS4|0:ZNF182|0:ZFP14|0:ZNF529|0:RING1|0:ZNF556|0:AIRE|0:FOXA2|0:PRDM16|0:NFKB2|0:HESX1|0:ZNF605|0:ATF1|0:AKNA|0:MAFA|0:BRD8|0:NR2C2|0:TLE2|0:MYOD1|0:ZFP41|0:CHAF1A|0:ZFPM2|0:FOXL1|0:NSD1|0:ZNF649|0:ZNF518B|0:SERTAD1|0:ZNF177|0:ZNF442|0:FOXR1|0:CTNNB1|0:ZNF479|0:ZNF705A|0:PRDM13|0:ZNF354A|0:L3MBTL4|0:ZXDC|0:EOMES|0:ZNF223|0:ZNF74|0:CREM|0:NR2F2|0:ZBTB24|0:PRDM1|0:TRIP6|0:NPAS2|0:NR3C2|0:MYBL1|0:ZFP62|0:PARP15|0:FOXJ3|0:LEO1|0:ZNF582|0:HOXA2|0:ZNF430|0:MAML1|0:ZNF808|0:TFAP4|0:PDX1|0:SMAD1|0:EYA3|0:ZNF501|0:TCEB3CL2|0:CBX7|0:RFC1|0:ZNF483|0:FOXI3|0:SSX6|0:RB1|0:MYST4|0:TFAP2A|0:ZNF169|0:ISX|0:MLL5|0:PHTF1|0:C20orf20|0:TGIF1|0:SETD1A|0:PURB|0:RELB|0:HNF1B|0:ZNF512B|0:SRA1|0:ZNF615|0:ZNF469|0:CNOT8|0:PIAS4|0:NCOA2|0:RORC|0:MXD1|0:C2orf3|0:SIRT1|0:FOXD4L5|0:ZKSCAN3|0:HOXC8|0:ZNF418|0:DEDD2|0:ZBTB3|0:SCMH1|0:ZNF233|0:ESR2|0:ZNF280A|0:SOX18|0:SATB1|0:VGLL4|0:ZFAT|0:ZNF734|0:L3MBTL1|0:MLXIP|0:EHF|0:CTNND2|0:ZNF189|0:SETD2|0:TFDP3|0:RFX5|0:ZBTB34|0:ESX1|0:ASCL3|0:HES5|0:ZNF202|0:ACTL6A|0:LIN54|0:ZNF277|0:ZNF197|0:PTOV1|0:ZNF148|0:ZNF141|0:IKZF1|0:ZNF596|0:FOXC1|0:C17orf79|0:PCGF6|0:TBX2|0:SFSWAP|0:ZNF716|0:NRIP1|0:ZNF707|0:ZNF639|0:HOXD4|0:FOXO6|0:ZNF138|0:HDAC9|0:CRY1|0:MYT1|0:ZBTB43|0:CDCA7L|0:ZNF585B|0:RCOR2|0:WT1|0:POU5F2|0:ZNF236|0:SUB1|0:ZNF546|0:CRTC2|0:C1orf77|0:HNRNPUL1|0:SIN3A|0:PNRC1|0:CIR1|0:ILF3|0:ZNF621|0:TADA1|0:ZFP82|0:ZNF292|0:TBX15|0:CTCF|0:ZBTB8A|0:PBX3|0:ZNF761|0:ZNF629|0:MTPAP|0:GZF1|0:MLX|0:DACH2|0:ZNF45|0:ZNF610|0:KLF1|0:SAP30L|0:VEZF1|0:ZNF394|0:DPF3|0:RRP8|0:ZFP91|0:ATAD2|0:PHF6|0:DNMT1|0:SMARCD2|0:ZNF283|0:ZNF699|0:T|0:NFIB|0:ZNF23|0:MXI1|0:SAP30|0:ZBTB9|0:SPDEF|0:MBD3L1|0:KHDRBS3|0:LHX6|0:JARID2|0:SSX1|0:GATA5|0:TCEAL5|0:NEUROG2|0:EID3|0:DDX54|0:ZNF569|0:MED28|0:HSF1|0:DR1|0:JMJD1C|0:PA2G4|0:NOTCH4|0:ZNF100|0:ATF6|0:REL|0:EWSR1|0:ZNF337|0:HEY2|0:CITED4|0:BCL11A|0:RFX4|0:HOXD9|0:ZNF436|0:HES4|0:PHF10|0:SALL3|0:GATAD2B|0:ZSCAN22|0:ONECUT2|0:ATOH7|0:ZNF845|0:YY2|0:PRMT7|0:ZNF562|0:ZNF383|0:ZNF358|0:PHF21A|0:EAF2|0:ST18|0:CALCOCO1|0:MLF1|0:TOPORS|0:RRAGC|0:MMS19|0:MED20|0:LZTS1|0:PTMA|0:ATF6B|0:PPP5C|0:DRG1|0:CREBL2|0:RNPS1|0:GRLF1|0:PWP1|0:NFKBIB|0:EPC1			
GO:0002726	P:positive regulation of T cell cytokine prod...; IMP:UniProtKB		0:TRAF6|0:MALT1|0:MAP3K7|0:TRAF2			
GO:0004982	F:N-formyl peptide receptor activity; TAS:ProtInc		0:FPR1|0:RXFP3|0:GPR32|0:GPR44|0:GPR33|0:FPR2|0:FPR3			
GO:0045955	P:negative regulation of calcium ion-dependen...; IMP:UniProtKB		0:ADRA2A|0:STXBP3			
GO:0090285	P:negative regulation of protein amino acid g...; IMP:UniProtKB		0:ACER2			
GO:0034451	C:centriolar satellite; IDA:BHF-UCL		0:KRT18|0:BBS4|0:FLOT1|0:EXOC7|0:PCM1|0:PAX2|0:ALDOB			
GO:0031065	P:positive regulation of histone deacetylation; IDA:UniProtKB		0:NIPBL|0:PML			
GO:0002523	P:leukocyte migration involved in inflammator...; TAS:BHF-UCL		0:SELE			
GO:0001824	P:blastocyst development; ISS:UniProtKB		0:NASP			
GO:0015889	P:cobalamin transport; TAS:ProtInc		0:GIF|0:CUBN|0:TCN2|0:TCN1			
GO:0016829	F:lyase activity; IEA:UniProtKB-KW		0:POLB|0:GLDC|0:RBMXL1|0:PTPLAD2|0:PTPLA|0:POLL|0:PTPLB|0:MOCOS|0:ECHDC2|0:DHDPSL|0:THNSL2|0:DDTL|0:PTPLAD1			
GO:0071664	C:catenin-TCF7L2 complex; IDA:BHF-UCL		0:JUP			
GO:0015152	F:glucose-6-phosphate transmembrane transport...; IMP:UniProtKB		0:SLC37A4			
GO:0003837	F:beta-ureidopropionase activity; EXP:Reactome		0:UPB1			
GO:0030155	P:regulation of cell adhesion; TAS:UniProtKB		0:CYTH1|0:CYTIP|0:IL8|0:IL18|0:LAMA4|0:LAMA1|0:LAMA3|0:LAMA2|0:LAMA5|0:PPP2R1A|0:PPP2CA|0:ENG|0:DLL1			
GO:0050849	P:negative regulation of calcium-mediated sig...; NAS:BHF-UCL		0:SLA2|0:PLEK			
GO:0032422	F:purine-rich negative regulatory element bin...; IDA:HGNC		0:ELK3			
GO:0004013	F:adenosylhomocysteinase activity; TAS:UniProtKB		0:AHCYL2|0:AHCYL1|0:AHCY			
GO:0047756	F:chondroitin 4-sulfotransferase activity; IDA:UniProtKB		0:CHST13|0:CHST12|0:CHST11			
GO:0008453	F:alanine-glyoxylate transaminase activity; TAS:HGNC		0:AGXT2|0:AGXT2L1|0:AGXT			
GO:0008466	F:glycogenin glucosyltransferase activity; TAS:ProtInc		0:GYG1|0:GYG2			
GO:0048538	P:thymus development; NAS:UniProtKB		0:FGF10|0:TBX1|0:TGFBR1|0:SIX1|0:SOD1			
GO:0004807	F:triose-phosphate isomerase activity; TAS:UniProtKB		0:TPI1			
GO:0070189	P:kynurenine metabolic process; ISS:UniProtKB		0:CCBL1|0:AADAT|0:KMO|0:CCBL2			
GO:0032957	P:inositol trisphosphate metabolic process; IEA:InterPro		0:ITPK1			
GO:0018016	P:N-terminal peptidyl-proline dimethylation; IDA:UniProtKB		0:METTL11A			
GO:0048741	P:skeletal muscle fiber development; ISS:UniProtKB		0:CAV2|0:ACTA1			
GO:0007090	P:regulation of S phase of mitotic cell cycle; NAS:UniProtKB		0:TFAP4|0:RCC1|0:UBE2L3|0:BRCA2			
GO:0034375	P:high-density lipoprotein particle remodeling; TAS:BHF-UCL		0:APOA4|0:APOA1|0:APOA2|0:LCAT|0:APOE|0:LIPG|0:CETP|0:LIPC|0:APOC3|0:APOM|0:ABCA5|0:SCARB1|0:ABCG1|0:APOC1			
GO:0008859	F:exoribonuclease II activity; IEA:EC		0:ISG20			
GO:0046479	P:glycosphingolipid catabolic process; TAS:UniProtKB		0:GLA			
GO:0003857	F:3-hydroxyacyl-CoA dehydrogenase activity; TAS:ProtInc		0:HSD17B4|0:HADH|0:HSD17B8|0:HSD17B10|0:HADHB|0:EHHADH|0:HADHA			
GO:0008271	F:secondary active sulfate transmembrane tran...; IEA:InterPro		0:SLC26A4|0:SLC26A11|0:SLC26A9|0:SLC26A5|0:SLC26A3|0:SLC26A2|0:SLC26A1|0:SLC26A6			
GO:0006739	P:NADP metabolic process; IDA:UniProtKB		0:NOX1|0:TP53I3			
GO:0010834	P:telomere maintenance via telomere shortening; IMP:BHF-UCL		0:TERF1|0:ERCC4			
GO:0031402	F:sodium ion binding; IDA:UniProtKB		0:SLC34A2|0:PDXK			
GO:0090260	P:negative regulation of retinal ganglion cel...; IDA:UniProtKB		0:SLIT2			
GO:0006465	P:signal peptide processing; IMP:UniProtKB		0:PCSK5|0:FURIN|0:SEC11A|0:SPCS2|0:SPCS1|0:SEC11C|0:SEC11B|0:SPCS3|0:LONP2			
GO:0046875	F:ephrin receptor binding; TAS:ProtInc		0:EFNB3|0:EFNA1|0:EFNA2|0:EFNB2|0:EFNA5|0:EFNB1			
GO:0000123	C:histone acetyltransferase complex; IDA:UniProtKB		0:ING4|0:PHF16|0:PHF17|0:MYST2|0:PHF15			
GO:0019201	F:nucleotide kinase activity; IDA:UniProtKB		0:PNKP			
GO:0006085	P:acetyl-CoA biosynthetic process; IDA:UniProtKB		0:ACSS1			
GO:0006595	P:polyamine metabolic process; TAS:ProtInc		0:OAZ2			
GO:0009789	P:positive regulation of abscisic acid mediat...; IDA:UniProtKB		0:LANCL2			
GO:0070198	P:protein localization to chromosome, telomer...; IMP:BHF-UCL		0:TNKS2|0:TNKS|0:TERF2|0:TERF2IP|0:ACD|0:TINF2			
GO:0035511	P:oxidative DNA demethylation; IDA:UniProtKB		0:ALKBH2			
GO:0030251	F:guanylate cyclase inhibitor activity; IDA:UniProtKB		0:PDZD3			
GO:0000819	P:sister chromatid segregation; IDA:UniProtKB		0:LATS1			
GO:0017016	F:Ras GTPase binding; TAS:UniProtKB		0:RAPGEF6|0:RAP1GAP|0:RAPGEF4|0:RIN3|0:SPHK2|0:MAPKAP1|0:PLCE1			
GO:0042475	P:odontogenesis of dentine-containing tooth; ISS:UniProtKB		0:AMBN|0:ODAM|0:WNT6|0:FOXC1|0:AMELX|0:AMTN|0:GLI2			
GO:0030814	P:regulation of cAMP metabolic process; IDA:BHF-UCL		0:DRD2			
GO:0006931	P:substrate-bound cell migration, cell attach...; NAS:UniProtKB		0:CUZD1			
GO:0009440	P:cyanate catabolic process; TAS:ProtInc		0:MPST|0:TST			
GO:0046618	P:drug export; IDA:UniProtKB		0:NR1I2			
GO:0009314	P:response to radiation; TAS:UniProtKB		0:COL3A1|0:SMC1A|0:FKBPL|0:CCL11|0:PPM1D|0:PNKP			
GO:0030290	F:sphingolipid activator protein activity; NAS:UniProtKB		0:GM2A			
GO:0047547	F:2-methylcitrate dehydratase activity; IEA:InterPro		0:IRG1			
GO:0004222	F:metalloendopeptidase activity; TAS:UniProtKB		0:MMP1|0:ADAM9|0:ADAM17|0:KEL|0:SPG7|0:MMP23B|0:IDE|0:MMP9|0:ASTL|0:ECE2|0:MMP23A|0:ADAM5P|0:UQCRC1|0:ADAM23|0:OSGEP|0:ADAM29|0:ADAM8|0:ADAM2|0:ADAMTSL2|0:ADAMTS13|0:ADAMTS5|0:ADAM20|0:ADAM7|0:ADAM32|0:ADAMTS17|0:ADAMTS12|0:ADAMTS19|0:ADAMTS4|0:MMEL1|0:NLN|0:MMP25|0:ADAM12|0:ADAM19|0:ADAMTS16|0:ADAM28|0:BMP1|0:MMP26|0:ADAMTSL5|0:AFG3L2|0:ADAMTS9|0:MMP21|0:ADAM15|0:MME|0:ADAMTS7|0:OSGEPL1|0:OMA1|0:ADAM21|0:THSD4|0:YME1L1|0:MMP27|0:ADAMTSL4|0:ADAMTS15|0:PMPCB|0:ADAM18|0:ADAM11|0:MEP1B|0:LMLN|0:TLL2|0:ADAMTS10|0:ADAMTS6|0:MMP8|0:ADAMTS8|0:UQCRC2|0:ADAM30|0:ADAMTS14|0:ADAM22|0:MMP19|0:ADAMTS18|0:PAPLN|0:TLL1|0:PITRM1|0:ECE1|0:ADAMDEC1|0:ADAM33|0:ADAMTS3|0:NRD1|0:ADAM10|0:MMP2|0:MMP7|0:MMP16|0:MMP24|0:MBTPS2|0:MMP13|0:MMP20|0:MIPEP|0:MMP3|0:MMP14|0:THOP1|0:MMP10|0:MMP17|0:MMP15|0:MMP11|0:PHEX|0:ADAMTS2|0:MEP1A|0:RCE1|0:FAP|0:PMPCA|0:MMP12|0:MMP28			
GO:0015226	F:carnitine transporter activity; IDA:UniProtKB		0:SLC22A5|0:SLC22A4|0:SLC22A16			
GO:0030178	P:negative regulation of Wnt receptor signali...; TAS:BHF-UCL		0:AXIN1|0:CXXC4|0:CHD8|0:FRZB|0:WWOX|0:APCDD1|0:GRB10|0:DKK2|0:DKK3|0:MED12|0:LRP1|0:HMGXB4|0:TAX1BP3|0:NLK|0:MDFI|0:TLE1|0:DKK4|0:CITED1			
GO:0048244	F:phytanoyl-CoA dioxygenase activity; IEA:EC		0:PHYH			
GO:0006999	P:nuclear pore organization; NAS:UniProtKB		0:NUP133|0:SEH1L|0:NUP98			
GO:0008121	F:ubiquinol-cytochrome-c reductase activity; TAS:ProtInc		0:UQCRQ|0:UQCRFSL1|0:UQCRB|0:MT-CYB|0:UQCRFS1|0:UQCR10|0:UQCRC1|0:UQCRH			
GO:0030731	F:guanidinoacetate N-methyltransferase activity; IMP:UniProtKB		0:GAMT			
GO:0006110	P:regulation of glycolysis; TAS:ProtInc		0:PGAM1|0:PRKAG2|0:PRKAG1|0:ECD			
GO:0021759	P:globus pallidus development; IMP:UniProtKB		0:NKX2-1			
GO:0031448	P:positive regulation of fast-twitch skeletal...; IDA:UniProtKB		0:ATP2A1			
GO:0030135	C:coated vesicle; IDA:BHF-UCL		0:HSPD1			
GO:0004890	F:GABA-A receptor activity; TAS:ProtInc		0:GABRG2|0:GABRA4|0:GABRA3|0:GABRA2|0:GABRQ|0:GABRR3|0:GABRP|0:GABRR2|0:GABRB3|0:GABRE|0:GABRR1|0:GABRD|0:GABRA1|0:GABRB2|0:GABRB1			
GO:0005326	F:neurotransmitter transporter activity; TAS:ProtInc		0:SLC22A2|0:GABRQ			
GO:0051048	P:negative regulation of secretion; IDA:BHF-UCL		0:NRG1|0:ERBB3|0:EGF			
GO:0045214	P:sarcomere organization; ISS:BHF-UCL		0:KRT19|0:TTN|0:TCAP|0:TPM1|0:MYH6|0:BMP10			
GO:0060426	P:lung vasculature development; ISS:UniProtKB		0:ERRFI1			
GO:0030030	P:cell projection organization; ISS:UniProtKB		0:SPAG6|0:TEKT4|0:B9D2|0:CEP290|0:DNAH9|0:DNAI1|0:TTC30B|0:CROCC|0:TEKT2|0:CC2D2A|0:TTC30A|0:AK7|0:SPAG16|0:DYNC2H1|0:IFT20|0:TTC8|0:DYNC2LI1|0:AKAP4|0:POC1B|0:NPHP1			
GO:0070330	F:aromatase activity; IEA:EC		0:CYP19A1|0:CYP2A6|0:CYP2S1|0:CYP2U1|0:CYP2D6|0:CYP1A2|0:CYP3A7|0:CYP2C8|0:CYP2B6|0:CYP1B1|0:CYP4X1|0:CYP1A1|0:CYP3A5|0:CYP4F11|0:CYP3A43|0:CYP2F1|0:CYP4F12|0:CYP4B1|0:CYP2A13|0:CYP2C18|0:CYP2A7|0:CYP4F8|0:CYP4Z1|0:CYP2J2			
GO:0048554	P:positive regulation of metalloenzyme activity; ISS:UniProtKB		0:FXN|0:CAV1|0:ATP7A			
GO:0003884	F:D-amino-acid oxidase activity; TAS:ProtInc		0:DDO|0:DAO			
GO:0031492	F:nucleosomal DNA binding; IDA:UniProtKB		0:RCC1			
GO:0002418	P:immune response to tumor cell; IDA:UniProtKB		0:MICA			
GO:0005874	C:microtubule; TAS:ProtInc		0:SIRT2|0:MAP1S|0:CEP57|0:CENPE|0:MAP3K11|0:ARHGEF2|0:SEPT9|0:GAS8|0:MAFIP|0:CCDC105|0:MAP1LC3C|0:FKBP4|0:CENPJ|0:DCTN1|0:SPAG6|0:TEKT4|0:TCTE3|0:KLC2|0:TUBGCP5|0:HAUS7|0:KIF22|0:HAUS3|0:LZTS2|0:MAP4|0:EML1|0:DYNC1LI2|0:DNAH1|0:MTUS1|0:DYNLRB2|0:KIF3B|0:DNAH2|0:TUBA4A|0:KIF26A|0:TUBB6|0:SHROOM3|0:MAP2|0:FAM82B|0:MAP9|0:KIF21B|0:TTLL8|0:RASSF1|0:KATNB1|0:DNM1|0:RACGAP1|0:DNAH12|0:TUBA1A|0:KIF12|0:KIF17|0:PTPN20A|0:DYNLL1|0:KIF27|0:KIAA1543|0:MAPRE2|0:KIF13A|0:MID1IP1|0:KIF5B|0:MAPT|0:TUBB4Q|0:KIAA0284|0:CEP57L1|0:TBCA|0:CKAP2|0:CYLD|0:KIF20A|0:CLIP1|0:TUBB1|0:TUBD1|0:DNAH17|0:FAM110C|0:TUBA3E|0:KIF14|0:KIF25|0:HAUS4|0:FSD1|0:KIF23|0:HAUS1|0:DYNC1LI1|0:TTLL9|0:PBXIP1|0:TEKT5|0:KIF26B|0:KATNAL1|0:KIF11|0:KIF4B|0:DYNLL2|0:INVS|0:DYNLRB1|0:EML2|0:KIF6|0:DNAH9|0:NAV1|0:SHROOM2|0:C18orf10|0:KIF3C|0:DNAI1|0:HOOK3|0:RASSF5|0:KIF2A|0:CSPP1|0:DNM2|0:MAP1LC3A|0:MAP1LC3B2|0:DNAI2|0:TBCB|0:DNAH6|0:KIF20B|0:KIF5A|0:GABARAPL1|0:TUBB3|0:HAUS8|0:SNTB2|0:KIFC3|0:KIF1C|0:KIF15|0:HAUS5|0:MAP1B|0:TUBGCP6|0:DNAH5|0:HAUS2|0:NINL|0:SHROOM1|0:FAM82A2|0:DNAH11|0:DNAL4|0:EML3|0:CAMSAP1|0:KIF19|0:TEKT2|0:MAP6|0:KIF1B|0:KIF5C|0:STMN1|0:NDE1|0:TUBB2B|0:TUBB4|0:LRRC49|0:NUDC|0:DNAH8|0:DYNLT3|0:TTLL1|0:KIF18B|0:KIFC1|0:RCC2|0:TUBE1|0:SPAG17|0:EMD|0:KIF24|0:KIF13B|0:INCENP|0:TEKT1|0:APPBP2|0:EML5|0:DISC1|0:MAP1LC3B|0:MAP1A|0:SPAST|0:MTUS2|0:TUBA1C|0:CAMSAP1L1|0:KATNAL2|0:TUBA4B|0:MID2|0:DNAH14|0:GABARAP|0:HAUS6|0:KIF16B|0:NICN1|0:KLC3|0:DYNC1I2|0:C19orf20|0:TUBB2A|0:KIF2B|0:HOOK2|0:TTLL3|0:PCNT|0:MEFV|0:STAU2|0:TUBB2C|0:TUBB|0:SPRY2|0:DNAH7|0:EML4|0:TUBGCP4|0:DNAH10|0:KIF1A|0:KIF3A|0:HOOK1|0:NDEL1|0:TUBAL3|0:TEKT3|0:KIF21A|0:DYNC2H1|0:TUBA8|0:KIFC2|0:DYNC1I1|0:DCTN2|0:TPX2|0:PTPN20B|0:CEP170|0:DYNC1H1|0:MAP7|0:TPPP3|0:KIF9|0:EML6|0:DYNC2LI1|0:DNAH3|0:APC2|0:RASSF3|0:KLC4|0:DYNLT1|0:KATNA1|0:STIM1|0:TUBA1B|0:JAKMIP1|0:KIF2C|0:DNM3|0:ODF2|0:NIN|0:KLC1|0:FAM82A1|0:GABARAPL3|0:MAPRE3|0:TRIM63|0:TRIM55|0:TUBA3D|0:TUBA3C|0:TRIM54|0:TBCE|0:TBCD|0:TBCC			
GO:0005230	F:extracellular ligand-gated ion channel acti...; NAS:UniProtKB		0:GABRP|0:GABRR2|0:HTR3D|0:GABRB3|0:GABRG2|0:GABRA4|0:GABRE|0:GABRG1|0:GABRR1|0:GABRA3|0:GABRD|0:HTR3E|0:GABRA2|0:GABRA1|0:GLRA4|0:CHRFAM7A|0:GABRA5|0:GABRB2|0:GABRR3|0:GABRQ|0:ZACN|0:HTR3C|0:GABRB1|0:GABRG3			
GO:0004658	F:propionyl-CoA carboxylase activity; TAS:ProtInc		0:PCCB|0:PCCA			
GO:0060324	P:face development; IMP:BHF-UCL		0:CHD7|0:WNT5A			
GO:0031340	P:positive regulation of vesicle fusion; ISS:UniProtKB		0:ANXA1|0:ANXA2|0:DOC2B			
GO:0000033	F:alpha-1,3-mannosyltransferase activity; IMP:UniProtKB		0:ALG2|0:ALG3|0:ALG8			
GO:0043621	F:protein self-association; ISS:UniProtKB		0:TTN|0:ATXN1|0:TRIM32|0:MALT1|0:BCL10|0:CCDC88C|0:DYRK1A			
GO:0032411	P:positive regulation of transporter activity; ISS:UniProtKB		0:PON1|0:SYNGR3			
GO:0008634	P:negative regulation of survival gene produc...; TAS:ProtInc		0:BAX|0:FOXA1|0:BNIP3L|0:BNIP3|0:HRK|0:BCL2L1			
GO:0045081	P:negative regulation of interleukin-10 biosy...; IMP:BHF-UCL		0:TRIB2			
GO:0033566	P:gamma-tubulin complex localization; IMP:UniProtKB		0:MZT1|0:CEP72			
GO:0042104	P:positive regulation of activated T cell pro...; TAS:UniProtKB		0:IL2|0:IL18|0:CD24|0:IL12B|0:ICOSLG			
GO:0019209	F:kinase activator activity; TAS:UniProtKB		0:MOBKL1A|0:IL2			
GO:0004126	F:cytidine deaminase activity; TAS:ProtInc		0:APOBEC3F|0:CDA|0:AICDA|0:APOBEC3G|0:APOBEC1|0:APOBEC2			
GO:0009403	P:toxin biosynthetic process; IDA:BHF-UCL		0:CYP1A2			
GO:0005782	C:peroxisomal matrix; TAS:ProtInc		0:CROT|0:PAOX|0:FAR1|0:HSD17B4|0:FAR2|0:BAAT|0:ACAA1|0:PEX5|0:PECI|0:LONP2|0:SLC27A2			
GO:0004575	F:sucrose alpha-glucosidase activity; IEA:EC		0:SI			
GO:0030845	P:inhibition of phospholipase C activity invo...; IDA:BHF-UCL		0:PLEK			
GO:0006695	P:cholesterol biosynthetic process; TAS:ProtInc		0:MVK|0:FDFT1|0:CYP51A1|0:PMVK|0:EBP|0:IDI1|0:HMGCR|0:PRKAA1|0:TM7SF2|0:HMGCS1|0:PRKAA2|0:HMGCS2|0:IDI2|0:CYB5R3|0:G6PD|0:LSS|0:NPC1L1|0:DHCR7|0:ACAA2|0:MVD|0:DHCR24|0:NSDHL|0:CNBP|0:FDPS			
GO:0042226	P:interleukin-6 biosynthetic process; NAS:UniProtKB		0:BCL10			
GO:0021553	P:olfactory nerve development; ISS:UniProtKB		0:SALL1			
GO:0032417	P:positive regulation of sodium:hydrogen anti...; NAS:UniProtKB		0:DRD4|0:ACTN4			
GO:0005731	C:nucleolus organizer region; IDA:UniProtKB		0:SIRT7			
GO:0016846	F:carbon-sulfur lyase activity; IEA:InterPro		0:CENPV|0:CENPVL1			
GO:0004439	F:phosphatidylinositol-4,5-bisphosphate 5-pho...; TAS:ProtInc		0:INPP5B|0:INPP5E|0:SYNJ2|0:SYNJ1|0:OCRL			
GO:0004515	F:nicotinate-nucleotide adenylyltransferase a...; IDA:UniProtKB		0:NMNAT1|0:NMNAT3|0:NMNAT2			
GO:0016575	P:histone deacetylation; TAS:UniProtKB		0:HDAC5|0:HDAC11|0:PHB|0:MORF4L1|0:HDAC10|0:SIRT1|0:HDAC8|0:HDAC2|0:PRDM5|0:RBM14|0:BAZ2A|0:HDAC6|0:SIRT2			
GO:0048771	P:tissue remodeling; IEA:UniProtKB-KW		0:PLG|0:CSPG4|0:IL23A			
GO:0033198	P:response to ATP; IDA:UniProtKB		0:KCNJ11|0:P2RX7|0:P2RX4|0:DGKQ			
GO:0003755	F:peptidyl-prolyl cis-trans isomerase activity; TAS:UniProtKB		0:FKBP1B|0:PPIH|0:PIN1|0:FKBP1A|0:PPP2R4|0:PPIL1|0:FKBP4|0:PPID|0:FKBP8|0:PPIC|0:PPIG|0:PIN4|0:FKBP3|0:FKBP10|0:PPIL4|0:PPIAL4C|0:FKBP14|0:PPWD1|0:FKBP11|0:FKBP6|0:FKBP2|0:PPIAL4A|0:FKBP7|0:PPIL3|0:PPIL2|0:RANBP2|0:FKBP5|0:PPIL6|0:NKTR|0:FKBP1C|0:CWC27|0:PPIA|0:PPIF|0:FKBP9|0:PPIB|0:PPIE			
GO:0007043	P:cell-cell junction assembly; TAS:UniProtKB		0:TRPV4|0:LIM2|0:DSG1|0:GJA4|0:GJC1|0:TJP1|0:GJA5|0:PARD6B|0:AMOT|0:TLN1|0:TLN2			
GO:0004523	F:ribonuclease H activity; TAS:UniProtKB		0:FEN1|0:RNASEH1|0:RNASEH2A|0:ERVK6|0:EXO1|0:APEX1			
GO:0022010	P:myelination in the central nervous system; ISS:UniProtKB		0:C11orf9			
GO:0051873	P:killing by host of symbiont cells; IDA:MGI		0:CAMP			
GO:0001757	P:somite specification; ISS:UniProtKB		0:RIPPLY1			
GO:0007495	P:visceral mesoderm-endoderm interaction invo...; ISS:UniProtKB		0:FOXL1			
GO:0000279	P:M phase; NAS:UniProtKB		0:RB1|0:ILF3			
GO:0004342	F:glucosamine-6-phosphate deaminase activity; IMP:UniProtKB		0:GNPDA2|0:GNPDA1			
GO:0042129	P:regulation of T cell proliferation; ISS:UniProtKB		0:IL27			
GO:0002102	C:podosome; ISS:UniProtKB		0:SH3PXD2A|0:SVIL|0:RHOU|0:FERMT3			
GO:0004904	F:interferon receptor activity; TAS:UniProtKB		0:IL22RA1			
GO:0043124	P:negative regulation of I-kappaB kinase/NF-k...; NAS:UniProtKB		0:ADIPOQ|0:NLRP12|0:CARD8|0:OTUD7B|0:RHOH|0:DNAJA3|0:TNFAIP3|0:C9orf89			
GO:0004252	F:serine-type endopeptidase activity; TAS:UniProtKB		0:C1R|0:CFB|0:F10|0:PLG|0:PCSK5|0:FURIN|0:F12|0:PCSK6|0:PCSK2|0:PLAT|0:PRSS36|0:ACR|0:MASP2|0:CORIN|0:KLK14|0:KLK6|0:PRSS2|0:GZMA|0:KLK5|0:C1S|0:PRSS3|0:KLK8|0:MMP8|0:MASP1|0:TMPRSS6|0:CTSG|0:F2|0:PRSSL1|0:CELA1|0:PRSS22|0:KLK7|0:KLK3|0:PRSS54|0:PRSS29P|0:HPR|0:LPA|0:TMPRSS11F|0:OVCH1|0:TPSD1|0:CLPP|0:GZMM|0:CTRC|0:TMPRSS11B|0:HPN|0:PROZ|0:TPSG1|0:PRSS48|0:LONP2|0:AZU1|0:FAP|0:PCSK4|0:PRSS50|0:PRTN3|0:KLK11|0:TMPRSS7|0:CTRL|0:EML2|0:PRSS23|0:KLK10|0:PRSS33|0:C1RL|0:RHBDL1|0:WDR7|0:PREPL|0:DPP4|0:PRSS35|0:CTRB2|0:TYSND1|0:TMPRSS15|0:LONP1|0:PWP2|0:HP|0:PRSS42|0:MST1|0:TPP1|0:TMPRSS5|0:RHBDL2|0:MST1P9|0:TMPRSS11D|0:HABP2|0:PRSS55|0:TMPRSS12|0:PCSK7|0:HTRA4|0:GZMK|0:NSF|0:PRSS45|0:OVCH2|0:PRSS37|0:TPP2|0:TMPRSS11E|0:RHBDL3|0:TMPRSS9|0:PAMR1|0:ST14|0:PRSS8|0:PRSS38|0:KLK4|0:PRSS27|0:FAM111A|0:C2|0:HGF|0:TMPRSS11A|0:HTRA3|0:TMPRSS2|0:PRSS53|0:SERPINB2|0:ENO1|0:SERPINE1|0:PLAU|0:PCSK1|0:CMA1|0:TMPRSS3|0:KLK15|0:TMPRSS4|0:KLK9|0:CELA3B|0:GZMH|0:KLK13|0:TPSB2|0:KLK1|0:CTRB1|0:F11|0:PCSK9|0:TMPRSS13|0:KLK12|0:TPSAB1|0:CELA3A|0:CFD|0:F7|0:TOR1A|0:KLK2|0:APEH|0:LTF|0:KLKB1|0:CELA2B|0:HTRA1|0:HGFAC|0:CFI|0:PREP|0:CELA2A|0:MBTPS1|0:F9|0:HTRA2|0:PROC|0:PRSS1|0:GZMB			
GO:0008308	F:voltage-gated anion channel activity; TAS:UniProtKB		0:TOMM40|0:TOMM40L|0:VDAC2|0:VDAC3|0:VDAC1			
GO:0010212	P:response to ionizing radiation; NAS:UniProtKB		0:AEN|0:EYA1|0:RNF8|0:USP28|0:RNF168|0:RFWD3|0:TOPBP1|0:EYA3|0:NHEJ1|0:UIMC1|0:BRE|0:OBFC2A|0:OBFC2B|0:INTS3|0:BRCA1|0:FAM175A|0:C9orf80|0:C7orf27|0:C19orf62|0:C15orf42|0:H2AFX			
GO:0032585	C:multivesicular body membrane; IEA:UniProtKB-SubCell		0:SILV|0:NDFIP2|0:HGS|0:CD300LG			
GO:0051659	P:maintenance of mitochondrion location; IMP:BHF-UCL		0:ALB|0:ATP2A1			
GO:0005381	F:iron ion transmembrane transporter activity; NAS:UniProtKB		0:SLC40A1|0:TTYH1			
GO:0005163	F:nerve growth factor receptor binding; IPI:BHF-UCL		0:NGF			
GO:0046676	P:negative regulation of insulin secretion; ISS:UniProtKB		0:IRS1|0:FAM3D|0:KCNJ11|0:ADRA2A|0:SIRT4|0:PSMD9|0:INHBB			
GO:0021545	P:cranial nerve development; ISS:BHF-UCL		0:CHD7|0:ERBB3			
GO:0019048	P:virus-host interaction; NAS:UniProtKB		0:RRAGA|0:VAPB|0:HIPK2			
GO:0031434	F:mitogen-activated protein kinase kinase bin...; IDA:BHF-UCL		0:TRIB1			
GO:0048027	F:mRNA 5'-UTR binding; IDA:UniProtKB		0:IGF2BP1|0:IGF2BP2|0:IGF2BP3|0:RPS14			
GO:0008233	F:peptidase activity; IEA:UniProtKB-KW		0:APH1B|0:SHFM1|0:TFR2|0:NCLN|0:QPCT|0:QPCTL|0:TFRC|0:NAALADL2|0:KY|0:SPCS2|0:DHH|0:SPCS1|0:IHH|0:SHH|0:SPCS3|0:PM20D1|0:MPND			
GO:0060398	P:regulation of growth hormone receptor signa...; NAS:BHF-UCL		0:HNF4A			
GO:0047757	F:chondroitin-glucuronate 5-epimerase activity; IDA:HGNC		0:DSE			
GO:0080025	F:phosphatidylinositol-3,5-bisphosphate binding; ISS:UniProtKB		0:CLVS2|0:SESTD1|0:PHLDA3|0:CLVS1|0:SH3PXD2B|0:RAG2			
GO:0034361	C:very-low-density lipoprotein particle; IEA:UniProtKB-KW		0:APOA4|0:APOC1|0:APOC4|0:APOE|0:APOC3|0:APOA2|0:APOL1|0:APOH|0:APOB|0:APOA5|0:PCYOX1|0:APOM|0:APOC2|0:APOA1|0:APOO|0:LPL|0:LSR|0:VLDLR			
GO:0042273	P:ribosomal large subunit biogenesis; ISS:UniProtKB		0:PES1|0:WDR12|0:RPL26|0:RPL35A|0:RPL14|0:RPL7|0:RPL5|0:RPL11|0:SDAD1			
GO:0003831	F:beta-N-acetylglucosaminylglycopeptide beta-...; IEA:EC		0:B4GALT1|0:B4GALT2|0:B4GALT3			
GO:0007097	P:nuclear migration; TAS:UniProtKB		0:SUN2			
GO:0032000	P:positive regulation of fatty acid beta-oxid...; TAS:UniProtKB		0:AKT2|0:IRS1|0:IRS2|0:PPARA			
GO:0009953	P:dorsal/ventral pattern formation; NAS:UniProtKB		0:NOG|0:LMX1B|0:AIDA|0:DSCAML1			
GO:0032732	P:positive regulation of interleukin-1 produc...; ISS:BHF-UCL		0:TLR4			
GO:0002079	C:inner acrosomal membrane; IEA:UniProtKB-SubCell		0:CD46			
GO:0048146	P:positive regulation of fibroblast prolifera...; NAS:UniProtKB		0:PLA2G1B|0:IGF1|0:PDGFRA|0:PDGFA|0:MIF|0:PDGFB|0:PDGFC|0:SPHK1|0:EREG|0:AQP1|0:WNT5A|0:WNT1|0:CDK6|0:CDKN1A|0:WNT2|0:CDK4|0:CD74|0:BMI1|0:NDUFS4|0:AGT|0:LIG4|0:S100A6			
GO:0006213	P:pyrimidine nucleoside metabolic process; TAS:ProtInc		0:TYMP|0:NT5C3|0:ERH			
GO:0045599	P:negative regulation of fat cell differentia...; NAS:BHF-UCL		0:WNT10B|0:ENPP1|0:ADIPOQ|0:TGFB1|0:WNT5A|0:TRIB3|0:TRIB2|0:SIRT1|0:CCDC85B|0:TNF|0:IL6			
GO:0043024	F:ribosomal small subunit binding; ISS:HGNC		0:NPM1|0:MTIF2|0:MTIF3			
GO:0006348	P:chromatin silencing at telomere; NAS:UniProtKB		0:HAT1|0:SIRT2			
GO:0070075	P:tear secretion; NAS:UniProtKB		0:FGF10|0:LACRT			
GO:0071681	P:cellular response to indole-3-methanol; IDA:UniProtKB		0:CDH1|0:BRCA1|0:CTNNA1|0:JUP|0:CTNNB1			
GO:0032468	P:Golgi calcium ion homeostasis; IMP:UniProtKB		0:ATP2C1			
GO:0005978	P:glycogen biosynthetic process; TAS:ProtInc		0:GYS2|0:PHKG2|0:PHKG1|0:AGL|0:AKT1|0:GYS1|0:GBE1|0:GYG1|0:GYG2			
GO:0055107	P:Golgi to secretory granule transport; ISS:UniProtKB		0:CCDC64			
GO:0017150	F:tRNA dihydrouridine synthase activity; IEA:InterPro		0:DUS3L|0:DUS1L|0:DUS4L|0:DUS2L			
GO:0030967	P:ER-nuclear sterol response pathway; IDA:UniProtKB		0:INSIG1|0:INSIG2			
GO:0004692	F:cGMP-dependent protein kinase activity; IEA:EC		0:PRKG2|0:PRKG1			
GO:0090022	P:regulation of neutrophil chemotaxis; ISS:UniProtKB		0:MPP1			
GO:0031465	C:Cul4B-RING ubiquitin ligase complex; IDA:UniProtKB		0:DDB1|0:CUL4B|0:DTL|0:RBX1			
GO:0046101	P:hypoxanthine biosynthetic process; IMP:UniProtKB		0:PRPS1			
GO:0003691	F:double-stranded telomeric DNA binding; ISS:BHF-UCL		0:TERF1|0:PURA|0:TERF2			
GO:0051716	P:cellular response to stimulus; IDA:UniProtKB		0:EIF2B2			
GO:0005577	C:fibrinogen complex; TAS:ProtInc		0:THBS1|0:FN1|0:FGA|0:FGL1|0:FGB|0:FGL2|0:FGG			
GO:0004686	F:elongation factor-2 kinase activity; IEA:EC		0:EEF2K			
GO:0001954	P:positive regulation of cell-matrix adhesion; ISS:BHF-UCL		0:CDK6|0:CD36|0:CDH13|0:GSK3B|0:PLEKHA2|0:UTRN|0:CSF1			
GO:0035329	P:hippo signaling cascade; TAS:UniProtKB		0:STK3|0:LATS1|0:STK4|0:TAZ|0:LATS2|0:MOBKL1A|0:TEAD2|0:MOBKL1B|0:TEAD3|0:WWTR1|0:TEAD4|0:TEAD1|0:SAV1|0:YAP1			
GO:0007217	P:tachykinin receptor signaling pathway; TAS:ProtInc		0:GRK5|0:ADRBK1|0:TAC1|0:TAC3			
GO:0004711	F:ribosomal protein S6 kinase activity; NAS:UniProtKB		0:RPS6KA4			
GO:0005062	F:hematopoietin/interferon-class (D200-domain...; TAS:ProtInc		0:STAT1|0:SP110|0:STAT2|0:STAT3			
GO:0008074	C:guanylate cyclase complex, soluble; TAS:ProtInc		0:GUCY1B3|0:GUCY1A3			
GO:0043651	P:linoleic acid metabolic process; IDA:BHF-UCL		0:CYP2J2			
GO:0031543	F:peptidyl-proline dioxygenase activity; TAS:HGNC		0:EGLN1			
GO:0030337	F:DNA polymerase processivity factor activity; IEA:InterPro		0:PCNA			
GO:0005130	F:granulocyte colony-stimulating factor recep...; TAS:ProtInc		0:CSF3			
GO:0001763	P:morphogenesis of a branching structure; TAS:UniProtKB		0:COL13A1|0:TDGF1			
GO:0006702	P:androgen biosynthetic process; TAS:UniProtKB		0:WNT4|0:MED1|0:HSD17B6|0:HSD3B1			
GO:0019897	C:extrinsic to plasma membrane; ISS:UniProtKB		0:SCUBE1|0:EEA1|0:USP8|0:SYTL2|0:SYTL1|0:TDGF1			
GO:0015631	F:tubulin binding; TAS:ProtInc		0:STMN1|0:CENPJ|0:DAG1|0:NCALD|0:TPPP3|0:BRCA1|0:GPAA1|0:ALDOA|0:RABGAP1			
GO:0016574	P:histone ubiquitination; IMP:HGNC		0:HUWE1|0:USP22|0:UBE2N			
GO:0019932	P:second-messenger-mediated signaling; NAS:UniProtKB		0:DGKD|0:PPP2R1A|0:PPP2CA			
GO:0019228	P:regulation of action potential in neuron; ISS:UniProtKB		0:KCNMB4|0:KCNMB2|0:KCNMB3|0:CHRNA1|0:KCNMA1			
GO:0008144	F:drug binding; TAS:ProtInc		0:UGT1A8|0:DRD3|0:PPARG|0:CYP2D6|0:DRD4|0:ACE|0:CYP2C9|0:UGT1A7|0:DRD2|0:DHFRP1|0:ALB|0:HTR2B|0:PYGL|0:CHKA|0:PNP|0:HTR2C|0:ATP5O|0:SFRP1|0:DHFR|0:SRP54|0:PPARD|0:TOP2A|0:NR1I2|0:HTR2A|0:PPARA|0:ACR|0:SIGMAR1			
GO:0050893	P:sensory processing; TAS:BHF-UCL		0:BBS4			
GO:0005886	C:plasma membrane; TAS:UniProtKB		0:PLXNA1|0:GNA11|0:CDH8|0:TAB2|0:HRAS|0:EPN1|0:BMF|0:MDM2|0:PDCD1LG2|0:SH3GL2|0:TREM1|0:SLIT2|0:GGT5|0:PPAP2C|0:PROKR1|0:F8|0:CAMK2G|0:CASP3|0:CDH12|0:SLC38A5|0:SLC7A3|0:FRS3|0:GPR18|0:SIRPA|0:DYNLL1|0:SEMA6D|0:TFPI|0:LAMP2|0:APH1B|0:MADCAM1|0:F5|0:ICOS|0:RAC1|0:GNAI2|0:SLC2A13|0:TAS1R3|0:CAMK2D|0:EPB41L1|0:FGFR2|0:SLC5A9|0:BCL2L11|0:RAP1B|0:GNAQ|0:TAS1R1|0:EPS15L1|0:SLC2A5|0:F7|0:GLYCAM1|0:TLR10|0:SLC10A6|0:DIO1|0:FPR2|0:COL1A2|0:GNAI3|0:FCGR2B|0:DYNLL2|0:CDH18|0:ADCY10|0:RTN4|0:ICAM4|0:SLC5A5|0:ATP6V1H|0:TNFRSF10B|0:SLC13A1|0:SLC38A4|0:FCGR3A|0:IRS2|0:CD14|0:GPBAR1|0:SEMA4A|0:GNA12|0:RHOA|0:SLCO1A2|0:SEMA4D|0:NOSTRIN|0:COL1A1|0:DNAL4|0:CAMK2B|0:SIRPG|0:TLR5|0:FPR1|0:LILRA1|0:ADCY4|0:LY96|0:PLXNA3|0:CDH6|0:PLCG2|0:LILRB1|0:SLC38A1|0:TRBC1|0:GNAL|0:CDH10|0:PLXNB3|0:GNAO1|0:P2RY8|0:AP2B1|0:SLC7A11|0:PLXND1|0:GNAZ|0:SLC43A2|0:TIRAP|0:PLAUR|0:DIO3|0:NRP1|0:APOB|0:NRP2|0:KRAS|0:PLXNC1|0:RXFP1|0:P2RY13|0:PLXNA2|0:SLC36A1|0:MAG|0:ARHGEF1|0:SERPINE1|0:CFB|0:SEMA5A|0:SPRY2|0:CDH11|0:PROC|0:PLXNA4|0:SPRY1|0:TREM2|0:PROKR2|0:DIO2|0:CDH7|0:OMG|0:RAP1A|0:F9|0:DLG3|0:SLC38A2|0:ATP1B2|0:SEMA7A|0:ADCY8|0:IYD|0:SERPINC1|0:APOA1|0:RASGRF2|0:RHOC|0:TICAM2|0:GNAT1|0:CDH15|0:F2|0:TAS1R2|0:PVR|0:PLAU|0:SLC28A3|0:RTN4R|0:ADCY5|0:NRAS|0:RAF1|0:P2RY12|0:LINGO1|0:CDH9|0:SLC36A2|0:KLRD1|0:VAV1|0:GRIP2|0:RXFP2|0:SLC22A16|0:SDCBP2|0:BMPR1A|0:MRAP|0:NISCH|0:ADIPOR1|0:GHRHR|0:SMAD7|0:LRP6|0:SLC30A8|0:RHOQ|0:FZD3|0:ADAM12|0:SORT1|0:BAMBI|0:ECE1|0:FCGR1A|0:GRK5|0:MRAP2|0:SH3D19|0:GRB14|0:SMURF1|0:FZD7|0:PON2|0:TLR7|0:APLP1|0:FLNA|0:MALL|0:FAM84B|0:PAG1|0:PIGU|0:DGKK|0:EPS15|0:TMEM8B|0:CRTAM|0:FYN|0:CRIPAK|0:NOD2|0:ZACN|0:PAWR|0:NAB1|0:IQGAP1|0:LAIR1|0:OLIG3|0:NGEF|0:PARP14|0:ARFGAP2|0:LY6K|0:NFIA|0:CALD1|0:AAK1|0:NPTXR|0:PICALM|0:CROCC|0:GPR173|0:CD2AP|0:PTGS1|0:SLK|0:SETDB1|0:TAF12|0:QKI|0:RDX|0:MCF2L|0:ATP2B3|0:ARHGEF11|0:AP1G2|0:TSG101|0:MIB1|0:UBQLN2|0:GP2|0:CNKSR2|0:TST|0:SLC16A1|0:FLNC|0:ZBTB33|0:NPSR1|0:UBAC1|0:PFDN1|0:KBTBD10|0:S100A12|0:BAIAP2|0:PKN1|0:RABEPK|0:CDC42EP1|0:SWAP70|0:FLNB|0:MTHFS|0:HDAC11|0:IFITM3|0:FXYD6|0:CD93|0:ABRA|0:STYK1|0:NRSN2|0:ANKRD20A1|0:GPR85|0:SCN3B|0:CCDC8|0:MARCKSL1|0:ACTL6A|0:CCDC70|0:AKTIP|0:ERMAP|0:PIGY|0:DKK1|0:CYTH1|0:SLC5A7|0:PTPRCAP|0:RIC8B|0:ABCA3|0:SKAP2|0:EIF2B1|0:ABCC4|0:LRPAP1|0:CCNY|0:BTK|0:SNCA|0:TRAF6|0:FGF10|0:ITCH|0:ADCY2|0:ATP6V1G3|0:SLC26A11|0:PRKCE|0:SKAP1|0:HTR2B|0:UNC93A|0:CDC42SE2|0:PDYN|0:PARM1|0:CCDC88A|0:PLCE1|0:ADI1|0:DGKD|0:PRMT8|0:TMEM97|0:CTNND1|0:CARD11|0:TTYH3|0:ATP5B|0:AGPAT3|0:MAPT|0:GAB2|0:SSH1|0:STEAP2|0:PROM1|0:LPAR6|0:DNER|0:PRKCA|0:ANXA3|0:RAPGEF6|0:DAPP1|0:SVIL|0:ATP2B2|0:ATP5A1|0:ELMO1|0:PTPRE|0:PLCG1|0:TAGLN2|0:HTR2C|0:PRKCD|0:CDC42EP2|0:ACE|0:USP6|0:AKT1|0:TESC|0:ARF6|0:LANCL2|0:SLC26A8|0:AOC3|0:ATP5O|0:CDK14|0:GOT2|0:TMEM50B|0:RAB22A|0:ADAP2|0:TMEM127|0:PLP2|0:APBB1|0:LYN|0:PTPN13|0:ARRB2|0:SH2B2|0:STIM2|0:PRKCH|0:STXBP1|0:PHLDA3|0:SEPT5|0:PDPK1|0:PTPRT|0:SLC11A2|0:RHOB|0:ATP6V1G1|0:PRKCB|0:STRN3|0:DGKQ|0:IL1RAPL1|0:RALB|0:ADCY1|0:MCC|0:HMOX2|0:CDC42|0:STXBP2|0:CACNB4|0:CTSG|0:SLC9A6|0:GPR109A|0:MGST2|0:ATP6V0A1|0:ABCB6|0:MGRN1|0:MTFR1|0:AMBP|0:TRDN|0:VAPA|0:ANGPT1|0:FGFRL1|0:RALA|0:ADAP1|0:C6orf25|0:CNST|0:FAT4|0:CDHR4|0:PCDHB16|0:DCHS2|0:FAT3|0:MBP|0:GPR98|0:OR2K2|0:OR2V2|0:OR7A17|0:POTED|0:TAOK3|0:OR10X1|0:OR10A2|0:OR8J3|0:OR6C1|0:OR9G1|0:PCDHA13|0:PTP4A2|0:OR4M2|0:IGSF11|0:OR4C13|0:OR4A4P|0:ARAP1|0:REM2|0:BST1|0:KISS1R|0:OR2T29|0:PRND|0:CELSR3|0:OR11L1|0:DNAJB4|0:CD177|0:RAB5A|0:OR8K3|0:UTS2R|0:GPR157|0:OR1L3|0:FOLR2|0:OR1B1|0:GPR124|0:OR5W2|0:OR13F1|0:OR8B4|0:GBA2|0:NKAIN1|0:OR5K4|0:CAPNS1|0:PCDH20|0:OR2C1|0:NDRG1|0:OR5L2|0:OR4C3|0:PSD4|0:OR52E1|0:OR13A1|0:OR2A25|0:P2RY10|0:GPR84|0:GPR150|0:OR4D5|0:NMUR2|0:DAGLA|0:LYPD2|0:PCDHGB3|0:RAB28|0:OR2M3|0:JPH1|0:OR52E6|0:OR2T6|0:RELL2|0:PHKB|0:OR6C3|0:OR2T33|0:OR51V1|0:OR5AS1|0:OR10D3|0:KCNIP3|0:GFRA4|0:OR4C46|0:OR51Q1|0:OR9G9|0:OR5AU1|0:RAPH1|0:SPRN|0:ESYT3|0:OR2W3|0:SLC47A1|0:OR1G1|0:CD180|0:RAB23|0:OR2A5|0:PCDHA9|0:OR2AK2|0:TUB|0:OR7C1|0:CD8BP|0:MTUS1|0:ACCN5|0:RAP2B|0:TRPM5|0:OR5M11|0:MRGPRX1|0:OR51L1|0:OR4A5|0:DIRAS3|0:OSCAR|0:GPR179|0:OR5M8|0:OR13C8|0:CDH22|0:LPHN1|0:PCDHB10|0:FCGR2C|0:SPACA4|0:OR2A42|0:TNFRSF1B|0:CORIN|0:CD300LB|0:EPM2A|0:OR51E1|0:FCRL4|0:OR2G3|0:TTYH1|0:SLC41A3|0:GNRHR2|0:CTNNAL1|0:RAB11A|0:OR1S1|0:OR51B5|0:GPR111|0:NOTCH3|0:PCDHGA6|0:ITPRIP|0:RAB43|0:OR10G2|0:NPFFR1|0:ADD2|0:OR4F6|0:G3BP1|0:SLC16A14|0:UNC5A|0:GPR153|0:OR6M1|0:MRGPRD|0:OR52D1|0:PIK3AP1|0:CNTFR|0:CD300A|0:ALPP|0:RALGPS1|0:OR13H1|0:LRBA|0:UBE2D3|0:RHOV|0:CNTN5|0:OR10A6|0:MFAP3L|0:TNFRSF8|0:ART4|0:OR4D2|0:OR4F29|0:OR52E5|0:WWP1|0:HTR3D|0:OR4A16|0:OR8G1|0:RHOD|0:OR1D5|0:ALG10B|0:PCDHGB7|0:OR51B4|0:ENOX1|0:GPRIN1|0:MARK2|0:KIR2DS2|0:OR52A5|0:KLB|0:OR6T1|0:CALN1|0:OR51F2|0:OR1F2P|0:MRGPRE|0:CD209|0:OR2AP1|0:OR5P2|0:OR51D1|0:OR56A5|0:OR2A14|0:OR4Q3|0:OR5H15|0:RAB18|0:TREML1|0:PEAR1|0:OR1S2|0:OR10J4|0:COMT|0:AOC2|0:OR52H1|0:OR1L6|0:C5orf50|0:MAST2|0:KEL|0:GPR101|0:OR14A16|0:OR7C2|0:PHKA2|0:MAPKAP1|0:OR10G7|0:OR2AE1|0:RAB11FIP2|0:OR13C4|0:OR10H4|0:IL31RA|0:RPSA|0:LY6G6C|0:DYTN|0:GPR133|0:OR4N4|0:LCK|0:FURIN|0:OR11H6|0:RAB33A|0:SLC44A1|0:TM7SF4|0:PCDHGA9|0:OR1Q1|0:RP2|0:OR12D2|0:OR5B21|0:OR2D2|0:OR2T34|0:KARS|0:GPR26|0:OR9K2|0:PCDHGA2|0:PLA2G3|0:CDH16|0:GPR115|0:CLECL1|0:RAB3B|0:TNFSF13B|0:GNB2L1|0:APLP2|0:GPR146|0:ZP4|0:SIGLEC10|0:OR5K2|0:VN1R1|0:OR4C6|0:RAB30|0:SLC26A5|0:BEST2|0:ERAS|0:CD300LF|0:CRK|0:OR51A4|0:NPTN|0:OR7G3|0:OR6V1|0:GPR87|0:C2orf28|0:CD300E|0:NRG1|0:OR2L3|0:OR51G1|0:GPR61|0:RAB39|0:OR13C2|0:OR5L1|0:CAPNS2|0:OR9I1|0:ROCK2|0:OR2J1|0:RHOH|0:PCDH18|0:SEZ6|0:OR2B2|0:GPR158|0:PACSIN3|0:OR52K1|0:CSMD3|0:PCDHGA10|0:GPR174|0:ATP6V0A2|0:EMR2|0:XKRX|0:DAGLB|0:NT5E|0:SIGLEC1|0:OR4F17|0:OR11H12|0:OR11H4|0:ITK|0:PCDHA12|0:ARHGAP10|0:OR6C4|0:GPR160|0:GPR81|0:SLAMF6|0:SMURF2|0:QSOX2|0:OR2V1|0:DHH|0:GPR97|0:OR6C2|0:RXFP4|0:RAB2B|0:CNTN1|0:OR4D6|0:OR4S2|0:LY6G6F|0:OR5D18|0:PCDHB9|0:ESYT2|0:GDPD2|0:OR8H2|0:CNNM3|0:GPR123|0:OR10AD1|0:OR52P1P|0:OR2S2|0:OR5AK3P|0:OR6C70|0:JAM3|0:MUC16|0:PCDHGA7|0:RASD2|0:OR7D4|0:OR2L5|0:MRGPRX2|0:OR2G2|0:FCRL3|0:ANTXR2|0:GPR112|0:RASA4|0:CHL1|0:OR1J1|0:FRMD6|0:DGKZ|0:PCDHGC4|0:OR4F5|0:RHEBL1|0:OR10P1|0:GBP2|0:PPP1R16A|0:OR2T2|0:PCDHGB2|0:OR4C45|0:CAMK1G|0:GPR149|0:OPALIN|0:RAB17|0:RAB11B|0:OR2A12|0:UBL3|0:OR10G3|0:IRGM|0:OR10G8|0:RAB3D|0:NKD2|0:OXGR1|0:EHD3|0:OR11H1|0:OR4K17|0:CDK5R1|0:SLC41A2|0:OXER1|0:NIPA1|0:OR5AR1|0:CAP2|0:MMP25|0:ENPP6|0:ERVWE1|0:TMEFF1|0:OR52N2|0:OR11A1|0:OR51I2|0:OR10A7|0:OR4D1|0:FRAS1|0:OR2B6|0:FNBP1L|0:S1PR2|0:OR5AC1|0:KRT1|0:LYPD4|0:OR14K1|0:OR2B8P|0:GUCA1B|0:OR2C3|0:MRGPRF|0:NKAIN3|0:VTCN1|0:VN1R4|0:CPAMD8|0:OR10J3|0:OR52E2|0:OR5K1|0:ASAP2|0:RPE65|0:EFNA2|0:TP53I13|0:NTM|0:TM4SF20|0:GLDN|0:OR1J2|0:SVIP|0:CRCP|0:OR8K1|0:OR52A4|0:OR51S1|0:ACE2|0:OR4K3|0:OR6Y1|0:OR3A1|0:OR1N2|0:KCNIP1|0:PIP5K1C|0:OR5H14|0:OR13C5|0:LSAMP|0:SMAP1|0:OR5T2|0:P2RY14|0:BEST3|0:EMCN|0:BLNK|0:OR6P1|0:OR52B2|0:OR4K14|0:NKAIN4|0:ADAM28|0:OR14I1|0:GPR128|0:OR2L2|0:RAB40AL|0:CSMD2|0:OR8B8|0:CLSTN3|0:GBP1|0:OR52N5|0:CD163L1|0:MCHR2|0:FCGR3B|0:SMPD3|0:RALGPS2|0:SYT8|0:OR56B1|0:STRA6|0:OR11H7|0:PCDH17|0:ENO1|0:OR5B17|0:OR13J1|0:KIR2DS1|0:OR6C68|0:GPR120|0:PCDHGB6|0:OR6N1|0:BOC|0:ELTD1|0:EXOC7|0:PCDHB5|0:NPBWR2|0:HTR3E|0:RGS7BP|0:OR2Z1|0:OR14J1|0:AMIGO2|0:XPNPEP2|0:PDE6A|0:OR2T7|0:KIR2DL2|0:BAI3|0:RAB3C|0:MDGA2|0:OR1E1|0:GPR116|0:TAPBPL|0:OR5H1|0:OR5K3|0:GPR148|0:IFITM5|0:PLCH2|0:ZP1|0:OR56A4|0:OR5M9|0:CRB2|0:SLC16A9|0:PHKA1|0:FCRL2|0:OR2I1P|0:ALPPL2|0:ZFYVE20|0:CDH26|0:NRG2|0:LAT2|0:SLC12A9|0:CDHR3|0:OR5H6|0:DEF6|0:RAB31|0:OR2M4|0:FREM2|0:GPR88|0:NFAM1|0:TRPM4|0:OR56B2P|0:OR9A2|0:OR2G6|0:OR2AT4|0:CNNM1|0:OR51A2|0:LIME1|0:OR2A2|0:GPR27|0:AAMP|0:OR8H3|0:OR7G2|0:CNTNAP3|0:NPBWR1|0:PCDH10|0:MRGPRX3|0:CABP2|0:OR1F1|0:TM7SF3|0:OR10H3|0:OR5AK2|0:KIAA0319|0:OR5V1|0:PTPN3|0:OR1A2|0:MYO1G|0:RGMA|0:P4HB|0:PMEPA1|0:LGR4|0:JPH3|0:ERVK5|0:OR5D13|0:PTPRR|0:OR7A10|0:OR2W1|0:DIRAS1|0:OR4A15|0:OR8J1|0:C20orf57|0:OR4N5|0:OR10J6P|0:OR4D10|0:CAPN1|0:OR4S1|0:CXCR7|0:RAB38|0:OR6A2|0:OR56B4|0:STOML3|0:CLEC2A|0:GPR135|0:SECTM1|0:NEGR1|0:EHD2|0:PTP4A3|0:OR6S1|0:OR2L13|0:SLC16A11|0:RTP1|0:OR2A7|0:OR52Z1|0:OR52N1|0:NIPA2|0:CDH20|0:OR9A1P|0:XKR3|0:CABP7|0:PAQR7|0:NRN1L|0:OR6B2|0:PCDHB14|0:OR8H1|0:GPSM1|0:OR2H2|0:GPR161|0:OR10H5|0:MUC17|0:ILDR1|0:PSKH1|0:RHOG|0:FCRL5|0:RAP2A|0:PCDHGA11|0:RAB40C|0:EMR3|0:SLC41A1|0:CHIC1|0:LPL|0:QRFPR|0:KIRREL|0:OR6C65|0:CDH19|0:TAAR1|0:GPR63|0:PCDHGC3|0:OR10G4|0:DCHS1|0:CD200R1|0:EFR3A|0:GBP5|0:TAAR8|0:OR4L1|0:OR4F16|0:KIR2DL5A|0:YIPF3|0:PCDHGA3|0:FLVCR2|0:OR2AJ1|0:OR6X1|0:OR4P4|0:OR10G9|0:SERINC3|0:KCNT1|0:SLC39A14|0:RAB7L1|0:DSCAML1|0:PTGDR|0:OR10J5|0:OR56A1|0:OR51J1|0:PCDHB8|0:GOLPH3|0:OR13G1|0:FAT2|0:OR4C16|0:OR52I1|0:OR2W6P|0:OR4E1|0:OR8A1|0:OR5M1|0:ABCA8|0:OR14A2|0:GPR126|0:C10orf72|0:OR9G4|0:GPR141|0:CAP1|0:SEZ6L2|0:OR5AN1|0:OR10K2|0:OR5AC2|0:OR4A8P|0:UBE2B|0:S100A8|0:OR2T11|0:OR51M1|0:GAPT|0:OR51I1|0:OR10S1|0:OR3A4|0:OR5A2|0:PCDH11Y|0:SLC24A6|0:OR52M1|0:TMPRSS5|0:OR10W1|0:VPS28|0:OR2B11|0:OR9Q1|0:RASD1|0:LY6H|0:OR2L8|0:LYNX1|0:PCDH9|0:OR4K5|0:MSLN|0:OR2T3|0:TMEM150A|0:OR5H2|0:OR52E8|0:OR2F2|0:RSC1A1|0:OR14C36|0:PRAME|0:TMEM90B|0:PCDHGB1|0:OR11H2|0:LRIG2|0:CLIC6|0:OR52K2|0:TECTA|0:RAB40B|0:OR5D14|0:OR10AG1|0:OR6B3|0:OR8D4|0:OR5AP2|0:IL17RC|0:PIP4K2B|0:PALM2|0:CLSTN2|0:OR4X1|0:OR1I1|0:OR8D1|0:OR13D1|0:GPR132|0:OR2T12|0:TMEM25|0:RRAD|0:IGHD|0:SYTL4|0:OR6N2|0:OR10T2|0:SGK1|0:OR5B2|0:ENO2|0:PRF1|0:OR6C76|0:OR8U9|0:OR10H2|0:FAM127A|0:RAB4B|0:OR51B6|0:GFRA2|0:VN1R3|0:OR10A4|0:OR8B12|0:CD68|0:FGFBP1|0:LYPD6B|0:IHH|0:OR10Z1|0:C11orf59|0:OR1P1|0:OR1M1|0:OR4F4|0:FAM57A|0:OR1F12|0:IZUMO3|0:GPR144|0:OR1E3|0:OR10V1|0:KIRREL2|0:FEZ1|0:NELF|0:TAAR2|0:SHB|0:GPR113|0:PCDHGA8|0:OR1C1|0:OR2F1|0:RAB9A|0:MUC13|0:CLEC12B|0:CD300LD|0:GPR139|0:OR7G1|0:BEST4|0:LPHN2|0:ZP2|0:FCRL1|0:FNBP1|0:OR8B2|0:RAB8B|0:RASL10B|0:MFAP3|0:CSF1|0:MRGPRX4|0:GPR151|0:NECAP2|0:SIGLEC14|0:PIM1|0:OR2T27|0:OR6C74|0:VAPB|0:IGHM|0:OR6J1|0:GPR45|0:OR4C12|0:ARAP3|0:ATF4|0:OR5F1|0:PDCD10|0:OR9Q2|0:OR2M5|0:KCNT2|0:OR4K13|0:OR4F15|0:OR56A3|0:CD24|0:STXBP5L|0:NFASC|0:OR2J3|0:MRGPRG|0:RASGRP1|0:UMODL1|0:VNN1|0:DOK3|0:OR1A1|0:LPAR5|0:TMEM173|0:PCDHGB5|0:OR10A3|0:CHIC2|0:OR52B6|0:TGOLN2|0:OR8K5|0:OR2B3|0:OR5I1|0:OR2T8|0:LYPD5|0:ALPI|0:RAB5C|0:RASL10A|0:OR7A2P|0:BAI2|0:OR2AG2|0:OR1N1|0:CDH23|0:EMR4P|0:S1PR5|0:OR5T3|0:MUC21|0:CDCP1|0:DUSP15|0:OR4N2|0:OR6K6|0:OR8S1|0:RFTN2|0:OR4K2|0:OR2Y1|0:GHSR|0:ECSCR|0:RELT|0:OR6B1|0:GPR78|0:USP14|0:OR4A47|0:OR5R1|0:CDIPT|0:ENTPD8|0:SPTBN1|0:PAQR8|0:OR10K1|0:PILRA|0:NEU1|0:CDHR5|0:NRG4|0:OR2W5|0:IL23R|0:MUC15|0:SLC46A2|0:PCDHGB4|0:JPH2|0:UPK3B|0:RELL1|0:FAM120A|0:SHH|0:RAB15|0:GPR62|0:OR2M2|0:GPR33|0:PCDHGA5|0:ADD1|0:OR51G2|0:RAB44|0:PTPN4|0:MAS1L|0:OR1L8|0:PCDHGA4|0:TAAR9|0:TRIP10|0:OR2T5|0:GPR110|0:CD109|0:OR2AG1|0:TAAR6|0:OR2T4|0:VNN3|0:NRN1|0:CXCR1|0:OR4K15|0:TECTB|0:RTP2|0:CALHM1|0:KIR2DL5B|0:CAPN2|0:OR51B2|0:OR4D11|0:IPCEF1|0:APOLD1|0:OR7E24|0:PRX|0:OR5G3|0:RHOJ|0:PLEKHA2|0:OR2A1|0:PDIA6|0:EHD1|0:ISLR2|0:FRMPD1|0:KIR3DL3|0:RAB10|0:LY6D|0:CRLF2|0:MAGED1|0:OR52N4|0:OR52L1|0:OR2A4|0:OR12D3|0:RHOF|0:PLIN4|0:GPR83|0:RGS3|0:HRH4|0:CYSLTR2|0:OR4B1|0:TMPRSS6|0:PIK3C2A|0:IFITM2|0:OR6C6|0:LEPR|0:OR8I2|0:OR1L1|0:OR1K1|0:TIGIT|0:GPRC6A|0:OR2M7|0:OR51T1|0:PCDHGA12|0:OR6K3|0:DYNC2H1|0:LYPD1|0:ZP3|0:OR8G5|0:OR5P3|0:CNTN3|0:OR6F1|0:ABCG2|0:PCDHB7|0:VN1R5|0:LSP1|0:FCGR1C|0:OR9A4|0:OR3A3|0:OR6K2|0:OR5D16|0:OR4E2|0:CX3CL1|0:OR6Q1|0:KCNIP4|0:OR4C15|0:OR52I2|0:SLC47A2|0:CLEC12A|0:NKAIN2|0:GPR142|0:OR1L4|0:C18orf1|0:PTP4A1|0:GPR156|0:OR10Q1|0:TNFSF14|0:OR51A7|0:NOTCH1|0:SNAP91|0:CNTN6|0:S100A9|0:OR4F3|0:MTMR1|0:LAX1|0:RAB19|0:ITM2B|0:GPR37L1|0:NKD1|0:PLEKHO1|0:CXorf61|0:PDE6C|0:OR2T1|0:GPR114|0:RHEB|0:RAB3A|0:PCDHGA1|0:GPR171|0:OR8G2|0:ASAH2|0:PCDHB18|0:TAAR3|0:PCDHGC5|0:GPR119|0:OR13C9|0:OR2H1|0:COL23A1|0:OR10AC1P|0:RAB9B|0:OR5AL1|0:RRAS|0:PCDH15|0:HSD17B7|0:OR10H1|0:GPR182|0:PCDHB13|0:OR5M3|0:OR10C1|0:CLIC1|0:TREML2|0:HYAL2|0:LPHN3|0:PTGER4|0:OR7D2|0:OR8U1|0:OR4X2|0:ZMYND19|0:IL17RD|0:NAE1|0:NECAP1|0:SLC2A6|0:OR52W1|0:LMBR1L|0:OR6C75|0:OR5M10|0:OR51E2|0:IGSF9B|0:KIRREL3|0:RAP2C|0:OR51H1P|0:OR2T10|0:GFRA1|0:OR10A5|0:SUCNR1|0:SLC39A1|0:VNN2|0:LGR6|0:OR52J3|0:GPR162|0:VEPH1|0:OR4D9|0:PTOV1|0:RFTN1|0:VN1R2|0:OR52E4|0:OR2J2|0:SLC16A12|0:FLT3LG|0:OR51F1|0:OR52L2P|0:HTR3C|0:SMAGP|0:OR7A5|0:OR4C5|0:SYT15|0:PIP5K1A|0:OR14L1P|0:CNNM4|0:CFC1|0:ADAM10|0:OR13C3|0:CRIM1|0:DIRAS2|0:OR5C1|0:OR4Q2|0:FCAMR|0:VDAC1|0:OR10D4P|0:SNX20|0:OR10R2|0:FAM123B|0:MAST1|0:RAB39B|0:GPR82|0:OR10G6|0:OR4K1|0:SOCS7|0:LY6G6D|0:OR5B12|0:BTC|0:GPR77|0:PCDH19|0:SLC16A13|0:GPR152|0:RAB40A|0:IGDCC4|0:ABCC10|0:SLC30A10|0:RECK|0:OR5J2|0:TTYH2|0:OR5A1|0:OR8D2|0:OR11G2|0:OR52B4|0:GPC2|0:OR5B3|0:EWSR1|0:OR52R1|0:PCDHB1|0:OR2D3|0:OR4F21|0:CAMKV|0:OR1J4|0:OR4C11|0:OR4M1|0:OR8U8|0:OR2T35|0:TMED1|0:OR8B3|0:CXCL16|0:OR5T1|0:TEX101|0:MARCH1|0:PNPLA2|0:RAB8A|0:SLC39A6|0:RYR2|0:CAPN10|0:CELSR2|0:MYO16|0:SERINC1|0:LSR|0:NBEA|0:ANO2|0:ATP6V1B2|0:DOC2B|0:ATP6V1C1|0:TRAK2|0:TMPRSS7|0:PRNP|0:ADCY7|0:PXK|0:MAP3K12|0:STAT3|0:SCFD1|0:STEAP4|0:ANO1|0:RRAS2|0:MCAM|0:PPFIBP1|0:BRS3|0:LILRB4|0:TGFA|0:FCGR2A|0:PLEC|0:CERCAM|0:SSFA2|0:MOG|0:ST6GALNAC6|0:CR2|0:PIK3C2B|0:KITLG|0:RASGRF1|0:TRGV3|0:GPRC5D|0:PLSCR3|0:TRB@|0:TULP3|0:ZAN|0:CNTN4|0:FCGR1B|0:TRBV12-3|0:PPP1R16B|0:ACSL6|0:CARD14|0:ANXA13|0:PLSCR2|0:SGMS1|0:GML|0:CD38|0:C1QBP|0:GYPA|0:GALR3|0:NCAM2|0:CD101|0:KLRB1|0:SILV|0:CPM|0:ARRB1|0:RIT1|0:PRSS21|0:RGS1|0:PSCA|0:LY86|0:GLP1R|0:CDC42SE1|0:CTGF|0:S1PR1|0:RAB5B|0:EGF|0:FSHR|0:MC4R|0:TRPC6|0:IL18R1|0:BASP1|0:SPAM1|0:COL13A1|0:RIN1|0:EPB41L2|0:CEACAM7|0:MAGEA1|0:CYTH3|0:CXCR4|0:EPB42|0:CD53|0:GIPR|0:CD1B|0:MRAS|0:LGALS3|0:IL10RA|0:GLP2R|0:CSNK2A1|0:GALR1|0:MADD|0:NUCB2|0:HSD17B10|0:SC4MOL|0:IFITM1|0:CLEC10A|0:ADAM11|0:GABARAP|0:FPR3|0:CD7|0:CYTH2|0:NPR2|0:CLNS1A|0:GCA|0:GALR2|0:TNFRSF17|0:LGALS4|0:GCGR|0:CPE|0:HDLBP|0:IRS4|0:VLDLR|0:DARC|0:GRB10|0:PRSS8|0:EBI3|0:STS|0:PKD2|0:ARF1|0:EPB41|0:LILRA3|0:STX6|0:CALM2|0:SLA2|0:RASGRP4|0:CALM3|0:RNPEP|0:ARFIP2|0:UPK1A|0:PLSCR1|0:RIT2|0:PREX1|0:ENDOU|0:CALM1			
GO:0004127	F:cytidylate kinase activity; IEA:EC		0:CMPK2|0:CMPK1			
GO:0070938	C:contractile ring; IDA:UniProtKB		0:DAG1			
GO:0050776	P:regulation of immune response; NAS:HGNC		0:FKBP1A|0:CD276			
GO:0048553	P:negative regulation of metalloenzyme activity; ISS:UniProtKB		0:ATP7A			
GO:0043113	P:receptor clustering; ISS:UniProtKB		0:FLNA|0:AGRN|0:DVL1|0:PICK1			
GO:0030409	F:glutamate formimidoyltransferase activity; IEA:EC		0:FTCD			
GO:0019955	F:cytokine binding; NAS:BHF-UCL		0:IL17F|0:FZD4|0:NOG|0:CRLF1|0:ELANE|0:CSF1R|0:CHRD			
GO:0000226	P:microtubule cytoskeleton organization; TAS:UniProtKB		0:MAPT|0:TEKT4|0:MAFIP|0:TEKT5|0:CCDC105|0:TEKT2|0:TEKT1|0:TEKT3|0:DOCK7|0:DISC1|0:PPP4C|0:MID1|0:MAP7|0:RNF19A			
GO:0021670	P:lateral ventricle development; ISS:UniProtKB		0:AQP1|0:NUMB|0:NUMBL			
GO:0051591	P:response to cAMP; ISS:UniProtKB		0:DUOX1|0:DUOX2|0:VGF|0:NDUFS4|0:CITED1			
GO:0050046	F:lathosterol oxidase activity; IEA:EC		0:SC5DL			
GO:0071480	P:cellular response to gamma radiation; IDA:BHF-UCL		0:ATM|0:ATR			
GO:0035050	P:embryonic heart tube development; ISS:UniProtKB		0:NKX2-6|0:IFT122			
GO:0045665	P:negative regulation of neuron differentiation; IMP:UniProtKB		0:CALR|0:ASCL1|0:DTX1|0:CNTN4			
GO:0090307	P:spindle assembly involved in mitosis; IDA:UniProtKB		0:KIF11			
GO:0051223	P:regulation of protein transport; IMP:UniProtKB		0:GAPVD1			
GO:0030897	C:HOPS complex; IDA:UniProtKB		0:VPS16|0:VPS39|0:VPS18|0:VPS11|0:VPS41			
GO:0071338	P:positive regulation of hair follicle cell p...; IDA:UniProtKB		0:FGF10			
GO:0005509	F:calcium ion binding; TAS:UniProtKB		0:CALM2|0:TTN|0:CALM3|0:SDF4|0:GALNT3|0:PLA2G1B|0:CALM1|0:TNNC1|0:GPR98|0:MCTP1|0:MCTP2|0:MYL2|0:CDH24|0:SNCA|0:COMP|0:ATP2C1|0:TGM3|0:AMY2A|0:EFCAB4B|0:ATP2B2|0:ASPN|0:DHH|0:S100A7|0:RUNX1|0:SLC25A12|0:TESC|0:PRSS2|0:GRM7|0:S100A13|0:ARSA|0:PON1|0:SLC25A13|0:SPOCK2|0:TPT1|0:STIM2|0:THBS4|0:S100A5|0:PRSS3|0:CALU|0:GCA|0:SHH|0:MASP1|0:CAMKK2|0:SNCB|0:STIM1|0:DUOX2|0:S100A6|0:FBN1|0:TPD52|0:FAT4|0:PCDHA13|0:CRELD2|0:MMP16|0:CDH8|0:EMR1|0:CELSR3|0:VWCE|0:LDLR|0:ANXA8|0:LRP1B|0:PROS1|0:EFCAB4A|0:MMP24|0:SLC25A24|0:CAPNS1|0:PCDH20|0:CDHR4|0:MASP2|0:CAPN11|0:PVALB|0:F10|0:PLG|0:CAPSL|0:FBLN7|0:PRRG3|0:DMD|0:PCDHGB3|0:MYL6B|0:SLC25A23|0:DTNA|0:MMP13|0:CLGN|0:EPDR1|0:HMCN1|0:EFCAB7|0:VSNL1|0:CDH17|0:LTBP2|0:PKD1L2|0:PCDHA9|0:C14orf143|0:ACTN2|0:EDIL3|0:DSC3|0:CDH22|0:PCDHB10|0:PCDHB16|0:S100A7L2|0:SPATA21|0:MATN2|0:PLCD3|0:CDH12|0:NOTCH3|0:PCDHGA6|0:CDH4|0:PKD2L2|0:PLCE1|0:CUBN|0:PADI1|0:RHOT1|0:KIAA2018|0:EFHC1|0:EFHA2|0:MMP20|0:S100A3|0:MYL10|0:DAG1|0:STAT1|0:DLL4|0:PROCA1|0:EFEMP1|0:PCDHB6|0:HRNR|0:CASQ1|0:PCDHGB7|0:CALN1|0:SPTA1|0:NID2|0:CBLC|0:CIB4|0:LPCAT1|0:PCDHA6|0:PROZ|0:CALML4|0:FBN2|0:PLA2G2A|0:PLCB3|0:SPTAN1|0:DYTN|0:CBLB|0:CETN1|0:LPCAT2|0:PCDHGA9|0:EFCAB3|0:HEG1|0:ANXA5|0:DUOX1|0:JAG2|0:PCDHGA2|0:PLA2G3|0:PPEF1|0:CDH16|0:CBL|0:SGCA|0:THBS2|0:PCDH8|0:DST|0:NECAB3|0:RPTN|0:PPP2R3C|0:GUCA1A|0:EPS15L1|0:TBC1D9|0:CAPNS2|0:ANXA3|0:PLCL2|0:F7|0:NUCB1|0:PCDH18|0:STAT5A|0:NECAB2|0:PCDHGA10|0:C9orf140|0:EMR2|0:NOTCH2|0:SULF2|0:CD93|0:PCDHA12|0:MMP1|0:MAN1A2|0:MMP3|0:MMP14|0:OC90|0:OIT3|0:PCDHB9|0:DGKA|0:MYL9|0:FAT1|0:EFCAB8|0:LTBP3|0:RCN3|0:ACTN3|0:CAPN3|0:CIB2|0:PPP3R2|0:COPA|0:PCDHGA7|0:TCHHL1|0:PRRG4|0:PCDHB11|0:RASEF|0:CDH18|0:PLS1|0:FKBP10|0:PCDHGC4|0:P4HTM|0:PCDHAC2|0:PCDHGB2|0:PLCD4|0:MYLPF|0:AIF1|0:NKD2|0:EHD3|0:ANKRD5|0:S100A10|0:MMP25|0:PCDHA8|0:EFCAB1|0:CALML6|0:CDH5|0:PCDH7|0:GUCA1B|0:RYR1|0:ANXA2P2|0:EGF|0:DRP2|0:KCNIP1|0:C17orf57|0:CAPN8|0:EGFL8|0:MYL12B|0:PCDHA5|0:MYL3|0:CLSTN3|0:EHD4|0:PLCZ1|0:BMP1|0:CAPS2|0:RHOT2|0:PCDH17|0:PCDHGB6|0:ELTD1|0:NCAN|0:PCDHB5|0:HMCN2|0:ANXA7|0:MMP10|0:DCHS2|0:C1R|0:PLCB2|0:CALR3|0:CDH13|0:FKBP14|0:PLCH2|0:CRB2|0:SYNRG|0:CDH26|0:CDHR3|0:FREM2|0:S100A11|0:EFHC2|0:DSG4|0:MMP21|0:PCDH10|0:TPO|0:SMOC1|0:MMP17|0:PADI2|0:DSG3|0:EYS|0:STAT2|0:NCALD|0:PKD2L1|0:PLA2G2E|0:ANXA11|0:FSTL1|0:EFCAB9|0:NINL|0:CETN3|0:MMP15|0:FSTL5|0:S100Z|0:RAB11FIP4|0:EHD2|0:DSC1|0:AIF1L|0:PLA2G10|0:CDH20|0:SMOC2|0:CABP7|0:ANXA2|0:PCDH12|0:BGLAP|0:PCDHB14|0:PADI4|0:LRP8|0:STAT5B|0:CANT1|0:PCDHGA11|0:EMR3|0:SULF1|0:CDH19|0:CCBE1|0:PCDHGC3|0:DCHS1|0:PLA2G12A|0:PCDHGA3|0:NID1|0:PCDHB8|0:TNNC2|0:PCDHA2|0:PCDHA11|0:FAM188A|0:ANXA6|0:STAT3|0:DGKB|0:CDH6|0:MYL1|0:MST1|0:PCDH1|0:CAPN13|0:PCDH11Y|0:PLA2G5|0:EFHB|0:EFEMP2|0:EDEM1|0:PCDH9|0:CASQ2|0:SNED1|0:PCDHGB1|0:SUSD1|0:FBLN5|0:SPOCK1|0:ACTN4|0:PLA2G2C|0:SCUBE3|0:MYL12A|0:CDH10|0:CLSTN2|0:ANXA8L2|0:PRRG1|0:MMP27|0:SVEP1|0:FBN3|0:MCFD2|0:EPS15|0:PLS3|0:MMP12|0:MMP11|0:C1S|0:PLCH1|0:PLCD1|0:FLG2|0:PCDHGA8|0:REPS1|0:PCDHB12|0:GUCA1C|0:GAS6|0:PPP2R3A|0:EDEM3|0:MYL4|0:PCDHA4|0:EFHD1|0:CDH2|0:DSG2|0:DLL1|0:MYL6|0:EGFL7|0:TLL2|0:PCDHB2|0:PCDHB4|0:SLC25A25|0:PLA2G2F|0:PLCB1|0:UMODL1|0:DLK2|0:NECAB1|0:PCDHGB5|0:RYR2|0:FAT3|0:CDH23|0:EMR4P|0:CDHR2|0:PCDHB15|0:PKDREJ|0:USP32|0:CAPN12|0:PCDHGB4|0:DTNB|0:PCDHGA5|0:NPNT|0:CDH11|0:EEF2K|0:PCDHGA4|0:PROC|0:LALBA|0:PLA2G12B|0:CRELD1|0:VCAN|0:CDH7|0:EHD1|0:CELSR2|0:ACTN1|0:CRB1|0:PADI3|0:CAPN14|0:F9|0:STAT4|0:DSC2|0:RET|0:ANXA9|0:NOTCH2NL|0:SPOCK3|0:VLDLR|0:RHBDL3|0:CD97|0:EDEM2|0:STAT6|0:PCDHGA12|0:CACNA1D|0:PCDHA10|0:CLSTN1|0:SPARCL1|0:KCNIP4|0:EFCAB6|0:PCDHA1|0:SCUBE2|0:CRTAC1|0:SGCE|0:S100A7A|0:NOTCH1|0:PCDHAC1|0:UTRN|0:NKD1|0:PPP2R3B|0:CDH15|0:LTBP1|0:PPEF2|0:PCDHGA1|0:TBC1D9B|0:PCDHB18|0:PCDHGC5|0:CDHR1|0:EFHA1|0:F2|0:PCDH15|0:CALB2|0:PCDH11X|0:PCDHB13|0:PCDHA7|0:CDH3|0:CGREF1|0:PLCB4|0:CIB3|0:PLA2G2D|0:NOX5|0:LRP2|0:CBARA1|0:UMOD|0:MMP19|0:RYR3|0:ANXA13|0:SRI|0:ITSN2|0:FBLN1|0:CD248|0:RAB11FIP3|0:MMP28|0:DGKG|0:CDH9|0:ANXA8L1|0:NELL1|0:PCDH19|0:PLCL1|0:PRRG2|0:EGFL6|0:CELSR1|0:MYL5|0:PCDHA3|0:PCDHB3|0:PCDHB1|0:EFCAB2|0:FLG|0:PADI6|0:TLL1|0:CIB1|0:ATP2A1|0:MEX3B|0:OTOF|0:PCLO|0:CDK5R1|0:PDCD6|0:GRIN1|0:RGN|0:CDHR5|0:SRR|0:FKBP9|0:THBS1|0:LTBP4|0:HPCA|0:ITSN1|0:OCM2|0:RASGRP3|0:SLIT2|0:EML1|0:SSR4|0:LCP1|0:S100A14|0:MEGF9|0:TPM4|0:CRNN|0:DNER|0:PLSCR3|0:SLIT3|0:PLA2G4B|0:RAPGEF2|0:CABP5|0:SCGN|0:MEGF8|0:CETN2|0:LRP4|0:ANXA4|0:PLSCR4|0:FAT2|0:OCM|0:S100B|0:SYP|0:PPP3R1|0:PLSCR1|0:NELL2|0:SLIT1|0:MACF1|0:PCDHB7|0:NDUFAB1|0:PPP3CA|0:PITPNM2|0:MEGF6|0:S100A2|0:PLSCR2|0:THBS3|0:JAG1|0:DSG1|0:MYL7|0:MAN1A1|0:HRC|0:RCN2|0:KCNIP3|0:DNASE1L3|0:S100P|0:S100G|0:FBLN2|0:CALB1|0:GSN|0:DSPP|0:DNASE1L2|0:GPD2|0:REPS2|0:CPNE6|0:ANXA1|0:S100A4|0:HPCAL1|0:CALML3|0:CABP2|0:CAPS|0:HPCAL4|0:PEF1|0:LRP1|0:THBD|0:RCVRN|0:S100A1|0:S100A8|0:NUCB2|0:CANX|0:CABP1|0:CAPN9|0:FCN2|0:RASGRP1|0:FCN1|0:ANXA10|0:S100A12|0:LETM1|0:ASPH|0:CSN2|0:SPARC|0:S100A9|0:DMP1|0:RCN1|0:CALML5|0:PKD2|0:ITIH1|0:LRPAP1|0:SCUBE1|0:ADAMTS13|0:KCNIP2|0:TCHH|0:HSP90B1|0:MAN1C1|0:MAN1B1|0:BNIP2|0:NCS1|0:SCIN|0:RASGRP2|0:CABP4|0:PITPNM3|0:CALR|0:HSPA5|0:NOTCH4			
GO:0000783	C:nuclear telomere cap complex; TAS:BHF-UCL		0:TERT|0:TERF1|0:POT1|0:TERF2|0:TERF2IP|0:ACD|0:TINF2|0:XRCC6|0:XRCC5			
GO:0002755	P:MyD88-dependent toll-like receptor signalin...; TAS:BHF-UCL		0:HSPD1|0:IRAK1|0:IRAK2|0:IRAK3			
GO:0070173	P:regulation of enamel mineralization; TAS:BHF-UCL		0:MMP20			
GO:0021758	P:putamen development; IMP:UniProtKB		0:FOXP2			
GO:0034647	F:histone demethylase activity (H3-trimethyl-...; IDA:UniProtKB		0:KDM5B			
GO:0045580	P:regulation of T cell differentiation; TAS:UniProtKB		0:CD2|0:SPINK5			
GO:0042313	P:protein kinase C deactivation; IDA:BHF-UCL		0:EDN1			
GO:0005307	F:choline:sodium symporter activity; IMP:MGI		0:SLC5A7			
GO:0010936	P:negative regulation of macrophage cytokine ...; ISS:BHF-UCL		0:IRAK3			
GO:0006621	P:protein retention in ER lumen; TAS:ProtInc		0:OS9|0:KDELR3|0:KDELR2|0:KDELR1|0:GPAA1|0:PDIA3|0:PDIA2			
GO:0046920	F:alpha(1,3)-fucosyltransferase activity; TAS:UniProtKB		0:FUT11|0:FUT4|0:FUT5|0:FUT6|0:FUT9|0:FUT7|0:FUT10			
GO:0030864	C:cortical actin cytoskeleton; ISS:UniProtKB		0:LLGL1|0:CORO1A|0:MYO1A|0:LANCL2|0:GYS2|0:LASP1			
GO:0004475	F:mannose-1-phosphate guanylyltransferase act...; IEA:EC		0:GMPPB|0:GMPPA			
GO:0010517	P:regulation of phospholipase activity; IDA:UniProtKB		0:SNCA			
GO:0006221	P:pyrimidine nucleotide biosynthetic process; NAS:UniProtKB		0:CAD|0:CMPK2|0:CTPS2|0:PRPS1			
GO:0051968	P:positive regulation of synaptic transmissio...; ISS:BHF-UCL		0:DRD1			
GO:0002318	P:myeloid progenitor cell differentiation; ISS:UniProtKB		0:MLF1			
GO:0047021	F:15-hydroxyprostaglandin dehydrogenase (NADP...; IEA:EC		0:CBR1			
GO:0030892	C:mitotic cohesin complex; IDA:MGI		0:SGOL1|0:SGOL2			
GO:0004637	F:phosphoribosylamine-glycine ligase activity; IEA:EC		0:GART			
GO:0070821	C:tertiary granule membrane; IDA:BHF-UCL		0:SLC11A1			
GO:0005313	F:L-glutamate transmembrane transporter activity; TAS:UniProtKB		0:SLC25A12|0:SLC25A13|0:SLC25A22|0:SLC1A7			
GO:0008159	F:positive transcription elongation factor ac...; TAS:ProtInc		0:SUPT5H|0:ELL3|0:SUPT4H1|0:SUPT16H|0:HMGN1|0:ELL			
GO:0035519	P:protein K29-linked ubiquitination; IDA:UniProtKB		0:ITCH|0:UBE2S|0:UBE2T|0:UBE2D4			
GO:0030140	C:trans-Golgi network transport vesicle; ISS:UniProtKB		0:FURIN|0:IGF2R|0:STEAP2|0:GOPC|0:SPG21|0:ATP7A|0:RAB14			
GO:0001660	P:fever; IEA:UniProtKB-KW		0:IL1A|0:IL1B			
GO:0031640	P:killing of cells of another organism; IEA:UniProtKB-KW		0:APOL1|0:GNLY|0:DEFA6|0:DEFA3|0:DEFA5|0:HAMP|0:HTN3|0:DEFA1B|0:DCD|0:DEFA1|0:S100A12|0:HTN1|0:DEFA4			
GO:0019215	F:intermediate filament binding; NAS:UniProtKB		0:TRADD|0:SYNM|0:PKP1			
GO:0047963	F:glycine N-choloyltransferase activity; IEA:EC		0:BAAT			
GO:0043620	P:regulation of transcription in response to ...; TAS:BHF-UCL		0:DDIT3			
GO:0006614	P:SRP-dependent cotranslational protein targe...; IEA:InterPro		0:SRP9L1|0:SRP19|0:SRP9|0:SRP14|0:SRPR|0:SRP72			
GO:0042093	P:T-helper cell differentiation; ISS:UniProtKB		0:IL12B|0:ATP7A			
GO:0003716	F:RNA polymerase I transcription termination ...; IDA:UniProtKB		0:PTRF			
GO:0003854	F:3-beta-hydroxy-delta5-steroid dehydrogenase...; TAS:ProtInc		0:HSD3B2|0:SDR42E2|0:SDR42E1|0:HSD3B1|0:HSD3B7|0:NSDHL			
GO:0051295	P:establishment of meiotic spindle localization; ISS:BHF-UCL		0:FMN2			
GO:0050778	P:positive regulation of immune response; TAS:UniProtKB		0:PLA2G1B|0:TGFB2|0:IL29			
GO:0030217	P:T cell differentiation; TAS:UniProtKB		0:CHD7|0:LCK|0:NHEJ1|0:SOX4|0:RHOH|0:IL2			
GO:0002651	P:positive regulation of tolerance induction ...; ISS:BHF-UCL		0:TGFBR2			
GO:0008446	F:GDP-mannose 4,6-dehydratase activity; TAS:UniProtKB		0:GMDS			
GO:0050379	F:UDP-glucuronate 5'-epimerase activity; IDA:HGNC		0:GLCE			
GO:0015220	F:choline transmembrane transporter activity; TAS:UniProtKB		0:SLC44A1|0:SLC44A2			
GO:0031685	F:adenosine receptor binding; IPI:UniProtKB		0:CECR1|0:USP4			
GO:0010826	P:negative regulation of centrosome duplication; IMP:UniProtKB		0:CCNF|0:TMEM67|0:NPM1			
GO:0050197	F:phytanate-CoA ligase activity; EXP:Reactome		0:SLC27A2			
GO:0045104	P:intermediate filament cytoskeleton organiza...; TAS:UniProtKB		0:DST|0:KRT3|0:ERBB2IP|0:SYNM			
GO:0032002	C:interleukin-28 receptor complex; NAS:UniProtKB		0:IL28RA|0:IL29|0:IL10RB			
GO:0030100	P:regulation of endocytosis; TAS:UniProtKB		0:STON1|0:BIN1|0:CDH13|0:TSC2|0:STON2|0:SNX17|0:AP2S1|0:ZFYVE16			
GO:0004536	F:deoxyribonuclease activity; TAS:ProtInc		0:NME1|0:DNASE1L2|0:DNASE1L1			
GO:0010385	F:double-stranded methylated DNA binding; IMP:MGI		0:MECP2			
GO:0004438	F:phosphatidylinositol-3-phosphatase activity; IDA:UniProtKB		0:MTMR14|0:PTEN			
GO:0010884	P:positive regulation of lipid storage; IMP:BHF-UCL		0:NFKB1|0:PLA2G10			
GO:0032332	P:positive regulation of chondrocyte differen...; ISS:UniProtKB		0:PKDCC			
GO:0008802	F:betaine-aldehyde dehydrogenase activity; IEA:EC		0:ALDH7A1			
GO:0019871	F:sodium channel inhibitor activity; IDA:BHF-UCL		0:NEDD4			
GO:0042627	C:chylomicron; TAS:BHF-UCL		0:APOA4|0:APOE|0:APOC3|0:APOA2|0:APOH|0:APOC2|0:APOA5|0:LPL|0:LSR|0:APOC1			
GO:0033829	F:O-fucosylpeptide 3-beta-N-acetylglucosaminy...; IEA:EC		0:RFNG|0:MFNG|0:LFNG			
GO:0004797	F:thymidine kinase activity; TAS:ProtInc		0:TK2|0:TK1			
GO:0001866	P:NK T cell proliferation; ISS:UniProtKB		0:ELF4			
GO:0000152	C:nuclear ubiquitin ligase complex; IDA:UniProtKB		0:BRE|0:BRCC3			
GO:0006679	P:glucosylceramide biosynthetic process; TAS:ProtInc		0:UGCG			
GO:0009083	P:branched chain family amino acid catabolic ...; TAS:HGNC		0:BCKDHA|0:AUH|0:ACAD8|0:HIBCH|0:BCKDHB|0:BCKDK			
GO:0016046	P:detection of fungus; NAS:UniProtKB		0:TLR4			
GO:0060559	P:positive regulation of calcidiol 1-monooxyg...; IDA:BHF-UCL		0:TNF|0:IL1B|0:IFNG			
GO:0004643	F:phosphoribosylaminoimidazolecarboxamide for...; TAS:ProtInc		0:ATIC			
GO:0004350	F:glutamate-5-semialdehyde dehydrogenase acti...; IEA:EC		0:ALDH18A1			
GO:0031398	P:positive regulation of protein ubiquitination; IMP:UniProtKB		0:SMAD7|0:STUB1|0:DNAJB2|0:SMURF1|0:HSPBP1|0:FKBP1A|0:RASSF1|0:DNAJA3|0:SPHK1|0:FBXO4|0:BCL10|0:BRCA1|0:LRRK2|0:RCHY1|0:ANGPT1|0:RIPK2|0:NDFIP2|0:NDFIP1			
GO:0070309	P:lens fiber cell morphogenesis; IEP:BHF-UCL		0:PROX1			
GO:0033798	F:thyroxine 5-deiodinase activity; IEA:EC		0:DIO3			
GO:0006533	P:aspartate catabolic process; TAS:UniProtKB		0:GOT2|0:GOT1|0:ASPA|0:DDO			
GO:0043161	P:proteasomal ubiquitin-dependent protein cat...; NAS:UniProtKB		0:SMURF1|0:PCNP|0:STUB1|0:ERCC8|0:KLHL20|0:UBE2D3|0:TRIM9|0:HECTD3|0:KCTD13|0:TNFAIP1|0:CDC34|0:BIRC2|0:UBE2B|0:NHLRC1|0:USP19|0:RAD23A|0:RAD23B|0:PPP2R5C|0:DDB1|0:RNF4|0:ARRB1|0:TOPORS|0:PCBP2|0:CRBN|0:WWP2|0:ARRB2|0:RBCK1|0:TBL1X|0:KCTD10|0:TBL1XR1|0:FBXO45|0:SIAH1|0:FAF1|0:UBXN1			
GO:0034236	F:protein kinase A catalytic subunit binding; IPI:BHF-UCL		0:RYR2|0:GSK3A|0:GSK3B			
GO:0045513	F:interleukin-27 binding; IPI:UniProtKB		0:IL12A			
GO:0002076	P:osteoblast development; ISS:UniProtKB		0:ACHE|0:MEN1|0:GLI2			
GO:0003148	P:outflow tract septum morphogenesis; IMP:BHF-UCL		0:GATA6			
GO:0045109	P:intermediate filament organization; IMP:UniProtKB		0:DNAJB6|0:KRT20|0:KRT9			
GO:0015643	F:toxin binding; NAS:UniProtKB		0:ALB|0:CHRNA7|0:AZU1|0:DSG1			
GO:0043567	P:regulation of insulin-like growth factor re...; IC:UniProtKB		0:IGFBP2			
GO:0047323	F:[3-methyl-2-oxobutanoate dehydrogenase (ace...; IEA:EC		0:BCKDK			
GO:0004873	F:asialoglycoprotein receptor activity; TAS:UniProtKB		0:ASGR1|0:LRPAP1|0:ASGR2			
GO:0003743	F:translation initiation factor activity; TAS:UniProtKB		0:EIF3E|0:EIF2S2|0:EIF4G2|0:EIF2S3|0:EIF2S1|0:EIF3I|0:EIF5B|0:EIF3B|0:GTF2B|0:LGTN|0:EIF1B|0:DENR|0:TRMT6|0:EIF1AD|0:BRF1|0:EIF3J|0:EIF1AY|0:EIF3G|0:EIF3M|0:EIF2B3|0:EIF3C|0:EIF4G3|0:EIF3D|0:EIF3K|0:EIF2B2|0:MTIF2|0:EIF4E3|0:EIF4E2|0:EIF3H|0:DHX29|0:EIF3CL|0:EIF6|0:EIF3L|0:EIF3A|0:MTIF3|0:EIF1AX|0:EIF2B1|0:EIF4E1B|0:EIF2B4|0:EIF4A1|0:EIF2A|0:EIF4E|0:EIF1|0:EIF2C2|0:EIF2B5|0:EIF5|0:COPS5|0:EIF4H|0:EIF4B|0:EIF4A2|0:EIF3F|0:EIF4G1			
GO:0004084	F:branched-chain-amino-acid transaminase acti...; TAS:ProtInc		0:BCAT1|0:BCAT2			
GO:0005913	C:cell-cell adherens junction; TAS:ProtInc		0:CDH1|0:PVRL1|0:ZYX|0:SCRIB|0:PTPRM|0:SHROOM2|0:TJP1			
GO:0031110	P:regulation of microtubule polymerization or...; IDA:UniProtKB		0:SKA3|0:SKA1|0:SKA2			
GO:0000164	C:protein phosphatase type 1 complex; TAS:UniProtKB		0:SHOC2|0:PPP1R9B			
GO:0033173	P:calcineurin-NFAT signaling pathway; IDA:UniProtKB		0:LACRT			
GO:0004757	F:sepiapterin reductase activity; ISS:UniProtKB		0:SPR			
GO:0001837	P:epithelial to mesenchymal transition; TAS:HGNC		0:WNT4|0:WNT5A|0:LEF1|0:AMELX|0:HIF1A|0:HNRNPAB|0:TRIM28|0:SNAI1|0:NOG|0:FOXF2|0:BMP7|0:S100A4|0:CTNNB1|0:HGF			
GO:0070382	C:exocytic vesicle; IDA:UniProtKB		0:SYTL2|0:UNC13D|0:RAB27A			
GO:0031117	P:positive regulation of microtubule depolyme...; IMP:UniProtKB		0:STMN2|0:KATNB1			
GO:0004395	F:hexaprenyldihydroxybenzoate methyltransfera...; IEA:EC		0:COQ3			
GO:0070300	F:phosphatidic acid binding; IDA:UniProtKB		0:SESTD1			
GO:0035034	F:histone acetyltransferase regulator activity; IDA:UniProtKB		0:EID1			
GO:0016580	C:Sin3 complex; NAS:BHF-UCL		0:HDAC1|0:CSNK2A1|0:MORF4L1|0:HDAC2|0:ING2|0:SIN3A|0:SUDS3|0:RBBP4			
GO:0018401	P:peptidyl-proline hydroxylation to 4-hydroxy...; IDA:MGI		0:P4HB			
GO:0007530	P:sex determination; TAS:ProtInc		0:WT1|0:SRD5A1|0:DMRT1|0:AMH|0:DMRT2			
GO:0000290	P:deadenylation-dependent decapping of nuclea...; IEA:InterPro		0:DCPS			
GO:0035067	P:negative regulation of histone acetylation; TAS:UniProtKB		0:SNCA|0:TAF7|0:SET			
GO:0003908	F:methylated-DNA-[protein]-cysteine S-methylt...; EXP:Reactome		0:MGMT			
GO:0060070	P:canonical Wnt receptor signaling pathway; TAS:BHF-UCL		0:TCF7L2|0:GSK3B|0:AXIN1|0:WNT10B|0:LEF1|0:PPAP2B|0:WNT2|0:WNT7A|0:DVL1|0:FZD2|0:SFRP1|0:FZD7|0:PTEN|0:CHD8|0:WNT3|0:LRP6|0:FZD1|0:WNT4|0:CTNNB1|0:PTPRU|0:WNT1|0:DVL3|0:TBL1X|0:TBL1XR1|0:SOX4|0:WNT7B|0:UBE2B|0:WNT8A|0:APC|0:FZD5|0:RARG			
GO:0033674	P:positive regulation of kinase activity; IDA:BHF-UCL		0:RAD50|0:NBN|0:MRE11A			
GO:0043499	F:eukaryotic cell surface binding; TAS:BHF-UCL		0:FGA|0:PCSK6|0:THBS1|0:FGB|0:FGG|0:APOH|0:ADIPOQ|0:ATP5B|0:ATP5A1|0:AGGF1|0:MBL2			
GO:0004813	F:alanine-tRNA ligase activity; IEA:InterPro		0:AARS2|0:AARS|0:AARSD1			
GO:0032007	P:negative regulation of TOR signaling cascade; IMP:UniProtKB		0:AKT1S1|0:DEPDC6|0:TSC1|0:TMEM127			
GO:0003197	P:endocardial cushion development; TAS:BHF-UCL		0:GATA4|0:BMP4|0:CRELD1			
GO:0003219	P:cardiac right ventricle formation; IMP:BHF-UCL		0:HAND1			
GO:0006670	P:sphingosine metabolic process; IDA:UniProtKB		0:SPHK1|0:SGPP2			
GO:0019987	P:negative regulation of anti-apoptosis; ISS:UniProtKB		0:SIVA1|0:TNFAIP8|0:RTN4|0:PIK3R2			
GO:0004313	F:[acyl-carrier-protein] S-acetyltransferase ...; EXP:Reactome		0:FASN			
GO:0051882	P:mitochondrial depolarization; IDA:HGNC		0:AIFM3			
GO:0050262	F:ribosylnicotinamide kinase activity; IEA:EC		0:C9orf95|0:ITGB1BP3			
GO:0043043	P:peptide biosynthetic process; ISS:BHF-UCL		0:MRPS26|0:MRPS9|0:MRPS35|0:PCSK5|0:FURIN|0:DMD|0:PCSK1			
GO:0019089	P:transmission of virus; IMP:BHF-UCL		0:NEDD4			
GO:0051181	P:cofactor transport; IMP:UniProtKB		0:PPT1			
GO:0009636	P:response to toxin; TAS:UniProtKB		0:BAX|0:BCL2|0:SLC23A1|0:SLC30A4|0:SLC6A4|0:AQP10|0:SLC6A14|0:DHRS2|0:SLC7A11|0:TRPM6|0:EPHX1|0:SLC22A8|0:SCFD1|0:HDAC6|0:SLC7A8|0:EPHX2|0:SRF|0:MPST|0:BPHL|0:NQO1|0:CES1|0:GLYAT|0:PDZD3			
GO:0046789	F:host cell surface receptor binding; TAS:UniProtKB		0:INHBB			
GO:0034673	C:inhibin-betaglycan-ActRII complex; IDA:BHF-UCL		0:ACVR2A|0:TGFBR3|0:INHA			
GO:0007196	P:inhibition of adenylate cyclase activity by...; IMP:UniProtKB		0:GRM4			
GO:0032318	P:regulation of Ras GTPase activity; IDA:UniProtKB		0:RAP1GAP			
GO:0006658	P:phosphatidylserine metabolic process; TAS:ProtInc		0:SERINC5|0:SERINC1|0:PLA1A			
GO:0016212	F:kynurenine-oxoglutarate transaminase activity; ISS:UniProtKB		0:CCBL1|0:AADAT|0:CCBL2			
GO:0005534	F:galactose binding; TAS:ProtInc		0:ENG|0:GALK1|0:COLEC12|0:LGALS9			
GO:0017000	P:antibiotic biosynthetic process; IEA:InterPro		0:NECAB3|0:NECAB2|0:NECAB1			
GO:0047066	F:phospholipid-hydroperoxide glutathione pero...; IEA:EC		0:GPX4			
GO:0061032	P:visceral serous pericardium development; IGI:UniProtKB		0:WT1			
GO:0042276	P:error-prone translesion synthesis; TAS:UniProtKB		0:REV1			
GO:0019031	C:viral envelope; IEA:UniProtKB-KW		0:ERV3|0:ERVWE1			
GO:0004057	F:arginyltransferase activity; TAS:UniProtKB		0:ATE1			
GO:0020027	P:hemoglobin metabolic process; NAS:UniProtKB		0:AHSP			
GO:0004876	F:complement component C3a receptor activity; TAS:ProtInc		0:C3AR1			
GO:0043035	F:chromatin insulator sequence binding; IDA:UniProtKB		0:CTCF			
GO:0016358	P:dendrite development; ISS:UniProtKB		0:GHRL|0:LST1|0:BBS4|0:APP|0:TRAPPC4|0:TULP1|0:STRN			
GO:0004668	F:protein-arginine deiminase activity; TAS:ProtInc		0:PADI1|0:PADI2|0:PADI6|0:PADI4|0:PADI3			
GO:0010332	P:response to gamma radiation; ISS:UniProtKB		0:FANCD2|0:MEN1|0:DCUN1D3|0:TP53|0:LIG4			
GO:0048193	P:Golgi vesicle transport; IMP:UniProtKB		0:STX6|0:STX10|0:VPS41			
GO:0004713	F:protein tyrosine kinase activity; TAS:UniProtKB		0:DYRK2|0:TWF1|0:TTN|0:WIF1|0:LMTK2|0:NEK10|0:LMTK3|0:PLK4|0:AATK|0:TP53RK|0:OBSCN|0:CLK2|0:MAP2K2|0:DYRK3|0:MAP2K6|0:MAP2K3|0:NEK1|0:MAP2K7|0:CLK4|0:MAP2K4|0:DYRK4|0:CLK3|0:TESK1|0:MAP2K1|0:DSTYK|0:TESK2|0:DYRK1B|0:MAP2K5|0:SCYL1|0:GOLGA5|0:CRKL|0:TTK|0:CAMKK2			
GO:0051310	P:metaphase plate congression; IDA:UniProtKB		0:CENPF			
GO:0007388	P:posterior compartment specification; TAS:ProtInc		0:PBX3			
GO:0071565	C:nBAF complex; ISS:UniProtKB		0:ARID1A|0:SMARCC2|0:SMARCD1|0:SMARCB1|0:SMARCC1|0:SMARCE1|0:DPF1|0:SMARCA2|0:SMARCD3|0:SMARCA4|0:ACTL6B|0:DPF3			
GO:0051721	F:protein phosphatase 2A binding; ISS:UniProtKB		0:SMG7|0:SMG5|0:PPME1|0:PPP2R4|0:STRN4|0:STRN3|0:STRN|0:TP53|0:GRIN3A			
GO:0050909	P:sensory perception of taste; TAS:ProtInc		0:TAS2R9|0:TAS2R20|0:LCN1|0:TAS2R42|0:TAS2R8|0:TAS2R13|0:SCNN1G|0:SCNN1A|0:SCNN1D|0:TAS2R38|0:TAS2R7|0:TAS2R50|0:TAS2R10|0:TAS2R45|0:TAS2R30|0:TAS2R39|0:TAS2R40|0:SCNN1B|0:TAS2R1|0:TAS2R12|0:TAS2R31|0:TAS2R41|0:TAS2R46|0:TAS2R19|0:TAS2R4|0:TAS2R3|0:TAS2R5			
GO:0045569	F:TRAIL binding; NAS:UniProtKB		0:TNFRSF10B|0:TNFRSF10A			
GO:0048245	P:eosinophil chemotaxis; IDA:HGNC		0:SCG2			
GO:0042592	P:homeostatic process; NAS:UniProtKB		0:MPV17|0:CREBBP|0:IL31RA|0:TRERF1|0:ANG|0:PKHD1			
GO:0035401	F:histone kinase activity (H3-Y41 specific); IDA:UniProtKB		0:JAK2			
GO:0045760	P:positive regulation of action potential; ISS:BHF-UCL		0:ADRA1A			
GO:0061099	P:negative regulation of protein tyrosine kin...; IDA:UniProtKB		0:SRCIN1			
GO:0030010	P:establishment of cell polarity; NAS:UniProtKB		0:BRSK2|0:BRSK1|0:ARHGEF11			
GO:0004767	F:sphingomyelin phosphodiesterase activity; TAS:ProtInc		0:ENPP7|0:SMPD3|0:SMPD4|0:SMPDL3B|0:SMPDL3A|0:SMPD2|0:SMPD1			
GO:0002384	P:hepatic immune response; TAS:BHF-UCL		0:IL6|0:IL6R			
GO:0008494	F:translation activator activity; TAS:UniProtKB		0:PAIP1|0:RPS27L|0:DAZ1|0:BOLL|0:DAZL|0:PABPC1			
GO:0048566	P:embryonic digestive tract development; ISS:UniProtKB		0:PCSK5|0:SALL1|0:GLI2|0:PKDCC			
GO:0019221	P:cytokine-mediated signaling pathway; TAS:UniProtKB		0:IL1B|0:EDN2|0:CCR2|0:EREG|0:DUOX1|0:ZNF675|0:PF4|0:NUMBL|0:RELA|0:DUOX2|0:IFNK|0:IL1A|0:SOCS5|0:SOCS1|0:JAK2|0:CEBPA|0:LRP8|0:PLP2|0:CCR1|0:CLCF1|0:CSF3|0:CX3CL1			
GO:0000421	C:autophagic vacuole membrane; IEA:UniProtKB-SubCell		0:GABARAPL2|0:GABARAP|0:WIPI1|0:MAP1LC3C|0:ATG9A|0:ATG9B|0:TM9SF1|0:TMEM74|0:IRGM|0:MAP1LC3A|0:MAP1LC3B2|0:MAP1LC3B|0:ENTPD4			
GO:0043951	P:negative regulation of cAMP-mediated signaling; IDA:UniProtKB		0:PDE3B|0:CDC34|0:UBE2B|0:MGRN1			
GO:0034067	P:protein localization in Golgi apparatus; IMP:UniProtKB		0:LACRT|0:GCC2|0:COG7			
GO:0050823	P:peptide antigen stabilization; ISS:UniProtKB		0:TAPBP			
GO:0005635	C:nuclear envelope; TAS:UniProtKB		0:TNKS2|0:SIRT1|0:FAM156A|0:FAM156B|0:WDFY3|0:NPC1|0:BNIP1|0:PARP1|0:RTN4|0:BNIP2|0:ANXA11|0:DHRS2|0:POLA1|0:HTATIP2|0:LMNA|0:BNIP3L|0:SLC22A18|0:BNIP3|0:CENPF|0:S100A6|0:LEMD1|0:ANKLE2|0:RNF43|0:MTMR6|0:OIT3|0:UBXN4|0:RNF180|0:PPAPDC3|0:MTMR8|0:GHDC|0:DNASE1|0:TREX1|0:PTGER3|0:XPO1|0:CBX5|0:SP140|0:GNAZ|0:SREBF1|0:ATF6			
GO:0007132	P:meiotic metaphase I; ISS:BHF-UCL		0:FMN2			
GO:0008269	F:JAK pathway signal transduction adaptor act...; TAS:ProtInc		0:SH2B2|0:SOCS2			
GO:0007184	P:SMAD protein nuclear translocation; TAS:ProtInc		0:JUN|0:TGFB2|0:TGFB1|0:ZFYVE9			
GO:0008186	F:RNA-dependent ATPase activity; TAS:ProtInc		0:DDX17			
GO:0005589	C:collagen type VI; TAS:ProtInc		0:COL6A1|0:COL6A3			
GO:0090082	P:negative regulation of canonical Wnt recept...; ISS:BHF-UCL		0:DKK1			
GO:0001766	P:membrane raft polarization; TAS:UniProtKB		0:MAL|0:CD2			
GO:0042088	P:T-helper 1 type immune response; TAS:UniProtKB		0:TLR6|0:IL18|0:IL18BP|0:TLR4|0:EBI3|0:IL12B			
GO:0070969	C:ULK1-ATG13-FIP200 complex; IPI:UniProtKB		0:RB1CC1|0:ULK1|0:ATG13			
GO:0006987	P:activation of signaling protein activity in...; IDA:UniProtKB		0:ERN1			
GO:0016010	C:dystrophin-associated glycoprotein complex; TAS:ProtInc		0:DMD|0:CAV3|0:PGM5|0:SNTB1|0:SSPN|0:SNTB2			
GO:0045410	P:positive regulation of interleukin-6 biosyn...; ISS:UniProtKB		0:EREG|0:TLR6|0:TLR1			
GO:0006281	P:DNA repair; TAS:UniProtKB		0:UPF1|0:ASF1A|0:APITD1|0:NUDT1|0:KIF22|0:TRANK1|0:RDM1|0:CRY2|0:EEPD1|0:C1orf124|0:FBXO18|0:RAD9B|0:ESCO2|0:GTF2H2B|0:ASTE1|0:ESCO1|0:CRY1|0:SMC6|0:CUL4B|0:EPC2|0:NONO|0:GTF2H2C|0:FANCD2|0:FZR1|0:SFPQ|0:TTC5|0:CINP|0:ATRIP|0:CHAF1B|0:C9orf102|0:UBE2D3|0:EME2|0:PTTG1|0:CLSPN|0:MORF4L1|0:C19orf40|0:PRPF19|0:TP53BP1|0:FANCF|0:C11orf30|0:BCCIP|0:EYA4|0:RTEL1|0:CEP164|0:SUPT16H|0:C17orf70|0:FANCL|0:DCLRE1B|0:SHPRH|0:RBX1|0:ATM|0:RRM2B|0:NSMCE2|0:SMC3|0:SSRP1|0:SMG1|0:USP28|0:MORF4L2|0:GTF2H2D|0:SETMAR|0:KIN|0:MDC1|0:FANCM|0:STRA13|0:RFWD3|0:HERC2|0:CDC14B|0:NSMCE1|0:APEX2|0:EYA2|0:JMY|0:ZSWIM7|0:SMC5|0:CUL4A|0:FANCB|0:GEN1|0:USP10|0:FANCI|0:UHRF1|0:USP1|0:CHAF1A|0:BARD1|0:EME1|0:REV3L|0:POLN|0:FANCE|0:XRCC3|0:RPS27L|0:INTS3|0:USP3|0:CHEK1|0:C9orf80|0:HINFP|0:MUM1|0:MUS81|0:CHRNA4|0:RPAIN|0:C15orf42|0:MEN1|0:NCOA6|0:POLG2|0:RBM14|0:TYMS|0:TOPBP1|0:PARP4|0:TOP2A|0:RAD18|0:SIRT1|0:SUMO1|0:RUVBL2|0:GADD45G|0:RAD51L1|0:RAD9A|0:CSNK1D|0:BTG2|0:IGHMBP2|0:RAD1|0:FANCA|0:RECQL5|0:CSNK1E|0:ATRX|0:POLI|0:POLQ|0:UVRAG|0:RAD51L3|0:PARP3|0:GADD45A|0:FANCG|0:RAD51C|0:RAD17|0:LIG3|0:ATR|0:TREX2|0:SMC1A|0:POLK|0:CHD1L|0:FBXO6			
GO:0005057	F:receptor signaling protein activity; TAS:UniProtKB		0:CD44|0:RGS12|0:TIAM2|0:TIAM1|0:ARAF|0:RGS14|0:RAF1|0:FLRT2|0:FLRT1|0:PLCG1|0:FLRT3|0:IL4R|0:DAXX|0:FCGR1A|0:NCR1|0:TBL3|0:PIP4K2B|0:GNAZ|0:BAG4|0:IFITM1|0:TYROBP|0:CD19|0:NSMAF|0:BAG1|0:IL1RL1|0:CD3E|0:DCLK1|0:ARF1|0:PLCE1			
GO:0004993	F:serotonin receptor activity; TAS:ProtInc		0:HTR4|0:HTR2C|0:HTR1E|0:HTR1F|0:HTR2B|0:HTR2A|0:HTR3A|0:HTR7|0:HTR1D|0:HTR1A|0:HTR3B|0:HTR1B			
GO:0016507	C:fatty acid beta-oxidation multienzyme complex; IEA:InterPro		0:HADHA			
GO:0050852	P:T cell receptor signaling pathway; TAS:UniProtKB		0:MALT1|0:PTPRC|0:BCL10|0:RNF31|0:RBCK1|0:FYN|0:TRAF6|0:SKAP1|0:UBE2N|0:THY1|0:THEMIS|0:BCAR1|0:MAP3K7|0:IKBKG			
GO:0051170	P:nuclear import; IDA:UniProtKB		0:HNRNPA1|0:HTATIP2			
GO:0000379	P:tRNA-type intron splice site recognition an...; IEA:InterPro		0:TSEN34			
GO:0008511	F:sodium:potassium:chloride symporter activity; TAS:ProtInc		0:SLC12A2|0:SLC12A1			
GO:0031023	P:microtubule organizing center organization; IMP:UniProtKB		0:PAFAH1B1			
GO:0045112	P:integrin biosynthetic process; IMP:UniProtKB		0:COL5A1			
GO:0070530	F:K63-linked polyubiquitin binding; IDA:UniProtKB		0:UIMC1|0:TAB2			
GO:0001848	F:complement binding; TAS:UniProtKB		0:CFB			
GO:0070361	F:mitochondrial light strand promoter anti-se...; IDA:UniProtKB		0:LONP1			
GO:0030579	P:ubiquitin-dependent SMAD protein catabolic ...; IDA:HGNC		0:SMURF2|0:TGFB1I1|0:SMURF1|0:STUB1			
GO:0000022	P:mitotic spindle elongation; TAS:ProtInc		0:KIF23|0:PRC1			
GO:0070991	F:medium-chain-acyl-CoA dehydrogenase activity; IDA:BHF-UCL		0:ACADM			
GO:0002031	P:G-protein coupled receptor internalization; IMP:UniProtKB		0:DRD3|0:ARRB2|0:ARRB1|0:HTR2B|0:GTF2H2			
GO:0004012	F:phospholipid-translocating ATPase activity; TAS:UniProtKB		0:ATP9A|0:ATP8A2|0:ATP10B|0:ATP11A|0:ATP8B3|0:ATP8B4|0:ATP11C|0:ATP9B|0:ATP8B2|0:ATP8A1|0:ATP10D|0:ATP10A|0:ATP11B|0:ATP8B1			
GO:0045028	F:purinergic nucleotide receptor activity, G-...; IEA:InterPro		0:P2RY10|0:GPR18|0:P2RY6|0:LPAR6|0:GPR87|0:GPR174|0:P2RY4|0:P2RY11|0:GPR183|0:OXGR1|0:P2RY14|0:GPR17|0:GPR109B|0:GPR34|0:P2RY8|0:LPAR5|0:LPAR4|0:P2RY2|0:GPR109A|0:GPR171|0:SUCNR1|0:GPR15			
GO:0033593	C:BRCA2-MAGE-D1 complex; IDA:UniProtKB		0:BRCA2			
GO:0045777	P:positive regulation of blood pressure; ISS:UniProtKB		0:CARTPT|0:QRFP			
GO:0010717	P:regulation of epithelial to mesenchymal tra...; IMP:UniProtKB		0:GREM1			
GO:0016773	F:phosphotransferase activity, alcohol group ...; IEA:InterPro		0:FAM20B|0:UCKL1|0:PI4KAP2|0:UCK2|0:DCK|0:UCK1|0:TK2|0:TRRAP|0:NDUFA10|0:DGUOK|0:FGGY			
GO:0042903	F:tubulin deacetylase activity; IDA:UniProtKB		0:SIRT2|0:HDAC6			
GO:0005850	C:eukaryotic translation initiation factor 2 ...; TAS:ProtInc		0:EIF2A|0:EIF2S1|0:EIF2S2			
GO:0051464	P:positive regulation of cortisol secretion; IDA:BHF-UCL		0:GHRL|0:CRH			
GO:0071603	P:endothelial cell-cell adhesion; ISS:BHF-UCL		0:THBS4|0:JUP			
GO:0043540	C:6-phosphofructo-2-kinase/fructose-2,6-bipho...; IDA:UniProtKB		0:PFKFB1			
GO:0060271	P:cilium morphogenesis; ISS:UniProtKB		0:LRRC50|0:BBS7|0:BBS2|0:IFT88|0:IFT122			
GO:0060263	P:regulation of respiratory burst; TAS:BHF-UCL		0:RAC1|0:RAC2|0:NOXA1|0:NOXO1			
GO:0045916	P:negative regulation of complement activation; IDA:UniProtKB		0:MASP1			
GO:0004826	F:phenylalanine-tRNA ligase activity; TAS:ProtInc		0:FARS2|0:LRRC47|0:FDXACB1|0:FARSB|0:FARSA			
GO:0004139	F:deoxyribose-phosphate aldolase activity; IDA:UniProtKB		0:DERA			
GO:0060694	P:regulation of cholesterol transporter activity; IC:BHF-UCL		0:PPARG			
GO:0008285	P:negative regulation of cell proliferation; TAS:UniProtKB		0:HRAS|0:IL1A|0:CDKN1A|0:CDKN2D|0:VDR|0:CYP27B1|0:F2R|0:IL1B|0:CDH13|0:MAP2K1|0:CDKN2C|0:RAF1|0:CHERP|0:BMP2|0:ENPP7|0:PPP2R5C|0:ING4|0:WDR6|0:RBM38|0:BNIPL|0:IRF6|0:MEN1|0:PODN|0:DNAJA3|0:SFRP2|0:NOTCH2|0:SOX7|0:ALOX15B|0:IL29|0:DLC1|0:BTG1|0:PDS5B|0:RERG|0:ALDH1A2|0:FOXO4|0:FRZB|0:NF2|0:NUP62|0:KAT2B|0:TAF6|0:INHBA|0:ING5|0:CTNNB1|0:PTPRU|0:WT1|0:DNAJB2|0:PML|0:HNF4A|0:PROX1|0:WNT9A|0:AXIN2|0:SFRP4|0:SFRP5|0:TBRG1|0:GTPBP4|0:ACVRL1|0:ROR2|0:TENC1|0:TESC|0:TSC1|0:TMEM127|0:HSPA1A|0:SCIN|0:HSPA1B|0:NPM1|0:TFAP4|0:STRN|0:TGFB3|0:RARG|0:DRD2|0:MYO16|0:NOX4|0:EEF1E1|0:FTH1|0:IL28RA|0:LEPRE1|0:PHB|0:PPAP2A|0:TMEM115|0:DHRS2|0:IFNB1|0:DLG3|0:AZGP1|0:CD164|0:IFNK|0:CSNK2B|0:TOB2|0:GML|0:RARRES3|0:COL18A1|0:KLF4|0:CGRRF1|0:PLG|0:SSTR3|0:CXCL1|0:CDKN3|0:BTG3|0:DEC1|0:TNFRSF8|0:IGFBP6|0:FABP6|0:ATP8A2|0:LDOC1|0:POU1F1|0:MXD4|0:ADAMTS1|0:ABI1|0:ING1|0:BTG2|0:TNFRSF9|0:IL8|0:OSM|0:SPEG|0:DLG5|0:PTHLH|0:COL4A3|0:AIF1|0:UTP20|0:PRKRA|0:SSTR2|0:CD33|0:RBBP4|0:CTBP1|0:S100A11|0:KLF10|0:ADRA1A|0:DLEC1|0:SIRPG|0:NCK2|0:CCL23|0:SESN1|0:RARRES1|0:GPNMB|0:CHEK1|0:IGFBP7|0:SSTR5|0:CDK10|0:MDM4|0:NDN|0:GNRH1|0:FGFBP1|0:ODZ1|0:TGFB1I1|0:IFITM1|0:HGS|0:KLF11|0:WARS|0:ETS1|0:SSTR1|0:OPRM1|0:CTBP2|0:CUL4A|0:VHL|0:ADAMTS8|0:FABP3|0:IL6|0:CUL1|0:CUL5|0:FRK|0:SSTR4|0:TOB1|0:CDC6|0:BAI1|0:GAS8|0:CGREF1|0:EMP3|0:TP53I11|0:MNT|0:UMOD|0:CNOT8|0:PPM1D|0:FABP7|0:CDKN1B|0:PRKRIR|0:MXI1|0:BAP1|0:CUL2|0:SST|0:NME1|0:CCL3L1|0:CCL3L3|0:RBM5|0:BTG4			
GO:0043924	F:suramin binding; IMP:BHF-UCL		0:RYR2			
GO:0032937	C:SREBP-SCAP-Insig complex; IDA:UniProtKB		0:SREBF2|0:INSIG2			
GO:0006956	P:complement activation; TAS:ProtInc		0:CFHR1			
GO:0043626	C:PCNA complex; IEA:InterPro		0:PCNA			
GO:0060313	P:negative regulation of blood vessel remodeling; IEP:BHF-UCL		0:CST3			
GO:0042989	P:sequestering of actin monomers; TAS:ProtInc		0:TMSL3|0:TMSB15A|0:TMSB4X|0:TMSB4XP1|0:TMSB10|0:TMSB4XP2|0:TMSL6|0:TMSB4Y			
GO:0060037	P:pharyngeal system development; ISS:BHF-UCL		0:TBX1|0:NKX2-6|0:TGFBR1|0:NKX2-5			
GO:0034389	P:lipid particle organization; ISS:BHF-UCL		0:FITM1|0:FITM2			
GO:0033260	P:DNA replication involved in S phase; IMP:UniProtKB		0:SLBP			
GO:0048034	P:heme O biosynthetic process; IEA:InterPro		0:COX10			
GO:0019861	C:flagellum; IEA:UniProtKB-SubCell		0:ROPN1B|0:ENKUR|0:SPAG6|0:TEKT4|0:SLC25A31|0:ADAM15|0:TEKT2			
GO:0003899	F:DNA-directed RNA polymerase activity; TAS:ProtInc		0:CRCP|0:POLR3H|0:RPAP1|0:POLR2J3|0:POLR3E|0:POLR1D|0:POLR2G|0:CD3EAP|0:POLR1A|0:POLR2C|0:POLR3D|0:POLR1E|0:POLR2F|0:POLR2B|0:POLR1B|0:POLR3B|0:ZNRD1|0:TWISTNB|0:POLR2K|0:POLR2J2|0:POLR2D|0:MED20|0:POLR3A|0:POLR2A|0:POLR3F|0:POLR2H|0:POLRMT|0:POLR2J|0:MED21|0:POLR3C|0:POLR3G|0:POLR2L|0:POLR3K|0:POLR2E|0:POLR2I|0:CTDP1|0:POLR1C			
GO:0032787	P:monocarboxylic acid metabolic process; IDA:BHF-UCL		0:CYP1A2|0:CYP2C9			
GO:0048706	P:embryonic skeletal system development; ISS:UniProtKB		0:WNT11|0:PCSK5|0:WNT5A|0:COL1A1|0:RBP4|0:DEAF1|0:KIAA1217			
GO:0030157	P:pancreatic juice secretion; NAS:UniProtKB		0:COPA|0:CEL|0:AQP1|0:AQP5|0:SCT			
GO:0004747	F:ribokinase activity; IEA:EC		0:RBKS			
GO:0050649	F:testosterone 6-beta-hydroxylase activity; IMP:BHF-UCL		0:CYP3A4			
GO:0051056	P:regulation of small GTPase mediated signal ...; IEA:InterPro		0:RASGRP3|0:RAPGEF5|0:RASAL1|0:RAPGEF1|0:IQGAP1|0:RASA3|0:TSC2|0:SIPA1L2|0:RASGEF1C|0:RGL3|0:RAPGEF6|0:RASA4|0:GARNL3|0:DAB2IP|0:SIPA1|0:RGL2|0:RAPGEF2|0:RASGEF1B|0:RASA1|0:RAP1GAP2|0:RGL1|0:RASGEF1A|0:IQGAP2|0:RASGRP2|0:RALGDS|0:RAPGEF4|0:GAPVD1|0:RASGRP1|0:RAPGEF3|0:KNDC1|0:RASA2|0:RASAL2|0:SYNGAP1|0:RASAL3|0:IQGAP3|0:SIPA1L3			
GO:0005943	C:1-phosphatidylinositol-4-phosphate 3-kinase...; ISS:UniProtKB		0:PIK3R1			
GO:0055078	P:sodium ion homeostasis; IMP:BHF-UCL		0:CYP11B2			
GO:0030150	P:protein import into mitochondrial matrix; NAS:UniProtKB		0:GRPEL2|0:C3orf31|0:GRPEL1			
GO:0006486	P:protein amino acid glycosylation; TAS:UniProtKB		0:B3GALT1|0:B3GNT3|0:B3GNT4|0:ST6GALNAC2|0:UGGT2|0:ST3GAL1|0:B3GALNT2|0:B3GNT7|0:ST6GALNAC3|0:ST3GAL5|0:B3GNT9|0:UGGT1|0:ST6GAL2|0:FUT11|0:B3GALT6|0:ST8SIA5|0:ST3GAL6|0:B3GNT8|0:ST3GAL3|0:ST6GALNAC4|0:FUT3|0:ST6GAL1|0:ST6GALNAC5|0:ST3GAL4|0:ST6GALNAC6|0:COG7|0:COG3|0:ABO|0:ST6GALNAC1|0:ALG3|0:SERP1|0:IL17A|0:B3GALT4|0:B3GALNT1|0:SDF2|0:B3GALT5|0:ALG1|0:B3GALT2|0:ALG5|0:COG2|0:LARGE|0:LRP2|0:TSPAN8|0:PMM2|0:FUT4|0:FUT1|0:FUT5|0:FUT2|0:FUT6|0:B3GNT5|0:FUT9|0:FUT7|0:FUT10			
GO:0006911	P:phagocytosis, engulfment; TAS:ProtInc		0:GULP1|0:ELMO1|0:VAMP7|0:FCGR1A|0:DOCK1			
GO:0007141	P:male meiosis I; TAS:ProtInc		0:SYCP3|0:CCNA1			
GO:0010890	P:positive regulation of sequestering of trig...; ISS:BHF-UCL		0:APOC4|0:LPL|0:FITM1|0:CIDEA|0:FITM2			
GO:0070524	F:11-beta-hydroxysteroid dehydrogenase (NADP+...; IEA:EC		0:HSD11B1			
GO:0001707	P:mesoderm formation; ISS:UniProtKB		0:BMPR2|0:SNAI1|0:SMAD2|0:EOMES			
GO:0045575	P:basophil activation; IDA:UniProtKB		0:PRG3			
GO:0030672	C:synaptic vesicle membrane; ISS:UniProtKB		0:SLC32A1|0:DTNBP1|0:SYN3|0:AMPH|0:SYT11|0:SYT4|0:SV2B|0:SCAMP5|0:SYT7|0:SLC17A7|0:SLC17A8|0:SLC30A3|0:SYT10|0:SVOP|0:STX1A|0:SV2C|0:DOC2A|0:DMXL2|0:SNAPIN|0:SLC17A6|0:SYT5|0:SYNPR|0:ZNRF1|0:SYT1|0:SYT12|0:SV2A|0:SYT6|0:SYT3|0:VAMP2|0:SYT2|0:VAMP1|0:SYT9|0:OTOF|0:ICA1|0:SEMA4C			
GO:0004510	F:tryptophan 5-monooxygenase activity; IEA:EC		0:TPH1|0:TPH2			
GO:0004046	F:aminoacylase activity; TAS:ProtInc		0:DARS|0:ASPA|0:ACY1			
GO:0017046	F:peptide hormone binding; IPI:BHF-UCL		0:ECE1|0:GHR|0:GHRHR|0:PRLR			
GO:0006206	P:pyrimidine base metabolic process; IEA:InterPro		0:TYMP			
GO:0003338	P:metanephros morphogenesis; ISS:UniProtKB		0:WNT7B			
GO:0007569	P:cell aging; TAS:ProtInc		0:MORC3|0:PDCD4|0:TBX3|0:TBX2|0:H2AFX|0:TP53|0:SOD1|0:NPM1|0:NOX4|0:SIRT1|0:LIMS1			
GO:0015578	F:mannose transmembrane transporter activity; IEA:InterPro		0:M6PR			
GO:0048384	P:retinoic acid receptor signaling pathway; IMP:UniProtKB		0:SP100|0:MLL5			
GO:0019747	P:regulation of isoprenoid metabolic process; TAS:UniProtKB		0:NPC2			
GO:0045652	P:regulation of megakaryocyte differentiation; IDA:UniProtKB		0:L3MBTL1			
GO:0003980	F:UDP-glucose:glycoprotein glucosyltransferas...; ISS:UniProtKB		0:UGGT1|0:UGGT2			
GO:0021696	P:cerebellar cortex morphogenesis; ISS:UniProtKB		0:GLI2			
GO:0006906	P:vesicle fusion; TAS:ProtInc		0:CAV2|0:VAMP7|0:EEA1|0:STX6|0:LRMP			
GO:0070181	F:SSU rRNA binding; IDA:UniProtKB		0:CIRBP			
GO:0030837	P:negative regulation of actin filament polym...; IDA:UniProtKB		0:KANK1|0:SLIT2			
GO:0004619	F:phosphoglycerate mutase activity; NAS:UniProtKB		0:BPGM|0:PGAM1|0:PGAM4			
GO:0001580	P:detection of chemical stimulus involved in ...; IDA:HGNC		0:RTP3|0:TAS2R16|0:RTP4|0:TAS2R43|0:TAS2R14			
GO:0050666	P:regulation of homocysteine metabolic process; NAS:UniProtKB		0:BHMT			
GO:0030378	F:serine racemase activity; IDA:UniProtKB		0:SRR			
GO:0015016	F:[heparan sulfate]-glucosamine N-sulfotransf...; IEA:EC		0:NDST4|0:NDST1|0:NDST3|0:NDST2			
GO:0050731	P:positive regulation of peptidyl-tyrosine ph...; ISS:UniProtKB		0:OSM|0:INS|0:VTN|0:CD74|0:MIF|0:CD44|0:AGT|0:VEGFA|0:IL11|0:FGF10|0:VEGFB|0:LACRT|0:FGF7|0:ANGPT4|0:TNK2|0:THBS4|0:TDGF1|0:ANGPT1|0:CD80|0:CD81|0:ITGB3|0:ITGA5|0:IL5			
GO:0002158	P:osteoclast proliferation; ISS:UniProtKB		0:NPR3			
GO:0042262	P:DNA protection; NAS:UniProtKB		0:NUDT1|0:GLRX2			
GO:0006338	P:chromatin remodeling; TAS:UniProtKB		0:HDAC1|0:HDAC2|0:SMARCA4|0:HDAC4|0:BPTF|0:RBBP4|0:RSF1|0:SMARCC2|0:SUV39H2|0:CHD1L|0:INO80|0:SMARCC1|0:NPM2|0:BNIP3|0:SMARCB1|0:FOXA1|0:BAZ2A|0:SUPT6H|0:SUPT5H|0:HILS1|0:FOXP3|0:CHD6|0:KAT2B|0:CHRAC1|0:CBX3|0:SMARCA2|0:BAZ1A|0:RB1|0:KAT2A|0:TAF6L|0:HDAC5|0:SUPT4H1|0:ACTL6A|0:PBRM1			
GO:0032515	P:negative regulation of phosphoprotein phosp...; IDA:HGNC		0:PPP2R4			
GO:0004142	F:diacylglycerol cholinephosphotransferase ac...; TAS:ProtInc		0:CHPT1|0:CEPT1|0:CDS1			
GO:0070314	P:G1 to G0 transition; IMP:BHF-UCL		0:CYP27B1			
GO:0009628	P:response to abiotic stimulus; TAS:ProtInc		0:SNN			
GO:0050760	P:negative regulation of thymidylate synthase...; ISS:UniProtKB		0:APBB1			
GO:0042167	P:heme catabolic process; TAS:UniProtKB		0:HMOX1|0:BLVRB|0:AMBP|0:BLVRA			
GO:0031224	C:intrinsic to membrane; IEA:InterPro		0:APOL1|0:GNAS|0:TGM1|0:MYD88|0:TIRAP|0:TICAM2|0:SARM1			
GO:0006013	P:mannose metabolic process; IEA:InterPro		0:MAN2B2|0:MAN2C1|0:SPATA20|0:MAN2A2|0:RENBP|0:MAN2A1			
GO:0015266	F:protein channel activity; TAS:UniProtKB		0:MCL1			
GO:0070986	P:left/right axis specification; ISS:UniProtKB		0:SETDB2			
GO:0032089	F:NACHT domain binding; IPI:UniProtKB		0:CARD8|0:TRIM16			
GO:0000334	F:3-hydroxyanthranilate 3,4-dioxygenase activity; IDA:UniProtKB		0:HAAO			
GO:0042135	P:neurotransmitter catabolic process; NAS:UniProtKB		0:MAOA|0:COMT|0:PRIMA1|0:ALDH5A1|0:ABAT			
GO:0005095	F:GTPase inhibitor activity; TAS:ProtInc		0:SLIT2|0:RTKN|0:RHOH|0:IQGAP1|0:ARL2|0:CDC42SE1|0:TNK2|0:IQGAP2|0:GPS1|0:IPO5|0:GPS2			
GO:0031696	F:alpha-2C adrenergic receptor binding; IPI:BHF-UCL		0:ADRA2A|0:APLP1			
GO:0008207	P:C21-steroid hormone metabolic process; NAS:UniProtKB		0:AKR1D1|0:DHRS2			
GO:0051374	F:FATZ 1 binding; IDA:UniProtKB		0:ACTN2			
GO:0034045	C:pre-autophagosomal structure membrane; ISS:UniProtKB		0:ATG14|0:WIPI1|0:ATG16L1|0:ATG12|0:ATG5			
GO:0005641	C:nuclear envelope lumen; IDA:UniProtKB		0:ALOX5			
GO:0006309	P:DNA fragmentation involved in apoptotic nuc...; TAS:ProtInc		0:DFFB|0:DFFA|0:PPT1|0:TPD52L1|0:BNIP3|0:CDKN2A|0:BAX|0:FOXL2|0:CYCS|0:CIDEA|0:SOD1|0:BIRC7|0:CECR2|0:AIFM1			
GO:0006573	P:valine metabolic process; NAS:UniProtKB		0:GHR|0:STAT5A|0:STAT5B|0:HIBADH			
GO:0015321	F:sodium-dependent phosphate transmembrane tr...; TAS:ProtInc		0:SLC17A1|0:SLC34A2|0:SLC34A3|0:SLC34A1|0:SLC17A7			
GO:0051635	F:bacterial cell surface binding; TAS:UniProtKB		0:SPN|0:STAB1|0:ELANE|0:MBL2|0:SELPLG|0:PGLYRP1|0:SFTPD|0:SPACA3			
GO:0031529	P:ruffle organization; TAS:UniProtKB		0:PLEK|0:PLEKHA1|0:ARF6|0:LIMA1|0:TPM1|0:CYFIP1|0:RAC1|0:ARFIP2			
GO:0035226	F:glutamate-cysteine ligase catalytic subunit...; IPI:UniProtKB		0:GCLM			
GO:0032924	P:activin receptor signaling pathway; IEA:InterPro		0:GDF6|0:GDF7|0:GDF2|0:BMP10|0:INHBB|0:ACVR2B|0:ACVR2A			
GO:0005350	F:pyrimidine transmembrane transporter activity; IDA:UniProtKB		0:AQP9			
GO:0050656	F:3'-phosphoadenosine 5'-phosphosulfate binding; NAS:UniProtKB		0:ENPP1|0:CHST15|0:GAL3ST3|0:HS3ST5|0:CHST12|0:GAL3ST4			
GO:0004705	F:JUN kinase activity; ISS:UniProtKB		0:MAPK8|0:MAPK9|0:MAPK10			
GO:0004366	F:glycerol-3-phosphate O-acyltransferase acti...; ISS:UniProtKB		0:AGPAT6|0:AGPAT9|0:GPAM|0:GPAT2			
GO:0072179	P:nephric duct formation; IDA:UniProtKB		0:BMP4			
GO:0034199	P:activation of protein kinase A activity; EXP:Reactome		0:ADCY2|0:PRKAR2A|0:ADCY9|0:PRKACA|0:PRKACG|0:ADCY6|0:ADCY3|0:ADCY10|0:PRKAR2B|0:ADCY7|0:PRKAR1A|0:ADCY4|0:PRKAR1B|0:ADCY1|0:ADCY8|0:PRKACB|0:ADCY5			
GO:0007010	P:cytoskeleton organization; TAS:UniProtKB		0:SVIL|0:ABLIM1|0:CAP2|0:SGCB|0:VILL|0:AVIL|0:SGCG|0:ABLIM2|0:SGCZ|0:VIL1|0:SGCD|0:ABLIM3|0:TNIK|0:PCLO|0:THY1|0:MAST1|0:PALLD|0:KRT4|0:PLCE1|0:KRT8|0:KRT6C|0:ANK1|0:SIPA1|0:KRT76|0:MICAL1|0:CECR2|0:KRT86|0:KRT7|0:LAMA5|0:SEMA6A|0:NCKIPSD|0:PAK1|0:KLHL20|0:ARHGAP4|0:CCL3|0:DES|0:PYY|0:PLD2|0:KISS1|0:APOE|0:ARAP3			
GO:0071558	F:histone demethylase activity (H3-K27 specific); IDA:UniProtKB		0:PHF8|0:JHDM1D			
GO:0051209	P:release of sequestered calcium ion into cyt...; ISS:UniProtKB		0:IBTK|0:HTR2B|0:HTR2A|0:HTR2C|0:RYR1|0:DRD2|0:PTPRC|0:LCK			
GO:0051205	P:protein insertion into membrane; TAS:UniProtKB		0:RTP1|0:REEP1|0:RTP2|0:OXA1L|0:GRIN3B|0:EGFR			
GO:0045449	P:regulation of transcription; NAS:UniProtKB		0:NARFL|0:ACVR2B|0:ASCC1|0:OR7D2|0:TGFBRAP1|0:ATP1B4|0:IGSF1|0:IFNK|0:TIGD4|0:SFMBT1|0:TERF1|0:JRKL|0:TIGD6|0:TLE6|0:TIGD1|0:TERF2|0:CENPB|0:TIGD7|0:TIGD5|0:POGZ|0:CCDC79|0:TIGD2|0:JRK|0:GTF2H2B|0:TIGD3|0:SFMBT2|0:CENPBD1|0:ZBTB12|0:MIER1|0:CHD9|0:ARID3C|0:PHF20|0:SNAPC1|0:ZNF687|0:HABP4|0:ZCCHC12|0:SAFB2|0:RUVBL2|0:ZNF775|0:RB1CC1|0:TCEAL2|0:PRMT5|0:ZNF16|0:EPC2|0:ZNF541|0:RBBP7|0:ZNF121|0:KLHL31|0:HDAC11|0:TOX2|0:MAFIP|0:ZNF532|0:BRMS1L|0:ZNF594|0:NONO|0:GTF2H2C|0:KDM2B|0:ZNF703|0:ZBTB46|0:ZNF280D|0:SAFB|0:ERBB4|0:KDM4D|0:IRF2BP2|0:ZNF434|0:SFPQ|0:ZNF581|0:VIPAR|0:WTIP|0:MAMSTR|0:ZNF502|0:EYA1|0:ZNF516|0:PHF19|0:ZNF497|0:CDCA7|0:RBL2|0:ZNF787|0:RQCD1|0:ZBTB6|0:ZNF619|0:CCNL1|0:ZBTB1|0:ZNF876P|0:CASZ1|0:FEZF2|0:KLF14|0:SAP30BP|0:MEAF6|0:ZNF575|0:CHAF1B|0:HDGF|0:ZNF579|0:ERN1|0:PHTF2|0:ARHGAP22|0:ZNF600|0:ZNF678|0:ATF7IP2|0:PCGF3|0:SUV39H2|0:CBX6|0:ZNF107|0:TCEAL6|0:ZNF362|0:ZBTB4|0:ATXN3L|0:BBX|0:IRAK1BP1|0:INSM1|0:ZNF493|0:ZNF271|0:C10orf137|0:CCNT1|0:DYNLL1|0:MSL3L2|0:ZFP2|0:DNTTIP2|0:TAF3|0:CTNND1|0:ASXL1|0:MORF4L1|0:ZNF658B|0:ZNF837|0:IKZF5|0:ACAD8|0:ASCC3|0:PIAS3|0:ZNF665|0:ZNF407|0:PARP14|0:MCM3|0:RDBP|0:ZNF252|0:CCNC|0:MAZ|0:C11orf30|0:PARP1|0:ZNF618|0:ZBTB42|0:ZNF276|0:ZNF526|0:BANP|0:CRTC3|0:ZNF525|0:EYA4|0:ZNF654|0:ZNF30|0:ZNF770|0:ZNF385A|0:ZBTB49|0:ZNF683|0:HIPK1|0:DPY30|0:BTG2|0:ZNF623|0:CCAR1|0:SPZ1|0:CNOT1|0:ZBTB11|0:ACTR5|0:TRAF7|0:GTF2H5|0:ZNF710|0:GPBP1|0:TXLNG|0:SP110|0:TGS1|0:MCM4|0:ZNF660|0:TCEAL3|0:NRBF2|0:BNC2|0:ZNF697|0:ZNF503|0:PRDM14|0:ZFP3|0:CRY2|0:SP6|0:SCYL1|0:ZBTB22|0:ZNF648|0:ZNF574|0:ZNF692|0:ZBTB2|0:ZNF721|0:CCNL2|0:TSPYL2|0:ZBTB45|0:ZNF578|0:ATXN3|0:LRPPRC|0:ZNF818P|0:ZBTB39|0:ZNF335|0:SUV420H2|0:ITGB3BP|0:DMRTC1|0:ZNF580|0:EZH1|0:CDK9|0:BCORL1|0:CIC|0:KDM4C|0:KHSRP|0:ARID3B|0:ZFP64|0:ZNF295|0:LMO3|0:CDKN2A|0:ZNF341|0:SCML4|0:MAMLD1|0:ZNF788|0:PUF60|0:ZNF702P|0:ZNF280C|0:CNOT6|0:SSRP1|0:ASXL2|0:MED25|0:CCNK|0:ZNF740|0:ZNF664|0:PRR13|0:RCOR1|0:ZNF322A|0:TCEAL7|0:MCM7|0:ZNF408|0:DPF1|0:ZNF507|0:PPRC1|0:EIF2C2|0:ZNF438|0:KDM1B|0:RBM39|0:LPIN1|0:SNAPC3|0:BRWD1|0:RRN3|0:RCBTB1|0:WASL|0:ZNF826P|0:CNOT4|0:ZNF749|0:ASF1B|0:ZNF771|0:ZNF410|0:MORF4L2|0:SOX3|0:BZW1|0:RBBP4|0:ASCC2|0:ZBTB26|0:ZNF644|0:ZNF653|0:ZNF521|0:KDM3B|0:ZNF329|0:PHF17|0:KLF8|0:JMJD6|0:CCDC101|0:ESF1|0:HIF1AN|0:GTF2H2D|0:SP5|0:TADA2B|0:CDK8|0:SETDB1|0:KDM4B|0:SUV420H1|0:GRHL1|0:ZNF511|0:SCRT2|0:TAF1D|0:MCM5|0:ZBTB41|0:PADI4|0:ERBB2|0:GTF2IRD2B|0:PRDM10|0:MBTD1|0:ZBTB10|0:ZMYM2|0:TLE4|0:PSPC1|0:NCOA7|0:LBH|0:FLII|0:AFF3|0:SLTM|0:THAP11|0:MIER3|0:PPP1R8|0:ZNF318|0:CC2D1A|0:ZNF518A|0:ZNF296|0:KHDRBS2|0:ZNF260|0:MOV10|0:ZNF512|0:ZNF491|0:GTF2IRD2|0:ZNF280B|0:MED9|0:WDR5|0:ZBTB44|0:RSC1A1|0:ARID4B|0:ZNF326|0:PAF1|0:IFT57|0:ZNF592|0:HIP1|0:PCGF1|0:ZNF200|0:FRY|0:ZNF48|0:RTF1|0:ZNF467|0:DPF2|0:ZNF322B|0:FRYL|0:ZNF672|0:ZNF827|0:NFKBIZ|0:DMRTC1B|0:ATXN7|0:ZNF781|0:EAF1|0:PSIP1|0:HIPK3|0:ZNF663|0:NCOA5|0:ZNF835|0:MACC1|0:ZNF415|0:SETD1B|0:FIZ1|0:C17orf81|0:ZNF32|0:SP8|0:RBM15B|0:MCM8|0:EYA2|0:ZNF652|0:CDYL|0:CCDC59|0:MED29|0:KDM5C|0:RCOR3|0:ZNF441|0:MNDA|0:PBRM1|0:ZFPM1|0:CBX8|0:TCEAL4|0:ZNF696|0:WHSC2|0:EIF2C1|0:MCTS1|0:ASXL3|0:ACTL6B|0:PNRC2|0:HNRPDL|0:PCGF5|0:ZBTB33|0:ZNF451|0:YLPM1|0:IL16|0:RBBP5|0:L3MBTL3|0:ZZZ3|0:ZXDB|0:FEZF1|0:ZNF646|0:MLF1IP|0:ING3|0:MED13L|0:WHSC1|0:WHSC1L1|0:ZNF239|0:XRN2|0:KDM2A|0:VPS25|0:ZNF655|0:ZBTB20|0:PRDM12|0:GPBP1L1|0:ZNF414|0:BDP1|0:ZNF524|0:ANP32A|0:ZBTB47|0:ZNF681|0:ZNF536|0:MIER2|0:TFB1M|0:EID2B|0:MCM2|0:ZBTB8B|0:C14orf43|0:ZNF668|0:BMI1|0:ZNF821|0:ZNF391|0:PHF11|0:ZBTB40|0:C14orf156|0:ZNF513|0:ZNF774|0:MED8|0:TCEAL8|0:VPS36|0:ZNF625|0:ZNF366|0:CGGBP1|0:INSM2|0:CCNT2|0:KDM4DL|0:ZBTB37|0:PRDM8|0:IRF2BP1|0:MYCBP2|0:ZNF841|0:ZNF784|0:ELOF1|0:ZNF319|0:EFCAB6|0:SRFBP1|0:TCEB2|0:CHD5|0:ZNF800|0:MCM6|0:VOPP1|0:ZBTB5|0:FAM120B|0:PNN|0:ZNF572|0:ZNF576|0:AKNA|0:TLE2|0:ZFP41|0:CHAF1A|0:ZNF518B|0:CEBPZ|0:PRDM13|0:ZBTB24|0:TRIP6|0:ZFP62|0:PARP15|0:LEO1|0:EYA3|0:ZNF501|0:CBX7|0:RFC1|0:C20orf20|0:SETD1A|0:ZNF512B|0:ZNF768|0:ZNF469|0:ZBTB3|0:ZNF280A|0:VGLL4|0:ZFAT|0:CTNND2|0:SETD2|0:ZBTB34|0:ACTL6A|0:LIN54|0:PTOV1|0:C17orf79|0:SFSWAP|0:CRY1|0:ZBTB43|0:CDCA7L|0:CRTC2|0:C1orf77|0:HNRNPUL1|0:MTERFD3|0:PNRC1|0:ZNF292|0:ZBTB8A|0:ZNF629|0:DACH2|0:SAP30L|0:DPF3|0:ZFP91|0:ATAD2|0:PHF6|0:ZBTB9|0:MBD3L1|0:KHDRBS3|0:TCEAL5|0:EID3|0:MED28|0:EWSR1|0:BCL11A|0:PHF10|0:SALL3|0:YY2|0:PRMT7|0:ZNF358|0:EAF2|0:ENG|0:PPIE|0:ABCG1|0:APBB2|0:NLK|0:CHD7|0:FADS1|0:PPP2R1A|0:RHOH|0:PPP2CA|0:ZNF22|0:GLRX2|0:SRSF10|0:POFUT1|0:ZFPL1			
GO:0003678	F:DNA helicase activity; TAS:UniProtKB		0:INO80|0:RUVBL1|0:CHD8|0:SMARCAL1|0:SUPV3L1|0:RECQL5|0:ATRX|0:RAD54B|0:SETX			
GO:0008198	F:ferrous iron binding; TAS:ProtInc		0:FXN|0:SNCA|0:HAAO|0:FTO|0:ALKBH3|0:ALKBH1|0:ALKBH2|0:ACP5|0:EGLN2|0:FECH			
GO:0016429	F:tRNA (adenine-N1-)-methyltransferase activity; IEA:EC		0:TRMT61B|0:TRMT61A			
GO:0017076	F:purine nucleotide binding; NAS:UniProtKB		0:FAM114A2|0:C15orf24			
GO:0051525	F:NFAT protein binding; IPI:UniProtKB		0:FOXP3			
GO:0006543	P:glutamine catabolic process; NAS:UniProtKB		0:GLS			
GO:0042787	P:protein ubiquitination involved in ubiquiti...; TAS:UniProtKB		0:MDM2|0:CBLC|0:DDB1|0:PARK2|0:RNF11|0:ARIH2|0:RNF144B|0:FBXO45|0:SMURF1|0:RCHY1|0:NEDD4|0:OS9|0:TRIM32|0:SIAH1|0:RNF217|0:UBE4B			
GO:0030549	F:acetylcholine receptor activator activity; ISS:UniProtKB		0:CDK5			
GO:0005115	F:receptor tyrosine kinase-like orphan recept...; IPI:UniProtKB		0:WNT5A			
GO:0006425	P:glutaminyl-tRNA aminoacylation; IEA:InterPro		0:QARS			
GO:0070576	F:vitamin D 24-hydroxylase activity; IDA:BHF-UCL		0:CYP1A1|0:CYP3A4			
GO:0005519	F:cytoskeletal regulatory protein binding; TAS:ProtInc		0:CDC42EP3			
GO:0004316	F:3-oxoacyl-[acyl-carrier-protein] reductase ...; EXP:Reactome		0:FASN			
GO:0030007	P:cellular potassium ion homeostasis; IDA:UniProtKB		0:KCNMA1			
GO:0008250	C:oligosaccharyltransferase complex; TAS:HGNC		0:STT3B|0:MAGT1|0:OSTC|0:TUSC3|0:STT3A|0:RPN2|0:RPN1|0:DDOST|0:DAD1			
GO:0070886	P:positive regulation of calcineurin-NFAT sig...; IMP:UniProtKB		0:LMCD1			
GO:0030165	F:PDZ domain binding; NAS:UniProtKB		0:ATP2B2|0:CLCN3|0:CFTR|0:SDC2|0:PARK2|0:SLC22A5|0:FZD3|0:FZD8|0:FZD7|0:ADAM17|0:SLC22A4|0:CXXC4|0:DOCK4|0:USHBP1|0:SLC9A3R1|0:PLEKHA1|0:PDZK1|0:SLC22A12|0:PSEN1|0:SSTR2|0:TBC1D10A|0:SNTG2|0:SRR|0:PTEN|0:TGFBR3|0:NOS1AP|0:CCDC88C|0:CADM1|0:GRM7			
GO:0007017	P:microtubule-based process; NAS:UniProtKB		0:DYNLL1|0:DYNLL2|0:TUBG2|0:MAP3K11|0:KIFAP3|0:GTSE1|0:EML4|0:TRIM54			
GO:0033044	P:regulation of chromosome organization; IMP:UniProtKB		0:CENPV			
GO:0032623	P:interleukin-2 production; ISS:BHF-UCL		0:SLC11A1			
GO:0009346	C:citrate lyase complex; TAS:ProtInc		0:CLYBL|0:ACLY			
GO:0042255	P:ribosome assembly; TAS:UniProtKB		0:NIP7|0:EIF2A|0:TSR1|0:BMS1|0:VCX|0:NPM1			
GO:0055085	P:transmembrane transport; IEA:UniProtKB-KW		0:SLC25A46|0:SVOPL|0:SLC25A24|0:SLC5A10|0:SLC25A31|0:SLC25A23|0:SLC22A20|0:SV2B|0:MTCH1|0:SLC22A9|0:SLC25A43|0:SLC25A34|0:SLC25A40|0:SLC37A2|0:SLC25A27|0:SLC22A24|0:AQP10|0:C19orf28|0:MFSD8|0:SLC37A1|0:SLC23A3|0:SLC25A30|0:C6orf192|0:SLC35B3|0:MFSD1|0:SPNS3|0:SV2C|0:SLC16A10|0:SLC17A9|0:HIATL2|0:SLC25A17|0:SLC25A36|0:SLC25A41|0:SLC25A47|0:SLC22A17|0:SLC22A25|0:MCART1|0:SLC25A39|0:SLC46A3|0:FLVCR2|0:SLC25A44|0:MFSD2A|0:SPNS2|0:SLC25A28|0:SLC25A42|0:GPR155|0:MFSD7|0:MTCH2|0:SLC25A25|0:SLC25A33|0:SLC45A4|0:SLC25A14|0:SPNS1|0:UCP2|0:MCART2|0:SV2A|0:SLC25A45|0:MFSD3|0:SLC37A3|0:MFSD6|0:SLC43A3|0:SLC45A2|0:SLC25A38|0:SLC25A35|0:MCART6|0:SLC22A23|0:SLC22A15|0:FLVCR1|0:MRPS17|0:MFSD4|0:SLC45A3|0:SLC22A10|0:SERP1|0:NUP85|0:TPR|0:XPO7|0:NUP93|0:PEX14|0:TNKS|0:NUP50|0:NUP160|0:SIL1|0:NPIP|0:GLE1|0:NUPL2|0:NUP107|0:POM121B|0:NUP205|0:NUP214|0:NUP153|0:RRBP1|0:RANBP17|0:DNAJC19|0:TIMM22|0:TRAM2|0:POM121C|0:DDX19B|0:MYO1C|0:NUP210|0:TMEM48|0:TRAM1|0:NUP37|0:SEC62|0:NUP98|0:NUP188|0:TIMM8B|0:NUP54|0:NUP43|0:ABRA|0:EIF5A|0:NUP133|0:AHCTF1|0:TIMM50|0:TRAM1L1|0:EIF5A2|0:DDX19A|0:TIMM10|0:POM121|0:NUP62|0:CHCHD4|0:FXC1|0:NUP155|0:NUP88|0:TIMM8A|0:SEC61B|0:ZMAT3|0:SENP2|0:RANBP2|0:C18orf55|0:SEH1L|0:EIF5AL1|0:MVP|0:TIMM9|0:TIMM13|0:NUP35|0:SERP2|0:NUPL1			
GO:0048257	F:3'-flap endonuclease activity; IMP:UniProtKB		0:MUS81			
GO:0005432	F:calcium:sodium antiporter activity; TAS:UniProtKB		0:SLC8A2|0:SLC8A3|0:SLC3A2			
GO:0008794	F:arsenate reductase (glutaredoxin) activity; TAS:UniProtKB		0:GLRX2			
GO:0014705	C:C zone; NAS:BHF-UCL		0:MYBPC3			
GO:0005261	F:cation channel activity; TAS:ProtInc		0:MCOLN1|0:GAR1			
GO:0046887	P:positive regulation of hormone secretion; IDA:BHF-UCL		0:EDN3|0:EDN1			
GO:0045091	P:regulation of retroviral genome replication; IDA:UniProtKB		0:IL8			
GO:0009950	P:dorsal/ventral axis specification; ISS:UniProtKB		0:SFRP1|0:MDFI			
GO:0047536	F:2-aminoadipate transaminase activity; IDA:UniProtKB		0:AADAT			
GO:0004853	F:uroporphyrinogen decarboxylase activity; IDA:UniProtKB		0:UROD			
GO:0045080	P:positive regulation of chemokine biosynthet...; TAS:BHF-UCL		0:TNF|0:WNT5A|0:HMOX1			
GO:0008295	P:spermidine biosynthetic process; NAS:UniProtKB		0:SRM|0:AGMAT|0:AMD1			
GO:0010512	P:negative regulation of phosphatidylinositol...; IDA:BHF-UCL		0:PDGFA|0:PDGFB			
GO:0051045	P:negative regulation of membrane protein ect...; IMP:BHF-UCL		0:IL10|0:TIMP1|0:PTPN3|0:TIMP3			
GO:0048286	P:lung alveolus development; ISS:UniProtKB		0:BMP4|0:SFTPD|0:TGFB3|0:BMPR2|0:ERRFI1|0:ATP7A|0:PKDCC			
GO:0046849	P:bone remodeling; IEA:InterPro		0:SPP2			
GO:0033600	P:negative regulation of mammary gland epithe...; IMP:BHF-UCL		0:BRCA2|0:ROBO1			
GO:0051444	P:negative regulation of ubiquitin-protein li...; ISS:BHF-UCL		0:SMAD7|0:LIMK1|0:CDKN2A|0:BAG5			
GO:0045079	P:negative regulation of chemokine biosynthet...; ISS:UniProtKB		0:ELANE|0:SIGIRR|0:IL6			
GO:0030147	P:natriuresis; TAS:UniProtKB		0:DRD2|0:NPR1|0:KNG1|0:NPPB			
GO:0035095	P:behavioral response to nicotine; IMP:UniProtKB		0:CHRNA5|0:CHRNA3|0:CHRNB1|0:CHRNB2|0:CHRNA4			
GO:0034452	F:dynactin binding; ISS:UniProtKB		0:BBS4|0:PAFAH1B1|0:CCDC64			
GO:0051233	C:spindle midzone; NAS:UniProtKB		0:CENPV|0:ARL8A|0:ARL8B|0:BUB1B			
GO:0045159	F:myosin II binding; NAS:UniProtKB		0:TRIOBP			
GO:0016597	F:amino acid binding; IEA:InterPro		0:TPH2|0:TPH1			
GO:0006784	P:heme a biosynthetic process; IMP:HGNC		0:COX15|0:COX10			
GO:0019319	P:hexose biosynthetic process; IDA:UniProtKB		0:CHST15			
GO:0043030	P:regulation of macrophage activation; NAS:UniProtKB		0:PLA2G10|0:CD74|0:MIF			
GO:0031380	C:nuclear RNA-directed RNA polymerase complex; IC:UniProtKB		0:PAPD4			
GO:0005071	F:transmembrane receptor protein serine/threo...; TAS:UniProtKB		0:AMHR2			
GO:0000480	P:endonucleolytic cleavage in 5'-ETS of trici...; ISS:UniProtKB		0:UTP20|0:NOP14			
GO:0034551	P:mitochondrial respiratory chain complex III...; IMP:UniProtKB		0:BCS1L			
GO:0045617	P:negative regulation of keratinocyte differe...; IMP:BHF-UCL		0:HOXA7|0:OVOL2			
GO:0008812	F:choline dehydrogenase activity; IEA:EC		0:CHDH			
GO:0016706	F:oxidoreductase activity, acting on paired d...; IEA:InterPro		0:EGLN2|0:TET2|0:TET3|0:OGFOD1			
GO:0051585	P:negative regulation of dopamine uptake; IDA:UniProtKB		0:SNCA			
GO:0004702	F:receptor signaling protein serine/threonine...; NAS:UniProtKB		0:TGFB2|0:STK39			
GO:0043197	C:dendritic spine; TAS:UniProtKB		0:APP|0:FRMPD4|0:IGF2BP1|0:OPHN1|0:CRIPT|0:ARC|0:SEPT11|0:NOS1|0:ANKS1B|0:LZTS1|0:ARHGAP32|0:PPP1R9B|0:GIPC1|0:DTNBP1|0:SIPA1L1|0:CDK5R1|0:DNM3|0:STRN|0:KCND2|0:ACTN2|0:SYNPO			
GO:0030121	C:AP-1 adaptor complex; TAS:UniProtKB		0:AFTPH|0:SYNRG|0:AP1S1|0:AP1G2			
GO:0002906	P:negative regulation of mature B cell apoptosis; IDA:UniProtKB		0:BCL10			
GO:0017137	F:Rab GTPase binding; TAS:UniProtKB		0:DMXL2|0:SGSM3|0:GOLGA5|0:ALS2|0:SYTL5|0:SYTL2|0:SYTL1|0:RPH3A|0:RPH3AL|0:SYTL4|0:RIMS2|0:SYTL3|0:RIMS1|0:EXPH5|0:SLC6A4|0:RAB3GAP1|0:RHOBTB3|0:RAB11FIP4|0:RAB11FIP3|0:CCDC64|0:RILP			
GO:0051649	P:establishment of localization in cell; IDA:HGNC		0:ZWINT			
GO:0050671	P:positive regulation of lymphocyte prolifera...; IDA:UniProtKB		0:FGF10			
GO:0050698	F:proteoglycan sulfotransferase activity; NAS:UniProtKB		0:GAL3ST3|0:GAL3ST4			
GO:0003785	F:actin monomer binding; ISS:UniProtKB		0:MYL3|0:MYL4|0:MYL2|0:LIMA1|0:MTSS1|0:NOS3|0:MKL1			
GO:0007624	P:ultradian rhythm; IDA:UniProtKB		0:ENOX2			
GO:0051001	P:negative regulation of nitric-oxide synthas...; ISS:UniProtKB		0:NOSIP|0:ENG|0:GLA			
GO:0071300	P:cellular response to retinoic acid; ISS:UniProtKB		0:RARA|0:AQP1|0:WNT7B|0:WNT10B|0:WNT8B|0:WNT3|0:WNT11|0:WNT6|0:WNT5B|0:WNT3A|0:WNT9A|0:FZD10|0:WNT2|0:FZD4|0:FZD7|0:WNT9B|0:WNT5A			
GO:0016412	F:serine O-acyltransferase activity; IDA:UniProtKB		0:MBOAT4			
GO:0042823	P:pyridoxal phosphate biosynthetic process; IDA:UniProtKB		0:PDXK			
GO:0004151	F:dihydroorotase activity; ISS:BHF-UCL		0:CAD			
GO:0045429	P:positive regulation of nitric oxide biosynt...; TAS:BHF-UCL		0:AGTR2|0:TNF|0:IL1B|0:IFNG|0:EGFR|0:AKT1|0:INSR|0:PTGS2|0:HSP90AA1|0:HSP90AB1|0:P2RX4|0:HBB|0:INS|0:EDN1			
GO:0007167	P:enzyme linked receptor protein signaling pa...; TAS:ProtInc		0:GP6			
GO:0000299	C:integral to membrane of membrane fraction; TAS:UniProtKB		0:TOMM22|0:TOMM40|0:SAMM50|0:CD70|0:SDR16C5|0:CERK|0:AMFR|0:DAG1|0:CORO7|0:MLC1			
GO:0005484	F:SNAP receptor activity; TAS:ProtInc		0:STX16|0:VTI1A|0:BET1L|0:STX5|0:GOSR1|0:YKT6|0:STX6|0:STX19|0:STX7|0:STX1A|0:STX2|0:STX12|0:STX1B|0:STX3|0:STX4|0:STX17|0:STX18|0:STX10|0:SNAP29|0:STX11			
GO:0005212	F:structural constituent of eye lens; NAS:UniProtKB		0:HSPB6|0:CRYBA2|0:CRYBB3|0:BFSP1|0:CRYBA1|0:CRYAB|0:BFSP2|0:CRYAA|0:CRYGS|0:CRYBB1|0:CRYBB2|0:CRYBA4|0:MIP|0:CRYGC|0:LIM2|0:CRYGD|0:CRYGB|0:CRYGA			
GO:0019834	F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW		0:SCGB1A1|0:ANXA3|0:ANXA1			
GO:0034653	P:retinoic acid catabolic process; IDA:BHF-UCL		0:CYP26C1|0:CYP26A1|0:CYP26B1			
GO:0005770	C:late endosome; ISS:UniProtKB		0:SLC30A4|0:SLC30A3|0:SLC30A2|0:PCSK9|0:LAMP2|0:RAB7A|0:RAB9A|0:TF|0:ATP7B|0:KIAA0368|0:VIPAR|0:PARM1|0:UVRAG|0:SLC11A2|0:CTNS|0:KIAA0226|0:ATP7A|0:RAB27A|0:BST2|0:SQSTM1|0:TMEM192|0:UNC13D|0:VPS36|0:CD1E|0:AP1AR|0:SDF4|0:SLC11A1|0:RAB14|0:CLN3|0:NBR1			
GO:0070560	P:protein secretion by platelet; ISS:BHF-UCL		0:PLEK			
GO:0021510	P:spinal cord development; ISS:HGNC		0:NF1			
GO:0004508	F:steroid 17-alpha-monooxygenase activity; EXP:Reactome		0:CYP17A1			
GO:0008470	F:isovaleryl-CoA dehydrogenase activity; ISS:BHF-UCL		0:IVD			
GO:0005092	F:GDP-dissociation inhibitor activity; TAS:ProtInc		0:RANBP1			
GO:0006120	P:mitochondrial electron transport, NADH to u...; NAS:UniProtKB		0:NDUFV2|0:NDUFS4|0:NDUFAF1|0:NDUFB3|0:NDUFV3|0:MT-ND3|0:NDUFA3|0:NDUFA7|0:MT-ND4|0:NDUFB6|0:NDUFS6|0:NDUFB7|0:NDUFS3|0:NDUFB4|0:MT-ND4L|0:NDUFA2|0:MT-ND5|0:NDUFA6|0:NDUFB8|0:MT-ND6|0:NDUFA5|0:NDUFS2|0:NDUFB5|0:MT-ND1|0:NDUFA9|0:NDUFS1|0:MT-ND2|0:NDUFV1|0:NDUFA1|0:NDUFB1|0:NDUFS8|0:NDUFC2|0:NDUFS5|0:NDUFA10|0:NDUFB2|0:NDUFA4|0:NDUFB10|0:NDUFB9|0:NDUFAB1|0:NDUFA8|0:NDUFC1|0:NDUFS7			
GO:0004119	F:cGMP-inhibited cyclic-nucleotide phosphodie...; TAS:ProtInc		0:PDE3A|0:PDE3B			
GO:0008237	F:metallopeptidase activity; TAS:UniProtKB		0:ERAP2|0:ACE|0:C9orf3|0:PAPPA2|0:PAPPA|0:ADAMTSL1|0:ACY1|0:ADAMTSL3|0:TAF2|0:TMEM27|0:STAMBPL1|0:ERMP1|0:AMZ1|0:NAALAD2|0:AMZ2|0:XPNPEP3|0:CNDP1|0:FOLH1|0:DPP3|0:NAALADL1|0:TRHDE|0:ACE2|0:C21orf57|0:DNPEP|0:STAMBP|0:XRCC6BP1|0:RNPEPL1|0:FOLH1B|0:CNDP2|0:LTA4H|0:NPEPPS|0:COPS5|0:BRCC3|0:MYSM1|0:ANPEP|0:CHMP1A|0:LNPEP|0:PSMD14			
GO:0017123	F:Ral GTPase activator activity; ISS:UniProtKB		0:RALGAPA2|0:RALGAPB|0:RALGAPA1			
GO:0003977	F:UDP-N-acetylglucosamine diphosphorylase act...; TAS:ProtInc		0:UAP1			
GO:0004304	F:estrone sulfotransferase activity; TAS:ProtInc		0:SULT1E1			
GO:0045713	P:low-density lipoprotein receptor biosynthet...; IDA:BHF-UCL		0:PPARG			
GO:0060079	P:regulation of excitatory postsynaptic membr...; ISS:UniProtKB		0:CHRNA3|0:GRIN1			
GO:0004461	F:lactose synthase activity; IEA:InterPro		0:B4GALT1|0:B4GALT2|0:LALBA			
GO:0090037	P:positive regulation of protein kinase C sig...; ISS:BHF-UCL		0:WNT11|0:WNT5A|0:MC1R|0:ADRA1A			
GO:0042391	P:regulation of membrane potential; ISS:UniProtKB		0:KCNJ11|0:ABCB5|0:GRIK3|0:CHRNB1			
GO:0006584	P:catecholamine metabolic process; IEA:UniProtKB-KW		0:MOXD2P|0:MOXD1|0:SULT1A1|0:AOC2|0:SULT1A2|0:SULT1A3|0:SULT1A4			
GO:0021919	P:BMP signaling pathway involved in spinal co...; IMP:BHF-UCL		0:CHRD			
GO:0017153	F:sodium:dicarboxylate symporter activity; IEA:InterPro		0:SLC1A1|0:SLC1A4|0:SLC1A2|0:SLC1A5|0:SLC1A3|0:SLC1A6|0:SLC1A7			
GO:0071223	P:cellular response to lipoteichoic acid; IDA:MGI		0:CD14|0:LBP|0:TLR2			
GO:0001772	C:immunological synapse; TAS:UniProtKB		0:LAT|0:DUSP3|0:GZMA|0:GZMB			
GO:0000221	C:vacuolar proton-transporting V-type ATPase,...; NAS:UniProtKB		0:ATP6V1H			
GO:0051258	P:protein polymerization; IEA:InterPro		0:TUBA4A|0:FGA|0:TUBB6|0:TUBA1A|0:MSTO1|0:TUBB4Q|0:TUBB1|0:TUBD1|0:TUBA3E|0:FGB|0:TUBG1|0:FGG|0:TUBA3D|0:TUBB3|0:TUBB2B|0:TUBB4|0:TUBE1|0:TUBG2|0:TUBA1C|0:TUBA4B|0:TUBA3C|0:TUBB2A|0:TUBB2C|0:TUBB|0:TUBAL3|0:TUBA8|0:TUBA1B			
GO:0045964	P:positive regulation of dopamine metabolic p...; IMP:UniProtKB		0:HPRT1			
GO:0030612	F:arsenate reductase (thioredoxin) activity; NAS:UniProtKB		0:TMX1			
GO:0034399	C:nuclear periphery; IDA:UniProtKB		0:SP100|0:ATF7|0:HTT			
GO:0006188	P:IMP biosynthetic process; IEA:InterPro		0:ATIC			
GO:0003846	F:2-acylglycerol O-acyltransferase activity; IEA:EC		0:MOGAT1|0:MOGAT3|0:MOGAT2			
GO:0010987	P:negative regulation of high-density lipopro...; IMP:BHF-UCL		0:APOC3			
GO:0050703	P:interleukin-1 alpha secretion; IDA:UniProtKB		0:S100A13			
GO:0004170	F:dUTP diphosphatase activity; TAS:ProtInc		0:DUT			
GO:0071676	P:negative regulation of mononuclear cell mig...; IDA:BHF-UCL		0:SLIT2			
GO:0031503	P:protein complex localization; IMP:UniProtKB		0:BIRC5			
GO:0072268	P:pattern specification involved in metanephr...; ISS:UniProtKB		0:OSR1			
GO:0050321	F:tau-protein kinase activity; ISS:UniProtKB		0:MARK4|0:GSK3A|0:GSK3B|0:CDK5			
GO:0021799	P:cerebral cortex radially oriented cell migr...; ISS:UniProtKB		0:LHX6			
GO:0048408	F:epidermal growth factor binding; TAS:UniProtKB		0:SEC61B|0:NRD1			
GO:0000060	P:protein import into nucleus, translocation; TAS:ProtInc		0:RBM22|0:TNF|0:IFNG|0:OPRD1|0:BCL6|0:AKT1|0:SEC61B|0:BCL3|0:OR1D2|0:SLC11A1|0:CEP57|0:TNPO1|0:KPNB1			
GO:0048340	P:paraxial mesoderm morphogenesis; ISS:UniProtKB		0:SMAD2			
GO:0007172	P:signal complex assembly; TAS:ProtInc		0:PTK2|0:NCK1|0:NCK2|0:PTK2B|0:PXN|0:SRC|0:MAPK8IP2|0:CD3E			
GO:0010803	P:regulation of tumor necrosis factor-mediate...; IDA:UniProtKB		0:SPHK1			
GO:0031071	F:cysteine desulfurase activity; IDA:HGNC		0:NFS1			
GO:0016717	F:oxidoreductase activity, acting on paired d...; IEA:InterPro		0:FADS3			
GO:0017053	C:transcriptional repressor complex; NAS:UniProtKB		0:NCOR2|0:HDAC4|0:ARID4A|0:JAZF1|0:ZBTB16|0:ZNF350|0:PHF12|0:NCOR1|0:CORO2A|0:TBL1X|0:HDAC3|0:TBL1XR1|0:GPS2|0:SMARCE1|0:CBX5|0:CTBP1|0:CTBP2|0:AKIRIN2|0:PRDM16|0:RLIM			
GO:0031663	P:lipopolysaccharide-mediated signaling pathway; IMP:BHF-UCL		0:LBP|0:IRAK1			
GO:0030506	F:ankyrin binding; NAS:UniProtKB		0:RHCG|0:SPTBN4|0:NRCAM|0:SLC4A1|0:RHAG|0:RHBG|0:TNKS1BP1			
GO:0090161	P:Golgi ribbon formation; IMP:UniProtKB		0:GCC2			
GO:0001960	P:negative regulation of cytokine-mediated si...; ISS:UniProtKB		0:IRAK3|0:SIGIRR|0:PTPRC			
GO:0005605	C:basal lamina; TAS:ProtInc		0:AGRN|0:ANG|0:COL4A4|0:AMTN|0:ACHE|0:COLQ			
GO:0005042	F:netrin receptor activity; TAS:ProtInc		0:UNC5C			
GO:0030317	P:sperm motility; TAS:UniProtKB		0:ATP1A4|0:SLC22A16|0:TNP1|0:AKAP4|0:SMCP|0:GAPDHS|0:GAS8|0:SORD|0:ROPN1B			
GO:0070104	P:negative regulation of interleukin-6-mediat...; IDA:BHF-UCL		0:IL6ST			
GO:0005971	C:ribonucleoside-diphosphate reductase complex; NAS:UniProtKB		0:RRM1			
GO:0051775	P:response to redox state; TAS:UniProtKB		0:FKBP1B|0:RYR2|0:ADH5|0:SIRT2|0:RNF7|0:GLRX2			
GO:0050890	P:cognition; IMP:UniProtKB		0:SHROOM4|0:SLC1A4|0:CTNS			
GO:0005884	C:actin filament; TAS:ProtInc		0:RHOQ|0:PALLD|0:EZR|0:ACTA1|0:AMOT|0:ARHGAP6|0:ACTN2|0:IQGAP1|0:ACTN3|0:GAS2			
GO:0035269	P:protein amino acid O-linked mannosylation; TAS:HGNC		0:DPM1|0:DPM2|0:DPM3			
GO:0042770	P:DNA damage response, signal transduction; IDA:UniProtKB		0:WNT1|0:SMC1A			
GO:0003876	F:AMP deaminase activity; TAS:ProtInc		0:AMPD2|0:AMPD1|0:AMPD3			
GO:0000822	F:inositol hexakisphosphate binding; ISS:BHF-UCL		0:ITPR3			
GO:0045820	P:negative regulation of glycolysis; ISS:BHF-UCL		0:HDAC4			
GO:0000956	P:nuclear-transcribed mRNA catabolic process; IDA:UniProtKB		0:EIF2C1			
GO:0051454	P:intracellular pH elevation; IDA:BHF-UCL		0:NOX1			
GO:0005384	F:manganese ion transmembrane transporter act...; ISS:BHF-UCL		0:SLC11A2|0:SLC11A1			
GO:0009841	C:mitochondrial endopeptidase Clp complex; IDA:UniProtKB		0:CLPX			
GO:0016098	P:monoterpenoid metabolic process; IDA:BHF-UCL		0:CYP2C19|0:CYP2E1|0:CYP2D6|0:CYP1A2|0:CYP2C9|0:CYP3A4			
GO:0031175	P:neuron projection development; ISS:UniProtKB		0:GDNF|0:NRTN|0:LAMB1|0:ATXN10|0:NEDD4|0:AGER|0:IL6|0:UHMK1|0:STMN3|0:RASGRF1|0:STX3|0:CCDC64|0:HMGB1|0:NCDN			
GO:0005369	F:taurine:sodium symporter activity; TAS:ProtInc		0:SLC6A6			
GO:0045333	P:cellular respiration; TAS:UniProtKB		0:COX4I2|0:CYCS			
GO:0035372	P:protein localization to microtubule; IDA:UniProtKB		0:MAPRE1			
GO:0005876	C:spindle microtubule; TAS:ProtInc		0:AURKA|0:CDC27|0:POLB|0:CDC16|0:NCOR1|0:SKA3|0:BIRC5|0:CALM2|0:TBL1X|0:CALM3|0:CDK1|0:HDAC3|0:TBL1XR1|0:SKA1|0:PARP4|0:SKA2|0:CALM1|0:KIF4A|0:PRC1|0:NUMA1			
GO:0030515	F:snoRNA binding; ISS:UniProtKB		0:NOP58|0:NOP56|0:NAF1|0:GAR1|0:NHP2|0:NOP14			
GO:0061036	P:positive regulation of cartilage development; IDA:MGI		0:BMP1|0:BMP4|0:BMP2			
GO:0031997	F:N-terminal myristoylation domain binding; IPI:UniProtKB		0:CALM2|0:CALM3|0:CALM1			
GO:0030362	F:protein phosphatase type 4 regulator activity; NAS:UniProtKB		0:PPP4R1			
GO:0045741	P:positive regulation of epidermal growth fac...; TAS:UniProtKB		0:ADRA2A|0:ADAM17|0:TGFA|0:EPGN|0:EREG|0:EGF			
GO:0042007	F:interleukin-18 binding; IDA:UniProtKB		0:IL18BP			
GO:0010224	P:response to UV-B; ISS:BHF-UCL		0:IL12A|0:RELA|0:IL12B|0:IVL|0:MSH2			
GO:0003084	P:positive regulation of systemic arterial bl...; IMP:BHF-UCL		0:ENG			
GO:0050290	F:sphingomyelin phosphodiesterase D activity; IDA:HGNC		0:SMPD4			
GO:0005006	F:epidermal growth factor receptor activity; NAS:UniProtKB		0:EGFR|0:ERBB2			
GO:0001732	P:formation of translation initiation complex; IDA:UniProtKB		0:EIF3A			
GO:0006800	P:oxygen and reactive oxygen species metaboli...; TAS:UniProtKB		0:ACE2|0:DRD5|0:BNIP3|0:NDUFS4|0:NDUFA13|0:NDUFS3|0:NDUFS1|0:EPHX2|0:MPV17|0:AGTR1|0:AGT|0:AOX1|0:SFTPD|0:ME3			
GO:0006875	P:cellular metal ion homeostasis; TAS:ProtInc		0:ASNA1|0:MTL5|0:MT3|0:CLDN16			
GO:0045732	P:positive regulation of protein catabolic pr...; NAS:UniProtKB		0:GSK3B|0:APC|0:AXIN1|0:NEDD4|0:EGLN2|0:WNT5A|0:GSK3A|0:BARD1			
GO:0040001	P:establishment of mitotic spindle localization; NAS:UniProtKB		0:NUSAP1|0:ESPL1			
GO:0032138	F:single base insertion or deletion binding; IDA:HGNC		0:PMS2			
GO:0030532	C:small nuclear ribonucleoprotein complex; TAS:UniProtKB		0:TGS1|0:SLU7|0:GEMIN4|0:RRP9|0:SF3A2|0:SF3B3|0:SNRPD1|0:SNRPD2|0:SNRPN|0:LSM6			
GO:0010572	P:positive regulation of platelet activation; ISS:BHF-UCL		0:SELP|0:TLR4|0:PLEK			
GO:0060347	P:heart trabecula formation; ISS:BHF-UCL		0:RBP4|0:TGFBR3|0:BMP10|0:FKBP1A			
GO:0045746	P:negative regulation of Notch signaling pathway; IDA:BHF-UCL		0:OVOL2			
GO:0040012	P:regulation of locomotion; IMP:BHF-UCL		0:LRRK2			
GO:0030285	C:integral to synaptic vesicle membrane; NAS:UniProtKB		0:GABRA2|0:SYP			
GO:0005248	F:voltage-gated sodium channel activity; TAS:ProtInc		0:SCN4B|0:SCN1A|0:SCN3A|0:SCN3B|0:SCN8A|0:SCN11A|0:SCN4A|0:SCN5A|0:SCN2A|0:SCN9A|0:SCN1B|0:SCN7A|0:SCN2B|0:PKD2			
GO:0006750	P:glutathione biosynthetic process; NAS:UniProtKB		0:HAGH|0:GCLM|0:GCLC|0:MGST2|0:GGT3P|0:GGT5|0:GGT1|0:GGT7|0:GGT6|0:GGTLC2|0:GGT2			
GO:0010756	P:positive regulation of plasminogen activation; IDA:BHF-UCL		0:F12			
GO:0046469	P:platelet activating factor metabolic process; ISS:BHF-UCL		0:PAFAH1B1			
